July 1, 2024 Title 40 Protection of Environment Parts 700 to 722 Revised as of July 1, 2024 Containing a codification of documents of general applicability and future effect As of July 1, 2024

Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register

 U.S. GOVERNMENT OFFICIAL EDITION NOTICE Legal Status and Use of Seals and Logos archives.ai

The seal of the National Archives and Records Administration (NARA) authenticates the Code of Federal Regulations (CFR) as the official codification of Federal regulations established under the Federal Register Act. Under the provisions of 44 U.S.C. 1507, the contents of the CFR, a special edition of the Federal Register, shall be judicially noticed. The CFR is prima facie evidence of the original documents published in the Federal Register (44 U.S.C. 1510).

It is prohibited to use NARA's official seal and the stylized Code of Federal Regulations logo on any republication of this material without the express, written permission of the Archivist of the United States or the Archivist's designee. Any person using NARA's official seals and logos in a manner inconsistent with the provisions of 36 CFR part 1200 is subject to the penalties specified in 18 U.S.C. 506, 701, and 1017.

Use of ISBN Prefix

This is the Official U.S. Government edition of this publication and is herein identified to certify its authenticity. Use of the 0-16 ISBN prefix is for U.S. Government Publishing Office Official Editions only. The Superintendent of Documents of the U.S. Government Publishing Office requests that any reprinted edition clearly be labeled as a copy of the authentic work with a new ISBN.

 gpologo2.eps

U . S . G O V E R N M E N T P U B L I S H I N G O F F I C E

U.S. Superintendent of Documents • Washington, DC 20402-0001

http://bookstore.gpo.gov

Phone: toll-free (866) 512-1800; DC area (202) 512-1800

 Table of Contents Page Explanation v Title 40: Chapter I—Environmental Protection Agency (Continued) 3 Finding Aids: Table of CFR Titles and Chapters 1277 Alphabetical List of Agencies Appearing in the CFR 1297 List of CFR Sections Affected 1307

Cite this Code:  CFR

To cite the regulations in this volume use title, part and section number. Thus, 40 CFR 700.17 refers to title 40, part 700, section 17. Explanation

The Code of Federal Regulations is a codification of the general and permanent rules published in the Federal Register by the Executive departments and agencies of the Federal Government. The Code is divided into 50 titles which represent broad areas subject to Federal regulation. Each title is divided into chapters which usually bear the name of the issuing agency. Each chapter is further subdivided into parts covering specific regulatory areas.

Each volume of the Code is revised at least once each calendar year and issued on a quarterly basis approximately as follows:

Title 1 through Title 16

as of January 1

Title 17 through Title 27

as of April 1

Title 28 through Title 41

as of July 1

Title 42 through Title 50

as of October 1

The appropriate revision date is printed on the cover of each volume.

LEGAL STATUS

The contents of the Federal Register are required to be judicially noticed (44 U.S.C. 1507). The Code of Federal Regulations is prima facie evidence of the text of the original documents (44 U.S.C. 1510).

 HOW TO USE THE CODE OF FEDERAL REGULATIONS

The Code of Federal Regulations is kept up to date by the individual issues of the Federal Register. These two publications must be used together to determine the latest version of any given rule.

To determine whether a Code volume has been amended since its revision date (in this case, July 1, 2024), consult the “List of CFR Sections Affected (LSA),” which is issued monthly, and the “Cumulative List of Parts Affected,” which appears in the Reader Aids section of the daily Federal Register. These two lists will identify the Federal Register page number of the latest amendment of any given rule.

 EFFECTIVE AND EXPIRATION DATES

Each volume of the Code contains amendments published in the Federal Register since the last revision of that volume of the Code. Source citations for the regulations are referred to by volume number and page number of the Federal Register and date of publication. Publication dates and effective dates are usually not the same and care must be exercised by the user in determining the actual effective date. In instances where the effective date is beyond the cut-off date for the Code a note has been inserted to reflect the future effective date. In those instances where a regulation published in the Federal Register states a date certain for expiration, an appropriate note will be inserted following the text.

 OMB CONTROL NUMBERS

The Paperwork Reduction Act of 1980 (Pub. L. 96-511) requires Federal agencies to display an OMB control number with their information collection request. Many agencies have begun publishing numerous OMB control numbers as amendments to existing regulations in the CFR. These OMB numbers are placed as close as possible to the applicable recordkeeping or reporting requirements.

PAST PROVISIONS OF THE CODE

Provisions of the Code that are no longer in force and effect as of the revision date stated on the cover of each volume are not carried. Code users may find the text of provisions in effect on any given date in the past by using the appropriate List of CFR Sections Affected (LSA). For the convenience of the reader, a “List of CFR Sections Affected” is published at the end of each CFR volume. For changes to the Code prior to the LSA listings at the end of the volume, consult previous annual editions of the LSA. For changes to the Code prior to 2001, consult the List of CFR Sections Affected compilations, published for 1949-1963, 1964-1972, 1973-1985, and 1986-2000.

 “[RESERVED]” TERMINOLOGY

The term “[Reserved]” is used as a place holder within the Code of Federal Regulations. An agency may add regulatory information at a “[Reserved]” location at any time. Occasionally “[Reserved]” is used editorially to indicate that a portion of the CFR was left vacant and not dropped in error.

 INCORPORATION BY REFERENCE

What is incorporation by reference? Incorporation by reference was established by statute and allows Federal agencies to meet the requirement to publish regulations in the Federal Register by referring to materials already published elsewhere. For an incorporation to be valid, the Director of the Federal Register must approve it. The legal effect of incorporation by reference is that the material is treated as if it were published in full in the Federal Register (5 U.S.C. 552(a)). This material, like any other properly issued regulation, has the force of law.

What is a proper incorporation by reference? The Director of the Federal Register will approve an incorporation by reference only when the requirements of 1 CFR part 51 are met. Some of the elements on which approval is based are:

(a) The incorporation will substantially reduce the volume of material published in the Federal Register.

(b) The matter incorporated is in fact available to the extent necessary to afford fairness and uniformity in the administrative process.

(c) The incorporating document is drafted and submitted for publication in accordance with 1 CFR part 51.

What if the material incorporated by reference cannot be found? If you have any problem locating or obtaining a copy of material listed as an approved incorporation by reference, please contact the agency that issued the regulation containing that incorporation. If, after contacting the agency, you find the material is not available, please notify the Director of the Federal Register, National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740-6001, or call 202-741-6010.

CFR INDEXES AND TABULAR GUIDES

A subject index to the Code of Federal Regulations is contained in a separate volume, revised annually as of January 1, entitled CFR Index and Finding Aids. This volume contains the Parallel Table of Authorities and Rules. A list of CFR titles, chapters, subchapters, and parts and an alphabetical list of agencies publishing in the CFR are also included in this volume.

An index to the text of “Title 3—The President” is carried within that volume.

The Federal Register Index is issued monthly in cumulative form. This index is based on a consolidation of the “Contents” entries in the daily Federal Register.

A List of CFR Sections Affected (LSA) is published monthly, keyed to the revision dates of the 50 CFR titles.

 REPUBLICATION OF MATERIAL

There are no restrictions on the republication of material appearing in the Code of Federal Regulations.

 INQUIRIES

For a legal interpretation or explanation of any regulation in this volume, contact the issuing agency. The issuing agency's name appears at the top of odd-numbered pages.

For inquiries concerning CFR reference assistance, call 202-741-6000 or write to the Director, Office of the Federal Register, National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740-6001 or e-mail fedreg.info@nara.gov.

SALES

The Government Publishing Office (GPO) processes all sales and distribution of the CFR. For payment by credit card, call toll-free, 866-512-1800, or DC area, 202-512-1800, M-F 8 a.m. to 4 p.m. e.s.t. or fax your order to 202-512-2104, 24 hours a day. For payment by check, write to: U.S. Government Publishing Office Superintendent of Documents, P.O. Box 37082, Washington, DC 20013-7082.

 ELECTRONIC SERVICES

The full text of the Code of Federal Regulations, the LSA (List of CFR Sections Affected), The United States Government Manual, the Federal Register, Public Laws, Compilation of Presidential Documents and the Privacy Act Compilation are available in electronic format via www.govinfo.gov. For more information, contact the GPO Customer Contact Center, U.S. Government Publishing Office. Phone 202-512-1800, or 866-512-1800 (toll-free). E-mail, ContactCenter@gpo.gov.

The Office of the Federal Register also offers a free service on the National Archives and Records Administration's (NARA) website for public law numbers, Federal Register finding aids, and related information. Connect to NARA's website at www.archives.gov/federal-register.

The eCFR is a regularly updated, unofficial editorial compilation of CFR material and Federal Register amendments, produced by the Office of the Federal Register and the Government Publishing Office. It is available at www.ecfr.gov.

Oliver A. Potts,

Director,

Office of the Federal Register

July 1, 2024

        THIS TITLE

Title 40— Protection of Environment is composed of thirty-seven volumes. The parts in these volumes are arranged in the following order: Parts 1-49, parts 50-51, part 52 (52.01-52.1018), part 52 (52.1019-52.2019), part 52 (52.2020-end of part 52), parts 53-59, part 60 (60.1-60.499), part 60 (60.500-end of part 60, sections), part 60 (Appendices), parts 61-62, part 63 (63.1-63.599), part 63 (63.600-63.1199), part 63 (63.1200-63.1439), part 63 (63.1440-63.6175), part 63 (63.6580-63.8830), part 63 (63.8980-end of part 63), parts 64-71, parts 72-78, parts 79-80, part 81, parts 82-84, parts 85-96, parts 97-99, parts 100-135, parts 136-149, parts 150-189, parts 190-259, parts 260-265, parts 266-299, parts 300-399, parts 400-424, parts 425-699, parts 700-722, parts 723-789, parts 790-999, parts 1000-1059, and part 1060 to end. The contents of these volumes represent all current regulations codified under this title of the CFR as of July 1, 2024.

Chapter I—Environmental Protection Agency appears in all thirty-seven volumes. OMB control numbers for title 40 appear in § 9.1 of this chapter.

Chapters IV-IX—Regulations issued by the Environmental Protection Agency and Department of Justice, Council on Environmental Quality, Chemical Safety and Hazard Investigation Board, Environmental Protection Agency and Department of Defense; Uniform National Discharge Standards for Vessels of the Armed Forces, Gulf Coast Ecosystem Restoration Council, and the Federal Permitting Improvement Steering Council appear in volume thirty-seven.

For this volume, Christine Colaninno was Chief Editor. The Code of Federal Regulations publication program is under the direction of John Hyrum Martinez, assisted by Stephen J. Frattini.

 <LRH>40 CFR Ch. I (7-1-24 Edition)</LRH> <RRH>Environmental Protection Agency</RRH> <CFRTITLE> <TITLEHD> <PRTPAGE P="1"/> <HD SOURCE="HED">Title 40—Protection of Environment</HD> <P>(This book contains parts 700 to 722)</P> </TITLEHD> <CFRTOC> <PTHD>Part</PTHD> <CHAPTI> <SUBJECT> <E T="04">chapter i</E> —Environmental Protection Agency (Continued) </SUBJECT> <PG>700</PG> </CHAPTI> </CFRTOC> </CFRTITLE> <CHAPTER> <TOC> <TOCHD> <PRTPAGE P="3"/> <HD SOURCE="HED">CHAPTER I—ENVIRONMENTAL PROTECTION AGENCY (CONTINUED)</HD> </TOCHD> <EDNOTE> <HD SOURCE="HED">Editorial Note:</HD> <P>Nomenclature changes to chapter I appear at 65 FR 47324, 47325, Aug. 2, 2000; 66 FR 34375, 34376, June 28, 2001.</P> </EDNOTE> <SUBCHAP> <HD SOURCE="HED">SUBCHAPTER R—TOXIC SUBSTANCES CONTROL ACT</HD> </SUBCHAP> <PTHD>Part</PTHD> <PGHD>Page</PGHD> <CHAPTI> <PT>700</PT> <SUBJECT>General</SUBJECT> <PG>5</PG> <PT>702</PT> <SUBJECT>General practices and procedures</SUBJECT> <PG>20</PG> <PT>703</PT> <SUBJECT>Confidentiality claims</SUBJECT> <PG>42</PG> <PT>704</PT> <SUBJECT>Reporting and recordkeeping requirements</SUBJECT> <PG>51</PG> <PT>705</PT> <SUBJECT>Reporting and recordkeeping requirements for certain per- and polyfluoroalkyl substances</SUBJECT> <PG>80</PG> <PT>707</PT> <SUBJECT>Chemical imports and exports</SUBJECT> <PG>100</PG> <PT>710</PT> <SUBJECT>Compilation of the TSCA chemical substance inventory</SUBJECT> <PG>105</PG> <PT>711</PT> <SUBJECT>TSCA chemical data reporting requirements</SUBJECT> <PG>119</PG> <PT>712</PT> <SUBJECT>Chemical information rules</SUBJECT> <PG>151</PG> <PT>713</PT> <SUBJECT>Reporting requirements for the TSCA inventory of mercury supply, use, and trade</SUBJECT> <PG>173</PG> <PT>716</PT> <SUBJECT>Health and safety data reporting</SUBJECT> <PG>179</PG> <PT>717</PT> <SUBJECT>Records and reports of allegations that chemical substances cause significant adverse reactions to health or the environment</SUBJECT> <PG>218</PG> <PT>720</PT> <SUBJECT>Premanufacture notification</SUBJECT> <PG>223</PG> <PT>721</PT> <SUBJECT>Significant new uses of chemical substances</SUBJECT> <PG>245</PG> <PT>722</PT> <RESERVED>[Reserved]</RESERVED> </CHAPTI> </TOC> <SUBCHAP TYPE="N"> <PRTPAGE P="5"/> <HD SOURCE="HED">SUBCHAPTER R—TOXIC SUBSTANCES CONTROL ACT</HD> <PART> <EAR>Pt. 700</EAR> <HD SOURCE="HED">PART 700—GENERAL</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—Addresses</HD> <SECHD>Sec.</SECHD> <SECTNO>700.17</SECTNO> <SUBJECT>Addresses for the Office of Pollution Prevention and Toxics.</SUBJECT> </SUBPART> <SUBPART> <RESERVED>Subpart B [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Fees</HD> <SECTNO>700.40</SECTNO> <SUBJECT>Purpose and applicability.</SUBJECT> <SECTNO>700.41</SECTNO> <SUBJECT>Radon user fees.</SUBJECT> <SECTNO>700.43</SECTNO> <SUBJECT>Definitions applicable to this subpart.</SUBJECT> <SECTNO>700.45</SECTNO> <SUBJECT>Fee payments.</SUBJECT> <SECTNO>700.49</SECTNO> <SUBJECT>Failure to remit fees.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2625 and 2665, 44 U.S.C. 3504.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>53 FR 31252, Aug. 17, 1988, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—Addresses</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>77 FR 46292, Aug. 3, 2012, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 700.17</SECTNO> <SUBJECT>Addresses for the Office of Pollution Prevention and Toxics.</SUBJECT> <P>The official addresses, unless otherwise noted, are as follows:</P> <P> (a) <E T="03">Correspondence and non-docket materials</E> —(1) <E T="03">United States Postal Service mailing address.</E> Office of Pollution Prevention and Toxics (7401M), Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001. </P> <P> (2) <E T="03">Hand/courier delivery address.</E> Office of Pollution Prevention and Toxics, Environmental Protection Agency, EPA East Bldg., 1201 Constitution Ave. NW., Washington, DC 20004. This is not a mailing address. You must make arrangements with the person receiving your delivery. </P> <P> (b) <E T="03">Office of Pollution Prevention and Toxics Docket (OPPT Docket)</E> —(1) <E T="03">Electronic docket address.</E> Publicly available docket materials are available in the electronic docket at <E T="03">http://www.regulations.gov.</E> Although listed in the docket index at regulations.gov, some information is not publicly available, e.g., Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, will be publicly available only at the OPPT Docket. </P> <P> (2) <E T="03">Physical location.</E> Environmental Protection Agency Docket Center (EPA/DC), Environmental Protection Agency, EPA West Bldg., Rm. 3334, 1301 Constitution Ave. NW., Washington, DC 20460-0001. The telephone number for the OPPT Docket is (202) 566-0280. This is not a mailing address. For instructions on visiting the docket, go to <E T="03">http://www.epa.gov/dockets/contacts.htm.</E> </P> <P> (3) <E T="03">United States Postal Service mailing address.</E> Document Control Office (7407M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001. </P> <P> (4) <E T="03">Hand/courier delivery address.</E> Document Control Office, Office of Pollution Prevention and Toxics, Environmental Protection Agency, EPA East Bldg., Rm. 6428, 1201 Constitution Ave. NW., Washington, DC. Deliveries are only accepted between 8:30 a.m. and 4 p.m., and special arrangements should be made for deliveries of boxed information. The telephone number for the Document Control Office is (202) 564-8930. </P> </SECTION> </SUBPART> <SUBPART> <RESERVED>Subpart B [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Fees</HD> <SECTION> <SECTNO>§ 700.40</SECTNO> <SUBJECT>Purpose and applicability.</SUBJECT> <P> (a) <E T="03">Purpose.</E> The purpose of this subpart is to establish and collect fees from manufacturers and processors to defray part of EPA's cost of administering the Toxic Substances Control Act (15 U.S.C. 2601-2692), as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Pub. L. 114-182). </P> <P> (b) <E T="03">Applicability.</E> This subpart applies to all manufacturers who are required to submit information under section 4 of the Act, who submit certain notices and exemption requests to EPA under section 5 of the Act, who manufacture a chemical substance that is subject to a risk evaluation under TSCA section 6(b)(4) of the Act, and who process a <PRTPAGE P="6"/> chemical substance that is the subject of a Significant New Use Notice (SNUN) or Test Market Exemption (TME) under section 5 of the Act and who are required to submit information under section 4 of the Act related to a SNUN submission. </P> <P> (c) <E T="03">Effective date.</E> After October 18, 2018, all persons specified in § 700.45 and paragraph (a) of this section must comply with this subpart. </P> <CITA>[83 FR 52713, Oct. 17, 2018]</CITA> </SECTION> <SECTION> <SECTNO>§ 700.41</SECTNO> <SUBJECT>Radon user fees.</SUBJECT> <P>User fees relating to radon proficiency programs authorized under the Toxic Substances Control Act appear at 40 CFR part 195.</P> <CITA>[59 FR 13177, Mar. 18, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 700.43</SECTNO> <SUBJECT>Definitions applicable to this subpart.</SUBJECT> <P>Definitions in section 3 of the Act (15 U.S.C. 2602), as well as definitions contained in §§ 704.3, 720.3, 723.175(b), 725.3, and 790.3 of this chapter, apply to this subpart unless otherwise specified in this section. In addition, the following definitions apply:</P> <P> <E T="03">Consolidated microbial commercial activity notice</E> or <E T="03">consolidated MCAN</E> means any MCAN submitted to EPA that covers more than one microorganism (each being assigned a separate MCAN number by EPA) as a result of a prenotice agreement with EPA. </P> <P> <E T="03">Consolidated premanufacture notice</E> or <E T="03">consolidated PMN</E> means any PMN submitted to EPA that covers more than one chemical substance (each being assigned a separate PMN number by EPA) as a result of a prenotice agreement with EPA ( <E T="03">See</E> 48 FR 21734). </P> <P> <E T="03">Consortium</E> means an association of manufacturers and/or processors who have made an agreement to jointly split the cost of applicable fees. </P> <P> <E T="03">Enforceable consent agreement</E> means a consent agreement used by EPA to accomplish testing where a consensus exists among EPA and interested parties (as identified in § 790.22(b)(2)) concerning the need for and scope of testing under section 4 of the Act. </P> <P> <E T="03">EPA-initiated risk evaluation</E> means any risk evaluation conducted pursuant to section 6(b)(4)(C)(i) of the Act. </P> <P> <E T="03">Exemption notice</E> means any notice submitted to EPA under § 723.175 of this chapter. </P> <P> <E T="03">Final product</E> means a new chemical substance (as “new chemical substance” is defined in § 720.3 of this chapter) that is manufactured by a person for distribution in commerce, or for use by the person other than as an intermediate. </P> <P> <E T="03">Joint submitters</E> mean two or more persons who submit a TSCA section 5 notice together. </P> <P> <E T="03">Manufacturer-requested risk evaluation</E> means any chemical substance risk evaluation conducted at the request of one or more manufacturers of that chemical substance pursuant to section 6(b)(4)(C)(ii) of the Act. </P> <P> <E T="03">Microbial commercial activity notice</E> or <E T="03">MCAN</E> means any notice for microorganisms submitted to EPA pursuant to section 5(a)(1) of the Act in accordance with subpart D of part 725 of this chapter. </P> <P> <E T="03">Person</E> means a manufacturer or processor. </P> <P> <E T="03">Premanufacture notice</E> or <E T="03">PMN</E> means any notice submitted to EPA pursuant to section 5(a)(1)(A) of the Act in accordance with part 720 of this chapter or § 723.250 of this chapter. </P> <P> <E T="03">Principal sponsor</E> means a person who assumes primary responsibility for the direction of study, the payment of fees to EPA, and for oral and written communication with EPA. </P> <P> <E T="03">Production volume</E> means manufactured (including imported) amount in pounds. </P> <P> <E T="03">Risk evaluation</E> means any risk evaluation conducted pursuant to section 6(b) of the Act. </P> <P> <E T="03">Section 5 notice</E> means any PMN, consolidated PMN, intermediate PMN, significant new use notice, exemption notice, exemption application, any MCAN or consolidated MCAN submitted under section 5 of the Act. </P> <P> <E T="03">Significant new use notice</E> or <E T="03">SNUN</E> means any notice submitted to EPA pursuant to section 5(a)(1)(B) of the Act in accordance with part 721 of this chapter. </P> <P> <E T="03">Small business concern</E> means a manufacturer or processor who meets the size standards identified in the following table. The number of employees indicates the maximum allowed for a <PRTPAGE P="7"/> manufacturer or processor to be considered small. If the North American Industry Classification System (NAICS) code of a manufacturer or processor is not represented in the table, it will be considered small if it has 500 or fewer employees. When calculating the number of employees, a manufacturer or processor must include the employees of all of its “parent companies” (if any) and all companies it “owns or controls,” as defined by 40 CFR 704.3. The number of employees are calculated as the average number of people employed for each pay period of the business' latest 12 calendar months, regardless of hours worked or temporary status. </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="xs72,r100,xs90"> <BOXHD> <CHED H="1">Potentially affected NAICS</CHED> <CHED H="1">NAICS description</CHED> <CHED H="1"> Small business concern size standards <LI>(number of employees)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">324110</ENT> <ENT>Petroleum Refineries</ENT> <ENT>1,500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325110</ENT> <ENT>Petrochemical Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325120</ENT> <ENT>Industrial Gas Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325130</ENT> <ENT>Synthetic Dye and Pigment Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325180</ENT> <ENT>Other Basic Inorganic Chemical Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325193</ENT> <ENT>Ethyl Alcohol Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325194</ENT> <ENT>Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325199</ENT> <ENT>All Other Basic Organic Chemical Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325211</ENT> <ENT>Plastics Material and Resin Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325212</ENT> <ENT>Synthetic Rubber Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325220</ENT> <ENT>Artificial and Synthetic Fibers and Filaments Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325311</ENT> <ENT>Nitrogenous Fertilizer Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325312</ENT> <ENT>Phosphatic Fertilizer Manufacturing</ENT> <ENT>750 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325314</ENT> <ENT>Fertilizer (Mixing Only) Manufacturing</ENT> <ENT>500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325320</ENT> <ENT>Pesticide and Other Agricultural Chemical Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325411</ENT> <ENT>Medicinal and Botanical Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325412</ENT> <ENT>Pharmaceutical Preparation Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325413</ENT> <ENT>InVitro Diagnostic Substance Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325414</ENT> <ENT>Biological Product (except Diagnostic) Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325510</ENT> <ENT>Paint and Coating Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325520</ENT> <ENT>Adhesive Manufacturing</ENT> <ENT>500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325611</ENT> <ENT>Soap and Other Detergent Manufacturing</ENT> <ENT>1,000 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325612</ENT> <ENT>Polish and Other Sanitation Good Manufacturing</ENT> <ENT>750 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325613</ENT> <ENT>Surface Active Agent Manufacturing</ENT> <ENT>750 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325620</ENT> <ENT>Toilet Preparation Manufacturing</ENT> <ENT>1,250 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325910</ENT> <ENT>Printing Ink Manufacturing</ENT> <ENT>500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325920</ENT> <ENT>Explosives Manufacturing</ENT> <ENT>750 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325991</ENT> <ENT>Custom Compounding of Purchased Resins</ENT> <ENT>500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325992</ENT> <ENT>Photographic Film, Paper, Plate and Chemical Manufacturing</ENT> <ENT>1,500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">325998</ENT> <ENT>All Other Miscellaneous Chemical Product and Preparation Manufacturing</ENT> <ENT>500 or fewer.</ENT> </ROW> <ROW> <ENT I="01">424690</ENT> <ENT>Other Chemical and Allied Products Merchant Wholesalers</ENT> <ENT>150 or fewer.</ENT> </ROW> <ROW> <ENT I="01">424710</ENT> <ENT>Petroleum Bulk Stations and Terminals</ENT> <ENT>200 or fewer.</ENT> </ROW> <ROW> <ENT I="01">424720</ENT> <ENT>Petroleum and Petroleum Products Merchant Wholesalers (except Bulk Stations and Terminals)</ENT> <ENT>200 or fewer.</ENT> </ROW> </GPOTABLE> <P> <E T="03">Small quantities solely for research and development</E> (or “small quantities solely for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including such research or analysis for the development of a product”) means quantities of a chemical substance manufactured (including imported), or processed or proposed to be manufactured (including imported), or processed solely for research and development that are not greater than reasonably necessary for such purposes. </P> <P> <E T="03">Test order</E> means an order to develop information pursuant to section 4(a) of the Act. </P> <P> <E T="03">Test rule</E> refers to a regulation requiring the development of information pursuant to section 4(a) of the Act. </P> <CITA>[53 FR 31252, Aug. 17, 1988, as amended at 62 FR 17931, Apr. 11, 1997; 83 FR 52713, Oct. 17, 2018; 89 FR 12974, Feb. 21, 2024]</CITA> </SECTION> <SECTION> <SECTNO>§ 700.45</SECTNO> <SUBJECT>Fee payments.</SUBJECT> <P> (a) <E T="03">Persons who must pay fees.</E> (1) Manufacturers submitting a TSCA section 5 notice to EPA shall remit for each such notice the applicable fee identified in <PRTPAGE P="8"/> paragraph (c) of this section in accordance with the procedures in paragraphs (f) and (g) of this section. </P> <P>(2) Manufacturers and processors of chemical substances and mixtures required to submit information for these chemical substances and mixtures under a TSCA section 4(a) test order or enforceable consent agreement, or manufacturers of chemical substances and mixtures required to submit information for these chemical substance and mixtures under a TSCA section 4(a) test rule, shall remit for each such test rule, order, or enforceable consent agreement the applicable fee identified in paragraph (c) of this section in accordance with the procedures in paragraphs (f) and (g) of this section. Manufacturers of a chemical substance subject to a test rule under TSCA section 4(a) are exempted from fee payment requirements in this section, if they meet one or more of the exemptions under this paragraphs (a)(2)(i) through (v) of this section on or after the certification cutoff date identified in paragraph (b)(6) of this section and do not conduct manufacturing outside of those exemptions after the certification cutoff dates or if they meet the exemptions under paragraph (a)(2)(vi) of this section for the five-year period preceding publication of the preliminary list and do not conduct manufacturing outside of that exemption during the five-year period preceding publication of the preliminary list; and the exemptions are only available if the manufacturer will meet one or more of the exemptions in this paragraph (a)(2)(i) through (vi) in the successive five years; and will not conduct manufacturing outside of the exemptions in paragraphs (a)(2)(i) through (v) of this section in the successive five years or will meet the exemption in paragraph (a)(2)(vi) of this section in the successive five years:</P> <P>(i) Import articles containing that chemical substance;</P> <P>(ii) Produce that chemical substance as a byproduct that is not later used for commercial purposes or distributed for commercial use;</P> <P>(iii) Manufacture that chemical substance as an impurity as defined in 40 CFR 704.3;</P> <P>(iv) Manufacture that chemical substance as a non-isolated intermediate as defined in 40 CFR 704.3;</P> <P>(v) Manufacture small quantities of that chemical substance solely for research and development, as defined in 40 CFR 700.43; or</P> <P>(vi) Manufacture that chemical substance in quantities below a 1,100 lbs annual production volume as described in § 700.43, unless all manufacturers of that chemical substance manufacture that chemical in quantities below a 1,100 lbs annual production volume as defined in § 700.43, in which case this exemption is not applicable.</P> <P>(3) Manufacturers of a chemical substance that is subject to a risk evaluation under section 6(b) of the Act, shall remit for each such chemical risk evaluation the applicable fee identified in paragraph (c) of this section in accordance with the procedures in paragraphs (f) and (g) of this section. Manufacturers of a chemical substance subject to risk evaluation under section 6(b) of the Act are exempted from fee payment requirements in this section, if they meet one or more of the exemptions under paragraphs (a)(3)(i) through (v) of this section on or after the certification cutoff date identified in paragraph (b)(6)(i) of this section and do not conduct manufacturing outside of those exemptions after the certification cutoff dates or if they meet the exemptions under paragraph (a)(3)(vi) of this section for the five-year period preceding publication of the preliminary list and do not conduct manufacturing outside of that exemption during the five-year period preceding publication of the preliminary list; and the exemptions are only available if the manufacturer will meet one or more of the exemptions in paragraphs (a)(3)(i) through (vi) of this section in the successive five years and will not conduct manufacturing outside of the exemptions in paragraphs (a)(3)(i) through (v) of this section in the successive five years or will meet the exemption in paragraph (a)(3)(vi) of this section in the successive five years:</P> <P>(i) Import articles containing that chemical substance;</P> <P> (ii) Produce that chemical substance as a byproduct that is not later used <PRTPAGE P="9"/> for commercial purposes or distributed for commercial use; </P> <P>(iii) Manufacture that chemical substance as an impurity as defined in 40 CFR 704.3;</P> <P>(iv) Manufacture that chemical substance as a non-isolated intermediate as defined in 40 CFR 704.3;</P> <P>(v) Manufacture small quantities of that chemical substance solely for research and development, as defined in § 700.43; or</P> <P>(vi) manufacture that chemical substance in quantities below a 2,500 lbs annual production volume as described in § 700.43, unless all manufacturers of that chemical substance manufacture that chemical in quantities below a 2,500 lbs annual production volume as defined in § 700.43, in which case this exemption is not applicable.</P> <P>(4) Processors submitting a SNUN or TME under TSCA section 5 to EPA shall remit for each such notice the applicable fee identified in paragraph (c) of this section in accordance with the procedures in paragraphs (f) and (g) of this section.</P> <P>(5) Processors of chemical substances and mixtures subject to a TSCA section 4(a) test rule, test order, or enforceable consent agreement in association with a SNUN submission referenced in paragraph (a)(4) of this section shall remit for each such test rule, order, or enforceable consent agreement the applicable fee identified in paragraph (c) of this section in accordance with the procedures in paragraphs (f) and (g) of this section.</P> <P> (b) <E T="03">Identifying manufacturers subject to fees</E> —(1) <E T="03">In general.</E> For purposes of identifying manufacturers subject to fees for section 4 test rules and section 6 EPA-initiated risk evaluations, EPA will publish a preliminary list of manufacturers identified through a review of data sources described in paragraph (b)(2) of this subsection; provide an opportunity for public comment; and publish a final list specifying the manufacturers responsible for payment. </P> <P> (2) <E T="03">Data sources.</E> To compile the preliminary list, EPA will rely on information submitted to the Agency (such as the information submitted under sections 5(a), 8(a), 8(b), and to the Toxics Release Inventory) as well as other information available to the Agency, including publicly available information or information submitted to other agencies to which EPA has access. To be able to include the most recent CDR data and to account for annual or other typical fluctuations in manufacturing, EPA will use the five most recent years of data submitted or available to the Agency to develop the preliminary list. </P> <P> (3) <E T="03">Publication of preliminary list.</E> (i) For risk evaluations initiated by EPA under section 6, the preliminary list will be published at the time of final designation of the chemical substance as a High-Priority Substance. </P> <P>(ii) For test rules under section 4, the preliminary list will be published with the proposed test rule.</P> <P> (4) <E T="03">Public comment period.</E> Following publication of the preliminary list, EPA will provide a period of public comment that is no less than 30 days. </P> <P> (5) <E T="03">Self-identification.</E> All manufacturers other than those listed in paragraphs (a)(2)(i) through (iii) and (a)(3)(i) through (iii) of this section who have manufactured (including imported) the chemical substance in the previous five years must submit notice to EPA, irrespective of whether they are included in the preliminary list specified in paragraph (b)(3) of this section. The notice must be submitted electronically via EPA's Central Data Exchange (CDX), the Agency's electronic reporting portal, using the Chemical Information Submission System (CISS) reporting tool, and must contain the following information: </P> <P> (i) <E T="03">Contact information.</E> The name and address of the submitting company, the name and address of the authorized official for the submitting company, and the name and telephone number of a person who will serve as technical contact for the submitting company and who will be able to answer questions about the information submitted by the company to EPA. </P> <P> (ii) <E T="03">Certification of cessation.</E> If a manufacturer has manufactured in the five-year period preceding publication of the preliminary list but has ceased manufacture prior to the certification cutoff dates identified in paragraph (b)(6) of this section and will not manufacture the substance again in the successive five years, the manufacturer <PRTPAGE P="10"/> may submit a certification statement attesting to these facts. If EPA receives such a certification statement from a manufacturer, the manufacturer will not be included in the final list of manufacturers described in paragraph (b)(7) of this section and will not be obligated to pay the fee under this section. </P> <P> (iii) <E T="03">Certification of no manufacture.</E> If a manufacturer is identified on the preliminary list but has not manufactured the chemical in the five-year period preceding publication of the preliminary list, the manufacturer may submit a certification statement attesting to these facts. If EPA receives such a certification statement from a manufacturer, the manufacturer will not be included in the final list of manufacturers described in paragraph (b)(7) of this section and will not be obligated to pay the fee under this section. </P> <P> (iv) <E T="03">Certification of meeting exemption.</E> If a manufacturer is identified on the preliminary list and exclusively meets one or more of the exemptions as described in paragraph (a)(2) or (a)(3) of this section, the manufacturer must submit a certification statement attesting to these facts in order to not be included in the final list of manufacturers described in paragraph (b)(7) of this section. If a manufacturer is not on a preliminary list and exclusively meets one or more of the exemptions as described in paragraph (a)(2) or (a)(3) of this section, the manufacturer may submit a certification statement attesting to these facts. If EPA receives such a certification statement from a manufacturer, the manufacturer will not be included in the final list of manufacturers described in paragraph (b)(7) of this section and will not be obligated to pay the fee under this section, unless all manufacturers of that chemical substance meet the exemption as described in (a)(2)(vi) or (a)(3)(vi) of this section. </P> <P> (v) <E T="03">Production volume.</E> If a manufacturer has not submitted certification of cessation, as described in paragraph (b)(5)(ii) of this section, or certification of no manufacture, as described in paragraph (b)(5)(iii) of this section, for purposes of identifying manufacturers subject to fees for TSCA section 6 EPA-initiated risk evaluations and does not meet one or more of the exemptions in paragraph (a)(3)(i) through (v) of this section, the manufacturer must submit their production volume as defined in 40 CFR 700.43 for the applicable substance for the three calendar years prior to publication of the preliminary list. Only production volume reported to EPA prior to the final list being published will be used in determining fees described in § 700.45(f). </P> <P> (6) <E T="03">Certification cutoff date.</E> (i) For a section 6 EPA-initiated risk evaluation, the cutoff date for purposes of paragraph (b)(5)(ii) of this section is the day prior to initiation of the prioritization process for the applicable chemical substance. </P> <P>(ii) For a section 4 test rule, the cutoff date for purposes of paragraph (b)(5)(ii) of this section is the day prior to publication of the proposed test rule for the applicable chemical substance.</P> <P> (7) <E T="03">Publication of final list.</E> EPA expects to publish a final list of manufacturers to identify the specific manufacturers subject to the applicable fee. This list will indicate if additional manufacturers self-identified pursuant to paragraph (b)(5) of this section, if other manufacturers were identified through credible public comment, and if manufacturers submitted certification of cessation, no manufacture, or meeting exemption pursuant to paragraph (b)(5)(ii), (iii), or (iv) of this section. The final list will be published no later than concurrently with the final scope document for risk evaluations initiated by EPA under TSCA section 6, and with the final test rule for test rules under TSCA section 4. EPA may modify the list after the publication of the final list. </P> <P> (8) <E T="03">Effect of final list.</E> Manufacturers who are listed on the final list are subject to the applicable fee identified in paragraph (c) of this section. </P> <P> (9) <E T="03">Identifying manufacturers for other fee categories.</E> For Section 4 Test Orders and enforceable consent agreements, and Section 6 Manufacturer-Requested Risk Evaluations, EPA will not conduct the identification process described in paragraphs (b)(1) through (8) of this section, as manufacturers self-identify through a submission or are already otherwise known to Agency. <PRTPAGE P="11"/> However, those manufacturers are required to provide an information submission to EPA for the purposes of fee administration. The notice must be submitted electronically via the Agency's electronic reporting software ( <E T="03">e.g.,</E> Central Data Exchange (CDX)) and must contain the manufacturers: Full name, address, telephone number and email address. Timing of this submission must be as follows: </P> <P>(i) For section 4 test orders and enforceable consent agreements, the informational submission in this paragraph (b)(9) must be provided within 30 days following notification from EPA.</P> <P>(ii) For section 6 manufacturer-requested risk evaluations, the informational submission in this paragraph (b)(9) is required as part of the procedural process for making such requests, and must be completed at the time of making the request.</P> <P> (10) <E T="03">Recordkeeping.</E> After April 22, 2024: </P> <P>(i) All manufacturers other than those listed in paragraph (a)(2)(i) through (v) or (a)(3)(i) through (v) of this section must maintain production volume records related to compliance with paragraph (b)(5)(v) of this section. These records must be maintained for a period of five years from the date notice is submitted pursuant to paragraph (b)(5) of this section.</P> <P>(ii) Those manufacturers that are exempt from fee payment requirements pursuant to paragraph (a)(2)(iv) or (a)(3)(iv) of this section must maintain manufacturing and other business records related to compliance with the exemption criteria described in paragraph (a)(2)(iv) or (a)(3)(iv) of this section, respectively. These records must be maintained for a period of five years from the date the notice is submitted pursuant to paragraph (b)(5) of this section.</P> <P>(iii) Those manufacturers that are exempt from fee payment requirements pursuant to paragraph (a)(2)(v) or (a)(3)(v) of this section must maintain manufacturing and other business records related to compliance with the exemption criteria described in paragraph (a)(2)(v) or (a)(3)(v) of this section, respectively, such as production volume, plans of study, information from research and development notebooks, study reports, or notice solely for research and development use. These records must be maintained for a period of five years from the date the notice is submitted pursuant to paragraph (b)(5) of this section.</P> <P>(iv) Those manufacturers that are exempt from fee payment requirements pursuant to paragraph (a)(2)(vi) or (a)(3)(vi) of this section must maintain production volume records related to compliance with the exemption criteria described in paragraph (a)(2)(vi) or (a)(3)(vi) of this section, respectively. These records must be maintained for a period of five years from the date the notice is submitted pursuant to paragraph (b)(5) of this section.</P> <P>(c) Fees for the 2024, 2025, and 2026 fiscal years. Persons shall remit fee payments to EPA as follows:</P> <P> (1) <E T="03">Small business concerns.</E> Small business concerns shall remit fees as follows: </P> <P> (i) <E T="03">Premanufacture notice and consolidated premanufacture notice.</E> Persons shall remit a fee totaling $6,480 for each premanufacture notice (PMN) or consolidated PMN submitted in accordance with part 720 of this chapter. </P> <P> (ii) <E T="03">Significant new use notice.</E> Persons shall remit a fee totaling $6,480 for each significant new use notice (SNUN) submitted in accordance with part 721 of this chapter. </P> <P> (iii) <E T="03">Exemption application.</E> Persons shall remit a fee totaling $2,180 for each of the following exemption requests submitted under TSCA section 5: </P> <P> (A) <E T="03">Low releases and low exposures exemption</E> or <E T="03">LoREX</E> request submitted to EPA pursuant to section 5(a)(1) of the Act in accordance with § 723.50(a)(1)(ii) of this chapter. </P> <P> (B) <E T="03">Low volume exemption</E> or <E T="03">LVE</E> request submitted to EPA pursuant to section 5(a)(1) of the Act in accordance with § 723.50(a)(1)(i) of this chapter. </P> <P> (C) <E T="03">Test marketing exemption</E> or <E T="03">TME</E> application submitted to EPA pursuant to section 5 of the Act in accordance with §§ 725.300 through 725.355 of this chapter. </P> <P> (D) <E T="03">TSCA experimental release application</E> or <E T="03">TERA</E> application submitted to EPA pursuant to section 5 of the Act for research and development activities <PRTPAGE P="12"/> involving microorganisms in accordance with §§ 725.200 through 725.260 of this chapter. </P> <P> (E) <E T="03">Tier II exemption</E> application submitted to EPA pursuant to section 5 of the Act in accordance with §§ 725.428 through 725.455 of this chapter. </P> <P> (iv) <E T="03">Instant photographic film article exemption notice.</E> Persons shall remit a fee totaling $2,180 for each instant photographic film article exemption notice submitted in accordance with § 723.175 of this chapter. </P> <P> (v) <E T="03">Microbial commercial activity notice</E> and <E T="03">consolidated microbial commercial activity notice.</E> Persons shall remit a fee totaling $6,480 for each microbial commercial activity notice (MCAN) or consolidated MCAN submitted in accordance with §§ 725.25 through 725.36 of this chapter. </P> <P>(vi) Persons shall remit a total of twenty percent of the applicable fee under paragraph (c)(2)(vi), (vii) or (viii) of this section for a test rule, test order, or enforceable consent agreement.</P> <P>(vii) Persons shall remit a total fee of twenty percent of the applicable fee under paragraphs (c)(2)(ix) of this section for an EPA-initiated risk evaluation.</P> <P>(viii) Persons shall remit the total fee under paragraph (c)(2)(x) or (xi) of this section, as applicable, for a manufacturer-requested risk evaluation.</P> <P> (2) <E T="03">Others.</E> Persons other than small business concerns shall remit fees as follows: </P> <P> (i) <E T="03">PMN</E> and <E T="03">consolidated PMN.</E> Persons shall remit a fee totaling $37,000 for each PMN or consolidated PMN submitted in accordance with part 720 of this chapter. </P> <P> (ii) <E T="03">SNUN.</E> Persons shall remit a fee totaling $37,000 for each significant new use notice submitted in accordance with part 721 of this chapter. </P> <P> (iii) <E T="03">Exemption applications.</E> Persons shall remit a fee totaling $10,870 for each of the following exemption requests, and modifications to previous exemption requests, submitted under section 5 of the Act: </P> <P> (A) <E T="03">Low releases and low exposures exemption</E> or <E T="03">LoREX</E> request submitted to EPA pursuant to section 5(a)(1) of the Act in accordance with § 723.50(a)(1)(ii) of this chapter. </P> <P> (B) <E T="03">Low volume exemption</E> or <E T="03">LVE</E> request submitted to EPA pursuant to section 5(a)(1) of the Act in accordance with § 723.50(a)(1)(i) of this chapter. </P> <P> (C) <E T="03">Test marketing exemption</E> or <E T="03">TME</E> application submitted to EPA pursuant to section 5 of the Act in accordance with §§ 725.300 through 725.355 of this chapter, unless the submitting company has graduated from EPA's Sustainable Futures program, in which case this exemption fee is waived. </P> <P> (D) <E T="03">TSCA experimental release application</E> or <E T="03">TERA</E> application submitted to EPA pursuant to section 5 of the Act for research and development activities involving microorganisms in accordance with §§ 725.200 through 725.260 of this chapter. </P> <P> (E) <E T="03">Tier II exemption</E> application submitted to EPA pursuant to section 5 of the Act in accordance with §§ 725.428 through 725.455 of this chapter. </P> <P> (iv) <E T="03">Instant photographic film article exemption notice.</E> Persons shall remit a fee totaling $10,870 for each exemption notice submitted in accordance with §  723.175 of this chapter. </P> <P> (v) <E T="03">MCAN and consolidated MCAN.</E> Persons shall remit a fee totaling $37,000 for each MCAN or consolidated MCAN submitted in accordance with §§  725.25 through 725.36 of this chapter. </P> <P> (vi) <E T="03">Test rule.</E> Persons shall remit a fee totaling $50,000 for each test rule. </P> <P> (vii) <E T="03">Test order.</E> Persons shall remit a fee totaling $25,000 for each test order. </P> <P> (viii) <E T="03">Enforceable consent agreement.</E> Persons shall remit a fee totaling $50,000 for each enforceable consent agreement. </P> <P> (ix) <E T="03">EPA-initiated chemical risk evaluation.</E> Persons shall remit a fee totaling $4,287,000. </P> <P> (x) <E T="03">Manufacturer-requested risk evaluation of a Work Plan Chemical.</E> Persons shall remit an initial fee of $1,414,924, a second payment of $1,414,924, and final payment to total 50% of the actual costs of this activity, in accordance with the procedures in paragraph (g) of this section. The final payment amount will be determined by EPA, and invoice issued to the requesting manufacturer. </P> <P> (xi) <E T="03">Manufacturer-requested risk evaluation of a non-work plan chemical.</E> Persons shall remit an initial fee of $2,829,847, a second payment of <PRTPAGE P="13"/> $2,829,847, and final payment to total 100% of the actual costs of the activity, in accordance with the procedures in paragraph (g) of this section. The final payment amount will be determined by EPA, and invoice issued to the requesting manufacturer. </P> <P> (d) <E T="03">Fees for 2026 fiscal year and beyond.</E> (1) Fees for the 2026 and later fiscal years will be adjusted on a three-year cycle by multiplying the fees in paragraph (c) of this section by the current PPI index value with a base year of 2024 using the following formula: </P> <FP SOURCE="FP-2">FA = F × I</FP> <EXTRACT> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">FA = the inflation-adjusted future year fee amount.</FP> <FP SOURCE="FP-2">F = the fee specified in paragraph (c) of this section.</FP> <FP SOURCE="FP-2">I = Producer Price Index for Chemicals and Allied Products inflation value with 2024 as a base year.</FP> </EXTRACT> <P>(2) Updated fee amounts for PMNs, SNUNs, MCANs, exemption notices, exemption applications, and manufacturer-requested risk evaluation requests apply to submissions received by the Agency on or after October 1 of every three-year fee adjustment cycle beginning in fiscal year 2024 (October 1, 2023). Updated fee amounts also apply to test rules, test orders, enforceable consent agreements and EPA-initiated risk evaluations that are “noticed” on or after October 1 of every three-year fee adjustment cycle, beginning in fiscal year 2026.</P> <P>(3) The Agency will initiate public consultation through notice-and-comment rulemaking prior to making fee adjustments beyond inflation. If it is determined that no additional adjustment is necessary beyond for inflation, EPA will provide public notice of the inflation-adjusted fee amounts through posting to the Agency's web page by the beginning of each three-year fee adjustment cycle (October 1, 2026, October 1, 2029, etc.). If the Agency determines that adjustments beyond inflation are necessary, EPA will provide public notice of that determination and the process to be followed to make those adjustments.</P> <P> (e) <E T="03">No fee required.</E> Persons are exempt from remitting any fee for Tier I exemption submissions under § 725.424 and polymer exemption reports submitted under § 723.250 of this chapter. </P> <P> (f) <E T="03">Multiple parties, including joint submitters and consortia.</E> (1) Joint submitters of a TSCA section 5 notice are required to remit the applicable fee identified in paragraph (c) of this section for each section 5 notice submitted. Only one fee is required for each submission, regardless of the number of joint submitters for that notice. To qualify for the fee identified in paragraph (c)(1) of this section, each joint submitter of a TSCA section 5 notice must qualify as a small business concern under § 700.43 of this chapter. </P> <P>(2) Any consortium formed to split the cost of the applicable fee under section 4 of the Act is required to remit the appropriate fee identified in paragraph (c) of this section for each test rule, test order, or enforceable consent agreement regardless of the number of manufacturers and/or processors in that consortium. For the consortium to qualify for the fee identified in paragraph (c)(1) of this section, each person in the consortium must qualify as a small business concern under § 700.43 of this chapter. Failure to submit fee payment pursuant to this paragraph, or to provide notice of failure to reach agreement pursuant to paragraph (f)(2)(v) of this section constitutes a violation by each consortium member.</P> <P>(i) The consortium must identify a principal sponsor and provide notification to EPA that a consortium has formed. The notification must be accomplished within 90 days of the publication date of a test rule under section 4 of the Act, or within 90 days of the effective date of a test order under section 4 of the Act, or within 90 days of the signing of an enforceable consent agreement under section 4 of the Act. EPA may permit additional entities to join an existing consortium after the expiration of the notification period if the principal sponsor provides updated notification.</P> <P>(ii) Notification must be submitted electronically via the Agency's electronic reporting software—Central Data Exchange (CDX)—and include the following information:</P> <P> (A) Full name, address, telephone number and signature of principal sponsor; <PRTPAGE P="14"/> </P> <P>(B) Name(s) and contact information for each manufacturer and/or processor associating with the consortium.</P> <P>(iii) It is up to the consortium to determine how fees will be split among the persons in the consortium.</P> <P>(iv) Consortia are strongly encouraged to set lower fees for small business concerns participating in the consortium.</P> <P>(v) If a consortium is unable to come to terms on how fees will be split among the persons in the consortium, the principal sponsor must notify EPA in writing before the end of the notification period in paragraph (f)(2)(i) of this section.</P> <P>(vi) If a consortium provides notice to EPA under paragraph (f)(2)(v) of this section that they failed to reach agreement on payment, EPA will assess fees to all persons as individuals described under paragraph (f)(4) of this section.</P> <P>(3) Any consortium formed to split the cost of the applicable fee supporting a risk evaluation under section 6(b) of the Act is required to remit the appropriate fee identified in paragraph (c) of this section for each risk evaluation, regardless of the number of manufacturers in that consortium. For the consortium to qualify for the fee identified in paragraph (c)(1)(vii) of this section, each person in the consortium must qualify as a small business concern under § 700.43 of this chapter. Failure to provide notice or submit fee payment pursuant to this paragraph (f)(3) constitutes a violation by each consortium member.</P> <P>(i) Notification must be provided to EPA that a consortium has formed. The notification must be accomplished within 90 days of the publication of the final scope of a chemical risk evaluation under section 6(b)(4)(D) of the Act or within 90 days of EPA providing notification to a manufacturer that a manufacturer-requested risk evaluation has been granted. EPA may permit additional entities to join an existing consortium after the expiration of the notification period if the principal sponsor provides updated notification.</P> <P>(ii) Notification must be submitted electronically via the Agency's electronic reporting software—Central Data Exchange (CDX)—and include the following information:</P> <P>(A) Full name, address, telephone number and signature of principal sponsor;</P> <P>(B) Name(s) and contact information for each manufacturer and/or processor associating with the consortium.</P> <P>(iii) It is up to the consortium to determine how fees will be split among the persons in the consortium.</P> <P>(iv) Consortia are strongly encouraged to set lower fees for small business concerns participating in the consortium.</P> <P>(v) If a consortium is unable to come to terms on how fees will be split among the persons in the consortium, the principal sponsor must notify EPA in writing before the end of the notification period in paragraph (f)(3)(i) of this section.</P> <P>(vi) If a consortium provides notice to EPA under paragraph (f)(3)(v) of this section that they failed to reach agreement on payment, EPA will assess fees to all persons as individuals as described under paragraph (f)(4) of this section.</P> <P>(4) If multiple persons are subject to fees triggered by section 4 or 6(b) of the Act and no consortium is formed, EPA will determine the portion of the total applicable fee to be remitted by each person subject to the requirement.</P> <P>(i) Each person's share of the applicable fees triggered by section 4 of the Act specified in paragraph (c) of this section shall be in proportion to the total number of manufacturers and/or processors of the chemical substance, with lower fees for small businesses:</P> <GPH SPAN="2" DEEP="67"> <PRTPAGE P="15"/> <GID>ER21FE24.000</GID> </GPH> <EXTRACT> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> P <E T="52">s</E> = the portion of the fee under paragraph (c) of this section that is owed by a person who qualifies as a small business concern under § 700.43 of this chapter. </FP> <FP SOURCE="FP-2"> P <E T="52">o</E> = the portion of the fee owed by a person other than a small business concern. </FP> <FP SOURCE="FP-2">F = the total fee required under paragraph (c) of this section.</FP> <FP SOURCE="FP-2"> M <E T="52">t</E> = the total number of persons subject to the fee requirement. </FP> <FP SOURCE="FP-2"> M <E T="52">s</E> = the number of persons subject to the fee requirement who qualify as a small business concern. </FP> </EXTRACT> <P>(ii) Each person's share of the applicable fees triggered by section 6(b) of the Act specified in paragraph (c) of this section shall be in proportion to the total number of manufacturers and their reported production volume as described in § 700.45(b)(v) of the chemical substance, with lower fees for small businesses:</P> <GPH SPAN="2" DEEP="58"> <GID>ER21FE24.001</GID> </GPH> <P> (iii) Remaining manufacturers ( <E T="03">i.e.,</E> those that do not qualify as a small business concern) are then ranked in ascending order (from lowest to highest) based on reported production volume as described in § 700.45(b)(v). Each remaining manufacturer is assigned a number with 1 for lowest production volume, 2 for second lowest production volume, etc. </P> <GPOTABLE COLS="2" OPTS="L2(,,0),nj" CDEF="s100,8"> <TTITLE> Table 1 to Paragraph <E T="01">(f)(4)(iii)</E> —Example of Placing Manufacturers That Do Not Qualify as a Small Business Concern in Ascending Order </TTITLE> <BOXHD> <CHED H="1">Manufacturer(s)</CHED> <CHED H="1"> Assigned <LI>No.</LI> <LI>(N)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Manufacturer with lowest production volume</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">Manufacturer with 2nd lowest production volume</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">Manufacturer with 3rd lowest production volume</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01" O="xl">. . . etc.</ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="85"> <GID>ER21FE24.002</GID> </GPH> <EXTRACT> <PRTPAGE P="16"/> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> P <E T="52">s</E> = the portion of the fee under paragraph (c) of this section that is owed by a person who qualifies as a small business concern under § 700.43 of this chapter. </FP> <FP SOURCE="FP-2"> P <E T="52">≥20th</E> = the portion of the fee owed by a person other than a small business concern in the top 20th percentile. </FP> <FP SOURCE="FP-2"> P <E T="52"><20th</E> = the portion of the fee owed by a person other than a small business concern not in the top 20th percentile. </FP> <FP SOURCE="FP-2">F = the total fee required under paragraph (c) of this section.</FP> <FP SOURCE="FP-2"> M <E T="52">t</E> = the total number of persons subject to the fee requirement. </FP> <FP SOURCE="FP-2"> M <E T="52">s</E> = the number of persons subject to the fee requirement who qualify as a small business concern. </FP> <FP SOURCE="FP-2"> N <E T="52">20th</E> = The assigned number as illustrated in Table 1 to the manufacturer(s) with a production volume as described in 700.45(b)(v) at which the manufacturers with production volume greater than or equal to are in the top 20th percentile. </FP> <FP SOURCE="FP-2"> M <E T="52">≥20th</E> = the total number of persons with production volume as described in 700.45(b)(v) greater than or equal to the manufacturer(s) with a production volume as N <E T="52">20th</E> . </FP> <FP SOURCE="FP-2"> M <E T="52"><20th</E> = the total number of persons with production volume as described in 700.45(b)(v) less than the manufacturer(s) with a production volume as N <E T="52">20th</E> . </FP> <FP SOURCE="FP-2"> F <E T="52">o</E> = the total fee required under paragraph (c) of this section by all person(s) other than a small business concern. </FP> </EXTRACT> <P>(iv) In the event there are three or less manufacturers identified for a chemical substance, EPA will distribute the fee evenly among those three or less fee payers, regardless of production volume.</P> <P>(v) In the event the number assigned to the top 20th percentile is not an integer, EPA will round to the nearest integer to determine the manufacturer(s) with the reported production volume as described in § 700.45(b)(v) greater than or equal to the top 20th percentile.</P> <P>(vi) In the event multiple manufacturers report the same production volume as described in § 700.45(b)(v) and are greater than or equal to the top 20th percentile, EPA will include all manufacturers with that same production volume in the fee calculation for the top 20th percentile group.</P> <P>(5) If multiple persons are subject to fees triggered by section 4 of the Act and some inform EPA of their intent to form a consortium while others choose not to associate with the consortium, EPA will take the following steps to allocate fee amounts:</P> <P>(i) Count the total number of manufacturers, including the number of manufacturers within any consortia; divide the total fee amount by the total number of manufacturers; and allocate equally on a per capita basis to generate a base fee;</P> <P>(ii) Provide all small businesses who are either not associated with a consortium, or associated with an all- small business consortium, with an 80% discount from the base fee referenced previously;</P> <P>(iii) Calculate the total remaining fee and total number of remaining manufacturers by subtracting out the discounted fees and the number of small businesses identified;</P> <P>(iv) Reallocate the remaining fee across those remaining individuals and groups in equal amounts, counting each manufacturer in a consortium as one person; and</P> <P>(v) Inform consortia and individuals of their requisite fee amount. Small businesses in a successfully-formed consortium, other than a consortium of all small businesses, will not be afforded the 80% discount by EPA, but consortia managers are strongly encouraged to provide a discount for small business concerns.</P> <P>(6) If multiple persons are subject to fees triggered by section 6(b) of the Act and some inform EPA of their intent to form a consortium while others choose not to associate with the consortium, EPA will take the following steps to allocate fee amounts:</P> <P>(i) Count the total number of manufacturers, including the number of manufacturers within any consortia; divide the total fee amount by the total number of manufacturers; and allocate equally on a per capita basis to generate a base fee;</P> <P>(ii) Provide all small businesses who are either not associated with a consortium, or associated with an all-small business consortium, with an 80% discount from the base fee referenced previously;</P> <P> (iii) Calculate the total remaining fee and total number of remaining manufacturers by subtracting out the discounted fees and the number of small businesses identified; <PRTPAGE P="17"/> </P> <P>(iv) Place remaining manufacturers in ascending order (from lowest to highest) based on reported production volume as described in § 700.45(b)(v). Assign each remaining manufacturer a number with 1 for lowest production volume, 2 for second lowest production volume, etc.;</P> <P>(v) Determine the manufacturer(s) in the top 20th percentile by multiplying the total number of remaining manufacturers by 0.8. then comparing that number to the manufacturer(s) with that assigned number as described in paragraph (f)(6)(iv) of this section;</P> <P>(vi) Reallocate 80% of the total remaining fee evenly across that manufacturer(s) with a production volume amount equal to or larger than that manufacturer(s) (the top 20th percentile), counting each manufacturer in a consortium as one person;</P> <P>(vii) Reallocate the remaining fee evenly across the remaining manufacturers, counting each manufacturer in a consortium as one person; and</P> <P>(viii) Inform consortia and individuals of their requisite fee amount. Small businesses in a successfully formed consortium, other than a consortium of all small businesses, will not be afforded the 80% discount by EPA, but consortia managers are strongly encouraged to provide a discount for small business concerns.</P> <P> (g) <E T="03">Remittance procedure</E> —(1) <E T="03">Electronic payment.</E> Each remittance under this section shall be paid electronically in U.S. dollars, using one of the electronic payment methods supported by the Department of the Treasury's <E T="03">Pay.gov</E> online electronic payment service, or any applicable additional or successor online electronic payment service offered by the Department of Treasury. </P> <P> (2) <E T="03">Fees incurred prior to</E> October 18, 2018. Timing of payment for fees incurred between October 1, 2018 and October 18, 2018. Fees required by paragraph (c) of this section for which the fee-triggering action or event occurred between October 1, 2018, and October 18, 2018 shall be paid in response to invoices EPA will send within 30 days of October 18, 2018. </P> <P> (3) <E T="03">Fees incurred after</E> October 18, 2018. Timing of payment for fees incurred after October 18, 2018. Fees required by paragraph (c) of this section for which the fee-triggering action or event occurred after October 18, 2018 shall be paid at the following time: </P> <P> (i) <E T="03">Test orders and test rules.</E> The applicable fee specified in paragraph (c) of this section shall be paid in full not later than 180 days after the effective date of a test rule or test order under section 4 of the Act. </P> <P> (ii) <E T="03">Enforceable</E> c <E T="03">onsent agreements.</E> The applicable fee specified in paragraph (c) of this section shall be paid in full not later than 120 days after the signing of an enforceable consent agreement under section 4 of the Act. </P> <P> (iii) <E T="03">Section 5 notice.</E> The applicable fee specified in paragraph (c) of this section shall be paid in full immediately upon submission of a TSCA section 5 notice. </P> <P> (iv) <E T="03">Risk evaluations.</E> (A) For EPA-initiated risk evaluations, the applicable fee specified in paragraph (c) of this section shall be paid in two installments, with the first payment of 50% due 180 days after publishing the final scope of a risk evaluation and the second payment for the remainder of the fee due 545 days after publishing the final scope of a risk evaluation under section 6(b)(4)(D) of the Act. </P> <P>(B) For manufacturer-requested risk evaluations under section 6(b)(4)(C)(ii) of the Act, the applicable fees specified in paragraph (c) of this section shall be paid as follows:</P> <P> ( <E T="03">1</E> ) The applicable fee specified in paragraph (c) of this section shall be paid in three installments. The first payment shall be due no later than 180 days after EPA provides the submitting manufacture(s) notice that it has granted the request. </P> <P> ( <E T="03">2</E> ) The second payment shall be due no later than 545 days after EPA provides the submitting manufacturer(s) notice that it has granted the request. </P> <P> ( <E T="03">3</E> ) The final payment shall be due no later than 30 days after EPA publishes the final risk evaluation. </P> <P> (4) <E T="03">Payment identity.</E> (i) Persons who submit a TSCA section 5 notice shall place an identifying number and a payment identity number on the front page of each TSCA section 5 notice submitted. The identifying number must include the letters “TS” followed by a combination of 6 numbers (letters may <PRTPAGE P="18"/> be substituted for some numbers). The payment identity number may be a “ <E T="03">Pay.gov</E> ” transaction number used to transmit the fee. The same TS number and the submitter's name must appear on the corresponding fee remittance under this section. If a remittance applies to more than one TSCA section 5 notice, the person shall include the name of the submitter and a new TS number for each TSCA section 5 notice to which the remittance applies, and the amount of the remittance that applies to each notice. </P> <P> (ii) Persons who are required to submit a letter of intent to conduct testing per § 790.45 of this chapter shall place a payment identity number on the front page of each letter submitted. The identifying number must include the letters “TS” followed by a combination of 6 numbers (letters may be substituted for some numbers). The payment identity number may be a “ <E T="03">Pay.gov</E> ” transaction number used to transmit the fee. The same TS number and the submitter's name must appear on the corresponding fee remittance under this section. If a remittance applies to more than one letter of intent to conduct testing, the person shall include the name of the submitter and a new TS number for each letter of intent to conduct testing to which the remittance applies, and the amount of the remittance that applies to each letter of intent. </P> <P> (iii) Persons who sign an enforceable consent agreement per § 790.60 of this chapter shall place a payment identity number within the contents of the signed agreement. The identifying number must include the letters “TS” followed by a combination of 6 numbers (letters may be substituted for some numbers). The payment identity number may be a “ <E T="03">Pay.gov</E> ” transaction number used to transmit the fee. The same TS number and the submitter's name must appear on the corresponding fee remittance under this section. If a remittance applies to more than one enforceable consent agreement, the party or parties shall include the name of the submitter(s) and a new TS number for each enforceable consent agreement to which the remittance applies, and the amount of the remittance that applies to each enforceable consent agreement. </P> <P> (5) <E T="03">Small business certification.</E> (i) Each person who remits the fee identified in paragraph (c)(1) of this section for a PMN, consolidated PMN, or SNUN shall insert a check mark for the statement, “The company named in part 1, section A is a small business concern under 40 CFR 700.43 and has remitted a fee of $6,480 in accordance with 40 CFR 700.45(c).” under “CERTIFICATION” on page 2 of the Premanufacture Notice for New Chemical Substances (EPA Form 7710-25). </P> <P>(ii) Each person who remits the fee identified in paragraph (c)(1) of this section for a LVE, LoREX, TERA, TME, or Tier II exemption request under TSCA section 5 shall insert a check mark for the statement, “The company named in part 1, section A is a small business concern under 40 CFR 700.43 and has remitted a fee of $2,180 in accordance with 40 CFR 700.45(c).” in the exemption application.</P> <P>(iii) Each person who remits the fee identified in paragraph (c)(1) of this section for an exemption notice under § 723.175 of this chapter shall include the words, “The company or companies identified in this notice is/are a small business concern under 40 CFR 700.43 and has/have remitted a fee of $2,180 in accordance with 40 CFR 700.45(c).” in the certification required in § 723.175(i)(1)(x) of this chapter.</P> <P>(iv) Each person who remits the fee identified in paragraph (c)(1) of this section for a MCAN or consolidated MCAN for a microorganism shall insert a check mark for the statement, “The company named in part 1, section A is a small business concern under 40 CFR 700.43 and has remitted a fee of $6,480 in accordance with 40 CFR 700.45(c).” in the certification required in § 725.25(b) of this chapter.</P> <P> (6) <E T="03">Payment certification statement.</E> (i) Each person who remits a fee identified in paragraph (c)(2) of this section for a PMN, consolidated PMN, or SNUN shall insert a check mark for the statement, “The company named in part 1, section A has remitted the fee of $37,000 specified in 40 CFR 700.45(c).” under “CERTIFICATION” on page 2 of the Premanufacture Notice for New Chemical Substances (EPA Form 7710-25). <PRTPAGE P="19"/> </P> <P>(ii) Each person who remits a fee identified in paragraph (c)(2) of this section for a LVE, LoREX, TERA, TME, or Tier II exemption request under TSCA section 5 shall insert a check mark for the statement, “The company named in part 1, section A has remitted the fee of $10,870 specified in 40 CFR 700.45(c).” in the exemption application.</P> <P>(iii) Each person who remits the fee identified in paragraph (c)(2) of this section for an exemption notice under § 723.175 of this chapter shall include the words, “The company or companies identified in this notice has/have remitted a fee of $10,870 in accordance with 40 CFR 700.45(c).” in the certification required in § 723.175(i)(1)(x) of this chapter.</P> <P>(iv) Each person who remits the fee identified in paragraph (c)(2) of this section for a MCAN for a microorganism shall insert a check mark for the statement, “The company named in part 1, section A has remitted the fee of $37,000 in accordance with 40 CFR 700.45(c).” in the certification required in § 725.25(b) of this chapter.</P> <P> (h) <E T="03">Full fee refunds.</E> EPA will refund, in totality, any fee paid for a section 5 notice whenever the Agency determines: </P> <P>(1) That the chemical substance that is the subject of a PMN, consolidated PMN, exemption request, or exemption notice, is not a new chemical substance as of the date of submission of the notice,</P> <P>(2) In the case of a SNUN, that the notice was not required,</P> <P>(3) That as of the date of submission of the notice: The microorganism that is the subject of a MCAN or consolidated MCAN is not a new microorganism; nor is the use involving the microorganism a significant new use; or</P> <P>(4) When the Agency fails to make a determination on a notice by the end of the applicable notice review period under § 720.75 or § 725.50 of this chapter, unless the Agency determines that the submitter unduly delayed the process, or</P> <P>(5) When the Agency fails to approve, or deny an exemption request within the applicable period under § 720.38(d), § 723.50(g), or § 725.50(b) of this chapter, unless the Agency determines that the submitter unduly delayed the process.</P> <P> (i) <E T="03">Partial fee refunds.</E> (1) If a TSCA section 5 notice is withdrawn during the first 10 business days after the beginning of the applicable review period under § 720.75(a) of this chapter, the Agency will refund all but 25% of the fee as soon as practicable. </P> <P>(2) Once withdrawn, any future submission related to the TSCA section 5 notice must be submitted as a new notice.</P> <P>(3) If EPA determines that the initial payment for a manufacturer-requested risk evaluation exceed the applicable fee in paragraph (c) of this section, EPA will refund the difference.</P> <CITA>[83 FR 52714, Oct. 17, 2018, as amended at 89 FR 12974, Feb. 21, 2024]</CITA> </SECTION> <SECTION> <SECTNO>§ 700.49</SECTNO> <SUBJECT>Failure to remit fees.</SUBJECT> <P>(a) EPA will not consider a TSCA section 5 notice to be complete unless the appropriate certification under § 700.45(g) is included and until the appropriate remittance under § 700.45(c) has been submitted as provided in § 700.45(g). EPA will notify the submitter of a section 5 notice that it is incomplete in accordance with §§ 720.65(c) and 725.33(b)(1) of this chapter.</P> <P>(b) Failure to submit the appropriate remittance specified under § 700.45(c) for a test order, test rule, enforceable consent agreement, or EPA-initiated risk evaluation as provided in § 700.45(g) is a violation of TSCA and enforceable under section 15 of the Act.</P> <P>(c) EPA will not initiate a manufacturer-requested risk evaluation the request for which the Agency has otherwise determined to be complete unless EPA has determined to grant the request and the appropriate initial remittance under § 700.45(c) has been submitted as provided in § 700.45(g).</P> <P>(d) Failure to submit the appropriate final remittance specified under § 700.45(c) for a manufacturer-requested risk evaluation as provided in § 700.45(g) is a violation of TSCA and enforceable under section 15 of the Act.</P> <CITA> [83 FR 52719, Oct. 17, 2018] <PRTPAGE P="20"/> </CITA> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 702</EAR> <HD SOURCE="HED">PART 702—GENERAL PRACTICES AND PROCEDURES</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—Procedures for Prioritization of Chemical Substances for Risk Evaluation</HD> <SECHD>Sec.</SECHD> <SECTNO>702.1</SECTNO> <SUBJECT>General provisions.</SUBJECT> <SECTNO>702.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>702.4</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>702.5</SECTNO> <SUBJECT>Candidate selection.</SUBJECT> <SECTNO>702.7</SECTNO> <SUBJECT>Initiation of prioritization process.</SUBJECT> <SECTNO>702.9</SECTNO> <SUBJECT>Screening review and proposed priority designation.</SUBJECT> <SECTNO>702.11</SECTNO> <SUBJECT>Final priority designation.</SUBJECT> <SECTNO>702.13</SECTNO> <SUBJECT>Revision of designation.</SUBJECT> <SECTNO>702.15</SECTNO> <SUBJECT>Effect of designation as a low-priority substance.</SUBJECT> <SECTNO>702.17</SECTNO> <SUBJECT>Effect of designation as a high-priority substance.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Procedures for Chemical Substance Risk Evaluations</HD> <SECTNO>702.31</SECTNO> <SUBJECT>General provisions.</SUBJECT> <SECTNO>702.33</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>702.35</SECTNO> <SUBJECT>Chemical substances designated for risk evaluation.</SUBJECT> <SECTNO>702.37</SECTNO> <SUBJECT>Submission of manufacturer requests for risk evaluations.</SUBJECT> <SECTNO>702.39</SECTNO> <SUBJECT>Interagency collaboration.</SUBJECT> <SECTNO>702.41</SECTNO> <SUBJECT>Evaluation requirements.</SUBJECT> <SECTNO>702.43</SECTNO> <SUBJECT>Risk Characterization.</SUBJECT> <SECTNO>702.45</SECTNO> <SUBJECT>Peer review.</SUBJECT> <SECTNO>702.47</SECTNO> <SUBJECT>Unreasonable risk determination.</SUBJECT> <SECTNO>702.49</SECTNO> <SUBJECT>Risk evaluation timeframes and actions.</SUBJECT> <SECTNO>702.51</SECTNO> <SUBJECT>Publically available information.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Citizen Suit</HD> <SECTNO>702.60</SECTNO> <SUBJECT>Purpose.</SUBJECT> <SECTNO>702.61</SECTNO> <SUBJECT>Service of notice.</SUBJECT> <SECTNO>702.62</SECTNO> <SUBJECT>Contents of notice.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2605 and 2619.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>47 FR 2773, Jan. 19, 1982, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—Procedures for Prioritization of Chemical Substances for Risk Evaluation</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>82 FR 33762, July 20, 2017, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 702.1</SECTNO> <SUBJECT>General provisions.</SUBJECT> <P> (a) <E T="03">Purpose.</E> This regulation establishes the risk-based screening process for designating chemical substances as a High-Priority Substance or a Low-Priority Substance for risk evaluation as required under section 6(b) of the Toxic Substances Control Act, as amended (15 U.S.C. 2605(b)). </P> <P> (b) <E T="03">Scope of designations.</E> EPA will make priority designations pursuant to these procedures for a chemical substance, not for a specific condition or conditions of uses of a chemical substance. </P> <P> (c) <E T="03">Categories of chemical substances.</E> Nothing in this subpart shall be interpreted as a limitation on EPA's authority under 15 U.S.C. 2625(c) to take action, including the actions contemplated in this subpart, on a category of chemical substances. </P> <P> (d) <E T="03">Prioritization timeframe.</E> The Agency will publish a final priority designation for a chemical substance in no fewer than 9 months and no longer than 1 year following initiation of prioritization pursuant to § 702.7. </P> <P> (e) <E T="03">Metals or metal compounds.</E> EPA will identify priorities for chemical substances that are metals or metal compounds in accordance with 15 U.S.C. 2605(b)(2)(E). </P> <P> (f) <E T="03">Applicability.</E> These regulations do not apply to any chemical substance for which a manufacturer requests a risk evaluation under 15 U.S.C. 2605(b)(4)(C). </P> <P> (g) <E T="03">Scientific standards and weight of the scientific evidence.</E> EPA's proposed priority designations under § 702.9 and final priority designations under § 702.11 will be consistent with the scientific standards provision in 15 U.S.C. 2625(h) and the weight of the scientific evidence provision in 15 U.S.C. 2625(i). </P> <P> (h) <E T="03">Interagency collaboration.</E> EPA will consult with other relevant Federal Agencies during the administration of this subpart. </P> </SECTION> <SECTION> <SECTNO>§ 702.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>For purposes of this subpart, the following definitions apply:</P> <P> <E T="03">Act</E> means the Toxic Substances Control Act, as amended (15 U.S.C. 2601 <E T="03">et seq.</E> ). </P> <P> <E T="03">Conditions of use</E> means the circumstances, as determined by the Administrator, under which a chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used, or disposed of. </P> <P> <E T="03">EPA</E> means the U.S. Environmental Protection Agency. <PRTPAGE P="21"/> </P> <P> <E T="03">High-priority substance</E> means a chemical substance that EPA determines, without consideration of costs or other non-risk factors, may present an unreasonable risk of injury to health or the environment because of a potential hazard and a potential route of exposure under the conditions of use, including an unreasonable risk to potentially exposed or susceptible subpopulations identified as relevant by EPA. </P> <P> <E T="03">Low-priority substance</E> means a chemical substance that EPA concludes, based on information sufficient to establish, without consideration of costs or other non-risk factors, does not meet the standard for a High-Priority Substance. </P> <P> <E T="03">Potentially exposed or susceptible subpopulation</E> means a group of individuals within the general population identified by the Administrator who, due to either greater susceptibility or greater exposure, may be at greater risk than the general population of adverse health effects from exposure to a chemical substance or mixture, such as infants, children, pregnant women, workers, or the elderly. </P> <P> <E T="03">Reasonably available information</E> means information that EPA possesses or can reasonably generate, obtain and synthesize for use, considering the deadlines specified in 15 U.S.C. 2605(b) for prioritization and risk evaluation. Information that meets such terms is reasonably available information whether or not the information is confidential business information that is protected from public disclosure under 15 U.S.C. 2613. </P> </SECTION> <SECTION> <SECTNO>§ 702.4</SECTNO> <RESERVED>[Reserved]</RESERVED> </SECTION> <SECTION> <SECTNO>§ 702.5</SECTNO> <SUBJECT>Candidate selection.</SUBJECT> <P> (a) <E T="03">General objective.</E> In selecting candidates for a High-Priority Substance designation, it is EPA's general objective to select those chemical substances with the greatest hazard and exposure potential first, considering reasonably available information on the relative hazard and exposure of potential candidates. In selecting candidates for Low-Priority Substance designation, it is EPA's general objective to select those chemical substances with hazard and/or exposure characteristics under the conditions of use such that a risk evaluation is not warranted at the time to determine whether the chemical substance presents an unreasonable risk of injury to health or the environment, including an unreasonable risk to potentially exposed or susceptible subpopulations identified as relevant by EPA. </P> <P> (b) <E T="03">Available information.</E> EPA expects to ensure that there is reasonably available information to meet the deadlines for prioritization under the Act. </P> <P> (c) <E T="03">Preferences and TSCA work plan.</E> In selecting a candidate for prioritization as a High-Priority Substance, EPA will: </P> <P>(1) Give preference to:</P> <P>(i) Chemical substances that are listed in the 2014 update of the TSCA Work Plan for Chemical Assessments as having a persistence and bioaccumulation score of 3; and</P> <P>(ii) Chemical substances that are listed in the 2014 update of the TSCA Work Plan for Chemical Assessments that are known human carcinogens and have high acute and chronic toxicity; and</P> <P>(2) Identify a sufficient number of candidates from the 2014 update of the TSCA Work Plan for Chemical Assessments to ensure that, at any given time, at least 50 percent of risk evaluations being conducted by EPA are drawn from that list until all substances on the list have been designated as either a High-Priority Substance or Low-Priority Substance pursuant to § 702.11.</P> <P> (d) <E T="03">Purpose.</E> The purpose of the preferences and criteria in paragraphs (a) through (c) of this section is to inform EPA's decision whether or not to initiate the prioritization process pursuant to § 702.7, and the proposed designation of the chemical substance as either a High-Priority Substance or a Low-Priority Substance pursuant to § 702.9. </P> <P> (e) <E T="03">Insufficient information.</E> If EPA believes it would not have sufficient information for purposes of prioritization, EPA generally expects to obtain the information necessary to inform prioritization prior to initiating the process pursuant to § 702.9, using <PRTPAGE P="22"/> voluntary means of information gathering and, as necessary, exercising its authorities under the Act in accordance with the requirements of 15 U.S.C. 2603, 15 U.S.C. 2607, and 15 U.S.C. 2610. In exercising its authority under 15 U.S.C. 2603(a)(2), EPA will identify the need for the information in accordance with 15 U.S.C. 2603(a)(3). </P> </SECTION> <SECTION> <SECTNO>§ 702.7</SECTNO> <SUBJECT>Initiation of prioritization process.</SUBJECT> <P>(a) EPA generally expects to initiate the prioritization process for a chemical substance only when it believes that the information necessary to prioritize the substance is reasonably available.</P> <P> (b) EPA will initiate prioritization by publishing a notice in the <E T="04">Federal Register</E> identifying a chemical substance for prioritization. EPA will include a general explanation in this notice for why it chose to initiate the process on the chemical substance. </P> <P>(c) The prioritization timeframe in § 702.1(d) begins upon EPA's publication of the notice described in paragraph (b) of this section.</P> <P> (d) Publication of the notice in the <E T="04">Federal Register</E> pursuant to paragraph (b) of this section will initiate a period of 90 days during which interested persons may submit relevant information on that chemical substance. Relevant information might include, but is not limited to, any information that may inform the screening review conducted pursuant to § 702.9(a). EPA will open a separate docket for each chemical substance to facilitate receipt of information. </P> <P>(e) EPA may, in its discretion, extend the public comment period in paragraph (d) of this section for up to three months in order to receive or evaluate information submitted under 15 U.S.C. 2603(a)(2)(B). The length of the extension will be based upon EPA's assessment of the time necessary for EPA to receive and/or evaluate information submitted under 15 U.S.C. 2603(a)(2)(B).</P> </SECTION> <SECTION> <SECTNO>§ 702.9</SECTNO> <SUBJECT>Screening review and proposed priority designation.</SUBJECT> <P> (a) <E T="03">Screening review.</E> Following the close of the comment period described in § 702.7(d), including any extension pursuant to paragraph (e) of that section, EPA will generally use reasonably available information to screen the candidate chemical substance against the following criteria and considerations: </P> <P>(1) The chemical substance's hazard and exposure potential;</P> <P>(2) The chemical substance's persistence and bioaccumulation;</P> <P>(3) Potentially exposed or susceptible subpopulations;</P> <P>(4) Storage of the chemical substance near significant sources of drinking water;</P> <P>(5) The chemical substance's conditions of use or significant changes in conditions of use;</P> <P>(6) The chemical substance's production volume or significant changes in production volume; and</P> <P>(7) Other risk-based criteria that EPA determines to be relevant to the designation of the chemical substance's priority.</P> <P> (b) <E T="03">Information sources.</E> In conducting the screening review in paragraph (a) of this section, EPA expects to consider sources of information relevant to the listed criteria and consistent with the scientific standards provision in 15 U.S.C. 2625(h), including, as appropriate, sources for hazard and exposure data listed in Appendices A and B of the TSCA Work Plan Chemicals: Methods Document (February 2012). </P> <P> (c) <E T="03">Proposed designation.</E> Based on the results of the screening review in paragraph (a) of this section, relevant information received from the public as described in § 702.7(d), and other information as appropriate and consistent with 15 U.S.C. 2625(h) and (i), EPA will propose to designate the chemical substance as either a High-Priority Substance or Low-Priority Substance, along with an identification of the information, analysis, and basis used to support the proposed designation. </P> <P> (d) <E T="03">Costs and non-risk factors.</E> EPA will not consider costs or other non-risk factors in making a proposed priority designation. </P> <P> (e) <E T="03">Insufficient information.</E> If information remains insufficient to enable the proposed designation of the chemical substance as a Low-Priority Substance after any extension of the initial public comment period pursuant to § 702.7(e), EPA will propose to designate <PRTPAGE P="23"/> the chemical substance as a High-Priority Substance. </P> <P> (f) <E T="03">Conditions of use.</E> EPA will propose to designate a chemical substance as a High-Priority Substance based on the proposed conclusion that the chemical substance satisfies the definition of High-Priority Substance in § 702.3 under one or more activities that the Agency determines constitute conditions of use. EPA will propose to designate a chemical substance as a Low-Priority Substance based on the proposed conclusion that the chemical substance meets the definition of Low-Priority Substance in § 702.3 under the activities that the Agency determines constitute conditions of use. </P> <P> (g) <E T="03">Publication.</E> EPA will publish the proposed designation in the <E T="04">Federal Register,</E> along with an identification of the information, analysis and basis used to support a proposed designation, in a form and manner that EPA deems appropriate, and provide a comment period of 90 days, during which time the public may submit comment on EPA's proposed designation. EPA will open a docket to facilitate receipt of public comment. </P> </SECTION> <SECTION> <SECTNO>§ 702.11</SECTNO> <SUBJECT>Final priority designation.</SUBJECT> <P>(a) After considering any additional information collected from the proposed designation process in § 702.9, as appropriate, EPA will finalize its designation of a chemical substance as either a High-Priority Substance or a Low-Priority Substance consistent with 15 U.S.C. 2625(h) and (i).</P> <P>(b) EPA will not consider costs or other non-risk factors in making a final priority designation.</P> <P> (c) EPA will publish each final priority designation in the <E T="04">Federal Register,</E> along with an identification of the information, analysis, and basis used to support a final designation consistent with 15 U.S.C. 2625(h), (i) and (j). For High-Priority Substance designations, EPA generally expects to indicate which condition(s) of use were the primary basis for such designations. </P> <P>(d) As required in 15 U.S.C. 2605(b)(3)(C), EPA will finalize a designation for at least one High-Priority Substance for each risk evaluation it completes, other than a risk evaluation that was requested by a manufacturer pursuant to subpart B of this part. The obligation in 15 U.S.C. 2605(b)(3)(C) will be satisfied by the designation of at least one High-Priority Substance where such designation specifies the risk evaluation that the designation corresponds to, and where the designation occurs within a reasonable time before or after the completion of the risk evaluation.</P> </SECTION> <SECTION> <SECTNO>§ 702.13</SECTNO> <SUBJECT>Revision of designation.</SUBJECT> <P>EPA may revise a final designation of a chemical substance from Low-Priority to High-Priority Substance at any time based on reasonably available information. To revise such a designation, EPA will re-initiate the prioritization process on that chemical substance in accordance with § 702.7, re-screen the chemical substance and propose a priority designation pursuant to § 702.9, and finalize the priority designation pursuant to § 702.11.</P> </SECTION> <SECTION> <SECTNO>§ 702.15</SECTNO> <SUBJECT>Effect of designation as a low-priority substance.</SUBJECT> <P>Designation of a chemical substance as a Low-Priority Substance under § 702.11 means that a risk evaluation of the chemical substance is not warranted at the time, but does not preclude EPA from later revising the designation pursuant to § 702.13, if warranted. Designation as a Low-Priority Substance is not a finding that the chemical substance does not present an unreasonable risk, but rather that it does not meet the High-Priority Substance definition.</P> </SECTION> <SECTION> <SECTNO>§ 702.17</SECTNO> <SUBJECT>Effect of designation as a high-priority substance.</SUBJECT> <P>Final designation of a chemical substance as a High-Priority Substance under § 702.11 initiates a risk evaluation pursuant to subpart B of this part. Designation as a High-Priority Substance is not a final agency action and is not subject to judicial review until the date of promulgation of the associated final rule under section 6(a). Designation as a High-Priority Substance is not a finding that the chemical substance presents an unreasonable risk.</P> </SECTION> </SUBPART> <SUBPART> <PRTPAGE P="24"/> <HD SOURCE="HED">Subpart B—Procedures for Chemical Substance Risk Evaluations</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>82 FR 33747, July 20, 2017, unless otherwise noted.</P> </SOURCE> <EFFDNOTP> <HD SOURCE="HED">Effective Date Note:</HD> <P>At 89 FR 37052, May 3, 2024, subpart B was revised and republished, effective July 2, 2024. For the convenience of the user, the new subpart 702 follows the text of this subpart.</P> </EFFDNOTP> <SECTION> <SECTNO>§ 702.31</SECTNO> <SUBJECT>General provisions.</SUBJECT> <P> (a) <E T="03">Purpose.</E> This subpart establishes the EPA process for conducting a risk evaluation to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment as required under TSCA section 6(b)(4)(B) (15 U.S.C. 2605(b)(4)(B)). </P> <P> (b) <E T="03">Scope.</E> These regulations establish the general procedures, key definitions, and timelines EPA will use in a risk evaluation conducted pursuant to TSCA section 6(b) (15 U.S.C. 2605(b)). </P> <P> (c) <E T="03">Applicability.</E> The requirements of this part apply to all chemical substance risk evaluations initiated pursuant to TSCA section 6(b) (15 U.S.C. 2605(b)). </P> <P> (d) <E T="03">Enforcement.</E> Submission to EPA of inaccurate, incomplete, or misleading information pursuant to a risk evaluation conducted pursuant to 15 U.S.C. 2605(b)(4)(B) is a prohibited act under 15 U.S.C. 2614, subject to penalties under 15 U.S.C. 2615 and Title 18 of the U.S. Code. </P> </SECTION> <SECTION> <SECTNO>§ 702.33</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>All definitions in TSCA apply to this subpart. In addition, the following definitions apply:</P> <P> <E T="03">Act</E> means the Toxic Substances Control Act, as amended (15 U.S.C. 2601 <E T="03">et seq.</E> ). </P> <P> <E T="03">Aggregate exposure</E> means the combined exposures to an individual from a single chemical substance across multiple routes and across multiple pathways. </P> <P> <E T="03">Best available science</E> means science that is reliable and unbiased. Use of best available science involves the use of supporting studies conducted in accordance with sound and objective science practices, including, when available, peer reviewed science and supporting studies and data collected by accepted methods or best available methods (if the reliability of the method and the nature of the decision justifies use of the data). Additionally, EPA will consider as applicable: </P> <P>(1) The extent to which the scientific information, technical procedures, measures, methods, protocols, methodologies, or models employed to generate the information are reasonable for and consistent with the intended use of the information;</P> <P>(2) The extent to which the information is relevant for the Administrator's use in making a decision about a chemical substance or mixture;</P> <P>(3) The degree of clarity and completeness with which the data, assumptions, methods, quality assurance, and analyses employed to generate the information are documented;</P> <P>(4) The extent to which the variability and uncertainty in the information, or in the procedures, measures, methods, protocols, methodologies, or models, are evaluated and characterized; and</P> <P>(5) The extent of independent verification or peer review of the information or of the procedures, measures, methods, protocols, methodologies or models.</P> <P> <E T="03">Conditions of use</E> means the circumstances, as determined by the Administrator, under which a chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used, or disposed of. </P> <P> <E T="03">EPA</E> means the U.S. Environmental Protection Agency. </P> <P> <E T="03">Pathways</E> means the mode through which one is exposed to a chemical substance, including but not limited to: Food, water, soil, and air. </P> <P> <E T="03">Potentially exposed or susceptible subpopulation</E> means a group of individuals within the general population identified by the Agency who, due to either greater susceptibility or greater exposure, may be at greater risk than the general population of adverse health effects from exposure to a chemical substance or mixture, such as infants, children, pregnant women, workers, or the elderly. </P> <P> <E T="03">Reasonably available information</E> means information that EPA possesses <PRTPAGE P="25"/> or can reasonably generate, obtain, and synthesize for use in risk evaluations, considering the deadlines specified in TSCA section 6(b)(4)(G) for completing such evaluation. Information that meets the terms of the preceding sentence is reasonably available information whether or not the information is confidential business information, that is protected from public disclosure under TSCA section 14. </P> <P> <E T="03">Routes</E> means the particular manner by which a chemical substance may contact the body, including absorption via ingestion, inhalation, or dermally (integument). </P> <P> <E T="03">Sentinel exposure</E> means the exposure from a single chemical substance that represents the plausible upper bound of exposure relative to all other exposures within a broad category of similar or related exposures. </P> <P> <E T="03">Uncertainty</E> means the imperfect knowledge or lack of precise knowledge of the real world either for specific values of interest or in the description of the system. </P> <P> <E T="03">Variability</E> means the inherent natural variation, diversity, and heterogeneity across time and/or space or among individuals within a population. </P> <P> <E T="03">Weight of scientific evidence</E> means a systematic review method, applied in a manner suited to the nature of the evidence or decision, that uses a pre-established protocol to comprehensively, objectively, transparently, and consistently, identify and evaluate each stream of evidence, including strengths, limitations, and relevance of each study and to integrate evidence as necessary and appropriate based upon strengths, limitations, and relevance. </P> </SECTION> <SECTION> <SECTNO>§ 702.35</SECTNO> <SUBJECT>Chemical substances designated for risk evaluation.</SUBJECT> <P> (a) <E T="03">Chemical substances undergoing risk evaluation.</E> A risk evaluation for a chemical substance designated by the Agency as a High-Priority Substance pursuant to the prioritization process described in subpart A, identified under 15 U.S.C. 2605(b)(2)(A), or initiated at the request of a manufacturer or manufacturers under § 702.37, will be conducted in accordance with this part, except that risk evaluations that are initiated prior to the effective date of this rule will be conducted in accordance with this part to the maximum extent practicable. </P> <P> (b) <E T="03">Percentage requirements.</E> The Agency will ensure that, of the number of chemical substances that undergo risk evaluation under 15 U.S.C. 2605(b)(4)(C)(i), the number of chemical substances undergoing risk evaluation under 15 U.S.C. 2605(b)(4)(C)(ii) is not less than 25%, if sufficient requests that comply with 702.37, and not more than 50%. </P> <P> (c) <E T="03">Manufacturer requests for work plan chemical substances.</E> Manufacturer requests for risk evaluations, described in paragraph (a) of this section, for chemical substances that are drawn from the 2014 update of the TSCA Work Plan for Chemical Assessments will be granted at the discretion of the Agency. Such evaluations are not subject to the percentage requirements in paragraph (b) of this section. </P> </SECTION> <SECTION> <SECTNO>§ 702.37</SECTNO> <SUBJECT>Submission of manufacturer requests for risk evaluations.</SUBJECT> <P> (a) <E T="03">General provision.</E> Any request that EPA conduct a risk evaluation pursuant to this part must comply with all the procedures and criteria in this section to be eligible to be granted by EPA. </P> <P> (b) <E T="03">Method for submission.</E> One or more manufacturers of a chemical substance may request that EPA conduct a risk evaluation. All requests submitted to EPA under this subpart must be submitted via the EPA Central Data Exchange (CDX) found at <E T="03">http://cdx.epa.gov.</E> Requests must include all of the following information: </P> <P>(1) Name, mailing address, and contact information of the entity (or entities) submitting the request. If more than one manufacturer submits the request, all individual manufacturers must provide their contact information.</P> <P> (2) The chemical identity of the chemical substance that is the subject of the request. At a minimum, this includes, all known names of the chemical substance, including common or trades names, CAS number, and molecular structure of the chemical substance A request for risk evaluations of a category of chemical substances must include an explanation of why the category is appropriate under 15 U.S.C. <PRTPAGE P="26"/> 2625(c), and EPA will grant such request only upon determining that the requested category is appropriate for risk evaluation. </P> <P>(3) The manufacturer must identify the circumstances on which they are requesting that EPA conduct a risk evaluation and include a rationale for why these circumstances constitute conditions of use under § 702.33.</P> <P>(4) The request must also include a list of all the existing information that is relevant to whether the chemical substance, under the circumstances identified by the manufacturer(s), presents an unreasonable risk of injury to health or the environment. The list must be accompanied by an explanation as to why such information is adequate to permit EPA to complete a risk evaluation addressing the circumstances identified by the manufacturer(s), The request need not include copies of the information; citations are sufficient, if the information is publically available. The request must include or reference all available information on the health and environmental hazard(s) of the chemical substance, human and environmental exposure(s), and exposed population(s), as relevant to the circumstances identified in the request. At a minimum, this must include all the following, as relevant to the circumstances identified:</P> <P>(i) The chemical substance's hazard and exposure potential;</P> <P>(ii) The chemical substance's persistence and bioaccumulation;</P> <P>(iii) Potentially exposed or susceptible subpopulations which the manufacturer(s) believes to be relevant to the EPA risk evaluation;</P> <P>(iv) Whether there is any storage of the chemical substance near significant sources of drinking water, including the storage facility location and the nearby drinking water source(s);</P> <P>(v) The chemical substance's production volume or significant changes in production volume; and</P> <P>(vi) Any other information relevant to the potential risks of the chemical substance under the circumstances identified in the request.</P> <P>(5) The request must include a commitment to provide to EPA any referenced information upon request.</P> <P>(6) Scientific information submitted must be consistent with the scientific standards in 15 U.S.C. 2625(h).</P> <P>(7) A signed certification that all information contained in the request is accurate and complete, as follows:</P> <P>(i) I certify that to the best of my knowledge and belief:</P> <P>(A) The company named in this request manufacturers the chemical substance identified for risk evaluation.</P> <P>(B) All information provided in the notice is complete and accurate as of the date of the request.</P> <P>(C) I have either identified or am submitting all information in my possession, control, and a description of all other data known to or reasonably ascertainable by me as required for this request under this part. I am aware it is unlawful to knowingly submit incomplete, false and/or misleading information in this request and there are significant criminal penalties for such unlawful conduct, including the possibility of fine and imprisonment.</P> <P>(ii) [Reserved]</P> <P> (c) <E T="03">Optional elements.</E> A manufacturer may provide information that will inform EPA's determination as to whether restrictions imposed by one or more States have the potential to have a significant impact on interstate commerce or health or the environment, and that as a consequence the request is entitled to preference pursuant to 15 U.S.C. 2605(b)(4)(E)(iii). </P> <P> (d) <E T="03">Confidential business information.</E> Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703. </P> <P> (e) <E T="03">EPA process for evaluating manufacturer requests</E> —(1) <E T="03">Review for completeness.</E> Upon receipt of the request, EPA will verify that the request is facially complete, <E T="03">i.e.,</E> that information has been submitted that appears to be consistent with the requirements in paragraphs (b) through (d) of this section. EPA will inform the submitting manufacturer(s) if EPA has determined that the request is incomplete, and cannot be processed. Facially complete requests will be processed as described in this subpart. </P> <P> (2) <E T="03">Public notification of receipt of request.</E> Within 15 business days of receipt of a facially complete submission, EPA will notify the public of receipt of <PRTPAGE P="27"/> the manufacturer request. This notification will include any information submitted by the manufacturer that is not CBI, including the condition(s) of use for which the evaluation is requested. </P> <P> (3) <E T="03">Conditions of use to be evaluated.</E> EPA will assess whether the circumstances identified in the request constitute condition of use under § 702.33, and whether those conditions of use warrant inclusion within the scope of a risk evaluation for the chemical substance. EPA will also assess what, if any, additional conditions of use that warrant inclusion within the scope of a risk evaluation for the chemical substance. EPA will conduct these assessments and make proposed determinations based on the same considerations applied in the same manner as it would for a risk evaluation for a high-priority substance. </P> <P> (4) <E T="03">Public notice and comment.</E> No later than 60 business days of receiving a request that EPA has determined to be complete under paragraph (e)(1) of this section, EPA will submit for publication the receipt of the request in the <E T="04">Federal Register,</E> open a docket for that request and provide no less than a 45 calendar day public comment period. The docket will contain the manufacturer request (excluding information claimed as CBI) and EPA' proposed additions of conditions of use as described in paragraph (e)(3) of this section, and the basis for these proposed additions. During the comment period the public may submit comments and information relevant to the requested risk evaluation, in particular, commenters are encouraged to identify any information not included in the request or the proposed determinations that the commenters believe would be needed to conduct a risk evaluation, and to provide any other information relevant to EPA's proposed determinations of the conditions of use, such as information on other conditions of use of the chemical than those included in the request or in EPA's proposed determinations </P> <P> (5) <E T="03">Supplementation of original request.</E> (i) At any time prior to the end of the comment period, the requesting manufacturer(s) may supplement the original request with any new information it receives. </P> <P>(ii) At any point prior to the completion of a risk evaluation pursuant to this section, manufacturer(s) must supplement the original request with any information that meets the criteria in 15 U.S.C. 2607(e) and this section, or with any other information that has the potential to change EPA's risk evaluation with respect to the conditions of use as requested by the manufacturer. Such information must be submitted consistent with section 8(e) if the information is subject to that section or otherwise within 30 calendar days of the manufacturer's obtaining the information.</P> <P> (6) <E T="03">EPA's decision.</E> (i) Within 60 days of the end of the comment period provided in paragraph (e)(4) of this section, EPA will review the request along with any additional information received during the comment period to determine whether the request meets the criteria and requirements of this section. </P> <P>(ii) EPA will grant the request if it determines that all of the following have been met:</P> <P>(A) That the circumstances identified in the request constitute conditions of use that warrant inclusion in a risk evaluation for the chemical substance;</P> <P>(B) That EPA has all of the information needed to conduct such risk evaluation on the conditions of use that were the subject of the request; and</P> <P>(C) All other criteria and requirements of this section have been met.</P> <P>(iii) At the end of this 60-day period, EPA will notify the submitting manufacturer(s) of its decision and include the basis for granting or denying the request. Bases for a denial, include the manufacturer has not provided sufficient information to complete the risk evaluation on the condition(s) of use requested, or that the circumstances identified in the request either do not constitute conditions of use, or the conditions of use do not warrant inclusion in a risk evaluation for the chemical substance. This notification will also identify any additional conditions of use, as determined by the Administrator, that will be included in this risk evaluation.</P> <P> (iv) Within 30 days of receipt of EPA's notification the requester(s) may withdraw the request. <PRTPAGE P="28"/> </P> <P> (7) <E T="03">Public notice of decision.</E> EPA will make public EPA's decision to grant or deny the request at the time that EPA notifies the manufacturer. </P> <P> (8) <E T="03">Compliant request.</E> EPA will initiate a risk evaluation for all requests for non-TSCA Work Plan Chemicals that meet the criteria in this subpart, until EPA determines that the number of manufacturer-requested chemical substances undergoing risk evaluation is equal to 25% of the High-Priority Substances identified in subpart A as undergoing risk evaluation. Once that level has been reached, EPA will initiate at least one new manufacturer-requested risk evaluation for each manufacturer-requested risk evaluation completed so long as there are sufficient requests that meet the criteria of this subpart, as needed to ensure that the number of manufacturer-requested risk evaluations is equal to at least 25% of the High-Priority substances risk evaluation and not more than 50%. </P> <P> (9) <E T="03">Preferences.</E> In conformance with § 702.35(c), in evaluating requests for TSCA Work Plan Chemicals and requests for non-TSCA Work Plan chemicals in excess of the 25% threshold in § 702.35(b), EPA will first give preference to requests for risk evaluations on chemical substances: </P> <P>(i) First, for which the Agency determines that restrictions imposed by one or more States have the potential to have a significant impact on interstate commerce, health or the environment; and then</P> <P>(ii) Second, based on the order in which the requests are received.</P> <P> (10) <E T="03">No preferential treatment.</E> Once granted, EPA will initiate the risk evaluation and thereafter will conduct the risk evaluation following the procedures in §§ 702.39 through 702.51. EPA will not expedite or otherwise provide special treatment to a risk evaluation conducted as a result of a manufacturer's request. </P> <P> (11) <E T="03">Fees.</E> Manufacturers must pay fees to support risk evaluations as specified under 15 U.S.C. 2605(b)(4)(E)(ii). </P> <CITA>[82 FR 33747, July 20, 2017, as amended at 88 FR 37166, June 7, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 702.39</SECTNO> <SUBJECT>Interagency collaboration.</SUBJECT> <P>During the risk evaluation process, not to preclude any additional, prior, or subsequent collaboration, EPA will consult with other relevant Federal agencies.</P> </SECTION> <SECTION> <SECTNO>§ 702.41</SECTNO> <SUBJECT>Evaluation requirements.</SUBJECT> <P> (a) <E T="03">Considerations.</E> (1) Each risk evaluation will include all of the following components: </P> <P>(i) A Scope, including a Conceptual Model and an Analysis Plan;</P> <P>(ii) A Hazard Assessment;</P> <P>(iii) An Exposure Assessment;</P> <P>(iv) A Risk Characterization; and</P> <P>(v) A Risk Determination.</P> <P>(2) EPA guidance will be used, as applicable where it represents the best available science appropriate for the particular risk evaluation.</P> <P>(3) Where appropriate, a risk evaluation will be conducted on a category of chemical substances. EPA will determine whether to conduct an evaluation on a category of chemical substances, and the composition of the category based on the considerations listed in 15 U.S.C. 2625(c).</P> <P>(4) EPA will document that it has used the best available science and weight of scientific evidence approaches in the risk evaluation process.</P> <P>(5) EPA will ensure that all supporting analyses and components of the risk evaluation are suitable for their intended purpose, and well-tailored to the problems and decision at hand, in order to inform the development of a technically sound determination as to whether a chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use within the scope of the risk evaluation, based on the weight of the scientific evidence.</P> <P>(6) The extent to which EPA will refine its evaluations for one or more condition of use in any risk evaluation will vary as necessary to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment.</P> <P> (7) To the extent a determination as to the level of risk presented by a condition of use can be made, for example, <PRTPAGE P="29"/> using assumptions, uncertainty factors, and models or screening methodologies, EPA may determine that no further information or analysis is needed to complete its risk evaluation of the condition(s) of use. </P> <P>(8) In general, EPA intends to determine whether a chemical substance does or does not present an unreasonable risk under all of the conditions of use within the scope of the risk evaluations, and intends to identify the individual conditions of use or categories of conditions of use that are responsible for such determinations.</P> <P>(9) Within the time frame in § 702.43(d), EPA will complete the risk evaluation of the chemical substance addressing all of the conditions of use within the scope of the evaluation. However, EPA may complete its evaluation of the chemical substance under specific conditions of use or categories of conditions of use at any point following the issuance of the final scope document, and issue its determination as to whether the chemical substance under those conditions of use does or does not present an unreasonable risk to health or the environment under those conditions of use. EPA will follow all of the requirements and procedures in this Subpart when it conducts its evaluation of the chemical substance under any individual or specific conditions of use.</P> <P>(10) EPA will evaluate chemical substances that are metals or metal compounds in accordance with 15 U.S.C. 2605(b)(2)(E).</P> <P> (b) <E T="03">Information and information sources.</E> (1) EPA will base each risk evaluation on reasonably available information. </P> <P>(2) EPA generally expects to initiate a risk evaluation for a chemical substance when EPA believes that all or most of the information necessary to perform the risk evaluation is reasonably available. EPA expects to use its authorities under the Act, and other information gathering authorities, when necessary to obtain the information needed to perform a risk evaluation for a chemical substance before initiating the risk evaluation for such substance. EPA will use such authorities on a case-by-case basis during the performance of a risk evaluation to obtain information as needed to ensure that EPA has adequate, reasonably available information to perform the evaluation.</P> <P>(3) Among other sources of information, the Agency will consider information and advice provided by the Science Advisory Committee on Chemicals established pursuant to 15 U.S.C. 2625.</P> <P>(4) In conducting risk evaluations, EPA will utilize reasonably available information including information, models, and screening methodologies, as appropriate. The approaches used will be determined by the quality of the information, the deadlines specified in TSCA section 6(b)(4)(G) for completing the risk evaluation, and the extent to which the information reduces uncertainty.</P> <P>(5) Where appropriate, to the extent practicable, and scientifically justified, EPA will require the development of information generated without the use of new testing on vertebrates in performing risk evaluation.</P> <P> (c) <E T="03">Scope of the risk evaluation.</E> The scope of the risk evaluation will include all the following: </P> <P>(1) The condition(s) of use, as determined by the Administrator, that the EPA plans to consider in the risk evaluation.</P> <P>(2) The potentially exposed populations, including any potentially exposed or susceptible subpopulations as identified as relevant to the risk evaluation by the Agency under the conditions of use, that EPA plans to evaluate; the ecological receptors that EPA plans to evaluate; and the hazards to health and the environment that EPA plans to evaluate.</P> <P>(3) A description of the reasonably available information and science approaches EPA plans to use in the risk evaluation.</P> <P>(4) A conceptual model:</P> <P>(i) The scope documents will include a Conceptual Model that describes actual or predicted relationships between the chemical substance, the conditions of use within the scope of the evaluation and human and environmental receptors.</P> <P> (ii) The conceptual model will identify human and ecological health hazards the EPA plans to evaluate for the <PRTPAGE P="30"/> exposure scenarios EPA plans to evaluate. </P> <P>(iii) Conceptual model development will consider the life cycle of the chemical substance, including manufacture, processing, distribution in commerce, storage, use, and disposal, relevant to the conditions of use within the scope of the evaluation</P> <P>(5) An analysis plan:</P> <P>(i) The scope documents will include an analysis plan that identifies the approaches, methods, and/or metrics that EPA plans to use to assess exposures, effects, and risk, including associated uncertainty and variability for each risk evaluation. The analysis plan will also identify the strategy for using information, accepted science policies, models, and screening methodologies.</P> <P>(ii) Hypotheses about the relationships identified in the conceptual model will be described. The relative strengths of alternative hypotheses if any will be evaluated to determine the appropriate risk assessment approaches.</P> <P>(6) The Agency's plan for peer review.</P> <P>(7) Developing the scope.</P> <P> (i) <E T="03">Draft scope.</E> For each risk evaluation to be conducted EPA will publish a document in the <E T="04">Federal Register</E> that specifies the draft scope of the risk evaluation the Agency plans to conduct. The document will address the elements in paragraphs (c)(1) through (6) of this section. </P> <P> (ii) <E T="03">Timeframes.</E> EPA generally expects to publish the draft scope no later than 3 months from the initiation of the risk evaluation process for the chemical substance. </P> <P> (iii) <E T="03">Public comments.</E> EPA will allow a public comment period of no less than 45 calendar days during which interested persons may submit comment on EPA's draft risk evaluation scope. EPA will open a docket to facilitate receipt of public comments. </P> <P>(8) Final scope:</P> <P> (i) The Agency will, no later than 6 months after the initiation of a risk evaluation, publish a document in the <E T="04">Federal Register</E> that specifies the final scope of the risk evaluation the Agency plans to conduct. The document shall address the elements in paragraphs (c)(1) through (6) of this section. </P> <P>(ii) For a chemical substance designated as a High-Priority Substance under subpart A of this part, EPA will not publish the final scope of the risk evaluation until at least 12 months have elapsed from the initiation of the prioritization process for the chemical substance.</P> <P> (d) <E T="03">Hazard assessment.</E> (1) The hazard information relevant to the chemical substance will be evaluated using hazards identified in the final scope document published pursuant to paragraph (c)(8) of this section, for the identified exposure scenarios, including any identified potentially exposed or susceptible subpopulation(s). </P> <P>(2) The hazard assessment process will identify the types of hazards to health or the environment posed by the chemical substance under the condition(s) of use within the scope of the risk evaluation. Hazard information related to potential health and environmental hazards of the chemical substance will be reviewed in a manner consistent with best available science and weight of scientific evidence as defined in § 702.33 and all assessment methods will be documented. This process includes the identification, evaluation, and synthesis of information to describe the potential health and environmental hazards of the chemical substance.</P> <P>(3) Relevant potential human and environmental hazards will be evaluated.</P> <P>(4) The relationship between the dose of the chemical substance and the occurrence of health and environmental effects or outcomes will be evaluated.</P> <P>(5) Studies evaluated may include, but would not be limited to: Human epidemiological studies, in vivo and/or in vitro laboratory studies, biomonitoring studies, mechanistic and/or kinetic studies in a variety of test systems, including but not limited to toxicokinetics and toxicodynamics, computational toxicology such as high-throughput assays, genomic response assays, data from structure-activity relationships, and ecological field data.</P> <P> (6) Hazard identification will include an evaluation of the strengths, limitations, and uncertainties associated with the reasonably available information. <PRTPAGE P="31"/> </P> <P>(7) The human health hazard assessment will consider all potentially exposed and susceptible subpopulation(s) determined to be relevant, as identified in the final scope document published pursuant to paragraph (c)(8) of this section.</P> <P>(8) The environmental health hazard assessment will consider the relationship between the chemical substance and the occurrence of an ecological hazard elicited.</P> <P> (e) <E T="03">Exposure assessment.</E> (1) Where relevant, the likely duration, intensity, frequency, and number of exposures under the conditions of use will be considered. </P> <P>(2) Chemical-specific factors including, but not limited to: Physical- chemical properties and environmental fate and transport parameters will be examined.</P> <P>(3) Exposure information related to potential human health or ecological hazards of the chemical substance will be reviewed in a manner consistent with the description of best available science and weight of scientific evidence in § 702.33 and all methods will be documented.</P> <P>(4) The human health exposure assessment will consider all potentially exposed and susceptible subpopulation(s) determined to be relevant, as identified in the final scope document published pursuant to paragraph (c)(8) of this section.</P> <P>(5) Environmental health exposure assessment:</P> <P>(i) The environmental health exposure assessment will characterize and evaluate the interaction of the chemical substance with the ecological receptors identified in the final scope document published pursuant to paragraph (c)(8) of this section.</P> <P>(ii) Exposures considered will include populations and communities, depending on the chemical substance and the ecological characteristic involved.</P> </SECTION> <SECTION> <SECTNO>§ 702.43</SECTNO> <SUBJECT>Risk Characterization.</SUBJECT> <P> (a) <E T="03">Risk Characterization considerations.</E> EPA will: </P> <P>(1) Integrate the hazard and exposure assessments into quantitative and/or qualitative estimates of risk for the identified populations (including any potentially exposed or susceptible subpopulation(s)) identified in the final scope document published pursuant to § 702.41(c)(8) and ecological characteristics for the conditions of use within the scope of the risk evaluation;</P> <P>(2) Describe whether aggregate or sentinel exposures under the conditions of use were considered and the basis for their consideration;</P> <P>(3) Not consider costs or other nonrisk factors;</P> <P>(4) Take into account, where relevant, the likely duration, intensity, frequency, and number of exposures under the condition(s) of use of the chemical substance; and</P> <P>(5) Describe the weight of the scientific evidence for the identified hazards and exposures.</P> <P> (b) <E T="03">Risk Characterization summary.</E> The Risk Characterization will summarize, as applicable, the considerations addressed throughout the evaluation components, in carrying out the obligations under 15 U.S.C. 2625(h). This summary will include, as appropriate, a discussion of: </P> <P> (1) <E T="03">Considerations regarding uncertainty and variability.</E> Information about uncertainty and variability in each step of the risk evaluation (e.g., use of default assumptions, scenarios, choice of models, and information used for quantitative analysis) will be integrated into an overall characterization and/or analysis of the impact of the uncertainty and variability on estimated risks. EPA may describe the uncertainty using a qualitative assessment of the overall strength and limitations of the data used in the assessment. </P> <P> (2) <E T="03">Considerations of data quality.</E> A discussion of data quality (e.g., reliability, relevance, and whether methods employed to generate the information are reasonable for and consistent with the intended use of the information), as well as assumptions used, will be included to the extent necessary. EPA also expects to include a discussion of the extent of independent verification or peer review of the information or of the procedures, measures, methods, protocols, methodologies, or models used in the risk evaluation. </P> <P> (3) <E T="03">Considerations of alternative interpretations.</E> If appropriate and relevant, where alternative interpretations are plausible, a discussion of alternative <PRTPAGE P="32"/> interpretations of the data and analyses will be included. </P> <P> (4) <E T="03">Considerations for environmental risk evaluations.</E> For environmental risk evaluations, it may be necessary to discuss the nature and magnitude of the effects, the spatial and temporal patterns of the effects, implications at the individual, species, population, and community level, and the likelihood of recovery subsequent to exposure to the chemical substance. </P> </SECTION> <SECTION> <SECTNO>§ 702.45</SECTNO> <SUBJECT>Peer review.</SUBJECT> <P> The <E T="03">EPA Peer Review Handbook</E> (2015), the Office of Management and Budget Final Information Quality Bulletin for Peer Review (OMB Bulletin), and other available, relevant and applicable methods consistent with 15 U.S.C. 2625, will serve as the guidance for peer review activities. Peer review will be conducted on the risk evaluations for the chemical substances identified pursuant to 15 U.S.C. 2605(b)(4)(A). </P> </SECTION> <SECTION> <SECTNO>§ 702.47</SECTNO> <SUBJECT>Unreasonable risk determination.</SUBJECT> <P>As part of the risk evaluation, EPA will determine whether the chemical substance presents an unreasonable risk of injury to health or the environment under each condition of uses within the scope of the risk evaluation, either in a single decision document or in multiple decision documents.</P> </SECTION> <SECTION> <SECTNO>§ 702.49</SECTNO> <SUBJECT>Risk evaluation timeframes and actions.</SUBJECT> <P> (a) <E T="03">Draft risk evaluation timeframe.</E> EPA will publish a draft risk evaluation in the <E T="04">Federal Register,</E> open a docket to facilitate receipt of public comment, and provide no less than a 60-day comment period, during which time the public may submit comment on EPA's draft risk evaluation. </P> <P> (b) <E T="03">Final risk evaluation.</E> (1) EPA will complete a risk evaluation for the chemical substance under the conditions of use within the scope of the risk evaluation as soon as practicable, but not later than 3 years after the date on which the Agency initiates the risk evaluation. </P> <P>(2) The Agency may extend the deadline for a risk evaluation for not more than 6 months. The total time elapsed between initiation of the risk evaluation and completion of the risk evaluation may not exceed 3 and one half years.</P> <P> (3) EPA will publish the final risk evaluation in the <E T="04">Federal Register</E> . </P> <P> (c) <E T="03">Final determination of unreasonable risk.</E> Upon determination by the EPA that a chemical substance under one or more of the conditions of use within the scope of the risk evaluation presents an unreasonable risk of injury to health or the environment as described in § 702.47, the Agency will initiate action as required pursuant to 15 U.S.C. 2605(a). </P> <P> (d) <E T="03">Final determination of no unreasonable risk.</E> A determination by EPA that the chemical substance, under one or more of the conditions of use within the scope of the risk evaluation, does not present an unreasonable risk of injury to health or the environment will be issued by order and considered to be a final Agency action, effective on the date of issuance of the order. </P> </SECTION> <SECTION> <SECTNO>§ 702.51</SECTNO> <SUBJECT>Publically available information.</SUBJECT> <P> For each risk evaluation, EPA will maintain a public docket at <E T="03">http://www.regulations.gov</E> to provide public access to the following information, as applicable for that risk evaluation: </P> <P>(a) The draft scope, final scope, draft risk evaluation, and final risk evaluation;</P> <P>(b) All notices, determinations, findings, consent agreements, and orders;</P> <P>(c) Any information required to be provided to the Agency under 15 U.S.C. 2603;</P> <P>(d) A nontechnical summary of the risk evaluation;</P> <P>(e) A list of the studies, with the results of the studies, considered in carrying out each risk evaluation;</P> <P>(f) The final peer review report, including the response to peer review and public comments received during peer review; and</P> <P>(g) Response to public comments received on the draft scope and the draft risk evaluation.</P> <EAR>Pt. 702, Subpt. B, Nt.</EAR> <EFFDNOTP> <HD SOURCE="HED">Effective Date Note:</HD> <P>At 89 FR 37052, May 3, 2024, subpart B was revised and republished, effective July 2, 2024. For the convenience of the user, the revised text is set forth as follows:</P> <REVTXT> <SUBPART> <PRTPAGE P="33"/> <HD SOURCE="HED">Subpart B—Procedures for Chemical Substance Risk Evaluations</HD> <SECTION> <SECTNO>§ 702.31</SECTNO> <SUBJECT>General provisions.</SUBJECT> <P> (a) <E T="03">Purpose.</E> This subpart establishes the EPA process for conducting a risk evaluation to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment as required under TSCA section 6(b)(4)(B) (15 U.S.C. 2605(b)(4)(B)). </P> <P> (b) <E T="03">Scope.</E> These regulations establish the general procedures, key definitions, and timelines EPA will use in a risk evaluation conducted pursuant to TSCA section 6(b) (15 U.S.C. 2605(b)). </P> <P> (c) <E T="03">Applicability.</E> The requirements of this part apply to all chemical substance risk evaluations initiated pursuant to TSCA section 6(b) (15 U.S.C. 2605(b)) beginning June 3, 2024. For risk evaluations initiated prior to this date, but not yet finalized, EPA will seek to apply the requirements in this subpart to the extent practicable. These requirements shall not apply retroactively to risk evaluations already finalized. </P> <P> (d) <E T="03">Categories of chemical substances.</E> Consistent with EPA's authority to take action with respect to categories of chemicals under 15 U.S.C. 2625(c), all references in this part to “chemical” or “chemical substance” shall also apply to “a category of chemical substances.” </P> </SECTION> <SECTION> <SECTNO>§ 702.33</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>All definitions in TSCA apply to this subpart. In addition, the following definitions apply:</P> <P> <E T="03">Act</E> means the Toxic Substances Control Act (TSCA), as amended (15 U.S.C. 2601 <E T="03">et seq.</E> ). </P> <P> <E T="03">Aggregate exposure</E> means the combined exposures from a chemical substance across multiple routes and across multiple pathways. </P> <P> <E T="03">Conditions of use</E> means the circumstances, as determined by the Administrator, under which a chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used, or disposed of. </P> <P> <E T="03">EPA</E> means the U.S. Environmental Protection Agency. </P> <P> <E T="03">Pathways</E> means the physical course a chemical substance takes from the source to the organism exposed. </P> <P> <E T="03">Potentially exposed or susceptible subpopulation</E> means a group of individuals within the general population identified by EPA who, due to either greater susceptibility or greater exposure, may be at greater risk than the general population of adverse health effects from exposure to a chemical substance or mixture, such as infants, children, pregnant women, workers, the elderly, or overburdened communities. </P> <P> <E T="03">Reasonably available information</E> means information that EPA possesses or can reasonably generate, obtain, and synthesize for use in risk evaluations, considering the deadlines specified in TSCA section 6(b)(4)(G) for completing such evaluation. Information that meets the terms of the preceding sentence is reasonably available information whether or not the information is confidential business information, that is protected from public disclosure under TSCA section 14. </P> <P> <E T="03">Routes</E> means the ways a chemical substance enters an organism after contact, <E T="03">e.g.,</E> by ingestion, inhalation, or dermal absorption. </P> <P> <E T="03">Sentinel exposure</E> means the exposure from a chemical substance that represents the plausible upper bound of exposure relative to all other exposures within a broad category of similar or related exposures. </P> <P> <E T="03">Uncertainty</E> means the imperfect knowledge or lack of precise knowledge of the real world either for specific values of interest or in the description of the system. </P> <P> <E T="03">Variability</E> means the inherent natural variation, diversity, and heterogeneity across time and/or space or among individuals within a population. </P> </SECTION> <SECTION> <SECTNO>§ 702.35</SECTNO> <SUBJECT>Chemical substances subject to risk evaluation.</SUBJECT> <P> (a) <E T="03">Chemical substances undergoing risk evaluation.</E> A risk evaluation for a chemical substance designated by EPA as a High-Priority Substance pursuant to the prioritization process described in subpart A or initiated at the request of a manufacturer or manufacturers under § 702.45, will be conducted in accordance with this part, subject to § 702.31(c). </P> <P> (b) <E T="03">Percentage requirements.</E> Pursuant to 15 U.S.C. 2605(b)(4)(E)(i) and in accordance with § 702.45(j)(1), EPA will ensure that the number of chemical substances for which a manufacturer-requested risk evaluation is initiated pursuant to § 702.45(e)(9) is not less than 25%and not more than 50% of the number of chemical substances for which a risk evaluation was initiated upon designation as a High-Priority Substance under subpart A. </P> <P> (c) <E T="03">Manufacturer-requested risk evaluations for work plan chemical substances.</E> Manufacturer requests for risk evaluations, described in paragraph (a) of this section, for chemical substances that are drawn from the 2014 update of the TSCA Work Plan for Chemical Assessments will be granted at the discretion of EPA. Such evaluations are not subject to the percentage requirements in paragraph (b) of this section. </P> </SECTION> <SECTION> <SECTNO>§ 702.37</SECTNO> <SUBJECT>Evaluation requirements.</SUBJECT> <P> (a) <E T="03">Considerations.</E> (1) EPA will use applicable EPA guidance when conducting risk evaluations, as appropriate and where it represents the best available science. <PRTPAGE P="34"/> </P> <P>(2) EPA will document that the risk evaluation is consistent with the best available science and based on the weight of the scientific evidence. In determining best available science, EPA shall consider as applicable:</P> <P>(i) The extent to which the scientific information, technical procedures, measures, methods, protocols, methodologies, or models employed to generate the information are reasonable for and consistent with the intended use of the information;</P> <P>(ii) The extent to which the information is relevant for the Administrator's use in making a decision about a chemical substance or mixture;</P> <P>(iii) The degree of clarity and completeness with which the data, assumptions, methods, quality assurance, and analyses employed to generate the information are documented;</P> <P>(iv) The extent to which the variability and uncertainty in the information, or in the procedures, measures, methods, protocols, methodologies, or models, are evaluated and characterized; and</P> <P>(v) The extent of independent verification or peer review of the information or of the procedures, measures, methods, protocols, methodologies or models.</P> <P>(3) EPA will ensure that all supporting analyses and components of the risk evaluation are suitable for their intended purpose, and tailored to the problems and decision at hand, in order to inform the development of a technically sound determination as to whether a chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use, based on the weight of the scientific evidence.</P> <P>(4) EPA will not exclude conditions of use from the scope of the risk evaluation, but a fit-for-purpose approach may result in varying types and levels of analysis and supporting information for certain conditions of use, consistent with paragraph (b) of this section. The extent to which EPA will refine its evaluations for one or more condition of use in any risk evaluation will vary as necessary to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment.</P> <P>(5) EPA will evaluate chemical substances that are metals or metal compounds in accordance with 15 U.S.C. 2605(b)(2)(E).</P> <P> (b) <E T="03">Information and information sources.</E> (1) EPA will base each risk evaluation on reasonably available information. </P> <P>(2) EPA will apply systematic review methods to assess reasonably available information, as needed to carry out risk evaluations that meet the requirements in TSCA section 26(h) and (i), in a manner that is objective, unbiased, and transparent.</P> <P>(3) EPA may determine that certain information gaps can be addressed through application of assumptions, uncertainty factors, models, and/or screening to conduct its analysis with respect to the chemical substance, consistent with 15 U.S.C. 2625. The approaches used will be determined by the quality of reasonably available information, the deadlines specified in TSCA section 6(b)(4)(G) for completing the risk evaluation, and the extent to which the information reduces uncertainty.</P> <P>(4) EPA expects to use its authorities under the Act, and other information gathering authorities, when necessary to obtain the information needed to perform a risk evaluation for a chemical substance before initiating the risk evaluation for such substance. EPA will also use such authorities during the performance of a risk evaluation to obtain information as needed and on a case-by-case basis to ensure that EPA has adequate, reasonably available information to perform the evaluation. Where appropriate, to the extent practicable, and scientifically justified, EPA will require the development of information generated without the use of new testing on vertebrates.</P> <P>(5) Among other sources of information, EPA will also consider information and advice provided by the Science Advisory Committee on Chemicals established pursuant to 15 U.S.C. 2625(o).</P> </SECTION> <SECTION> <SECTNO>§ 702.39</SECTNO> <SUBJECT>Components of risk evaluation.</SUBJECT> <P> (a) <E T="03">In general.</E> Each risk evaluation will include all of the following components: </P> <P>(1) A Scope;</P> <P>(2) A Hazard Assessment;</P> <P>(3) An Exposure Assessment;</P> <P>(4) A Risk Characterization; and</P> <P>(5) A Risk Determination.</P> <P> (b) <E T="03">Scope of the risk evaluation.</E> The scope of the risk evaluation will include all the following: </P> <P>(1) The condition(s) of use the EPA expects to consider in the risk evaluation.</P> <P>(2) The potentially exposed populations, including any potentially exposed or susceptible subpopulations as identified as relevant to the risk evaluation by EPA under the conditions of use that EPA plans to evaluate.</P> <P>(3) The ecological receptors that EPA plans to evaluate.</P> <P>(4) The hazards to health and the environment that EPA plans to evaluate.</P> <P>(5) A description of the reasonably available information and scientific approaches EPA plans to use in the risk evaluation.</P> <P>(6) A conceptual model that describes the actual or predicted relationships between the chemical substance, its associated conditions of use through predicted exposure scenarios, and the identified human and environmental receptors and human and ecological health hazards.</P> <P> (7) An analysis plan that includes hypotheses and descriptions about the relationships identified in the conceptual model <PRTPAGE P="35"/> and the approaches and strategies EPA intends to use to assess exposure and hazard effects, and to characterize risk; and a description, including quality, of the data, information, methods, and models, that EPA intends to use in the analysis and how uncertainty and variability will be characterized. </P> <P>(8) EPA's plan for peer review consistent with § 702.41.</P> <P> (c) <E T="03">Hazard assessment.</E> (1) The hazard assessment process includes the identification, evaluation, and synthesis of information to describe the potential health and environmental hazards of the chemical substance under the conditions of use. </P> <P>(2) Hazard information related to potential health and environmental hazards of the chemical substance will be reviewed in a manner consistent with best available science based on the weight of scientific evidence and all assessment methods will be documented.</P> <P> (3) Consistent with § 702.37(b), information evaluated may include, but would not be limited to: Human epidemiological studies, in vivo and/or in vitro laboratory studies, biomonitoring and/or human clinical studies, ecological field data, read across, mechanistic and/or kinetic studies in a variety of test systems. These may include but are not limited to: toxicokinetics and toxicodynamics ( <E T="03">e.g.,</E> physiological-based pharmacokinetic modeling), and computational toxicology ( <E T="03">e.g.,</E> high-throughput assays, genomic response assays, data from structure-activity relationships, in silico approaches, and other health effects modeling). </P> <P>(4) The hazard information relevant to the chemical substance will be evaluated for identified human and environmental receptors, including all identified potentially exposed or susceptible subpopulation(s) determined to be relevant, for the exposure scenarios relating to the conditions of use.</P> <P>(5) The relationship between the dose of the chemical substance and the occurrence of health and environmental effects or outcomes will be evaluated.</P> <P>(6) Hazard identification will include an evaluation of the strengths, limitations, and uncertainties associated with the reasonably available information.</P> <P> (d) <E T="03">Exposure assessment.</E> (1) Where relevant, the likely duration, intensity, frequency, and number of exposures under the conditions of use will be considered. </P> <P>(2) Exposure information related to potential human health or ecological hazards of the chemical substance will be reviewed in a manner consistent with best available science based on the weight of scientific evidence and all assessment methods will be documented.</P> <P>(3) Consistent with § 702.37(b), information evaluated may include, but would not be limited to: chemical release reports, release or emission scenarios, data and information collected from monitoring or reporting, release estimation approaches and assumptions, biological monitoring data, workplace monitoring data, chemical exposure health data, industry practices with respect to occupational exposure control measures, and exposure modeling.</P> <P>(4) Chemical-specific factors, including, but not limited to physical-chemical properties and environmental fate and transport parameters, will be examined.</P> <P>(5) The human health exposure assessment will consider all potentially exposed or susceptible subpopulation(s) determined to be relevant.</P> <P>(6) Environmental health exposure assessment will characterize and evaluate the interaction of the chemical substance with the ecological receptors and the exposures considered, including populations and communities, depending on the chemical substance and the ecological characteristic involved.</P> <P>(7) EPA will describe whether sentinel exposures under the conditions of use were considered and the basis for their consideration.</P> <P>(8) EPA will consider aggregate exposures to the chemical substance, and, when supported by reasonably available information, consistent with the best available science and based on the weight of scientific evidence, include an aggregate exposure assessment in the risk evaluation, or will otherwise explain in the risk evaluation the basis for not including such an assessment.</P> <P>(9) EPA will assess all exposure routes and pathways relevant to the chemical substance under the conditions of use, including those that are regulated under other federal statutes.</P> <P> (e) <E T="03">Risk characterization.</E> (1) <E T="03">Requirements.</E> To characterize the risks from the chemical substance, EPA will: </P> <P>(i) Integrate the hazard and exposure assessments into quantitative and/or qualitative estimates relevant to specific risks of injury to health or the environment, including any potentially exposed or susceptible subpopulations identified, under the conditions of use;</P> <P>(ii) Not consider costs or other non-risk factors; and</P> <P>(iii) Describe the weight of the scientific evidence for the identified hazards and exposures.</P> <P> (2) <E T="03">Summary of considerations.</E> EPA will summarize, as applicable, the considerations addressed throughout the evaluation components, in carrying out the obligations under 15 U.S.C. 2625(h). This summary will include, as appropriate, a discussion of: </P> <P> (i) <E T="03">Considerations regarding uncertainty and variability.</E> Information about uncertainty and variability in each step of the risk evaluation ( <E T="03">e.g.,</E> use of default assumptions, scenarios, choice of models, and information <PRTPAGE P="36"/> used for quantitative analysis) will be integrated into an overall characterization and/or analysis of the impact of the uncertainty and variability on estimated risks. EPA may describe the uncertainty using a qualitative assessment of the overall strength and limitations of the data and approaches used in the assessment. </P> <P> (ii) <E T="03">Considerations of data quality.</E> A discussion of data quality ( <E T="03">e.g.,</E> reliability, relevance, and whether methods employed to generate the information are reasonable for and consistent with the intended use of the information), as well as assumptions used, will be included to the extent necessary. EPA also expects to include a discussion of the extent of independent verification or peer review of the information or of the procedures, measures, methods, protocols, methodologies, or models used in the risk evaluation. </P> <P> (iii) <E T="03">Considerations of alternative interpretations.</E> If appropriate and relevant, where alternative interpretations are plausible, a discussion of alternative interpretations of the data and analyses will be included. </P> <P> (iv) <E T="03">Additional considerations for environmental risk.</E> For evaluation of environmental risk, it may be necessary to discuss the nature and magnitude of the effects, the spatial and temporal patterns of the effects, implications at the individual, species, population, and community level, and the likelihood of recovery subsequent to exposure to the chemical substance. </P> <P> (f) <E T="03">Risk determination.</E> (1) As part of the risk evaluation, EPA will make a single determination as to whether the chemical substance presents an unreasonable risk of injury to health or the environment, without consideration of costs or other non-risk factors, including an unreasonable risk to a potentially exposed or susceptible subpopulation, under the conditions of use. </P> <P>(2) In determining whether unreasonable risk is presented, EPA's consideration of occupational exposure scenarios will take into account reasonably available information, including known and reasonably foreseen circumstances where subpopulations of workers are exposed due to the absence or ineffective use of personal protective equipment. EPA will not consider exposure reduction based on assumed use of personal protective equipment as part of the risk determination.</P> <P>(3) EPA will determine whether a chemical substance does or does not present an unreasonable risk after considering the risks posed under the conditions of use and, where EPA makes a determination of unreasonable risk, EPA will identify the conditions of use that significantly contribute to such determination.</P> </SECTION> <SECTION> <SECTNO>§ 702.41</SECTNO> <SUBJECT>Peer review.</SUBJECT> <P>EPA will conduct peer review activities on risk evaluations conducted pursuant to 15 U.S.C. 2605(b)(4)(A). EPA expects such activities, including decisions regarding the appropriate scope and type of peer review, to be consistent with the applicable peer review policies, procedures, and methods in guidance promulgated by the Office of Management and Budget and EPA, and in accordance with 15 U.S.C. 2625(h) and (i).</P> </SECTION> <SECTION> <SECTNO>§ 702.43</SECTNO> <SUBJECT>Risk evaluation actions and timeframes.</SUBJECT> <P> (a) <E T="03">Draft scope.</E> (1) For each risk evaluation to be conducted, EPA will publish a document that specifies the draft scope of the risk evaluation EPA plans to conduct and publish a notice of availability in the <E T="04">Federal Register.</E> The document will address the elements in § 702.39(b). </P> <P>(2) EPA generally expects to publish the draft scope during the prioritization process concurrent with publication of a proposed designation as a High-Priority Substance pursuant to § 702.9(g), but no later than 3 months after the initiation of the risk evaluation process for the chemical substance.</P> <P>(3) EPA will allow a public comment period of no less than 45 calendar days during which interested persons may submit comment on EPA's draft scope. EPA will open a docket to facilitate receipt of public comments.</P> <P> (b) <E T="03">Final scope.</E> (1) EPA will, no later than 6 months after the initiation of a risk evaluation, publish a document that specifies the final scope of the risk evaluation EPA plans to conduct, and publish a notice of availability in the <E T="04">Federal Register.</E> The document shall address the elements in § 702.39(b). </P> <P>(2) For a chemical substance designated as a High-Priority Substance under subpart A of this part, EPA will not publish the final scope of the risk evaluation until at least 12 months have elapsed from the initiation of the prioritization process for the chemical substance.</P> <P> (c) <E T="03">Draft risk evaluation.</E> EPA will publish a draft risk evaluation, publish a notice of availability in the <E T="04">Federal Register,</E> open a docket to facilitate receipt of public comment, and provide no less than a 60-day comment period, during which time the public may submit comment on EPA's draft risk evaluation. The document shall include the elements in § 702.39(c) through (f). </P> <P> (d) <E T="03">Final risk evaluation.</E> (1) EPA will complete and publish a final risk evaluation for the chemical substance under the conditions of use as soon as practicable, but not later than 3 years after the date on which EPA initiates the risk evaluation. The document shall include the elements in § 702.39(c) through (f) and EPA will publish a notice of availability in the <E T="04">Federal Register</E> . </P> <P> (2) EPA may extend the deadline for a risk evaluation for not more than 6 months. The total time elapsed between initiation of the risk evaluation and completion of the risk <PRTPAGE P="37"/> evaluation may not exceed 3- and one-half years. </P> <P> (e) <E T="03">Final determination of unreasonable risk.</E> Upon determination by the EPA pursuant to § 702.39(f) that a chemical substance presents an unreasonable risk of injury to health or the environment, EPA will initiate action as required pursuant to 15 U.S.C. 2605(a). </P> <P> (f) <E T="03">Final determination of no unreasonable risk.</E> A determination by the EPA pursuant to § 702.39(f) that the chemical substance does not present an unreasonable risk of injury to health or the environment will be issued by order and considered to be a final Agency action, effective on the date of issuance of the order. </P> <P> (g) <E T="03">Substantive revisions to scope documents and risk evaluations.</E> The circumstances under which EPA will undertake substantive revisions to scope and risk evaluation documents are as follows: </P> <P> (1) <E T="03">Draft documents.</E> To the extent there are changes to a draft scope or draft risk evaluation, EPA will describe such changes in the final document. </P> <P> (2) <E T="03">Final scope.</E> To the extent there are changes to the scope of the risk evaluation after publication of the final scope document, EPA will describe such changes in the draft risk evaluation, or, where appropriate and prior to the issuance of a draft risk evaluation, may make relevant information publicly available in the docket and publish a notice of availability of that information in the <E T="04">Federal Register</E> . </P> <P> (3) <E T="03">Final risk evaluation.</E> For any chemical substance for which EPA has already finalized a risk evaluation, EPA will generally not revise, supplement, or reissue a final risk evaluation without first undergoing the procedures at § 702.7 to re-initiate the prioritization process for that chemical substance, except where EPA has determined it to be in the interest of protecting human health or the environment to do so, considering the statutory responsibilities and deadlines under 15 U.S.C. 2605. </P> <P> (4) <E T="03">Process for revisions to final risk evaluations.</E> Where EPA determines to revise or supplement a final risk evaluation pursuant to paragraph (g)(3) of this section, EPA will follow the same procedures in this section including publication of a new draft and final risk evaluation and solicitation of public comment in accordance with §§ 702.43(c) and (d), and peer review, as appropriate, in accordance with § 702.41. </P> </SECTION> <SECTION> <SECTNO>§ 702.45</SECTNO> <SUBJECT>Submission of manufacturer requests for risk evaluations.</SUBJECT> <P> (a) <E T="03">General provisions.</E> (1) One or more manufacturers of a chemical substance may request that EPA conduct a risk evaluation on a chemical substance. </P> <P>(2) Such requests must comply with all the requirements, procedures, and criteria in this section.</P> <P>(3) Subject to limited exceptions in paragraph (e)(7)(iii) of this section, it is the burden of the requesting manufacturer(s) to provide EPA with the information necessary to carry out the risk evaluation.</P> <P>(4) In determining whether there is sufficient information to support a manufacturer-requested risk evaluation, EPA expects to apply the same standard as it would for EPA-initiated risk evaluations, including but not limited to the considerations and requirements in § 702.37.</P> <P>(5) EPA may identify data needs at any time during the process described in this section, and, by submitting a request for risk evaluation under this section, the requesting manufacturer(s) agrees to provide, or develop and provide, EPA with information EPA deems necessary to carry out the risk evaluation, consistent with the provisions described in this subpart.</P> <P>(6) EPA will not expedite or otherwise provide special treatment to a manufacturer-requested risk evaluation pursuant to 15 U.S.C. 2605(b)(4)(E)(ii).</P> <P>(7) Once initiated in accordance with paragraph (e)(9) of this section, EPA will conduct manufacturer-requested risk evaluations following the procedures in §§ 702.37 through 702.43 and §§ 702.47 through 702.49 of this subpart.</P> <P>(8) For purposes of this section, information that is “known to or reasonably ascertainable by” the requesting manufacturer(s) would include all information in the requesting manufacturer's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know. Meeting this standard requires an exercise and documentation of due diligence that may vary depending on the circumstances and parties involved. At a minimum, due diligence requires:</P> <P>(i) A thorough search and collection of publicly available information;</P> <P>(ii) A reasonable inquiry within the requesting manufacturer's entire organization; and</P> <P>(iii) A reasonably inquiry outside of the requesting manufacturer's organization, including inquiries to upstream suppliers; downstream users; and employees or other agents of the manufacturer, including persons involved in research and development, import or production, or marketing.</P> <P>(9) In the event that a group of manufacturers of a chemical substance submit a request for risk evaluation under this section, the term “requesting manufacturer” in paragraphs (a), (c), and (i) of this section shall apply to all manufacturers in the group. EPA will otherwise coordinate with the primary contact named in the request for purposes of communication, payment of fees, and other actions as needed.</P> <P> (b) <E T="03">Method for submission.</E> All manufacturer-requested risk evaluations under this <PRTPAGE P="38"/> subpart must be submitted via the EPA Central Data Exchange (CDX) found at <E T="03">https://cdx.epa.gov.</E> </P> <P> (c) <E T="03">Content of request.</E> Requests must include all of the following information: </P> <P>(1) Name, mailing address, and contact information of the entity (or entities) submitting the request. If more than one manufacturer submits the request, all individual manufacturers must provide their contact information.</P> <P>(2) The chemical identity of the chemical substance that is the subject of the request. At a minimum, this includes: all known names of the chemical substance, including common or trades names, CAS number, and molecular structure of the chemical substance.</P> <P>(3) For requests pertaining to a category of chemical substances, an explanation of why the category is appropriate under 15 U.S.C. 2625(c). EPA will determine whether the category is appropriate for risk evaluation as part of reviewing the request in paragraph (e) of this section.</P> <P>(4) A description of the circumstances under which the chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used, or disposed of, and all information known to or reasonably ascertainable by the requesting manufacturer that supports the identification of the circumstances described in this paragraph (c)(4).</P> <P>(5) All information known to or reasonably ascertainable by the requesting manufacturer(s) on the health and environmental hazard(s) of the chemical substance, human and environmental exposure(s), and exposed population(s), including but not limited to:</P> <P>(i) The chemical substance's exposure potential, including occupational, general population and consumer exposures, and facility release information;</P> <P>(ii) The chemical substance's hazard potential, including all potential environmental and human health hazards;</P> <P>(iii) The chemical substance's physical and chemical properties;</P> <P>(iv) The chemical substance's fate and transport properties including persistence and bioaccumulation;</P> <P>(v) Industrial and commercial locations where the chemical is used or stored;</P> <P>(vi) Whether there is any storage of the chemical substance near significant sources of drinking water, including the storage facility location and the nearby drinking water source(s);</P> <P>(vii) Consumer products containing the chemical;</P> <P>(viii) The chemical substance's production volume or significant changes in production volume; and</P> <P>(ix) Any other information relevant to the hazards, exposures and/or risks of the chemical substance.</P> <P>(6) Where information described in paragraph (c)(4) or (5) of this section is unavailable, an explanation as to why, and the rationale for why, in the requester's view, the provided information is nonetheless sufficient to allow EPA to complete a risk evaluation on the chemical substance.</P> <P>(7) Copies of all information referenced in paragraph (c)(5) of this section, or citations if the information is readily available from public sources.</P> <P>(8) A signed certification from the requesting manufacturer(s) that all information contained in the request is accurate and complete, as follows:</P> <EXTRACT> <P>I certify that to the best of my knowledge and belief:</P> <P>(A) The company named in this request manufactures the chemical substance identified for risk evaluation.</P> <P>(B) All information provided in the request is complete and accurate as of the date of the request.</P> <P>(C) I have either identified or am submitting all information in my possession and control, and a description of all other data known to or reasonably ascertainable by me as required under this part. I am aware it is unlawful to knowingly submit incomplete, false and/or misleading information in this request and there are significant criminal penalties for such unlawful conduct, including the possibility of fine and imprisonment.</P> </EXTRACT> <P>(9) Where appropriate, information that will inform EPA's determination as to whether restrictions imposed by one or more States have the potential to have a significant impact on interstate commerce or health or the environment, and that as a consequence the request is entitled to preference pursuant to 15 U.S.C. 2605(b)(4)(E)(iii).</P> <P> (d) <E T="03">Confidential business information.</E> Persons submitting a request under this subpart are subject to EPA confidentiality regulations at 40 CFR part 2, subpart B, and 40 CFR part 703. </P> <P> (e) <E T="03">EPA process for reviewing requests.</E> (1) <E T="03">Public notification of receipt of request.</E> Within 15 days of receipt of a manufacturer-requested risk evaluation, EPA will notify the public that such request has been received. </P> <P> (2) <E T="03">Initial review for completeness.</E> EPA will determine whether the request appears to meet the requirements specified in this section ( <E T="03">i.e.,</E> complete), or whether the request appears to not have met the requirements specified in this section ( <E T="03">i.e.,</E> incomplete). EPA will notify the requesting manufacturer of the outcome of this initial review. For requests initially determined to be incomplete, EPA will cease review, pending actions taken by the requesting manufacturer pursuant to paragraph (f) of this section. For requests initially determined to be complete, EPA will proceed to the public notice and <PRTPAGE P="39"/> comment process described in paragraph (e)(3) of this section. </P> <P> (3) <E T="03">Public notice and comment.</E> No later than 90 days after initially determining a request to be complete pursuant to paragraph (e)(2) of this section, EPA will submit for publication the receipt of the request in the <E T="04">Federal Register,</E> open a docket for that request and provide no less than a 60-day public comment period. The docket will contain the CBI sanitized copies of the request and all supporting information. The notice will encourage the public to submit comments and information relevant to the manufacturer-requested risk evaluation, including, but not limited to, identifying information not provided in the request, information the commenter believes necessary to conduct a risk evaluation, and any other information relevant to the conditions of use. </P> <P> (4) <E T="03">Secondary review for sufficiency.</E> Within 90 days following the end of the comment period in paragraph (e)(3) of this section, EPA will further consider whether public comments highlight deficiencies in the request not identified during EPA's initial review, and/or that the available information is not sufficient to support a reasoned evaluation. EPA will notify the requesting manufacturer of the outcome of this review. For requests determined to not be supported by sufficient information, EPA will cease review, pending actions taken pursuant to paragraph (f) of this section. For requests determined to be supported by sufficient information, EPA will proceed with request review process in accordance with paragraph (e)(5) of this section. </P> <P> (5) <E T="03">Grant.</E> Where EPA determines a request to be complete and sufficiently supported in accordance with paragraphs (e)(2) and (4) of this section, and subject to the percentage limitations in TSCA section 6(b)(4)(E)(i)(II), EPA will grant the request. A grant does not mean that EPA has all information necessary to complete the risk evaluation. </P> <P> (6) <E T="03">Publication of draft conditions of use and request for information.</E> EPA will publish a notice in the <E T="04">Federal Register</E> that identifies draft conditions of use, requests relevant information from the public, and provides no less than a 60-day public comment period. Within 90 days following the close of the public comment period in this paragraph, EPA will determine whether further information is needed to carry out the risk evaluation and notify the requesting manufacturer of its determination, pursuant to paragraph (e)(7) of this section. If EPA determines at this time that no further information is necessary, EPA will initiate the risk evaluation, pursuant to paragraph (e)(9) of this section. </P> <P> (7) <E T="03">Identification of information needs.</E> Where additional information needs are identified, EPA will notify the requesting manufacturer and set a reasonable amount of time, as determined by EPA, for response. In response to EPA's notice, and subject to the limitations in paragraph (g) of this section, the requesting manufacturer may: </P> <P> (i) <E T="03">Provide the necessary information.</E> EPA will set a reasonable amount of time, as determined by EPA, for the requesting manufacturer to produce or develop and produce the information. Upon receipt of the new information, EPA will review for sufficiency and make publicly available to the extent possible, including CBI-sanitized copies of that information; or </P> <P> (ii) <E T="03">Withdraw the risk evaluation request.</E> Fees to be collected or refunded shall be determined pursuant to paragraph (k) of this section and 40 CFR 700.45; or </P> <P> (iii) <E T="03">Request that EPA obtain the information using authorities under TSCA sections 4, 8 or 11.</E> The requesting manufacturer must provide a rationale as to why the information is not reasonably ascertainable to them. EPA will review and provide notice of its determination to the requesting manufacturer. Upon receipt of the information, EPA will review the additional information for sufficiency and provide additional public notice. </P> <P> (8) <E T="03">Unfulfilled information needs.</E> In circumstances where there have been additional data needs identified pursuant to paragraph (e)(7) of this section that are not fulfilled, because the requesting manufacturer is unable or unwilling to fulfill those needs in a timely manner, the requesting manufacture has produced information that is insufficient as determined by EPA, or EPA determines that a request to use TSCA authorities under section 4, 8 or 11 is not warranted, EPA may deem the request to be constructively withdrawn under paragraph (e)(7)(ii) of this section. </P> <P> (9) <E T="03">Initiation of the risk evaluation.</E> Within 90 days of the end of the comment period provided in paragraph (e)(6) of this section, or within 90 days of EPA determining that information identified and received pursuant to paragraph (e)(7) of this section is sufficient, EPA will initiate the requested risk evaluation and follow all requirements in this subpart, including but not limited to §§ 702.37 through 702.43 and §§ 702.47 through 702.49 of this subpart, and notify the requesting manufacturer and the public. Initiation of the risk evaluation does not limit or prohibit the Agency from identifying additional data needs during the risk evaluation process. </P> <P> (f) <E T="03">Incomplete or insufficient request.</E> Where EPA has determined that a request is incomplete or insufficient pursuant to paragraph (e)(2) or (4) of this section, the requesting manufacturer may supplement and resubmit the request. EPA will follow the process described in paragraph (e) of this section as it would for a new request. </P> <P> (g) <E T="03">Withdrawal of request.</E> The requesting manufacturer may withdraw a request at <PRTPAGE P="40"/> any time prior to EPA's grant of such request pursuant to paragraph (e)(5) of this section, or in accordance with paragraph (e)(7) of this section and subject to payment of applicable fees. The requesting manufacturer may not withdraw a request once EPA has initiated the risk evaluation. EPA may deem a request constructively withdrawn in the event of unfulfilled information needs pursuant to paragraph (e)(8) of this section or non-payment of fees as required in 40 CFR 700.45. EPA will notify the requesting manufacturer and the public of the withdrawn request. </P> <P> (h) <E T="03">Data needs identified post-initiation.</E> Where EPA identifies additional data needs after the risk evaluation has been initiated, the requesting manufacturer may remedy the deficiency pursuant to paragraph (e)(7)(i) or (iii) of this section. </P> <P> (i) <E T="03">Supplementation of original request.</E> At any time prior to the end of the comment period described in paragraph (e)(6) of this section, the requesting manufacturer(s) may supplement the original request with any new information that becomes available to the requesting manufacturer(s). At any point prior to the completion of a manufacturer-requested risk evaluation pursuant to this section, the requesting manufacturer(s) must supplement the original request with any information that meets the criteria in 15 U.S.C. 2607(e) and this section, or with any other reasonably ascertainable information that has the potential to change EPA's risk evaluation. Such information must be submitted consistent with 15 U.S.C. 2607(e) if the information is subject to that section or otherwise within 30 days of when the requesting manufacturer(s) obtain the information. </P> <P> (j) <E T="03">Limitations on manufacturer-requested risk evaluations.</E> (1) <E T="03">In general.</E> EPA will initiate a risk evaluation for all requests from manufacturers for non-TSCA Work Plan Chemicals that meet the criteria in this subpart, until EPA determines that the number of manufacturer-requested chemical substances undergoing risk evaluation is equal to 25% of the High-Priority Substances identified in subpart A as undergoing risk evaluation. Once that level has been reached, EPA will initiate at least one new manufacturer-requested risk evaluation for each manufacturer-requested risk evaluation completed so long as there are sufficient requests that meet the criteria of this subpart, as needed to ensure that the number of manufacturer-requested risk evaluations is equal to at least 25% of the High-Priority substances risk evaluations and not more than 50%. </P> <P> (2) <E T="03">Preferences.</E> In conformance with § 702.35(c), in evaluating requests for TSCA Work Plan Chemicals and requests for non-TSCA Work Plan chemicals, EPA will give preference to requests for risk evaluations on chemical substances: </P> <P>(i) First, for which EPA determines that restrictions imposed by one or more States have the potential to have a significant impact on interstate commerce, health or the environment; and then</P> <P>(ii) Second, based on the order in which the requests are received.</P> <P> (k) <E T="03">Fees.</E> Manufacturers must pay fees to support risk evaluations as specified under 15 U.S.C. 2605(b)(4)(E)(ii), and in accordance with 15 U.S.C. 2625(b) and 40 CFR 700.45. In the event that a request for a risk evaluation is withdrawn by the requesting manufacturer pursuant to paragraph (g) of this section, the total fee amount due will be either, in accordance with 40 CFR 700.45(c)(2)(x) or (xi) (as adjusted by 40 CFR 700.45(d) when applicable), 50% or 100% of the actual costs expended in carrying out the risk evaluation as of the date of receipt of the withdrawal notice. The payment amount will be determined by EPA, and invoice or refund issued to the requesting manufacturer as appropriate. </P> </SECTION> <SECTION> <SECTNO>§ 702.47</SECTNO> <SUBJECT>Interagency collaboration.</SUBJECT> <P>During the risk evaluation process, not to preclude any additional, prior, or subsequent collaboration, EPA will consult with other relevant Federal agencies.</P> </SECTION> <SECTION> <SECTNO>§ 702.49</SECTNO> <SUBJECT>Publicly available information.</SUBJECT> <P> For each risk evaluation, EPA will maintain a public docket at <E T="03">https://www.regulations.gov</E> to provide public access to the following information, as applicable for that risk evaluation: </P> <P>(a) The draft scope, final scope, draft risk evaluation, and final risk evaluation;</P> <P>(b) All notices, determinations, findings, consent agreements, and orders;</P> <P>(c) Any information required to be provided to EPA under 15 U.S.C. 2603;</P> <P>(d) A nontechnical summary of the risk evaluation;</P> <P>(e) A list of the studies, with the results of the studies, considered in carrying out each risk evaluation;</P> <P>(f) Any final peer review report, including the response to peer review and public comments received during peer review;</P> <P>(g) Response to public comments received on the draft scope and the draft risk evaluation; and</P> <P>(h) Where unreasonable risk to workers is identified via inhalation, EPA's calculation of a risk-based occupational exposure value.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Citizen Suit</HD> <SECTION> <SECTNO>§ 702.60</SECTNO> <SUBJECT>Purpose.</SUBJECT> <P> Section 20 of the Toxic Substances Control Act (TSCA) authorizes any person to begin a civil action to compel performance by the Environmental <PRTPAGE P="41"/> Protection Agency (EPA) of TSCA non-discretionary acts or duties (section 20(a)(2)) or to restrain any violation of TSCA, or of any rule promulgated under sections 4, 5, or 6, or of any order issued under section 5 of TSCA (section 20(a)(1)). The purpose of this regulation is to prescribe procedures governing the giving of a notice of intent to file suit required by section 20(b) of TSCA as a prerequisite to beginning such civil actions. </P> </SECTION> <SECTION> <SECTNO>§ 702.61</SECTNO> <SUBJECT>Service of notice.</SUBJECT> <P> (a) <E T="03">Notice as a prerequisite to suit.</E> Under section 20 of TSCA, no civil action may be commenced by a citizen to restrain a violation of TSCA, or a rule or order thereunder, unless at least 60 days in advance the citizen has given notice of the intent to file suit to the Administrator and to the person who is alleged to have committed the violation. No civil action may be commenced by a citizen to compel the Administrator to perform any non-discretionary act or duty under TSCA, unless at least 60 days in advance the citizen has given notice of the intent to file suit to the Administrator. However, in the case of an alleged failure by the Administrator to file an action under section 7 of TSCA, the citizen must give notice to the Administrator only 10 days in advance of filing the civil action. </P> <P> (b) <E T="03">Method of service.</E> Notice of intent to file suit can be either personally served or served by certified mail—return receipt requested—to persons identified in paragraph (d) of this section. </P> <P> (c) <E T="03">Date of service.</E> The effective date of service of a notice given in accordance with this rule shall be the date of the return receipt, if served by mail, or the date of receipt if personally served. </P> <P> (d) <E T="03">Persons to be served</E> —(1) <E T="03">Violations of TSCA rules or TSCA order.</E> (i) If the alleged violator is a private individual or a corporation, notice of intent to file suit shall be served on the individual or the owner or managing agent of the plant, facility, or activity alleged to be in violation. If the alleged violator is a corporation, a copy of the notice shall also be sent to the registered agent, if any, of such corporation in the State in which such violation is alleged to have occurred. Notice shall also be served on the Administrator of the EPA. </P> <P>(ii) If the alleged violator is a State or local government entity, notice of intent to file suit shall be served on the head of the agency. Notice shall also be served on the Administrator of the EPA, and a copy shall be sent to the Attorney General of the United States.</P> <P>(iii) If the alleged violator is a Federal agency, notice of intent to file suit shall be served on the head of the agency. Notice shall also be served on the Administrator of the EPA, and a copy shall be sent to the Attorney General of the United States.</P> <P> (2) <E T="03">Performance of non-discretionary TSCA acts or duties.</E> Notice of intent to file suit shall be served on the Administrator of the EPA and a copy shall be sent to the Attorney General of the United States. </P> <P> (3) <E T="03">Address of persons to be served.</E> (i) EPA Administrator: 1200 Pennsylvania Ave., NW., Washington, DC 20460. (ii) Attorney General of the United States: 10th and Constitution Avenue, NW., Washington, DC 20530. </P> </SECTION> <SECTION> <SECTNO>§ 702.62</SECTNO> <SUBJECT>Contents of notice.</SUBJECT> <P> (a) <E T="03">Violation of TSCA rule or TSCA order.</E> Notice of intent to file suit regarding an alleged violation of TSCA or any rule promulgated under sections 4, 5, or 6, or an order issued under section 5, shall include sufficient information to permit the recipient to identify: </P> <P>(1) The specific provision of TSCA or of the rule or order under TSCA alleged to have been violated.</P> <P>(2) The activity alleged to constitute a violation.</P> <P>(3) The person or persons responsible for the alleged violation.</P> <P>(4) The location of the alleged violation.</P> <P>(5) The date or dates of the alleged violation as closely as the citizen is able to specify them.</P> <P>(6) The full name, address, and telephone number of the citizen giving notice.</P> <P> (b) <E T="03">Failure to act.</E> Notice regarding an alleged failure of the Administrator to perform any act or duty which is not discretionary shall: <PRTPAGE P="42"/> </P> <P>(1) Identify the specific provision of TSCA which requires an act or creates a duty.</P> <P>(2) Describe with reasonable specificity the action taken or not taken by the Administrator which is alleged to constitute a failure to perform the act or duty.</P> <P>(3) State the full name, address, and telephone number of the citizen giving the notice.</P> <P> (c) <E T="03">Identification of Counsel.</E> The notice shall state the name, address, and telephone number of the Legal Counsel, if any, representing the citizen giving the notice. </P> </SECTION> </SUBPART> <PART> <EAR>Pt. 703</EAR> <HD SOURCE="HED">PART 703—CONFIDENTIALITY CLAIMS</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>703.1</SECTNO> <SUBJECT>Purpose and applicability.</SUBJECT> <SECTNO>703.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>703.5</SECTNO> <SUBJECT>Requirements for asserting and maintaining confidentiality claims.</SUBJECT> <SECTNO>703.7</SECTNO> <SUBJECT>EPA review of confidentiality claims under TSCA section 14(g).</SUBJECT> <SECTNO>703.8</SECTNO> <SUBJECT>EPA review of confidentiality claims under TSCA section 14(f).</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2613.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>88 FR 37166, June 7, 2023, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 703.1</SECTNO> <SUBJECT>Purpose and applicability.</SUBJECT> <P>(a) The purpose of this part is to describe procedures for asserting and maintaining confidentiality claims in accordance with TSCA section 14, and for EPA review of such claims. The procedures described in this part are generally applicable to the submission and EPA review of any TSCA submission, except to the extent that application of the requirements would be inconsistent with TSCA section 14(i). The procedures include requirements concerning the form and manner in which TSCA submissions must be made to meet requirements in TSCA sections 14(b) and (c), to facilitate EPA review of such claims in accordance with TSCA sections 14(f) and (g), and to facilitate disclosure of non-confidential information to the public in accordance with TSCA, FOIA, and their implementing regulations.</P> <P>(b) This part applies to all information that is reported to or otherwise obtained by EPA pursuant to TSCA or its implementing regulations. This includes information that was first obtained by EPA other than pursuant to the authority of TSCA or its implementing regulations, provided that the following two criteria have been met:</P> <P>(1) EPA has authority to collect the information under TSCA; and</P> <P>(2) Either:</P> <P>(i) Subsequent to its submission the information is being used to satisfy the obligation of a person under TSCA or its implementing regulations; or</P> <P>(ii) EPA makes use of the information in the course of carrying out its responsibilities under TSCA (e.g., EPA considered such information in its actions under TSCA sections 4, 5, or 6).</P> <P>(c)(1) This part applies regardless of the following:</P> <P>(i) Whether the information is intended by its submitter to be used by EPA in implementing TSCA;</P> <P>(ii) Whether TSCA or an implementing regulation was cited as authority for the request or submission of the information; or</P> <P>(iii) Whether the information was provided directly to EPA or through some third person.</P> <P>(2) However, where such information is not protected from disclosure under TSCA Section 14, but the statute under which the information was originally provided to EPA limits disclosure for reasons other than business confidentiality (for example, limited disclosure of pesticide data to multinational pesticide producers under 7 U.S.C. 136h(g)), the disclosure limitation in the statute under which the information was obtained by EPA continues to apply, except where TSCA expressly requires disclosure of that information.</P> <P>(d) The provisions of 40 CFR part 2, subpart B, apply to this section, as modified by 40 CFR 2.306.</P> </SECTION> <SECTION> <SECTNO>§ 703.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P> The definitions in this section and the definitions in TSCA section 3 apply to this part. In addition, the definition in § 720.3(ff) of this subchapter for <E T="03">test data</E> also applies in this part. </P> <P> <E T="03">Accept</E> in the context of asserting a TSCA CBI claim means EPA's first approval of the submission containing the CBI claim in CISS, or its successor system. <PRTPAGE P="43"/> </P> <P> <E T="03">Act,</E> or <E T="03">TSCA,</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 <E T="03">et seq.</E> </P> <P> <E T="03">CDX</E> or <E T="03">Central Data Exchange</E> means EPA's centralized electronic document receiving system, or its successor system. </P> <P> <E T="03">CISS</E> or <E T="03">Chemical Information Submission System</E> means EPA's web-based reporting tool for preparing and submitting TSCA submissions, or its successor system. </P> <P> <E T="03">Confidentiality claim</E> means a claim or allegation that business information is entitled to confidential treatment. </P> <P> <E T="03">FOIA</E> means the Freedom of Information Act, 5 U.S.C. 552, <E T="03">et seq.</E> </P> <P> <E T="03">Health and safety study</E> has the same meaning as that provided in § 720.3(k) of this subchapter, except that for purposes of this part 703 the following information is not part of a health and safety study: </P> <P>(1) The name, address, or other identifying information for the submitting company, including identification of the laboratory that conducted the study in cases where the laboratory is part of or closely affiliated with the submitting company.</P> <P> (2) Internal product codes ( <E T="03">i.e.,</E> code names for the test substance used internally by the submitting company or to identify the test substance to the test laboratory). </P> <P>(3) Names and contact details for testing laboratory personnel and names and other private information for health and safety study participants or persons involved in chemical incidents such as would typically be withheld under 5 U.S.C. 552(b)(6) or under other privacy laws.</P> <P>(4) Information pertaining to test substance product development, advertising, or marketing plans, or to cost and other financial data.</P> </SECTION> <SECTION> <SECTNO>§ 703.5</SECTNO> <SUBJECT>Requirements for asserting and maintaining confidentiality claims.</SUBJECT> <P>Any person who submits information under TSCA or these implementing regulations may assert a business confidentiality claim to information included in such submission except where such a claim is disallowed by applicable regulation under this subchapter. Such claim must be made concurrent with submission of the information. If no such claim accompanies the submission, EPA will not recognize a confidentiality claim, and the information in or referred to in that submission may be made available to the public (e.g., by publication of specific chemical name and CASRN on the public portion of the TSCA Inventory) without further notice.</P> <P> (a) <E T="03">Supporting statement and certification.</E> (1) A person asserting a confidentiality claim must submit a statement that the person has: </P> <P>(i) Taken reasonable measures to protect the confidentiality of the information;</P> <P>(ii) Determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law;</P> <P>(iii) A reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of the person; and</P> <P>(iv) A reasonable basis to believe that the information is not readily discoverable through reverse engineering.</P> <P>(2) The person must also certify that these four statements and any information required to substantiate the confidentiality claim in accordance with paragraph (b) of this section are true and correct.</P> <P> (b) <E T="03">Substantiation.</E> (1) Confidentiality claims must be substantiated at the time of submission to EPA, unless exempt under paragraph (b)(5) of this section. In the case of information collected by EPA or on behalf of EPA in person at the site of a TSCA inspection under section 11 of the Act, the affected company must assert its confidentiality claim(s) in writing at the time the information is collected, and then must provide substantiation of its confidentiality claims and the supporting statement and certification described in paragraph (a) of this section within ten business days after the inspection ends. Confidentiality claims lacking required substantiation after ten business days will be treated as deficient under paragraph (e) of this section. Unless otherwise directed by EPA, such information or materials must be submitted via CDX. In the case of an unusually voluminous document collection under section 11 of the Act, <PRTPAGE P="44"/> the affected company may request additional time to assert claims and provide substantiation, which EPA may grant at its discretion. The inspection is considered to have ended when the inspector physically exits the regulated facility on the last day of the inspection. </P> <P>(2) Information in substantiations may be claimed as confidential. Such claims must be accompanied by the certification described in paragraph (a) of this section but need not be themselves separately substantiated.</P> <P>(3) Substantiation questions for all claims. Unless otherwise specified elsewhere in this subchapter (e.g., 40 CFR part 711), answers to the following questions must be provided for each confidentiality claim in a TSCA submission:</P> <P> (i) Please specifically explain what harm to the competitive position of your business would be likely to result from the release of the information claimed as confidential. How would that harm be <E T="03">substantial</E> ? Why is the substantial harm to your competitive position <E T="03">likely</E> ( <E T="03">i.e.,</E> probable) to be caused by release of the information rather than just <E T="03">possible</E> ? If you claimed multiple types of information to be confidential (e.g., site information, exposure information, environmental release information, etc.), explain how disclosure of each type of information would be likely to cause substantial harm to the competitive position of your business. </P> <P>(ii) Has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify the specific measures, including but not limited to internal controls, that your business has taken to protect the information claimed as confidential. If the same or similar information was previously reported to EPA as non-confidential (such as in an earlier version of this submission), please explain the circumstances of that prior submission and reasons for believing the information is nonetheless still confidential.</P> <P>(iii)(A) Is any of the information claimed as confidential required to be publicly disclosed under any other Federal law? If yes, please explain.</P> <P>(B) Does any of the information claimed as confidential otherwise appear in any public documents, including (but not limited to) safety data sheets; advertising or promotional material; professional or trade publications; State, local, or Federal agency files; or any other media or publications available to the general public? If yes, please explain why the information should be treated as confidential. If this chemical is patented and the patent reveals the information you are claiming confidential, please explain your reasons for believing the information is nonetheless still confidential.</P> <P>(iv) Is the claim of confidentiality intended to last less than 10 years (see TSCA section 14(e)(1)(B))? If yes, please indicate the number of years (between 1 and 10 years) or the specific date after which the claim is withdrawn.</P> <P>(v) Has EPA, another Federal agency, or court made any confidentiality determination regarding information associated with this chemical substance? If yes, please provide the circumstances associated with the prior determination, whether or not the information was found to be entitled to confidential treatment, the entity that made the decision, and the date of the determination.</P> <P>(4) Additional substantiation questions for chemical identity-related claims only. Unless otherwise specified in the relevant electronic reporting form, answers to the following questions must be provided for each chemical identity-related confidentiality claim in a TSCA submission:</P> <P>(i) Is this chemical substance publicly known (including by your competitors) to be in U.S. commerce? If yes, please explain why the specific chemical identity should still be afforded confidential status (e.g., the chemical substance is publicly known only as being distributed in commerce for research and development purposes, but no other information about the current commercial distribution of the chemical substance in the United States is publicly available). If no, please complete the certification statement:</P> <EXTRACT> <PRTPAGE P="45"/> <P> I certify that on the date referenced I searched the internet for the chemical substance identity ( <E T="03">i.e.,</E> by both chemical substance name and CASRN). I did not find a reference to this chemical substance and have no knowledge of public information that would indicate that the chemical is being manufactured or imported by anyone for a commercial purpose in the United States. [provide date]. </P> </EXTRACT> <P>(ii) Does this specific chemical substance leave the site of manufacture (including import) in any form, e.g., as a product, effluent, emission? If yes, please explain what measures have been taken to guard against the discovery of its identity.</P> <P>(iii) If the chemical substance leaves the site in a form that is available to the public or your competitors, can the chemical identity be readily discovered by analysis of the substance (e.g., product, effluent, emission), in light of existing technologies and any costs, difficulties, or limitations associated with such technologies? Please explain why or why not.</P> <P>(iv) Would disclosure of the specific chemical identity release confidential process information? If yes, please explain.</P> <P>(5) Information described in paragraphs (b)(5)(i) and (ii) of this section is exempt from the requirement to substantiate the claim at the time of submission. EPA may identify on a reporting form certain information as exempt from substantiation. Additional assertions of exemption from substantiation may be asserted by the submitter. Each such assertion must include a detailed explanation for why the information falls within the claimed exemption. If the explanation is missing or inadequate, and the claim is not otherwise substantiated, EPA will place a hold on the submission, as described in paragraph (e) of this section.</P> <P>(i) The following information types are exempt from the substantiation requirement at the time of information submission:</P> <P>(A) Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or article;</P> <P>(B) Marketing and sales information;</P> <P>(C) Information identifying a supplier or customer;</P> <P>(D) Details of the full composition of a mixture and the respective percentages of constituents;</P> <P>(E) Specific information regarding the use, function, or application of a chemical substance or mixture in a process, mixture, or article; and</P> <P>(F) Specific production or import volumes.</P> <P>(ii) Exemption for chemical substances not yet offered for commercial distribution.</P> <P>(A) A confidentiality claim for specific identity of a chemical substance, where the submission is made prior to the date on which the chemical substance whose identity is claimed as confidential is first offered for commercial distribution, is exempt from the requirement to substantiate confidentiality claims at the time of submission.</P> <P>(B) A specific chemical identity claim includes specific chemical names, CAS numbers, molecular formulas, reactants (if required to be reported as part of the identification of the chemical, such as for Class 2 substances in § 720.45(a) of this subchapter), and structural diagrams; or in the case of microorganisms, genus and species name and genetic construct.</P> <P>(C) This exemption applies where the submitter lacks information to reasonably conclude that the chemical substance has been offered for commercial distribution, where both:</P> <P> ( <E T="03">1</E> ) The chemical substance is not on the TSCA Inventory; and </P> <P> ( <E T="03">2</E> ) The substance is otherwise not publicly known to have been offered for commercial distribution. </P> <P> (c) <E T="03">Public copies.</E> All TSCA submissions and their accompanying attachments that include a confidentiality claim must be accompanied, at the time of submission, by a public version of the submission and any attachments, with all information that is claimed as confidential removed. In the case of documents collected by EPA or on behalf of EPA in person at the site of a TSCA inspection under section 11 of the Act, the affected company must provide such public copies at the same <PRTPAGE P="46"/> time and in the same manner as it provides substantiation of its confidentiality claims in accordance with paragraph (b)(1) of this section, within ten working days after the inspection ends. Only information that is claimed as confidential may be redacted or removed. Generally, a public copy that removes all or substantially all of the information would not meet the requirements of this paragraph (c) so will likely be treated as deficient under paragraph (e) of this section. </P> <P>(1) Where the applicable reporting form or electronic reporting tool contains a checkbox or other means of designating with specificity what information is claimed as confidential, no further action by the submitter is required to satisfy this requirement.</P> <P> (2) For all other information claimed as confidential, including but not limited to information in attachments and in substantiations required under paragraph (b) of this section, the submitter must prepare and attach a public copy. EPA may treat as deficient submissions with public copies that are entirely blank or that are substantially reduced in length as compared to the CBI version ( <E T="03">see</E> paragraph (e) of this section). </P> <P> (d) <E T="03">Generic name.</E> Each confidentiality claim for specific chemical identity must be accompanied by a structurally descriptive generic name for that substance. This generic name must be consistent with guidance on the determination of structurally descriptive generic names developed in accordance with, and made binding by, section 14(c)(4)(A) of the Act (e.g., <E T="03">Guidance for Creating Generic Names for Confidential Chemical Substance Identity Reporting under TSCA;</E> available at <E T="03">https://www.epa.gov/tsca-inventory/guidance-creating-generic-names-confidential-chemical-substance-identity-reporting</E> ), and 15 U.S.C. 2613(c)(1)(C)(ii). </P> <P>(1) At a minimum, the generic name must either:</P> <P>(i) Be identical to the generic name for the same substance included on the non-confidential portion of the TSCA Inventory (if the substance is listed on the TSCA Inventory), or</P> <P>(ii) For substances that are not listed on the TSCA Inventory, mask only the confidential portions of the specific chemical name. In most cases, only one structural element of a specific chemical name may be masked to protect a confidential chemical identity—if the submitter of a proposed generic name wishes to mask more than one such element, the submission must include an explanation of why masking only one element is insufficient to protect the confidential identity.</P> <P>(2) Notwithstanding paragraph (d)(1) of this section, EPA may conclude that a generic name provided with the submission and listed on the current non-confidential version of the TSCA Inventory does not comply with 15 U.S.C. 2613(c)(1)(C). In such cases, EPA will notify the submitting company and proceed as described in paragraph (c)(4) of this section.</P> <P>(3) A generic name that meets the requirements of section 14(c)(1)(C) of the Act prior to the date on which the chemical substance is first offered for commercial distribution for the purposes of a pre-market submission (e.g., a PMN) may not be sufficient for the purposes of subsequent listing on the TSCA Inventory, as identified upon review under section 14(g)(1)(C)(i) of the Act of a confidentiality claim for specific chemical identity made in a Notice of Commencement required under § 720.102 or § 725.190(f) of this subchapter. In such cases, EPA will notify the submitting company and proceed as described in § 720.102(f) or § 725.190(f) of this subchapter.</P> <P>(4) If EPA concludes that the proposed generic name does not comply with 15 U.S.C. 2613(c)(1)(C), EPA will notify the submitter, and provide 10 business days for the submitter to provide a revised generic name. If EPA concludes that the revised generic name is still not acceptable, EPA will hold the submission for an additional period of up to 10 business days, proceeding as set out in paragraph (e) of this section.</P> <P> (e) <E T="03">Deficient confidentiality claims.</E> (1) A confidentiality claim under TSCA is deficient if it meets one or more of the following criteria: </P> <P> (i) The confidentiality claim is not accompanied by the supporting statement and certification required by paragraph (a) of this section. <PRTPAGE P="47"/> </P> <P>(ii) The confidentiality claim is not accompanied by the substantiation required by paragraph (b) of this section. If the submitter claims an exemption from substantiation under paragraph (b)(5) of this section and the exemption does not apply or an explanation is not provided for the exemption pursuant to paragraph (b)(5) of this section, the confidentiality claim is deficient.</P> <P>(iii) The confidentiality claim is not accompanied by a public copy that meets the requirements of paragraph (c) of this section.</P> <P>(iv) The confidentiality claim is for a specific chemical identity and is not accompanied by a generic name that meets the requirements of paragraph (d) of this section.</P> <P>(2) A submission that is identified as deficient under paragraph (e)(1) of this section will be held for a period of up to 10 business days, and the submitter will be notified via CDX as described in paragraph (h) of this section. During the hold, which commences on the day the CDX notice is sent, any applicable review period for the underlying submission will be suspended until either the deficiency is corrected or the 10 business days elapse without such correction. Upon the occurrence of the first of either of these events, the applicable review period for the underlying submission commences or comes out of suspension. If the deficiency is not remedied during the suspension, EPA will proceed with review of the submission and may deny the CBI claim(s).</P> <P> (f) <E T="03">Electronic reporting required.</E> (1) TSCA submissions bearing confidentiality claims must be submitted via CDX, except where EPA directs that information subpoenaed under section 11(c) of the Act or materials collected or requested by EPA as part of an inspection under section 11(a) of the Act, not be submitted via CDX. Any required TSCA submission asserting a CBI claim that does not meet the requirements of this paragraph will be deemed incomplete. EPA reserves the ability to waive the requirements of this paragraph, at its discretion, where compliance is infeasible. </P> <P> (2) You must use CISS to complete and submit TSCA submissions via CDX. To access CISS go to <E T="03">https://cdx.epa.gov/</E> and follow the appropriate links. </P> <P> (3) On receipt by EPA, each electronic TSCA submission will be assigned a case number or document identifier, which will be available to the submitter in their CDX account. This identifier may be used as a reference in future communications that concern the substance and may be used by EPA in public communications (e.g., <E T="04">Federal Register</E> notices) that concern the submission, such as notices of receipt, final confidentiality determination, pending confidentiality claim expiration, or in other regulatory actions that concern the TSCA submission. </P> <P> (g) <E T="03">Requirement to report health and safety studies using templates.</E> Submitters of health and safety studies or information from such studies must provide such data in templated form, using an appropriate OECD harmonized template, if such template is available for the data type ( <E T="03">https://www.oecd.org/ehs/templates/</E> ). Individual test or data submission rules or orders may specify an appropriate template or templates. Submission of templated data is not a substitute for submitting a full study report where a specific TSCA rule or order requires submission of the full study report (e.g., § 720.50(a) of this subchapter, or according to the terms of a specific order under section 5(e) of the Act). </P> <P> (h) <E T="03">Requirement to maintain company contact information; electronic notices concerning confidentiality claims.</E> (1) To facilitate ongoing or future communication concerning TSCA submissions, current contact information for all of the individuals associated with a particular TSCA submission must be maintained. Contact information for all the individuals associated with a particular TSCA submission must be updated by amending the submission via CDX, except that submissions that are either no longer accessible to the submitting company or that were not submitted via CDX (e.g., submissions that were originally provided on paper or other physical media), updated company contact must be provided via CDX using the appropriate EPA-provided electronic reporting application in <PRTPAGE P="48"/> CISS. In circumstances where ownership of the company or unit of a company has changed, such that contact information for one or more prior TSCA submissions that include confidentiality claims is affected, a notice of transfer of ownership must be directed to EPA via CDX. Instructions for providing this notice and for requesting access to copies of a prior TSCA submission are available at <E T="03">https://cdx.epa.gov/.</E> </P> <P>(2) When EPA contacts a TSCA submitter concerning confidentiality claims (e.g., related to a pending or concluded confidentiality claim review, a deficient submission, or in relation to the 10-year expiration of a confidentiality claim (described in section 14(e) of the Act)), EPA may provide notices and other correspondence to the submitter via CDX, using the contact information provided in the most recent version of the submission, or using the contact information provided in a more recent notice of transfer of ownership relating to that submission. The fact and date of delivery of such notice is verified automatically by CDX.</P> <P>(3) In addition to individual notice described in paragraph (h)(2) of this section, EPA will publish on its website, or other appropriate platform, a list of TSCA submissions with confidentiality claims that are approaching the end of the ten-year period of protection described in section 14(e) of the Act. Such TSCA submissions will be referred to by the TSCA case or document identifier (as described in paragraph (f)(3) of this section) that was assigned to the submission by EPA when it was originally submitted. TSCA submissions will be added to this list at least 60 days prior to the end of the ten-year period of protection, along with instructions for reasserting and substantiating expiring claims.</P> <P>(4) When a confidentiality claim is being reviewed pursuant to section 14(f) of the Act, EPA will provide, when necessary, notice of such review and an opportunity to substantiate or resubstantiate the affected confidentiality claim to the submitter using the contact information for the authorized official or technical contact provided in the most recent version of the submission or in a more recent notice of transfer of ownership relating to that submission.</P> <P>(5) Where the submission with the relevant CBI claim was not originally made via CDX, EPA will send the notice via courier or US Mail to the company address provided in the most recent TSCA submission made by that company, or via other means that allows verification of the fact and date of receipt. The notice will provide instructions for substantiating claims that were exempt from substantiation when the confidentiality claim was asserted or for which the submitter was otherwise not required to provide substantiation at the time of initial submission, and for updating or re-substantiating as necessary any claims that were previously substantiated.</P> <P> (i) <E T="03">Withdrawing confidentiality claims.</E> TSCA confidentiality claims may be voluntarily withdrawn by the submitter at any time. </P> <P>(1) Confidentiality claims in TSCA submissions that were originally made via electronic submission may be withdrawn. To withdraw a claim, a person must reopen the submission in CDX, remove confidentiality markings (e.g., confidential checkmarks or bracketing), revise public copies including any attachments to unredact the information no longer claimed confidential, and then resubmit the submission.</P> <P>(2) For submissions that were not originally made via CDX, or that are no longer accessible to the submitting company via CDX, confidentiality claims may also be withdrawn via CDX using the “TSCA Communications” application or successor system. The withdrawal correspondence must indicate the case or document number (or other applicable document identifier or document identifying details) from which CBI claims are being withdrawn, identify the submitting company, and include a list or description of the information for which CBI claims are being withdrawn, including page numbers where relevant. Current contact information for the person withdrawing the claim must also be provided, in the event EPA needs clarification concerning which claim or claims are being withdrawn.</P> <P> (j) <E T="03">Amending public copy following confidentiality claim denial or expiration.</E> (1) <PRTPAGE P="49"/> Following the expiration or EPA's denial of a TSCA confidentiality claim, the person who asserted the denied or expired claim should prepare and submit a revised public copy of the submission to EPA, following the procedures for voluntarily withdrawing claims described in paragraph (i) of this section. </P> <P>(2) If the person who asserted the denied or expired claim declines or fails to provide within 30 days a revised public copy of the submission that includes the information for which the confidentiality claim(s) were denied or expired, EPA may prepare an addendum to the original public copy, as needed, disclosing the information to the public.</P> </SECTION> <SECTION> <SECTNO>§ 703.7</SECTNO> <SUBJECT>EPA review of confidentiality claims under TSCA section 14(g).</SUBJECT> <P> (a) <E T="03">Representative subset and selection of submissions for review.</E> (1) A representative subset consists of at least 25 percent of confidentiality claims asserted under TSCA, not including claims for specific chemical identity or for the categories of information listed in section 14(c)(2) of the Act. Excluded from the representative subset are: </P> <P>(i) Inquiries with respect to potential submission to EPA of a notification under 40 CFR part 720, 721, 723, or 725 by a person who has not submitted the notification at the time of the inquiry, including inquiries under § 720.25(b) or § 721.11 of this subchapter;</P> <P>(ii) Submissions or other communication not submitted to EPA via CDX; and</P> <P>(iii) Amendments to previous TSCA submissions.</P> <P>(2) To satisfy its confidentiality claim review obligations under section 14(g)(1)(C)(ii) of the Act, EPA will generally review all claims (except those exempt from substantiation under section 14(c)(2) of the Act) in every fourth TSCA submission submitted via CDX that is part of the representative subset, in chronological order of receipt by EPA. For each submission selected for review as part of the representative subset, EPA reviews and approves or denies every individual confidentiality claim in that submission (except claims that are exempt under sections 14(c)(2) and 14(g) of the Act), including claims made in attachments and amendments available to EPA at the time of the review.</P> <P> (b) <E T="03">Review of new and expiring confidentiality claims under TSCA Section 14(g).</E> (1)(i) Under section 14(g) of the Act, EPA will review: </P> <P>(A) All chemical identity claims asserted in TSCA submissions except those that are exempt from substantiation according to section 14(c)(2)(G) of the Act; and</P> <P>(B) a representative subset of other confidentiality claims as provided in paragraph (a) of this section.</P> <P>(ii) Final determinations will be issued by the General Counsel or their designee, which may include personnel outside of the Office of General Counsel.</P> <P>(2) EPA will review all timely requests for extension of claims under section 14(e) of the Act within 30 days of receipt.</P> <P>(3) EPA will also review or re-review confidentiality claims under certain other circumstances, as set out in section 14(f) of the Act. Review under section 14(f) of the Act are conducted in accordance with procedures set out in § 703.8.</P> <P> (c) <E T="03">Commencement of the review period and effect of amendments.</E> Subject to § 703.5(e), the 90-day review period described in section 14(g) of the Act begins on the day that EPA accepts a new TSCA submission that includes confidentiality claims. For new information, other than specific chemical identity, added to a submission after EPA first accepts the submission, the review will take into account such amendments to that submission that are made either up to 60 days from the original submission date, or until the Agency issues a final confidentiality determination for the submission, whichever comes first. If a submission is amended to report an additional or different chemical substance that includes a new specific chemical identity claim, the TSCA section 14(g) review period for the added chemical identity begins on the day EPA accepts the amendment including the new claim. </P> <P> (d) <E T="03">Publication of final determinations.</E> Final confidentiality determinations will be published on EPA's website, or <PRTPAGE P="50"/> other platform, periodically, in accordance with the requirements of section 26(j) of the Act. </P> <P> (e) <E T="03">Claim denials and notice period.</E> In the case that EPA determines that a claim or part of a claim is not entitled to confidential treatment, EPA will provide notice of the denial to the person who made the claim and provide reasons for the denial or denial in part. The notice will be provided, as described in § 703.5(h). The 30-day notice period described in section 14(g)(2)(B) of the Act begins on the next business day following the date the notice is made available to the submitter in their CDX account. </P> <P> (f) <E T="03">Substantive criteria for use in confidentiality determinations.</E> Information claimed as confidential under section 14 of the Act will be approved if all of the following apply: </P> <P>(1) The business has asserted a business confidentiality claim which has not expired by its terms, nor been waived nor withdrawn;</P> <P>(2) The business has satisfactorily shown that it has taken reasonable measures to protect the confidentiality of the information, and that it intends to continue to take such measures for as long as the claim is maintained;</P> <P>(3) The information is not, and has not been, reasonably obtainable without the business's consent by other persons (other than governmental bodies) by use of legitimate means (other than discovery based on a showing of special need in a judicial or quasi-judicial proceeding; e.g., the business has demonstrated a reasonable basis to believe the information is not readily discoverable through reverse engineering);</P> <P>(4) The business has demonstrated a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of the business; and</P> <P>(5) No statute denies confidential protection to the information. Information from health and safety studies respecting any chemical that has been offered for commercial distribution or for which testing is required under section 4 of the Act or notice is required under section 5 of the Act is not entitled to confidential treatment, except that the following information may be entitled to confidential treatment if it otherwise meets the remainder of criteria in this paragraph (f):</P> <P>(i) Any information, including formulas (including molecular structures) of a chemical substance or mixture, that discloses processes used in the manufacturing or processing of a chemical substance or mixture; or</P> <P>(ii) In the case of a mixture, the portion of the mixture comprised by any of the chemical substances in the mixture.</P> <P>(6) The business adequately demonstrates that the information is commercial or financial information obtained from a person and is confidential within the meaning of FOIA Exemption 4 (5 U.S.C. 552(b)(4)).</P> <P> (g) <E T="03">Criteria to use in consideration of requests for extension under TSCA section 14(e).</E> Requests to extend the period of confidentiality protection under TSCA section 14(e) will be evaluated using the same criteria as described in paragraph (f) of this section. Requests for extension may rely on a substantiation previously provided to EPA, but the submitter must recertify that the substantiation is still true and correct. </P> </SECTION> <SECTION> <SECTNO>§ 703.8</SECTNO> <SUBJECT>EPA review of confidentiality claims under TSCA section 14(f).</SUBJECT> <P> (a) <E T="03">Review of confidentiality claims initiated under TSCA Section 14(f).</E> In accordance with the procedures described in this section, EPA may review confidentiality claims where authorized by TSCA section 14(f)(1), and will review confidentiality claims subject to TSCA section 14(f)(2) in the following situations: </P> <P>(1) In response to a request under the Freedom of Information Act (5 U.S.C. 552) for TSCA information claimed confidential;</P> <P>(2) If EPA has reason to believe that information claimed confidential does not qualify for protection from disclosure; or</P> <P>(3) For any chemical substance which EPA determines under TSCA section 6(b)(4)(A) presents an unreasonable risk of injury to health or the environment.</P> <P> (b) <E T="03">Substantiation exemptions not applicable.</E> The exemptions from substantiation requirements contained in section 14(c)(2) of TSCA do not apply to confidentiality claims reviewed under <PRTPAGE P="51"/> this section 703.8, even if such exemptions applied when the information was originally submitted to EPA. </P> <P> (c) <E T="03">Additional substantiation.</E> If necessary, such as where substantiation has not previously been provided for confidentiality claims under review, or where EPA has reason to believe the substantiation is incomplete or out of date, EPA will request additional substantiation from the person(s) that claimed the information as confidential. </P> <P> (d) <E T="03">Additional substantiation notice.</E> If additional substantiation is necessary, EPA will provide notice to the person that claimed the information as confidential in the manner specified in § 703.5(h)(4). The notice will provide the time allowed for additional substantiation from the business and the method for requesting a time extension if necessary. If the person does not make a timely response or extension request, EPA will consider any existing substantiations in its review of the claims or, in the case of any unsubstantiated claim, EPA will construe this as a waiver of the claim and may make the information public without any further notice to the submitter. </P> <P> (e) <E T="03">Substantive criteria for use in confidentiality determinations.</E> The criteria in § 703.7(f) apply to confidentiality determinations initiated under TSCA section 14(f). </P> <P> (f) <E T="03">Adverse determinations and notice period.</E> Final determinations will be issued by the General Counsel or their designee, including personnel outside of the Office of General Counsel. Except for instances where claims were waived, if EPA determines that information claimed confidential does not qualify for protection from disclosure, EPA will provide written notice to the person who asserted the claim. The notice will be provided electronically, as described in § 703.5(h)(2). The 30-day notice period described in TSCA section 14(g)(2)(B) begins on the next business day following the date the notice is made available to the submitter in their CDX account. </P> <P> (g) <E T="03">Disclosure of Information.</E> After a final determination has been made by EPA to release some or all of the information claimed as confidential, the Agency shall make the information available to the public (in the absence of a court order prohibiting disclosure) whenever: </P> <P>(1) The period provided for commencement by a business of an action to obtain judicial review of the determination has expired without notice to EPA of commencement of such an action; or</P> <P>(2) The court, in a timely-commenced action, has denied the person's motion for a preliminary injunction, or has otherwise upheld the EPA determination.</P> <P> (h) <E T="03">Notice relating to public requests for records.</E> Any person whose request for release of the information under 5 U.S.C. 552 is pending at the time notice is given under paragraph (f) of this section shall be furnished notice under 5 U.S.C. 552 either stating the circumstances under which the some or all of the information will be released or denying the request if all requested information was found to be entitled to confidential treatment. </P> </SECTION> </PART> <PART> <EAR>Pt. 704</EAR> <HD SOURCE="HED">PART 704—REPORTING AND RECORDKEEPING REQUIREMENTS</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Reporting and Recordkeeping Provisions for Section 8(a) Information-Gathering Rules</HD> <SECHD>Sec.</SECHD> <SECTNO>704.1</SECTNO> <SUBJECT>Scope.</SUBJECT> <SECTNO>704.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>704.5</SECTNO> <SUBJECT>Exemptions.</SUBJECT> <SECTNO>704.7</SECTNO> <SUBJECT>Confidential business information claims.</SUBJECT> <SECTNO>704.9</SECTNO> <SUBJECT>Where to send reports.</SUBJECT> <SECTNO>704.11</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <SECTNO>704.13</SECTNO> <SUBJECT>Compliance and enforcement.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Chemical-Specific Reporting and Recordkeeping Rules</HD> <SECTNO>704.20</SECTNO> <SUBJECT>Chemical substances manufactured or processed at the nanoscale.</SUBJECT> <SECTNO>704.25</SECTNO> <SUBJECT>11-Aminoundecanoic acid.</SUBJECT> <SECTNO>704.33</SECTNO> <SUBJECT>P-tert-butylbenzoic acid (P-TBBA), p-tert-butyltoluene (P-TBT) and p-tert-butylbenzaldehyde (P-TBB).</SUBJECT> <SECTNO>704.43</SECTNO> <SUBJECT>Chlorinated naphthalenes.</SUBJECT> <SECTNO>704.45</SECTNO> <SUBJECT>Chlorinated terphenyl.</SUBJECT> <SECTNO>704.95</SECTNO> <SUBJECT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis-(methylene)]]tetrakis-(EDTMPA) and its salts.</SUBJECT> <SECTNO>704.102</SECTNO> <SUBJECT>Hexachloronorbornadiene.</SUBJECT> <SECTNO>704.104</SECTNO> <SUBJECT>Hexafluoropropylene oxide.</SUBJECT> <SECTNO>704.175</SECTNO> <SUBJECT>4,4′-methylenebis(2-chloroaniline) (MBOCA).</SUBJECT> <SECTNO>704.180</SECTNO> <SUBJECT>Asbestos.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <PRTPAGE P="52"/> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(a).</P> </AUTH> <SUBPART> <HD SOURCE="HED">Subpart A—General Reporting and Recordkeeping Provisions for Section 8(a) Information-Gathering Rules</HD> <SECTION> <SECTNO>§ 704.1</SECTNO> <SUBJECT>Scope.</SUBJECT> <P>(a) This part specifies reporting and recordkeeping procedures under section 8(a) of the Toxic Substances Control Act (TSCA) for manufacturers, importers, and processors of chemical substances and mixtures (hereafter collectively referred to as substances) that are identified in subpart B of this part. The reporting and recordkeeping provisions in subpart A of this part apply throughout this part unless revised in any other subpart.</P> <P>(b) Subpart B of this part sets out chemical-specific reporting and recordkeeping requirements under section 8(a) of TSCA.</P> <CITA>[53 FR 51715, Dec. 22, 1988, as amended at 60 FR 31920, June 19, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>All definitions as set forth in section 3 of TSCA apply in this part. In addition, the following definitions are provided for the purposes of this part.</P> <P> <E T="03">Annual</E> means the corporate fiscal year. </P> <P> <E T="03">Article</E> means a manufactured item (1) which is formed to a specific shape or design during manufacture, (2) which has end use function(s) dependent in whole or in part upon its shape or design during end use, and (3) which has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article, and that result from a chemical reaction that occurs upon end use of other chemical substances, mixtures, or articles; except that fluids and particles are not considered articles regardless of shape or design. </P> <P> <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s). </P> <P> <E T="03">CAS Number</E> means Chemical Abstracts Service Registry Number. </P> <P> <E T="03">Coproduct</E> means a chemical substance produced for a commercial purpose during the manufacture, processing, use, or disposal of another chemical substance or mixture. </P> <P> <E T="03">Customer</E> means any person to whom a manufacturer, importer, or processor directly distributes any quantity of a chemical substance, mixture, mixture containing the substance or mixture, or article containing the substance or mixture, whether or not a sale is involved. </P> <P> <E T="03">Domestic</E> means within the geographical boundaries of the 50 United States, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Northern Mariana Islands, and any other territory or possession of the United States. </P> <P> <E T="03">Enclosed process</E> means a manufacturing or processing operation that is designed and operated so that there is no intentional release into the environment of any substance present in the operation. An operation with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases. </P> <P> <E T="03">EPA</E> means the United States Environmental Protection Agency. </P> <P> <E T="03">Import</E> means to import for commercial purposes. </P> <P> <E T="03">Import for commercial purposes</E> means to import with the purpose of obtaining an immediate or eventual commercial advantage for the importer, and includes the importation of any amount of a chemical substance or mixture. If a chemical substance or mixture containing impurities is imported for commercial purposes, then those impurities also are imported for commercial purposes. </P> <P> <E T="03">Import in bulk form</E> means to import a chemical substance (other than as part of a mixture or article) in any quantity, in cans, bottles, drums, barrels, packages, tanks, bags, or other containers, if the chemical substance is intended to be removed from the container and the substance has an end use <PRTPAGE P="53"/> or commercial purpose separate from the container. </P> <P> <E T="03">Importer</E> means (1) any person who imports any chemical substance or any chemical substance as part of a mixture or article into the customs territory of the United States, and includes: </P> <P>(i) The person primarily liable for the payment of any duties on the merchandise, or</P> <P>(ii) An authorized agent acting on his behalf.</P> <P>(2) Importer also includes, as appropriate:</P> <P>(i) The consignee.</P> <P>(ii) The importer of record.</P> <P>(iii) The actual owner if an actual owner's declaration and superseding bond have been filed in accordance with 19 CFR 141.20.</P> <P>(iv) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144.</P> <P>(3) For the purposes of this definition, the customs territory of the United States consists of the 50 States, Puerto Rico, and the District of Columbia.</P> <P> <E T="03">Impurity</E> means a chemical substance which is unintentionally present with another chemical substance. </P> <P> <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reactions used for the intentional manufacture of other chemical substances or mixtures, or that is intentionally present for the purpose of altering the rates of such chemical reactions. </P> <P> <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know. </P> <P> <E T="03">Manufacture</E> means to manufacture for commercial purposes. </P> <P> <E T="03">Manufacture for commercial purposes</E> means: (1) To import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes among other things, such “manufacture” of any amount of a chemical substance or mixture: </P> <P>(i) For commercial distribution, including for test marketing.</P> <P>(ii) For use by the manufacturer, including use for product research and development, or as an intermediate.</P> <P>(2) Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including both byproducts that are separated from that other substance or mixture and impurities that remain in that substance or mixture. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose.</P> <P> <E T="03">Manufacturer</E> means a person who imports, produces, or manufactures a chemical substance. A person who extracts a component chemical substance from a previously existing chemical substance or a complex combination of substances is a manufacturer of that component chemical substance. </P> <P> <E T="03">Non-isolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture. Mechanical or gravity transfer through a closed system is not considered to be intentional removal, but storage or transfer to shipping containers “isolates” the substance by removing it from process equipment in which it is manufactured. </P> <P> <E T="03">Own or control</E> means ownership of 50 percent or more of a company's voting stock or other equity rights, or the power to control the management and policies of that company. A company may own or control one or more sites. A company may be owned or controlled by a foreign or domestic parent company. </P> <P> <E T="03">Parent company</E> is a company that owns or controls another company. </P> <P> <E T="03">Person</E> includes any individual, firm, company, corporation, joint venture, <PRTPAGE P="54"/> partnership, sole proprietorship, association, or any other business entity; any State or political subdivision thereof; any municipality; any interstate body; and any department, agency, or instrumentality of the Federal Government. </P> <P> <E T="03">Possession or control</E> means in the possession or control of any person, or of any subsidiary, partnership in which the person is a general partner, parent company, or any company or partnership which the parent company owns or controls, if the subsidiary, parent company, or other company or partnership is associated with the person in the research, development, test marketing, or commercial marketing of the substance in question. Information is in the possession or control of a person if it is: </P> <P>(1) In the person's own files including files maintained by employees of the person in the course of their employment.</P> <P>(2) In commercially available data bases to which the person has purchased access.</P> <P>(3) Maintained in the files in the course of employment by other agents of the person who are associated with research, development, test marketing, or commercial marketing of the chemical substance in question.</P> <P> <E T="03">Process</E> means to process for commercial purposes. </P> <P> <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture after its manufacture for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included in this definition. If a chemical substance or mixture containing impurities is processed for commercial purposes, then the impurities also are processed for commercial purposes. </P> <P> <E T="03">Processor</E> means any person who processes a chemical substance or mixture. </P> <P> <E T="03">Production volume</E> means the quantity of a substance which is produced by a manufacturer, as measured in kilograms or pounds. </P> <P> <E T="03">Propose to manufacture, import, or process</E> means that a person has made a firm management decision to commit financial resources for the manufacture, import, or processing of a specified chemical substance or mixture. </P> <P> <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way shall be considered one site. There may be more than one plant on a single site. The site for a person who imports a substance is the site of the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction and may in some cases be the organization's headquarters office in the United States. </P> <P> <E T="03">Small government</E> means the government of a city, county, town, township, village, school district, or special district with a population of less than 50,000. </P> <P> <E T="03">Small manufacturer</E> means a manufacturer (including importer) that meets either of the following standards: </P> <P> (1) <E T="03">First standard.</E> A manufacturer (including importer) of a substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $120 million. However, if the annual production or importation volume of a particular substance at any individual site owned or controlled by the manufacturer or importer is greater than 45,400 kilograms (100,000 lbs), the manufacturer (including importer) will not qualify as small for purposes of reporting on the production or importation of that substance at that site, unless the manufacturer (including importer) qualifies as small under paragraph (2) of this definition. </P> <P> (2) <E T="03">Second standard.</E> A manufacturer (including importer) of a substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $12 million, regardless of the quantity of substances produced or imported by that manufacturer (including importer). </P> <P> (3) <E T="03">Inflation index.</E> EPA shall make use of the Producer Price Index for Chemicals and Allied Products, as compiled by the U.S. Bureau of Labor Statistics, for purposes of determining the need to adjust the total annual sales values and for determining new sales values when adjustments are made. EPA may adjust the total annual sales <PRTPAGE P="55"/> values whenever the Agency deems it necessary to do so, provided that the five-year average of the Producer Price Index for Chemicals and Allied Products has changed more than 20 percent since either the most recent previous change in sales values or May 28, 2020, whichever is later. EPA shall provide <E T="04">Federal Register</E> notification when changing the total annual sales values. </P> <P> <E T="03">Small quantities solely for research and development</E> (or “small quantities solely for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including such research or analysis for the development of a product”) means quantities of a chemical substance manufactured, imported, or processed or proposed to be manufactured, imported, or processed solely for research and development that are not greater than reasonably necessary for such purposes. </P> <P> <E T="03">Substance</E> means either a chemical substance or mixture unless otherwise indicated. </P> <P> <E T="03">Test marketing</E> means the distribution in commerce of no more than a predetermined amount of a chemical substance, mixture, article containing that chemical substance or mixture, or a mixture containing that substance, by a manufacturer or processor, to no more than a defined number of potential customers to explore market capability in a competitive situation during a predetermined testing period prior to the broader distribution of that chemical substance, mixture, or article in commerce. </P> <P> <E T="03">Total annual sales</E> means the total annual revenue (in dollars) generated by the sale of all products of a company. Total annual sales must include the total annual sales revenue of all sites owned or controlled by that company and the total annual sales revenue of that company's subsidiaries and foreign or domestic parent company, if any. </P> <P> <E T="03">TSCA</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 <E T="03">et seq.</E> </P> <CITA>[53 FR 51715, Dec. 22, 1988, as amended at 76 FR 50858, Aug. 16, 2011; 76 FR 54933, Sept. 6, 2011; 85 FR 31995, May 28, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.5</SECTNO> <SUBJECT>Exemptions.</SUBJECT> <P>A person who is subject to reporting requirements for a substance identified in this part is exempt from those requirements to the extent that the person and that person's use of the substance is described in this section. This section is superseded by any TSCA section 8(a) rule that adds to, removes, or revises the exemptions described in this section.</P> <P> (a) <E T="03">Articles.</E> A person who imports, processes, or proposes to import or process a substance identified in this part solely as part of an article is exempt from the reporting requirements of this part with regard to that substance. </P> <P> (b) <E T="03">Byproducts.</E> A person who manufactures, imports, or proposes to manufacture or import a substance identified in this part solely as a byproduct is exempt from the reporting requirements of this part. </P> <P> (c) <E T="03">Impurities.</E> A person who manufactures, imports, processes, or proposes to manufacture, import, or process a substance identified in this part solely as an impurity is exempt from the reporting requirements of this part. </P> <P> (d) <E T="03">Non-isolated intermediate.</E> A person who manufactures or proposes to manufacture a substance identified in this part solely as a non-isolated intermediate is exempt from the reporting requirements of this part. </P> <P> (e) <E T="03">Research and development.</E> A person who manufactures, imports, processes, or proposes to manufacture, import, or process a substance identified in this part only in small quantities solely for research and development is exempt from the reporting requirements of this part. </P> <P> (f) <E T="03">Small manufacturers and importers.</E> Small manufacturers and importers are exempt from the reporting requirements of this part. </P> <CITA>[53 FR 51717, Dec. 22, 1988]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.7</SECTNO> <SUBJECT>Confidential business information claims.</SUBJECT> <P>Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703.</P> <CITA>[88 FR 37171, June 7, 2023]</CITA> </SECTION> <SECTION> <PRTPAGE P="56"/> <SECTNO>§ 704.9</SECTNO> <SUBJECT>Where to send reports.</SUBJECT> <P>Reports must be submitted by certified mail to the Document Control Office (DCO) (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001, ATTN: 8(a) Reporting.</P> <CITA>[60 FR 34463, July 3, 1995, as amended at 71 FR 33641, June 12, 2006]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.11</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <P>Each person who is subject to the reporting requirements of this part must retain the following records for 3 years following the creation or compilation of the record.</P> <P>(a) A copy of each report submitted by the person in response to the requirements of this part.</P> <P>(b) Materials and documentation sufficient to verify or reconstruct the values submitted in the report.</P> <P>(c) A copy of each notice sent by the person, return receipt requested, to that person's customers for the purpose of notifying their customers of the customer's reporting obligations under this part.</P> <P>(d) All return receipts signed by the person's customers who received the notice described in paragraph (c) of this section.</P> <CITA>[53 FR 51717, Dec. 22, 1988, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.13</SECTNO> <SUBJECT>Compliance and enforcement.</SUBJECT> <P>Violators of the requirements of this part may be subject to civil administrative penalties up to $25,000 per day of violation or criminal prosecution, as provided in sections 15 and 16 of TSCA. In addition, under section 17, EPA may seek judicial relief to compel submission of required information.</P> <CITA>[53 FR 51717, Dec. 22, 1989]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Chemical-Specific Reporting and Recordkeeping Rules</HD> <SECTION> <SECTNO>§ 704.20</SECTNO> <SUBJECT>Chemical substances manufactured or processed at the nanoscale.</SUBJECT> <P> (a) <E T="03">Definitions.</E> For purposes of this section the terms below are defined as follows: </P> <P> An <E T="03">agglomerate</E> is a collection of weakly bound particles or aggregates or mixtures of the two where the resulting external surface area is similar to the sum of the surface areas of the individual components. </P> <P> An <E T="03">aggregate</E> is a particle comprising strongly bonded or fused particles where the resulting external surface area may be significantly smaller than the sum of calculated surface areas of the individual components. </P> <P> <E T="03">Central Data Exchange</E> or <E T="03">CDX</E> means EPA's centralized electronic submission receiving system. </P> <P> <E T="03">CISS tool</E> means the Chemical Information Submission System, EPA's electronic, web-based reporting tool for the completion and submission of data, reports, and other information, or its successors. </P> <P> <E T="03">Discrete form of a reportable chemical substance</E> differs from another form of the same reportable chemical substance in one or more of the following 3 characteristics: </P> <P>(i) The change in the reportable chemical substance is due to all of the following:</P> <P>(A) There is a change in process to effect a change in size, a change in one or more of the properties of the reportable chemical substances identified in paragraph (i)(C) of this definition, or both;</P> <P>(B) There is a size variation in the mean particle size that is greater than 7 times the standard deviation of the mean particle size (± 7 times the standard deviation); and</P> <P>(C) There is a change in at least one of the following properties: Zeta potential, specific surface area, dispersion stability, or surface reactivity, that is greater than 7 times the standard deviation of the measured value (± 7 times the standard deviation).</P> <P>(ii) The reportable chemical substance has a different morphology. Examples of morphologies include but are not limited to sphere, rod, ellipsoid, cylinder, needle, wire, fiber, cage, hollow shell, tree, flower, ring, torus, cone, and sheet.</P> <P> (iii) A reportable chemical substance that is coated with another chemical substance or mixture at the end of manufacturing or processing has a coating that consists of a different chemical substance or mixture. <PRTPAGE P="57"/> </P> <P> <E T="03">Nanoscale Materials Stewardship Program</E> was a program conducted by EPA from January 2008 to December 2009 under which some nanoscale material manufacturers and processors voluntarily provided EPA available information on engineered nanoscale materials that were manufactured, processed or used. </P> <P> <E T="03">Particle</E> is a minute piece of matter with defined physical boundaries. </P> <P> <E T="03">Primary particles</E> are particles or droplets that form during manufacture of a <E T="03">chemical</E> substance before aggregation or agglomerization occurs. </P> <P> <E T="03">Reportable chemical substance</E> is a chemical substance as defined in section 3 of TSCA that is solid at 25 °C and standard atmospheric pressure, that is manufactured or processed in a form where any particles, including aggregates and agglomerates, are in the size range of 1-100 nm in at least one dimension, and that is manufactured or processed to exhibit unique and novel properties because of its size. A reportable chemical substance does not include a chemical substance that is manufactured or processed in a form where less than 1% of any particles, including aggregates, and agglomerates, measured by weight are in the size range of 1-100 nm. </P> <P> <E T="03">Small manufacturer or processor</E> means any manufacturer or processor whose total annual sales, when combined with those of its parent company (if any), are less than $11 million. The definition of <E T="03">small manufacturer</E> in section 704.3 of this title does not apply to reporting under this section (40 CFR 704.20). </P> <P> <E T="03">Specific surface area</E> means the ratio of the area of the surface of the reportable chemical substance to its mass or volume. Specific surface area by mass is the ratio of the area of the surface of a nanoscale material divided by the mass (m <SU>2</SU> /kg) and the specific surface area by volume is the area of the surface of the reportable chemical substance divided by its volume m <SU>2</SU> /m <SU>3</SU> . </P> <P> <E T="03">Surface reactivity</E> means the reactivity at the surface of a reportable chemical substance. It is dependent upon factors such as redox potential, which is a measure of the tendency of a substance to lose or acquire electrons, photocatalytic activity, including the potential to generate free radicals. </P> <P> <E T="03">Unique and novel properties</E> means any size-dependent properties that vary from those associated with other forms or sizes of the same chemical substance, and such properties are a reason that the chemical substance is manufactured or processed in that form or size. </P> <P> <E T="03">Zeta potential</E> is the electrostatic potential near the particle surface. </P> <P> (b) <E T="03">Persons who must report.</E> (1) Persons who can reasonably ascertain that they are manufacturers and processors of a discrete form of a reportable chemical substance during the three years prior to the final effective date of the rule must report except as provided in paragraph (c) of this section. </P> <P>(2) Persons who can reasonably ascertain that they propose to manufacture or process a discrete form of a reportable chemical substance after the final effective date of the rule which was not reported under paragraph (b)(1) of this section must report except as provided in paragraph (c) of this section.</P> <P> (c) <E T="03">When reporting is not required.</E> (1) The following chemical substances are not subject to reporting under this section: </P> <P>(i) Chemical substances formed at the nanoscale as part of a film on a surface.</P> <P>(ii) DNA.</P> <P>(iii) RNA.</P> <P>(iv) Proteins.</P> <P>(v) Enzymes.</P> <P>(vi) Lipids.</P> <P>(vii) Carbohydrates.</P> <P>(viii) Peptides.</P> <P>(ix) Liposomes.</P> <P>(x) Antibodies.</P> <P>(xi) Viruses.</P> <P>(xii) Microorganisms.</P> <P>(xiii) Chemical substances which dissociate completely in water to form ions that are smaller than 1 nanometer.</P> <P>(xiv) Chemical substances that are not on the TSCA Chemical Substance Inventory at the time reporting would otherwise be required under this section.</P> <P> (2) Persons who submitted a notice under 40 CFR parts 720, 721, or 723 for a reportable chemical substance on or after January 1, 2005 are not required <PRTPAGE P="58"/> to submit a report for the reportable chemical substance submitted except where the person manufactures or processes a discrete form of the reportable chemical substance. </P> <P>(3) Section 704.5(a) through (e) apply to reporting under this section. Small manufacturers and processors as defined in paragraph (a) of this section are exempt from reporting under this section.</P> <P>(4) Persons who submitted some or all of the required information for a reportable chemical substance as part of the Nanoscale Materials Stewardship Program are not required to report the information previously submitted except where the person manufactures or processes a discrete form of the reportable chemical substance.</P> <P> (d) <E T="03">What information to report.</E> The following information must be reported for each discrete form of a reportable chemical substance to the extent that it is known to or reasonably ascertainable by the person reporting: </P> <P>(1) The common or trade name, the specific chemical identity including the correct Chemical Abstracts (CA) Index Name and available Chemical Abstracts Service (CAS) Registry Number, and the molecular structure of each chemical substance or mixture. Information must be reported as specified in § 720.45.</P> <P>(2) Material characteristics including particle size, morphology, and surface modifications.</P> <P>(3) Physical/chemical properties.</P> <P>(4) The maximum weight percentage of impurities and byproducts resulting from the manufacture, processing, use, or disposal of each chemical substance.</P> <P>(5)(i) Persons described in paragraph (b)(1) of this section must report the annual production volume for the previous three years before the effective date of the final rule and an estimate of the maximum production volume for any consecutive 12-month period during the next two years of production after the final effective date of this rule.</P> <P>(ii) Persons described in paragraph (b)(2) of this section must report the estimated maximum 12 month production volume and the estimated maximum production volume for any consecutive 12 month period during the first three years of production.</P> <P>(iii) Estimates for paragraphs (d)(5)(i) and (ii) of this section must be on 100% chemical basis of the discrete form of the solid nanoscale material.</P> <P>(6) Use information describing the category of each use by function and application, estimates of the amount manufactured or processed for each category of use, and estimates of the percentage in the formulation for each use.</P> <P>(7) Detailed information on methods of manufacturing or processing.</P> <P>(8) Exposure information with estimates of the number of individuals exposed in their places of employment, descriptions and duration of the occupational tasks that cause such exposure, descriptions and estimates of any general population or consumer exposures.</P> <P>(9) Release information with estimates of the amounts released, descriptions and duration of the activities that cause such releases, and whether releases are directly to the environment or to control technology.</P> <P>(10) Risk management practices describing protective equipment for individuals, engineering controls, control technologies used, any hazard warning statement, label, safety data sheet, customer training, or other information which is provided to any person who is reasonably likely to be exposed to this substance regarding protective equipment or practices for the safe handing, transport, use, or disposal of the substance.</P> <P>(11) Existing information concerning the environmental and health effects.</P> <P> (e) <E T="03">How to report.</E> You must use CDX and the CISS tool to complete and submit the information required under this part to EPA electronically. </P> <P> (1) <E T="03">Reporting form.</E> You must complete EPA Form No. 7710-xx, TSCA § 8(a) Reporting for Nanoscale Materials: Information Submission Form. </P> <P> (2) <E T="03">Electronic submission.</E> You must submit the required information to EPA electronically via CDX and using the CISS tool. </P> <P> (i) To access the CDX portal, go to <E T="03">https://cdx.epa.gov.</E> </P> <P> (ii) The CISS tool is accessible in CDX. <PRTPAGE P="59"/> </P> <P> (f) <E T="03">When to report.</E> (1) Persons specified in paragraph (b)(1) of this section must report the information specified in paragraph (d) of this section within one year after the final effective date of the rule. </P> <P>(2) Persons specified in paragraph (b)(2) of this section must report the information specified in paragraph (d) of this section at least 135 days before commencing manufacture or processing of a discrete form of the reportable chemical substance, except where the person has not formed an intent to manufacture or process that discrete form at least 135 days before commencing such manufacture or processing, in which case the information must be filed within 30 days of the formation of such an intent.</P> <P> (g) <E T="03">Recordkeeping.</E> Any person subject to the reporting requirements of this section is subject to the recordkeeping requirements in § 704.11(a) and (b). </P> <P> (h) <E T="03">Confidential business information.</E> (1) Persons submitting a notice under this rule are subject to the requirements for confidential business information claims in § 704.7(a) through (c). </P> <P>(2) In submitting a claim of confidentiality, a person attests to the truth of the following four statements concerning all information which is claimed confidential:</P> <P>(i) My company has taken measures to protect the confidentiality of the information,</P> <P>(ii) I have determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law.</P> <P>(iii) I have a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of the person.</P> <P>(iv) I have a reasonable basis to believe that the information is not readily discoverable through reverse engineering.</P> <CITA>[82 FR 3653, Jan. 12, 2017]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.25</SECTNO> <SUBJECT>11-Aminoundecanoic acid.</SUBJECT> <P> (a) <E T="03">Definitions</E> —(1) <E T="03">11-AA</E> means the chemical substance 11-aminoundecanoic acid, CAS Number 2432-99-7. </P> <P> (2) <E T="03">Enclosed process</E> means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to an environmental contamination from the releases. </P> <P> (3) <E T="03">Internal subunit</E> means a subunit that is covalently linked to at least two other subunits. <E T="03">Internal subunits</E> of polymer molecules are chemically derived from monomer molecules that have formed covalent links between two or more other molecules. </P> <P> (4) <E T="03">Monomer</E> means a chemical substance that has the capacity to form links between two or more other molecules. </P> <P> (5) <E T="03">Polymer</E> means a chemical substance that consists of at least a simple weight majority of polymer molecules but consists of less than a simple weight majority of molecules with the same molecular weight. Collectively, such polymer molecules must be distributed over a range of molecular weights wherein differences in molecular weight are primarily attributable to differences in the number of internal subunits. </P> <P> (6) <E T="03">Polymer molecule</E> means a molecule which includes at least four covalently linked subunits, at least two of which are internal subunits. </P> <P> (7) <E T="03">Small processor</E> means a processor that meets either the standard in paragraph (a)(7)(i) of this section or the standard in paragraph (a)(7)(ii) of this section. </P> <P> (i) <E T="03">First standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company, if any, are less than $40 million. However, if the annual processing volume of a particular chemical substance at any individual site owned or controlled by the processor is greater than 45,400 kilograms (100,000 pounds), the processor shall not qualify as small for purposes of reporting on the processing of that chemical substance at that site, unless the processor qualifies as small under paragraph (a)(7)(ii) of this section. </P> <P> (ii) <E T="03">Second standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), <PRTPAGE P="60"/> are less than $4 million, regardless of the quantity of the particular chemical substance processed by that company. </P> <P> (iii) <E T="03">Inflation index.</E> EPA will use the Inflation Index described in the definition of <E T="03">small manufacturer</E> set forth in § 704.3, for purposes of adjusting the total annual sales values of this small processor definition. EPA will provide notice in the <E T="04">Federal Register</E> when changing the total annual sales values of this definition. </P> <P> (8) <E T="03">Subunit</E> means an atom or group of associated atoms chemically derived from corresponding reactants. </P> <P> (b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to this section: </P> <P>(1) Persons who manufacture or propose to manufacture 11-AA:</P> <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P> <P>(ii) For use as a component in photoprocessing solutions.</P> <P>(2) Persons who import or propose to import 11-AA:</P> <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P> <P>(ii) For use as a component in photoprocessing solutions.</P> <P>(3) Persons who process or propose to process 11-AA:</P> <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P> <P>(ii) For use as a component in photoprocessing solutions.</P> <P> (c) <E T="03">Persons not subject to this section.</E> The following persons are not subject to this section: </P> <P>(1) Small manufacturers (includes importers) as described in § 704.3.</P> <P>(2) Small processors.</P> <P>(3) Persons described in § 704.5.</P> <P>(4) Persons who, at any time during the 3-year period ending July 22, 1986, manufactured, imported, or processed 11-AA:</P> <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P> <P>(ii) For use as a component in photoprocessing solutions.</P> <P> (d) <E T="03">What information to report.</E> Persons identified in paragraph (b) of this section must submit a Premanufacture Notice Form (EPA Form 7710-25). </P> <P> (e) <E T="03">When to report.</E> (1) Persons who intend to manufacture, import, or process 11-AA for use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process or for use as a component in photoprocessing solutions must notify EPA within 30 days after making a firm management decision to commit financial resources for the manufacturing, importing, or processing of 11-AA. </P> <P>(2) Persons who initiated manufacturing, importing, or processing of 11-AA for use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or for use as a component in photoprocessing solutions during the time period between July 22, 1986 and July 13, 1987 must notify EPA by August 10, 1987.</P> <P> (f) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of submission of the report. </P> <P> (g) <E T="03">Where to send reports.</E> Reports must be submitted by certified mail to the Document Control Office (DCO) (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001, ATTN: 11-AA Notification. </P> <CITA>[52 FR 19864, May 28, 1987, as amended at 60 FR 16308, Mar. 29, 1995; 60 FR 34463, July 3, 1995; 71 FR 33641, June 12, 2006]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.33</SECTNO> <SUBJECT>P-tert-butylbenzoic acid (P-TBBA), p-tert-butyltoluene (P-TBT) and p-tert-butylbenzaldehyde (P-TBB).</SUBJECT> <P> (a) <E T="03">Definitions</E> —(1) <E T="03">P-TBBA</E> means the substance p-tert-butylbenzoic acid, <PRTPAGE P="61"/> also identified as 4-(1,1-dimethylethyl)benzoic acid, CAS No. 98-73-7. </P> <P> (2) <E T="03">P-TBT</E> means the substance p-tert-butyltoluene, also identified as 1-(1,1-dimethylethyl)-4-methylbenzene, CAS No. 98-51-1. </P> <P> (3) <E T="03">P-TBB</E> means the substance p-tert-butylbenzaldehyde, also identified as 4-(1,1-dimethylethyl)benzaldehyde, CAS No. 939-97-9. </P> <P> (4) <E T="03">Small processor</E> means a processor that meets either the standard in paragraph (a)(4)(i) of this section or the standard in paragraph (a)(4)(ii) of this section. </P> <P> (i) <E T="03">First standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company, if any, are less than $40 million. However, if the annual processing volume of a particular chemical substance at any individual site owned or controlled by the processor is greater than 45,400 kilograms (100,000 pounds), the processor shall not qualify as small for purposes of reporting on the processing of that chemical substance at that site, unless the processor qualifies as small under paragraph (a)(1)(ii) of this section. </P> <P> (ii) <E T="03">Second standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance processed by that company. </P> <P> (iii) <E T="03">Inflation index.</E> EPA shall use the Inflation Index described in the definition of <E T="03">small manufacturer</E> that is set forth in § 704.3, for purposes of adjusting the total annual sales values of this small processor definition. EPA shall provide <E T="04">Federal Register</E> notification when changing the total annual sales values of this definition. </P> <P> (b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to the reporting requirements of this rule; a person may become subject to this rule more than once, for more than one substance or under more than one of the criteria listed in this paragraph (b). </P> <P>(1) Persons who manufactured, imported, or processed P-TBBA, P-TBT, and/or P-TBB for commercial purposes during the person's latest complete corporate fiscal year prior to June 25, 1986. For purposes of this provision, processors of P-TBBA, P-TBT, and/or P-TBB shall include only those persons who processed the substances other than as non-isolated intermediates.</P> <P>(2) Persons who commence manufacture or importation of P-TBBA, P-TBT, and/or P-TBB for commercial purposes after June 25, 1986. This provision is applicable to persons who cease manufacture or importation of P-TBBA, P-TBT, and/or P-TBB after June 25, 1986 and then subsequently resume manufacture or importation of the substance(s).</P> <P>(3) Persons who process P-TBBA, P-TBT, and/or P-TBB for commercial purposes in any way other than as a non-isolated intermediate after June 25, 1986.</P> <P> (c) <E T="03">Persons not subject to this rule.</E> In addition to the persons described in § 704.5, small processors, as defined in paragraph (a)(4) of this section, are not subject to this rule. </P> <P> (d) <E T="03">Information to report.</E> Persons subject to this rule as described in paragraph (b) of this section shall report information to EPA as specified in this paragraph (d). Respondents to this rule shall report all information that is known to or reasonably ascertainable by the person reporting. For purposes of importer reporting under this paragraph, a site is the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction. The import site may in some cases be the organization's headquarters office in the United States. </P> <P>(1) All manufacturers, importers, and processors specified in paragraph (b) of this section shall report their name and headquarters address.</P> <P>(2) All manufacturers, importers, and processors specified in paragraph (b) of this section shall report the name, address, and office telephone number (including area code) of their principal technical contact.</P> <P> (3) All manufacturers, importers, and processors specified in paragraph (b) of this section shall report the name and address of each site where P-TBBA, P-TBT, and/or P-TBB is manufactured, imported, or processed. <PRTPAGE P="62"/> </P> <P>(4) All manufacturers, importers, and processors specified in paragraph (b)(1) of this section only shall report the information described in this paragraph (d)(4). Respondents to this paragraph (d)(4) shall report separately for each substance that they manufacture, import, or process, and for each site at which they do so. However, if the information to be reported in response to this paragraph (d)(4) is the same for different sites, the respondent need not report separately for each site but need only notify EPA that the information is the same for each site. The information to be reported under this paragraph (d)(4) shall cover the respondent's latest complete corporate fiscal year prior to June 25, 1986. Respondents to this paragraph (d)(4) shall report the following information:</P> <P>(i) The total quantity (by weight) of P-TBBA, P-TBT, or P-TBB manufactured, imported, or processed for commercial purposes per site.</P> <P>(ii) A narrative description of the manufacturing, importing, or processing operation(s) involving P-TBBA, P-TBT, or P-TBB at each site.</P> <P>(iii) A narrative description of worker activities involving P-TBBA, P-TBT, or P-TBB at each site, including the number of workers potentially exposed to each substance and, if applicable, the number of workers potentially exposed to more than one substance.</P> <P>(iv) The potential routes of worker exposure to P-TBBA, P-TBT, or P-TBB at each site (e.g., inhalation, ingestion, dermal absorption).</P> <P>(v) Available monitoring data from employee breathing zones with potential exposure to P-TBBA, P-TBT, or P-TBB at each site, including a description of the method of monitoring, the number of samples taken, and the potential number of workers similarly exposed for each worker job category. Respondents to this paragraph (d)(4)(v) shall submit data showing a range of 8-hour time weighted averages (TWAs), provided that the data are available in that form. Respondents also shall submit a calculated geometric mean of these data, with an explanation of the method by which the mean was derived. However, if the monitoring data are not available in the form of 8-hour TWAs, respondents shall submit raw sample data results and the duration time of sampling for each job category.</P> <P>(vi) A narrative description of any personal protective equipment and/or engineering controls used to prevent exposure to P-TBBA, P-TBT, or P-TBB at each site.</P> <P>(vii) A listing of the estimated quantities of P-TBBA, P-TBT, or P-TBB released directly into air, water, or land from each site.</P> <P>(viii) A narrative description of the times during the manufacturing, importing, or processing operations involving P-TBBA, P-TBT, or P-TBB when environmental release occurs at each site.</P> <P>(ix) A narrative description of any engineering controls used to prevent environmental release of P-TBBA, P-TBT, or P-TBB at each site.</P> <P>(x) A narrative description of all known end uses of any P-TBBA, P-TBT, or P-TBB that is manufactured, imported, or processed by the respondent. The narrative need not include customer identity.</P> <P>(xi) A narrative description of the methods used at each site for disposing of wastes generated during the manufacture, importation, or processing of P-TBBA, P-TBT, or P-TBB, including the quantity and content of such wastes (per site), the method of disposal, and an identification of the disposal site(s).</P> <P> (5) All manufactureres, importers, and processors specified in paragraph (b) of this section shall report the information described in this paragraph (d)(5). Respondents to this paragraph (d)(5) shall report separately for each substance that they intend to manufacture, import, or process during the first 2 years following the date on which they become subject to this rule. The data reported under this paragraph (d)(5) shall cover that 2-year period. Respondents to this paragraph (d)(5) shall report separately for each site at which they intend to manufacture, import, or process each substance. Respondents need not comply with this paragraph (d)(5) if the information to be reported is identical to that reported by the respondent under paragraph (d)(4) of this section, provided that the respondent makes note of that <PRTPAGE P="63"/> fact to EPA. Respondents to this paragraph (d)(5) shall report the following information: </P> <P>(i) An estimate of the total quantity (by weight) of P-TBBA, P-TBT, or P-TBB that the respondent intends to manufacture, import, or process for commercial purposes per site during each of the first 2 years following the date on which the respondent becomes subject to this rule.</P> <P>(ii) A narrative description of the intended manufacturing, importing, or processing activities involving P-TBBA, P-TBT, or P-TBB at each site during the first 2 years following the date on which the respondent becomes subject to this rule. The description shall include a summary of the intended manufacturing, importing, or processing operation(s); a summary of intended worker activities involving the substances, including an estimate of the number of persons anticipated to be exposed annually to P-TBBA, P-TBT, or P-TBB (per site) during the 2-year period, the anticipated routes of worker exposure to the substances (e.g., inhalation, ingestion, dermal absorption); and a summary of any personal protective equipment and/or engineering controls that the respondent intends to use to prevent exposure to the substances.</P> <P>(iii) A narrative description of anticipated environmental releases of P-TBBA, P-TBT, or P-TBB at each site from the manufacture, importation, or processing of these substances during the first 2 years following the date on which the respondent becomes subject to this rule. The narrative shall include the anticipated quantities of each substance released directly into air, water, or land, the anticipated routes of environmental release, and any intended engineering controls to be used to prevent environmental release of the substances.</P> <P>(iv) A narrative description of all anticipated end uses or P-TBBA, P-TBT, or P-TBB resulting from the respondent's manufacture, importation, or processing of the substances during the first 2 years following the date on which the respondent becomes subject to this rule. The summary need not include customer identity.</P> <P>(v) A narrative summary of the anticipated disposal of wastes generated from the manufacture, importation, or processing of P-TBBA, P-TBT, or P-TBB during the first 2 years following the date on which the respondent becomes subject to this rule. The summary shall include the anticipated quantity and content of such wastes (per site), the intended method of disposal, and an identification of intended disposal site(s).</P> <P> (e) <E T="03">When to report.</E> Persons subject to this rule must submit the requisite information to EPA within 60 days of becoming subject to the rule under the standards set forth in paragraph (b) of this section. </P> <P> (f) <E T="03">Certification.</E> Persons subject to this rule must attach the following statement to any information submitted to EPA in response to this rule: “I hereby certify that, to the best of my knowledge and belief, all of the attached information is complete and accurate.” This statement shall be signed and dated by the company's principal technical contact. </P> <P> (g) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of the submission of the report. </P> <CITA>[51 FR 17339, May 12, 1986; 51 FR 18323, May 19, 1986, as amended at 52 FR 20083, May 29, 1987; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.43</SECTNO> <SUBJECT>Chlorinated naphthalenes.</SUBJECT> <P> (a) <E T="03">Definitions</E> —(1) <E T="03">Extent of chlorination</E> means the percent by weight of chlorine. </P> <P> (2) <E T="03">Import</E> means to import in bulk form or as part of a mixture. </P> <P> (3) <E T="03">Isomeric ratio</E> means the relative amounts of each isomeric chlorinated naphthalene that composes the chemical substance; and for each isomer the relative amounts of each chlorinated naphthalene designated by the position of the chlorine atom(s) on the naphthalene. </P> <P> (4) <E T="03">Polychlorinated biphenyl</E> means any chemical substance that is limited to the biphenyl molecule and that has been chlorinated to varying degrees. </P> <P> (5) <E T="03">Small manufacturer</E> means a manufacturer (including importers) who <PRTPAGE P="64"/> meets either paragraph (a)(5) (i) or (ii) of this section: </P> <P>(i) A manufacturer of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $40 million. However, if the annual production volume of a particular chemical substance at any individual site owned or controlled by the manufacturer is greater than 45,400 kilograms (100,000 pounds), the manufacturer shall not qualify as small for purposes of reporting on the production of that chemical substance at that site, unless the manufacturer qualifies as small under paragraph (a)(5)(ii) of this section.</P> <P>(ii) A manufacturer of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance produced by that manufacturer.</P> <P>(iii) For imported mixtures containing a chemical substance identified in paragraph (b) of this section, the 45,400 kilograms (100,000 pounds) standard in paragraph (a)(5)(i) of this section applies only to the amount of the chemical substance in a mixture and not the other components of the mixture.</P> <P> (6) <E T="03">Waste</E> means any solid liquid, semisolid, or contained gaseous material that results from the production of a chemical substance identified in paragraph (b) of this section and which is to be disposed. </P> <P> (b) <E T="03">Substances for which reports must be submitted.</E> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s40,xs94"> <BOXHD> <CHED H="1">CAS registry number</CHED> <CHED H="1">Chemical substance</CHED> </BOXHD> <ROW> <ENT I="01">  90-13-1</ENT> <ENT>Naphthalene, 1-chloro-</ENT> </ROW> <ROW> <ENT I="01">  91-58-7</ENT> <ENT>Naphthalene, 2-chloro-</ENT> </ROW> <ROW> <ENT I="01"> 1321-64-8</ENT> <ENT>Naphthalene, pentachloro-</ENT> </ROW> <ROW> <ENT I="01"> 1321-65-9</ENT> <ENT>Naphthalene, trichloro-</ENT> </ROW> <ROW> <ENT I="01"> 1335-87-1</ENT> <ENT>Naphthalene, hexachloro-</ENT> </ROW> <ROW> <ENT I="01"> 1335-88-2</ENT> <ENT>Naphthalene, tetrachloro-</ENT> </ROW> <ROW> <ENT I="01"> 1825-30-5</ENT> <ENT>Naphthalene, 1,5-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 1825-31-6</ENT> <ENT>Naphthalene, 1,4-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2050-69-3</ENT> <ENT>Naphthalene, 1,2-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2050-72-8</ENT> <ENT>Naphthalene, 1,6-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2050-73-9</ENT> <ENT>Naphthalene, 1,7-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2050-74-0</ENT> <ENT>Naphthalene, 1,8-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2050-75-1</ENT> <ENT>Naphthalene, 2,3-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2065-70-5</ENT> <ENT>Naphthalene, 2,6-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2198-75-6</ENT> <ENT>Naphthalene, 1,3-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2198-77-8</ENT> <ENT>Naphthalene, 2,7-dichloro-</ENT> </ROW> <ROW> <ENT I="01"> 2234-13-1</ENT> <ENT>Naphthalene, octachloro-</ENT> </ROW> <ROW> <ENT I="01">25586-43-0</ENT> <ENT>Naphthalene, chloro-</ENT> </ROW> <ROW> <ENT I="01">32241-08-0</ENT> <ENT>Naphthalene, heptachloro-</ENT> </ROW> <ROW> <ENT I="01">70776-03-3</ENT> <ENT>Naphthalene, chloro derivatives.</ENT> </ROW> </GPOTABLE> <P> (c) <E T="03">Persons who must report.</E> (1) Persons who are manufacturing or importing a chemical substance identified in paragraph (b) of this section on October 8, 1984. </P> <P>(2) Persons who propose to import a chemical substance identified in paragraph (b) of this section on or after October 8, 1984.</P> <P>(3) Persons who manufacture a chemical substance identified in paragraph (b) of this section after October 8, 1984.</P> <P>(4) A person is required to report only once for each chemical substance identified in paragraph (b) of this section.</P> <P> (d) <E T="03">Persons exempt from reporting.</E> (1) Small manufacturers. </P> <P>(2) Persons described in § 704.5.</P> <P> (e) <E T="03">What information to report.</E> Persons described in paragraph (c) of this section must notify EPA of current or prospective manufacture or import. The notice must include, to the extent that it is known to or reasonably ascertainable by the person making the report, the following information: </P> <P>(1) Company name and address.</P> <P>(2) Name, address, and telephone number of the principal technical contact.</P> <P>(3) For chemical substances proposed to be imported, the proposed date of import.</P> <P>(4) A description of the use(s) or intended use(s) for the chemical substance.</P> <P>(5) A description of the isomeric ratio and extent of chlorination of the chemical substance and the impurity level of polychlorinated biphenyls.</P> <P>(6) The quantity (by weight) manufactured or imported within 12 months prior to October 8, 1984, if any, and the estimated quantity (by weight) to be manufactured or imported for the first 3 years following the date of the report or the date of the intended start of import whichever occurs later.</P> <P>(7) The number of persons exposed to the chemical substance during manufacture, import, processing, distribution in commerce, use, and disposal.</P> <P>(8) If a manufacturer's waste contains one or more of the chemical substances identified in paragraph (b) of this section, the manufacturer must:</P> <P> (i) Provide the quantity (by weight) of the chemical substances identified <PRTPAGE P="65"/> in paragraph (b) of this section present in the waste. </P> <P>(ii) Identify the constituents of the waste and their concentrations,</P> <P>(iii) State the rate of waste generation as a percentage of production volume,</P> <P>(iv) Describe where in the manufacturing process the waste is generated, and</P> <P>(v) Describe the method for disposal of the waste.</P> <P> (f) <E T="03">When to report.</E> (1) Persons who are manufacturing or importing a chemical substance identified in paragraph (b) of this section on October 8, 1984 must notify EPA by November 6, 1984. </P> <P>(2) Persons who propose to import a chemical substance identified in paragraph (b) of this section on or after October 8, 1984 must notify EPA by November 6, 1984, or 15 days after making the management decision described in § 704.3, whichever is later in time.</P> <P>(3) Persons who manufacture a chemical substance identified in paragraph (b) of this section after October 8, 1984 must notify EPA within 30 days after the initial date of manufacture.</P> <CITA>[49 FR 33653, Aug. 24, 1984; 49 FR 45133, Nov. 15, 1984; 50 FR 1215, Jan. 10, 1985; 51 FR 19839, June 3, 1986; 52 FR 20083, May 29, 1987. Redesignated at 53 FR 51717, Dec. 22, 1988]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.45</SECTNO> <SUBJECT>Chlorinated terphenyl.</SUBJECT> <P> (a) <E T="03">Definitions</E> —(1) <E T="03">Chlorinated terphenyl</E> means a chemical substance, CAS No. 61788-33-6, comprised of chlorinated ortho-, meta-, and paraterphenyl. </P> <P> (2) <E T="03">Extent of chlorination</E> means the percent by weight of chlorine for each isomer (ortho, meta, and para). </P> <P> (3) <E T="03">Isomeric ratio</E> means the ratios of ortho-, meta-, and parachlorinated terphenyls. </P> <P> (4) <E T="03">Polychlorinated biphenyl</E> means any chemical substance that is limited to the biphenyl molecule that has been chlorinated to varying degrees. </P> <P> (5) <E T="03">Small manufacturer</E> means a manufacturer (importers are defined as manufacturers under TSCA) who meets either of the following standards under this rule: </P> <P> (i) <E T="03">First standard.</E> A manufacturer of an existing chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $40 million. However, if the annual production volume of a particular chemical substance at any individual site owned or controlled by the manufacturer is greater than 45,400 kilograms (100,000 pounds), the manufacturer shall not qualify as small for purposes of reporting on the production of that chemical substance at the site, unless the manufacturer qualified as small under paragraph (a)(5)(ii) of this section. </P> <P> (ii) <E T="03">Second standard.</E> A manufacturer of an existing chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of chemicals produced by that manufacturer. </P> <P> (b) <E T="03">Persons who must report.</E> Except for small manufacturers and as provided in § 704.5, the following persons are subject to the rule: </P> <P>(1) Persons who manufacture or propose to manufacture chlorinated terphenyl.</P> <P>(2) Persons who import (importers) or propose to import chlorinated terphenyl as a chemical substance in bulk or as part of a mixture.</P> <P> (c) <E T="03">What information to report.</E> Persons subject to this rule as described in paragraph (b) of this section must notify EPA of current or proposed manufacture or import of chlorinated terphenyl. The notice must include, to the extent that it is known to the person making the report or is reasonably ascertainable, the following information: </P> <P>(1) Company name and address.</P> <P>(2) Name, address, and telephone number of principal technical contact.</P> <P>(3) A description of the use(s) or intended use(s) for chlorinated terphenyl.</P> <P>(4) A description of the isomeric ratio and extent of chlorination of the chlorinated terphenyl and the impurity level of polychlorinated biphenyls.</P> <P> (5) The quantity (by weight) manufactured or imported within 12 months prior to the effective date of the rule, if any, and the estimated quantity (by weight) to be manufactured or imported for the first three years following the date of the report or the date of the intended start of production, whichever occurs later. <PRTPAGE P="66"/> </P> <P>(6) The proposed date for the initiation of manufacturing or importation of chlorinated terphenyl, if appropriate.</P> <P> (d) <E T="03">When to report.</E> Persons who are manufacturing or importing chlorinated terphenyl on the effective date of the rule must notify EPA within 30 days of the effective date of the rule. Persons who propose to manufacture or import chlorinated terphenyl must notify EPA within 15 days after making the management decision described in § 704.3 “Proposed to manufacture or import”. </P> <CITA>[49 FR 11184, Mar. 26, 1984, as amended at 49 FR 32068, Aug. 10, 1984; 50 FR 2048, Jan. 15, 1985; 52 FR 20083, May 29, 1987. Redesignated at 53 FR 51717, Dec. 22, 1988; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.95</SECTNO> <SUBJECT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis-(methylene)]]tetrakis- (EDTMPA) and its salts.</SUBJECT> <P> (a) <E T="03">Substances for which reporting is required.</E> The chemical substances for which reporting is required under this section are: </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="10,r25"> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Chemical name</CHED> </BOXHD> <ROW> <ENT I="01">1429-50-1</ENT> <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis (methylene)]] tetrakis- (EDTMPA)</ENT> </ROW> <ROW> <ENT I="01">15142-96-8</ENT> <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis(methylene)]] tetrakis-, hexasodium salt</ENT> </ROW> <ROW> <ENT I="01">34274-30-1</ENT> <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis(methylene)]] tetrakis-, potassium salt</ENT> </ROW> <ROW> <ENT I="01">57011-27-5</ENT> <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis (methylene)]] tetrakis-, ammonium salt</ENT> </ROW> <ROW> <ENT I="01">67924-23-6</ENT> <ENT>Cobaltate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis-[phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">67969-67-9</ENT> <ENT>Cobaltate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)-N,N′,O,O″,O″″,O″″″]-, pentasodium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">67989-89-3</ENT> <ENT>Cuprate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">68025-39-8</ENT> <ENT>Cobaltate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (6-)-N,N′,O,O″,O″″,O″″″]-, pentaammonium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">68188-96-5</ENT> <ENT>Phosphonic acid, [1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis-, tetrapotassium salt</ENT> </ROW> <ROW> <ENT I="01">68309-98-8</ENT> <ENT>Cadmate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">68901-17-7</ENT> <ENT>Phosphonic acid, [1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis-, octaammonium salt</ENT> </ROW> <ROW> <ENT I="01">68958-86-1</ENT> <ENT>Nickelate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentaammonium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">68958-87-2</ENT> <ENT>Nickelate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT> </ROW> <ROW> <ENT I="01">68958-88-3</ENT> <ENT>Nickelate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis [phosphonato]] (8-)]-, pentasodium hydrogen, (OC-6-21)-</ENT> </ROW> </GPOTABLE> <P> (b) <E T="03">Persons who must report.</E> Unless exempt as provided in § 704.5, reports must be submitted by: </P> <P>(1) Persons who manufacture or import any of the substances identified in paragraph (a) of this section.</P> <P>(2) Persons who propose to manufacture or propose to import any of the substances identified in paragraph (a) of this section. For the purposes of importer reporting under this section, an import site is the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction; the import site may in some cases be the organization's headquarters office in the United States.</P> <P> (c) <E T="03">What information to report.</E> Persons identified in paragraph (b) of this section must report to EPA, for each of the substances identified in paragraph (a) of this section, the following information to the extent known to or reasonably ascertainable by them. </P> <P>(1) Initial Report:</P> <P>(i) Name and Chemical Abstracts Service Registry Number of the substance for which the report is submitted.</P> <P>(ii) Company name and headquarters address.</P> <P>(iii) Name, address, and telephone number of the principal technical contact.</P> <P>(iv) The total quantity (by weight in pounds) of the substance manufactured or imported for the person's most recently completed corporate fiscal year.</P> <P>(v) A description of the commercial uses of the substance during the person's most recently completed corporate fiscal year, including the production volume for each use.</P> <P> (vi) The estimated quantity (by weight in pounds) of the substance proposed to be manufactured or imported in the person's current corporate fiscal year. <PRTPAGE P="67"/> </P> <P>(vii) A description of the intended commercial uses of the substance during the person's current corporate fiscal year, including the estimated production volume for each use.</P> <P>(2) Follow-up Report:</P> <P>(i) Name and Chemical Abstracts Service Registry Number of the substance for which the report is submitted.</P> <P>(ii) Company name and headquarters address.</P> <P>(iii) Name, address, and telephone number of the principal technical contact.</P> <P>(iv) The estimated quantity (by weight in pounds) of the substance proposed to be manufactured or imported in the person's current corporate fiscal year.</P> <P>(v) A description of the intended commercial uses of the substance during the person's current corporate fiscal year, including the estimated production volume for each use.</P> <P> (d) <E T="03">When to report.</E> (1) Persons specified in paragraph (b)(1) of this section who are manufacturing or importing the substance as of December 5, 1988 must submit an initial report described in paragraph (c)(1) of this section by January 3, 1989. </P> <P>(2) Persons specified in paragraph (b)(2) of this section must submit an initial report within 30 days after making the management decision described in § 704.3 or by January 3, 1989, whichever is later.</P> <P>(3) Persons specified in paragraph (b) of this section, who submitted a report described in paragraph (c)(1) of this section, must submit a follow-up report described in paragraph (c)(2) of this section within 30 days of making the management decision, described at § 704.3, to do either of the following events:</P> <P>(i) Manufacture or import the substance in a quantity 50 percent greater than the quantity reported in the most recently submitted report.</P> <P>(ii) Manufacture or import the substance for a use not reported for that substance in any previous report.</P> <P> (e) <E T="03">Certification.</E> Persons subject to this section must attach the following statement to any information submitted to EPA in response to this section: “I hereby certify that, to the best of my knowledge and belief, all of the attached information is complete and accurate.” This statement must be signed and dated by the company's principal technical contact. </P> <P> (f) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of the submission of the report. </P> <CITA>[53 FR 41337, Oct. 21, 1988, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.102</SECTNO> <SUBJECT>Hexachloronorbornadiene.</SUBJECT> <P> (a) <E T="03">Definitions</E> —(1) <E T="03">Endrin</E> means the pesticide 2,7:3,6-Dimethanonaphth[2,3-b]oxirene,3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1a <E T="03">alpha,</E> 2 <E T="03">beta,</E> 2a <E T="03">beta,</E> 3 <E T="03">alpha,</E> 6 <E T="03">alpha,</E> 6 <E T="03">abeta,</E> 7 <E T="03">beta,</E> 7a <E T="03">alpha</E> )-, CAS Number 72-20-8. </P> <P> (2) <E T="03">HEX-BCH</E> means the chemical substance 1,2,3,4,7,7-hexachloronorbornadiene, CAS Number 3389-71-7. </P> <P> (3) <E T="03">Isodrin</E> means the pesticide 1,4:5,8-Dimethanonaphthalene,1,2,3,4,10,10-hexacholoro-1,4,4a,5,8,8a-hexahydro-, (1 <E T="03">alpha,</E> 4 <E T="03">alpha,</E> 4a <E T="03">beta,</E> 5 <E T="03">beta,</E> 8 <E T="03">beta,</E> 8a <E T="03">beta</E> )-, CAS Number 465-73-6. </P> <P> (4) <E T="03">Small business</E> means any manufacturer, importer, or processor who meets either paragraph (a)(4)(i) or (ii) of this section: </P> <P>(i) A business is small if its total annual sales, when combined with those of its parent (if any), are less than $40 million. However, if the annual manufacture, importation, or processing volume of a particular chemical substance at any individual site owned or controlled by the business is greater than 45,400 kilograms (100,000 pounds), the business shall not qualify as small for purposes of reporting on the manufacture, importation, or processing of that chemical substance at that site, unless the business qualifies as small under paragraph (a)(4)(ii) of this section.</P> <P>(ii) A business is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance manufactured, imported, or processed by that business.</P> <P> (iii) For imported and processed mixtures containing HEX-BCH, the 45,400 kilograms (100,000 pounds) standard in <PRTPAGE P="68"/> paragraph (a)(4)(i) of this section applies only to the amount of HEX-BCH in a mixture and not the other components of the mixture. </P> <P> (5) <E T="03">8-hour time weighted average</E> means the cumulative exposure for an 8-hour work shift computed as follows: </P> <MATH SPAN="1" DEEP="28"> <MID>ER25SE06.003</MID> </MATH> <EXTRACT> <FP>Where:</FP> <FP SOURCE="FP-2">E is the equivalent exposure for the working shift.</FP> <FP SOURCE="FP-2"> C <E T="52">i</E> is the concentration (i.e., parts per million) during any period of time (T <E T="52">i</E> ) where the concentration remains constant. </FP> <FP SOURCE="FP-2"> T <E T="52">i</E> is the duration in hours of the exposure at the concentration C <E T="52">i</E> . </FP> </EXTRACT> <P> (6) <E T="03">Year</E> means corporate fiscal year. </P> <P> (b) <E T="03">Persons who must report.</E> (1) Reports must be submitted by: </P> <P>(i) Persons who are manufacturing, importing, or processing HEX-BCH for use as an intermediate in the production or isodrin or endrin on or after January 2, 1986; and</P> <P>(ii) Persons who propose to manufacture, import, or process HEX-BCH for use as an intermediate in the production of isodrin or endrin, on or after January 2, 1986.</P> <P>(2) Persons described in paragraph (b)(1) of this section who engage or propose to engage in more than one activity (i.e., manufacture and processing) must report the information required in paragraph (d) separately for each activity.</P> <P> (c) <E T="03">Persons exempt from reporting.</E> (1) Small businesses. </P> <P>(2) Persons described in § 704.5(a) and (c).</P> <P> (d) <E T="03">Information to report.</E> (1) Initial reports must include, to the extent that it is known to or reasonably ascertainable by the person reporting, the following information: </P> <P>(i) Company name and address.</P> <P>(ii) Name, address, and telephone number of the principal contact.</P> <P>(iii) Name and address of plant sites where HEX-BCH is or is proposed to be manufactured, imported, or processed, noting for each plant site which activity takes or would take place at each site.</P> <P>(iv) If applicable, the intended date for initiating the manufacture, import, or processing of HEX-BCH.</P> <P>(v) If applicable, the actual quantity (by weight) of HEX-BCH manufactured, imported, or processed during the most recently concluded year.</P> <P>(vi) The estimated quantity (by weight) of HEX-BCH to be manufactured, imported, or processed each year during the first 3 years following the date of the report or the date of the intended start of manufacture, import, or processing, whichever occurs later.</P> <P>(vii) For each year described in paragraphs (d)(1) (v) and (vi) of this section: the number or expected number of employees exposed to HEX-BCH during the manufacture, import, processing, distribution in commerce, use, and disposal; the routes of exposure; and the 8-hour time weighted average of exposure.</P> <P>(viii) If employees are exposed or expected to be exposed to HEX-BCH, state for each reported route of exposure, whether personal protective equipment is used or expected to be used, and a description of the personal protective equipment.</P> <P>(ix) The actual or anticipated quantity, content, method of disposal, and disposal site of any wastes generated or expected to be generated during the manufacture, importation, or processing of HEX-BCH.</P> <P>(2) Subsequent reports must provide, to the extent known to or reasonably ascertainable by the person reporting, the information in paragraph (d)(1) of this section and a statement explaining why the subsequent report is required.</P> <P> (e) <E T="03">When to report.</E> (1) Persons who are manufacturing, importing, or processing HEX-BCH on January 2, 1986, must submit an initial report to EPA by February 3, 1986. </P> <P>(2) Persons who propose to manufacture, import, or process HEX-BCH on or after January 2, 1986, must submit an initial report to EPA by February 3, 1986, or 30 days after making the management decision described in § 704.3 “Propose to manufacture, import, or process,” whichever is later in time.</P> <P> (3) Persons described in paragraph (b) of this section, who have submitted a report described in paragraph (d) of this section, must submit a subsequent <PRTPAGE P="69"/> report within 30 days of any of the following events. Based on the most recently submitted report: </P> <P>(i) The manufacture, importation, or processing of HEX-BCH begins at a plant site different than that reported pursuant to paragraph (d)(1)(iii) of this section.</P> <P>(ii) The actual quantity (by weight) of HEX-BCH manufactured, imported, or processed in a given year is greater than or equal to 200 percent of the estimated value for that year reported pursuant to paragraph (d)(1)(vi) of this section.</P> <P>(iii) The total number of employees exposed to HEX-BCH is greater than 130 percent of the projected value reported pursuant to paragraph (d)(1)(vii) of this section.</P> <P>(iv) The route of exposures to HEX-BCH differs from that reported pursuant to paragraph (d)(1)(vii) of this section.</P> <P>(v) The actual 8-hour time weighted average exposure for any activity exceeds the projection reported pursuant to paragraph (d)(1)(vii) of this section by more than 100 percent.</P> <P>(vi) The method of disposal or disposal site reported pursuant to paragraph (d)(1)(ix) of this section has changed.</P> <P>(vii) Three years have passed since the most recent submission of a report and the person is still engaged in the manufacture, importation, or processing of HEX-BCH.</P> <P> (f) <E T="03">Certification of review.</E> Each person who submits a report under this section must for 3 years following the submission date of the most recent submission, review their activities at the end of each year to determine whether any reportable event specified in paragraph (e)(3) of this section has occurred. If a review shows that none of these events has occurred, the person is required to certify this fact in writing. </P> <P> (g) <E T="03">Recordkeeping.</E> Any person subject to the reporting requirements of this section must: </P> <P>(1) Retain documentation of information contained in their reports. This documentation must be maintained for a period of 3 years from the date of the submission of the report; and</P> <P>(2) Retain the certification required by paragraph (f) of this section for 3 years from the date of its creation.</P> <CITA>[50 FR 47536, Nov. 19, 1985, as amended at 52 FR 20083, May 29, 1987. Redesignated at 53 FR 51717, Dec. 22, 1988; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.104</SECTNO> <SUBJECT>Hexafluoropropylene oxide.</SUBJECT> <P> (a) <E T="03">Definitions.</E> (1) “HFPO” means the chemical substance hexafluoropropylene oxide, CAS Number 428-59-1. [Listed in TSCA Inventory as oxirane, trifluoro(trifluoromethyl)-] </P> <P>(2) “Enclosed process” means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases.</P> <P>(3) “Small processor” means a processor that meets either the standard in paragraph (a)(3)(i) of this section or the standard in paragraph (a)(3)(ii) of this section.</P> <P> (i) <E T="03">First standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company, if any, are less than $40 million. However, if the annual processing volume of a particular chemical substance at any individual site owned or controlled by the processor is greater than 45,400 kilograms (100,000 pounds), the processor shall not qualify as small for purposes of reporting on the processing of that chemical substance at that site, unless the processor qualifies as small under paragraph (a)(3)(ii) of this section. </P> <P> (ii) <E T="03">Second standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance processed by that company. </P> <P> (iii) <E T="03">Inflation index.</E> EPA will use the Inflation Index described in the definition of “small manufacturer” that is set forth in § 704.3 for purposes of adjusting the total annual sales values of this small processor definition. EPA will provide <E T="04">Federal Register</E> notification when changing the total annual sales values of this definition. <PRTPAGE P="70"/> </P> <P> (b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to this section: </P> <P>(1) Persons who manufacture or propose to manufacture HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P> <P>(2) Persons who import or propose to import HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P> <P>(3) Persons who process or propose to process HFPO as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P> <P> (c) <E T="03">Persons not subject to this rule.</E> The following persons are not subject to this rule: </P> <P>(1) Small processors.</P> <P>(2) Persons described in § 704.5(a) through (f).</P> <P>(3) Persons who have already submitted to EPA a completed copy of the Preliminary Assessment Information Manufacturer's Report (EPA Form 7710-35, as described at § 712.28 of this chapter) for HFPO are not required to report under this section with respect to activities previously reported on.</P> <P> (d) <E T="03">What information to report.</E> Persons identified in paragraph (b) of this section must submit a Premanufacture Notice Form (EPA Form 7710-25). </P> <P> (e) <E T="03">When to report.</E> (1) Persons who are manufacturing, importing, or processing, or who propose to manufacture, import, or process HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process as of December 10, 1987, must report by February 8, 1988. </P> <P>(2) Persons who propose to manufacture, import, or process HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process after December 10, 1987, must report within 30 days after making a firm management decision to commit financial resources for the manufacturing, importing, or processing of HFPO.</P> <P> (f) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of submission of the reports. </P> <P> (g) <E T="03">Where to send reports.</E> Reports must be submitted by certified mail to the Document Control Office (DCO) (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001, ATTN: HFPO Reporting. </P> <CITA>[52 FR 41299, Oct. 27, 1987, as amended at 58 FR 34204, June 23, 1993; 60 FR 16308, Mar. 29, 1995; 60 FR 31920, June 19, 1995; 60 FR 34463, July 3, 1995; 71 FR 33641, June 12, 2006; 85 FR 31995, May 28, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.175</SECTNO> <SUBJECT>4,4′-methylenebis(2-chloroaniline) (MBOCA).</SUBJECT> <P> (a) <E T="03">Substance subject to reporting.</E> The chemical substance 4,4′-methylenebis(2-chloroaniline) (CAS No. 101-14-4) is subject to reporting under this section. The substance also is identified as 4,4′-methylenebis(2-chlorobenzenamine) and MBOCA. </P> <P> (b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to this rule. </P> <P>(1) Persons who propose to manufacture MBOCA in the United States on or after June 2, 1986.</P> <P>(2) Persons who are manufacturing MBOCA in the United States as of June 2, 1986.</P> <P>(3) Persons manufacturing MBOCA in the United States on or after June 2, 1986 who propose to change their manner or method of manufacturing the substance from a manner or method of manufacturing that previously was reported under this section.</P> <P> (c) <E T="03">Persons not subject to this rule.</E> The following persons are exempt from the reporting requirements of this section: </P> <P>(1) Persons who import MBOCA into the customs territory of the United States and do not otherwise manufacture the substance in the United States.</P> <P>(2) Persons who complied with the requirements of this section prior to June 2, 1986 and received written notification of compliance from EPA.</P> <P> (d) <E T="03">What information to report.</E> Persons who are subject to this rule as described in paragraph (b) of this section must report information to EPA by completing the following parts of the <PRTPAGE P="71"/> notice form contained in appendix A to part 720 of this chapter: Parts I.A., I.B., I.C.1., I.C.3., and II.A.; also, part III as appropriate. Persons subject to the requirements of this section also must submit a narrative description of any processing and packaging of MBOCA that occurs at the manufacturing plant site, including the number of workers potentially exposed to MBOCA during on-site processing and packaging of MBOCA and a description of any personal protective equipment and/or engineering controls that would be used to prevent release of and exposure to MBOCA during on-site processing and packaging. Persons subject to the requirements of this section are not required to submit information on processing or use of MBOCA away from the manufacturing plant site. Respondents to this rule shall report all information that is known to or reasonably ascertainable by the person reporting. </P> <P> (e) <E T="03">When to report.</E> (1) Persons specified in paragraph (b)(1) of this section must report by July 2, 1986 or within 30 days after making a firm management decision to commit financial resources for the manufacture of MBOCA, whichever is later in time. </P> <P>(2) Persons specified in paragraph (b)(2) of this section must report by July 2, 1986.</P> <P>(3) Persons specified in paragraph (b)(3) of this section must report within 30 days of making a firm management decision to commit financial resources to change their manner or method of manufacturing the substance from a manner or method of manufacturing that previously was reported under this section.</P> <CITA>[51 FR 13223, Apr. 18, 1986, as amended at 52 FR 20083, May 29, 1987; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 704.180</SECTNO> <SUBJECT>Asbestos.</SUBJECT> <P> (a) <E T="03">Definitions.</E> The definitions in subpart A of this part apply to § 704.180 unless otherwise specified in this section. </P> <P> <E T="03">Asbestos</E> is a collective term meaning any of the substances listed in Table 1 of this paragraph (a). </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs60,r50"> <TTITLE> Table 1 to Paragraph ( <E T="01">a</E> )—CASRN of Asbestos Types </TTITLE> <BOXHD> <CHED H="1">CASRN</CHED> <CHED H="1">Asbestos type</CHED> </BOXHD> <ROW> <ENT I="01">1332-21-4</ENT> <ENT>Asbestos.</ENT> </ROW> <ROW> <ENT I="01">12001-29-5</ENT> <ENT>Chrysotile.</ENT> </ROW> <ROW> <ENT I="01">12001-28-4</ENT> <ENT>Crocidolite.</ENT> </ROW> <ROW> <ENT I="01">12172-73-5</ENT> <ENT>Amosite.</ENT> </ROW> <ROW> <ENT I="01">77536-67-5</ENT> <ENT>Anthophyllite.</ENT> </ROW> <ROW> <ENT I="01">77536-68-6</ENT> <ENT>Tremolite.</ENT> </ROW> <ROW> <ENT I="01">77536-66-4</ENT> <ENT>Actinolite.</ENT> </ROW> <ROW> <ENT I="01">NA</ENT> <ENT>Libby amphibole asbestos (mainly consisting of tremolite [CASRN 77536-68-6], winchite [CASRN 12425-92-2], and richterite [CASRN 17068-76-7]).</ENT> </ROW> </GPOTABLE> <P> <E T="03">Bulk asbestos</E> means any quantity of asbestos fiber of any type or grade, or combination of types or grades, that is mined or milled with the purpose of obtaining asbestos. This term does not include asbestos that is produced or processed as a contaminant or an impurity. </P> <P> <E T="03">Bulk materials containing asbestos</E> means bulk materials in which asbestos is being mined or milled as an impurity. </P> <P> <E T="03">Chemical Information Submission System</E> or <E T="03">CISS</E> means EPA's electronic, web-based reporting tool for the completion and submission of CDR data, reports, and other information, or its successors. </P> <P> <E T="03">Form A</E> means an abbreviated form for persons who know or can reasonably ascertain that they manufactured (including imported) or processed asbestos, including as an impurity, during the reporting period described in paragraph (f) of this section but do not know and cannot reasonably ascertain the amount of asbestos manufactured (including imported) or processed by them. </P> <P> <E T="03">Form B</E> means the standard form to be used by persons who know or can reasonably ascertain that they manufactured (including imported) or processed asbestos, including as an impurity, during the reporting period described in paragraph (f) of this section and know or can reasonably ascertain how much asbestos they manufactured (including imported) or produced. </P> <P> <E T="03">Primary processor</E> means a person who starts with bulk asbestos or bulk materials containing asbestos, and makes a mixture that contains asbestos as a component. <PRTPAGE P="72"/> </P> <P> <E T="03">Secondary processor</E> means a person who further processes asbestos, after primary processing of asbestos is completed, including as a component of a mixture, or an article containing asbestos. </P> <P> <E T="03">Small processor</E> means any processor whose total annual sales, when combined with those of its parent company (if any), are less than $12 million. </P> <P> (b) <E T="03">Substance for which reports must be submitted.</E> The requirements of this section apply to asbestos, including asbestos in bulk form, in an article and/or product, as an impurity, or as a component of a mixture. </P> <P> (c) <E T="03">Persons who must report.</E> Persons ( <E T="03">i.e.,</E> plant sites) who have manufactured (including imported), or processed asbestos, including asbestos as a component of a mixture, asbestos in articles, or asbestos as an impurity in the four full calendar years prior to the effective date of this rule, and with annual sales greater than or equal to $500,000, in any calendar year from 2019 to 2022, when combined with those of their ultimate parent company (if any), must report under this subpart. </P> <P> (d) <E T="03">Persons exempt from reporting.</E> A person who is subject to reporting requirements pursuant to paragraph (c) of this section is exempt from the requirements in this subpart to the extent that the person and that person's use of asbestos is described in this paragraph (d). </P> <P> (1) <E T="03">Non-isolated intermediate.</E> A person who manufactures or proposes to manufacture asbestos, as described in paragraph (c) of this section, solely as a non-isolated intermediate is exempt from the reporting requirements of this subpart. </P> <P> (2) <E T="03">Research and development.</E> A person who manufactures (including imports), processes, or proposes to manufacture (including import), or process asbestos, as described in paragraph (c) of this section, only in small quantities solely for research and development is exempt from the reporting requirements of this subpart. </P> <P> (3) <E T="03">Small manufacturers (including importers) and processors.</E> Small manufacturers (including importers) and processors are exempt from the reporting requirements of this subpart for Libby amphibole asbestos only. </P> <P> (4) <E T="03">Byproducts.</E> A person who manufactures (including imports) or proposes to manufacture (including import) asbestos solely as a byproduct is exempt from the reporting requirements of this subpart. </P> <P> (e) <E T="03">Reporting information to EPA.</E> Persons described in paragraph (c) of this section and not described and exempted in paragraph (d) of this section must report to EPA the following information, to the extent known to or reasonably ascertainable by them. In the event that specific numeric data are not known or are not reasonably ascertainable by the submitter, then reasonable estimates may be submitted. </P> <P> (1) <E T="03">Required forms.</E> Report using the appropriate Form, based on whether you know or can reasonably ascertain a quantity for asbestos. </P> <P> (i) <E T="03">Form A.</E> Report using Form A if you know or can reasonably ascertain that asbestos, including as a component of a mixture or article, or as an impurity, but are unable to determine the asbestos quantity by weight. </P> <P> (ii) <E T="03">Form B.</E> Report using Form B if you know or can reasonably ascertain a quantity for asbestos, including as a component of a mixture or article, or as an impurity. </P> <P> (2) <E T="03">A certification statement signed and dated by an authorized official of the submitter company.</E> The authorized official must certify that the submitted information has been completed in compliance with the requirements of this part and that the confidentiality claims made on Form A or Form B are true and correct. The certification must be signed and dated by the authorized official for the submitter company, and provide that person's name, official title, and email address. </P> <P> (3) <E T="03">Company and plant site information.</E> The following currently correct company and plant site information must be reported for each site at which a reportable chemical substance is manufactured (including imported) or processed (see § 704.3 for the definition of “site,” which includes what “site” means for importers): </P> <P> (i) <E T="03">Company name.</E> The highest-level U.S. parent company name, address, and Dun and Bradstreet D-U-N-S® (D&B) number. A submitter under this <PRTPAGE P="73"/> part must obtain a D&B number for the U.S. parent company if none exists. </P> <P> (ii) <E T="03">Authorized official.</E> The name of a person who will serve as Authorized Official for the submitter company, and who will be able to sign the certification statement as described in paragraph (e)(2) of this section, the Authorized Official's full mailing address, telephone number, and email address. </P> <P> (iii) <E T="03">Point of contact.</E> The name of a person who will serve as technical contact for the submitter company, and who will be able to answer questions about the information submitted by the company to EPA, the contact person's full mailing address, telephone number, and email address. </P> <P> (iv) <E T="03">Site information.</E> The site name, full street address, including the county or parish (or other jurisdictional indicator) in which the plant site is located. Also report the following: </P> <P>(A) The appropriate D&B number for the plant site. If none exists, you must obtain a D&B number for the reported site.</P> <P>(B) Other site identification numbers, including the Facility Registry Service (FRS) identification number, if they exist.</P> <P> (v) <E T="03">Applicable NAICS code.</E> The six-digit North American Industry Classification System (NAICS) code(s) of the site. </P> <P> (vi) <E T="03">Number of employees.</E> The total number of employees at the site. Select from among the ranges of employees listed in Table 2 of this paragraph (e) and report the corresponding code ( <E T="03">i.e.,</E> W1 through W8): </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs36,r50"> <TTITLE> Table 2 to Paragraph ( <E T="01">e</E> )—Codes for Reporting Number of Employees </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Range</CHED> </BOXHD> <ROW> <ENT I="01">W1</ENT> <ENT>Fewer than 10 employees.</ENT> </ROW> <ROW> <ENT I="01">W2</ENT> <ENT>At least 10 but fewer than 25 employees.</ENT> </ROW> <ROW> <ENT I="01">W3</ENT> <ENT>At least 25 but fewer than 50 employees.</ENT> </ROW> <ROW> <ENT I="01">W4</ENT> <ENT>At least 50 but fewer than 100 employees.</ENT> </ROW> <ROW> <ENT I="01">W5</ENT> <ENT>At least 100 but fewer than 500 employees.</ENT> </ROW> <ROW> <ENT I="01">W6</ENT> <ENT>At least 500 but fewer than 1,000 employees.</ENT> </ROW> <ROW> <ENT I="01">W7</ENT> <ENT>At least 1,000 but fewer than 10,000 employees.</ENT> </ROW> <ROW> <ENT I="01">W8</ENT> <ENT>At least 10,000 employees.</ENT> </ROW> </GPOTABLE> <P> (4) <E T="03">Activity information.</E> The following activity information must be reported. </P> <P> (i) <E T="03">Type of activity at reporting site.</E> Report all that apply. </P> <P>(A) Mining of bulk asbestos or bulk materials containing asbestos, including as an impurity.</P> <P>(B) Milling of bulk asbestos or bulk materials containing asbestos, including as an impurity.</P> <P>(C) Importing of bulk asbestos or bulk materials containing asbestos, including as an impurity.</P> <P> ( <E T="03">1</E> ) <E T="03">For importing only.</E> For importing only, if the imported bulk material was never physically present at the reporting site. </P> <P> ( <E T="03">2</E> ) [Reserved] </P> <P>(D) Primary processing of bulk asbestos or bulk materials containing asbestos, including as an impurity.</P> <P>(E) Secondary processing of asbestos, including as a component of a mixture, or an article containing asbestos.</P> <P>(F) Importing of asbestos, including as a component of a mixture, or an article containing asbestos.</P> <P> (ii) <E T="03">For importing only.</E> For importing only, if the imported bulk material was never physically present at the reporting site. </P> <P> (iii) <E T="03">Form B only.</E> For mining, milling, or importing of bulk asbestos reported under activity in paragraphs (e)(4)(i)(A) through (C) of this section, report by year: </P> <P> (A) <E T="03">The most specific asbestos type that applies.</E> Select from among the asbestos types listed in Table 1 of paragraph (a) in this section. If the specific asbestos type is not known or reasonably ascertainable, report the general listing, “asbestos CASRN 1332-21-4”. </P> <P> (B) <E T="03">Report.</E> For each asbestos type, report the following: </P> <P> ( <E T="03">1</E> ) Quantity of asbestos, in pounds. </P> <P> ( <E T="03">2</E> ) Disposition of asbestos (see Table 3 to this paragraph (e)). </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs36,r50"> <TTITLE> Table 3 to Paragraph ( <E T="01">e</E> )—Disposition </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Disposition description</CHED> </BOXHD> <ROW> <ENT I="01">1</ENT> <ENT>Used on-site, including further processed.</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>Stored on-site.</ENT> </ROW> <ROW> <ENT I="01">3</ENT> <ENT>Sent to another U.S. site (including intra-company transfer) for use or processing.</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT>Stored at another U.S. site (including intra-company transfer).</ENT> </ROW> <ROW> <ENT I="01">5</ENT> <ENT>Exported outside of the U.S. without further processing.</ENT> </ROW> <ROW> <ENT I="01">6</ENT> <ENT>Disposed of within the U.S. (explain).</ENT> </ROW> <ROW> <ENT I="01">7</ENT> <ENT>Other (explain).</ENT> </ROW> </GPOTABLE> <P> (iv) <E T="03"> Reporting information for mining, milling, or importing of bulk materials <PRTPAGE P="74"/> containing asbestos, including as an impurity. </E> For mining, milling, or importing of bulk materials containing asbestos reported under the activity identified in paragraphs (e)(4)(i)(A) through (C) of this section, report by year: </P> <P>(A) Bulk material type manufactured or processed.</P> <P>(B) For Form B only, for each bulk material type:</P> <P> ( <E T="03">1</E> ) Quantity of bulk material manufactured or processed. </P> <P> ( <E T="03">2</E> ) Percent asbestos impurity by weight in bulk material. </P> <P> ( <E T="03">3</E> ) The most specific asbestos type that applies. Select from among the asbestos types listed in Table 1 to paragraph (a) of this section. If the specific asbestos type is not known or reasonably ascertainable, report the general listing, asbestos CASRN 1332-21-4. </P> <P> ( <E T="03">4</E> ) Any testing of or test results assessing the asbestos content of your bulk material in the applicable reporting years. </P> <P> ( <E T="03">i</E> ) If testing was conducted, specify how often testing was conducted on the presence of asbestos in your bulk material and what method and type of test was used for determining asbestos content, and provide the test results. </P> <P> ( <E T="03">ii</E> ) If testing was not conducted, explain how you knew or reasonably ascertained the presence and amount of asbestos in the bulk materials. </P> <P>(C) For each bulk material type, the disposition of bulk material (see Table 3 of this paragraph (e)).</P> <P>(D) For importing only, if the imported bulk material was never physically present at the reporting site.</P> <P> (v) <E T="03">Reporting information for primary processors.</E> For primary processing reported under activity identified in paragraph (e)(4)(i)(D) of this section, report by year: </P> <P>(A) For Form B only, the total quantity of asbestos processed.</P> <P>(B) End product type, selecting from products listed in Table 4 of this paragraph (e). If your end product is not listed, report “other” and provide a brief description. For each end product type, report:</P> <P> ( <E T="03">1</E> ) For Form B only, the most specific asbestos types that apply. Select from among the asbestos types listed in Table 1 in paragraph (a) of this section. If the specific asbestos types are not known or reasonably ascertainable, report the general listing, “asbestos CASRN 1332-21-4”. Report also the total annual quantity of each of the asbestos types processed. </P> <P> ( <E T="03">2</E> ) The total annual production quantity of end products produced, using the associated unit of measure listed in Table 4 of this paragraph (e). If a unit of measure is not listed, provide the unit of measure associated with the quantity reported. </P> <P> ( <E T="03">3</E> ) For Form B only, the percentage of asbestos in the end product. </P> <P> ( <E T="03">4</E> ) For Form B only, the disposition of the end product (see Table 3 of this paragraph (e)). </P> <P> ( <E T="03">5</E> ) For Form B only, explain if you tested or received test results assessing the asbestos content of your end product in the applicable reporting years. </P> <P> ( <E T="03">i</E> ) If testing was conducted, specify how often testing was conducted on the presence of asbestos in your end product and what method and type of test was used for determining asbestos content, and provide the test results. </P> <P> ( <E T="03">ii</E> ) If testing was not conducted, explain how you knew or reasonably ascertain the presence and amount of asbestos in the end product. </P> <GPOTABLE COLS="3" OPTS="L2,nj" CDEF="s25,r100,xs60"> <TTITLE> Table 4 to Paragraph ( <E T="01">e</E> )—End Product Types </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Name</CHED> <CHED H="1">End product unit of measure</CHED> </BOXHD> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Papers, Felts, and Related Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">01</ENT> <ENT>Commercial paper</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">02</ENT> <ENT>Rollerboard</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">03</ENT> <ENT>Millboard</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">04</ENT> <ENT>Pipeline wrap</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">05</ENT> <ENT>Beater-add gasketing paper</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">06</ENT> <ENT>High-grade electrical paper</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">07</ENT> <ENT>Unsaturated roofing felt</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">08</ENT> <ENT>Saturated roofing felt</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">09</ENT> <ENT>Flooring felt</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <PRTPAGE P="75"/> <ENT I="01">10</ENT> <ENT>Corrugated paper</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">11</ENT> <ENT>Specialty paper (specify generic name)</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">12</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Floor Coverings</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">13</ENT> <ENT>Vinyl asbestos floor tile</ENT> <ENT>Square yards.</ENT> </ROW> <ROW> <ENT I="01">14</ENT> <ENT>Asbestos felt backed vinyl flooring</ENT> <ENT>Square yards.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">15</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Asbestos Cement Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">16</ENT> <ENT>A/C pipe and fittings</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">17</ENT> <ENT>A/C sheet, flat</ENT> <ENT>100 sq. ft.</ENT> </ROW> <ROW> <ENT I="01">18</ENT> <ENT>A/C sheet corrugated</ENT> <ENT>100 sq. ft.</ENT> </ROW> <ROW> <ENT I="01">19</ENT> <ENT>A/C shingle</ENT> <ENT>Squares.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">20</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Transportation Friction Materials (including aircrafts, marine vessels, railroad engine and railcars, and other vehicles)</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">21</ENT> <ENT>Drum brake lining (light-medium vehicle)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">22</ENT> <ENT>Disc brake pads (light-medium vehicle)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">23</ENT> <ENT>Disc brake pads (heavy vehicle)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">24</ENT> <ENT>Brake block (heavy equipment)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">25</ENT> <ENT>Clutch facings (all)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">26</ENT> <ENT>Automatic transmission friction components</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">27</ENT> <ENT>Friction materials (industrial and commercial)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">28</ENT> <ENT>Custom automotive body filler</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">29</ENT> <ENT>Transmissions</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">30</ENT> <ENT>Mufflers</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">31</ENT> <ENT>Radiator top insulation</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">32</ENT> <ENT>Radiator sealant</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">33</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Appliances</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">34</ENT> <ENT>Appliance Industrial and consumer (specify generic name)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">35</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Construction Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">36</ENT> <ENT>Boiler and furnace baffles</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">37</ENT> <ENT>Decorated building panels</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">38</ENT> <ENT>Asbestos cement sheet</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">39</ENT> <ENT>Flexible Air Conductor</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">40</ENT> <ENT>Hoods and Vents</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">41</ENT> <ENT>Portable construction building</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">42</ENT> <ENT>Roofing, saturated</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">43</ENT> <ENT>Roof shingles</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">44</ENT> <ENT>Wallboard</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">45</ENT> <ENT>Wall/roofing panels</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">46</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Electrical Products and Components</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">47</ENT> <ENT>Cable insulation</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">48</ENT> <ENT>Electronic motor components</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">49</ENT> <ENT>Electrical resistance supports</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">50</ENT> <ENT>Electrical switchboard</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">51</ENT> <ENT>Electrical switch supports</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">52</ENT> <ENT>Electrical wire insulation</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">53</ENT> <ENT>Motor armature</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">54</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Fire and Heat Shielding Equipment and Components</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">55</ENT> <ENT>Arc deflectors</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">56</ENT> <ENT>Fire doors</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">57</ENT> <ENT>Fireproof absorbent paper</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">58</ENT> <ENT>Heat shields</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">59</ENT> <ENT>Molten metal handling equipment</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">60</ENT> <ENT>Oven and stove insulation</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <PRTPAGE P="76"/> <ENT I="01">61</ENT> <ENT>Pipe wrap</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">62</ENT> <ENT>Stove lining, wood and coal</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">63</ENT> <ENT>Stove pipe rings</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">64</ENT> <ENT>Sleeves</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">65</ENT> <ENT>Thermal Insulation</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">66</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Textiles and Clothing</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">67</ENT> <ENT>Cloth</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">68</ENT> <ENT>Thread, yarn, lap, roving, cord, rope, or wick</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">69</ENT> <ENT>Aprons</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">70</ENT> <ENT>Boots</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">71</ENT> <ENT>Gloves and mittens</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">72</ENT> <ENT>Hats and helmets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">73</ENT> <ENT>Overgaiters</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">74</ENT> <ENT>Suits</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">75</ENT> <ENT>Aluminized cloth</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">76</ENT> <ENT>Rope or braiding</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">77</ENT> <ENT>Yarn, lap or roving</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">78</ENT> <ENT>Wicks</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">79</ENT> <ENT>Bags</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">80</ENT> <ENT>Belting</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">81</ENT> <ENT>Blankets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">82</ENT> <ENT>Carpet padding</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">83</ENT> <ENT>Commercial/industrial dryer felts</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">84</ENT> <ENT>Draperies</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">85</ENT> <ENT>Drip cloths</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">86</ENT> <ENT>Fire hoses</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">87</ENT> <ENT>Ironing board pads and insulation</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">88</ENT> <ENT>Mantles, lamp or catalytic heater</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">89</ENT> <ENT>Packing and packaging components</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">90</ENT> <ENT>Piano and organ felts</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">91</ENT> <ENT>Rugs</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">92</ENT> <ENT>Tape</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">93</ENT> <ENT>Theater curtains</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">94</ENT> <ENT>Umbrellas</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">95</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Gaskets</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">96</ENT> <ENT>Sheet gasketing, rubber encapsulated beater addition</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">97</ENT> <ENT>Sheet gasketing, rubber encapsulated compressed</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">98</ENT> <ENT>Compressed sheet gasketing (other)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">99</ENT> <ENT>Metal reinforced gaskets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT>Automotive gaskets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">101</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Marine Equipment and Supplies</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">102</ENT> <ENT>Caulks, marine</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">103</ENT> <ENT>Liners, pond or canal</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">104</ENT> <ENT>Marine bulkheads</ENT> <ENT>Pieces.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">105</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Paints, Coatings, Sealants and Compounds</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">106</ENT> <ENT>Asphaltic compounds</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">107</ENT> <ENT>Automotive/truck body coatings</ENT> <ENT>Gallons.</ENT> </ROW> <ROW> <ENT I="01">108</ENT> <ENT>Buffing and polishing compounds</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">109</ENT> <ENT>Caulking and patching compounds</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">110</ENT> <ENT>Drilling fluid</ENT> <ENT>Gallons.</ENT> </ROW> <ROW> <ENT I="01">111</ENT> <ENT>Flashing compounds</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">112</ENT> <ENT>Furnace cement</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">113</ENT> <ENT>Glazing compounds</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">114</ENT> <ENT>Plaster and stucco</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">115</ENT> <ENT>Pump valve, flange and tank sealing components</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">116</ENT> <ENT>Roof coatings</ENT> <ENT>Gallons.</ENT> </ROW> <ROW> <ENT I="01">117</ENT> <ENT>Textured paints</ENT> <ENT>Gallons.</ENT> </ROW> <ROW> <ENT I="01">118</ENT> <ENT>Tile cement</ENT> <ENT>Pounds.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">119</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <PRTPAGE P="77"/> <ENT I="21"> <E T="02">Other Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">120</ENT> <ENT>Sheet gasketing (other than beater-add)</ENT> <ENT>Square yards.</ENT> </ROW> <ROW> <ENT I="01">122</ENT> <ENT>Packing</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">123</ENT> <ENT>Paints and surface coatings</ENT> <ENT>Gallons.</ENT> </ROW> <ROW> <ENT I="01">124</ENT> <ENT>Adhesives and sealants</ENT> <ENT>Gallons.</ENT> </ROW> <ROW> <ENT I="01">125</ENT> <ENT>Asbestos-reinforced plastics</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">126</ENT> <ENT>Insulation materials not elsewhere classified (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> <ROW> <ENT I="01">127</ENT> <ENT>Mixed or repackaged asbestos</ENT> <ENT>Short Tons.</ENT> </ROW> <ROW> <ENT I="01">128</ENT> <ENT>Aerial distress flares</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">129</ENT> <ENT>Acoustical product</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">130</ENT> <ENT>Ammunition wadding</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">131</ENT> <ENT>Ash trays</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">132</ENT> <ENT>Baking sheets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">133</ENT> <ENT>Blackboards</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">134</ENT> <ENT>Candlesticks</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">135</ENT> <ENT>Chemical tanks and vessels</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">136</ENT> <ENT>Filters</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">137</ENT> <ENT>Grommets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">138</ENT> <ENT>Gun grips</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">139</ENT> <ENT>Jewelry making equipment</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">140</ENT> <ENT>Kilns</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">141</ENT> <ENT>Lamp sockets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">142</ENT> <ENT>Light bulbs (all types)</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">143</ENT> <ENT>Linings for vaults, safes, humidifiers and filing cabinets</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">144</ENT> <ENT>Phonograph records</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">145</ENT> <ENT>Pottery clay</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">146</ENT> <ENT>Welding rod coatings</ENT> <ENT>Pieces.</ENT> </ROW> <ROW> <ENT I="01">147</ENT> <ENT>Other (specify generic name)</ENT> <ENT>(Specify).</ENT> </ROW> </GPOTABLE> <P> (vi) <E T="03">Reporting information for secondary processors.</E> For secondary processing reported under the activity identified in paragraph (e)(4)(i)(E) of this section, report by year: </P> <P>(A) For Form B only, the estimated total quantity of asbestos processed.</P> <P>(B) End product type listed in Table 4 of this paragraph (e). For each product type, report:</P> <P> ( <E T="03">1</E> ) For Form B only, the most specific asbestos types that apply. Select from among the asbestos types listed in Table 1 in paragraph (a) of this section. If the specific asbestos type is not known or reasonably ascertainable, report the general listing, asbestos CASRN 1332-21-4. Also report the quantity of each type of asbestos. </P> <P> ( <E T="03">2</E> ) The total annual production quantity of the end products produced, using the associated unit of measure listed in Table 4 of this paragraph (e). </P> <P> ( <E T="03">3</E> ) For Form B only, the percentage of asbestos in the end product. </P> <P> ( <E T="03">i</E> ) If testing was conducted, specify how often testing was conducted on the presence of asbestos in your products and what method and type of test was used for determining asbestos content, and provide the test results. </P> <P> ( <E T="03">ii</E> ) If testing was not conducted, explain how you knew or reasonably ascertained the presence and amount of asbestos in the end product. </P> <P> ( <E T="03">4</E> ) For Form B only, the disposition of the end product (see Table 3 of this paragraph (e)). </P> <P> (vii) <E T="03">Reporting information for importers.</E> For importing reported under an activity identified in paragraph (e)(4)(i)(F) of this section, report by year: </P> <P>(A) For Form B only, the estimated total quantity of asbestos imported.</P> <P>(B) Imported product type (Table 4 of this paragraph (e)). For each imported product type, report:</P> <P> ( <E T="03">1</E> ) Whether the imported product is a mixture or an article. </P> <P> ( <E T="03">2</E> ) For Form B only, the most specific asbestos types that apply. Select from among the asbestos types listed in Table 1 in paragraph (a) of this section. If a specific asbestos type is not known or reasonably ascertainable, report the general listing, “asbestos CASRN 1332-21-4”. Also report the quantity of each asbestos type. <PRTPAGE P="78"/> </P> <P> ( <E T="03">3</E> ) The total annual import quantity of the imported product, using the associated unit of measure listed in Table 4 of this paragraph (e). </P> <P> ( <E T="03">4</E> ) Whether the imported asbestos was never physically present at the reporting site. </P> <P> ( <E T="03">5</E> ) For Form B only, the percentage of asbestos in the product. </P> <P> ( <E T="03">6</E> ) For Form B only, explain if you tested or received test results assessing the asbestos content of your imported product in the applicable reporting years. </P> <P> ( <E T="03">i</E> ) If testing was conducted, specify how often testing was conducted on the presence of asbestos in your imported product and what method and type of test was used for determining asbestos content, and provide the test results. </P> <P> ( <E T="03">ii</E> ) If testing was not conducted, explain how you knew or reasonably ascertained the presence and amount of asbestos in the imported product. </P> <P> ( <E T="03">7</E> ) For Form B only, the disposition of the imported product (see Table 3 of this paragraph (e)). </P> <P> (5) <E T="03">Employee information.</E> For each activity reported, report the following information about employees at the associated site: </P> <P> (i) Number of employees involved with activity. Select from among the ranges of employees listed in Table 2 of this paragraph (e) and report the corresponding code ( <E T="03">i.e.,</E> W1 through W8). </P> <P>(ii) Is personal protective equipment used? If yes, identify the type(s) of personal protective equipment used.</P> <P> (iii) For Form B only, submit any workplace exposure measurement assessments and data ( <E T="03">e.g.,</E> monitoring). </P> <P> (f) <E T="03">When to report.</E> All information reported to EPA under this section must be submitted during the applicable submission period. The submission period shall begin six months following the effective date of this rule and last for three months. </P> <P> (g) <E T="03">Recordkeeping requirements.</E> Each person who reports under this part must maintain records that document information reported under this part and in accordance with TSCA, permit access to, and the copying of such records by EPA officials. Relevant records must be retained for a period of five years beginning on the last day of the submission period. </P> <P> (h) <E T="03">Confidentiality claims</E> —(1) <E T="03">Assertion of confidentiality claims</E> —(i) <E T="03">Generally.</E> Any person submitting information under this part may assert a confidentiality claim for that information, except for information described in paragraph (h)(1)(ii) of this section. Any such confidentiality claims must be asserted electronically, pursuant to § 704.180(i), at the time the information is submitted. Information claimed as confidential in accordance with this section will be treated and disclosed in accordance with the procedures in 40 CFR part 2 and section 14 of TSCA. </P> <P> (ii) <E T="03">Exceptions.</E> Confidentiality claims may not be asserted with respect to the following: </P> <P>(A) Site NAICS code required by § 704.180(e)(3)(v);</P> <P> (B) For chemical identities and bulk material forms required by §§ 704.180(e)(4)(iii)(A), (iv)(A), (iv)(B)( <E T="03">3</E> ), (v)(B)( <E T="03">1</E> ), (vi)(B)( <E T="03">1</E> ), and (vii)(B)( <E T="03">2</E> ); </P> <P>(C) Any data element that is left blank or designated as “not known or reasonably ascertainable;” or</P> <P>(D) Health and safety data required by § 704.180(e)(5)(iii), except that the following information may be claimed as confidential:</P> <P> ( <E T="03">1</E> ) Information that would reveal processes used in the manufacturing, importing, or processing of the substance or mixture, or the portion of a mixture comprised by any of the substances in the mixture, provided that the information is expressly identified as revealing processing information or portion of a mixture; </P> <P> ( <E T="03">2</E> ) Company name or address, financial statistics, and product codes used by a company and contained in a study; and </P> <P> ( <E T="03">3</E> ) Information other than company name or address, financial statistics, and product codes used by a company, which is contained in a study, the disclosure of which would clearly be an unwarranted invasion of personal privacy (such as individual medical records). </P> <P> (iii) <E T="03">Certification statement for claims.</E> An authorized official representing a person asserting a claim of confidentiality must certify that the submission complies with the requirements of this part by signing and dating the following certification statement: </P> <EXTRACT> <PRTPAGE P="79"/> <P>“I certify that all claims for confidentiality asserted with this submission are true and correct, and all information submitted herein to substantiate such claims is true and correct. Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. 1001. I further certify that: I have taken reasonable measures to protect the confidentiality of the information; I have determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law; I have a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of my company; and I have a reasonable basis to believe that the information is not readily discoverable through reverse engineering.”</P> </EXTRACT> <P> (2) <E T="03">Substantiation</E> —(i) <E T="03">Requirement to substantiate.</E> Confidentiality claims must be substantiated at the time of submission to EPA, unless exempt under paragraph (h)(2)(iv) of this section. </P> <P> (ii) <E T="03">Information in substantiations may be claimed as confidential.</E> Such claims must be accompanied by the certification described in paragraph (h)(1)(iii) of this section, but need not be themselves substantiated. </P> <P> (iii) <E T="03">Substantiation questions for all claims.</E> Answers to the following questions must be provided for each confidentiality claim in a TSCA submission: </P> <P> (A) Please specifically explain what harm to the competitive position of your business would be likely to result from the release of the information claimed as confidential. How would that harm be <E T="03">substantial?</E> Why is the substantial harm to your competitive position <E T="03">likely</E> ( <E T="03">i.e.,</E> probable) to be caused by release of the information rather than just <E T="03">possible</E> ? If you claimed multiple types of information to be confidential ( <E T="03">e.g.,</E> site information, exposure information, environmental release information), explain how disclosure of each type of information would be likely to cause substantial harm to the competitive position of your business. </P> <P>(B) Has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify the specific measures, including but not limited to internal controls, that your business has taken to protect the information claimed as confidential. If the same or similar information was previously reported to EPA as non-confidential (such as in an earlier version of this submission), please explain the circumstances of that prior submission and reasons for believing the information is nonetheless still confidential.</P> <P> (C)( <E T="03">1</E> ) Is any of the information claimed as confidential required to be publicly disclosed under any other Federal law? If yes, please explain. </P> <P> ( <E T="03">2</E> ) Does any of the information claimed as confidential otherwise appear in any public documents, including (but not limited to) safety data sheets; advertising or promotional material; professional or trade publications; state, local, or Federal agency files; or any other media or publications available to the general public? If yes, please explain why the information should be treated as confidential. </P> <P> ( <E T="03">3</E> ) Does any of the information claimed as confidential appear in one or more patents or patent applications? If yes, please provide the associated patent number or patent application number (or numbers) and explain why the information should be treated as confidential. </P> <P>(D) Is the claim of confidentiality intended to last less than 10 (ten) years (see TSCA section 14(e)(1)(B))? If yes, please indicate the number of years (between 1 (one) and 10 (ten) years) or the specific date after which the claim is withdrawn.</P> <P>(E) Has EPA, another federal agency, or court made any confidentiality determination regarding information associated with this chemical substance? If yes, please provide the circumstances associated with the prior determination, whether the information was found to be entitled to confidential treatment, the entity that made the decision, and the date of the determination.</P> <P> (iv) <E T="03">Exemptions from the substantiation requirement.</E> Confidentiality claims are exempt from the requirement to substantiate the claim at the time of submission for the data elements required pursuant to paragraphs (e)(4)(iii)(B)( <E T="03">1</E> ), (iv)(B)( <E T="03">1</E> ), (v)(A), (v)(B)( <E T="03">2</E> ), (vi)(A), (vi)(B)( <E T="03">2</E> ), (vii)(A), and (vii)(B)( <E T="03">3</E> ) of this section. <PRTPAGE P="80"/> </P> <P> (v) <E T="03">No claim of confidentiality.</E> Information not claimed as confidential in accordance with the requirements of this section may be made public without further notice. </P> <P> (vi) <E T="03">Public copies.</E> Submissions and their accompanying attachments that include a confidentiality claim must be accompanied, at the time of submission, by a public version of the submission and any attachments, with all information that is claimed as confidential removed. Only information that is claimed as confidential may be redacted or removed. Generally, a public copy that removes all or substantially all of the information would not meet the requirements of this paragraph. </P> <P>(A) Where the electronic reporting tool contains a checkbox or other means of designating with specificity what information is claimed as confidential, no further action by the submitter is required to satisfy this requirement.</P> <P>(B) For all other information claimed as confidential, including but not limited to information in attachments and in substantiations required under paragraph (h) of this section, the submitter must prepare and attach a public copy. Submissions with public or sanitized copies that are entirely blank or that are substantially reduced in length as compared to the CBI version will not meet the requirements of this paragraph (h)(2)(vi) of this section.</P> <P> (i) <E T="03">Electronic reporting.</E> You must use the EPA Central Data Exchange (CDX) to complete and submit the information required under this section. Submissions may only be made as set forth in this paragraph. Submissions must be sent electronically to EPA using the asbestos reporting tool in CDX. The information submitted and all attachments (unless the attachment appears in scientific literature) must be in English. All information must be true and correct. Access the asbestos reporting tool and instructions, as follows: </P> <P> (1) <E T="03">By website.</E> Access the asbestos reporting tool via the CDX homepage at <E T="03">https://cdx.epa.gov/</E> and follow the applicable instructions. </P> <P> (2) <E T="03">By phone or email.</E> Contact the EPA TSCA Hotline at (202) 554-1404 or <E T="03">TSCA-Hotline@epa.gov.</E> </P> <CITA>[88 FR 47800, July 25, 2023; 88 FR 84242, Dec. 5, 2023]</CITA> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 705</EAR> <HD SOURCE="HED">PART 705—REPORTING AND RECORDKEEPING REQUIREMENTS FOR CERTAIN PER- AND POLYFLUOROALKYL SUBSTANCES</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>705.1</SECTNO> <SUBJECT>Scope, compliance, and enforcement.</SUBJECT> <SECTNO>705.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>705.5</SECTNO> <SUBJECT>Substances for which reports must be submitted.</SUBJECT> <SECTNO>705.10</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <SECTNO>705.12</SECTNO> <SUBJECT>Activities for which reporting is not required.</SUBJECT> <SECTNO>705.15</SECTNO> <SUBJECT>What information to report.</SUBJECT> <SECTNO>705.18</SECTNO> <SUBJECT>Article importer and R&D substance reporting options.</SUBJECT> <SECTNO>705.20</SECTNO> <SUBJECT>When to report.</SUBJECT> <SECTNO>705.22</SECTNO> <SUBJECT>Duplicative reporting.</SUBJECT> <SECTNO>705.25</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <SECTNO>705.30</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <SECTNO>705.35</SECTNO> <SUBJECT>Electronic reporting.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(a)(7).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>88 FR 70548, Oct. 11, 2023, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 705.1</SECTNO> <SUBJECT>Scope, compliance, and enforcement.</SUBJECT> <P>(a) This part specifies reporting and recordkeeping procedures for manufacturers (including importers) of per- and polyfluoroalkyl substances (hereafter referred to as PFAS) under section 8(a)(7) of the Toxic Substances Control Act (TSCA).</P> <P> (b) TSCA section 15(3) makes it unlawful for any person to fail or refuse to submit information required under this part. In addition, TSCA section 15(3) makes it unlawful for any person to fail to keep, and permit access to, records required by this part. TSCA section 16 provides that any person who violates a provision of TSCA section 15 is liable to the United States for a civil penalty and may be criminally prosecuted. Pursuant to TSCA section 17, the Federal Government may seek judicial relief to compel submission of TSCA section 8(a) information and to otherwise restrain any violation of TSCA section 15. TSCA section 11 allows for inspections to assure compliance, and the Environmental Protection Agency's (EPA) Administrator <PRTPAGE P="81"/> may by subpoena require the attendance and testimony of witnesses and the production of reports, papers, documents, answers to questions, and other information that the Administrator deems necessary. </P> <P>(c) Each person who reports under this part must maintain records that document information reported under this part and, in accordance with TSCA, permit access to, and the copying of, such records by EPA officials.</P> </SECTION> <SECTION> <SECTNO>§ 705.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P> The definitions in this section and the definitions in TSCA section 3 apply to this part. In addition, the definitions in 40 CFR 704.3 also apply to this part, except the definition for <E T="03">small quantities solely for research and development.</E> </P> <P> <E T="03">Article</E> means a manufactured item which: </P> <P>(1) Is formed to a specific shape or design during manufacture;</P> <P>(2) Has end use function(s) depending in whole or in part upon its shape or design during end use; and</P> <P>(3) Has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article, and that result from a chemical reaction that occurs upon end use of other chemical substances, mixtures, or articles; except that fluids and particles are not considered articles regardless of shape or design.</P> <P> <E T="03">Central Data Exchange</E> or <E T="03">CDX</E> means EPA's centralized electronic submission receiving system. </P> <P> <E T="03">Chemical Information Submission System</E> or <E T="03">CISS</E> means EPA's electronic, web-based reporting tool for the completion and submission of data, reports, and other information, or its successors. </P> <P> <E T="03">Commercial use</E> means the use of a chemical substance or a mixture containing a chemical substance (including as part of an article) in a commercial enterprise providing saleable goods or services. </P> <P> <E T="03">Consumer use</E> means the use of a chemical substance or a mixture containing a chemical substance (including as part of an article) when sold to or made available to consumers for their use. </P> <P> <E T="03">Environmental or health effects information</E> means any information of any effect of a chemical substance or mixture containing a chemical substance on health or the environment or on both. This includes all health and safety studies. </P> <P>(1) Not only is information that arises as a result of a formal, disciplined study included, but other information relating to the effects of a chemical substance or mixture containing a chemical substance on health or the environment is also included. Any information that bears on the effects of a chemical substance on health or the environment would be included.</P> <P>(2) Examples are:</P> <P>(i) Long- and short-term tests of mutagenicity, carcinogenicity, or teratogenicity; data on behavioral disorders; dermatoxicity; pharmacological effects; mammalian absorption, distribution, metabolism, and excretion; cumulative, additive, and synergistic effects; and acute, subchronic, and chronic effects.</P> <P>(ii) Tests for ecological or other environmental effects on invertebrates, fish, or other animals, and plants, including acute toxicity tests, chronic toxicity tests, critical life-stage tests, behavioral tests, algal growth tests, seed germination tests, plant growth or damage tests, microbial function tests, bioconcentration or bioaccumulation tests, and model ecosystem (microcosm) studies.</P> <P> (iii) Assessments of human and environmental exposure, including workplace exposure, and impacts of a particular chemical substance or mixture containing a chemical substance on the environment, including surveys, tests, and studies of: Biological, photochemical, and chemical degradation; structure/activity relationships; air, water, and soil transport; biomagnification and bioconcentration; and chemical and physical properties, <E T="03">e.g.,</E> boiling point, vapor pressure, evaporation rates from soil and water, octanol/water partition coefficient, and water solubility. </P> <P> (iv) Monitoring data, including but not limited to when they have been aggregated and analyzed to measure the <PRTPAGE P="82"/> exposure of humans or the environment to a chemical substance or mixture containing a chemical substance. </P> <P> <E T="03">Health and safety studies</E> means any study of any effect of a chemical substance or mixture on health or the environment or on both, including underlying information and epidemiological studies, studies of occupational exposure to a chemical substance or mixture, toxicological, clinical, and ecological studies of a chemicals substance or mixture containing a chemical substance, and any test performed under TSCA. The following information is not part of a health and safety study: </P> <P>(1) The name, address, or other identifying information for the submitting company, including identification of the laboratory that conducted the study in cases where the laboratory is part of or closely affiliated with the submitting company;</P> <P> (2) Internal product codes ( <E T="03">i.e.,</E> code names for the test substance used internally by the submitting company or to identify the test substance to the test laboratory); </P> <P>(3) Names and contact details for testing laboratory personnel and names and other private information for health and safety study participants or persons involved in chemical incidents such as would typically be withheld under 5 U.S.C. 552(b)(6) or under other privacy laws; and</P> <P>(4) Information pertaining to test substance product development, advertising, or marketing plans, or to cost and other financial data.</P> <P> <E T="03">Highest-level U.S. parent company</E> means the highest-level company of the site's ownership hierarchy as of the start of the submission period during which data are being reported according to the following instructions. The highest-level U.S. parent company is located within the United States. The following rules govern how to identify the highest-level U.S. parent company: </P> <P>(1) If the site is entirely owned by a single U.S. company that is not owned by another company, that single company is the U.S. parent company.</P> <P> (2) If the site is entirely owned by a single U.S. company that is, itself, owned by another U.S.-based company ( <E T="03">e.g.,</E> it is a division or subsidiary of a higher-level company), the highest-level domestic company in the ownership hierarchy is the U.S. parent company. </P> <P> (3) If the site is owned by more than one company ( <E T="03">e.g.,</E> company A owns 40 percent, company B owns 35 percent, and company C owns 25 percent), the company with the largest ownership interest in the site is the U.S. parent company. If a higher-level company in the ownership hierarchy owns more than one ownership company, then determine the entity with the largest ownership by considering the lower-level ownerships in combination ( <E T="03">e.g.,</E> corporation X owns companies B and C, for a total ownership of 60 percent for the site). </P> <P>(4) If the site is owned by a 50:50 joint venture or a cooperative, the joint venture or cooperative is its own parent company. If the site is owned by a U.S. joint venture or cooperative, the highest level of the joint venture or cooperative is the U.S. parent company.</P> <P>(5) If the site is federally owned, the highest-level Federal agency or department is the U.S. parent company.</P> <P>(6) If the site is owned by a non-Federal public entity, that entity (such as a municipality, State, or tribe) is the U.S. parent company.</P> <P> <E T="03">Industrial function</E> means the intended physical or chemical characteristic for which a chemical substance or mixture is consumed as a reactant; incorporated into a formulation, mixture, reaction product or article; repackaged; or used. </P> <P> <E T="03">Industrial use</E> means use at a site at which one or more chemical substances or mixtures are manufactured (including imported) or processed. </P> <P> <E T="03">Intended for use by children</E> means the chemical substance or mixture is used in or on a product that is specifically intended for use by children aged 14 or younger. A chemical substance or mixture containing a chemical substance is intended for use by children when the submitter answers “yes” to at least one of the following questions for the product into which the submitter's chemical substance or mixture containing a chemical substance is incorporated: </P> <P> (1) Is the product commonly recognized ( <E T="03">i.e.,</E> by a reasonable person) as <PRTPAGE P="83"/> being intended for children aged 14 or younger? </P> <P>(2) Does the manufacturer of the product state through product labeling or other written materials that the product is intended for or will be used by children aged 14 or younger?</P> <P>(3) Is the advertising, promotion, or marketing of the product aimed at children aged 14 or younger?</P> <P> <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know. </P> <P> <E T="03">Manufacture</E> means to import into the customs territory of the United States (as defined in general note 2 of the Harmonized Tariff Schedule of the United States (19 U.S.C. 1202)), produce, or manufacture for commercial purposes. </P> <P> <E T="03">Manufacture for commercial purposes</E> means: </P> <P>(1) To import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes among other things, such “manufacture” of any amount of a chemical substance or mixture containing a chemical substance:</P> <P>(i) For commercial distribution, including for test marketing; and/or</P> <P>(ii) For use by the manufacturer, including use for product research and development, or as an intermediate.</P> <P>(2) Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture containing a chemical substance, including both byproducts that are separated from that other substance or mixture containing a chemical substance and impurities that remain in that substance or mixture containing a chemical substance. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose.</P> <P> <E T="03">Per- and polyfluoroalkyl substances</E> or <E T="03">PFAS</E> means, for the purpose of this part, any chemical substance or mixture containing a chemical substance that structurally contains at least one of the following three sub-structures: </P> <P> (1) R-(CF <E T="52">2</E> )-CF(R′)R″, where both the CF <E T="52">2</E> and CF moieties are saturated carbons. </P> <P> (2) R-CF <E T="52">2</E> OCF <E T="52">2</E> -R′, where R and R′ can either be F, O, or saturated carbons. </P> <P> (3) CF <E T="52">3</E> C(CF <E T="52">3</E> )R′R″, where R′ and R″ can either be F or saturated carbons. </P> <P> <E T="03">Possession or control</E> means in possession or control of the submitter, or of any subsidiary, partnership in which the submitter is a general partner, parent company, or any company or partnership which the parent company owns or controls, if the subsidiary, parent company, or other company or partnership is associated with the submitter in the research, development, test marketing, or commercial marketing of the chemical substance in question. (A parent company owns or controls another company if the parent owns or controls 50 percent or more of the other company's voting stock. A parent company owns or controls any partnership in which it is a general partner.) Information is included within this definition if it is: </P> <P>(1) In files maintained by submitter's employees who are:</P> <P>(i) Associated with research, development, test marketing, or commercial marketing of the chemical substance in question; and/or</P> <P>(ii) Reasonably likely to have such data.</P> <P>(2) Maintained in the files of other agents of the submitter who are associated with research, development, test marketing, or commercial marketing of the chemical substance in question in the course of their employment as such agents.</P> <P> <E T="03">Research and development (R&D)</E> means activities intended solely as scientific experimentation, research, or analysis. R&D focuses on the analysis of the chemical or physical characteristics, the performance, or the production characteristics of a chemical substance, a mixture containing the substance, or an article. R&D encompasses a wide range of activities which may occur in a laboratory, pilot plant, commercial plant outside the research facility, or at other sites appropriate for <PRTPAGE P="84"/> R&D. General distribution of chemical substances to consumers does not constitute R&D. </P> <P> <E T="03">Site-limited</E> means a chemical substance is manufactured and processed only within a site and is not distributed as a chemical substance or as part of a mixture or article containing a chemical substance outside the site. Imported chemical substances are never site-limited. </P> <P> <E T="03">Worker</E> means someone at a site of manufacture, import, or processing who performs work activities near sources of a chemical substance or mixture or directly handles the chemical substance or mixture during the performance of work activities. </P> </SECTION> <SECTION> <SECTNO>§ 705.5</SECTNO> <SUBJECT>Substances for which reports must be submitted.</SUBJECT> <P>The requirements of this part apply to all chemical substances and mixtures containing a chemical substance (including articles) that are a PFAS, consistent with the definition of PFAS at § 705.3.</P> </SECTION> <SECTION> <SECTNO>§ 705.10</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <P>Persons who have manufactured for commercial purposes a chemical substance identified in § 705.5 at any period from January 1, 2011, through the end of the last calendar year prior to November 13, 2023, except as described in § 705.12, is subject to the requirements of this part.</P> </SECTION> <SECTION> <SECTNO>§ 705.12</SECTNO> <SUBJECT>Activities for which reporting is not required.</SUBJECT> <P>Reporting under this part is not required for the import of municipal solid waste streams for the purpose of disposal or destruction of the waste. Additionally, reporting is not required for a Federal agency which imports PFAS when it is not for any immediate or eventual commercial advantage.</P> </SECTION> <SECTION> <SECTNO>§ 705.15</SECTNO> <SUBJECT>What information to report.</SUBJECT> <P>For the one-time submission, persons identified in § 705.10 must report to EPA, for each site of each of the chemical substances identified in § 705.5, the following information to the extent known to or reasonably ascertainable by them, except as allowed under § 705.18. In the event that actual data is not known to or reasonably ascertainable by the submitter, then reasonable estimates may be submitted:</P> <P> (a) <E T="03">Company and plant site information.</E> The following currently correct company and plant site information must be reported for each site at which a reportable chemical substance is manufactured (see 40 CFR 711.3 for the “site” for importers): </P> <P>(1) The highest-level U.S. parent company name, address, and Dun and Bradstreet D-U-N-S® (D&B) number, if one exists.</P> <P>(2) The name of a person who will serve as Authorized Official for the submitter company, and who will be able to sign the certification statement as described in § 705.30(d), the Authorized Official's full mailing address, telephone number, and email address.</P> <P>(3) The name of a person who will serve as technical contact for the submitter company, and who will be able to answer questions about the information submitted by the company to EPA, the contact person's full mailing address, telephone number, and email address.</P> <P>(4) The name, full street address, and six-digit North American Industry Classification System (NAICS) code(s) of the site. A submitter under this part must include the appropriate D&B number for each plant site reported, and the county or parish (or other jurisdictional indicator) in which the plant site is located. A submitter under this part must obtain a D&B number for the site reported if none exists. A submitter under this part must also provide other site identification numbers, including the Facility Registry Service (FRS) identification number, if they exist.</P> <P> (b) <E T="03">Chemical-specific information.</E> The following chemical-specific information must be reported for each chemical substance that is a PFAS manufactured for each year since January 1, 2011, except as allowed under § 705.18. This includes each chemical substance that is a PFAS and incorporated into mixtures: </P> <P> (1) The common or trade name, the chemical identity, and, except for chemical substances that are Class 1 substances on the TSCA Inventory, the representative molecular structure of <PRTPAGE P="85"/> each PFAS for which such a report is required. </P> <P>(i) The specific, currently correct Chemical Abstracts (CA) Index name as used to list the chemical substance on the TSCA Inventory and the correct corresponding Chemical Abstracts Service Registry Number (CASRN) for each reportable PFAS at each site. Submitters who wish to report chemical substances listed on the confidential portion of the TSCA Inventory will need to report the chemical substance using a TSCA Accession Number. If a submitter has a low-volume exemption (LVE) case number for the chemical substance, that number may also be used if a CASRN is not known to or reasonably ascertainable by the submitter.</P> <P>(ii) In addition to reporting the number itself, submitters must specify the type of number they are reporting by selecting from among the codes in table 1 to this paragraph (b)(1)(ii).</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="xs25,r50"> <TTITLE> Table 1 to Paragraph ( <E T="01">b</E> )(1)( <E T="01">ii</E> )—Codes To Specify Type of Chemical Identifying Number </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Number type</CHED> </BOXHD> <ROW> <ENT I="01">A</ENT> <ENT>TSCA Accession Number.</ENT> </ROW> <ROW> <ENT I="01">C</ENT> <ENT>Chemical Abstracts Service Registry Number (CASRN).</ENT> </ROW> <ROW> <ENT I="01">L</ENT> <ENT>Low-volume exemption (LVE) case number.</ENT> </ROW> </GPOTABLE> <P> (iii) If the CASRN or specific identifier ( <E T="03">i.e.,</E> Accession Number or LVE number) of the PFAS is not known to or reasonably ascertainable (NKRA) to the submitter ( <E T="03">e.g.,</E> if the chemical identity is claimed as confidential business information by the submitter's supplier, or if the submitter knows they have a PFAS but are unable to ascertain its specific identifier and/or specific chemical identity), the submitter may provide a generic name or description of the PFAS and also initiate a joint submission if the secondary submitter is known. The submitter may only initiate a joint submission if the CASRN or the specific identifier ( <E T="03">i.e.,</E> Accession Number or LVE number) is not known or reasonably ascertainable, and a secondary submitter (who would provide such information) is known. The manufacturer (including importer) must use the reporting tool described under § 705.35 to ask the supplier or other entity to provide the chemical identity directly to EPA in a joint submission. Such request must include instructions for submitting chemical identity information electronically, using e-CDRweb and CDX (see 40 CFR 711.35), and for clearly referencing the manufacturer's (including importer) submission. Contact information for the supplier or other entity, a trade name or other designation for the chemical substance, and a copy of the request to the supplier or other entity must be included with the manufacturer's (including importer) submission. If, after conducting due diligence and reviewing known or reasonably ascertainable information, a secondary submitter to complete the joint submission is not known, the reporter may indicate that the secondary submitter is NKRA. However, the PFAS manufacturer would be required to provide as much identifying detail as they have regarding the PFAS identity, and would be able to report to EPA without initiating a joint submission even if they do not know the underlying identity of the chemical substance. </P> <P>(2) The physical form(s) of the PFAS as it is sent off-site from each site. If the PFAS is site-limited, you must report the physical form(s) of the PFAS at the time it is reacted on-site to produce a different chemical substance. For each PFAS at each site, the submitter must report as many physical forms as applicable from among the physical forms listed in this unit:</P> <P>(i) Dry powder.</P> <P>(ii) Pellets or large crystals.</P> <P>(iii) Water- or solvent-wet solid.</P> <P>(iv) Other solid.</P> <P>(v) Gas or vapor.</P> <P>(vi) Liquid.</P> <P> (c) <E T="03">Categories of use.</E> For each year since January 1, 2011, report the following information on categories of use of each chemical substance that is a PFAS manufactured for commercial purposes. </P> <P> (1) <E T="03">Industrial processing and use information.</E> A designation indicating the type of industrial processing or use operation(s) at each site that receives a PFAS from the submitter site directly or indirectly (whether the recipient site(s) are controlled by the submitter <PRTPAGE P="86"/> site or not). For each PFAS, report the letters which correspond to the appropriate processing or use operation(s) listed in table 2 to this paragraph (c)(1). A particular designation may need to be reported more than once, to the extent that a submitter reports more than one sector that applies to a given designation under this paragraph (c)(1). </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="xs50,r50"> <TTITLE> Table 2 to Paragraph ( <E T="01">c</E> )(1)—Codes for Reporting Type of Industrial Processing or Use Operation </TTITLE> <BOXHD> <CHED H="1">Designation</CHED> <CHED H="1">Operation</CHED> </BOXHD> <ROW> <ENT I="01">PC</ENT> <ENT>Processing as a reactant.</ENT> </ROW> <ROW> <ENT I="01">PF</ENT> <ENT>Processing—incorporation into formulation, mixture, or reaction product.</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Processing—incorporation into article.</ENT> </ROW> <ROW> <ENT I="01">PK</ENT> <ENT>Processing—repackaging.</ENT> </ROW> <ROW> <ENT I="01">U</ENT> <ENT>Use—non-incorporative activities.</ENT> </ROW> </GPOTABLE> <P> (2) <E T="03">Corresponding sector code.</E> A code indicating the sector(s) that best describes the industrial activities associated with each industrial processing or use operation reported under this section. For each chemical substance, report the code that corresponds to the appropriate sector(s) listed in table 3 to this paragraph (c)(2). A particular sector code may need to be reported more than once, to the extent that a submitter reports more than one function code that applies to a given sector code under this paragraph (c)(2). </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="xs25,r50"> <TTITLE> Table 3 to Paragraph ( <E T="01">c</E> )(2)—Codes for Reporting Industrial Sectors </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Sector description</CHED> </BOXHD> <ROW> <ENT I="01">IS1</ENT> <ENT>Agriculture, forestry, fishing, and hunting.</ENT> </ROW> <ROW> <ENT I="01">IS2</ENT> <ENT>Oil and gas drilling, extraction, and support activities.</ENT> </ROW> <ROW> <ENT I="01">IS3</ENT> <ENT>Mining (except oil and gas) and support activities.</ENT> </ROW> <ROW> <ENT I="01">IS4</ENT> <ENT>Utilities.</ENT> </ROW> <ROW> <ENT I="01">IS5</ENT> <ENT>Construction.</ENT> </ROW> <ROW> <ENT I="01">IS6</ENT> <ENT>Food, beverage, and tobacco product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS7</ENT> <ENT>Textiles, apparel, and leather manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS8</ENT> <ENT>Wood product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS9</ENT> <ENT>Paper manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS10</ENT> <ENT>Printing and related support activities.</ENT> </ROW> <ROW> <ENT I="01">IS11</ENT> <ENT>Petroleum refineries.</ENT> </ROW> <ROW> <ENT I="01">IS12</ENT> <ENT>Asphalt paving, roofing, and coating materials manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS13</ENT> <ENT>Petroleum lubricating oil and grease manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS14</ENT> <ENT>All other petroleum and coal products manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS15</ENT> <ENT>Petrochemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS16</ENT> <ENT>Industrial gas manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS17</ENT> <ENT>Synthetic dye and pigment manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS18</ENT> <ENT>Carbon black manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS19</ENT> <ENT>All other basic inorganic chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS20</ENT> <ENT>Cyclic crude and intermediate manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS21</ENT> <ENT>All other basic organic chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS22</ENT> <ENT>Plastics material and resin manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS23</ENT> <ENT>Synthetic rubber manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS24</ENT> <ENT>Organic fiber manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS25</ENT> <ENT>Pesticide, fertilizer, and other agricultural chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS26</ENT> <ENT>Pharmaceutical and medicine manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS27</ENT> <ENT>Paint and coating manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS28</ENT> <ENT>Adhesive manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS29</ENT> <ENT>Soap, cleaning compound, and toilet preparation manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS30</ENT> <ENT>Printing ink manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS31</ENT> <ENT>Explosives manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS32</ENT> <ENT>Custom compounding of purchased resins.</ENT> </ROW> <ROW> <ENT I="01">IS33</ENT> <ENT>Photographic film, paper, plate, and chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS34</ENT> <ENT>All other chemical product and preparation manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS35</ENT> <ENT>Plastics product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS36</ENT> <ENT>Rubber product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS37</ENT> <ENT>Non-metallic mineral product manufacturing (includes cement, clay, concrete, glass, gypsum, lime, and other non-metallic mineral product manufacturing).</ENT> </ROW> <ROW> <ENT I="01">IS38</ENT> <ENT>Primary metal manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS39</ENT> <ENT>Fabricated metal product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS40</ENT> <ENT>Machinery manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS41</ENT> <ENT>Computer and electronic product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS42</ENT> <ENT>Electrical equipment, appliance, and component manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS43</ENT> <ENT>Transportation equipment manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS44</ENT> <ENT>Furniture and related product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS45</ENT> <ENT>Miscellaneous manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS46</ENT> <ENT>Wholesale and retail trade.</ENT> </ROW> <ROW> <ENT I="01">IS47</ENT> <ENT>Services.</ENT> </ROW> <ROW> <ENT I="01">IS48</ENT> <ENT>Other (requires additional information).</ENT> </ROW> </GPOTABLE> <P> (3) <E T="03">Corresponding function category.</E> For each sector reported under paragraph (c)(2) of this section, the applicable code(s) from table 4 to this paragraph (c)(3) must be selected to designate the function category(ies) that best represents the specific manner in which the PFAS is used. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="xs25,r50"> <TTITLE> Table 4 to Paragraph ( <E T="01">c</E> )(3)—Codes for Reporting Function Categories </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Category</CHED> </BOXHD> <ROW> <ENT I="01">F001</ENT> <ENT>Abrasives.</ENT> </ROW> <ROW> <ENT I="01">F002</ENT> <ENT>Etching agent.</ENT> </ROW> <ROW> <ENT I="01">F003</ENT> <ENT>Adhesion/cohesion promoter.</ENT> </ROW> <ROW> <ENT I="01">F004</ENT> <ENT>Binder.</ENT> </ROW> <ROW> <ENT I="01">F005</ENT> <ENT>Flux agent.</ENT> </ROW> <ROW> <ENT I="01">F006</ENT> <ENT>Sealant (barrier).</ENT> </ROW> <ROW> <ENT I="01">F007</ENT> <ENT>Absorbent.</ENT> </ROW> <ROW> <ENT I="01">F008</ENT> <ENT>Adsorbent.</ENT> </ROW> <ROW> <ENT I="01">F009</ENT> <ENT>Dehydrating agent (desiccant).</ENT> </ROW> <ROW> <ENT I="01">F010</ENT> <ENT>Drier.</ENT> </ROW> <ROW> <ENT I="01">F011</ENT> <ENT>Humectant.</ENT> </ROW> <ROW> <ENT I="01">F012</ENT> <ENT>Soil amendments (fertilizers).</ENT> </ROW> <ROW> <ENT I="01">F013</ENT> <ENT>Anti-adhesive/cohesive.</ENT> </ROW> <ROW> <ENT I="01">F014</ENT> <ENT>Dusting agent.</ENT> </ROW> <ROW> <ENT I="01">F015</ENT> <ENT>Bleaching agent.</ENT> </ROW> <ROW> <ENT I="01">F016</ENT> <ENT>Brightener.</ENT> </ROW> <ROW> <PRTPAGE P="87"/> <ENT I="01">F017</ENT> <ENT>Anti-scaling agent.</ENT> </ROW> <ROW> <ENT I="01">F018</ENT> <ENT>Corrosion inhibitor.</ENT> </ROW> <ROW> <ENT I="01">F019</ENT> <ENT>Dye.</ENT> </ROW> <ROW> <ENT I="01">F020</ENT> <ENT>Fixing agent (mordant).</ENT> </ROW> <ROW> <ENT I="01">F021</ENT> <ENT>Hardener.</ENT> </ROW> <ROW> <ENT I="01">F022</ENT> <ENT>Filler.</ENT> </ROW> <ROW> <ENT I="01">F023</ENT> <ENT>Anti-static agent.</ENT> </ROW> <ROW> <ENT I="01">F024</ENT> <ENT>Softener and conditioner.</ENT> </ROW> <ROW> <ENT I="01">F025</ENT> <ENT>Swelling agent.</ENT> </ROW> <ROW> <ENT I="01">F026</ENT> <ENT>Tanning agents not otherwise specified.</ENT> </ROW> <ROW> <ENT I="01">F027</ENT> <ENT>Waterproofing agent.</ENT> </ROW> <ROW> <ENT I="01">F028</ENT> <ENT>Wrinkle resisting agent.</ENT> </ROW> <ROW> <ENT I="01">F029</ENT> <ENT>Flame retardant.</ENT> </ROW> <ROW> <ENT I="01">F030</ENT> <ENT>Fuel agents.</ENT> </ROW> <ROW> <ENT I="01">F031</ENT> <ENT>Fuel.</ENT> </ROW> <ROW> <ENT I="01">F032</ENT> <ENT>Heat transferring agent.</ENT> </ROW> <ROW> <ENT I="01">F033</ENT> <ENT>Hydraulic fluids.</ENT> </ROW> <ROW> <ENT I="01">F034</ENT> <ENT>Insulators.</ENT> </ROW> <ROW> <ENT I="01">F035</ENT> <ENT>Refrigerants.</ENT> </ROW> <ROW> <ENT I="01">F036</ENT> <ENT>Anti-freeze agent.</ENT> </ROW> <ROW> <ENT I="01">F037</ENT> <ENT>Intermediate.</ENT> </ROW> <ROW> <ENT I="01">F038</ENT> <ENT>Monomers.</ENT> </ROW> <ROW> <ENT I="01">F039</ENT> <ENT>Ion exchange agent.</ENT> </ROW> <ROW> <ENT I="01">F040</ENT> <ENT>Anti-slip agent.</ENT> </ROW> <ROW> <ENT I="01">F041</ENT> <ENT>Lubricating agent.</ENT> </ROW> <ROW> <ENT I="01">F042</ENT> <ENT>Deodorizer.</ENT> </ROW> <ROW> <ENT I="01">F043</ENT> <ENT>Fragrance.</ENT> </ROW> <ROW> <ENT I="01">F044</ENT> <ENT>Oxidizing agent.</ENT> </ROW> <ROW> <ENT I="01">F045</ENT> <ENT>Reducing agent.</ENT> </ROW> <ROW> <ENT I="01">F046</ENT> <ENT>Photosensitive agent.</ENT> </ROW> <ROW> <ENT I="01">F047</ENT> <ENT>Photosensitizers.</ENT> </ROW> <ROW> <ENT I="01">F048</ENT> <ENT>Semiconductor and photovoltaic agent.</ENT> </ROW> <ROW> <ENT I="01">F049</ENT> <ENT>UV stabilizer.</ENT> </ROW> <ROW> <ENT I="01">F050</ENT> <ENT>Opacifer.</ENT> </ROW> <ROW> <ENT I="01">F051</ENT> <ENT>Pigment.</ENT> </ROW> <ROW> <ENT I="01">F052</ENT> <ENT>Plasticizer.</ENT> </ROW> <ROW> <ENT I="01">F053</ENT> <ENT>Plating agent.</ENT> </ROW> <ROW> <ENT I="01">F054</ENT> <ENT>Catalyst.</ENT> </ROW> <ROW> <ENT I="01">F055</ENT> <ENT>Chain transfer agent.</ENT> </ROW> <ROW> <ENT I="01">F056</ENT> <ENT>Chemical reaction regulator.</ENT> </ROW> <ROW> <ENT I="01">F057</ENT> <ENT>Crystal growth modifiers (nucleating agents).</ENT> </ROW> <ROW> <ENT I="01">F058</ENT> <ENT>Polymerization promoter.</ENT> </ROW> <ROW> <ENT I="01">F059</ENT> <ENT>Terminator/Blocker.</ENT> </ROW> <ROW> <ENT I="01">F060</ENT> <ENT>Processing aids, specific to petroleum production.</ENT> </ROW> <ROW> <ENT I="01">F061</ENT> <ENT>Antioxidant.</ENT> </ROW> <ROW> <ENT I="01">F062</ENT> <ENT>Chelating agent.</ENT> </ROW> <ROW> <ENT I="01">F063</ENT> <ENT>Defoamer.</ENT> </ROW> <ROW> <ENT I="01">F064</ENT> <ENT>pH regulating agent.</ENT> </ROW> <ROW> <ENT I="01">F065</ENT> <ENT>Processing aids not otherwise specified.</ENT> </ROW> <ROW> <ENT I="01">F066</ENT> <ENT>Energy Releasers (explosives, motive propellant).</ENT> </ROW> <ROW> <ENT I="01">F067</ENT> <ENT>Foamant.</ENT> </ROW> <ROW> <ENT I="01">F068</ENT> <ENT>Propellants, non-motive (blowing agents).</ENT> </ROW> <ROW> <ENT I="01">F069</ENT> <ENT>Cloud-point depressant.</ENT> </ROW> <ROW> <ENT I="01">F070</ENT> <ENT>Flocculating agent.</ENT> </ROW> <ROW> <ENT I="01">F071</ENT> <ENT>Flotation agent.</ENT> </ROW> <ROW> <ENT I="01">F072</ENT> <ENT>Solids separation (precipitating) agent, not otherwise specified.</ENT> </ROW> <ROW> <ENT I="01">F073</ENT> <ENT>Cleaning agent.</ENT> </ROW> <ROW> <ENT I="01">F074</ENT> <ENT>Diluent.</ENT> </ROW> <ROW> <ENT I="01">F075</ENT> <ENT>Solvent.</ENT> </ROW> <ROW> <ENT I="01">F076</ENT> <ENT>Surfactant (surface active agent).</ENT> </ROW> <ROW> <ENT I="01">F077</ENT> <ENT>Emulsifier.</ENT> </ROW> <ROW> <ENT I="01">F078</ENT> <ENT>Thickening agent.</ENT> </ROW> <ROW> <ENT I="01">F079</ENT> <ENT>Viscosity modifiers.</ENT> </ROW> <ROW> <ENT I="01">F080</ENT> <ENT>Laboratory chemicals.</ENT> </ROW> <ROW> <ENT I="01">F081</ENT> <ENT>Dispersing agent.</ENT> </ROW> <ROW> <ENT I="01">F082</ENT> <ENT>Freeze-thaw additive.</ENT> </ROW> <ROW> <ENT I="01">F083</ENT> <ENT>Surface modifier.</ENT> </ROW> <ROW> <ENT I="01">F084</ENT> <ENT>Wetting agent (non-aqueous).</ENT> </ROW> <ROW> <ENT I="01">F085</ENT> <ENT>Aerating and deaerating agents.</ENT> </ROW> <ROW> <ENT I="01">F086</ENT> <ENT>Explosion inhibitor.</ENT> </ROW> <ROW> <ENT I="01">F087</ENT> <ENT>Fire extinguishing agent.</ENT> </ROW> <ROW> <ENT I="01">F088</ENT> <ENT>Flavoring and nutrient.</ENT> </ROW> <ROW> <ENT I="01">F089</ENT> <ENT>Anti-redeposition agent.</ENT> </ROW> <ROW> <ENT I="01">F090</ENT> <ENT>Anti-stain agent.</ENT> </ROW> <ROW> <ENT I="01">F091</ENT> <ENT>Anti-streaking agent.</ENT> </ROW> <ROW> <ENT I="01">F092</ENT> <ENT>Conductive agent.</ENT> </ROW> <ROW> <ENT I="01">F093</ENT> <ENT>Incandescent agent.</ENT> </ROW> <ROW> <ENT I="01">F094</ENT> <ENT>Magnetic element.</ENT> </ROW> <ROW> <ENT I="01">F095</ENT> <ENT>Anti-condensation agent.</ENT> </ROW> <ROW> <ENT I="01">F096</ENT> <ENT>Coalescing agent.</ENT> </ROW> <ROW> <ENT I="01">F097</ENT> <ENT>Film former.</ENT> </ROW> <ROW> <ENT I="01">F098</ENT> <ENT>Demulsifier.</ENT> </ROW> <ROW> <ENT I="01">F099</ENT> <ENT>Stabilizing agent.</ENT> </ROW> <ROW> <ENT I="01">F100</ENT> <ENT>Alloys.</ENT> </ROW> <ROW> <ENT I="01">F101</ENT> <ENT>Density modifier.</ENT> </ROW> <ROW> <ENT I="01">F102</ENT> <ENT>Elasticizer.</ENT> </ROW> <ROW> <ENT I="01">F103</ENT> <ENT>Flow promoter.</ENT> </ROW> <ROW> <ENT I="01">F104</ENT> <ENT>Sizing agent.</ENT> </ROW> <ROW> <ENT I="01">F105</ENT> <ENT>Solubility enhancer.</ENT> </ROW> <ROW> <ENT I="01">F106</ENT> <ENT>Vapor pressure modifiers.</ENT> </ROW> <ROW> <ENT I="01">F107</ENT> <ENT>Embalming agent.</ENT> </ROW> <ROW> <ENT I="01">F108</ENT> <ENT>Heat stabilizer.</ENT> </ROW> <ROW> <ENT I="01">F109</ENT> <ENT>Preservative.</ENT> </ROW> <ROW> <ENT I="01">F110</ENT> <ENT>Anti-caking agent.</ENT> </ROW> <ROW> <ENT I="01">F111</ENT> <ENT>Deflocculant.</ENT> </ROW> <ROW> <ENT I="01">F112</ENT> <ENT>Dust suppressant.</ENT> </ROW> <ROW> <ENT I="01">F113</ENT> <ENT>Impregnation agent.</ENT> </ROW> <ROW> <ENT I="01">F114</ENT> <ENT>Leaching agent.</ENT> </ROW> <ROW> <ENT I="01">F115</ENT> <ENT>Tracer.</ENT> </ROW> <ROW> <ENT I="01">F116</ENT> <ENT>X-ray absorber.</ENT> </ROW> <ROW> <ENT I="01">F999</ENT> <ENT>Other.</ENT> </ROW> </GPOTABLE> <P> (4) <E T="03">Consumer and commercial use information.</E> Using the applicable codes listed in table 5 to this paragraph (c)(4), submitters must designate the consumer and commercial product category(ies) that best describe the consumer and commercial products in which each PFAS is used (whether the recipient site(s) are controlled by the submitter site or not). If more than 10 codes apply to a PFAS, submitters need only report the 10 codes for PFAS that cumulatively represent the largest percentage of the submitter's production volume for that chemical, measured by weight. If none of the listed consumer and commercial product categories accurately describes the consumer and commercial products in which each PFAS is used, the category “Other” may be used, and must include a description of the use. <PRTPAGE P="88"/> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="xs25,r50"> <TTITLE> Table 5 to Paragraph ( <E T="01">c</E> )(4)—Codes for Reporting Consumer and Commercial Product Categories </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Category</CHED> </BOXHD> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Furnishing, Cleaning, Treatment Care Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC101</ENT> <ENT>Construction and building materials covering large surface areas including stone, plaster, cement, glass and ceramic articles; fabrics, textiles, and apparel.</ENT> </ROW> <ROW> <ENT I="01">CC102</ENT> <ENT>Furniture & furnishings including plastic articles (soft); leather articles.</ENT> </ROW> <ROW> <ENT I="01">CC103</ENT> <ENT>Furniture & furnishings including stone, plaster, cement, glass and ceramic articles; metal articles; or rubber articles.</ENT> </ROW> <ROW> <ENT I="01">CC104</ENT> <ENT>Leather conditioner.</ENT> </ROW> <ROW> <ENT I="01">CC105</ENT> <ENT>Leather tanning, dye, finishing, impregnation and care products.</ENT> </ROW> <ROW> <ENT I="01">CC106</ENT> <ENT>Textile (fabric) dyes.</ENT> </ROW> <ROW> <ENT I="01">CC107</ENT> <ENT>Textile finishing and impregnating/surface treatment products.</ENT> </ROW> <ROW> <ENT I="01">CC108</ENT> <ENT>All-purpose foam spray cleaner.</ENT> </ROW> <ROW> <ENT I="01">CC109</ENT> <ENT>All-purpose liquid cleaner/polish.</ENT> </ROW> <ROW> <ENT I="01">CC110</ENT> <ENT>All-purpose liquid spray cleaner.</ENT> </ROW> <ROW> <ENT I="01">CC111</ENT> <ENT>All-purpose waxes and polishes.</ENT> </ROW> <ROW> <ENT I="01">CC112</ENT> <ENT>Appliance cleaners.</ENT> </ROW> <ROW> <ENT I="01">CC113</ENT> <ENT>Drain and toilet cleaners (liquid).</ENT> </ROW> <ROW> <ENT I="01">CC114</ENT> <ENT>Powder cleaners (floors).</ENT> </ROW> <ROW> <ENT I="01">CC115</ENT> <ENT>Powder cleaners (porcelain).</ENT> </ROW> <ROW> <ENT I="01">CC116</ENT> <ENT>Dishwashing detergent (liquid/gel).</ENT> </ROW> <ROW> <ENT I="01">CC117</ENT> <ENT>Dishwashing detergent (unit dose/granule).</ENT> </ROW> <ROW> <ENT I="01">CC118</ENT> <ENT>Dishwashing detergent liquid (hand-wash).</ENT> </ROW> <ROW> <ENT I="01">CC119</ENT> <ENT>Dry cleaning and associated products.</ENT> </ROW> <ROW> <ENT I="01">CC120</ENT> <ENT>Fabric enhancers.</ENT> </ROW> <ROW> <ENT I="01">CC121</ENT> <ENT>Laundry detergent (unit-dose/granule).</ENT> </ROW> <ROW> <ENT I="01">CC122</ENT> <ENT>Laundry detergent (liquid).</ENT> </ROW> <ROW> <ENT I="01">CC123</ENT> <ENT>Stain removers.</ENT> </ROW> <ROW> <ENT I="01">CC124</ENT> <ENT>Ion exchangers.</ENT> </ROW> <ROW> <ENT I="01">CC125</ENT> <ENT>Liquid water treatment products.</ENT> </ROW> <ROW> <ENT I="01">CC126</ENT> <ENT>Solid/Powder water treatment products.</ENT> </ROW> <ROW> <ENT I="01">CC127</ENT> <ENT>Liquid body soap.</ENT> </ROW> <ROW> <ENT I="01">CC128</ENT> <ENT>Liquid hand soap.</ENT> </ROW> <ROW> <ENT I="01">CC129</ENT> <ENT>Solid bar soap.</ENT> </ROW> <ROW> <ENT I="01">CC130</ENT> <ENT>Air fresheners for motor vehicles.</ENT> </ROW> <ROW> <ENT I="01">CC131</ENT> <ENT>Continuous action air fresheners.</ENT> </ROW> <ROW> <ENT I="01">CC132</ENT> <ENT>Instant action air fresheners.</ENT> </ROW> <ROW> <ENT I="01">CC133</ENT> <ENT>Anti-static spray.</ENT> </ROW> <ROW> <ENT I="01">CC134</ENT> <ENT>Apparel finishing, and impregnating/surface treatment products.</ENT> </ROW> <ROW> <ENT I="01">CC135</ENT> <ENT>Insect repellent treatment.</ENT> </ROW> <ROW> <ENT I="01">CC136</ENT> <ENT>Pre-market waxes, stains, and polishes applied to footwear.</ENT> </ROW> <ROW> <ENT I="01">CC137</ENT> <ENT>Post-market waxes, and polishes applied to footwear (shoe polish).</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC138</ENT> <ENT>Waterproofing and water-resistant sprays.</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Construction, Paint, Electrical, and Metal Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC201</ENT> <ENT>Fillers and putties.</ENT> </ROW> <ROW> <ENT I="01">CC202</ENT> <ENT>Hot-melt adhesives.</ENT> </ROW> <ROW> <ENT I="01">CC203</ENT> <ENT>One-component caulks.</ENT> </ROW> <ROW> <ENT I="01">CC204</ENT> <ENT>Solder.</ENT> </ROW> <ROW> <ENT I="01">CC205</ENT> <ENT>Single-component glues and adhesives.</ENT> </ROW> <ROW> <ENT I="01">CC206</ENT> <ENT>Two-component caulks.</ENT> </ROW> <ROW> <ENT I="01">CC207</ENT> <ENT>Two-component glues and adhesives.</ENT> </ROW> <ROW> <ENT I="01">CC208</ENT> <ENT>Adhesive/Caulk removers.</ENT> </ROW> <ROW> <ENT I="01">CC209</ENT> <ENT>Aerosol spray paints.</ENT> </ROW> <ROW> <ENT I="01">CC210</ENT> <ENT>Lacquers, stains, varnishes and floor finishes.</ENT> </ROW> <ROW> <ENT I="01">CC211</ENT> <ENT>Paint strippers/removers.</ENT> </ROW> <ROW> <ENT I="01">CC212</ENT> <ENT>Powder coatings.</ENT> </ROW> <ROW> <ENT I="01">CC213</ENT> <ENT>Radiation curable coatings.</ENT> </ROW> <ROW> <ENT I="01">CC214</ENT> <ENT>Solvent-based paint.</ENT> </ROW> <ROW> <ENT I="01">CC215</ENT> <ENT>Thinners.</ENT> </ROW> <ROW> <ENT I="01">CC216</ENT> <ENT>Water-based paint.</ENT> </ROW> <ROW> <ENT I="01">CC217</ENT> <ENT>Construction and building materials covering large surface areas, including wood articles.</ENT> </ROW> <ROW> <ENT I="01">CC218</ENT> <ENT>Construction and building materials covering large surface areas, including paper articles; metal articles; stone, plaster, cement, glass and ceramic articles.</ENT> </ROW> <ROW> <ENT I="01">CC219</ENT> <ENT>Machinery, mechanical appliances, electrical/electronic articles.</ENT> </ROW> <ROW> <ENT I="01">CC220</ENT> <ENT>Other machinery, mechanical appliances, electronic/electronic articles.</ENT> </ROW> <ROW> <ENT I="01">CC221</ENT> <ENT>Construction and building materials covering large surface areas, including metal articles.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC222</ENT> <ENT>Electrical batteries and accumulators.</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Packaging, Paper, Plastic, Toys, Hobby Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC990</ENT> <ENT>Non-TSCA use.</ENT> </ROW> <ROW> <ENT I="01">CC301</ENT> <ENT>Packaging (excluding food packaging), including paper articles.</ENT> </ROW> <ROW> <ENT I="01">CC302</ENT> <ENT>Other articles with routine direct contact during normal use, including paper articles.</ENT> </ROW> <ROW> <ENT I="01">CC303</ENT> <ENT>Packaging (excluding food packaging), including rubber articles; plastic articles (hard); plastic articles (soft).</ENT> </ROW> <ROW> <ENT I="01">CC304</ENT> <ENT>Other articles with routine direct contact during normal use including rubber articles; plastic articles (hard).</ENT> </ROW> <ROW> <ENT I="01">CC305</ENT> <ENT>Toys intended for children's use (and child dedicated articles), including fabrics, textiles, and apparel; or plastic articles (hard).</ENT> </ROW> <ROW> <ENT I="01">CC306</ENT> <ENT>Adhesives applied at elevated temperatures.</ENT> </ROW> <ROW> <ENT I="01">CC307</ENT> <ENT>Cement/concrete.</ENT> </ROW> <ROW> <ENT I="01">CC308</ENT> <ENT>Crafting glue.</ENT> </ROW> <ROW> <ENT I="01">CC309</ENT> <ENT>Crafting paint (applied to body).</ENT> </ROW> <ROW> <ENT I="01">CC310</ENT> <ENT>Crafting paint (applied to craft).</ENT> </ROW> <ROW> <ENT I="01">CC311</ENT> <ENT>Fixatives and finishing spray coatings.</ENT> </ROW> <ROW> <ENT I="01">CC312</ENT> <ENT>Modelling clay.</ENT> </ROW> <ROW> <ENT I="01">CC313</ENT> <ENT>Correction fluid/tape.</ENT> </ROW> <ROW> <ENT I="01">CC314</ENT> <ENT>Inks in writing equipment (liquid).</ENT> </ROW> <ROW> <ENT I="01">CC315</ENT> <ENT>Inks used for stamps.</ENT> </ROW> <ROW> <ENT I="01">CC316</ENT> <ENT>Toner/Printer cartridge.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC317</ENT> <ENT>Liquid photographic processing solutions.</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Automotive, Fuel, Agriculture, Outdoor Use Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC401</ENT> <ENT>Exterior car washes and soaps.</ENT> </ROW> <ROW> <ENT I="01">CC402</ENT> <ENT>Exterior car waxes, polishes, and coatings.</ENT> </ROW> <ROW> <ENT I="01">CC403</ENT> <ENT>Interior car care.</ENT> </ROW> <ROW> <ENT I="01">CC404</ENT> <ENT>Touch up auto paint.</ENT> </ROW> <ROW> <ENT I="01">CC405</ENT> <ENT>Degreasers.</ENT> </ROW> <ROW> <ENT I="01">CC406</ENT> <ENT>Liquid lubricants and greases.</ENT> </ROW> <ROW> <ENT I="01">CC407</ENT> <ENT>Paste lubricants and greases.</ENT> </ROW> <ROW> <ENT I="01">CC408</ENT> <ENT>Spray lubricants and greases.</ENT> </ROW> <ROW> <ENT I="01">CC409</ENT> <ENT>Anti-freeze liquids.</ENT> </ROW> <ROW> <ENT I="01">CC410</ENT> <ENT>De-icing liquids.</ENT> </ROW> <ROW> <ENT I="01">CC411</ENT> <ENT>De-icing solids.</ENT> </ROW> <ROW> <ENT I="01">CC412</ENT> <ENT>Lock de-icers/releasers.</ENT> </ROW> <ROW> <ENT I="01">CC413</ENT> <ENT>Cooking and heating fuels.</ENT> </ROW> <ROW> <ENT I="01">CC414</ENT> <ENT>Fuel additives.</ENT> </ROW> <ROW> <ENT I="01">CC415</ENT> <ENT>Vehicular or appliance fuels.</ENT> </ROW> <ROW> <ENT I="01">CC416</ENT> <ENT>Explosive materials.</ENT> </ROW> <ROW> <ENT I="01">CC417</ENT> <ENT>Agricultural non-pesticidal products.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC418</ENT> <ENT>Lawn and garden care products.</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <PRTPAGE P="89"/> <ENT I="21"> <E T="02">Chemical Substances in Products Not Described by Other Codes</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC980</ENT> <ENT>Other (specify).</ENT> </ROW> <ROW> <ENT I="01">CC990</ENT> <ENT>Non-TSCA use.</ENT> </ROW> </GPOTABLE> <P> (5) <E T="03">Applicable codes for each commercial and consumer products.</E> For each consumer and commercial product category reported under paragraph (c)(4) of this section, the applicable code(s) described in table 4 to paragraph (c)(3) of this section must be selected to designate the function category(ies) that best represents the specific manner in which the PFAS is used. </P> <P> (6) <E T="03">Commercial and consumer products.</E> Submitters must indicate, for each consumer and commercial product category reported under paragraph (c)(4) of this section, whether the use is a consumer or a commercial use, or both. </P> <P> (7) <E T="03">Consumer product category.</E> Submitters must determine, within each consumer and commercial product category reported under paragraph (c)(4) of this section, whether any amount of each reportable chemical substance manufactured (including imported) by the submitter is present in (for example, a plasticizer chemical substance used to make pacifiers) or on (for example, as a component in the paint on a toy) any consumer products intended for use by children age 14 or younger, regardless of the concentration of the chemical substance remaining in or on the product. Submitters must select from the following options: The chemical substance is used in or on any consumer products intended for use by children; the chemical substance is not used in or on any consumer products intended for use by children; or information as to whether the chemical substance is used in or on any consumer products intended for use by children is not known to or reasonably ascertainable by the submitter. </P> <P> (8) <E T="03">Concentrations of PFAS.</E> For each year where the PFAS is used in consumer or commercial products, the estimated typical maximum concentration, measured by weight, of the chemical substance in each consumer and commercial product category reported under paragraph (c)(4) of this section. For each PFAS in each commercial and consumer product category reported under paragraph (c)(4) of this section, submitters must select from among the ranges of concentrations listed in table 6 to this paragraph (c)(8) and report the corresponding code ( <E T="03">i.e.,</E> M1 through M5): </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs25,r50"> <TTITLE> Table 6 to Paragraph <E T="01">(c)</E> (8)—Codes for Reporting Maximum Concentration of Chemical Substance </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1"> Concentration range <LI>(% weight)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">M1</ENT> <ENT>Less than 1% by weight.</ENT> </ROW> <ROW> <ENT I="01">M2</ENT> <ENT>At least 1 but less than 30% by weight.</ENT> </ROW> <ROW> <ENT I="01">M3</ENT> <ENT>At least 30 but less than 60% by weight.</ENT> </ROW> <ROW> <ENT I="01">M4</ENT> <ENT>At least 60 but less than 90% by weight.</ENT> </ROW> <ROW> <ENT I="01">M5</ENT> <ENT>At least 90% by weight.</ENT> </ROW> </GPOTABLE> <P> (d) <E T="03">Manufactured amounts.</E> For each year since January 1, 2011, the total amounts manufactured of each PFAS, including the amounts manufactured in each calendar year for each category of use as described in paragraph (c) of this section. </P> <P> (1) <E T="03">Total volume.</E> For each year the PFAS was manufactured, the total annual volume (in pounds) of each PFAS domestically manufactured or imported at each site. The total annual domestically manufactured volume (not including imported volume) and the total annual imported volume must be separately reported. These amounts must be reported to two significant figures of accuracy. </P> <P> (2) <E T="03">Site designation.</E> A designation indicating, for each PFAS at each site, whether the imported PFAS is physically present at the reporting site. </P> <P> (3) <E T="03">Volume imported.</E> The volume directly exported of each PFAS domestically manufactured or imported at each site. These amounts must be reported to two significant figures of accuracy. </P> <P> (4) <E T="03">Production volume.</E> The estimated percentage, rounded off to the closest 10 percent, of total production volume of the reportable chemical substance associated with each combination of industrial processing or use operation, sector, and function category as reported in paragraph (c) of this section. Where a particular combination of industrial processing or use operation, <PRTPAGE P="90"/> sector, and function category accounts for less than 5 percent of the submitter's site's total production volume of a reportable chemical substance, the percentage must not be rounded off to 0 percent. Instead, in such a case, submitters must report the percentage, rounded off to the closest 1 percent, of the submitter's site's total production volume of the reportable chemical substance associated with the particular combination of industrial processing or use operation, sector, and function category. </P> <P> (5) <E T="03">Site production volume.</E> The estimated percentage, rounded off to the closest 10 percent, of the submitter's site's total production volume of the PFAS associated with each consumer and commercial product category as reported in paragraph (c)(4) of this section. Where a particular consumer and commercial product category accounts for less than 5 percent of the total production volume of a reportable chemical substance, the percentage must not be rounded off to 0 percent. Instead, in such a case, submitters must report the percentage, rounded off to the closest 1 percent, of the submitter's site's total production volume of the reportable chemical substance associated with the particular consumer and commercial product category. </P> <P> (6) <E T="03">Site-limited.</E> An indication of whether the PFAS was site-limited. </P> <P> (7) <E T="03">Volume recycled.</E> The total volume (in pounds) of each PFAS recycled on-site. </P> <P> (e) <E T="03">Byproduct reporting.</E> A description of the byproducts resulting from the manufacture, processing, use, or disposal of each PFAS. </P> <P> (1) <E T="03">Byproduct identification.</E> For each byproduct produced from the manufacture, processing, use, or disposal of a PFAS, the submitter will identify the byproduct by its specific, currently correct CA Index name as used to list the chemical substance on the TSCA Inventory and the correct corresponding CASRN. A submitter under this part may use a known EPA-designated TSCA Accession Number for a chemical substance in lieu of a CASRN when a CASRN is not known to or reasonably ascertainable by the submitter. Submitters who wish to report chemical substances listed on the confidential portion of the TSCA Inventory will need to report the chemical substance using a TSCA Accession Number. </P> <P>(i) In addition to reporting the number itself, submitters must specify the type of number they are reporting by selecting from among the codes in table 1 to paragraph (b)(1)(ii) of this section.</P> <P>(ii) If the specific chemical identity of the byproduct is unknown to the submitter, the submitter may provide a description of the chemical substance.</P> <P> (iii) An indication of which specific PFAS activity(ies) ( <E T="03">i.e.,</E> manufacture, process, use, or disposal) manufactured the byproduct. </P> <P> (2) <E T="03">Releases.</E> An indication of whether the byproduct is released to the environment, and if so, the environmental medium to which it is released ( <E T="03">i.e.,</E> air, water, land). </P> <P> (3) <E T="03">Volume.</E> For each year, the byproduct volume (in pounds) released to the environment. </P> <P> (f) <E T="03">Environmental and health effects.</E> All existing information concerning the environmental and health effects of such substance or mixture containing a chemical substance in the manufacturer's possession or control. The scope of this information shall not be limited to studies conducted or published since 2011. </P> <P> (1) <E T="03">Organization for Economic Cooperation and Development (OECD) Harmonized Templates.</E> For each published study report, the submitter shall complete an OECD Harmonized Templates for Reporting Chemical Test Summaries and submit the accompanying study reports and supporting information. This can be accomplished by using the freely available IUCLID software. </P> <P> (2) <E T="03">Human health data—preliminary studies.</E> Submitters shall also provide any additional human health data not in study reports, including but not limited to any preliminary studies, informal test results in workers, or inhalation studies. </P> <P> (3) <E T="03">Analytical tests.</E> Submitters shall also provide the names of any analytical or test methods used to detect or otherwise test for the PFAS. <PRTPAGE P="91"/> </P> <P> (g) <E T="03">Worker exposure data.</E> The number of individuals exposed to PFAS in their places of employment and the duration of such exposure. </P> <P> (1) <E T="03">Employment activities.</E> A narrative description of worker activities involving the PFAS at the manufacturing site, such as bag dumping, sampling, cleaning, or unloading drums. </P> <P> (2) <E T="03">Number of workers.</E> For each worker activity in this paragraph, indicate the number of workers reasonably likely to be exposed. The submitter must select from among the worker ranges listed in table 7 to this paragraph (g)(2) and report the corresponding code ( <E T="03">i.e.,</E> W1 though W8). </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs25,r50"> <TTITLE> Table 7 to Paragraph ( <E T="01">g</E> )(2)—Codes for Reporting Number of Workers Reasonably Likely To Be Exposed </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Range</CHED> </BOXHD> <ROW> <ENT I="01">W1</ENT> <ENT>Fewer than 10 workers.</ENT> </ROW> <ROW> <ENT I="01">W2</ENT> <ENT>At least 10 but fewer than 25 workers.</ENT> </ROW> <ROW> <ENT I="01">W3</ENT> <ENT>At least 25 but fewer than 50 workers.</ENT> </ROW> <ROW> <ENT I="01">W4</ENT> <ENT>At least 50 but fewer than 100 workers.</ENT> </ROW> <ROW> <ENT I="01">W5</ENT> <ENT>At least 100 but fewer than 500 workers.</ENT> </ROW> <ROW> <ENT I="01">W6</ENT> <ENT>At least 500 but fewer than 1,000 workers.</ENT> </ROW> <ROW> <ENT I="01">W7</ENT> <ENT>At least 1,000 but fewer than 10,000 workers.</ENT> </ROW> <ROW> <ENT I="01">W8</ENT> <ENT>At least 10,000 workers.</ENT> </ROW> </GPOTABLE> <P> (3) <E T="03">Exposure scenarios.</E> For each worker activity in this paragraph (g), the maximum duration of exposure for any worker at the manufacturing site, for each of the following scenarios: </P> <P> (i) The daily exposure duration (in hours per day) in the case of the worker with greatest annual exposure frequency ( <E T="03">i.e.,</E> the worker exposed the most days per year); and </P> <P> (ii) The annual exposure frequency (in days per year) in the case of the worker with greatest daily exposure duration ( <E T="03">i.e.,</E> the worker exposed for the most hours per day during the year). </P> <P> (4) <E T="03">Exposure by category.</E> For each combination of industrial processing or use operation, sector, and function category identified in paragraph (c) of this section, the submitter must estimate the number of workers reasonably likely to be exposed to each PFAS. For each combination associated with each chemical substance, the submitter must select from among the worker ranges listed in table 7 to paragraph (g)(2) of this section and report the corresponding code ( <E T="03">i.e.,</E> W1 though W8). </P> <P> (5) <E T="03">Duration of exposure industrial use.</E> For each PFAS, the maximum duration of exposure for any worker for each combination of industrial processing or use operation, sector, and function category, for each of the following scenarios: </P> <P> (i) The daily exposure duration (in hours per day) in the case of the worker with the greatest annual exposure frequency ( <E T="03">i.e.,</E> the worker exposed the most days per year); and </P> <P> (ii) The annual exposure frequency (in days per year) in the case of the worker with the greatest daily exposure duration ( <E T="03">i.e.,</E> the worker exposed for the most hours per day during the year). </P> <P> (6) <E T="03">Commercial workers.</E> Where the PFAS is used in a commercial product, the submitter must estimate the number of commercial workers reasonably likely to be exposed to each reportable chemical substance. For each commercial use associated with each substance, the submitter must select from among the worker ranges listed in table 7 to paragraph (g)(2) of this section and report the corresponding code ( <E T="03">i.e.,</E> W1 though W8). </P> <P> (7) <E T="03">Duration of exposure commercial use.</E> For each PFAS, the maximum duration of exposure for any worker for each commercial use, for each of the following scenarios: </P> <P> (i) The daily exposure duration (in hours per day) in the case of the worker with greatest annual exposure frequency ( <E T="03">i.e.,</E> the worker exposed the most days per year); and </P> <P> (ii) The annual exposure frequency (in days per year) in the case of the worker with greatest daily exposure duration ( <E T="03">i.e.,</E> the worker exposed for the most hours per day during the year). </P> <P> (h) <E T="03">Disposal data.</E> During the years in which the PFAS was manufactured, the manners or methods of its disposal, and any changes to the disposal methods or processes. </P> <P> (1) <E T="03">Categories of disposal methods.</E> Description of disposal processes or methods, using the appropriate codes in table 8 to this paragraph (h)(1), and additional descriptions as needed. <PRTPAGE P="92"/> </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs25,r50"> <TTITLE> Table 8 to Paragraph ( <E T="01">h</E> )(1)—Codes for Reporting Disposal Methods </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Disposal method</CHED> </BOXHD> <ROW> <ENT I="01">D1</ENT> <ENT>On-site land disposal: Resource Conservation and Recovery Act (RCRA) Class C landfill (hazardous).</ENT> </ROW> <ROW> <ENT I="01">D2</ENT> <ENT>On-site land disposal: other landfill.</ENT> </ROW> <ROW> <ENT I="01">D3</ENT> <ENT>Other on-site land disposal.</ENT> </ROW> <ROW> <ENT I="01">D4</ENT> <ENT>On-site underground injection (UIC).</ENT> </ROW> <ROW> <ENT I="01">D5</ENT> <ENT>Off-site land disposal: RCRA Class C landfill (hazardous).</ENT> </ROW> <ROW> <ENT I="01">D6</ENT> <ENT>Off-site land disposal: other landfill.</ENT> </ROW> <ROW> <ENT I="01">D7</ENT> <ENT>On-site incineration.</ENT> </ROW> <ROW> <ENT I="01">D8</ENT> <ENT>Off-site incineration.</ENT> </ROW> <ROW> <ENT I="01">D9</ENT> <ENT>Publicly owned treatment works (POTW).</ENT> </ROW> <ROW> <ENT I="01">D10</ENT> <ENT>Other off-site waste transfer.</ENT> </ROW> <ROW> <ENT I="01">D11</ENT> <ENT>Release to surface water.</ENT> </ROW> <ROW> <ENT I="01">D12</ENT> <ENT>Release to air (stack emissions).</ENT> </ROW> <ROW> <ENT I="01">D13</ENT> <ENT>Release to air (fugitive emissions).</ENT> </ROW> <ROW> <ENT I="01">D99</ENT> <ENT>Other.</ENT> </ROW> </GPOTABLE> <P> (2) <E T="03">Disposal processes.</E> Describe any changes to the disposal process(es) or method(s) indicated in paragraph (h)(1) of this section for any PFAS manufactured since 2011. </P> <P> (3) <E T="03">Disposal volume.</E> Indicate total volume of the PFAS that was released to each environmental medium in each year since 2011: land, water, and air. </P> <P> (4) <E T="03">Incineration volume.</E> Indicate total volume of the PFAS that was incinerated on-site in each year since 2011. If incineration occurred, indicate the temperature (in degrees Celsius) at which the PFAS was incinerated. If incineration occurred at multiple temperatures, indicate the minimum temperature (in degrees Celsius) at which the PFAS was incinerated. </P> </SECTION> <SECTION> <SECTNO>§ 705.18</SECTNO> <SUBJECT>Article importer and R&D substance reporting options.</SUBJECT> <P>For the one-time submission, certain manufacturers have the option to use a streamlined reporting form if they do not know nor can reasonably ascertain information requested under § 705.15, beyond what is listed in this part. Paragraph (a) of this section lists the information which a manufacturer who has imported a PFAS within an article must report to the extent they know or can reasonably ascertain. Paragraph (b) of this section lists the information that manufacturers of PFAS that are solely R&D substances manufactured in volumes no greater than 10 kilograms per year must report to the extent they know or can reasonably ascertain.</P> <P> (a) <E T="03">Article reporting.</E> Any importer of an article which contains a chemical substance that is a PFAS and who meets the reporting requirements described in § 705.10 has the option to submit information to EPA using a streamlined reporting form for that PFAS in the imported article, for each year since January 1, 2011, in which the PFAS was imported in an article. Information must be submitted to the extent the submitter knows or can reasonably ascertain. In the event that actual data is not known to or reasonably ascertainable by the submitter, then reasonable estimates may be submitted. The information requested on the streamlined reporting form for article importers includes: </P> <P> (1) <E T="03">Company and plant site information.</E> All company and plant site information requested under § 705.15(a) shall be reported. </P> <P> (2) <E T="03">Chemical-specific information.</E> The following chemical-specific information must be reported for each chemical substance that is a PFAS imported in an article, for each year since January 1, 2011, in which that PFAS was imported within an article. </P> <P>(i) The common or trade name, the chemical identity, and, except for chemical substances that are Class 1 substances on the TSCA Inventory (Inventory), the representative molecular structure of each PFAS for which such a report is required. Submitters who wish to report chemical substances listed on the confidential portion of the Inventory will need to report the chemical substance using a TSCA Accession Number. If a submitter has a low-volume exemption (LVE) case number for the chemical substance, that number may also be used if a CASRN is not known to or reasonably ascertainable by the submitter. In addition to reporting the number itself, submitters must specify the type of number they are reporting by selecting from among the codes in table 1 to § 705.15(b)(1)(ii).</P> <P> (ii) If the specific chemical identity of the PFAS imported in an article is not known to or reasonably ascertainable to the submitter ( <E T="03">e.g.,</E> if the chemical identity is claimed as confidential business information by the submitter's supplier, or if the submitter knows they have a PFAS but is unable <PRTPAGE P="93"/> to ascertain its specific chemical identity), the submitter may provide a generic name or description of the PFAS. </P> <P> (3) <E T="03">Categories of use.</E> For each year since January 1, 2011, report the following information on categories of use of each PFAS imported in an article. </P> <P> (i) <E T="03">Industrial processing and use information.</E> A designation indicating the type of industrial processing or use operation(s) at each site that receives a PFAS from the submitter site directly or indirectly (whether the recipient site(s) are controlled by the submitter site or not). For each PFAS that was imported in an article, report the letters which correspond to the appropriate processing or use operation(s) listed in table 2 to § 705.15(c)(1). A particular designation may need to be reported more than once, to the extent that a submitter reports more than one sector that applies to a given designation under this paragraph (a)(3)(i). </P> <P> (ii) <E T="03">Industrial activities sector.</E> A code indicating the sector(s) that best describe the industrial activities associated with each industrial processing or use operation reported under this section. For each PFAS that was imported in an article, report the code that corresponds to the appropriate sector(s) listed in table 3 to § 705.15(c)(2). A particular sector code may need to be reported more than once, to the extent that a submitter reports more than one function code that applies to a given sector code under this paragraph (a)(3)(ii). </P> <P> (iii) <E T="03">Sector specific function categories.</E> For each sector reported under paragraph (a)(3)(ii) of this section, the applicable code(s) from table 4 to § 705.15(c)(3) must be selected to designate the function category(ies) that best represents the specific manner in which the PFAS in the imported article is used. </P> <P> (iv) <E T="03">Consumer and commercial use information.</E> Using the applicable codes listed in table 5 to § 705.15(c)(4), submitters must designate the consumer and commercial product category(ies) that best describe the consumer and commercial products in which each PFAS that is in an imported article is used (whether the recipient site(s) are controlled by the submitter site or not). If more than 10 codes apply to a PFAS in an imported article, submitters need only report the 10 codes for PFAS that cumulatively represent the largest percentage of the submitter's production volume for that chemical, measured by weight. If none of the listed consumer and commercial product categories accurately describe the consumer and commercial products in which each PFAS is used, the category “Other” may be used, and must include a description of the use. </P> <P> (v) <E T="03">Product specific function categories.</E> For each consumer and commercial product category reported under paragraph (a)(3)(iv) of this section, the applicable code(s) described in table 4 to § 705.15(c)(3) must be selected to designate the function category(ies) that best represents the specific manner in which the PFAS in an imported article is used. </P> <P> (vi) <E T="03">Consumer or commercial use designation.</E> Submitters must indicate, for each consumer and commercial product category reported under paragraph (a)(3)(v) of this section, whether the use is a consumer or a commercial use, or both. </P> <P> (vii) <E T="03">In or on consumer products intended for children.</E> Submitters must determine, within each consumer and commercial product category reported under paragraph (a)(3)(v) of this section, whether any amount of each reportable chemical substance manufactured (including imported) by the submitter is present in (for example, a plasticizer chemical substance used to make pacifiers) or on (for example, as a component in the paint on a toy) any consumer products intended for use by children age 14 or younger, regardless of the concentration of the chemical substance remaining in or on the product. Submitters must select from the following options: The chemical substance is used in or on any consumer products intended for use by children; the chemical substance is not used in or on any consumer products intended for use by children; or information as to whether the chemical substance is used in or on any consumer products intended for use by children is not known to or reasonably ascertainable by the submitter. </P> <P> (viii) <E T="03">Estimated maximum concentration.</E> For each year where the PFAS in <PRTPAGE P="94"/> an imported article is used in consumer or commercial products, the submitter must report the estimated typical maximum concentration, measured by weight, of the chemical substance in each consumer and commercial product category reported under paragraph (a)(3)(v) of this section. For each PFAS in an imported article in each commercial and consumer product category reported under paragraph (a)(3)(v) of this section, submitters must select from among the ranges of concentrations listed in table 1 to this paragraph (a)(3)(viii) and report the corresponding code ( <E T="03">i.e.,</E> AM1 through AM5): </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs25,r50"> <TTITLE> Table 1 to Paragraph <E T="01">(a)(3)(viii)</E> —Codes for Reporting Maximum Concentration of PFAS in an Imported Article </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1"> Concentration range <LI>(% weight)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">AM1</ENT> <ENT>Less than 0.1% by weight.</ENT> </ROW> <ROW> <ENT I="01">AM2</ENT> <ENT>At least 0.1% but less than 1% by weight.</ENT> </ROW> <ROW> <ENT I="01">AM3</ENT> <ENT>At least 1% but less than 10% by weight.</ENT> </ROW> <ROW> <ENT I="01">AM4</ENT> <ENT>At least 10% but less than 30% by weight.</ENT> </ROW> <ROW> <ENT I="01">AM5</ENT> <ENT>At least 30% by weight.</ENT> </ROW> </GPOTABLE> <P> (4) <E T="03">Imported article production volume.</E> For each calendar year since January 1, 2011, in which the PFAS was imported in an article, the production volume of the imported article. The imported production volume must be reported to two significant figures of accuracy. The submitter must also provide the unit of measurement of the imported production volume by selecting among the table 2 to this paragraph (a)(4). The submitter must also designate, for each PFAS imported in an article, whether the imported PFAS was ever physically present at the reporting site. </P> <GPOTABLE COLS="2" OPTS="L2,nj" CDEF="xs25,r50"> <TTITLE> Table 2 to Paragraph <E T="01">(a)(4)</E> —Codes To Specify Unit of Measurement for the Imported Article Production Volume </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Unit of measurement</CHED> </BOXHD> <ROW> <ENT I="01">LB</ENT> <ENT>Pounds.</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Tons.</ENT> </ROW> <ROW> <ENT I="01">QT</ENT> <ENT>Quantity of imported article.</ENT> </ROW> <ROW> <ENT I="01">O</ENT> <ENT>Other (must specify).</ENT> </ROW> </GPOTABLE> <P> (5) <E T="03">Additional article data.</E> The submitter has the option to provide any additional information to EPA that is requested under § 705.15 on the PFAS imported in an article, including supplemental attachments. </P> <P> (b) <E T="03">Research and development (R&D).</E> Any manufacturer of a PFAS R&D substance that was manufactured in volumes no greater than 10 kilograms per year and who meets the reporting requirements described in § 705.10 has the option to submit information to EPA using a streamlined reporting form for each such PFAS, for each year since January 1, 2011, in which the PFAS was manufactured for R&D purposes in volumes no greater than 10 kilograms per year. Information must be submitted to the extent the submitter knows or can reasonably ascertain. In the event that actual data is not known to or reasonably ascertainable by the submitter, then reasonable estimates may be submitted. The information requested on the streamlined reporting form for R&D manufacturers includes: </P> <P> (1) <E T="03">Company and plant site information.</E> All company and plant site information requested under § 705.15(a) shall be reported. </P> <P> (2) <E T="03">Chemical-specific information.</E> The following chemical-specific information must be reported for each R&D chemical substance that is a PFAS and each mixture containing a chemical substance that is a PFAS and meets the requirements for the reporting option under this paragraph (b)(2). The information must be reported for each year since January 1, 2011, in which that PFAS was manufactured for R&D purposes in quantities no greater than 10 kilograms per year. </P> <P> (i) The common or trade name, the chemical identity, and, except for chemical substances that are Class 1 substances on the TSCA Inventory, the representative molecular structure of each PFAS for which such a report is required. Submitters who wish to report chemical substances listed on the confidential portion of the TSCA Inventory will need to report the chemical substance using a TSCA Accession Number. If a submitter has a low-volume exemption (LVE) case number for the chemical substance, that number may also be used if a CASRN is not known to or reasonably ascertainable by the submitter. In addition to reporting the number itself, submitters must specify the type of number they are reporting by selecting from among the codes in table 1 to § 705.15(b)(1)(ii). <PRTPAGE P="95"/> </P> <P> (ii) If the specific chemical identity of the PFAS is not known to or reasonably ascertainable to the submitter ( <E T="03">e.g.,</E> if the chemical identity is claimed as confidential business information by the submitter's supplier, or if the submitter knows they have a PFAS but are unable to ascertain its specific chemical identity), the submitter may provide a generic name or description of the PFAS. </P> <P> (3) <E T="03">Production volume.</E> The submitter must report for each year since January 1, 2011, in which the PFAS was manufactured, the total annual volume (in pounds) of each PFAS domestically manufactured or imported at each site. The total annual domestically manufactured volume (not including imported volume) and the total annual imported volume must be separately reported. These amounts must be reported to two significant figures of accuracy. </P> <P>(i) A designation indicating, for each PFAS at each site, whether any imported PFAS is ever physically present at the reporting site.</P> <P>(ii) [Reserved]</P> <P> (4) <E T="03">Additional R&D data.</E> The submitter has the option to provide any additional information to EPA that is requested under § 705.15 on the PFAS, including supplemental attachments. </P> </SECTION> <SECTION> <SECTNO>§ 705.20</SECTNO> <SUBJECT>When to report.</SUBJECT> <P>All information reported to EPA in response to the requirements of this part must be submitted during the applicable submission period. For all reporters submitting information pursuant to §§ 705.15 and 705.18(b) (research and development), the submission period shall begin one year following November 13, 2023, and last for six months: November 12, 2024, through May 8, 2025. For any reporter who is reporting under this part exclusively pursuant to § 705.18(a) (article importers), and is also considered a small manufacturer under the definition at 40 CFR 704.3, the submission period shall begin one year following November 13, 2023, and last for 12 months: November 12, 2024, through November 10, 2025.</P> </SECTION> <SECTION> <SECTNO>§ 705.22</SECTNO> <SUBJECT>Duplicative reporting.</SUBJECT> <P> Any person covered in this part may notify EPA through the electronic reporting system in § 705.35 that certain information has already been submitted to EPA, and any such person does not need to re-submit the information. The notification must include the statutory and regulatory provision under which the information was submitted and in which year it was submitted. This ability is limited to the type of information listed in this section. If the previous submission did not account for all information required to be submitted pursuant to this part ( <E T="03">e.g.,</E> due to exemptions inapplicable to this part), then the person may not rely on that prior submission to satisfy the reporting requirements of this part. </P> <P> (a) <E T="03">Chemical Data Reporting rule.</E> If a person identified in § 705.10 has already reported certain information in § 705.15 to EPA pursuant to the Chemical Data Reporting rule at 40 CFR part 711, then duplicative reporting of that information is not required of the years for which the information has already been reported. Such information that may potentially be duplicative under this part is limited to: </P> <P> (1) <E T="03">Chemical description.</E> Physical state of the chemical or mixture containing a chemical substance, pursuant to 40 CFR 711.15(b)(3)(C)(ix). </P> <P> (2) <E T="03">Sector description.</E> Industrial processing and use type, sector(s), functional category(ies), and percent of production volume for each use, pursuant to 40 CFR 711.15(b)(4)(i)(A) through (D). </P> <P> (3) <E T="03">Product category.</E> Consumer and/or commercial indicator, product category(ies), functional category(ies), percent of production volume for each use, indicator for use in products intended for children, and maximum concentration in the product, pursuant to 40 CFR 711.15(b)(4)(ii)(A) through (F). </P> <P> (4) <E T="03">Workers.</E> Number of workers reasonably likely to be exposed for each combination of industrial processing or use operation, sector, and function, pursuant to 40 CFR 711.15(b)(4)(i)(F), and the number of commercial workers reasonably likely to be exposed when the substance is used in a commercial product, pursuant to 40 CFR 711.15(b)(4)(ii)(G). <PRTPAGE P="96"/> </P> <P> (5) <E T="03">Volume.</E> Production volume, both domestically manufactured and imported, an indicator for the imported chemical never physically at site, and the volume directly exported, pursuant to 40 CFR 711.15(b)(3)(iii) through (v). </P> <P> (b) <E T="03">Greenhouse Gas Reporting rule.</E> If a person identified in § 705.10 has already reported certain information in § 705.15 to EPA pursuant to the Greenhouse Gas Reporting rule at 40 CFR part 98, then duplicative reporting of that information is not required of the years for which the information has already been reported. Such information that may potentially be duplicative under this part is limited to: </P> <P> (1) <E T="03">Imported.</E> Production volume (imported), pursuant to 40 CFR 98.416(c)(1) and (2). </P> <P> (2) <E T="03">Exported.</E> Volume directly exported, pursuant to 40 CFR 98.416(d)(1). </P> <P> (3) <E T="03">Incinerated.</E> Total volume incinerated on-site, pursuant to 40 CFR part 98. </P> <P> (c) <E T="03">Toxics Release Inventory reporting rule.</E> If a person identified in § 705.10 has already reported certain information in § 705.15 to EPA pursuant to the Toxics Release Inventory reporting rule at 40 CFR part 372, then duplicative reporting of that information is not required of the years for which the information has already been reported. Such information that may potentially be duplicative under this part is limited to: </P> <P> (1) <E T="03">Recycled.</E> Total volume recycled on-site, pursuant to 40 CFR 372.85(b)(16). </P> <P> (2) <E T="03">Disposal.</E> Description of disposal process(es), pursuant to 40 CFR 372.85(b)(14) and (15). </P> <P> (3) <E T="03">Release to land.</E> Total volume released to land, pursuant to 40 CFR 372.85(b)(14)(i)(D) and (E). </P> <P> (4) <E T="03">Release to water.</E> Total volume released to water, pursuant to 40 CFR 372.85(b)(14)(i)(C). </P> <P> (5) <E T="03">Release to air.</E> Total volume released to air, pursuant to 40 CFR 372.85(b)(14)(i)(A) and (B). </P> <P> (6) <E T="03">Incinerated.</E> Total volume incinerated on-site, pursuant to 40 CFR 372.85(b)(16). </P> <P> (d) <E T="03">TSCA sections 8(d) and 8(e) reporting.</E> If a person identified in § 705.10 has already reported certain information in § 705.15(f) to EPA, then duplicative reporting of that information is not required of the years for which the information has already been reported. Such information that may potentially be duplicative under this part is limited to health and safety studies submitted pursuant to TSCA section 8(d), notification of substantial risks pursuant to TSCA section 8(e), or other information concerning environmental and health effects of the PFAS. </P> <P> (e) <E T="03">Byproduct reporting.</E> If a person identified in § 705.10 must report byproducts information pursuant to § 705.15(e), and those byproducts are also PFAS that are reported independently pursuant to this part, then duplicative reporting of the environmental releases as byproducts is not required. Such information that may potentially be duplicative is limited to: </P> <P> (1) <E T="03">Incineration.</E> An indication of whether the byproduct is released to the environment, and if so, the environmental medium to which it is released ( <E T="03">i.e.,</E> air, water, land), pursuant to § 705.15(e)(2). </P> <P> (2) <E T="03">Byproduct volume.</E> For each year, the byproduct volume (in pounds) released to the environment, pursuant to § 705.15(e)(3). </P> <P> (f) <E T="03">Environmental and health effects information.</E> If a person identified in § 705.10 has already reported the information in § 705.15(f) to EPA, then duplicative reporting of that information is not required, except to the extent required by to § 705.30. The notification required by this paragraph (f) must also include the EPA office ( <E T="03">e.g.,</E> EPA region or Headquarters Office) and case number or other identifier for the prior submission. </P> <P> (g) <E T="03">Reporting timeframe.</E> Any person covered in this part must report all information to EPA in § 705.15 for each year since January 1, 2011, in which that person manufactured a chemical substance that is a PFAS or a mixture containing a PFAS. If a person has already reported any of the data elements identified in paragraph (a) of this section, but not for all years since 2011, then that person must submit the required information for the intervening years. If a person has already reported any of the data elements identified in paragraph (a), (b), or (c) of this section, and the previous submissions did not account for all activities that <PRTPAGE P="97"/> are reportable under this part due to exemptions or thresholds that do not apply to this part, then that information is not considered duplicative reporting, and the person must submit information for that data element responsive to this part. </P> </SECTION> <SECTION> <SECTNO>§ 705.25</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P>Each person who is subject to the reporting requirements of this part must retain records that document any information reported to EPA. Relevant records must be retained for a period of 5 years beginning on the last day of the submission period.</P> </SECTION> <SECTION> <SECTNO>§ 705.30</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <P> (a) <E T="03">Making confidentiality claims</E> —(1) <E T="03">Generally.</E> Any person submitting information under this part may assert a confidentiality claim for that information, except for information described in paragraph (a)(2) of this section. All such confidentiality claims must be asserted at the time the information is submitted. Instructions for asserting confidentiality claims are provided in the document identified in § 705.35. Information claimed as confidential business information in accordance with this section will be treated and disclosed in accordance with the procedures in 40 CFR part 703 and TSCA section 14. </P> <P> (2) <E T="03">Exceptions.</E> Confidentiality claims cannot be asserted for the following: </P> <P>(i) Specific chemical identity if the chemical is on the public (non-confidential) TSCA Inventory or reported as non-confidential in an LVE;</P> <P>(ii) For processing and use data elements required by §§ 705.15(c)(1) through (7) and 705.18(a)(3)(i) through (vii);</P> <P>(iii) When a response is left blank or designated as “not known or reasonably ascertainable;”</P> <P>(iv) For specific chemical identity by submitters of article importer forms described in § 705.18(a);</P> <P>(v) For all generic chemical names;</P> <P>(vi) For any PFAS that are on the public (non-confidential) TSCA Inventory, the chemical's CASRN;</P> <P>(vii) For the Inventory Accession Numbers for PFAS that are on the confidential TSCA Inventory; or,</P> <P>(viii) For LVE numbers.</P> <P> (3) <E T="03">All existing information concerning environmental and health effects.</E> (i) Any person submitting a health and safety study, or information from a healthy and safety study, under this part may only assert a confidentiality claim for information that discloses processes used in the manufacturing or processing of a chemical substance or mixture or, in the case of a mixture, the release of data disclosing the portion of the mixture comprised by any of the chemical substances in the mixture. </P> <P>(ii) If any information submitted under § 705.15(f) is claimed as confidential business information, a person who submits the information must provide EPA, at the time of submission, a sanitized copy for public release, removing only that information that is claimed as confidential business information.</P> <P>(iii) Any person who has previously submitted information under § 705.15(f) and claimed it as confidential business information is required to reassert and re-substantiate the confidential business information claim if they seek to maintain the claim of confidential business information. Such persons are required to submit s a revised sanitized copy.</P> <P> (b) <E T="03">Substantiation of confidentiality claims.</E> (1) Unless exempted, all confidentiality claims require substantiation at the time of submission and must be signed and dated by an authorized official. </P> <P>(2) Confidentiality claims for the following data elements are exempt from the substantiation requirement in paragraph (b)(1) of this section:</P> <P> (i) <E T="03">Volume.</E> Production volume information required pursuant to §§ 705.15(d)(1), (5), and (6) and 705.18(a)(4) and (b)(3)(i). </P> <P> (ii) <E T="03">Primary submitter.</E> Joint submission information from the primary submitter, consisting of trade name and supplier identification required pursuant to § 705.15(b)(1)(i) and (ii). </P> <P> (iii) <E T="03">Secondary submitter.</E> Joint submission information from the secondary submitter, consisting of the percentage of formulation required pursuant to § 705.15(b)(1)(i) and (ii). </P> <P> (c) <E T="03">Marking information claimed as confidential business information in confidentiality substantiation documentation.</E> If any of the information contained in <PRTPAGE P="98"/> the answers to the questions listed in paragraph (e) of this section is asserted to contain information that itself is considered to be confidential, you must clearly identify the information that is claimed confidential. </P> <P> (d) <E T="03">Certification statement for claims.</E> An authorized official representing a person asserting a claim of confidentiality must certify that the submission complies with the requirements of this part by signing and dating the following certification statement: </P> <EXTRACT> <P>“I certify that all claims for confidentiality asserted with this submission are true and correct, and all information submitted herein to substantiate such claims is true and correct. Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. 1001. I further certify that: (1) I have taken reasonable measures to protect the confidentiality of the information; (2) I have determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law; (3) I have a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of my company; and (4) I have a reasonable basis to believe that the information is not readily discoverable through reverse engineering.”</P> </EXTRACT> <P> (e) <E T="03">Substantiation requirements for all types of confidentiality claims.</E> For each data element that is claimed as confidential business information, you must submit with your report detailed written answers to the following questions: </P> <P> (1) <E T="03">Substantial harm due to release.</E> Please specifically explain what harm to the competitive position of your business would be likely to result from the release of the information claimed as confidential business information. How would that harm be <E T="03">substantial?</E> Why is the substantial harm to your competitive position <E T="03">likely</E> ( <E T="03">i.e.,</E> probable) to be caused by release of the information rather than just <E T="03">possible</E> ? If you claimed multiple types of information to be confidential ( <E T="03">e.g.,</E> site information, exposure information, environmental release information, etc.), explain how disclosure of each type of information would be likely to cause substantial harm to the competitive position of your business. (40 CFR 703.5(b)(3)) </P> <P> (2) <E T="03">Precautions to protect confidentiality.</E> Has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify the specific measures, including but not limited to internal controls, that your business has taken to protect the information claimed as confidential business information. If the same or similar information was previously reported to EPA as non-confidential (such as in an earlier version of this submission), please explain the circumstances of that prior submission and reasons for believing the information is nonetheless still confidential. </P> <P> (3) <E T="03">Disclosure under Federal law or publicly available information.</E> (i) Is any of the information claimed as confidential business information required to be publicly disclosed under any other Federal law? If yes, please explain. </P> <P>(ii) Does any of the information claimed as confidential business information otherwise appear in any public documents, including (but not limited to) safety data sheets; advertising or promotional material; professional or trade publications; state, local, or Federal agency files; or any other media or publications available to the general public? If yes, please explain why the information should be treated as confidential. If this chemical is patented and the patent reveals the information you are claiming to be confidential business information, please explain your reasons for believing the information is nonetheless still confidential.</P> <P> (4) <E T="03">Duration of claims.</E> Is the claim of confidentiality intended to last less than 10 years (see TSCA section 14(e)(1)(B))? If yes, please indicate the number of years (between 1-10 years) or the specific date after which the claim is withdrawn. </P> <P> (5) <E T="03">Previously disclosed information.</E> Has EPA, another Federal agency, or court made any confidentiality determination regarding information associated with this chemical substance? If yes, please provide the circumstances associated with the prior determination, whether the information was found to be entitled to confidential treatment, the entity that made the decision, and the date of the determination. <PRTPAGE P="99"/> </P> <P> (f) <E T="03">Additional requirements for specific chemical identity.</E> A person may assert a claim of confidentiality for the specific chemical identity of a chemical substance as described in §§ 705.15(b)(1)(i) and 705.18(b)(2)(i) only if the identity of that chemical substance is treated as confidential in the Master Inventory File (or as a confidential LVE) as of the time the report is submitted for that chemical substance, if that substance is currently on the Inventory or is an LVE. Any person who asserts a claim of confidentiality for the specific chemical identity under this paragraph must provide a generic chemical name. To assert a claim of confidentiality for the identity of a reportable chemical substance, you must submit with the report detailed written answers to the questions from paragraph (b) of this section and to the following questions. </P> <P> (1) <E T="03">Chemical substance in U.S. commerce.</E> Is this chemical substance publicly known (including by your competitors) to be in U.S. commerce? If yes, please explain why the specific chemical identity should still be afforded confidential status ( <E T="03">e.g.,</E> the chemical substance is publicly known only as being distributed in commerce for research and development purposes, but no other information about the current commercial distribution of the chemical substance in the United States is publicly available) (40 CFR 703.5(b)(4)). If no, please complete the certification statement: </P> <EXTRACT> <P> “I certify that on the date referenced, I searched the internet for the chemical substance identity ( <E T="03">i.e.,</E> by both chemical substance name and CASRN). I did not find a reference to this chemical substance and have no knowledge of public information that would indicate that the chemical is being manufactured or imported by anyone for a commercial purpose in the United States. [provide date].” </P> </EXTRACT> <P> (2) <E T="03">Leave manufacturing site.</E> Does this particular chemical substance leave the site of manufacture (including import) in any form, <E T="03">e.g.,</E> as a product, effluent, emission? If yes, please explain what measures have been taken to guard against the discovery of its identity. </P> <P> (3) <E T="03">Chemical identity.</E> If the chemical substance leaves the site in a form that is available to the public or your competitors, can the chemical identity be readily discovered by analysis of the substance ( <E T="03">e.g.,</E> product, effluent, emission), in light of existing technologies and any costs, difficulties, or limitations associated with such technologies? Please explain why or why not. </P> <P> (4) <E T="03">Chemical name.</E> Would disclosure of the specific chemical name release confidential process information? If yes, please explain. </P> <P> (g) <E T="03">Joint submissions.</E> If a primary submitter asks a secondary submitter to provide information directly to EPA in a joint submission under §§ 705.15(b)(1)(i) and 705.18(b)(2)(i), only the primary submitter may assert a confidentiality claim for the data elements that it directly submits to EPA. The primary submitter must substantiate those claims that are not exempt under paragraph (b)(2) of this section. The secondary submitter is responsible for asserting all confidentiality claims for the data elements that it submits directly to EPA and for substantiating those claims that are not exempt under paragraph (b)(3) of this section. </P> <P> (h) <E T="03">No claim of confidentiality.</E> Except for the chemical identity on article importer forms submitted under § 705.18(a), information not claimed as confidential business information in accordance with the requirements of this section may be made public ( <E T="03">e.g.,</E> by publication of specific chemical name and CASRN on the public portion of the TSCA Inventory). EPA will provide advance public notice of specific chemical identities to be added to the public portion of the TSCA Inventory. </P> </SECTION> <SECTION> <SECTNO>§ 705.35</SECTNO> <SUBJECT>Electronic reporting.</SUBJECT> <P>You must use CDX to complete and submit the reporting form required under this part. Submissions may only be made as set forth in this section. Submissions must be sent electronically to EPA via CDX. The information submitted and all attachments (unless the attachment appears in scientific literature) must be in English. All information must be true and correct. Access the PFAS 8(a)(7) reporting tool and instructions, as follows:</P> <P> (a) <E T="03">By website.</E> Access the PFAS 8(a)(7) reporting tool via the CDX <PRTPAGE P="100"/> homepage at <E T="03">https://cdx.epa.gov/</E> and follow the appropriate links. </P> <P> (b) <E T="03">By phone or email.</E> Contact the EPA TSCA Hotline at (202) 554-1404 or <E T="03">TSCA-Hotline@epa.gov.</E> </P> </SECTION> </PART> <PART> <EAR>Pt. 707</EAR> <HD SOURCE="HED">PART 707—CHEMICAL IMPORTS AND EXPORTS</HD> <CONTENTS> <SUBPART> <RESERVED>Subpart A [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—General Import Requirements and Restrictions</HD> <SECHD>Sec.</SECHD> <SECTNO>707.20</SECTNO> <SUBJECT>Chemical substances import policy.</SUBJECT> </SUBPART> <SUBPART> <RESERVED>Subpart C [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Notices of Export Under Section 12(b)</HD> <SECTNO>707.60</SECTNO> <SUBJECT>Applicability and compliance.</SUBJECT> <SECTNO>707.63</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>707.65</SECTNO> <SUBJECT>Submission to the agency.</SUBJECT> <SECTNO>707.67</SECTNO> <SUBJECT>Contents of notice.</SUBJECT> <SECTNO>707.70</SECTNO> <SUBJECT>EPA notice to foreign governments.</SUBJECT> <SECTNO>707.72</SECTNO> <SUBJECT>Termination of reporting requirements.</SUBJECT> <SECTNO>707.75</SECTNO> <SUBJECT>Confidentiality.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2611(b) and 2612.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>45 FR 82850, Dec. 16, 1980, unless otherwise noted.</P> </SOURCE> <SUBPART> <RESERVED>Subpart A [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—General Import Requirements and Restrictions</HD> <SECTION> <SECTNO>§ 707.20</SECTNO> <SUBJECT>Chemical substances import policy.</SUBJECT> <P> (a) <E T="03">Scope.</E> (1) This statement addresses the policy of the Environmental Protection Agency (EPA) on importation of chemical substances, mixtures, and articles under section 13 of the Toxic Substances Control Act (TSCA; 15 U.S.C. 2601 <E T="03">et seq.</E> ). In particular, it addresses aspects of the regulation promulgated by the United States Customs Service (Customs), Department of the Treasury (19 CFR 12.118 through 12.127, and 127.28 [amended]) to implement section 13 of TSCA, 15 U.S.C. 2612. Section 13 requires the Secretary of the Treasury to refuse entry into the Customs territory of the United States of a chemical substance, mixture, or article if it does not comply with rules in effect under TSCA, or if it is offered for entry in violation of TSCA or rules or orders under TSCA. </P> <P>(2) In addition to this statement of policy, EPA will continue, as necessary, to address problems associated with imports in rulemaking and other actions under individual sections of TSCA, i.e., sections 4, 5, 6, 7, 8, and 12. Sections 5, 6, and 7 apply directly to imports subject to the section 13 requirements. Section 12 may apply to export of a shipment that is refused entry under section 13. Importers may have obligations under sections 4 and 8; section 4 and 8 requirements for importers would not apply to individual chemical shipments and thus are not included under section 13 requirements. Interested persons should refer to the records of these individual rulemaking actions for specific information and guidance.</P> <P> (b) <E T="03">Objectives.</E> (1) TSCA is intended to be comprehensive, and assure protection of health and the environment from unreasonable risks associated with chemicals whether the chemicals are imported or produced domestically. This intent is manifested by the inclusion of importation in the Act's definition of the term “manufacture”: “[M]anufacture means to import * * *, produce, or manufacture” (15 U.S.C. 2602(7)). Thus, importers are responsible for insuring that chemical importation complies with TSCA just as domestic manufacturers are responsible for insuring that chemical manufacture complies with TSCA. </P> <P>(2)(i) The section 13 rule requires importers to sign the following statement for each import of chemical substances subject to TSCA: “I certify that all chemical substances in this shipment comply with all applicable rules or orders under TSCA and that I am not offering a chemical substance for entry in violation of TSCA or any applicable rule or order under TSCA.” The certification will document that, in accordance with TSCA, the importer has taken the necessary steps to insure compliance.</P> <P> (ii) The section 13 rule requires importers of chemicals not subject to TSCA (e.g., pesticides) to certify that compliance with TSCA is not required. Importers must certify this by signing the statement: “I certify that all <PRTPAGE P="101"/> chemicals in this shipment are not subject to TSCA.” This is appropriate when a chemical import is not clearly identified as a pesticide or other chemical not subject to TSCA. </P> <P>(3) The United States is involved in a major effort toward international harmonization in the control of chemicals. At such time as international agreement is reached on this issue, EPA would be prepared to modify its policy if necessary. EPA believes that its international harmonization efforts in the control of chemicals will protect health and the environment while fulfilling its obligations under the Trade Agreements Act of 1979.</P> <P> (c) <E T="03">The section 13 rule</E> —(1) <E T="03">General certification.</E> (i) The rule promulgated under section 13 of TSCA by Customs, in consultation with EPA, implements the requirement of section 13 that chemical substances, mixtures, or articles not in compliance with TSCA, or whose importation is not in compliance with TSCA, shall be denied entry into the customs territory of the United States. The rule requires that importers certify by a statement, on the entry document or invoice, that any shipment of a chemical substance subject to TSCA, imported in bulk or as part of a mixture, complies with TSCA, and that it is not offered for entry in violation of TSCA or any rule or order under TSCA, or that the chemicals imported are not subject to TSCA. </P> <P>(ii) The certification applies to TSCA sections 5, 6, and 7.</P> <P>(iii) EPA expects that this certification will be based upon actual knowledge of the importer in most cases. However, EPA realizes that sometimes importers may not have actual knowledge of the chemical composition of imported mixtures. In these cases, the importer should attempt to discover the chemical constituents of the shipment by contacting another party to the transaction (e.g., his principal or the foreign manufacturer). This person may be able to identify the components of the mixture, or at least state that the substances comply with TSCA. The greater the effort an importer makes to learn the identities of the imported substances and their compliance with TSCA, the smaller his chance of committing a violation by importing a noncomplying shipment. If a shipment is ultimately determined to have violated TSCA, the good faith efforts of the importer to verify compliance, as evidenced by documents contained in his files, may obviate or mitigate the assessment of a civil penalty under section 16 of TSCA.</P> <P> (2) <E T="03">EPA enforcement.</E> (i) EPA and Customs will monitor chemical imports to determine if shipments and their import comply with the certification requirements and the substantive mandates of TSCA. Customs will refuse entry to any shipment until such time as the certification is properly submitted. Customs will also detain a shipment if there are reasonable grounds to believe that such shipment or its import violates TSCA or regulations or orders thereunder. A violative shipment must either be brought into compliance, exported, destroyed, or voluntarily abandoned within the time periods prescribed in 19 CFR 12.124 of the section 13 rule. </P> <P>(ii) When EPA determines that a shipment should be detained, EPA will identify the reasons for the detention and the necessary actions for an importer to bring the shipment into compliance with TSCA. If EPA has given this information to Customs before the district director issues the detention notice, the information will become part of the detention notice. The importer should contact one of the following EPA regional offices for guidance as to the proper procedures to correct any deficiencies in the shipment.</P> <EXTRACT> <HD SOURCE="HD1">Region I</HD> <P>5 Post Office Square—Suite 100, Boston, MA 02109-3912 (617-918-1700).</P> <HD SOURCE="HD1">Region II</HD> <FP SOURCE="FP-1">26 Federal Plaza, New York, NY 10278 (201-321-6669)</FP> <HD SOURCE="HD1">Region III</HD> <FP SOURCE="FP-1">Curtis Building, 6th and Walnut Streets, Philadelphia, PA 19106 (215-597-7668)</FP> <HD SOURCE="HD1">Region IV</HD> <FP SOURCE="FP-1">345 Courtland Street, NE., Atlanta, GA 30365 (404-881-3864)</FP> <HD SOURCE="HD1">Region V</HD> <FP SOURCE="FP-1"> 77 West Jackson Boulevard, Chicago, IL 60604 (312-353-2291) <PRTPAGE P="102"/> </FP> <HD SOURCE="HD1">Region VI</HD> <FP SOURCE="FP-1">1201 Elm Street, Suite 500, Dallas, Texas 75270-2102 (214-665-2760)</FP> <HD SOURCE="HD1">Region VII</HD> <FP SOURCE="FP-1">11201 Renner Boulevard, AWMD/WEMM, Lenexa, Kansas 66219</FP> <HD SOURCE="HD1">Region VIII</HD> <FP SOURCE="FP-1">1860 Lincoln Street, Denver, CO 80295 (303-837-3926)</FP> <HD SOURCE="HD1">Region IX</HD> <FP SOURCE="FP-1">75 Hawthorne Street, San Francisco, CA 94105 (415) 947-4402.</FP> <HD SOURCE="HD1">Region X</HD> <FP SOURCE="FP-1">1200 Sixth Avenue, Seattle, WA 98101 (206-442-2871)</FP> </EXTRACT> <P>(iii) If Customs detains or refuses entry of a shipment (other than for failure to make the general certification) and the importer takes measures necessary to bring the shipment into conformity with the requirements of TSCA, EPA officials will reassess the shipment to determine its current compliance status. When a shipment is no longer in violation, EPA will notify the district director and the importer. The district director will then release the shipment. This notice will also serve as a determination to permit entry under 19 CFR 12.123(c) if a shipment is brought into compliance before the 19 CFR 12.123(c) decisionmaking process has been completed. If compliance is achieved after a 19 CFR 12.123(c) determination (adverse to the importer) has been made, the EPA notice to the district director will serve as a reversal of the decision to refuse entry.</P> <P> (3) <E T="03">EPA assistance.</E> Assistance in determining whether a chemical shipment is in compliance with TSCA can be obtained from the Director, Environmental Assistance Division (7408), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room E-543B, 1200 Pennsylvania Ave., NW., Washington, DC 20460, Telephone: (202) 554-1404, TDD: (202) 544-0551. </P> <CITA>[48 FR 55464, Dec. 13, 1983, as amended at 60 FR 34463, July 3, 1995; 62 FR 1834, Jan. 14, 1997; 75 FR 69353, Nov. 12, 2010; 76 FR 49674, Aug. 11, 2011; 78 FR 37978, June 25, 2013; 84 FR 44232, Aug. 23, 2019]</CITA> </SECTION> </SUBPART> <SUBPART> <RESERVED>Subpart C [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Notices of Export Under Section 12(b)</HD> <SECTION> <SECTNO>§ 707.60</SECTNO> <SUBJECT>Applicability and compliance.</SUBJECT> <P>(a) Section 12(b) of the Toxic Substances Control Act requires any person who exports or intends to export a chemical substance or mixture to notify the Environmental Protection Agency of such exportation to a particular country if any of the following actions have been taken under the Act with respect to that chemical substance or mixture:</P> <P>(1) Data are required under section 4 or 5(b),</P> <P>(2) An order has been issued under section 5,</P> <P>(3) A rule has been proposed or promulgated under section 5 or 6, or</P> <P>(4) An action is pending, or relief has been granted under section 5 or 7.</P> <P>(b) No notice of export will be required for articles, except PCB articles, unless the Agency so requires in the context of individual section 5, 6, or 7 actions.</P> <P>(c)(1) Except as provided in paragraphs (c)(2) and (3) of this section no notice of export is required for the export of a chemical substance or mixture for which export notification is otherwise required, where such chemical substance or mixture is present in a concentration of less than 1% (by weight or volume).</P> <P>(2) No notice of export is required for the export of a chemical substance or mixture that is a known or potential human carcinogen where such chemical substance or mixture is present in a concentration of less than 0.1% (by weight or volume). A chemical is considered to be a known or potential human carcinogen, for purposes of TSCA section 12(b) export notification, if that chemical is:</P> <P> (i) A chemical substance or mixture listed as a “known to be human carcinogen” or “reasonably anticipated to be human carcinogen” in the Report on Carcinogens (latest edition) issued by the U.S. Department of Health and Human Services, Public Heath Service, National Toxicology Program, <PRTPAGE P="103"/> </P> <P>(ii) A chemical substance or mixture is classified as “carcinogenic to humans” (Group 1), “probably carcinogenic to humans” (Group 2A), or “probably carcinogenic to humans” (Group 2B) in the Monographs and Supplements on the Evaluation of Carcinogenic Risks to Humans issued by the World Health Organization International Agency for Research on Cancer (IARC), Lyons, France (latest editions), or</P> <P>(iii) Alpha-naphthylamine (Chemical Abstract Service Registry Number (CAS No.) 134-32-7) or 4-nitrobiphenyl (CAS No. 92-93-3).</P> <P>(3) No notice of export is required for the export of polychlorinated biphenyl chemicals (PCBs) (see definition in 40 CFR 761.3), where such chemical substances are present in a concentration of less than or equal to 50 ppm (by weight or volume).</P> <P>(d) Any person who exports or intends to export PCBs or PCB articles (see definition in 40 CFR 761.3), for any purpose other than disposal, shall notify EPA of such intent or exportation under TSCA section 12(b), except as specified in § 707.60(c)(3). PCBs and PCB articles have the definitions published in 40 CFR 761.3.</P> <P>(e) Any person who would be prohibited by a TSCA section 5 or 6 regulation from exporting a chemical substance or mixture, but who is granted an exemption by EPA to export that chemical substance or mixture, shall notify EPA under TSCA section 12(b) of such intent to export or exportation.</P> <P>(f) Failure to comply with TSCA section 12(b) as set forth in this part will be considered a violation of TSCA section 15(3), and will subject the exporter to the penalty, enforcement, and seizure provisions of TSCA sections 16 and 17.</P> <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 71 FR 66244, Nov. 14, 2006; 71 FR 68751, Nov. 28, 2006]</CITA> </SECTION> <SECTION> <SECTNO>§ 707.63</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>The definitions set forth in the Toxic Substances Control Act, section 3, apply for this part. In addition, the following abbreviations and definitions are provided for purposes of this rule:</P> <P> <E T="03">CDX</E> or <E T="03">Central Data Exchange</E> means EPA's centralized electronic document receiving system, or its successor system. </P> <P> <E T="03">EPA</E> means the Environmental Protection Agency. </P> <P> <E T="03">Exporter</E> means the person who, as the principal party in interest in the export transaction, has the power and responsibility for determining and controlling the sending of the chemical substance or mixture to a destination out of the customs territory of the United States. </P> <P> <E T="03">Regulated chemical</E> means any chemical substance or mixture for which export notice is required under § 707.60. </P> <P> <E T="03">TSCA</E> means the Toxic Substances Control Act. </P> <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 88 FR 37171, June 7, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 707.65</SECTNO> <SUBJECT>Submission to the agency.</SUBJECT> <P>(a) For each action under TSCA triggering export notification, exporters must notify EPA of their export or intended export of each subject chemical substance or mixture for which export notice is required under § 707.60 in accordance with the following:</P> <P>(1)(i) The export notice must be for the first export or intended export by an exporter to a particular country in a calendar year when the chemical substance or mixture is the subject of an order issued, an action that is pending, or relief that has been granted under TSCA section 5(f), a rule that has been proposed or promulgated under TSCA section 6, or an action that is pending or relief that has been granted under TSCA section 7.</P> <P>(ii) The export notice must only be for the first export or intended export by an exporter to a particular country when the chemical substance or mixture is the subject of an order issued, an action that is pending, or relief that has been granted under TSCA section 5(e), a rule that has been proposed or promulgated under TSCA section 5(a)(2), or when the submission of data is required under TSCA section 4 or 5(b). Under this paragraph, notice of export to a particular country is not required if an exporter previously submitted to EPA a notice of export to that country prior to January 16, 2007.</P> <P> (2) The export notice must be submitted to EPA within seven days of forming the intent to export or on the <PRTPAGE P="104"/> date of export, whichever is earlier. A notice of intent to export must be based on a definite contractual obligation, or an equivalent intra-company agreement, to export the regulated chemical. </P> <P> (b) If the EPA action that prompts the notice is a proposed rule, the requirement to submit export notices to EPA shall begin thirty days after publication of the action in the <E T="04">Federal Register</E> . </P> <P>(c) Export notices must be submitted via CDX, using the TSCA section 12(b) Export Notification Application or its successor.</P> <CITA>[88 FR 37171, June 7, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 707.67</SECTNO> <SUBJECT>Contents of notice.</SUBJECT> <P>The notice to EPA shall include:</P> <P>(a) The name of the regulated chemical as it appears in the TSCA section 4, 5, 6, and/or 7 action. For substances on the confidential portion of the TSCA Inventory, the substance must be identified by generic name and accession number, or by any other non-confidential identifier under which it is listed on the TSCA section 12(b) reporting list maintained by EPA and available in the TSCA section 12(b) Export Notification Application described in § 707.65(c). If a category is regulated, the name of the individual regulated chemical within that category, as well as the category, must be given. The name must be that which appears in the TSCA Inventory if the chemical appears there.</P> <P>(b) The name and address of the exporter.</P> <P>(c) The country (countries) of import.</P> <P>(d) The date(s) of export or intended export.</P> <P>(e) The section (4, 5, 6, and/or 7) of TSCA under which EPA has taken action.</P> <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 71 FR 66245, Nov. 14, 2006; 88 FR 37172, June 7, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 707.70</SECTNO> <SUBJECT>EPA notice to foreign governments.</SUBJECT> <P>(a)(1) Notice by EPA to the importing country shall be sent no later than 5 working days after receipt by the TSCA Document Processing Center of the first annual notification from any exporter for each chemical substance or mixture that is the subject of an order issued, an action that is pending, or relief that has been granted under TSCA section 5(f), a rule that has been proposed or promulgated under TSCA section 6, or an action that is pending or relief that has been granted under TSCA section 7.</P> <P>(2) Notice by EPA to the importing country shall be sent no later than 5 working days after receipt by the TSCA Document Processing Center of the first notification from any exporter for each chemical substance or mixture that is the subject of an order issued, an action that is pending, or relief that has been granted under TSCA section 5(e), a rule that has been proposed or promulgated under TSCA section 5(a)(2), or for which the submission of data is required under TSCA section 4 or 5(b).</P> <P>(b) Notices shall:</P> <P>(1) Identify the regulated chemical.</P> <P>(2) Summarize the regulatory action taken, or indicate the availability of data under section 4 or 5(b) of TSCA.</P> <P>(3) Identify an EPA official to contact for further information.</P> <P> (4) Include a copy of the pertinent <E T="04">Federal Register</E> notice. </P> <P>(c) Notices shall be sent to the country's ambassador in Washington, DC, or other official designated by the foreign government, and to the United States Department of State.</P> <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 58 FR 40242, July 27, 1993; 71 FR 66245, Nov. 14, 2006]</CITA> </SECTION> <SECTION> <SECTNO>§ 707.72</SECTNO> <SUBJECT>Termination of reporting requirements.</SUBJECT> <P>(a) The reporting requirements of subpart D of this part are terminated for certain specific chemical substances and mixtures as set forth in this paragraph.</P> <P>(1) When data required under part 766 of this chapter have been submitted to EPA for a specific chemical substance produced by a specific process, and the data show no positive test result as defined in § 766.3 of this chapter, reporting is no longer required by persons who export or intend to export that substance produced by that process.</P> <P> (2) [Reserved] <PRTPAGE P="105"/> </P> <P>(b) [Reserved]</P> <CITA>[52 FR 21437, June 5, 1987]</CITA> </SECTION> <SECTION> <SECTNO>§ 707.75</SECTNO> <SUBJECT>Confidentiality.</SUBJECT> <P>(a) A person may assert a claim of confidentiality for any information which is submitted to EPA in a notice.</P> <P>(b) Any claim of confidentiality must accompany the information at the time it is submitted to EPA. In the notice, the submitter must clearly identify the information that is claimed confidential by marking the specific information on each page with a label such as “confidential business information”, “proprietary”, or “trade secret”.</P> <P>(c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will disclose information that is covered by a claim of confidentiality asserted in accordance with this section only to the extent permitted by, and in accordance with, the procedures set forth in TSCA and part 2 of this chapter.</P> <P>(d) Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703.</P> <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 88 FR 37172, June 7, 2023]</CITA> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 710</EAR> <HD SOURCE="HED">PART 710—COMPILATION OF THE TSCA CHEMICAL SUBSTANCE INVENTORY</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>710.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <SECTNO>710.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>710.4</SECTNO> <SUBJECT>Scope of the inventory.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Commercial Activity Notification</HD> <SECTNO>710.23</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>710.25</SECTNO> <SUBJECT>Persons subject to the notification requirement.</SUBJECT> <SECTNO>710.27</SECTNO> <SUBJECT>Activities for which notification is not required.</SUBJECT> <SECTNO>710.29</SECTNO> <SUBJECT>Information required in the notification.</SUBJECT> <SECTNO>710.30</SECTNO> <SUBJECT>When to submit notifications.</SUBJECT> <SECTNO>710.33</SECTNO> <SUBJECT>Co-manufacturers and co-processors.</SUBJECT> <SECTNO>710.35</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <SECTNO>710.37</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <SECTNO>710.39</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Review Plan</HD> <SECTNO>710.41</SECTNO> <SUBJECT>Scope.</SUBJECT> <SECTNO>710.43</SECTNO> <SUBJECT>Persons subject to substantiation requirement.</SUBJECT> <SECTNO>710.45</SECTNO> <SUBJECT>Contents of substantiation.</SUBJECT> <SECTNO>710.47</SECTNO> <SUBJECT>When to submit substantiation or information on previous substantiation.</SUBJECT> <SECTNO>710.49</SECTNO> <SUBJECT>Failure to report.</SUBJECT> <SECTNO>710.51</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> <SECTNO>710.53</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <SECTNO>710.55</SECTNO> <SUBJECT>Claim review, duration of protection, TSCA Inventory maintenance, posting results, and extension.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(a) and (b).</P> </AUTH> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 710.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <P>(a) This part establishes regulations governing reporting and recordkeeping by certain persons who manufacture, import, or process chemical substances for commercial purposes under section 8(a) of the Toxic Substances Control Act (15 U.S.C. 2607(a)) (TSCA). Section 8(a) authorizes the Administrator to require reporting of information necessary for administration of the Act and requires EPA to issue regulations for the purpose of compiling and keeping current an inventory of chemical substances manufactured or processed for a commercial purpose, as required by section 8(b) of the Act. Following an initial reporting period, EPA published an initial inventory of chemical substances manufactured, processed, or imported for commercial purposes. In accordance with section 8(b), EPA periodically amends the inventory to include new chemical substances which are manufactured or imported for a commercial purpose and reported under section 5(a)(1) of the Act. EPA also revises the categories of chemical substances and makes other amendments as appropriate.</P> <P>(b) This part applies to the activities associated with the compilation of the TSCA Chemical Substance Inventory (Inventory) and the designation of chemical substances on the TSCA Inventory as active or inactive in U.S. commerce.</P> <P> (c) Section 15(3) of TSCA makes it unlawful for any person to fail or refuse to submit information required under these reporting regulations. In <PRTPAGE P="106"/> addition, section 15(3) makes it unlawful for any person to fail to keep, and permit access to, records required by these regulations. Section 16 provides that any person who violates a provision of section 15 is liable to the United States for a civil penalty and may be criminally prosecuted. Pursuant to section 17, the Government may seek judicial relief to compel submission of section 8(a) information and to otherwise restrain any violation of section 15. (EPA does not intend to concentrate its enforcement efforts on insignificant clerical errors in reporting.) </P> <P>(d) Each person who reports under these regulations must maintain records that document information reported under these regulations and, in accordance with the Act, permit access to, and the copying of, such records by EPA officials.</P> <CITA>[68 FR 887, Jan. 7, 2003, as amended at 76 FR 50859, Aug. 16, 2011; 76 FR 54933, Sept. 6, 2011; 82 FR 37539, Aug. 11, 2017]</CITA> </SECTION> <SECTION> <SECTNO>§ 710.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>For purposes of this part:</P> <P> (a) The following terms will have the meaning contained in the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 321 <E T="03">et seq.,</E> and the regulations issued under such Act: <E T="03">Cosmetic, device, drug, food,</E> and <E T="03">food additive.</E> In addition, the term <E T="03">food</E> includes poultry and poultry products, as defined in the Poultry Products Inspection Act, 21 U.S.C. 453 <E T="03">et seq.;</E> meats and meat food products, as defined in the Federal Meat Inspection Act, 21 U.S.C. 60 <E T="03">et seq.;</E> and eggs and egg products, as defined in the Egg Products Inspection Act, 21 U.S.C. 1033 <E T="03">et seq.</E> </P> <P> (b) The term <E T="03">pesticide</E> will have the meaning contained in the Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. 136 <E T="03">et seq.</E> , and the regulations issued thereunder. </P> <P> (c) The following terms will have the meaning contained in the Atomic Energy Act of 1954, 42 U.S.C. 2014 <E T="03">et seq.</E> , and the regulations issued thereunder: <E T="03">Byproduct material, source material,</E> and <E T="03">special nuclear material.</E> </P> <P>(d) The following definitions also apply to this part:</P> <P> <E T="03">Act</E> means the Toxic Substances Control Act (TSCA), 15 U.S.C. 2601 <E T="03">et seq.</E> </P> <P> <E T="03">Administrator</E> means the Administrator of the U.S. Environmental Protection Agency, any employee or authorized representative of the Agency to whom the Administrator may either herein or by order delegate his/her authority to carry out his/her functions, or any other person who will by operation of law be authorized to carry out such functions. </P> <P> <E T="03">Article</E> means a manufactured item: </P> <P>(1) Which is formed to a specific shape or design during manufacture,</P> <P>(2) Which has end use function(s) dependent in whole or in part upon its shape or design during end use, and</P> <P>(3) Which has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article and that may occur as described in § 710.4(d)(5); except that fluids and particles are not considered articles regardless of shape or design.</P> <P> <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s). </P> <P> <E T="03">CASRN</E> means Chemical Abstracts Service Registry Number. </P> <P> <E T="03">Chemical substance</E> means any organic or inorganic substance of a particular molecular identity, including any combination of such substances occurring in whole or in part as a result of a chemical reaction or occurring in nature, and any chemical element or uncombined radical; except that “chemical substance” does <E T="03">not</E> include: </P> <P>(1) Any mixture;</P> <P>(2) Any pesticide when manufactured, processed, or distributed in commerce for use as a pesticide;</P> <P>(3) Tobacco or any tobacco product, but not including any derivative products;</P> <P>(4) Any source material, special nuclear material, or byproduct material;</P> <P>(5) Any pistol, firearm, revolver, shells, and cartridges; and</P> <P> (6) Any food, food additive, drug, cosmetic, or device, when manufactured, processed, or distributed in commerce for use as a food, food additive, drug, cosmetic, or device. <PRTPAGE P="107"/> </P> <P> <E T="03">Commerce</E> means trade, traffic, transportation, or other commerce: </P> <P>(1) Between a place in a State and any place outside of such State or</P> <P>(2) Which affects trade, traffic, transportation, or commerce between a place in a State and any place outside of such State.</P> <P> <E T="03">Customs territory of the United States</E> means the 50 States, Puerto Rico, and the District of Columbia. </P> <P> <E T="03">Distribute in commerce</E> and <E T="03">distribution in commerce</E> means to sell in commerce, to introduce or deliver for introduction into commerce, or to hold after its introduction into commerce. </P> <P> <E T="03">Domestic</E> means within the geographical boundaries of the 50 United States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Northern Mariana Islands, and any other territory or possession of the United States. </P> <P> <E T="03">EPA</E> means the U.S. Environmental Protection Agency. </P> <P> <E T="03">Importer</E> means any person who imports any chemical substance, including a chemical substance as part of a mixture or article, into the customs territory of the United States. “Importer” includes the person primarily liable for the payment of any duties on the merchandise or an authorized agent acting on his or her behalf. The term also includes, as appropriate, </P> <P>(1) The consignee,</P> <P>(2) The importer of record,</P> <P>(3) the actual owner if an actual owner's declaration and superseding bond has been filed in accordance with 19 CFR 141.20, or</P> <P>(4) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR 144.</P> <P> <E T="03">Impurity</E> means a chemical substance which is unintentionally present with another chemical substance. </P> <P> <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reaction(s) used for the intentional manufacture of other chemical substance(s) or mixture(s), or that is intentionally present for the purpose of altering the rate(s) of such chemical reaction(s). </P> <P> <E T="03">Inventory</E> means the TSCA Chemical Substance Inventory, which is EPA's comprehensive list of confidential and non-confidential chemical substances manufactured or processed in the United States for nonexempt commercial purpose that EPA compiled and keeps current under section 8(b) of the Act. </P> <P> <E T="03">Manufacture</E> means to manufacture, produce, or import, for commercial purposes. Manufacture includes the extraction, for commercial purposes, of a component chemical substance from a previously existing chemical substance or complex combination of chemical substances. When a chemical substance, manufactured other than by import, is: (1) Produced exclusively for another person who contracts for such production, and (2) that other person specifies the identity of the chemical substance and controls the total amount produced and the basic technology for the plant process, then that chemical substance is co-manufactured by the producing manufacturer and the person contracting for such production. </P> <P> <E T="03">Manufacture for commercial purposes</E> means: (1) To manufacture, produce, or import with the purpose of obtaining an immediate or eventual commercial advantage, and includes, among other things, the “manufacture” of any amount of a chemical substance or mixture (i) for commercial distribution, including for test marketing, or (ii) for use by the manufacturer, including use for product research and development or as an intermediate. (2) The term also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts that are separated from that other substance or mixture and impurities that remain in that substance or mixture. Byproducts and impurities without separate commercial value are nonetheless produced for the purpose of obtaining a commercial advantage, since they are part of the manufacture of a chemical substance for commercial purposes. </P> <P> <E T="03">Manufacturer</E> means a person who manufactures a chemical substance. </P> <P> <E T="03">Mixture</E> means any combination of two or more chemical substances if the combination does not occur in nature and is not, in whole or in part, the result of a chemical reaction; except that <PRTPAGE P="108"/> “mixture” does include (1) any combination which occurs, in whole or in part, as a result of a chemical reaction if the combination could have been manufactured for commercial purposes without a chemical reaction at the time the chemical substances comprising the combination were combined, and if all of the chemical substances comprising the combination are not new chemical substances, and (2) hydrates of a chemical substance or hydrated ions formed by association of a chemical substance with water, so long as the nonhydrated form is itself not a new chemical substance. </P> <P> <E T="03">New chemical substance</E> means any chemical substance which is not included on the Inventory. </P> <P> <E T="03">Person</E> includes any individual, firm, company, corporation, joint-venture, partnership, sole proprietorship, association, or any other business entity; any State or political subdivision thereof; any municipality; any interstate body; and any department, agency, or instrumentality of the Federal Government. </P> <P> <E T="03">Process</E> means to process for commercial purposes. Process includes the preparation of a chemical substance or mixture, after its manufacture, (1) in the same form or physical state as, or in a different form or physical state from, that in which it was received by the person so preparing such substance or mixture, or (2) as part of a mixture or article containing the chemical substance or mixture. </P> <P> <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture after its manufacture for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included in this definition. If a chemical substance or mixture containing impurities is processed for commercial purposes, then the impurities also are processed for commercial purposes. </P> <P> <E T="03">Processor</E> means any person who processes a chemical substance or mixture. </P> <P> <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way will be considered one site. More than one manufacturing plant may be located on a single site. </P> <P> (1) For chemical substances manufactured under contract, <E T="03">i.e.,</E> by a toll manufacturer, the site is the location where the chemical substance is physically manufactured. </P> <P>(2) The site for an importer who imports a chemical substance described in § 710.25 is the U.S. site of the operating unit within the person's organization that is directly responsible for importing the chemical substance. The import site, in some cases, may be the organization's headquarters in the United States. If there is no such operating unit or headquarters in the United States, the site address for the importer is the U.S. address of an agent acting on behalf of the importer who is authorized to accept service of process for the importer.</P> <P> <E T="03">Small quantities solely for research and development (or</E> “ <E T="03">small quantities solely for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including such research or analysis for the development of a product”)</E> means quantities of a chemical substance manufactured, imported, or processed or proposed to be manufactured, imported, or processed solely for research and development that are not greater than reasonably necessary for such purposes. </P> <P> <E T="03">State</E> means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Northern Mariana Islands, or any other territory or possession of the United States. </P> <P> <E T="03">Technically qualified individual</E> means a person: </P> <P>(1) Who because of his/her education, training, or experience, or a combination of these factors, is capable of appreciating the health and environmental risks associated with the chemical substance which is used under his/her supervision,</P> <P>(2) Who is responsible for enforcing appropriate methods of conducting scientific experimentation, analysis, or chemical research in order to minimize such risks, and</P> <P> (3) Who is responsible for the safety assessments and clearances related to <PRTPAGE P="109"/> the procurement, storage, use, and disposal of the chemical substance as may be appropriate or required within the scope of conducting the research and development activity. The responsibilities in this paragraph may be delegated to another individual, or other individuals, as long as each meets the criteria in paragraph (1) of this definition. </P> <P> <E T="03">Test marketing</E> means the distribution in commerce of no more than a predetermined amount of a chemical substance, mixture, or article containing that chemical substance or mixture, by a manufacturer or processor to no more than a defined number of potential customers to explore market capability in a competitive situation during a predetermined testing period prior to the broader distribution of that chemical substance, mixture, or article in commerce. </P> <P> <E T="03">United States,</E> when used in the geographic sense, means all of the States, territories, and possessions of the United States. </P> <CITA>[68 FR 888, Jan. 7, 2003, as amended at 69 FR 40791, July 7, 2004; 76 FR 50859, Aug. 16, 2011; 76 FR 54933, Sept. 6, 2011; 82 FR 37539, Aug. 11, 2017]</CITA> </SECTION> <SECTION> <SECTNO>§ 710.4</SECTNO> <SUBJECT>Scope of the inventory.</SUBJECT> <P> (a) <E T="03">Chemical substances subject to these regulations.</E> Only chemical substances which are manufactured, imported, or processed “for a commercial purpose,” as defined in § 710.3(d), are subject to these regulations. </P> <P> (b) <E T="03">Naturally occurring chemical substances automatically included.</E> Any chemical substance which is naturally occurring and: </P> <P>(1) Which is (i) unprocessed or (ii) processed only by manual, mechanical, or gravitational means; by dissolution in water; by flotation; or by heating solely to remove water; or</P> <P>(2) Which is extracted from air by any means, will automatically be included in the inventory under the category “Naturally Occurring Chemical Substances.” Examples of such substances are: raw agricultural commodities; water, air, natural gas, and crude oil; and rocks, ores, and minerals.</P> <P> (c) <E T="03">Substances excluded by definition or section 8(b) of TSCA.</E> The following substances are excluded from the inventory: </P> <P>(1) Any substance which is not considered a “chemical substance” as provided in subsection 3(2)(B) of the Act and in the definition of “chemical substance” in § 710.3(d);</P> <P>(2) Any mixture as defined in § 710.3(d);</P> <NOTE> <HD SOURCE="HED">Note:</HD> <P>A chemical substance that is manufactured as part of a mixture is subject to these reporting regulations. This exclusion applies only to the mixture and not to the chemical substances of which the mixture is comprised. The term “mixture” includes alloys, inorganic glasses, ceramics, frits, and cements, including Portland cement.</P> </NOTE> <P>(3) Any chemical substance which is manufactured, imported, or processed solely in small quantities for research and development, as defined in § 710.3(d); and</P> <P>(4) Any chemical substance not manufactured, processed or imported for a commercial purpose since January 1, 1975.</P> <P> (d) <E T="03">Chemical substances excluded from the inventory.</E> The following chemical substances are excluded from the inventory. Although they are considered to be manufactured or processed for a commercial purpose for the purpose of section 8 of the Act, they are not manufactured or processed for distribution in commerce as chemical substances <E T="03">per se</E> and have no commercial purpose separate from the substance, mixture, or article of which they may be a part. </P> <NOTE> <HD SOURCE="HED">Note:</HD> <P>In addition, chemical substances excluded here will not be subject to premanufacture notification under section 5 of the Act.</P> </NOTE> <P>(1) Any impurity.</P> <P>(2) Any byproduct which has no commercial purpose.</P> <NOTE> <HD SOURCE="HED">Note:</HD> <P>A byproduct which has commercial value only to municipal or private organizations who (i) burn it as a fuel, (ii) dispose of it as a waste, including in a landfill or for enriching soil, or (iii) extract component chemical substances which have commercial value, may be reported for the inventory, but will not be subject to premanufacture notification under section 5 of the Act if not included.</P> </NOTE> <P> (3) Any chemical substance which results from a chemical reaction that occurs incidental to exposure of another chemical substance, mixture, or article to environmental factors such as air, <PRTPAGE P="110"/> moisture, microbial organisms, or sunlight. </P> <P>(4) Any chemical substance which results from a chemical reaction that occurs incidental to storage of another chemical substance, mixture, or article.</P> <P>(5) Any chemical substance which results from a chemical reaction that occurs upon end use of other chemical substances, mixtures, or articles such as adhesives, paints, miscellaneous cleansers or other housekeeping products, fuels and fuel additives, water softening and treatment agents, photographic films, batteries, matches, and safety flares, and which is not itself manufactured for distribution in commerce or for use as an intermediate.</P> <P>(6) Any chemical substance which results from a chemical reaction that occurs upon use of curable plastic or rubber molding compounds, inks, drying oils, metal finishing compounds, adhesives, or paints; or other chemical substances formed during manufacture of an article destined for the marketplace without further chemical change of the chemical substance except for those chemical changes that may occur as described elsewhere in this § 710.4(d).</P> <P>(7) Any chemical substance which results from a chemical reaction that occurs when (i) a stabilizer, colorant, odorant, antioxidant, filler, solvent, carrier, surfactant, plasticizer, corrosion inhibitor, antifoamer or de-foamer, dispersant, precipitation inhibitor, binder, emulsifier, de-emulsifier, dewatering agent, agglomerating agent, adhesion promoter, flow modifier, pH neutralizer, sequesterant, coagulant, flocculant, fire retardant, lubricant, chelating agent, or quality control reagent functions as intended or (ii) a chemical substance, solely intended to impart a specific physicochemical characteristic, functions as intended.</P> <P>(8) Chemical substances which are not intentionally removed from the equipment in which they were manufactured.</P> <NOTE> <HD SOURCE="HED">Note:</HD> <P>See note to definition of “intermediate” at § 710.3(d) for explanation of “equipment in which it was manufactured.”</P> </NOTE> <CITA>[42 FR 64572, Dec. 23, 1977, as amended at 68 FR 889, Jan. 7, 2003]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Commercial Activity Notification</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>82 FR 37540, Aug. 11, 2017, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 710.23</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>The following definitions also apply to subpart B of this part.</P> <P> <E T="03">Active substance</E> means any interim active substance, any naturally occurring chemical substance as defined by § 710.27(b), any chemical substance that was added to the Inventory on or after June 21, 2006 pursuant to a Notice of Commencement under § 720.102 received by the Agency on or after June 21, 2006, and any chemical substance subject to commercial activity designation that the Administrator designates as active based on the receipt of a notice under this subpart. </P> <P> <E T="03">Central Data Exchange or CDX</E> means EPA's centralized electronic document reporting portal, or its successors. </P> <P> <E T="03">Chemical Information Submission System or CISS</E> means EPA's web-based reporting tool for preparing and submitting a Notice of Activity. </P> <P> <E T="03">Chemical substance subject to commercial activity designation</E> means a chemical substance that requires a designation as either an active or an inactive substance. A chemical substance is subject to commercial activity designation if it is not an interim active substance, it was added to the Inventory before June 21, 2006, it is not a naturally occurring chemical substance as defined by § 710.27(b), and it has not yet been designated by the Administrator as either an active or an inactive substance. </P> <P> <E T="03">e-NOA</E> means EPA's software module within CISS for generating and completing Notice of Activity Forms A and B. </P> <P> <E T="03">Existing claim for protection of specific chemical identity against disclosure</E> is a claim for protection of the specific chemical identity of a chemical substance that is listed on the confidential portion of the Inventory, asserted prior to June 22, 2016. </P> <P> <E T="03">Inactive substance</E> means any chemical substance subject to commercial activity designation, that the Administrator designates as inactive based on the lack of receipt of a notice under <PRTPAGE P="111"/> this subpart, effective 90 days after the Administrator identifies the chemical substance for such designation. </P> <P> <E T="03">Interim active substance</E> means any chemical substance that was reported, pursuant to 40 CFR part 711, as having been manufactured in and of the calendar years: 2010, 2011, 2012, 2013, 2014, or 2015. </P> <P> <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know. </P> <P> <E T="03">Notice of Activity Form A</E> means the form for supplying retrospective notification under TSCA section 8(b)(4), for which the submission obligation is described in § 710.25(a). </P> <P> <E T="03">Notice of Activity Form B</E> means the form for supplying forward-looking reporting under TSCA section 8(b)(5), for which the submission obligation is described in § 710.25(c). </P> <P> <E T="03">Lookback period</E> means the period beginning on June 21, 2006 and ending on June 21, 2016. </P> <P> <E T="03">Possession</E> or <E T="03">Control</E> means in the possession or control of any person, or of any subsidiary, partnership in which the person is a general partner, parent company, or any company or partnership which the parent company owns or controls, if the subsidiary, parent company, or other company or partnership is associated with the person in the research, development, test marketing, or commercial marketing of the chemical substance in question. Information is in the possession or control of a person if it is: </P> <P>(1) In the person's own files including files maintained by employees of the person in the course of their employment.</P> <P>(2) In commercially available data bases to which the person has purchased access.</P> <P>(3) Maintained in the files in the course of employment by other agents of the person who are associated with research, development, test marketing, or commercial marketing of the chemical substance in question.</P> <P> <E T="03">Reportable chemical substance</E> means a chemical substance that is listed on the Inventory and that is either: </P> <P>(1) A chemical substance subject to commercial activity designation for which notification is required or allowed under § 710.25(a) and § 710.25(b),</P> <P>(2) A chemical substance that was added to the confidential portion of the Inventory before June 22, 2016, or (3) an inactive substance for which notification is required under § 710.25(c).</P> <P> <E T="03">Submission period</E> means the applicable period for submitting a Notice of Activity under § 710.25. </P> </SECTION> <SECTION> <SECTNO>§ 710.25</SECTNO> <SUBJECT>Persons subject to the notification requirement.</SUBJECT> <P>The following persons are subject to the requirements of this subpart.</P> <P> (a) <E T="03">Who must submit the Notice of Activity Form A?</E> Any person who manufactured (including imported) a chemical substance subject to commercial activity designation at any time during the lookback period, except as provided in § 710.27, must submit a Notice of Activity Form A as specified under §§ 710.29 and 710.30(a), unless such person has evidence in the form of a CDX receipt, documenting EPA's receipt of a Notice of Activity Form A from another person, for the same chemical substance, or unless the prior manufacturing of such a substance is not known to or reasonably ascertainable by the person. Evidence in the form of a CDX receipt for a Notice of Activity Form A is not a basis for exemption from the requirements of § 710.25(c) if the chemical substance is ultimately designated as inactive due to withdrawal of the Notice of Activity Form A. </P> <P> (b) <E T="03">Who else may submit the Notice of Activity Form A?</E> Any person not required to submit a Notice of Activity Form A under § 710.25(a), who manufactured (including imported) or processed a reportable chemical substance, at any time during the lookback period, may submit a Notice of Activity Form A as specified under §§ 710.29 and 710.30(a). </P> <P> (c) <E T="03">Who must submit the Notice of Activity Form B?</E> Any person who intends to manufacture (including import) or process an inactive substance, except as provided in § 710.27, after the effective date of the Administrator's designation of such chemical substance as an inactive substance, must submit a <PRTPAGE P="112"/> Notice of Activity Form B as specified under §§ 710.29 and 710.30(b), unless the presence of the inactive substance on the confidential portion of the Inventory is not known to or reasonably ascertainable by the person. </P> </SECTION> <SECTION> <SECTNO>§ 710.27</SECTNO> <SUBJECT>Activities for which notification is not required.</SUBJECT> <P> (a) <E T="03">In general.</E> The following activities do not trigger notification requirements under this subpart: </P> <P>(1) The manufacturing or processing of a chemical substance in small quantities solely for research and development.</P> <P>(2) The import or processing of a chemical substance as part of an article.</P> <P>(3) The manufacturing or processing of a chemical substance as described in § 720.30(g) or (h).</P> <P>(4) The manufacturing or processing of a chemical substance solely for export from the United States as described in § 720.30(e) or § 721.3, except where the Administrator has made a finding described in TSCA section 12(a)(2).</P> <P>(5) The manufacturing or processing of a chemical substance solely for test marketing purposes.</P> <P> (b) <E T="03">Manufacturing or processing naturally occurring chemical substances.</E> The following activities do not trigger notification requirements under this subpart: </P> <P>(1) The manufacture of a naturally occurring chemical substance, as described in § 710.4(b). Some chemical substances can be manufactured both as described in § 710.4(b) and by means other than those described in § 710.4(b). If a person manufactures a chemical substance by means other than those described in § 710.4(b), this exemption is inapplicable, regardless of whether the chemical substance also could have been produced as described in § 710.4(b). This exemption does not cover the manufacture of a chemical substance from a naturally occurring chemical substance.</P> <P>(2) The processing of a naturally occurring chemical substance only by manual, mechanical, or gravitational means; by dissolution in water; by flotation; or by heating solely to remove water.</P> </SECTION> <SECTION> <SECTNO>§ 710.29</SECTNO> <SUBJECT>Information required in the notification.</SUBJECT> <P> (a) <E T="03">Reporting information to EPA.</E> A person who reports information to EPA under this subpart must do so using the e-NOA software module, the CISS reporting tool, and the CDX electronic reporting portal provided by EPA at the addresses set forth in § 710.39. For notices of activity under §§ 710.25(a) and 710.25(b), the submission must include all information described in paragraph (b) of this section. For a Notice of Activity under § 710.25(c), the submission must include all information described in paragraph (c) of this section. A person must submit a separate notice for each chemical substance that the person is required to report. Using e-NOA and CISS and registering in CDX are described in instructions available from EPA at the Web sites set forth in § 710.39. </P> <P> (b) <E T="03">Information to be reported on the Notice of Activity Form A.</E> A person submitting a Notice of Activity Form A under § 710.25(a) or § 710.25(b) must submit the information specified in § 710.29(d) for each reportable chemical substance. A person submitting information under § 710.25(a) or § 710.25(b) must report information to the extent that such information is known to or reasonably ascertainable by that person. </P> <P> (c) <E T="03">Information to be reported on a Notice of Activity Form B.</E> Any person submitting a Notice of Activity Form B under § 710.25(c) must provide the information described in this paragraph for each inactive substance intended to be manufactured or processed. </P> <P>(1) Information specified in § 710.29(d).</P> <P>(2) The anticipated date by which the inactive substance is to be manufactured or processed in the United States. If the Notice of Activity Form B is filed prior to the effective date of the chemical substance's inactive designation, the most recent date of manufacturing or processing may be provided in lieu of an anticipated date.</P> <P> (d) <E T="03">Information to be reported on either the Notice of Activity Form A or Form B.</E> </P> <P> (1) <E T="03">Company.</E> The name and address of the submitting company. </P> <P> (2) <E T="03">Authorized official.</E> The name and address of the authorized official for the submitting company. <PRTPAGE P="113"/> </P> <P> (3) <E T="03">Technical contact.</E> The name and telephone number of a person who will serve as technical contact for the submitting company and who will be able to answer questions about the information submitted by the company to EPA. </P> <P> (4) <E T="03">Chemical-specific information.</E> The system described under § 710.29(a) will provide a list of reportable chemical substances from which a person can select his or her chemical. The list will include the correct CASRN and CA Index name used to list a non-confidential chemical substance on the Inventory. For confidential substances on the Inventory, the list will include the TSCA Accession Number and generic name. </P> <P>(i) If an importer submitting a notice cannot provide the information specified in § 710.29(d)(4) because it is unknown to the importer and claimed as confidential by the supplier of the chemical substance or mixture, the importer must ask the supplier to provide the specific chemical identity information directly to EPA in a joint submission using the same e-NOA software module used for commercial activity reporting. Such request must refer the supplier to EPA's instructions for submitting chemical identity information electronically, using e-NOA, CISS, and CDX (see § 710.39), and for clearly referencing the importer's submission. Contact information for the supplier, a trade name or other name for the chemical substance or mixture, and a copy of the request to the supplier must be included with the importer's submission.</P> <P>(ii) If a manufacturer or processor submitting a notice cannot provide the information specified in § 710.29(d)(4) because the reportable chemical substance is manufactured or processed using a reactant having a specific chemical identity that is unknown to the manufacturer or processor and claimed as confidential by its supplier, the manufacturer or processor must ask the supplier of the confidential reactant to provide the specific chemical identity of the confidential reactant directly to EPA in a joint submission using the same e-NOA software module used for commercial activity reporting. Such request must refer the supplier to EPA's instructions for submitting chemical identity information electronically using e-NOA, CISS, and CDX (see § 710.39), and for clearly referencing the manufacturer's or processor's submission. Contact information for the supplier, a trade name or other name for the chemical substance, and a copy of the request to the supplier must be included with the manufacturer's or processor's submission with respect to the chemical substance.</P> <P>(iii) Joint submissions must be submitted electronically using e-NOA, CISS, and CDX (see § 710.39).</P> <P> (5) <E T="03">Certification statements.</E> The authorized official must certify that the submitted information has been completed in compliance with the requirements of this part as described in this paragraph. </P> <P>(i) The certification must be signed and dated by the authorized official for the submitting company.</P> <P>(ii) The following is required certification language for an authorized official submitting a Notice of Activity Form A under § 710.25(a) or § 710.25(b): “I certify under penalty of law that this document and all attachments were prepared under my direction or supervision and the information contained therein, to the best of my knowledge, is true, accurate, and complete. I also certify that I have manufactured, imported, or processed the above chemical between the dates of June 21, 2006 and June 21, 2016. I am aware it is unlawful to knowingly submit incomplete, false and/or misleading information, and there are significant criminal penalties for such unlawful conduct, including the possibility of fine and imprisonment.”</P> <P> (iii) The following is required certification language for an authorized official submitting a Notice of Activity Form B under § 710.25(c): “I certify under penalty of law that this document and all attachments were prepared under my direction or supervision and the information contained therein, to the best of my knowledge, is true, accurate, and complete. I also certify that I have intent to manufacture, import, or process the above chemical within 90 days of submission. I am aware it is unlawful to knowingly <PRTPAGE P="114"/> submit incomplete, false and/or misleading information, and there are significant criminal penalties for such unlawful conduct, including the possibility of fine and imprisonment.” </P> </SECTION> <SECTION> <SECTNO>§ 710.30</SECTNO> <SUBJECT>When to submit notifications.</SUBJECT> <P> (a) <E T="03">When must a Notice of Activity Form A be submitted?</E> The Notice of Activity Form A required to be submitted under § 710.25(a) must be submitted during the applicable submission period. </P> <P> (1) <E T="03">Manufacturers.</E> The submission period for manufacturers under §§ 710.25(a) and 710.25(b) begins on August 11, 2017 and ends on February 7, 2018. </P> <P> (2) <E T="03">Processors.</E> The submission period for processors under § 710.25(b) begins on August 11, 2017 and ends on October 5, 2018. </P> <P> (3) <E T="03">Withdrawal of a Notice of Activity Form A.</E> A Notice of Activity Form A submitted under § 710.30(a)(1) or § 710.30(a)(2) may be withdrawn by the submitter no later than October 5, 2018. If EPA receives a timely request to withdraw a previously submitted Notice of Activity Form A for a chemical substance subject to commercial activity designation, and EPA has not received a Notice of Activity Form A from another submitter for the same chemical substance, EPA will not designate the chemical substance as active. A Form A withdrawn under this paragraph will not satisfy the obligation under this rule to submit a Form A. </P> <P> (b) <E T="03">When must a Notice of Activity Form B be submitted?—</E> (1) <E T="03">Manufacturers and processors.</E> The Notice of Activity Form B required to be submitted under § 710.25(c) must be submitted before a person manufactures or processes the inactive substance, but not more than 90 days prior to the anticipated date of manufacturing or processing. </P> <P> (2) <E T="03">When else may a Notice of Activity Form B be submitted?</E> A Notice of Activity Form B that will later be required to be submitted under § 710.25(c) may be submitted during the 90-day period between EPA's identification of a chemical substance for inactive designation and the effective date for such designation, by a person who is currently manufacturing or processing such chemical substance or who anticipates manufacturing or processing such chemical substance within 90 days following submission. </P> <P> (3) <E T="03">When may EPA execute a request to withdraw a Notice of Activity Form B?</E> If EPA receives a request to withdraw a previously submitted Notice of Activity Form B from the submitter of the Notice of Activity Form B and EPA has neither yet moved the subject chemical substance from the inactive to the active Inventory nor yet moved the subject chemical substance from the confidential portion of the Inventory to the public portion of the Inventory as a result of the original submission, then EPA may execute the request. </P> </SECTION> <SECTION> <SECTNO>§ 710.33</SECTNO> <SUBJECT>Co-manufacturers and co-processors.</SUBJECT> <P> (a) <E T="03">Notice of Activity submitted by co-manufacturers.</E> When, in a single instance of manufacturing or importing a particular volume of a chemical substance during the lookback period, two or more persons qualify as the manufacturer or importer of that volume, they may determine among themselves who should make the required submission under § 710.25(a). If no notice is submitted as required under this subpart, EPA will hold each such person liable for failure to submit a notice. </P> <P> (b) <E T="03">Notice of Activity by prospective co-manufacturers or co-processors.</E> If two or more persons intend to manufacture, import, or process a particular volume of an inactive substance, such that multiple persons would qualify as the manufacturer, importer, or processor of that volume, they may determine among themselves who will submit the required notice under § 710.25(c). If no notice is submitted as required under this subpart, all of the persons remain subject to the reporting requirements, and EPA will hold each such person liable for a failure to submit a notice prior to the date of manufacturing, importing, or processing. </P> </SECTION> <SECTION> <SECTNO>§ 710.35</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P> Each person who is subject to the notification requirements of this part must retain records that document any information reported to EPA. Records relevant to a Notice of Activity under <PRTPAGE P="115"/> §§ 710.25(a) and 710.25(b) must be retained for a period of 5 years beginning on the last day of the submission period. Records relevant to a Notice of Activity under § 710.25(c) must be retained for a period of 5 years beginning on the day that the notice was submitted. </P> </SECTION> <SECTION> <SECTNO>§ 710.37</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <P> (a) <E T="03">Chemical identity.</E> A person submitting information under this part may request to maintain an existing claim of confidentiality for the specific chemical identity of a reportable chemical substance, but may do so only if the identity of the chemical substance is listed on the confidential portion of the Inventory as of the time the notice is submitted for that chemical substance under this part. A request to maintain an existing claim of confidentiality must be made at the time the information is submitted. If no person submitting the information specified in § 710.29(d)(4) for a particular chemical substance requests that the claim be maintained, EPA will treat the specific chemical identity of that chemical substance as not subject to a confidentiality claim and will move the chemical substance to the public portion of the Inventory. Except as set forth in this subsection, information claimed as confidential in accordance with this section will be treated and disclosed in accordance with the procedures in 40 CFR part 2, subpart B. </P> <P> (1) <E T="03">Notice of Activity Form A.</E> A person requesting to maintain an existing claim of confidentiality for specific chemical identity may submit with the notice answers to the questions in paragraphs (c)(1) and(c)(2) of this section, signed and dated by an authorized official. If these answers are submitted less than five years before the date on which substantiation is due pursuant to TSCA section 8(b)(4)(D)(i), the answers will be deemed to be substantiations made under TSCA section (8)(b)(4)(D)(i) and the person will be exempt from further substantiation requirements under TSCA section (8)(b)(4)(D)(i). Answers that do not include the answers to all applicable questions in paragraph (c) of this section will not be deemed to be substantiations made under the TSCA section (8)(b)(4)(D)(i) requirement. </P> <P> (2) <E T="03">Notice of Activity Form B.</E> A person requesting to maintain an existing claim of confidentiality for specific chemical identity must submit answers to the questions in paragraphs (c)(1) and (c)(2) of this section within 30 days of submitting the notice, signed and dated by an authorized official. If this information is not submitted within 30 days of submitting the notice, EPA will consider the confidentiality claim as deficient, so that the specific chemical identity is not subject to a confidentiality claim, and may make the information public without further notice. </P> <P>(i) Persons who submitted the information described in paragraph (a)(2) of this section before May 5, 2020 must submit answers to the questions in paragraphs (c)(2)(ii) and (iii) of this section not later than June 4, 2020.</P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Information other than specific chemical identity.</E> A person submitting information under this part may assert a claim of confidentiality for information other than specific chemical identity. Any such confidentiality claim must be made at the time the information is submitted. Except as set forth in this section, information claimed as confidential in accordance with this subsection will be treated and disclosed in accordance with 40 CFR part 2, subpart B. A person asserting a claim of confidentiality under this subsection must submit with the notice answers to the questions in paragraph (c)(1) of this section, signed and dated by an authorized official. If no claim is asserted at the time the information is submitted, or if the answers to the questions in paragraph (c)(1) of this section are not provided, EPA will consider the information as not subject to a confidentiality claim and may make the information public without further notice. </P> <P> (c) <E T="03">Substantiation questions.</E> Persons asserting that information is exempt from substantiation pursuant to TSCA section 14(c)(2) must answer only the question in paragraph (c)(1)(i) of this section. <PRTPAGE P="116"/> </P> <P> (1) <E T="03">Substantiation questions for any confidentiality claim.</E> For any information with a confidentiality claim that you assert is exempt from substantiation pursuant to TSCA section 14(c)(2), answer only the question in paragraph (c)(1)(i) of this section. For all other information with a confidentiality claim, answer the questions in paragraphs (c)(1)(ii) through (vi) of this section. If more than one data element on Form A or Form B is claimed as confidential, you must answer the applicable questions individually for each data element. If the answer to a question applies for all confidentiality claims on the form, indicate this in your substantiation response. </P> <P>(i) Do you believe that the information is exempt from substantiation pursuant to TSCA section 14(c)(2)? If you answered yes, you must individually identify the specific information claimed as confidential and specify the applicable exemption(s).</P> <P>(ii) Will disclosure of the information likely result in substantial harm to your business's competitive position? If you answered yes, describe with specificity the substantial harmful effects that would likely result to your competitive position if the information is made available to the public.</P> <P>(iii) To the extent your business has disclosed the information to others (both internally and externally), what precautions has your business taken? Identify the measures or internal controls your business has taken to protect the information claimed as confidential: Non-disclosure agreement required prior to access; access is limited to individuals with a need-to-know; information is physically secured; other internal control measure(s). If yes, explain.</P> <P>(iv) Does the information appear in any public documents, including (but not limited to) safety data sheets, advertising or promotional material, professional or trade publication, or any other media or publications available to the general public? If you answered yes, explain why the information should be treated as confidential.</P> <P>(v) Is the claim of confidentiality intended to last less than 10 years? If so, indicate the number of years (between 1-10 years) or the specific date/occurrence after which the claim is withdrawn.</P> <P>(vi) Has EPA, another federal agency, or court made any confidentiality determination regarding information associated with this chemical substance? If you answered yes, explain the outcome of that determination and provide a copy of the previous confidentiality determination or any other information that will assist in identifying the prior determination.</P> <P> (2) <E T="03">Substantiation for confidentiality claims for specific chemical identity.</E> (i) Is the confidential chemical substance publicly known to have ever been offered for commercial distribution in the United States? If you answered yes, explain why the information should be treated as confidential. </P> <P> (ii) Does this particular chemical substance leave the site of manufacture (including import) or processing in any form, <E T="03">e.g.,</E> as a product, effluent, or emission? If yes, please explain what measures have been taken, if any, to guard against the discovery of its identity. </P> <P> (iii) If the chemical substance leaves the site in a form that is available to the public or your competitors, can the chemical identity be readily discovered by analysis of the substance ( <E T="03">e.g.,</E> product, effluent, or emission), in light of existing technologies and any costs, difficulties, or limitations associated with such technologies? Please explain why or why not. </P> <P> (d) <E T="03">Confidentiality of substantiation.</E> If any of the information contained in the answers to the questions listed in paragraph (c)(1) or (c)(2) of this section is claimed as confidential business information, the submitter must clearly indicate such by marking the substantiation as confidential business information as provided in a Notice of Activity Form A or Form B. </P> <P> (e) <E T="03">Certification statement for claims.</E> An authorized official of a person submitting or substantiating a claim of confidentiality or a request to maintain an existing claim of confidentiality for specific chemical identity must certify that the submission complies with the requirements of this part by signing and dating the following certification statement: “I certify that all claims for confidentiality made or <PRTPAGE P="117"/> sought to be maintained with this submission are true and correct, and all information submitted herein to substantiate such claims is true and correct. Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. 1001.” I further certify that it is true and correct that: </P> <P>(1) My company has taken reasonable measures to protect the confidentiality of the information;</P> <P>(2) I have determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law;</P> <P>(3) I have a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of my company; and</P> <P>(4) I have a reasonable basis to believe that the information is not readily discoverable through reverse engineering.</P> <CITA>[82 FR 37540, Aug. 11, 2017, as amended at 85 FR 13067, Mar. 6, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 710.39</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> <P>(a) EPA will accept information submitted under this subpart only if submitted in accordance with this section. All information must be submitted electronically to EPA via CDX. Prior to submission to EPA via CDX, Notices of Activity and any associated information must be generated and completed using the e-NOA software module.</P> <P>(b) Obtain instructions for registering in CDX as follows:</P> <P> (1) <E T="03">Web site.</E> The CDX Registration User Guide is available at <E T="03">https://www.epa.gov/sites/production/files/documents/cdx__registration__guide__v0__02.pdf.</E> To register in CDX, go to <E T="03">https://cdx.epa.gov</E> and follow the appropriate links. </P> <P> (2) <E T="03">Telephone.</E> Contact the EPA CDX Help Desk at 1-888-890-1995. </P> <P> (3) <E T="03">Email.</E> Email the EPA CDX Help Desk at <E T="03">HelpDesk@epacdx.net.</E> </P> <P>(c) Obtain instructions for using CISS and the e-NOA software module as follows:</P> <P> (1) <E T="03">Web site.</E> Go to the EPA New Chemicals under the Toxic Substances Control Act Web site at <E T="03">https://www.epa.gov/reviewing-new-chemicalsunder-toxic-substances-control-act-tsca/how-submit-e-pmn</E> and follow the appropriate links. </P> <P> (2) <E T="03">Telephone.</E> Contact the EPA TSCA Hotline at 1-202-554-1404. </P> <P> (3) <E T="03">Email.</E> Email the EPA TSCA Hotline at <E T="03">TSCA-Hotline@epa.gov.</E> </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Review Plan</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>85 FR 13068, Mar. 6, 2020, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 710.41</SECTNO> <SUBJECT>Scope.</SUBJECT> <P>This subpart applies to the substantiation and review of claims of confidentiality asserted in Notices of Activity Form A to protect the specific chemical identities of chemical substances.</P> </SECTION> <SECTION> <SECTNO>§ 710.43</SECTNO> <SUBJECT>Persons subject to substantiation requirement.</SUBJECT> <P> (a) <E T="03">Who must substantiate.</E> Any person who filed a Notice of Activity Form A requesting to maintain an existing confidentiality claim for a specific chemical identity must substantiate that confidentiality claim as specified in §§ 710.45 and 710.47 unless eligible for an exemption in paragraph (b) of this section. </P> <P> (b) <E T="03">Exemptions.</E> (1) Any person who completed the voluntary substantiation process set forth in § 710.37(a)(1) is exempt from the substantiation requirement of this subpart pertaining to the submission of answers to the questions in § 710.45(b)(1) through (6). All remaining requirements of § 710.45 must be met in accordance with the deadline specified in § 710.47(a), including the requirement to submit answers to the questions in § 710.45(b)(7) and (8), signed and dated by an authorized official, and to complete the certification statement in § 710.37(e). </P> <P> (2) A person who has previously substantiated the confidentiality claim for a specific chemical identity that the person requested to maintain in a Notice of Activity Form A, by submitting information that is responsive to all questions in § 710.45, is exempt from the substantiation requirement of this subpart if both of the following conditions are met: <PRTPAGE P="118"/> </P> <P>(i) The previous substantiation was submitted to EPA on or after November 1, 2015; and</P> <P>(ii) The person reports to EPA the submission date, submission type, and case number, transaction ID, or equivalent identifier for the previous submission that contained the substantiation, not later than the deadline specified in § 710.47.</P> </SECTION> <SECTION> <SECTNO>§ 710.45</SECTNO> <SUBJECT>Contents of substantiation.</SUBJECT> <P> (a) <E T="03">The submission.</E> A person substantiating a confidentiality claim for a specific chemical identity must submit written answers to the questions in paragraph (b) of this section, signed and dated by an authorized official, and complete the certification statement in § 710.37(e). If any of the information contained in the answers to the questions listed in paragraph (b) of this section is itself claimed as confidential, the submitter must clearly indicate such by marking that information as confidential business information. </P> <P> (b) <E T="03">Substantiation questions.</E> (1) Will disclosure of the information claimed as confidential likely cause substantial harm to your business's competitive position? If you answered yes, describe the substantial harmful effects that would likely result to your competitive position if the information is disclosed, including but not limited to how a competitor could use such information and the causal relationship between the disclosure and the harmful effects. </P> <P>(2) To the extent your business has disclosed the information to others (both internally and externally), has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify the specific measures, including but not limited to internal controls, that your business has taken to protect the information claimed as confidential.</P> <P>(3)(i) Is any of the information claimed as confidential required to be publicly disclosed under any other Federal law? If yes, please explain.</P> <P>(ii) Does any of the information claimed as confidential otherwise appear in any public documents, including (but not limited to) safety data sheets; advertising or promotional material; professional or trade publications; state, local, or Federal agency files; or any other media or publications available to the general public? If yes, please explain why the information should be treated as confidential.</P> <P>(iii) Does any of the information claimed as confidential appear in one or more patents or patent applications? If yes, please provide the associated patent number or patent application number (or numbers) and explain why the information should be treated as confidential.</P> <P>(4) Is the claim of confidentiality intended to last less than 10 years? If yes, please indicate the number of years (between 1-10 years) or the specific date/occurrence after which the claim is withdrawn.</P> <P>(5) Has EPA, another Federal agency, or court made any confidentiality determination regarding information associated with this chemical substance? If yes, please provide the circumstances associated with the prior determination, whether the information was found to be entitled to confidential treatment, the entity that made the decision, and the date of the determination.</P> <P> (6) Is the confidential chemical substance publicly known (including by your competitors) to have ever been offered for commercial distribution in the United States? If yes, please explain why the specific chemical identity should still be afforded confidential status ( <E T="03">e.g.,</E> the chemical substance is publicly known only as being distributed in commerce for research and development purposes, but no other information about the current commercial distribution of the chemical substance in the United States is publicly available). </P> <P> (7) Does this particular chemical substance leave the site of manufacture (including import) or processing in any form, <E T="03">e.g.,</E> as a product, effluent, or emission? If yes, please explain what measures have been taken, if any, to guard against the discovery of its identity. </P> <P> (8) If the chemical substance leaves the site in a form that is available to the public or your competitors, can the chemical identity be readily discovered by analysis of the substance ( <E T="03">e.g.,</E> product, effluent, or emission), in light of <PRTPAGE P="119"/> existing technologies and any costs, difficulties, or limitations associated with such technologies? Please explain why or why not. </P> </SECTION> <SECTION> <SECTNO>§ 710.47</SECTNO> <SUBJECT>When to submit substantiation or information on previous substantiation.</SUBJECT> <P>(a) All persons required to substantiate a confidentiality claim pursuant to § 710.43(a) or (b)(1) must submit their substantiation not later than November 1, 2020.</P> <P>(b) All persons who seek an exemption under § 710.43(b)(2) must submit the information specified in § 710.43(b)(2)(ii) not later than November 1, 2020.</P> </SECTION> <SECTION> <SECTNO>§ 710.49</SECTNO> <SUBJECT>Failure to report.</SUBJECT> <P>If neither the substantiation required under § 710.43(a) or (b)(1), nor the information specified in § 710.43(b)(2)(ii), is submitted to EPA in accordance with the provisions of this subpart, then EPA will deny the confidentiality claim in accordance with the procedures set forth in TSCA section 14(g)(2) and 40 CFR part 2, subpart B.</P> </SECTION> <SECTION> <SECTNO>§ 710.51</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> <P>EPA will accept information submitted under this subpart only if submitted in accordance with § 710.39.</P> </SECTION> <SECTION> <SECTNO>§ 710.53</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P>Each person who is subject to this part must retain records that document any information reported to EPA. Records must be retained for a period of 5 years beginning on the last day of the submission period.</P> </SECTION> <SECTION> <SECTNO>§ 710.55</SECTNO> <SUBJECT>Claim review, duration of protection, TSCA Inventory maintenance, posting results, and extension.</SUBJECT> <P> (a) <E T="03">Review criteria and procedures.</E> Except as set forth in this subpart, confidentiality claims for specific chemical identities asserted in Notices of Activity Form A will be reviewed and approved or denied in accordance with the criteria and procedures in TSCA section 14 and 40 CFR part 2, subpart B. </P> <P> (b) <E T="03">Duration of protection from disclosure.</E> Except as provided in 40 CFR part 2, subpart B, and section 14 of TSCA, a specific chemical identity that is the subject of an approved confidentiality claim under this subpart will be protected from disclosure for a period of 10 years from the date on which the confidentiality claim was first asserted by any submitter after June 22, 2016, unless, prior to the expiration of the period, the claimant notifies EPA that the person is withdrawing the confidentiality claim, in which case EPA will not protect the information from disclosure; or EPA otherwise becomes aware that the information does not qualify for protection from disclosure, in which case EPA will take the actions described in TSCA section 14(g)(2) to notify the claimant of EPA's intent to disclose the information. </P> <P> (c) <E T="03">Updating the TSCA Inventory.</E> EPA will periodically update the TSCA Inventory based on the results of the reviews of the confidentiality claims asserted in Notices of Activity Form A. </P> <P> (d) <E T="03">Posting of annual goals and numbers of reviews completed.</E> At the beginning of each calendar year until all reviews are completed, EPA will publish an annual goal for reviews and the number of reviews completed in the prior year on the Agency website. Determination of annual review goals will take into consideration the number of claims needing review, available resources, and a target completion date for all reviews under this subpart not later than February 19, 2024. </P> <P> (e) <E T="03">Extension.</E> If EPA determines that the target completion date in paragraph (d) of this section cannot be met based on the number of claims needing review and the available resources, then EPA will publish a document in the <E T="04">Federal Register</E> announcing the extension of the deadline to complete its review of all confidentiality claims under this subpart for not more than two additional years, together with an explanation of the reasons for the extension. </P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 711</EAR> <HD SOURCE="HED">PART 711—TSCA CHEMICAL DATA REPORTING REQUIREMENTS</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>711.1</SECTNO> <SUBJECT>Scope, compliance, and enforcement.</SUBJECT> <SECTNO>711.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>711.5</SECTNO> <SUBJECT>Chemical substances for which information must be reported.</SUBJECT> <SECTNO>711.6</SECTNO> <SUBJECT> Chemical substances for which information is not required. <PRTPAGE P="120"/> </SUBJECT> <SECTNO>711.8</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <SECTNO>711.9</SECTNO> <SUBJECT>Persons not subject to this part.</SUBJECT> <SECTNO>711.10</SECTNO> <SUBJECT>Activities for which reporting is not required.</SUBJECT> <SECTNO>711.15</SECTNO> <SUBJECT>Reporting information to EPA.</SUBJECT> <SECTNO>711.20</SECTNO> <SUBJECT>When to report.</SUBJECT> <SECTNO>711.22</SECTNO> <SUBJECT>Duplicative reporting.</SUBJECT> <SECTNO>711.25</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <SECTNO>711.30</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <SECTNO>711.35</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(a).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>76 FR 54933, Sept. 6, 2011, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 711.1</SECTNO> <SUBJECT>Scope, compliance, and enforcement.</SUBJECT> <P>(a) This subpart specifies reporting and recordkeeping procedures under section 8(a) of the Toxic Substances Control Act (TSCA) (15 U.S.C. 2607(a)) for certain manufacturers (including importers) of chemical substances. TSCA section 8(a) authorizes the EPA Administrator to require reporting of information necessary for the administration of TSCA.</P> <P>(b) This part applies to the activities associated with the periodic update of information on a subset of the chemical substances included on the TSCA Inventory.</P> <P>(c) TSCA section 15(3) makes it unlawful for any person to fail or refuse to submit information required under this part. In addition, TSCA section 15(3) makes it unlawful for any person to fail to keep, and permit access to, records required by this part. Section 16 of TSCA provides that any person who violates a provision of TSCA section 15 is liable to the United States for a civil penalty and may be criminally prosecuted. Pursuant to TSCA section 17, the Federal Government may seek judicial relief to compel submission of TSCA section 8(a) information and to otherwise restrain any violation of TSCA section 15. (EPA does not intend to concentrate its enforcement efforts on insignificant clerical errors in reporting.) TSCA section 11 allows for inspections to assure compliance, and the Administrator may by subpoena require the attendance and testimony of witnesses and the production of reports, papers, documents, answers to questions, and other information that the Administrator deems necessary.</P> <P>(d) Each person who reports under this part must maintain records that document information reported under this part and, in accordance with TSCA, permit access to, and the copying of, such records by EPA officials.</P> <CITA>[76 FR 54933, Sept. 6, 2011, as amended at 85 FR 20138, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P> The definitions in this section and the definitions in TSCA section 3 apply to this part. In addition, the definitions in 40 CFR 704.3 also apply to this part, except the definitions <E T="03">manufacture</E> and <E T="03">manufacturer</E> in 40 CFR 704.3. </P> <P> <E T="03">CDX</E> or <E T="03">Central Data Exchange</E> means EPA's centralized electronic document receiving system, or its successors. </P> <P> <E T="03">Commercial use</E> means the use of a chemical substance or a mixture containing a chemical substance (including as part of an article) in a commercial enterprise providing saleable goods or services. </P> <P> <E T="03">Consumer use</E> means the use of a chemical substance or a mixture containing a chemical substance (including as part of an article) when sold to or made available to consumers for their use. </P> <P> <E T="03">e-CDRweb</E> means the electronic, web-based tool provided by EPA for the completion of Form U and submission of the CDR data. </P> <P> <E T="03">Highest-level parent company</E> means the highest-level company of the site's ownership hierarchy as of the start of the submission period during which data are being reported according to the following instructions. The highest-level U.S. parent company is located within the United States while the highest-level foreign parent company is located outside the United States. The following rules govern how to identify the highest-level U.S. parent company and highest-level foreign parent company (if applicable): </P> <P>(1) If the site is entirely owned by a single U.S. company that is not owned by another company, that single company is the U.S. parent company.</P> <P> (2) If the site is entirely owned by a single U.S. company that is, itself, owned by another U.S.-based company ( <E T="03">e.g.,</E> it is a division or subsidiary of a higher-level company), the highest- <PRTPAGE P="121"/> level domestic company in the ownership hierarchy is the United States parent company. If there is a higher-level parent company that is outside of the United States, the highest-level foreign company in the ownership hierarchy is the foreign parent company. </P> <P> (3) If the site is owned by more than one company ( <E T="03">e.g.,</E> company A owns 40 percent, company B owns 35 percent, and company C owns 25 percent), the company with the largest ownership interest in the site is the parent company. If a higher-level company in the ownership hierarchy owns more than one ownership company, then determine the entity with the largest ownership by considering the lower-level ownerships in combination ( <E T="03">e.g.,</E> corporation x owns companies B and C, for a total ownership of 60 percent for the site). </P> <P>(i) If the parent company is a U.S. company owned by another U.S. company, then the highest-level domestic company in the ownership hierarchy is the U.S. parent company. If the U.S. parent company has a higher-level foreign company in the ownership hierarchy, then the highest-level foreign company in the ownership hierarchy is the foreign parent company.</P> <P>(ii) If the parent company is a foreign company, then the site is its own U.S. parent company and the foreign parent company is the highest-level foreign company in the ownership hierarchy.</P> <P>(4) If the site is owned by a 50:50 joint venture or a cooperative, the joint venture or cooperative is its own parent company. If the site is owned by a U.S. joint venture or cooperative, the highest level of the joint venture or cooperative is the U.S. parent company. If the site is owned by a joint venture or cooperative outside the United States, the highest level of the joint venture or cooperative outside the United States is the foreign parent company.</P> <P> (5) If the site is entirely owned by a foreign company ( <E T="03">i.e.,</E> without a U.S.-based subsidiary within the site's ownership hierarchy), the highest-level foreign company in the ownership hierarchy is the site's foreign parent company. </P> <P>(6) If the site is federally owned, the highest-level federal agency or department is the U.S. parent company.</P> <P>(7) If the site is owned by a non-federal public entity, that entity (such as a municipality, State, or tribe) is the U.S. parent company.</P> <P> <E T="03">Industrial function</E> means the intended physical or chemical characteristic for which a chemical substance or mixture is consumed as a reactant; incorporated into a formulation, mixture, reaction product, or article; repackaged; or used. </P> <P> <E T="03">Industrial use</E> means use at a site at which one or more chemical substances or mixtures are manufactured (including imported) or processed. </P> <P> <E T="03">Intended for use by children</E> means the chemical substance or mixture is used in or on a product that is specifically intended for use by children age 14 or younger. A chemical substance or mixture is intended for use by children when the submitter answers “yes” to at least one of the following questions for the product into which the submitter's chemical substance or mixture is incorporated: </P> <P>(1) Is the product commonly recognized (i.e., by a reasonable person) as being intended for children age 14 or younger?</P> <P>(2) Does the manufacturer of the product state through product labeling or other written materials that the product is intended for or will be used by children age 14 or younger?</P> <P>(3) Is the advertising, promotion, or marketing of the product aimed at children age 14 or younger?</P> <P> <E T="03">Manufacture</E> means to manufacture, produce, or import, for commercial purposes. Manufacture includes the extraction, for commercial purposes, of a component chemical substance from a previously existing chemical substance or complex combination of chemical substances. A chemical substance is co-manufactured by the person who physically performs the manufacturing and the person contracting for such production when that chemical substance, manufactured other than by import, is: </P> <P>(1) Produced exclusively for another person who contracts for such production, and</P> <P> (2) That other person dictates the specific chemical identity of the chemical substance and controls the total amount produced and the basic technology for the manufacturing process. <PRTPAGE P="122"/> </P> <P> <E T="03">Manufacturer</E> means a person who manufactures a chemical substance. </P> <P> <E T="03">Master Inventory File</E> means EPA's comprehensive list of chemical substances which constitutes the TSCA Inventory compiled under TSCA section 8(b). It includes chemical substances reported under 40 CFR part 710 and substances reported under 40 CFR part 720 for which a Notice of Commencement of Manufacture or Import has been received under 40 CFR 720.120. </P> <P> <E T="03">Principal reporting year</E> means the latest complete calendar year preceding the submission period. </P> <P> <E T="03">Reasonably likely to be exposed</E> means an exposure to a chemical substance which, under foreseeable conditions of manufacture (including import), processing, distribution in commerce, or use of the chemical substance, is more likely to occur than not to occur. Such exposures would normally include, but would not be limited to, activities such as charging reactor vessels, drumming, bulk loading, cleaning equipment, maintenance operations, materials handling and transfers, and analytical operations. Covered exposures include exposures through any route of entry (inhalation, ingestion, skin contact, absorption, etc.), but excludes accidental or theoretical exposures. </P> <P> <E T="03">Repackaging</E> means the physical transfer of a chemical substance or mixture, as is, from one container to another container or containers in preparation for distribution of the chemical substance or mixture in commerce. </P> <P> <E T="03">Reportable chemical substance</E> means a chemical substance described in § 711.5. </P> <P> <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way shall be considered one site. More than one manufacturing plant may be located on a single site. </P> <P> (1) For chemical substances manufactured under contract, <E T="03">i.e.,</E> by a co-manufacturer, the site is the location where the chemical substance is physically manufactured. </P> <P>(2) The site for an importer who imports a chemical substance described in § 711.5 is the U.S. site of the operating unit within the person's organization that is directly responsible for importing the chemical substance. The import site, in some cases, may be the organization's headquarters in the United States. If there is no such operating unit or headquarters in the United States, the site address for the importer is the U.S. address of an agent acting on behalf of the importer who is authorized to accept service of process for the importer.</P> <P>(3) For portable manufacturing units sent to different locations from a single distribution center, the distribution center shall be considered the site.</P> <P> <E T="03">Site-limited</E> means a chemical substance is manufactured and processed only within a site and is not distributed for commercial purposes as a chemical substance or as part of a mixture or article outside the site. Imported chemical substances are never site-limited. Although a site-limited chemical substance is not distributed for commercial purposes outside the site at which it is manufactured and processed, the chemical substance is considered to have been manufactured and processed for commercial purposes. </P> <P> <E T="03">Submission period</E> means the period in which the manufacturing, processing, and use data are submitted to EPA. </P> <P> <E T="03">Use</E> means any utilization of a chemical substance or mixture that is not otherwise covered by the terms manufacture or process. Relabeling or redistributing a container holding a chemical substance or mixture where no repackaging of the chemical substance or mixture occurs does not constitute use or processing of the chemical substance or mixture. </P> <CITA>[76 FR 54933, Sept. 6, 2011, as amended at 85 FR 20138, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.5</SECTNO> <SUBJECT>Chemical substances for which information must be reported.</SUBJECT> <P>Any chemical substance that is in the Master Inventory File at the beginning of a submission period described in § 711.20, unless the chemical substance is specifically excluded by § 711.6.</P> </SECTION> <SECTION> <SECTNO>§ 711.6</SECTNO> <SUBJECT>Chemical substances for which information is not required.</SUBJECT> <P> The following groups or categories of chemical substances are exempted from some or all of the reporting requirements of this part, with the following exception: A chemical substance described in paragraph (a)(1), <PRTPAGE P="123"/> (2), or (4), or (b) of this section is not exempted from any of the reporting requirements of this part if that chemical substance is the subject of a rule proposed or promulgated under TSCA sections 4, 5(a)(2), 5(b)(4), or 6, or is the subject of an enforceable consent agreement (ECA) developed under the procedures of 40 CFR part 790, or is the subject of an order issued under TSCA sections 4, 5(e), or 5(f), or is the subject of relief that has been granted under a civil action under TSCA sections 5 or 7. </P> <P> (a) <E T="03">Full exemptions.</E> The following categories of chemical substances are exempted from the reporting requirements of this part. </P> <P> (1) <E T="03">Polymers.</E> (i) Any chemical substance described with the word fragments “*polym,” “*alkyd,” or “*oxylated” in the Chemical Abstracts (CA) Index Name in the Master Inventory File, where the asterisk (*) in the listed word fragments indicates that any sets of characters may precede, or follow, the character string defined. </P> <P>(ii) Any chemical substance that is identified in the Master Inventory File as an enzyme, lignin, a polysaccharide (cellulose, gum, starch), a protein (albumin, casein, gelatin, gluten, hemoglobin), rubber, siloxane and silicone, or silsesquioxane.</P> <P>(iii) This exclusion does not apply to a polymeric substance that has been depolymerized, hydrolyzed, or otherwise chemically modified, except in cases where the intended product of this reaction is totally polymeric in structure.</P> <P> (2) <E T="03">Microorganisms.</E> Any combination of chemical substances that is a living organism, and that meets the definition of <E T="03">microorganism</E> at 40 CFR 725.3. Any chemical substance produced from a living microorganism is reportable under this part unless otherwise excluded. </P> <P> (3) <E T="03">Naturally occurring chemical substances.</E> Any naturally occurring chemical substance, as described in 40 CFR 710.4(b). The applicability of this exclusion is determined in each case by the specific activities of the person who manufactures the chemical substance in question. Some chemical substances can be manufactured both as described in 40 CFR 710.4(b) and by means other than those described in 40 CFR 710.4(b). If a person described in § 711.8 manufactures a chemical substance by means other than those described in 40 CFR 710.4(b), the person must report regardless of whether the chemical substance also could have been produced as described in 40 CFR 710.4(b). Any chemical substance that is produced from such a naturally occurring chemical substance described in 40 CFR 710.4(b) is reportable unless otherwise excluded. </P> <P> (4) <E T="03">Water and certain forms of natural gas.</E> Chemical substances with the following Chemical Abstracts Service Registry Number (CASRN): CASRN 7732-18-5, water; CASRN 8006-14-2, natural gas; CASRN 8006-61-9, gasoline, natural; CASRN 64741-48-6, natural gas (petroleum), raw liq. mix; CASRN 68410-63-9, natural gas, dried; CASRN 68425-31-0, gasoline (natural gas), natural; and CASRN 68919-39-1, natural gas condensates. </P> <P> (b) <E T="03">Partial exemptions.</E> The following groups of chemical substances are partially exempted from the reporting requirements of this part ( <E T="03">i.e.,</E> the information described in § 711.15(b)(4) need not be reported for these chemical substances). Such chemical substances are not excluded from the other reporting requirements under this part. </P> <P> (1) <E T="03">Petroleum process streams.</E> EPA has designated the chemical substances listed in Table 1 of this paragraph by CASRN, as partially exempt from reporting under the CDR. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,r150"> <TTITLE>Table 1—CASRNs of Partially Exempt Chemical Substances Termed “Petroleum Process Streams” for Purposes of TSCA Chemical Data Reporting</TTITLE> <BOXHD> <CHED H="1">CASRN</CHED> <CHED H="1">Product</CHED> </BOXHD> <ROW> <ENT I="01">8002-05-9</ENT> <ENT>Petroleum.</ENT> </ROW> <ROW> <ENT I="01">8002-74-2</ENT> <ENT>Paraffin waxes and hydrocarbon waxes.</ENT> </ROW> <ROW> <ENT I="01">8006-20-0</ENT> <ENT>Fuel gases, low and medium B.T.U.</ENT> </ROW> <ROW> <ENT I="01">8008-20-6</ENT> <ENT>Kerosine (petroleum).</ENT> </ROW> <ROW> <ENT I="01">8009-03-8</ENT> <ENT>Petrolatum.</ENT> </ROW> <ROW> <ENT I="01">8012-95-1</ENT> <ENT>Paraffin oils.</ENT> </ROW> <ROW> <PRTPAGE P="124"/> <ENT I="01">8030-30-6</ENT> <ENT>Naphtha.</ENT> </ROW> <ROW> <ENT I="01">8032-32-4</ENT> <ENT>Ligroine.</ENT> </ROW> <ROW> <ENT I="01">8042-47-5</ENT> <ENT>White mineral oil (petroleum).</ENT> </ROW> <ROW> <ENT I="01">8052-41-3</ENT> <ENT>Stoddard solvent.</ENT> </ROW> <ROW> <ENT I="01">8052-42-4</ENT> <ENT>Asphalt.</ENT> </ROW> <ROW> <ENT I="01">61789-60-4</ENT> <ENT>Pitch.</ENT> </ROW> <ROW> <ENT I="01">63231-60-7</ENT> <ENT>Paraffin waxes and hydrocarbon waxes, microcryst.</ENT> </ROW> <ROW> <ENT I="01">64741-41-9</ENT> <ENT>Naphtha (petroleum), heavy straight-run.</ENT> </ROW> <ROW> <ENT I="01">64741-42-0</ENT> <ENT>Naphtha (petroleum), full-range straight-run.</ENT> </ROW> <ROW> <ENT I="01">64741-43-1</ENT> <ENT>Gas oils (petroleum), straight-run.</ENT> </ROW> <ROW> <ENT I="01">64741-44-2</ENT> <ENT>Distillates (petroleum), straight-run middle.</ENT> </ROW> <ROW> <ENT I="01">64741-45-3</ENT> <ENT>Residues (petroleum), atm. tower.</ENT> </ROW> <ROW> <ENT I="01">64741-46-4</ENT> <ENT>Naphtha (petroleum), light straight-run.</ENT> </ROW> <ROW> <ENT I="01">64741-47-5</ENT> <ENT>Natural gas condensates (petroleum).</ENT> </ROW> <ROW> <ENT I="01">64741-49-7</ENT> <ENT>Condensates (petroleum), vacuum tower.</ENT> </ROW> <ROW> <ENT I="01">64741-50-0</ENT> <ENT>Distillates (petroleum), light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64741-51-1</ENT> <ENT>Distillates (petroleum), heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64741-52-2</ENT> <ENT>Distillates (petroleum), light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64741-53-3</ENT> <ENT>Distillates (petroleum), heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64741-54-4</ENT> <ENT>Naphtha (petroleum), heavy catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-55-5</ENT> <ENT>Naphtha (petroleum), light catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-56-6</ENT> <ENT>Residues (petroleum), vacuum.</ENT> </ROW> <ROW> <ENT I="01">64741-57-7</ENT> <ENT>Gas oils (petroleum), heavy vacuum.</ENT> </ROW> <ROW> <ENT I="01">64741-58-8</ENT> <ENT>Gas oils (petroleum), light vacuum.</ENT> </ROW> <ROW> <ENT I="01">64741-59-9</ENT> <ENT>Distillates (petroleum), light catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-60-2</ENT> <ENT>Distillates (petroleum), intermediate catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-61-3</ENT> <ENT>Distillates (petroleum), heavy catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-62-4</ENT> <ENT>Clarified oils (petroleum), catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-63-5</ENT> <ENT>Naphtha (petroleum), light catalytic reformed.</ENT> </ROW> <ROW> <ENT I="01">64741-64-6</ENT> <ENT>Naphtha (petroleum), full-range alkylate.</ENT> </ROW> <ROW> <ENT I="01">64741-65-7</ENT> <ENT>Naphtha (petroleum), heavy alkylate.</ENT> </ROW> <ROW> <ENT I="01">64741-66-8</ENT> <ENT>Naphtha (petroleum), light alkylate.</ENT> </ROW> <ROW> <ENT I="01">64741-67-9</ENT> <ENT>Residues (petroleum), catalytic reformer fractionator.</ENT> </ROW> <ROW> <ENT I="01">64741-68-0</ENT> <ENT>Naphtha (petroleum), heavy catalytic reformed.</ENT> </ROW> <ROW> <ENT I="01">64741-69-1</ENT> <ENT>Naphtha (petroleum), light hydrocracked.</ENT> </ROW> <ROW> <ENT I="01">64741-70-4</ENT> <ENT>Naphtha (petroleum), isomerization.</ENT> </ROW> <ROW> <ENT I="01">64741-73-7</ENT> <ENT>Distillates (petroleum), alkylate.</ENT> </ROW> <ROW> <ENT I="01">64741-74-8</ENT> <ENT>Naphtha (petroleum), light thermal cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-75-9</ENT> <ENT>Residues (petroleum), hydrocracked.</ENT> </ROW> <ROW> <ENT I="01">64741-76-0</ENT> <ENT>Distillates (petroleum), heavy hydrocracked.</ENT> </ROW> <ROW> <ENT I="01">64741-77-1</ENT> <ENT>Distillates (petroleum), light hydrocracked.</ENT> </ROW> <ROW> <ENT I="01">64741-78-2</ENT> <ENT>Naphtha (petroleum), heavy hydrocracked.</ENT> </ROW> <ROW> <ENT I="01">64741-79-3</ENT> <ENT>Coke (petroleum).</ENT> </ROW> <ROW> <ENT I="01">64741-80-6</ENT> <ENT>Residues (petroleum), thermal cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-81-7</ENT> <ENT>Distillates (petroleum), heavy thermal cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-82-8</ENT> <ENT>Distillates (petroleum), light thermal cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-83-9</ENT> <ENT>Naphtha (petroleum), heavy thermal cracked.</ENT> </ROW> <ROW> <ENT I="01">64741-84-0</ENT> <ENT>Naphtha (petroleum), solvent-refined light.</ENT> </ROW> <ROW> <ENT I="01">64741-85-1</ENT> <ENT>Raffinates (petroleum), sorption process.</ENT> </ROW> <ROW> <ENT I="01">64741-86-2</ENT> <ENT>Distillates (petroleum), sweetened middle.</ENT> </ROW> <ROW> <ENT I="01">64741-87-3</ENT> <ENT>Naphtha (petroleum), sweetened.</ENT> </ROW> <ROW> <ENT I="01">64741-88-4</ENT> <ENT>Distillates (petroleum), solvent-refined heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64741-89-5</ENT> <ENT>Distillates (petroleum), solvent-refined light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64741-90-8</ENT> <ENT>Gas oils (petroleum), solvent-refined.</ENT> </ROW> <ROW> <ENT I="01">64741-91-9</ENT> <ENT>Distillates (petroleum), solvent-refined middle.</ENT> </ROW> <ROW> <ENT I="01">64741-92-0</ENT> <ENT>Naphtha (petroleum), solvent-refined heavy.</ENT> </ROW> <ROW> <ENT I="01">64741-95-3</ENT> <ENT>Residual oils (petroleum), solvent deasphalted.</ENT> </ROW> <ROW> <ENT I="01">64741-96-4</ENT> <ENT>Distillates (petroleum), solvent-refined heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64741-97-5</ENT> <ENT>Distillates (petroleum), solvent-refined light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64741-98-6</ENT> <ENT>Extracts (petroleum), heavy naphtha solvent.</ENT> </ROW> <ROW> <ENT I="01">64741-99-7</ENT> <ENT>Extracts (petroleum), light naphtha solvent.</ENT> </ROW> <ROW> <ENT I="01">64742-01-4</ENT> <ENT>Residual oils (petroleum), solvent-refined.</ENT> </ROW> <ROW> <ENT I="01">64742-03-6</ENT> <ENT>Extracts (petroleum), light naphthenic distillate solvent.</ENT> </ROW> <ROW> <ENT I="01">64742-04-7</ENT> <ENT>Extracts (petroleum), heavy paraffinic distillate solvent.</ENT> </ROW> <ROW> <ENT I="01">64742-05-8</ENT> <ENT>Extracts (petroleum), light paraffinic distillate solvent.</ENT> </ROW> <ROW> <ENT I="01">64742-06-9</ENT> <ENT>Extracts (petroleum), middle distillate solvent.</ENT> </ROW> <ROW> <ENT I="01">64742-07-0</ENT> <ENT>Raffinates (petroleum), residual oil decarbonization.</ENT> </ROW> <ROW> <ENT I="01">64742-08-1</ENT> <ENT>Raffinates (petroleum), heavy naphthenic distillate decarbonization.</ENT> </ROW> <ROW> <ENT I="01">64742-09-2</ENT> <ENT>Raffinates (petroleum), heavy paraffinic distillate decarbonization.</ENT> </ROW> <ROW> <ENT I="01">64742-10-5</ENT> <ENT>Extracts (petroleum), residual oil solvent.</ENT> </ROW> <ROW> <ENT I="01">64742-11-6</ENT> <ENT>Extracts (petroleum), heavy naphthenic distillate solvent.</ENT> </ROW> <ROW> <PRTPAGE P="125"/> <ENT I="01">64742-12-7</ENT> <ENT>Gas oils (petroleum), acid-treated.</ENT> </ROW> <ROW> <ENT I="01">64742-13-8</ENT> <ENT>Distillates (petroleum), acid-treated middle.</ENT> </ROW> <ROW> <ENT I="01">64742-14-9</ENT> <ENT>Distillates (petroleum), acid-treated light.</ENT> </ROW> <ROW> <ENT I="01">64742-15-0</ENT> <ENT>Naphtha (petroleum), acid-treated.</ENT> </ROW> <ROW> <ENT I="01">64742-16-1</ENT> <ENT>Petroleum resins.</ENT> </ROW> <ROW> <ENT I="01">64742-18-3</ENT> <ENT>Distillates (petroleum), acid-treated heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-19-4</ENT> <ENT>Distillates (petroleum), acid-treated light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-20-7</ENT> <ENT>Distillates (petroleum), acid-treated heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-21-8</ENT> <ENT>Distillates (petroleum), acid-treated light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-22-9</ENT> <ENT>Naphtha (petroleum), chemically neutralized heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-23-0</ENT> <ENT>Naphtha (petroleum), chemically neutralized light.</ENT> </ROW> <ROW> <ENT I="01">64742-24-1</ENT> <ENT>Sludges (petroleum), acid.</ENT> </ROW> <ROW> <ENT I="01">64742-25-2</ENT> <ENT>Lubricating oils (petroleum), acid-treated spent.</ENT> </ROW> <ROW> <ENT I="01">64742-26-3</ENT> <ENT>Hydrocarbon waxes (petroleum), acid-treated.</ENT> </ROW> <ROW> <ENT I="01">64742-27-4</ENT> <ENT>Distillates (petroleum), chemically neutralized heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-28-5</ENT> <ENT>Distillates (petroleum), chemically neutralized light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-29-6</ENT> <ENT>Gas oils (petroleum), chemically neutralized.</ENT> </ROW> <ROW> <ENT I="01">64742-30-9</ENT> <ENT>Distillates (petroleum), chemically neutralized middle.</ENT> </ROW> <ROW> <ENT I="01">64742-31-0</ENT> <ENT>Distillates (petroleum), chemically neutralized light.</ENT> </ROW> <ROW> <ENT I="01">64742-32-1</ENT> <ENT>Lubricating oils (petroleum), chemically neutralized spent.</ENT> </ROW> <ROW> <ENT I="01">64742-33-2</ENT> <ENT>Hydrocarbon waxes (petroleum), chemically neutralized.</ENT> </ROW> <ROW> <ENT I="01">64742-34-3</ENT> <ENT>Distillates (petroleum), chemically neutralized heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-35-4</ENT> <ENT>Distillates (petroleum), chemically neutralized light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-36-5</ENT> <ENT>Distillates (petroleum), clay-treated heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-37-6</ENT> <ENT>Distillates (petroleum), clay-treated light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-38-7</ENT> <ENT>Distillates (petroleum), clay-treated middle.</ENT> </ROW> <ROW> <ENT I="01">64742-39-8</ENT> <ENT>Neutralizing agents (petroleum), spent sodium carbonate.</ENT> </ROW> <ROW> <ENT I="01">64742-40-1</ENT> <ENT>Neutralizing agents (petroleum), spent sodium hydroxide.</ENT> </ROW> <ROW> <ENT I="01">64742-41-2</ENT> <ENT>Residual oils (petroleum), clay-treated.</ENT> </ROW> <ROW> <ENT I="01">64742-42-3</ENT> <ENT>Hydrocarbon waxes (petroleum), clay-treated microcryst.</ENT> </ROW> <ROW> <ENT I="01">64742-43-4</ENT> <ENT>Paraffin waxes (petroleum), clay-treated.</ENT> </ROW> <ROW> <ENT I="01">64742-44-5</ENT> <ENT>Distillates (petroleum), clay-treated heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-45-6</ENT> <ENT>Distillates (petroleum), clay-treated light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-46-7</ENT> <ENT>Distillates (petroleum), hydrotreated middle.</ENT> </ROW> <ROW> <ENT I="01">64742-47-8</ENT> <ENT>Distillates (petroleum), hydrotreated light.</ENT> </ROW> <ROW> <ENT I="01">64742-48-9</ENT> <ENT>Naphtha (petroleum), hydrotreated heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-49-0</ENT> <ENT>Naphtha (petroleum), hydrotreated light.</ENT> </ROW> <ROW> <ENT I="01">64742-50-3</ENT> <ENT>Lubricating oils (petroleum), clay-treated spent.</ENT> </ROW> <ROW> <ENT I="01">64742-51-4</ENT> <ENT>Paraffin waxes (petroleum), hydrotreated.</ENT> </ROW> <ROW> <ENT I="01">64742-52-5</ENT> <ENT>Distillates (petroleum), hydrotreated heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-53-6</ENT> <ENT>Distillates (petroleum), hydrotreated light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-54-7</ENT> <ENT>Distillates (petroleum), hydrotreated heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-55-8</ENT> <ENT>Distillates (petroleum), hydrotreated light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-56-9</ENT> <ENT>Distillates (petroleum), solvent-dewaxed light paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-57-0</ENT> <ENT>Residual oils (petroleum), hydrotreated.</ENT> </ROW> <ROW> <ENT I="01">64742-58-1</ENT> <ENT>Lubricating oils (petroleum), hydrotreated spent.</ENT> </ROW> <ROW> <ENT I="01">64742-59-2</ENT> <ENT>Gas oils (petroleum), hydrotreated vacuum.</ENT> </ROW> <ROW> <ENT I="01">64742-60-5</ENT> <ENT>Hydrocarbon waxes (petroleum), hydrotreated microcryst.</ENT> </ROW> <ROW> <ENT I="01">64742-61-6</ENT> <ENT>Slack wax (petroleum).</ENT> </ROW> <ROW> <ENT I="01">64742-62-7</ENT> <ENT>Residual oils (petroleum), solvent-dewaxed.</ENT> </ROW> <ROW> <ENT I="01">64742-63-8</ENT> <ENT>Distillates (petroleum), solvent-dewaxed heavy naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-64-9</ENT> <ENT>Distillates (petroleum), solvent-dewaxed light naphthenic.</ENT> </ROW> <ROW> <ENT I="01">64742-65-0</ENT> <ENT>Distillates (petroleum), solvent-dewaxed heavy paraffinic.</ENT> </ROW> <ROW> <ENT I="01">64742-67-2</ENT> <ENT>Foots oil (petroleum).</ENT> </ROW> <ROW> <ENT I="01">64742-68-3</ENT> <ENT>Naphthenic oils (petroleum), catalytic dewaxed heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-69-4</ENT> <ENT>Naphthenic oils (petroleum), catalytic dewaxed light.</ENT> </ROW> <ROW> <ENT I="01">64742-70-7</ENT> <ENT>Paraffin oils (petroleum), catalytic dewaxed heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-71-8</ENT> <ENT>Paraffin oils (petroleum), catalytic dewaxed light.</ENT> </ROW> <ROW> <ENT I="01">64742-72-9</ENT> <ENT>Distillates (petroleum), catalytic dewaxed middle.</ENT> </ROW> <ROW> <ENT I="01">64742-73-0</ENT> <ENT>Naphtha (petroleum), hydrodesulfurized light.</ENT> </ROW> <ROW> <ENT I="01">64742-75-2</ENT> <ENT>Naphthenic oils (petroleum), complex dewaxed heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-76-3</ENT> <ENT>Naphthenic oils (petroleum), complex dewaxed light.</ENT> </ROW> <ROW> <ENT I="01">64742-78-5</ENT> <ENT>Residues (petroleum), hydrodesulfurized atmospheric tower.</ENT> </ROW> <ROW> <ENT I="01">64742-79-6</ENT> <ENT>Gas oils (petroleum), hydrodesulfurized.</ENT> </ROW> <ROW> <ENT I="01">64742-80-9</ENT> <ENT>Distillates (petroleum), hydrodesulfurized middle.</ENT> </ROW> <ROW> <ENT I="01">64742-81-0</ENT> <ENT>Kerosine (petroleum), hydrodesulfurized.</ENT> </ROW> <ROW> <ENT I="01">64742-82-1</ENT> <ENT>Naphtha (petroleum), hydrodesulfurized heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-83-2</ENT> <ENT>Naphtha (petroleum), light steam-cracked.</ENT> </ROW> <ROW> <ENT I="01">64742-85-4</ENT> <ENT>Residues (petroleum), hydrodesulfurized vacuum.</ENT> </ROW> <ROW> <ENT I="01">64742-86-5</ENT> <ENT>Gas oils (petroleum), hydrodesulfurized heavy vacuum.</ENT> </ROW> <ROW> <ENT I="01">64742-87-6</ENT> <ENT>Gas oils (petroleum), hydrodesulfurized light vacuum.</ENT> </ROW> <ROW> <PRTPAGE P="126"/> <ENT I="01">64742-88-7</ENT> <ENT>Solvent naphtha (petroleum), medium aliph.</ENT> </ROW> <ROW> <ENT I="01">64742-89-8</ENT> <ENT>Solvent naphtha (petroleum), light aliph.</ENT> </ROW> <ROW> <ENT I="01">64742-90-1</ENT> <ENT>Residues (petroleum), steam-cracked.</ENT> </ROW> <ROW> <ENT I="01">64742-91-2</ENT> <ENT>Distillates (petroleum), steam-cracked.</ENT> </ROW> <ROW> <ENT I="01">64742-92-3</ENT> <ENT>Petroleum resins, oxidized.</ENT> </ROW> <ROW> <ENT I="01">64742-93-4</ENT> <ENT>Asphalt, oxidized.</ENT> </ROW> <ROW> <ENT I="01">64742-94-5</ENT> <ENT>Solvent naphtha (petroleum), heavy arom.</ENT> </ROW> <ROW> <ENT I="01">64742-95-6</ENT> <ENT>Solvent naphtha (petroleum), light arom.</ENT> </ROW> <ROW> <ENT I="01">64742-96-7</ENT> <ENT>Solvent naphtha (petroleum), heavy aliph.</ENT> </ROW> <ROW> <ENT I="01">64742-97-8</ENT> <ENT>Distillates (petroleum), oxidized heavy.</ENT> </ROW> <ROW> <ENT I="01">64742-98-9</ENT> <ENT>Distillates (petroleum), oxidized light.</ENT> </ROW> <ROW> <ENT I="01">64742-99-0</ENT> <ENT>Residual oils (petroleum), oxidized.</ENT> </ROW> <ROW> <ENT I="01">64743-00-6</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized.</ENT> </ROW> <ROW> <ENT I="01">64743-01-7</ENT> <ENT>Petrolatum (petroleum), oxidized.</ENT> </ROW> <ROW> <ENT I="01">64743-02-8</ENT> <ENT>Alkenes, C>10 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">64743-03-9</ENT> <ENT>Phenols (petroleum).</ENT> </ROW> <ROW> <ENT I="01">64743-04-0</ENT> <ENT>Coke (petroleum), recovery.</ENT> </ROW> <ROW> <ENT I="01">64743-05-1</ENT> <ENT>Coke (petroleum), calcined.</ENT> </ROW> <ROW> <ENT I="01">64743-06-2</ENT> <ENT>Extracts (petroleum), gas oil solvent.</ENT> </ROW> <ROW> <ENT I="01">64743-07-3</ENT> <ENT>Sludges (petroleum), chemically neutralized.</ENT> </ROW> <ROW> <ENT I="01">64754-89-8</ENT> <ENT>Naphthenic acids (petroleum), crude.</ENT> </ROW> <ROW> <ENT I="01">64771-71-7</ENT> <ENT>Paraffins (petroleum), normal C>10.</ENT> </ROW> <ROW> <ENT I="01">64771-72-8</ENT> <ENT>Paraffins (petroleum), normal C5-20.</ENT> </ROW> <ROW> <ENT I="01">67254-74-4</ENT> <ENT>Naphthenic oils.</ENT> </ROW> <ROW> <ENT I="01">67674-12-8</ENT> <ENT>Residual oils (petroleum), oxidized, compounds with triethanolamine.</ENT> </ROW> <ROW> <ENT I="01">67674-13-9</ENT> <ENT>Petrolatum (petroleum), oxidized, partially deacidified.</ENT> </ROW> <ROW> <ENT I="01">67674-15-1</ENT> <ENT>Petrolatum (petroleum), oxidized, Me ester.</ENT> </ROW> <ROW> <ENT I="01">67674-16-2</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, partially deacidified.</ENT> </ROW> <ROW> <ENT I="01">67674-17-3</ENT> <ENT>Distillates (petroleum), oxidized light, compounds with triethanolamine.</ENT> </ROW> <ROW> <ENT I="01">67674-18-4</ENT> <ENT>Distillates (petroleum), oxidized light, Bu esters.</ENT> </ROW> <ROW> <ENT I="01">67891-79-6</ENT> <ENT>Distillates (petroleum), heavy arom.</ENT> </ROW> <ROW> <ENT I="01">67891-80-9</ENT> <ENT>Distillates (petroleum), light arom.</ENT> </ROW> <ROW> <ENT I="01">67891-81-0</ENT> <ENT>Distillates (petroleum), oxidized light, potassium salts.</ENT> </ROW> <ROW> <ENT I="01">67891-82-1</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, compounds with ethanolamine.</ENT> </ROW> <ROW> <ENT I="01">67891-83-2</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, compounds with isopropanolamine.</ENT> </ROW> <ROW> <ENT I="01">67891-85-4</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, compounds with triisopropanolamine.</ENT> </ROW> <ROW> <ENT I="01">67891-86-5</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, compds. with diisopropanolamine.</ENT> </ROW> <ROW> <ENT I="01">68131-05-5</ENT> <ENT>Hydrocarbon oils, process blends.</ENT> </ROW> <ROW> <ENT I="01">68131-49-7</ENT> <ENT>Aromatic hydrocarbons, C6-10, acid-treated, neutralized.</ENT> </ROW> <ROW> <ENT I="01">68131-75-9</ENT> <ENT>Gases (petroleum), C3-4.</ENT> </ROW> <ROW> <ENT I="01">68153-22-0</ENT> <ENT>Paraffin waxes and Hydrocarbon waxes, oxidized.</ENT> </ROW> <ROW> <ENT I="01">68187-57-5</ENT> <ENT>Pitch, coal tar-petroleum.</ENT> </ROW> <ROW> <ENT I="01">68187-58-6</ENT> <ENT>Pitch, petroleum, arom.</ENT> </ROW> <ROW> <ENT I="01">68187-60-0</ENT> <ENT>Hydrocarbons, C4, ethane-propane-cracked.</ENT> </ROW> <ROW> <ENT I="01">68307-98-2</ENT> <ENT>Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber.</ENT> </ROW> <ROW> <ENT I="01">68307-99-3</ENT> <ENT>Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer.</ENT> </ROW> <ROW> <ENT I="01">68308-00-9</ENT> <ENT>Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68308-01-0</ENT> <ENT>Tail gas (petroleum), cracked distillate hydrotreater stripper.</ENT> </ROW> <ROW> <ENT I="01">68308-02-1</ENT> <ENT>Tail gas (petroleum), distn., hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68308-03-2</ENT> <ENT>Tail gas (petroleum), gas oil catalytic cracking absorber.</ENT> </ROW> <ROW> <ENT I="01">68308-04-3</ENT> <ENT>Tail gas (petroleum), gas recovery plant.</ENT> </ROW> <ROW> <ENT I="01">68308-05-4</ENT> <ENT>Tail gas (petroleum), gas recovery plant deethanizer.</ENT> </ROW> <ROW> <ENT I="01">68308-06-5</ENT> <ENT>Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free.</ENT> </ROW> <ROW> <ENT I="01">68308-07-6</ENT> <ENT>Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68308-08-7</ENT> <ENT>Tail gas (petroleum), isomerized naphtha fractionation stabilizer.</ENT> </ROW> <ROW> <ENT I="01">68308-09-8</ENT> <ENT>Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68308-10-1</ENT> <ENT>Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68308-11-2</ENT> <ENT>Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer.</ENT> </ROW> <ROW> <ENT I="01">68308-12-3</ENT> <ENT>Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68308-27-0</ENT> <ENT>Fuel gases, refinery.</ENT> </ROW> <ROW> <ENT I="01">68333-22-2</ENT> <ENT>Residues (petroleum), atmospheric.</ENT> </ROW> <ROW> <ENT I="01">68333-23-3</ENT> <ENT>Naphtha (petroleum), heavy coker.</ENT> </ROW> <ROW> <ENT I="01">68333-24-4</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, compds. with triethanolamine.</ENT> </ROW> <ROW> <ENT I="01">68333-25-5</ENT> <ENT>Distillates (petroleum), hydrodesulfurized light catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">68333-26-6</ENT> <ENT>Clarified oils (petroleum), hydrodesulfurized catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">68333-27-7</ENT> <ENT>Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">68333-28-8</ENT> <ENT>Distillates (petroleum), hydrodesulfurized heavy catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">68333-29-9</ENT> <ENT>Residues (petroleum), light naphtha solvent extracts.</ENT> </ROW> <ROW> <ENT I="01">68333-30-2</ENT> <ENT>Distillates (petroleum), oxidized heavy thermal cracked.</ENT> </ROW> <ROW> <PRTPAGE P="127"/> <ENT I="01">68333-81-3</ENT> <ENT>Alkanes, C4-12.</ENT> </ROW> <ROW> <ENT I="01">68333-88-0</ENT> <ENT>Aromatic hydrocarbons, C9-17.</ENT> </ROW> <ROW> <ENT I="01">68334-30-5</ENT> <ENT>Fuels, diesel.</ENT> </ROW> <ROW> <ENT I="01">68409-99-4</ENT> <ENT>Gases (petroleum), catalytic cracked overheads.</ENT> </ROW> <ROW> <ENT I="01">68410-00-4</ENT> <ENT>Distillates (petroleum), crude oil.</ENT> </ROW> <ROW> <ENT I="01">68410-05-9</ENT> <ENT>Distillates (petroleum), straight-run light.</ENT> </ROW> <ROW> <ENT I="01">68410-12-8</ENT> <ENT>Distillates (petroleum), steam-cracked, C5-10 fraction, high-temperature stripping products with light steam-cracked petroleum naphtha C5 fraction polymers.</ENT> </ROW> <ROW> <ENT I="01">68410-71-9</ENT> <ENT>Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.</ENT> </ROW> <ROW> <ENT I="01">68410-96-8</ENT> <ENT>Distillates (petroleum), hydrotreated middle, intermediate boiling.</ENT> </ROW> <ROW> <ENT I="01">68410-97-9</ENT> <ENT>Distillates (petroleum), light distillate hydrotreating process, low-boiling.</ENT> </ROW> <ROW> <ENT I="01">68410-98-0</ENT> <ENT>Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68411-00-7</ENT> <ENT>Alkenes, C>8.</ENT> </ROW> <ROW> <ENT I="01">68425-29-6</ENT> <ENT>Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending.</ENT> </ROW> <ROW> <ENT I="01">68425-33-2</ENT> <ENT>Petrolatum (petroleum), oxidized, barium salt.</ENT> </ROW> <ROW> <ENT I="01">68425-34-3</ENT> <ENT>Petrolatum (petroleum), oxidized, calcium salt.</ENT> </ROW> <ROW> <ENT I="01">68425-35-4</ENT> <ENT>Raffinates (petroleum), reformer, Lurgi unit-sepd.</ENT> </ROW> <ROW> <ENT I="01">68425-39-8</ENT> <ENT>Alkenes, C>10 .alpha.-, oxidized.</ENT> </ROW> <ROW> <ENT I="01">68441-09-8</ENT> <ENT>Hydrocarbon waxes (petroleum), clay-treated microcryst., contg. polyethylene, oxidized.</ENT> </ROW> <ROW> <ENT I="01">68459-78-9</ENT> <ENT>Alkenes, C18-24 .alpha.-, dimers.</ENT> </ROW> <ROW> <ENT I="01">68475-57-0</ENT> <ENT>Alkanes, C1-2.</ENT> </ROW> <ROW> <ENT I="01">68475-58-1</ENT> <ENT>Alkanes, C2-3.</ENT> </ROW> <ROW> <ENT I="01">68475-59-2</ENT> <ENT>Alkanes, C3-4.</ENT> </ROW> <ROW> <ENT I="01">68475-60-5</ENT> <ENT>Alkanes, C4-5.</ENT> </ROW> <ROW> <ENT I="01">68475-61-6</ENT> <ENT>Alkenes, C5, naphtha-raffinate pyrolyzate-derived.</ENT> </ROW> <ROW> <ENT I="01">68475-70-7</ENT> <ENT>Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived.</ENT> </ROW> <ROW> <ENT I="01">68475-79-6</ENT> <ENT>Distillates (petroleum), catalytic reformed depentanizer.</ENT> </ROW> <ROW> <ENT I="01">68475-80-9</ENT> <ENT>Distillates (petroleum), light steam-cracked naphtha.</ENT> </ROW> <ROW> <ENT I="01">68476-26-6</ENT> <ENT>Fuel gases.</ENT> </ROW> <ROW> <ENT I="01">68476-27-7</ENT> <ENT>Fuel gases, amine system residues.</ENT> </ROW> <ROW> <ENT I="01">68476-28-8</ENT> <ENT>Fuel gases, C6-8 catalytic reformer.</ENT> </ROW> <ROW> <ENT I="01">68476-29-9</ENT> <ENT>Fuel gases, crude oil distillates.</ENT> </ROW> <ROW> <ENT I="01">68476-30-2</ENT> <ENT>Fuel oil, no. 2.</ENT> </ROW> <ROW> <ENT I="01">68476-31-3</ENT> <ENT>Fuel oil, no. 4.</ENT> </ROW> <ROW> <ENT I="01">68476-32-4</ENT> <ENT>Fuel oil, residues-straight-run gas oils, high-sulfur.</ENT> </ROW> <ROW> <ENT I="01">68476-33-5</ENT> <ENT>Fuel oil, residual.</ENT> </ROW> <ROW> <ENT I="01">68476-34-6</ENT> <ENT>Fuels, diesel, no. 2.</ENT> </ROW> <ROW> <ENT I="01">68476-39-1</ENT> <ENT>Hydrocarbons, aliph.-arom.-C4-5-olefinic.</ENT> </ROW> <ROW> <ENT I="01">68476-40-4</ENT> <ENT>Hydrocarbons, C3-4.</ENT> </ROW> <ROW> <ENT I="01">68476-42-6</ENT> <ENT>Hydrocarbons, C4-5.</ENT> </ROW> <ROW> <ENT I="01">68476-43-7</ENT> <ENT>Hydrocarbons, C4-6, C5-rich.</ENT> </ROW> <ROW> <ENT I="01">68476-44-8</ENT> <ENT>Hydrocarbons, C>3.</ENT> </ROW> <ROW> <ENT I="01">68476-45-9</ENT> <ENT>Hydrocarbons, C5-10 arom. conc., ethylene-manuf.-by-product.</ENT> </ROW> <ROW> <ENT I="01">68476-46-0</ENT> <ENT>Hydrocarbons, C3-11, catalytic cracker distillates.</ENT> </ROW> <ROW> <ENT I="01">68476-47-1</ENT> <ENT>Hydrocarbons, C2-6, C6-8 catalytic reformer.</ENT> </ROW> <ROW> <ENT I="01">68476-49-3</ENT> <ENT>Hydrocarbons, C2-4, C3-rich.</ENT> </ROW> <ROW> <ENT I="01">68476-50-6</ENT> <ENT>Hydrocarbons, C≥5, C5-6-rich.</ENT> </ROW> <ROW> <ENT I="01">68476-52-8</ENT> <ENT>Hydrocarbons, C4, ethylene-manuf.-by-product.</ENT> </ROW> <ROW> <ENT I="01">68476-53-9</ENT> <ENT>Hydrocarbons, C≥20, petroleum wastes.</ENT> </ROW> <ROW> <ENT I="01">68476-54-0</ENT> <ENT>Hydrocarbons, C3-5, polymn. unit feed.</ENT> </ROW> <ROW> <ENT I="01">68476-55-1</ENT> <ENT>Hydrocarbons, C5-rich.</ENT> </ROW> <ROW> <ENT I="01">68476-56-2</ENT> <ENT>Hydrocarbons, cyclic C5 and C6.</ENT> </ROW> <ROW> <ENT I="01">68476-77-7</ENT> <ENT>Lubricating oils, refined used.</ENT> </ROW> <ROW> <ENT I="01">68476-81-3</ENT> <ENT>Paraffin waxes and Hydrocarbon waxes, oxidized, calcium salts.</ENT> </ROW> <ROW> <ENT I="01">68476-84-6</ENT> <ENT>Petroleum products, gases, inorg.</ENT> </ROW> <ROW> <ENT I="01">68476-85-7</ENT> <ENT>Petroleum gases, liquefied.</ENT> </ROW> <ROW> <ENT I="01">68476-86-8</ENT> <ENT>Petroleum gases, liquefied, sweetened.</ENT> </ROW> <ROW> <ENT I="01">68477-25-8</ENT> <ENT>Waste gases, vent gas, C1-6.</ENT> </ROW> <ROW> <ENT I="01">68477-26-9</ENT> <ENT>Wastes, petroleum.</ENT> </ROW> <ROW> <ENT I="01">68477-29-2</ENT> <ENT>Distillates (petroleum), catalytic reformer fractionator residue, high-boiling.</ENT> </ROW> <ROW> <ENT I="01">68477-30-5</ENT> <ENT>Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling.</ENT> </ROW> <ROW> <ENT I="01">68477-31-6</ENT> <ENT>Distillates (petroleum), catalytic reformer fractionator residue, low-boiling.</ENT> </ROW> <ROW> <ENT I="01">68477-33-8</ENT> <ENT>Gases (petroleum), C3-4, isobutane-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-34-9</ENT> <ENT>Distillates (petroleum), C3-5, 2-methyl-2-butene-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-35-0</ENT> <ENT>Distillates (petroleum), C3-6, piperylene-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-36-1</ENT> <ENT>Distillates (petroleum), cracked steam-cracked, C5-18 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-38-3</ENT> <ENT>Distillates (petroleum), cracked steam-cracked petroleum distillates.</ENT> </ROW> <ROW> <ENT I="01">68477-39-4</ENT> <ENT>Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-40-7</ENT> <ENT>Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-41-8</ENT> <ENT>Gases (petroleum), extractive, C3-5, butadiene-butene-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-42-9</ENT> <ENT>Gases (petroleum), extractive, C3-5, butene-isobutylene-rich.</ENT> </ROW> <ROW> <PRTPAGE P="128"/> <ENT I="01">68477-44-1</ENT> <ENT>Distillates (petroleum), heavy naphthenic, mixed with steam-cracked petroleum distillates C5-12 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-47-4</ENT> <ENT>Distillates (petroleum), mixed heavy olefin vacuum, heart-cut.</ENT> </ROW> <ROW> <ENT I="01">68477-48-5</ENT> <ENT>Distillates (petroleum), mixed heavy olefin vacuum, low-boiling.</ENT> </ROW> <ROW> <ENT I="01">68477-53-2</ENT> <ENT>Distillates (petroleum), steam-cracked, C5-12 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-54-3</ENT> <ENT>Distillates (petroleum), steam-cracked, C8-12 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-55-4</ENT> <ENT>Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-58-7</ENT> <ENT>Distillates (petroleum), steam-cracked petroleum distillates, C5-18 fraction.</ENT> </ROW> <ROW> <ENT I="01">68477-59-8</ENT> <ENT>Distillates (petroleum), steam-cracked petroleum distillates cyclopentadiene conc.</ENT> </ROW> <ROW> <ENT I="01">68477-60-1</ENT> <ENT>Extracts (petroleum), cold-acid.</ENT> </ROW> <ROW> <ENT I="01">68477-61-2</ENT> <ENT>Extracts (petroleum), cold-acid, C4-6.</ENT> </ROW> <ROW> <ENT I="01">68477-62-3</ENT> <ENT>Extracts (petroleum), cold-acid, C3-5, butene-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-63-4</ENT> <ENT>Extracts (petroleum), reformer recycle.</ENT> </ROW> <ROW> <ENT I="01">68477-64-5</ENT> <ENT>Gases (petroleum), acetylene manuf. off.</ENT> </ROW> <ROW> <ENT I="01">68477-65-6</ENT> <ENT>Gases (petroleum), amine system feed.</ENT> </ROW> <ROW> <ENT I="01">68477-66-7</ENT> <ENT>Gases (petroleum), benzene unit hydrodesulfurizer off.</ENT> </ROW> <ROW> <ENT I="01">68477-67-8</ENT> <ENT>Gases (petroleum), benzene unit recycle, hydrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-68-9</ENT> <ENT>Gases (petroleum), blend oil, hydrogen-nitrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-69-0</ENT> <ENT>Gases (petroleum), butane splitter overheads.</ENT> </ROW> <ROW> <ENT I="01">68477-70-3</ENT> <ENT>Gases (petroleum), C2-3.</ENT> </ROW> <ROW> <ENT I="01">68477-71-4</ENT> <ENT>Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free.</ENT> </ROW> <ROW> <ENT I="01">68477-72-5</ENT> <ENT>Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-73-6</ENT> <ENT>Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free.</ENT> </ROW> <ROW> <ENT I="01">68477-74-7</ENT> <ENT>Gases (petroleum), catalytic cracker.</ENT> </ROW> <ROW> <ENT I="01">68477-75-8</ENT> <ENT>Gases (petroleum), catalytic cracker, C1-5-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-76-9</ENT> <ENT>Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-77-0</ENT> <ENT>Gases (petroleum), catalytic reformed naphtha stripper overheads.</ENT> </ROW> <ROW> <ENT I="01">68477-79-2</ENT> <ENT>Gases (petroleum), catalytic reformer, C1-4-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-80-5</ENT> <ENT>Gases (petroleum), C6-8 catalytic reformer recycle.</ENT> </ROW> <ROW> <ENT I="01">68477-81-6</ENT> <ENT>Gases (petroleum), C6-8 catalytic reformer.</ENT> </ROW> <ROW> <ENT I="01">68477-82-.7</ENT> <ENT>Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-83-8</ENT> <ENT>Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed.</ENT> </ROW> <ROW> <ENT I="01">68477-84-9</ENT> <ENT>Gases (petroleum), C2-return stream.</ENT> </ROW> <ROW> <ENT I="01">68477-85-0</ENT> <ENT>Gases (petroleum), C4-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-86-1.</ENT> <ENT>Gases (petroleum), deethanizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68477-87-2.</ENT> <ENT>Gases (petroleum), deisobutanizer tower overheads.</ENT> </ROW> <ROW> <ENT I="01">68477-88-3</ENT> <ENT>Gases (petroleum), deethanizer overheads, C3-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-89-4</ENT> <ENT>Distillates (petroleum), depentanizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68477-90-7</ENT> <ENT>Gases (petroleum), depropanizer dry, propene-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-91-8</ENT> <ENT>Gases (petroleum), depropanizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68477-92-9</ENT> <ENT>Gases (petroleum), dry sour, gas-concentration concn.-unit-off.</ENT> </ROW> <ROW> <ENT I="01">68477-93-0</ENT> <ENT>Gases (petroleum), gas concn. reabsorber distn.</ENT> </ROW> <ROW> <ENT I="01">68477-94-1</ENT> <ENT>Gases (petroleum), gas recovery plant depropanizer overheads</ENT> </ROW> <ROW> <ENT I="01">68477-95-2</ENT> <ENT>Gases (petroleum), Girbatol unit feed.</ENT> </ROW> <ROW> <ENT I="01">68477-96-3</ENT> <ENT>Gases (petroleum), hydrogen absorber off.</ENT> </ROW> <ROW> <ENT I="01">68477-97-4</ENT> <ENT>Gases (petroleum), hydrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68477-98-5</ENT> <ENT>Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen rich.</ENT> </ROW> <ROW> <ENT I="01">68477-99-6</ENT> <ENT>Gases (petroleum), isomerized naphtha fractionater, C4-rich, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68478-00-2</ENT> <ENT>Gases (petroleum), recycle, hydrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68478-01-3</ENT> <ENT>Gases (petroleum), reformer make-up, hydrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68478-02-4</ENT> <ENT>Gases (petroleum), reforming hydrotreater.</ENT> </ROW> <ROW> <ENT I="01">68478-03-5</ENT> <ENT>Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich.</ENT> </ROW> <ROW> <ENT I="01">68478-04-6</ENT> <ENT>Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich.</ENT> </ROW> <ROW> <ENT I="01">68478-05-7</ENT> <ENT>Gases (petroleum), thermal cracking distn.</ENT> </ROW> <ROW> <ENT I="01">68478-08-0</ENT> <ENT>Naphtha (petroleum), light steam-cracked, C5-fraction, oligomer conc.</ENT> </ROW> <ROW> <ENT I="01">68478-10-4</ENT> <ENT>Naphtha (petroleum), light steam-cracked, debenzenized, C8-16-cycloalkadiene conc.</ENT> </ROW> <ROW> <ENT I="01">68478-12-6</ENT> <ENT>Residues (petroleum), butane splitter bottoms.</ENT> </ROW> <ROW> <ENT I="01">68478-13-7</ENT> <ENT>Residues (petroleum), catalytic reformer fractionator residue distn.</ENT> </ROW> <ROW> <ENT I="01">68478-15-9</ENT> <ENT>Residues (petroleum), C6-8 catalytic reformer.</ENT> </ROW> <ROW> <ENT I="01">68478-16-0</ENT> <ENT>Residual oils (petroleum), deisobutanizer tower.</ENT> </ROW> <ROW> <ENT I="01">68478-17-1</ENT> <ENT>Residues (petroleum), heavy coker gas oil and vacuum gas oil.</ENT> </ROW> <ROW> <ENT I="01">68478-18-2</ENT> <ENT>Residues (petroleum), heavy olefin vacuum.</ENT> </ROW> <ROW> <ENT I="01">68478-19-3</ENT> <ENT>Residual oils (petroleum), propene purifn. splitter.</ENT> </ROW> <ROW> <ENT I="01">68478-20-6</ENT> <ENT>Residues (petroleum), steam-cracked petroleum distillates cyclopentadiene conc., C4-cyclopentadiene-free.</ENT> </ROW> <ROW> <ENT I="01">68478-22-8</ENT> <ENT>Tail gas (petroleum), catalytic cracked naphtha stabilization absorber.</ENT> </ROW> <ROW> <ENT I="01">68478-24-0</ENT> <ENT>Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater.</ENT> </ROW> <ROW> <ENT I="01">68478-25-1</ENT> <ENT>Tail gas (petroleum), catalytic cracker refractionation absorber.</ENT> </ROW> <ROW> <ENT I="01">68478-26-2</ENT> <ENT>Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer.</ENT> </ROW> <ROW> <PRTPAGE P="129"/> <ENT I="01">68478-27-3</ENT> <ENT>Tail gas (petroleum), catalytic reformed naphtha separator.</ENT> </ROW> <ROW> <ENT I="01">68478-28-4</ENT> <ENT>Tail gas (petroleum), catalytic reformed naphtha stabilizer.</ENT> </ROW> <ROW> <ENT I="01">68478-29-5</ENT> <ENT>Tail gas (petroleum), cracked distillate hydrotreater separator.</ENT> </ROW> <ROW> <ENT I="01">68478-30-8</ENT> <ENT>Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator.</ENT> </ROW> <ROW> <ENT I="01">68478-31-9</ENT> <ENT>Tail gas (petroleum), isomerized naphtha fractionates, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68478-32-0</ENT> <ENT>Tail gas (petroleum), saturate gas plant mixed stream, C4-rich.</ENT> </ROW> <ROW> <ENT I="01">68478-33-1</ENT> <ENT>Tail gas (petroleum), saturate gas recovery plant, C1-2-rich.</ENT> </ROW> <ROW> <ENT I="01">68478-34-2</ENT> <ENT>Tail gas (petroleum), vacuum residues thermal cracker.</ENT> </ROW> <ROW> <ENT I="01">68512-61-8</ENT> <ENT>Residues (petroleum), heavy coker and light vacuum.</ENT> </ROW> <ROW> <ENT I="01">68512-62-9</ENT> <ENT>Residues (petroleum), light vacuum.</ENT> </ROW> <ROW> <ENT I="01">68512-78-7</ENT> <ENT>Solvent naphtha (petroleum), light arom., hydrotreated.</ENT> </ROW> <ROW> <ENT I="01">68512-91-4</ENT> <ENT>Hydrocarbons, C3-4-rich, petroleum distillates.</ENT> </ROW> <ROW> <ENT I="01">68513-02-0</ENT> <ENT>Naphtha (petroleum), full-range coker.</ENT> </ROW> <ROW> <ENT I="01">68513-03-1</ENT> <ENT>Naphtha (petroleum), light catalytic reformed, arom.-free.</ENT> </ROW> <ROW> <ENT I="01">68513-11-1</ENT> <ENT>Fuel gases, hydrotreater fractionation, scrubbed.</ENT> </ROW> <ROW> <ENT I="01">68513-12-2</ENT> <ENT>Fuel gases, saturate gas unit fractionater-absorber overheads.</ENT> </ROW> <ROW> <ENT I="01">68513-13-3</ENT> <ENT>Fuel gases, thermal cracked catalytic cracking residue.</ENT> </ROW> <ROW> <ENT I="01">68513-14-4</ENT> <ENT>Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68513-15-5</ENT> <ENT>Gases (petroleum), full-range straight-run naphtha dehexanizer off.</ENT> </ROW> <ROW> <ENT I="01">68513-16-6</ENT> <ENT>Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich.</ENT> </ROW> <ROW> <ENT I="01">68513-17-7</ENT> <ENT>Gases (petroleum), light straight-run naphtha stabilizer off.</ENT> </ROW> <ROW> <ENT I="01">68513-18-8</ENT> <ENT>Gases (petroleum), reformer effluent high-pressure flash drum off.</ENT> </ROW> <ROW> <ENT I="01">68513-19-9</ENT> <ENT>Gases (petroleum), reformer effluent low-pressure flash drum off.</ENT> </ROW> <ROW> <ENT I="01">68513-62-2</ENT> <ENT>Disulfides, C5-12-alkyl.</ENT> </ROW> <ROW> <ENT I="01">68513-63-3</ENT> <ENT>Distillates (petroleum), catalytic reformed straight-run naphtha overheads.</ENT> </ROW> <ROW> <ENT I="01">68513-65-5</ENT> <ENT>Butane, branched and linear.</ENT> </ROW> <ROW> <ENT I="01">68513-66-6</ENT> <ENT>Residues (petroleum), alkylation splitter, C4-rich.</ENT> </ROW> <ROW> <ENT I="01">68513-67-7</ENT> <ENT>Residues (petroleum), cyclooctadiene bottoms.</ENT> </ROW> <ROW> <ENT I="01">68513-68-8</ENT> <ENT>Residues (petroleum), deethanizer tower.</ENT> </ROW> <ROW> <ENT I="01">68513-69-9</ENT> <ENT>Residues (petroleum), steam-cracked light.</ENT> </ROW> <ROW> <ENT I="01">68513-74-6</ENT> <ENT>Waste gases, ethylene oxide absorber-reactor.</ENT> </ROW> <ROW> <ENT I="01">68514-15-8</ENT> <ENT>Gasoline, vapor-recovery.</ENT> </ROW> <ROW> <ENT I="01">68514-29-4</ENT> <ENT>Hydrocarbons, amylene feed debutanizer overheads non-extractable raffinates.</ENT> </ROW> <ROW> <ENT I="01">68514-31-8</ENT> <ENT>Hydrocarbons, C1-4.</ENT> </ROW> <ROW> <ENT I="01">68514-32-9</ENT> <ENT>Hydrocarbons, C10 and C12, olefin-rich.</ENT> </ROW> <ROW> <ENT I="01">68514-33-0</ENT> <ENT>Hydrocarbons, C12 and C14, olefin-rich.</ENT> </ROW> <ROW> <ENT I="01">68514-34-1</ENT> <ENT>Hydrocarbons, C9-14, ethylene-manuf.-by-product.</ENT> </ROW> <ROW> <ENT I="01">68514-35-2</ENT> <ENT>Hydrocarbons, C14-30, olefin-rich.</ENT> </ROW> <ROW> <ENT I="01">68514-36-3</ENT> <ENT>Hydrocarbons, C1-4, sweetened.</ENT> </ROW> <ROW> <ENT I="01">68514-37-4</ENT> <ENT>Hydrocarbons, C4-5-unsatd..</ENT> </ROW> <ROW> <ENT I="01">68514-38-5</ENT> <ENT>Hydrocarbons, C4-10-unsatd..</ENT> </ROW> <ROW> <ENT I="01">68514-39-6</ENT> <ENT>Naphtha (petroleum), light steam-cracked, isoprene-rich.</ENT> </ROW> <ROW> <ENT I="01">68514-79-4</ENT> <ENT>Petroleum products, hydrofiner-powerformer reformates.</ENT> </ROW> <ROW> <ENT I="01">68515-25-3</ENT> <ENT>Benzene, C1-9-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">68515-26-4</ENT> <ENT>Benzene, di-C12-14-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">68515-27-5</ENT> <ENT>Benzene, di-C10-14-alkyl derivs., fractionation overheads, heavy ends.</ENT> </ROW> <ROW> <ENT I="01">68515-28-6</ENT> <ENT>Benzene, di-C10-14-alkyl derivs., fractionation overheads, light ends.</ENT> </ROW> <ROW> <ENT I="01">68515-29-7</ENT> <ENT>Benzene, di-C10-14-alkyl derivs., fractionation overheads, middle cut.</ENT> </ROW> <ROW> <ENT I="01">68515-30-0</ENT> <ENT>Benzene, mono-C20-48-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">68515-32-2</ENT> <ENT>Benzene, mono-C12-14-alkyl derivs., fractionation bottoms.</ENT> </ROW> <ROW> <ENT I="01">68515-33-3</ENT> <ENT>Benzene, mono-C10-12-alkyl derivs., fractionation bottoms, heavy ends.</ENT> </ROW> <ROW> <ENT I="01">68515-34-4</ENT> <ENT>Benzene, mono-C12-14-alkyl derivs., fractionation bottoms, heavy ends.</ENT> </ROW> <ROW> <ENT I="01">68515-35-5</ENT> <ENT>Benzene, mono-C10-12-alkyl derivs., fractionation bottoms, light ends.</ENT> </ROW> <ROW> <ENT I="01">68515-36-6</ENT> <ENT>Benzene, mono-C12-14-alkyl derivs., fractionation bottoms, light ends.</ENT> </ROW> <ROW> <ENT I="01">68516-20-1</ENT> <ENT>Naphtha (petroleum), steam-cracked middle arom.</ENT> </ROW> <ROW> <ENT I="01">68526-52-3</ENT> <ENT>Alkenes, C6.</ENT> </ROW> <ROW> <ENT I="01">68526-53-4</ENT> <ENT>Alkenes, C6-8, C7-rich.</ENT> </ROW> <ROW> <ENT I="01">68526-54-5</ENT> <ENT>Alkenes, C7-9, C8-rich.</ENT> </ROW> <ROW> <ENT I="01">68526-55-6</ENT> <ENT>Alkenes, C8-10, C9-rich.</ENT> </ROW> <ROW> <ENT I="01">68526-56-7</ENT> <ENT>Alkenes, C9-11, C10-rich.</ENT> </ROW> <ROW> <ENT I="01">68526-57-8</ENT> <ENT>Alkenes, C10-12, C11-rich.</ENT> </ROW> <ROW> <ENT I="01">68526-58-9</ENT> <ENT>Alkenes, C11-13, C12-rich.</ENT> </ROW> <ROW> <ENT I="01">68526-77-2</ENT> <ENT>Aromatic hydrocarbons, ethane cracking scrubber effluent and flare drum.</ENT> </ROW> <ROW> <ENT I="01">68526-99-8</ENT> <ENT>Alkenes, C6-9 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68527-00-4</ENT> <ENT>Alkenes, C8-9 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68527-11-7</ENT> <ENT>Alkenes, C5.</ENT> </ROW> <ROW> <ENT I="01">68527-13-9</ENT> <ENT>Gases (petroleum), acid, ethanolamine scrubber.</ENT> </ROW> <ROW> <ENT I="01">68527-14-0</ENT> <ENT>Gases (petroleum), methane-rich off.</ENT> </ROW> <ROW> <ENT I="01">68527-15-1</ENT> <ENT>Gases (petroleum), oil refinery gas distn. off.</ENT> </ROW> <ROW> <ENT I="01">68527-16-2</ENT> <ENT>Hydrocarbons, C1-3.</ENT> </ROW> <ROW> <ENT I="01">68527-18-4</ENT> <ENT>Gas oils (petroleum), steam-cracked.</ENT> </ROW> <ROW> <PRTPAGE P="130"/> <ENT I="01">68527-19-5</ENT> <ENT>Hydrocarbons, C1-4, debutanizer fraction.</ENT> </ROW> <ROW> <ENT I="01">68527-21-9</ENT> <ENT>Naphtha (petroleum), clay-treated full-range straight-run.</ENT> </ROW> <ROW> <ENT I="01">68527-22-0</ENT> <ENT>Naphtha (petroleum), clay-treated light straight-run.</ENT> </ROW> <ROW> <ENT I="01">68527-23-1</ENT> <ENT>Naphtha (petroleum), light steam-cracked arom.</ENT> </ROW> <ROW> <ENT I="01">68527-26-4</ENT> <ENT>Naphtha (petroleum), light steam-cracked, debenzenized.</ENT> </ROW> <ROW> <ENT I="01">68527-27-5</ENT> <ENT>Naphtha (petroleum), full-range alkylate, butane-contg.</ENT> </ROW> <ROW> <ENT I="01">68553-00-4</ENT> <ENT>Fuel oil, no. 6.</ENT> </ROW> <ROW> <ENT I="01">68553-14-0</ENT> <ENT>Hydrocarbons, C8-11.</ENT> </ROW> <ROW> <ENT I="01">68602-79-9</ENT> <ENT>Distillates (petroleum), benzene unit hydrotreater dipentanizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68602-81-3</ENT> <ENT>Distillates, hydrocarbon resin prodn. higher boiling.</ENT> </ROW> <ROW> <ENT I="01">68602-82-4</ENT> <ENT>Gases (petroleum), benzene unit hydrotreater depentenizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68602-83-5</ENT> <ENT>Gases (petroleum), C1-5, wet.</ENT> </ROW> <ROW> <ENT I="01">68602-84-6</ENT> <ENT>Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionater.</ENT> </ROW> <ROW> <ENT I="01">68602-96-0</ENT> <ENT>Distillates (petroleum), oxidized light, strong acid components, compds. with diethanolamine.</ENT> </ROW> <ROW> <ENT I="01">68602-97-1</ENT> <ENT>Distillates (petroleum), oxidized light, strong acid components, sodium salts.</ENT> </ROW> <ROW> <ENT I="01">68602-98-2</ENT> <ENT>Distillates (petroleum), oxidized light, strong acid components.</ENT> </ROW> <ROW> <ENT I="01">68602-99-3</ENT> <ENT>Distillates (petroleum), oxidized light, strong acid-free.</ENT> </ROW> <ROW> <ENT I="01">68603-00-9</ENT> <ENT>Distillates (petroleum), thermal cracked naphtha and gas oil.</ENT> </ROW> <ROW> <ENT I="01">68603-01-0</ENT> <ENT>Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.</ENT> </ROW> <ROW> <ENT I="01">68603-02-1</ENT> <ENT>Distillates (petroleum), thermal cracked naphtha and gas oil, dimerized.</ENT> </ROW> <ROW> <ENT I="01">68603-03-2</ENT> <ENT>Distillates (petroleum), thermal cracked naphtha and gas oil, extractive.</ENT> </ROW> <ROW> <ENT I="01">68603-08-7</ENT> <ENT>Naphtha (petroleum), arom.- contg.</ENT> </ROW> <ROW> <ENT I="01">68603-09-8</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, calcium salts.</ENT> </ROW> <ROW> <ENT I="01">68603-10-1</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, Me esters, barium salts.</ENT> </ROW> <ROW> <ENT I="01">68603-11-2</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, Me esters, calcium salts.</ENT> </ROW> <ROW> <ENT I="01">68603-12-3</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, Me esters, sodium salts.</ENT> </ROW> <ROW> <ENT I="01">68603-13-4</ENT> <ENT>Petrolatum (petroleum), oxidized, ester with sorbitol.</ENT> </ROW> <ROW> <ENT I="01">68603-14-5</ENT> <ENT>Residual oils (petroleum), oxidized, calcium salts.</ENT> </ROW> <ROW> <ENT I="01">68603-31-6</ENT> <ENT>Alkenes, C10, tert-amylene concentrator by-product.</ENT> </ROW> <ROW> <ENT I="01">68603-32-7</ENT> <ENT>Alkenes, C15-20 .alpha.-, isomerized.</ENT> </ROW> <ROW> <ENT I="01">68606-09-7</ENT> <ENT>Fuel gases, expander off.</ENT> </ROW> <ROW> <ENT I="01">68606-10-0</ENT> <ENT>Gasoline, pyrolysis, debutanizer bottoms.</ENT> </ROW> <ROW> <ENT I="01">68606-11-1</ENT> <ENT>Gasoline, straight-run, topping-plant.</ENT> </ROW> <ROW> <ENT I="01">68606-24-6</ENT> <ENT>Hydrocarbons, C4, butene concentrator by-product.</ENT> </ROW> <ROW> <ENT I="01">68606-25-7</ENT> <ENT>Hydrocarbons, C2-4.</ENT> </ROW> <ROW> <ENT I="01">68606-26-8</ENT> <ENT>Hydrocarbons, C3.</ENT> </ROW> <ROW> <ENT I="01">68606-27-9</ENT> <ENT>Gases (petroleum), alkylation feed.</ENT> </ROW> <ROW> <ENT I="01">68606-28-0</ENT> <ENT>Hydrocarbons, C5 and C10-aliph. and C6-8-arom.</ENT> </ROW> <ROW> <ENT I="01">68606-31-5</ENT> <ENT>Hydrocarbons, C3-5, butadiene purification (purifn.) by-product.</ENT> </ROW> <ROW> <ENT I="01">68606-34-8</ENT> <ENT>Gases (petroleum), depropanizer bottoms fractionation off.</ENT> </ROW> <ROW> <ENT I="01">68606-36-0</ENT> <ENT>Hydrocarbons, C5-unsatd. rich, isoprene purifn. by-product.</ENT> </ROW> <ROW> <ENT I="01">68607-11-4</ENT> <ENT>Petroleum products, refinery gases.</ENT> </ROW> <ROW> <ENT I="01">68607-30-7</ENT> <ENT>Residues (petroleum), topping plant, low-sulfur.</ENT> </ROW> <ROW> <ENT I="01">68608-56-0</ENT> <ENT>Waste gases, from carbon black manuf.</ENT> </ROW> <ROW> <ENT I="01">68647-60-9</ENT> <ENT>Hydrocarbons, C>4.</ENT> </ROW> <ROW> <ENT I="01">68647-61-0</ENT> <ENT>Hydrocarbons, C4-5, tert-amylene concentrator by-product.</ENT> </ROW> <ROW> <ENT I="01">68647-62-1</ENT> <ENT>Hydrocarbons, C4-5, butene concentrator by-product, sour.</ENT> </ROW> <ROW> <ENT I="01">68650-36-2</ENT> <ENT> Aromatic hydrocarbons, C8, <E T="03">o</E> -xylene-lean. </ENT> </ROW> <ROW> <ENT I="01">68650-37-3</ENT> <ENT>Paraffin waxes (petroleum), oxidized, sodium salts.</ENT> </ROW> <ROW> <ENT I="01">68782-97-8</ENT> <ENT>Distillates (petroleum), hydrofined lubricating-oil.</ENT> </ROW> <ROW> <ENT I="01">68782-98-9</ENT> <ENT>Extracts (petroleum), clarified oil solvent, condensed-ring-arom.-contg.</ENT> </ROW> <ROW> <ENT I="01">68782-99-0</ENT> <ENT>Extracts (petroleum), heavy clarified oil solvent, condensed-ring-arom.-contg.</ENT> </ROW> <ROW> <ENT I="01">68783-00-6</ENT> <ENT>Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.</ENT> </ROW> <ROW> <ENT I="01">68783-01-7</ENT> <ENT>Extracts (petroleum), heavy naphthenic distillate solvent, paraffinic conc.</ENT> </ROW> <ROW> <ENT I="01">68783-02-8</ENT> <ENT>Extracts (petroleum), intermediate clarified oil solvent, condensed-ring-arom.-contg.</ENT> </ROW> <ROW> <ENT I="01">68783-04-0</ENT> <ENT>Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent.</ENT> </ROW> <ROW> <ENT I="01">68783-05-1</ENT> <ENT>Gases (petroleum), ammonia-hydrogen sulfide, water-satd.</ENT> </ROW> <ROW> <ENT I="01">68783-06-2</ENT> <ENT>Gases (petroleum), hydrocracking low-pressure separator.</ENT> </ROW> <ROW> <ENT I="01">68783-07-3</ENT> <ENT>Gases (petroleum), refinery blend.</ENT> </ROW> <ROW> <ENT I="01">68783-08-4</ENT> <ENT>Gas oils (petroleum), heavy atmospheric.</ENT> </ROW> <ROW> <ENT I="01">68783-09-5</ENT> <ENT>Naphtha (petroleum), catalytic cracked light distd.</ENT> </ROW> <ROW> <ENT I="01">68783-12-0</ENT> <ENT>Naphtha (petroleum), unsweetened.</ENT> </ROW> <ROW> <ENT I="01">68783-13-1</ENT> <ENT>Residues (petroleum), coker scrubber, condensed-ring-arom.-contg.</ENT> </ROW> <ROW> <ENT I="01">68783-15-3</ENT> <ENT>Alkenes, C6-7 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68783-61-9</ENT> <ENT>Fuel gases, refinery, sweetened.</ENT> </ROW> <ROW> <ENT I="01">68783-62-0</ENT> <ENT>Fuel gases, refinery, unsweetened.</ENT> </ROW> <ROW> <ENT I="01">68783-64-2</ENT> <ENT>Gases (petroleum), catalytic cracking.</ENT> </ROW> <ROW> <ENT I="01">68783-65-3</ENT> <ENT>Gases (petroleum), C2-4, sweetened.</ENT> </ROW> <ROW> <ENT I="01">68783-66-4</ENT> <ENT>Naphtha (petroleum), light, sweetened.</ENT> </ROW> <ROW> <ENT I="01">68814-47-1</ENT> <ENT>Waste gases, refinery vent.</ENT> </ROW> <ROW> <ENT I="01">68814-67-5</ENT> <ENT>Gases (petroleum), refinery.</ENT> </ROW> <ROW> <PRTPAGE P="131"/> <ENT I="01">68814-87-9</ENT> <ENT>Distillates (petroleum), full-range straight-run middle.</ENT> </ROW> <ROW> <ENT I="01">68814-89-1</ENT> <ENT>Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted.</ENT> </ROW> <ROW> <ENT I="01">68814-90-4</ENT> <ENT>Gases (petroleum), platformer products separator off.</ENT> </ROW> <ROW> <ENT I="01">68814-91-5</ENT> <ENT>Alkenes, C5-9 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68855-57-2</ENT> <ENT>Alkenes, C6-12 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68855-58-3</ENT> <ENT>Alkenes, C10-16 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68855-59-4</ENT> <ENT>Alkenes, C14-18 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68855-60-7</ENT> <ENT>Alkenes, C14-20 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">68911-58-0</ENT> <ENT>Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off.</ENT> </ROW> <ROW> <ENT I="01">68911-59-1</ENT> <ENT>Gases (petroleum), hydrotreated sour kerosine flash drum.</ENT> </ROW> <ROW> <ENT I="01">68915-96-8</ENT> <ENT>Distillates (petroleum), heavy straight-run.</ENT> </ROW> <ROW> <ENT I="01">68915-97-9</ENT> <ENT>Gas oils (petroleum), straight-run, high-boiling.</ENT> </ROW> <ROW> <ENT I="01">68918-69-4</ENT> <ENT>Petrolatum (petroleum), oxidized, zinc salt.</ENT> </ROW> <ROW> <ENT I="01">68918-73-0</ENT> <ENT>Residues (petroleum), clay-treating filter wash.</ENT> </ROW> <ROW> <ENT I="01">68918-93-4</ENT> <ENT>Paraffin waxes and Hydrocarbon waxes, oxidized, alkali metal salts.</ENT> </ROW> <ROW> <ENT I="01">68918-98-9</ENT> <ENT>Fuel gases, refinery, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68918-99-0</ENT> <ENT>Gases (petroleum), crude oil fractionation off.</ENT> </ROW> <ROW> <ENT I="01">68919-00-6</ENT> <ENT>Gases (petroleum), dehexanizer off.</ENT> </ROW> <ROW> <ENT I="01">68919-01-7</ENT> <ENT>Gases (petroleum), distillate unifiner desulfurization stripper off.</ENT> </ROW> <ROW> <ENT I="01">68919-02-8</ENT> <ENT>Gases (petroleum), fluidized catalytic cracker fractionation off.</ENT> </ROW> <ROW> <ENT I="01">68919-03-9</ENT> <ENT>Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off.</ENT> </ROW> <ROW> <ENT I="01">68919-04-0</ENT> <ENT>Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off.</ENT> </ROW> <ROW> <ENT I="01">68919-05-1</ENT> <ENT>Gases (petroleum), light straight run gasoline fractionation stabilizer off.</ENT> </ROW> <ROW> <ENT I="01">68919-06-2</ENT> <ENT>Gases (petroleum), naphtha unifiner desulfurization stripper off.</ENT> </ROW> <ROW> <ENT I="01">68919-07-3</ENT> <ENT>Gases (petroleum), platformer stabilizer off, light ends fractionation.</ENT> </ROW> <ROW> <ENT I="01">68919-08-4</ENT> <ENT>Gases (petroleum), preflash tower off, crude distn.</ENT> </ROW> <ROW> <ENT I="01">68919-09-5</ENT> <ENT>Gases (petroleum), straight-run naphtha catalytic reforming off.</ENT> </ROW> <ROW> <ENT I="01">68919-10-8</ENT> <ENT>Gases (petroleum), straight-run stabilizer off.</ENT> </ROW> <ROW> <ENT I="01">68919-11-9</ENT> <ENT>Gases (petroleum), tar stripper off.</ENT> </ROW> <ROW> <ENT I="01">68919-12-0</ENT> <ENT>Gases (petroleum), unifiner stripper off.</ENT> </ROW> <ROW> <ENT I="01">68919-15-3</ENT> <ENT>Hydrocarbons, C6-12, benzene-recovery.</ENT> </ROW> <ROW> <ENT I="01">68919-16-4</ENT> <ENT>Hydrocarbons, catalytic alkylation, by-products, C3-6.</ENT> </ROW> <ROW> <ENT I="01">68919-17-5</ENT> <ENT>Hydrocarbons, C12-20, catalytic alkylation by-products.</ENT> </ROW> <ROW> <ENT I="01">68919-19-7</ENT> <ENT>Gases (petroleum), fluidized catalytic cracker splitter residues.</ENT> </ROW> <ROW> <ENT I="01">68919-20-0</ENT> <ENT>Gases (petroleum), fluidized catalytic cracker splitter overheads.</ENT> </ROW> <ROW> <ENT I="01">68919-37-9</ENT> <ENT>Naphtha (petroleum), full-range reformed.</ENT> </ROW> <ROW> <ENT I="01">68920-06-9</ENT> <ENT>Hydrocarbons, C7-9.</ENT> </ROW> <ROW> <ENT I="01">68920-07-0</ENT> <ENT>Hydrocarbons, C<10-linear.</ENT> </ROW> <ROW> <ENT I="01">68920-64-9</ENT> <ENT>Disulfides, di-C1-2-alkyl.</ENT> </ROW> <ROW> <ENT I="01">68921-07-3</ENT> <ENT>Distillates (petroleum), hydrotreated light catalytic cracked.</ENT> </ROW> <ROW> <ENT I="01">68921-08-4</ENT> <ENT>Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads.</ENT> </ROW> <ROW> <ENT I="01">68921-09-5</ENT> <ENT>Distillates (petroleum), naphtha unifiner stripper.</ENT> </ROW> <ROW> <ENT I="01">68921-67-5</ENT> <ENT>Hydrocarbons, ethylene-manuf.-by-product distn. residues.</ENT> </ROW> <ROW> <ENT I="01">68952-76-1</ENT> <ENT>Gases (petroleum), catalytic cracked naphtha debutanizer.</ENT> </ROW> <ROW> <ENT I="01">68952-77-2</ENT> <ENT>Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer.</ENT> </ROW> <ROW> <ENT I="01">68952-78-3</ENT> <ENT>Tail gas (petroleum), catalytic hydrodesulfurized distillate fractionation stabilizer, hydrogen sulfide-free.</ENT> </ROW> <ROW> <ENT I="01">68952-79-4</ENT> <ENT>Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator.</ENT> </ROW> <ROW> <ENT I="01">68952-80-7</ENT> <ENT>Tail gas (petroleum), straight-run naphtha hydrodesulfurizer.</ENT> </ROW> <ROW> <ENT I="01">68952-81-8</ENT> <ENT>Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber.</ENT> </ROW> <ROW> <ENT I="01">68952-82-9</ENT> <ENT>Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking.</ENT> </ROW> <ROW> <ENT I="01">68953-80-0</ENT> <ENT>Benzene, mixed with toluene, dealkylation product.</ENT> </ROW> <ROW> <ENT I="01">68955-27-1</ENT> <ENT>Distillates (petroleum), petroleum residues vacuum.</ENT> </ROW> <ROW> <ENT I="01">68955-28-2</ENT> <ENT>Gases (petroleum), light steam-cracked, butadiene conc.</ENT> </ROW> <ROW> <ENT I="01">68955-31-7</ENT> <ENT>Gases (petroleum), butadiene process, inorg.</ENT> </ROW> <ROW> <ENT I="01">68955-32-8</ENT> <ENT>Natural gas, substitute, steam-reformed desulfurized naphtha.</ENT> </ROW> <ROW> <ENT I="01">68955-33-9</ENT> <ENT>Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation.</ENT> </ROW> <ROW> <ENT I="01">68955-34-0</ENT> <ENT>Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead.</ENT> </ROW> <ROW> <ENT I="01">68955-35-1</ENT> <ENT>Naphtha (petroleum), catalytic reformed.</ENT> </ROW> <ROW> <ENT I="01">68955-36-2</ENT> <ENT>Residues (petroleum), steam-cracked, resinous.</ENT> </ROW> <ROW> <ENT I="01">68955-76-0</ENT> <ENT>Aromatic hydrocarbons, C9-16, biphenyl deriv.-rich.</ENT> </ROW> <ROW> <ENT I="01">68955-96-4</ENT> <ENT>Disulfides, dialkyl and di-Ph, naphtha sweetening.</ENT> </ROW> <ROW> <ENT I="01">68956-47-8</ENT> <ENT>Fuel oil, isoprene reject absorption.</ENT> </ROW> <ROW> <ENT I="01">68956-48-9</ENT> <ENT>Fuel oil, residual, wastewater skimmings.</ENT> </ROW> <ROW> <ENT I="01">68956-52-5</ENT> <ENT>Hydrocarbons, C4-8.</ENT> </ROW> <ROW> <ENT I="01">68956-54-7</ENT> <ENT>Hydrocarbons, C4-unsatd.</ENT> </ROW> <ROW> <ENT I="01">68956-55-8</ENT> <ENT>Hydrocarbons, C5-unsatd.</ENT> </ROW> <ROW> <ENT I="01">68956-70-7</ENT> <ENT>Petroleum products, C5-12, reclaimed, wastewater treatment.</ENT> </ROW> <ROW> <ENT I="01">68988-79-4</ENT> <ENT>Benzene, C10-12-alkyl derivs., distn. residues.</ENT> </ROW> <ROW> <ENT I="01">68988-99-8</ENT> <ENT>Phenols, sodium salts, mixed with sulfur compounds, gasoline alk. scrubber residues.</ENT> </ROW> <ROW> <PRTPAGE P="132"/> <ENT I="01">68989-88-8</ENT> <ENT>Gases (petroleum), crude distn. and catalytic cracking.</ENT> </ROW> <ROW> <ENT I="01">68990-35-2</ENT> <ENT>Distillates (petroleum), arom., hydrotreated, dicyclopentadiene-rich.</ENT> </ROW> <ROW> <ENT I="01">68991-49-1</ENT> <ENT>Alkanes, C10-13, arom.-free desulfurized.</ENT> </ROW> <ROW> <ENT I="01">68991-50-4</ENT> <ENT>Alkanes, C14-17, arom.-free desulfurized.</ENT> </ROW> <ROW> <ENT I="01">68991-51-5</ENT> <ENT>Alkanes, C10-13, desulfurized.</ENT> </ROW> <ROW> <ENT I="01">68991-52-6</ENT> <ENT>Alkenes, C10-16.</ENT> </ROW> <ROW> <ENT I="01">69013-21-4</ENT> <ENT>Fuel oil, pyrolysis.</ENT> </ROW> <ROW> <ENT I="01">69029-75-0</ENT> <ENT>Oils, reclaimed.</ENT> </ROW> <ROW> <ENT I="01">69430-33-7</ENT> <ENT>Hydrocarbons, C6-30.</ENT> </ROW> <ROW> <ENT I="01">70024-88-3</ENT> <ENT>Ethene, thermal cracking products.</ENT> </ROW> <ROW> <ENT I="01">70528-71-1</ENT> <ENT>Distillates (petroleum), heavy distillate solvent ext. heart-cut.</ENT> </ROW> <ROW> <ENT I="01">70528-72-2</ENT> <ENT>Distillates (petroleum), heavy distillate solvent ext. vacuum overheads.</ENT> </ROW> <ROW> <ENT I="01">70528-73-3</ENT> <ENT>Residues (petroleum), heavy distillate solvent ext. vacuum.</ENT> </ROW> <ROW> <ENT I="01">70592-76-6</ENT> <ENT>Distillates (petroleum), intermediate vacuum.</ENT> </ROW> <ROW> <ENT I="01">70592-77-7</ENT> <ENT>Distillates (petroleum), light vacuum.</ENT> </ROW> <ROW> <ENT I="01">70592-78-8</ENT> <ENT>Distillates (petroleum), vacuum.</ENT> </ROW> <ROW> <ENT I="01">70592-79-9</ENT> <ENT>Residues (petroleum), atm. tower, light.</ENT> </ROW> <ROW> <ENT I="01">70693-00-4</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, sodium salts.</ENT> </ROW> <ROW> <ENT I="01">70693-06-0</ENT> <ENT>Aromatic hydrocarbons, C9-11.</ENT> </ROW> <ROW> <ENT I="01">70913-85-8</ENT> <ENT>Residues (petroleum), solvent-extd. vacuum distilled atm. residuum.</ENT> </ROW> <ROW> <ENT I="01">70913-86-9</ENT> <ENT>Alkanes, C18-70.</ENT> </ROW> <ROW> <ENT I="01">70955-08-7</ENT> <ENT>Alkanes, C4-6.</ENT> </ROW> <ROW> <ENT I="01">70955-09-8</ENT> <ENT>Alkenes, C13-14 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">70955-10-1</ENT> <ENT>Alkenes, C15-18 .alpha.-.</ENT> </ROW> <ROW> <ENT I="01">70955-17-8</ENT> <ENT>Aromatic hydrocarbons, C12-20.</ENT> </ROW> <ROW> <ENT I="01">71243-66-8</ENT> <ENT>Hydrocarbon waxes (petroleum), clay-treated, microcryst., oxidized, potassium salts.</ENT> </ROW> <ROW> <ENT I="01">71302-82-4</ENT> <ENT>Hydrocarbons, C5-8, houdry butadiene manuf. by-product.</ENT> </ROW> <ROW> <ENT I="01">71329-37-8</ENT> <ENT>Residues (petroleum), catalytic cracking depropanizer, C4-rich.</ENT> </ROW> <ROW> <ENT I="01">71808-30-5</ENT> <ENT>Tail gas (petroleum), thermal cracking absorber.</ENT> </ROW> <ROW> <ENT I="01">72230-71-8</ENT> <ENT>Distillates (petroleum), cracked steam-cracked, C5-17 fraction.</ENT> </ROW> <ROW> <ENT I="01">72623-83-7</ENT> <ENT>Lubricating oils (petroleum), C>25, hydrotreated bright stock-based.</ENT> </ROW> <ROW> <ENT I="01">72623-84-8</ENT> <ENT>Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based, contg. solvent deasphalted residual oil.</ENT> </ROW> <ROW> <ENT I="01">72623-85-9</ENT> <ENT>Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity.</ENT> </ROW> <ROW> <ENT I="01">72623-86-0</ENT> <ENT>Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based.</ENT> </ROW> <ROW> <ENT I="01">72623-87-1</ENT> <ENT>Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based.</ENT> </ROW> <ROW> <ENT I="01">73138-65-5</ENT> <ENT>Hydrocarbon waxes (petroleum), oxidized, magnesium salts.</ENT> </ROW> <ROW> <ENT I="01">92045-43-7</ENT> <ENT>Lubricating oils (petroleum), hydrocracked non-arom. solvent deparaffined.</ENT> </ROW> <ROW> <ENT I="01">92045-58-4</ENT> <ENT>Naphtha (petroleum), isomerization, C6-fraction.</ENT> </ROW> <ROW> <ENT I="01">92062-09-4</ENT> <ENT>Slack wax (petroleum), hydrotreated.</ENT> </ROW> <ROW> <ENT I="01">93762-80-2</ENT> <ENT>Alkenes, C15-18.</ENT> </ROW> <ROW> <ENT I="01">98859-55-3</ENT> <ENT>Distillates (petroleum), oxidized heavy, compds. with diethanolamine.</ENT> </ROW> <ROW> <ENT I="01">98859-56-4</ENT> <ENT>Distillates (petroleum), oxidized heavy, sodium salts.</ENT> </ROW> <ROW> <ENT I="01">101316-73-8</ENT> <ENT>Lubricating oils (petroleum), used, non-catalytically refined.</ENT> </ROW> <ROW> <ENT I="01">164907-78-2</ENT> <ENT>Extracts (petroleum), asphaltene-low vacuum residue solvent.</ENT> </ROW> <ROW> <ENT I="01">164907-79-3</ENT> <ENT>Residues (petroleum), vacuum, asphaltene-low.</ENT> </ROW> <ROW> <ENT I="01">178603-63-9</ENT> <ENT>Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C10-25.</ENT> </ROW> <ROW> <ENT I="01">178603-64-0</ENT> <ENT>Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C15-30, branched and cyclic.</ENT> </ROW> <ROW> <ENT I="01">178603-65-1</ENT> <ENT>Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C20-40, branched and cyclic.</ENT> </ROW> <ROW> <ENT I="01">178603-66-2</ENT> <ENT>Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C25-55, branched and cyclic.</ENT> </ROW> <ROW> <ENT I="01">212210-93-0</ENT> <ENT>Solvent naphtha (petroleum), heavy arom., distn. residues.</ENT> </ROW> <ROW> <ENT I="01">221120-39-4</ENT> <ENT>Distillates (petroleum), cracked steam-cracked, C5-12 fraction.</ENT> </ROW> <ROW> <ENT I="01">445411-73-4</ENT> <ENT>Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C10-25, branched and cyclic.</ENT> </ROW> </GPOTABLE> <P> (2) <E T="03">Specific exempted chemical substances</E> —(i) <E T="03">Exemption.</E> EPA has determined that, at this time, the information in § 711.15(b)(4) associated with the chemical substances listed in paragraph (b)(2)(iv) of this section is of low current interest. </P> <P> (ii) <E T="03">Considerations.</E> In making its determination of whether this partial exemption should apply to a particular chemical substance, EPA will consider the totality of information available for the chemical substance in question, including but not limited to, one or more of the following considerations: <PRTPAGE P="133"/> </P> <P>(A) Whether the chemical substance qualifies or has qualified in past IUR or CDR collections for the reporting of the information described in § 711.15(b)(4).</P> <P>(B) The chemical substance's chemical and physical properties or potential for persistence, bioaccumulation, health effects, or environmental effects (considered independently or together).</P> <P>(C) The information needs of EPA, other Federal agencies, Tribes, States, and local governments, as well as members of the public.</P> <P>(D) The availability of other complementary risk screening information.</P> <P>(E) The availability of comparable processing and use information.</P> <P>(F) Whether the potential risks of the chemical substance are adequately managed.</P> <P> (iii) <E T="03">Amendments.</E> EPA may amend the chemical substance list in paragraph (b)(2)(iv) of this section on its own initiative or in response to a request from the public based on EPA's determination of whether the information in § 711.15(b)(4) is of low interest. </P> <P>(A) Any person may request that EPA amend the chemical substance list in Table 2 in paragraph (b)(2)(iv) of this section. Your request must be in writing and must be submitted to the address provided in 40 CFR 700.17(a). Please label your request as follows: Attention: TSCA Chemical Data Reporting—Partial Exemption Request. Requests must identify the chemical substance in question, as well as its CASRN or other chemical identification number as identified in § 711.15(b)(3)(i), and must contain a written rationale for the request that provides sufficient specific information, addressing the considerations listed in § 711.6(b)(2)(ii), including cites and relevant documents, to demonstrate to EPA that the collection of the information in § 711.15(b)(4) for the chemical substance in question either is or is not of low current interest. If a request related to a particular chemical substance is resubmitted, any subsequent request must clearly identify new information contained in the request. EPA may request other information that it believes necessary to evaluate the request. EPA will issue a written response to each request within 120 days of receipt of the request, and will maintain copies of these responses in a docket that will be established for each reporting cycle.</P> <P>(B) As needed, the Agency will initiate rulemaking to make revisions to Table 2 in paragraph (b)(2)(iv) of this section.</P> <P>(C) To assist EPA in reaching a decision regarding a particular request prior to a given principal reporting year, requests must be submitted to EPA no later than 12 months prior to the start of the next principal reporting year.</P> <P> (iv) <E T="03">List of chemical substances.</E> EPA has designated the chemical substances listed in Table 2 of this paragraph by CASRN, as partially exempt from reporting under the CDR. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,r150"> <TTITLE>Table 2—CASRN of Partially Exempt Chemical Substances</TTITLE> <BOXHD> <CHED H="1">CASRN</CHED> <CHED H="1">Chemical</CHED> </BOXHD> <ROW> <ENT I="01">50-70-4</ENT> <ENT> <E T="03">D</E> -glucitol. </ENT> </ROW> <ROW> <ENT I="01">50-81-7</ENT> <ENT> <E T="03">L</E> -ascorbic acid. </ENT> </ROW> <ROW> <ENT I="01">50-99-7</ENT> <ENT> <E T="03">D</E> -glucose. </ENT> </ROW> <ROW> <ENT I="01">56-81-5</ENT> <ENT>1,2,3-Propanetriol.</ENT> </ROW> <ROW> <ENT I="01">56-87-1</ENT> <ENT> <E T="03">L</E> -lysine. </ENT> </ROW> <ROW> <ENT I="01">57-48-7</ENT> <ENT>D-fructose.</ENT> </ROW> <ROW> <ENT I="01">57-50-1</ENT> <ENT> .alpha.- <E T="03">D</E> -Glucopyranoside, .beta.- <E T="03">D</E> -fructofuranosyl. </ENT> </ROW> <ROW> <ENT I="01">58-95-7</ENT> <ENT>2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12- trimethyltridecyl]-, acetate, (2R)-.</ENT> </ROW> <ROW> <ENT I="01">59-02-9</ENT> <ENT>2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12- trimethyltridecyl]-, (2R)-.</ENT> </ROW> <ROW> <ENT I="01">59-51-8</ENT> <ENT>Methionine.</ENT> </ROW> <ROW> <ENT I="01">68-04-2</ENT> <ENT>1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt (1:3).</ENT> </ROW> <ROW> <ENT I="01">69-65-8</ENT> <ENT> <E T="03">D</E> -mannitol. </ENT> </ROW> <ROW> <ENT I="01">77-92-9</ENT> <ENT>1,2,3-Propanetricarboxylic acid, 2-hydroxy-.</ENT> </ROW> <ROW> <ENT I="01">87-79-6</ENT> <ENT> <E T="03">L</E> -sorbose. </ENT> </ROW> <ROW> <ENT I="01">87-99-0</ENT> <ENT>Xylitol.</ENT> </ROW> <ROW> <ENT I="01">96-10-6</ENT> <ENT>Aluminum, chlorodiethyl-.</ENT> </ROW> <ROW> <ENT I="01">97-93-8</ENT> <ENT>Aluminum, triethyl-.</ENT> </ROW> <ROW> <ENT I="01">100-99-2</ENT> <ENT>Aluminum, tris(2-methylpropyl)-.</ENT> </ROW> <ROW> <PRTPAGE P="134"/> <ENT I="01">123-94-4</ENT> <ENT>Octadecanoic acid, 2,3-dihydroxypropyl ester.</ENT> </ROW> <ROW> <ENT I="01">124-38-9</ENT> <ENT>Carbon dioxide.</ENT> </ROW> <ROW> <ENT I="01">137-08-6</ENT> <ENT>.beta.-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]-, calcium alt (2:1).</ENT> </ROW> <ROW> <ENT I="01">142-47-2</ENT> <ENT> <E T="03">L</E> -glutamic acid, monosodium salt. </ENT> </ROW> <ROW> <ENT I="01">150-30-1</ENT> <ENT>Phenylalanine.</ENT> </ROW> <ROW> <ENT I="01">504-63-2</ENT> <ENT>1,3-Propanediol.</ENT> </ROW> <ROW> <ENT I="01">563-43-9</ENT> <ENT>Aluminum, dichloroethyl-.</ENT> </ROW> <ROW> <ENT I="01">866-84-2</ENT> <ENT>1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3).</ENT> </ROW> <ROW> <ENT I="01">1070-00-4</ENT> <ENT>Aluminum, trioctyl-.</ENT> </ROW> <ROW> <ENT I="01">1116-70-7</ENT> <ENT>Aluminum, tributyl-.</ENT> </ROW> <ROW> <ENT I="01">1116-73-0</ENT> <ENT>Aluminum, trihexyl-.</ENT> </ROW> <ROW> <ENT I="01">1191-15-7</ENT> <ENT>Aluminum, hydrobis(2-methylpropyl)-.</ENT> </ROW> <ROW> <ENT I="01">1317-65-3</ENT> <ENT>Limestone.</ENT> </ROW> <ROW> <ENT I="01">1333-74-0</ENT> <ENT>Hydrogen.</ENT> </ROW> <ROW> <ENT I="01">1592-23-0</ENT> <ENT>Octadecanoic acid, calcium salt.</ENT> </ROW> <ROW> <ENT I="01">7440-37-1</ENT> <ENT>Argon.</ENT> </ROW> <ROW> <ENT I="01">7440-44-0</ENT> <ENT>Carbon.</ENT> </ROW> <ROW> <ENT I="01">7727-37-9</ENT> <ENT>Nitrogen.</ENT> </ROW> <ROW> <ENT I="01">7782-42-5</ENT> <ENT>Graphite.</ENT> </ROW> <ROW> <ENT I="01">7782-44-7</ENT> <ENT>Oxygen.</ENT> </ROW> <ROW> <ENT I="01">8001-21-6</ENT> <ENT>Sunflower oil.</ENT> </ROW> <ROW> <ENT I="01">8001-22-7</ENT> <ENT>Soybean oil.</ENT> </ROW> <ROW> <ENT I="01">8001-23-8</ENT> <ENT>Safflower oil.</ENT> </ROW> <ROW> <ENT I="01">8001-26-1</ENT> <ENT>Linseed oil.</ENT> </ROW> <ROW> <ENT I="01">8001-29-4</ENT> <ENT>Cottonseed oil.</ENT> </ROW> <ROW> <ENT I="01">8001-30-7</ENT> <ENT>Corn oil.</ENT> </ROW> <ROW> <ENT I="01">8001-31-8</ENT> <ENT>Coconut oil.</ENT> </ROW> <ROW> <ENT I="01">8001-78-3</ENT> <ENT>Castor oil, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">8001-79-4</ENT> <ENT>Castor oil.</ENT> </ROW> <ROW> <ENT I="01">8002-03-7</ENT> <ENT>Peanut oil.</ENT> </ROW> <ROW> <ENT I="01">8002-13-9</ENT> <ENT>Rape oil.</ENT> </ROW> <ROW> <ENT I="01">8002-43-5</ENT> <ENT>Lecithins.</ENT> </ROW> <ROW> <ENT I="01">8002-75-3</ENT> <ENT>Palm oil.</ENT> </ROW> <ROW> <ENT I="01">8006-54-0</ENT> <ENT>Lanolin.</ENT> </ROW> <ROW> <ENT I="01">8013-07-8</ENT> <ENT>Soybean oil, epoxidized.</ENT> </ROW> <ROW> <ENT I="01">8016-28-2</ENT> <ENT>Lard, oil.</ENT> </ROW> <ROW> <ENT I="01">8016-70-4</ENT> <ENT>Soybean oil, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">8021-99-6</ENT> <ENT>Charcoal, bone.</ENT> </ROW> <ROW> <ENT I="01">8023-79-8</ENT> <ENT>Oils, palm kernel.</ENT> </ROW> <ROW> <ENT I="01">8029-43-4</ENT> <ENT>Syrups, hydrolyzed starch.</ENT> </ROW> <ROW> <ENT I="01">11103-57-4</ENT> <ENT>Vitamin A.</ENT> </ROW> <ROW> <ENT I="01">12075-68-2</ENT> <ENT>Aluminum, di-.mu.-chlorochlorotriethyldi-.</ENT> </ROW> <ROW> <ENT I="01">12542-85-7</ENT> <ENT>Aluminum, trichlorotrimethyldi-.</ENT> </ROW> <ROW> <ENT I="01">16291-96-6</ENT> <ENT>Charcoal.</ENT> </ROW> <ROW> <ENT I="01">26836-47-5</ENT> <ENT> <E T="03">D</E> -glucitol, monooctadecanoate. </ENT> </ROW> <ROW> <ENT I="01">61788-61-2</ENT> <ENT>Fatty acids, tallow, methyl esters.</ENT> </ROW> <ROW> <ENT I="01">61789-44-4</ENT> <ENT>Fatty acids, castor-oil.</ENT> </ROW> <ROW> <ENT I="01">61789-97-7</ENT> <ENT>Tallow.</ENT> </ROW> <ROW> <ENT I="01">61789-99-9</ENT> <ENT>Lard.</ENT> </ROW> <ROW> <ENT I="01">64147-40-6</ENT> <ENT>Castor oil, dehydrated.</ENT> </ROW> <ROW> <ENT I="01">64755-01-7</ENT> <ENT>Fatty acids, tallow, calcium salts.</ENT> </ROW> <ROW> <ENT I="01">65996-63-6</ENT> <ENT>Starch, acid-hydrolyzed.</ENT> </ROW> <ROW> <ENT I="01">65996-64-7</ENT> <ENT>Starch, enzyme-hydrolyzed.</ENT> </ROW> <ROW> <ENT I="01">66071-94-1</ENT> <ENT>Corn, steep liquor.</ENT> </ROW> <ROW> <ENT I="01">67701-01-3</ENT> <ENT>Fatty acids, C12-18.</ENT> </ROW> <ROW> <ENT I="01">67762-26-9</ENT> <ENT>Fatty acids, C14-18 and C16-18 unsaturated, methyl esters.</ENT> </ROW> <ROW> <ENT I="01">67762-38-3</ENT> <ENT>Fatty acids, C16-18 and C-18 unsaturated, methyl esters.</ENT> </ROW> <ROW> <ENT I="01">67784-80-9</ENT> <ENT>Soybean oil, methyl esters.</ENT> </ROW> <ROW> <ENT I="01">68002-85-7</ENT> <ENT>Fatty acids, C14-22 and C16-22-unsatd.</ENT> </ROW> <ROW> <ENT I="01">68131-37-3</ENT> <ENT>Syrups, hydrolyzed starch, dehydrated.</ENT> </ROW> <ROW> <ENT I="01">68188-81-8</ENT> <ENT>Grease, poultry.</ENT> </ROW> <ROW> <ENT I="01">68308-36-1</ENT> <ENT>Soybean meal.</ENT> </ROW> <ROW> <ENT I="01">68308-54-3</ENT> <ENT>Glycerides, tallow mono-, di- and tri-, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">68334-00-9</ENT> <ENT>Cottonseed oil, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">68334-28-1</ENT> <ENT>Fats and glyceridic oils, vegetable, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">68409-76-7</ENT> <ENT>Bone meal, steamed.</ENT> </ROW> <ROW> <ENT I="01">68424-45-3</ENT> <ENT>Fatty acids, linseed-oil.</ENT> </ROW> <ROW> <ENT I="01">68424-61-3</ENT> <ENT>Glycerides, C16-18 and C18-unsatd. mono- and di-.</ENT> </ROW> <ROW> <ENT I="01">68425-17-2</ENT> <ENT>Syrups, hydrolyzed starch, hydrogenated</ENT> </ROW> <ROW> <ENT I="01">68439-86-1</ENT> <ENT>Bone, ash.</ENT> </ROW> <ROW> <ENT I="01">68442-69-3</ENT> <ENT>Benzene, mono-C10-14-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">68476-78-8</ENT> <ENT>Molasses.</ENT> </ROW> <ROW> <PRTPAGE P="135"/> <ENT I="01">68514-27-2</ENT> <ENT>Grease, catch basin.</ENT> </ROW> <ROW> <ENT I="01">68514-74-9</ENT> <ENT>Palm oil, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">68525-87-1</ENT> <ENT>Corn oil, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">68648-87-3</ENT> <ENT>Benzene, C10-16-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">68918-42-3</ENT> <ENT>Soaps, stocks, soya.</ENT> </ROW> <ROW> <ENT I="01">68952-94-3</ENT> <ENT>Soaps, stocks, vegetable-oil.</ENT> </ROW> <ROW> <ENT I="01">68956-68-3</ENT> <ENT>Fats and glyceridic oils, vegetable.</ENT> </ROW> <ROW> <ENT I="01">68989-98-0</ENT> <ENT>Fats and glyceridic oils, vegetable, residues.</ENT> </ROW> <ROW> <ENT I="01">70131-50-9</ENT> <ENT>Bentonite, acid-leached.</ENT> </ROW> <ROW> <ENT I="01">73138-67-7</ENT> <ENT>Lard, hydrogenated.</ENT> </ROW> <ROW> <ENT I="01">120962-03-0</ENT> <ENT>Canola oil.</ENT> </ROW> <ROW> <ENT I="01">129813-58-7</ENT> <ENT>Benzene, mono-C10-13-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">129813-59-8</ENT> <ENT>Benzene, mono-C12-14-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">129813-60-1</ENT> <ENT>Benzene, mono-C14-16-alkyl derivs.</ENT> </ROW> <ROW> <ENT I="01">129828-16-6</ENT> <ENT>Fatty acids, canola oil, methyl esters.</ENT> </ROW> <ROW> <ENT I="01">515152-40-6</ENT> <ENT>Fatty acids, corn oil, methyl esters.</ENT> </ROW> </GPOTABLE> <CITA>[76 FR 54933, Sept. 6, 2011, as amended at 79 FR 35098, June 19, 2014; 79 FR 66658, Nov. 10, 2014; 81 FR 17395, Mar. 29, 2016; 85 FR 20138, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.8</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <P>Except as provided in §§ 711.9 and 711.10, the following persons are subject to the requirements of this part. Persons must determine whether they must report under this section for each chemical substance that they manufacture (including import) at an individual site.</P> <P> (a) <E T="03">Persons subject to recurring reporting.</E> Any person who manufactured (including imported) for commercial purposes 25,000 lb (11,340 kg) or more of a chemical substance described in § 711.5 at any single site owned or controlled by that person during any calendar year since the last principal reporting year. </P> <P> (b) <E T="03">Exceptions.</E> Any person who manufactured (including imported) for commercial purposes any chemical substance that is the subject of a rule proposed or promulgated under TSCA section 5(a)(2), 5(b)(4), or 6, or is the subject of an order in effect under TSCA section 4, 5(e) or 5(f), or is the subject of relief that has been granted under a civil action under TSCA sections 5 or 7 is subject to reporting as described in § 711.8(a), except that the applicable production volume threshold is 2,500 lb (1,134 kg). </P> <CITA>[76 FR 54933, Sept. 6, 2011, as amended at 85 FR 20139, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.9</SECTNO> <SUBJECT>Persons not subject to this part.</SUBJECT> <P>A person described in § 711.8 is not subject to the requirements of this part if that person qualifies as a small manufacturer or small government as those terms are defined in 40 CFR 704.3. Notwithstanding this exclusion, a person who qualifies as a small manufacturer or small government is subject to this part with respect to any chemical substance that is the subject of a rule proposed or promulgated under TSCA section 4, 5(b)(4), or 6, or is the subject of an order in effect under TSCA section 4 or 5(e), or is the subject of relief that has been granted under a civil action under TSCA section 5 or 7.</P> <CITA>[85 FR 20139, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.10</SECTNO> <SUBJECT>Activities for which reporting is not required.</SUBJECT> <P>A person described in § 711.8 is not subject to the requirements of this part with respect to any chemical substance described in § 711.5, when:</P> <P>(a) The person manufactured or imported the chemical substance solely in small quantities for research and development.</P> <P>(b) The person imported the chemical substance as part of an article.</P> <P> (c) The person manufactured the chemical substance in a manner described in 40 CFR 720.30(g) or (h). <PRTPAGE P="136"/> </P> <P>(d) The person manufactured the chemical substance in any of the following manners:</P> <P>(1) Byproduct substances listed in paragraph (i) of this section for the following manufacturing processes, when recycled or otherwise used within a site-limited, physically enclosed system that is part of the same overall manufacturing process from which the byproduct substance was generated, and when the site is reporting the byproduct or a different chemical substance that was manufactured from the recycled byproduct or manufactured in the same overall manufacturing process:</P> <P> (i) <E T="03">List of processes and certain related byproduct substances.</E> (A) Portland Cement Manufacturing ( <E T="03">i.e.,</E> CASRN 68475-76-3, Flue dust, portland cement). </P> <P> (B) Kraft Pulping Process ( <E T="03">i.e.,</E> CASRN 66071-92-9, Sulfite liquors and Cooking liquors, spent; CASRN 68514-09-0, Sulfite liquors and Cooking liquors, spent, oxidized; and CASRN 471-34-1, Carbonic acid calcium salt (1:1)). </P> <P> (ii) <E T="03">Amendments.</E> EPA may amend the exemptions list in paragraph (d)(1)(i) of this section on its own initiative or in response to a request from the public based on EPA's determination of whether the byproduct substance and process described meet the criteria explained in this paragraph (d)(1), based on the requirements and considerations listed in paragraphs (d)(1)(ii)(B) and (C) of this section. </P> <P>(A) Any person may request that EPA amend the chemical substance list in paragraph (d)(1)(i) of this section. Your request must be in writing and must be submitted to the address provided in 40 CFR 700.17(a). Please label your request as follows: Attention: TSCA Chemical Data Reporting—Byproduct Exemption Request. Requests must identify the manufacturing process and byproduct chemical substance in question, as well as its CASRN or other chemical identification number as identified in 40 CFR 711.15(b)(3)(i), and must contain a written rationale for the request that provides sufficient specific information, addressing the requirements and considerations listed in paragraphs (d)(1)(ii)(B) and (C) of this section, including citations and relevant documents, to demonstrate to EPA that the byproduct substance and process in question either does or does not meet the criteria explained in this paragraph (d)(1). If a request related to a particular byproduct substance and process is resubmitted, any subsequent request must clearly identify new information contained in the request. EPA may request other information that it believes necessary to evaluate the request. EPA will issue a written response to each request within 120 days of receipt of the request and will maintain copies of these responses in a docket that will be established for each reporting cycle.</P> <P>(B) In making its determination whether this exemption should apply to a particular manufacturing process and related byproduct substance, the following two requirements must be met:</P> <P> ( <E T="03">1</E> ) The byproduct substance is recycled or otherwise used to manufacture another chemical substance within an enclosed system, within the same overall manufacturing process, and on the same site as that byproduct was originally manufactured. </P> <P> ( <E T="03">2</E> ) The site is reporting under CDR other chemical substances, in particular a chemical substance other than the byproduct substance that was manufactured from the byproduct or manufactured in the same overall manufacturing process. </P> <P>(C) In addition to the requirements in paragraph (d)(1)(ii)(B) of this section, EPA will consider the totality of information available for the process and related byproduct substance in question, including but not limited to, one or both of the following considerations:</P> <P> ( <E T="03">1</E> ) Whether EPA has a current interest in the byproduct substance. </P> <P> ( <E T="03">2</E> ) Whether the byproduct substance must have already been reported under CDR, or would be expected to be reported if not exempted by this exemption. </P> <P>(D) After granting a petition, the Agency will initiate rulemaking to make revisions to the list of substances in paragraph (d)(1)(i) of this section.</P> <P> (E) To assist EPA in reaching a decision regarding a particular request prior to a given principal reporting year, requests must be submitted to EPA no later than 12 months prior to <PRTPAGE P="137"/> the start of the next principal reporting year. </P> <P>(2) A quantity of the byproduct that is manufactured solely in the following equipment when it is not integral to the chemical manufacturing processes of the site:</P> <P>(i) Pollution control equipment.</P> <P>(ii) Boilers used to generate heat or electricity for that site.</P> <CITA>[85 FR 20139, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.15</SECTNO> <SUBJECT>Reporting information to EPA.</SUBJECT> <P> Any person who must report under this part, as described in § 711.8, must submit the information described in this section for each chemical substance described in § 711.5 that the person manufactured (including imported) for commercial purposes in an amount of 25,000 lb (11,340 kg) or more (or in an amount of 2,500 lb (1,134 kg) or more for chemical substances subject to the rules, orders, or actions described in § 711.8(b)) at any one site during any calendar year since the last principal reporting year ( <E T="03">e.g.,</E> for the 2020 submission period, consider calendar years 2016, 2017, 2018, and 2019, because 2015 was the last principal reporting year). The principal reporting year for each submission period is the previous calendar year ( <E T="03">e.g.,</E> the principal reporting year for the 2020 submission period is calendar year 2019). For all submission periods, a separate report must be submitted for each chemical substance at each site for which the submitter is required to report. A submitter of information under this part must report information as described in this section to the extent that such information is known to or reasonably ascertainable by that person. </P> <P> (a) <E T="03">Reporting information to EPA.</E> Any person who reports information to EPA must complete a Form U using the e-CDRweb reporting tool provided by EPA at the address set forth in § 711.35. The submission must include all information described in paragraph (b) of this section. Persons must submit the chemical reports on a separate single Form U for each site for which the person is required to report. The e-CDRweb reporting tool is described in the instructions available from EPA at the website set forth in § 711.35. </P> <P> (b) <E T="03">Information to be reported.</E> The information described in paragraphs (b)(1) through (4) of this section must be reported for each chemical substance manufactured (including imported) in an amount of 25,000 lb (11,340 kg) or more (or in an amount of 2,500 lb (1,134 kg) or more for chemical substances subject to the rules, orders, or actions described in § 711.8(b)) at any one site during any calendar year since the last principal reporting year. The requirement to report information described in paragraph (b)(4) of this section is subject to exemption as described in § 711.6. </P> <P> (1) <E T="03">A certification statement signed and dated by an authorized official of the submitter company.</E> The authorized official must certify that the submitted information has been completed in compliance with the requirements of this part and that the confidentiality claims made on the Form U are true and correct. The certification must be signed and dated by the authorized official for the submitter company, and provide that person's name, official title, and email address. </P> <P> (2) <E T="03">Company and site information.</E> The following currently correct parent company and site information at the date of CDR submission must be reported for each site at which a reportable chemical substance is manufactured (including imported) above the applicable production volume threshold, as described in this section (see § 711.3 for the “site” for importers and special situations). </P> <P>(i) The legal name, address, and Dun and Bradstreet D-U-N-S® (D&B) number for the highest-level parent company located in the United States and, if one exists, for the highest-level foreign-based parent company. A submitter under this part must obtain a D&B number for the parent company if none exists and must report using the standardized conventions for the naming of a parent company as provided in the CDR Instructions for Reporting identified in § 711.35.</P> <P> (ii) The name of a person who will serve as technical contact for the submitter company who will be able to answer questions about the information submitted by the company to EPA, and that technical contact person's full <PRTPAGE P="138"/> mailing address, telephone number, and email address. </P> <P>(iii) The legal name and full street address of each site. A submitter under this part must include the appropriate D&B number for each site reported, and the county or parish (or other jurisdictional indicator) in which the site is located. A submitter under this part must obtain a D&B number for the site reported if none exists. For a co-manufacturing situation in which the contracting company initiates the report, the contracting company must report both the site controlling the contract and the producing company's site information.</P> <P>(iv) The six-digit NAICS code for the site. A submitter under this part must include the appropriate six-digit NAICS code for each site reported.</P> <P> (3) <E T="03">Chemical-specific information.</E> The following chemical-specific information must be reported for each reportable chemical substance manufactured (including imported) above the applicable production volume threshold, as described in paragraph (b) of this section: </P> <P>(i) The specific, currently correct CA Index name as used to list the chemical substance on the TSCA Inventory and the correct corresponding CASRN for each reportable chemical substance at each site. Submitters who wish to report chemical substances listed on the confidential portion of the TSCA Inventory will need to report the chemical substance using the corresponding TSCA Accession Number that is listed on the public portion of the Inventory. In addition to reporting the chemical identifying number itself, submitters must specify the type of number they are reporting by selecting from among the codes in Table 1 to paragraph (b)(3)(i).</P> <GPOTABLE COLS="2" OPTS="L2,nj,p7,7/8" CDEF="xs24,r75"> <TTITLE> Table 1 to Paragraph <E T="01">(b)(3)(i)</E> —Codes To Specify Type of Chemical Identifying Number </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Number type</CHED> </BOXHD> <ROW> <ENT I="01">A</ENT> <ENT>TSCA Accession Number.</ENT> </ROW> <ROW> <ENT I="01">C</ENT> <ENT>Chemical Abstracts Service Registry Number (CASRN).</ENT> </ROW> </GPOTABLE> <P>(A) If an importer submitting a report cannot provide the information specified in this paragraph (b)(3)(i) because it is unknown to the importer and claimed as confidential by the supplier of the chemical substance or mixture, the importer must use e-CDRweb to ask the supplier to provide the correct chemical identity and, in the case of a mixture, the percentage of formulation and chemical function information directly to EPA in a joint submission. Such request must include instructions for submitting chemical identity information electronically, using e-CDRweb and CDX (see § 711.35), and for clearly referencing the importer's submission. Contact information for the supplier, a trade name or other designation for the chemical substance or mixture, and a copy of the request to the supplier must be included with the importer's submission.</P> <P>(B) If a manufacturer submitting a report cannot provide the information specified in this paragraph (b)(3)(i) because the reportable chemical substance is manufactured using a reactant having a specific chemical identity that is unknown to the manufacturer and claimed as confidential by its supplier, the manufacturer must use e-CDRweb to ask the supplier of the confidential reactant to provide the correct chemical identity of the confidential reactant directly to EPA in a joint submission. Such request must include instructions for submitting chemical identity information electronically using e-CDRweb and CDX (see § 711.35), and for clearly referencing the manufacturer's submission. Contact information for the supplier, a trade name or other designation for the chemical substance, and a copy of the request to the supplier must be included with the importer's submission.</P> <P>(C) EPA will accept only joint submissions that are submitted electronically using e-CDRweb and CDX (see § 711.35) and that clearly reference the primary submission to which they refer.</P> <P> (ii) For the principal reporting year only, a statement indicating, for each reportable chemical substance at each site, whether the chemical substance is manufactured in the United States, imported into the United States, or both manufactured in the United States and imported into the United States. <PRTPAGE P="139"/> </P> <P>(iii) For the principal reporting year only, the total annual volume (in pounds) of each reportable chemical substance domestically manufactured or imported at each site. The total annual domestically manufactured volume (not including imported volume) and the total annual imported volume must be separately reported. These amounts must be reported to two significant figures of accuracy. In addition, the total annual volume (domestically manufactured plus imported volumes in pounds) of each reportable chemical substance at each site for each complete calendar year since the last principal reporting year.</P> <P>(iv) For the principal reporting year only, the volume used on site and the volume directly exported of each reportable chemical substance domestically manufactured or imported at each site. These amounts must be reported to two significant figures of accuracy.</P> <P>(v) For the principal reporting year only, a designation indicating, for each imported reportable chemical substance at each site, whether the imported chemical substance is physically present at the reporting site.</P> <P>(vi) For the principal reporting year only, a designation indicating, for each reportable chemical substance at each site, whether the chemical substance is being recycled or otherwise used for a commercial purpose instead of being disposed of as a waste or included in a waste stream.</P> <P> (vii) For the principal reporting year only, the total number of workers reasonably likely to be exposed to each reportable chemical substance at each site. For each reportable chemical substance at each site, the submitter must select from among the ranges of workers listed in Table 2 to paragraph (b)(3)(vii) and report the corresponding code ( <E T="03">i.e.,</E> W1 through W8): </P> <GPOTABLE COLS="2" OPTS="L2,p7,7/8" CDEF="xs24,r75"> <TTITLE> Table 2 to Paragraph <E T="01">(b)(3)(vii)</E> —Codes for Reporting Number of Workers Reasonably Likely To Be Exposed </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Range</CHED> </BOXHD> <ROW> <ENT I="01">W1</ENT> <ENT>Fewer than 10 workers.</ENT> </ROW> <ROW> <ENT I="01">W2</ENT> <ENT>At least 10 but fewer than 25 workers.</ENT> </ROW> <ROW> <ENT I="01">W3</ENT> <ENT>At least 25 but fewer than 50 workers.</ENT> </ROW> <ROW> <ENT I="01">W4</ENT> <ENT>At least 50 but fewer than 100 workers.</ENT> </ROW> <ROW> <ENT I="01">W5</ENT> <ENT>At least 100 but fewer than 500 workers.</ENT> </ROW> <ROW> <ENT I="01">W6</ENT> <ENT>At least 500 but fewer than 1,000 workers.</ENT> </ROW> <ROW> <ENT I="01">W7</ENT> <ENT>At least 1,000 but fewer than 10,000 workers.</ENT> </ROW> <ROW> <ENT I="01">W8</ENT> <ENT>At least 10,000 workers.</ENT> </ROW> </GPOTABLE> <P> (viii) For the principal reporting year only, the maximum concentration, measured by percentage of weight, of each reportable chemical substance at the time it is sent off-site from each site. If the chemical substance is site-limited, you must report the maximum concentration, measured by percentage of weight of the reportable chemical substance at the time it is reacted on-site to produce a different chemical substance. This information must be reported regardless of the physical form(s) in which the chemical substance is sent off-site/reacted on-site. For each chemical substance at each site, select the maximum concentration of the chemical substance from among the ranges listed in Table 3 to paragraph (b)(3)(viii) and report the corresponding code ( <E T="03">i.e.,</E> M1 through M5): </P> <GPOTABLE COLS="2" OPTS="L2,p7,7/8" CDEF="xs24,r75"> <TTITLE> Table 3 to Paragraph <E T="01">(b)(3)(viii)</E> —Codes for Reporting Maximum Concentration of Chemical Substance </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1"> Concentration range <LI>(percent weight)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">M1</ENT> <ENT>Less than 1 percent by weight.</ENT> </ROW> <ROW> <ENT I="01">M2</ENT> <ENT>At least 1 but less than 30 percent by weight.</ENT> </ROW> <ROW> <ENT I="01">M3</ENT> <ENT>At least 30 but less than 60 percent by weight.</ENT> </ROW> <ROW> <ENT I="01">M4</ENT> <ENT>At least 60 but less than 90 percent by weight.</ENT> </ROW> <ROW> <ENT I="01">M5</ENT> <ENT>At least 90 percent by weight.</ENT> </ROW> </GPOTABLE> <P> (ix) For the principal reporting year only, the physical form(s) of the reportable chemical substance as it is sent off-site from each site. If the chemical substance is site-limited, you must report the physical form(s) of the reportable chemical substance at the time it is reacted on-site to produce a different chemical substance. For each chemical substance at each site, the <PRTPAGE P="140"/> submitter must report as many physical forms as applicable from among the physical forms listed in this Unit: </P> <P>(A) Dry powder.</P> <P>(B) Pellets or large crystals.</P> <P>(C) Water- or solvent-wet solid.</P> <P>(D) Other solid.</P> <P>(E) Gas or vapor.</P> <P>(F) Liquid.</P> <P>(x) For the principal reporting year only, submitters must report the percentage, rounded off to the closest 10 percent, of total production volume of the reportable chemical substance, reported in response to paragraph (b)(3)(iii) of this section, that is associated with each physical form reported under paragraph (b)(3)(ix) of this section.</P> <P> (4) <E T="03">Chemical-specific information related to processing and use.</E> The following chemical-specific information must be reported for each reportable chemical substance manufactured (including imported) above the applicable production volume threshold, as described in this section. Persons subject to paragraph (b)(4) of this section must report the information described in paragraphs (b)(4)(i) and (ii) of this section for each reportable chemical substance at sites under their control and at sites that receive a reportable chemical substance from the submitter directly or indirectly (including through a broker/distributor, from a customer of the submitter, <E T="03">etc.</E> ). Information reported in response to this paragraph must be reported for the principal reporting year only and only to the extent that it is known to or reasonably ascertainable by the submitter. Information required to be reported under this paragraph is limited to domestic ( <E T="03">i.e.,</E> within the customs territory of the United States) processing and use activities. If information responsive to a given data requirement under this paragraph, including information in the form of an estimate, is not known or reasonably ascertainable, the submitter is not required to respond to the requirement. </P> <P> (i) <E T="03">Industrial processing and use information.</E> (A) A designation indicating the type of industrial processing or use operation(s) at each site that receives a reportable chemical substance from the submitter site directly or indirectly (whether the recipient site(s) are controlled by the submitter site or not). For each chemical substance, report the letters which correspond to the appropriate processing or use operation(s) listed in Table 4 to paragraph (b)(4)(i)(A). A particular designation may need to be reported more than once, to the extent that a submitter reports more than one sector (under paragraph (b)(4)(i)(B) of this section) that applies to a given designation under this paragraph. </P> <GPOTABLE COLS="2" OPTS="L2,p7,7/8" CDEF="s25,r75"> <TTITLE> Table 4 to Paragraph <E T="01">(b)(4)(i)(A)</E> —Codes for Reporting Type of Industrial Processing or Use Operation </TTITLE> <BOXHD> <CHED H="1">Designation</CHED> <CHED H="1">Operation</CHED> </BOXHD> <ROW> <ENT I="01">PC</ENT> <ENT>Processing as a reactant.</ENT> </ROW> <ROW> <ENT I="01">PF</ENT> <ENT>Processing—incorporation into formulation, mixture, or reaction product.</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Processing—incorporation into article.</ENT> </ROW> <ROW> <ENT I="01">PK</ENT> <ENT>Processing—repackaging.</ENT> </ROW> <ROW> <ENT I="01">U</ENT> <ENT>Use—non-incorporative activities.</ENT> </ROW> </GPOTABLE> <P>(B) A code indicating the sector(s) that best describe the industrial activities associated with each industrial processing or use operation reported under paragraph (b)(4)(i)(A) of this section. For each chemical substance, report the code that corresponds to the appropriate sector(s) listed in Table 5 to paragraph (b)(4)(i)(B). A particular sector code may need to be reported more than once, to the extent that a submitter reports more than one function code (under paragraph (b)(4)(i)(C) of this section) that applies to a given sector code under this paragraph.</P> <GPOTABLE COLS="2" OPTS="L2,nj,p7,7/8" CDEF="s24,r75"> <TTITLE> Table 5 to Paragraph <E T="01">(b)(4)(i)(B)</E> —Codes for Reporting Industrial Sectors </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Sector description</CHED> </BOXHD> <ROW> <ENT I="01">IS1</ENT> <ENT>Agriculture, forestry, fishing, and hunting.</ENT> </ROW> <ROW> <ENT I="01">IS2</ENT> <ENT>Oil and gas drilling, extraction, and support activities.</ENT> </ROW> <ROW> <ENT I="01">IS3</ENT> <ENT>Mining (except oil and gas) and support activities.</ENT> </ROW> <ROW> <ENT I="01">IS4</ENT> <ENT>Utilities.</ENT> </ROW> <ROW> <ENT I="01">IS5</ENT> <ENT>Construction.</ENT> </ROW> <ROW> <ENT I="01">IS6</ENT> <ENT>Food, beverage, and tobacco product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS7</ENT> <ENT>Textiles, apparel, and leather manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS8</ENT> <ENT>Wood product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS9</ENT> <ENT>Paper manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS10</ENT> <ENT>Printing and related support activities.</ENT> </ROW> <ROW> <PRTPAGE P="141"/> <ENT I="01">IS11</ENT> <ENT>Petroleum refineries.</ENT> </ROW> <ROW> <ENT I="01">IS12</ENT> <ENT>Asphalt paving, roofing, and coating materials manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS13</ENT> <ENT>Petroleum lubricating oil and grease manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS14</ENT> <ENT>All other petroleum and coal products manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS15</ENT> <ENT>Petrochemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS16</ENT> <ENT>Industrial gas manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS17</ENT> <ENT>Synthetic dye and pigment manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS18</ENT> <ENT>Carbon black manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS19</ENT> <ENT>All other basic inorganic chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS20</ENT> <ENT>Cyclic crude and intermediate manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS21</ENT> <ENT>All other basic organic chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS22</ENT> <ENT>Plastics material and resin manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS23</ENT> <ENT>Synthetic rubber manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS24</ENT> <ENT>Organic fiber manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS25</ENT> <ENT>Pesticide, fertilizer, and other agricultural chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS26</ENT> <ENT>Pharmaceutical and medicine manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS27</ENT> <ENT>Paint and coating manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS28</ENT> <ENT>Adhesive manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS29</ENT> <ENT>Soap, cleaning compound, and toilet preparation manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS30</ENT> <ENT>Printing ink manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS31</ENT> <ENT>Explosives manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS32</ENT> <ENT>Custom compounding of purchased resins.</ENT> </ROW> <ROW> <ENT I="01">IS33</ENT> <ENT>Photographic film, paper, plate, and chemical manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS34</ENT> <ENT>All other chemical product and preparation manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS35</ENT> <ENT>Plastics product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS36</ENT> <ENT>Rubber product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS37</ENT> <ENT>Non-metallic mineral product manufacturing (includes cement, clay, concrete, glass, gypsum, lime, and other non-metallic mineral product manufacturing).</ENT> </ROW> <ROW> <ENT I="01">IS38</ENT> <ENT>Primary metal manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS39</ENT> <ENT>Fabricated metal product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS40</ENT> <ENT>Machinery manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS41</ENT> <ENT>Computer and electronic product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS42</ENT> <ENT>Electrical equipment, appliance, and component manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS43</ENT> <ENT>Transportation equipment manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS44</ENT> <ENT>Furniture and related product manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS45</ENT> <ENT>Miscellaneous manufacturing.</ENT> </ROW> <ROW> <ENT I="01">IS46</ENT> <ENT>Wholesale and retail trade.</ENT> </ROW> <ROW> <ENT I="01">IS47</ENT> <ENT>Services.</ENT> </ROW> <ROW> <ENT I="01">IS48</ENT> <ENT>Other (requires additional information).</ENT> </ROW> </GPOTABLE> <P>(C) For each sector reported under paragraph (b)(4)(i)(B) of this section, the applicable code(s) from Table 6 to paragraph (b)(4)(i)(C) must be selected to designate the function category(ies) that best represents the specific manner in which the chemical substance is used. For the 2020 submission period:</P> <P> ( <E T="03">1</E> ) Use column A in Table 6 to paragraph (b)(4)(i)(C) for chemical substances designated in 2019 as high priority for risk evaluation (those chemicals listed in Table 7 to paragraph (b)(4)(i)(C)); and </P> <P> ( <E T="03">2</E> ) Use either column A or B in Table 6 to paragraph (b)(4)(i)(C) for chemical substances not listed in Table 7 to paragraph (b)(4)(i)(C). For the 2024 and future submission periods, use only column A in Table 6 to paragraph (b)(4)(i)(C). A particular function category may need to be reported more than once, to the extent that a submitter reports more than one industrial processing or use operation/sector combination (under paragraphs (b)(4)(i)(A) and (B) of this section) that applies to a given function category under this paragraph. If more than 10 unique combinations of industrial processing or use operations/sector/function categories apply to a chemical substance, submitters need only report the 10 unique combinations for the chemical substance that cumulatively represent the largest percentage of the submitter's production volume for that chemical substance, measured by weight. If none of the listed function categories accurately describes a use of a chemical substance, the category “Other” may be used, and must include a description of the use. </P> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs20,r50,xs24,r50"> <TTITLE> Table 6 to Paragraph <E T="01">(b)(4)(i)(C)</E> —Codes for Reporting Function Categories </TTITLE> <BOXHD> <CHED H="1">Column A</CHED> <CHED H="2">Code</CHED> <CHED H="2">Category</CHED> <CHED H="1">Column B</CHED> <CHED H="2">Code</CHED> <CHED H="2">Category</CHED> </BOXHD> <ROW> <ENT I="01">F001</ENT> <ENT>Abrasives</ENT> <ENT>U001</ENT> <ENT>Abrasives.</ENT> </ROW> <ROW> <ENT I="01">F002</ENT> <ENT>Etching agent</ENT> </ROW> <ROW> <PRTPAGE P="142"/> <ENT I="01">F003</ENT> <ENT>Adhesion/cohesion promoter</ENT> <ENT>U002</ENT> <ENT>Adhesives and sealant chemicals.</ENT> </ROW> <ROW> <ENT I="01">F004</ENT> <ENT>Binder</ENT> </ROW> <ROW> <ENT I="01">F005</ENT> <ENT>Flux agent</ENT> </ROW> <ROW> <ENT I="01">F006</ENT> <ENT>Sealant (barrier)</ENT> </ROW> <ROW> <ENT I="01">F007</ENT> <ENT>Absorbent</ENT> <ENT>U003</ENT> <ENT>Adsorbents and absorbents.</ENT> </ROW> <ROW> <ENT I="01">F008</ENT> <ENT>Adsorbent</ENT> </ROW> <ROW> <ENT I="01">F009</ENT> <ENT>Dehydrating agent (desiccant)</ENT> </ROW> <ROW> <ENT I="01">F010</ENT> <ENT>Drier</ENT> </ROW> <ROW> <ENT I="01">F011</ENT> <ENT>Humectant</ENT> </ROW> <ROW> <ENT I="01">F012</ENT> <ENT>Soil amendments (fertilizers)</ENT> <ENT>U004</ENT> <ENT>Agricultural chemicals (non-pesticidal).</ENT> </ROW> <ROW> <ENT I="01">F013</ENT> <ENT>Anti-adhesive/cohesive</ENT> <ENT>U005</ENT> <ENT>Anti-adhesive agents.</ENT> </ROW> <ROW> <ENT I="01">F014</ENT> <ENT>Dusting agent</ENT> </ROW> <ROW> <ENT I="01">F015</ENT> <ENT>Bleaching agent</ENT> <ENT>U006</ENT> <ENT>Bleaching agents.</ENT> </ROW> <ROW> <ENT I="01">F016</ENT> <ENT>Brightener</ENT> </ROW> <ROW> <ENT I="01">F017</ENT> <ENT>Anti-scaling agent</ENT> <ENT>U007</ENT> <ENT>Corrosion inhibitors and anti-scaling agents.</ENT> </ROW> <ROW> <ENT I="01">F018</ENT> <ENT>Corrosion inhibitor</ENT> </ROW> <ROW> <ENT I="01">F019</ENT> <ENT>Dye</ENT> <ENT>U008</ENT> <ENT>Dyes.</ENT> </ROW> <ROW> <ENT I="01">F020</ENT> <ENT>Fixing agent (mordant)</ENT> </ROW> <ROW> <ENT I="01">F021</ENT> <ENT>Hardener</ENT> <ENT>U009</ENT> <ENT>Fillers.</ENT> </ROW> <ROW> <ENT I="01">F022</ENT> <ENT>Filler</ENT> </ROW> <ROW> <ENT I="01">F023</ENT> <ENT>Anti-static agent</ENT> <ENT>U010</ENT> <ENT>Finishing agents.</ENT> </ROW> <ROW> <ENT I="01">F024</ENT> <ENT>Softener and conditioner</ENT> </ROW> <ROW> <ENT I="01">F025</ENT> <ENT>Swelling agent</ENT> </ROW> <ROW> <ENT I="01">F026</ENT> <ENT>Tanning agents not otherwise specified</ENT> </ROW> <ROW> <ENT I="01">F027</ENT> <ENT>Waterproofing agent</ENT> </ROW> <ROW> <ENT I="01">F028</ENT> <ENT>Wrinkle resisting agent</ENT> </ROW> <ROW> <ENT I="01">F029</ENT> <ENT>Flame retardant</ENT> <ENT>U011</ENT> <ENT>Flame retardants.</ENT> </ROW> <ROW> <ENT I="01">F030</ENT> <ENT>Fuel agents</ENT> <ENT>U012</ENT> <ENT>Fuels and fuel additives.</ENT> </ROW> <ROW> <ENT I="01">F031</ENT> <ENT>Fuel</ENT> </ROW> <ROW> <ENT I="01">F032</ENT> <ENT>Heat transferring agent</ENT> <ENT>U013</ENT> <ENT>Functional fluids (closed systems).</ENT> </ROW> <ROW> <ENT I="01">F033</ENT> <ENT>Hydraulic fluids</ENT> </ROW> <ROW> <ENT I="01">F034</ENT> <ENT>Insulators</ENT> </ROW> <ROW> <ENT I="01">F035</ENT> <ENT>Refrigerants</ENT> </ROW> <ROW> <ENT I="01">F036</ENT> <ENT>Anti-freeze agent</ENT> <ENT>U014</ENT> <ENT>Functional fluids (open systems).</ENT> </ROW> <ROW> <ENT I="01">F037</ENT> <ENT>Intermediate</ENT> <ENT>U015</ENT> <ENT>Intermediates.</ENT> </ROW> <ROW> <ENT I="01">F038</ENT> <ENT>Monomers</ENT> </ROW> <ROW> <ENT I="01">F039</ENT> <ENT>Ion exchange agent</ENT> <ENT>U016</ENT> <ENT>Ion exchange agents.</ENT> </ROW> <ROW> <ENT I="01">F040</ENT> <ENT>Anti-slip agent</ENT> <ENT>U017</ENT> <ENT>Lubricants and lubricant additives.</ENT> </ROW> <ROW> <ENT I="01">F041</ENT> <ENT>Lubricating agent</ENT> </ROW> <ROW> <ENT I="01">F042</ENT> <ENT>Deodorizer</ENT> <ENT>U018</ENT> <ENT>Odor agents.</ENT> </ROW> <ROW> <ENT I="01">F043</ENT> <ENT>Fragrance</ENT> </ROW> <ROW> <ENT I="01">F044</ENT> <ENT>Oxidizing agent</ENT> <ENT>U019</ENT> <ENT>Oxidizing/reducing agents.</ENT> </ROW> <ROW> <ENT I="01">F045</ENT> <ENT>Reducing agent</ENT> </ROW> <ROW> <ENT I="01">F046</ENT> <ENT>Photosensitive agent</ENT> <ENT>U020</ENT> <ENT>Photosensitive chemicals.</ENT> </ROW> <ROW> <ENT I="01">F047</ENT> <ENT>Photosensitizers</ENT> </ROW> <ROW> <ENT I="01">F048</ENT> <ENT>Semiconductor and photovoltaic agent</ENT> </ROW> <ROW> <ENT I="01">F049</ENT> <ENT>UV stabilizer</ENT> </ROW> <ROW> <ENT I="01">F050</ENT> <ENT>Opacifer</ENT> <ENT>U021</ENT> <ENT>Pigments.</ENT> </ROW> <ROW> <ENT I="01">F051</ENT> <ENT>Pigment</ENT> </ROW> <ROW> <ENT I="01">F052</ENT> <ENT>Plasticizer</ENT> <ENT>U022</ENT> <ENT>Plasticizers.</ENT> </ROW> <ROW> <ENT I="01">F053</ENT> <ENT>Plating agent</ENT> <ENT>U023</ENT> <ENT>Plating agents and surface treating agents.</ENT> </ROW> <ROW> <ENT I="01">F054</ENT> <ENT>Catalyst</ENT> <ENT>U024</ENT> <ENT>Process regulators.</ENT> </ROW> <ROW> <ENT I="01">F055</ENT> <ENT>Chain transfer agent</ENT> </ROW> <ROW> <ENT I="01">F056</ENT> <ENT>Chemical reaction regulator</ENT> </ROW> <ROW> <ENT I="01">F057</ENT> <ENT>Crystal growth modifiers (nucleating agents)</ENT> </ROW> <ROW> <ENT I="01">F058</ENT> <ENT>Polymerization promoter</ENT> </ROW> <ROW> <ENT I="01">F059</ENT> <ENT>Terminator/Blocker</ENT> </ROW> <ROW> <ENT I="01">F060</ENT> <ENT>Processing aids, specific to petroleum production</ENT> <ENT>U025</ENT> <ENT>Processing aids, specific to petroleum production.</ENT> </ROW> <ROW> <ENT I="01">F061</ENT> <ENT>Antioxidant</ENT> <ENT>U026</ENT> <ENT>Processing aids, not otherwise listed.</ENT> </ROW> <ROW> <ENT I="01">F062</ENT> <ENT>Chelating agent</ENT> </ROW> <ROW> <ENT I="01">F063</ENT> <ENT>Defoamer</ENT> </ROW> <ROW> <ENT I="01">F064</ENT> <ENT>pH regulating agent</ENT> </ROW> <ROW> <ENT I="01">F065</ENT> <ENT>Processing aids not otherwise specified</ENT> </ROW> <ROW> <ENT I="01">F066</ENT> <ENT>Energy Releasers (explosives, motive propellant)</ENT> <ENT>U027</ENT> <ENT>Propellants and blowing agents.</ENT> </ROW> <ROW> <ENT I="01">F067</ENT> <ENT>Foamant</ENT> </ROW> <ROW> <ENT I="01">F068</ENT> <ENT>Propellants, non-motive (blowing agents)</ENT> </ROW> <ROW> <ENT I="01">F069</ENT> <ENT>Cloud-point depressant</ENT> <ENT>U028</ENT> <ENT>Solids separation agents.</ENT> </ROW> <ROW> <ENT I="01">F070</ENT> <ENT>Flocculating agent</ENT> </ROW> <ROW> <ENT I="01">F071</ENT> <ENT>Flotation agent</ENT> </ROW> <ROW> <ENT I="01">F072</ENT> <ENT>Solids separation (precipitating) agent, not otherwise specified</ENT> </ROW> <ROW> <ENT I="01">F073</ENT> <ENT>Cleaning agent</ENT> <ENT>U029</ENT> <ENT>Solvents (for cleaning or degreasing).</ENT> </ROW> <ROW> <ENT I="01">F074</ENT> <ENT>Diluent</ENT> <ENT>U030</ENT> <ENT>Solvents (which become part of product formulation or mixture).</ENT> </ROW> <ROW> <ENT I="01">F075</ENT> <ENT>Solvent</ENT> </ROW> <ROW> <ENT I="01">F076</ENT> <ENT>Surfactant (surface active agent)</ENT> <ENT>U031</ENT> <ENT>Surface active agents.</ENT> </ROW> <ROW> <ENT I="01">F077</ENT> <ENT>Emulsifier</ENT> </ROW> <ROW> <ENT I="01">F078</ENT> <ENT>Thickening agent</ENT> <ENT>U032</ENT> <ENT>Viscosity adjustors.</ENT> </ROW> <ROW> <ENT I="01">F079</ENT> <ENT>Viscosity modifiers</ENT> </ROW> <ROW> <ENT I="01">F080</ENT> <ENT>Laboratory chemicals</ENT> <ENT>U033</ENT> <ENT>Laboratory chemicals.</ENT> </ROW> <ROW> <PRTPAGE P="143"/> <ENT I="01">F081</ENT> <ENT>Dispersing agent</ENT> <ENT>U034</ENT> <ENT>Paint additives and coating additives not described by other categories.</ENT> </ROW> <ROW> <ENT I="01">F082</ENT> <ENT>Freeze-thaw additive</ENT> </ROW> <ROW> <ENT I="01">F083</ENT> <ENT>Surface modifier</ENT> </ROW> <ROW> <ENT I="01">F084</ENT> <ENT>Wetting agent (non-aqueous)</ENT> </ROW> <ROW> <ENT I="01">F085</ENT> <ENT>Aerating and deaerating agents</ENT> <ENT>U999</ENT> <ENT>Other (specify).</ENT> </ROW> <ROW> <ENT I="01">F086</ENT> <ENT>Explosion inhibitor</ENT> </ROW> <ROW> <ENT I="01">F087</ENT> <ENT>Fire extinguishing agent</ENT> </ROW> <ROW> <ENT I="01">F088</ENT> <ENT>Flavoring and nutrient</ENT> </ROW> <ROW> <ENT I="01">F089</ENT> <ENT>Anti-redeposition agent</ENT> </ROW> <ROW> <ENT I="01">F090</ENT> <ENT>Anti-stain agent</ENT> </ROW> <ROW> <ENT I="01">F091</ENT> <ENT>Anti-streaking agent</ENT> </ROW> <ROW> <ENT I="01">F092</ENT> <ENT>Conductive agent</ENT> </ROW> <ROW> <ENT I="01">F093</ENT> <ENT>Incandescent agent</ENT> </ROW> <ROW> <ENT I="01">F094</ENT> <ENT>Magnetic element</ENT> </ROW> <ROW> <ENT I="01">F095</ENT> <ENT>Anti-condensation agent</ENT> </ROW> <ROW> <ENT I="01">F096</ENT> <ENT>Coalescing agent</ENT> </ROW> <ROW> <ENT I="01">F097</ENT> <ENT>Film former</ENT> </ROW> <ROW> <ENT I="01">F098</ENT> <ENT>Demulsifier</ENT> </ROW> <ROW> <ENT I="01">F099</ENT> <ENT>Stabilizing agent</ENT> </ROW> <ROW> <ENT I="01">F100</ENT> <ENT>Alloys</ENT> </ROW> <ROW> <ENT I="01">F101</ENT> <ENT>Density modifier</ENT> </ROW> <ROW> <ENT I="01">F102</ENT> <ENT>Elasticizer</ENT> </ROW> <ROW> <ENT I="01">F103</ENT> <ENT>Flow promoter</ENT> </ROW> <ROW> <ENT I="01">F104</ENT> <ENT>Sizing agent</ENT> </ROW> <ROW> <ENT I="01">F105</ENT> <ENT>Solubility enhancer</ENT> </ROW> <ROW> <ENT I="01">F106</ENT> <ENT>Vapor pressure modifiers</ENT> </ROW> <ROW> <ENT I="01">F107</ENT> <ENT>Embalming agent</ENT> </ROW> <ROW> <ENT I="01">F108</ENT> <ENT>Heat stabilizer</ENT> </ROW> <ROW> <ENT I="01">F109</ENT> <ENT>Preservative</ENT> </ROW> <ROW> <ENT I="01">F110</ENT> <ENT>Anti-caking agent</ENT> </ROW> <ROW> <ENT I="01">F111</ENT> <ENT>Deflocculant</ENT> </ROW> <ROW> <ENT I="01">F112</ENT> <ENT>Dust suppressant</ENT> </ROW> <ROW> <ENT I="01">F113</ENT> <ENT>Impregnation agent</ENT> </ROW> <ROW> <ENT I="01">F114</ENT> <ENT>Leaching agent</ENT> </ROW> <ROW> <ENT I="01">F115</ENT> <ENT>Tracer</ENT> </ROW> <ROW> <ENT I="01">F116</ENT> <ENT>X-ray absorber</ENT> </ROW> <ROW> <ENT I="01">F999</ENT> <ENT>Other</ENT> </ROW> <TNOTE>For the 2020 submission period: (1) Use column A for chemical substances designated in 2019 as high priority for risk evaluation (those chemicals listed in Table 7 to paragraph(b)(4)(i)(C) and (2) use either column A or B for chemical substances not listed in Table 7 to paragraph (b)(4)(i)(C).</TNOTE> <TNOTE>For the 2024 and future submission periods, use only column A.</TNOTE> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s40,r60"> <TTITLE> Table 7 to Paragraph <E T="01">(b)(4)(i)(C)</E> —CASRNs of Chemical Substances Designated as High Priority for Risk Evaluation Under TSCA Section 6 <E T="01">(b)</E> on December 30, 2019 </TTITLE> <BOXHD> <CHED H="1">CASRN</CHED> <CHED H="1">Chemical substance</CHED> </BOXHD> <ROW> <ENT I="01">106-46-7</ENT> <ENT>p-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">107-06-2</ENT> <ENT>1,2-Dichloroethane.</ENT> </ROW> <ROW> <ENT I="01">156-60-5</ENT> <ENT>trans-1,2-Dichloroethylene.</ENT> </ROW> <ROW> <ENT I="01">95-50-1</ENT> <ENT>o-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">79-00-5</ENT> <ENT>1,1,2-Trichloroethane.</ENT> </ROW> <ROW> <ENT I="01">78-87-5</ENT> <ENT>1,2-Dichloropropane.</ENT> </ROW> <ROW> <ENT I="01">75-34-3</ENT> <ENT>1,1-Dichloroethane.</ENT> </ROW> <ROW> <ENT I="01">84-74-2</ENT> <ENT>Dibutyl phthalate (DBP) (1,2-Benzene-dicarboxylic acid, 1,2-dibutyl ester).</ENT> </ROW> <ROW> <ENT I="01">85-68-7</ENT> <ENT>Butyl benzyl phthalate (BBP)—1,2-Benzene-dicarboxylic acid, 1-butyl 2(phenylmethyl) ester.</ENT> </ROW> <ROW> <ENT I="01">117-81-7</ENT> <ENT>Di-ethylhexyl phthalate (DEHP)—(1,2-Benzene-dicarboxylic acid, 1,2-bis(2-ethylhexyl) ester).</ENT> </ROW> <ROW> <ENT I="01">84-69-5</ENT> <ENT>Di-isobutyl phthalate (DIBP)—(1,2-Benzene-dicarboxylic acid, 1,2-bis-(2methylpropyl) ester).</ENT> </ROW> <ROW> <ENT I="01">84-61-7</ENT> <ENT>Dicyclohexyl phthalate.</ENT> </ROW> <ROW> <ENT I="01">79-94-7</ENT> <ENT>4,4′-(1-Methylethylidene)bis[2,6-dibromophenol] (TBBPA).</ENT> </ROW> <ROW> <ENT I="01">115-96-8</ENT> <ENT>Tris(2-chloroethyl) phosphate (TCEP).</ENT> </ROW> <ROW> <ENT I="01">115-86-6</ENT> <ENT>Phosphoric acid, triphenyl ester (TPP).</ENT> </ROW> <ROW> <ENT I="01">106-93-4</ENT> <ENT>Ethylene dibromide.</ENT> </ROW> <ROW> <ENT I="01">106-99-0</ENT> <ENT>1,3-Butadiene.</ENT> </ROW> <ROW> <ENT I="01">1222-05-5</ENT> <ENT>1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopental[g]-2-benzopyran (HHCB).</ENT> </ROW> <ROW> <ENT I="01">50-00-0</ENT> <ENT>Formaldehyde.</ENT> </ROW> <ROW> <ENT I="01">85-44-9</ENT> <ENT>Phthalic anhydride.</ENT> </ROW> </GPOTABLE> <P> (D) The estimated percentage, rounded off to the closest 10 percent, of total production volume of the reportable chemical substance associated with each combination of industrial processing or use operation, sector, and function category. Where a particular combination of industrial processing or use operation, sector, and function category accounts for less than 5 percent of the submitter's site's total production volume of a reportable chemical substance, the percentage must not be rounded off to 0 percent if the production volume attributable to that industrial processing or use operation, sector, and function category combination is 25,000 lb (11,340 kg) or more during the reporting year. Instead, in such a case, submitters must report the percentage, rounded off to the closest 1 percent, of the submitter's site's total production volume of the reportable chemical substance associated with the particular combination of industrial <PRTPAGE P="144"/> processing or use operation, sector, and function category. </P> <P> (E) For each combination of industrial processing or use operation, sector, and function category, the submitter must estimate the number of sites at which each reportable chemical substance is processed or used. For each combination associated with each chemical substance, the submitter must select from among the ranges of sites listed in Table 8 to paragraph (b)(4)(i)(E) and report the corresponding code ( <E T="03">i.e.,</E> S1 through S7): </P> <GPOTABLE COLS="2" OPTS="L2,p7,7/8" CDEF="s40,r60"> <TTITLE> Table 8 to Paragraph <E T="01">(b)(4)(i)(E)</E> —Codes for Reporting Numbers of Sites </TTITLE> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Range</CHED> </BOXHD> <ROW> <ENT I="01">S1</ENT> <ENT>Fewer than 10 sites.</ENT> </ROW> <ROW> <ENT I="01">S2</ENT> <ENT>At least 10 but fewer than 25 sites.</ENT> </ROW> <ROW> <ENT I="01">S3</ENT> <ENT>At least 25 but fewer than 100 sites.</ENT> </ROW> <ROW> <ENT I="01">S4</ENT> <ENT>At least 100 but fewer than 250 sites.</ENT> </ROW> <ROW> <ENT I="01">S5</ENT> <ENT>At least 250 but fewer than 1,000 sites.</ENT> </ROW> <ROW> <ENT I="01">S6</ENT> <ENT>At least 1,000 but fewer than 10,000 sites.</ENT> </ROW> <ROW> <ENT I="01">S7</ENT> <ENT>At least 10,000 sites.</ENT> </ROW> </GPOTABLE> <P> (F) For each combination of industrial processing or use operation, sector, and function category, the submitter must estimate the number of workers reasonably likely to be exposed to each reportable chemical substance. For each combination associated with each chemical substance, the submitter must select from among the worker ranges listed in paragraph (b)(3)(vii) of this section and report the corresponding code ( <E T="03">i.e.,</E> W1 though W8). </P> <P> (ii) <E T="03">Consumer and commercial use information.</E> (A) Using the applicable codes listed in Table 9 to paragraph (b)(4)(ii)(A), submitters must designate the consumer and commercial product category(ies) that best describe the consumer and commercial products in which each reportable chemical substance is used (whether the recipient site(s) are controlled by the submitter site or not). For the 2020 submission period: </P> <P> ( <E T="03">1</E> ) Use column A in Table 9 to paragraph (b)(4)(ii)(A) for chemical substances designated in 2019 as high priority for risk evaluation (those chemicals listed in Table 7 to paragraph (b)(4)(i)(C); and </P> <P> ( <E T="03">2</E> ) Use either column A or B in Table 9 to paragraph (b)(4)(ii)(A) for chemical substances not listed in Table 7 to paragraph (b)(4)(i)(C). For the 2024 and future submission periods, use only column A in Table 9 to paragraph (b)(4)(ii)(A). If more than 10 codes apply to a chemical substance, submitters need only report the 10 codes for the chemical substance that cumulatively represent the largest percentage of the submitter's production volume for that chemical, measured by weight. If none of the listed consumer and commercial product categories accurately describes the consumer and commercial products in which each reportable chemical substance is used, the category “Other” may be used, and must include a description of the use. </P> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs20,r50,xs24,r50"> <TTITLE> Table 9 to Paragraph <E T="01">(b)(4)(ii)(A)</E> —Codes for Reporting Consumer and Commercial Product Categories </TTITLE> <BOXHD> <CHED H="1">Column A</CHED> <CHED H="2">Code</CHED> <CHED H="2">Category</CHED> <CHED H="1">Column B</CHED> <CHED H="2">Code</CHED> <CHED H="2">Category</CHED> </BOXHD> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Furnishing, Cleaning, Treatment Care Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC101</ENT> <ENT>Construction and building materials covering large surface areas including stone, plaster, cement, glass and ceramic articles; fabrics, textiles, and apparel</ENT> <ENT>C101</ENT> <ENT>Floor coverings.</ENT> </ROW> <ROW> <ENT I="01">CC102</ENT> <ENT>Furniture & furnishings including plastic articles (soft); leather articles</ENT> <ENT>C102</ENT> <ENT>Foam seating and bedding products.</ENT> </ROW> <ROW> <ENT I="01">CC103</ENT> <ENT>Furniture & furnishings including stone, plaster, cement, glass and ceramic articles; metal articles; or rubber articles</ENT> <ENT>C103</ENT> <ENT>Furniture and furnishings not covered elsewhere.</ENT> </ROW> <ROW> <ENT I="01">CC104</ENT> <ENT>Leather conditioner</ENT> <ENT>C104</ENT> <ENT>Fabric, textile, and leather products not covered elsewhere.</ENT> </ROW> <ROW> <ENT I="01">CC105</ENT> <ENT>Leather tanning, dye, finishing, impregnation and care products</ENT> </ROW> <ROW> <PRTPAGE P="145"/> <ENT I="01">CC106</ENT> <ENT>Textile (fabric) dyes</ENT> </ROW> <ROW> <ENT I="01">CC107</ENT> <ENT>Textile finishing and impregnating/surface treatment products</ENT> </ROW> <ROW> <ENT I="01">CC108</ENT> <ENT>All-purpose foam spray cleaner</ENT> <ENT>C105</ENT> <ENT>Cleaning and furnishing care products.</ENT> </ROW> <ROW> <ENT I="01">CC109</ENT> <ENT>All-purpose liquid cleaner/polish</ENT> </ROW> <ROW> <ENT I="01">CC110</ENT> <ENT>All-purpose liquid spray cleaner</ENT> </ROW> <ROW> <ENT I="01">CC111</ENT> <ENT>All-purpose waxes and polishes</ENT> </ROW> <ROW> <ENT I="01">CC112</ENT> <ENT>Appliance cleaners</ENT> </ROW> <ROW> <ENT I="01">CC113</ENT> <ENT>Drain and toilet cleaners (liquid)</ENT> </ROW> <ROW> <ENT I="01">CC114</ENT> <ENT>Powder cleaners (floors)</ENT> </ROW> <ROW> <ENT I="01">CC115</ENT> <ENT>Powder cleaners (porcelain)</ENT> </ROW> <ROW> <ENT I="01">CC116</ENT> <ENT>Dishwashing detergent (liquid/gel)</ENT> <ENT>C106</ENT> <ENT>Laundry and dishwashing products.</ENT> </ROW> <ROW> <ENT I="01">CC117</ENT> <ENT>Dishwashing detergent (unit dose/granule)</ENT> </ROW> <ROW> <ENT I="01">CC118</ENT> <ENT>Dishwashing detergent liquid (hand-wash)</ENT> </ROW> <ROW> <ENT I="01">CC119</ENT> <ENT>Dry cleaning and associated products</ENT> </ROW> <ROW> <ENT I="01">CC120</ENT> <ENT>Fabric enhancers</ENT> </ROW> <ROW> <ENT I="01">CC121</ENT> <ENT>Laundry detergent (unit-dose/granule)</ENT> </ROW> <ROW> <ENT I="01">CC122</ENT> <ENT>Laundry detergent (liquid)</ENT> </ROW> <ROW> <ENT I="01">CC123</ENT> <ENT>Stain removers</ENT> </ROW> <ROW> <ENT I="01">CC124</ENT> <ENT>Ion exchangers</ENT> <ENT>C107</ENT> <ENT>Water treatment products.</ENT> </ROW> <ROW> <ENT I="01">CC125</ENT> <ENT>Liquid water treatment products</ENT> </ROW> <ROW> <ENT I="01">CC126</ENT> <ENT>Solid/Powder water treatment products</ENT> </ROW> <ROW> <ENT I="01">CC127</ENT> <ENT>Liquid body soap</ENT> <ENT>C108</ENT> <ENT>Personal care products.</ENT> </ROW> <ROW> <ENT I="01">CC128</ENT> <ENT>Liquid hand soap</ENT> </ROW> <ROW> <ENT I="01">CC129</ENT> <ENT>Solid bar soap</ENT> </ROW> <ROW> <ENT I="01">CC130</ENT> <ENT>Air fresheners for motor vehicles</ENT> <ENT>C109</ENT> <ENT>Air care products.</ENT> </ROW> <ROW> <ENT I="01">CC131</ENT> <ENT>Continuous action air fresheners</ENT> </ROW> <ROW> <ENT I="01">CC132</ENT> <ENT>Instant action air fresheners</ENT> </ROW> <ROW> <ENT I="01">CC133</ENT> <ENT>Anti-static spray</ENT> <ENT>C110</ENT> <ENT>Apparel and footwear care products.</ENT> </ROW> <ROW> <ENT I="01">CC134</ENT> <ENT>Apparel finishing, and impregnating/surface treatment products</ENT> </ROW> <ROW> <ENT I="01">CC135</ENT> <ENT>Insect repellent treatment</ENT> </ROW> <ROW> <ENT I="01">CC136</ENT> <ENT>Pre-market waxes, stains, and polishes applied to footwear</ENT> </ROW> <ROW> <ENT I="01">CC137</ENT> <ENT>Post-market waxes, and polishes applied to footwear (shoe polish)</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC138</ENT> <ENT>Waterproofing and water-resistant sprays</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Construction, Paint, Electrical, and Metal Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC201</ENT> <ENT>Fillers and putties</ENT> <ENT>C201</ENT> <ENT>Adhesives and sealants.</ENT> </ROW> <ROW> <ENT I="01">CC202</ENT> <ENT>Hot-melt adhesives</ENT> </ROW> <ROW> <ENT I="01">CC203</ENT> <ENT>One-component caulks</ENT> </ROW> <ROW> <ENT I="01">CC204</ENT> <ENT>Solder</ENT> </ROW> <ROW> <ENT I="01">CC205</ENT> <ENT>Single-component glues and adhesives</ENT> </ROW> <ROW> <ENT I="01">CC206</ENT> <ENT>Two-component caulks</ENT> </ROW> <ROW> <ENT I="01">CC207</ENT> <ENT>Two-component glues and adhesives</ENT> </ROW> <ROW> <ENT I="01">CC208</ENT> <ENT>Adhesive/Caulk removers</ENT> <ENT>C202</ENT> <ENT>Paints and coatings.</ENT> </ROW> <ROW> <ENT I="01">CC209</ENT> <ENT>Aerosol spray paints</ENT> </ROW> <ROW> <ENT I="01">CC210</ENT> <ENT>Lacquers, stains, varnishes and floor finishes</ENT> </ROW> <ROW> <ENT I="01">CC211</ENT> <ENT>Paint strippers/removers</ENT> </ROW> <ROW> <ENT I="01">CC212</ENT> <ENT>Powder coatings</ENT> </ROW> <ROW> <ENT I="01">CC213</ENT> <ENT>Radiation curable coatings</ENT> </ROW> <ROW> <ENT I="01">CC214</ENT> <ENT>Solvent-based paint</ENT> </ROW> <ROW> <ENT I="01">CC215</ENT> <ENT>Thinners</ENT> </ROW> <ROW> <ENT I="01">CC216</ENT> <ENT>Water-based paint</ENT> </ROW> <ROW> <ENT I="01">CC217</ENT> <ENT>Construction and building materials covering large surface areas, including wood articles</ENT> <ENT>C203</ENT> <ENT>Building/construction materials—wood and engineered wood products.</ENT> </ROW> <ROW> <ENT I="01">CC218</ENT> <ENT>Construction and building materials covering large surface areas, including paper articles; metal articles; stone, plaster, cement, glass and ceramic articles</ENT> <ENT>C204</ENT> <ENT>Building/construction materials not covered elsewhere.</ENT> </ROW> <ROW> <PRTPAGE P="146"/> <ENT I="01">CC219</ENT> <ENT>Machinery, mechanical appliances, electrical/electronic articles</ENT> <ENT>C205</ENT> <ENT>Electrical and electronic products.</ENT> </ROW> <ROW> <ENT I="01">CC220</ENT> <ENT>Other machinery, mechanical appliances, electronic/electronic articles</ENT> </ROW> <ROW> <ENT I="01">CC221</ENT> <ENT>Construction and building materials covering large surface areas, including metal articles</ENT> <ENT>C206</ENT> <ENT>Metal products not covered elsewhere.</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC222</ENT> <ENT>Electrical batteries and accumulators</ENT> <ENT>C207</ENT> <ENT>Batteries.</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Packaging, Paper, Plastic, Toys, Hobby Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC990</ENT> <ENT>Non-TSCA use</ENT> <ENT>C301</ENT> <ENT>Food packaging.</ENT> </ROW> <ROW> <ENT I="01">CC301</ENT> <ENT>Packaging (excluding food packaging), including paper articles</ENT> <ENT>C302</ENT> <ENT>Paper products.</ENT> </ROW> <ROW> <ENT I="01">CC302</ENT> <ENT>Other articles with routine direct contact during normal use, including paper articles</ENT> </ROW> <ROW> <ENT I="01">CC303</ENT> <ENT>Packaging (excluding food packaging), including rubber articles; plastic articles (hard); plastic articles (soft)</ENT> <ENT>C303</ENT> <ENT>Plastic and rubber products not covered elsewhere.</ENT> </ROW> <ROW> <ENT I="01">CC304</ENT> <ENT>Other articles with routine direct contact during normal use including rubber articles; plastic articles (hard)</ENT> </ROW> <ROW> <ENT I="01">CC305</ENT> <ENT>Toys intended for children's use (and child dedicated articles), including fabrics, textiles, and apparel; or plastic articles (hard)</ENT> <ENT>C304</ENT> <ENT>Toys, playground, and sporting equipment.</ENT> </ROW> <ROW> <ENT I="01">CC306</ENT> <ENT>Adhesives applied at elevated temperatures</ENT> <ENT>C305</ENT> <ENT>Arts, crafts, and hobby materials.</ENT> </ROW> <ROW> <ENT I="01">CC307</ENT> <ENT>Cement/concrete</ENT> </ROW> <ROW> <ENT I="01">CC308</ENT> <ENT>Crafting glue</ENT> </ROW> <ROW> <ENT I="01">CC309</ENT> <ENT>Crafting paint (applied to body)</ENT> </ROW> <ROW> <ENT I="01">CC310</ENT> <ENT>Crafting paint (applied to craft)</ENT> </ROW> <ROW> <ENT I="01">CC311</ENT> <ENT>Fixatives and finishing spray coatings</ENT> </ROW> <ROW> <ENT I="01">CC312</ENT> <ENT>Modelling clay</ENT> </ROW> <ROW> <ENT I="01">CC313</ENT> <ENT>Correction fluid/tape</ENT> <ENT>C306</ENT> <ENT>Ink, toner, and colorant products.</ENT> </ROW> <ROW> <ENT I="01">CC314</ENT> <ENT>Inks in writing equipment (liquid)</ENT> </ROW> <ROW> <ENT I="01">CC315</ENT> <ENT>Inks used for stamps</ENT> </ROW> <ROW> <ENT I="01">CC316</ENT> <ENT>Toner/Printer cartridge</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC317</ENT> <ENT>Liquid photographic processing solutions</ENT> <ENT>C307</ENT> <ENT>Photographic supplies, film, and photochemicals.</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Automotive, Fuel, Agriculture, Outdoor Use Products</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC401</ENT> <ENT>Exterior car washes and soaps</ENT> <ENT>C401</ENT> <ENT>Automotive care products.</ENT> </ROW> <ROW> <ENT I="01">CC402</ENT> <ENT>Exterior car waxes, polishes, and coatings</ENT> </ROW> <ROW> <ENT I="01">CC403</ENT> <ENT>Interior car care</ENT> </ROW> <ROW> <ENT I="01">CC404</ENT> <ENT>Touch up auto paint</ENT> </ROW> <ROW> <ENT I="01">CC405</ENT> <ENT>Degreasers</ENT> <ENT>C402</ENT> <ENT>Lubricants and greases.</ENT> </ROW> <ROW> <ENT I="01">CC406</ENT> <ENT>Liquid lubricants and greases</ENT> </ROW> <ROW> <ENT I="01">CC407</ENT> <ENT>Paste lubricants and greases</ENT> </ROW> <ROW> <ENT I="01">CC408</ENT> <ENT>Spray lubricants and greases</ENT> </ROW> <ROW> <ENT I="01">CC409</ENT> <ENT>Anti-freeze liquids</ENT> <ENT>C403</ENT> <ENT>Anti-freeze and de-icing products.</ENT> </ROW> <ROW> <ENT I="01">CC410</ENT> <ENT>De-icing liquids</ENT> </ROW> <ROW> <ENT I="01">CC411</ENT> <ENT>De-icing solids</ENT> </ROW> <ROW> <ENT I="01">CC412</ENT> <ENT>Lock de-icers/releasers</ENT> </ROW> <ROW> <ENT I="01">CC413</ENT> <ENT>Cooking and heating fuels</ENT> <ENT>C404</ENT> <ENT>Fuels and related products.</ENT> </ROW> <ROW> <ENT I="01">CC414</ENT> <ENT>Fuel additives</ENT> </ROW> <ROW> <ENT I="01">CC415</ENT> <ENT>Vehicular or appliance fuels</ENT> </ROW> <ROW> <ENT I="01">CC416</ENT> <ENT>Explosive materials</ENT> <ENT>C405</ENT> <ENT>Explosive materials.</ENT> </ROW> <ROW> <ENT I="01">CC417</ENT> <ENT>Agricultural non-pesticidal products</ENT> <ENT>C406</ENT> <ENT>Agricultural products (non-pesticidal).</ENT> </ROW> <ROW RUL="s"> <ENT I="01">CC418</ENT> <ENT>Lawn and garden care products</ENT> <ENT>C407</ENT> <ENT>Lawn and garden care products.</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Chemical Substances in Products not Described by Other Codes</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">CC980</ENT> <ENT>Other (specify)</ENT> <ENT>C909</ENT> <ENT>Other (specify).</ENT> </ROW> <ROW> <ENT I="01">CC990</ENT> <ENT>Non-TSCA use</ENT> <ENT>C980</ENT> <ENT>Non-TSCA use.</ENT> </ROW> <TNOTE> For the 2020 submission period: (1) Use column A for chemical substances designated in 2019 as high priority for risk evaluation (those chemicals listed in Table 7 to paragraph (b)(4)(i)(C) and (2) use either column A or B for chemical substances not listed in Table 7 to paragraph (b)(4)(i)(C). <PRTPAGE P="147"/> </TNOTE> <TNOTE>For the 2024 and future submission periods, use only column A.</TNOTE> </GPOTABLE> <P>(B) For each consumer and commercial product category reported under paragraph (b)(4)(ii)(A) of this section, the applicable code(s) described in paragraph (b)(4)(i)(C) of this section must be selected to designate the function category(ies) that best represents the specific manner in which the chemical substance is used. For the 2020 submission period:</P> <P> ( <E T="03">1</E> ) Use column A in Table 6 to paragraph (b)(4)(i)(C) for chemical substances designated in 2019 as high priority for risk evaluation (those chemicals listed in Table 7 to paragraph (b)(4)(i)(C); and </P> <P> ( <E T="03">2</E> ) Use either column A or B in Table 6 to paragraph (b)(4)(i)(C) for chemical substances not listed in Table 7 to paragraph (b)(4)(i)(C). For the 2024 and future submission periods, use only column A in Table 6 to paragraph (b)(4)(i)(C). A particular function category may need to be reported more than once, to the extent that a submitter reports more than one consumer or commercial product category (under paragraph (b)(4)(ii)(A) of this section) that applies to a given function category under this paragraph. If none of the listed function categories accurately describes a use of a chemical substance, the category “Other” may be used, and must include a description of the use. </P> <P>(C) An indication, within each consumer and commercial product category reported under paragraph (b)(4)(ii)(A) of this section, whether the use is a consumer or a commercial use.</P> <P>(D) Submitters must determine, within each consumer and commercial product category reported under paragraph (b)(4)(ii)(A) of this section, whether any amount of each reportable chemical substance manufactured (including imported) by the submitter is present in (for example, a plasticizer chemical substance used to make pacifiers) or on (for example, as a component in the paint on a toy) any consumer products intended for use by children age 14 or younger, regardless of the concentration of the chemical substance remaining in or on the product. Submitters must select from the following options: The chemical substance is used in or on any consumer products intended for use by children; the chemical substance is not used in or on any consumer products intended for use by children; or information as to whether the chemical substance is used in or on any consumer products intended for use by children is not known to or reasonably ascertainable by the submitter.</P> <P>(E) The estimated percentage, rounded off to the closest 10 percent, of the submitter's site's total production volume of the reportable chemical substance associated with each consumer and commercial product category. Where a particular consumer and commercial product category accounts for less than 5 percent of the total production volume of a reportable chemical substance, the percentage must not be rounded off to 0 percent if the production volume attributable to that commercial and consumer product category is 25,000 lb (11,340 kg) or more during the reporting year. Instead, in such a case, submitters must report the percentage, rounded off to the closest 1 percent, of the submitter's site's total production volume of the reportable chemical substance associated with the particular consumer and commercial product category.</P> <P> (F) Where the reportable chemical substance is used in consumer or commercial products, the estimated typical maximum concentration, measured by weight, of the chemical substance in each consumer and commercial product category reported under paragraph (b)(4)(ii)(A) of this section. For each chemical substance in each commercial and consumer product category reported under paragraph (b)(4)(ii)(A) of this section, submitters must select from among the ranges of concentrations listed in Table 3 to paragraph (b)(3)(viii) of this section and report the corresponding code ( <E T="03">i.e.,</E> M1 through M5). </P> <P> (G) Where the reportable chemical substance is used in a commercial product, the submitter must estimate the number of commercial workers reasonably likely to be exposed to each reportable chemical substance. For each combination associated with each substance, the submitter must select from among the worker ranges listed in <PRTPAGE P="148"/> Table 2 to paragraph (b)(3)(vii) of this section and report the corresponding code ( <E T="03">i.e.,</E> W1 though W8). </P> <CITA>[85 FR 20139, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.20</SECTNO> <SUBJECT>When to report.</SUBJECT> <P>All information reported to EPA in response to the requirements of this part must be submitted during an applicable submission period. The 2020 CDR submission period is from June 1, 2020, to January 29, 2021. Subsequent recurring submission periods are from June 1 to September 30 at 4-year intervals, beginning in 2024. In each submission period, any person described in § 711.8 must report as described in this part.</P> <CITA>[85 FR 75238, Nov. 25, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.22</SECTNO> <SUBJECT>Duplicative reporting.</SUBJECT> <P> (a) <E T="03">With regard to TSCA section 8(a) rules.</E> Any person subject to the requirements of this part who previously has complied with reporting requirements of a rule under TSCA section 8(a) by submitting the information described in § 711.15 for a chemical substance described in § 711.5 to EPA, and has done so within 1 year of the start of a submission period described in § 711.20, is not required to report again on the manufacture of that chemical substance at that site during that submission period. </P> <P> (b) <E T="03">With regard to importers.</E> This part requires that only one report be submitted on each import transaction involving a chemical substance described in § 711.5. When two or more persons are involved in a particular import transaction and each person meets the Agency's definition of “importer” as set forth in 40 CFR 704.3, they may determine among themselves who should submit the required report; if no report is submitted as required under this part, EPA will hold each such person liable for failure to report. </P> <P> (c) <E T="03">Co-manufactured chemicals.</E> This part requires that only one report per site be submitted on each chemical substance described in § 711.5. However, both the contracting company and producing company are liable if no report is made. When a company contracts with a producing company to manufacture a chemical substance, and each party meets the definition of “manufacturer” as set forth in § 711.3, reporting of the co-manufactured chemical can be performed by one of the following methods: </P> <P>(1) The contracting company initiates the required report for that site as the primary submitter. The contracting company must indicate on the report that this is a co-manufacturing situation, notify the producing company, and record the production volume domestically co-manufactured as set forth in § 711.15(b)(3) and processing and use information set forth in § 711.15(b)(4). Upon notification by the contracting company, the producing company must also record the production volume domestically co-manufactured and complete the rest of the report as prompted by e-CDRweb.</P> <P>(2) Upon written agreement between the contracting company and the producing company, the producing company completes the full report for the co-manufactured chemical. The contracting company supplies the information not otherwise known to or reasonably ascertainable by the producing company.</P> <CITA>[76 FR 54933, Sept. 6, 2011, as amended at 85 FR 20148, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.25</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P>Each person who is subject to the reporting requirements of this part must retain records that document any information reported to EPA. Records relevant to reporting during a submission period must be retained for a period of 5 years beginning on the last day of the submission period. Submitters are encouraged to retain their records longer than 5 years to ensure that past records are available as a reference when new submissions are being generated.</P> </SECTION> <SECTION> <SECTNO>§ 711.30</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <P> (a) <E T="03">Making confidentiality claims</E> —(1) <E T="03">Generally.</E> Any person submitting information under this part may assert a confidentiality claim for that information at the time it is submitted, except for information described in paragraph (a)(2). Any such confidentiality claims must be asserted at the time the information is submitted. These claims will <PRTPAGE P="149"/> apply only to the information submitted with the claim. Instructions for asserting confidentiality claims are provided in the document identified in § 711.35. Information claimed as confidential in accordance with this section will be treated and disclosed in accordance with the procedures in 40 CFR part 2 and section 14 of TSCA. </P> <P> (2) <E T="03">Exceptions.</E> Confidentiality claims cannot be asserted: </P> <P>(i) For chemical identities listed on the public portion of the TSCA Inventory;</P> <P>(ii) For processing and use data elements required by § 711.15(b)(4)(i)(A), (B), and (C) and § 711.15(b)(4)(ii)(A), (B), (C), and (D); or</P> <P>(iii) When a response is left blank or designated as “not known or reasonably ascertainable.”</P> <P> (3) <E T="03">Substantiations.</E> All confidentiality claims must be substantiated at time of submission, in accordance with the requirements in paragraphs (b), (c), and (d)(1) of this section, and must be signed and dated by an authorized official. Confidentiality claims for the following data elements are exempt from this substantiation requirement: </P> <P>(i) Production volume information required pursuant to § 711.15(b)(3)(iii).</P> <P>(ii) Joint submission information from the primary submitter, consisting of trade name and supplier identification required pursuant to § 711.15(b)(3)(i)(A) and (B).</P> <P>(iii) Joint submission information from the secondary submitter, consisting of the percentage of formulation required pursuant to § 711.15(b)(3)(i)(A) and (B).</P> <P>(iv) Information that is supplied in a petition submitted under § 711.6(b)(2)(iii) or § 711.10(d)(1)(ii) and that is described in section 14(c)(2) of TSCA.</P> <P> (4) <E T="03">Marking information claimed as confidential in confidentiality substantiation documentation.</E> If any of the information contained in the answers to the questions listed in paragraphs (b) and (c) of this section is asserted to contain information that itself is considered to be confidential, you must clearly identify the information that is claimed confidential. </P> <P> (5) <E T="03">Certification statement for claims.</E> An authorized official representing a person asserting a claim of confidentiality must certify that the submission complies with the requirements of this part by signing and dating the following certification statement: </P> <EXTRACT> <P>“I certify that all claims for confidentiality asserted with this submission are true and correct, and all information submitted herein to substantiate such claims is true and correct. Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. 1001. I further certify that: (1) I have taken reasonable measures to protect the confidentiality of the information; (2) I have determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law; (3) I have a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of my company; and (4) I have a reasonable basis to believe that the information is not readily discoverable through reverse engineering.”</P> </EXTRACT> <P> (6) <E T="03">Company, site, and technical contact identity information.</E> A submitter may assert a claim of confidentiality for a site, company, or technical contact identity to protect the link between that information and the reported chemical substance. Such claim may be asserted only when the linkage of that information to a reportable chemical substance is confidential and not publicly available. </P> <P> (7) <E T="03">Processing and use information.</E> A submitter may assert a claim of confidentiality for each data element required by § 711.15(b)(4)(i)(D), (E) and (F) and § 711.15(b)(4)(ii)(E), (F), and (G) to protect the link between that information and the reported chemical substance. Such claim may be asserted only when the linkage of that information to a reportable chemical substance is confidential and not publicly available. </P> <P> (b) <E T="03">All confidentiality claims requiring substantiation at time of submission.</E> For each data element (or information supplied in a petition submitted under § 711.6(b)(2)(iii)(A) or § 711.10(d)(1)(ii)(A)) that is claimed as confidential, you must submit with your report detailed written answers to the following questions: </P> <P> (1) Will disclosure of the information claimed as confidential likely cause substantial harm to your business's competitive position? If you answered <PRTPAGE P="150"/> yes, describe the substantial harmful effects that would likely result to your competitive position if the information is disclosed, including but not limited to how a competitor could use such information, and the causal relationship between the disclosure and the harmful effects. </P> <P>(2) To the extent your business has disclosed the information to others (both internally and externally), has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify the specific measures, including but not limited to internal controls, that your business has taken to protect the information claimed as confidential.</P> <P>(3)(i) Is any of the information claimed as confidential required to be publicly disclosed under any other Federal law? If yes, please explain.</P> <P>(ii) Does any of the information claimed as confidential otherwise appear in any public documents, including (but not limited to) safety data sheets; advertising or promotional material; professional or trade publications; state, local, or Federal agency files; or any other media or publications available to the general public? If yes, please explain why the information should be treated as confidential.</P> <P>(iii) Does any of the information claimed as confidential appear in one or more patents or patent applications? If yes, please provide the associated patent number or patent application number (or numbers) and explain why the information should be treated as confidential.</P> <P>(4) Does any of the information that you are claiming as confidential constitute a trade secret? If yes, please explain how the information you are claiming as confidential constitutes a trade secret.</P> <P>(5) Is the claim of confidentiality intended to last less than 10 years (see TSCA section 14(e)(1)(B))? If yes, please indicate the number of years (between 1-10 years) or the specific date after which the claim is withdrawn.</P> <P>(6) Has EPA, another federal agency, or court made any confidentiality determination regarding information associated with this chemical substance? If yes, please provide the circumstances associated with the prior determination, whether the information was found to be entitled to confidential treatment, the entity that made the decision, and the date of the determination.</P> <P> (c) <E T="03">Additional requirements for specific chemical identity.</E> A person may assert a claim of confidentiality for the specific chemical identity of a chemical substance as described in § 711.15(b)(3) of this part only if the identity of that chemical substance is treated as confidential in the Master Inventory File as of the time the report is submitted for that chemical substance. Generic chemical identities and accession numbers may not be claimed as confidential. To assert a claim of confidentiality for the identity of a reportable chemical substance, you must submit with the report detailed written answers to the questions from paragraph (b) of this section and to the following questions. </P> <P> (1) Is this chemical substance publicly known (including by your competitors) to be in U.S. commerce? If yes, please explain why the specific chemical identity should still be afforded confidential status ( <E T="03">e.g.,</E> the chemical substance is publicly known only as being distributed in commerce for research and development purposes, but no other information about the current commercial distribution of the chemical substance in the United States is publicly available). If no, please complete the certification statement: </P> <EXTRACT> <P> I certify that on the date referenced, I searched the internet for the chemical substance identity ( <E T="03">i.e.,</E> by both chemical substance name and CASRN). I did not find a reference to this chemical substance that would indicate that the chemical is being manufactured or imported by anyone for a commercial purpose in the United States. [provide date]. </P> </EXTRACT> <P> (2) Does this particular chemical substance leave the site of manufacture (including import) in any form, <E T="03">e.g.,</E> as a product, effluent, emission? If yes, please explain what measures have been taken to guard against the discovery of its identity. </P> <P> (3) If the chemical substance leaves the site in a form that is available to the public or your competitors, can the <PRTPAGE P="151"/> chemical identity be readily discovered by analysis of the substance ( <E T="03">e.g.,</E> product, effluent, emission), in light of existing technologies and any costs, difficulties, or limitations associated with such technologies? Please explain why or why not. </P> <P>(4) Would disclosure of the specific chemical name release confidential process information? If yes, please explain.</P> <P> (d) <E T="03">Special situations</E> —(1) <E T="03">Joint submissions.</E> If a primary submitter asks a secondary submitter to provide information directly to EPA in a joint submission under § 711.15(b)(3)(i)(A) and (B), only the primary submitter may assert a confidentiality claim for the data elements that it directly submits to EPA. The primary submitter must substantiate those claims that are not exempt under paragraph (a)(3)(ii) of this section. The secondary submitter is responsible for asserting all confidentiality claims for the data elements that it submits directly to EPA and for substantiating those claims that are not exempt under paragraph (a)(3)(iii) of this section. </P> <P> (2) <E T="03">Petitions.</E> If a petition submitted under § 711.6(b)(2)(iii)(A) or § 711.10(d)(1)(ii)(A) includes any information claimed as confidential, the petitioner must provide a version of the petition that redacts the information claimed as confidential. </P> <P> (e) <E T="03">No claim of confidentiality.</E> Information not claimed as confidential in accordance with the requirements of this section may be made public without further notice to the submitter. </P> <CITA>[85 FR 20148, Apr. 9, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 711.35</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> <P>(a) You must use e-CDRweb to complete and submit Form U (EPA Form 7740-8). Submissions may only be made as set forth in this section.</P> <P>(b) Submissions must be sent electronically to EPA via CDX.</P> <P>(c) Access e-CDRweb and instructions, as follows:</P> <P> (1) <E T="03">By website.</E> Go to the EPA Chemical Data Reporting internet homepage at <E T="03">http://www.epa.gov/cdr</E> and follow the appropriate links. </P> <P> (2) <E T="03">By phone or e-mail.</E> Contact the EPA TSCA Hotline at (202) 554-1404 or <E T="03">TSCA-Hotline@epa.gov</E> for a CD-ROM containing the instructions. </P> <CITA>[76 FR 54933, Sept. 6, 2011, as amended at 85 FR 20149, Apr. 9, 2020]</CITA> </SECTION> </PART> <PART> <EAR>Pt. 712</EAR> <HD SOURCE="HED">PART 712—CHEMICAL INFORMATION RULES</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>712.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <SECTNO>712.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>712.5</SECTNO> <SUBJECT>Method of identification of substances for reporting purposes.</SUBJECT> <SECTNO>712.7</SECTNO> <SUBJECT>Report of readily obtainable information for subparts B and C.</SUBJECT> <SECTNO>712.15</SECTNO> <SUBJECT>Confidentiality.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Manufacturers Reporting—Preliminary Assessment Information</HD> <SECTNO>712.20</SECTNO> <SUBJECT>Manufacturers and importers who must report.</SUBJECT> <SECTNO>712.25</SECTNO> <SUBJECT>Exempt manufacturers and importers.</SUBJECT> <SECTNO>712.28</SECTNO> <SUBJECT>Form and instructions.</SUBJECT> <SECTNO>712.30</SECTNO> <SUBJECT>Chemical lists and reporting periods.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(a).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>47 FR 26998, June 22, 1982, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 712.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <P>(a) This part establishes procedures for chemical manufacturers and processors to report production, use, and exposure-related information on listed chemical substances. Subpart A establishes requirements that apply to all reporting under this part. Subpart B covers manufacturers' and processors' reporting.</P> <P> (b) Chemical substances, mixtures, and categories of substances or mixtures which have been recommended by the Interagency Testing Committee for testing consideration by the Agency but not designated for Agency response within 12 months, will be added to § 712.30 using the procedure specified in § 712.30(c) only to the extent that the total number of designated and recommended chemicals has not exceeded <PRTPAGE P="152"/> 50 in any 1 year. Additional recommended but not designated chemicals may be added after proposal, and consideration of public comment. </P> <CITA>[47 FR 26998, June 22, 1982, as amended at 50 FR 34809, Aug. 28, 1985; 60 FR 31921, June 19, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 712.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>The definitions in section 3 of TSCA, 15 U.S.C. 2602, apply for this part. In addition, the following definitions apply:</P> <P> (a) <E T="03">Byproduct</E> means any chemical substance or mixture produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance or mixture. </P> <P> (b) <E T="03">EPA</E> means the U.S. Environmental Protection Agency. </P> <P> (c) <E T="03">Import in bulk form</E> means to import a chemical substance (other than as part of a mixture or article) in any quantity, in cans, bottles, drums, barrels, packages, tanks, bags, or other containers used for purposes of transportation or containment, if the chemical substance has an end use or commercial purpose separate from the container. </P> <P> (d) <E T="03">Importer</E> means anyone who imports a chemical substance, including a chemical substance as part of a mixture or article, into the customs territory of the U.S. and includes the person liable for the payment of any duties on the merchandise, or an authorized agent on his behalf. Importer also includes, as appropriate: </P> <P>(1) The consignee.</P> <P>(2) The importer of record.</P> <P>(3) The actual owner if an actual owner's declaration and superseding bond has been filed in accordance with 19 CFR 141.20.</P> <P>(4) The transferee, if the right to withdraw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144. For the purposes of this definition, the customs territory of the U.S. consists of the 50 states, Puerto Rico, and the District of Columbia.</P> <P> (e) <E T="03">Impurity</E> means a chemical substance unintentionally present with another chemical substance or mixture. </P> <P> (f) <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reactions used for the intentional manufacture of other chemical substances or mixtures, or that is intentionally present for the purpose of altering the rates of such chemical reactions. (See also paragraph (j) of this section.) </P> <P> (g) <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know, or could obtain without unreasonable burden. </P> <P> (h) <E T="03">Manufacture for commercial purposes</E> means to import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer and includes, among other things, such “manufacture” of any amount of a chemical substance or mixture: </P> <P>(1) For commercial distribution, including for test marketing.</P> <P>(2) For use by the manufacturer, including use for product research and development, or as an intermediate. Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts and coproducts that are separated from that other substance or mixture, and impurities that remain in that substance or mixture. Byproducts and impurities may not in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical produced for a commercial purpose.</P> <P> (i) <E T="03">Mixture</E> means any combination of two or more chemical substances if the combination does not occur in nature and is not, in whole or in part, the result of a chemical reaction; except that <E T="03">mixture</E> does include (1) any combination which occurs, in whole or in part, as a result of a chemical reaction if the combination could have been manufactured for commercial purposes without a chemical reaction at the time the chemical substances comprising the combination were combined, and if all <PRTPAGE P="153"/> of the chemical substances comprising the combination are included in the EPA, TSCA Chemical Substance Inventory after the effective date of the premanufacture notification requirement under 40 CFR part 720, and (2) hydrates of a chemical substance or hydrated ions formed by association of a chemical substance with water. The term mixture includes alloys, inorganic glasses, ceramics, frits, and cements, including Portland cement. </P> <P> (j) <E T="03">Non-isolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture. (See also paragraph (f) of this section.) </P> <P> (k) <E T="03">Owned or controlled by the parent company</E> means the parent owns or controls 50 percent or more of the other company's voting stock or other equity rights, or has the power to control the management and policies of the other company. </P> <P> (l) <E T="03">Person</E> means any natural person, firm, company, corporation, joint venture, partnership, sole proprietorship, association, or any other business entity, any State or political subdivision thereof, any municipality, any interstate body, and any department, agency, or instrumentality of the Federal government. </P> <P> (m) <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included. If a chemical or mixture containing impurities is processed for commercial purposes, then those impurities are also processed for commercial purposes. </P> <P> (n) <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way shall be considered one site. There may be more than one manufacturing plant on a single site. </P> <P> (o) <E T="03">Test marketing</E> means distributing in commerce a limited amount of a chemical substance or mixture, or article containing such substance or mixture, to a defined number of potential customers, during a predetermined testing period, to explore market capability prior to broader distribution in commerce. </P> <P> (p) <E T="03">TSCA</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 <E T="03">et seq.</E> </P> <P> (q) <E T="03">Central Data Exchange</E> or <E T="03">CDX</E> means EPA's centralized electronic submission receiving system. </P> <P> (r) <E T="03">Chemical Information Submission System</E> or <E T="03">CISS</E> means EPA's electronic, web-based reporting tool for the completion and submission of data, reports, and other information, or its successors. </P> <CITA>[47 FR 26998, June 22, 1982, as amended at 78 FR 72825, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 712.5</SECTNO> <SUBJECT>Method of identification of substances for reporting purposes.</SUBJECT> <P> (a) <E T="03">Report on TSCA-regulable quantities.</E> Unless specifically otherwise required, respondents must report only about quantities of a chemical that is defined as a chemical substance under TSCA section 3(2). </P> <P> (b) <E T="03">Chemicals from natural sources.</E> A manufacturer of a chemical substance which is extracted from an ore, from oil, or from any other natural source must report only about the manufacturing steps for, and the uses of, that chemical, not about production of the natural source material or other crude precursors derived from the natural source material. </P> <EXTRACT> <P>For example, persons who manufacture a chemical substance such as “sweetened naphtha, 64741-87-3,” but do not refine the naphtha to produce “hexane, 110-54-3” would not report on hexane. Only the production of “hexane” as an isolated product must be reported—not previous production of more crude, complex substances such as naphtha from which hexane is extracted. Thus, persons who produce crude oil, ores, and other crude natural materials, but do not carry them through further manufacturing steps that produce a listed chemical have no reporting responsibilities under this Part. Note, however, that any method of extraction, refinement, or purification of a listed chemical substance is considered to be manufacturing for the purposes of this rule.</P> </EXTRACT> <PRTPAGE P="154"/> <P> (c) <E T="03">Chemical substances as marketed.</E> This part requires reporting about chemical substances as they are marketed or used in practice. The following preparations of a chemical substance must be reported as the substance itself, not as a mixture, since these preparations are regarded as the substance in practice. </P> <P>(1) The chemical substance in aqueous solution.</P> <P>(2) The chemical substance containing an additive (such as a stabilizer or other chemical) to maintain the integrity or physical form of the substance.</P> <P>(3) The chemical substance in any grade of purity.</P> </SECTION> <SECTION> <SECTNO>§ 712.7</SECTNO> <SUBJECT>Report of readily obtainable information for subparts B and C.</SUBJECT> <P>TSCA section 8(a) authorizes EPA to require persons to report information that is known to or reasonably ascertainable by them. For purposes of subpart B, however, a lesser standard applies. Companies must report information that is readily obtainable by management and supervisory employees responsible for manufacturing, processing, distributing, technical services, and marketing. Extensive file searches are not required.</P> <CITA>[47 FR 26998, June 22, 1982, as amended at 60 FR 31921, June 19, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 712.15</SECTNO> <SUBJECT>Confidentiality.</SUBJECT> <P>(a) Any person submitting information under this part may assert business confidentiality claims for the information as described in the pertinent reporting form and its instructions. Any information covered by a claim will be disclosed by EPA only as provided in the procedures set forth at 40 CFR part 2.</P> <P>(b) Persons must certify to the validity of a claim of confidentiality they make for information reported under this part, as specified on the reporting form.</P> <P>(c) If no claim accompanies the information at the time it is submitted to EPA or if certification as to the claim is not made on the reporting form, EPA may place the information in an open file available to the public without further notice to the submitter.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Manufacturers Reporting—Preliminary Assessment Information</HD> <SECTION> <SECTNO>§ 712.20</SECTNO> <SUBJECT>Manufacturers and importers who must report.</SUBJECT> <P>Except as described in § 712.25, at the time a chemical substance is listed in § 712.3, the following persons must submit the “Manufacturer's Report—Preliminary Assessment Information” (as described in § 712.28) for each plant site at which they manufactured or imported the chemical substance during the reporting period specified in § 712.30:</P> <P>(a) Persons who manufactured one or more of the chemical substances listed in § 712.30 for commercial purposes.</P> <P>(b) Persons who imported in bulk form one or more of the chemical substances listed in § 712.30 for commercial purposes.</P> </SECTION> <SECTION> <SECTNO>§ 712.25</SECTNO> <SUBJECT>Exempt manufacturers and importers.</SUBJECT> <P>(a) Persons who manufactured or imported the chemical substance during the reporting period, solely for purposes of scientific experimentation, analysis, or research, including research or analysis for product development, are not subject to reporting under § 712.20.</P> <P>(b) Persons who, during the reporting period, manufactured or imported fewer than 500 kilograms (1100 pounds) of the chemical substance at a single plant site are not subject to reporting for that site under § 712.20.</P> <P>(c) Persons who qualify as small manufacturers (including importers) in respect to a specific chemical substance listed in § 712.30 are exempt. However, the exemption in this paragraph (c) does not apply with respect to any chemical in § 712.30 designated by an asterisk. A manufacturer is qualified as small and is exempt from submitting a report under this subpart for a chemical substance manufactured at a particular plant site if it meets the definition for small manufacturer in § 704.3 of this chapter.</P> <P> (d) Persons are not subject to reporting under § 712.20 if they manufactured or imported the chemical substance during the reporting period only in the following forms: <PRTPAGE P="155"/> </P> <P>(1) As a byproduct that was not used or sold or that was formed as described in 40 CFR 710.4(d) (3) through (7).</P> <P>(2) As a non-isolated intermediate.</P> <P>(3) As an impurity.</P> <CITA>[47 FR 26998, June 22, 1982; 47 FR 28382, June 30, 1982, as amended at 85 FR 31995, May 28, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 712.28</SECTNO> <SUBJECT>Form and instructions.</SUBJECT> <P>(a) Manufacturers and importers subject to this subpart must submit a single EPA Form No. 7710-35, “Manufacturer's Report—Preliminary Assessment Information,” for each plant site manufacturing or importing a chemical substance listed in § 712.30.</P> <P>(b) Reporting companies may submit their reports through individual plant sites or company headquarters as they choose. A separate form must be submitted for each plant site manufacturing the chemical substance.</P> <P>(c) Persons authorized to report information under this subpart must include the following information on Form 7710-35, Manufacturer's Report—Preliminary Assessment Information (Manufacturer's Report):</P> <P>(1) A certification as to the truth and accuracy of the information reported signed and dated by an authorized person located at the plant site or corporate headquarters of the respondent company.</P> <P>(2) A confidentiality statement signed and dated by an authorized person located at the plant site or corporate headquarters of the respondent company.</P> <P>(3) The specific chemical name and Chemical Abstracts Service (CAS) Registry Number listed in 40 CFR 712.30.</P> <P>(4) The name, company, address, city, State, ZIP code, and telephone number of a person who is submitting the form, which may be a person located at a plant site or corporate headquarters that will serve as the respondent, and will be able to answer questions about the information submitted by the company to EPA. A respondent to this subpart must include the appropriate Dun and Bradstreet Number for each plant site reported.</P> <P>(5) The plant site activities, such as the manufacturing of a chemical substance, including the total quantity of the chemical substance (in kilograms) imported in bulk during the reporting period.</P> <P>(6) The total number of workers and total worker-hours in each process category, which includes enclosed process, controlled release process, and open process.</P> <P>(7) The information related to chemical substance processing by customers, including customers' use in industrial and consumer products, the market names under which the chemical substance is manufactured or imported, and the customer's process categories that are sold to customers for further processing.</P> <P>(d) Persons must use the CISS tool to complete and submit Form 7710-35, Manufacturer's Report, and accompanying letters, via CDX. Submission requires registration with CDX, and must be made only as set forth in this section.</P> <P> (e) To access the CISS tool go to <E T="03">https://cdx.epa.gov/ssl/CSPP/PrimaryAuthorizedOfficial/Home.aspx</E> and follow the appropriate links, and for further instructions to go <E T="03">http://www.epa.gov/oppt/chemtest/ereporting/index.html.</E> </P> <CITA>[47 FR 26998, June 22, 1982, as amended at 52 FR 20083, May 29, 1987; 53 FR 12523, Apr. 15, 1988; 60 FR 31921, June 19, 1995; 60 FR 34463, July 3, 1995; 71 FR 47126, Aug. 16, 2006; 78 FR 72825, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 712.30</SECTNO> <SUBJECT>Chemical lists and reporting periods.</SUBJECT> <P>(a)(1) Persons subject to this subpart B must submit a Preliminary Assessment Information Manufacturer's Report for each chemical substance or mixture that is listed or designated in this section.</P> <P> (2) Unless a respondent has already prepared a Manufacturer's Report in conformity with conditions set forth in paragraph (a)(3) of this section, the information in each Manufacturer's Report must cover the respondent's latest complete corporate fiscal year as of the effective date. The effective date will be 30 days after the <E T="04">Federal Register</E> publishes a rule amendment making the substance or mixture subject to this subpart B. </P> <P> (3) Persons subject to this subpart B need not comply with the requirements of paragraph (a)(2) of this section if <PRTPAGE P="156"/> they meet either one of the following conditions: </P> <P>(i)(A) The respondent has previously and voluntarily provided EPA with a Manufacturer's Report on a chemical substance or mixture subject to subpart B of this part, which contains data for a 1-year period ending no more than 3 years prior to the effective date described in paragraph (a)(2) of this section. Respondents meeting this condition must notify EPA by letter of their desire to have the voluntary submission used in lieu of a current data submission and must verify the completeness and current accuracy of the voluntarily submitted data. Such letters, sent in accordance with the method specified in § 712.28(d) to EPA, must contain the following language:</P> <EXTRACT> <P>I hereby certify that, to the best of my knowledge and belief, all information entered on this form is complete and accurate. I agree to permit access to, and the copying of records by, a duly authorized representative of the EPA Administrator, in accordance with the Toxic Substances Control Act, to document any information reported on the form.</P> </EXTRACT> <P>(B) Notification letters must be submitted in accordance with the method specified in § 712.28(d) prior to the reporting deadline.</P> <P>(ii)(A) The respondent has previously submitted a Manufacturer's Report on a chemical substance or mixture subject to subpart B of this part to the Interagency Testing Committee, but not to EPA, and that Manufacturer's Report contained data for a 1-year period ending less than 3 years prior to the effective date described in paragraph (a)(2) of this section. Respondents meeting this condition must submit a copy of the Manufacture's Report, in accordance with the method specified in § 712.28(d) to EPA, and must submit an accompanying letter, also in accordance with the methods specified in § 712.28(d), notifying EPA of the respondent's intent that the submission be used in lieu of a current Manufacturer's Report. The notification letter must verify the completeness and current accuracy of the voluntarily submitted data. Such a letter must contain the following language:</P> <EXTRACT> <P>I hereby certify that, to the best of my knowledge and belief, all information entered on this form is complete and accurate. I agree to permit access to, and the copying of records by, a duly authorized representative of the EPA Administrator, in accordance with the Toxic Substances Control Act, to document any information reported on the form.</P> </EXTRACT> <P>(B) The submission must be made prior to the reporting deadline.</P> <P> (b) Except as provided in paragraph (c) of this section, chemical substances and designated mixtures will be added after a notice of proposed amendment of this subpart is published in the <E T="04">Federal Register.</E> There will be a 30 day public comment period on each notice; after consideration of the comments, a final amendment will identify the substances and mixtures added. </P> <P> (c)(1) Chemical substances, mixtures, and categories of substances or mixtures that have been added by the Interagency Testing Committee, established under section 4(e) of TSCA, to the section 4(e) Priority List, for testing consideration by the Agency, will be added to this section 30 days after EPA issues for publication in the <E T="04">Federal Register</E> a rule amendment listing these chemical substances, mixtures and categories. A Preliminary Assessment Information—Manufacturer's Report must be submitted for each chemical substance and mixture within 60 days after the effective date of the listing. At the discretion of the Assistant Administrator for Chemical Safety and Pollution Prevention, a listed substance, mixture or category may be withdrawn, for good cause, from the rule's reporting requirements prior to the effective date. Any information submitted showing why a substance, mixture or category should be removed from the rule must be received by EPA within 14 days after the date of publication of the notice under this paragraph. If a substance, mixture or category is removed, a <E T="04">Federal Register</E> notice announcing this decision will be published no later than the effective date of the amendment. </P> <P>(2) You must submit the information using the method specified in § 712.28(d).</P> <P> (d) Manufacturers and importers of the substances listed below must submit a Preliminary Assessment Information Manufacturer's Report for each <PRTPAGE P="157"/> site at which they manufacture or import each substance by the reporting date shown in the table below. The substances are listed in Chemical Abstracts Service Registry Number order. Typically EPA lists the trivial or common name first, then, following the symbol “- -”, EPA lists the substance by its TSCA Chemical Substance Inventory name. Whenever EPA lists a single name, the name may be either the TSCA Chemical Substance Inventory name, a trivial name, or a common name. Generally, when a single name is listed, it is the TSCA Chemical Substances Inventory name. </P> <GPOTABLE COLS="4" OPTS="L2" CDEF="xls50,r90,9,9"> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Substance</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Reporting date</CHED> </BOXHD> <ROW> <ENT I="01">78-10-4</ENT> <ENT>Ethyl silicate</ENT> <ENT>8/23/00</ENT> <ENT>10/23/00</ENT> </ROW> <ROW> <ENT I="01">90-30-2</ENT> <ENT>N-Phenyl-1-naphthylamine</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">100-40-3</ENT> <ENT>4-Vinylcyclohexene</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">108-95-5</ENT> <ENT>Thiophenol</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">109-87-5</ENT> <ENT>Methylal</ENT> <ENT>8/23/00</ENT> <ENT>10/23/00</ENT> </ROW> <ROW> <ENT I="01">118-79-6</ENT> <ENT>2,4,6-tribromophenol</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">133-49-3</ENT> <ENT>Pentachlorothiophenol</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">136-35-6</ENT> <ENT>1-Triazene, 1,3-diphenyl-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">143-33-9</ENT> <ENT>Sodium cyanide</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">496-46-8</ENT> <ENT>Glycoluril</ENT> <ENT>8/23/00</ENT> <ENT>10/23/00</ENT> </ROW> <ROW> <ENT I="01">632-79-1</ENT> <ENT>Tetrabromophthalic anhydride</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">637-92-3</ENT> <ENT>Ethyl tert-butyl ether</ENT> <ENT>12/28/94</ENT> <ENT>2/27/95</ENT> </ROW> <ROW> <ENT I="01">994-05-8</ENT> <ENT>Tert-amyl methyl ether</ENT> <ENT>12/28/94</ENT> <ENT>2/27/95</ENT> </ROW> <ROW> <ENT I="01">1163-19-5</ENT> <ENT>Decabromodiphenyl ether</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">1198-55-6</ENT> <ENT>Tetrachloropyrocatechol</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">1806-24-2</ENT> <ENT> <E T="03">p</E> -toluidine, 5-chloro-.alpha.,.alpha.,.alpha.-trifluoro-2-nitro- <E T="03">N</E> -phenyl- </ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">3194-55-6</ENT> <ENT>Hexabromocyclododecane</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">3278-89-5</ENT> <ENT>Benzene, 1,3,5-tribromo-2-(2-propenyloxy)-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">3296-90-0</ENT> <ENT>Dibromoneopentyl glycol</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">12185-10-3</ENT> <ENT>White phosphorus</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">16691-43-3</ENT> <ENT>3-Amino-5-mercapto-1,2,4-triazole</ENT> <ENT>8/23/00</ENT> <ENT>10/23/00</ENT> </ROW> <ROW> <ENT I="01">29091-20-1</ENT> <ENT>Benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">32534-81-9</ENT> <ENT>Pentabromodiphenyl ether</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">32536-52-0</ENT> <ENT>Octabromodiphenyl ether</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">32588-76-4</ENT> <ENT>Ethylene Bis-(tetrabromophthalimide)</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">37853-59-1</ENT> <ENT>1,2-Bis(tribromophenoxy) ethane</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">41291-34-3</ENT> <ENT>Ethylene(5,6-dibromonorbornane-2,3-dicarboximide)</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">52907-07-0</ENT> <ENT>Ethylene bis(5,6-dibromonorbornane-2,3-dicarboximide)</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">57137-10-7</ENT> <ENT>Tribrominated polystyrene</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">61262-53-1</ENT> <ENT>Ethylene bis(pentabromophenoxide)</ENT> <ENT>1/11/90</ENT> <ENT>3/12/90</ENT> </ROW> <ROW> <ENT I="01">68928-76-7</ENT> <ENT>Stannane, dimethylbis[(1-oxoneodecyl)oxy]-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">88185-22-2</ENT> <ENT>Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, 2-ethoxy-1-methyl-2-oxoethyl ester</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> </GPOTABLE> <P>(e) Manufacturers and importers of the substances listed below by category must submit a Preliminary Assessment Information Manufacturers Report for each site at which they manufacture or import each substance by the reporting date shown in the table below. The categories are listed in alphabetic order with the chemical substances within each category listed by ascending numerical CAS number.</P> <GPOTABLE COLS="4" OPTS="L2" CDEF="xl30,r120,9,9"> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Substance</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Reporting date</CHED> </BOXHD> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Aldehydes</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">66-77-3</ENT> <ENT>1-Naphthalenecarboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">75-07-0</ENT> <ENT>Acetaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">75-87-6</ENT> <ENT>Acetaldehyde, trichloro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">78-84-2</ENT> <ENT>Propanal, 2-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">78-85-3</ENT> <ENT>2-Propenal, 2-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">80-54-6</ENT> <ENT>Benzenepropanal,4-(1,1-dimethylethyl)-.alpha.-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">84-83-3</ENT> <ENT>Acetaldehyde, (1,3-dihydro-1,3, 3-trimethyl-2H-indol-2-ylidene)</ENT> </ROW> <ROW> <ENT I="01">89-98-5</ENT> <ENT>Benzaldehyde, 2-chloro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">90-02-8</ENT> <ENT>Benzaldehyde, 2-hydroxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">93-02-7</ENT> <ENT>Benzaldehyde, 2,5-dimethoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">93-53-8</ENT> <ENT>Benzeneacetaldehyde, .alpha.-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">95-01-2</ENT> <ENT>Benzaldehyde, 2,4-dihydroxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <PRTPAGE P="158"/> <ENT I="01">97-51-8</ENT> <ENT>Benzaldehyde, 2-hydroxy-5-nitro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">98-01-1</ENT> <ENT>2-Furancarboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">98-03-3</ENT> <ENT>2-Thiophenecarboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">100-10-7</ENT> <ENT>Benzaldehyde, 4-(dimethylamino)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">100-50-5</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">100-52-7</ENT> <ENT>Benzaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">101-39-3</ENT> <ENT>2-Propenal, 2-methyl-3-phenyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">101-86-0</ENT> <ENT>Octanal, 2-(phenylmethylene)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">103-95-7</ENT> <ENT>Benzenepropanal, .alpha.-methyl-4-(1-methylethyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">104-09-6</ENT> <ENT>Benzeneacetaldehyde, 4-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">104-55-2</ENT> <ENT>2-Propenal, 3-phenyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">104-87-0</ENT> <ENT>Benzaldehyde, 4-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">104-88-1</ENT> <ENT>Benzaldehyde, 4-chloro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">106-23-0</ENT> <ENT>6-Octenal, 3,7-dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">106-26-3</ENT> <ENT>2,6-Octadienal, 3,7-dimethyl-, (Z)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">106-72-9</ENT> <ENT>5-Heptenal, 2,6-dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">107-02-8</ENT> <ENT>2-Propenal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">107-20-0</ENT> <ENT>Acetaldehyde, chloro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">107-22-2</ENT> <ENT>Ethanedial</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">107-75-5</ENT> <ENT>Octanal, 7-hydroxy-3,7-dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">110-41-8</ENT> <ENT>Undecanal, 2-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">110-62-3</ENT> <ENT>Pentanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">111-30-8</ENT> <ENT>Pentanedial</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">111-71-7</ENT> <ENT>Heptanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">112-31-2</ENT> <ENT>Decanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">112-44-7</ENT> <ENT>Undecanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">112-45-8</ENT> <ENT>10-Undecenal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">112-54-9</ENT> <ENT>Dodecanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">120-14-9</ENT> <ENT>Benzaldehyde, 3,4-dimethoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">120-21-8</ENT> <ENT>Benzaldehyde, 4-(diethylamino)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">120-57-0</ENT> <ENT>1,3-Benzodioxole-5-carboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">121-32-4</ENT> <ENT>Benzaldehyde, 3-ethoxy-4-hydroxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">121-33-5</ENT> <ENT>Benzaldehyde, 4-hydroxy-3-methoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">122-40-7</ENT> <ENT>Heptanal, 2-(phenylmethylene)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">122-78-1</ENT> <ENT>Benzeneacetaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">123-05-7</ENT> <ENT>Hexanal, 2-ethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">123-08-0</ENT> <ENT>Benzaldehyde, 4-hydroxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">123-11-5</ENT> <ENT>Benzaldehyde, 4-methoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">123-38-6</ENT> <ENT>Propanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">124-13-0</ENT> <ENT>Octanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">124-19-6</ENT> <ENT>Nonanal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">126-15-8</ENT> <ENT>4a(4H)-Dibenzofurancarboxaldehyde, 1,5a,6,9,9a,9b-hexahydro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">135-02-4</ENT> <ENT>Benzaldehyde, 2-methoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">141-27-5</ENT> <ENT>2,6-Octadienal, 3,7-dimethyl-, (E)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">143-14-6</ENT> <ENT>9-Undecenal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">455-19-6</ENT> <ENT>Benzaldehyde, 4-(trifluoromethyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">505-57-7</ENT> <ENT>02-Hexenal</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">552-89-6</ENT> <ENT>Benzaldehyde, 2-nitro-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">590-86-3</ENT> <ENT>Butanal, 3-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">597-31-9</ENT> <ENT>Propanal, 3-hydroxy-2,2-dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">939-97-9</ENT> <ENT>Benzaldehyde, 4-(1,1-dimethylethyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1121-60-4</ENT> <ENT>2-Pyridinecarboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1200-14-2</ENT> <ENT>Benzaldehyde, 4-butyl</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1331-92-6</ENT> <ENT>2-Propenal, 3-phenyl-, monopentyl deriv.</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1334-78-7</ENT> <ENT>Benzaldehyde, methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1423-46-7</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde, 2,4,6-trimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1504-74-1</ENT> <ENT>2-Propenal, 3-(2-methoxyphenyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">2591-86-8</ENT> <ENT>1-Piperidinecarboxaldehyde</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">3132-99-8</ENT> <ENT>Benzaldehyde, 3-bromo-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">3268-49-3</ENT> <ENT>Propanal, 3-(methylthio)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">3613-30-7</ENT> <ENT>Octanal, 7-methoxy-3,7-dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">4501-58-0</ENT> <ENT>3-Cyclopentene-1-acetaldehyde, 2,2,3-trimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">5435-64-3</ENT> <ENT>Hexanal, 3,5,5-trimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">5780-07-4</ENT> <ENT>1,3-Benzodioxole-5-carboxaldehyde, 7-methoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">5949-05-3</ENT> <ENT>6-Octenal, 3,7-dimethyl-, (S)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">5988-91-0</ENT> <ENT>Octanal, 3,7-dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">10031-82-0</ENT> <ENT>Benzaldehyde, 4-ethoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">13586-68-0</ENT> <ENT>2-Propenal, 3- 4-(1,1-dimethylethyl)phenyl-2-methyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">17754-90-4</ENT> <ENT>Benzaldehyde, 4-(diethylamino)-2-hydroxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">26266-68-2</ENT> <ENT>Hexenal, 2-ethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">27939-60-2</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde, dimethyl-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <PRTPAGE P="159"/> <ENT I="01">28602-27-9</ENT> <ENT>Benzaldehyde, (dimethylamino)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">31906-04-4</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde, 4-(4-hydroxy-4-methylpentyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">37677-14-8</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde, 4-(4-methyl-3-pentenyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">39515-51-0</ENT> <ENT>Benzaldehyde, 3-phenoxy-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">52475-86-2</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methyl-3-pentenyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW RUL="s"> <ENT I="01">66327-54-6</ENT> <ENT>3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methylpentyl)-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Alkyl-, Chloro-, and Hydroxymethyl Diaryl Ethers</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">3061-36-7</ENT> <ENT>1,4-Diphenoxybenzene</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">3586-14-9</ENT> <ENT>Benzene, 1-methyl-3-phenoxy-</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">13826-35-2</ENT> <ENT>Benzenemethanol, 3-phenoxy-,</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">28299-41-4</ENT> <ENT>Benzene, 1,1,′-oxybis[methyl-</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">28984-89-6</ENT> <ENT>1,1′-Biphenyl, phenoxy-</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">42874-96-4</ENT> <ENT>2-Chloro-1-(3-methylphenoxy)-4-(trifluoromethyl)benzene</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">50594-77-9</ENT> <ENT>Phenol, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, acetate</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">50789-44-1</ENT> <ENT>Benzenemethanol, 3-phenoxy-, acetate</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">51632-16-7</ENT> <ENT>Benzene, 1-(bromomethyl)-3-phenoxy-</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">61702-88-3</ENT> <ENT>Benzene, 1,1′-oxybis[(1,1,3,3-tetramethylbutyl)-</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">63734-62-3</ENT> <ENT>Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-,</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW> <ENT I="01">69834-19-1</ENT> <ENT>Benzene, 1,1′-oxybis[dodecyl-</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW RUL="s"> <ENT I="01">72252-48-3</ENT> <ENT>Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, potassium salt</ENT> <ENT>04/12/93</ENT> <ENT>06/10/93</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Alkylphenols, Alkylphenol ethoxylates, and Polyalkylphenols</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">80-46-6</ENT> <ENT>4-tert-Pentylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">88-18-6</ENT> <ENT>2-tert-Butylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">94-06-4</ENT> <ENT>4-(1-Methylbutyl)phenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">98-54-4</ENT> <ENT>4-tert-Butylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">99-71-8</ENT> <ENT>4-sec-Butylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">104-40-5</ENT> <ENT>4-Nonylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">104-43-8</ENT> <ENT>4-Dodecylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">136-81-2</ENT> <ENT>Phenol, 2-pentyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">140-66-9</ENT> <ENT>Phenol, 4-(1,1,3,3-tetramethylbutyl)-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">949-13-3</ENT> <ENT>2-Octylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">1300-16-9</ENT> <ENT>Nonylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">1322-69-6</ENT> <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">1331-57-3</ENT> <ENT>Dodecylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">1638-22-8</ENT> <ENT>4-n-Butylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">1806-26-4</ENT> <ENT>4-Octylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">1987-50-4</ENT> <ENT>Phenol, 4-heptyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">2315-66-4</ENT> <ENT>Decaethylene glycol 4-isooctylphenyl ether</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">2446-69-7</ENT> <ENT>Phenol, 4-hexyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">2497-58-7</ENT> <ENT>Hexaethylene glycol 4-isooctylphenyl ether</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">2589-78-8</ENT> <ENT>Phenol, 4-hexadecyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">3180-09-4</ENT> <ENT>2-Butylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">3279-27-4</ENT> <ENT>Phenol, 2-(1,1-dimethylpropyl)-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">3884-95-5</ENT> <ENT>2-(1,1,3,3-Tetramethylbutyl)phenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">9002-93-1</ENT> <ENT>Polyethylene glycol 4-(tert-octyl)phenyl ether</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">9004-87-9</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(isooctylphenyl)-ω-hydroxy-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">9014-92-0</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(dodecylphenyl)-ω-hydroxy-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">9036-19-5</ENT> <ENT>Polyethylene glycol mono(octyl)phenyl ether</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">9063-89-2</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(octylphenyl)-ω-hydroxy-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">11066-49-2</ENT> <ENT>Isononylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">14938-35-3</ENT> <ENT>4-Pentylphenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">17404-66-9</ENT> <ENT>4-(1-Methyloctyl)phenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">25154-52-3</ENT> <ENT>Nonylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">25401-86-9</ENT> <ENT>Phenol, 2-hexadecyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">25735-67-5</ENT> <ENT>Phenol, 4-sec-pentyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">26401-47-8</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(4-dodecylphenyl)-ω-hydroxy-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">26401-74-1</ENT> <ENT>Phenol, 2-sec-pentyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">27157-66-0</ENT> <ENT>Phenol, decyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">27178-34-3</ENT> <ENT>tert-Butylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">27193-28-8</ENT> <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">27193-86-8</ENT> <ENT>Dodecylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">27985-70-2</ENT> <ENT>(1-Methylheptyl)phenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">29932-96-5</ENT> <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">30105-54-5</ENT> <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">31195-95-6</ENT> <ENT>Isobutylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">54932-78-4</ENT> <ENT>4-(2,2,3,3-Tetramethylbutyl)phenol</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">59911-95-4</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(4-hexadecylphenyl)-ω-hydroxy-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">61723-87-3</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(tridecylphenyl)-ω-hydroxy-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <PRTPAGE P="160"/> <ENT I="01">62744-41-6</ENT> <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">68081-86-7</ENT> <ENT>Phenol, nonyl derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">68784-24-7</ENT> <ENT>Phenol, C18-30-alkyl derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">68891-67-8</ENT> <ENT>Phenol, polypropene derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">68908-55-4</ENT> <ENT>Phenol, polybutene derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">68954-70-1</ENT> <ENT>Phenol, polyethyl derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">68987-90-6</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-(octylphenyl)-ω-hydroxy-, branched</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">70682-80-3</ENT> <ENT>Phenol, tetradecyl-</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">71902-25-5</ENT> <ENT>Phenol, octenylated</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">72624-02-3</ENT> <ENT>Phenol, heptyl derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">74499-35-7</ENT> <ENT>Phenol, (tetrapropenyl) derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">84605-25-4</ENT> <ENT>Phenol, 1-methylhexyl derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">84852-15-3</ENT> <ENT>Branched 4-nonylphenol (mixed isomers)</ENT> <ENT>3/29/96</ENT> <ENT>5/29/96</ENT> </ROW> <ROW> <ENT I="01">91672-41-2</ENT> <ENT>Phenol, 2-nonyl-, branched</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW> <ENT I="01">112375-88-9</ENT> <ENT>Phenol, polyisobutylene derivs.</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW RUL="s"> <ENT I="01">112375-89-0</ENT> <ENT>Phenol, poly(2,4,4-trimethylpentene) derivs</ENT> <ENT>8/4/00</ENT> <ENT>10/3/00</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Alkyl phosphates</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">78-40-0</ENT> <ENT>Phosphoric acid, triethyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">78-42-2</ENT> <ENT>Phosphoric acid, tris(2-ethylhexyl)ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">78-51-3</ENT> <ENT>Ethanol, 2-butoxy-, phosphate (3:1)</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">107-66-4</ENT> <ENT>Phosphoric acid, dibutyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">126-71-6</ENT> <ENT>Phosphoric acid, tris(2-methylpropyl) ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">126-73-8</ENT> <ENT>Phosphoric acid tributyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">298-07-7</ENT> <ENT>Phosphoric acid, bis(2-ethylhexyl)ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">812-00-0</ENT> <ENT>Phosphoric acid, monomethyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">1070-03-7</ENT> <ENT>Phosphoric acid, mono(2-ethylhexyl)ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">1498-51-7</ENT> <ENT>Phosphorodichloridic acid, ethylester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">1623-15-0</ENT> <ENT>Phosphoric acid, monobutyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">1623-24-1</ENT> <ENT>Phosphoric acid, mono(1-methylethyl)ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">2958-09-0</ENT> <ENT>Phosphoric acid, monooctadecyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">3900-04-7</ENT> <ENT>Phosphoric acid, monohexyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">3991-73-9</ENT> <ENT>Phosphoric acid, monooctyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">7057-92-3</ENT> <ENT>Phosphoric acid, didodecyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">7332-46-9</ENT> <ENT>Ethanol, 2-(2-butoxyethoxy)-, phosphate (3:1)</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">12645-31-7</ENT> <ENT>Phosphoric acid, 2-ethylhexyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">12751-23-4</ENT> <ENT>Phosphoric acid, dodecyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW RUL="s"> <ENT I="01">27215-10-7</ENT> <ENT>Phosphoric acid, diisooctyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Brominated flame retardants</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">87-10-5</ENT> <ENT>Benzamide, 3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">87-83-2</ENT> <ENT>Benzene, pentabromomethyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">87-84-3</ENT> <ENT>Cyclohexane,1,2,3,4,5-pentabromo-6-chloro-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">96-13-9</ENT> <ENT>1-Propanol, 2,3-dibromo-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">593-60-2</ENT> <ENT>Ethene, bromo-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">615-58-7</ENT> <ENT>Phenol, 2,4-dibromo-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">4162-45-2</ENT> <ENT>Ethanol,2,2′-((1-methylethylidene)bis((2,6-dibromo-4,1-phenylene)oxy))bis-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">25327-89-3</ENT> <ENT>Benzene, 1,1′-(1-methylethylidene)bis(3,5-dibromo-4-(2-propenyloxy)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">30554-72-4</ENT> <ENT>Cyclohexane, tetrabromodichloro-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">30554-73-5</ENT> <ENT>Cyclohexane, tribromotrichloro-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">36483-57-5</ENT> <ENT>1-Propanol, 2,2-dimethyl-, tribromo deriv.</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">55205-38-4</ENT> <ENT>2-Propenoic acid, (1-methylethylidene)bis(2,6-dibromo-4,1-phenylene) ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">68955-41-9</ENT> <ENT>Alkanes, C10-18, bromochloro-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">69882-11-7</ENT> <ENT>Phenol, 2,4(or 2,6)-dibromo-, homopolymer</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW RUL="s"> <ENT I="01">88497-56-7</ENT> <ENT>Benzene, ethenyl-, homopolymer, brominated</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Chloralkyl phosphates</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">34621-99-3</ENT> <ENT>1,2-Ethanediyltetrakis(2-chloro-1-methylethylene) phosphate</ENT> <ENT>6/14/93</ENT> <ENT>8/12/93</ENT> </ROW> <ROW> <ENT I="01">38051-10-4</ENT> <ENT>2,2-Bis(chloromethyl)-1,3-propanediyltetrakis(2-chloroethyl) phosphate</ENT> <ENT>6/14/93</ENT> <ENT>8/12/93</ENT> </ROW> <ROW> <ENT I="01">53461-82-8</ENT> <ENT>Oxydi-2,1-ethanediyltetrakis(2-chloroethyl) phosphate</ENT> <ENT>6/14/93</ENT> <ENT>8/12/93</ENT> </ROW> <ROW RUL="s"> <ENT I="01">76649-15-5</ENT> <ENT>2-Chloro-1-methylethylbis(2-chloropropyl) phosphate</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Cyanoacrylates</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">137-05-3</ENT> <ENT>2-Propenoic acid, 2-cyano-, methyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">1069-55-2</ENT> <ENT>2-Propenoic acid, 2-cyano-, isobutyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">6197-30-4</ENT> <ENT>2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">6606-65-1</ENT> <ENT>2-Propenoic acid, 2-cyano-, butyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">7085-85-0</ENT> <ENT>2-Propenoic acid, 2-cyano-, ethyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <PRTPAGE P="161"/> <ENT I="01">7324-02-9</ENT> <ENT>2-Propenoic acid, 2-cyano-, 2-propenyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">10586-17-1</ENT> <ENT>2-Propenoic acid, 2-cyano-, 1-methylethyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">21982-43-4</ENT> <ENT>2-Propenoic acid, 2-cyano-, ethoxyethyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">23023-91-8</ENT> <ENT>2-Propenoic acid, 2-cyano-, 2,2,2-trifluoromethyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">27816-23-5</ENT> <ENT>2-Propenoic acid, 2-cyano-, 2-methoxyethyl ester</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW RUL="s"> <ENT I="01">64992-16-1</ENT> <ENT> Ethanaminium, 2-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxo-2-propenyl]oxy]- <E T="03">N,N,N</E> -trimethyl-, chloride </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Indium Chemicals</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">923-34-2</ENT> <ENT>Triethylindium</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">1303-11-3</ENT> <ENT>Indium arsenide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">1312-41-0</ENT> <ENT>Indium antimonide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">1312-43-2</ENT> <ENT>Indium (III) oxide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">1312-45-4</ENT> <ENT>Indium (III) telluride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">4194-69-8</ENT> <ENT>Indium (III) citrate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">7440-74-6</ENT> <ENT>Indium</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">7783-52-0</ENT> <ENT>Indium (III) fluoride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">10025-82-8</ENT> <ENT>Indium (III) chloride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">12018-95-0</ENT> <ENT>Copper indium diselenide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">12030-14-7</ENT> <ENT>Indium (II) sulfide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">12030-24-9</ENT> <ENT>Indium (III) sulfide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">12056-07-4</ENT> <ENT>Indium selenide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">12672-70-7</ENT> <ENT>Indium chloride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">12672-71-8</ENT> <ENT>Indium oxide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13464-82-9</ENT> <ENT>Indium (III) sulfate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13465-09-3</ENT> <ENT>Indium (III) bromide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13465-10-6</ENT> <ENT>Indium (I) chloride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13510-35-5</ENT> <ENT>Indium (III) iodide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13709-93-8</ENT> <ENT>Indium (III) borate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13770-61-1</ENT> <ENT>Indium (III) nitrate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">13966-94-4</ENT> <ENT>Indium (I) iodide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">14166-78-0</ENT> <ENT>Indium (III) fluoride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">14280-53-6</ENT> <ENT>Indium (I) bromide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">14405-45-9</ENT> <ENT>Indium tris(acetylacetonate)</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">20661-21-6</ENT> <ENT>Indium (III) hydroxide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">22398-80-7</ENT> <ENT>Indium (I) phosphide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">25114-58-3</ENT> <ENT>Indium (III) acetate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">25617-98-5</ENT> <ENT>Indium nitride</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">27765-48-6</ENT> <ENT>Indium (III) tetrafluoroborate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">50926-11-9</ENT> <ENT>Indium tin oxide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">55326-87-9</ENT> <ENT>Indium hydroxide</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">66027-93-8</ENT> <ENT>Indium (III) sulfamate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">66027-94-9</ENT> <ENT> Hydroxybis(trifluoroacetato- <E T="03">O</E> )indium </ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">67816-06-2</ENT> <ENT>Indium (III) 2-ethylhexanoate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW> <ENT I="01">68310-35-0</ENT> <ENT>Indium (III) neodecanoate</ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW RUL="s"> <ENT I="01">71243-84-0</ENT> <ENT> Indium tin oxide (In <E T="52">1.69</E> Sn <E T="52">0.1502</E> O <E T="52">2.85</E> ) </ENT> <ENT>8/27/01</ENT> <ENT>10/24/01</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">IRIS Chemicals</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">51-28-5</ENT> <ENT>2,4 Dinitrophenol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW RUL="s"> <ENT I="01">95-65-8</ENT> <ENT>3,4 Dinethylphenol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Isocyanates</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">91-97-4</ENT> <ENT>1,1′-Biphenyl, 4,4′-diisocyanato-3,3′-dimethyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">100-28-7</ENT> <ENT>Benzene, 1-isocyanato-4-nitro-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">101-68-8</ENT> <ENT>Benzene, 1,1′-methylenebis(4-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">102-36-3</ENT> <ENT>Benzene, 1,2-dichloro-4-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">103-71-9</ENT> <ENT>Benzene, isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">104-12-1</ENT> <ENT>Benzene, 1-chloro-4-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">104-49-4</ENT> <ENT>Benzene, 1,4-diisocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">109-90-0</ENT> <ENT>Ethane, isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">110-78-1</ENT> <ENT>Propane, 1-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">111-36-4</ENT> <ENT>Butane, 1-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">112-96-9</ENT> <ENT>Octadecane, 1-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">123-61-5</ENT> <ENT>Benzene, 1,3-diisocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">329-01-1</ENT> <ENT>Benzene, 1-isocyanato-3-(trifluoromethyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">614-68-6</ENT> <ENT>Benzene, 1-isocyanato-2-methyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">622-58-2</ENT> <ENT>Benzene, 1-isocyanato-4-methyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">624-83-9</ENT> <ENT>Methane, isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">1476-23-9</ENT> <ENT>1-Propene, 3-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <PRTPAGE P="162"/> <ENT I="01">2422-91-5</ENT> <ENT>Benzene, 1,1′,1″-methylidynetris(4-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">2493-02-9</ENT> <ENT>Benzene, 1-bromo-4-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">2909-38-8</ENT> <ENT>Benzene, 1-chloro-3-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">2949-22-6</ENT> <ENT>Acetic acid, isocyanato-, ethyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">3173-53-3</ENT> <ENT>Cyclohexane, isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">4035-89-6</ENT> <ENT>Imidodicarbonic diamide,N,N′,2-tris(6-isocyanatohexyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">4098-71-9</ENT> <ENT>Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">4151-51-3</ENT> <ENT>Phenol, 4-isocyanato-, phosphorothioate (3:1) (ester)</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">5124-30-1</ENT> <ENT>Cyclohexane, 1,1′-methylenebis(4-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">5873-54-1</ENT> <ENT>Benzene, 1-isocyanato-2-((4-isocyanatophenyl)methyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">10031-75-1</ENT> <ENT>Benzene, 1,1′-(diisocyanatomethylene)bis-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">15646-96-5</ENT> <ENT>Hexane, 1,6-diisocyanato-2,4,4-trimethyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">16938-22-0</ENT> <ENT>Hexane, 1,6-diisocyanato-2,2,4-trimethyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">25854-16-4</ENT> <ENT>Benzene, bis(isocyanatomethyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">26447-40-5</ENT> <ENT>Benzene, 1,1′-methylenebis(isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">26603-40-7</ENT> <ENT>1,3,5,-Triazine-2,4,6(1H.3H,5H-trione, 1,3,5-tris(3-isocyanatomethylphenyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">26747-90-0</ENT> <ENT>1,3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanatomethylphenyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">28178-42-9</ENT> <ENT>Benzene, 2-isocyanato-1,3-bis(1-methylethyl)-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">28556-81-2</ENT> <ENT>Benzene, 2-isocyanato-1,3-dimethyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">30674-80-7</ENT> <ENT>2-Propenoic acid, 2-methyl-,2-isocyanatoethyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">34893-92-0</ENT> <ENT>Benzene, 1,3-dichloro-5-isocyanato-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW> <ENT I="01">68239-06-5</ENT> <ENT>Cyclohexane, 2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentyl-</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW RUL="s"> <ENT I="01">73597-26-9</ENT> <ENT>2-Propenoic acid, 2-methyl-, 2-(((((5-isocyanato-1,3,3-trimethylcyclohexyl) methyl)amino)carbonyl)oxy)ethyl ester</ENT> <ENT>10/29/90</ENT> <ENT>12/27/90</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Methyl ethylene glycol ethers and esters</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">3121-61-7</ENT> <ENT>Ethylene glycol monomethyl ether acrylate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW RUL="s"> <ENT I="01">23783-42-8</ENT> <ENT>Tetraethylene glycol monomethyl ether</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Nonylphenol ethoxylates</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">7311-27-5</ENT> <ENT>Ethanol, 2-[2-[2-[2-(p-nonylphenoxy)ethoxy]ethoxy]ethoxy]-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">9016-45-9</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(nonylphenyl)-omega-hydroxy-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">20427-84-3</ENT> <ENT>Ethanol, 2-[2-(p-nonylphenoxy)ethoxy]-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">20636-48-0</ENT> <ENT>3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">26027-38-3</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">26264-02-8</ENT> <ENT>3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">26571-11-9</ENT> <ENT>3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-(nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">27176-93-8</ENT> <ENT>Ethanol, 2-[2-(nonylphenoxy)ethoxy]-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">27177-01-1</ENT> <ENT>3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-(nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">27177-05-5</ENT> <ENT>3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">27177-08-8</ENT> <ENT>3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">27986-36-3</ENT> <ENT>Ethanol, 2-(nonylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">37205-87-1</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(isononylphenyl)-omega-hydroxy-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">51938-25-1</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(2-nonylphenyl)-omega-hydroxy-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">65455-72-3</ENT> <ENT>3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">68412-54-4</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(nonylphenyl)-omega-hydroxy-, branched</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">98113-10-1</ENT> <ENT>NP9</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW> <ENT I="01">127087-87-0</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-, branched</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW RUL="s"> <ENT I="01">152143-22-1</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-, branched, phosphates</ENT> <ENT>2/10/00</ENT> <ENT>4/10/00</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">OSHA Chemicals in Need of Dermal Absorption Testing</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">60-29-7</ENT> <ENT>Ethyl ether</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">61-82-5</ENT> <ENT>Amitrole</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">74-96-4</ENT> <ENT>Ethyl bromide</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">75-05-8</ENT> <ENT>Acetonitrile</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">75-12-7</ENT> <ENT>Formamide</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">75-15-0</ENT> <ENT>Carbon disulfide</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">75-25-2</ENT> <ENT>Bromoform</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">75-34-3</ENT> <ENT>1,1-Dichloroethane</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">75-35-4</ENT> <ENT>Vinylidene chloride</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">75-65-0</ENT> <ENT> <E T="03">tert</E> -Butyl alcohol </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">76-22-2</ENT> <ENT>Camphor</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">77-73-6</ENT> <ENT>Dicyclopentadiene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">77-78-1</ENT> <ENT>Dimethyl sulfate</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">78-59-1</ENT> <ENT>Isophorone</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">78-87-5</ENT> <ENT>Propylene dichloride</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">78-92-2</ENT> <ENT> <E T="03">sec</E> -Butyl alcohol </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">79-20-9</ENT> <ENT>Methyl acetate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <PRTPAGE P="163"/> <ENT I="01">79-46-9</ENT> <ENT>2-Nitropropane</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">88-72-2</ENT> <ENT>o-Nitrotoluene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">89-72-5</ENT> <ENT>o-sec-Butylphenol</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">90-04-0</ENT> <ENT>o-Anisidine</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">91-20-3</ENT> <ENT>Naphthalene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">92-52-4</ENT> <ENT>Biphenyl</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">95-13-6</ENT> <ENT>Indene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">95-49-8</ENT> <ENT>o-Chlorotoluene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">95-50-1</ENT> <ENT>o-Dichlorobenzene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">96-18-4</ENT> <ENT>1,2,3-Trichloropropane</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">97-77-8</ENT> <ENT>Disulfiram</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">98-29-3</ENT> <ENT>t-Butylcatechol</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">99-08-1</ENT> <ENT>m-Nitrotoluene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">99-65-0</ENT> <ENT>m-Dinitrobenzene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">99-99-0</ENT> <ENT>p-Nitrotoluene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">100-00-5</ENT> <ENT>p-Nitrochlorobenzene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">100-01-6</ENT> <ENT>p-Nitroaniline</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">100-44-7</ENT> <ENT>Benzyl chloride</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">100-25-4</ENT> <ENT> <E T="03">p</E> -Dinitrobenzene </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">100-63-0</ENT> <ENT>Phenylhydrazine</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">105-46-4</ENT> <ENT> <E T="03">sec</E> -Butyl acetate </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">106-42-3</ENT> <ENT> <E T="03">p</E> -Xylene </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">106-46-7</ENT> <ENT>p-Dichlorobenzene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">106-49-0</ENT> <ENT>p-Toluidine</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">107-06-2</ENT> <ENT>Ethylene dichloride</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">107-31-3</ENT> <ENT>Methyl formate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">107-66-4</ENT> <ENT>Dibutyl phosphate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">108-03-2</ENT> <ENT>1-Nitropropane</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">108-44-1</ENT> <ENT>m-Toluidine</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">108-87-2</ENT> <ENT>Methylcyclohexane</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">108-90-7</ENT> <ENT>Chlorobenzene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">108-93-0</ENT> <ENT>Cyclohexanol</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">109-66-0</ENT> <ENT>Pentane</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">109-99-9</ENT> <ENT>Tetrahydrofuran</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">110-12-3</ENT> <ENT>Methyl isoamyl ketone</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">110-83-8</ENT> <ENT>Cyclohexene</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">111-84-2</ENT> <ENT>Nonane</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">120-80-9</ENT> <ENT>Catechol</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">121-14-2</ENT> <ENT>2,4-Dinitrotoluene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">121-69-7</ENT> <ENT>Dimethylaniline</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">122-39-4</ENT> <ENT>Diphenylamine</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">123-42-2</ENT> <ENT>Diacetone alcohol</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">123-92-2</ENT> <ENT>Isoamyl acetate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">126-99-8</ENT> <ENT>beta-Chloroprene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">127-19-5</ENT> <ENT>Dimethyl acetamide</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">142-82-5</ENT> <ENT> Heptane ( <E T="03">n</E> -Heptane) </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">150-76-5</ENT> <ENT>p-Methoxyphenol</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">287-92-3</ENT> <ENT>Cyclopentane</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">528-29-0</ENT> <ENT>o-Dinitrobenzene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">532-27-4</ENT> <ENT> <E T="03">a</E> -Chloroacetophenone </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">540-59-0</ENT> <ENT>1,2-Dichloroethylene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">540-88-5</ENT> <ENT> <E T="03">tert</E> -Butyl acetate </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">542-92-7</ENT> <ENT>Cyclopentadiene</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW> <ENT I="01">626-17-5</ENT> <ENT>m-Phthalodinitrile</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">628-63-7</ENT> <ENT> <E T="03">n</E> -Amyl acetate </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">768-52-5</ENT> <ENT>N-Isopropylaniline</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">1300-73-8</ENT> <ENT>Xylidine</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">6423-43-4</ENT> <ENT>Propylene glycol dinitrate</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW> <ENT I="01">7631-90-5</ENT> <ENT>Sodium bisulfite</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">7681-57-4</ENT> <ENT>Sodium metabisulfite</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">25013-15-4</ENT> <ENT>Vinyl toluene</ENT> <ENT>3/11/94</ENT> <ENT>5/10/94</ENT> </ROW> <ROW RUL="s"> <ENT I="01">34590-94-8</ENT> <ENT>Dipropylene glycol methyl ether</ENT> <ENT>8/4/95</ENT> <ENT>10/3/95</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Propylene glycol ethers and esters</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">108-65-6</ENT> <ENT>Propylene glycol monomethyl ether acetate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">110-98-5</ENT> <ENT>Dipropylene glycol</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">770-35-4</ENT> <ENT>1-Phenoxy-2-propanol</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">20324-32-7</ENT> <ENT>1-(2-Methoxy-1-methylethoxy)-2-propanol</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">20324-33-8</ENT> <ENT>Tripropylene glycol methyl ether</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">28677-93-2</ENT> <ENT>Methoxy-1-propanol</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <PRTPAGE P="164"/> <ENT I="01">29387-86-8</ENT> <ENT>Propylene glycol monobutyl ether</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">29911-28-2</ENT> <ENT>Dipropylene glycol butyl ether</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">42978-66-5</ENT> <ENT>Tripropylene glycol diacrylate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW> <ENT I="01">57018-52-7</ENT> <ENT> Propylene glycol mono- <E T="03">tert</E> -butyl ether </ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW RUL="s"> <ENT I="01">88917-22-0</ENT> <ENT>Dipropylene glycol monomethyl ether acetate</ENT> <ENT>1/26/94</ENT> <ENT>3/28/94</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Pyridinamines</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">462-08-8</ENT> <ENT>3-Pyridinamine</ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">504-24-5</ENT> <ENT>4-Pyridinamine</ENT> <ENT> <E T="03">1/6/05</E> </ENT> <ENT>3/7/05</ENT> </ROW> <ROW RUL="s"> <ENT I="01">504-29-0</ENT> <ENT>2-Pyridinamine</ENT> <ENT> <E T="03">1/6/05</E> </ENT> <ENT>3/7/05</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Siloxanes</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">107-46-0</ENT> <ENT>Hexamethyldisiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">107-50-6</ENT> <ENT>Tetradecamethylcycloheptasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">107-51-7</ENT> <ENT>Octamethyltrisiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">107-52-8</ENT> <ENT>Tetradecamethylhexasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">107-53-9</ENT> <ENT>Tetracosamethylundecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">141-62-8</ENT> <ENT>Decamethyltetrasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">141-63-9</ENT> <ENT>Dodecamethylpentasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">540-97-6</ENT> <ENT>Dodecamethylcyclohexasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">541-01-5</ENT> <ENT>Hexadecamethylheptasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">541-02-6</ENT> <ENT>Decamethylcyclopentasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">541-05-9</ENT> <ENT>Hexamethylcyclotrisiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">546-56-5</ENT> <ENT>Octaphenylcyclotetrasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">556-67-2</ENT> <ENT>Octamethylcyclotetrasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">556-68-3</ENT> <ENT>Hexadecamethylcyclooctasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">556-69-4</ENT> <ENT>Octadecamethyloctasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">556-70-7</ENT> <ENT>Docosamethyldecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">556-71-8</ENT> <ENT>Octadecamethylcyclononasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">999-97-3</ENT> <ENT>Hexamethyldisilazane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2370-88-9</ENT> <ENT>Tetramethylcyclotetrasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2374-14-3</ENT> <ENT>Trifluoropropylmethylcyclotrisiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2471-08-1</ENT> <ENT>Hexacosamethyldodecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2471-09-2</ENT> <ENT>Octacosamethyltridecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2471-10-5</ENT> <ENT>Triacontamethyltetradecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2471-11-6</ENT> <ENT>Dotriacontamethylpentadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2554-06-5</ENT> <ENT>Methylvinylcyclosiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2627-95-4</ENT> <ENT>Tetramethyldivinyldisiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">2652-13-3</ENT> <ENT>Eicosamethylnonasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">70131-67-8</ENT> <ENT>Siloxanes and silicones, di-Me, hydroxy-terminated</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">9004-73-3</ENT> <ENT>Methylpolysiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">18766-38-6</ENT> <ENT>Docosamethylcycloundecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">18772-36-6</ENT> <ENT>Eicosamethylcyclodecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">18844-04-7</ENT> <ENT>Hexatriacontamethylheptadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">18919-94-3</ENT> <ENT>Tetracosamethylcyclododecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">23523-12-8</ENT> <ENT>Hexatriacontamethylcyclooctadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">23523-14-0</ENT> <ENT>Triacontamethylcyclopentadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">23732-94-7</ENT> <ENT>Hexacosamethylcyclotridecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">36938-50-8</ENT> <ENT>Tetratriacontamethyl hexadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">36938-52-0</ENT> <ENT>Octatriacontamethyl octadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">63148-62-9</ENT> <ENT>Dimethyl silicones and siloxanes</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">67762-90-7</ENT> <ENT>Dimethyl silicones and siloxane, reaction products with silica</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">67762-94-1</ENT> <ENT>Dimethylmethylvinylsiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">68037-59-2</ENT> <ENT>Dimethylhydropolylsiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">68037-74-1</ENT> <ENT>Dimethylpolysiloxanes</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">68083-14-7</ENT> <ENT>Dimethyldiphenylsiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">69430-24-6</ENT> <ENT>Cyclopolydimethylsiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">115361-68-7</ENT> <ENT>Dimethylmethyl 3,3,3-trifluoropropyl siloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">149050-40-8</ENT> <ENT>Octacosamethylcyclotetradecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">150026-95-2</ENT> <ENT>Dotriacontamethylcyclohexadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">150026-96-3</ENT> <ENT>Tetratriacontamethylcycloheptadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">150026-97-4</ENT> <ENT>Octatriacontamethylcyclononadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">150026-98-5</ENT> <ENT>Tetracontamethylcycloeicosasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">150026-99-6</ENT> <ENT>Tetracontamethylnonadecasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW> <ENT I="01">150027-00-2</ENT> <ENT>Dotetracontamethyleicosasiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW RUL="s"> <ENT I="01">not available</ENT> <ENT>Polymethyloctadecylsiloxane</ENT> <ENT>10/12/93</ENT> <ENT>2/28/94</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Substantially produced chemicals in need of subchronic tests</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">80-51-3</ENT> <ENT>p,p′-Oxybis(benzenesulfonylhydrazide)</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <PRTPAGE P="165"/> <ENT I="01">81-84-5</ENT> <ENT>Naphthalenedicarboxylic anhydride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">84-51-5</ENT> <ENT>2-Ethylanthraquinone</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">87-02-5</ENT> <ENT>7-Amino-4-hydroxy-2-naphthalenesulfonic acid</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">90-15-3</ENT> <ENT>1-Naphthol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">92-70-6</ENT> <ENT>3-Hydroxy-2-naphthoic acid</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">94-28-0</ENT> <ENT>Triethylene glycol bis(2-ethylhexanoate)</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">95-32-9</ENT> <ENT>2-(4-Morpholinyldithio)-benzothiazole</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">97-88-1</ENT> <ENT>N-Butyl methacrylate</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">98-48-6</ENT> <ENT>1,3-Benzenedisulfonic Acid</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">99-54-7</ENT> <ENT>3,4-Dichloronitrobenzene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">99-63-8</ENT> <ENT>Isophthaloyl chloride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">100-20-9</ENT> <ENT>Terephthaloyl chloride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">100-29-8</ENT> <ENT>4-Ethoxynitrobenzene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">102-01-2</ENT> <ENT>Acetoacetanilide</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">106-31-0</ENT> <ENT>Butyric anhydride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">106-63-8</ENT> <ENT>Isobutyl acrylate</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">111-96-6</ENT> <ENT>Diethylene glycol dimethyl ether</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">112-15-2</ENT> <ENT>Ethanol, 2-(2-ethoxyethoxy)-, acetate</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">116-81-4</ENT> <ENT>Bromamine acid</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">119-33-5</ENT> <ENT>4-Methyl-2-nitro-phenol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">121-60-8</ENT> <ENT>4-(Acetylamino)benzenesulfonyl chloride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">123-54-6</ENT> <ENT>2,4-Pentanedione</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">123-62-6</ENT> <ENT>Propanoic anhydride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">142-16-5</ENT> <ENT>Bis(2-ethylhexyl)-2-butenedioate</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">311-89-7</ENT> <ENT>Perfluorotributylamine</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">355-42-0</ENT> <ENT>Perfluoro-N-hexane</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">594-42-3</ENT> <ENT>Trichloromethanesulfenyl chloride</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">616-21-7</ENT> <ENT>1,2-Dichlorobutane</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">626-17-5</ENT> <ENT>1,3-Dicyanobenzene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">760-23-6</ENT> <ENT>3,4-Dichlorobutene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">929-06-6</ENT> <ENT>2-(2-Aminoethoxy)-ethanol</ENT> <ENT>6/30/92</ENT> <ENT>9/28/92</ENT> </ROW> <ROW> <ENT I="01">1047-16-1</ENT> <ENT>Quinacridone</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">1111-78-0</ENT> <ENT>Ammonium carbamate</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW RUL="s"> <ENT I="01">3089-11-0</ENT> <ENT>Hexa(methoxymethyl) melamine</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Sulphones</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">67-71-0</ENT> <ENT>Dimethylsulfone</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">77-79-2</ENT> <ENT>3-Sulfolene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">80-07-9</ENT> <ENT>Sulfonyl bis-(4-chlorobenzene)</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">80-08-0</ENT> <ENT>4,4′-Diaminodiphenyl sulfone</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">80-09-1</ENT> <ENT>Bisphenol S</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">98-30-6</ENT> <ENT>2-Amino-4-(methylsulfonyl)phenol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">126-33-0</ENT> <ENT>Sulfolane</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">127-63-9</ENT> <ENT>Diphenylsulfone</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">2580-77-0</ENT> <ENT>2,2′-Sulfonyl bis-ethanol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">3278-22-6</ENT> <ENT>1,1′-[Methylene bis(sulfonyl)]bisethene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">5246-57-1</ENT> <ENT>2-[(3-Aminophenyl)sulfonyl]ethanol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">16588-67-3</ENT> <ENT>3-[N-Ethyl-4-[[6-(methylsulfonyl)-2-benzothiazolyl] azo]-m-toluidino]- propionitrile</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">17557-67-4</ENT> <ENT>6-(Methylsulfonyl)-2-benzothiazolamine</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">17601-96-6</ENT> <ENT>2-Amino-4-[(2-hydroxyethyl) sulfonyl]phenol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">17688-68-5</ENT> <ENT>4-Phenylthiomorpholine, 1,1-dioxide</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">17741-62-7</ENT> <ENT>4-[4-[(2,6-Dichloro-4-nitrophenyl) azo]phenyl]thiomorpholine, 1,1-dioxide-</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">18760-44-6</ENT> <ENT>3-(Decyloxy)tetrahydrothiophene 1,1-dioxide</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">20018-09-1</ENT> <ENT>1-(Diiodomethyl) sulfonyl-4-methyl benzene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">26750-50-5</ENT> <ENT>1,1′-[Oxybis(methylenesulfonyl)] bisethene</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">36724-43-3</ENT> <ENT>2,2′-[Oxybis(methylenesulfonyl)]bisethanol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">41123-59-5</ENT> <ENT>1,1′-[Methylenebis(sulfonyl)]bis-2-chloroethane</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">41123-69-7</ENT> <ENT>2,2′-[Methylenebis(sulfonyl)]bisethanol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">41687-30-3</ENT> <ENT>2-[(3-Nitrophenyl)sulfonyl]ethanol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">52218-35-6</ENT> <ENT>2-[(6-Amino-2-naphthalenyl)sulfonyl]ethanol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW> <ENT I="01">53061-10-2</ENT> <ENT>1,1′-[Oxybis(methylenesulfonyl)]bis-2-chloroethane</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW RUL="s"> <ENT I="01">63134-33-8</ENT> <ENT>4-[[4-(Phenylmethoxy)phenyl]sulfonyl]phenol</ENT> <ENT>9/30/91</ENT> <ENT>11/27/91</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Tungsten compounds</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">1314-35-8</ENT> <ENT> Tungsten oxide (WO <E T="52">3</E> ) </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">7440-33-7</ENT> <ENT>Tungsten</ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">7783-03-1</ENT> <ENT> Tungstate (WO <E T="52">4</E> <E T="51">2−</E> ), dihydrogen, (T-4)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">7783-82-6</ENT> <ENT> Tungsten fluoride (WF <E T="52">6</E> ), (OC-6-11)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">7790-60-5</ENT> <ENT> Tungstate (WO <E T="52">4</E> <E T="51">2−</E> ), dipotassium, (T-4)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <PRTPAGE P="166"/> <ENT I="01">7790-85-4</ENT> <ENT> Cadmium tungsten oxide (CdWO <E T="52">4</E> ) </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">10213-10-2</ENT> <ENT> Tungstate (WO <E T="52">4</E> <E T="51">2−</E> ), disodium, dihydrate, (T-4)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">11105-11-6</ENT> <ENT> Tungsten oxide (WO <E T="52">3</E> ), hydrate </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">11120-01-7</ENT> <ENT>Sodium tungsten oxide</ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">11120-25-5</ENT> <ENT> Tungstate (W <E T="52">12</E> (OH) <E T="52">2</E> O <E T="52">40</E> <E T="51">10−</E> ), decaammonium </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">12027-38-2</ENT> <ENT>Tungstate(4-),[.mu.12-[orthosilicato(4-)- .kappa.O:.kappa.O:.kappa.O: .kappa.O′.kappa.O′.kappa.O′ .kappa.O′:.kappa.O′ :.kappa.O′ :.kappa.O″:.kappa.O″ :.kappa.O″]]tetracosa- .mu.-oxododecaoxododeca-, tetrahydrogen</ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">12028-48-7</ENT> <ENT> Tungstate (W <E T="52">12</E> (OH) <E T="52">2</E> O <E T="52">38</E> <E T="51">6−</E> ), hexaammonium </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">12036-22-5</ENT> <ENT> Tungsten oxide (WO <E T="52">2</E> ) </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">12067-99-1</ENT> <ENT>Tungsten hydroxide oxide phosphate</ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">12138-09-9</ENT> <ENT> Tungsten sulfide (WS <E T="52">2</E> ) </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">12141-67-2</ENT> <ENT> Tungstate (W <E T="52">12</E> (OH) <E T="52">2</E> O <E T="52">38</E> <E T="51">6−</E> ), hexasodium </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">13283-01-7</ENT> <ENT> Tungsten chloride (WCl <E T="52">6</E> ), (OC-6-11)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">13472-45-2</ENT> <ENT> Tungstate (WO <E T="52">4</E> <E T="51">2−</E> ), disodium, (T-4)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW> <ENT I="01">14040-11-0</ENT> <ENT> Tungsten carbonyl (W(CO) <E T="52">6</E> ), (OC-6-11)- </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW RUL="s"> <ENT I="01">23321-70-2</ENT> <ENT> Tungsten oxide (WO <E T="52">3</E> ), dihydrate </ENT> <ENT>1/6/05</ENT> <ENT>3/7/05</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="25">Vanadium compounds</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">1314-34-7</ENT> <ENT>Vanadium oxide (V2O3) [Vanadium trioxide]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">1314-62-1</ENT> <ENT>Vanadium oxide (V2O5) [Vanadium pentoxide]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">1686-22-2</ENT> <ENT>Vanadium, triethoxyoxo-, (T-4)- [Triethyl orthovanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">3153-26-2</ENT> <ENT>Vanadium, oxobis (2,4-pentanedionato-.kappa.O,.kappa.O')-, (SP-5-21)-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">5588-84-1</ENT> <ENT>Vanadium, oxotris(2-propanolato)-, (T-4)- [Vanadium triisopropoxide oxide]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">7440-62-2</ENT> <ENT>Vanadium</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">7632-51-1</ENT> <ENT>Vanadium chloride (VCl4), (T-4)- [Vanadium tetrachloride]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">7718-98-1</ENT> <ENT>Vanadium chloride (VCl3) [Vanadium trichloride]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">7727-18-6</ENT> <ENT>Vanadium, trichlorooxo-, (T-4)- [Vanadium oxytrichloride]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">7803-55-6</ENT> <ENT>Vanadate (VO31-), ammonium [Ammonium metavanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">10049-16-8</ENT> <ENT>Vanadium fluoride (VF4) [Vanadium tetrafluoride]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">10213-09-9</ENT> <ENT>Vanadium, dichlorooxo- [Vanadyl dichloride]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">10580-52-6</ENT> <ENT>Vanadium chloride (VCl2) [Vanadium dichloride]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">11099-11-9</ENT> <ENT>Vanadium oxide [Polyvanadic acid]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">11115-67-6</ENT> <ENT>Ammonium vanadium oxide</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">11130-21-5</ENT> <ENT>Vanadium carbide</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12007-37-3</ENT> <ENT>Vanadium boride (VB2)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12035-98-2</ENT> <ENT>Vanadium oxide (VO)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12036-21-4</ENT> <ENT>Vanadium oxide (VO2)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12070-10-9</ENT> <ENT>Vanadium carbide (VC)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12083-48-6</ENT> <ENT>Vanadium, dichlorobis (.eta.5-2,4-cyclopentadien-1-yl)-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12166-27-7</ENT> <ENT>Vanadium sulfide (VS)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12439-96-2</ENT> <ENT>Vanadium, oxo[sulfato(2-)-.kappa.O]-, pentahydrate [Vanadyl sulfate (VOSO4), pentahydrate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">12604-58-9</ENT> <ENT>Vanadium alloy, base, V,C,Fe (Ferrovanadium)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13470-26-3</ENT> <ENT>Vanadium bromide (VBr3)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13476-99-8</ENT> <ENT>Vanadium, tris(2,4-pentanedionato-.kappa.O,.kappa.O')-, (OC-6-11)- [Vanadium tris(acetylacetonate)]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13497-94-4</ENT> <ENT>Silver vanadium oxide (AgVO3)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13517-26-5</ENT> <ENT>Sodium vanadium oxide (Na4V2O7) [Sodium pyrovanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13718-26-8</ENT> <ENT>Vanadate (VO31-), sodium [Sodium metavanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13721-39-6</ENT> <ENT>Sodium vanadium oxide (Na3VO4) [Sodium orthovanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13769-43-2</ENT> <ENT>Vanadate (VO31-), potassium [Potassium metavanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">13930-88-6</ENT> <ENT>Vanadium, oxo[29H,31H-phthalocyaninato(2-)-.kappa.N29,.kappa.N30,.kappa.N31,.kappa.N32]-, (SP-5-12)-</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">14059-33-7</ENT> <ENT>Bismuth vanadium oxide (BiVO4)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">19120-62-8</ENT> <ENT>Vanadium, tris(2-methyl-1-propanolato)oxo-, (T-4)- [Isobutyl orthovanadate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">24646-85-3</ENT> <ENT>Vanadium nitride (VN)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">27774-13-6</ENT> <ENT>Vanadium, oxo[sulfato(2-)-.kappa.O]- [Vanadyl sulfate]</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">30486-37-4</ENT> <ENT>Vanadium hydroxide oxide (V(OH)2O)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">39455-80-6</ENT> <ENT>Ammonium sodium vanadium oxide</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">53801-77-7</ENT> <ENT>Bismuth vanadium oxide</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">65232-89-5</ENT> <ENT>Vanadium hydroxide oxide phosphate</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">68130-18-7</ENT> <ENT>Vanadium hydroxide oxide phosphate (V6(OH)3O3(PO4)7)</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW> <ENT I="01">68815-09-8</ENT> <ENT>Naphthenic acids, vanadium salts</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW RUL="s"> <ENT I="01">68990-29-4</ENT> <ENT>Balsams, copaiba, sulfurized, vanadium salts</ENT> <ENT>7/11/03</ENT> <ENT>9/9/03</ENT> </ROW> <ROW EXPSTB="03" RUL="s,"> <ENT I="25">Voluntary HPV Challenge Program orphan (unsponsored) chemicals</ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">62-56-6</ENT> <ENT>Thiourea</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="167"/> <ENT I="01">77-76-9</ENT> <ENT>Propane, 2,2-dimethoxy-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">81-07-2</ENT> <ENT>1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">81-16-3</ENT> <ENT>1-Naphthalenesulfonic acid, 2-amino-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">81-84-5</ENT> <ENT>1H,3H-Naphtho[1,8-cd]pyran-1,3-dione</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">83-41-0</ENT> <ENT>Benzene, 1,2-dimethyl-3-nitro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">84-69-5</ENT> <ENT>1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">85-40-5</ENT> <ENT>1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">91-68-9</ENT> <ENT>Phenol, 3-(diethylamino)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">94-96-2</ENT> <ENT>1,3-Hexanediol, 2-ethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">96-22-0</ENT> <ENT>3-Pentanone</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">97-00-7</ENT> <ENT>Benzene, 1-chloro-2,4-dinitro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">98-09-9</ENT> <ENT>Benzenesulfonyl chloride</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">98-16-8</ENT> <ENT>Benzenamine, 3-(trifluoromethyl)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">98-56-6</ENT> <ENT>Benzene, 1-chloro-4-(trifluoromethyl)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">101-34-8</ENT> <ENT>9-Octadecenoic acid, 12-(acetyloxy)-, 1,2,3-propanetriyl ester, (9Z,9'Z,9”,12R,12'R,12”)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">104-66-5</ENT> <ENT>Benzene, 1,1'-[1,2-ethanediylbis(oxy)]bis-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">104-93-8</ENT> <ENT>Benzene, 1-methoxy-4-methyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">107-39-1</ENT> <ENT>1-Pentene, 2,4,4-trimethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">107-40-4</ENT> <ENT>2-Pentene, 2,4,4-trimethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">110-18-9</ENT> <ENT>1,2-Ethanediamine, N,N,N′,N′-tetramethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">110-33-8</ENT> <ENT>Hexanedioic acid, dihexyl ester</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">111-44-4</ENT> <ENT>Ethane, 1,1'-oxybis[2-chloro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">111-85-3</ENT> <ENT>Octane, 1-chloro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">111-91-1</ENT> <ENT>Ethane, 1,1'-[methylenebis(oxy)]bis[2-chloro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">118-90-1</ENT> <ENT>Benzoic acid, 2-methyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">119-33-5</ENT> <ENT>Phenol, 4-methyl-2-nitro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">121-69-7</ENT> <ENT>Benzenamine, N,N-dimethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">121-82-4</ENT> <ENT>1,3,5-Triazine, hexahydro-1,3,5-trinitro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">124-63-0</ENT> <ENT>Methanesulfonyl chloride</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">127-68-4</ENT> <ENT>Benzenesulfonic acid, 3-nitro-, sodium salt</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">131-57-7</ENT> <ENT>Methanone, (2-hydroxy-4-methoxyphenyl)phenyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">137-20-2</ENT> <ENT>Ethanesulfonic acid, 2-[methyl[(9Z)-1-oxo-9-octadecenyl]amino]-, sodium salt</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">138-25-0</ENT> <ENT>1,3-Benzenedicarboxylic acid, 5-sulfo-, 1,3-dimethyl ester</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">139-40-2</ENT> <ENT>1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-bis(1-methylethyl)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">140-93-2</ENT> <ENT>Carbonodithioic acid, O-(1-methylethyl) ester, sodium salt</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="168"/> <ENT I="01">142-73-4</ENT> <ENT>Glycine, N-(carboxymethyl)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">330-54-1</ENT> <ENT>Urea, N'-(3,4-dichlorophenyl)-N,N-dimethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">460-00-4</ENT> <ENT>Benzene, 1-bromo-4-fluoro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">506-51-4</ENT> <ENT>1-Tetracosanol</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">506-52-5</ENT> <ENT>1-Hexacosanol</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">513-74-6</ENT> <ENT>Carbamodithioic acid, monoammonium salt</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">515-40-2</ENT> <ENT>Benzene, (2-chloro-1,1-dimethylethyl)-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">529-33-9</ENT> <ENT>1-Naphthalenol, 1,2,3,4-tetrahydro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">529-34-0</ENT> <ENT>1(2H)-Naphthalenone, 3,4-dihydro-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">542-92-7</ENT> <ENT>1,3-Cyclopentadiene</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">557-61-9</ENT> <ENT>1-Octacosanol</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">563-72-4</ENT> <ENT>Ethanedioic acid, calcium salt (1:1)</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">590-19-2</ENT> <ENT>1,2-Butadiene</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">592-45-0</ENT> <ENT>1,4-Hexadiene</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">598-72-1</ENT> <ENT>Propanoic acid, 2-bromo-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">617-94-7</ENT> <ENT>Benzenemethanol, .alpha.,.alpha.-dimethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">628-13-7</ENT> <ENT>Pyridine, hydrochloride</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">628-96-6</ENT> <ENT>1,2-Ethanediol, dinitrate</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">645-62-5</ENT> <ENT>2-Hexenal, 2-ethyl-</ENT> <ENT>September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">693-95-8</ENT> <ENT>Thiazole, 4-methyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">756-80-9</ENT> <ENT>Phosphorodithioic acid, O,O-dimethyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">870-72-4</ENT> <ENT>Methanesulfonic acid, hydroxy-, monosodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">928-72-3</ENT> <ENT>Glycine, N-(carboxymethyl)-, disodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">939-97-9</ENT> <ENT>Benzaldehyde, 4-(1,1-dimethylethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1000-82-4</ENT> <ENT>Urea, (hydroxymethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1002-69-3</ENT> <ENT>Decane, 1-chloro-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1111-78-0</ENT> <ENT>Carbamic acid, monoammonium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1401-55-4</ENT> <ENT>Tannins</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1445-45-0</ENT> <ENT>Ethane, 1,1,1-trimethoxy-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1498-51-7</ENT> <ENT>Phosphorodichloridic acid, ethyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1738-25-6</ENT> <ENT>Propanenitrile, 3-(dimethylamino)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">1912-24-9</ENT> <ENT>1,3,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-N'-(1-methylethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2152-64-9</ENT> <ENT>Benzenamine, N-phenyl-4-[[4-(phenylamino)phenyl][4-(phenylimino)-2,5-cyclohexadien-1-ylidene]methyl]-, monohydrochloride</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2210-79-9</ENT> <ENT>Oxirane, [(2-methylphenoxy)methyl]-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2372-45-4</ENT> <ENT>1-Butanol, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="169"/> <ENT I="01">2409-55-4</ENT> <ENT>Phenol, 2-(1,1-dimethylethyl)-4-methyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2425-54-9</ENT> <ENT>Tetradecane, 1-chloro-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2494-89-5</ENT> <ENT>Ethanol, 2-[(4-aminophenyl)sulfonyl]-, hydrogen sulfate (ester)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2524-03-0</ENT> <ENT>Phosphorochloridothioic acid, O,O-dimethyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2691-41-0</ENT> <ENT>1,3,5,7-Tetrazocine, octahydro-1,3,5,7-tetranitro-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2814-20-2</ENT> <ENT>4(1H)-Pyrimidinone, 6-methyl-2-(1-methylethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2905-62-6</ENT> <ENT>Benzoyl chloride, 3,5-dichloro-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">2915-53-9</ENT> <ENT>2-Butenedioic acid (2Z)-, dioctyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">3039-83-6</ENT> <ENT>Ethenesulfonic acid, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">3132-99-8</ENT> <ENT>Benzaldehyde, 3-bromo-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">3386-33-2</ENT> <ENT>Octadecane, 1-chloro-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">3779-63-3</ENT> <ENT>1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(6-isocyanatohexyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">3965-55-7</ENT> <ENT>1,3-Benzenedicarboxylic acid, 5-sulfo-, 1,3-dimethyl ester, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">4035-89-6</ENT> <ENT>Imidodicarbonic diamide, N,N′,2-tris(6-isocyanatohexyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">4170-30-3</ENT> <ENT>2-Butenal</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">4316-73-8</ENT> <ENT>Glycine, N-methyl-, monosodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">4860-03-1</ENT> <ENT>Hexadecane, 1-chloro-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">5026-74-4</ENT> <ENT>Oxiranemethanamine, N-[4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">5216-25-1</ENT> <ENT>Benzene, 1-chloro-4-(trichloromethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">5460-09-3</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, monosodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">5915-41-3</ENT> <ENT>1,3,5-Triazine-2,4-diamine, 6-chloro-N-(1,1-dimethylethyl)-N'-ethyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">6473-13-8</ENT> <ENT>2-Naphthalenesulfonic acid, 6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]phenyl]amino]-3-sulfophenyl]azo]-4-hydroxy-, trisodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">7795-95-1</ENT> <ENT>1-Octanesulfonyl chloride</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">8001-58-9</ENT> <ENT>Creosote</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">10265-69-7</ENT> <ENT>Glycine, N-phenyl-, monosodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">13749-94-5</ENT> <ENT>Ethanimidothioic acid, N-hydroxy-, methyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">13826-35-2</ENT> <ENT>Benzenemethanol, 3-phenoxy-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">17103-31-0</ENT> <ENT>Urea, sulfate (2:1)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">17321-47-0</ENT> <ENT>Phosphoramidothioic acid, O,O-dimethyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">17976-43-1</ENT> <ENT>2,4,6,8,3,5,7-Benzotetraoxatriplumbacycloundecin-3,5,7-triylidene, 1,9-dihydro-1,9-dioxo-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">19438-61-0</ENT> <ENT>1,3-Isobenzofurandione, 5-methyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">19525-59-8</ENT> <ENT>Glycine, N-phenyl-, monopotassium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">20068-02-4</ENT> <ENT>2-Butenenitrile, 2-methyl-, (2Z)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">20227-53-6</ENT> <ENT>Phosphorous acid, 2-(1,1-dimethylethyl)-4-[1-[3-(1,1-dimethylethyl)-4-hydroxyphenyl]-1-methylethyl]phenyl bis(4-nonylphenyl) ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">21351-39-3</ENT> <ENT>Urea, sulfate (1:1)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="170"/> <ENT I="01">22527-63-5</ENT> <ENT>Propanoic acid, 2-methyl-, 3-(benzoyloxy)-2,2,4-trimethylpentyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">24615-84-7</ENT> <ENT>2-Propenoic acid, 2-carboxyethyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">24794-58-9</ENT> <ENT>Formic acid, compd. with 2,2′,2[ethanol] (1:1)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">25154-38-5</ENT> <ENT>Piperazineethanol</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">25168-05-2</ENT> <ENT>Benzene, chloromethyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">25168-06-3</ENT> <ENT>Phenol, (1-methylethyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">25321-41-9</ENT> <ENT>Benzenesulfonic acid, dimethyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">25383-99-7</ENT> <ENT>Octadecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">25646-71-3</ENT> <ENT>Methanesulfonamide, N-[2-[(4-amino-3-methylphenyl)ethylamino]ethyl]-, sulfate (2:3)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">26377-29-7</ENT> <ENT>Phosphorodithioic acid, O,O-dimethyl ester, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">26401-27-4</ENT> <ENT>Phosphorous acid, isooctyl diphenyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">26680-54-6</ENT> <ENT>2,5-Furandione, dihydro-3-(octenyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">27193-28-8</ENT> <ENT>Phenol, (1,1,3,3-tetramethylbutyl)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">28106-30-1</ENT> <ENT>Benzene, ethenylethyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">28188-24-1</ENT> <ENT>Octadecanoic acid, 2-(hydroxymethyl)-2-[[(1-oxooctadecyl)oxy]methyl]-1,3-propanediyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">28908-00-1</ENT> <ENT>Benzothiazole, 2-[(chloromethyl)thio]-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">30574-97-1</ENT> <ENT>2-Butenenitrile, 2-methyl-, (2E)-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">34689-46-8</ENT> <ENT>Phenol, methyl-, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">35203-06-6</ENT> <ENT>Benzenamine, 2-ethyl-6-methyl-N-methylene-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">35203-08-8</ENT> <ENT>Benzenamine, 2,6-diethyl-N-methylene-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">37734-45-5</ENT> <ENT>Carbonochloridothioic acid, S-(phenylmethyl) ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">37764-25-3</ENT> <ENT>Acetamide, 2,2-dichloro-N,N-di-2-propenyl-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">38185-06-7</ENT> <ENT>Benzenesulfonic acid, 4-chloro-3,5-dinitro-, potassium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">38321-18-5</ENT> <ENT>Ethanol, 2-(2-butoxyethoxy)-, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">39515-51-0</ENT> <ENT>Benzaldehyde, 3-phenoxy-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">40630-63-5</ENT> <ENT>1-Octanesulfonyl fluoride</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">40876-98-0</ENT> <ENT>Butanedioic acid, oxo-, diethyl ester, ion(1-), sodium</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">51632-16-7</ENT> <ENT>Benzene, 1-(bromomethyl)-3-phenoxy-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">52184-19-7</ENT> <ENT>Phenol, 2,4-bis(1,1-dimethylpropyl)-6-[(2-nitrophenyl)azo]-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">52556-42-0</ENT> <ENT>1-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, monosodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">52663-57-7</ENT> <ENT>Ethanol, 2-butoxy-, sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">56803-37-3</ENT> <ENT>Phosphoric acid, (1,1-dimethylethyl)phenyl diphenyl ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">57693-14-8</ENT> <ENT>Chromate(3-), bis[3-(hydroxy-.kappa.O)-4-[[2-(hydroxy-.kappa.O)-1-naphthalenyl]azo-.kappa.N1]-7-nitro-1-naphthalenesulfonato(3-)]-, trisodium</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">61788-44-1</ENT> <ENT>Phenol, styrenated</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">61788-76-9</ENT> <ENT>Alkanes, chloro</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="171"/> <ENT I="01">61789-85-3</ENT> <ENT>Sulfonic acids, petroleum</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">63302-49-8</ENT> <ENT>Phosphorochloridous acid, bis(4-nonylphenyl) ester</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">64743-02-8</ENT> <ENT>Alkenes, C>10 .alpha.-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">64743-03-9</ENT> <ENT>Phenols (petroleum)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-79-4</ENT> <ENT>Solvent naphtha (coal)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-82-9</ENT> <ENT>Tar oils, coal</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-83-0</ENT> <ENT>Extracts, coal tar oil alk.</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-86-3</ENT> <ENT>Extract oils (coal), tar base</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-87-4</ENT> <ENT>Extract residues (coal), tar oil alk.</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-89-6</ENT> <ENT>Tar, coal, high-temp.</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-91-0</ENT> <ENT>Distillates (coal tar), upper</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">65996-92-1</ENT> <ENT>Distillates (coal tar)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68081-86-7</ENT> <ENT>Phenol, nonyl derivs.</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68082-78-0</ENT> <ENT>Lard, oil, Me esters</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68153-60-6</ENT> <ENT>Fatty acids, tall-oil, reaction products with diethylenetriamine, acetates</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68187-41-7</ENT> <ENT>Phosphorodithioic acid, O,O-di-C1-14-alkyl esters</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68187-57-5</ENT> <ENT>Pitch, coal tar-petroleum</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68187-59-7</ENT> <ENT>Coal, anthracite, calcined</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68188-18-1</ENT> <ENT>Paraffin oils, chlorosulfonated, saponified</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68308-74-7</ENT> <ENT>Amides, tall-oil fatty, N,N-di-Me</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68309-16-0</ENT> <ENT>Fatty acids, tall-oil, 2-(2-hydroxyethoxy)ethyl esters</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68309-27-3</ENT> <ENT>Fatty acids, tall-oil, sulfonated, sodium salts</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68334-01-0</ENT> <ENT>Disulfides, alkylaryl dialkyl diaryl, petroleum refinery spent caustic oxidn. products</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68441-66-7</ENT> <ENT>Decanoic acid, mixed esters with dipentaerythritol, octanoic acid and valeric acid</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68442-60-4</ENT> <ENT>Acetaldehyde, reaction products with formaldehyde, by-products from</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68442-77-3</ENT> <ENT>2-Butenediamide, (2E)-, N,N'-bis[2-(4,5-dihydro-2-nortall-oil alkyl-1H-imidazol-1-yl)ethyl] derivs.</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68457-74-9</ENT> <ENT>Phenol, isobutylenated methylstyrenated</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68513-62-2</ENT> <ENT>Disulfides, C5-12-alkyl</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68515-89-9</ENT> <ENT>Barium, carbonate nonylphenol complexes</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68527-22-0</ENT> <ENT>Naphtha (petroleum), clay-treated light straight-run</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68584-25-8</ENT> <ENT>Benzenesulfonic acid, C10-16-alkyl derivs., compds. with triethanolamine</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68602-81-3</ENT> <ENT>Distillates, hydrocarbon resin prodn. higher boiling</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68608-59-3</ENT> <ENT>Ethane, 1,2-dichloro-, manuf. of, by-products from, distn. lights</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68609-05-2</ENT> <ENT>Cyclohexane, oxidized, non-acidic by-products, distn. lights</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68610-90-2</ENT> <ENT>2-Butenedioic acid (2E)-, di-C8-18-alkyl esters</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="172"/> <ENT I="01">68649-42-3</ENT> <ENT>Phosphorodithioic acid, O,O-di-C1-14-alkyl esters, zinc salts</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68650-36-2</ENT> <ENT>Aromatic hydrocarbons, C8, o-xylene-lean</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68782-97-8</ENT> <ENT>Distillates (petroleum), hydrofined lubricating-oil</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68815-50-9</ENT> <ENT>Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68909-77-3</ENT> <ENT>Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine derivs. residues</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68915-05-9</ENT> <ENT>Fatty acids, tall-oil, low-boiling, reaction products with ammonia-ethanolamine reaction by-products</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68915-39-9</ENT> <ENT>Cyclohexane, oxidized, aq. ext., sodium salt</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68918-16-1</ENT> <ENT>Tar, coal, dried and oxidized</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68919-17-5</ENT> <ENT>Hydrocarbons, C12-20, catalytic alkylation by-products</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68937-29-1</ENT> <ENT>1,6-Hexanediol, distn. residues</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68937-70-2</ENT> <ENT>Carboxylic acids, C6-18 and C8-15-di-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68937-72-4</ENT> <ENT>Carboxylic acids, di-, C4-11</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68953-80-0</ENT> <ENT>Benzene, mixed with toluene, dealkylation product</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68955-37-3</ENT> <ENT>Acid chlorides, tallow, hydrogenated</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68955-76-0</ENT> <ENT>Aromatic hydrocarbons, C9-16, biphenyl deriv.-rich</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68987-41-7</ENT> <ENT>Benzene, ethylenated</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68987-66-6</ENT> <ENT>Ethene, hydrated, by-products from</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68988-22-7</ENT> <ENT>1,4-Benzenedicarboxylic acid, dimethyl ester, manuf. of, by-products from</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68990-61-4</ENT> <ENT>Tar, coal, high-temp., high-solids</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">68990-65-8</ENT> <ENT>Fats and Glyceridic oils, vegetable, reclaimed</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">70084-98-9</ENT> <ENT>Terpenes and Terpenoids, C10-30, distn. residues</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">70693-50-4</ENT> <ENT>Phenol, 2,4-bis(1-methyl-1-phenylethyl)-6-[(2-nitrophenyl)azo]-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">70851-08-0</ENT> <ENT>Amides, coco, N-[3-(dimethylamino)propyl], alkylation products with sodium 3-chloro-2-hydroxypropanesulfonate</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">71077-05-9</ENT> <ENT>Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine product tower residues</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">72162-15-3</ENT> <ENT>1-Decene, sulfurized</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">72854-27-4</ENT> <ENT>Tannins, reaction products with sodium bisulfite, sodium polysulfide and sodium sulfite</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">73665-18-6</ENT> <ENT>Extract residues (coal), tar oil alk., naphthalene distn. residues</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">83864-02-2</ENT> <ENT>Nickel, bis[(cyano-C)triphenylborato(1-)-N]bis(hexanedinitrile-N,N')-</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">84501-86-0</ENT> <ENT>Hexanedioic acid, esters with high-boiling C6-10-alkene hydroformylation products</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">90640-80-5</ENT> <ENT>Anthracene oil</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">90640-86-1</ENT> <ENT>Distillates (coal tar), heavy oils</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">119345-02-7</ENT> <ENT>Benzene, 1,1'-oxybis-, tetrapropylene derivs.</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="01">125997-20-8</ENT> <ENT>Phosphoric acid, mixed 3-bromo-2,2-dimethylpropyl and 2-bromoethyl and 2-chloroethyl esters</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> </GPOTABLE> <SECAUTH>(Secs 8(a) and 8(d), 90 Stat. 2027, 2029; 15 U.S.C. 2607 (a) and (d))</SECAUTH> <CITA>[47 FR 26998, June 22, 1982]</CITA> <EDNOTE> <PRTPAGE P="173"/> <HD SOURCE="HED">Editorial Note:</HD> <P> For <E T="04">Federal Register</E> citations affecting § 712.30, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at <E T="03">www.govinfo.gov.</E> </P> </EDNOTE> <EFFDNOT> <HD SOURCE="HED">Effective Date Note:</HD> <P>At 59 FR 14115, Mar. 25, 1994, in § 712.30 paragraph (x), the chemical substances under the category “propylene glycol ethers esters” and all related dates were stayed, effective Mar. 25, 1994. At 60 FR 31921, June 19, 1995, § 712.30 was amended in part by redesignating paragraph (x) as paragraph (e).</P> </EFFDNOT> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 713</EAR> <HD SOURCE="HED">PART 713—REPORTING REQUIREMENTS FOR THE TSCA INVENTORY OF MERCURY SUPPLY, USE, AND TRADE</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>713.1</SECTNO> <SUBJECT>Purpose, scope, and compliance.</SUBJECT> <SECTNO>713.5</SECTNO> <SUBJECT>Mercury for which information must be reported.</SUBJECT> <SECTNO>713.7</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <SECTNO>713.9</SECTNO> <SUBJECT>General requirements for which information must be reported.</SUBJECT> <SECTNO>713.11</SECTNO> <SUBJECT>Specific requirements for which information must be reported.</SUBJECT> <SECTNO>713.13</SECTNO> <SUBJECT>Contextual requirements for which information must be reported.</SUBJECT> <SECTNO>713.15</SECTNO> <SUBJECT>Reporting information to EPA.</SUBJECT> <SECTNO>713.17</SECTNO> <SUBJECT>When to report.</SUBJECT> <SECTNO>713.19</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <SECTNO>713.21</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(b)(10)(D).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>83 FR 30073, June 27, 2018, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 713.1</SECTNO> <SUBJECT>Purpose, scope, and compliance.</SUBJECT> <P> (a) This part specifies reporting and recordkeeping procedures under section 8(b)(10) of the Toxic Substances Control Act (TSCA) (15 U.S.C. 2607(b)(10)) for certain manufacturers (including importers) and processers of mercury as defined in section 8(b)(10)(A) to include elemental mercury and mercury compounds. Hereinafter “mercury” will refer to both elemental mercury and mercury compounds collectively, except where separately identified. Section 8(b)(10)(D) of TSCA authorizes the EPA Administrator to require reporting from any person who manufactures mercury or mercury-added products or otherwise intentionally uses mercury in a manufacturing process to carry out and publish in the <E T="04">Federal Register</E> an inventory of mercury supply, use, and trade in the United States. In administering this mercury inventory, EPA is directed to identify any manufacturing processes or products that intentionally add mercury and to recommend actions, including proposed revisions of Federal law or regulations, to achieve further reductions in mercury use. EPA intends to use the collected information to implement TSCA and shape the Agency's efforts to recommend actions, both voluntary and regulatory, to reduce the use of mercury in commerce. In so doing, the Agency will conduct timely evaluation and refinement of these reporting requirements so that they are efficient and non-duplicative for reporters. </P> <P>(b) This part applies to the activities associated with the periodic publication of information on mercury supply, use, and trade in the United States. Except as described at § 713.7, the reporting requirements for mercury supply, use, and trade apply to the following activities:</P> <P>(1) Activities undertaken with the purpose of obtaining an immediate or eventual commercial advantage:</P> <P>(i) Import of mercury;</P> <P>(ii) Manufacture (other than import) of mercury;</P> <P>(iii) Import of a mercury-added product;</P> <P>(iv) Manufacture (other than import) of a mercury-added product; and</P> <P>(v) Intentional use of mercury in a manufacturing process.</P> <P>(2) Activities undertaken in relationship to those activities described in paragraph (b)(1) of this section:</P> <P>(i) Distribution in commerce, including domestic sale or transfer, of mercury;</P> <P>(ii) Distribution in commerce, including domestic sale or transfer, of a mercury-added product;</P> <P>(iii) Storage of mercury (including import);</P> <P>(iv) Export of a mercury compound (unless specifically prohibited); and</P> <P>(v) Export of a mercury-added product.</P> <P> (c) Section 15(3) of TSCA makes it unlawful for any person to fail or <PRTPAGE P="174"/> refuse to submit information required under this part. In addition, TSCA section 15(3) makes it unlawful for any person to fail to: Establish or maintain records, or permit access to records required by this part. Section 16 of TSCA provides that any person who violates a provision of TSCA section 15 is liable to the United States for a civil penalty and may be criminally prosecuted. Pursuant to TSCA section 17, the Federal Government may seek judicial relief to compel submission of TSCA section 8 information and to otherwise restrain any violation of TSCA section 15. </P> <P>(d) Each person who reports under this part must certify the accuracy and maintain records of the information reported under this part and, in accordance with TSCA, permit access to, and the copying of, such records by EPA officials.</P> </SECTION> <SECTION> <SECTNO>§ 713.5</SECTNO> <SUBJECT>Mercury for which information must be reported.</SUBJECT> <P>(a) Elemental mercury (Chemical Abstracts Service Registry Number 7439-97-6); or</P> <P>(b) A mercury compound, including but not limited to the mercury compounds listed in Table 1 of this part by Chemical Abstracts Service Registry Number:</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="xs90,r100"> <TTITLE>Table 1—Mercury Compounds</TTITLE> <BOXHD> <CHED H="1"> Chemical Abstracts <LI>Service Registry No.</LI> </CHED> <CHED H="1">Mercury compound</CHED> </BOXHD> <ROW> <ENT I="01">10045-94-0</ENT> <ENT>Nitric acid, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">100-57-2</ENT> <ENT>Mercury, hydroxyphenyl-.</ENT> </ROW> <ROW> <ENT I="01">10112-91-1</ENT> <ENT>Mercury chloride (Hg2Cl2).</ENT> </ROW> <ROW> <ENT I="01">10124-48-8</ENT> <ENT>Mercury amide chloride (Hg(NH2)Cl).</ENT> </ROW> <ROW> <ENT I="01">103-27-5</ENT> <ENT>Mercury, phenyl(propanoato-.kappa.O)-.</ENT> </ROW> <ROW> <ENT I="01">10415-75-5</ENT> <ENT>Nitric acid, mercury(1+) salt (1:1).</ENT> </ROW> <ROW> <ENT I="01">104-60-9</ENT> <ENT>Mercury, (9-octadecenoato-.kappa.O)phenyl-.</ENT> </ROW> <ROW> <ENT I="01">1191-80-6</ENT> <ENT>9-Octadecenoic acid (9Z)-, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">12068-90-5</ENT> <ENT>Mercury telluride (HgTe).</ENT> </ROW> <ROW> <ENT I="01">13170-76-8</ENT> <ENT>Hexanoic acid, 2-ethyl-, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">13302-00-6</ENT> <ENT>Mercury, (2-ethylhexanoato-.kappa.O)phenyl-.</ENT> </ROW> <ROW> <ENT I="01">1335-31-5</ENT> <ENT>Mercury cyanide oxide (Hg2(CN)2O).</ENT> </ROW> <ROW> <ENT I="01">1344-48-5</ENT> <ENT>Mercury sulfide (HgS).</ENT> </ROW> <ROW> <ENT I="01">1345-09-1</ENT> <ENT>Cadmium mercury sulfide.</ENT> </ROW> <ROW> <ENT I="01">13876-85-2</ENT> <ENT>Mercurate(2-), tetraiodo-, copper(1+) (1:2), (T-4)-.</ENT> </ROW> <ROW> <ENT I="01">138-85-2</ENT> <ENT>Mercurate(1-), (4-carboxylatophenyl)hydroxy-, sodium (1:1).</ENT> </ROW> <ROW> <ENT I="01">141-51-5</ENT> <ENT>Mercury, iodo(iodomethyl)-.</ENT> </ROW> <ROW> <ENT I="01">14783-59-6</ENT> <ENT>Mercury, bis[(2-phenyldiazenecarbothioic acid-.kappa.S) 2-phenylhydrazidato-.kappa.N2]-, (T-4)-.</ENT> </ROW> <ROW> <ENT I="01">15385-58-7</ENT> <ENT>Mercury, dibromodi-, (Hg-Hg).</ENT> </ROW> <ROW> <ENT I="01">15785-93-0</ENT> <ENT>Mercury, chloro[4-[(2,4-dinitrophenyl)amino]phenyl]-.</ENT> </ROW> <ROW> <ENT I="01">15829-53-5</ENT> <ENT>Mercury oxide (Hg2O).</ENT> </ROW> <ROW> <ENT I="01">1600-27-7</ENT> <ENT>Acetic acid, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">1785-43-9</ENT> <ENT>Mercury, chloro(ethanethiolato)-.</ENT> </ROW> <ROW> <ENT I="01">19447-62-2</ENT> <ENT>Mercury, (acetato-.kappa.O)[4-[2-[4-(dimethylamino)phenyl]diazenyl]phenyl]-.</ENT> </ROW> <ROW> <ENT I="01">20582-71-2</ENT> <ENT>Mercurate(2-), tetrachloro-, potassium (1:2), (T-4)-.</ENT> </ROW> <ROW> <ENT I="01">20601-83-6</ENT> <ENT>Mercury selenide (HgSe).</ENT> </ROW> <ROW> <ENT I="01">21908-53-2</ENT> <ENT>Mercury oxide (HgO).</ENT> </ROW> <ROW> <ENT I="01">22450-90-4</ENT> <ENT>Mercury(1+), amminephenyl-, acetate (1:1).</ENT> </ROW> <ROW> <ENT I="01">24579-90-6</ENT> <ENT>Mercury, chloro(2-hydroxy-5-nitrophenyl)-.</ENT> </ROW> <ROW> <ENT I="01">24806-32-4</ENT> <ENT>Mercury, [.mu.-[2-dodecylbutanedioato(2-).kappa.O1:.kappa.O4]]diphenyldi-.</ENT> </ROW> <ROW> <ENT I="01">26545-49-3</ENT> <ENT>Mercury, (neodecanoato-.kappa.O)phenyl-.</ENT> </ROW> <ROW> <ENT I="01">27685-51-4</ENT> <ENT>Cobaltate(2-), tetrakis(thiocyanato-.kappa.N)-, mercury(2+) (1:1), (T-4)-.</ENT> </ROW> <ROW> <ENT I="01">29870-72-2</ENT> <ENT>Cadmium mercury telluride ((Cd,Hg)Te).</ENT> </ROW> <ROW> <ENT I="01">3294-57-3</ENT> <ENT>Mercury, phenyl(trichloromethyl)-.</ENT> </ROW> <ROW> <ENT I="01">33770-60-4</ENT> <ENT>Mercury, [3,6-dichloro-4,5-di(hydroxy-.kappa.O)-3,5cyclohexadiene-1,2-dionato(2-)]-.</ENT> </ROW> <ROW> <ENT I="01">3570-80-7</ENT> <ENT>Mercury, bis(acetato-.kappa.O)[.mu.-(3',6'-dihydroxy-3oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'diyl)]di-.</ENT> </ROW> <ROW> <ENT I="01">537-64-4</ENT> <ENT>Mercury, bis(4-methylphenyl)-.</ENT> </ROW> <ROW> <ENT I="01">539-43-5</ENT> <ENT>Mercury, chloro(4-methylphenyl)-.</ENT> </ROW> <ROW> <ENT I="01">54-64-8</ENT> <ENT>Mercurate(1-), ethyl[2-(mercapto-.kappa.S)benzoato(2-).kappa.O]-, sodium (1:1).</ENT> </ROW> <ROW> <ENT I="01">55-68-5</ENT> <ENT>Mercury, (nitrato-.kappa.O)phenyl-.</ENT> </ROW> <ROW> <ENT I="01">56724-82-4</ENT> <ENT>Mercury, phenyl[(2-phenyldiazenecarbothioic acid.kappa.S) 2-phenylhydrazidato-.kappa.N2]-.</ENT> </ROW> <ROW> <ENT I="01">587-85-9</ENT> <ENT>Mercury, diphenyl-.</ENT> </ROW> <ROW> <ENT I="01">592-04-1</ENT> <ENT>Mercury cyanide (Hg(CN)2).</ENT> </ROW> <ROW> <ENT I="01">592-85-8</ENT> <ENT>Thiocyanic acid, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">593-74-8</ENT> <ENT>Mercury, dimethyl-.</ENT> </ROW> <ROW> <ENT I="01">59-85-8</ENT> <ENT>Mercurate(1-), (4-carboxylatophenyl)chloro-, hydrogen.</ENT> </ROW> <ROW> <ENT I="01">623-07-4</ENT> <ENT>Mercury, chloro(4-hydroxyphenyl)-.</ENT> </ROW> <ROW> <PRTPAGE P="175"/> <ENT I="01">62-38-4</ENT> <ENT>Mercury, (acetato-.kappa.O)phenyl-.</ENT> </ROW> <ROW> <ENT I="01">62638-02-2</ENT> <ENT>Cyclohexanebutanoic acid, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">627-44-1</ENT> <ENT>Mercury, diethyl-.</ENT> </ROW> <ROW> <ENT I="01">6283-24-5</ENT> <ENT>Mercury, (acetato-.kappa.O)(4-aminophenyl)-.</ENT> </ROW> <ROW> <ENT I="01">628-86-4</ENT> <ENT>Mercury, bis(fulminato-.kappa.C)-.</ENT> </ROW> <ROW> <ENT I="01">629-35-6</ENT> <ENT>Mercury, dibutyl-.</ENT> </ROW> <ROW> <ENT I="01">63325-16-6</ENT> <ENT>Mercurate(2-), tetraiodo-, (T-4)-, hydrogen, compd. with 5-iodo-2-pyridinamine (1:2:2).</ENT> </ROW> <ROW> <ENT I="01">63468-53-1</ENT> <ENT>Mercury, (acetato-.kappa.O)(2-hydroxy-5-nitrophenyl)-.</ENT> </ROW> <ROW> <ENT I="01">63549-47-3</ENT> <ENT>Mercury, bis(acetato-.kappa.O)(benzenamine)-.</ENT> </ROW> <ROW> <ENT I="01">68201-97-8</ENT> <ENT>Mercury, (acetato-.kappa.O)diamminephenyl-, (T-4)-.</ENT> </ROW> <ROW> <ENT I="01">72379-35-2</ENT> <ENT>Mercurate(1-), triiodo-, hydrogen, compd. with 3-methyl2(3H)-benzothiazolimine (1:1:1).</ENT> </ROW> <ROW> <ENT I="01">7439-97-6</ENT> <ENT>Mercury.</ENT> </ROW> <ROW> <ENT I="01">7487-94-7</ENT> <ENT>Mercury chloride (HgCl2).</ENT> </ROW> <ROW> <ENT I="01">7546-30-7</ENT> <ENT>Mercury chloride (HgCl).</ENT> </ROW> <ROW> <ENT I="01">7616-83-3</ENT> <ENT>Perchloric acid, mercury(2+) salt (2:1).</ENT> </ROW> <ROW> <ENT I="01">7774-29-0</ENT> <ENT>Mercury iodide (HgI2).</ENT> </ROW> <ROW> <ENT I="01">7783-33-7</ENT> <ENT>Mercurate(2-), tetraiodo-, potassium (1:2), (T-4)-.</ENT> </ROW> <ROW> <ENT I="01">7783-35-9</ENT> <ENT>Sulfuric acid, mercury(2+) salt (1:1).</ENT> </ROW> <ROW> <ENT I="01">7783-39-3</ENT> <ENT>Mercury fluoride (HgF2).</ENT> </ROW> <ROW> <ENT I="01">7789-47-1</ENT> <ENT>Mercury bromide (HgBr2).</ENT> </ROW> <ROW> <ENT I="01">90-03-9</ENT> <ENT>Mercury, chloro(2-hydroxyphenyl)-.</ENT> </ROW> <ROW> <ENT I="01">94070-93-6</ENT> <ENT>Mercury, [.mu.-[(oxydi-2,1-ethanediyl 1,2benzenedicarboxylato-.kappa.O2)(2-)]]diphenyldi-.</ENT> </ROW> </GPOTABLE> </SECTION> <SECTION> <SECTNO>§ 713.7</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <P>(a) Any person who manufactures (including imports) mercury, except:</P> <P>(1) A person who does not manufacture (including import) mercury with the purpose of obtaining an immediate or eventual commercial advantage;</P> <P>(2) A person who manufactures (including imports) mercury only as an impurity; or</P> <P>(3) A person engaged only in the generation, handling, or management of mercury-containing waste, including recovered mercury that is discarded or elemental mercury that is managed for long-term storage and management under section 6939f(g)(2) of the Resource Conservation and Recovery Act;</P> <P>(b) Any person who manufactures (including imports) a mercury-added product, except:</P> <P>(1) A person who does not manufacture (including import) a mercury-added product with the purpose of obtaining an immediate or eventual commercial advantage; or</P> <P>(2) A person engaged only in the manufacture (other than import) of a product that contains a component that is a mercury-added product who did not first manufacture (including import) the component that is a mercury-added product; and</P> <P>(c) Any person who otherwise intentionally uses mercury in a manufacturing process, except a person who does not intentionally use mercury in a manufacturing process with the purpose of obtaining an immediate or eventual commercial advantage.</P> <CITA>[83 FR 30073, June 27, 2018, as amended at 86 FR 61712, Nov. 8, 2021]</CITA> </SECTION> <SECTION> <SECTNO>§ 713.9</SECTNO> <SUBJECT>General requirements for which information must be reported.</SUBJECT> <P>Except as described at § 713.7:</P> <P>(a) Persons who manufacture (including import) mercury in amounts greater than or equal to 2,500 pounds (lbs.) for elemental mercury or greater than or equal to 25,000 lbs. for mercury compounds for a specific reporting year must report, as applicable:</P> <P>(1) Amount of mercury stored (lbs.); and</P> <P>(2) Amount of mercury distributed in commerce (lbs.).</P> <P>(b) All other persons who manufacture (including import) mercury must report, as applicable:</P> <P>(1) Amount of mercury manufactured (other than imported) (lbs.);</P> <P>(2) Amount of mercury imported (lbs.);</P> <P>(3) Amount of mercury exported (lbs.), except mercury prohibited from export at 15 U.S.C. 2611(c)(1) and (7);</P> <P> (4) Amount of mercury stored (lbs.); and <PRTPAGE P="176"/> </P> <P>(5) Amount of mercury distributed in commerce (lbs.).</P> <P>(c) Persons who report sales of mercury-added products to the Interstate Mercury Education and Reduction Clearinghouse (IMERC) must report, as applicable:</P> <P>(1) Amount of mercury in manufactured (other than imported) products (lbs.);</P> <P>(2) Amount of mercury in imported products (lbs.); and</P> <P>(3) Amount of mercury in exported products (lbs.).</P> <P>(d) All other persons who manufacture (including import) mercury-added products must report, as applicable:</P> <P>(1) Amount of mercury in manufactured (other than imported) products (lbs.);</P> <P>(2) Amount of mercury in imported products (lbs.);</P> <P>(3) Amount of mercury in exported products (lbs.); and</P> <P>(4) Amount of mercury in products distributed in commerce (lbs.).</P> <P>(e) Persons who otherwise intentionally use mercury in a manufacturing process must report, as applicable:</P> <P>(1) Amount of mercury otherwise intentionally used (lbs.) in a manufacturing process; and</P> <P>(2) Amount of mercury stored (lbs.).</P> </SECTION> <SECTION> <SECTNO>§ 713.11</SECTNO> <SUBJECT>Specific requirements for which information must be reported.</SUBJECT> <P>Except as described at § 713.7:</P> <P>(a) Any person who manufactures (including imports) mercury must specify, as applicable, the specific mercury compound(s) from a pre-selected list (as listed in Table 1 of this part).</P> <P>(b) Any person who manufactures (including imports) a mercury-added product must specify as applicable, the specific category(ies) and subcategory(ies) from a pre-selected list, as listed in Table 2 of this part:</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,r100"> <TTITLE>Table 2—Categories and Subcategories of Mercury-Added Products</TTITLE> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">Subcategory</CHED> </BOXHD> <ROW> <ENT I="01">Batteries</ENT> <ENT> —Button cell, silver. <LI>—Button cell, zinc-air.</LI> <LI>—Button cell, alkaline.</LI> <LI>—Stacked button cell batteries.</LI> <LI>—Manganese oxide.</LI> <LI>—Silver oxide.</LI> <LI>—Mercuric oxide, non-button cell.</LI> <LI>—Button cell, mercuric oxide.</LI> <LI>—Button cell, zinc carbon.</LI> <LI>—Other (specify).</LI> </ENT> </ROW> <ROW> <ENT I="01">Dental amalgam</ENT> <ENT>[No subcategories].</ENT> </ROW> <ROW> <ENT I="01">Formulated products (includes uses in cosmetics, pesticides, and laboratory chemicals)</ENT> <ENT> —Skin-lightening creams. <LI>—Lotions.</LI> <LI>—Soaps and sanitizers.</LI> <LI>—Bath oils and salts.</LI> <LI>—Topical antiseptics.</LI> <LI> —Preservatives ( <E T="03">e.g.,</E> for use in vaccines and eye-area cosmetics when no preservative alternatives are available). </LI> <LI>—Pharmaceuticals (including prescription and over-the-counter drug products).</LI> <LI>—Cleaning products (not registered as pesticides under the Federal Insecticide, Fungicide, and Rodenticide Act).</LI> <LI>—Pesticides.</LI> <LI>—Paints.</LI> <LI>—Dyes.</LI> <LI> —Reagents ( <E T="03">e.g.,</E> catalysts, buffers, fixatives). </LI> <LI>—Other (specify).</LI> </ENT> </ROW> <ROW> <ENT I="01">Lighting, lamps, bulbs</ENT> <ENT> —Linear fluorescent. <LI>—Compact fluorescent.</LI> <LI>—U-tube and circular fluorescent.</LI> <LI>—Cold cathode fluorescent.</LI> <LI>—External electrode fluorescent.</LI> <LI>—Mercury vapor.</LI> <LI>—Metal halide.</LI> <LI>—High pressure sodium.</LI> <LI>—Mercury short arc.</LI> <LI>—Neon.</LI> <LI>—Other (specify).</LI> </ENT> </ROW> <ROW> <PRTPAGE P="177"/> <ENT I="01">Measuring instruments</ENT> <ENT> —Barometer. <LI>—Fever thermometer.</LI> <LI>—Flow meter.</LI> <LI>—Hydrometer.</LI> <LI>—Hygrometer/psychrometer.</LI> <LI>—Manometer.</LI> <LI>—Non-fever thermometer.</LI> <LI>—Pyrometer.</LI> <LI>—Sphygmomanometer.</LI> <LI>—Other (specify).</LI> </ENT> </ROW> <ROW> <ENT I="01">Pump seals</ENT> <ENT>[No subcategories].</ENT> </ROW> <ROW> <ENT I="01">Switches, relays, sensors, valves</ENT> <ENT> —Tilt switch. <LI>—Vibration switch.</LI> <LI>—Float switch.</LI> <LI>—Pressure switch.</LI> <LI>—Temperature switch.</LI> <LI>—Displacement relay.</LI> <LI>—Wetted reed relay.</LI> <LI>—Contact relay.</LI> <LI>—Flame sensor.</LI> <LI>—Thermostat.</LI> <LI>—Other (specify).</LI> </ENT> </ROW> <ROW> <ENT I="01">Miscellaneous/novelty mercury-added products</ENT> <ENT> —Wheel weights. <LI>—Wheel rotation balancers/stabilizers.</LI> <LI>—Firearm recoil suppressors.</LI> <LI>—Carburetor synchronizers.</LI> <LI>—Joint support/shock absorption bands.</LI> <LI>—Other (specify).</LI> </ENT> </ROW> </GPOTABLE> <P>(c) Any person who otherwise intentionally uses mercury in a manufacturing process, other than the manufacture of a mercury compound or a mercury-added product, must identify, as applicable:</P> <P>(1) The specific manufacturing process for which mercury is otherwise intentionally used from a pre-selected list, as listed in Table 3 of this part:</P> <GPOTABLE COLS="1" OPTS="L2,p1,8/9" CDEF="s100"> <TTITLE>Table 3—Manufacturing Process for Which Mercury Is Otherwise Intentionally Used</TTITLE> <BOXHD> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01"> Chlorine production ( <E T="03">e.g.</E> , mercury-cell chlor-alkali process). </ENT> </ROW> <ROW> <ENT I="01">Acetaldehyde production.</ENT> </ROW> <ROW> <ENT I="01">Sodium/potassium methylate/ethylate production.</ENT> </ROW> <ROW> <ENT I="01">Polyurethane/plastic production.</ENT> </ROW> <ROW> <ENT I="01">Other (specify).</ENT> </ROW> </GPOTABLE> <P>(2) The specific use of mercury in a manufacturing process from a pre-selected list, as listed in Table 4 of this part:</P> <GPOTABLE COLS="1" OPTS="L2,p1,8/9" CDEF="s100"> <TTITLE>Table 4—Specific Use of Mercury in a Manufacturing Process</TTITLE> <BOXHD> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01">Catalyst.</ENT> </ROW> <ROW> <ENT I="01">Cathode.</ENT> </ROW> <ROW> <ENT I="01">Reactant.</ENT> </ROW> <ROW> <ENT I="01">Reagent.</ENT> </ROW> <ROW> <ENT I="01">Other (specify).</ENT> </ROW> </GPOTABLE> </SECTION> <SECTION> <SECTNO>§ 713.13</SECTNO> <SUBJECT>Contextual requirements for which information must be reported.</SUBJECT> <P>Except as described at § 713.7:</P> <P>(a) Persons who manufacture (including import) mercury in amounts greater than or equal to 2,500 lbs. for elemental mercury or greater than or equal to 25,000 lbs. for mercury compounds for a specific reporting year must report, as applicable:</P> <P>(1) Country(ies) of origin for imported mercury;</P> <P>(2) Country(ies) of destination for exported mercury; and</P> <P>(3) NAICS code(s) for mercury distributed in commerce.</P> <P>(b) All other persons who manufacture (including import) mercury must report, as applicable:</P> <P> (1) Country(ies) of origin for imported mercury; <PRTPAGE P="178"/> </P> <P>(2) Country(ies) of destination for exported mercury; and</P> <P>(3) NAICS code(s) for mercury distributed in commerce.</P> <P>(c) Persons who report sales of mercury-added products to IMERC must report, as applicable:</P> <P>(1) Country(ies) of origin for imported products;</P> <P>(2) Country(ies) of destination for exported products; and</P> <P>(3) NAICS code(s) for products distributed in commerce.</P> <P>(d) All other persons who manufacture (including import) mercury-added products must report, as applicable:</P> <P>(1) Country(ies) of origin for imported products;</P> <P>(2) Country(ies) of destination for exported products; and</P> <P>(3) NAICS code(s) for products distributed in commerce.</P> <P>(e) Persons who otherwise intentionally use mercury in a manufacturing process, other than the manufacture of a mercury compound or a mercury-added product, must report, as applicable:</P> <P>(1) Country(ies) of destination for exported final product(s); and</P> <P>(2) NAICS code(s) for mercury in final product(s) distributed in commerce.</P> </SECTION> <SECTION> <SECTNO>§ 713.15</SECTNO> <SUBJECT>Reporting information to EPA.</SUBJECT> <P>Any person who must report under this part must report for the submission period described at § 713.17:</P> <P>(a) Quantities of mercury in pounds per applicable activity listed under the general requirements for which information must be reported described at § 713.9;</P> <P>(b) Specific requirements for which information must be reported described at § 713.11;</P> <P>(c) Contextual requirements for which information must be reported described at § 713.13; and</P> <P>(d) According to the procedures described at § 713.21.</P> </SECTION> <SECTION> <SECTNO>§ 713.17</SECTNO> <SUBJECT>When to report.</SUBJECT> <P>(a) Any person who must report under this part must report for the reporting year described as follows. A reporting year is the year during which mercury activity, required to be reported by this rule, has occurred. The 2018 reporting year is from January 1, 2018 to December 31, 2018. Subsequent reporting years are from January 1 to December 31 at 3-year intervals, beginning in 2021.</P> <P>(b) All information reported for an applicable reporting year must be submitted on or before the first day of July following the reporting year. The submission deadline for the 2018 reporting year is July 1, 2019. Subsequent submission deadlines are on or before the first day of July following the reporting year, in 3-year intervals, beginning in 2022.</P> <P>(c) The data from the 2018 reporting year will be used for the 2020 mercury inventory, the data from the 2021 reporting year will be used for the 2023 mercury inventory, and so forth at three-year intervals.</P> </SECTION> <SECTION> <SECTNO>§ 713.19</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P>Each person who is subject to the reporting requirements of this part must retain records that document any information reported to EPA. Records relevant to a reporting year must be retained for a period of 3 years beginning on the last day of the reporting year. Submitters are encouraged to retain their records longer than 3 years to ensure that past records are available as a reference when new submissions are being generated.</P> </SECTION> <SECTION> <SECTNO>§ 713.21</SECTNO> <SUBJECT>Electronic filing.</SUBJECT> <P>(a) You must use the Mercury Electronic Reporting (MER) application to complete and submit required information as set forth in § 713.17. Submissions may only be made as set forth in this section.</P> <P>(b) Submissions must be sent electronically to EPA via CDX.</P> <P>(c) Access MER and instructions, as follows:</P> <P> (1) By website. Access MER via the CDX homepage at <E T="03">https://cdx.epa.gov/</E> and follow the appropriate links. </P> <P> (2) By phone or email. Contact the EPA TSCA Hotline at (202) 554-1404 or <E T="03">TSCA-Hotline@epa.gov.</E> <PRTPAGE P="179"/> </P> </SECTION> </PART> <PART> <EAR>Pt. 716</EAR> <HD SOURCE="HED">PART 716—HEALTH AND SAFETY DATA REPORTING</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>716.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <SECTNO>716.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>716.5</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <SECTNO>716.10</SECTNO> <SUBJECT>Studies to be reported.</SUBJECT> <SECTNO>716.20</SECTNO> <SUBJECT>Studies not subject to the reporting requirements.</SUBJECT> <SECTNO>716.21</SECTNO> <SUBJECT>Chemical specific reporting requirements.</SUBJECT> <SECTNO>716.25</SECTNO> <SUBJECT>Adequate file search.</SUBJECT> <SECTNO>716.30</SECTNO> <SUBJECT>Submission of copies of studies.</SUBJECT> <SECTNO>716.35</SECTNO> <SUBJECT>Submission of lists of studies.</SUBJECT> <SECTNO>716.40</SECTNO> <SUBJECT>EPA requests for submission of further information.</SUBJECT> <SECTNO>716.45</SECTNO> <SUBJECT>How to report on substances and mixtures.</SUBJECT> <SECTNO>716.50</SECTNO> <SUBJECT>Reporting physical and chemical properties.</SUBJECT> <SECTNO>716.55</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <SECTNO>716.60</SECTNO> <SUBJECT>Reporting schedule.</SUBJECT> <SECTNO>716.65</SECTNO> <SUBJECT>Reporting period.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Specific Chemical Listings</HD> <SECTNO>716.105</SECTNO> <SUBJECT>Additions of substances and mixtures to which this subpart applies.</SUBJECT> <SECTNO>716.120</SECTNO> <SUBJECT>Substances and listed mixtures to which this subpart applies.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(d).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>51 FR 32726, Sept. 15, 1986, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 716.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <P>(a) This subpart sets forth requirements for the submission of lists and copies of health and safety studies on chemical substances and mixtures selected for priority consideration for testing rules under section 4(a) of the Toxic Substances Control Act (TSCA) and on other chemical substances and mixtures for which EPA requires health and safety information in fulfilling the purposes of TSCA.</P> <P>(b) Section 15(3) of TSCA makes it unlawful for any person to fail or refuse to submit information required under this subpart. Section 16 provides that a violation of section 15 renders a person liable to the United States for a civil penalty and possible criminal prosecution. Under section 17, the district courts of the United States have jurisdiction to restrain any violation of section 15.</P> </SECTION> <SECTION> <SECTNO>§ 716.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>The definitions in section 3 of TSCA apply to this subpart. In addition, the following definitions are provided for the purposes of this subpart:</P> <P> <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s). </P> <P> <E T="03">Central Data Exchange</E> or <E T="03">CDX</E> means EPA's centralized electronic submission receiving system. </P> <P> <E T="03">Chemical Information Submission System</E> or <E T="03">CISS</E> means EPA's electronic, web-based tool for the completion and submission of data, reports, and other information, or its successors. </P> <P> <E T="03">Co-product</E> means a chemical substance produced for a commercial purpose during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s). </P> <P> <E T="03">Copy of study</E> means the written presentation of the purpose and methodology of a study and its results. </P> <P> <E T="03">EPA</E> means the United States Environmental Protection Agency. </P> <P> <E T="03">Health and safety study</E> or <E T="03">study</E> means any study of any effect of a chemical substance or mixture on health or the environment or on both, including underlying data and epidemiological studies, studies of occupational exposure to a chemical substance or mixture, toxicological, clinical, and ecological or other studies of a chemical substance or mixture, and any test performed under TSCA. </P> <P> (1) It is intended that the term <E T="03">health and safety study</E> be interpreted broadly. Not only is information which arises as a result of a formal, disciplined study included, but other information relating to the effects of a chemical substance or mixture on health or the environment is also included. Any data that bear on the effects of a chemical substance on health or the environment would be included. Chemical identity is part of, or underlying data to, a health and safety study. </P> <P>(2) Examples are:</P> <P> (i) Long- and short-term tests of mutagenicity, carcinogenicity, or teratogenicity; data on behavioral disorders; dermatoxicity; pharmacological <PRTPAGE P="180"/> effects; mammalian absorption, distribution, metabolism, and excretion; cumulative, additive, and synergistic effects; and acute, subchronic, and chronic effects. </P> <P>(ii) Tests for ecological or other environmental effects on invertebrates, fish, or other animals, and plants, including: Acute toxicity tests, chronic toxicity tests, critical life-stage tests, behavioral tests, algal growth tests, seed germination tests, plant growth or damage tests, microbial function tests, bioconcentration or bioaccumulation tests, and model ecosystem (microcosm) studies.</P> <P>(iii) Assessments of human and environmental exposure, including workplace exposure, and impacts of a particular chemical substance or mixture on the environment, including surveys, tests, and studies of: Biological, photochemical, and chemical degradation; structure/activity relationships; air, water, and soil transport; biomagnification and bioconcentration; and chemical and physical properties, e.g., boiling point, vapor pressure, evaporation rates from soil and water, octanol/water partition coefficient, and water solubility.</P> <P>(iv) Monitoring data, when they have been aggregated and analyzed to measure the exposure of humans or the environment to a chemical substance or mixture.</P> <P> <E T="03">Import</E> means to import for commercial purposes. </P> <P> <E T="03">Import for commercial purposes</E> means to import with the purpose of obtaining an immediate or eventual commercial advantage for the importer, and includes the importation of any amount of a chemical substance or mixture. If a chemical substance or mixture containing impurities is imported for commercial purposes, then those impurities are also imported for commercial purposes. </P> <P> <E T="03">Importer</E> means any person who imports a chemical substance, including a chemical substance as a part of a mixture or article, into the customs territory of the United States and includes the person primarily liable for the payment of any duties on the merchandise or an authorized agent acting on his behalf (as defined in 19 CFR 1.11). Importer also includes, as appropriate: </P> <P>(1) The consignee.</P> <P>(2) The importer of record.</P> <P>(3) The actual owner, if an actual owner's declaration and superseding bond has been filed in accordance with 19 CFR 141.20.</P> <P>(4) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144. For the purpose of this definition, the customs territory of the United States consists of the 50 States, Puerto Rico, and the District of Columbia.</P> <P> <E T="03">Impurity</E> means a chemical substance which is unintentionally present with another chemical substance. </P> <P> <E T="03">Listed mixture</E> means any mixture listed in § 716.120. </P> <P> <E T="03">Manufacture</E> means to manufacture for commercial purposes. </P> <P> <E T="03">Manufacture for commercial purposes</E> means: (1) To produce, with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes among other things such “manufacture” of any amount of a chemical substance or mixture: </P> <P>(i) For commercial distribution, including for test marketing.</P> <P>(ii) For use by the manufacturer, including use for product research and development, or as an intermediate.</P> <P>(2) Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts and impurities. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose.</P> <P> <E T="03">Manufacturer</E> means a person who produces or manufactures a chemical substance. A person who extracts a component chemical substance from a previously existing chemical substance or a complex combination of substances is a manufacturer of that component chemical substance. </P> <P> <E T="03">Person</E> includes any individual, firm, company, corporation, joint-venture, partnership, sole proprietorship, association, or any other business entity, <PRTPAGE P="181"/> any State or political subdivision thereof, any municipality, any interstate body, and any department, agency, or instrumentality of the Federal government. </P> <P> <E T="03">Process</E> means to process for commercial purposes. </P> <P> <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included. If a chemical substance or mixture containing impurities is processed for commercial purposes, then those impurities are also processed for commercial purposes. </P> <P> <E T="03">Propose to manufacture, import, or process</E> means that a person has made a management decision to commit financial resources toward the manufacture, importation, or processing of a substance or mixture. </P> <P> <E T="03">Substance</E> means <E T="03">chemical substance</E> as defined at section 3(2)(A) of TSCA, 15 U.S.C. 2602(2)(A). </P> <P> <E T="03">TSCA</E> means the Toxic Substances Control Act (15 U.S.C. 2601 <E T="03">et seq.</E> ). </P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 78 FR 72826, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.5</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <P>(a) Except as provided in paragraphs (b) and (c) of this section, only those persons described in this section are required to report under this part. Persons who must report include manufacturers (including importers) who fall within the North American Industry Classification System (NAICS) (in effect as of January 1, 1997) Subsector 325 (chemical manufacturing and allied products) or Industry Group 32411 (petroleum refineries), who:</P> <P>(1) In the 10 years preceding the effective date on which a substance or mixture is added to § 716.120, either had proposed to manufacture (including import), or had manufactured (including imported) the listed substance or listed mixture (including as a known byproduct), are required to report during the reporting period specified in § 716.65.</P> <P>(2) As of the effective date on which a substance or mixture is added to § 716.120, and who propose to manufacture (including import), or who are manufacturing (including importing) the listed substance or listed mixture (including as a known byproduct), are required to report during the reporting period specified in § 716.65.</P> <P>(3) After the effective date on which a substance or mixture is added to § 716.120, and who propose to manufacture (including import) the listed substance or listed mixture (including as a known byproduct), are required to report during the reporting period specified in § 716.65.</P> <P>(b) A rule promulgated under the authority of 15 U.S.C. 2607(d) may require that any person who does not fall within NAICS (in effect as of January 1, 1997) Subsector 325 or Industry Group 32411, and who had proposed to manufacture (including import) or process, had manufactured (including imported) or processed, proposes to manufacture (including import) or process, or is manufacturing (including importing) or processing a substance or mixture listed in § 716.120 must report under this part.</P> <P>(c) Processors and persons who propose to process a substance or mixture otherwise subject to the reporting requirements imposed by this part are not subject to this part unless EPA specifically states otherwise in a particular notice or rule promulgated under the authority of 15 U.S.C. 2607(d).</P> <CITA>[63 FR 15773, Apr. 1, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.10</SECTNO> <SUBJECT>Studies to be reported.</SUBJECT> <P>(a) In general, health and safety studies, as defined in § 716.3, on any substance or listed mixture listed in § 716.120, that are unpublished are reportable, i.e., must be submitted or listed. However, this requirement has limitations according to the nature of the material studied, so that:</P> <P>(1) All studies of substances and listed mixtures are reportable. However, in the case of physical and chemical properties, only those studies listed in § 716.50 must be submitted.</P> <P> (2) Studies of mixtures known to contain substances or listed mixtures listed in § 716.120 are reportable except for studies of physical and chemical properties and the studies exempted at § 716.20(a)(6) (i) through (vi). <PRTPAGE P="182"/> </P> <P>(3) Studies of substances or listed mixtures that a person who is reporting has manufactured, imported, or processed or proposed to manufacture, import, or process only as impurities are not generally reportable under § 716.20(a)(9).</P> <P>(4) Underlying data, such as medical or health records, individual files, lab notebooks, and daily monitoring records supporting studies do not have to be submitted initially. EPA may request underlying data later under § 716.40.</P> <P>(b) [Reserved]</P> </SECTION> <SECTION> <SECTNO>§ 716.20</SECTNO> <SUBJECT>Studies not subject to the reporting requirements.</SUBJECT> <P>(a) Excluding paragraph (a)(3) of this section, the following types of studies are exempt from the copy and list submission requirements of §§ 716.30 and 716.35.</P> <P>(1) Studies which have been published in the scientific literature.</P> <P>(2) Studies previously submitted to the EPA Office of Pollution Prevention and Toxics. These studies are limited to section 8(e) submissions, studies submitted during section 4 proceedings, studies submitted with premanufacture notices or significant new use notices, and studies submitted “for your information” (FYI submissions) in support of EPA's TSCA Existing Chemicals Program. Studies which have been initiated pursuant to a TSCA section 4(a) test rule, for which the person has submitted a letter of intent to conduct testing in accordance with the provisions of § 790.25 of part 790 of this chapter, are exempt from the list submission requirements of § 716.35.</P> <P>(3) Except for those studies described in paragraph (a)(2) of this section, studies previously submitted to any Federal agency with no claims of confidentiality are exempt only from the copy submission requirements of § 716.30, and must be listed in accordance with the provisions of § 716.35.</P> <P>(4) Studies conducted or initiated by or for another person who is subject to, and who will report the studies under §§ 716.30 and 716.35.</P> <P>(5) Studies of chemical substances which are not on the TSCA Chemical Substances Inventory. This exemption applies only to those substances within categories listed under § 716.120(c).</P> <P>(6) The following types of studies when the subject of the study is a mixture known to contain a substance or listed mixture listed under § 716.120.</P> <P>(i) Acute oral toxicity studies.</P> <P>(ii) Acute dermal toxicity studies.</P> <P>(iii) Acute inhalation toxicity studies.</P> <P>(iv) Primary eye irritation studies.</P> <P>(v) Primary dermal irritation studies.</P> <P>(vi) Dermal sensitization studies.</P> <P>(vii) Physical and chemical properties.</P> <FP>If the substance or listed mixture is an impurity, no reporting is required (see paragraph (a)(9) of this section).</FP> <P>(7) Analyzed aggregations of monitoring data based on monitoring data acquired more than 5 years preceding the date the substance or listed mixture was added to the list under § 716.120.</P> <P>(8) Analyzed aggregations of monitoring data on mixtures known to contain one or more substances or listed mixtures listed in § 716.120, when the monitoring data are not analyzed to determine the exposure or concentration levels of the substances or listed mixture listed under § 716.120.</P> <P> (9) Studies on a substance or listed mixture listed under § 716.120 that the person who is reporting has manufactured, imported, or processed or proposed to manufacture, import, or process only as an impurity. When reporting of such studies is to be required, that reporting will be separately proposed in the <E T="04">Federal Register.</E> </P> <P>(10) Studies of chemical substances or listed mixtures previously submitted by trade associations in accordance with the provisions of § 716.30.</P> <P>(b) The following types of studies on substances or listed mixtures listed under § 716.120 are exempt from the copy and list submission requirements of §§ 716.30 and 716.35.</P> <P> (1) For the listed ureaformaldehyde resins (CAS Nos. 9011-05-6 and 68611-64-3), studies on agronomic plant growth or damage which demonstrate only that the resins stimulate plant growth or cause plant damage when applied as a fertilizer. <PRTPAGE P="183"/> </P> <P>(2) For the specified chemicals in § 716.120(d) under the category “Siloxanes,” acute oral, dermal, and inhalation toxicity studies and primary eye and dermal irritation studies.</P> <P>(3) For the listed chemicals under § 716.120(d) in the category “OSHA Chemicals in Need of Dermal Absorption Testing,” studies on ecological effects.</P> <P>(4) For the chemicals listed at § 716.120 with a special exemption referencing this paragraph, studies on mixtures containing the listed substance at levels below 1 percent of the mixture, except when a purpose of the study includes the investigation of the effects of the listed substance at levels below 1 percent.</P> <P>(5) Rulemaking proceedings that add substances and mixtures to § 716.120 will specify the types of health and/or environmental effects studies that must be reported and will specify the chemical grade/purity requirements that must be met or exceeded in individual studies. Chemical grade/purity requirements will be specified on a per chemical basis or for a category of chemicals for which reporting is required.</P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 58 FR 47649, Sept. 10, 1993; 58 FR 68315, Dec. 27, 1993; 60 FR 34884, July 5, 1995; 63 FR 15773, Apr. 1, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.21</SECTNO> <SUBJECT>Chemical specific reporting requirements.</SUBJECT> <P>(a) Health and safety studies reportable under part 716 for the following chemical substances, mixtures, or categories of chemical substances, as listed in § 716.120, must be submitted or listed only as specified in this section:</P> <P>(1) For 3H-1,2,4-triazole-3-thione, 5-amino-1,2-dihydro- and imidazo[4,5-d]imidazole-2,5-(1H,3H)-dione, tetrahydro-, all unpublished environmental effects studies and health effects studies on pharmacokinetics, genotoxicity, subchronic toxicity, immunotoxicity, carcinogenicity, reproductive effects, and developmental toxicity where the purity of 3H-1,2,4-triazole-3-thione, 5-amino-1,2-dihydro- or imidazo[4,5-d]imidazole-2,5-(1H,3H)-dione, tetrahydro- is greater than or equal to 90% of the test substance by weight must be submitted.</P> <P>(2) For benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-, all unpublished environmental effects studies including bioconcentration, environmental fate studies on biodegradation, and health effects studies on pharmacokinetics, subchronic toxicity, mutagenicity, reproductive effects, and developmental toxicity, and carcinogenicity where the purity of benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)- is greater than or equal to 90% of the test substance by weight must be submitted.</P> <P>(3) For stannane, dimethylbis[(1-oxoneodecyl)oxy]-, all unpublished environmental effects studies including bioconcentration, environmental fate studies on hydrolysis and biodegradation and health effects studies on pharmacokinetics, subchronic toxicity, mutagenicity, neurotoxicity, reproductive effects, and developmental toxicity, and carcinogenicity where the purity of stannane, dimethylbis[(1-oxoneodecyl)oxy]- is greater than or equal to 90% of the test substance by weight must be submitted.</P> <P>(4) For benzene, 1,3,5-tribromo-2-(2-propenyloxy)-, all unpublished environmental effects studies including bioconcentration, environmental fate studies on biodegradation and health effects studies on pharmacokinetics, subchronic toxicity, neurotoxicity, reproductive effects, and developmental toxicity, and carcinogenicity where the purity of benzene, 1,3,5-tribromo-2-(2-propenyloxy)- is greater than or equal to 90% of the test substance by weight must be submitted.</P> <P>(5) For 1-triazene, 1,3-diphenyl-, all unpublished health effects studies on pharmacokinetics, genotoxicity, subchronic and chronic toxicity, reproductive effects, and developmental toxicity where the purity of 1-triazene, 1,3-diphenyl- is greater than or equal to 90% of the test substance by weight must be submitted.</P> <P> (6) For the 9 chemicals in the indium compound category, all unpublished health effects studies on pharmacokinetics, genotoxicity, subchronic and chronic toxicity, reproductive effects, and developmental toxicity where the purity of the indium compound is greater than or equal to 90% of the test <PRTPAGE P="184"/> substance by weight must be submitted. </P> <P>(7) For all voluntary HPV Challenge Program orphan (unsponsored) chemicals:</P> <P>(i) All unpublished environmental fate studies, meeting the criteria set forth in paragraph (a)(7)(iv) of this section, on water solubility; adsorption/desorption on particulate surfaces, e.g., soil; vapor pressure; octanol/water partition coefficient; density/relative density (specific gravity); particle size distribution for insoluble solids; dissociation constant; degradation by photochemical mechanisms—aquatic and atmospheric; degradation by chemical mechanisms—hydrolytic, reductive, and oxidative; degradation by biological mechanisms—aerobic and anaerobic. Studies of physical and chemical properties meeting the criteria set forth in paragraph (a)(7)(iv) of this section must be reported if performed for the purpose of determining the environmental or biological fate of a substance, and only if they investigated one or more of the properties listed in this paragraph. In addition, all unpublished studies meeting the criteria set forth in paragraph (a)(7)(iv) of this section on melting point and boiling point must be submitted.</P> <P>(ii) All unpublished health effects studies meeting the criteria set forth in paragraph (a)(7)(iv) of this section including pharmacokinetics, genotoxicity, acute toxicity, subacute toxicity, subchronic toxicity, chronic toxicity, reproductive toxicity, developmental toxicity, immunotoxicity, neurotoxicity, and oncogenicity/carcinogenicity.</P> <P>(iii) All unpublished environmental effects studies meeting the criteria set forth in paragraph (a)(7)(iv) of this section including acute and chronic toxicity studies of aquatic and terrestrial vertebrates and invertebrates and aquatic plants.</P> <P>(iv) Only studies where the voluntary HPV Challenge Program orphan (unsponsored) chemical is ≥90% of the test substance by weight should be submitted. In addition, only studies that were conducted using TSCA, Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Organization for Economic Cooperation and Development (OECD) or other internationally accepted test guidelines or voluntary consensus standards should be submitted. Studies performed where the voluntary HPV Challenge Program orphan (unsponsored) chemical is <90% of the test substance by weight are not requested at this time.</P> <P>(8)(i) Reporting requirements apply only to manufacturers (including importers) of consumer products intended for use by children who also manufacture (including import) lead or lead compounds. For the category “lead and lead compounds,” all unpublished health and safety studies that:</P> <P>(A) Relate to the lead content of consumer products that are “intended for use by children” as that term is defined at 40 CFR 710.43 (excluding children's metal jewelry), or</P> <P>(B) Assess children's exposure to lead from such products (including studies of bioavailability).</P> <P>(ii) With regard to purity, studies showing any measurable lead content in such products must be submitted.</P> <P> (9) For 1,3-Butadiene (106-99-0), Butyl benzyl phthalate (BBP)—1,2-Benzene- dicarboxylic acid, 1- butyl 2(phenylmethyl) ester (85-68-7), Dibutyl phthalate (DBP) (1,2-Benzene- dicarboxylic acid, 1,2- dibutyl ester) (84-74-2), o-Dichlorobenzene (95-50-1), p-Dichlorobenzene (106-46-7), trans-1,2-Dichloroethylene (156-60-5), 1,2-Dichloropropane (78-87-5), Dicyclohexyl phthalate (84-61-7), Di-ethylhexyl phthalate (DEHP)—(1,2-Benzene- dicarboxylic acid, 1,2- bis(2-ethylhexyl) ester) (117-81-7), Di-isobutyl phthalate (DIBP)—(1,2-Benzene- dicarboxylic acid, 1,2- bis-(2methylpropyl) ester) (84-69-5), Formaldehyde (50-00-0), 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta [g]-2-benzopyran (HHCB) (1222-05-5), Phthalic anhydride (85-44-9), 4,4′-(1-Methylethylidene)bis[2, 6-dibromophenol] (TBBPA) (79-94-7), and 1,1,2-Trichloroethane (79-00-5), all unpublished studies on health effects (including toxicity studies (in vivo and in vitro) on carcinogenicity, reproductive and developmental effects, genotoxicity, neurotoxicity, immunotoxicity, endocrine effects, and other systemic toxicity); <PRTPAGE P="185"/> toxicokinetics (absorption, distribution, metabolism, or elimination), including modelling studies, in humans or animals; environmental effects; environmental fate; physical-chemical properties if performed as described in 40 CFR 716.50; and occupational (both users and non-users), general population, consumer, bystander, and environmental exposure must be submitted. Studies showing any measurable content of the High-Priority Substance in the tested substance (single substances or mixture) must be reported. The composition and purity of test substances must be reported if included as part of the study. Studies previously submitted to EPA pursuant to a requirement under TSCA or of the submitter's own accord and studies conducted or to be conducted pursuant to a TSCA section 4 action are exempt from the submission of lists of health and safety studies required under 40 CFR 716.35 and the submission of studies required under this rule. </P> <P> (10) For purposes of this paragraph, the term <E T="03">organohalogen flame retardant</E> includes any substances listed in paragraph(d) of this section under the category “Organohalogen flame retardants”. For any organohalogen flame retardant, all unpublished studies on health effects (including toxicity studies (in vivo and in vitro) on carcinogenicity, reproductive and developmental effects, genotoxicity, neurotoxicity, immunotoxicity, endocrine effects, and other systemic toxicity); toxicokinetics (absorption, distribution, metabolism, or elimination), including modelling studies, in humans or animals; environmental fate; physical-chemical properties if performed as described in 40 CFR 716.50; and occupational (both users and non-users), general population, consumer, bystander, and environmental exposure must be submitted. Studies showing any measurable content of the organohalogen flame retardant in the tested substance (single substances or mixture) must be reported. The composition and purity of test substances must be reported if included as part of the study. Studies previously submitted to EPA pursuant to a requirement under TSCA or of the submitter's own accord and studies conducted or to be conducted pursuant to a TSCA section 4 action are exempt from the submission of lists of health and safety studies requirements under 40 CFR 716.35 and the submission of studies requirements under this rule. </P> <P>(b) [Reserved]</P> <CITA>[69 FR 24522, May 4, 2004, as amended at 71 FR 47135, Aug. 16, 2006; 73 FR 5115, Jan. 29, 2008; 86 FR 34152, June 29, 2021]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.25</SECTNO> <SUBJECT>Adequate file search.</SUBJECT> <P>The scope of a person's responsibility to search records is limited to records in the location(s) where the required information is typically kept, and to records kept by the person or the person's individual employee(s) who is/are responsible for keeping such records or advising the person on the health and environmental effects of chemicals. Persons are not required to search for reportable information dated before January 1, 1977, to comply with this subpart unless specifically required to do so in a rule.</P> <CITA>[63 FR 15773, Apr. 1, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.30</SECTNO> <SUBJECT>Submission of copies of studies.</SUBJECT> <P>(a)(1) Except as provided in §§ 716.5, 716.20, and 716.50, persons must send to EPA copies of any health and safety studies in their possession for the substances or mixtures listed in § 716.120. Persons are responsible for submitting copies on only the substances or listed mixtures which they: Have manufactured, imported, or processed or proposed to manufacture, import, or process (including as known byproducts) within the 10 years preceding the effective date for reporting on the substances or listed mixtures; manufacture, import, or process on the effective date for reporting on the substances or listed mixtures; and propose to manufacture, import, or process following the effective date for reporting on the substances or listed mixtures. Persons who list studies as ongoing or initiated under § 716.35(a) (1) and (2) must submit them when they are completed.</P> <P>(2) [Reserved]</P> <P> (b) Submissions under paragraph (a) of this section must be identified either on the face of the study or otherwise <PRTPAGE P="186"/> by the applicable chemical name and CAS number (if any) listed in § 716.120(a) (1) and (2), and must be accompanied by a cover letter containing the name, job title, address and telephone number of the submitting official, and the name and address of the manufacturing or processing establishment on whose behalf the submission is made. In the cover letter, submitters must identify any impurity or additive known to have been present in the substance or listed mixtures as studied unless its presence is specifically noted in the study itself. The cover letter accompanying a study submitted by a trade association must also state that the submission is to satisfy reporting requirements under this part. </P> <P>(c) Persons must use the CISS tool to complete and submit all data, reports, and other information required by 40 CFR part 716, via CDX. Submission requires registration with CDX, and must be made only as set forth in this section.</P> <P> (d) To access the CISS tool go to <E T="03">https://cdx.epa.gov/ssl/CSPP/PrimaryAuthorizedOfficial/Home.aspx</E> and follow the appropriate links and for further instructions to go <E T="03">http://www.epa.gov/oppt/chemtest/ereporting/index.html.</E> </P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 52 FR 20084, May 29, 1987; 52 FR 44828, Nov. 20, 1987; 53 FR 12523, Apr. 15, 1988; 60 FR 34463, July 3, 1995; 63 FR 15773, Apr. 1, 1998; 71 FR 47135, Aug. 16, 2006; 78 FR 72826, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.35</SECTNO> <SUBJECT>Submission of lists of studies.</SUBJECT> <P>(a) Except as provided in §§ 716.5, 716.20, and 716.50, persons subject to this rule must send lists of studies to EPA for each of the listed substances or listed mixtures (including as a known byproduct) in § 716.120 which they are manufacturing, importing, or processing, or which they propose to manufacture (including import) or process.</P> <P> (1) <E T="03">Ongoing studies.</E> As of the date a person becomes subject to this part, a list of ongoing health and safety studies being conducted by or initiated for them, noting for each entry: The beginning date of the study, the purpose of the study, the types of data to be collected, the anticipated date of completion, and the name and address of the laboratory conducting the study. </P> <P> (2) <E T="03">Initiated studies.</E> After the date a person becomes subject to this part, a list of studies initiated by or for them, noting for each entry: The beginning date of the study, the purpose of the study, the types of data to be collected, the anticipated date of completion, and the name and address of the laboratory conducting the study. </P> <P> (3) <E T="03">Studies which are known but without possession of copies.</E> As of the date a person becomes subject to this part, a list of unpublished health and safety studies known to them of which they do not have copies. The name and address of any person known to them to possess a copy of the unpublished study must accompany each entry on the list. For purposes of this section only, an unpublished study will be considered to be “known to” a person, if the study can be discovered by a file search in accordance with § 716.25. </P> <P> (4) <E T="03">Studies previously sent to Federal agencies without confidentiality claims.</E> A list of unpublished studies which have been sent to a Federal Agency with no claims of confidentiality. The submission must for each study: Identify the study by title, state the name and address to whom the study was sent, and the month and year in which the study was submitted. Any study identified will be treated as if it were submitted under section 8(d) and will be available for public disclosure under section 14(b) of TSCA. Persons subject to this requirement may submit either a list of unpublished health and safety studies previously submitted to any Federal agency without claims of confidentiality in accordance with § 716.35(a)(4), or copies of each such study in accordance with § 716.30. </P> <P> (b) Submission under paragraph (a) of this section must be identified either on the face of the study or otherwise by the applicable chemical name and CAS number (if any) listed in § 716.120(a) (1) and (2), and must be accompanied by a cover letter containing the name, job title, address and telephone numbers of the submitting official, and the name and address of the manufacturing or processing establishment on whose behalf the submission is made. <PRTPAGE P="187"/> </P> <P>(c) Persons must use the CISS tool to complete and submit all data, reports, and other information required by 40 CFR part 716, via CDX. Submission requires registration with CDX, and must be made only as set forth in this section.</P> <P> (d) To access the CISS tool go to <E T="03">https://cdx.epa.gov/ssl/CSPP/PrimaryAuthorizedOfficial/Home.aspx</E> and follow the appropriate links and for further instructions to go <E T="03">http://www.epa.gov/oppt/chemtest/ereporting/index.html.</E> </P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 52 FR 20084, May 29, 1987; 52 FR 44828, Nov. 20, 1987; 53 FR 12523, Apr. 15, 1988; 53 FR 46746, Nov. 18, 1988; 60 FR 34463, July 3, 1995; 63 FR 15774, Apr. 1, 1998; 71 FR 47135, Aug. 16, 2006; 78 FR 72826, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.40</SECTNO> <SUBJECT>EPA requests for submission of further information.</SUBJECT> <P>EPA may, by letter, request a person to submit or make available for review the following information after the initial reporting under §§ 716.30 and 716.35. If the requested submissions are not made, EPA may subpoena them under section 11 of TSCA, 15 U.S.C. 2610.</P> <P>(a) Submission of underlying data of the kind described in § 716.10(a)(4) by persons who submit copies of studies under § 716.30 or list studies under § 716.35(a)(1) or § 716.35(a)(2).</P> <P>(b) Submission of preliminary reports of ongoing studies by persons who list the studies under § 716.35(a)(1) or § 716.35(a)(2).</P> <P>(c) Submission of copies of studies by persons listed under § 716.35(a)(3) as possessing them.</P> </SECTION> <SECTION> <SECTNO>§ 716.45</SECTNO> <SUBJECT>How to report on substances and mixtures.</SUBJECT> <P>Section 716.120 lists substances and mixtures, in order by Chemical Abstract Service Registry Number and by alphabetical order. Studies of listed substances and listed mixtures shall be reported as follows:</P> <P>(a) When a substance is individually listed under § 716.120(a), studies of the substance and studies of mixtures known to contain the substance must be reported as studies of that substance.</P> <P>(b) When two or more substances are listed as a mixture under § 716.120(b), studies of the listed mixture and studies of any mixture known to contain the listed mixture must be reported as studies of the listed mixture.</P> <P>(c) Studies of the following preparations of a substance must be reported as studies of the substance itself, not as studies of mixtures known to contain the substance.</P> <P>(1) The substance in aqueous solution.</P> <P>(2) The substance containing a small amount of an additive, such as a stabilizer, emulsifier, or other chemical added for purposes of maintaining the integrity or physical form of the substance.</P> <P>(3) The substance of the grade/purity specified in each rule promulgated under 15 U.S.C. 2607(d).</P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 63 FR 15774, Apr. 1, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.50</SECTNO> <SUBJECT>Reporting physical and chemical properties.</SUBJECT> <P>Studies of physical and chemical properties must be reported under this subpart if performed for the purpose of determining the environmental or biological fate of a substance, and only if they investigated one or more of the following properties:</P> <P>(a) Water solubility.</P> <P>(b) Adsorption/desorption on particulate surfaces, e.g., soil.</P> <P>(c) Vapor pressure.</P> <P>(d) Octanol/water partition coefficient.</P> <P>(e) Density/relative density (specific gravity).</P> <P>(f) Particle size distribution for insoluble solids.</P> <P>(g) Dissociation constant.</P> <P>(h) Degradation by photochemical mechanisms—aquatic and atmospheric.</P> <P>(i) Degradation by chemical mechanisms—hydrolytic, reductive, and oxidative.</P> <P>(j) Degradation by biological mechanisms—aerobic and anaerobic.</P> </SECTION> <SECTION> <SECTNO>§ 716.55</SECTNO> <SUBJECT>Confidentiality claims.</SUBJECT> <P>Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703.</P> <CITA>[88 FR 37172, June 7, 2023]</CITA> </SECTION> <SECTION> <PRTPAGE P="188"/> <SECTNO>§ 716.60</SECTNO> <SUBJECT>Reporting schedule.</SUBJECT> <P> (a) <E T="03">General requirements.</E> Except as provided in § 716.5 and paragraphs (b) and (c) of this section, submissions under §§ 716.30 and 716.35 must be submitted using the electronic method specified in §§ 716.30(c) and 716.35(c), on or before 60 days after the effective date of the listing of a substance or mixture in § 716.120 or within 60 days of proposing to manufacture (including import) or process a listed substance or listed mixture (including as a known byproduct) if first done after the effective date of the substance or mixture being listed in § 716.120. </P> <P> (b)(1) <E T="03">Submission of lists of initiated studies.</E> Persons subject to the listing requirements of § 716.35(a)(2) must inform EPA of the initiated study within 30 days of its initiation. </P> <P> (2) <E T="03">Submission of copies of completed studies.</E> Persons must submit studies listed as ongoing or initiated under § 716.35(a)(1) and (2) within 30 days of completing the study, using the method specified in §§ 716.30(c) and 716.35(c). </P> <P> (c) <E T="03">Requests for extensions of time.</E> Respondents who cannot meet a deadline under this section may apply for a reasonable extension of time. Extension requests must be submitted on or before 40 days after the effective date of the listing of a substance or mixture in § 716.120, using the electronic method specified in §§ 716.30(c) and 716.35(c). The Director of EPA's Office of Pollution Prevention and Toxics will grant or deny extension requests. </P> <P> (d) <E T="03">Submission methods.</E> Persons must use the CISS tool to complete and submit all data, reports, and other information required by 40 CFR part 716, via CDX. Submission requires registration with CDX, and must be made only as set forth in this section. </P> <P> (e) To access the CISS tool go to <E T="03">https://cdx.epa.gov/ssl/CSPP/PrimaryAuthorizedOfficial/Home.aspx</E> and follow the appropriate links and for further instructions to go <E T="03">http://www.epa.gov/oppt/chemtest/ereporting/index.html.</E> </P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 60 FR 34464, July 3, 1995; 63 FR 15774, Apr. 1, 1998; 71 FR 47135, Aug. 16, 2006; 78 FR 72826, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.65</SECTNO> <SUBJECT>Reporting period.</SUBJECT> <P>Unless otherwise required in a rule promulgated under 15 U.S.C. 2607(d) relating to a listed chemical substance or listed mixture [hereinafter “rule”], the reporting period for a listed chemical substance or listed mixture will terminate 60 days after the effective date on which the listed chemical substance or listed mixture is added to 40 CFR 716.120. EPA may require reporting for a listed chemical substance or listed mixture beyond the 60 day period in a rule promulgated under 15 U.S.C. 2607(d), however EPA will not extend any reporting period later than 2 years after the effective date on which a listed chemical substance or listed mixture is added to 40 CFR 716.120. After the applicable reporting period terminates, any person subject to the rule under 40 CFR 716.5 (a)(2) or (a)(3) and who has submitted to EPA lists of ongoing or initiated studies under 40 CFR 716.35 (a)(1) or (a)(2) must submit a copy of any such study within 30 days after its completion, regardless of the study's completion date.</P> <CITA>[63 FR 15774, Apr. 1, 1998]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Specific Chemical Listings</HD> <SECTION> <SECTNO>§ 716.105</SECTNO> <SUBJECT>Additions of substances and mixtures to which this subpart applies.</SUBJECT> <P>The requirements of this subpart will be extended periodically to cover additional substances and mixtures. Two procedures will be used to add substances and mixtures.</P> <P> (a) Except as provided in paragraph (b) of this section, substances and mixtures will be added to § 716.120 after publication in the <E T="04">Federal Register</E> of a notice of proposed amendment to this subpart. There will be at least a 30-day public comment period on the notice. After consideration of the comments, EPA will amend § 716.120 by final rule to add the substances and listed mixtures. </P> <P> (b) Except as provided in paragraph (c) of this section, chemical substances, mixtures, and categories of chemical substances that have been added to the TSCA section 4(e) Priority <PRTPAGE P="189"/> List by the Interagency Testing Committee, established under section 4 of TSCA, will be added to § 716.120 but only to the extent that the total number of designated and recommended substances, mixtures and categories of chemical substances has not exceeded 50 in any 1 year. The addition of such chemical substances, mixtures, and categories of chemical substances to § 716.120 will be effective 30 days after publication of a notice to that effect in the <E T="04">Federal Register.</E> </P> <P> (c) Prior to the effective date of an amendment under paragraph (b) of this section, the Assistant Administrator for Chemical Safety and Pollution Prevention may for good cause withdraw a chemical substance, mixture, or category of chemical substances from § 716.120. Any information submitted showing why a chemical substance, mixture, or category of chemical substances should be withdrawn from the amendment must be received by EPA within 14 days after the date of publication of the notice under paragraph (b) of this section. If a chemical substance, mixture, or category of chemical substances is withdrawn, a <E T="04">Federal Register</E> notice announcing this decision will be published no later than the effective date of the amendment under paragraph (b) of this section. </P> <P>(d) Persons who wish to submit information that shows why a substance should be withdrawn must submit their comments by using the CISS tool to complete and submit all data, reports, and other information required by 40 CFR part 716, via CDX. Submission requires registration with CDX, and must be made only as set forth in this section.</P> <P> (e) To access the CISS tool go to <E T="03">https://cdx.epa.gov/ssl/CSPP/PrimaryAuthorizedOfficial/Home.aspx</E> and follow the appropriate links and for further instructions to go <E T="03">http://www.epa.gov/oppt/chemtest/ereporting/index.html.</E> </P> <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 60 FR 34464, July 3, 1995; 71 FR 47135, Aug. 16, 2006; 77 FR 46292, Aug. 3, 2012; 78 FR 72827, Dec. 4, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 716.120</SECTNO> <SUBJECT>Substances and listed mixtures to which this subpart applies.</SUBJECT> <P>Substances listed in this section appear in order by Chemical Abstract Service Registry Number. Chemical mixtures and categories are listed separately and by alphabetical order. Chemical substances listed within a category are provided only as examples of the category, and are not included on the list of substances. When a chemical substance in the substance or category list had been listed previously by a trivial (or common) name, it appears first, followed by the Chemical Abstract Service (CAS) name appearing in the TSCA Chemical Substance Inventory.</P> <P> (a) <E T="03">List of substances.</E> The following chemical substances are subject to all the provisions of part 716. Manufacturers, importers, and processors of a listed substance are subject to the reporting requirements of subpart A for that substance. </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="10,r125,xs50,9,9"> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Substance</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="01">62-74-8</ENT> <ENT>Acetic acid, fluoro-, sodium salt</ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>03/07/96</ENT> </ROW> <ROW> <ENT I="01">67-63-0</ENT> <ENT>2-Propanol</ENT> <ENT/> <ENT>12/15/86</ENT> <ENT>12/15/96</ENT> </ROW> <ROW> <ENT I="01">67-66-3</ENT> <ENT>Methane, trichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">67-72-1</ENT> <ENT>Ethane, hexachloro-</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>01/13/86</ENT> </ROW> <ROW> <ENT I="01">68-12-2</ENT> <ENT>Dimethyl formamide-Formamide, N,N-dimethyl-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">71-55-6</ENT> <ENT>1,1,1-Trichloroethane—Ethane, 1,1,1-trichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">74-83-9</ENT> <ENT>Methane, bromo-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">74-87-3</ENT> <ENT>Chloromethane—Methane, chloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">74-95-3</ENT> <ENT>Methane, dibromo-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">74-97-5</ENT> <ENT>Methane, bromochloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-00-3</ENT> <ENT>Ethane, chloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">75-02-5</ENT> <ENT>Vinyl fluoride—Ethene, fluoro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">75-04-7</ENT> <ENT>Ethanamine</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-05-8</ENT> <ENT>Acetonitrile</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">75-09-2</ENT> <ENT>Methylene chloride—Methane, dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">75-12-7</ENT> <ENT>Formamide</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">75-21-8</ENT> <ENT>Oxirane</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">75-25-2</ENT> <ENT>Methane, tribromo-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">75-27-4</ENT> <ENT>Methane, bromodichloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-29-6</ENT> <ENT>Propane, 2-chloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <PRTPAGE P="190"/> <ENT I="01">75-34-3</ENT> <ENT>Ethane, 1,1-dichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">75-37-6</ENT> <ENT>1,1-Difluoroethane-Ethane, 1,1-difluoro-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-38-7</ENT> <ENT>Vinylidene fluoride—Ethene, 1,1-difluoro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">75-43-4</ENT> <ENT>Dichloromonofluoromethane-Methane, dichlorofluoro-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-45-6</ENT> <ENT>Chlorodifluoromethane—Methane, chlorodifluoro-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">75-52-5</ENT> <ENT>Nitromethane-Methane, nitro-</ENT> <ENT/> <ENT O="xl">4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-56-9</ENT> <ENT>Oxirane, methyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">75-68-3</ENT> <ENT>1-Chloro-1,1-difluoroethane-Ethane, 1-chloro-1,1-difluoro</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-86-5</ENT> <ENT>Propanenitrile, 2-hydroxy-2-methyl-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">75-88-7</ENT> <ENT>Ethane, 2-chloro- 1,1,1-trifluoro</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">76-13-1</ENT> <ENT>1,1,2-Trichloro-1,2,2-trifluoroethane-Ethane, 1,1,2-trichloro-1,2,2-trifluoro-1</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">77-47-4</ENT> <ENT>Hexachlorocyclopentadiene—1,3-Cyclopentadiene, 1,2,3,4,5,5-hexachloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">77-58-7</ENT> <ENT>Dibutyltin dilaurate—Stannane, dibutylbis[(1-oxododecyl)oxy]-</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">78-59-1</ENT> <ENT>Isophorone—2-Cyclohexen-1-one, 3,5,5-trimethyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">78-83-1</ENT> <ENT>1-Propanol, 2-methyl-</ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>03/07/96</ENT> </ROW> <ROW> <ENT I="01">78-87-5</ENT> <ENT>1,2-Dichloropropane—Propane, 1,2-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">78-88-6</ENT> <ENT>1-Propene, 2,3-dichloro-</ENT> <ENT/> <ENT O="xl">6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">78-93-3</ENT> <ENT>Methyl ethyl ketone—2-Butanone</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">78-97-7</ENT> <ENT>Propanenitrile, 2-hydroxy-</ENT> <ENT/> <ENT O="xl">6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">78-99-9</ENT> <ENT>Propane, 1,1-dichloro-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">79-00-5</ENT> <ENT>Ethane, 1,1,2-trichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">79-06-1</ENT> <ENT>Acrylamide—2-Propenamide</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">79-24-3</ENT> <ENT>Nitroethane-Ethane, nitro-</ENT> <ENT/> <ENT O="xl">4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">79-94-7</ENT> <ENT>Tetrabromobisphenol A—Phenol, 4,4′-(methylethylidene)bis[2,6-dibromo-</ENT> <ENT/> <ENT>06/20/85</ENT> <ENT>06/20/95</ENT> </ROW> <ROW> <ENT I="01">80-05-7</ENT> <ENT>Bisphenol A—Phenol, 4,4′-(1-methylethylidene)bis-</ENT> <ENT/> <ENT>06/28/84</ENT> <ENT>06/28/94</ENT> </ROW> <ROW> <ENT I="01">80-15-9</ENT> <ENT>Hydroperoxide, 1-methyl-1-phenylethyl</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">80-62-6</ENT> <ENT>Methyl methacrylate—2-Propenoic acid, 2-methyl-, methyl ester</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">84-65-1</ENT> <ENT>Anthraquinone—9,10-Anthracenedione</ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">85-22-3</ENT> <ENT>Pentabromoethylbenzene—Benzene, pentabromoethyl-</ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>12/28/94</ENT> </ROW> <ROW> <ENT I="01">85-68-7</ENT> <ENT>Benzyl butyl phthalate—1,2-Benzenedicarboxylic acid, butyl phenylmethyl ester</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">86-74-8</ENT> <ENT> 9 <E T="03">H</E> -Carbazole </ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>03/07/96</ENT> </ROW> <ROW> <ENT I="01">87-68-3</ENT> <ENT>Hexachloro-1,3-butadiene—1,3-Butadiene, 1,1,2,3,4,4-hexachloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">88-04-0</ENT> <ENT>p-Chloro-m-xylenol-Phenol, 4-chloro-3,5-dimethyl-</ENT> <ENT/> <ENT>l4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">90-30-2</ENT> <ENT>N-Phenyl-1-naphthylamine</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">90-42-6</ENT> <ENT>[1,1′-Bicyclohexyl]-2-one</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">91-08-7</ENT> <ENT>Benzene, 1,3-diisocyanato-2-methyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">91-20-3</ENT> <ENT>Naphthalene</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">91-58-7</ENT> <ENT>Naphthalene, 2-chloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">92-52-4</ENT> <ENT>1,1′-Biphenyl</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">92-69-3</ENT> <ENT>[1,1′-Biphenyl]-4-ol</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">92-84-2</ENT> <ENT> 10 <E T="03">H</E> -Phenothiazine </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">92-87-5</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">95-14-7</ENT> <ENT>1,2,3-Benzotriazole-1H-Benzotriazole</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">95-47-6</ENT> <ENT> <E T="03">o</E> -Xylene—Benzene, 1,2-dimethyl- </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">95-48-7</ENT> <ENT> <E T="03">o</E> -Cresol—Phenol, 2-methyl- </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">95-49-8</ENT> <ENT>2/Chlorotoluene—Benzene, 1-chloro-2-methyl-</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">95-53-4</ENT> <ENT>Benzenamine, 2-methyl-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">95-63-6</ENT> <ENT>1,2,4-Trimethylbenzene—Benzene, 1,2,4-trimethyl-</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">96-18-4</ENT> <ENT>Propane, 1,2,3-trichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">96-29-7</ENT> <ENT>2-Butanone, oxime</ENT> <ENT/> <ENT>12/15/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">96-37-7</ENT> <ENT>Methylcyclopentane—Cyclopentane, methyl-</ENT> <ENT/> <ENT>06/20/85</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">97-18-7</ENT> <ENT>Phenol, 2,2′-thiobis[4,6-dichloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">97-23-4</ENT> <ENT>Phenol, 2,2′-methylenebis[4-chloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">97-88-1</ENT> <ENT>Butyl methacrylate-2-Propenoic acid, 2-methyl-,butyl ester</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">98-01-1</ENT> <ENT>2-Furancarboxaldehyde</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">98-06-6</ENT> <ENT>Benzene, (1,1-dimethylethyl)-</ENT> <ENT/> <ENT O="xl">6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">98-09-9</ENT> <ENT>Benzenesulfonyl chloride</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">98-51-1</ENT> <ENT> <E T="03">p-tert</E> -Butyltoluene—Benzene, 1-(1,1-dimethylethyl)-4-methyl- </ENT> <ENT/> <ENT>06/25/86</ENT> <ENT>06/25/96</ENT> </ROW> <ROW> <ENT I="01">98-56-6</ENT> <ENT>4-Chlorobenzotrifluoride—Benzene, 1-chloro-4-(trifluoromethyl)-</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">98-73-7</ENT> <ENT>p-tert-Butylbenzoic acid-Benzoic acid, 4-(1,1-dimethylethyl)-</ENT> <ENT/> <ENT>6/25/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">98-82-8</ENT> <ENT>Cumene—Benzene, (1-methylethyl)-</ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>12/28/94</ENT> </ROW> <ROW> <ENT I="01">98-83-9</ENT> <ENT>Benzene, (1-methylethenyl)-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">98-95-3</ENT> <ENT>Nitrobenzene—Benzene, nitro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">100-02-7</ENT> <ENT> <E T="03">p</E> -Nitrophenol—Phenol, 4-nitro- </ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">100-40-3</ENT> <ENT>4-Vinylcyclohexene</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">100-41-4</ENT> <ENT>Benzene, ethyl-</ENT> <ENT/> <ENT>06/19/87</ENT> <ENT>06/19/97</ENT> </ROW> <ROW> <ENT I="01">100-48-1</ENT> <ENT>4-Pyridinecarbonitrile</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/87</ENT> </ROW> <ROW> <ENT I="01">100-54-9</ENT> <ENT>3-Pyridinecarbonitrile</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <PRTPAGE P="191"/> <ENT I="01">100-70-9</ENT> <ENT>2-Pyridinecarbonitrile</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">101-68-8</ENT> <ENT>Benzene, 1,1′-methylenebis[4-isocyanato-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">101-77-9</ENT> <ENT>Benzenamine, 4,4′-methylenebis-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">101-84-8</ENT> <ENT>Diphenyl oxide—Benzene, 1,1′-oxybis-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">102-71-6</ENT> <ENT>Triethanolamine-Ethanol, 2,2′,2″-nitrilotris-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">104-49-4</ENT> <ENT>Benzene, 1,4-diisocyanato-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">104-51-8</ENT> <ENT>Benzene, butyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">104-76-7</ENT> <ENT>1-Hexanol, 2-ethyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">105-60-2</ENT> <ENT> 2 <E T="03">H</E> -Azepin-2-one, hexahydro- </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">106-42-3</ENT> <ENT> <E T="03">p</E> -Xylene—Benzene, 1,4-dimethyl- </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">106-43-4</ENT> <ENT>Benzene, 1-chloro-4-methyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">106-44-5</ENT> <ENT> <E T="03">p</E> -Cresol—Phenol, 4-methyl- </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">106-49-0</ENT> <ENT>Benzenamine, 4-methyl-</ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>03/07/96</ENT> </ROW> <ROW> <ENT I="01">106-50-3</ENT> <ENT> <E T="03">p</E> -Phenylenediamine—1,4-Benzenediamine </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">106-51-4</ENT> <ENT>Quinone—2,5-Cyclohexadiene-1,4-dione</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">106-88-7</ENT> <ENT>Oxirane, ethyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">106-89-8</ENT> <ENT>Oxirane, (chloromethyl)-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">107-06-2</ENT> <ENT>Ethane, 1,2-dichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">107-10-8</ENT> <ENT>1-Propanamine</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">107-19-7</ENT> <ENT>2-Propyn-1-ol</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">107-98-2</ENT> <ENT>1-Methoxy-2-propanol—2-Propanol, 1-methoxy-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">108-05-4</ENT> <ENT>Vinyl acetate—Acetic acid ethenyl ester</ENT> <ENT/> <ENT>02/10/86</ENT> <ENT>02/10/96</ENT> </ROW> <ROW> <ENT I="01">108-10-1</ENT> <ENT>Methyl isobutyl ketone—2-Pentanone, 4-methyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">108-31-6</ENT> <ENT>Maleic anhydride—2,5-Furandione</ENT> <ENT/> <ENT>09/10/84</ENT> <ENT>09/10/94</ENT> </ROW> <ROW> <ENT I="01">108-38-3</ENT> <ENT> <E T="03">m</E> -Xylene—Benzene, 1,3-dimethyl- </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">108-39-4</ENT> <ENT> <E T="03">m</E> -Cresol—Phenol, 3-methyl- </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">108-60-1</ENT> <ENT>Propane, 2,2′-oxybis[1-chloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">108-67-8</ENT> <ENT>1,3,5-Trimethylbenezene—Benzene, 1,3,5-trimethyl-</ENT> <ENT/> <ENT>02/13/84</ENT> <ENT>02/13/94</ENT> </ROW> <ROW> <ENT I="01">108-86-1</ENT> <ENT>Benzene, bromo-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">108-88-3</ENT> <ENT>Toluene—Benzene, methyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">108-89-4</ENT> <ENT>4-Methylpyridine—Pyridine, 4-methyl-</ENT> <ENT/> <ENT>09/10/84</ENT> <ENT>09/10/94</ENT> </ROW> <ROW> <ENT I="01">108-94-1</ENT> <ENT>Cyclohexanone</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">108-95-2</ENT> <ENT>Phenol</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">108-95-5</ENT> <ENT>Thiophenol</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">108-98-5</ENT> <ENT>Benzenethiol</ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>03/07/96</ENT> </ROW> <ROW> <ENT I="01">108-99-6</ENT> <ENT>3-Methylpyridine—Pyridine, 3-methyl-</ENT> <ENT/> <ENT>09/10/84</ENT> <ENT>09/10/94</ENT> </ROW> <ROW> <ENT I="01">109-06-8</ENT> <ENT>2-Methylpyridine—Pyridine, 2-methyl-</ENT> <ENT/> <ENT>09/10/84</ENT> <ENT>09/10/94</ENT> </ROW> <ROW> <ENT I="01">109-77-3</ENT> <ENT>Propanedinitrile</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">109-87-5</ENT> <ENT>Methane, Dimethoxy-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">109-89-7</ENT> <ENT> Ethanamine, <E T="03">N</E> -ethyl- </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">110-75-8</ENT> <ENT>Ethene, (2-chloroethoxy)-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">110-82-7</ENT> <ENT>Cyclohexane</ENT> <ENT/> <ENT>12/19/85</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">110-86-1</ENT> <ENT>Pyridine</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">111-21-7</ENT> <ENT>Ethylene bisoxyethylene diacetate—Ethanol, 2,2′]-[1,2-ethanediylbis(oxy)]bis-, diacetate</ENT> <ENT/> <ENT>01/13/84</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">111-40-0</ENT> <ENT> Diethylenetriamine—1,2-Ethanediamine, <E T="03">N</E> -(2-aminoethyl)- </ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">111-42-2</ENT> <ENT>Diethanolamine—Ethanol, 2,2′-iminobis-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">111-69-3</ENT> <ENT>Hexanedinitrile</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">111-76-2</ENT> <ENT>2-Butoxyethanol—Ethanol, 2-butoxy-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">111-77-3</ENT> <ENT>Diethylene glycol monomethyl ether-Ethanol, 2-(2-methoxyethoxy)-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">111-90-0</ENT> <ENT>Diethylene glycol monoethyl ether-Ethanol, 2-(2-ethoxyethoxy)-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">111-91-1</ENT> <ENT>Ethane, 1,1′-[methylenebis(oxy)]bis[2-chloro-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">111-92-2</ENT> <ENT>1-Butanamine, N-butyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">112-35-6</ENT> <ENT>Triethyleneglycol monomethyl ether—Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-</ENT> <ENT/> <ENT>06/20/85</ENT> <ENT>06/20/95</ENT> </ROW> <ROW> <ENT I="01">112-50-5</ENT> <ENT>Triethyleneglycol monoethyl ether—Ethanol, 2-[2-(2-ethoxyethoxy)ethoxy]-</ENT> <ENT/> <ENT>06/20/85</ENT> <ENT>06/20/95</ENT> </ROW> <ROW> <ENT I="01">112-90-3</ENT> <ENT> Oleylamine—9-Octadecen-1-amine, ( <E T="03">Z</E> )- </ENT> <ENT/> <ENT>01/13/84</ENT> <ENT>01/13/94</ENT> </ROW> <ROW> <ENT I="01">115-28-6</ENT> <ENT>Chlorendic acid—Bicyclo[2.2.1] hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro-</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>01/13/86</ENT> </ROW> <ROW> <ENT I="01">115-96-8</ENT> <ENT>Ethanol, 2-chloro-, phosphate (3:1)</ENT> <ENT/> <ENT>12/16/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">118-79-6</ENT> <ENT>2,4,6-Tribromophenol</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">120-20-7</ENT> <ENT>Anthracene</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">120-32-1</ENT> <ENT>2-Benzyl-4-chlorophenol-Phenol, 4-chloro-2-chlorophenol(phenyl methyl)-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">121-44-8</ENT> <ENT> Ethanamine, <E T="03">N,N</E> -diethyl- </ENT> <ENT/> <ENT>01/13/84</ENT> <ENT>01/13/94</ENT> </ROW> <ROW> <ENT I="01">121-47-1</ENT> <ENT>Benzenesulfonic acid, 3-amino-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">122-09-8</ENT> <ENT>Benzeneethanamine, alpha,alpha-dimethyl-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">122-66-7</ENT> <ENT>Hydrazine, 1,2-diphenyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">122-99-6</ENT> <ENT>2-Phenoxyethanol—Ethanol, 2-phenoxy-</ENT> <ENT/> <ENT>07/01/83</ENT> <ENT>07/01/93</ENT> </ROW> <ROW> <ENT I="01">123-31-9</ENT> <ENT>Hydroquinone—1,4-Benzenediol</ENT> <ENT/> <ENT>10/04/84</ENT> <ENT>10/04/94</ENT> </ROW> <ROW> <ENT I="01">123-61-5</ENT> <ENT>Benzene, 1,3-diisocyanato-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <PRTPAGE P="192"/> <ENT I="01">123-72-8</ENT> <ENT>Butanal</ENT> <ENT/> <ENT>12/16/88</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">124-16-3</ENT> <ENT>1-Butoxyethoxy-2-propanol-2-Propanol, 1-(2-butoxyethoxy)-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">124-17-4</ENT> <ENT>2-(2-Butoxyethoxy)ethyl acetate—Ethanol, 2-(2-butoxyethoxy)-, acetate</ENT> <ENT/> <ENT>01/13/82</ENT> <ENT>01/13/92</ENT> </ROW> <ROW> <ENT I="01">124-48-1</ENT> <ENT>Methane, dibromochloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">126-73-8</ENT> <ENT>Phosphoric acid, tributyl ester</ENT> <ENT/> <ENT>06/18/86</ENT> <ENT>06/18/96</ENT> </ROW> <ROW> <ENT I="01">126-99-8</ENT> <ENT>Chloroprene—1,3-Butadiene, 2-chloro-</ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>12/28/94</ENT> </ROW> <ROW> <ENT I="01">127-18-4</ENT> <ENT>Ethene, tetrachloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">128-39-2</ENT> <ENT>Phenol, 2,6-bis(1,1-dimethylethyl)-</ENT> <ENT/> <ENT>12/19/85</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">128-86-9</ENT> <ENT>2,6-Anthracenedisulfonic acid, 4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxo-</ENT> <ENT/> <ENT>12/21/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">129-00-0</ENT> <ENT>Pyrene</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">131-17-9</ENT> <ENT>Diallyl phthalate-1,2-Benzenedicarboxylic acid, di-2-propenyl ester</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">135-98-8</ENT> <ENT>Benzene, (1-methylpropyl)-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">136-35-6</ENT> <ENT>1-Triazene, 1,3-diphenyl-</ENT> <ENT O="xl">§ 716.21(a)(5)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">137-20-2</ENT> <ENT> Soldium <E T="03">N</E> -methyl- <E T="03">N</E> -oleoyltaurine—Ethanesulfonic acid, 2-[methyl (1-oxo-9-octadecenyl)amino]-, sodium salt, ( <E T="03">Z</E> )- </ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>12/28/94</ENT> </ROW> <ROW> <ENT I="01">137-26-8</ENT> <ENT>Thioperoxydicarbonic diamide, tetramethyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">139-25-3</ENT> <ENT> Benzene, 1,1  <SU>1</SU> -methylenebis[4-isocyanato-3-methyl- </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">140-08-9</ENT> <ENT>Tris(2-chloroethyl)phosphite—Ethanol, 2-chloro-, phosphite (3:1)</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>01/13/86</ENT> </ROW> <ROW> <ENT I="01">140-66-9</ENT> <ENT>4-(1,1,3,3-Tetramethylbutyl) phenol—Phenol, 4-(1,1,3,3-tetramethylbutyl)-</ENT> <ENT/> <ENT>01/30/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">140-88-5</ENT> <ENT>Ethyl acrylate—2-Propenoic acid, ethyl ester</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">141-79-7</ENT> <ENT>Mesityl oxide—3-Penten-2-one, 4-methyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">142-28-9</ENT> <ENT>Propane, 1,3,-dichloro-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">142-84-7</ENT> <ENT> 1-Propanamine, <E T="03">N</E> -propyl- </ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>12/5/90</ENT> </ROW> <ROW> <ENT I="01">143-22-6</ENT> <ENT>Triethyleneglycol monobutyl ether—Ethanol, 2-[-2-(2-butoxyethoxy)ethoxy]-</ENT> <ENT/> <ENT>06/20/85</ENT> <ENT>06/20/95</ENT> </ROW> <ROW> <ENT I="01">143-33-9</ENT> <ENT>Sodium cyanide</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">149-30-4</ENT> <ENT> Mercaptobenzothiazole—2(3 <E T="03">H</E> -Benzothiazolethione </ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>12/28/94</ENT> </ROW> <ROW> <ENT I="01">149-57-5</ENT> <ENT>2-Ethylhexanoic acid—Hexanoic acid, 2-ethyl-</ENT> <ENT/> <ENT>06/28/84</ENT> <ENT>06/28/94</ENT> </ROW> <ROW> <ENT I="01">306-83-2</ENT> <ENT>Ethane, 2,2-dichloro-1,1,1-trifluoro</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">328-84-7</ENT> <ENT>3,4-Dichlorobenzotrifluoride—Benzene, 1,2-dichloro-4-(trifluoromethyl)-</ENT> <ENT/> <ENT>05/08/85</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">354-33-6</ENT> <ENT>Ethane, pentafluoro</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">357-57-3</ENT> <ENT>Strychnidin-10-one, 2,3-dimethoxy-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">428-59-1</ENT> <ENT>Oxirane, trifluoro(trifluoromethyl)-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">496-46-8</ENT> <ENT>Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-</ENT> <ENT>§ 716.21(a)(1)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">472-41-3</ENT> <ENT> Phenol, 4-(3,4-dihydro-2,2,4-trimethyl-2 <E T="03">H</E> -1-benzopyran-4-yl)- </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">506-96-7</ENT> <ENT>Acetyl bromide</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">526-73-8</ENT> <ENT>1,2,3-Trimethylbenzene—Benzene, 1,2,3-trimethyl-</ENT> <ENT/> <ENT>02/13/84</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">530-50-7</ENT> <ENT>Hydrazine, 1,1-diphenyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">534-07-6</ENT> <ENT>2-Propanone, 1,3-dichloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">540-54-5</ENT> <ENT>Propane, 1-chloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">540-84-1</ENT> <ENT>Pentane, 2,2,4-trimethyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">542-75-6</ENT> <ENT>1-Propene, 1,3-dichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">556-67-2</ENT> <ENT>Octamethylcyclotetrasiloxane—Cyclotetrasiloxane, octamethyl-</ENT> <ENT/> <ENT>12/28/84</ENT> <ENT>12/28/94</ENT> </ROW> <ROW> <ENT I="01">563-54-2</ENT> <ENT>1-Propene, 1,2-dichloro-</ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">563-58-6</ENT> <ENT>1-Propene, 1,1-dichloro-</ENT> <ENT/> <ENT>03/07/86</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">580-51-8</ENT> <ENT>[1,1′-Biphenyl]-3-ol</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">584-84-9</ENT> <ENT>Benzene, 2,4-diisocyanato-1-methyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">591-08-2</ENT> <ENT>Acetamide, N-(aminothioxomethyl)-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">594-20-7</ENT> <ENT>Propane, 2,2-dichloro-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">598-21-0</ENT> <ENT>Acetyl bromide, bromo-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">598-31-2</ENT> <ENT>2-Propanone, 1-bromo-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">616-23-9</ENT> <ENT>1-Propanol, 2,3-dichloro-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">620-14-4</ENT> <ENT> <E T="03">m</E> -Ethyltoluene—Benzene, 1-ethyl-3-methyl- </ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">622-96-8</ENT> <ENT> <E T="03">p</E> -Ethyltoluene—Benzene, 1-ethyl-4-methyl- </ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">630-20-6</ENT> <ENT>Ethane, 1,1,1,2-tetrachloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">632-79-1</ENT> <ENT>Tetrabromophthalic anhydride</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">637-92-3</ENT> <ENT O="xl">Ethyl-tert-butyl ether</ENT> <ENT O="xl">§ 716.20(b)(3) applies</ENT> <ENT O="xl">12/28/94</ENT> <ENT O="xl">6/30/98</ENT> </ROW> <ROW> <ENT I="01">646-06-0</ENT> <ENT>1,3-Dioxolane</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">677-21-4</ENT> <ENT>Trifluoromethylethene—1-Propene, 3,3,3-trifluoro-</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>01/13/86</ENT> </ROW> <ROW> <ENT I="01">685-91-6</ENT> <ENT> Acetamide, <E T="03">N</E> , <E T="03">N</E> -diethyl- </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">692-42-2</ENT> <ENT>Arsine, diethyl-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">696-28-6</ENT> <ENT>Arsonous dichloride, phenyl-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">757-58-4</ENT> <ENT>Tetraphosphoric acid, hexaethyl ester</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">811-97-2</ENT> <ENT>Ethane, 1,1,2-tetrafluoro-</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">812-03-3</ENT> <ENT>Propane, 1,1,1,2-tetrachloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">822-06-0</ENT> <ENT>Hexane, 1,6-diisocyanato-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">828-00-2</ENT> <ENT>1,3-Dioxan-4-ol, 2,6-dimethyl-, acetate</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <PRTPAGE P="193"/> <ENT I="01">930-22-3</ENT> <ENT>Oxirane, ethenyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">939-97-9</ENT> <ENT> <E T="03">p-tert</E> -Butylbenzaldehyde—Benzaldehyde, 4-(1,1-dimethylethyl)- </ENT> <ENT/> <ENT>06/25/86</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">994-05-8</ENT> <ENT O="xl">Tert-amyl methyl ether</ENT> <ENT O="xl">§ 716.20(b)(3) applies</ENT> <ENT O="xl">12/28/94</ENT> <ENT O="xl">06/30/98</ENT> </ROW> <ROW> <ENT I="01">1000-82-4</ENT> <ENT>Methylolurea—Urea, (hydroxymethyl)-</ENT> <ENT/> <ENT>07/01/83</ENT> <ENT>07/01/93</ENT> </ROW> <ROW> <ENT I="01">1070-78-6</ENT> <ENT>Propane, 1,1,1,3-tetrachloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">1163-19-5</ENT> <ENT>Decabromodiphenyl ether</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">1185-81-5</ENT> <ENT>Dibutyltin bis(lauryl mercaptide)—Stannane, dibutylbis(dodecylthio)</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">1208-52-2</ENT> <ENT>Benzenamine, 2-[(4-aminophenyl)methyl]-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">1300-71-6</ENT> <ENT>Phenol, dimethyl-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">1309-64-4</ENT> <ENT>Antimony trioxide</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1321-38-6</ENT> <ENT>Benzene, diisocyanatomethyl-(unspecified isomer)</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">1321-64-8</ENT> <ENT>Naphthalene, pentachloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1321-65-9</ENT> <ENT>Naphthalene, trichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1331-47-1</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamino, dichloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">1333-41-1</ENT> <ENT>Methyl pyridine—Pyridine, methyl-</ENT> <ENT/> <ENT>09/10/84</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">1335-87-1</ENT> <ENT>Naphthalene, hexachloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1335-88-2</ENT> <ENT>Naphthalene, tetrachloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1345-04-6</ENT> <ENT>Antimony trisulfide</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1464-53-5</ENT> <ENT>2,2′-Bioxirane</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1634-04-4</ENT> <ENT>Propane, 2-methoxy-2-methyl-</ENT> <ENT/> <ENT>12/15/86</ENT> <ENT>12/15/96</ENT> </ROW> <ROW> <ENT I="01">1649-08-7</ENT> <ENT>Ethane, 1,2-dichloro-1,1-difluoro</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">1717-00-6</ENT> <ENT>Ethane, 1,1-dichloro-1-fluoro-</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">1825-30-5</ENT> <ENT>Naphthalene, 1,5-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1825-31-6</ENT> <ENT>Naphthalene, 1,4-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">1888-71-7</ENT> <ENT>1-Propene, 1,1,2,3,3,3-hexachloro-</ENT> <ENT/> <ENT>3/7/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">2050-69-3</ENT> <ENT>Naphthalene, 1,2-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2050-72-8</ENT> <ENT>Naphthalene, 1,6-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2050-73-9</ENT> <ENT>Naphthalene, 1,7-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2050-74-0</ENT> <ENT>Naphthalene, 1,8-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2050-75-1</ENT> <ENT>Naphthalene, 2,3-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2065-70-5</ENT> <ENT>Naphthalene, 2,6-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2198-75-6</ENT> <ENT>Naphthalene, 1,3-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2198-77-8</ENT> <ENT>Naphthalene, 2,7-dichloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2234-13-1</ENT> <ENT>Naphthalene, octachloro-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">2536-05-2</ENT> <ENT>Benzene, 1,1′-methylenebis[2-isocyanato-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">2556-36-7</ENT> <ENT>Cyclohexane, 1,4-diisocyanato</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">2763-96-4</ENT> <ENT>3(2H)-Isoxazolone, 5-(aminomethyl)-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>2/19/95</ENT> </ROW> <ROW> <ENT I="01">2778-42-9</ENT> <ENT>Benzene, 1,3-bis(1-isocyanato-1-methylethyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">2861-02-1</ENT> <ENT O="xl">2,6-Anthracenedisulfonic acid, 4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxo-, disodium salt</ENT> <ENT/> <ENT>12/21/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">2873-89-0</ENT> <ENT>Ethane, 2-chloro-1,1,1,2-tetrafluoro-</ENT> <ENT/> <ENT>10/15/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">3083-25-8</ENT> <ENT>Oxirane, (2,2,2-trichloroethyl)-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">3173-72-6</ENT> <ENT>Naphthalene, 1,5,-diisocyanato-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">3194-55-6</ENT> <ENT>Hexabromocyclododecane</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">3278-89-5</ENT> <ENT>Benzene, 1,3,5-tribromo-2-(2-propenyloxy)-</ENT> <ENT>§ 716.21(a)(4)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">3288-58-2</ENT> <ENT>Phosphorodithioic acid, O,O-diethyl-S-methyl ester</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">3296-90-0</ENT> <ENT>1,3-Propanediol, 2,2-bis(bromomethyl)-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">3319-31-1</ENT> <ENT>Tris(2-ethylhexyl) trimellitate—1,2,4-Benzenetricarboxylic acid, tris(2-ethylhexyl)ester</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">3322-93-8</ENT> <ENT>1,2-Dibromo-4-(1,2-dibromoethyl) cyclohexane—Cyclohexane, 1,2-dibromo-4-(1,2-dibromoethyl)-</ENT> <ENT/> <ENT>06/28/84</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">3389-71-7</ENT> <ENT>1,2,3,4,7,7-Hexachloronorbornadiene—Bicyclo[2.2.1]hepta-2,5-diene, 1,2,3,4,7,7-hexachloro-</ENT> <ENT/> <ENT>01/13/84</ENT> <ENT>01/13/94</ENT> </ROW> <ROW> <ENT I="01">3618-72-2</ENT> <ENT> Acetamide, <E T="03">N</E> -[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4- methoxyphenyl]- </ENT> <ENT/> <ENT>06/19/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">3618-73-3</ENT> <ENT> Acetamide, <E T="03">N</E> -[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]- </ENT> <ENT/> <ENT>06/19/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">3956-55-6</ENT> <ENT> Acetamide, <E T="03">N</E> -[5-[bis[2-(acetyloxy)ethyl]-amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4-ethoxyphenyl </ENT> <ENT/> <ENT>12/15/86</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">4098-71-9</ENT> <ENT>Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">4170-30-3</ENT> <ENT>2-Butenal</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">5124-30-1</ENT> <ENT>Cyclohexane, 1,1′-methylenebis[4-isocyanato-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">5131-66-8</ENT> <ENT>1-Butoxy-2-propanol-2-Propanol, 1-butoxy-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">5344-82-1</ENT> <ENT>Thiourea, (2-chlorophenyl)-</ENT> <ENT/> <ENT>3/7/86</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">5873-54-1</ENT> <ENT>Benzene, 1-isocyanato-2-[4-isocyanatophenyl)methyl]-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">6145-73-9</ENT> <ENT>1-Propanol, 2-chloro-, phosphate (3:1)</ENT> <ENT/> <ENT>12/16/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">6247-34-3</ENT> <ENT>2-Anthracenesulfonic acid, 4-[[4-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxo-</ENT> <ENT/> <ENT>12/21/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">6422-86-2</ENT> <ENT>Bis(2-ethylhexyl) terephthalate—1,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">6424-85-7</ENT> <ENT>2-Anthracenesulfonic acid, 4-[[4- (acetylamino)phenyl]amino]- 1-amino-9,10-dihydro-9,10-dioxo-, monosodium salt</ENT> <ENT/> <ENT>12/21/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <PRTPAGE P="194"/> <ENT I="01">7320-37-8</ENT> <ENT>Oxirane, tetradecyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">7440-28-0</ENT> <ENT>Thallium</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">7440-36-0</ENT> <ENT>Antimony</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">7440-48-4</ENT> <ENT>Cobalt</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">7723-14-0</ENT> <ENT>White phosphorus</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">9011-05-6</ENT> <ENT>Urea, polymer with formaldehyde</ENT> <ENT>§ 716.20(b)(1) applies</ENT> <ENT>06/03/85</ENT> <ENT>06/03/95</ENT> </ROW> <ROW> <ENT I="01">9016-87-9</ENT> <ENT>Isocyanic acid, polymethylenepolyphenylene ester</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">10347-54-3</ENT> <ENT>Cyclohexane, 1,4-bis(isocyanatomethyl)-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/87</ENT> </ROW> <ROW> <ENT I="01">10436-39-2</ENT> <ENT>1-Propene, 1,1,2,3-tetrachloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">12001-85-3</ENT> <ENT>Naphthenic acids, zinc salts</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">12185-10-3</ENT> <ENT>White phosphorus</ENT> <ENT/> <ENT>01/26/94</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">12217-79-7</ENT> <ENT>9,10-Anthracenedione, 1,5-diamino-chloro-4,8-dihydroxy-</ENT> <ENT/> <ENT>12/21/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">13414-54-5</ENT> <ENT>Methallyl 2-nitrophenyl ether—Benzene, 1-[(2-methyl-2-propenyl)oxy]-2-nitro-</ENT> <ENT/> <ENT>02/13/84</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">13414-55-6</ENT> <ENT>7-Nitro-2,2-dimethyl-2,3-dihydro-benzofuran—Benzofuran, 2,3-dihydro-2,2-dimethyl-7-nitro-</ENT> <ENT/> <ENT>02/13/84</ENT> <ENT>02/13/94</ENT> </ROW> <ROW> <ENT I="01">13674-84-5</ENT> <ENT>2-Propanol, 1-chloro-, phosphate (3:1)</ENT> <ENT/> <ENT>12/16/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">13674-87-8</ENT> <ENT>2-Propanol, 1,3-dichloro-, phosphate (3:1)</ENT> <ENT/> <ENT>12/16/88</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">15646-96-5</ENT> <ENT>Hexane, 1,6-diisocyanato-2,4,4-trimethyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">16691-43-3</ENT> <ENT>3H-1,2,4-Triazole-3-thione, 5-amino-1,2-dihydro-</ENT> <ENT>§ 716.21(a)(1)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">16938-22-0</ENT> <ENT>Hexane, 1,6-diisocyanato-2,2,4-trimethyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">17418-58-5</ENT> <ENT>9,10-Anthracenedione, 1-amino-4-hydroxy-2-phenoxy-</ENT> <ENT/> <ENT>12/21/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">18495-30-2</ENT> <ENT>Propane, 1,1,2,3-tetrachloro-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">18633-25-5</ENT> <ENT>Oxirane, tridecyl-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">19660-16-3</ENT> <ENT>2-Propenoic acid, 2,3-dibromopropyl ester</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">21429-43-6</ENT> <ENT> Acetamide, <E T="03">N</E> -[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]- </ENT> <ENT/> <ENT>06/19/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">25168-06-3</ENT> <ENT>Isopropyl phenol—Phenol, (1-methylethyl)-</ENT> <ENT/> <ENT>04/13/89</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">25168-21-2</ENT> <ENT> Dibutyltin bis (isooctyl maleate)—2-Butenoic acid, 4,4′-[(dibutylstannylene)bis(oxy)]bis-[4-oxo-, diisoctyl ester, ( <E T="03">Z</E> , <E T="03">Z</E> )- </ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">25498-49-1</ENT> <ENT>Tripropylene glycol monomethyl ether-Propanol, [2-(2-methoxy methylethoxy)methylethoxy]-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">25550-14-5</ENT> <ENT>Benzene, ethylmethyl- (mixed isomers)</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">25550-98-5</ENT> <ENT>Phosphorous acid, diisodecyl phenyl ester</ENT> <ENT/> <ENT>12/19/85</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">25551-13-7</ENT> <ENT>Trimethylbenzene—Benzene, trimethyl- (mixed isomers)</ENT> <ENT/> <ENT>02/13/84</ENT> <ENT>02/13/94</ENT> </ROW> <ROW> <ENT I="01">25640-78-2</ENT> <ENT>Isopropyl biphenyl—1,1′-Biphenyl, (1-methylethyl)-</ENT> <ENT/> <ENT>06/28/84</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">25852-70-4</ENT> <ENT>Monobutyltin tris (isooctyl) mercapto-acetate—Acetic acid, 2,2′,2″-[(butylstannylidyne)tris(thio)]tris-, triisooctyl ester</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>01/03/93</ENT> </ROW> <ROW> <ENT I="01">26447-40-5</ENT> <ENT>Benzene, 1,1′-methylenebis[isocyanato-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">26471-62-5</ENT> <ENT>Benzene, 1,3-diisocyanatomethyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>06/01/97</ENT> </ROW> <ROW> <ENT I="01">26530-20-1</ENT> <ENT> 3(2 <E T="03">H</E> )-Isothiazolone, 2-octyl- </ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">26952-23-8</ENT> <ENT>1-Propene, dichloro-</ENT> <ENT/> <ENT>6/1/87</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">29091-20-1</ENT> <ENT>Benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-</ENT> <ENT>§ 716.21(a)(2)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">29385-43-1</ENT> <ENT>Tolyl triazole-1H-Benzotriazole, methyl-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">32052-51-0</ENT> <ENT>Isocyanic acid, trimethylcyclohexyl ester</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">32534-81-9</ENT> <ENT>Pentabromodiphenyl ether</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">32536-52-0</ENT> <ENT>Octabromodiphenyl ether</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">32588-76-4</ENT> <ENT>Ethylene Bis-(tetrabromophthalimide)</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">33125-86-9</ENT> <ENT>Phosphoric acid, 1,2-ethanediyl tetrakis (2-chloroethyl) ester</ENT> <ENT/> <ENT>12/16/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">34590-94-8</ENT> <ENT>Dipropylene glycol monomethyl ether—Propanol, (2-methoxymethylethoxy)-</ENT> <ENT/> <ENT>4/13/89</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">37853-59-1</ENT> <ENT>1,2-Bis(tribromophenoxy) ethane</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">38661-72-2</ENT> <ENT>Cyclohexane, 1,3-bis(isocyanatomethyl)-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">41291-34-3</ENT> <ENT>Ethylene(5,6-dibromonorbornane-2,3-dicarboximide)</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">52907-07-0</ENT> <ENT>Ethylene bis(5,6-dibromonorbornane-2,3-dicarboximide</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">57137-10-7</ENT> <ENT>Tribrominated polystyrene</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">61262-53-1</ENT> <ENT>Ethylene bis(pentabromophenoxide)</ENT> <ENT/> <ENT>1/11/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">61788-33-8</ENT> <ENT>Terphenyl, chlorinated</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">61789-36-4</ENT> <ENT>Calcium naphthenate—Naphthenic acids, calcium salts</ENT> <ENT/> <ENT>07/01/83</ENT> <ENT>07/01/93</ENT> </ROW> <ROW> <ENT I="01">61789-51-3</ENT> <ENT>Cobalt naphthenate—Naphthenic acids, cobalt salts</ENT> <ENT/> <ENT>07/01/83</ENT> <ENT>07/01/93</ENT> </ROW> <ROW> <ENT I="01">61790-14-5</ENT> <ENT>Lead naphthenate—Naphthenic acids, lead salts</ENT> <ENT/> <ENT>07/01/83</ENT> <ENT>07/01/93</ENT> </ROW> <ROW> <ENT I="01">64742-95-6</ENT> <ENT>Solvent naphtha (petroleum), light arom</ENT> <ENT/> <ENT>2/13/84</ENT> <ENT>2/13/94</ENT> </ROW> <ROW> <ENT I="01">68081-84-5</ENT> <ENT> Oxirane, mono[(C <E T="52">10-16</E> -alkyloxy) methyl] derivatives </ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">68122-86-1</ENT> <ENT>Imidazolium compounds, 4,5-dihydro-1-methyl-2-nortallow alkyl-1-(2-tallow amidoethyl), methyl sulfates</ENT> <ENT/> <ENT>6/20/88</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">68153-35-5</ENT> <ENT> Ethanaminium, 2-amino- <E T="03">N</E> -(2-aminoethyl- <E T="03">N</E> -(2-hydroxyethyl)- <E T="03">N</E> -methyl-, <E T="03">N</E> , <E T="03">N</E> ″-ditallow acyl derivatives, methyl sulfates (salts) </ENT> <ENT/> <ENT>06/20/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">68298-46-4</ENT> <ENT>7-Amino-2,2-dimethyl-2,3-dihydrobenzofuran—7-Benzofuranamine,2,3-dihydro-2,2-dimethyl-</ENT> <ENT/> <ENT>02/13/84</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">68389-88-8</ENT> <ENT> Poly(oxy-1,2-ethanediyl), α-[2-[bis(2-aminoethyl)methylammonio]ethyl]-ω-hydroxy-, <E T="03">N</E> , <E T="03">N</E> ″-dicoco acyl derivatives, methyl sulfates (salts) </ENT> <ENT/> <ENT>06/20/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <PRTPAGE P="195"/> <ENT I="01">68389-89-9</ENT> <ENT> Poly(oxy-1,2-ethanediyl), α-[2-[bis(2-aminoethyl)methylammonio]ethyl]-ω-hydroxy-, <E T="03">N</E> , <E T="03">N</E> ″-bis(hydrogenated tallow acyl) derivatives, methyl sulfates (salts) </ENT> <ENT/> <ENT>06/20/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">68410-69-5</ENT> <ENT>Poly(oxy-1,2-ethanediyl), alpha-[2-[bis(2-aminoethyl) methylammonio]ethyl]-w-hydroxy,- N,N′-ditallow acyl derivatives, methyl sulfates (salts)</ENT> <ENT/> <ENT>6/20/88</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">68413-04-7</ENT> <ENT> Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[bis(2-aminoethyl)methylammonio] methylethyl]-ω-hydroxy-, <E T="03">N</E> , <E T="03">N</E> ″-ditallow acyl derivatives, methyl sulfates (salts) </ENT> <ENT/> <ENT>06/20/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">68554-06-3</ENT> <ENT> Poly(oxy-1,2-ethanediyl), α-[3-[bis(2-aminoethyl)methylammonio]-2-hydroxy-propyl]-ω-hydroxy-, <E T="03">N</E> -coco acyl derivatives, methyl sulfates (salts) </ENT> <ENT/> <ENT>06/20/88</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">68611-64-3</ENT> <ENT>Urea, reaction products with formaldehyde</ENT> <ENT>§ 716.20(b)(1) applies</ENT> <ENT>06/03/85</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">68928-76-7</ENT> <ENT>Stannane, dimethylbis[(1-oxoneodecyl)oxy]-</ENT> <ENT>§ 716.21(a)(3)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">69009-90-1</ENT> <ENT>Diisopropyl biphenyl—1,1′-Biphenyl, bis(1-methylethyl)-</ENT> <ENT/> <ENT>06/28/84</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">70914-09-9</ENT> <ENT> Poly(oxy-1,2-ethanediyl), α-[2-[bis(2-aminoethyl)methylammonio]ethyl]-ω-hydroxy-, <E T="03">N</E> , <E T="03">N</E> ″-di[C <E T="52">14-18</E> acyl] derivatives, methyl sulfates (salts) </ENT> <ENT/> <ENT>06/20/88</ENT> <ENT>06/20/88</ENT> </ROW> <ROW> <ENT I="01">75790-84-0</ENT> <ENT>Benzene, 2-isocyanato-4-[(4-isocyanato-phenyl)methyl]-1-methyl-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">75790-87-3</ENT> <ENT>Benzene, 1-isocyanato-2-[(4-isocyanato-phenyl)thio]-</ENT> <ENT/> <ENT>06/01/87</ENT> <ENT>11/09/93</ENT> </ROW> </GPOTABLE> <P>(b) [Reserved]</P> <P> (c) <E T="03">By category.</E> The following categories are listed in alphabetical order. Chemical substances listed within a category are provided only as examples of the category. All chemical substances within a category are subject to all the provisions of part 716 for the time period from the effective date of the category until the sunset date. Manufacturers, importers, and processors of any chemical substance within a category are subject to the reporting requirements of subpart A for that category, except when the sunset date for the particular substance predates the sunset date for the category, or when the exemption of § 716.20(b) of this part applies. </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,12,10,10,11"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No. (examples for category)</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="01">Alkyl epoxides—including all noncyclic aliphatic hydrocarbons with one or more epoxy functional groups.</ENT> <ENT/> <ENT/> <ENT>10/4/82</ENT> <ENT>12/29/88 </ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="143"> <GID>716-106a.eps</GID> </GPH> <PRTPAGE P="196"/> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,12,10,10,11"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No. (examples for category)</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="11"> R <E T="52">1</E> = R <E T="52">2</E> = R <E T="52">3 </E> = R <E T="52">4</E> = H or alkyl. Groups R <E T="52">1</E> -R <E T="52">4</E> may contain one or more epoxide functions. </ENT> </ROW> <ROW> <ENT I="02">Oxirane, decyl-</ENT> <ENT>2855-19-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2, 2 - dimethyl -</ENT> <ENT>558-30-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2, 3 - dimethyl -</ENT> <ENT>3266-23-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, dodecyl</ENT> <ENT>3234-28-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, heptadecyl -</ENT> <ENT>67860-04-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, octyl-</ENT> <ENT>2404-44-6</ENT> <ENT/> <ENT>10/04/82, 12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, pentadecyl -</ENT> <ENT>22092-38-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01"> Alkyl phthalates — all alkyl esters of 1, 2-benzenedicarboxylic acid ( <E T="03">ortho </E> -phthalic acid). </ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="130"> <GID>716-106b.eps</GID> </GPH> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,12,10,10,11"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No. (examples for category)</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="11"> R <E T="52">1</E> = R <E T="52">2</E> = alkyl. </ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester</ENT> <ENT>117-81-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, bis(1-methylheptyl) ester</ENT> <ENT>131-15-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester</ENT> <ENT>84-69-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, 2-butoxy-2-oxyethyl butyl ester</ENT> <ENT>85-70-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>01/13/86</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, butyl cyclohexyl ester</ENT> <ENT>84-64-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, butyl 2-ethylhexyl ester</ENT> <ENT>85-69-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, butyl octyl ester</ENT> <ENT>84-78-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, decyl hexyl ester</ENT> <ENT>25724-58-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, decyl octyl ester</ENT> <ENT>119-07-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, dibutyl ester</ENT> <ENT>84-74-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, dicyclohexyl ester</ENT> <ENT>84-61-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, diethyl ester</ENT> <ENT>84-66-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, dihexyl ester</ENT> <ENT>84-75-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, diisodecyl ester</ENT> <ENT>26761-40-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, diisononyl ester</ENT> <ENT>28553-12-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, diisooctyl ester</ENT> <ENT>27554-26-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, demethyl ester</ENT> <ENT>131-11-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, dinonyl ester</ENT> <ENT>84-76-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, dioctyl ester</ENT> <ENT>117-84-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, diundecyl ester</ENT> <ENT>119-06-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, isodecyl tridecyl ester</ENT> <ENT>3648-20-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, 2-ethylhexyl-8-methylnonyl ester</ENT> <ENT>89-13-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, hexyl isodecyl ester</ENT> <ENT>61702-81-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, isodecyl tridecyl ester</ENT> <ENT>61886-60-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">Alkyltin compounds.</ENT> <ENT/> <ENT/> <ENT>01/03/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02"> Dibutyltin <E T="03">S,S</E> ′-bis(isooctyl mercaptoacetate)—Acetic acid, 2,2′-[(dibutylstannylene)bis(thio)]bis-, diisooctyl ester </ENT> <ENT>25168-24-5</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02"> Dibutyltin <E T="03">S,S</E> ′-bis(isooctyl mercaptoacetate)—Acetic acid, 2,2′-[(dimethylstannylene)bis(thio)]bis-, diisooctyl ester </ENT> <ENT>26636-01-1</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Mono methyltin tris(isooctylmercaptoacetate) Acetic acid, 2,2′,2″-[(methylstannylidyne)tris(thio)]tris-triisoacetyl ester</ENT> <ENT>54849-38-6</ENT> <ENT/> <ENT>01/03/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">Aniline and chloro-, bromo-, and/or nitroanilines.</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <PRTPAGE P="197"/> <ENT I="02">Benzenamine</ENT> <ENT>62-53-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 4-bromo-</ENT> <ENT>106-40-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-bromo-6-chloro-4-nitro-</ENT> <ENT>99-29-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-bromo-,4,6-dinitro-</ENT> <ENT>1817-73-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-chloro-</ENT> <ENT>95-51-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 3-chloro-</ENT> <ENT>108-42-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 4-chloro-</ENT> <ENT>106-47-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-chloro-4,6-dinitro-</ENT> <ENT>3531-19-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 4-chloro-2,6-dinitro-</ENT> <ENT>5388-62-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 3-chloro-, hydrochloride</ENT> <ENT>141-85-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-chloro-4-nitro-</ENT> <ENT>121-87-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-chloro-5-nitro-</ENT> <ENT>6283-25-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 4-chloro-2-nitro-</ENT> <ENT>89-63-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 4-chloro-3-nitro-</ENT> <ENT>635-22-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,6-dibromo-4-nitro-</ENT> <ENT>827-94-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,3-dichloro-</ENT> <ENT>608-27-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,4-dichloro-</ENT> <ENT>554-00-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,5-dichloro-</ENT> <ENT>95-82-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 3,4-dichloro-</ENT> <ENT>95-76-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 3,5-dichloro-</ENT> <ENT>626-43-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,6-dichloro-4-nitro-</ENT> <ENT>99-30-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,4-dinitro-</ENT> <ENT>97-02-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-nitro-</ENT> <ENT>88-74-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 3-nitro-</ENT> <ENT>99-09-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 4-nitro-</ENT> <ENT>100-01-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,4,6-tribromo-</ENT> <ENT>147-82-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,4,6-trichloro-</ENT> <ENT>634-93-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">Aryl phosphates—phosphate esters of phenol or of alkyl-substituted phenols. Triaryl and mixed alkyl and aryl esters are included but trialkyl esters are excluded</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="125"> <GID>716-108.eps</GID> </GPH> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,12,10,10,11"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No. (examples for category)</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="11"> R <E T="52">1</E> = phenyl, either unsubstituted or substituted with one or more alkyl or aralkyl groups R <E T="52">2</E> = R <E T="52">3</E> alkyl; or phenyl, either unsubstituted or substituted with one or more alkyl or aralkyl groups </ENT> </ROW> <ROW> <ENT I="02">Phenol, dimethyl-, phosphate (3:1)</ENT> <ENT>25155-23-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phenol, 4-(1,1-dimethylethyl)-, phosphate (3:1)</ENT> <ENT>78-33-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, dibutyl phenyl ester</ENT> <ENT>2528-36-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, diisodecyl phenyl ester</ENT> <ENT>51363-64-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, (1,1-dimethylethyl) phenyl diphenyl ester</ENT> <ENT>56803-37-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, 2-ethylhexyl diphenyl ester</ENT> <ENT>1241-94-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, isodecyl diphenyl ester</ENT> <ENT>29761-21-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, (1-methylethyl)phenyl diphenyl ester</ENT> <ENT>28108-99-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, methylphenyl diphenyl ester</ENT> <ENT>25444-49-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, (1-methyl-l-phenylethyl)phenyl diphenyl ester</ENT> <ENT>34364-42-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, triphenyl ester</ENT> <ENT>115-86-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, tris(methylphenyl) ester</ENT> <ENT>1330-78-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <PRTPAGE P="198"/> <ENT I="02">Phosphoric acid, tris(2-methylphenyl) ester</ENT> <ENT>78-30-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, tris(3-methylphenyl) ester</ENT> <ENT>563-04-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, tris(4-methylphenyl) ester</ENT> <ENT>78-32-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">Asbestos—asbestiform varieties of chrysolite (serpentine); crocidolite (riebeckite); amosite (cummingtonite—grunerite); anthophyllite; tremolite; and actinolite.</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Asbestos</ENT> <ENT>1332-21-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Asbestiform minerals</ENT> <ENT>12001-29-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Asbestiform minerals</ENT> <ENT>17068-78-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Asbestiform minerals</ENT> <ENT>12172-73-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01"> Bisazobiphenyl dyes derived from benzidine and its congeners, <E T="03">ortho</E> -toluidine (dimethylbenzidine) and dianisidine (dimethoxybenzidine). </ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benoic acid, 2-[[2-amino-6-[[4′-[(-carboxy-4-hydroxphenyl) azo[-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-7-sulfo-1-naphthalenylazo]-5-nitro-, trisodium salt</ENT> <ENT>6739-62-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[2-amino-8-hydroxy-6-sulfo-1-naphthalenyl) azo] [1,1′-biphenyl]-4-yl]-azo]-2-hydroxy-, disodium salt</ENT> <ENT>2429-84-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo] [1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT> <ENT>2429-82-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[(1-amino-4-sulfo-2-naphthalenyl)azo] [1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT> <ENT>2429-79-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[[2,6-diamino-3-[[8-hydroxy-3,6-disulfo-7-[(4-sulfo-1-naphthalenyl)azo]-2-naphthalenyl]azo]-5-methylphenyl]azo] [1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, tetrasodium salt</ENT> <ENT>2429-81-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[(2,6-diamino-3-methyl-5-sulfophenyl)azo]-3,3′-dimethyl[1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT> <ENT>6637-88-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo][1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT> <ENT>2586-58-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo]1,1′-biphenyl]-4-yl]azo]-2-hydroxy-3-methly-, disodium salt</ENT> <ENT>6360-54-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 5-[[4′-[[2,4-dihydroxy-3-[(4-sulfophenyl)azo]phenyl]azo] [1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT> <ENT>2893-80-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 3,3′-[(3,7-disulfo-1,5-naphthalene-diyl)bis[azo(6-hydroxy-3,1-phenylene)azo[6(or 7)-sulfo-4,1-naphthalenediyl]azo[1,1′-biphenyl]-4,4′-diylazo]]bis[6-hydroxy-, hexasodium salt</ENT> <ENT>8014-91-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">[1,1′-Biphenyl]-4,1′-bis diazonium), 3,3′-dimethoxy-</ENT> <ENT>20282-70-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Butanamide, <E T="03">N</E> , <E T="03">N</E> ′-(3,3′-dimethyl [1,1′-biphenyl]-4,4′-diyl)bis[3-oxo- </ENT> <ENT>91-96-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">C.I. Direct Blue 218</ENT> <ENT>10401-50-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Cuprate(2-), [5-[[4′-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulfophenyl)azo]phenyl]azo][1,1′-biphenyl]-4-yl]azo]-2-hydroxybenzoato(4-)]-, disodium</ENT> <ENT>16071-86-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Cuprate(3-), [μ-[7-[[3,3′-dihydroxy-4′-[[1-hydroxy-6-(phenylamino)-3-sulfo-2-naphthalenyl]azo] [1,1′-biphenyl]-4-yl]azo]-8-hydroxy-1,6-naphthalenedisulfonato(7-)]]di-, trisodium</ENT> <ENT>6656-03-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Cuprate(4-), [μ-[[6,6′-[3,3′-dihydroxy[1,1′-biphenyl]-4-4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-1,3-naphthalendisulfonato]](8-)]]di-, tetrasodium</ENT> <ENT>16143-79-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> 2-Naphthalenecarboxamide, <E T="03">N</E> , <E T="03">N</E> ′-(3,3′-dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis[3-hydroxy- </ENT> <ENT>91-92-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-[[4′-[(2hydroxy-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-, disodium salt</ENT> <ENT>2586-57-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethoxy[1,1′-biphenyl]-4,4′diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt</ENT> <ENT>2610-05-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,3-Naphthalenedisulfonic acid, 8-[[4′-[(4-ethoxyphenyl)azo] [1,1′-biphenyl]-4-yl]azo]-7-hydroxy-, disodium salt</ENT> <ENT>3530-19-6-</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1,3-Naphthalenedisulfonic acid, 8-[[4′-[4-ethoxyphenyl)azo]-3,3′-dimethyl] [1,1′-biphenyl]-4-yl]azo]-7-hydroxy-, disodium salt</ENT> <ENT>6358-29-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <PRTPAGE P="199"/> <ENT I="02">1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-[[4′-[[4-[[(4-methylphenyl) sulfonyl]oxy]phenyl]-azo] [1,1′-biphenyl]-4-yl]azo]-, disodium salt</ENT> <ENT>3567-65-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4′-(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)-azo] [1,1′-biphenyl]-4-yl]azo]-4-hydroxy-, trisodium salt</ENT> <ENT>2429-73-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′-[(2,4-diamino-5-methylphenyl)azo] [1,1′-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt</ENT> <ENT>2429-83-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′-[(2,4-diaminophenyl)azo] [1,1′-biphenyl]-4-yl]azo] 5-hydroxy-6-(phenylazo)-, disodium salt</ENT> <ENT>1937-37-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6[[4′-[(4-hydroxyphenyl)azo] [1,1′-biphenyl]-4-yl]-azo]-3-[(4-nitrophenyl)azo]-, disodium salt</ENT> <ENT>4335-09-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[[4′-[(4-hydroxyphenyl)azo] [1,1′-biphenyl]-4-yl]azo)-6-(phenylazo)-, disodium salt</ENT> <ENT>3626-28-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt</ENT> <ENT>2602-46-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt</ENT> <ENT>2429-74-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt</ENT> <ENT>72-57-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis-[4,5-dihydroxy-, tetrasodium salt</ENT> <ENT>2150-54-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalenesulfonic acid, 3-[[4′[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-4-hydroxy-, disodium salt</ENT> <ENT>6449-35-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalenesulfonic acid, 3,3′-[[1,1′-biphenyl]-4,4′-diyl-4,4′-diyl)bis(azo)]bis[(4-amino-,disodium salt</ENT> <ENT>573-58-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalenesulfonic acid, 3,3′-[3,3′-dimethoxy-[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-hydroxy-, disodium salt</ENT> <ENT>2429-71-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalenesulfonic acid, 3,3′-[(3,3′dimethyl[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-,disodium salt</ENT> <ENT>992-59-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">Chlorinated benzenes, mono-, di-, tri-, tetra-, and penta-</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, chloro-</ENT> <ENT>108-90-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2-dichloro-</ENT> <ENT>95-50-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,3-dichloro-</ENT> <ENT>541-73-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,4-dichloro-</ENT> <ENT>106-46-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, pentachloro-</ENT> <ENT>608-93-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2,3,4-tetrachloro-</ENT> <ENT>634-66-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2,3,5-tetrachloro-</ENT> <ENT>634-90-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2,4,5-tetrachloro-</ENT> <ENT>95-94-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2,3-trichloro-</ENT> <ENT>87-61-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2,4-trichloro-</ENT> <ENT>120-82-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,3,5-trichloro-</ENT> <ENT>108-70-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01"> Chlorinated naphthalenes—chlorinated derivatives of naphthalene (empirical formula) C <E T="52">10</E> H <E T="52">x</E> Cl <E T="52">y</E> where x = y = 8. </ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Naphthalene, chloro-</ENT> <ENT>25586-43-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Naphthalene, chloro derivatives</ENT> <ENT>70776-03-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Naphthalene, 1-chloro-</ENT> <ENT>90-13-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Naphthalene, heptachloro-</ENT> <ENT>32241-08-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01">Chlorinated paraffins—chlorinated paraffin oils and chlorinated paraffin waxes, with chlorine content of 35 percent through 70 percent by weight.</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Alkanes, chloro-</ENT> <ENT>61788-76-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Alkanes, C <E T="52">6-18</E> , chloro- </ENT> <ENT>68920-70-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Paraffin waxes and hydrocarbon waxes, chlorinated</ENT> <ENT>63449-39-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">Ethyltoluenes—This category consists of ethyltoluene (mixed isomers) and the ortho (1,2-), meta (1,3-) and para (1,4-) isomers</ENT> <ENT/> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-ethyl-2-methyl-</ENT> <ENT>611-14-3</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="01"> Fluoroalkenes—This category is defined as fluroalkenes of the general formula: C <E T="52">n</E> H <E T="52">2n-x</E> F <E T="52">x</E> where n equals 2 to 3 and X equals 1 to 6. </ENT> <ENT/> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">Ethene, tetrafluoro-</ENT> <ENT>116-14-3</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">Ethene, trifluoro-</ENT> <ENT>359-11-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>01/13/86</ENT> </ROW> <ROW> <ENT I="02">1-Propene, 1,1,2,3,3,3-hexafluoro-</ENT> <ENT>116-15-4</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="01">Glycidol (oxiranemethanol) and its derivatives</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="146"> <PRTPAGE P="200"/> <GID>716-106a.eps</GID> </GPH> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,12,10,10,11"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No. (examples for category)</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="11">R = H; alkyl, alkenyl or alkynyl; aryl; acyl. where R = alkyl, alkenyl, alkynyl, aryl, or acyl; any substituents or functional groups may be present with the alkyl, etc., groups</ENT> </ROW> <ROW> <ENT I="02">1,2-Cyclohexanedicarboxylic acid, bis(oxiranylmethyl) ester</ENT> <ENT>5493-45-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Disiloxane, 1,1,3,3-tetramethyl-1,3-bis[3-oxiranylmethoxy)propyl]-</ENT> <ENT>126-80-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,4-Imidazolidinedione, 5,5-dimethyl-3-[2-(oxiranylmethoxy)propyl]-1-(oxiranylmethyl)-</ENT> <ENT>32568-89-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2,4-Imidazolidenedione, 3,3′-[2-(oxiranylmethoxy)-1,3-propanediyl]bis[5,5-dimethyl-1-(oxiranyl-methyl)-</ENT> <ENT>38304-52-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Neodecanoic acid, oxiranylmethyl ester</ENT> <ENT>26761-45-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[1,4-butanediylbis(oxymethylene)]bis</ENT> <ENT>2425-79-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (butoxymethyl)-</ENT> <ENT>2426-08-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[1,4-cyclohexanedilbis (methyleneoxymethylene)]bis-</ENT> <ENT>14228-73-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(2,4-dibromophenoxy)methyl]-</ENT> <ENT>20217-01-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(1,2-dibromopropoxy)methyl]-</ENT> <ENT>35243-89-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(1,1-dimethylethoxy)methyl]-</ENT> <ENT>7665-72-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [[4-(1,1-dimethylethyl)phenoxy]methyl]-</ENT> <ENT>3101-60-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[(2,2-dimethyl-1,3-propanediyl)bis(oxymethylene)]bis-</ENT> <ENT>17557-23-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(dodecyloxy)methyl]-</ENT> <ENT>2461-18-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[1,2-ethanediylbis (oxymethylene)]bis-</ENT> <ENT>2224-15-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′,2″,2′′′-[1,2-ethanediylidenetetrakis-(4,1-phenyleneoxymethylene)]tetrakis-</ENT> <ENT>7328-97-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (ethoxymethyl)-</ENT> <ENT>4016-11-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [[(2-ethylhexyl)oxy]methyl]-</ENT> <ENT>2461-15-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(hexadecyloxy)methyl]-</ENT> <ENT>15965-99-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′,2″-[1,2,6-hexanetriyltris-(oxymethylene)]tris-</ENT> <ENT>68959-23-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (methoxymethyl)-</ENT> <ENT>930-37-0</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[methylenebis(phenyleneoxymethylene)]bis-</ENT> <ENT>39817-09-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[methylenebis(2,1-phenyleneoxymethylene)]bis-</ENT> <ENT>54208-63-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(1-methylethoxy)methyl]-</ENT> <ENT>4016-14-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyl-eneoxy[1-(butoxymethyl)-2,1-ethanediyl]oxymethylene]]bis-</ENT> <ENT>71033-08-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[1-methylethylidene) bis(4,1-phenyl-eneoxymethylene)]bis-</ENT> <ENT>1675-54-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[(1-methylethylidene)bis(4,1-phenyl-eneoxymethylene)[bis-, homopolymer</ENT> <ENT>25085-99-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyleneoxy-3,1-propanediyloxy-4,1-phenylene(1-methylethylidene)-4,1-phenyleneoxymethylene]]bis-</ENT> <ENT>72319-24-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(methylphenoxy)methyl]-</ENT> <ENT>26447-14-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(2-methylphenoxy)methyl]-</ENT> <ENT>2210-79-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [[4-(1-methyl-1-phenylethyl)phenoxy]-methyl]-</ENT> <ENT>61578-04-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, mono[C <E T="52">6</E> -C <E T="52">12</E> -alkyloxy)methyl]derivatives </ENT> <ENT>68987-80-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, mono[(C <E T="52">8</E> -C <E T="52">12</E> -alkyloxy)methyl]derivatives </ENT> <ENT>68609-96-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, mono[C <E T="52">10</E> -C <E T="52">16</E> -alkyloxy)methyl]derivatives </ENT> <ENT>68081-84-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, mono[(C <E T="52">10</E> -C <E T="52">14</E> -alkyloxy)methyl]derivatives </ENT> <ENT>68609-97-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(4-nitrophenoxy)methyl]-</ENT> <ENT>5255-75-4</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <PRTPAGE P="201"/> <ENT I="02">Oxirane, [(4-nonylphenoxy)methyl]-</ENT> <ENT>6178-32-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, [(9-octadecenyloxy)methyl]-, ( <E T="03">Z</E> )- </ENT> <ENT>60501-41-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(octadecyloxy)methyl]-</ENT> <ENT>16245-97-9</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-(oxiranylmethoxy)-1,3-phenylene]bis(methylene)]bis-</ENT> <ENT>13561-08-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[[[2-oxiranylmethyoxy) phenyl]methylene]bis(4,1-phenyl-eneoxymethylene)]bis-</ENT> <ENT>67786-03-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[oxybis(methylene)]bis-</ENT> <ENT>2238-07-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (phenoxymethyl)-</ENT> <ENT>122-60-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[1,3-phenylenebis (oxymethylene)]bis-</ENT> <ENT>2425-01-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, 2,2′-[1,4-phenylenebis (oxymethylene)]bis-</ENT> <ENT>101-90-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, 2,2′,2 <FR>1/4</FR> -[1,2,3-propanetriyl tris(oxymethylene)]tris- </ENT> <ENT>13236-02-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(2-propenyloxy)methyl]-</ENT> <ENT>106-92-3</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02"> Oxirane, 2,2′,2 <FR>1/4</FR> -[propylidynetris (4,1-phenyleneoxymethylene)]tris- </ENT> <ENT>68517-02-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(tetradecyloxy)methyl]-</ENT> <ENT>38954-75-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Oxiranecarboxylic acid, 3-methyl-3-phenyl-, ethyl ester</ENT> <ENT>77-83-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Poly(oxy-1,2-ethanediyl),-α-[4-oxiranylmethyoxy)benzoyl]-ω-[[4-oxiranylmethoxy)benzoyl]oxy]-</ENT> <ENT>69943-75-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-methyl-, oxiranylmethyl ester</ENT> <ENT>106-91-2</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, oxiranylmethyl ester</ENT> <ENT>106-90-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Silane, [(3-chloropropyl)(dimethoxy)[3-(oxiranylmethoxy)propyl]-</ENT> <ENT>71808-64-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Silane, diethoxymethyl[3-(oxiranyl-methoxy)propyl]-</ENT> <ENT>2897-60-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Silane, ethoxydimethyl[3-(oxiranyl-methoxy)propyl]-</ENT> <ENT>17963-04-1</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Silane, trimethyoxy[3-(oxiranyl-methoxy)propyl]-</ENT> <ENT>2530-83-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Tetrasiloxane, 1,1,1,3,5,7,7,7-octamethyl-3,5-bis[3-(oxiranylmethoxy)propyl]-</ENT> <ENT>69155-42-6</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="02">Trisiloxane, 1,1,1,3,5,5,5-heptamethyl-3-[3-(oxiranyl-methoxy)propyl]-</ENT> <ENT>7422-52-8</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>10/04/92</ENT> </ROW> <ROW> <ENT I="01">Halogenated alkyl epoxides—halogenated noncyclic aliphatic hydrocarbons with one or more epoxy functional groups.</ENT> <ENT/> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="143"> <GID>716-106a.eps</GID> </GPH> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,12,10,10,11"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No. (examples for category)</CHED> <CHED H="1">Special exemptions</CHED> <CHED H="1">Effective date</CHED> <CHED H="1">Sunset date</CHED> </BOXHD> <ROW> <ENT I="11"> R <E T="52">1</E> = X or C <E T="52">n</E> H <E T="52">2n = 1−y</E> X <E T="52">y</E> (y = 1 to 1n = 1) </ENT> <ENT/> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="11"> R <E T="52">2</E> = H or X or C <E T="52">n</E> H <E T="52">2n = 1−y</E> X <E T="52">y</E> (y = 0 to 2n = 1) </ENT> <ENT/> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="11"> R <E T="52">3</E> = H or X or C <E T="52">n</E> H <E T="52">2n = 1−y</E> X <E T="52">y</E> (y = 0 to 2n = 1) </ENT> <ENT/> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="11"> R <E T="52">4</E> = H or X or C <E T="52">n</E> H <E T="52">2n = 1−y</E> X <E T="52">y</E> (y = 0 to 2n = 1) </ENT> <ENT/> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="11"> X = halogen. Groups R <E T="52">1</E> -R <E T="52">4</E> may contain one or more expoxide functions. </ENT> </ROW> <ROW> <ENT I="01">Lead and lead compounds</ENT> <ENT/> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Lead</ENT> <ENT>7439-92-1</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Acetic acid, lead (2 + ) salt</ENT> <ENT>301-04-2</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <PRTPAGE P="202"/> <ENT I="02">Carbonic acid, lead (2 + ) salt (1:1)</ENT> <ENT>598-63-0</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02"> Lead chloride (PbCl <E T="52">2 </E> ) </ENT> <ENT>7758-95-4</ENT> <ENT>§ 716.21 (a) (8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02"> Chromic acid (H <E T="52">2 </E> Cr0 <E T="52">4 </E> ), lead (2 + ) salt (1:1) </ENT> <ENT>7758-97-6</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02"> Lead oxide (PbO <E T="52">2</E> ) </ENT> <ENT>1309-60-0</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptyl)-</ENT> <ENT>38565-52-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Borate (1-), tetrafluoro-, lead (2 + ) (2:1)</ENT> <ENT>13814-96-5</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, lead (2 + ) salt (2:3)</ENT> <ENT>7446-27-7</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Silicic acid, lead salt, basic</ENT> <ENT>53466-66-3</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Octadecanoic acid, lead salt (1:?)</ENT> <ENT>7428-48-0</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Sulfuric acid, lead salt (1:?), basic</ENT> <ENT>63653-42-9</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (bromomethyl)-</ENT> <ENT>3132-463-7</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Oxirane, (2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptyl)-</ENT> <ENT>38565-52-5</ENT> <ENT/> <ENT>10/04/82</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Lead sulfide (PbS)</ENT> <ENT>1314-8 7-0</ENT> <ENT>§ 716.21 (a)(8)</ENT> <ENT>February 28, 2008</ENT> <ENT>April 28, 2008</ENT> </ROW> <ROW> <ENT I="02">Phenylenediamines (Benzenediamines). This category is defined as all nitrogen unsubstituted phenylenediamines and their salts with zero to two substitutents on the ring selected from the same of different members of the group of halo, nitro, hydroxy, hydroxy-lower alkoxy, lower-alkyl, and lower alkoxy. For this purpose, the term “lower” is defined as a group containing between one and four carbons.</ENT> <ENT/> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine</ENT> <ENT>95-54-5</ENT> <ENT/> <ENT>4/29/83</ENT> <ENT>4/29/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine</ENT> <ENT>108-45-2</ENT> <ENT/> <ENT>4/29/83</ENT> <ENT>4/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2 - Benzenediamine, 4-butyl-</ENT> <ENT>3663-23-8</ENT> <ENT/> <ENT>4/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,2 - Benzenediamine, 4-butyl-</ENT> <ENT>95-83-0</ENT> <ENT/> <ENT>4/29/83</ENT> <ENT>4/29/83</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-chloro-</ENT> <ENT>5131-60-2</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-chloro-, dihydrochloride</ENT> <ENT>615-46-3</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 5-chloro-3-nitro-</ENT> <ENT>42389-30-0</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-chloro-, sulfate (1:1)</ENT> <ENT>68459-98-3</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-chloro-, sulfate (1:1)</ENT> <ENT>68239-80-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-chloro-, sulfate</ENT> <ENT>6219-71-2</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2,5-dichloro-</ENT> <ENT>20103-09-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, dihydrochloride</ENT> <ENT>615-28-1</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, dihydrochloride</ENT> <ENT>541-69-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, dihydrochloride</ENT> <ENT>624-18-0</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, ethanedioate (1:1)</ENT> <ENT>62654-17-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-ethoxy-</ENT> <ENT>1197-37-1</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-ethoxy-dihydrochloride</ENT> <ENT>67801-06-3</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1)</ENT> <ENT>68015-98-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02"> 1,3-Benzenediamine, <E T="03">ar</E> -ethyl- <E T="03">ar-</E> methyl- </ENT> <ENT>68966-84-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-methoxy</ENT> <ENT>5307-02-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-methoxy-, dihydrochloride</ENT> <ENT>614-94-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-methoxy-, sulfate</ENT> <ENT>6219-67-6</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-methoxy-, sulfate (1:1)</ENT> <ENT>39156-41-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02"> Benzenediamine, <E T="03">ar</E> -methyl- </ENT> <ENT>25376-45-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 3-methyl-</ENT> <ENT>2687-25-4</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-methyl-</ENT> <ENT>496-72-0</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 2-methyl-</ENT> <ENT>823-40-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-methyl-</ENT> <ENT>95-80-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 5-methyl-</ENT> <ENT>108-71-4</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-methyl-</ENT> <ENT>95-70-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-methyl-, dihydrochloride-</ENT> <ENT>615-45-2</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-methyl-, sulfate</ENT> <ENT>6369-59-1</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-methyl-, sulfate (1:1)</ENT> <ENT>615-50-9</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-nitro-</ENT> <ENT>99-56-9</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 4-nitro-,</ENT> <ENT>5131-58-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, 5-nitro-,</ENT> <ENT>5042-55-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-nitro-,</ENT> <ENT>5307-14-2</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-nitro-, dihydrochloride</ENT> <ENT>6219-77-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-nitro-, dihydrochloride</ENT> <ENT>18266-52-9</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenediamine, 4-nitro-, sulfate (1:1)</ENT> <ENT>68239-82-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenediamine, 2-nitro-, sulfate (1:1)</ENT> <ENT>68239-83-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenediamine, sulfate (1:1)</ENT> <ENT>541-70-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <PRTPAGE P="203"/> <ENT I="02">1,4-Benzenediamine, sulfate (1:1)</ENT> <ENT>16245-77-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-(2,4-diaminophenoxy)-, dihydrochloride</ENT> <ENT>66422-95-5</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4-diamino-, dihydrochloride</ENT> <ENT>137-09-7</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>04/29/93</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4-diamino-6-methyl-</ENT> <ENT>15872-73-8</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4-diamino-6-methyl-, hydrochloride</ENT> <ENT>65879-44-9</ENT> <ENT/> <ENT>04/29/83</ENT> <ENT>12/29/88</ENT> </ROW> </GPOTABLE> <P> (d) <E T="03">Listed members of categories.</E> The following categories are listed in alphabetical order with the chemical substances identified in each category also listed alphabetically. Only those chemical substances specifically listed within a category are subject to all provisions of part 716 for the time period from the effective date of the rule until the sunset date. </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s90,r50,r45,r30,r30"> <BOXHD> <CHED H="1">Category</CHED> <CHED H="1">CAS No.</CHED> <CHED H="1">Special Exemptions</CHED> <CHED H="1">Effective Date</CHED> <CHED H="1">Sunset Date</CHED> </BOXHD> <ROW> <ENT I="01">Aldehydes:</ENT> </ROW> <ROW> <ENT I="02">Acetaldehyde</ENT> <ENT>75-07-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Acetaldehyde, chloro-</ENT> <ENT>107-20-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> Acetaldehyde, (1,3-dihydro-1,3,3-trimethyl-2 <E T="03">H</E> -indol-2-ylidene) </ENT> <ENT>84-83-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Acetaldehyde, trichloro-</ENT> <ENT>75-87-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde</ENT> <ENT>100-52-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 3-bromo-</ENT> <ENT>3132-99-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-butyl-</ENT> <ENT>1200-14-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2-chloro-</ENT> <ENT>89-98-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-chloro-</ENT> <ENT>104-88-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-(diethylamino)-</ENT> <ENT>120-21-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-(diethylamino)-2-hydroxy-</ENT> <ENT>17754-90-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2,4-dihydroxy-</ENT> <ENT>95-01-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2,5-dimethoxy-</ENT> <ENT>93-02-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 3,4-dimethoxy-</ENT> <ENT>120-14-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, (dimethylamino)-</ENT> <ENT>28602-27-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-(dimethylamino)-</ENT> <ENT>100-10-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-ethoxy-</ENT> <ENT>10031-82-0</ENT> <ENT/> <ENT>l9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 3-ethoxy-4-hydroxy-</ENT> <ENT>121-32-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2-hydroxy-</ENT> <ENT>90-02-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-hydroxy-</ENT> <ENT>123-08-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-hydroxy-3-methoxy-</ENT> <ENT>121-33-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2-hydroxy-5-nitro-</ENT> <ENT>97-51-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2-methoxy-</ENT> <ENT>135-02-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-methoxy-</ENT> <ENT>123-11-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, methyl-</ENT> <ENT>1334-78-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-methyl-</ENT> <ENT>104-87-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 2-nitro-</ENT> <ENT>552-89-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 3-phenoxy-</ENT> <ENT>39515-51-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-(trifluoromethyl)-</ENT> <ENT>455-19-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzeneacetaldehyde</ENT> <ENT>122-78-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzeneacetaldehyde, alpha-methyl-</ENT> <ENT>93-53-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzeneacetaldehyde, 4-methyl-</ENT> <ENT>104-09-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzenepropanal, 4-(1,1-dimethylethyl)-.α.-methyl-</ENT> <ENT>80-54-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzenepropanal, .α.-methyl-4-(1-methylethyl)-</ENT> <ENT>103-95-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzodioxole-5-carboxaldehyde</ENT> <ENT>120-57-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzodioxole-5-carboxaldehyde, 7-methoxy-</ENT> <ENT>5780-07-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Butanal, 3-methyl-</ENT> <ENT>590-86-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Cyclohexene-1-carboxaldehyde</ENT> <ENT>100-50-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Cyclohexene-1-carboxaldehyde, dimethyl-</ENT> <ENT>27939-60-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 4-(4-hydroxy-4-methylpentyl)-</ENT> <ENT>31906-04-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methyl-3-pentenyl)-</ENT> <ENT>52475-86-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methylpentyl)-</ENT> <ENT>66327-54-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 4-(4-methyl-3-pentenyl)-</ENT> <ENT>37677-14-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <PRTPAGE P="204"/> <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 2,4,6-trimethyl-</ENT> <ENT>1423-46-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">3-Cyclopentene-1-acetaldehyde, 2,2,3-trimethyl-</ENT> <ENT>4501-58-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Decanal</ENT> <ENT>112-31-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> 4a(4 <E T="03">H</E> )-Dibenzofurancarboxaldehyde, 1,5a,6,9,9a,9b-hexahydro- </ENT> <ENT>126-15-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dodecanal</ENT> <ENT>112-54-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Ethanedial</ENT> <ENT>107-22-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Heptanal</ENT> <ENT>111-71-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Heptanal, 2-(phenylmethylene)-</ENT> <ENT>122-40-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">5-Heptenal, 2,6-dimethyl-</ENT> <ENT>106-72-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Hexanal, 2-ethyl-</ENT> <ENT>123-05-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexanal, 3,5,5-trimethyl-</ENT> <ENT>5435-64-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Hexenal</ENT> <ENT>505-57-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Hexenal, 2-ethyl-</ENT> <ENT>26266-68-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01" O="xl">Indium Compounds:</ENT> </ROW> <ROW> <ENT I="01"> Acetic acid, indium(3 + ) salt</ENT> <ENT>25114-58-3</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Indium</ENT> <ENT>7440-74-6</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Indium chloride (InCl3)</ENT> <ENT>10025-82-8</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Indium hydroxide (In(OH)3)</ENT> <ENT>20661-21-6</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Indium oxide (In2O3)</ENT> <ENT>1312-43-2</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Indium phosphide (InP)</ENT> <ENT>22398-80-7</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Indium tin oxide</ENT> <ENT>50926-11-9</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Sulfamic acid, indium(3 + ) salt</ENT> <ENT>66027-93-8</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="01"> Sulfuric acid, indium(3 + ) salt (3:2)</ENT> <ENT>13464-82-9</ENT> <ENT O="xl">§ 716.21(a)(6)</ENT> <ENT O="xl">6/3/04</ENT> <ENT O="xl">8/2/04</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalene carboxaldehyde</ENT> <ENT>66-77-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Nonanal</ENT> <ENT>124-19-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2,6-Octadienal, 3,7-dimethyl-, (E)</ENT> <ENT>141-27-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2,6-Octadienal, 3,7-dimethyl-, (Z)</ENT> <ENT>106-26-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Octanal</ENT> <ENT>124-13-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Octanal, 3,7-dimethyl-</ENT> <ENT>5988-91-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Octanal, 7-hydroxy-3,7-dimethyl-</ENT> <ENT>107-75-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Octanal, 7-methoxy-3,7-dimethyl-</ENT> <ENT>3613-30-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Octanal, 2-(phenylmethylene)-</ENT> <ENT>101-86-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">6-Octenal, 3,7-dimethyl-</ENT> <ENT>106-23-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">6-Octenal, 3,7-dimethyl-, (S)-</ENT> <ENT>5949-05-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Pentanal</ENT> <ENT>110-62-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Pentanedial</ENT> <ENT>111-30-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1-Piperidinecarboxaldehyde</ENT> <ENT>2591-86-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Propanal</ENT> <ENT>123-38-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Propanal, 3-hydroxy-2,2-dimethyl-</ENT> <ENT>597-31-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 2-methyl-</ENT> <ENT>78-85-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Propanal, 3-(methylthio)-</ENT> <ENT>3268-49-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal</ENT> <ENT>107-02-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 3- 4-(1,1-dimethylethyl)phenyl -2-methyl-</ENT> <ENT>13586-68-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 3-(2-methoxyphenyl)-</ENT> <ENT>1504-74-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 2-methyl-</ENT> <ENT>78-85-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 2-methyl-3-phenyl-</ENT> <ENT>101-39-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 3-phenyl-</ENT> <ENT>104-55-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Propenal, 3-phenyl-, monopentyl deriv.</ENT> <ENT>1331-92-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Pyridinecarboxaldehyde</ENT> <ENT>1121-60-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Thiophene carboxaldehyde</ENT> <ENT>98-03-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Undecanal</ENT> <ENT>112-44-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Undecanal, 2-methyl-</ENT> <ENT>110-41-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">9-Undecenal</ENT> <ENT>143-14-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">10-Undecenal</ENT> <ENT>112-45-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">Alkyl-, Chloro-, and Hydroxymethyl Diaryl Ethers:</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-(bromomethyl)-3-phenoxy-</ENT> <ENT>51632-16-7</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzenemethanol, 3-phenoxy-,</ENT> <ENT>13826-35-2</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzenemethanol, 3-phenoxy-, acetate</ENT> <ENT>50789-44-1</ENT> <ENT/> <ENT>4/12/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-methyl-3-phenoxy-</ENT> <ENT>3586-14-9</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1′-oxybis[dodecyl-</ENT> <ENT>69834-19-1</ENT> <ENT/> <ENT>4/12/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1,′-oxybis[methyl-</ENT> <ENT>28299-41-4</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1′-oxybis[(1,1,3,3-tetramethylbutyl)-</ENT> <ENT>61702-88-3</ENT> <ENT/> <ENT>4/12/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-,</ENT> <ENT>63734-62-3</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy], potassium salt</ENT> <ENT>72242-48-3</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <PRTPAGE P="205"/> <ENT I="02">1,1′-Biphenyl, phenoxy-</ENT> <ENT>28984-89-6</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Chloro-1-(3-methylphenoxy)-4-(trifluoromethyl)benzene</ENT> <ENT>42874-96-4</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">1,4-Diphenoxybenzene</ENT> <ENT>3061-36-7</ENT> <ENT/> <ENT>4/12/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Phenol, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, acetate</ENT> <ENT>50594-77-9</ENT> <ENT/> <ENT>04/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">Alkyl Phosphates:</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-butoxy-, phosphate (3:1)</ENT> <ENT>78-51-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-(2-butoxyethoxy)-, phosphate (3:1)</ENT> <ENT>7332-46-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, bis(2-ethylhexyl) ester</ENT> <ENT>298-07-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, dibutyl ester</ENT> <ENT>107-66-4</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, didodecyl ester</ENT> <ENT>7057-92-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, diisooctyl ester</ENT> <ENT>27215-10-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, dodecyl ester</ENT> <ENT>12751-23-4</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, 2-ethylhexyl ester</ENT> <ENT>12645-31-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, monobutyl ester</ENT> <ENT>1623-15-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, mono(2-ethylhexyl)ester</ENT> <ENT>1070-03-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, monohexyl ester</ENT> <ENT>3900-04-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, monomethyl ester</ENT> <ENT>812-00-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, mono(1-methylethyl)ester</ENT> <ENT>1623-24-1</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, monooctyl ester</ENT> <ENT>3991-73-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, monooctadecyl ester</ENT> <ENT>2958-09-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, triethyl ester</ENT> <ENT>78-40-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, tris(2-ethylhexyl) ester</ENT> <ENT>78-42-2</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, tris(2-methylpropyl) ester</ENT> <ENT>126-71-6</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phosphorodichloridic acid, ethyl ester</ENT> <ENT>1498-51-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">Alkylphenols and Alkylphenol Ethoxyates:</ENT> </ROW> <ROW> <ENT I="02">tert-Butylphenol (mixed isomers)</ENT> <ENT>27178-34-3</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Butylphenol</ENT> <ENT>3180-09-4</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-tert-Butylphenol</ENT> <ENT>88-18-6</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-n-Butylphenol</ENT> <ENT>1638-22-8</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-sec-Butylphenol</ENT> <ENT>99-71-8</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-tert-Butylphenol</ENT> <ENT>98-54-4</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Decaethylene glycol 4-isoctylphenyl ether</ENT> <ENT>2315-66-4</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-Dodecylphenol</ENT> <ENT>104-43-8</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dodecylphenol (mixed isomers)</ENT> <ENT>1331-57-3</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dedecylphenol (mixed isomers)</ENT> <ENT>27193-86-8</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexaethylene glycol 4-isoctylphenyl ether</ENT> <ENT>2497-58-7</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Isobutylphenol (mixed isomers)</ENT> <ENT>31195-95-6</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Isononylphenol (mixed isomers)</ENT> <ENT>11066-49-2</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-(1-Methylbutyl)phenol</ENT> <ENT>94-06-4</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">(1-Methylheptyl)phenol (mixed isomers)</ENT> <ENT>27985-70-2</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-(1-Methyloctyl)phenol</ENT> <ENT>17404-66-9</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Nonylphenol (mixed isomers)</ENT> <ENT>1300-16-9</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="22"/> <ENT>25154-52-3</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-Nonylphenol</ENT> <ENT>104-40-5</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Branched 4-nonylphenol (mixed isomers)</ENT> <ENT>84852-15-3</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Octylphenol</ENT> <ENT>949-13-3</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-Octylphenol</ENT> <ENT>1806-26-4</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-Pentylphenol</ENT> <ENT>14938-35-3</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-tert-Pentylphenol</ENT> <ENT>80-46-6</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Polyethylene glycol mono(octyl)phenyl ether</ENT> <ENT>9036-19-5</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Polyethylene glycol 4-(tert-octyl)phenyl ether</ENT> <ENT>9002-93-1</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Poly(oxy-1,2-ethanediyl), α-(octylphenyl)-ω-hydroxy-, branched</ENT> <ENT>68987-90-6</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-(1,1,3,3-Tetramethylbutyl)phenol</ENT> <ENT>3884-95-5</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT> <ENT>1322-69-6</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>27193-28-8</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>29932-96-5</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>30105-54-5</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>62744-41-6</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-(2,2,3,3-Tetramethylbutyl)phenol</ENT> <ENT>54932-78-4</ENT> <ENT>§ 716.20(b)(4) applies</ENT> <ENT>3/29/96</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">Brominated flame retardants:</ENT> </ROW> <ROW> <ENT I="02">Alkanes, C10-18, bromochloro-</ENT> <ENT>68955-41-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <PRTPAGE P="206"/> <ENT I="02">Benzamide, 3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-</ENT> <ENT>87-10-5</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Benzene, ethenyl-, homopolymer, brominated</ENT> <ENT>88497-56-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1′-(1-methylethylidene)bis (3,5-dibromo-4-(2-propenyloxy)-</ENT> <ENT>25327-89-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, pentabromomethyl-</ENT> <ENT>87-83-2</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, 1,2,3,4,5-pentabromo-6-chloro-</ENT> <ENT>87-84-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, tetrabromodichloro-</ENT> <ENT>30554-72-4</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, tribromotrichloro-</ENT> <ENT>30554-73-5</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2,2′-((1-methylethylidene)bis ((2,6-dibromo-4,1-phenylene)oxy)) bis-</ENT> <ENT>4162-45-2</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Ethene, bromo-</ENT> <ENT>593-60-2</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4-dibromo-</ENT> <ENT>615-58-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4(or 2,6)-dibromo-,homopolymer</ENT> <ENT>69882-11-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1-Propanol, 2,3-dibromo-</ENT> <ENT>96-13-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1-Propanol, 2,2-dimethyl-,tribromo deriv</ENT> <ENT>36483-57-5</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid,(1-methylethylidene)bis (2,6-dibromo-4,1-phenylene) ester</ENT> <ENT>55205-38-4</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">Chloroalkyl phosphates:</ENT> </ROW> <ROW> <ENT I="02">2,2-Bis(chloromethyl)-1,3-propanediyltetrakis(2-chloroethyl) phosphate</ENT> <ENT>38051-10-4</ENT> <ENT/> <ENT>6/14/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Chloro-1-methylethylbis(2-chloropropyl) phosphate-</ENT> <ENT>76649-15-5</ENT> <ENT/> <ENT>6/14/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1,2-Ethanediyl tetrakis(2-chloro-1-methylethylene) phosphate</ENT> <ENT>34621-99-3</ENT> <ENT/> <ENT>6/14/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Oxydi-2,1-ethanediyltetrakis(2-choloroethyl) phosphate</ENT> <ENT>53461-82-8</ENT> <ENT/> <ENT>6/14/93</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">Cyanoacrylates:</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, methyl ester</ENT> <ENT>137-05-3</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, isobutyl ester</ENT> <ENT>1069-55-2</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester</ENT> <ENT>6197-30-4</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, butyl ester</ENT> <ENT>6606-65-1</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, ethyl ester</ENT> <ENT>7085-85-0</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, 2-propenyl ester</ENT> <ENT>7324-02-9</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, 1-methylethyl ester</ENT> <ENT>10586-17-1</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, ethoxy ethyl ester</ENT> <ENT>21982-43-4</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, 2,2,2-trifluoromethyl ester</ENT> <ENT>23023-91-8</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-cyano-, 2-methoxyethyl ester</ENT> <ENT>27816-23-5</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Ethanaminium, 2-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxo-2-propenyl]oxy]-N,N,N-trimethyl-, chloride</ENT> <ENT>64992-16-1</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="22">High-Priority Substances:</ENT> </ROW> <ROW> <ENT I="02">1,3-Butadiene</ENT> <ENT>106-99-0</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Butyl benzyl phthalate (BBP)—1,2-Benzene-dicarboxylic acid, 1-butyl 2(phenylmethyl) ester</ENT> <ENT>85-68-7</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Dibutyl phthalate (DBP) (1,2-Benzene-dicarboxylic acid, 1,2-dibutyl ester)</ENT> <ENT>84-74-2</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">o-Dichlorobenzene</ENT> <ENT>95-50-1</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">p-Dichlorobenzene</ENT> <ENT>106-46-7</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">1,1-Dichloroethane</ENT> <ENT>75-34-3</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">1,2-Dichloroethane</ENT> <ENT>107-06-2</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Trans-1,2-Dichloroethylene</ENT> <ENT>156-60-5</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">1,2-Dichloropropane</ENT> <ENT>78-87-5</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Dicyclohexyl phthalate</ENT> <ENT>84-61-7</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Di-ethylhexyl phthalate (DEHP)—(1,2-Benzene-dicarboxylic acid, 1,2-bis(2-ethylhexyl) ester)</ENT> <ENT>117-81-7</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <PRTPAGE P="207"/> <ENT I="02">Di-isobutyl phthalate (DIBP)—(1,2-Benzene-dicarboxylic acid, 1,2-bis-(2methylpropyl) ester)</ENT> <ENT>84-69-5</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Ethylene dibromide</ENT> <ENT>106-93-4</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Formaldehyde</ENT> <ENT>50-00-0</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta [g]-2-benzopyran (HHCB)</ENT> <ENT>1222-05-5</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">4,4′-(1-Methylethylidene)bis[2,6-dibromophenol] (TBBPA)</ENT> <ENT>79-94-7</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, triphenyl ester (TPP)</ENT> <ENT>115-86-6</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Phthalic anhydride</ENT> <ENT>85-44-9</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">1,1,2-Trichloroethane</ENT> <ENT>79-00-5</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="02">Tris(2-chloroethyl) phosphate (TCEP)</ENT> <ENT>115-96-8</ENT> <ENT>§  716.21(a)(9)</ENT> <ENT>7/29/21</ENT> <ENT>12/01/21</ENT> </ROW> <ROW> <ENT I="01" O="xl">Indium Compounds:</ENT> </ROW> <ROW> <ENT I="02">Acetic acid, indium(3 + ) salt</ENT> <ENT>25114-58-3</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Indium</ENT> <ENT>7440-74-6</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Indium chloride (InCl3)</ENT> <ENT>10025-82-8</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Indium hydroxide (In(OH)3)</ENT> <ENT>20661-21-6</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Indium oxide (In2O3)</ENT> <ENT>1312-43-2</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Indium phosphide (InP)</ENT> <ENT>22398-80-7</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Indium tin oxide</ENT> <ENT>50926-11-9</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Sulfamic acid, indium(3 + ) salt</ENT> <ENT>66027-93-8</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="02">Sulfuric acid, indium(3 + ) salt (3:2)</ENT> <ENT>13464-82-9</ENT> <ENT>§ 716.21(a)(6)</ENT> <ENT>6/3/04</ENT> <ENT>8/2/04</ENT> </ROW> <ROW> <ENT I="01">IRIS Chemicals:</ENT> </ROW> <ROW> <ENT I="02">3,4-Dimethylphenol</ENT> <ENT>95-65-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2,4-Dinitrophenol</ENT> <ENT>51-28-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">Isocyanates:</ENT> </ROW> <ROW> <ENT I="02">Acetic acid, isocyanato-, ethyl ester</ENT> <ENT>2949-22-6</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, bis(isocyanatomethyl)-</ENT> <ENT>25854-16-4</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-bromo-4-isocyanato-</ENT> <ENT>2493-02-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-chloro-3-isocyanato-</ENT> <ENT>2909-38-8</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-chloro-4-isocyanato-</ENT> <ENT>104-12-1</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2-dichloro-4-isocyanato-</ENT> <ENT>102-36-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,3-dichloro-5-isocyanato-</ENT> <ENT>34893-92-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1′-(diisocyanatomethylene)bis-</ENT> <ENT>10031-75-1</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, isocyanato-</ENT> <ENT>103-71-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzene, 2-isocyanato-1,3-bis(1-methylethyl)-</ENT> <ENT>28178-42-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 2-isocyanato-1,3-dimethyl-, ester</ENT> <ENT>28556-81-2</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-isocyanato-2-methyl-</ENT> <ENT>614-68-6</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-isocyanato-4-methyl-</ENT> <ENT>622-58-2</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-isocyanato-4-nitro-</ENT> <ENT>100-28-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-isocyanato-3-(trifluoromethyl)-</ENT> <ENT>329-01-1</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1′,1″-methylidynetris(4-isocyanato-</ENT> <ENT>2422-91-5</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Butane, 1-isocyanato-</ENT> <ENT>111-36-4</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, 2-heptyl-3,4-bis (9-isocyanatononyl)-1-pentyl-</ENT> <ENT>68239-06-5</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, isocyanato-</ENT> <ENT>3173-53-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">1,3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanato methylphenyl)-</ENT> <ENT>26747-90-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Ethane, isocyanato-</ENT> <ENT>109-90-0</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Imidodicarbonic diamide, N,N′-2-tris(6-isocyanatohexyl)-</ENT> <ENT>4035-89-6</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Methane, isocyanato-</ENT> <ENT>624-83-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Octadecane, 1-isocyanato-</ENT> <ENT>112-96-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Phenol, 4-isocyanato-, phosphorothioate (3:1) (ester)</ENT> <ENT>4151-51-3</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">Propane, 1-isocyanato-</ENT> <ENT>110-78-1</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">1-Propene, 3-isocyanato-</ENT> <ENT>1476-23-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-methyl-, 2- isocyanatoethyl ester</ENT> <ENT>30674-80-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-methyl-2-(((((5-isocyanato-1,3,3-trimethylcyclohexyl)methyl)amino) carbonyl)oxy)ethyl ester</ENT> <ENT>73597-26-9</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="02">1,3,5,-Triazine-2,4,6(1H.3H.5H-trione, 1,3,5-tris(3-isocyanatomethylphenyl)-</ENT> <ENT>26603-40-7</ENT> <ENT/> <ENT>10/29/90</ENT> <ENT>11/09/93</ENT> </ROW> <ROW> <ENT I="01">Methyl ethylene glycol ethers and esters:</ENT> </ROW> <ROW> <ENT I="02">Ethylene glycol monomethy ether acrylate</ENT> <ENT>3121-61-7</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <PRTPAGE P="208"/> <ENT I="02">Tetraethylene glycol monomethyl ether</ENT> <ENT>23783-42-8</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="22">Organohalogen flame retardants:</ENT> </ROW> <ROW> <ENT I="02">Bis(2-ethylhexyl) tetrabromophthalate</ENT> <ENT>26040-51-7</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Bis(hexachlorocyclopentadieno) cyclooctane</ENT> <ENT>13560-89-9</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">1,2-Bis(2,4,6-tribromophenoxy)ethane</ENT> <ENT>37853-59-1</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">1,1′-Ethane-1,2-diylbis(pentabromobenzene)</ENT> <ENT>84852-53-9</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">2-Ethylhexyl-2,3,4,5-tetrabromobenzoate</ENT> <ENT>183658-27-7</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">2-(2-Hydroxyethoxy)ethyl 2-hydroxypropyl 3,4,5,6-tetrabromophthalate</ENT> <ENT>20566-35-2</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">2,2′-[(1-Methylethylidene)bis[(2,6-dibromo-4,1-phenylene)oxymethylene]]bis[oxirane]</ENT> <ENT>3072-84-2</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Mixture of chlorinated linear alkanes C14-17 with 45-52% chlorine</ENT> <ENT>85535-85-9</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">N,N-Ethylene-bis(tetrabromophthalimide)</ENT> <ENT>32588-76-4</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Pentabromochlorocyclohexane</ENT> <ENT>87-84-3</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">(Pentabromophenyl)methyl acrylate</ENT> <ENT>59447-55-1</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Pentabromotoluene</ENT> <ENT>87-83-2</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Perbromo-1,4-diphenoxybenzene</ENT> <ENT>58965-66-5</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Phosphonic acid, (2-chloroethyl)-, bis(2-chloroethyl) ester</ENT> <ENT>6294-34-4</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, 2,2-bis(chloromethyl)-1,3-propanediyl tetrakis(2-chloroethyl) ester</ENT> <ENT>38051-10-4</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Propanoic acid, 2-bromo-, methyl ester</ENT> <ENT>5445-17-0</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tetrabromobisphenol A-bis(2,3-dibromopropyl ether)</ENT> <ENT>21850-44-2</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tetrabromobisphenol A bis(2-hydroxyethyl) ether</ENT> <ENT>4162-45-2</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tetrabromobisphenol A diallyl ether</ENT> <ENT>25327-89-3</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tetrabromobisphenol A dimethyl ether</ENT> <ENT>37853-61-5</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">2,4,6-Tribromoaniline</ENT> <ENT>147-82-0</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Tribromo-2-(prop-2-en-1-yloxy)benzene</ENT> <ENT>3278-89-5</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tris(2-chloroethyl)phosphite</ENT> <ENT>140-08-9</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tris(1-chloro-2-propyl)phosphate</ENT> <ENT>13674-84-5</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tris(2-chloro-1-propyl)phosphate</ENT> <ENT>6145-73-9</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tris(2,3-dibromopropyl)phosphate</ENT> <ENT>126-72-7</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Tris(2,3-dibromopropyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione</ENT> <ENT>52434-90-9</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tris(1,3-dichloro-2-propyl)phosphate</ENT> <ENT>13674-87-8</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">Tris(tribromoneopentyl)phosphate</ENT> <ENT>19186-97-1</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="02">2,4,6-Tris-(2,4,6-tribromophenoxy)-1,3,5-triazine</ENT> <ENT>25713-60-4</ENT> <ENT>§  716.21(a)(10)</ENT> <ENT>7/29/21</ENT> <ENT>1/25/22</ENT> </ROW> <ROW> <ENT I="01">OSHA Chemicals in Need of Dermal Absorption Testing:</ENT> </ROW> <ROW> <ENT I="02">Amitrole</ENT> <ENT>61-82-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">n</E> -Amyl acetate </ENT> <ENT>628-63-7</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">o-Anisidine</ENT> <ENT>90-04-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Benzyl chloride</ENT> <ENT>100-44-7</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">sec</E> -Butyl acetate </ENT> <ENT>105-46-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">tert</E> -Butyl acetate </ENT> <ENT>540-88-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">sec</E> -Butyl alcohol </ENT> <ENT>78-92-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">tert</E> -Butyl alcohol </ENT> <ENT>75-65-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">t-Butylcatechol</ENT> <ENT>98-29-3</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">o-sec-butylphenol</ENT> <ENT>89-72-5</ENT> <ENT/> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Camphor</ENT> <ENT>76-22-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Carbon disulfide</ENT> <ENT>75-15-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Catechol</ENT> <ENT>120-80-9</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">a</E> -Chloroacetophenone </ENT> <ENT>532-27-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Chlorobenzene</ENT> <ENT>108-90-7</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">o-Chlorotoluene</ENT> <ENT>95-49-8</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Cyclohexene</ENT> <ENT>110-83-8</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Cyclohexanol</ENT> <ENT>108-93-0</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Cyclopentadiene</ENT> <ENT>542-92-7</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <PRTPAGE P="209"/> <ENT I="02">Cyclopentane</ENT> <ENT>287-92-3</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Diacetone alcohol</ENT> <ENT>123-42-2</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dibutyl phosphate</ENT> <ENT>107-66-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1,2-Dichloroethylene</ENT> <ENT>540-59-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dicylcopentadiene</ENT> <ENT>77-73-6</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethyl acetamide</ENT> <ENT>127-19-5</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethylaniline</ENT> <ENT>121-69-7</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethyl sulfate</ENT> <ENT>77-78-1</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">m-Dinitrobenzene</ENT> <ENT>99-65-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">o-Dinitrobenzene</ENT> <ENT>528-29-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">p</E> -Dinitrobenzene </ENT> <ENT>100-25-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2,4-Dinitrotoluene</ENT> <ENT>121-14-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Diphenylamine</ENT> <ENT>122-39-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Disulfiram</ENT> <ENT>97-77-8</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>1/26/94</ENT> </ROW> <ROW> <ENT I="02">Ethyl bromide</ENT> <ENT>74-96-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Ethyl ether</ENT> <ENT>60-29-7</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> Heptane ( <E T="03">n</E> -Heptane) </ENT> <ENT>142-82-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Indene</ENT> <ENT>95-13-6</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Isoamyl acetate</ENT> <ENT>123-92-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">N-Isopropylaniline</ENT> <ENT>768-52-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">p-Methoxyphenol</ENT> <ENT>150-76-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Methyl acetate</ENT> <ENT>79-20-9</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Methylcyclohexane</ENT> <ENT>108-87-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Methyl formate</ENT> <ENT>107-31-3</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Methyl isoamyl ketone</ENT> <ENT>110-12-3</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">p-Nitroaniline</ENT> <ENT>100-01-6</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">p-Nitrochlorobenzene</ENT> <ENT>100-00-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1-Nitropropane</ENT> <ENT>108-03-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-Nitropropane</ENT> <ENT>79-46-9</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">m-Nitrotoluene</ENT> <ENT>99-08-1</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">o-Nitrotoluene</ENT> <ENT>88-72-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">p-Nitrotoluene</ENT> <ENT>99-99-0</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Nonane</ENT> <ENT>111-84-2</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Pentane</ENT> <ENT>109-66-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Phenylhydrazine</ENT> <ENT>100-63-0</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Propylene glycol dinitrate</ENT> <ENT>6423-43-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Sodium bisulfite</ENT> <ENT>7631-90-5</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Sodium metabisulfite</ENT> <ENT>7681-57-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetrahydrofuran</ENT> <ENT>109-99-9</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">m-Toluidine</ENT> <ENT>108-44-1</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Vinylidene chloride</ENT> <ENT>75-35-4</ENT> <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT> <ENT>8/4/95</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Vinyl toluene</ENT> <ENT>25013-15-4</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">p</E> -Xylene </ENT> <ENT>106-42-3</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>1/26/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Xylidine</ENT> <ENT>1300-73-8</ENT> <ENT>§ 716.20(b)(3) applies</ENT> <ENT>3/11/94</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="01">Propylene glycol ethers and esters:</ENT> </ROW> <ROW> <ENT I="02">Dipropylene glycol</ENT> <ENT>110-96-5</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Dipropylene glycol butyl ether</ENT> <ENT>29911-28-2</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Dipropylene glycol monomethyl ether acetate</ENT> <ENT>88917-22-0</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1-(2-Methoxy-1-methylethoxy)-2-propanol</ENT> <ENT>20324-32-7</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Methoxy-1-propanol</ENT> <ENT>28677-93-2</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1-Phenoxy-2-propanol</ENT> <ENT>770-35-4</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Propylene glycol monobutyl ether</ENT> <ENT>29387-86-8</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Propylene glycol monomethyl ether acetate</ENT> <ENT>108-65-6</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Propylene glycol mono-tert-butyl ether</ENT> <ENT>57018-52-7</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Tripropylene glycol diacrylate</ENT> <ENT>42978-66-5</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Tripropylene glycol methyl ether</ENT> <ENT>20324-33-8</ENT> <ENT/> <ENT>1/26/94</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">Siloxanes:</ENT> </ROW> <ROW> <ENT I="02">Cyclopolydimethylsiloxane</ENT> <ENT>69430-24-6</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Decamethylcyclopentasiloxane</ENT> <ENT>541-02-6</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Decamethyltetrasiloxane</ENT> <ENT>141-62-8</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethyldiphenylsiloxane</ENT> <ENT>68083-14-7</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethylhydropolylsiloxane</ENT> <ENT>68037-59-2</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethylmethyl 3,3,3-trifluoropropyl siloxane</ENT> <ENT>115361-68-7</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <PRTPAGE P="210"/> <ENT I="02">Dimethylmethylvinylsiloxane</ENT> <ENT>67762-94-1</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethylpolysiloxanes</ENT> <ENT>68037-74-1</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethyl silicones and siloxanes</ENT> <ENT>63148-62-9</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dimethyl silicones and siloxane, reaction products with silica</ENT> <ENT>67762-90-7</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Docosamethylcycloundecasiloxane</ENT> <ENT>18766-38-6</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Docosamethyldecasiloxane</ENT> <ENT>556-70-7</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dodecamethylcyclohexasiloxane</ENT> <ENT>540-97-6</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dodecamethylpentasiloxane</ENT> <ENT>141-63-9</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dotetracontamethyleicosasiloxane</ENT> <ENT>150027-00-2</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dotriacontamethylcyclohexadecasiloxane</ENT> <ENT>150026-95-2</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Dotriacontamethylpentadecasiloxane</ENT> <ENT>2471-11-6</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Eicosamethylcyclodecasiloxane</ENT> <ENT>18772-36-6</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Eicosamethylnonasiloxane</ENT> <ENT>2652-13-3</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexacosamethylcyclotridecasiloxane</ENT> <ENT>23732-94-7</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexacosamethyldodecasiloxane</ENT> <ENT>2471-08-1</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexadecamethylcyclooctasiloxane</ENT> <ENT>556-68-3</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexadecamethylheptasiloxane</ENT> <ENT>541-01-5</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexamethylcyclotrisiloxane</ENT> <ENT>541-05-9</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexamethyldisilazane</ENT> <ENT>999-97-3</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexamethyldisiloxane</ENT> <ENT>107-46-0</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexatriacontamethylcyclooctadecasiloxane</ENT> <ENT>23523-12-8</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Hexatriacontamethylheptadecasiloxane</ENT> <ENT>18844-04-7</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Methylpolysiloxane</ENT> <ENT>9004-73-3</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Methylvinylcyclosiloxane</ENT> <ENT>2554-06-5</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Siloxanes and silicones, di-Me, hydroxy-terminated</ENT> <ENT>70131-67-8</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octacosamethylcyclotetradecasiloxane</ENT> <ENT>149050-40-8</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octacosamethyltridecasiloxane</ENT> <ENT>2471-09-2</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octadecamethylcyclononasiloxane</ENT> <ENT>556-71-8</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octadecamethyloctasiloxane</ENT> <ENT>556-69-4</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octamethyltrisiloxane</ENT> <ENT>107-51-7</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octaphenylcyclotetrasiloxane</ENT> <ENT>546-56-5</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octatriacontamethylcyclononadecasiloxane</ENT> <ENT>150026-97-4</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Octatriacontamethyloctadecasiloxane</ENT> <ENT>36938-52-0</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Polymethyloctadecylsiloxane</ENT> <ENT>not available</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetracontamethylcycloeicosasiloxane</ENT> <ENT>150026-98-5</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetracontamethylnonadecasiloxane</ENT> <ENT>150026-99-6</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetracosamethylcyclododecasiloxane</ENT> <ENT>18919-94-3</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetracosamethylundecasiloxane</ENT> <ENT>107-53-9</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetradecamethylcycloheptasiloxane</ENT> <ENT>107-50-6</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetradecamethylhexasiloxane</ENT> <ENT>107-52-8</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetramethylcyclotetrasiloxane</ENT> <ENT>2370-88-9</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetramethyldivinyldisiloxane</ENT> <ENT>2627-95-4</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetratriacontamethylcycloheptadecasiloxane</ENT> <ENT>150026-96-3</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Tetratriacontamethylhexadecasiloxane</ENT> <ENT>36938-50-8</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Triacontamethylcyclopentadecasiloxane</ENT> <ENT>23523-14-0</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Triacontamethyltetradecasiloxane</ENT> <ENT>2471-10-5</ENT> <ENT>§ 716.20(b)(2) applies</ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="02">Trifluoropropylmethylcyclotrisiloxane</ENT> <ENT>2374-14-3</ENT> <ENT> </ENT> <ENT>10/12/93</ENT> <ENT>06/30/98</ENT> </ROW> <ROW> <ENT I="01">Substantially produced chemicals in need of subchronic tests:</ENT> </ROW> <ROW> <ENT I="02">Acetoacetanilide</ENT> <ENT>102-01-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">4-(Acetylamino)benzenesulfonyl chloride</ENT> <ENT>121-60-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-(2-Aminoethoxy)-ethanol</ENT> <ENT>929-06-6</ENT> <ENT/> <ENT>6/30/92</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">7-Amino-4-hydroxy-2-naphthalenesulfonic acid</ENT> <ENT>87-02-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Ammonium carbamate</ENT> <ENT>1111-78-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenedisulfonic acid</ENT> <ENT>98-48-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Bis(2-ethylhexyl)-2-butenedioate</ENT> <ENT>142-16-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Bromamine acid</ENT> <ENT>116-81-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Butyric anhydride</ENT> <ENT>106-31-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-(2-ethoxyethoxy)-, acetate</ENT> <ENT>112-15-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1,2-Dichlorobutane</ENT> <ENT>616-21-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">3,4-Dichlorobutene</ENT> <ENT>760-23-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">3,4-Dichloronitrobenzene</ENT> <ENT>99-54-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1,3-Dicyanobenzene</ENT> <ENT>626-17-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Diethylene glycol dimethyl ether</ENT> <ENT>111-96-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">4-Ethoxynitrobenzene</ENT> <ENT>100-29-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <PRTPAGE P="211"/> <ENT I="02">2-Ethylanthraquinone</ENT> <ENT>84-51-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Hexa(methoxymethyl) melamine</ENT> <ENT>3089-11-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">3-Hydroxy-2-naphthoic acid</ENT> <ENT>92-70-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Isobutyl acrylate</ENT> <ENT>106-63-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Isophthaloyl chloride</ENT> <ENT>9-63-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">4-Methyl-2-nitro-phenol</ENT> <ENT>119-33-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2-(4-Morpholinyldithio)-benzothiazole</ENT> <ENT>95-32-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Naphthalenedicarboxylic anhydride</ENT> <ENT>81-84-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">1-Naphthol</ENT> <ENT>90-15-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02"> <E T="03">p</E> , <E T="03">p</E> ′-Oxybis(benzenesulfonylhydrazide) </ENT> <ENT>80-51-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">2,4-Pentanedione</ENT> <ENT>123-54-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Perfluoro-N-hexane</ENT> <ENT>355-42-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Perfluorotributylamine</ENT> <ENT>311-89-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Propanoic anhydride</ENT> <ENT>123-62-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Quinacridone</ENT> <ENT>1047-16-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Terephthaloyl chloride</ENT> <ENT>100-20-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT/> </ROW> <ROW> <ENT I="02">Trichloromethanesulfenyl chloride</ENT> <ENT>594-42-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>6/30/98</ENT> </ROW> <ROW> <ENT I="02">Triethylene glycol bis(2-ethylhexanoate)</ENT> <ENT>94-28-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01">Sulphones:</ENT> </ROW> <ROW> <ENT I="02">2-Amino-4-[(2-hydroxyethyl) sulfonyl]phenol</ENT> <ENT>17601-96-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-Amino-4-(methylsulfonyl)phenol</ENT> <ENT>98-30-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-[(6-Amino-2-naphthalenyl) sulfonyl]ethanol</ENT> <ENT>52218-35-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-[(3-Aminophenyl)sulfonyl]ethanol</ENT> <ENT>5246-57-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Bisphenol S</ENT> <ENT>80-09-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">3-(Decyloxy)tetrahydrothiophene 1,1-dioxide</ENT> <ENT>18760-44-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">4,4′-Diaminodiphenyl sulfone</ENT> <ENT>80-08-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">4-[4-[(2,6-Dichloro-4-nitrophenyl)azo]phenyl] thiomorpholine, 11,1-dioxide</ENT> <ENT>17741-62-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1-(Diiodomethyl)sulfonyl-4-methyl benzene</ENT> <ENT>20018-09-1</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Dimethylsulfone</ENT> <ENT>67-71-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Diphenylsulfone</ENT> <ENT>127-63-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">3-[N-Ethyl-4-[[6-(methylsulfonyl)-2-benzothiazolyl]azo]-m-toluidino]propionitrile</ENT> <ENT>16588-67-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1,1′-[Methylenebis(sulfonyl)]bis-2-chloroethane</ENT> <ENT>41123-59-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2,2′-[Methylenebis(sulfonyl)]bisethanol</ENT> <ENT>41123-69-7</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1,1′-[Methylenebis(sulfonyl)]bisethene</ENT> <ENT>3278-22-6</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">6-Methylsulfonyl)-2-benzothiazolamine</ENT> <ENT>17557-67-4</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2-[(3-Nitrophenyl)sulfonyl]ethanol</ENT> <ENT>41687-30-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1,1′-[Oxybis(methylenesulfonyl)]bis-2-chloroethane</ENT> <ENT>53061-10-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2,2′-[Oxybis(methylenesulfonyl)] bisethanol</ENT> <ENT>36724-43-3</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">1,1′-[Oxybis(methylenesulfonyl)] bisethene</ENT> <ENT>26750-50-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">4-[[4-(Phenylmethoxy)phenyl]sulfonyl] phenol</ENT> <ENT>63134-33-8</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">4-Phenylthiomorpholine, 1,1-dioxide</ENT> <ENT>17688-68-5</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Sulfolane</ENT> <ENT>126-33-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">3-Sulfolene</ENT> <ENT>77-79-2</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">Sulfonyl bis(4-chlorobenzene)</ENT> <ENT>80-07-9</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="02">2,2′-Sulfonyl bisethanol</ENT> <ENT O="xl">2580-77-0</ENT> <ENT/> <ENT>9/30/91</ENT> <ENT>12/19/95</ENT> </ROW> <ROW> <ENT I="01" O="xl">Voluntary HPV Challenge Program orphan (unsponsored) chemicals:</ENT> <ENT O="xl"> </ENT> <ENT O="xl"> </ENT> <ENT O="xl"> </ENT> <ENT> </ENT> </ROW> <ROW> <ENT I="02">Acetaldehyde, reaction products with formaldehyde, by-products from</ENT> <ENT>68442-60-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Acetamide, 2,2-dichloro-N,N-di-2-propenyl-</ENT> <ENT>37764-25-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Acid chlorides, tallow, hydrogenated</ENT> <ENT>68955-37-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Alkanes, chloro</ENT> <ENT>61788-76-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Alkenes, C>10 .alpha.-</ENT> <ENT>64743-02-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Amides, coco, N-[3-(dimethylamino)propyl], alkylation products with sodium 3-chloro-2-hydroxypropanesulfonate</ENT> <ENT>70851-08-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="212"/> <ENT I="02">Amides, tall-oil fatty, N,N-di-Me</ENT> <ENT>68308-74-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Anthracene oil</ENT> <ENT>90640-80-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Aromatic hydrocarbons, C8, o-xylene-lean</ENT> <ENT>68650-36-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Aromatic hydrocarbons, C9-16, biphenyl deriv.-rich</ENT> <ENT>68955-76-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Barium, carbonate nonylphenol complexes</ENT> <ENT>68515-89-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 3-bromo-</ENT> <ENT>3132-99-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 3-phenoxy-</ENT> <ENT>39515-51-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzaldehyde, 4-(1,1-dimethylethyl)-</ENT> <ENT>939-97-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2,6-diethyl-N-methylene-</ENT> <ENT>35203-08-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 2-ethyl-6-methyl-N-methylene-</ENT> <ENT>35203-06-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, 3-(trifluoromethyl)-</ENT> <ENT>98-16-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, N,N-dimethyl-</ENT> <ENT>121-69-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenamine, N-phenyl-4-[[4-(phenylamino)phenyl][4-(phenylimino)-2,5-cyclohexadien-1-ylidene]methyl]-, monohydrochloride</ENT> <ENT>2152-64-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, (2-chloro-1,1-dimethylethyl)-</ENT> <ENT>515-40-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-(bromomethyl)-3-phenoxy-</ENT> <ENT>51632-16-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1'-[1,2-ethanediylbis(oxy)]bis-</ENT> <ENT>104-66-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,1'-oxybis-, tetrapropylene derivs.</ENT> <ENT>119345-02-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1,2-dimethyl-3-nitro-</ENT> <ENT>83-41-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-bromo-4-fluoro-</ENT> <ENT>460-00-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-chloro-2,4-dinitro-</ENT> <ENT>97-00-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-chloro-4-(trichloromethyl)-</ENT> <ENT>5216-25-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-chloro-4-(trifluoromethyl)-</ENT> <ENT>98-56-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, 1-methoxy-4-methyl-</ENT> <ENT>104-93-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, chloromethyl-</ENT> <ENT>25168-05-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, ethenylethyl-</ENT> <ENT>28106-30-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, ethylenated</ENT> <ENT>68987-41-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzene, mixed with toluene, dealkylation product</ENT> <ENT>68953-80-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenedicarboxylic acid, 5-sulfo-, 1,3-dimethyl ester</ENT> <ENT>138-25-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3-Benzenedicarboxylic acid, 5-sulfo-, 1,3-dimethyl ester, sodium salt</ENT> <ENT>3965-55-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester</ENT> <ENT>84-69-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,4-Benzenedicarboxylic acid, dimethyl ester, manuf. of, by-products from</ENT> <ENT>68988-22-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenemethanol, .alpha.,.alpha.-dimethyl-</ENT> <ENT>617-94-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenemethanol, 3-phenoxy-</ENT> <ENT>13826-35-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenesulfonic acid, 3-nitro-, sodium salt</ENT> <ENT>127-68-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenesulfonic acid, 4-chloro-3,5-dinitro-, potassium salt</ENT> <ENT>38185-06-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenesulfonic acid, C10-16-alkyl derivs., compds. with triethanolamine</ENT> <ENT>68584-25-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="213"/> <ENT I="02">Benzenesulfonic acid, dimethyl-</ENT> <ENT>25321-41-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzenesulfonyl chloride</ENT> <ENT>98-09-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide</ENT> <ENT>81-07-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzoic acid, 2-methyl-</ENT> <ENT>118-90-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2,4,6,8,3,5,7-Benzotetraoxatriplumbacycloundecin-3,5,7-triylidene, 1,9-dihydro-1,9-dioxo-</ENT> <ENT>17976-43-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzothiazole, 2-[(chloromethyl)thio]-</ENT> <ENT>28908-00-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Benzoyl chloride, 3,5-dichloro-</ENT> <ENT>2905-62-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,2-Butadiene</ENT> <ENT>590-19-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Butanedioic acid, oxo-, diethyl ester, ion(1-), sodium</ENT> <ENT>40876-98-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Butanol, sodium salt</ENT> <ENT>2372-45-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Butenal</ENT> <ENT>4170-30-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Butenediamide, (2E)-, N,N'-bis[2-(4,5-dihydro-2-nortall-oil alkyl-1H-imidazol-1-yl)ethyl] derivs.</ENT> <ENT>68442-77-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Butenedioic acid (2E)-, di-C8-18-alkyl esters</ENT> <ENT>68610-90-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Butenedioic acid (2Z)-, dioctyl ester</ENT> <ENT>2915-53-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Butenenitrile, 2-methyl-, (2E)-</ENT> <ENT>30574-97-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Butenenitrile, 2-methyl-, (2Z)-</ENT> <ENT>20068-02-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Carbamic acid, monoammonium salt</ENT> <ENT>1111-78-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Carbamodithioic acid, monoammonium salt</ENT> <ENT>513-74-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Carbonochloridothioic acid, S-(phenylmethyl) ester</ENT> <ENT>37734-45-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Carbonodithioic acid, O-(1-methylethyl) ester, sodium salt</ENT> <ENT>140-93-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Carboxylic acids, di-, C4-11</ENT> <ENT>68937-72-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Chromate(3-), bis[3-(hydroxy-.kappa.O)-4-[[2-(hydroxy-.kappa.O)-1-naphthalenyl]azo-.kappa.N1]-7-nitro-1-naphthalenesulfonato(3-)]-, trisodium</ENT> <ENT>57693-14-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Coal, anthracite, calcined</ENT> <ENT>68187-59-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Creosote</ENT> <ENT>8001-58-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, oxidized, aq. ext., sodium salt</ENT> <ENT>68915-39-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Cyclohexane, oxidized, non-acidic by-products, distn. lights</ENT> <ENT>68609-05-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3-Cyclopentadiene</ENT> <ENT>542-92-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Decane, 1-chloro-</ENT> <ENT>1002-69-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Decanoic acid, mixed esters with dipentaerythritol, octanoic acid and valeric acid</ENT> <ENT>68441-66-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Decene, sulfurized</ENT> <ENT>72162-15-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Distillates (coal tar)</ENT> <ENT>65996-92-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Distillates (coal tar), heavy oils</ENT> <ENT>90640-86-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Distillates (coal tar), upper</ENT> <ENT>65996-91-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="214"/> <ENT I="02">Distillates (petroleum), hydrofined lubricating-oil</ENT> <ENT>68782-97-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Distillates, hydrocarbon resin prodn. higher boiling</ENT> <ENT>68602-81-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Disulfides, alkylaryl dialkyl diaryl, petroleum refinery spent caustic oxidn. products</ENT> <ENT>68334-01-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Disulfides, C5-12-alkyl</ENT> <ENT>68513-62-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethane, 1,1,1-trimethoxy-</ENT> <ENT>1445-45-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethane, 1,1'-[methylenebis(oxy)]bis[2-chloro-</ENT> <ENT>111-91-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethane, 1,1'-oxybis[2-chloro-</ENT> <ENT>111-44-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethane, 1,2-dichloro-, manuf. of, by-products from, distn. lights</ENT> <ENT>68608-59-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,2-Ethanediamine, N,N,N′,N′-tetramethyl-</ENT> <ENT>110-18-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanedioic acid, calcium salt (1:1)</ENT> <ENT>563-72-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,2-Ethanediol, dinitrate</ENT> <ENT>628-96-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanesulfonic acid, 2-[methyl[(9Z)-1-oxo-9-octadecenyl]amino]-, sodium salt</ENT> <ENT>137-20-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanimidothioic acid, N-hydroxy-, methyl ester</ENT> <ENT>13749-94-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-(2-butoxyethoxy)-, sodium salt</ENT> <ENT>38321-18-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine derivs. residues</ENT> <ENT>68909-77-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine product tower residues</ENT> <ENT>71077-05-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-[(4-aminophenyl)sulfonyl]-, hydrogen sulfate (ester)</ENT> <ENT>2494-89-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethanol, 2-butoxy-, sodium salt</ENT> <ENT>52663-57-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethene, hydrated, by-products from</ENT> <ENT>68987-66-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Ethenesulfonic acid, sodium salt</ENT> <ENT>3039-83-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Extract oils (coal), tar base</ENT> <ENT>65996-86-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Extract residues (coal), tar oil alk.</ENT> <ENT>65996-87-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Extract residues (coal), tar oil alk., naphthalene distn. residues</ENT> <ENT>73665-18-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Extracts, coal tar oil alk.</ENT> <ENT>65996-83-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Fats and Glyceridic oils, vegetable, reclaimed</ENT> <ENT>68990-65-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Fatty acids, tall-oil, 2-(2-hydroxyethoxy)ethyl esters</ENT> <ENT>68309-16-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Fatty acids, tall-oil, low-boiling, reaction products with ammonia-ethanolamine reaction by-products</ENT> <ENT>68915-05-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Fatty acids, tall-oil, reaction products with diethylenetriamine, acetates</ENT> <ENT>68153-60-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Fatty acids, tall-oil, sulfonated, sodium salts</ENT> <ENT>68309-27-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Formic acid, compd. with 2,2′,2[ethanol] (1:1)</ENT> <ENT>24794-58-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2,5-Furandione, dihydro-3-(octenyl)-</ENT> <ENT>26680-54-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Glycine, N-(carboxymethyl)-</ENT> <ENT>142-73-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Glycine, N-(carboxymethyl)-, disodium salt</ENT> <ENT>928-72-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Glycine, N-methyl-, monosodium salt</ENT> <ENT>4316-73-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="215"/> <ENT I="02">Glycine, N-phenyl-, monopotassium salt</ENT> <ENT>19525-59-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Glycine, N-phenyl-, monosodium salt</ENT> <ENT>10265-69-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Hexacosanol</ENT> <ENT>506-52-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Hexadecane, 1-chloro-</ENT> <ENT>4860-03-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,4-Hexadiene</ENT> <ENT>592-45-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Hexanedioic acid, dihexyl ester</ENT> <ENT>110-33-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Hexanedioic acid, esters with high-boiling C6-10-alkene hydroformylation products</ENT> <ENT>84501-86-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3-Hexanediol, 2-ethyl-</ENT> <ENT>94-96-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,6-Hexanediol, distn. residues</ENT> <ENT>68937-29-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Hexenal, 2-ethyl-</ENT> <ENT>645-62-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-</ENT> <ENT>85-40-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Hydrocarbons, C12-20, catalytic alkylation by-products</ENT> <ENT>68919-17-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Imidodicarbonic diamide, N,N′,2-tris(6-isocyanatohexyl)-</ENT> <ENT>4035-89-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3-Isobenzofurandione, 5-methyl-</ENT> <ENT>19438-61-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Lard, oil, Me esters</ENT> <ENT>68082-78-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Methanesulfonamide, N-[2-[(4-amino-3-methylphenyl)ethylamino]ethyl]-, sulfate (2:3)</ENT> <ENT>25646-71-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Methanesulfonic acid, hydroxy-, monosodium salt</ENT> <ENT>870-72-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Methanesulfonyl chloride</ENT> <ENT>124-63-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Methanone, (2-hydroxy-4-methoxyphenyl)phenyl-</ENT> <ENT>131-57-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Naphtha (petroleum), clay-treated light straight-run</ENT> <ENT>68527-22-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, monosodium salt</ENT> <ENT>5460-09-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalenesulfonic acid, 2-amino-</ENT> <ENT>81-16-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Naphthalenesulfonic acid, 6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]phenyl]amino]-3-sulfophenyl]azo]-4-hydroxy-, trisodium salt</ENT> <ENT>6473-13-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Naphthalenol, 1,2,3,4-tetrahydro-</ENT> <ENT>529-33-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1(2H)-Naphthalenone, 3,4-dihydro-</ENT> <ENT>529-34-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1H,3H-Naphtho[1,8-cd]pyran-1,3-dione</ENT> <ENT>81-84-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Nickel, bis[(cyano-C)triphenylborato(1-)-N]bis(hexanedinitrile-N,N')-</ENT> <ENT>83864-02-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Octacosanol</ENT> <ENT>557-61-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Octadecane, 1-chloro-</ENT> <ENT>3386-33-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Octadecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt</ENT> <ENT>25383-99-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Octadecanoic acid, 2-(hydroxymethyl)-2-[[(1-oxooctadecyl)oxy]methyl]-1,3-propanediyl ester</ENT> <ENT>28188-24-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol</ENT> <ENT>68815-50-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="216"/> <ENT I="02">9-Octadecenoic acid, 12-(acetyloxy)-, 1,2,3-propanetriyl ester, (9Z,9'Z,9”,12R,12'R,12”)-</ENT> <ENT>101-34-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Octane, 1-chloro-</ENT> <ENT>111-85-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Octanesulfonyl chloride</ENT> <ENT>7795-95-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Octanesulfonyl fluoride</ENT> <ENT>40630-63-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Oxirane, [(2-methylphenoxy)methyl]-</ENT> <ENT>2210-79-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Oxiranemethanamine, N-[4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)-</ENT> <ENT>5026-74-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Paraffin oils, chlorosulfonated, saponified</ENT> <ENT>68188-18-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">3-Pentanone</ENT> <ENT>96-22-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Pentene, 2,4,4-trimethyl-</ENT> <ENT>107-39-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Pentene, 2,4,4-trimethyl-</ENT> <ENT>107-40-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, (1,1,3,3-tetramethylbutyl)-</ENT> <ENT>27193-28-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, (1-methylethyl)-</ENT> <ENT>25168-06-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2-(1,1-dimethylethyl)-4-methyl-</ENT> <ENT>2409-55-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4-bis(1,1-dimethylpropyl)-6-[(2-nitrophenyl)azo]-</ENT> <ENT>52184-19-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, 2,4-bis(1-methyl-1-phenylethyl)-6-[(2-nitrophenyl)azo]-</ENT> <ENT>70693-50-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, 3-(diethylamino)-</ENT> <ENT>91-68-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, 4-methyl-2-nitro-</ENT> <ENT>119-33-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, isobutylenated methylstyrenated</ENT> <ENT>68457-74-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, methyl-, sodium salt</ENT> <ENT>34689-46-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, nonyl derivs.</ENT> <ENT>68081-86-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenol, styrenated</ENT> <ENT>61788-44-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phenols (petroleum)</ENT> <ENT>64743-03-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphoramidothioic acid, O,O-dimethyl ester</ENT> <ENT>17321-47-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, (1,1-dimethylethyl)phenyl diphenyl ester</ENT> <ENT>56803-37-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphoric acid, mixed 3-bromo-2,2-dimethylpropyl and 2-bromoethyl and 2-chloroethyl esters</ENT> <ENT>125997-20-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorochloridothioic acid, O,O-dimethyl ester</ENT> <ENT>2524-03-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorochloridous acid, bis(4-nonylphenyl) ester</ENT> <ENT>63302-49-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorodichloridic acid, ethyl ester</ENT> <ENT>1498-51-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorodithioic acid, O,O-di-C1-14-alkyl esters</ENT> <ENT>68187-41-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorodithioic acid, O,O-di-C1-14-alkyl esters, zinc salts</ENT> <ENT>68649-42-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorodithioic acid, O,O-dimethyl ester</ENT> <ENT>756-80-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorodithioic acid, O,O-dimethyl ester, sodium salt</ENT> <ENT>26377-29-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorous acid, 2-(1,1-dimethylethyl)-4-[1-[3-(1,1-dimethylethyl)-4-hydroxyphenyl]-1-methylethyl]phenyl bis(4-nonylphenyl) ester</ENT> <ENT>20227-53-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Phosphorous acid, isooctyl diphenyl ester</ENT> <ENT>26401-27-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <PRTPAGE P="217"/> <ENT I="02">Piperazineethanol</ENT> <ENT>25154-38-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Pitch, coal tar-petroleum</ENT> <ENT>68187-57-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Propane, 2,2-dimethoxy-</ENT> <ENT>77-76-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Propanenitrile, 3-(dimethylamino)-</ENT> <ENT>1738-25-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, monosodium salt</ENT> <ENT>52556-42-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Propanoic acid, 2-bromo-</ENT> <ENT>598-72-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Propanoic acid, 2-methyl-, 3-(benzoyloxy)-2,2,4-trimethylpentyl ester</ENT> <ENT>22527-63-5</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">2-Propenoic acid, 2-carboxyethyl ester</ENT> <ENT>24615-84-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Pyridine, hydrochloride</ENT> <ENT>628-13-7</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">4(1H)-Pyrimidinone, 6-methyl-2-(1-methylethyl)-</ENT> <ENT>2814-20-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Solvent naphtha (coal)</ENT> <ENT>65996-79-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Sulfonic acids, petroleum</ENT> <ENT>61789-85-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tannins</ENT> <ENT>1401-55-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tannins, reaction products with sodium bisulfite, sodium polysulfide and sodium sulfite</ENT> <ENT>72854-27-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tar oils, coal</ENT> <ENT>65996-82-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tar, coal, dried and oxidized</ENT> <ENT>68918-16-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tar, coal, high-temp.</ENT> <ENT>65996-89-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tar, coal, high-temp., high-solids</ENT> <ENT>68990-61-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Terpenes and Terpenoids, C10-30, distn. residues</ENT> <ENT>70084-98-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1-Tetracosanol</ENT> <ENT>506-51-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Tetradecane, 1-chloro-</ENT> <ENT>2425-54-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3,5,7-Tetrazocine, octahydro-1,3,5,7-tetranitro-</ENT> <ENT>2691-41-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Thiazole, 4-methyl-</ENT> <ENT>693-95-8</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Thiourea</ENT> <ENT>62-56-6</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Triazine, hexahydro-1,3,5-trinitro-</ENT> <ENT>121-82-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(6-isocyanatohexyl)-</ENT> <ENT>3779-63-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Triazine-2,4-diamine, 6-chloro-N-(1,1-dimethylethyl)-N'-ethyl-</ENT> <ENT>5915-41-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-bis(1-methylethyl)-</ENT> <ENT>139-40-2</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">1,3,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-N'-(1-methylethyl)-</ENT> <ENT>1912-24-9</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Urea, (hydroxymethyl)-</ENT> <ENT>1000-82-4</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Urea, N'-(3,4-dichlorophenyl)-N,N-dimethyl-</ENT> <ENT>330-54-1</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Urea, sulfate (1:1)</ENT> <ENT>21351-39-3</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> <ROW> <ENT I="02">Urea, sulfate (2:1)</ENT> <ENT>17103-31-0</ENT> <ENT O="xl">§ 716.21(a)(7)</ENT> <ENT O="xl">September 29, 2006</ENT> <ENT>November 28, 2006</ENT> </ROW> </GPOTABLE> <CITA>[53 FR 38645, Sept. 30, 1988]</CITA> <EDNOTE> <PRTPAGE P="218"/> <HD SOURCE="HED">Editorial Note:</HD> <P> For <E T="04">Federal Register</E> citations affecting § 716.120, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at <E T="03">www.govinfo.gov.</E> </P> </EDNOTE> <EFFDNOT> <HD SOURCE="HED">Effective Date Note:</HD> <P>At 59 FR 14115, Mar. 25, 1994, in § 716.120 paragraph (d), the chemical substances under the category “propylene glycol ethers and esters” and all related dates, were stayed effective Mar. 25, 1994.</P> </EFFDNOT> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 717</EAR> <HD SOURCE="HED">PART 717—RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH OR THE ENVIRONMENT</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>717.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <SECTNO>717.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>717.5</SECTNO> <SUBJECT>Persons subject to this part.</SUBJECT> <SECTNO>717.7</SECTNO> <SUBJECT>Persons not subject to this part.</SUBJECT> <SECTNO>717.10</SECTNO> <SUBJECT>Allegations subject to this part.</SUBJECT> <SECTNO>717.12</SECTNO> <SUBJECT>Significant adverse reactions that must be recorded.</SUBJECT> <SECTNO>717.15</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <SECTNO>717.17</SECTNO> <SUBJECT>Inspection and reporting requirements.</SUBJECT> <SECTNO>717.19</SECTNO> <SUBJECT>Confidentiality.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2607(c).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>48 FR 38187, Aug. 22, 1983, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 717.1</SECTNO> <SUBJECT>Scope and compliance.</SUBJECT> <P>Section 8 (c) of the Toxic Substances Control Act (TSCA) requires manufacturers, processors, and distributors of chemical substances and mixtures:</P> <P>(a) To keep “records of significant adverse reactions to health or the environment, as determined by the Administrator by rule, alleged to have been caused by the substance or mixture.”</P> <P>(b) To “permit inspection and submit copies of such records”, upon request of any designated representative of the Administrator. This rule implements section 8(c) of TSCA. It describes the records to be kept and prescribes the conditions under which certain firms must submit or make the records available to a duly designated representative of the Administrator.</P> </SECTION> <SECTION> <SECTNO>§ 717.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>The definitions set forth in section 3 of TSCA and the following definitions apply to this part:</P> <P> (a) <E T="03">Allegation</E> means a statement, made without formal proof or regard for evidence, that a chemical substance or mixture has caused a significant adverse reaction to health or the environment. </P> <P> (b) <E T="03">Firm</E> or <E T="03">company</E> means any person, that is subject to this part, as defined in § 717.5. </P> <P> (c)(1) <E T="03">Known human effects</E> means a commonly recognized human health effect of a particular substance or mixture as described either in: </P> <P>(i) Scientific articles or publications abstracted in standard reference sources.</P> <P>(ii) The firm's product labeling or material safety data sheets (MSDS).</P> <P>(2) However, an effect is not a “known human effect” if it:</P> <P>(i) Was a significantly more severe toxic effect than previously described.</P> <P>(ii) Was a manifestation of a toxic effect after a significantly shorter exposure period or lower exposure level than described.</P> <P>(iii) Was a manifestation of a toxic effect by an exposure route different from that described.</P> <P> (d) <E T="03">Manufacture</E> or <E T="03">process</E> means to manufacture or process for commercial purposes. </P> <P> (e)(1) <E T="03">Manufacture for commercial purposes</E> means to import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes, among other things, such “manufacture” of any amount of a chemical substance or mixture: </P> <P>(i) For distribution in commerce, including for test marketing.</P> <P> (ii) For use by the manufacturer, including use for product research and development, or as an intermediate. <PRTPAGE P="219"/> </P> <P> (2) <E T="03">Manufacture for commercial purposes</E> also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including both byproducts that are separated from that other substances or mixture and impurities that remain in that substance or mixture. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose. </P> <P> (f) <E T="03">Person</E> includes any individual, firm, company, corporation, joint venture, partnership, sole proprietorship, association, or any other business entity, any State or political subdivision thereof, and any department, agency, or instrumentally of the Federal Government. </P> <P> (g) <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included. If a chemical substance or mixture containing impurities is processed for commercial purposes, then those impurities are also processed for commercial purposes. </P> <P> (h) <E T="03">Retailer</E> means a person who distributes in commerce a chemical substance, mixture, or article to ultimate purchasers who are not commercial entities. </P> <P> (i) <E T="03">Significant adverse reactions</E> are reactions that may indicate a substantial impairment of normal activities, or long-lasting or irreversible damage to health or the environment. </P> <P> (j) <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way is considered one site. There may be multiple manufacturing, processing, or distribution activities occurring within a single site. </P> <P> (k) <E T="03">Substance</E> means a chemical substance or mixture unless otherwise indicated. </P> </SECTION> <SECTION> <SECTNO>§ 717.5</SECTNO> <SUBJECT>Persons subject to this part.</SUBJECT> <P> (a) <E T="03">Manufacturers.</E> (1) All manufacturers of chemical substances are subject to this part except as provided in § 717.7(a). If manufacture of a chemcial substance occurs at any site owned or controlled by a firm then that firm is subject to this part. </P> <P>(2) A manufacturer must collect:</P> <P>(i) Any allegation identifying a chemical substance it manufactures and any allegation identifying the operations in the manufacture of any chemical substance it manufactures.</P> <P>(ii) Any allegation identifying any of its own processing or distribution in commerce activities with respect to any chemical substance it manufactures.</P> <P>(iii) Any allegation identifying emissions, effluents, or other discharges from activities described in this paragraph.</P> <P>(iv) Any allegation identifying a substance produced coincidentally during processing, use, storage or disposal of a chemical substance it manufactures.</P> <P>(3) For the purpose of this part, owned or controlled means ownership of 50 percent or more of a firm's voting stock or other equity rights, or the power to control the management and policies of that firm.</P> <P> (b) <E T="03">Processors.</E> (1) A person who processes chemical substances, who is not also a manufacturer of those chemical substances, is subject to this part if (i) the person processes chemical substances to produce mixtures, or (ii) the person repackages chemical substances or mixtures. </P> <P>(2) As a processor subject to this part such person must collect:</P> <P>(i) Any allegation identifying any mixture it produces and distributes in commerce and any allegation identifying any chemical substance or mixture it repackages and distributes in commerce.</P> <P>(ii) Any allegation identifying any of its own further processing or distribution in commerce activities of the products described in paragraph (b)(2)(i) of this section.</P> <P> (iii) Any allegation identifying emissions, effluents, or other discharges from activities described in this paragraph. <PRTPAGE P="220"/> </P> <P>(iv) Any allegation identifying a substance produced coincidentally during the processing, use, storage or disposal of the products described in paragraph (b)(2)(i) of this section.</P> <P> (c) <E T="03">SIC code.</E> SIC codes applicable to this part are published in Standard Industrial Classification Manual—1972 and the 1977 Supplement. This manual and supplement may be obtained from the U.S. Government Printing Office, Washington, D.C. 20402—stock number 4101-0006 and stock number 003-005-0170-0 respectively. Where there is a conflict between the SIC code use of a term and the definition of that term in this part, the definition in this part applies. </P> <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 50 FR 46769, Nov. 13, 1985]</CITA> </SECTION> <SECTION> <SECTNO>§ 717.7</SECTNO> <SUBJECT>Persons not subject to this part.</SUBJECT> <P> (a) <E T="03">Manufacturers.</E> (1) Persons or site activities are exempt from this part if the means by which they manufacture a chemical substance solely involves mining or other solely extractive functions, e.g., those companies or sites within a company whose sole function is to mine mineral ores, extract petroleum or natural gas, quarry non-metallic minerals (including extraction of salts from seawater or brines), mine or otherwise extract coal, or separate gases from the atmosphere. This exemption may include, but is not necessarily limited to, firms engaged in activities as described in SIC Division B—Mining and SIC Code 2813—Industrial Gases. </P> <P>(2) A person is not subject to this part if the chemical substances that person causes to be produced are limited to:</P> <P>(i) Chemical substances that result from chemical reactions that occur incidental to exposure of another chemical substance, mixture, or article to environmental factors such as air, moisture, microbial organisms, or sunlight.</P> <P>(ii) Chemical substances that result from chemical reactions that occur incidental to storage or disposal of other chemical substances, mixtures, or articles.</P> <P>(iii) Chemical substances that result from chemical reactions that occur upon end use of other chemical substances, mixtures, or articles such as adhesives, paints, miscellaneous cleaners or other housekeeping products, fuel additives, water softening and treatment agents, photographic films, batteries, matches, or safety flares, and that are not themselves manufactured or imported for distribution in commerce for use as chemical intermediates.</P> <P>(iv) Chemical substances that result from chemical reactions that occur upon use of curable plastic or rubber molding compounds, inks, drying oils, metal finishing compounds, adhesives, or paints, or other chemical substance formed during the manufacture of an article destined for the marketplace without further chemical change of the chemical substance.</P> <P>(v) Chemical substances that result from chemical reactions that occur when (A) a stabilizer, colorant, odorant, antioxidant, filler, solvent, carrier, surfactant, plasticizer, corrosion inhibitor, antifoamer or defoamer, dispersant, precipitation-inhibitor, binder, emulsifier, deemulsifier, dewatering agent, agglomerating agent, adhesion promoter, flow modifier, pH adjuster, sequestrant, coagulant, flocculant, fire retardant, lubricant, chelating agent, or quality control reagent functions as intended, or (B) a chemical substance, which is intended solely to impart a specific physicochemical characteristic, functions as intended.</P> <P>(b) [Reserved]</P> <P> (c) <E T="03">Sole distributors.</E> A person solely engaged in the distribution of chemical substances is exempt from this part, unless such person is also a manufacturer or processor subject to this part. For example, a “distributor” who repackages chemical substances or mixtures is considered to be a processor and, thus, is not a sole distributor. Sole distributors may include, but are not limited to, those firms that distribute chemical substances as described in the wholesale trade SIC codes 5161—Chemicals and Allied Products, 5171—Petroleum Bulk Stations and Terminals, and 5172—Petroleum and Petroleum Products Wholesalers, Except Bulk Stations and Terminals. </P> <P> (d) <E T="03">Retailers.</E> A person who is a retailer is exempt from this part unless <PRTPAGE P="221"/> such person is also a manufacturer or a processor subject to this part. </P> <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 50 FR 46770, Nov. 13, 1985]</CITA> </SECTION> <SECTION> <SECTNO>§ 717.10</SECTNO> <SUBJECT>Allegations subject to this part.</SUBJECT> <P>(a) Allegations subject to this part are those allegations received on or after November 21, 1983 by persons subject to this part.</P> <P>(b) Allegations subject to this part are those that:</P> <P>(1) Are submitted either in writing and are signed by the alleger, or are submitted orally. In the case of an oral allegation, the firm must transcribe the allegation into written form, or it must inform the alleger that such allegation may be subject to this part and request that the alleger submit such allegation to the firm in writing and signed.</P> <P>(2) Implicate a substance that caused the stated significant adverse reaction by one of the following:</P> <P>(i) Naming the specific substance.</P> <P>(ii) Naming a mixture that contains a specific substance.</P> <P>(iii) Naming an article that contains a specific substance.</P> <P>(iv) Naming a company process or operation in which substances are involved.</P> <P>(v) Identifying an effluent, emission, or other discharge from a site of manufacturing, processing or distribution of a substance.</P> <P>(c) Allegations subject to this part may be made to a firm by any person, such as an employee of the firm, individual consumer, a neighbor of the firm's plant, another firm on behalf of its employees or an organization on behalf of its members.</P> <P>(d) EPA intends that firms should, to the maximum practical extent, provide allegers with information regarding the ultimate disposition of their allegations. For example, firms could provide a brief notice to the alleger stating that a record was created under this part based upon their allegation, or that a record was not created and briefly explain the reasons why not.</P> </SECTION> <SECTION> <SECTNO>§ 717.12</SECTNO> <SUBJECT>Significant adverse reactions that must be recorded.</SUBJECT> <P>(a) Except as provided in paragraph (b) of this section, significant adverse reactions to human health that must be recorded include but are not limited to:</P> <P>(1) Long-lasting or irreversible damage, such as cancer or birth defects.</P> <P>(2) Partial or complete impairment of bodily functions, such as reproductive disorders, neurological disorders or blood disorders.</P> <P>(3) An impairment of normal activities experienced by all or most of the persons exposed at one time.</P> <P>(4) An impairment of normal activities which is experienced each time an individual is exposed.</P> <P>(b) Firms are not required to record significant adverse reactions that are known human effects as defined in § 717.3(c).</P> <P>(c) Except as provided in paragraph (d) of this section, significant adverse reactions to the environment that must be recorded, even if restricted to the environs of a plant or disposal site, include but are not limited to:</P> <P>(1) Gradual or sudden changes in the composition of animal life or plant life, including fungal or microbial organisms, in an area.</P> <P>(2) Abnormal number of deaths of organisms (e.g., fish kills).</P> <P>(3) Reduction of the reproductive success or the vigor of a species.</P> <P>(4) Reduction in agricultural productivity, whether crops or livestock.</P> <P>(5) Alterations in the behavior or distribution of a species.</P> <P>(6) Long lasting or irreversible contamination of components of the physical environment, especially in the case of ground water, and surface water and soil resources that have limited self-cleansing capability.</P> <P> (d) Firms are not required to record a significant adverse reaction to the environment if the alleged cause of that significant adverse reaction can be directly attributable to an accidental spill or other accidental discharge, emission exceeding permitted limits, or other incident of environmental contamination that has been reported to <PRTPAGE P="222"/> the Federal Government under any applicable authority. </P> <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 49 FR 23183, June 5, 1984; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 717.15</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P> (a) <E T="03">Establishment and location of records.</E> A firm subject to this part shall establish and maintain records of significant adverse reactions alleged to have been caused by chemical substances or mixtures manufactured or processed by the firm. Such records shall be kept at the firm's headquarters or at any other appropriate location central to the firm's chemical operations. </P> <P> (b) <E T="03">Content of records.</E> The record shall consist of the following: </P> <P>(1) The original allegation as received.</P> <P>(2) An abstract of the allegation and other pertinent information as follows:</P> <P>(i) The name and address of the plant site which received the allegation.</P> <P>(ii) The date the allegation was received at that site.</P> <P>(iii) The implicated substance, mixture, article, company process or operation, or site discharge.</P> <P>(iv) A description of the alleger (e.g., “company employee,” “individual consumer,” “plant neighbor”). If the allegation involves a health effect, the sex and year of birth of the individual should be recorded, if ascertainable.</P> <P>(v) A description of the alleged health effect(s). The description must relate how the effect(s) became known and the route of exposure, if explained in the allegation.</P> <P>(vi) A description of the nature of the alleged environmental effect(s), identifying the affected plant and/or animal species, or contaminated portion of the physical environment.</P> <P>(3) The results of any self-initiated investigation with respect to an allegation. (EPA does not require persons subject to this part to investigate allegations received, and no provision of this part shall be construed to imply that EPA recommends, encourages or requires such investigation.)</P> <P>(4) Copies of any further required records or reports relating to the allegation. For example, if an employee allegation results in a requirement for the firm to record the case on Occupational Safety and Health Form 101 or appropriate substitute (see 29 CFR part 1904 for requirements under the Occupational Safety and Health Act of 1970), a copy of that OSHA record must be included in the allegation record.</P> <P> (c) <E T="03">File structure.</E> Records must be retrievable by the alleged cause of the significant adverse reaction, which cause may be one of the following: </P> <P>(1) A specific chemical identity.</P> <P>(2) A mixture.</P> <P>(3) An article.</P> <P>(4) A company process or operation.</P> <P>(5) A site emission, effluent or other discharge.</P> <P> (d) <E T="03">Retention period.</E> Records of significant adverse reactions to the health of employees shall be retained for a period of 30 years from the date such reactions were first reported to or known by the person maintaining such records. This provision requires persons subject to this part to retain for 30 years an employee health related allegation, arising from any employment related exposure, whether or not such allegation was submitted by or on the behalf of that recordkeeper's own employee. Any other record of significant adverse reactions shall be maintained for a period of five years from the date the information contained in the record was first reported to or known by the person maintaining the record. </P> <P> (e) <E T="03">Transfer of records.</E> (1) If a firm ceases to do business, the successor must receive and keep all the records that must be kept under this part. </P> <P>(2) If a firm ceases to do business and there is no successor to receive and keep the records for the prescribed period, these records must be transmitted to EPA. See § 717.17(c) for the address to which such records must be sent.</P> <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 49 FR 23183, June 5, 1984; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 717.17</SECTNO> <SUBJECT>Inspection and reporting requirements.</SUBJECT> <P> (a) <E T="03">Inspection.</E> Firms must make records of allegations available for inspection by any duly designated representative of the Administrator. </P> <P> (b) <E T="03">Reporting.</E> Each person who is required to keep records under this part must submit copies of those records to <PRTPAGE P="223"/> the Agency as required by the EPA Administrator or appropriate designee. EPA will notify those responsible for reporting by letter or will announce any such requirements for submitting copies of records by a notice in the <E T="04">Federal Register.</E> Such letter or notice will be signed by the Administrator or appropriate designee, and will specify which records or portion of records must be submitted. The reporting period will be specified by the letter or notice but in no case will such reporting period be less than 45 days from the date of the letter or the effective date of the notice. </P> <P> (c) <E T="03">How to report.</E> When required to report, firms must submit copies of records via CDX <E T="03">https://cdx.epa.gov/</E> using the EPA provided electronic reporting application. </P> <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 49 FR 23183, June 5, 1984; 52 FR 20084, May 29, 1987; 53 FR 12523, Apr. 15, 1988; 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995; 71 FR 33641, June 12, 2006; 88 FR 37172, June 7, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 717.19</SECTNO> <SUBJECT>Confidentiality.</SUBJECT> <P>Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703.</P> <CITA>[88 FR 37172, June 7, 2023]</CITA> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 720</EAR> <HD SOURCE="HED">PART 720—PREMANUFACTURE NOTIFICATION</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>720.1</SECTNO> <SUBJECT>Scope.</SUBJECT> <SECTNO>720.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Applicability</HD> <SECTNO>720.22</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <SECTNO>720.25</SECTNO> <SUBJECT>Determining whether a chemical substance is on the Inventory.</SUBJECT> <SECTNO>720.30</SECTNO> <SUBJECT>Chemicals not subject to notification requirements.</SUBJECT> <SECTNO>720.36</SECTNO> <SUBJECT>Exemption for research and development.</SUBJECT> <SECTNO>720.38</SECTNO> <SUBJECT>Exemptions for test marketing.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Notice Form</HD> <SECTNO>720.40</SECTNO> <SUBJECT>General.</SUBJECT> <SECTNO>720.45</SECTNO> <SUBJECT>Information that must be included in the notice form.</SUBJECT> <SECTNO>720.50</SECTNO> <SUBJECT>Submission of test data and other data concerning the health and environmental effects of a substance.</SUBJECT> <SECTNO>720.57</SECTNO> <SUBJECT>Imports.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Disposition of Notices</HD> <SECTNO>720.60</SECTNO> <SUBJECT>General.</SUBJECT> <SECTNO>720.62</SECTNO> <SUBJECT>Notice that notification is not required.</SUBJECT> <SECTNO>720.65</SECTNO> <SUBJECT>Acknowledgement of receipt of a notice; errors in the notice; incomplete submissions; and false and misleading statements.</SUBJECT> <SECTNO>720.70</SECTNO> <SUBJECT>Notice in the Federal Register.</SUBJECT> <SECTNO>720.75</SECTNO> <SUBJECT>Notice review period.</SUBJECT> <SECTNO>720.78</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Confidentiality and Public Access to Information</HD> <SECTNO>720.80</SECTNO> <SUBJECT>General provisions.</SUBJECT> <SECTNO>720.87</SECTNO> <SUBJECT>Categories or proposed categories of uses of a new chemical substance.</SUBJECT> <SECTNO>720.95</SECTNO> <SUBJECT>Public file.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart F—Commencement of Manufacture or Import</HD> <SECTNO>720.102</SECTNO> <SUBJECT>Notice of commencement of manufacture.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart G—Compliance and Inspections</HD> <SECTNO>720.120</SECTNO> <SUBJECT>Compliance.</SUBJECT> <SECTNO>720.122</SECTNO> <SUBJECT>Inspections.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2604, 2607, and 2613.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>48 FR 21742, May 13, 1983, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 720.1</SECTNO> <SUBJECT>Scope.</SUBJECT> <P>This part establishes procedures for the reporting of new chemical substances by manufacturers under section 5 of the Toxic Substances Control Act, 15 U.S.C. 2604. This part applies to microorganisms only to the extent provided by part 725 of this chapter. The rule defines the persons and chemical substances subject to the reporting requirements, prescribes the contents of section 5 notices, and establishes procedures for submitting notices. The rule also establishes EPA policy regarding claims of confidentiality for, and public disclosure of, various categories of information submitted in connection with section 5 notices.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 62 FR 17932, Apr. 11, 1997; 87 FR 39763, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P> (a)(1) For the purposes of this part, the terms <E T="03">cosmetic, device, drug, food,</E> <PRTPAGE P="224"/> and <E T="03">food additive</E> have the meanings contained in the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 321 <E T="03">et seq.,</E> and the regulations issued under it. In addition, the term “food” includes poultry and poultry products, as defined in the Poultry Products Inspection Act, 21 U.S.C. 453 <E T="03">et seq.;</E> meats and meat food products, as defined in the Federal Meat Inspection Act, 21 U.S.C. 60 <E T="03">et seq.;</E> and eggs and egg products, as defined in the Egg Products Inspection Act, 21 U.S.C. 1033 <E T="03">et seq.</E> </P> <P> (2) The term <E T="03">pesticide</E> has the meaning contained in the Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. 136 <E T="03">et seq.</E> and the regulations issued under it. </P> <P> (3) The terms <E T="03">byproduct material, source material,</E> and <E T="03">special nuclear material</E> have the meanings contained in the Atomic Energy Act of 1954, 42 U.S.C 2014 <E T="03">et seq.</E> and the regulations issued under it. </P> <P> (b) <E T="03">Act</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 <E T="03">et seq.</E> </P> <P> (c) <E T="03">Article</E> means a manufactured item: </P> <P>(1) Which is formed to a specific shape or design during manufacture;</P> <P>(2) Which has end use function(s) dependent in whole or in part upon its shape or design during end use; and</P> <P>(3) Which has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article and that may occur as described in § 720.30(h)(5), except that fluids and particles are not considered articles regardless of shape or design.</P> <P> (d) <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance or mixture. </P> <P> (e) <E T="03">Chemical substance</E> means any organic or inorganic substance of a particular molecular identity, including any combination of such substances occurring in whole or in part as a result of a chemical reaction or occurring in nature, and any chemical element or uncombined radical, except that “chemical substance” does not include: </P> <P>(1) Any mixture.</P> <P>(2) Any pesticide when manufactured, processed, or distributed in commerce for use as a pesticide.</P> <P>(3) Tobacco or any tobacco product.</P> <P>(4) Any source material, special nuclear material, or byproduct material.</P> <P>(5) Any pistol, firearm, revolver, shells, or cartridges.</P> <P>(6) Any food, food additive, drug, cosmetic, or device, when manufactured, processed, or distributed in commerce for use as a food, food additive, drug, cosmetic, or device.</P> <P> (f) <E T="03">Commerce</E> means trade, traffic, transportation, or other commerce (1) between a place in a State and any place outside of such State, or (2) which affects trade, traffic, transportation, or commerce between a place in a State and any place outside of such State. </P> <P> (g) <E T="03">Customs territory of the United States</E> means the 50 States, Puerto Rico, and the District of Columbia. </P> <P> (h) <E T="03">Director</E> means the Director of the EPA Office of Pollution Prevention and Toxics. </P> <P> (i) <E T="03">Distribute in commerce</E> means to sell in commerce, to introduce or deliver for introduction into commerce, or to hold after introduction into commerce. </P> <P> (j) <E T="03">EPA</E> means the U.S. Environmental Protection Agency. </P> <P> (k) <E T="03">Health and safety study</E> or <E T="03">study</E> means any study of any effect of a chemical substance or mixture on health or the environment or on both, including underlying data and epidemiological studies, studies of occupational exposure to a chemical substance or mixture, toxicological, clinical, and ecological, or other studies of a chemical substance or mixture, and any test performed under the Act. Chemical identity is always part of a health and safety study. </P> <P>(1) Not only is information which arises as a result of a formal, disciplined study included, but other information relating to the effects of a chemical substance or mixture on health or the environment is also included. Any data that bear on the effects of a chemical substance on health or the environment would be included.</P> <P>(2) Examples include:</P> <P> (i) Long- and short-term tests of mutagenicity, carcinogenicity, or <PRTPAGE P="225"/> teratogenicity; data on behavioral disorders; dermatoxicity; pharmacological effects; mammalian absorption, distribution, metabolism, and excretion; cumulative, additive, and synergistic effects; acute, subchronic, and chronic effects; and structure/activity analyses. </P> <P>(ii) Tests for ecological or other environmental effects on invertebrates, fish, or other animals, and plants, including: Acute toxicity tests, chronic toxicity tests, critical life stage tests, behavioral tests, algal growth tests, seed germination tests, plant growth or damage tests, microbial function tests, bioconcentration or bioaccumulation tests, and model ecosystem (microcosm) studies.</P> <P>(iii) Assessments of human and environmental exposure, including workplace exposure, and impacts of a particular chemical substance or mixture on the environment, including surveys, tests, and studies of: Biological, photochemical, and chemical degradation; air, water, and soil transport; biomagnification and bioconcentration; and chemical and physical properties, e.g., boiling point, vapor pressure, evaporation rates from soil and water, octanol/water partition coefficient, and water solubility.</P> <P>(iv) Monitoring data, when they have been aggregated and analyzed to measure the exposure of humans or the environment to a chemical substance or mixture.</P> <P>(v) Any assessments of risk to health and the environment resulting from the manufacture, processing, distribution in commerce, use, or disposal of the chemical substance.</P> <P> (l) <E T="03">Importer</E> means any person who imports a chemical substance, including a chemical substance as part of a mixture or article, into the customs territory of the United States. “Importer” includes the person primarily liable for the payment of any duties on the merchandise or an authorized agent acting on his or her behalf. The term also includes, as appropriate: </P> <P>(1) The consignee.</P> <P>(2) The importer of record.</P> <P>(3) The actual owner if an actual owner's declaration and superseding bond has been filed in accordance with 19 CFR 141.20; or</P> <P>(4) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144. (See “principal importer.”)</P> <P> (m) <E T="03">Impurity</E> means a chemical substance which is unintentionally present with another chemical substance. </P> <P> (n) <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reactions used for the intentional manufacture of another chemical substance(s) or mixture(s), or that is intentionally present for the purpose of altering the rates of such chemical reactions. </P> <P> (o) <E T="03">Inventory</E> means the list of chemical substances manufactured or processed in the United States that EPA compiled and keeps current under section 8(b) of the Act. </P> <P> (p) <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know. </P> <P> (q) <E T="03">Manufacture</E> means to produce or manufacture in the United States or import into the customs territory of the United States. </P> <P> (r) <E T="03">Manufacture for commercial purposes</E> means: </P> <P>(1) To manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes, among other things, “manufacture” of any amount of a chemical substance or mixture:</P> <P>(2) The term also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts that are separated from that other substance or mixture and impurities that remain in that substance or mixture. Byproducts and impurities without separate commercial value are nonetheless produced for the purpose of obtaining a commercial advantage, since they are part of the manufacture of a chemical substance for commercial purposes.</P> <P> (s) <E T="03">Manufacture solely for export</E> means to manufacture for commercial purposes a chemical substance solely for export from the United States <PRTPAGE P="226"/> under the following restrictions on activities in the United States: </P> <P>(1) Distribution in commerce is limited to purposes of export or processing solely for export as defined in § 721.3 of this chapter.</P> <P>(2) The manufacturer and any person to whom the substance is distributed for purposes of export or processing solely for export (as defined in § 721.3 of this chapter), may not use the substance except in small quantities solely for research and development in accordance with § 720.36.</P> <P> (t) <E T="03">Manufacturer</E> means a person who imports, produces, or manufactures a chemical substance. A person who extracts a component chemical substance from a previously existing chemical substance or a complex combination of substances is a manufacturer of that component chemical substance. A person who contracts with a manufacturer to manufacture or produce a chemical substance is also a manufacturer if (1) the manufacturer manufactures or produces the substance exclusively for that person, and (2) that person specifies the identity of the substance and controls the total amount produced and the basic technology for the plant process. </P> <P> (u) <E T="03">Mixture</E> means any combination of two or more chemical substances if the combination does not occur in nature and is not, in whole or in part, the result of a chemical reaction; except “mixture” does include (1) any combination which occurs, in whole or in part, as a result of a chemical reaction if the combination could have been manufactured for commercial purposes without a chemical reaction at the time the chemical substances comprising the combination were combined, and if all of the chemical substances comprising the combination are not new chemical substances, and (2) hydrates of a chemical substance or hydrated ions formed by association of a chemical substance with water, so long as the nonhydrated form is itself not a new chemical substance. </P> <P> (v) <E T="03">New chemical substance</E> means any chemical substance which is not included on the Inventory. </P> <P> (w) <E T="03">Nonisolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the chemical substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture. </P> <P> (x) <E T="03">Person</E> means any natural person, firm, company, corporation, joint-venture, partnership, sole proprietorship, association, or any other business entity, any State or political subdivision thereof, any municipality, any interstate body, and any department, agency or instrumentality of the Federal Government. </P> <P> (y) <E T="03">Possession or control</E> means in possession or control of the submitter, or of any subsidiary, partnership in which the submitter is a general partner, parent company, or any company or partnership which the parent company owns or controls, if the subsidiary, parent company, or other company or partnership is associated with the submitter in the research, development, test marketing, or commercial marketing of the chemical substance in question. (A parent company owns or controls another company if the parent owns or controls 50 percent or more of the other company's voting stock. A parent company owns or controls any partnership in which it is a general partner). Information is included within this definition if it is: </P> <P>(1) In files maintained by submitter's employees who are:</P> <P>(i) Associated with research, development, test marketing, or commercial marketing of the chemical substance in question.</P> <P>(ii) Reasonably likely to have such data.</P> <P>(2) Maintained in the files of other agents of the submitter who are associated with research, development, test marketing, or commercial marketing of the chemical substance in question in the course of their employment as such agents.</P> <P> (z) <E T="03">Principal importer</E> means the first importer who, knowing that a new chemical substance will be imported rather than manufactured domestically, specifies the identity of the chemical substance and the total <PRTPAGE P="227"/> amount to be imported. Only persons who are incorporated, licensed, or doing business in the United States may be principal importers. </P> <P> (aa) <E T="03">Process</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce (1) in the same form or physical state as, or in a different form or physical state from, that in which it was received by the person so preparing such substance or mixture, or (2) as part of a mixture or article containing the chemical substance or mixture. </P> <P> (bb) <E T="03">Processor</E> means any person who processes a chemical substance or mixture. </P> <P> (cc) <E T="03">Small quantities solely for research and development</E> (or “small quantities solely for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including such research or analysis for the development of a product”) means quantities of a chemical substance manufactured or processed or proposed to be manufactured or processed solely for research and development that are not greater than reasonably necessary for such purposes. </P> <P> (dd) <E T="03">State</E> means any State of the United States and the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Canal Zone, American Samoa, the Northern Mariana Islands, and any other territory or possession of the United States. </P> <P> (ee) <E T="03">Technically qualified individual</E> means a person or persons (1) who, because of education, training, or experience, or a combination of these factors, is capable of understanding the health and environmental risks associated with the chemical substance which is used under his or her supervision, (2) who is responsible for enforcing appropriate methods of conducting scientific experimentation, analysis, or chemical research to minimize such risks, and (3) who is responsible for the safety assessments and clearances related to the procurement, storage, use, and disposal of the chemical substance as may be appropriate or required within the scope of conducting a research and development activity. </P> <P> (ff) <E T="03">Test data</E> means data from a formal or informal test or experiment, including information concerning the objectives, experimental methods and materials, protocols, results, data analyses, recorded observations, monitoring data, measurements, and conclusions from a test or experiment. </P> <P> (gg) <E T="03">Test marketing</E> means the distribution in commerce of no more than a predetermined amount of a chemical substance, mixture, or article containing that chemical substance or mixture, by a manufacturer or processor, to no more than a defined number of potential customers to explore market capability in a competitive situation during a predetermined testing period prior to the broader distribution of that chemical substance, mixture, or article in commerce. </P> <P> (hh) <E T="03">United States,</E> when used in the geographic sense, means all of the States. </P> <P> (ii) <E T="03">Central Data Exchange</E> or <E T="03">CDX</E> means EPA's centralized electronic document receiving system, or its successors. </P> <P> (jj) <E T="03">e-PMN software</E> means electronic-PMN software created by EPA for use in preparing and submitting Premanufacture Notices (PMNs) and other TSCA section 5 notices and support documents electronically to the Agency. </P> <P> (kk) <E T="03">Support documents</E> means material and information submitted to EPA in support of a TSCA section 5 notice, including but not limited to, correspondence, amendments (if notices for these amendments were submitted prior to January 19, 2016), and test data. The term “support documents” does not include orders under TSCA section 5(e) (either consent orders or orders imposed pursuant to TSCA section 5(e)(2)(B)). </P> <CITA>[48 FR 21742, May 13, 1983, as amended at 51 FR 15101, Apr. 22, 1986; 75 FR 784, Jan. 6, 2010; 80 FR 42745, July 20, 2015; 87 FR 39763, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Applicability</HD> <SECTION> <SECTNO>§ 720.22</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <P> (a)(1) Any person who intends to manufacture a new chemical substance in the United States for commercial <PRTPAGE P="228"/> purposes must submit a notice unless the substance is excluded under § 720.30. </P> <P>(2) If a person contracts with a manufacturer to manufacture or produce a new chemical substance, and (i) the manufacturer manufactures or produces the substance exclusively for that person, and (ii) that person specifies the identity of the substance, and controls the total amount produced and the basic technology for the plant process, that person must submit the notice. If it is unclear who must report, EPA should be contacted to determine who must submit the notice.</P> <P>(3) Only manufacturers that are incorporated, licensed, or doing business in the United States may submit a notice.</P> <P>(b)(1) Any person who intends to import a new chemical substance into the United States for commercial purposes must submit a notice, unless the substance is excluded under § 720.30 or unless the substance is imported as part of an article.</P> <P>(2) When several persons are involved in an import transaction, the notice must be submitted by the principal importer. If no one person fits the principal importer definition in a particular transaction, the importer should contact EPA to determine who must submit the notice for that transaction.</P> </SECTION> <SECTION> <SECTNO>§ 720.25</SECTNO> <SUBJECT>Determining whether a chemical substance is on the Inventory.</SUBJECT> <P>(a) A new chemical substance is any chemical substance that is not currently listed on the Inventory.</P> <P> (b)(1) A chemical substance is listed in the public portion of the Inventory by a specific chemical name (either a Chemical Abstracts (CA) Index Name or a CA Preferred Name) and a Chemical Abstracts Service (CAS) Registry Number if its identity is not confidential. If its identity is confidential, it is listed in the public portion of the Inventory by a TSCA Accession Number and a generic chemical name that masks the specific substance identity. The confidential substance is listed by its specific chemical name only in the confidential portion of the Inventory, which is not available to the public. A person who intends to manufacture (including import) a chemical substance not listed by specific chemical name in the public portion of the Inventory may ask EPA whether the substance is included in the confidential Inventory. EPA will answer such an inquiry only if EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture (including import) the chemical substance for commercial purposes. </P> <P> (2) To establish a <E T="03">bona fide</E> intent to manufacture (including import) a chemical substance, the person who proposes to manufacture the substance must submit the request to EPA via CDX. Prior to submission to EPA via CDX, such <E T="03">bona fide</E> intents to manufacture (including import) must be generated and completed using e-PMN software. See § 720.40(a)(2)(ii) for information on how to access the e-PMN software. A <E T="03">bona fide</E> intent to manufacture (including import) must contain: </P> <P>(i) Except as provided in paragraphs (b)(3)(i) and (ii) of this section, the specific chemical identity of the substance that the person intends to manufacture (including import), using the currently correct CA Index name for the substance and the other correct chemical identity information in accordance with § 720.45(a) (1), (2), and (3).</P> <P>(ii) A signed statement that the person intends to manufacture (including import) that chemical substance for commercial purposes.</P> <P>(iii)(A) A brief description of the research and development activities conducted to date related to the substance, including the year in which the person first started to conduct research or development activity on the substance, and the general types of research and development activities conducted thus far (e.g., synthesis, substance isolation/purification, formulating, product development, process development, end-use application, toxicity testing, etc.). The person must also indicate whether any pilot plant or production-scale plant evaluations have been conducted involving the manufacture or processing of the substance.</P> <P> (B) If an importer is unable to provide the information requested in paragraph (b)(2)(iii)(A) of this section from the foreign manufacturer or supplier, <PRTPAGE P="229"/> the following information shall be submitted: </P> <P> ( <E T="03">1</E> ) A brief statement indicating how long the substance has been in commercial use outside of the United States. </P> <P> ( <E T="03">2</E> ) The name of a country in which it has been commercially used. </P> <P> ( <E T="03">3</E> ) Whether the importer believes that the substance has already been used commercially, in any country, for the same purpose or application that the importer is intending. </P> <P>(iv) A specific description of the major intended application or use of the substance.</P> <P>(v) An infrared spectrum of the substance, or alternative spectra or other data which identify the substance if infrared analysis is not suitable for the substance or does not yield a reasonable amount of structural information. When using alternative spectra or instrumental analysis, the person must submit a spectrum or instrumental readout for the substance.</P> <P>(vi) The estimated date (month/year) in which the person intends to submit a Premanufacture Notice (PMN) for this substance if EPA informs the notice submitter that the substance is not on the Inventory.</P> <P>(vii) The address of the facility under the control of the submitter at which the manufacture or processing of the substance would most likely occur. For an imported substance, the facility under the control of the importer at which processing of the substance would likely occur, if any.</P> <P>(viii)(A) For substances intended to be manufactured in the United States, a description of the most probable manufacturing process that would be used by the submitter to produce the substance for non-exempt commercial purposes.</P> <P>(B) For substances intended to be imported, a brief description of how the submitter is most likely to process or use the substance for a commercial purpose. If the substance is not expected to be processed or used at any facility under the importer's control, a statement to this effect must be included along with a description of how the substance will be processed or used at sites controlled by others, if this information is known or reasonably ascertainable.</P> <P>(3)(i) If an importer cannot provide the chemical identity information required by paragraph (b)(2) (i) and (v) of this section because it is claimed confidential by its foreign manufacturer or supplier, the foreign manufacturer or supplier must supply the required information directly to EPA in accordance with § 720.45(a) (1), (2), and (3) and reference the importer's notice. If the appropriate supporting document from the foreign party is not received within 30 days after EPA receives the importer's notice, the notice will be considered incomplete.</P> <P>(ii) If a manufacturer cannot provide all of the required information in accordance with § 720.45(a) (1), (2), and (3) because the new chemical substance is manufactured using a reactant that has a specific chemical identity claimed as confidential by its supplier, the notice must contain chemical identity information that is as complete as known by the manufacturer. In addition, a letter of support for the notice must then be sent to EPA by the chemical supplier of the confidential reactant, providing the specific chemical identity of the proprietary reactant. The letter of support must reference the manufacturer's notice. If the appropriate supporting document from the supplier is not received within 30 days after EPA receives the manufacturer's notice, the notice will be considered incomplete.</P> <P> (4) EPA will review the information submitted by the proposed manufacturer (including importer) under this paragraph to determine whether it has a <E T="03">bona fide</E> intent to manufacture (including import) the chemical substance. If necessary, EPA will compare this information to the information requested for the confidential chemical substance under § 720.85(b)(3)(iii). </P> <P> (5) If the proposed manufacturer (including importer) has shown a <E T="03">bona fide</E> intent to manufacture (including import) the substance, and has provided sufficient unambiguous chemical identity information so EPA can make a conclusive determination of the chemical substance's Inventory status, EPA will search the confidential Inventory and inform the proposed manufacturer <PRTPAGE P="230"/> (including importer) whether the chemical substance is on the confidential Inventory. </P> <P> (6) If the chemical substance is found on the confidential Inventory, EPA will notify the person(s) who originally reported the chemical substance that another person has demonstrated a <E T="03">bona fide</E> intent to manufacture (including import) the substance and therefore was told that the chemical substance is on the Inventory. </P> <P> (7) A disclosure of a confidential chemical identity to a person with a <E T="03">bona fide</E> intent to manufacture (including import) the particular chemical substance will not be considered a public disclosure of confidential business information under section 14 of the Act. </P> <P>(8) EPA will answer an inquiry on whether a particular chemical substance is on the confidential Inventory within 30 days after receipt of a complete submission under paragraph (b)(2) of this section.</P> <P> (9) If the required chemical identity information has not been reported correctly or completely in the notice (except as provided under paragraph (b)(3)(ii) of this section) or if any other required data or information has been omitted or is incomplete, EPA will consider the whole notice to be incomplete. As soon as an incomplete notice is identified as such by EPA, the Agency will immediately return the notice directly to the submitter. The submitter must then resubmit the whole, completed <E T="03">bona fide</E> notice to EPA in order to have the Agency perform the desired Inventory search and respond to the notice. </P> <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 60 FR 16309, Mar. 29, 1995; 80 FR 42745, July 20, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.30</SECTNO> <SUBJECT>Chemicals not subject to notification requirements.</SUBJECT> <P>The following substances are not subject to the notification requirements of this part:</P> <P>(a) Any substance which is not a “chemical substance” as defined in § 720.3(e).</P> <P> (b) Any mixture as defined in § 720.3(u).  <SU>1</SU> <FTREF/> </P> <FTNT> <P> <SU>1</SU>  A new chemical substance that is manufactured as part of a mixture is subject to the requirements of this part. This exclusion applies only to a mixture as a whole and not to any chemical substances which are part of the mixture. </P> </FTNT> <P>(c) Any new chemical substance which will be manufactured in small quantities solely for research and development under § 720.36.</P> <P>(d) Any new chemical substance which will be manufactured solely for test-marketing purposes under an exemption granted under § 720.38.</P> <P>(e) Any new chemical substance manufactured solely for export if, when the substance is distributed in commerce:</P> <P>(1) The substance is labeled in accordance with section 12(a)(1)(B) of the Act.</P> <P>(2) The manufacturer knows that the person to whom the substance is being distributed intends to export it or process it solely for export as defined in § 721.3 of this chapter.</P> <P>(f) Any new chemical substance which is manufactured under the terms of a rule promulgated under section 5(h)(4) of the Act.</P> <P>(g) Any byproduct if its only commercial purpose is for use by public or private organizations that (1) burn it as a fuel, (2) dispose of it as a waste, including in a landfill or for enriching soil, or (3) extract component chemical substances from it for commercial purposes. (This exclusion only applies to the byproduct; it does not apply to the component substances extracted from the byproduct.)</P> <P>(h) The chemical substances described below: (Although they are manufactured for commercial purposes under the Act, they are not manufactured for distribution in commerce as chemical substances per se and have no commercial purpose separate from the substance, mixture, or article of which they are a part.)</P> <P>(1) Any impurity.</P> <P>(2) Any byproduct which is not used for commercial purposes.</P> <P> (3) Any chemical substance which results from a chemical reaction that occurs incidental to exposure of another chemical substance, mixture, or article to environmental factors such as air, <PRTPAGE P="231"/> moisture, microbial organisms, or sunlight. </P> <P>(4) Any chemical substance which results from a chemical reaction that occurs incidental to storage or disposal of another chemical substance, mixture, or article.</P> <P>(5) Any chemical substance which results from a chemical reaction that occurs upon end use of another chemical substance, mixture, or article such as an adhesive, paint, miscellaneous cleanser or other housekeeping product, fuel additive, water softening and treatment agent, photographic film, battery, match, or safety flare, and which is not itself manufactured for distribution in commerce or for use as an intermediate.</P> <P>(6) Any chemical substance which results from a chemical reaction that occurs upon use of curable plastic or rubber molding compounds, inks, drying oils, metal finishing compounds, adhesives, or paints, or any other chemical substance formed during the manufacture of an article destined for the marketplace without further chemical change of the chemical substance except for those chemical changes that occur as described elsewhere in this paragraph.</P> <P>(7) Any chemical substance which results from a chemical reaction that occurs when (i) a stabilizer, colorant, odorant, antioxidant, filler, solvent, carrier, surfactant, plasticizer, corrosion inhibitor, antifoamer or defoamer, dispersant, precipitation inhibitor, binder, emulsifier, deemulsifier, dewater­ing agent, agglomerating agent, adhesion promoter, flow modifier, pH neutralizer, sequesterant, coagulant, flocculant, fire retardant, lubricant, chelating agent, or quality control reagent functions as intended, or (ii) a chemical substance, which is intended solely to impart a specific physiochemical characteristic, functions as intended.</P> <P>(8) Any nonisolated intermediate.</P> <P>(i) Any chemical substance which is manufactured solely for non-commercial research and development purposes. Non-commercial research and development purposes include scientific experimentation, research, or analysis conducted by academic, government, or independent not-for-profit research organizations (e.g., universities, colleges, teaching hospitals, and research institutes), unless the activity is for eventual commercial purposes.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 51 FR 15101, Apr. 22, 1986; 87 FR 39763, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.36</SECTNO> <SUBJECT>Exemption for research and development.</SUBJECT> <P>(a) This part does not apply to a chemical substance if the following conditions are met:</P> <P>(1) The chemical substance is manufactured only in small quantities solely for research and development.</P> <P>(2) The manufacturer notifies all persons in its employ or to whom it directly distributes the chemical substance, who are engaged in experimentation, research, or analysis on the chemical substance, including the manufacture, processing, use, transport, storage, and disposal of the substance associated with research and development activities, of any risk to health, identified under paragraph (b) of this section, which may be associated with the substance. The notification must be made in accordance with paragraph (c) of this section.</P> <P>(3) The chemical substance is used by, or directly under the supervision of, a technically qualified individual.</P> <P>(b)(1) To determine whether notification under paragraph (a)(2) of this section is required, the manufacturer must review and evaluate the following information to determine whether there is reason to believe there is any potential risk to health which may be associated with the chemical substance:</P> <P>(i) Information in its possession or control concerning any significant adverse reaction by persons exposed to the chemical substance which may reasonably be associated with such exposure.</P> <P>(ii) Information provided to the manufacturer by a supplier or any other person concerning a health risk believed to be associated with the substance.</P> <P>(iii) Health and environmental effects data in its possession or control concerning the substance.</P> <P> (iv) Information on health effects which accompanies any EPA rule or <PRTPAGE P="232"/> order issued under sections 4, 5, or 6 of the Act that applies to the substance and of which the manufacturer has knowledge. </P> <P>(2) When the research and development activity is conducted solely in a laboratory and exposure to the chemical substance is controlled through the implementation of prudent laboratory practices for handling chemical substances of unknown toxicity, and any distribution, except for purposes of disposal, is to other such laboratories for further research and development activity, the information specified in paragraph (b)(1) of this section need not be reviewed and evaluated. (For purposes of this paragraph, a laboratory is a contained research facility where relatively small quantities of chemical substances are used on a non-production basis, and where activities involve the use of containers for reactions, transfers, and other handling of substances designed to be easily manipulated by a single individual.)</P> <P>(c)(1) The manufacturer must notify the persons identified in paragraph (a)(2) of this section by means of a container labeling system, conspicuous placement of notices in areas where exposure may occur, written notification to each person potentially exposed, or any other method of notification which adequately informs persons of health risks which the manufacturer has reason to believe may be associated with the substance, as determined under paragraph (b)(1) of this section.</P> <P>(2) If the manufacturer distributes a chemical substance manufactured under this section to persons not in its employ, the manufacturer must in written form:</P> <P>(i) Notify those persons that the substance is to be used only for research and development purposes.</P> <P>(ii) Provide the notice of health risks specified in paragraph (c)(1) of this section.</P> <P>(3) The adequacy of any notification under this section is the responsibility of the manufacturer.</P> <P>(d) A chemical substance is not exempt from reporting under this part if any amount of the substance, including as part of a mixture, is processed, distributed in commerce, or used, for any commercial purpose other than research and development, except where the chemical substance is processed, distributed in commerce, or used only as an impurity or as part of an article.</P> <P>(e) Quantities of the chemical substance, or of mixtures or articles containing the chemical substance, remaining after completion of research and development activities may be:</P> <P>(1) Disposed of as a waste in accordance with applicable Federal, state, and local regulations, or</P> <P>(2) Used for the following commercial purposes:</P> <P>(i) Burning it as a fuel.</P> <P>(ii) Reacting or otherwise processing it to form other chemical substances for commercial purposes, including extracting component chemical substances.</P> <P>(f) Quantities of research and development substances existing solely as impurities in a product or incorporated into an article, in accordance with paragraph (d) of this section, and quantities of research and development substances used solely for commercial purposes listed in paragraph (e) of this section, are not subject to the requirements of paragraphs (a), (b), and (c) of this section, once research and development activities have been completed.</P> <P>(g) A person who manufactures a chemical substance in small quantities solely for research and development is not required to comply with the requirements of this section if the person's exclusive intention is to perform research and development activities solely for the purpose of determining whether the substance can be used as a pesticide.</P> <CITA>[51 FR 15102, Apr. 22, 1986, as amended at 87 FR 39763, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.38</SECTNO> <SUBJECT>Exemptions for test marketing.</SUBJECT> <P>(a) Any person may apply for an exemption to manufacture a new chemical substance for test marketing. EPA may grant the exemption if the person demonstrates that the chemical substance will not present an unreasonable risk to injury to health or the environment as a result of the test marketing.</P> <P> (b) Persons applying for a test-marketing exemption should provide the following information: <PRTPAGE P="233"/> </P> <P>(1) All existing data regarding health and environmental effects of the chemical substance, including physical/chemical properties or, in the absence of such data, a discussion of toxicity based on structure-activity relationships (SAR) and relevant data on chemical analogues.</P> <P>(2) The maximum quantity of the chemical substance which the applicant will manufacture for test marketing.</P> <P>(3) The maximum number of persons who may be provided the chemical substance during test marketing.</P> <P>(4) The maximum number of persons who may be exposed to the chemical substance as a result of test marketing, including information regarding duration and route of such exposures.</P> <P>(5) A description of the test-marketing activity, including its length and how it can be distinguished from full-scale commercial production and research and development.</P> <P>(6) A fee payment identity number, as required in 40 CFR 700.45(g)(4).</P> <P>(7) Any safety data sheet already developed for the chemical substance, including draft safety data sheets.</P> <P>(c) In accordance with section 5(h)(6) of the Act, after EPA receives an application for exemption under this section, the Agency will file with the Office of the Federal Register a notice containing a summary of the information provided in the application, to the extent it has not been claimed confidential.</P> <P> (d) No later than 45 days after EPA receives an application, the Agency will either approve or deny the application. Thereafter, EPA will publish a notice in the <E T="04">Federal Register</E> explaining the reasons for approval or denial. </P> <P>(e) In approving an application for exemption, EPA may impose any restrictions necessary to ensure that the substance will not present an unreasonable risk of injury to health and the environment as a result of test marketing.</P> <P>(f) When applying for a test marketing exemption, persons are subject to fees in accordance with 40 CFR 700.45.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 83 FR 52719, Oct. 17, 2018; 87 FR 39763, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Notice Form</HD> <SECTION> <SECTNO>§ 720.40</SECTNO> <SUBJECT>General.</SUBJECT> <P> (a) <E T="03">Use of the notice form; electronic submissions.</E> (1) Each person who is required by subpart B of this part to submit a notice must complete, sign, and submit a notice containing the information in the form and manner specified in this paragraph. The information submitted and all attachments (unless the attachment appears in the open scientific literature) must be in English. All information submitted must be true and correct. </P> <P>(2) All notices must be submitted on EPA Form 7710-25. Notices, and any support documents related to these notices, may only be submitted in a manner set forth in this paragraph.</P> <P> (i) <E T="03">Submission via CDX.</E> TSCA section 5 notices and any related support documents must be submitted electronically to EPA via CDX. Prior to submission to EPA via CDX, such notices must be generated and completed on EPA Form 7710-25 using e-PMN software. </P> <P>(ii) You can access the e-PMN software as follows:</P> <P> (A) <E T="03">Website.</E> Go to EPA's TSCA New Chemicals Program website at <E T="03">http://www.epa.gov/oppt/newchems</E> and follow the appropriate links. </P> <P> (B) <E T="03">Telephone.</E> Call the EPA CDX Help Desk at 1-888-890-1995. </P> <P> (C) <E T="03">E-mail.</E> <E T="03">HelpDesk@epacdx.net.</E> </P> <P> (b) <E T="03">When to submit a notice.</E> Each person who is required to submit a notice must submit the notice at least 90 calendar days before manufacture of the new chemical substance for commercial purposes begins. </P> <P> (c) <E T="03">Where to submit a notice or support documents.</E> For submitting notices or support documents via CDX, use the e-PMN software. </P> <P> (d) <E T="03">General notice requirements.</E> (1) Each person who submits a notice must provide the information described in § 720.45 and specified on the notice form, to the extent such information is known to or reasonably ascertainable <PRTPAGE P="234"/> by the person. In accordance with § 720.50, the notice must also include any test data in the person's possession or control, and descriptions of other data which are known to or reasonably ascertainable by the person and which concern the health and environmental effects of the new chemical substance. </P> <P>(2) If information is claimed as confidential pursuant to § 720.80, a person who submits a notice to EPA in the manner set forth in § 720.40(a)(2)(i), (ii), or (iii) must also provide EPA with a sanitized copy.</P> <P> (e) <E T="03">Agency or joint submissions.</E> (1) A manufacturer (including importer) may designate an agent to assist in submitting the notice. If so, only the manufacturer (including importer), and not the agent, signs the certification on the form. </P> <P>(2) A manufacturer may authorize another person, (e.g., a supplier or a toll manufacturer) to report some of the information required in the notice to EPA on its behalf. The manufacturer should indicate in a cover letter accompanying the notice which information will be supplied by another person and must identify that other person as a joint submitter where indicated on their notice form. The other person supplying information (i.e., the joint submitter) may submit the information to EPA using either the notice form or a Letter of Support, except that if the joint submitter is not incorporated, licensed, or doing business in the United States, the joint submitter must submit the information to EPA in a Letter of Support only, not in a notice form. The joint submitter must indicate in the notice or Letter of Support the identity of the manufacturer. Any person who submits a notice form or Letter of Support for a joint submission must sign and certify the notice form or Letter of Support.</P> <P>(3) Only the Authorized Official (AO) of a submitting company can certify initial notices and submit all TSCA section 5 documents.</P> <P>(i) An AO can authorize other persons to be non-certifying AOs who may conduct all section 5 business on behalf of the submitting company except for certifying and submitting initial notices to EPA via CDX.</P> <P>(ii) An AO may grant access to a support registrant to edit section 5 documents.</P> <P> (f) <E T="03">New information.</E> During the notice review period, if the submitter possesses, controls, or knows of new information that materially adds to, changes, or otherwise makes significantly more complete the information included in the notice, the submitter must that information to the address listed on the notice form within ten days of receiving the new information, but no later than five days before the end of the notice review period. The new submission must clearly identify the submitter and the notice to which the new information is related. If the new information becomes available during the last five days of the notice review period, the submitter must immediately inform its EPA contract for that notice by telephone. </P> <P> (g) <E T="03">Chemical substances subject to a section 4 test rule.</E> (1) Except as provided in paragraph (g)(3) of this section, if (i) A person intends to manufacture a new chemical substance which is subject to the notification requirements of this part, and (ii) The chemical substance is subject to a test rule promulgated under section 4 of the Act before the notice is submitted, section 5(b)(1) of the Act requires the person to submit the test data required by the testing rule with the notice. The person must submit the data in the form and manner specified in the test rule and in accordance with § 720.50. If the person does not submit the test data, the submission is incomplete and EPA will follow the procedures in § 720.65. </P> <P>(2) If EPA has granted the submitter an exemption under section 4(c) of the Act from the requirement to conduct tests and submit data, the submitter may not submit a notice until EPA receives the test data.</P> <P>(3) If EPA has granted the submitter an exemption under section 4(c) of the Act and if another person previously has submitted the test data to EPA, the exempted person may either submit the test data or provide the following information as part of the notice:</P> <P> (i) The name, title, and address of the person who submitted the test data to EPA. <PRTPAGE P="235"/> </P> <P>(ii) The date the test data were submitted to EPA.</P> <P>(iii) A citation for the test rule.</P> <P>(iv) A description of the exemption and a reference identifying it.</P> <P> (h) <E T="03">Chemical substances subject to a section 5(b)(4) rule.</E> (1) If a person (i) intends to manufacture a new chemical substance which is subject to the notification requirements of this part and which is subject to a rule issued under section 5(b)(4) of the Act; and (ii) is not required by a rule issued under section 4 of the Act to submit test data for the substance before the submission of a notice, the person must submit to EPA data described in paragraph (h)(2) of this section at the time the notice is submitted. </P> <P>(2) Data submitted under paragraph (h)(1) of this section must be data which the person submitting the notice believes show that the manufacture, processing, distribution in commerce, use and disposal of the substance, or any combination of such activities, will not present an unreasonable risk of injury to health or the environment.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 60 FR 16309, Mar. 29, 1995; 75 FR 784, Jan. 6, 2010; 78 FR 72827, Dec. 4, 2013; 80 FR 42746, July 20, 2015; 87 FR 39763, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.45</SECTNO> <SUBJECT>Information that must be included in the notice form.</SUBJECT> <P>Each person who submits a notice must include the information specified in the notice form to the extent it is known to or reasonably ascertainable by the submitter. However, no person is required to include information which relates solely to exposure of human or ecological populations outside of the United States. The notice form requires the following information relating to the manufacture, processing, distribution in commerce, use, and disposal of the new chemical substance:</P> <P>(a)(1) The specific chemical identity of the substance that the person intends to manufacture or import, which includes the following:</P> <P>(i) The currently correct Chemical Abstracts (CA) name for the substance, based on the Ninth Collective Index (9CI) of CA nomenclature rules and conventions, and consistent with listings for similar substances in the Inventory. For each substance having a chemical composition that can be represented by a specific, complete chemical structure diagram (a Class 1 substance), a CA Index Name must be provided. For each chemical substance that cannot be fully represented by a complete, specific chemical structure diagram (a Class 2 substance), or if the substance is a polymer, a CA Index Name or CA Preferred Name must be provided (whichever is appropriate based on CA 9CI nomenclature rules and conventions). In addition, for a Class 2 substance, the notice must identify the immediate chemical precursors and reactants by specific chemical name and Chemical Abstracts Service Registry Number (CASRN), if the number is available. Tradenames or generic names of chemical precursors or reactants are not acceptable as substitutes for specific chemical names.</P> <P>(ii) The currently correct CASRN for the substance if a CASRN already exists for the substance.</P> <P>(iii) For a Class 1 substance and for any Class 2 substance for which a definite molecular formula is known or reasonably ascertainable, the correct molecular formula.</P> <P>(iv) For a Class 1 substance, a complete, correct chemical structure diagram; for a Class 2 substance or polymer, a correct representative or partial chemical structure diagram, as complete as can be known, if one can be reasonably ascertained.</P> <P>(2) For a polymer, the submitter must also report the following:</P> <P>(i) The specific chemical name and CASRN, if the number is available, of each monomer and other reactant used, at any weight percent, to manufacture the polymer. Tradenames or generic names of chemical reactants or monomers are not acceptable as substitutes for specific chemical names.</P> <P>(ii) The typical percent by weight of each monomer and other reactant in the polymer (weight of the monomer or other reactant expressed as a percentage of the weight of the polymeric chemical substance manufactured), and the maximum residual amount of each monomer present in the polymer.</P> <P> (iii) For monomers and other reactants used at 2 weight percent or <PRTPAGE P="236"/> less (based on the dry weight of the polymer manufactured), indicate on the PMN form any such monomers and other reactants that should be included as part of the polymer description on the Inventory, where the weight percent is based on either (A) the weight of monomer or other reactant actually charged to the reaction vessel, or (B) the minimum weight of monomer or other reactant required in theory to account for the actual weight of monomer or other reactant molecules or fragments chemically incorporated (chemically combined) in the polymeric substance manufactured. </P> <P>(iv) For a determination that 2 weight percent or less of a monomer or other reactant is incorporated (chemically combined) in a polymeric substance manufactured, as specified in paragraphs (a)(2)(iii)(B) of this section, analytical data or appropriate theoretical calculations (if it can be documented that analytical measurement is not feasible or not necessary) to support this determination must be maintained at the site of manufacture or import of the polymer.</P> <P>(v) Measured or estimated values of the minimum number-average molecular weight of the polymer and the amount of low molecular weight species below 500 and below 1,000 molecular weight, with a description of how the measured or estimated values were obtained.</P> <P>(3) The person must use one of the following two methods to develop or obtain the specified chemical identity information reported under paragraphs (a) (1) and (2) of this section and must identify the method used in the notice:</P> <P> (i) <E T="03">Method 1.</E> Obtain the correct chemical identity information required by paragraphs (a) (1) and (2) of this section directly from the Chemical Abstracts Service (CAS), specifically from the CAS Registry Services Inventory Expert Service, prior to submitting a notice to EPA. A copy of the chemical identification report obtained from CAS must be submitted with the notice. </P> <P> (ii) <E T="03">Method 2.</E> Obtain the correct chemical identity information required by paragraphs (a) (1) and (2) from any source. The notice will be incomplete according to § 720.65(c)(1)(vi) if the person uses Method 2 and any chemical identity information is determined to be incorrect by EPA. </P> <P>(4) If an importer submitting the notice cannot provide all the information specified in paragraphs (a) (1) and (2) of this section because it is claimed as confidential by the foreign supplier of the substance, the importer must have the foreign supplier follow the procedures in paragraph (a)(3) of this section and provide the correct chemical identity information specified in paragraphs (a) (1) and (2) of this section directly to EPA in a joint submission or as a letter of support to the notice, which clearly references the importer's notice and PMN User Fee Identification Number. The statutory review process will commence upon receipt of both the notice and the complete, correct information.</P> <P>(5) If a manufacturer cannot provide all the information specified in paragraphs (a)(1) and (2) of this section because the new chemical substance is manufactured using a reactant having a specific chemical identity claimed as confidential by its supplier, the manufacturer must submit a notice directly to EPA containing all the information known by the manufacturer about the chemical identity of the reported substance and its proprietary reactant. In addition, the manufacturer must ensure that the supplier of the confidential reactant submit a letter of support directly to EPA providing the specific chemical identity of the confidential reactant, including the CAS number, if available, and the appropriate PMN or exemption number, if applicable. The letter of support must reference the manufacturer's name and PMN Fee Identification Number. The statutory review period will commence upon receipt of both the notice and the letter of support.</P> <P>(b) The impurities anticipated to be present in the substance by name, CAS Registry number, and weight percent of the total substance.</P> <P>(c) Known synonyms or trade names of the new chemical substance.</P> <P> (d) A description of the byproducts resulting from the manufacture, processing, use, and disposal of the new chemical substance. <PRTPAGE P="237"/> </P> <P>(e) The estimated maximum amount to be manufactured during the first year of production and the estimated maximum amount to be manufactured during any 12-month period during the first three years of production.</P> <P>(f) A description of intended categories of use by function and application, the estimated percent of production volume devoted to each category of use, and the percent of the new substance in the formulation for each commercial or consumer use.</P> <P>(g) For sites controlled by the submitter:</P> <P>(1) The identity of sites where the new substance will be manufactured, processed, or used.</P> <P>(2) A process description of each manufacture, processing, and use operation which includes a diagram of the major unit operations and chemical conversions, the identity and entry point of all feedstocks, and the points of release of the new chemical substance.</P> <P>(3) Worker exposure information, including worker activities, physical form of the new substance to which workers may be exposed, the number of workers, and the duration of activities.</P> <P>(4) Information on release of the new substance to the environment, including the quantity and media of release and type of control technology used.</P> <P>(h) For sites not controlled by the submitter, a description of each type of processing and use operation involving the new chemical substance, including identification of the estimated number of processing or use sites, situations in which worker exposure to and/or environmental release of the new chemical substance will occur, the number of workers exposed and the duration of exposure, and controls which limit worker exposure and environmental release.</P> <P>(i) Any safety data sheet already developed for the new chemical substance, including draft safety data sheets.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 60 FR 16310, Mar. 29, 1995; 83 FR 52719, Oct. 17, 2018; 87 FR 39763, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.50</SECTNO> <SUBJECT>Submission of test data and other data concerning the health and environmental effects of a substance.</SUBJECT> <P> (a) <E T="03">Test data on the new chemical substance in the possession or control of the submitter.</E> (1) Except as provided in paragraph (d) of this section, each notice must contain all test data in the submitter's possession or control which are related to the effects on health or the environment of any manufacture, processing, distribution in commerce, use, or disposal of the new chemical substance or any mixture or article containing the new chemical substance, or any combination of such activities. This includes test data concerning the new chemical substance in a pure, technical grade, or formulated form. </P> <P>(2) A full report or standard literature citation must be submitted for the following types of test data:</P> <P>(i) Health effects data.</P> <P>(ii) Ecological effects data.</P> <P>(iii) Physical and chemical properties data.</P> <P>(iv) Environmental fate characteristics.</P> <P>(v) Monitoring data and other test data related to human exposure to or environmental release of the chemical substance.</P> <P>(3)(i) If the data do not appear in the open scientific literature, the submitter must provide a full report. A full report includes the experimental methods and materials, results, discussion and data analysis, conclusions, references, and the name and address of the laboratory that developed the data.</P> <P>(ii) If the data appear in the open scientific literature, the submitter need only provide a standard literature citation. A standard literature citation includes author, title, periodical name, date of publication, volume, and page numbers.</P> <P> (4)(i) If a study, report, or test is incomplete when a person submits a notice, the submitter must identify the nature and purpose of the study; name and address of the laboratory developing the data; progress to date; types of data collected; significant preliminary results; and anticipated completion date. <PRTPAGE P="238"/> </P> <P>(ii) If a test or experiment is completed before the notice review period ends, the person must submit the study, report, or test to the address listed on the notice form, as specified in paragraph (a)(3)(i) of this section, within ten days of receiving it, but no later than five days before the end of the review period. If the test or experiment is completed during the last five days of the review period, the submitter must immediately inform its EPA contact for that notice by telephone.</P> <P>(5) For test data in the submitter's possession or control which are not listed in paragraph (a)(2) of this section, a person is not required to submit a complete report. The person must submit a summary of the data. If EPA so requests, the person must submit a full report within ten days of the request, but no later than five days before the end of the review period.</P> <P>(6) All test data described by paragraph (a) are subject to these requirements, regardless of their age, quality, or results.</P> <P> (b) <E T="03">Other data concerning the health and environmental effects of the new chemical substance that are known to or reasonably ascertainable by the submitter.</E> (1) Except as provided in paragraph (d) of this section, any person who submits a notice must describe the following data, including any data from a health and safety study, if the data are related to the effects on health or the environment of any manufacture, processing, distribution in commerce, use, or disposal of the new chemical substance, of any mixture or article containing the new chemical substance, or of any combination of such activities: </P> <P>(i) Any data, other than test data, in the submitter's possession or control.</P> <P>(ii) Any data, including test data, which are not in the submitter's possession or control, but which are known to or reasonably ascertainable by the submitter. For the purposes of this section, data are known to or reasonably ascertainable by the submitter if the data are known to any of its employees or other agents who are associated with the research and development, test marketing, or commercial marketing of the substance.</P> <P>(2) Data that must be described include data concerning the new chemical substance in a pure, technical grade, or formulated form.</P> <P>(3) The description of data reported under this paragraph must include:</P> <P>(i) If the data appear in the open scientific literature, a standard literature citation, which includes the author, title, periodical name, date of publication, volume, and pages.</P> <P>(ii) If the data are not contained in the open scientific literature, a description of the type of data and summary of the results, if available, and the names and addresses of persons the submitter believes may have possession or control of the data.</P> <P>(4) All data described by this paragraph are subject to these requirements, regardless of their age, quality, or results; and regardless of whether they are complete at the time the notice is submitted.</P> <P>(c) [Reserved]</P> <P> (d) <E T="03">Data that need not be submitted</E> —(1) <E T="03">Data previously submitted to EPA.</E> (i) A person need not submit any data previously submitted to EPA with no claims of confidentiality if the notice includes the office or person to whom the data were submitted, the date of submission, and, if appropriate, a standard literature citation as specified in paragraph (a)(3)(ii) of this section. </P> <P>(ii) For data previously submitted to EPA with a claim of confidentiality, the person must resubmit the data with the notice and any claim of confidentiality, under § 720.80.</P> <P> (2) <E T="03">Efficacy data.</E> This part does not require submission of any data related solely to product efficacy. This does not exempt a person from submitting any of the data specified in paragraph (a), (b), or (c) of this section. </P> <P> (3) <E T="03">Non-U.S. exposure data.</E> This part does not require submission of any data which relates only to exposure of humans or the environment outside the United States. This does not exclude nonexposure data such as data on health effects (including epidemiological studies), ecological effects, physical and chemical properties, or environmental fate characteristics. </P> <CITA>[48 FR 21742, May 13, 1983, as amended at 51 FR 15102, Apr. 22, 1986]</CITA> </SECTION> <SECTION> <PRTPAGE P="239"/> <SECTNO>§ 720.57</SECTNO> <SUBJECT>Imports.</SUBJECT> <P>(a) Except as otherwise provided in this section, the provisions of this subpart C apply to each person who submits a notice for a new chemical substance which he or she intends to import for a commercial purpose. In addition, each importer must comply with this section.</P> <P>(b) EPA will hold the principal importer, or the importer that EPA determines must submit the notice when there is no principal importer under § 720.22(b)(2), liable for complying with this part, for completing the notice form and for the completeness and truthfulness of all information which it submits.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 87 FR 39764, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Disposition of Notices</HD> <SECTION> <SECTNO>§ 720.60</SECTNO> <SUBJECT>General.</SUBJECT> <P>This subpart establishes procedures that EPA will follow in reviewing notices.</P> </SECTION> <SECTION> <SECTNO>§ 720.62</SECTNO> <SUBJECT>Notice that notification is not required.</SUBJECT> <P>When EPA receives a notice, EPA will review it to determine whether the chemical substance is subject to the requirements of this part. If EPA determines that the chemical substance is not subject to these requirements, EPA will notify the submitter that section 5 of the Act does not prevent the manufacture or import of the substance and that the submission is not a notice under this part.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.65</SECTNO> <SUBJECT>Acknowledgement of receipt of a notice; errors in the notice; incomplete submissions; and false and misleading statements.</SUBJECT> <P> (a) <E T="03">Notification to the submitter.</E> EPA will acknowledge receipt of each notice by sending a letter via CDX or U.S. mail to the submitter that identifies the premanufacture notice number assigned to the new chemical substance and date on which the review period begins. The review period will begin on the date the notice is received by the Office of Pollution Prevention and Toxics Document Control Officer. The acknowledgment does not constitute a finding by EPA that the notice, as submitted, is in compliance with this part. </P> <P> (b) <E T="03">Errors in the notice.</E> (1) Within 30 days of receipt of the notice, EPA may request that the submitter remedy errors in the notice. The following are examples of such errors: </P> <P>(i) Failure to date the notice form.</P> <P>(ii) Typographical errors that cause data to be misleading or answers to any questions to be unclear.</P> <P>(iii) Contradictory information.</P> <P>(iv) Ambiguous statements or information.</P> <P>(2) In the request to correct the notice, EPA will explain the action which the submitter must take to correct the notice.</P> <P>(3) If the submitter fails to correct the notice within 15 days of receipt of the request, EPA may extend the notice period under section (5)(c) of the Act, in accordance with § 720.75(c).</P> <P> (c) <E T="03">Incomplete submissions.</E> (1) A submission is not complete, and the notification period does not begin, if: </P> <P>(i) The wrong person submits the notice form.</P> <P>(ii) The submitter does not sign the notice form.</P> <P>(iii) Some or all of the information in the notice or the attachments are not in English, except for published scientific literature.</P> <P>(iv) The submitter does not submit the notice in the manner set forth in § 720.40(a)(2).</P> <P>(v) The submitter does not provide information that is required by section 5(d)(1) (B) and (C) of the Act and § 720.50.</P> <P>(vi) The submitter does not provide information required on the notice form and by § 720.45 or indicate that it is not known to or reasonably ascertainable by the submitter.</P> <P>(vii) The submitter does not submit a second copy of the submission with all confidential information deleted for the public file, as required by § 720.80(b)(2).</P> <P> (viii) The submitter does not include any information required by section 5(b)(1) of the Act and pursuant to a rule promulgated under section 4 of the Act, as required by § 720.40(g). <PRTPAGE P="240"/> </P> <P>(ix) The submitter does not submit data which the submitter believes show that the chemical substance will not present an unreasonable risk of injury to health or the environment, if EPA has listed the chemical substance under section 5(b)(4) of the Act, as required in § 720.40(h).</P> <P>(x) The submitter does not include an identifying number and a payment identity number as required by 40 CFR 700.45(e)(3).</P> <P>(2)(i) If EPA receives an incomplete submission, the Director, or his or her delegate, will notify the submitter within 30 days of receipt that the submission is incomplete and that the notice review period will not begin until EPA receives a complete notice.</P> <P>(ii) If EPA obtains additional information during the notice review period that indicates the original submission was incomplete, the Director, or his or her delegate, may declare the submission incomplete within 30 days after EPA obtains the additional information and so notify the submitter.</P> <P>(3) The notification that a submission is incomplete under paragraph (c)(2) (i) or (ii) of this section will include:</P> <P>(i) A statement of the basis of EPA's determination that the submission is incomplete.</P> <P>(ii) The requirements for correcting the incomplete submission.</P> <P>(iii) Information on procedures under paragraph (c)(4) of this section for filing objections to the determination or requesting modification of the requirements for completing the submission.</P> <P>(4) Within ten days after receipt of notification by EPA that a submission is incomplete, the submitter may file written objections requesting that EPA accept the submission as a complete notice or modify the requirements necessary to complete the submission.</P> <P>(5)(i) EPA will consider the objections filed by the submitter. The Director, or his or her delegate, will determine whether the submission was complete or incomplete, or whether to modify the requirements for completing the submission. EPA will notify the submitter in writing of EPA's response within ten days of receiving the objections.</P> <P>(ii) If the Director, or his or her delegate, determines, in response to the objection, that the submission was complete, the notice review period will be deemed suspended on the date EPA declared the notice incomplete, and will resume on the date that the notice is declared complete. The submitter need not correct the notice as EPA originally requested. If EPA can complete its review within 90 days from the date of the original submission, the Director, or his or her delegate, may inform the submitter that the running of the review period will resume on the date EPA originally declared it incomplete.</P> <P>(iii) If the Director, or his or her delegate, modifies the requirements for completing the submission or concurs with EPA's original determination, the notice review period will begin when EPA receives a complete notice.</P> <P> (d) <E T="03">Materially false or misleading statements.</E> If EPA discovers at any time that person submitted materially false or misleading statements in the notice, EPA may find that the notice was incomplete from the date it was submitted, and take any other appropriate action. </P> <CITA>[48 FR 21742, May 13, 1983, as amended at 75 FR 785, Jan. 6, 2010]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.70</SECTNO> <SUBJECT>Notice in the Federal Register.</SUBJECT> <P> (a) <E T="03">Filing of</E> <E T="04">Federal Register</E> <E T="03">notice.</E> In accordance with section 5(d)(2) of the Act, after EPA receives a notice, EPA will file with the Office of the Federal Register a notice including the information specified in paragraph (b) of this section. </P> <P> (b) <E T="03">Contents of notice.</E> (1) In the public interest, the specific chemical identity listed in the notice will be published in the <E T="04">Federal Register</E> unless the submitter has claimed chemical identity confidential. If the submitter claims confidentiality, a generic name will be published in accordance with § 720.85(a)(3). </P> <P>(2) The categories of use of the new chemical substance will be published as reported in the notice unless this information is claimed confidential. If confidentiality is claimed, the generic information which is submitted under § 720.87(b) will be published.</P> <P> (3) A list of data submitted in accordance with § 720.50(a) will be published. <PRTPAGE P="241"/> In addition, for test data submitted in accordance with § 720.40(g), a summary of the data will be published. </P> <P>(4) The submitter's identity will be published, unless the submitter has claimed it confidential.</P> </SECTION> <SECTION> <SECTNO>§ 720.75</SECTNO> <SUBJECT>Notice review period.</SUBJECT> <P> (a) <E T="03">Length of notice review period.</E> The notice review period specified in section 5(a) of the Act runs for 90 days from the date the Document Control Officer for the Office of Pollution Prevention and Toxics receives a complete notice, or the date EPA determines the notice is complete under § 720.65(c), unless the Agency extends the period under section 5(c) of TSCA and paragraph (c) of this section. </P> <P> (b) <E T="03">Suspension of the running of the notice review period.</E> (1) A submitter may voluntarily suspend the running of the notice review period if the Director or his or her delegate agrees. If the Director does not agree, the review period will continue to run, and EPA will notify the submitter. A submitter may request a suspension at any time during the notice review period. The suspension must be for a specified period of time. </P> <P> (2)(i) <E T="03">Oral requests.</E> A request for a suspension of 15 days or less may be made orally, including by telephone, to the submitter's EPA contact for that notice. Any request for a suspension exceeding 15 days must be submitted in the manner set forth in paragraph (b)(2)(ii) of this section. The running of the notice review period will be suspended upon approval of the oral request by the Director or her or his delegate. </P> <P> (ii) <E T="03">Written requests.</E> Requests for suspensions exceeding 15 days must be submitted electronically to EPA via CDX using e-PMN software. Requests for suspensions of 15 days or less may also be submitted electronically to EPA via CDX using e-PMN software. See § 720.40(a)(2)(ii) for information on how to access the e-PMN software. The running of the notice review period will be suspended upon approval of the written request by the Director or her or his delegate. </P> <P> (c) <E T="03">Extension of notice review period.</E> (1) At any time during the notice review period, EPA may determine that good cause exists to extend the notice review period specified in paragraph (a) of this section. </P> <P>(2) If EPA makes such a determination, EPA will:</P> <P>(i) Notify the submitter that EPA is extending the notice review period for a specified length of time, and state the reasons for the extension.</P> <P> (ii) Issue a notice for publication in the <E T="04">Federal Register</E> which states that EPA is extending the notice review period and gives the reasons for the extension. </P> <P>(3) The initial extension may be for a period of up to 90 days. If the initial extension is for less than 90 days, EPA may make additional extensions. However, the total period of extensions may not exceed 90 days for any notice.</P> <P>(4) The following are examples of situations in which EPA may find that good cause exists for extending the notice review period:</P> <P>(i) EPA has reviewed the notice and determined that there is a significant possibility that the chemical substance will be regulated under section 5(e) or section 5(f) of the Act, but EPA is unable to initiate regulatory action within the initial 90-day period.</P> <P>(ii) EPA has reviewed the submission and is seeking additional information.</P> <P>(iii) EPA has received significant additional information during the notice review period.</P> <P>(iv) The submitter has failed to correct a notice after receiving EPA's request under § 720.65(b).</P> <P> (d) <E T="03">Notice of expiration of notice review period.</E> EPA will notify the submitter that the notice review period has expired or that EPA has completed its review of the notice. Expiration of the review period does not constitute EPA approval or certification of the new chemical substance, and does not mean that EPA may not take regulatory action against the substance in the future. After expiration of the statutory notice review period, in the absence of regulatory action by EPA under section 5(e), 5(f), or 6(a) of the Act, the submitter may manufacture or import the chemical substance even if the submitter has not received notice of expiration. </P> <P> (e) <E T="03">Withdrawal of a notice by the submitter.</E> (1)(i) A submitter may withdraw <PRTPAGE P="242"/> a notice during the notice review period by submitting a statement of withdrawal in a manner set forth in this paragraph. The withdrawal is effective upon receipt by EPA of the CDX submission. </P> <P> (ii) <E T="03">Submission of withdrawal notices.</E> EPA will accept statements of withdrawal only if submitted in accordance with this paragraph. Statements of withdrawal must be generated, completed, and submitted to EPA (via CDX) using e-PMN software. See § 720.40(a)(2)(ii) for information on how to obtain e-PMN software. </P> <P>(2) If a manufacturer (including importer) which withdrew a notice later resubmits a notice for the same chemical substance, a new notice review period begins.</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 53 FR 12523, Apr. 15, 1988; 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995; 71 FR 33641, June 12, 2006; 75 FR 786, Jan. 6, 2010; 78 FR 72827, Dec. 4, 2013; 80 FR 42746, July 20, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.78</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <P>(a) Any person who submits a notice under this part must retain documentation of information in the notice, including (1) other data, as defined in § 720.50(b), in the submitter's possession or control; and (2) records of production volume for the first three years of production or import, the date of commencement of manufacture or import, and documentation of this information. This information must be retained for five years from the date of commencement of manufacture of import.</P> <P>(b)(1) Persons who manufacture a chemical substance under § 720.36 must retain the following records:</P> <P>(i) Copies of, or citations to, information reviewed and evaluated under § 720.36(b)(1) to determine the need to make any notification of risk.</P> <P>(ii) Documentation of the nature and method of notification under § 720.36(c)(1) including copies of any labels or written notices used.</P> <P>(iii) Documentation of prudent laboratory practices used instead of notification and evaluation under § 720.36(b)(2).</P> <P>(iv) The names and addresses of any persons other than the manufacturer or importer to whom the substance is distributed, the identity of the substance to the extent known, the amount distributed, and copies of the notifications required under § 720.36(c)(2). These records are not required when substances are distributed as impurities or incorporated into an article, in accordance with paragraph (d) of this section.</P> <P>(2) A person who manufactures a chemical substance under § 720.36 and who manufactures the substance in quantities greater than 100 kilograms per year must retain records of the identity of the substance to the extent known, the production volume of the substance, and the person's disposition of the substance. The person is not required to maintain records of the disposition of products containing the substance as an impurity or of articles incorporating the substances.</P> <P>(3) Records under this paragraph must be retained for 5 years after they are developed.</P> <P>(c) Any person who obtains a test-marketing exemption under this part must retain documentation of information in the application and documentation of compliance with any restrictions imposed by EPA when it granted the application. This information must be retained for five years from the final date of manufacture under the exemption.</P> <CITA>[48 FR 21742, May 13, 1983; 48 FR 33872, July 26, 1983, as amended at 51 FR 15102, Apr. 22, 1986; 58 FR 34204, June 23, 1993; 87 FR 39764, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Confidentiality and Public Access to Information</HD> <SECTION> <SECTNO>§ 720.80</SECTNO> <SUBJECT>General provisions.</SUBJECT> <P>Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703.</P> <CITA>[88 FR 37172, June 7, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.87</SECTNO> <SUBJECT>Categories or proposed categories of uses of a new chemical substance.</SUBJECT> <P> (a) A person who submits information to EPA under this part on the categories or proposed categories of use of a new chemical substance may assert a claim of confidentiality for this information. <PRTPAGE P="243"/> </P> <P>(b) A submitter that asserts such a claim must:</P> <P>(1) Report the categories or proposed categories of use of the chemical substance.</P> <P> (2) Provide, in nonconfidential form, a description of the uses that is only as generic as necessary to protect the confidential business information. The generic use description will be included in the <E T="04">Federal Register</E> notice described in § 720.70. </P> <P>(c) The person must submit the information required by paragraph (b) of this section in the manner specified in the notice form.</P> </SECTION> <SECTION> <SECTNO>§ 720.95</SECTNO> <SUBJECT>Public file.</SUBJECT> <P>All information submitted with a notice, including any health and safety study and other supporting documentation, will become part of the public file for that notice, unless such materials are claimed confidential in accordance with procedures in 40 CFR 703.5. In addition, EPA may add materials to the public file, subject to subpart E of this part. Publicly available materials are available at the docket addresses in § 700.17(b)(1) and (2) of this subchapter and on EPA's website.</P> <CITA>[88 FR 37172, June 7, 2023]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart F—Commencement of Manufacture or Import</HD> <SECTION> <SECTNO>§ 720.102</SECTNO> <SUBJECT>Notice of commencement of manufacture.</SUBJECT> <P> (a) <E T="03">Applicability.</E> Any person who commences the manufacture of a new chemical substance for a nonexempt commercial purpose for which that person previously submitted a section 5(a) notice under this part must submit a notice of commencement of manufacture. </P> <P> (b) <E T="03">When to report.</E> (1) If manufacture for commercial purposes begins on or after the effective date of this rule, the submitter must submit the notice to EPA on, or no later than 30 calendar days, after the first day of such manufacture. </P> <P>(2) If manufacture for commercial purposes began or will begin before the effective date of this rule, the submitter must submit the notice by the effective date of this rule.</P> <P> (c) <E T="03">Information to be reported on form.</E> (1) The notice must be submitted on EPA Form 7710-56, which is available as part of EPA's e-PMN software. See § 720.40(a)(2)(iv) for information on how to obtain e-PMN software. The form must be signed and dated by an Authorized Official (AO). All information specified on the form must be provided. The notice must contain the following information: </P> <P>(i) The specific chemical identity of the PMN substance.</P> <P>(ii) A generic chemical name (if the chemical identity is claimed as confidential by the submitter).</P> <P>(iii) The premanufacture notice (PMN) number assigned by EPA.</P> <P>(iv) The date of commencement for the submitter's manufacture for a non-exempt commercial purpose (indicating whether the substance was initially manufactured in the United States or imported). The date of commencement is the date of completion of non-exempt manufacture of the first amount (batch, drum, etc.) of new chemical substance identified in the submitter's PMN. For importers, the date of commencement is the date the new chemical substance clears United States customs.</P> <P>(v) The name and address of the submitter.</P> <P>(vi) The name of the authorized official.</P> <P>(vii) The name and telephone number of a technical contact in the United States.</P> <P>(viii) The address of the site where commencement of manufacture occurred.</P> <P>(ix) Clear indications of whether the chemical identity, submitter identity, and/or other information are claimed as confidential by the submitter.</P> <P> (2) If the submitter claims any information on the form as confidential, the claim must be asserted and substantiated in accordance with the requirements described in 40 CFR part 703 and must be submitted via EPA Form 7710-56. If the submitter wants the chemical identity to be listed on the confidential portion of the TSCA Inventory, the chemical identity must be claimed as confidential and the submitter must also follow the certification, substantiation, and generic name requirements <PRTPAGE P="244"/> described 40 CFR part 703 and paragraphs (e) and (f) of this section. Otherwise, EPA will list the specific chemical identity on the public TSCA Inventory. Submitters who did not claim the chemical identity, submitter identity, or other information to be confidential in the PMN cannot claim this information as confidential in the notice of commencement. </P> <P> (d)(1) <E T="03">Where to submit.</E> All notices of commencement must be submitted to EPA on EPA Form 7710-56. Notices may only be submitted in a manner set forth in this paragraph. </P> <P> (2) <E T="03">Submission of notice of commencement.</E> EPA will accept notices of commencement only if submitted in accordance with this paragraph. All notices of commencement must be submitted electronically to EPA via CDX. Prior to submission to EPA via CDX, such notices of commencement must be generated and completed using e-PMN software. See § 720.40(a)(2)(ii) for information on how to obtain e-PMN software. </P> <P> (e) <E T="03">Confidentiality.</E> (1) Any person who asserts a confidentiality claim for chemical identity in a Notice of Commencement submitted under this section must: </P> <P>(i) Comply with generic name requirements described in 40 CFR part 703 and as specified in paragraph (f) of this section.</P> <P> (ii) Agree that EPA may disclose to a person with a <E T="03">bona fide</E> intent to manufacture or import the chemical substance the fact that the particular chemical substance is included on the confidential TSCA Inventory for purposes of notification under section 5(a)(1)(A) of the Act. </P> <P>(iii) Have available for the particular chemical substance, and agree to furnish to EPA upon request:</P> <P>(A) An elemental analysis.</P> <P>(B) Either an X-ray diffraction pattern (for inorganic substances), a mass spectrum (for most other substances), or an infrared spectrum of the particular chemical substance, or if such data do not resolve uncertainties with respect to the identity of the chemical substance, additional or alternative spectra or other data to identify the chemical substance.</P> <P>(2) Claims of confidentiality must be made in accordance with the procedures described in 40 CFR part 703.</P> <P> (f) <E T="03">Generic name.</E> If a submitter asserts a claim of confidentiality for chemical identity in a notice of commencement, they must provide a structurally descriptive generic name. </P> <P>(1) Generic names must:</P> <P>(i) Be structurally descriptive (e.g., not a trade name);</P> <P>(ii) Describe the chemical structure of the chemical substance as specifically as practicable while protecting only those features of the chemical structure that are claimed as confidential and disclosure of which would likely cause substantial harm to the competitive position of the person—the generic name should generally only obscure one structural feature, but in any case, should conceal only the feature(s) necessary to avoid a likelihood of substantial competitive harm to the submitter; and</P> <P> (iii) Be consistent with guidance on the determination of structurally descriptive generic names, developed in accordance with TSCA section 14(c)(4)(A) (e.g., Guidance for Creating Generic Names for Confidential Chemical Substance Identity Reporting under TSCA; available at <E T="03">https://www.epa.gov/tsca-inventory/guidance-creating-generic-names-confidential-chemical-substance-identity-reporting</E> ). </P> <P>(2) Generic names will be reviewed by EPA at the time of submission.</P> <P>(i) If EPA concludes that a proposed generic name meets the criteria in paragraph (f)(1) of this section, EPA will include that generic name in the public TSCA Inventory listing for that substance.</P> <P> (ii) If the proposed generic name does not meet the criteria in paragraph (f)(1) of this section, EPA will notify the submitter concerning the deficiency via CDX, as described in 40 CFR 703.5(f). EPA will provide 10 business days to correct the deficiency and provide an alternative generic name that would be acceptable to EPA. If the alternative generic name proposed by EPA is acceptable to the submitter (or if the submitter does not respond within the 10-day period), EPA will place that alternative generic name on the <PRTPAGE P="245"/> public TSCA Inventory. If the alternative generic name proposed by EPA is not acceptable to the submitter, the submitter must submit a revised generic name that meets the criteria in paragraph (f)(1) of this section and an explanation of how EPA's proposed generic name reveals confidential information. If EPA concludes that the submitter's revised generic name also does not meet the criteria in paragraph (f)(1) of this section, EPA will hold the notice of commencement for a period of up to 10 business days. Reporting requirements will not be considered to have been met and the substance will not be added to the TSCA Inventory during this period. If the submission remains deficient after this 10-day period, EPA will proceed with CBI review of the chemical identity claim and will likely deny the claim. </P> <CITA>[48 FR 21742, May 13, 1983, as amended at 48 FR 41140, Sept. 13, 1983; 51 FR 15103, Apr. 22, 1986; 53 FR 12523, Apr. 15, 1988; 60 FR 16311, Mar. 29, 1995; 60 FR 34464, July 3, 1995; 65 FR 39304, June 26, 2000; 71 FR 33641, June 12, 2006; 75 FR 786, Jan. 6, 2010; 78 FR 72827, Dec. 4, 2013; 87 FR 39764, July 5, 2022; 88 FR 37172, June 7, 2023]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart G—Compliance and Inspections</HD> <SECTION> <SECTNO>§ 720.120</SECTNO> <SUBJECT>Compliance.</SUBJECT> <P>(a) Failure to comply with any provision of this part is a violation of section 15 of the Act (15 U.S.C 2614).</P> <P>(b) A person who manufactures a new chemical substance before a notice is submitted and the notice review period expires is in violation of section 15 of the Act even if that person was not required to submit the notice under § 720.22.</P> <P>(c) Using for commercial purposes a chemical substance or mixture which a person knew or had reason to know was manufactured, processed, or distributed in commerce in violation of section 5 of this rule is a violation of section 15 of the Act (15 U.S.C. 2614).</P> <P>(d) Failure or refusal to establish and maintain records or to permit access to or copying of records, as required by the Act, is a violation of section 15 of the Act (15 U.S.C. 2614).</P> <P>(e) Failure or refusal to permit entry or inspection as required by section 11 is a violation of section 15 of the Act (15 U.S.C. 2614).</P> <P>(f) Violators may be subject to the civil and criminal penalties in section 16 of the Act (15 U.S.C. 2615) for each violation. Persons who submit materially misleading or false information in connection with the requirements of any provision of this rule may be subject to penalties calculated as if they never filed their notices.</P> <P>(g) EPA may seek to enjoin the manufacture or processing of a chemical substance in violation of this rule or act to seize any chemical substance manufactured or processed in violation of this rule or take other actions under the authority of section 7 of this Act (15 U.S.C. 2606) or section 17 or this Act (15 U.S.C. 2616).</P> <CITA>[48 FR 21742, May 13, 1983, as amended at 87 FR 39764, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 720.122</SECTNO> <SUBJECT>Inspections.</SUBJECT> <P>EPA will conduct inspections under section 11 of the Act to assure compliance with section 5 of the Act and this rule, to verify that information submitted to EPA under this rule is true and correct, and to audit data submitted to EPA under this rule.</P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 721</EAR> <HD SOURCE="HED">PART 721—SIGNIFICANT NEW USES OF CHEMICAL SUBSTANCES</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>721.1</SECTNO> <SUBJECT>Scope and applicability.</SUBJECT> <SECTNO>721.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>721.5</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <SECTNO>721.11</SECTNO> <SUBJECT>Applicability determination when the specific chemical identity is confidential.</SUBJECT> <SECTNO>721.20</SECTNO> <SUBJECT>Exports and imports.</SUBJECT> <SECTNO>721.25</SECTNO> <SUBJECT>Notice requirements and procedures.</SUBJECT> <SECTNO>721.30</SECTNO> <SUBJECT>EPA approval of alternative control measures.</SUBJECT> <SECTNO>721.35</SECTNO> <SUBJECT>Compliance and enforcement.</SUBJECT> <SECTNO>721.40</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <SECTNO>721.45</SECTNO> <SUBJECT>Exemptions.</SUBJECT> <SECTNO>721.47</SECTNO> <SUBJECT>Conditions for research and development exemption.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Certain Significant New Uses</HD> <SECTNO>721.50</SECTNO> <SUBJECT>Applicability.</SUBJECT> <SECTNO>721.63</SECTNO> <SUBJECT>Protection in the workplace.</SUBJECT> <SECTNO>721.72</SECTNO> <SUBJECT>Hazard communication program.</SUBJECT> <SECTNO>721.80</SECTNO> <SUBJECT>Industrial, commercial, and consumer activities.</SUBJECT> <SECTNO>721.85</SECTNO> <SUBJECT>Disposal.</SUBJECT> <SECTNO>721.90</SECTNO> <SUBJECT> Release to water. <PRTPAGE P="246"/> </SUBJECT> <SECTNO>721.91</SECTNO> <SUBJECT>Computation of estimated surface water concentrations: Instructions.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Recordkeeping Requirements</HD> <SECTNO>721.100</SECTNO> <SUBJECT>Applicability.</SUBJECT> <SECTNO>721.125</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Expedited Process for Issuing Significant New Use Rules for Selected Chemical Substances and Limitation or Revocation of Selected Significant New Use Rules</HD> <SECTNO>721.160</SECTNO> <SUBJECT>Notification requirements for new chemical substances subject to section 5(e) orders.</SUBJECT> <SECTNO>721.170</SECTNO> <SUBJECT>Notification requirements for selected new chemical substances that have completed premanufacture review.</SUBJECT> <SECTNO>721.185</SECTNO> <SUBJECT>Limitation or revocation of certain notification requirements.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Significant New Uses for Specific Chemical Substances</HD> <SECTNO>721.225</SECTNO> <SUBJECT>2-Chloro-N-methyl-N-substituted acetamide (generic name).</SUBJECT> <SECTNO>721.267</SECTNO> <SUBJECT>N-[2-[(substituted dinitrophenyl)azo]diallylamino-4-substituted phenyl] acetamide (generic name).</SUBJECT> <SECTNO>721.275</SECTNO> <SUBJECT>Halogenated-N-(2-propenyl)-N-(substituted phenyl) acetamide.</SUBJECT> <SECTNO>721.285</SECTNO> <SUBJECT> Acetamide, <E T="03">N</E> -[4-(pentyloxy)phenyl]-, acetamide, <E T="03">N</E> -[2-nitro-4-(pentyloxy)phenyl]-, and acetamide, <E T="03">N</E> -[2-amino-4-(pentyloxy)phenyl]-. </SUBJECT> <SECTNO>721.303</SECTNO> <SUBJECT>Acetic acid, 2-methoxy-, methyl ester.</SUBJECT> <SECTNO>721.304</SECTNO> <SUBJECT>Acetic acid, [(5-chloro-8-quinolinyl)oxy-], 1-methyl hexyl ester.</SUBJECT> <SECTNO>721.305</SECTNO> <SUBJECT>Di-substituted acetophenone (generic).</SUBJECT> <SECTNO>721.320</SECTNO> <SUBJECT>Acrylamide-substituted epoxy.</SUBJECT> <SECTNO>721.321</SECTNO> <SUBJECT>Substituted acrylamides and acrylic acid copolymer (generic).</SUBJECT> <SECTNO>721.323</SECTNO> <SUBJECT>Substituted acrylamide.</SUBJECT> <SECTNO>721.324</SECTNO> <SUBJECT>Alkoxylated acrylate polymer (generic).</SUBJECT> <SECTNO>721.329</SECTNO> <SUBJECT>Halogenated benzyl ester acrylate (generic).</SUBJECT> <SECTNO>721.330</SECTNO> <SUBJECT>Aromatic acrylate (generic).</SUBJECT> <SECTNO>721.333</SECTNO> <SUBJECT>Dimethyl alkylamine salt (generic).</SUBJECT> <SECTNO>721.336</SECTNO> <SUBJECT>Perfluoroalkylethyl acrylate copolymer (generic name).</SUBJECT> <SECTNO>721.338</SECTNO> <SUBJECT>Certain salts of an acrylate copolymer.</SUBJECT> <SECTNO>721.405</SECTNO> <SUBJECT>Polyether acrylate.</SUBJECT> <SECTNO>721.430</SECTNO> <SUBJECT>Oxo-substituted aminoalkanoic acid derivative.</SUBJECT> <SECTNO>721.435</SECTNO> <SUBJECT>Alkylphenylpolyetheralkanolamines (generic).</SUBJECT> <SECTNO>721.445</SECTNO> <SUBJECT>Substituted ethyl alkenamide.</SUBJECT> <SECTNO>721.450</SECTNO> <SUBJECT>Hydrofluorochloroalkene (generic).</SUBJECT> <SECTNO>721.463</SECTNO> <SUBJECT>Acrylate of polymer based on isophorone diisocyanate (generic).</SUBJECT> <SECTNO>721.465</SECTNO> <SUBJECT>Alkoxylated alkylpolyol acrylates, adduct with alkylamine (generic).</SUBJECT> <SECTNO>721.480</SECTNO> <SUBJECT>Aminoester of polyalkenylated alkyldicarboxylic acid (generic).</SUBJECT> <SECTNO>721.484</SECTNO> <SUBJECT>Fluorinated acrylic copolymer (generic name).</SUBJECT> <SECTNO>721.505</SECTNO> <SUBJECT>Halogenated acrylonitrile.</SUBJECT> <SECTNO>721.520</SECTNO> <SUBJECT>Alanine, N-(2-carboxyethyl)-N- alkyl-, salt.</SUBJECT> <SECTNO>721.522</SECTNO> <SUBJECT>Oxirane, methyl-, polymer with oxirane, mono(3,5,5,-trimethylhexyl) ether.</SUBJECT> <SECTNO>721.524</SECTNO> <SUBJECT> Alcohols, C <E T="52">6-12</E> , ethoxylated, reaction product with maleic anhydride. </SUBJECT> <SECTNO>721.525</SECTNO> <SUBJECT>1-propanol, 3-propoxy-.</SUBJECT> <SECTNO>721.530</SECTNO> <SUBJECT>Propanoyl chloride, 3-chloro-2,2-dimethyl-.</SUBJECT> <SECTNO>721.532</SECTNO> <SUBJECT>1-Butanol, 3-methoxy-3-methyl-, acetate.</SUBJECT> <SECTNO>721.533</SECTNO> <SUBJECT>Propane, 1,1,1,3,3-pentachloro-.</SUBJECT> <SECTNO>721.535</SECTNO> <SUBJECT>Halogenated alkane (generic).</SUBJECT> <SECTNO>721.536</SECTNO> <SUBJECT>Halogenated phenyl alkane.</SUBJECT> <SECTNO>721.537</SECTNO> <SUBJECT>Organosilane ester.</SUBJECT> <SECTNO>721.538</SECTNO> <SUBJECT>Phenol, 4-(1,1-dimethylethyl)-, homopolymer.</SUBJECT> <SECTNO>721.539</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[1-[(4-nonylphenoxy)methyl]-2-(2-propenyloxy)ethoxy]-, branched, ammonium salts.</SUBJECT> <SECTNO>721.540</SECTNO> <SUBJECT>Alkylphenoxypolyalkoxy­amine (generic name).</SUBJECT> <SECTNO>721.545</SECTNO> <SUBJECT>Polyalkenylalkylphenol (generic).</SUBJECT> <SECTNO>721.550</SECTNO> <SUBJECT>Alkyl alkenoate, azobis-.</SUBJECT> <SECTNO>721.555</SECTNO> <SUBJECT>Alkyl amino nitriles (generic).</SUBJECT> <SECTNO>721.558</SECTNO> <SUBJECT>2-Propanol, 1,1′-iminobis-, N-tallow alkyl derivs., hydrochlorides.</SUBJECT> <SECTNO>721.562</SECTNO> <SUBJECT>Substituted alkylamine salt.</SUBJECT> <SECTNO>721.575</SECTNO> <SUBJECT>Substituted alkyl halide.</SUBJECT> <SECTNO>721.600</SECTNO> <SUBJECT>3-Alkyl-2-(2-anilino)vinyl thi­azo­lin­i­um salt (generic name).</SUBJECT> <SECTNO>721.625</SECTNO> <SUBJECT>Alkylated diarylamine, sul­furized (generic name).</SUBJECT> <SECTNO>721.630</SECTNO> <SUBJECT>Salt of a modified tallow alkylenediamine (generic).</SUBJECT> <SECTNO>721.632</SECTNO> <SUBJECT>Silicoaluminophosphates, compd. with organic amine (generic).</SUBJECT> <SECTNO>721.633</SECTNO> <SUBJECT>Aluminosilicates, phospho-.</SUBJECT> <SECTNO>721.638</SECTNO> <SUBJECT>Silyl amine, potassium salt (generic).</SUBJECT> <SECTNO>721.639</SECTNO> <SUBJECT>Amine aldehyde condensate.</SUBJECT> <SECTNO>721.640</SECTNO> <SUBJECT>Amine substituted metal salts.</SUBJECT> <SECTNO>721.641</SECTNO> <SUBJECT>Alkylpoly(oxyalkylene)amine.</SUBJECT> <SECTNO>721.642</SECTNO> <SUBJECT> Amines, <E T="03">N</E> -(C <E T="52">14-18</E> and C <E T="52">16-18</E> unsaturated alkyl)] dipropylene-tri-, tripropylenetetra-, and tetrapropylenepenta-. </SUBJECT> <SECTNO>721.643</SECTNO> <SUBJECT>Ethoxylated alcohol, phosphated, amine salt.</SUBJECT> <SECTNO>721.644</SECTNO> <SUBJECT> Amines, C <E T="52">12-14</E> -tert-alkyl, sulfonates. </SUBJECT> <SECTNO>721.646</SECTNO> <SUBJECT>Aminofluoran derivative (generic name).</SUBJECT> <SECTNO>721.647</SECTNO> <SUBJECT>Alkoxylated alkyl amine (generic).</SUBJECT> <SECTNO>721.648</SECTNO> <SUBJECT>Alkyl dialkylamino phenylsulfonyl alkenoate (generic).</SUBJECT> <SECTNO>721.650</SECTNO> <SUBJECT>11-Aminoundecanoic acid.</SUBJECT> <SECTNO>721.655</SECTNO> <SUBJECT> Ethoxylated alkyl quaternary ammonium compound. <PRTPAGE P="247"/> </SUBJECT> <SECTNO>721.715</SECTNO> <SUBJECT>Trisubstituted anthracene.</SUBJECT> <SECTNO>721.720</SECTNO> <SUBJECT>Alkoxylated fatty acid amide, alkylsulfate salt.</SUBJECT> <SECTNO>721.750</SECTNO> <SUBJECT>Aromatic amine compound.</SUBJECT> <SECTNO>721.757</SECTNO> <SUBJECT>Polyoxyalkylene substituted aromatic azo colorant.</SUBJECT> <SECTNO>721.775</SECTNO> <SUBJECT>Brominated aromatic com­pound (generic name).</SUBJECT> <SECTNO>721.785</SECTNO> <SUBJECT>Halogenated alkane aromatic compound (generic name).</SUBJECT> <SECTNO>721.805</SECTNO> <SUBJECT>Benzenamine, 4,4′-[1,3-phe­nyl­ene­bis(1-methylethyl idene)]bis[2,6-di­methyl-.</SUBJECT> <SECTNO>721.825</SECTNO> <SUBJECT>Certain aromatic ether diamines.</SUBJECT> <SECTNO>721.840</SECTNO> <SUBJECT>Alkyl substituted diaromatic hydrocarbons.</SUBJECT> <SECTNO>721.843</SECTNO> <SUBJECT>Substituted phenylazophenylazo phenol (generic).</SUBJECT> <SECTNO>721.875</SECTNO> <SUBJECT>Aromatic nitro compound.</SUBJECT> <SECTNO>721.910</SECTNO> <SUBJECT>Propanetriol polyalkylenepolyolamine aryl aldimine (generic).</SUBJECT> <SECTNO>721.925</SECTNO> <SUBJECT>Substituted aromatic (generic).</SUBJECT> <SECTNO>721.950</SECTNO> <SUBJECT>Sodium salt of an alkylated, sulfonated aromatic (generic name).</SUBJECT> <SECTNO>721.977</SECTNO> <SUBJECT>Aryloxyarene.</SUBJECT> <SECTNO>721.980</SECTNO> <SUBJECT>Sodium salt of azo acid dye.</SUBJECT> <SECTNO>721.981</SECTNO> <SUBJECT>Substituted naphtholoazo-substituted naphthalenyl-substituted azonaphthol chromium complex.</SUBJECT> <SECTNO>721.982</SECTNO> <SUBJECT> Calcium, bis(2,4-pentanedionato- <E T="03">O,O</E> ′). </SUBJECT> <SECTNO>721.983</SECTNO> <SUBJECT>Sulfonyl azide intermediate (generic).</SUBJECT> <SECTNO>721.984</SECTNO> <SUBJECT>Amino-hydroxy sulfonaphthylazo-disubstituted phenyl azo benzene carboxylate salt (generic).</SUBJECT> <SECTNO>721.987</SECTNO> <SUBJECT>Dialkylaminophenyl imino pyrazole acid ester (generic).</SUBJECT> <SECTNO>721.988</SECTNO> <SUBJECT>Pyrazolone azomethine dye (generic).</SUBJECT> <SECTNO>721.990</SECTNO> <SUBJECT>1,4-Benzedicarboxylic acid, dimethyl ester, polymer with 1,4-butanediol, cyclized.</SUBJECT> <SECTNO>721.1000</SECTNO> <SUBJECT>Benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(tri­fluoro­methyl)-.</SUBJECT> <SECTNO>721.1025</SECTNO> <SUBJECT>Benzenamine, 4-chloro-2-methyl-; benzenamine, 4-chloro-2-methyl-, hydrochloride; and ben­zenamine, 2-chloro-6-methyl-.</SUBJECT> <SECTNO>721.1050</SECTNO> <SUBJECT>Benzenamine, 2,5-dibutoxy-4-(4-mor­pho­linyl)-, sulfate.</SUBJECT> <SECTNO>721.1055</SECTNO> <SUBJECT>Benzeneamine, 3,5-difluoro-.</SUBJECT> <SECTNO>721.1068</SECTNO> <SUBJECT> Benzenamine, 4-isocyanato- <E T="03">N,N</E> -bis(4-isocyanatophenyl)-2,5-dimethoxy-. </SUBJECT> <SECTNO>721.1070</SECTNO> <SUBJECT>Benzenamine, 4-methoxy-2-methyl-N-(3-methylphenyl).</SUBJECT> <SECTNO>721.1075</SECTNO> <SUBJECT>Benzenamine, 4-(1-methylbutoxy)-, hydrochloride.</SUBJECT> <SECTNO>721.1085</SECTNO> <SUBJECT>Benzenamine,4,4′-methylenebis[N-ethyl-N-methyl-.</SUBJECT> <SECTNO>721.1105</SECTNO> <SUBJECT>Benzenamine, 4,4′-methylenebis[2-methyl-6-(1-methylethyl)]-.</SUBJECT> <SECTNO>721.1120</SECTNO> <SUBJECT>Benzenamine, 4,4′-[1,4-phe­nyl­ene­bis(1-methyle­thy­li­dene)]bis[2,6- dimethyl-.</SUBJECT> <SECTNO>721.1150</SECTNO> <SUBJECT>Substituted polyglycidyl ben­zena­mine.</SUBJECT> <SECTNO>721.1155</SECTNO> <SUBJECT>1,4-benzenediol, 2-(1,1,3,3-tetramethylbutyl)-and Bis(dimethylamino substituted)carbomonocycle.</SUBJECT> <SECTNO>721.1187</SECTNO> <SUBJECT>Bis(imidoethylene) benzene.</SUBJECT> <SECTNO>721.1193</SECTNO> <SUBJECT>Benzene, 2-bromo-1,4-dimethoxy-.</SUBJECT> <SECTNO>721.1210</SECTNO> <SUBJECT>Benzene, (2-chloroethoxy)-.</SUBJECT> <SECTNO>721.1225</SECTNO> <SUBJECT>Benzene, 1,2-dimethyl-, poly­propene derivatives, sulfonated, po­tas­sium salts.</SUBJECT> <SECTNO>721.1230</SECTNO> <SUBJECT>Benzene, ethenyl-, ar-bromo derivatives.</SUBJECT> <SECTNO>721.1240</SECTNO> <SUBJECT>Benzene, (2-bromoethyl)-, ar-bromo derivatives.</SUBJECT> <SECTNO>721.1300</SECTNO> <SUBJECT>[(Dinitrophenyl)azo]-[2,4-dia­mino-5-methoxybenzene] derivatives.</SUBJECT> <SECTNO>721.1325</SECTNO> <SUBJECT>Benzene, 1-(1-methylbutoxy)-4-nitro-.</SUBJECT> <SECTNO>721.1350</SECTNO> <SUBJECT>Benzene, (1-methylethyl)(2-phenylethyl)-.</SUBJECT> <SECTNO>721.1372</SECTNO> <SUBJECT>Substituted nitrobenzene.</SUBJECT> <SECTNO>721.1375</SECTNO> <SUBJECT>Disubstituted nitrobenzene (generic name).</SUBJECT> <SECTNO>721.1425</SECTNO> <SUBJECT>Pentabromoethylbenzene.</SUBJECT> <SECTNO>721.1430</SECTNO> <SUBJECT>Pentachlorobenzene.</SUBJECT> <SECTNO>721.1435</SECTNO> <SUBJECT>1,2,4,5-Tetrachlorobenzene.</SUBJECT> <SECTNO>721.1440</SECTNO> <SUBJECT>1,3,5-Trinitrobenzene.</SUBJECT> <SECTNO>721.1450</SECTNO> <SUBJECT>1,3-Benzenediamine, 4-(1,1-di­methyl­ethyl)-ar-methyl.</SUBJECT> <SECTNO>721.1500</SECTNO> <SUBJECT>1,2-Benzenediamine, 4-ethoxy, sulfate.</SUBJECT> <SECTNO>721.1550</SECTNO> <SUBJECT>Benzenediazonium, 4-(di­methyl­amino)-, salt with 2-hy­droxy-5-sul­fo­benzoic acid (1:1).</SUBJECT> <SECTNO>721.1555</SECTNO> <SUBJECT>Substituted phenyl azo substituted benzenediazonium salt.</SUBJECT> <SECTNO>721.1568</SECTNO> <SUBJECT>Benzenediazonium, 2-(methoxycarbonyl)-, chloride (1:1).</SUBJECT> <SECTNO>721.1576</SECTNO> <SUBJECT>1,3-Benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester.</SUBJECT> <SECTNO>721.1577</SECTNO> <SUBJECT>1,4-Benzenedicarboxylic acid, bis [4-(ethenyloxy) butyl] ester.</SUBJECT> <SECTNO>721.1578</SECTNO> <SUBJECT>1,4-Benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester.</SUBJECT> <SECTNO>721.1579</SECTNO> <SUBJECT>1,2,4-Benzenetricarboxylic acid, tris [4-(ethenyloxy) butyl] ester.</SUBJECT> <SECTNO>721.1580</SECTNO> <SUBJECT>Disubstituted benzene ether, polymer with substituted phenol (generic).</SUBJECT> <SECTNO>721.1612</SECTNO> <SUBJECT>Substituted 2-nitro- and 2-aminobenzesulfonamide.</SUBJECT> <SECTNO>721.1620</SECTNO> <SUBJECT>Benzenesulfonamide, alkylphenyl substituted phenyl substituted carbonyl- (generic).</SUBJECT> <SECTNO>721.1625</SECTNO> <SUBJECT>Benzenesulfonic acid, dodecyl-, branched, compds. with N,N-dimethyl-1,3-propanediamine (2:1).</SUBJECT> <SECTNO>721.1630</SECTNO> <SUBJECT> 1,2-Ethanediol bis(4-methylbenzenesulfonate); 2,2-oxybis-ethane bis(4-methylbenzenesulfonate); ethanol, 2,2′-[oxybis(2,1-ethanediyl oxy)]bis-, bis(4-methylbenzenesulfonate); ethanol, 2,2′-[oxybis (2,1-ethane diyloxy)] bis-, bis(4-methylbenzenesulfonate); ethanol, 2,2′-[[1-[(2-propenyloxy) methyl]-1,2- <PRTPAGE P="248"/> ethanediyl] bis(oxy)]bis-, bis(4-methylbenzene sulfonate); and ethanol, 2-[1-[[2-[2-[[(4-methylphenyl)sulfonyl] oxy]ethoxy] ethoxy]methyl]-2-(2-propenyloxy)ethoxy]-, 4-methylbenzenesulfonate. </SUBJECT> <SECTNO>721.1637</SECTNO> <SUBJECT>1,2-Propanediol, 3-(2-propenyloxy)-, bis(4-methylbenzene sulfonate); 2-propanol, 1-[2-[[(4-methylphenyl)sulfonyl] oxy]ethoxy]-3-(2-propenyloxy)-4-methylbenzenesulfonate; and 2-propanol, 1-[2-[2-[[(4-methylphenyl)sulfonyl]oxy] ethoxy]ethoxy]-3-(2-propenyloxy)-, 4-methylbenzenesulfonate.</SUBJECT> <SECTNO>721.1640</SECTNO> <SUBJECT>3,6,9,12,-Tetraoxatetradecane-1,14-diol, bis(4-methylbenzenesulfonate; 3,6,9,13-tetraoxahexadec-15-ene-1,11-diol, bis(4-methylbenzenesulfonate); 3,6,9,12,16-pentaoxanonadec-18-ene-1,14-diol, bis(4-methyl benzenesulfonate); and 3,6,9,12-tetraoxatetradecane-1,14-diol, 7-[(2-propenyloxy)methyl]-, bis(4-methylbenzenesulfonate).</SUBJECT> <SECTNO>721.1643</SECTNO> <SUBJECT>Benzenesulfonic acid, amino substituted phenylazo-.</SUBJECT> <SECTNO>721.1645</SECTNO> <SUBJECT> Benzenesulfonic acid, 4-methyl-, reaction products with oxirane mono[(C <E T="52">10-16</E> -alkyloxy)methyl] derivatives and 2,2,4(or 2,4,4)-trimethyl-1,6-hexanediamine. </SUBJECT> <SECTNO>721.1648</SECTNO> <SUBJECT>Substituted benzenesulfonic acid salt (generic).</SUBJECT> <SECTNO>721.1650</SECTNO> <SUBJECT>Alkylbenzenesulfonic acid and sodium salts.</SUBJECT> <SECTNO>721.1655</SECTNO> <SUBJECT>Alkylbenzenesulfonic acid (generic).</SUBJECT> <SECTNO>721.1660</SECTNO> <SUBJECT>Benzidine-based chemical substances.</SUBJECT> <SECTNO>721.1675</SECTNO> <SUBJECT>Disulfonic acid rosin amine salt of a benzidine derivative (generic name).</SUBJECT> <SECTNO>721.1680</SECTNO> <SUBJECT>Substituted benzoic acid (generic).</SUBJECT> <SECTNO>721.1700</SECTNO> <SUBJECT>Halonitrobenzoic acid, substituted (generic name).</SUBJECT> <SECTNO>721.1705</SECTNO> <SUBJECT>Benzoic acid, 3-amino-, diazotized, coupled with 6-amino-4-hydroxy-2-naphthalenesulfonic acid, diazotized, (3-aminophenyl)phosphonic acid and diazotized 2,5-diethoxybenzenamine.</SUBJECT> <SECTNO>721.1725</SECTNO> <SUBJECT>Benzoic acid, 3,3′-methyl­enebis [6 amino-, di-2-propenyl ester.</SUBJECT> <SECTNO>721.1728</SECTNO> <SUBJECT>Benzoic acid, 2-(3-phenylbutylidene)amino-, methyl ester.</SUBJECT> <SECTNO>721.1729</SECTNO> <SUBJECT> Boric acid (H <E T="52">3</E> BO <E T="52">3</E> ), mixed esters with polyethylene glycol mono-Bu ether and polyethylene glycol mono Me ether. </SUBJECT> <SECTNO>721.1730</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), α-butyl-ω-hydroxy, ester with boric acid (H <E T="52">3</E> BO <E T="52">3</E> ). </SUBJECT> <SECTNO>721.1731</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy, ester with boric acid (H <E T="52">3</E> BO <E T="52">3</E> ). </SUBJECT> <SECTNO>721.1732</SECTNO> <SUBJECT>Nitrobenzoic acid octyl ester.</SUBJECT> <SECTNO>721.1734</SECTNO> <SUBJECT>Substituted benzonitrile (generic).</SUBJECT> <SECTNO>721.1735</SECTNO> <SUBJECT>Alkylbisoxyalkyl (sub­sti­tut­ed-1,1-dimethylethylphenyl) ben­zo­tria­zole (generic name).</SUBJECT> <SECTNO>721.1738</SECTNO> <SUBJECT>Substituted benzotriazole (generic name).</SUBJECT> <SECTNO>721.1745</SECTNO> <SUBJECT>Ethoxybenzothiazole disulfide.</SUBJECT> <SECTNO>721.1747</SECTNO> <SUBJECT>Substituted benzophenone (generic).</SUBJECT> <SECTNO>721.1750</SECTNO> <SUBJECT> 1 <E T="03">H</E> -Benzotriazole, 5-(pentyloxy)- and 1 <E T="03">H</E> -benzotriazole, 5-(pentyloxy)-, sodium and potassium salts. </SUBJECT> <SECTNO>721.1755</SECTNO> <SUBJECT>Methylenebisbenzotriazole.</SUBJECT> <SECTNO>721.1760</SECTNO> <SUBJECT>Substituted benzotriazole derivatives.</SUBJECT> <SECTNO>721.1765</SECTNO> <SUBJECT>2-Substituted benzotriazole.</SUBJECT> <SECTNO>721.1767</SECTNO> <SUBJECT>Substituted 6,6′-(1-methylethylidene)bis[3,4-dihydro-3-phenyl-1,3-benzoxazine] (generic).</SUBJECT> <SECTNO>721.1775</SECTNO> <SUBJECT> 6-Nitro-2(3 <E T="03">H</E> )-benzo­xazo­lone. </SUBJECT> <SECTNO>721.1790</SECTNO> <SUBJECT>Polybrominated biphenyls.</SUBJECT> <SECTNO>721.1800</SECTNO> <SUBJECT>3,3′,5,5′-Tetra­methyl­bi­phenyl-4,4′-diol.</SUBJECT> <SECTNO>721.1805</SECTNO> <SUBJECT>Substituted bisaniline.</SUBJECT> <SECTNO>721.1820</SECTNO> <SUBJECT>Bisphenol derivative.</SUBJECT> <SECTNO>721.1825</SECTNO> <SUBJECT>Bisphenol A, epichloro­hy­drin, poly­al­ky­lenepolyol and poly­iso­cyanato derivative.</SUBJECT> <SECTNO>721.1850</SECTNO> <SUBJECT>Toluene sulfonamide bisphe­nol A epoxy adduct.</SUBJECT> <SECTNO>721.1852</SECTNO> <SUBJECT>Di-alkyl borane (generic).</SUBJECT> <SECTNO>721.1875</SECTNO> <SUBJECT>Boric acid, alkyl and substituted alkyl esters (generic name).</SUBJECT> <SECTNO>721.1878</SECTNO> <SUBJECT>Alkali metal alkyl borohydride (generic).</SUBJECT> <SECTNO>721.1880</SECTNO> <SUBJECT>Borate(1-), tris(acetato-.kappa.O)hydro-, sodium, (T-4)-.</SUBJECT> <SECTNO>721.1900</SECTNO> <SUBJECT>Substituted bromothiophene.</SUBJECT> <SECTNO>721.1907</SECTNO> <SUBJECT> Butanamide, 2,2′-[3′dichloro[1,1′-biphenyl]-4,4′-diyl)bisazobis <E T="03">N</E> -2,3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo-. </SUBJECT> <SECTNO>721.1920</SECTNO> <SUBJECT>1,4-Bis(3-hydroxy-4-benzoylphenoxy)butane.</SUBJECT> <SECTNO>721.1925</SECTNO> <SUBJECT>Substituted carboheterocyclic butane tetracarboxylate (generic).</SUBJECT> <SECTNO>721.1930</SECTNO> <SUBJECT>Butanoic acid, antimony (3=) salt.</SUBJECT> <SECTNO>721.1950</SECTNO> <SUBJECT> 2-Butenedioic acid ( <E T="03">Z</E> ), mono(2-((1-oxopropenyloxy)ethyl) ester. </SUBJECT> <SECTNO>721.2025</SECTNO> <SUBJECT>Substituted phenylimino carbamate derivative.</SUBJECT> <SECTNO>721.2060</SECTNO> <SUBJECT>Disubstituted benzenedicarboxylic acid (generic).</SUBJECT> <SECTNO>721.2075</SECTNO> <SUBJECT>Carbamodithioic acid, methyl-, compound with methanamine (1:1).</SUBJECT> <SECTNO>721.2076</SECTNO> <SUBJECT>D-Glucuronic acid, polymer with 6-deoxy-L-mannose and D-glucose, acetate, calcium magnesium potassium sodium salt.</SUBJECT> <SECTNO>721.2077</SECTNO> <SUBJECT>Substituted carbazate (generic).</SUBJECT> <SECTNO>721.2078</SECTNO> <SUBJECT>1-Piperidinecarboxylic acid, 2-[(dichloro-hydroxy-carbomonocycle)hydrazono]-, methyl ester (generic).</SUBJECT> <SECTNO>721.2079</SECTNO> <SUBJECT>Dichloro, hydroxy, hydrazino-carbomonocycle (generic).</SUBJECT> <SECTNO>721.2081</SECTNO> <SUBJECT>Dichloro, hydroxy, hydrazino-carbomonocycle-monohydrochloride (generic).</SUBJECT> <SECTNO>721.2083</SECTNO> <SUBJECT>Polysubstituted carbomonocyclic hydroxylamine (generic).</SUBJECT> <SECTNO>721.2084</SECTNO> <SUBJECT> Carbon oxyfluoride (Carbonic difluoride). <PRTPAGE P="249"/> </SUBJECT> <SECTNO>721.2085</SECTNO> <SUBJECT>Hydroxyalkylquinoline dioxoindandialkylcarboxamide.</SUBJECT> <SECTNO>721.2086</SECTNO> <SUBJECT>Coco acid triamine condensate, polycarboxylic acid salts.</SUBJECT> <SECTNO>721.2087</SECTNO> <SUBJECT>3-furancarboxaldehyde, tetrahydro-.</SUBJECT> <SECTNO>721.2088</SECTNO> <SUBJECT>Carboxylic acids, (C6-C9) branched and linear.</SUBJECT> <SECTNO>721.2089</SECTNO> <SUBJECT>Tetrasubstituted aminocarboxylic acid.</SUBJECT> <SECTNO>721.2091</SECTNO> <SUBJECT>Propane, 1,1,1,3,3,3-hexachloro-.</SUBJECT> <SECTNO>721.2092</SECTNO> <SUBJECT>3-Methylcholanthrene.</SUBJECT> <SECTNO>721.2093</SECTNO> <SUBJECT>Alkenyl carboxylate, metal salt (generic).</SUBJECT> <SECTNO>721.2094</SECTNO> <SUBJECT> <E T="03">N,N</E> ′-di(alkyl heteromonocycle)amino chlorotriazine. </SUBJECT> <SECTNO>721.2095</SECTNO> <SUBJECT>Chromate(3), bis 2-[[substituted-3-[(5-sulfo-1-napthalenyl)azo]phenyl]azo]substituted monocycle, trisodium (generic name).</SUBJECT> <SECTNO>721.2097</SECTNO> <SUBJECT>Azo chromium complex dyestuff preparation (generic name).</SUBJECT> <SECTNO>721.2098</SECTNO> <SUBJECT>Aliphatic polycarboxylic acid metal salt (generic).</SUBJECT> <SECTNO>721.2120</SECTNO> <SUBJECT>Cyclic amide.</SUBJECT> <SECTNO>721.2121</SECTNO> <SUBJECT>Thiosubstituted carbonate ester (generic).</SUBJECT> <SECTNO>721.2122</SECTNO> <SUBJECT>Substituted phenyl azo substituted sulfo carbopolycycle.</SUBJECT> <SECTNO>721.2140</SECTNO> <SUBJECT>Carbo­poly­cycli­col azo­alkyl­amino­al­kyl­carbo­mono­cyclic ester, halogen acid salt.</SUBJECT> <SECTNO>721.2145</SECTNO> <SUBJECT>Ceteareth-25 sorbate.</SUBJECT> <SECTNO>721.2155</SECTNO> <SUBJECT>Alkoxyamino-alkyl-coumarin (generic).</SUBJECT> <SECTNO>721.2175</SECTNO> <SUBJECT>Salt of cyclodiamine and mineral acid.</SUBJECT> <SECTNO>721.2222</SECTNO> <SUBJECT> Cyclohexanamine, <E T="03">N,N</E> -dimethyl-, compd. with alpha-isotridecyl-omega-hydroxypoly(oxy-1,2-ethanediyl) phosphate. </SUBJECT> <SECTNO>721.2250</SECTNO> <SUBJECT> 1,4-Cyclohexanediamine, <E T="03">cis</E> - and <E T="03">trans</E> -. </SUBJECT> <SECTNO>721.2260</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, 2,2-bis[[[[2-[(oxiranylmethoxy) carbonyl]cyclohexy]carbonyl]oxy]methyl]-1,3-propanediyl bis(oxiranylmethyl) ester.</SUBJECT> <SECTNO>721.2265</SECTNO> <SUBJECT>Polyalkylene oxide dialkylamine (generic).</SUBJECT> <SECTNO>721.2270</SECTNO> <SUBJECT>Aliphatic dicarboxylic acid salt.</SUBJECT> <SECTNO>721.2275</SECTNO> <SUBJECT> <E T="03">N,N,N′,N′</E> -Tetrakis(oxi­ranyl methyl)-1,3-cyclohexane di­meth­anamine. </SUBJECT> <SECTNO>721.2280</SECTNO> <SUBJECT>Cyclopropanecarboxaldehyde.</SUBJECT> <SECTNO>721.2287</SECTNO> <SUBJECT>DDT (Dichlorodiphenyltrichloroethane).</SUBJECT> <SECTNO>721.2340</SECTNO> <SUBJECT>Dialkenylamide (generic name).</SUBJECT> <SECTNO>721.2345</SECTNO> <SUBJECT>Alkyletherpropyl dialkylamines.</SUBJECT> <SECTNO>721.2350</SECTNO> <SUBJECT>Alkyltri, tetra, and pentaamines.</SUBJECT> <SECTNO>721.2355</SECTNO> <SUBJECT>Diethylstilbestrol.</SUBJECT> <SECTNO>721.2380</SECTNO> <SUBJECT>Disubstituted diamino ani­sole.</SUBJECT> <SECTNO>721.2385</SECTNO> <SUBJECT>Fluoroalkyl diester (generic).</SUBJECT> <SECTNO>721.2410</SECTNO> <SUBJECT>Alkoxylated alkyldiethylenetriamine, alkyl sulfate salts.</SUBJECT> <SECTNO>721.2420</SECTNO> <SUBJECT>Alkoxylated di­al­kyl­die­thy­lene­tri­a­mine, alkyl sulfate salt.</SUBJECT> <SECTNO>721.2465</SECTNO> <SUBJECT>Xanthylium, 9-(2- (ethoxycarbonyl)phenyl)-3,6- bis(ethylamino)-2,7-dimethyl-, ethyl sulfate.</SUBJECT> <SECTNO>721.2475</SECTNO> <SUBJECT>Dimetridazole.</SUBJECT> <SECTNO>721.2480</SECTNO> <SUBJECT>Isoalkyldimethylamine (generic).</SUBJECT> <SECTNO>721.2485</SECTNO> <SUBJECT>1,3-Dioxolane, 2-ethenyl-.</SUBJECT> <SECTNO>721.2520</SECTNO> <SUBJECT>Alkylated diphenyls.</SUBJECT> <SECTNO>721.2527</SECTNO> <SUBJECT>Acetamide, N-[2-[2-(2-bromo-6-cyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]-.</SUBJECT> <SECTNO>721.2532</SECTNO> <SUBJECT>Substituted diphenylmethane (generic).</SUBJECT> <SECTNO>721.2535</SECTNO> <SUBJECT>Benzene, 1,1′-methylanebis[4-isocyanato-, homopolymer, Bu alc.-blocked.</SUBJECT> <SECTNO>721.2540</SECTNO> <SUBJECT>Diphenylmethane diisocyanate (MDI) modified.</SUBJECT> <SECTNO>721.2560</SECTNO> <SUBJECT>Alkylated diphenyl oxide (generic name).</SUBJECT> <SECTNO>721.2565</SECTNO> <SUBJECT>Alkylated sulfonated diphenyl oxide, alkali and amine salts.</SUBJECT> <SECTNO>721.2570</SECTNO> <SUBJECT>Alkylated diphenyls (generic).</SUBJECT> <SECTNO>721.2575</SECTNO> <SUBJECT>Disubstituted diphenylsulfone.</SUBJECT> <SECTNO>721.2577</SECTNO> <SUBJECT>Certain copper complexes of (substituted sulfonaphthyl azo substituted phenyl) disulfonaphthyl azo, amine salt.</SUBJECT> <SECTNO>721.2580</SECTNO> <SUBJECT>C.I. Disperse Red 152 (generic).</SUBJECT> <SECTNO>721.2582</SECTNO> <SUBJECT>Reaction product of alkylene diamine, MDI, substituted carbomonocyclic amine and alkylamine (generic).</SUBJECT> <SECTNO>721.2584</SECTNO> <SUBJECT>Dodecanoic acid, 12-amino-.</SUBJECT> <SECTNO>721.2585</SECTNO> <SUBJECT>Sodium salts of dodecylphenol (generic).</SUBJECT> <SECTNO>721.2600</SECTNO> <SUBJECT>Epibromohydrin.</SUBJECT> <SECTNO>721.2625</SECTNO> <SUBJECT>Reaction product of alkane­diol and epichlorohydrin.</SUBJECT> <SECTNO>721.2673</SECTNO> <SUBJECT>Aromatic epoxide resin (generic).</SUBJECT> <SECTNO>721.2675</SECTNO> <SUBJECT>Perfluoroalkyl epoxide (generic name).</SUBJECT> <SECTNO>721.2685</SECTNO> <SUBJECT>Polyisobutene epoxide (generic).</SUBJECT> <SECTNO>721.2725</SECTNO> <SUBJECT>Trichlorobutylene oxide.</SUBJECT> <SECTNO>721.2752</SECTNO> <SUBJECT>Epoxy resin containing phosphorus (generic).</SUBJECT> <SECTNO>721.2755</SECTNO> <SUBJECT>Cycloaliphatic epoxy resin (generic).</SUBJECT> <SECTNO>721.2800</SECTNO> <SUBJECT>Erionite fiber.</SUBJECT> <SECTNO>721.2805</SECTNO> <SUBJECT>2-Propenoic acid, 2-(phenylthio)ethyl ester.</SUBJECT> <SECTNO>721.2825</SECTNO> <SUBJECT>Alkyl ester (generic name).</SUBJECT> <SECTNO>721.2900</SECTNO> <SUBJECT>Substituted aminobenzoic acid ester (generic name).</SUBJECT> <SECTNO>721.2920</SECTNO> <SUBJECT> <E T="03">tert</E> -Amyl peroxy alkylene ester (generic name). </SUBJECT> <SECTNO>721.2925</SECTNO> <SUBJECT>Brominated aromatic ester.</SUBJECT> <SECTNO>721.2950</SECTNO> <SUBJECT>Carboxylic acid glycidyl esters.</SUBJECT> <SECTNO>721.3000</SECTNO> <SUBJECT>Dicarboxylic acid monoester.</SUBJECT> <SECTNO>721.3020</SECTNO> <SUBJECT>Ethaneperoxoic acid, 1,1-dimethylpropyl ester.</SUBJECT> <SECTNO>721.3025</SECTNO> <SUBJECT> Fatty acids C <E T="52">12-18</E> , C <E T="52">18</E> unsaturated, C <E T="52">12-18</E> alkyl esters (generic). </SUBJECT> <SECTNO>721.3031</SECTNO> <SUBJECT> Boric acid (H <E T="52">3</E> BO <E T="52">3</E> ), zinc salt (2 = 3). </SUBJECT> <SECTNO>721.3032</SECTNO> <SUBJECT> Boric acid (H <E T="52">3</E> BO <E T="52">2</E> ), zinc salt. </SUBJECT> <SECTNO>721.3034</SECTNO> <SUBJECT>Methylamine esters.</SUBJECT> <SECTNO>721.3062</SECTNO> <SUBJECT> 1H-Indene-2-carboxylic acid, 5-chloro-2,3-dihydro-1-oxo-, methyl ester. <PRTPAGE P="250"/> </SUBJECT> <SECTNO>721.3063</SECTNO> <SUBJECT>Certain substituted phenyl azo substituted phenyl esters.</SUBJECT> <SECTNO>721.3080</SECTNO> <SUBJECT>Substituted phosphate ester (generic).</SUBJECT> <SECTNO>721.3085</SECTNO> <SUBJECT>Brominated phthalate ester.</SUBJECT> <SECTNO>721.3100</SECTNO> <SUBJECT>Oligomeric silicic acid ester compound with a hydroxylalkylamine.</SUBJECT> <SECTNO>721.3110</SECTNO> <SUBJECT>Polycarboxylic acid ester (generic).</SUBJECT> <SECTNO>721.3130</SECTNO> <SUBJECT> Sulfuric acid, mono-C <E T="52">9-11</E> -alkyl esters, sodium salts. </SUBJECT> <SECTNO>721.3135</SECTNO> <SUBJECT>Phosphorous modified epoxy resin (generic).</SUBJECT> <SECTNO>721.3140</SECTNO> <SUBJECT>Vinyl epoxy ester.</SUBJECT> <SECTNO>721.3152</SECTNO> <SUBJECT> Ethanaminium, <E T="03">N</E> -ethyl-2-hydroxy- <E T="03">N,N</E> -bis(2-hydroxyethyl)-, diester with C <E T="52">12-18</E> fatty acids, ethyl sulfates (salts). </SUBJECT> <SECTNO>721.3155</SECTNO> <SUBJECT>3,8-Dioxa-4,7-disiladecane, 4,4,7,7-tetraethoxy-.</SUBJECT> <SECTNO>721.3160</SECTNO> <SUBJECT>1-Chloro-2-bromoethane.</SUBJECT> <SECTNO>721.3220</SECTNO> <SUBJECT>Pentachloroethane.</SUBJECT> <SECTNO>721.3248</SECTNO> <SUBJECT>Ethane, 1,2,2-trichlorodifluoro-.</SUBJECT> <SECTNO>721.3260</SECTNO> <SUBJECT>Ethanediimidic acids.</SUBJECT> <SECTNO>721.3310</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)],α-(1-oxo-2-propenyl)-ω-[(tetrahydro-2-furanyl)methoxy]-.</SUBJECT> <SECTNO>721.3320</SECTNO> <SUBJECT> Ethanol, 2-amino-, com­pound with <E T="03">N</E> -hydroxy- <E T="03">N</E> -nitro­soben­zena­mine (1:1). </SUBJECT> <SECTNO>721.3340</SECTNO> <SUBJECT>Ethanol, 2,2′-(hexylamino)bis-.</SUBJECT> <SECTNO>721.3350</SECTNO> <SUBJECT>N-Nitrosodiethanolamine.</SUBJECT> <SECTNO>721.3360</SECTNO> <SUBJECT>Substituted ethanolamine.</SUBJECT> <SECTNO>721.3364</SECTNO> <SUBJECT>Aliphatic ether.</SUBJECT> <SECTNO>721.3374</SECTNO> <SUBJECT>Alkylenediolalkyl ether.</SUBJECT> <SECTNO>721.3380</SECTNO> <SUBJECT>Benzenamine, 4-methoxy-2-methyl-N-phenyl-.</SUBJECT> <SECTNO>721.3420</SECTNO> <SUBJECT>Benzene, 1-bromo-4-methoxy-2-methyl-.</SUBJECT> <SECTNO>721.3430</SECTNO> <SUBJECT>4-Bromophenyl phenyl ether.</SUBJECT> <SECTNO>721.3435</SECTNO> <SUBJECT>Butoxy-substituted ether alkane.</SUBJECT> <SECTNO>721.3437</SECTNO> <SUBJECT>Dialkyl ether.</SUBJECT> <SECTNO>721.3438</SECTNO> <SUBJECT>Chlorohydroxyalkyl butyl ether (generic).</SUBJECT> <SECTNO>721.3440</SECTNO> <SUBJECT>Haloalkyl substituted cyclic ethers.</SUBJECT> <SECTNO>721.3465</SECTNO> <SUBJECT>Stilbene diglycidyl ether.</SUBJECT> <SECTNO>721.3480</SECTNO> <SUBJECT>Halogenated biphenyl glycidyl ethers.</SUBJECT> <SECTNO>721.3485</SECTNO> <SUBJECT>Hydrofluorocarbon alkyl ether.</SUBJECT> <SECTNO>721.3486</SECTNO> <SUBJECT>Polyglycerin mono(4-nonylphenyl) ether.</SUBJECT> <SECTNO>721.3488</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), alpha substituted-omega-hydroxy-, C <E T="52">16-20</E> alkyl ethers. </SUBJECT> <SECTNO>721.3500</SECTNO> <SUBJECT>Perhalo alkoxy ether.</SUBJECT> <SECTNO>721.3520</SECTNO> <SUBJECT>Aliphatic polyglycidyl ether.</SUBJECT> <SECTNO>721.3550</SECTNO> <SUBJECT>Dipropylene glycol dimethyl ether.</SUBJECT> <SECTNO>721.3560</SECTNO> <SUBJECT>Derivative of tetra­chloro­ethy­lene.</SUBJECT> <SECTNO>721.3565</SECTNO> <SUBJECT>Ethylenediamine, substituted, sodium salt.</SUBJECT> <SECTNO>721.3620</SECTNO> <SUBJECT>Fatty acid amine condensate, polycarboxylic acid salts.</SUBJECT> <SECTNO>721.3625</SECTNO> <SUBJECT>Fatty acid amine salt (generic name).</SUBJECT> <SECTNO>721.3627</SECTNO> <SUBJECT>Branched synthetic fatty acid.</SUBJECT> <SECTNO>721.3629</SECTNO> <SUBJECT>Triethanolamine salts of fatty acids.</SUBJECT> <SECTNO>721.3635</SECTNO> <SUBJECT> Octadecanoic acid, ester with 1,2-propanediol, phosphate, anhydride with silicic acid (H <E T="52">4</E> SiO <E T="52">4</E> ). </SUBJECT> <SECTNO>721.3680</SECTNO> <SUBJECT>Ethylene oxide adduct of fatty acid ester with pentaerythritol.</SUBJECT> <SECTNO>721.3700</SECTNO> <SUBJECT>Fatty acid, ester with styrenated phenol, ethylene oxide adduct.</SUBJECT> <SECTNO>721.3710</SECTNO> <SUBJECT>Polyether modified fatty acids (generic).</SUBJECT> <SECTNO>721.3720</SECTNO> <SUBJECT>Fatty amide.</SUBJECT> <SECTNO>721.3740</SECTNO> <SUBJECT>Bisalkylated fatty alkyl amine oxide.</SUBJECT> <SECTNO>721.3760</SECTNO> <SUBJECT>Fluorene-containing diaromatic amines.</SUBJECT> <SECTNO>721.3764</SECTNO> <SUBJECT>Fluorene substituted aromatic amine.</SUBJECT> <SECTNO>721.3780</SECTNO> <SUBJECT>Substituted and disubstituted tetrafluoro alkenes (generic).</SUBJECT> <SECTNO>721.3790</SECTNO> <SUBJECT>Polyfluorocarboxylates.</SUBJECT> <SECTNO>721.3800</SECTNO> <SUBJECT>Formaldehyde, condensated poly­ox­y­eth­y­lene fatty acid, ester with styrenated phenol, ethylene oxide adduct.</SUBJECT> <SECTNO>721.3805</SECTNO> <SUBJECT>Formaldehyde, reaction products with 1,3-benzenedimethanamine and bisphenol A.</SUBJECT> <SECTNO>721.3807</SECTNO> <SUBJECT>Formaldehyde, polymer with phenol and 1,2,3-propanetriol, methylated.</SUBJECT> <SECTNO>721.3810</SECTNO> <SUBJECT>Formaldehyde, polymers with substituted phenols (generic).</SUBJECT> <SECTNO>721.3812</SECTNO> <SUBJECT>Substituted phenols and formaldehyde polymer, alkylated (generic).</SUBJECT> <SECTNO>721.3815</SECTNO> <SUBJECT>Furan, 2-(ethoxymethyl)- tetrahydro-.</SUBJECT> <SECTNO>721.3818</SECTNO> <SUBJECT>Furan, octafluorotetrahydro-.</SUBJECT> <SECTNO>721.3820</SECTNO> <SUBJECT>L-Glutamic acid, N-(1-oxododecyl)-, disodium salt.</SUBJECT> <SECTNO>721.3821</SECTNO> <SUBJECT>L-Gutamic acid, N-(1-oxododecyl)-.</SUBJECT> <SECTNO>721.3830</SECTNO> <SUBJECT>Phenol, 2-[[[3-(dimethylamino)propyl]amino]methyl]-6-methyl-, 4-polybutene derivs.</SUBJECT> <SECTNO>721.3835</SECTNO> <SUBJECT>Chloroformate (generic).</SUBJECT> <SECTNO>721.3840</SECTNO> <SUBJECT>Tetraglycidalamines (generic name).</SUBJECT> <SECTNO>721.3845</SECTNO> <SUBJECT>Alkyl substituted aromatic glycidyl ether (generic).</SUBJECT> <SECTNO>721.3848</SECTNO> <SUBJECT> Glycine, <E T="03">N</E> -(carboxymethyl)- <E T="03">N</E> -dodecyl-, monosodium salt. </SUBJECT> <SECTNO>721.3860</SECTNO> <SUBJECT>Glycol monobenzoate.</SUBJECT> <SECTNO>721.3880</SECTNO> <SUBJECT>Polyalkylene glycol substituted acetate.</SUBJECT> <SECTNO>721.3900</SECTNO> <SUBJECT>Alkyl polyethylene glycol phosphate, potassium salt.</SUBJECT> <SECTNO>721.4000</SECTNO> <SUBJECT>Polyoxy alkylene glycol amine.</SUBJECT> <SECTNO>721.4040</SECTNO> <SUBJECT> Glycols, polyethylene-, 3-sulfo-2-hy­drox­y­pro­pyl- <E T="03">p</E> -(1,1,3,3-tetra­methylbutyl)phenyl ether, sodium salt. </SUBJECT> <SECTNO>721.4060</SECTNO> <SUBJECT>Alkylene glycol tereph­tha­late and substituted benzoate esters (generic name).</SUBJECT> <SECTNO>721.4080</SECTNO> <SUBJECT>MNNG (N-methyl-N′-nitro-N-nitrosoguanidine).</SUBJECT> <SECTNO>721.4085</SECTNO> <SUBJECT>Guanidine, pentaethyl-.</SUBJECT> <SECTNO>721.4090</SECTNO> <SUBJECT> Ethanaminium, <E T="03">N</E> -[bis(diethylamino)-methylene]- <E T="03">N</E> -ethyl-, bromide. </SUBJECT> <SECTNO>721.4095</SECTNO> <SUBJECT>Quaternary ammonium alkyltherpropyl trialkylamine halides.</SUBJECT> <SECTNO>721.4096</SECTNO> <SUBJECT> Substituted anilino halobenzamide (generic). <PRTPAGE P="251"/> </SUBJECT> <SECTNO>721.4097</SECTNO> <SUBJECT>7-Oxabicyclo[4.1.0]heptane-3-carboxylic acid, methyl ester.</SUBJECT> <SECTNO>721.4098</SECTNO> <SUBJECT>Substituted heteroaromatic-2[[4-(dimethylamino) phenyl]azo]-3-methyl-, salts (generic).</SUBJECT> <SECTNO>721.4100</SECTNO> <SUBJECT>Tris(disubstituted alkyl) heter­o­cy­cle.</SUBJECT> <SECTNO>721.4105</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-butyl-.</SUBJECT> <SECTNO>721.4106</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-hexyl-.</SUBJECT> <SECTNO>721.4107</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-octyl-.</SUBJECT> <SECTNO>721.4108</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-decyl-.</SUBJECT> <SECTNO>721.4110</SECTNO> <SUBJECT>Allyloxysubstituted heterocycle.</SUBJECT> <SECTNO>721.4128</SECTNO> <SUBJECT>Dimethyl-3-substituted heter­o­mon­o­cy­cle.</SUBJECT> <SECTNO>721.4133</SECTNO> <SUBJECT>Dimethyl-3-substituted heteromonocyclic amine.</SUBJECT> <SECTNO>721.4136</SECTNO> <SUBJECT>Alkyl heteropolycyclic-aniline (generic).</SUBJECT> <SECTNO>721.4140</SECTNO> <SUBJECT>Hexachloronorbornadiene.</SUBJECT> <SECTNO>721.4155</SECTNO> <SUBJECT>Hexachloropropene.</SUBJECT> <SECTNO>721.4158</SECTNO> <SUBJECT>Hexadecanoic acid, ethenyl ester.</SUBJECT> <SECTNO>721.4160</SECTNO> <SUBJECT>Hexafluoropropylene oxide.</SUBJECT> <SECTNO>721.4180</SECTNO> <SUBJECT>Hexamethylphosphoramide.</SUBJECT> <SECTNO>721.4215</SECTNO> <SUBJECT>Hexanedioic acid, diethenyl ester.</SUBJECT> <SECTNO>721.4250</SECTNO> <SUBJECT>Hexanoic acid, 2-ethyl-, ethenyl ester.</SUBJECT> <SECTNO>721.4255</SECTNO> <SUBJECT>1,4,7,10,13,16-Hexaoxacyclooctadecane, 2-[(2-propenyl oxy)methyl]-.</SUBJECT> <SECTNO>721.4257</SECTNO> <SUBJECT>Hydrazine, (2-fluorophenyl).</SUBJECT> <SECTNO>721.4258</SECTNO> <SUBJECT>Substituted naphthalene hydrazide (generic).</SUBJECT> <SECTNO>721.4259</SECTNO> <SUBJECT>Aliphatic polyisocyanate homopolymer.</SUBJECT> <SECTNO>721.4260</SECTNO> <SUBJECT>Hydrazine, [4-(1-meth­yl­bu­toxy)phenyl]-, monohydrochloride.</SUBJECT> <SECTNO>721.4265</SECTNO> <SUBJECT> Hydrazinecarboxamide, <E T="03">N</E> -(3,5-difluorophenyl-). </SUBJECT> <SECTNO>721.4270</SECTNO> <SUBJECT>Nitrophenoxylalkanoic acid substituted thiazino hydrazide (generic name).</SUBJECT> <SECTNO>721.4280</SECTNO> <SUBJECT>Substituted hydrazine.</SUBJECT> <SECTNO>721.4300</SECTNO> <SUBJECT> Hydrazinecarboxamide, <E T="03">N,N′</E> -1,6-hexanediylbis [2,2-dimethyl-]. </SUBJECT> <SECTNO>721.4320</SECTNO> <SUBJECT> Hydrazinecarboxamide, <E T="03">N,N′</E> -(meth­yl­en­edi-4,1-phenylene)bis [2,2-dimethyl-. </SUBJECT> <SECTNO>721.4340</SECTNO> <SUBJECT>Substituted thiazino hydrazine salt (generic name).</SUBJECT> <SECTNO>721.4360</SECTNO> <SUBJECT>Certain hydrogen containing chlor­o­fluor­o­carbons.</SUBJECT> <SECTNO>721.4365</SECTNO> <SUBJECT>Substituted ethoxylated hydrocarbon (generic).</SUBJECT> <SECTNO>721.4380</SECTNO> <SUBJECT>Modified hydrocarbon resin.</SUBJECT> <SECTNO>721.4385</SECTNO> <SUBJECT>Hydrofluoric acid, reaction products with heptane.</SUBJECT> <SECTNO>721.4390</SECTNO> <SUBJECT>Trisubstituted hydroquinone diester.</SUBJECT> <SECTNO>721.4420</SECTNO> <SUBJECT>Substituted hydroxylamine.</SUBJECT> <SECTNO>721.4460</SECTNO> <SUBJECT>Amidinothiopropionic acid hydrochloride.</SUBJECT> <SECTNO>721.4461</SECTNO> <SUBJECT>Hydrofluoric acid, reaction products with octane (generic).</SUBJECT> <SECTNO>721.4462</SECTNO> <SUBJECT>Hydrochlorofluorocarbon.</SUBJECT> <SECTNO>721.4463</SECTNO> <SUBJECT>Hydrochlorofluorocarbon.</SUBJECT> <SECTNO>721.4464</SECTNO> <SUBJECT>Mixture of hydrofluoro alkanes and hydrofluoro alkene.</SUBJECT> <SECTNO>721.4465</SECTNO> <SUBJECT>Hydrofluoroalkane.</SUBJECT> <SECTNO>721.4467</SECTNO> <SUBJECT>Quaternary ammonium hydroxide.</SUBJECT> <SECTNO>721.4468</SECTNO> <SUBJECT>1H-Imidazole, 2-ethyl-4,5-dihydro-4-methyl-.</SUBJECT> <SECTNO>721.4469</SECTNO> <SUBJECT>Imidazolethione.</SUBJECT> <SECTNO>721.4470</SECTNO> <SUBJECT>2,4-Imidazolidinedione, bromochloro-5,5-dimethyl-.</SUBJECT> <SECTNO>721.4472</SECTNO> <SUBJECT>Phenyl, alkyl, hydroxyalkyl substituted imidazole (generic).</SUBJECT> <SECTNO>721.4473</SECTNO> <SUBJECT>Dialkylamidoimidazoline.</SUBJECT> <SECTNO>721.4476</SECTNO> <SUBJECT>Substituted imines.</SUBJECT> <SECTNO>721.4480</SECTNO> <SUBJECT>2-Imino-1,3-thiazin-4-one-5,6-dihydromonohydrochloride.</SUBJECT> <SECTNO>721.4484</SECTNO> <SUBJECT>Halogenated indane (generic name).</SUBJECT> <SECTNO>721.4486</SECTNO> <SUBJECT>Propanoic acid, 2-methyl-, (1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester, rel-.</SUBJECT> <SECTNO>721.4490</SECTNO> <SUBJECT>Capped aliphatic isocyanate.</SUBJECT> <SECTNO>721.4494</SECTNO> <SUBJECT>Polycyclic isocyanate.</SUBJECT> <SECTNO>721.4497</SECTNO> <SUBJECT>Aliphatic polyisocyanates (generic name).</SUBJECT> <SECTNO>721.4500</SECTNO> <SUBJECT>Isopropylamine distillation residues and ethylamine distillation residues.</SUBJECT> <SECTNO>721.4520</SECTNO> <SUBJECT>Isopropylidene, bis(1,1-di­meth­yl­pro­pyl) derivative.</SUBJECT> <SECTNO>721.4550</SECTNO> <SUBJECT>Diperoxy ketal.</SUBJECT> <SECTNO>721.4565</SECTNO> <SUBJECT>Modified hydroxystyrene homopolymer (generic).</SUBJECT> <SECTNO>721.4568</SECTNO> <SUBJECT>Methylpolychloro aliphatic ketone.</SUBJECT> <SECTNO>721.4575</SECTNO> <SUBJECT> L-aspartic acid, <E T="03">N,N′</E> -[(1E) - 1,2- ethenediylbis[(3-sulfo-4, 1-phenylene)imino [6-(phenylamino)-1,3,5- triazine- 4,2- diyl]]]bis-, hexasodium salt. </SUBJECT> <SECTNO>721.4585</SECTNO> <SUBJECT>Lecithins, phospholipase A2-hydrolyzed.</SUBJECT> <SECTNO>721.4587</SECTNO> <SUBJECT>Lithium manganese oxide (LiMn204) (generic name).</SUBJECT> <SECTNO>721.4589</SECTNO> <SUBJECT>Propanedioic acid, [(4-methoxyphenyl)methylene]-, bis(1,2,2,6,6-pentamethyl-4-piperdinyl) ester (9CI).</SUBJECT> <SECTNO>721.4590</SECTNO> <SUBJECT>Mannich-based adduct.</SUBJECT> <SECTNO>721.4594</SECTNO> <SUBJECT>Substituted azo metal complex dye.</SUBJECT> <SECTNO>721.4596</SECTNO> <SUBJECT>Diazo substituted carbomonocyclic metal complex.</SUBJECT> <SECTNO>721.4600</SECTNO> <SUBJECT>Recovered metal hydroxide.</SUBJECT> <SECTNO>721.4610</SECTNO> <SUBJECT>Mixed metal oxides (generic).</SUBJECT> <SECTNO>721.4620</SECTNO> <SUBJECT>Zinc, bis(N,N-dipropyl-.beta.-alaninato-.kappa.N,.kappa.O)-, (T-4)-.</SUBJECT> <SECTNO>721.4660</SECTNO> <SUBJECT>Alcohol, alkali metal salt.</SUBJECT> <SECTNO>721.4663</SECTNO> <SUBJECT>Fluorinated carboxylic acid alkali metal salts.</SUBJECT> <SECTNO>721.4668</SECTNO> <SUBJECT>Hydrated alkaline earth metal salts of metalloid oxyanions.</SUBJECT> <SECTNO>721.4685</SECTNO> <SUBJECT>Substituted purine metal salt (generic name).</SUBJECT> <SECTNO>721.4700</SECTNO> <SUBJECT>Metalated alkylphenol copolymer (generic name).</SUBJECT> <SECTNO>721.4720</SECTNO> <SUBJECT>Disubstituted phenoxazine, chlor­o­me­tal­ate salt.</SUBJECT> <SECTNO>721.4740</SECTNO> <SUBJECT>Alkali metal nitrites.</SUBJECT> <SECTNO>721.4792</SECTNO> <SUBJECT> 2-Propenoic acid, 2-methyl-, C <E T="52">11-14</E> -isoalkyl esters, C <E T="52">13</E> -rich. </SUBJECT> <SECTNO>721.4794</SECTNO> <SUBJECT>Polypiperidinol-acrylate methacrylate.</SUBJECT> <SECTNO>721.4820</SECTNO> <SUBJECT>Methane, bromodifluoro-.</SUBJECT> <SECTNO>721.4840</SECTNO> <SUBJECT> Substituted tri­phenyl­meth­ane. <PRTPAGE P="252"/> </SUBJECT> <SECTNO>721.4880</SECTNO> <SUBJECT>Methanol, trichloro-, carbonate (2:1).</SUBJECT> <SECTNO>721.4885</SECTNO> <SUBJECT>Methanone, [5-[[3-(2H-benzotriazol-2-yl)-2-hydroxy-5-(1,1,3,3-tetramethylbutyl)phenyl]methyl]-2-hydroxy-4-(octyloxy) phenyl]phenyl-.</SUBJECT> <SECTNO>721.4925</SECTNO> <SUBJECT>Methyl n-butyl ketone.</SUBJECT> <SECTNO>721.5050</SECTNO> <SUBJECT>2,2′-[(1-Methyl­ethylidene)­bis[4,1-phenyl­oxy[1-(butoxy­methyl)-(2,1-ethan­ediyl]oxy­methyl­ene]]biso­xirane, reaction product with a diamine.</SUBJECT> <SECTNO>721.5075</SECTNO> <SUBJECT>Mixed methyltin mercaptoester sulfides.</SUBJECT> <SECTNO>721.5175</SECTNO> <SUBJECT>Mitomycin C.</SUBJECT> <SECTNO>721.5185</SECTNO> <SUBJECT>2-Propen-1-one, 1-(4-morpholinyl)-.</SUBJECT> <SECTNO>721.5192</SECTNO> <SUBJECT>Substituted 1,6-dihydroxy naphthalene.</SUBJECT> <SECTNO>721.5200</SECTNO> <SUBJECT>Disubstituted phenylazo tri­sub­sti­tut­ed naphthalene.</SUBJECT> <SECTNO>721.5225</SECTNO> <SUBJECT>Naphthalene,1,2,3,4-tetra­hy­dro(1-phenylethyl) (specific name).</SUBJECT> <SECTNO>721.5250</SECTNO> <SUBJECT>Trimethyl spiropolyheterocyclic naph­tha­lene compound.</SUBJECT> <SECTNO>721.5252</SECTNO> <SUBJECT>2-Naphthalenecarboxylic acid, 4,4′-methylenebis [3-hydroxy-, zinc salt.</SUBJECT> <SECTNO>721.5253</SECTNO> <SUBJECT>2-Naphthalenecarboxylic acid, 4,4′-methylenebis [3-hydroxy-, strontium salt.</SUBJECT> <SECTNO>721.5255</SECTNO> <SUBJECT>2-Naphthalenol, mono and dioctyl derivs.</SUBJECT> <SECTNO>721.5260</SECTNO> <SUBJECT>1,3,6-Naphthalenetrisulfonic acid, 7-[[2-[(aminocarbonyl)amino]-4-[[4-[[2-[2-(ethenylsulfonyl)ethoxy]ethyl]amino]-6-fluoro-1,3,5-triazin-2-yl]amino]phenyl]azo], trisodium salt.</SUBJECT> <SECTNO>721.5262</SECTNO> <SUBJECT>2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[2-[2-(ethenylsulfonyl)ethoxy]ethyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-(1-sulfo-2-naphthalenyl)diazenyl]-, sodium salt (1:3).</SUBJECT> <SECTNO>721.5275</SECTNO> <SUBJECT>2-Napthalenecarboxamide-N-aryl-3-hydroxy-4-arylazo (generic name).</SUBJECT> <SECTNO>721.5276</SECTNO> <SUBJECT> 2-Napthalenol, heptyl-1-[[(4-phenylazo)phenyl]azo]-, <E T="03">ar′, ar″</E> -Me derivs. </SUBJECT> <SECTNO>721.5278</SECTNO> <SUBJECT>Substituted naphthalenesulfonic acid, alkali salt.</SUBJECT> <SECTNO>721.5279</SECTNO> <SUBJECT>2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′2-amino-4-[(3-butoxy-2-hydroxypropyl)amino]phebyl]azo]-3,3′-dimethyl[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt.</SUBJECT> <SECTNO>721.5280</SECTNO> <SUBJECT>2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, coupled with diazotized 4-butylbenzenamine, diazotized 4,4′-cyclohexylidenebis[benzenamine] and m-phenylenediamine, sodium salt.</SUBJECT> <SECTNO>721.5281</SECTNO> <SUBJECT>2-Naphthalenesulfonic acid, 3-[[4-[(2,4-dimethyl-6-sulfophenyl)azo]-2-methoxy-5-methylphenyl]azo]-4-hydroxy-7-(phenylamino)-, sodium salt, compd. With 2,2′,2″-nitrilotris [ethanol] (9CI).</SUBJECT> <SECTNO>721.5282</SECTNO> <SUBJECT>Trisodium chloro [(trisubstituted heteromonocycle amino) propylamino]triazinylamino hydroxyazo naphthalenetrisulfonate.</SUBJECT> <SECTNO>721.5283</SECTNO> <SUBJECT>Cobaltate (5-), bis[4-[[6-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amio]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]-3-hydroxy-7-nitro-1-naphthalenesulfonato(4-)]-, pentasodium.</SUBJECT> <SECTNO>721.5284</SECTNO> <SUBJECT>Chromate (5-), bis[4-hydroxy-7-[(2-hydroxy-1-naphthalenyl)azo]- 3-[(2-hydroxy-3-nitro-5-sulfophenyl)azo]-2- naphthalenesulfonato(4-)]-, pentasodium.</SUBJECT> <SECTNO>721.5285</SECTNO> <SUBJECT>Ethoxylated substituted naphthol.</SUBJECT> <SECTNO>721.5286</SECTNO> <SUBJECT>Benzenediazonium, [[[[(substituted)azo]phenyl]sulfonyl]amino]-, coupled with aminophenol, diazotized aminobenzoic acid, diazotized (substituted) benzenesulfonic acid and naphthalenol (generic).</SUBJECT> <SECTNO>721.5288</SECTNO> <SUBJECT>Chromate(2-), [3-hydroxy-4-[(2-hydroxy-1-naphthenyl)azo]-7-nitro-1-substituted][N-[7-hydroxy-8-[(2-hydroxy-5-nitrophenyl)azo]-1-substituted]-, salt (generic).</SUBJECT> <SECTNO>721.5290</SECTNO> <SUBJECT>Phenylazoalkoxy naphthylamines (generic).</SUBJECT> <SECTNO>721.5293</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), alpha-(9Z)-9-octadecenyl-.omega.-hydroxy-, phosphate, ammonium salt.</SUBJECT> <SECTNO>721.5310</SECTNO> <SUBJECT>Neononanoic acid, ethenyl ester.</SUBJECT> <SECTNO>721.5315</SECTNO> <SUBJECT>Nickel, cobalt mixed metal oxide (generic).</SUBJECT> <SECTNO>721.5325</SECTNO> <SUBJECT>Nickel, tris(neodecanoato-.kappa.O)[.mu.3-[orthoborato(3-)-.kappa.O:.kappa.O′:.kappa.O″]]tri-.</SUBJECT> <SECTNO>721.5330</SECTNO> <SUBJECT>Nickel salt of an organo compound containing nitrogen.</SUBJECT> <SECTNO>721.5340</SECTNO> <SUBJECT>Substituted benzothiazole-azo-substituted benzoquinoline nickel complex (generic).</SUBJECT> <SECTNO>721.5350</SECTNO> <SUBJECT>Butanenitrile, 2-amino-2,3-dimethyl-.</SUBJECT> <SECTNO>721.5356</SECTNO> <SUBJECT>Ethanol, 2,2′2″-nitrilotris-, compound with alpha-2,4,6-tris (1-phenylethyl)phenyl]-omega-hydroxypoly (oxy-1,2-ethanediyl) phosphate.</SUBJECT> <SECTNO>721.5358</SECTNO> <SUBJECT> 2-propanol, 1,1′,1′-nitrilotris-, compds. with ethanol 2-[2-(C <E T="52">12-14</E> - alkyloxy) ethoxy] derivs. hydrogen sulfates. </SUBJECT> <SECTNO>721.5360</SECTNO> <SUBJECT>Substituted nitrobenezene (generic).</SUBJECT> <SECTNO>721.5375</SECTNO> <SUBJECT>Ni­tro­thio­phene­car­boxy­lic acid, ethyl es­ter, bis[[[[(substi­tut­ed)] ami­no­]alkyl­phenyl]­az­o] (ge­ner­ic name).</SUBJECT> <SECTNO>721.5378</SECTNO> <SUBJECT>9-Phosphabicyclo[3.3.1]nonane,9,9′-(1,2-ethanediyl)bis- (9C1).</SUBJECT> <SECTNO>721.5380</SECTNO> <SUBJECT>Mixed alkyl phenolic novolak resin (generic).</SUBJECT> <SECTNO>721.5385</SECTNO> <SUBJECT>Octanoic acid, hydrazide.</SUBJECT> <SECTNO>721.5400</SECTNO> <SUBJECT>3,6,9,12,15,18,21-Hepta­oxa­tetra­triaoctanoic acid, sodium salt.</SUBJECT> <SECTNO>721.5425</SECTNO> <SUBJECT>α-Olefin sulfonate, potassium salts.</SUBJECT> <SECTNO>721.5450</SECTNO> <SUBJECT>α-Olefin sulfonate, sodium salt.</SUBJECT> <SECTNO>721.5452</SECTNO> <SUBJECT>Alkali metal salt of halogenated organoborate (generic).</SUBJECT> <SECTNO>721.5454</SECTNO> <SUBJECT> Methylium, tripohenyl-, tetrakis(pentafluorophenyl) borate (1-). <PRTPAGE P="253"/> </SUBJECT> <SECTNO>721.5460</SECTNO> <SUBJECT>Organosolv lignin.</SUBJECT> <SECTNO>721.5465</SECTNO> <SUBJECT>Amine salt of organic acid (generic).</SUBJECT> <SECTNO>721.5475</SECTNO> <SUBJECT>1-Oxa-4-azaspiro[4.5]decane, 4-di­chlor­o­ace­tyl-.</SUBJECT> <SECTNO>721.5500</SECTNO> <SUBJECT>7-Oxabicyclo[4.1.0]heptane, 3-ethenyl, homopolymer, ether with 2-ethyl-2-(hydroxymethyl)-1,3-pro­pane­diol (3:1), epoxidized.</SUBJECT> <SECTNO>721.5525</SECTNO> <SUBJECT>Substituted spiro oxazine.</SUBJECT> <SECTNO>721.5540</SECTNO> <SUBJECT> 1 <E T="03">H</E> ,3 <E T="03">H</E> ,5 <E T="03">H</E> -oxazolo [3,4-c] oxazole, dihydro-7a-methyl-. </SUBJECT> <SECTNO>721.5545</SECTNO> <SUBJECT>3-(Dichloroacetyl)-5-(2-furanyl)-2,2-dimethyl-oxazolidine.</SUBJECT> <SECTNO>721.5546</SECTNO> <SUBJECT>Halogen substituted oxetanes (generic).</SUBJECT> <SECTNO>721.5547</SECTNO> <SUBJECT>Antimony double oxide.</SUBJECT> <SECTNO>721.5548</SECTNO> <SUBJECT>Mixed metal oxide (generic).</SUBJECT> <SECTNO>721.5549</SECTNO> <SUBJECT>Lithiated metal oxide.</SUBJECT> <SECTNO>721.5550</SECTNO> <SUBJECT>Substituted dialkyl oxa­zo­lone (generic name).</SUBJECT> <SECTNO>721.5560</SECTNO> <SUBJECT>Formaldehyde, polymer with (chloromethyl) oxirane and phenol, reaction products with 6H-dibenz[c,e][1,2]oxaphosphorin-6-oxide.</SUBJECT> <SECTNO>721.5575</SECTNO> <SUBJECT>Oxirane, 2,2′-(1,6-hex­ane­diyl­bis (oxy­meth­y­lene)) bis-.</SUBJECT> <SECTNO>721.5580</SECTNO> <SUBJECT>Oxirane, 2,2′-[methylenebis[(2,6-dimethyl-4,1-phenylene)oxymethylene]]bis-.</SUBJECT> <SECTNO>721.5585</SECTNO> <SUBJECT>4,4′-(1-methylethylidene)bisphenol, polymer with (chloromethyl)oxirane and a diamine (generic).</SUBJECT> <SECTNO>721.5590</SECTNO> <SUBJECT>Oxirane, [[[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]oxy]methyl]-.</SUBJECT> <SECTNO>721.5600</SECTNO> <SUBJECT>Substituted oxirane.</SUBJECT> <SECTNO>721.5625</SECTNO> <SUBJECT> Oxiranemethanamine, <E T="03">N,N′</E> -[methylenebis(2-ethyl-4,1-phenylene)]bis[N-(oxiranylmethyl)]-. </SUBJECT> <SECTNO>721.5645</SECTNO> <SUBJECT>Pentane 1,1,1,2,3,4,4,5,5,5,-decafluoro.</SUBJECT> <SECTNO>721.5650</SECTNO> <SUBJECT>Pentanediol light residues.</SUBJECT> <SECTNO>721.5700</SECTNO> <SUBJECT>Pentanenitrile, 3-amino-.</SUBJECT> <SECTNO>721.5708</SECTNO> <SUBJECT>2-Pentene, 1,1,1,2,3,4,4,5,5,5-decafluoro-.</SUBJECT> <SECTNO>721.5710</SECTNO> <SUBJECT>Phenacetin.</SUBJECT> <SECTNO>721.5713</SECTNO> <SUBJECT>Phenol - biphenyl polymer condensate (generic).</SUBJECT> <SECTNO>721.5725</SECTNO> <SUBJECT>Phenol, 2,4-dimethyl-6-(1-methylpentadecyl)-.</SUBJECT> <SECTNO>721.5740</SECTNO> <SUBJECT>Phenol, 4,4′-methy­lenebis (2,6-dimethyl-.</SUBJECT> <SECTNO>721.5760</SECTNO> <SUBJECT>Phenol, 4,4′-[methylene­bis (oxy-2,1-ethanediylthio)]bis-.</SUBJECT> <SECTNO>721.5762</SECTNO> <SUBJECT>Aromatic aldehyde phenolic resin (generic).</SUBJECT> <SECTNO>721.5763</SECTNO> <SUBJECT>Methylenebisbenzotriazolyl phenols.</SUBJECT> <SECTNO>721.5769</SECTNO> <SUBJECT>Mixture of nitrated alkylated phenols.</SUBJECT> <SECTNO>721.5775</SECTNO> <SUBJECT>Phenol, 5-amino-2,4-dicholoro-, hydrochloride.</SUBJECT> <SECTNO>721.5780</SECTNO> <SUBJECT>Phenol, 4,4′-(oxybis(2,1-ethan­ed­iyl­thio)bis-.</SUBJECT> <SECTNO>721.5800</SECTNO> <SUBJECT>Sulfurized alkylphenol.</SUBJECT> <SECTNO>721.5820</SECTNO> <SUBJECT>Aminophenol.</SUBJECT> <SECTNO>721.5840</SECTNO> <SUBJECT>Ethylated aminophenol.</SUBJECT> <SECTNO>721.5860</SECTNO> <SUBJECT>Methylphenol, bis(sub­sti-tut­ed)alkyl.</SUBJECT> <SECTNO>721.5867</SECTNO> <SUBJECT>Substituted phenol.</SUBJECT> <SECTNO>721.5880</SECTNO> <SUBJECT>Sulfur bridged substituted phenols (generic name).</SUBJECT> <SECTNO>721.5900</SECTNO> <SUBJECT>Trisubstituted phenol (generic name).</SUBJECT> <SECTNO>721.5905</SECTNO> <SUBJECT>Modified phenolic resin (generic).</SUBJECT> <SECTNO>721.5908</SECTNO> <SUBJECT>Modified phenolic resin (generic).</SUBJECT> <SECTNO>721.5912</SECTNO> <SUBJECT>Phenoxazin-5-ium, 3-dialkylamino-7-arylamino-, salt (generic).</SUBJECT> <SECTNO>721.5913</SECTNO> <SUBJECT>Phenothiazine derivative.</SUBJECT> <SECTNO>721.5914</SECTNO> <SUBJECT>Polysubstituted bis phenylazonapthalene disulfonic acid (generic).</SUBJECT> <SECTNO>721.5915</SECTNO> <SUBJECT>Polysubstituted phenyl­azo­poly­substi­tuted­phenyl dye.</SUBJECT> <SECTNO>721.5917</SECTNO> <SUBJECT>Phenyl azo dye (generic).</SUBJECT> <SECTNO>721.5920</SECTNO> <SUBJECT>Phenyl(disubstitutedpolycyclic).</SUBJECT> <SECTNO>721.5925</SECTNO> <SUBJECT>Bis heterocyclic phenylene derivative (generic).</SUBJECT> <SECTNO>721.5930</SECTNO> <SUBJECT>Phenylenebis[imino (chlorotriazinyl)-imino (substituted napthyl)azo (substituted phenyl)­azo, sodium salt (generic name).</SUBJECT> <SECTNO>721.5935</SECTNO> <SUBJECT>Alkylated nitroso-phenylenediamine (generic).</SUBJECT> <SECTNO>721.5960</SECTNO> <SUBJECT> <E T="03">N,N′</E> -Bis(2-(2-(3-alkyl)thia­zoline) vinyl)-1,4-pheny­lene­dia­mine methyl sulfate double salt (generic name). </SUBJECT> <SECTNO>721.5965</SECTNO> <SUBJECT>Substituted S-phenylthiazole (generic).</SUBJECT> <SECTNO>721.5970</SECTNO> <SUBJECT>Phosphated polyarylphenol ethoxylate, potassium salt.</SUBJECT> <SECTNO>721.5980</SECTNO> <SUBJECT>Dialkyl phosphorodithioate phosphate compounds.</SUBJECT> <SECTNO>721.5985</SECTNO> <SUBJECT>Fatty alkyl phosphate, alkali metal salt (generic).</SUBJECT> <SECTNO>721.6000</SECTNO> <SUBJECT>Tris (2,3-dibromopropyl) phosphate.</SUBJECT> <SECTNO>721.6005</SECTNO> <SUBJECT>Rare earth phosphate (generic).</SUBJECT> <SECTNO>721.6020</SECTNO> <SUBJECT>Phosphine, dialkylyphenyl.</SUBJECT> <SECTNO>721.6045</SECTNO> <SUBJECT>Phosphinothioic acid, bis(2,4,4-trimethylpentyl)- (9CI).</SUBJECT> <SECTNO>721.6060</SECTNO> <SUBJECT>Alkylaryl substituted phosphite.</SUBJECT> <SECTNO>721.6070</SECTNO> <SUBJECT>Alkyl phosphonate ammonium salts.</SUBJECT> <SECTNO>721.6075</SECTNO> <SUBJECT>Phosphonic acid, 1,1-methylenebis-tetrakis(1-methylethyl) ester.</SUBJECT> <SECTNO>721.6080</SECTNO> <SUBJECT>Phosphonium salt (generic name).</SUBJECT> <SECTNO>721.6085</SECTNO> <SUBJECT>Phosphonocarboxylate salts.</SUBJECT> <SECTNO>721.6090</SECTNO> <SUBJECT>Phosphoramide.</SUBJECT> <SECTNO>721.6097</SECTNO> <SUBJECT>Phosphoric acid derivative (generic name).</SUBJECT> <SECTNO>721.6100</SECTNO> <SUBJECT> Phosphoric acid, C <E T="52">6-12</E> -alkyl esters, compounds with 2-(dibutylamino) ethanol. </SUBJECT> <SECTNO>721.6110</SECTNO> <SUBJECT>Alkyldi(alkyloxyhydroxypropyl) derivative, phosphoric acid esters, potassium salts.</SUBJECT> <SECTNO>721.6120</SECTNO> <SUBJECT>Phosphoric acid, 1,2-ethanediyl tetrakis(2-chloro-1-methylethyl) ester.</SUBJECT> <SECTNO>721.6140</SECTNO> <SUBJECT>Dialkyldithiophosphoric acid, aliphatic amine salt.</SUBJECT> <SECTNO>721.6160</SECTNO> <SUBJECT>Piperazinone, 1,1′,1″-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris-[3,3,4,5,5-pentamethyl]-.</SUBJECT> <SECTNO>721.6165</SECTNO> <SUBJECT> Polysubstituted piperidine. <PRTPAGE P="254"/> </SUBJECT> <SECTNO>721.6167</SECTNO> <SUBJECT>Piperdinium, 1,1-dimethyl-, chloride.</SUBJECT> <SECTNO>721.6170</SECTNO> <SUBJECT>Siloxanes and silicones, Me hydrogen, reaction products with 2,2,6,6-tetramethyl-4-(2-propenyloxy)piperdine.</SUBJECT> <SECTNO>721.6175</SECTNO> <SUBJECT>2-Piperdinone, 1,3-dimethyl-,.</SUBJECT> <SECTNO>721.6176</SECTNO> <SUBJECT>2-Piperdinone, 1,5-dimethyl-,.</SUBJECT> <SECTNO>721.6178</SECTNO> <SUBJECT>Alkylaminated polyolefin (generic).</SUBJECT> <SECTNO>721.6180</SECTNO> <SUBJECT>Polyalkylene glycol polyamide ester phosphate (generic).</SUBJECT> <SECTNO>721.6181</SECTNO> <SUBJECT>Fatty acid, reaction product with substituted oxirane, formaldehyde-phenol polymer glycidyl ether, substituted proplyamine and polyethylenepolyamines (generic).</SUBJECT> <SECTNO>721.6183</SECTNO> <SUBJECT>Amides, from ammonium hydroxide - maleic anhydride polymer and hydrogenated tallow alkyl amines, sodium salts, compds. with ethanolamine.</SUBJECT> <SECTNO>721.6186</SECTNO> <SUBJECT>Polyamine dithiocarbamate.</SUBJECT> <SECTNO>721.6193</SECTNO> <SUBJECT>Polyalkylene polyamine.</SUBJECT> <SECTNO>721.6196</SECTNO> <SUBJECT>Hydrochloride salt of a fatty polyalkkylene polyamine (generic).</SUBJECT> <SECTNO>721.6200</SECTNO> <SUBJECT>Fatty acid polyamine condensate, phosphoric acid ester salts.</SUBJECT> <SECTNO>721.6205</SECTNO> <SUBJECT>Hexamethylenediamine adduct of substituted piperidinyloxy (generic).</SUBJECT> <SECTNO>721.6220</SECTNO> <SUBJECT>Aryl sulfonate of a fatty acid mixture, polyamine condensate.</SUBJECT> <SECTNO>721.6440</SECTNO> <SUBJECT>Polyamine urea­for­malde­hyde condensate (specific name).</SUBJECT> <SECTNO>721.6470</SECTNO> <SUBJECT>Polyaminopolyacid.</SUBJECT> <SECTNO>721.6475</SECTNO> <SUBJECT>Alkyl polycarboxylic acids, esters with ethoxylated fatty alcohols.</SUBJECT> <SECTNO>721.6477</SECTNO> <SUBJECT>Alkyl polycarboxylic acids, esters with ethoxylated fatty alcohols, reaction products with maleic anhydride.</SUBJECT> <SECTNO>721.6479</SECTNO> <SUBJECT>Tetrahydroheteropolycycle (generic).</SUBJECT> <SECTNO>721.6485</SECTNO> <SUBJECT>Hydroxy terminated polyester.</SUBJECT> <SECTNO>721.6490</SECTNO> <SUBJECT>Alkyl phenyl polyetheramines.</SUBJECT> <SECTNO>721.6493</SECTNO> <SUBJECT>Amidoamine modified polyethylene glycol (generic).</SUBJECT> <SECTNO>721.6495</SECTNO> <SUBJECT>Aliphatic polyisocyanate.</SUBJECT> <SECTNO>721.6498</SECTNO> <SUBJECT>Modified polyisocyanates (generic).</SUBJECT> <SECTNO>721.6505</SECTNO> <SUBJECT> Polymers of C <E T="52">13</E> C <E T="52">15</E> oxoalcohol ethoxolates. </SUBJECT> <SECTNO>721.6515</SECTNO> <SUBJECT>Polymerof polyalkylenepolyol and trisubstituted phenol (generic).</SUBJECT> <SECTNO>721.6520</SECTNO> <SUBJECT>Acrylamide, polymer with substituted alkylacrylamide salt (generic name).</SUBJECT> <SECTNO>721.6540</SECTNO> <SUBJECT>Acrylamide, polymers with tetraalkyl ammonium salt and polyalkyl, aminoalkyl methacrylamide salt.</SUBJECT> <SECTNO>721.6560</SECTNO> <SUBJECT>Acrylic acid, polymer with substituted ethene.</SUBJECT> <SECTNO>721.6620</SECTNO> <SUBJECT>Alkanaminium, polyalkyl-[(2-methyl-1-oxo-2-propenyl)oxy] salt, polymer with acrylamide and substituted alkyl methacrylate.</SUBJECT> <SECTNO>721.6660</SECTNO> <SUBJECT>Polymer of alkanepolyol and poly­alkyl­poly­iso­cyan­ato­car­bo­mo­no­cycle, acetone oxime-blocked (generic name).</SUBJECT> <SECTNO>721.6680</SECTNO> <SUBJECT>Alkanoic acid, butanediol and cyclohexanealkanol polymer (generic name).</SUBJECT> <SECTNO>721.6900</SECTNO> <SUBJECT>Polymer of bisphenol A diglycidal ether, substituted alkenes, and butadiene.</SUBJECT> <SECTNO>721.6920</SECTNO> <SUBJECT>Butyl acrylate, polymer with substituted methyl styrene, methyl methacrylate, and substituted silane.</SUBJECT> <SECTNO>721.6980</SECTNO> <SUBJECT>Dimer acids, polymer with poly­al­ky­lene glycol, bisphenol A-diglycidyl ether, and alky­lenepolyols polyglycidyl ethers (generic name).</SUBJECT> <SECTNO>721.7000</SECTNO> <SUBJECT>Polymer of disodium maleate, allyl ether, and ethylene oxide.</SUBJECT> <SECTNO>721.7020</SECTNO> <SUBJECT>Distillates (petroleum), C(3-6), polymers with styrene and mixed terpenes (generic name).</SUBJECT> <SECTNO>721.7046</SECTNO> <SUBJECT>Formaldehyde, polymer with substituted phenols, glycidyl ether.</SUBJECT> <SECTNO>721.7160</SECTNO> <SUBJECT>2-Oxepanone, polymer with 4,4′-(1-methylethylidene)bisphenol and 2,2-[(1-methylethylidene)bis(4,1-phe­ny­lene­oxy­methyl­ene)]­bi­soxirane, graft.</SUBJECT> <SECTNO>721.7200</SECTNO> <SUBJECT>Perfluoroalkyl aromatic carbamate modified alkyl methacrylate copolymer.</SUBJECT> <SECTNO>721.7210</SECTNO> <SUBJECT>Epoxidized copolymer of phenol and substituted phenol.</SUBJECT> <SECTNO>721.7220</SECTNO> <SUBJECT>Polymer of substituted phenol, formaldehyde, epichlorohydrin, and disubstituted benzene.</SUBJECT> <SECTNO>721.7250</SECTNO> <SUBJECT>Polyaziridinyl ester of an aliphatic alcohol (generic).</SUBJECT> <SECTNO>721.7255</SECTNO> <SUBJECT>Polyethyleneamine crosslinked with substituted polyethylene glycol (generic).</SUBJECT> <SECTNO>721.7260</SECTNO> <SUBJECT>Polymer of poly­ethylene­polyamine and alkanediol diglycidyl ether.</SUBJECT> <SECTNO>721.7270</SECTNO> <SUBJECT> 1-propanaminium, 3-amino-, <E T="03">N,N,N</E> -trimethyl-N-soya acyl derivs., chloride. </SUBJECT> <SECTNO>721.7280</SECTNO> <SUBJECT> 1,3-Propanediamine, <E T="03">N,N′</E> -1,2-eth­an­ediyl­bis-, polymer with 2,4,6-trichloro-1,3,5-triazine, reaction products with N-butyl-2,2,6,6-tetramethyl-4-pip­er­i­dinamine. </SUBJECT> <SECTNO>721.7285</SECTNO> <SUBJECT> Amines, <E T="03">N</E> -cocoalkyltrimethylenedi-, citrates. </SUBJECT> <SECTNO>721.7286</SECTNO> <SUBJECT> Amines, <E T="03">N</E> -tallowalkyltripropylenetetra-, citrates. </SUBJECT> <SECTNO>721.7290</SECTNO> <SUBJECT>Propanoic acid, 2-(trimethoxysilyl)-, ethyl ester.</SUBJECT> <SECTNO>721.7375</SECTNO> <SUBJECT>Potassium salt of polyolefin acid.</SUBJECT> <SECTNO>721.7378</SECTNO> <SUBJECT>Substituted polyoxyethylene.</SUBJECT> <SECTNO>721.7440</SECTNO> <SUBJECT>Polyalkylenepolyol alky­la­mine. (generic name).</SUBJECT> <SECTNO>721.7450</SECTNO> <SUBJECT>Aromatic amine polyols.</SUBJECT> <SECTNO>721.7480</SECTNO> <SUBJECT>Isocyanate terminated polyols.</SUBJECT> <SECTNO>721.7500</SECTNO> <SUBJECT>Nitrate polyether polyol (generic name).</SUBJECT> <SECTNO>721.7600</SECTNO> <SUBJECT>Alkyl(heterocyclicyl) phe­nyl­az­o­he­tero monocyclic poly­one (generic name).</SUBJECT> <SECTNO>721.7620</SECTNO> <SUBJECT>Alkyl(heterocyclicyl) phe­nyl­az­o­he­tero monocyclic polyone, ((alkylimidazolyl) methyl) derivative (generic name).</SUBJECT> <SECTNO>721.7655</SECTNO> <SUBJECT> Alkylsulfonium salt. <PRTPAGE P="255"/> </SUBJECT> <SECTNO>721.7700</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), α-hydro-ω-(oxiranylmethoxy)-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1).</SUBJECT> <SECTNO>721.7710</SECTNO> <SUBJECT>Polyepoxy polyol.</SUBJECT> <SECTNO>721.7720</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), α,α′-[(1-methylethylidene) di-4,1-phenylene] bis [ω-(oxiranyl­methoxy)-.</SUBJECT> <SECTNO>721.7770</SECTNO> <SUBJECT>Alkylphenoxypoly(oxyethylene) sulfuric acid ester, substituted amine salt.</SUBJECT> <SECTNO>721.7780</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethane­diyl)], α,α′-(2,2-dimethyl-1,3-propanediyl)bis[ω-(oxirany­methoxy)-.</SUBJECT> <SECTNO>721.7785</SECTNO> <SUBJECT>Substituted alkyl aminomethylene polyphosphonic acid, salt (generic).</SUBJECT> <SECTNO>721.8079</SECTNO> <SUBJECT>Isophorone diisocyanate neopentyl glycol adipate polyurethane prepolymer.</SUBJECT> <SECTNO>721.8082</SECTNO> <SUBJECT>Polyester polyurethane acrylate.</SUBJECT> <SECTNO>721.8085</SECTNO> <SUBJECT>Reaction product of substituted aromatic diol, formaldehyde and alkanolamine, propoxylated (generic).</SUBJECT> <SECTNO>721.8090</SECTNO> <SUBJECT>Polyurethane polymer.</SUBJECT> <SECTNO>721.8095</SECTNO> <SUBJECT>Silylated polyurethane.</SUBJECT> <SECTNO>721.8100</SECTNO> <SUBJECT>Potassium N,N-bis (hydroxy­ethyl) cocoamine oxide phosphate, and potassium N,N-bis (hydroxyethyl) tallowamine oxide phosphate.</SUBJECT> <SECTNO>721.8130</SECTNO> <SUBJECT>Propanamide, -(2-hydroxyethyl)-3-methoxy-.</SUBJECT> <SECTNO>721.8140</SECTNO> <SUBJECT>Substituted propane (generic).</SUBJECT> <SECTNO>721.8145</SECTNO> <SUBJECT>Propane,1,1,1,2,2,3,3-heptafluoro-3-methoxy-.</SUBJECT> <SECTNO>721.8153</SECTNO> <SUBJECT>Di-substituted propanedione (generic).</SUBJECT> <SECTNO>721.8155</SECTNO> <SUBJECT> Propanenitrile, 3-[amino, <E T="03">N</E> -tallowalkyl] dipropylenetri- and tripropylenetri- and propanenitrile, 3-[amino, (C <E T="52">14-18</E> and C <E T="52">16-18</E> unsaturated alkyl)] trimethylenedi-, dipropylenetri-, and tripropylenetetra-. </SUBJECT> <SECTNO>721.8160</SECTNO> <SUBJECT>Propanoic acid, 2,2-dimethyl-, ethenyl ester.</SUBJECT> <SECTNO>721.8175</SECTNO> <SUBJECT>1-Propanol, 3-mercapto-.</SUBJECT> <SECTNO>721.8225</SECTNO> <SUBJECT> 2-Propenamide, <E T="03">N</E> -[3-di­methyl­amino)propyl]-. </SUBJECT> <SECTNO>721.8250</SECTNO> <SUBJECT>1-Propanol, 3,3′-oxybis[2,2-bis(bro­mo­methyl)-.</SUBJECT> <SECTNO>721.8340</SECTNO> <SUBJECT>Mono esters from 2- propenoic acid (generic).</SUBJECT> <SECTNO>721.8350</SECTNO> <SUBJECT>2-Propenoic acid, 7-ox­a­bi­cy­clo[4.1.0]hept-3-ylmethyl ester.</SUBJECT> <SECTNO>721.8450</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 2-[3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]ethyl ester.</SUBJECT> <SECTNO>721.8485</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, (octahydro-4,7-methano-1H- indene-5-diyl)bis(methylene) ester.</SUBJECT> <SECTNO>721.8500</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 7-oxabicyclo [4.1.0]hept-3-ylmethyl ester.</SUBJECT> <SECTNO>721.8657</SECTNO> <SUBJECT>Cerium, hydroxy oleate propionate complexes.</SUBJECT> <SECTNO>721.8658</SECTNO> <SUBJECT>Modified polymer of vinyl acetate and quaternary ammonium compound (generic).</SUBJECT> <SECTNO>721.8660</SECTNO> <SUBJECT>Propionic acid methyl ester (generic).</SUBJECT> <SECTNO>721.8670</SECTNO> <SUBJECT>Alkylcyano substituted pyridazo benzoate.</SUBJECT> <SECTNO>721.8673</SECTNO> <SUBJECT>[(Disubstituted phenyl)]azo dihydro hydroxy alkyl oxo alkyl-substituted-pyridines (generic name).</SUBJECT> <SECTNO>721.8675</SECTNO> <SUBJECT>Halogenated pyridines.</SUBJECT> <SECTNO>721.8700</SECTNO> <SUBJECT>Pyridine, 2,3-dichloro-5-(trifluoromethyl)-.</SUBJECT> <SECTNO>721.8750</SECTNO> <SUBJECT>Halogenated substituted pyridine.</SUBJECT> <SECTNO>721.8775</SECTNO> <SUBJECT>Substituted pyridines.</SUBJECT> <SECTNO>721.8780</SECTNO> <SUBJECT>Substituted pyridine azo substituted phenyl.</SUBJECT> <SECTNO>721.8825</SECTNO> <SUBJECT>Substituted methylpyridine and substituted 2-phenoxypyridine.</SUBJECT> <SECTNO>721.8850</SECTNO> <SUBJECT>Disubstituted halogenated py­rid­i­nol.</SUBJECT> <SECTNO>721.8875</SECTNO> <SUBJECT>Substituted halogenated pyridinol.</SUBJECT> <SECTNO>721.8900</SECTNO> <SUBJECT>Substituted halogenated pyridinol, alkali salt.</SUBJECT> <SECTNO>721.8920</SECTNO> <SUBJECT>4,6-Disubstituted pyrimidine (generic).</SUBJECT> <SECTNO>721.8940</SECTNO> <SUBJECT>Chromate(3-), bis[3-[[6-amino-1,4-dihydro-2-[[[4-[(2-hydroxy-1-naphthalenyl)azo] phenyl]sulfonyl] amino]-4-(oxo-.kappa.O)-5- pyrimidinyl]azo-.kappaN1] -4-hydroxy-.kappa.O)-5-nitrobenzenesulfonato(3-)]-, trisodium.</SUBJECT> <SECTNO>721.8950</SECTNO> <SUBJECT>Chromate(3-), bis[3-[[6-amino-1,4-dihydro-2-[[[4-[(2-hydroxy-1-naphthalenyl)azo] phenyl]sulfonyl]amino]-4-(oxo-.kappa.O)-5-pyrimidinyl]azo-.kappaN1]-4-hydroxy-.kappa.O)-5-nitrobenzenesulfonato(3-)]-, sodium triethanolamine salts.</SUBJECT> <SECTNO>721.8965</SECTNO> <SUBJECT> 1 <E T="03">H</E> -Pyrole-2, 5-dione, 1-(2,4,6-tribromophenyl)-. </SUBJECT> <SECTNO>721.9000</SECTNO> <SUBJECT>N-Nitrosopyrrolidine.</SUBJECT> <SECTNO>721.9005</SECTNO> <SUBJECT>2-Pyrrolidinone, 1,1′-(2-methyl-1,5-pentanediyl)bis-.</SUBJECT> <SECTNO>721.9010</SECTNO> <SUBJECT>2-pyrrolidone, 1-ethenyl-3-ethylidene-, (E)-.</SUBJECT> <SECTNO>721.9075</SECTNO> <SUBJECT>Quaternary ammonium salt of fluorinated alkylaryl amide.</SUBJECT> <SECTNO>721.9078</SECTNO> <SUBJECT>6-Methoxy-1H-benz[de]isoquinoline-2 [3H]-dione derivative (generic).</SUBJECT> <SECTNO>721.9079</SECTNO> <SUBJECT>Dihydro quinacridone derivative (generic).</SUBJECT> <SECTNO>721.9080</SECTNO> <SUBJECT>Nitro methyl quinoline.</SUBJECT> <SECTNO>721.9100</SECTNO> <SUBJECT>Substituted quinoline.</SUBJECT> <SECTNO>721.9220</SECTNO> <SUBJECT>Reaction products of secondary alkyl amines with a substituted benzenesulfonic acid and sulfuric acid (generic name).</SUBJECT> <SECTNO>721.9265</SECTNO> <SUBJECT>Reaction product of dichlorobenzidine and substituted alkylamide.</SUBJECT> <SECTNO>721.9270</SECTNO> <SUBJECT>Reaction product of epoxy with anhydride and glycerol and glycol.</SUBJECT> <SECTNO>721.9280</SECTNO> <SUBJECT>Reaction product of ethoxylated fatty acid oils and a phenolic pentaerythritol tetraester.</SUBJECT> <SECTNO>721.9285</SECTNO> <SUBJECT> Schiff bases, from ammonia-diethylene glycol reaction product fractionation forecuts and formaldehyde. <PRTPAGE P="256"/> </SUBJECT> <SECTNO>721.9300</SECTNO> <SUBJECT>Reaction products of substituted hydroxy­alkanes and polyalkyl­polyiso­cyanato­carbomono­cycle.</SUBJECT> <SECTNO>721.9400</SECTNO> <SUBJECT>Reaction product of phenolic pentaerythritol tetraesters with fatty acid esters and oils, and glyceride triesters.</SUBJECT> <SECTNO>721.9460</SECTNO> <SUBJECT>Tall oil fatty acids, reaction products with polyamines, alkyl substituted.</SUBJECT> <SECTNO>721.9470</SECTNO> <SUBJECT>Reserpine.</SUBJECT> <SECTNO>721.9480</SECTNO> <SUBJECT>Formaldehyde, polymer with 1,3-benzenediol and ethenylbenzene.</SUBJECT> <SECTNO>721.9484</SECTNO> <SUBJECT>Dimer acid/rosin amidoamine reaction product (generic).</SUBJECT> <SECTNO>721.9485</SECTNO> <SUBJECT>Dimer acid/polymerized rosin amidoamine reaction product (generic).</SUBJECT> <SECTNO>721.9486</SECTNO> <SUBJECT>Roxin amidoamine (generic).</SUBJECT> <SECTNO>721.9487</SECTNO> <SUBJECT>Polymerized rosin amidoamine (generic).</SUBJECT> <SECTNO>721.9488</SECTNO> <SUBJECT>Substituted resorcinols.</SUBJECT> <SECTNO>721.9490</SECTNO> <SUBJECT>Coco alklydimethyl amine salts (generic).</SUBJECT> <SECTNO>721.9492</SECTNO> <SUBJECT>Certain polymers of styrene, cyclohexyl methacrylate and substituted methacrylate.</SUBJECT> <SECTNO>721.9495</SECTNO> <SUBJECT>Acrylosilane resins.</SUBJECT> <SECTNO>721.9497</SECTNO> <SUBJECT>Certain trifunctional ketoximino silanes.</SUBJECT> <SECTNO>721.9499</SECTNO> <SUBJECT>Modified silicone resin.</SUBJECT> <SECTNO>721.9500</SECTNO> <SUBJECT>Silane, (1,1-dimethylethoxy) di­meth­oxy(2-methyl propyl)-.</SUBJECT> <SECTNO>721.9501</SECTNO> <SUBJECT>Silane, triethoxy[3-oxiranylmethoxy)propyl]-.</SUBJECT> <SECTNO>721.9502</SECTNO> <SUBJECT>Siloxanes and silicones, aminoalkyl, fluorooctyl, hydroxy-terminated salt (generic).</SUBJECT> <SECTNO>721.9503</SECTNO> <SUBJECT>Silane, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)trimethoxy-.</SUBJECT> <SECTNO>721.9504</SECTNO> <SUBJECT>Silane, triethoxy (3,3,4,4,5,5, 6,6,7,7,8,8,8-tridecafluorooctyl)-.</SUBJECT> <SECTNO>721.9505</SECTNO> <SUBJECT>Silanes substituted macrocycle polyethyl.</SUBJECT> <SECTNO>721.9506</SECTNO> <SUBJECT>Halogenated arylsilane (generic).</SUBJECT> <SECTNO>721.9507</SECTNO> <SUBJECT>Polyester silane.</SUBJECT> <SECTNO>721.9508</SECTNO> <SUBJECT>Perfluorinatedalkyl polyhydroxysilane (generic).</SUBJECT> <SECTNO>721.9509</SECTNO> <SUBJECT>Perfluorinatedalkyl polyalkoxysilane (generic).</SUBJECT> <SECTNO>721.9511</SECTNO> <SUBJECT> Silicic acid (H <E T="52">6</E> SiO <E T="52">2</E> O <E T="52">7</E> ), magnesium, strontium salt(1:1:2), dysprosium and europium-doped. </SUBJECT> <SECTNO>721.9513</SECTNO> <SUBJECT>Modified magnesium silicate polymer (generic).</SUBJECT> <SECTNO>721.9514</SECTNO> <SUBJECT>Ethyl silicate, reaction products with modified alkoxysilane salt (generic).</SUBJECT> <SECTNO>721.9515</SECTNO> <SUBJECT>Aminofunctional alkoxy alkyl siloxane.</SUBJECT> <SECTNO>721.9516</SECTNO> <SUBJECT>Siloxanes and silicones, 3-[(2-aminoethyl) amino]propyl Me, di-Me, reaction products with polyethylene-polypropylene glycol Bu glycidal ether.</SUBJECT> <SECTNO>721.9517</SECTNO> <SUBJECT>Siloxanes and silicones, de-Me, 3-[4-[[[3-(dimethyl amino) propyl] amino]carbonyl]-2-oxo-1-pyrrolidinyl] propyl Me.</SUBJECT> <SECTNO>721.9518</SECTNO> <SUBJECT> <E T="03">Sinorhizobuim meliloti</E> strain RMBPC-2. </SUBJECT> <SECTNO>721.9520</SECTNO> <SUBJECT>Methylated-para-rosaniline salt of a trisulfonated triarylmethane dye (generic).</SUBJECT> <SECTNO>721.9526</SECTNO> <SUBJECT>Sodium perthiocarbonate.</SUBJECT> <SECTNO>721.9527</SECTNO> <SUBJECT>Bis(1,2,2,6,6-pentamethyl-4-piperidin-4-ol) ester of cycloaliphatic spiroketal.</SUBJECT> <SECTNO>721.9530</SECTNO> <SUBJECT>Bis(2,2,6,6-tetra­methyl­piper­idinyl) ester of cycloalkyl spiroketal.</SUBJECT> <SECTNO>721.9535</SECTNO> <SUBJECT>1,4-Dioxa-7,9-dithia-8-stannacycloundecane-5,11-dione, 8,8-dioctyl-.</SUBJECT> <SECTNO>721.9538</SECTNO> <SUBJECT>Lithium salt of sulfophenyl azo phenyl azo disulfostilbene (generic).</SUBJECT> <SECTNO>721.9540</SECTNO> <SUBJECT>Polysulfide mixture.</SUBJECT> <SECTNO>721.9545</SECTNO> <SUBJECT>Substituted phenyl azo substituted sulfocarbopolycle, sodium salt.</SUBJECT> <SECTNO>721.9550</SECTNO> <SUBJECT>Sulfonamide.</SUBJECT> <SECTNO>721.9570</SECTNO> <SUBJECT>Halophenyl sulfonamide salt.</SUBJECT> <SECTNO>721.9572</SECTNO> <SUBJECT>Substituted alkyl sulfonamide (generic).</SUBJECT> <SECTNO>721.9573</SECTNO> <SUBJECT>Substituted perfluoroalkyl sulfonamide (generic).</SUBJECT> <SECTNO>721.9575</SECTNO> <SUBJECT>Chromate(3-), bis[3-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4-hydroxy-7-[[2-oxo-1-[(phenylamino)carbonyl] propyl]azo]-2-naphthalenesulfonato(3-)]-, trisodium (9CI).</SUBJECT> <SECTNO>721.9576</SECTNO> <SUBJECT>Chromate(3-), bis[7-[(aminohydroxyphenyl)azo]-3-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4-hydroxy-2-naphthalene-sulfonato (3-)]-, trisodium (9CI).</SUBJECT> <SECTNO>721.9577</SECTNO> <SUBJECT>Chromate(3-), bis[7-[(aminohydroxyphenyl)azo]-3-[[5-(aminosulfonyl)-2-hydroxyphenyl] azo]-4-hydroxy-2-naphthalene sulfonato (3-)]-,-[[5-(aminosulfonyl) -2-hydroxyphenyl]azo]-4-hydroxy-7-[[2-hydroxy-1-[(phenylamino) carbonyl]-1-propenyl]azo]-2-naphthalenesulfonato(3-)]-, trisodium (9CI).</SUBJECT> <SECTNO>721.9580</SECTNO> <SUBJECT>Ethyl methanesulfonate.</SUBJECT> <SECTNO>721.9582</SECTNO> <SUBJECT>Certain perfluoroalkyl sulfonates.</SUBJECT> <SECTNO>721.9595</SECTNO> <SUBJECT> Benzenesulfonic acid, mono C- <E T="52">10-16</E> -alkyl derivs., compounds with 2-propen-1-amine and Alkyl benzene sulfonic acids and alkyl sulfates, amine salts. </SUBJECT> <SECTNO>721.9597</SECTNO> <SUBJECT>Salt of a substituted sulfonated aryl azo compound (generic).</SUBJECT> <SECTNO>721.9620</SECTNO> <SUBJECT>Aromatic sulfonic acid compound with amine.</SUBJECT> <SECTNO>721.9630</SECTNO> <SUBJECT>Polyfluorosulfonic acid salt.</SUBJECT> <SECTNO>721.9635</SECTNO> <SUBJECT>Terpenes and terpenoids, limonene fraction, distn. residues, distillates.</SUBJECT> <SECTNO>721.9640</SECTNO> <SUBJECT>Salt of an acrylic acid-acrylamide terpolymer (generic).</SUBJECT> <SECTNO>721.9650</SECTNO> <SUBJECT>Tetramethylammonium salts of alkylbenzenesulfonic acid.</SUBJECT> <SECTNO>721.9656</SECTNO> <SUBJECT>Thiaalkanethiol.</SUBJECT> <SECTNO>721.9657</SECTNO> <SUBJECT>Disubstituted thiadiazole.</SUBJECT> <SECTNO>721.9658</SECTNO> <SUBJECT>Thiadiazole derivative.</SUBJECT> <SECTNO>721.9659</SECTNO> <SUBJECT>Disubstituted thiadiazosulfone.</SUBJECT> <SECTNO>721.9660</SECTNO> <SUBJECT> Methylthiouracil. <PRTPAGE P="257"/> </SUBJECT> <SECTNO>721.9661</SECTNO> <SUBJECT>Diphenol tars (generic).</SUBJECT> <SECTNO>721.9662</SECTNO> <SUBJECT>Thieno[3,4-b]-1,4-dioxin, 2,3-dihydro- (9CI).</SUBJECT> <SECTNO>721.9663</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), alpha, alpha′-[thiobis (1-oxo-3,1-propanediyl)]bis [omega-hydroxy-,bis (C <E T="52">11-15</E> and C <E T="52">11-15-isoalkyl</E> ) ethers. </SUBJECT> <SECTNO>721.9664</SECTNO> <SUBJECT>9H-Thioxanthen-9-one,2,4-diethyl.</SUBJECT> <SECTNO>721.9665</SECTNO> <SUBJECT>Organotin catalysts.</SUBJECT> <SECTNO>721.9668</SECTNO> <SUBJECT>Organotin lithium compound.</SUBJECT> <SECTNO>721.9670</SECTNO> <SUBJECT>Tetraaryltin (generic).</SUBJECT> <SECTNO>721.9671</SECTNO> <SUBJECT>Triaryltin (generic).</SUBJECT> <SECTNO>721.9672</SECTNO> <SUBJECT> Amides, tall-oil fatty, <E T="03">N</E> -[2-[2-hydroxyethyl)amino]ethyl], reaction products with sulfur dioxide; fatty acids, tall-oil, reaction products with 1-piperazineethanamine and sulfur dioxide; fatty acids, tall-oil reaction products with sulfur dioxide and triethylenetetramine. </SUBJECT> <SECTNO>721.9674</SECTNO> <SUBJECT>Sulfonated-copper phthalocyanine salt of a triarylmethane dye (generic).</SUBJECT> <SECTNO>721.9675</SECTNO> <SUBJECT> Titanate [Ti <E T="52">6</E> O <E T="52">13</E> (2-)], di­potas­sium. </SUBJECT> <SECTNO>721.9680</SECTNO> <SUBJECT>Alkaline titania silica gel (generic name).</SUBJECT> <SECTNO>721.9685</SECTNO> <SUBJECT>Mixed trialkylamines (generic).</SUBJECT> <SECTNO>721.9700</SECTNO> <SUBJECT>Monosubstituted alkoxy­amino­tra­zines (generic name).</SUBJECT> <SECTNO>721.9717</SECTNO> <SUBJECT>Azo monochloro triazine reactive dye.</SUBJECT> <SECTNO>721.9719</SECTNO> <SUBJECT>Tris carbamoyl triazine (generic).</SUBJECT> <SECTNO>721.9720</SECTNO> <SUBJECT>Certain disubstituted alkyl triazines.</SUBJECT> <SECTNO>721.9730</SECTNO> <SUBJECT>Certain 1,3,5-triazine-2-amine, 4-dimethylamino-6-substituted.</SUBJECT> <SECTNO>721.9740</SECTNO> <SUBJECT>Brominated triazine derivative.</SUBJECT> <SECTNO>721.9750</SECTNO> <SUBJECT>2-Chloro-4,6-bis(substituted)-1,3,5-triazine, dihydrochloride.</SUBJECT> <SECTNO>721.9790</SECTNO> <SUBJECT>Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxypropyl) amino]- 6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, disodium salt, compd. with 2,2′,2″-nitrilo-tris[ethanol] (1:2); Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxypropyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-, disodium salt, compd. with 2,2′,2″-nitrilotris[ethanol] (1:2).</SUBJECT> <SECTNO>721.9795</SECTNO> <SUBJECT>Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[(4,6-dichloro-1,3,5-triazin-2-yl) amino]-, disodium salt, substituted with dialkyl amines (generic).</SUBJECT> <SECTNO>721.9798</SECTNO> <SUBJECT>Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-substituted-6-substituted-1,3,5-triazin-2-yl]amino]-, sodium salt (generic).</SUBJECT> <SECTNO>721.9800</SECTNO> <SUBJECT>1,3,5-Triazine, 2,4,6-trichloro-, polymer with piperazine, reaction products with morpholine.</SUBJECT> <SECTNO>721.9820</SECTNO> <SUBJECT>Substituted triazole.</SUBJECT> <SECTNO>721.9825</SECTNO> <SUBJECT>Phenyl substituted triazolinones.</SUBJECT> <SECTNO>721.9830</SECTNO> <SUBJECT>1-Tridecyn-3-ol, 3-methyl.</SUBJECT> <SECTNO>721.9840</SECTNO> <SUBJECT>Tungstate (W12(OH)2O386-) hexasodium (9CI).</SUBJECT> <SECTNO>721.9850</SECTNO> <SUBJECT>2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4,6-tris(1,1-dimethylethyl)phenoxy]-.</SUBJECT> <SECTNO>721.9892</SECTNO> <SUBJECT>1,3-Dimethyl-2-imidazolidinone.</SUBJECT> <SECTNO>721.9900</SECTNO> <SUBJECT>Urea, condensate with poly[oxy(methyl-1,2ethanediyl)]-α- (2-aminomethylethyl)-μ-(2-amino­ethylethoxy) (generic name).</SUBJECT> <SECTNO>721.9920</SECTNO> <SUBJECT>Urea, (hexahydro-6-methyl-2-ox­o­py­rim­idinyl)-.</SUBJECT> <SECTNO>721.9925</SECTNO> <SUBJECT>Aminoethylethylene urea methacrylamide.</SUBJECT> <SECTNO>721.9928</SECTNO> <SUBJECT>Urea, tetaethyl-.</SUBJECT> <SECTNO>721.9929</SECTNO> <SUBJECT>Polyurea (generic).</SUBJECT> <SECTNO>721.9930</SECTNO> <SUBJECT>Urethane.</SUBJECT> <SECTNO>721.9952</SECTNO> <SUBJECT>Alkoxylated aliphatic diisocyanate allyl ether (generic).</SUBJECT> <SECTNO>721.9957</SECTNO> <SUBJECT>N-Nitroso-N-methylurethane.</SUBJECT> <SECTNO>721.9959</SECTNO> <SUBJECT>Polyurethane polymer (generic).</SUBJECT> <SECTNO>721.9965</SECTNO> <SUBJECT> Fatty acids, C <E T="52">10-13</E> - branched, vinyl esters. </SUBJECT> <SECTNO>721.9969</SECTNO> <SUBJECT>3,6-Bis(dialkylamino) -9-[2-alkoxycarbonyl) phenyl]-xanthylium salt (generic).</SUBJECT> <SECTNO>721.9970</SECTNO> <SUBJECT>o-Xylene compound (generic name).</SUBJECT> <SECTNO>721.9973</SECTNO> <SUBJECT>Zirconium dichlorides (generic).</SUBJECT> <SECTNO>721.10000</SECTNO> <SUBJECT>Certain polybrominated diphenylethers.</SUBJECT> <SECTNO>721.10001</SECTNO> <SUBJECT>2-Ethoxyethanol, 2-ethoxyethanol acetate, 2-methoxyethanol, and 2-methoxyethanol acetate.</SUBJECT> <SECTNO>721.10002</SECTNO> <SUBJECT>2-Thiazolidinone.</SUBJECT> <SECTNO>721.10003</SECTNO> <SUBJECT>Manganese heterocyclic tetraamine complex (generic).</SUBJECT> <SECTNO>721.10004</SECTNO> <SUBJECT> 2-Butenoic acid, 4,4′-[(dibutylstannylene)bis(oxy)]bis[4-oxo-, (2Z,2′Z)-, di-C <E T="52">8-10</E> -isoalkyl esters, C <E T="52">9</E> -rich. </SUBJECT> <SECTNO>721.10005</SECTNO> <SUBJECT> 2-Butenoic acid, 4,4′-[(dibutylstannylene)bis(oxy)]bis [4-oxo-, (2Z,2′Z)-, di-C <E T="52">9-11</E> -isoalkyl esters, C <E T="52">10</E> -rich. </SUBJECT> <SECTNO>721.10006</SECTNO> <SUBJECT>Mixed metal oxide (generic).</SUBJECT> <SECTNO>721.10007</SECTNO> <SUBJECT> Alcohols, C <E T="52">12-14</E> - secondary, ethoxylated propoxylated. </SUBJECT> <SECTNO>721.10008</SECTNO> <SUBJECT> Manganese strontium oxide (MnSrO <E T="52">3</E> ). </SUBJECT> <SECTNO>721.10009</SECTNO> <SUBJECT> Manganese yttrium oxide (MnYO <E T="52">3</E> ). </SUBJECT> <SECTNO>721.10010</SECTNO> <SUBJECT> Barium manganese oxide (BaMnO <E T="52">3</E> ). </SUBJECT> <SECTNO>721.10011</SECTNO> <SUBJECT>Barium calcium manganese strontium oxide.</SUBJECT> <SECTNO>721.10012</SECTNO> <SUBJECT> Manganate (MnO <E T="52">2</E> <E T="51">1−</E> ), calcium (2:1). </SUBJECT> <SECTNO>721.10013</SECTNO> <SUBJECT> Manganese yttrium oxide (Mn <E T="52">2</E> YO <E T="52">5</E> ). </SUBJECT> <SECTNO>721.10014</SECTNO> <SUBJECT>Halogenated naphthalic anhydride (generic).</SUBJECT> <SECTNO>721.10015</SECTNO> <SUBJECT>Halogenated benzimidazole (generic).</SUBJECT> <SECTNO>721.10016</SECTNO> <SUBJECT>Dibenzimidazothianaphthalene (generic).</SUBJECT> <SECTNO>721.10017</SECTNO> <SUBJECT>Amine terminated bisphenol A diglycidyl ether polymer (generic).</SUBJECT> <SECTNO>721.10018</SECTNO> <SUBJECT> Calcium hydroxide oxide silicate (Ca <E T="52">6</E> (OH) <E T="52">2</E> O <E T="52">2</E> (Si <E T="52">2</E> O <E T="52">5</E> ) <E T="52">3</E> ). <PRTPAGE P="258"/> </SUBJECT> <SECTNO>721.10019</SECTNO> <SUBJECT>Benzoic acid, 2-chloro-5-nitro-, 1,1-dimethyl-2-oxo-2-(2-propenyloxy) ethyl ester.</SUBJECT> <SECTNO>721.10020</SECTNO> <SUBJECT>Benzoic acid, 5-amino-2-chloro-, 1,1-dimethyl-2-oxo-2-(2-propenyloxy) ethyl ester.</SUBJECT> <SECTNO>721.10021</SECTNO> <SUBJECT>Magnesium potassium titanium oxide.</SUBJECT> <SECTNO>721.10022</SECTNO> <SUBJECT> Benzenamine, <E T="03">N</E> -phenyl-, ar′-(C <E T="52">9</E> -rich C <E T="52">8-10</E> -branched alkyl) derivs. </SUBJECT> <SECTNO>721.10023</SECTNO> <SUBJECT> Benzenamine, <E T="03">N</E> -phenyl-, ar ar′-(C <E T="52">9</E> -rich C <E T="52">8-10</E> -branched alkyl) derivs. </SUBJECT> <SECTNO>721.10024</SECTNO> <SUBJECT> 10H-Phenothiazine, ar-(C <E T="52">9</E> -rich C <E T="52">8-10</E> -branched alkyl) derivs. </SUBJECT> <SECTNO>721.10025</SECTNO> <SUBJECT> 10H-Phenothiazine, ar, ar′-(C <E T="52">9</E> -rich C <E T="52">8-10</E> -branched alkyl) derivs. </SUBJECT> <SECTNO>721.10026</SECTNO> <SUBJECT>Cashew, nutshell liq., ethoxylated.</SUBJECT> <SECTNO>721.10027</SECTNO> <SUBJECT>Ethoxylated alkylsulfate, substituted alkylamine salt (generic).</SUBJECT> <SECTNO>721.10028</SECTNO> <SUBJECT>Disubstituted benzene metal salts (generic).</SUBJECT> <SECTNO>721.10029</SECTNO> <SUBJECT>Isocyanate compound, modified with methoxysilane (generic).</SUBJECT> <SECTNO>721.10030</SECTNO> <SUBJECT>Pyrimido[5,4-g]pteridine-2,4,6,8-tetramine, 4-methylbenzenesulfonate, base-hydrolyzed.</SUBJECT> <SECTNO>721.10031</SECTNO> <SUBJECT>Lithium potassium titanium oxide.</SUBJECT> <SECTNO>721.10032</SECTNO> <SUBJECT>Acrylic acid, polymer with substituted acrylamides (generic).</SUBJECT> <SECTNO>721.10033</SECTNO> <SUBJECT> Zinc, [ethanedioato(2-)-. kappa. O <SU>1</SU> , . kappa. O <SU>2</SU> ]-. </SUBJECT> <SECTNO>721.10034</SECTNO> <SUBJECT>Substituted pyridine coupled with diazotized substituted nitrobenzonitrile, diazotized substituted benzenamine and substituted pyridinecarbonitrile (generic).</SUBJECT> <SECTNO>721.10035</SECTNO> <SUBJECT>Alkylbenzene sulfonate (generic).</SUBJECT> <SECTNO>721.10036</SECTNO> <SUBJECT>Acetaldehyde based polymer (generic).</SUBJECT> <SECTNO>721.10037</SECTNO> <SUBJECT>Complex halogenated salt of tris(ethylatedaminocarbocyclic)methane (generic).</SUBJECT> <SECTNO>721.10038</SECTNO> <SUBJECT>Trimellitic anhydride, polymer with substituted glycol, alkyl phenols and ethoxylated nonylphenol (generic).</SUBJECT> <SECTNO>721.10039</SECTNO> <SUBJECT>Diethoxybenzenamine derivative, diazotized, coupled with aminonaphthalenesulfonic acid derivative, ammonium salt (generic).</SUBJECT> <SECTNO>721.10040</SECTNO> <SUBJECT>Substituted acridine naphtha substituted benzamide (generic).</SUBJECT> <SECTNO>721.10041</SECTNO> <SUBJECT>1-Butanone, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-.</SUBJECT> <SECTNO>721.10042</SECTNO> <SUBJECT>2-Propanol, 1-[bis(2-hydroxyethyl)amino]-.</SUBJECT> <SECTNO>721.10043</SECTNO> <SUBJECT>Dineopentyl-4-substituted phthalate (generic).</SUBJECT> <SECTNO>721.10044</SECTNO> <SUBJECT>Metal oxide, modified with alkyl and vinyl terminated polysiloxanes (generic).</SUBJECT> <SECTNO>721.10045</SECTNO> <SUBJECT>Diazotized substituted heteromonocycle coupled with naphthalene sulfonic acid derivative, nickel complex, alkaline salt (generic).</SUBJECT> <SECTNO>721.10046</SECTNO> <SUBJECT>Polyaromatic amine phosphate (generic).</SUBJECT> <SECTNO>721.10047</SECTNO> <SUBJECT>Polyphosphoric acids, compds. with piperazine.</SUBJECT> <SECTNO>721.10048</SECTNO> <SUBJECT>Substituted anthraquinone (generic).</SUBJECT> <SECTNO>721.10049</SECTNO> <SUBJECT>Phenol, 4,4′- cyclohexylidene bis[2-methyl-.</SUBJECT> <SECTNO>721.10050</SECTNO> <SUBJECT> Disubstituted- <E T="03">N</E> ′- hydroxy-benzenecarboximidamide (generic). </SUBJECT> <SECTNO>721.10051</SECTNO> <SUBJECT>Spiro naphthoxazine (generic).</SUBJECT> <SECTNO>721.10052</SECTNO> <SUBJECT>Aminoalkyl substituted alkylphenol (generic).</SUBJECT> <SECTNO>721.10053</SECTNO> <SUBJECT>Alkyl silane methacrylate (generic).</SUBJECT> <SECTNO>721.10054</SECTNO> <SUBJECT>Phenol, polymer with formaldehyde, 3-[(2-aminocyclohexyl)amino]-2-hydroxypropyl ethers.</SUBJECT> <SECTNO>721.10055</SECTNO> <SUBJECT> 1-Propanaminium, 3-amino- <E T="03">N</E> -(carboxymethyl)- <E T="03">N</E> , <E T="03">N</E> -dimethyl-, <E T="03">N</E> -soya acyl derivs., inner salts. </SUBJECT> <SECTNO>721.10056</SECTNO> <SUBJECT> Benzenemethanaminium, <E T="03">N</E> -(3-aminopropyl)- <E T="03">N</E> , <E T="03">N</E> -dimethyl-, <E T="03">N</E> -soya acyl derivs., chlorides. </SUBJECT> <SECTNO>721.10057</SECTNO> <SUBJECT>Dodecanedioic acid, 1, 12-dihydrazide.</SUBJECT> <SECTNO>721.10058</SECTNO> <SUBJECT>Reaction product of alkylphenol, aromatic cyclicamine, alkyl diglycidyl dibenzene, and formaldehyde (generic).</SUBJECT> <SECTNO>721.10059</SECTNO> <SUBJECT>Reaction product of alkylphenyl glycidyl ether, polyalkylenepolyamine, and alkyl diglycidyl dibenzene (generic).</SUBJECT> <SECTNO>721.10060</SECTNO> <SUBJECT>Reaction product of alkylphenyl glycidyl ether, polyalkylenepolyamine, alkyl diglycidyl dibenzene, and polyalkylcyclicdiamine (generic).</SUBJECT> <SECTNO>721.10061</SECTNO> <SUBJECT>Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-.</SUBJECT> <SECTNO>721.10062</SECTNO> <SUBJECT>2,5-Furandione, polymer with oxybis[propanol], benzoate.</SUBJECT> <SECTNO>721.10063</SECTNO> <SUBJECT>Halo substituted hydroxy nitrophenyl amide (generic).</SUBJECT> <SECTNO>721.10064</SECTNO> <SUBJECT>2-Propenoic acid, 2-[2-(ethenyloxy)ethoxy]ethyl ester.</SUBJECT> <SECTNO>721.10065</SECTNO> <SUBJECT>1-Tetradecanesulfonic acid, (dimethylphenyl)-.</SUBJECT> <SECTNO>721.10066</SECTNO> <SUBJECT>1-Hexanesulfonic acid, (dimethylphenyl)-.</SUBJECT> <SECTNO>721.10067</SECTNO> <SUBJECT>Ether amine phosphonate salt (generic).</SUBJECT> <SECTNO>721.10068</SECTNO> <SUBJECT>Elemental mercury.</SUBJECT> <SECTNO>721.10069</SECTNO> <SUBJECT>Ether amine phosphonate (generic).</SUBJECT> <SECTNO>721.10070</SECTNO> <SUBJECT>1,3-Butanediol, 3-methyl-.</SUBJECT> <SECTNO>721.10071</SECTNO> <SUBJECT>9H-Thioxanthenium, 10-[1,1′-biphenyl]-4-yl-2-(1-methylethyl)-9-oxo-, hexafluorophosphate (1-) (1:1).</SUBJECT> <SECTNO>721.10072</SECTNO> <SUBJECT> Benzene, 1,1′-methylenebis[4-isocyanato-, polymer with benzenedicarboxylic acid, butyl dialkyl ester, poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, oxirane, alkyl-, polymer with oxirane, ether with propanepolyol and Sartomer's HLBH P-3000 and Lexorez 1180 (generic). <PRTPAGE P="259"/> </SUBJECT> <SECTNO>721.10073</SECTNO> <SUBJECT>Modified alkyl acrylamide (generic).</SUBJECT> <SECTNO>721.10074</SECTNO> <SUBJECT>Acetic acid, 2-chloro-, 1-(3,3-dimethylcyclohexyl)ethyl ester.</SUBJECT> <SECTNO>721.10075</SECTNO> <SUBJECT>Carbon black, 4-[[2-(Sulfooxy) ethyl]substituted] phenyl- modified, sodium salts (generic).</SUBJECT> <SECTNO>721.10076</SECTNO> <SUBJECT>Substituted benzenediamine (generic).</SUBJECT> <SECTNO>721.10077</SECTNO> <SUBJECT>3H-1,2,4-Triazol-3-one, 1,2-dihydro-.</SUBJECT> <SECTNO>721.10078</SECTNO> <SUBJECT> Butanamide, 2-[(2-methoxy-4-nitrophenyl)azo]- <E T="03">N</E> -(2-methoxyphenyl)-3-oxo-, 4-[(17-substituted-3,6,9,12,15-pentaazaheptadec-1-yl)substituted]phenyl derivs., hydrochlorides (generic). </SUBJECT> <SECTNO>721.10079</SECTNO> <SUBJECT>Quino[2,3-b]acridine-7, 14-dione, 5,12-dihydro-2,9-dimethyl-, 4-[(17-substituted-3,6,9,12,15-pentaazaheptadec-1-yl)substituted]phenyl derivs., hydrochlorides (generic).</SUBJECT> <SECTNO>721.10080</SECTNO> <SUBJECT>Carbon black, 4-[(17-substituted-3,6,9,12,15-pentaazaheptadec-1-yl) substituted] phenyl-modified, hydrochlorides (generic).</SUBJECT> <SECTNO>721.10081</SECTNO> <SUBJECT>Aromatic urethane acrylate oligomer (generic).</SUBJECT> <SECTNO>721.10082</SECTNO> <SUBJECT>Amine modified monomer acrylate (generic).</SUBJECT> <SECTNO>721.10083</SECTNO> <SUBJECT> Copper, [29H, 31H-phthalocyaninato (2-)- <E T="03">N</E> 29, <E T="03">N</E> 30, <E T="03">N</E> 31, <E T="03">N</E> 32]-, 4-[(17-substituted-3,6,9,12,15- pentaazaheptadec-1-yl) substituted] phenyl derivs., hydrochlorides (generic). </SUBJECT> <SECTNO>721.10084</SECTNO> <SUBJECT>Modified thionocarbamate (generic).</SUBJECT> <SECTNO>721.10085</SECTNO> <SUBJECT>Substituted polyaryl sulfonium polyhalide phosphate salt (generic).</SUBJECT> <SECTNO>721.10086</SECTNO> <SUBJECT>Ethane, 2-(difluoromethoxy)-1,1,1-trifluoro-.</SUBJECT> <SECTNO>721.10087</SECTNO> <SUBJECT>Substituted alkyl phosphine oxide (generic).</SUBJECT> <SECTNO>721.10088</SECTNO> <SUBJECT>Thiophene, 2,5-dibromo-3-hexyl-.</SUBJECT> <SECTNO>721.10089</SECTNO> <SUBJECT>Modified salicylic acid, zirconium complex (generic).</SUBJECT> <SECTNO>721.10090</SECTNO> <SUBJECT>Tertiary amine salt of glycol succinate (generic).</SUBJECT> <SECTNO>721.10091</SECTNO> <SUBJECT>2(1H)-Pyrimidinone, tetrahydro-1,3-dimethyl-.</SUBJECT> <SECTNO>721.10092</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-[[1-[(2-propen-1-yloxy)methyl]undecyl]oxy]-, ammonium salt (1:1); Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-[[1-[(2-propen-1-yloxy)methyl]tridecyl]oxy]-, ammonium salt (1:1).</SUBJECT> <SECTNO>721.10093</SECTNO> <SUBJECT>Alkylamides, ethoxylated (generic).</SUBJECT> <SECTNO>721.10094</SECTNO> <SUBJECT>Decene, branched and linear.</SUBJECT> <SECTNO>721.10095</SECTNO> <SUBJECT>Oxetane, 3,3′-[oxybis(methylene)] bis[3-ethyl-.</SUBJECT> <SECTNO>721.10096</SECTNO> <SUBJECT>Benzene, 1,4-bis (methoxymethyl)-.</SUBJECT> <SECTNO>721.10097</SECTNO> <SUBJECT>Disubstituted benzenesulfonic acid, alkali metal salt (generic).</SUBJECT> <SECTNO>721.10098</SECTNO> <SUBJECT>Disubstituted benzoic acid, alkali metal salt (generic).</SUBJECT> <SECTNO>721.10099</SECTNO> <SUBJECT>Dialkyl dimethyl ammonium carbonate (generic).</SUBJECT> <SECTNO>721.10100</SECTNO> <SUBJECT>Dialkyl dimethyl ammonium carbonate (2:1) (generic).</SUBJECT> <SECTNO>721.10101</SECTNO> <SUBJECT>Copolymer of alkyl acrylate and ethyleneglycol dimethacrylate (generic).</SUBJECT> <SECTNO>721.10102</SECTNO> <SUBJECT>Diphosphoric acid, compd. with piperazine (1:1).</SUBJECT> <SECTNO>721.10103</SECTNO> <SUBJECT>Naphtha (Fischer-Tropsch), C4-11-alkane, branched and linear.</SUBJECT> <SECTNO>721.10104</SECTNO> <SUBJECT>Halophosphate mixed metal complex (generic).</SUBJECT> <SECTNO>721.10105</SECTNO> <SUBJECT>Polyfluoroalkylether (generic).</SUBJECT> <SECTNO>721.10106</SECTNO> <SUBJECT>Silica, [(ethenylsilylidyne)tris(oxy)] - modified.</SUBJECT> <SECTNO>721.10107</SECTNO> <SUBJECT>Naphthalenedisulfonic acid, [amino-hydroxy-[(substituted)azo-sulfo-naphthaleneyl]azo]-hydroxy-[(methoxy-sulfophenyl)azo], metal salt (generic).</SUBJECT> <SECTNO>721.10108</SECTNO> <SUBJECT>Naphthalenedisulfonic acid, hydrozy-[[[(hydroxyl-disulfo-naphthaleneyl)azo]-alkyl(C = 1-5)-(sulfoalkoxy)cyclic]azo]-substituted azo-, metal salt (generic).</SUBJECT> <SECTNO>721.10109</SECTNO> <SUBJECT>Hexanoic acid, 2-ethyl-, mixed triesters with benzoic acid and trimethylolpropane.</SUBJECT> <SECTNO>721.10110</SECTNO> <SUBJECT>Hexanoic acid, 2-ethyl-, mixed diesters with benzoic acid and neopentlyl glycol.</SUBJECT> <SECTNO>721.10111</SECTNO> <SUBJECT>Hexanoic acid, 2-ethyl-, mixed diesters with benzoic acid and diethylene glycol.</SUBJECT> <SECTNO>721.10112</SECTNO> <SUBJECT>Ethanone, 2-chloro-1-(1-chlorocyclopropyl)-.</SUBJECT> <SECTNO>721.10113</SECTNO> <SUBJECT>Thioether epoxy (generic).</SUBJECT> <SECTNO>721.10114</SECTNO> <SUBJECT>Polyhydroxyaminoether salts (generic).</SUBJECT> <SECTNO>721.10115</SECTNO> <SUBJECT>1-Hexadecanaminium, N,N-dibutyl-N-(2-hydroxyethyl)-, bromide (1:1).</SUBJECT> <SECTNO>721.10116</SECTNO> <SUBJECT>Blocked polymeric isocyanate (generic).</SUBJECT> <SECTNO>721.10117</SECTNO> <SUBJECT>Heteromonocyclo-beta-(2,4-dichlorophenyl) -1-propanol (generic).</SUBJECT> <SECTNO>721.10118</SECTNO> <SUBJECT>Substituted aryl acetonitrile (generic).</SUBJECT> <SECTNO>721.10119</SECTNO> <SUBJECT>Siloxane modified silica nanoparticles (generic).</SUBJECT> <SECTNO>721.10120</SECTNO> <SUBJECT>Siloxane modified alumina nanoparticles (generic).</SUBJECT> <SECTNO>721.10121</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-methyl-.omega.-(4-nonylphenoxy)-, branched.</SUBJECT> <SECTNO>721.10122</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 1,1′-[2-ethyl-2-[[(2-methyl-1-oxo-2-propen-1-yl)oxy]methyl]- 1,3-propanediyl] ester, polymer with 1,3-butadiene, ethenylbenzene and 2-hydroxyethyl 2-methyl-2-propenoate.</SUBJECT> <SECTNO>721.10123</SECTNO> <SUBJECT>[1,2,4-Triazolo[1,5-a]pyrimidin-2-amine, 5,7-dimethoxy-].</SUBJECT> <SECTNO>721.10124</SECTNO> <SUBJECT>Brominated polyaromatic compound (generic).</SUBJECT> <SECTNO>721.10125</SECTNO> <SUBJECT> Alkenedioic acid, dialkyl ester, reaction products with polyaminocarbomonocycle and alkenoic acid alkyl ester (generic). <PRTPAGE P="260"/> </SUBJECT> <SECTNO>721.10126</SECTNO> <SUBJECT>Alkyl amino substituted triazine amino substituted benezenesulfonic acid reaction product with naphthalenesulfonato azo substituted phenyl azo substituted benzenesulfonic acid copper compound (generic).</SUBJECT> <SECTNO>721.10127</SECTNO> <SUBJECT>Alkenyl dimethyl betaine (generic).</SUBJECT> <SECTNO>721.10128</SECTNO> <SUBJECT>Modified imidazole (generic).</SUBJECT> <SECTNO>721.10129</SECTNO> <SUBJECT>Alkylamine ethoxylated (generic).</SUBJECT> <SECTNO>721.10130</SECTNO> <SUBJECT>Quino[2,3-b]acridine-7,14-dione, 5,12-dihydro-ar-[4-[[2-(sulfooxy)ethyl]substituted]phenyl]-, monosodium salt (generic).</SUBJECT> <SECTNO>721.10131</SECTNO> <SUBJECT>Isononanamide, N-(2-ethylhexyl)-.</SUBJECT> <SECTNO>721.10132</SECTNO> <SUBJECT>Phosphoramidic acid, carbomonocyclic-, diphenylester (generic).</SUBJECT> <SECTNO>721.10133</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl, 2-hydroxyethyl ester, homopolymer.</SUBJECT> <SECTNO>721.10134</SECTNO> <SUBJECT>Formaldehyde, polymer with dialkylphenylamine, dialkylphenol and trimethylhexanediamine (generic).</SUBJECT> <SECTNO>721.10135</SECTNO> <SUBJECT>Phosphinic acid, P,P-diethyl-, zinc salt (2:1).</SUBJECT> <SECTNO>721.10136</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, reaction products with hexakis(alkoxyalkyl)melamine (generic).</SUBJECT> <SECTNO>721.10137</SECTNO> <SUBJECT>Halogenated phenoxy aromatic (generic).</SUBJECT> <SECTNO>721.10138</SECTNO> <SUBJECT>3-Isoxazolecarboxylic acid, 4,5-dihydro-5,5-diphenyl-, ethyl ester.</SUBJECT> <SECTNO>721.10139</SECTNO> <SUBJECT>Ethanone, 1-(1-chlorocyclopropyl)-.</SUBJECT> <SECTNO>721.10140</SECTNO> <SUBJECT>Phosphoric acid, tin (2 + ) salt (2:3).</SUBJECT> <SECTNO>721.10141</SECTNO> <SUBJECT>Oils, ginger, zingiber purpureum.</SUBJECT> <SECTNO>721.10142</SECTNO> <SUBJECT>Oxabicycloalkane carboxylic acid alkanediyl ester (generic).</SUBJECT> <SECTNO>721.10143</SECTNO> <SUBJECT>Amines, bis (C11-14-branched and linear alkyl).</SUBJECT> <SECTNO>721.10144</SECTNO> <SUBJECT>Modified thiocarbamate (generic).</SUBJECT> <SECTNO>721.10145</SECTNO> <SUBJECT>Modified reaction products of alkyl alcohol, halogenated alkane, substituted epoxide, and amino compound (generic).</SUBJECT> <SECTNO>721.10146</SECTNO> <SUBJECT>Partially fluorinated condensation polymer (generic).</SUBJECT> <SECTNO>721.10147</SECTNO> <SUBJECT>Acrylate derivative of alkoxysilylalkane ester and mixed metal oxides (generic).</SUBJECT> <SECTNO>721.10148</SECTNO> <SUBJECT>Acryloxy alkanoic alkane derivative with mixed metal oxides (generic).</SUBJECT> <SECTNO>721.10149</SECTNO> <SUBJECT>Carbon black, (3-methylphenyl)-modified, substituted (generic).</SUBJECT> <SECTNO>721.10150</SECTNO> <SUBJECT>Carbon black, (4-methylphenyl)-modified, substituted (generic).</SUBJECT> <SECTNO>721.10151</SECTNO> <SUBJECT>Modified styrene, divinylbenzene polymer (generic).</SUBJECT> <SECTNO>721.10152</SECTNO> <SUBJECT>Oxirane, substituted silylmethyl-, hydrolysis products with alkanol zirconium(4 + ) salt and silica, acetates (generic).</SUBJECT> <SECTNO>721.10153</SECTNO> <SUBJECT>Modified methyl methacrylate, 2-hydroxyethyl methacrylate polymer (generic).</SUBJECT> <SECTNO>721.10154</SECTNO> <SUBJECT>Quaternary ammonium compounds, dicoco alkyldimethyl, chlorides, reaction products with silica.</SUBJECT> <SECTNO>721.10155</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10156</SECTNO> <SUBJECT>Single-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10157</SECTNO> <SUBJECT>Benzeneethanol,halo-,halocycloalkyl-,hydrazinealkyl- (generic).</SUBJECT> <SECTNO>721.10158</SECTNO> <SUBJECT>2-Pentanone, 3,5-dichloro-.</SUBJECT> <SECTNO>721.10159</SECTNO> <SUBJECT>1-Docosanamine, N,N-dimethyl-.</SUBJECT> <SECTNO>721.10160</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.-[(13Z)-1-oxo-13-docosen-1-yl]-.omega.-[[(13Z)-1-oxo-13-docosen-1-yl]oxy]-.</SUBJECT> <SECTNO>721.10161</SECTNO> <SUBJECT>Substituted silyl methacrylate (generic).</SUBJECT> <SECTNO>721.10162</SECTNO> <SUBJECT>1,3 Dioxolane-4-butanol, 2-ethenyl-.</SUBJECT> <SECTNO>721.10163</SECTNO> <SUBJECT>Chloro fluoro alkane (generic).</SUBJECT> <SECTNO>721.10164</SECTNO> <SUBJECT>Benzenecarboximidamide, N-hydroxy-4-nitro-.</SUBJECT> <SECTNO>721.10165</SECTNO> <SUBJECT>Carbonotrithioic acid, bis(phenylmethyl) ester.</SUBJECT> <SECTNO>721.10166</SECTNO> <SUBJECT>1,3-Cyclohexanedione, 2-[2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl]-, ion(1-), potassium salt (1:1).</SUBJECT> <SECTNO>721.10167</SECTNO> <SUBJECT>Tetrafluoro nitrotoluene (generic).</SUBJECT> <SECTNO>721.10168</SECTNO> <SUBJECT>Cesium tungsten oxide.</SUBJECT> <SECTNO>721.10169</SECTNO> <SUBJECT>Cyclopentane, methoxy-.</SUBJECT> <SECTNO>721.10170</SECTNO> <SUBJECT>Polyoxyethylene polyalkylarylphenylether sulfate ammonium salt (generic).</SUBJECT> <SECTNO>721.10171</SECTNO> <SUBJECT>1H-benz(e)indolium, 1,1,2,3-tetramethyl-, 4-methylbenzenesulfonic acid (1:1).</SUBJECT> <SECTNO>721.10172</SECTNO> <SUBJECT>Alkylamide derivative (generic).</SUBJECT> <SECTNO>721.10173</SECTNO> <SUBJECT>Silanamine,1,1,1-triethoxy-N,N-diethyl-.</SUBJECT> <SECTNO>721.10174</SECTNO> <SUBJECT>1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-peanut-oil acyl derivs., inner salts.</SUBJECT> <SECTNO>721.10175</SECTNO> <SUBJECT>1-Propanaminium, N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-3-sulfo-, N-(C12-18 and C18-unsatd. acyl) derivs., inner salts.</SUBJECT> <SECTNO>721.10176</SECTNO> <SUBJECT>Amides, peanut-oil, N-[3-(dimethylamino)propyl].</SUBJECT> <SECTNO>721.10177</SECTNO> <SUBJECT>Phosphoric acid, yttrium(3 + ) salt (1:1).</SUBJECT> <SECTNO>721.10178</SECTNO> <SUBJECT>Distillates (Fischer-Tropsch), hydroisomerized middle, C10-13-branched alkane fraction.</SUBJECT> <SECTNO>721.10179</SECTNO> <SUBJECT>Copolymers of phenol and aromatic hydocarbon (generic).</SUBJECT> <SECTNO>721.10180</SECTNO> <SUBJECT>Trifunctional acrylic ester (generic).</SUBJECT> <SECTNO>721.10181</SECTNO> <SUBJECT>Halide salt of an alkylamine (generic).</SUBJECT> <SECTNO>721.10182</SECTNO> <SUBJECT>1-Propene, 2,3,3,3-tetrafluoro-.</SUBJECT> <SECTNO>721.10183</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10184</SECTNO> <SUBJECT>Aliphatic triamine (generic).</SUBJECT> <SECTNO>721.10185</SECTNO> <SUBJECT> 1,2-Propanediol, 3-(diethylamino)-, polymers with 5-isocyanato-1- (isocyanatomethyl)-1,3,3-trimethylcyclohexane, propylene glycol <PRTPAGE P="261"/> and reduced Me esters of reduced polymd. oxidized tetrafluoroethylene, 2-ethyl-1-hexanol-blocked, acetates (salts). </SUBJECT> <SECTNO>721.10186</SECTNO> <SUBJECT>Ethylhexyl oxetane (generic).</SUBJECT> <SECTNO>721.10187</SECTNO> <SUBJECT>4-Morpholinepropanamine, N-(1,3-dimethylbutylidene)-.</SUBJECT> <SECTNO>721.10188</SECTNO> <SUBJECT>Fatty acids, tall-oil, reaction products with 4-methyl-2-pentanone and aliphatic polyamine (generic).</SUBJECT> <SECTNO>721.10189</SECTNO> <SUBJECT>Fatty acids, tall-oil, reaction products with (butoxymethyl) oxirane formaldehyde-phenol polymer glycidyl ether, morpholinepropanamine, propylene glycol diamine and aliphatic polyamine, N-(1,3 -dimethylbutylidene) derivs (generic).</SUBJECT> <SECTNO>721.10190</SECTNO> <SUBJECT>Formaldehyde, polymer with aliphatic diamine and phenol, reaction products with 4-methyl-2-pentanone (generic).</SUBJECT> <SECTNO>721.10191</SECTNO> <SUBJECT>Amides, coco, N-[3-(dibutylamino)propyl].</SUBJECT> <SECTNO>721.10192</SECTNO> <SUBJECT>Amides, coco, N-[3-(dibutylamino)propyl], acrylates.</SUBJECT> <SECTNO>721.10193</SECTNO> <SUBJECT>1-Butanaminium, N-(3-aminopropyl)-N-butyl-N-(2-carboxyethyl)-, N-coco acyl derivs., inner salts.</SUBJECT> <SECTNO>721.10194</SECTNO> <SUBJECT>Dialkylcocoamidoalkylpropionate (generic).</SUBJECT> <SECTNO>721.10195</SECTNO> <SUBJECT>Dialkylcornoilamidoalkylamine (generic).</SUBJECT> <SECTNO>721.10196</SECTNO> <SUBJECT>Dialkylcornoilamidoacrylate (generic).</SUBJECT> <SECTNO>721.10197</SECTNO> <SUBJECT>Dialkycornoilamidoalkylbetaine (generic).</SUBJECT> <SECTNO>721.10198</SECTNO> <SUBJECT>Dialkylcornoilamidopropionate (generic).</SUBJECT> <SECTNO>721.10199</SECTNO> <SUBJECT>Substituted aliphatic amine (generic).</SUBJECT> <SECTNO>721.10200</SECTNO> <SUBJECT>Benzenacetonitrile, cyclohexylidene-alkyl substituted (generic).</SUBJECT> <SECTNO>721.10201</SECTNO> <SUBJECT>Cobalt lithium manganese nickel oxide.</SUBJECT> <SECTNO>721.10202</SECTNO> <SUBJECT>Benzoic acid, 4-chloro-2- [(substituted)azo]-, strontium salt (1:1) (generic).</SUBJECT> <SECTNO>721.10203</SECTNO> <SUBJECT>Phosphonium, tetrabutyl-, hydroxide (1:1).</SUBJECT> <SECTNO>721.10204</SECTNO> <SUBJECT>Aryloxyacrylate (generic).</SUBJECT> <SECTNO>721.10205</SECTNO> <SUBJECT>Formaldehyde, polymer with 1,3-benzenediol and 1,1′-methylenebis[isocyanatobenzene].</SUBJECT> <SECTNO>721.10206</SECTNO> <SUBJECT>4-Cyclohexene-1,2-dicarboxylic acid, 1,2-bis(2-oxiranylmethyl) ester.</SUBJECT> <SECTNO>721.10207</SECTNO> <SUBJECT>1,3-Cyclohexanedimethanamine, N1,N3-bis(2-methylpropylidene)-.</SUBJECT> <SECTNO>721.10208</SECTNO> <SUBJECT>Amines, di-C11-14-isoalkyl, C13-rich.</SUBJECT> <SECTNO>721.10209</SECTNO> <SUBJECT>Epoxy terminated, hydrolyzed trialkoxysilane and glycidyl ether of phenol-formaldehyde resin (generic).</SUBJECT> <SECTNO>721.10210</SECTNO> <SUBJECT>Soybean oil, epoxidized, reaction products with diethanolamine.</SUBJECT> <SECTNO>721.10211</SECTNO> <SUBJECT>Octadecanoic acid, reaction products with diethylenetriamine and urea, acetates.</SUBJECT> <SECTNO>721.10212</SECTNO> <SUBJECT>1,2-Ethanediol, reaction products with epichlorohydrin.</SUBJECT> <SECTNO>721.10213</SECTNO> <SUBJECT>Polyether polyester copolymer phosphate (generic).</SUBJECT> <SECTNO>721.10214</SECTNO> <SUBJECT>Poly(oxyalkylenediyl),.alpha.-substituted carbomonocycle-.omega.-substituted carbomonocycle (generic).</SUBJECT> <SECTNO>721.10215</SECTNO> <SUBJECT>Benzenepropanol, .beta.-methyl-.</SUBJECT> <SECTNO>721.10216</SECTNO> <SUBJECT>2-Propenoic acid, 3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)cyclohexyl ester].</SUBJECT> <SECTNO>721.10217</SECTNO> <SUBJECT>Branched and linear alcohols (generic).</SUBJECT> <SECTNO>721.10218</SECTNO> <SUBJECT>2-Propenoic acid, 2-mehtyl-, C12-15-branched and linear alkyl esters, telomers with alkyl 2-[[(alkylthio)thioxomethyl]thio]-2-alkanoate, aminoalkyl methacrylate and alkyl methacrylate, tert-Bu 2-ethylhexanoperoxoate-initiated (generic).</SUBJECT> <SECTNO>721.10219</SECTNO> <SUBJECT>Butanamide,N-[substituted phenyl]-[(alkoxynitrophenyl)diazenyl]-3-oxo- (generic).</SUBJECT> <SECTNO>721.10220</SECTNO> <SUBJECT>Phosphoric acid, polymer with cycloaliphatic diglycidyl ether, alkylethers (generic).</SUBJECT> <SECTNO>721.10221</SECTNO> <SUBJECT>3-Nonen-1-ol, 1-acetate, (3Z)-.</SUBJECT> <SECTNO>721.10222</SECTNO> <SUBJECT>Styrenyl surface treated manganese ferrite (generic).</SUBJECT> <SECTNO>721.10223</SECTNO> <SUBJECT>Styrenyl surface treated manganese ferrite with acrylic ester polymer (generic).</SUBJECT> <SECTNO>721.10224</SECTNO> <SUBJECT>Diglycidylaniline (generic).</SUBJECT> <SECTNO>721.10225</SECTNO> <SUBJECT>Quino[2,3-b] acridine-7,14-dione, 2,9-dichloro-5,12-dihydro [4-[[2-(sulfooxy) ethyl] substituted] phenyl]-, sodium salt (1:1) (generic).</SUBJECT> <SECTNO>721.10226</SECTNO> <SUBJECT>Di-n-pentyl phthalate (DnPP).</SUBJECT> <SECTNO>721.10227</SECTNO> <SUBJECT> Alkanes, C <E T="52">12-13</E> , chloro (CAS No. 71011-12-6). </SUBJECT> <SECTNO>721.10229</SECTNO> <SUBJECT>Ethylene glycol ethers.</SUBJECT> <SECTNO>721.10230</SECTNO> <SUBJECT>Rutile, tin zinc, calcium doped.</SUBJECT> <SECTNO>721.10231</SECTNO> <SUBJECT>Rutile, tin zinc, sodium-doped.</SUBJECT> <SECTNO>721.10232</SECTNO> <SUBJECT>N-arylamino-phenol-formaldehyde condensate (generic)</SUBJECT> <SECTNO>721.10233</SECTNO> <SUBJECT>Linear alkyl epoxide (generic).</SUBJECT> <SECTNO>721.10234</SECTNO> <SUBJECT>Hydroxy-chloro-cyclopropyl-heteromonocyclic carboxylic acid (generic).</SUBJECT> <SECTNO>721.10235</SECTNO> <SUBJECT>Phenol, 2-ethoxy-4-(ethoxymethyl)-.</SUBJECT> <SECTNO>721.10236</SECTNO> <SUBJECT>1-Propanamine, 3-[2-(2-methoxyethoxy)ethoxy]-.</SUBJECT> <SECTNO>721.10237</SECTNO> <SUBJECT>Formaldehyde, polymers with acetone-phenol reaction products and phenol, sodium salts.</SUBJECT> <SECTNO>721.10238</SECTNO> <SUBJECT>Formaldehyde, polymers with acetone-phenol reaction products and phenol, potassium sodium salts.</SUBJECT> <SECTNO>721.10239</SECTNO> <SUBJECT> Trivalent chromium complexes of a substituted beta-naphthol amine azo dye (generic). <PRTPAGE P="262"/> </SUBJECT> <SECTNO>721.10240</SECTNO> <SUBJECT>Olefinic carbocycle, reaction products with alkoxysilane (generic).</SUBJECT> <SECTNO>721.10241</SECTNO> <SUBJECT>Olefinic carbocycle, reaction products with alkoxysilane, sulfurized (generic).</SUBJECT> <SECTNO>721.10242</SECTNO> <SUBJECT>Olefinic carbocycle, reaction products with alkoxysilane, polysulfurized (generic).</SUBJECT> <SECTNO>721.10243</SECTNO> <SUBJECT>Phosphonic acid, P-[2-[bis(2-hydroxyethyl)amino]ethyl]-, bis(2-chloroethyl) ester.</SUBJECT> <SECTNO>721.10244</SECTNO> <SUBJECT>Phosphonic acid, P-[2-[bis(2-hydroxyethyl)amino]ethyl]-, 2-[bis(2- chloroethoxy)phosphinyl]ethyl 2-chloroethyl ester.</SUBJECT> <SECTNO>721.10245</SECTNO> <SUBJECT>Branched and linear fatty alcohol ethoxylate (generic).</SUBJECT> <SECTNO>721.10246</SECTNO> <SUBJECT>Alkylpolyhydroxy polymer (generic).</SUBJECT> <SECTNO>721.10247</SECTNO> <SUBJECT>Bis-phenoxyethanol fluorene diacrylate (generic).</SUBJECT> <SECTNO>721.10248</SECTNO> <SUBJECT>Aromatic bromide (generic).</SUBJECT> <SECTNO>721.10249</SECTNO> <SUBJECT>Disubstituted phenol (generic).</SUBJECT> <SECTNO>721.10250</SECTNO> <SUBJECT>Zirconium lysine complex (generic).</SUBJECT> <SECTNO>721.10251</SECTNO> <SUBJECT>Fatty acids, reaction products with alkanolamine (generic).</SUBJECT> <SECTNO>721.10252</SECTNO> <SUBJECT> Thiosulfuric acid (H <E T="52">2</E> S <E T="52">2</E> O <E T="52">3</E> ), manganese(2 + ) salt (1:1). </SUBJECT> <SECTNO>721.10253</SECTNO> <SUBJECT>Butanedioic acid, 2-methylene-, polymer with 2,5 furanedione, copper(2 + ) manganese(2 + ) sodium zinc salt, hydrogen peroxide-initiated.</SUBJECT> <SECTNO>721.10254</SECTNO> <SUBJECT>Substituted acrylamide (generic).</SUBJECT> <SECTNO>721.10255</SECTNO> <SUBJECT>Vinyl carboxylic acid ester (generic).</SUBJECT> <SECTNO>721.10256</SECTNO> <SUBJECT>Benzoic acid, 4-(dimethylamino)-, 1,1′-[(methylimino)di-2,1-ethanediyl] ester.</SUBJECT> <SECTNO>721.10257</SECTNO> <SUBJECT>Butyl aromatic bisurea (generic).</SUBJECT> <SECTNO>721.10258</SECTNO> <SUBJECT>Aromatic hydrocarbon (generic).</SUBJECT> <SECTNO>721.10259</SECTNO> <SUBJECT>Halogenated aromatic hydrocarbon (generic).</SUBJECT> <SECTNO>721.10260</SECTNO> <SUBJECT>Benzene, 1,3-bis(1-chloro-1-methylethyl)-.</SUBJECT> <SECTNO>721.10261</SECTNO> <SUBJECT>Oxime, di-Me silane (generic).</SUBJECT> <SECTNO>721.10262</SECTNO> <SUBJECT>Oxime, Me vinyl silane (generic).</SUBJECT> <SECTNO>721.10263</SECTNO> <SUBJECT>Phenol, 4-(1,1-dimethylethyl)-2-nitro-.</SUBJECT> <SECTNO>721.10264</SECTNO> <SUBJECT>Polycarbocyclic methacrylate (generic).</SUBJECT> <SECTNO>721.10265</SECTNO> <SUBJECT>Ethane, 2-bromo-1, 1-difluoro-.</SUBJECT> <SECTNO>721.10266</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic) (P-08-733 and P-08-734).</SUBJECT> <SECTNO>721.10267</SECTNO> <SUBJECT>[5,6]Fullerene-C60-Ih.</SUBJECT> <SECTNO>721.10268</SECTNO> <SUBJECT>[5,6]Fullerene-C70-D5h(6).</SUBJECT> <SECTNO>721.10269</SECTNO> <SUBJECT>[5,6]Fullerene-C84-D2.</SUBJECT> <SECTNO>721.10270</SECTNO> <SUBJECT>[5,6]Fullerene-C84-D2d.</SUBJECT> <SECTNO>721.10271</SECTNO> <SUBJECT>3′H-Cyclopropa[1,9][5,6]fullerene-C60-Ih-3′-butanoic acid, 3′-phenyl-, methyl ester.</SUBJECT> <SECTNO>721.10272</SECTNO> <SUBJECT>3′H-Cyclopropa[8,25][5,6]fullerene-C70-D5h(6)-3′-butanoic acid, 3′-phenyl-,methyl ester.</SUBJECT> <SECTNO>721.10273</SECTNO> <SUBJECT>3′H-Cyclopropa[7,22][5,6]fullerene-C70-D5h(6)-3′-butanoic acid, 3′-phenyl-, methyl ester.</SUBJECT> <SECTNO>721.10274</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic) (P-09-188).</SUBJECT> <SECTNO>721.10275</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic) (P-09-0417).</SUBJECT> <SECTNO>721.10276</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic) (P-10-39).</SUBJECT> <SECTNO>721.10277</SECTNO> <SUBJECT>Single-walled and multi-walled carbon nanotubes (generic) (P-10-40).</SUBJECT> <SECTNO>721.10278</SECTNO> <SUBJECT>4,4′-Bipyridinium, 1-(phosphonoalkyl)-1′-substituted-, salt with anion (1:2) (generic).</SUBJECT> <SECTNO>721.10279</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic) (P-10-246).</SUBJECT> <SECTNO>721.10280</SECTNO> <SUBJECT>Benzene ethenyl-, polymer with 1,3-butadiene, brominated.</SUBJECT> <SECTNO>721.10281</SECTNO> <SUBJECT>Hexabromocyclododecane and 1,2,5,6,9,10-hexabromocyclododecane.</SUBJECT> <SECTNO>721.10282</SECTNO> <SUBJECT>Ethyleneamine polyphosphates (generic).</SUBJECT> <SECTNO>721.10283</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-sulfo-.omega.-hydroxy-, C12-13-branched and linear alkyl ethers, sodium salts.</SUBJECT> <SECTNO>721.10284</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-sulfo-.omega.-hydroxy-, C14-15-branched and linear alkyl ethers, sodium salts.</SUBJECT> <SECTNO>721.10285</SECTNO> <SUBJECT>Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, reaction products with 1-piperazineethanamine.</SUBJECT> <SECTNO>721.10286</SECTNO> <SUBJECT>Formaldehyde, polymer with .alpha.-(2-aminomethylethyl)-.omega.-(2-aminomethylethoxy)poly[oxy(methyl-1,2-ethanediyl)] and 4-(1,1-dimethylethyl)phenol.</SUBJECT> <SECTNO>721.10287</SECTNO> <SUBJECT>Infused carbon nanostructures (generic).</SUBJECT> <SECTNO>721.10288</SECTNO> <SUBJECT>Cyclohexane, oxidized, by-products from, distn. residues.</SUBJECT> <SECTNO>721.10289</SECTNO> <SUBJECT>Hexanedioic acid polymer with aliphatic polyol dihydrogen phosphate aromatic ester (generic).</SUBJECT> <SECTNO>721.10290</SECTNO> <SUBJECT>Alkenoyloxy arylphenone (generic).</SUBJECT> <SECTNO>721.10292</SECTNO> <SUBJECT>Silicate (2-), hexafluoro-, cesium (1:2).</SUBJECT> <SECTNO>721.10293</SECTNO> <SUBJECT>Benzoic acid, 4-(1,1-dimethylethyl)-, hydrazide.</SUBJECT> <SECTNO>721.10294</SECTNO> <SUBJECT>Cyclohexanol, 2,6-bis(1,1-dimethylethyl)-4-methyl-.</SUBJECT> <SECTNO>721.10295</SECTNO> <SUBJECT>IPDI modified isophthalic acid, neopentyl glycol and adipic acid (generic).</SUBJECT> <SECTNO>721.10296</SECTNO> <SUBJECT>1,3-Benzenediol, 4-[1-[[3-(lH-imidazol-1-yl)propyl]imino] ethyl]-.</SUBJECT> <SECTNO>721.10297</SECTNO> <SUBJECT>Tin, C16-18 and C18-unsatd. fatty acids castor-oil fatty acids complexes.</SUBJECT> <SECTNO>721.10298</SECTNO> <SUBJECT>MDI terminated polyester polyurethane polymer (generic).</SUBJECT> <SECTNO>721.10299</SECTNO> <SUBJECT>Polymeric MDI based polyurethanes (generic).</SUBJECT> <SECTNO>721.10300</SECTNO> <SUBJECT>Benzeneacetic acid, .alpha.-chloro-.alpha.-phenyl-, ethyl ester.</SUBJECT> <SECTNO>721.10301</SECTNO> <SUBJECT> Reaction products of fatty alcohols, (aminoethylaminopropyl) <PRTPAGE P="263"/> dialkoxymethylsilane, glycidol, and hydroxy-terminated polydimethylsiloxane (generic). </SUBJECT> <SECTNO>721.10302</SECTNO> <SUBJECT>Zinc ammonium phosphate (generic).</SUBJECT> <SECTNO>721.10303</SECTNO> <SUBJECT>Polyether modified polysiloxane, acrylated (generic).</SUBJECT> <SECTNO>721.10304</SECTNO> <SUBJECT>Functionalized polymethine (generic).</SUBJECT> <SECTNO>721.10305</SECTNO> <SUBJECT>Modified cyclohexane esters (generic).</SUBJECT> <SECTNO>721.10306</SECTNO> <SUBJECT>Substituted phenylepoxide (generic).</SUBJECT> <SECTNO>721.10307</SECTNO> <SUBJECT>Acrylate resin (generic).</SUBJECT> <SECTNO>721.10308</SECTNO> <SUBJECT>Ethoxylated, propoxylated diamine diaryl substituted phenylmethane ester with alkenylsuccinate, dialkylethanolamine salt (generic).</SUBJECT> <SECTNO>721.10313</SECTNO> <SUBJECT>Fatty acids, C16-18 and C18-unsatd., Me esters, epoxidized.</SUBJECT> <SECTNO>721.10314</SECTNO> <SUBJECT>Dialkyl dithiocarbamate esters (generic).</SUBJECT> <SECTNO>721.10315</SECTNO> <SUBJECT>1,5-Dioxa-9-azaspiro[5.5]undecane, 3,3,8,8,10,10-hexamethyl-9-[1-[4-(2-oxiranylmethoxy)phenyl]ethoxy]-.</SUBJECT> <SECTNO>721.10316</SECTNO> <SUBJECT>Dicyclopentadiene polymer with maleic anhydride and alkyl alcohols (generic).</SUBJECT> <SECTNO>721.10317</SECTNO> <SUBJECT>Alkyl phosphate derivative (generic).</SUBJECT> <SECTNO>721.10318</SECTNO> <SUBJECT>Mannich bases (generic).</SUBJECT> <SECTNO>721.10319</SECTNO> <SUBJECT>Alkylamides, ethoxylated (generic).</SUBJECT> <SECTNO>721.10320</SECTNO> <SUBJECT>Fatty acid amide (generic).</SUBJECT> <SECTNO>721.10321</SECTNO> <SUBJECT>Bis[phenyl, 2H-1,3-benzoxazine]derivative (generic).</SUBJECT> <SECTNO>721.10322</SECTNO> <SUBJECT>Metallic diol (generic).</SUBJECT> <SECTNO>721.10323</SECTNO> <SUBJECT>Glycerol fatty acid ester (generic).</SUBJECT> <SECTNO>721.10324</SECTNO> <SUBJECT>Thionocarbamate derivative (generic).</SUBJECT> <SECTNO>721.10325</SECTNO> <SUBJECT>Cyclosilazanes, di-Me, Me hydrogen, polymers with di-Me, Me hydrogen silazanes, reaction products with 3-(triethoxysilyl)-1-propanamine.</SUBJECT> <SECTNO>721.10326</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, ethyl 2-propenoate, zinc 2-methyl-2-propenoate (1:2) and zinc 2-propenoate (1:2), 2,2'-(1,2-diazenediyl)bis[2-methylbutanenitrile]- and 2,2'-(1,2-diazenediyl)bis[2-methylpropanenitrile]-initiated.</SUBJECT> <SECTNO>721.10327</SECTNO> <SUBJECT>Salt of mixed fatty amidoamines and polyethylenepolyamines (generic).</SUBJECT> <SECTNO>721.10328</SECTNO> <SUBJECT>Salt of polyalkylenepolyamine derivative (generic).</SUBJECT> <SECTNO>721.10329</SECTNO> <SUBJECT>Salt of mixed fatty amidoamines (generic).</SUBJECT> <SECTNO>721.10330</SECTNO> <SUBJECT>Pyrazolone derivative (generic).</SUBJECT> <SECTNO>721.10331</SECTNO> <SUBJECT>Aromatic isocyanate methacrylate blocked (generic).</SUBJECT> <SECTNO>721.10332</SECTNO> <SUBJECT>Lithium metal phosphate (generic).</SUBJECT> <SECTNO>721.10333</SECTNO> <SUBJECT>Substituted benzamine thio-ether (generic).</SUBJECT> <SECTNO>721.10334</SECTNO> <SUBJECT>Ethanol, 2,2′-[(3-[(2-ethylhexyl)oxy]pentyl]imino]bis-].</SUBJECT> <SECTNO>721.10335</SECTNO> <SUBJECT>1-Pentanamine, 3-[(2-ethylhexyl)oxy]-.</SUBJECT> <SECTNO>721.10336</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxo-2-propen-1-yl)-.omega.-([1,1′-biphenyl]-2-yloxy)-.</SUBJECT> <SECTNO>721.10337</SECTNO> <SUBJECT>Copper, iodotris(triphenylphosphine)-, (T-4)-.</SUBJECT> <SECTNO>721.10338</SECTNO> <SUBJECT>2-Propenoic acid, 1,1′-(1,9-nonanediyl) ester.</SUBJECT> <SECTNO>721.10339</SECTNO> <SUBJECT>Adipic acid, substituted propane, alkyldiol, acrylate (generic).</SUBJECT> <SECTNO>721.10340</SECTNO> <SUBJECT> Potassium zinc fluoride (KZnF <E T="52">3</E> ). </SUBJECT> <SECTNO>721.10341</SECTNO> <SUBJECT>Amino alkyl organoborane (generic).</SUBJECT> <SECTNO>721.10342</SECTNO> <SUBJECT>Quaternary ammonium compounds, fatty alkyl dialkyl hydroxide (generic).</SUBJECT> <SECTNO>721.10343</SECTNO> <SUBJECT>Alkylated aryloxyaniline thiourea (generic).</SUBJECT> <SECTNO>721.10344</SECTNO> <SUBJECT>Alkylated aromatic isothiocyanate (generic).</SUBJECT> <SECTNO>721.10345</SECTNO> <SUBJECT>1,2-Benzenedicarboxylic acid, 1,2-bis(methylcyclohexyl) ester.</SUBJECT> <SECTNO>721.10346</SECTNO> <SUBJECT>3H-Indolium, 2-[2-[2-chloro-3-[2-(1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-3,3-dimethyl-1-propyl-, iodide (1:1).</SUBJECT> <SECTNO>721.10347</SECTNO> <SUBJECT>Bicyclo[2.2.1] heptanedimethanamine, N,N′-bis(1,2-dimethylpropylidene)-.</SUBJECT> <SECTNO>721.10348</SECTNO> <SUBJECT>Aspartic acid, N,N′-(iminodi-alkanediyl)bis, tetraalkane esters (generic).</SUBJECT> <SECTNO>721.10349</SECTNO> <SUBJECT>1,4-Benzenediamine, N′-(alkyl)-N-[4-[(alkyl)amino]phenyl]-N-phenyl- (generic).</SUBJECT> <SECTNO>721.10350</SECTNO> <SUBJECT>Amines, C11-14-branched and linear alkyl.</SUBJECT> <SECTNO>721.10351</SECTNO> <SUBJECT>Carbomonocycle, bis[(4-methylphenoxy)methyl]- (generic).</SUBJECT> <SECTNO>721.10352</SECTNO> <SUBJECT>Dimethyl terephthalate, polymer with alkyl diol and substituted benzoates (generic).</SUBJECT> <SECTNO>721.10353</SECTNO> <SUBJECT>Organosulfide (generic).</SUBJECT> <SECTNO>721.10354</SECTNO> <SUBJECT>1,1′-Biphenyl, 3,3′,4,4′-tetramethyl-.</SUBJECT> <SECTNO>721.10355</SECTNO> <SUBJECT>Poly[oxy-1,2-ethanediyl), .alpha.-(1-oxododecyl)-.omega.-[3-triethoxysilyl)propoxy]-.</SUBJECT> <SECTNO>721.10356</SECTNO> <SUBJECT>Zinc, bis[3-(acetyl-.kappa.O)-6-methyl-2H-pyran-2,4(3H)-dionato-.kappa.O4]diaqua-.</SUBJECT> <SECTNO>721.10357</SECTNO> <SUBJECT>Iron, citrate phosphate potassium complexes.</SUBJECT> <SECTNO>721.10358</SECTNO> <SUBJECT>Formaldehyde reaction products with aryl amine (generic).</SUBJECT> <SECTNO>721.10359</SECTNO> <SUBJECT>Cardanol-based alkyl phosphate (generic).</SUBJECT> <SECTNO>721.10360</SECTNO> <SUBJECT>1-Substituted propane, 3-(triethoxysilyl)-, reaction products with polyethylene glycol mono-(branched tridecyl) ether (generic).</SUBJECT> <SECTNO>721.10361</SECTNO> <SUBJECT>Anthraquinonedicarboximide, diamino-N-alkyl- (generic).</SUBJECT> <SECTNO>721.10362</SECTNO> <SUBJECT> Oils, callitropsis nootkatensis. <PRTPAGE P="264"/> </SUBJECT> <SECTNO>721.10363</SECTNO> <SUBJECT>Alkenoic acid, 2-methyl-, 2-oxiranylmethyl ester, reaction products with 4,4′ -methylenebis (cyclohexanamine) (generic).</SUBJECT> <SECTNO>721.10364</SECTNO> <SUBJECT>Halogenated aromatic amine (generic).</SUBJECT> <SECTNO>721.10365</SECTNO> <SUBJECT>Butanoic acid, 3-mercapto-2-methyl-, ethyl ester.</SUBJECT> <SECTNO>721.10366</SECTNO> <SUBJECT>Benzene, 4-bromo-1,2-dimethyl-.</SUBJECT> <SECTNO>721.10367</SECTNO> <SUBJECT>Hydroxy-aryl, polymer with substituted benzene, cyanate (generic).</SUBJECT> <SECTNO>721.10368</SECTNO> <SUBJECT>Triphenodioxazine derivatives (generic).</SUBJECT> <SECTNO>721.10369</SECTNO> <SUBJECT>Carbonic acid, diphenyl ester, polymer with diphenyl P-methylphosphonate and 4,4′-(1-methylethylidene) bis[phenol].</SUBJECT> <SECTNO>721.10370</SECTNO> <SUBJECT>Phosphonic acid, p-octyl-, lanthanum (3 + ) salt (2:1).</SUBJECT> <SECTNO>721.10371</SECTNO> <SUBJECT>Butanoic acid, 3-mercapto-,1,1′-[2-(hydroxymethyl)-2-(substituted-1-oxoalkoxy)methyl)-1,3-propanediyl] ester (generic).</SUBJECT> <SECTNO>721.10372</SECTNO> <SUBJECT>Butanoic acid, 3-mercapto-,1,1′-[2,2-bis[(substituted-1-oxoalkoxy)methyl]-1,3-propanediyl] ester (generic).</SUBJECT> <SECTNO>721.10373</SECTNO> <SUBJECT>1H-Imidazole, 1-(1-methylethyl)-.</SUBJECT> <SECTNO>721.10374</SECTNO> <SUBJECT>Silane, (3-chloropropoxy)dimethyl(1-methylethyl)-.</SUBJECT> <SECTNO>721.10375</SECTNO> <SUBJECT>Hydroxypropyl methacrylate, reaction products with propylene oxide and ethylene oxide, copolymer with N-vinyl caprolactam (generic).</SUBJECT> <SECTNO>721.10376</SECTNO> <SUBJECT>Alkyltin halide (generic).</SUBJECT> <SECTNO>721.10377</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, benzyl C8-10-isoalkyl esters, C9-rich.</SUBJECT> <SECTNO>721.10378</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, benzyl nonyl ester, branched and linear.</SUBJECT> <SECTNO>721.10379</SECTNO> <SUBJECT>Propanoic acid, 3-(dodecylthio)-, 2-(1,1-dimethylethyl)-4-[[5-(1,1-dimethylethyl)-4-hydroxy-2-methylphenyl]thio]-5-methylphenyl ester.</SUBJECT> <SECTNO>721.10380</SECTNO> <SUBJECT>Benzoic acid, 3-amino-2-mercapto-.</SUBJECT> <SECTNO>721.10381</SECTNO> <SUBJECT>Cyclic carboxylic acid, polymer with dihydroxy dialkyl ether, hydroxy substituted alkane and carboxylic acid anhydride, methacrylate terminated.</SUBJECT> <SECTNO>721.10382</SECTNO> <SUBJECT>Diphosphoric acid, calcium salt (1:1).</SUBJECT> <SECTNO>721.10383</SECTNO> <SUBJECT>Urea, N,N′-(methyl-1,3-phenylene)bis[N′,N′-bis[3-polyalkyleneamino]-, compd. with formaldehyde polymer with phenol (generic).</SUBJECT> <SECTNO>721.10384</SECTNO> <SUBJECT>Substituted alkanolamine phenol (generic).</SUBJECT> <SECTNO>721.10385</SECTNO> <SUBJECT>Phenoxy alkyl ether (generic).</SUBJECT> <SECTNO>721.10386</SECTNO> <SUBJECT>Substituted phenol (generic).</SUBJECT> <SECTNO>721.10387</SECTNO> <SUBJECT>Substituted bis-phenol (generic).</SUBJECT> <SECTNO>721.10388</SECTNO> <SUBJECT>Bisphospite nickel cyanoalkyl complex (generic).</SUBJECT> <SECTNO>721.10389</SECTNO> <SUBJECT>Styrene, copolymer with acrylic acid, salt with alkoxylated alkenylamine (generic).</SUBJECT> <SECTNO>721.10390</SECTNO> <SUBJECT>Acetoacetanilide reaction product with multifunctional acrylate (generic).</SUBJECT> <SECTNO>721.10391</SECTNO> <SUBJECT>Copper gallium indium selenide.</SUBJECT> <SECTNO>721.10392</SECTNO> <SUBJECT>Halo substituted sulfamidylbenzyluracil (generic).</SUBJECT> <SECTNO>721.10393</SECTNO> <SUBJECT>Sodium bromide MDA complex (generic).</SUBJECT> <SECTNO>721.10394</SECTNO> <SUBJECT>Copolymer of anhydride, a diol and a disubstituted diol (generic).</SUBJECT> <SECTNO>721.10395</SECTNO> <SUBJECT>Fatty acids, C14-18 and C16-18 unsatd., polymers with adipic acid and triethanolamine, di-Me sulfate-quaternized.</SUBJECT> <SECTNO>721.10396</SECTNO> <SUBJECT>Dimethyl siloxy-polyfluoro methyl siloxy-poly(oxyalkylenediyl) methyl siloxy copolymer (generic).</SUBJECT> <SECTNO>721.10397</SECTNO> <SUBJECT>Alkyl acrylate-polyfluoro methacrylate-poly(oxyalkylenediyl)-methacrylates (generic).</SUBJECT> <SECTNO>721.10398</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl),. alpha., -monoalkyl ethers-.omega.-mono (hydrogen maleate)- (generic).</SUBJECT> <SECTNO>721.10399</SECTNO> <SUBJECT>Benzoic acid azo-substituted pyridine (generic).</SUBJECT> <SECTNO>721.10400</SECTNO> <SUBJECT>Oxirane, 2-ethyl-, polymer with oxirane, mono-C12-14-sec-alkyl ethers.</SUBJECT> <SECTNO>721.10401</SECTNO> <SUBJECT>Oxirane, 2-ethyl-, polymer with oxirane, mono-C11-15-sec-alkyl ethers.</SUBJECT> <SECTNO>721.10408</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-[2-[[2,2-dimethyl-3-[(1-oxododecyl) oxy]propylidene] amino] methylethyl]-.omega.-[2-[[2,2-dimethyl-3-[(1-oxododecyl)oxy]propylidene] amino]methylethoxy]-.</SUBJECT> <SECTNO>721.10409</SECTNO> <SUBJECT>Poly(oxyalkylenediyl), .alpha.-[[[methyl-3- [[[(polyfluoroalkyl)oxy]carbonyl]amino] phenyl]amino]carbonyl]-.omega.-methoxy-(generic).</SUBJECT> <SECTNO>721.10410</SECTNO> <SUBJECT>Polyether ester acid compound with a polyamine amide (generic) (P-05-714).</SUBJECT> <SECTNO>721.10411</SECTNO> <SUBJECT>Alkanenitrile, bis(cyanoalkyl)amino (generic) (P-07-537).</SUBJECT> <SECTNO>721.10412</SECTNO> <SUBJECT>Phosphonic acid ester (generic) (P-07-706).</SUBJECT> <SECTNO>721.10413</SECTNO> <SUBJECT>Fluorinated dialkyl ketone (generic) (P-10-135).</SUBJECT> <SECTNO>721.10414</SECTNO> <SUBJECT>Polycyclic polyamine diester organometallic compound (generic) (P-10-358).</SUBJECT> <SECTNO>721.10415</SECTNO> <SUBJECT>3H-indolium, 2-[2-[3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene]-2-[(1-phenyl-1H-tetrazol-5-yl)thio]-1-cyclohexen-1-yl]ethenyl]-1, 3, 3-trimethyl-, chloride (1:1).</SUBJECT> <SECTNO>721.10416</SECTNO> <SUBJECT>Brominated polyphenyl ether (generic) (P-11-264).</SUBJECT> <SECTNO>721.10417</SECTNO> <SUBJECT>Biphenyl alkyl morpholino ketone (generic) (P-11-338).</SUBJECT> <SECTNO>721.10418</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, 1-butyl 2-(phenylmethyl) ester.</SUBJECT> <SECTNO>721.10419</SECTNO> <SUBJECT>Tetrafluoroethylene chlorotrifluoroethylene copolymer (generic) (P-11-561).</SUBJECT> <SECTNO>721.10420</SECTNO> <SUBJECT> Fluoropolymers (generic) (P-11-567, P-11-568, and P-11-569). <PRTPAGE P="265"/> </SUBJECT> <SECTNO>721.10421</SECTNO> <SUBJECT>Mercaptoalkoxysilane (generic) (P-11-594).</SUBJECT> <SECTNO>721.10422</SECTNO> <SUBJECT>Phenol, 2-[[[3-(1H-imidazol-1-yl)propyl]imino]phenylmethyl]-5-(octyloxy)-.</SUBJECT> <SECTNO>721.10423</SECTNO> <SUBJECT>Complex strontium aluminate, rare earth doped (generic).</SUBJECT> <SECTNO>721.10424</SECTNO> <SUBJECT>Benzoic acid, 4-(1,1-dimethylethyl)-, methyl.</SUBJECT> <SECTNO>721.10425</SECTNO> <SUBJECT>Substituted alkylamides (generic) (P-12-51 and P-12-52).</SUBJECT> <SECTNO>721.10426</SECTNO> <SUBJECT>1-Octadecanol, manuf. of, distn. lights, fractionation heavies, distn. lights.</SUBJECT> <SECTNO>721.10427</SECTNO> <SUBJECT>Aminoalkanol (generic).</SUBJECT> <SECTNO>721.10428</SECTNO> <SUBJECT> Fatty acids, C <E T="52">18</E> -unsatd., dimers, reaction products with 1-piperazineethanamine. </SUBJECT> <SECTNO>721.10429</SECTNO> <SUBJECT> Fatty acids, C <E T="52">18</E> -unsatd., dimers, reaction products with 1-piperazineethanamine and tall-oil fatty acids. </SUBJECT> <SECTNO>721.10430</SECTNO> <SUBJECT>Tetra alkyl ammonium salt (generic).</SUBJECT> <SECTNO>721.10431</SECTNO> <SUBJECT>Phosphoric acid esters (generic).</SUBJECT> <SECTNO>721.10432</SECTNO> <SUBJECT>1,2,4,5,7,8-Hexoxonane, 3,6,9-triethyl-3,6,9-trimethyl-.</SUBJECT> <SECTNO>721.10433</SECTNO> <SUBJECT>Cyclopentene, 1,2,3,3,4,4,5,5-octafluoro-.</SUBJECT> <SECTNO>721.10434</SECTNO> <SUBJECT>Cyclopentane, 1,1,2,2,3,3,4-heptafluoro-.</SUBJECT> <SECTNO>721.10435</SECTNO> <SUBJECT>Phenol, 2-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)-.</SUBJECT> <SECTNO>721.10436</SECTNO> <SUBJECT>Amine neutralized phosphated polyesters (generic).</SUBJECT> <SECTNO>721.10437</SECTNO> <SUBJECT>Sulfonic acid, linear xylene alkylate, mono, sodium salts (generic).</SUBJECT> <SECTNO>721.10438</SECTNO> <SUBJECT>Dialkyl hydroxybenzenealkanoic acid ester (generic).</SUBJECT> <SECTNO>721.10439</SECTNO> <SUBJECT>1,3-Dioxolan-2-one, 4-ethenyl.</SUBJECT> <SECTNO>721.10440</SECTNO> <SUBJECT>Diphosphoric acid, polymers with ethoxylated reduced Me esters of reduced polymd. oxidized tetrafluoroethylene.</SUBJECT> <SECTNO>721.10441</SECTNO> <SUBJECT> 1,2-Benzenedicarboxylic acid, di-C <E T="52">7-14</E> -branched and linear alkyl esters. </SUBJECT> <SECTNO>721.10442</SECTNO> <SUBJECT> 1,2-Benzenedicarboxylic acid, di-C <E T="52">6-14</E> -branched and linear alkyl esters. </SUBJECT> <SECTNO>721.10443</SECTNO> <SUBJECT>Ethoxylated alkylphenol sulfate, ammonium salt (generic).</SUBJECT> <SECTNO>721.10444</SECTNO> <SUBJECT>Propanol, mercapto-.</SUBJECT> <SECTNO>721.10445</SECTNO> <SUBJECT>2-Propen-1-ol, reaction products with hydrogen sulfide, distn. residues.</SUBJECT> <SECTNO>721.10446</SECTNO> <SUBJECT>1, 9-Cyclohexadecadiene.</SUBJECT> <SECTNO>721.10447</SECTNO> <SUBJECT>17-Oxabicyclo[14.1.0]heptadec-8-ene.</SUBJECT> <SECTNO>721.10448</SECTNO> <SUBJECT>Acetic acid, hydroxy- methoxy-, methylester, reaction products with substituted alkylamine (generic).</SUBJECT> <SECTNO>721.10449</SECTNO> <SUBJECT>Aromatic polyester polyol (generic).</SUBJECT> <SECTNO>721.10450</SECTNO> <SUBJECT> Oxirane, 2-[[3-(trimethoxysilyl)propoxy]methyl]-, reaction products with wollastonite (Ca(SiO <E T="52">3</E> )). </SUBJECT> <SECTNO>721.10451</SECTNO> <SUBJECT>Alkyd amide polyol (generic).</SUBJECT> <SECTNO>721.10452</SECTNO> <SUBJECT>9-Octadecenoic acid (9Z)-, 1,1′-(dimethylstannylene) ester.</SUBJECT> <SECTNO>721.10453</SECTNO> <SUBJECT>Polyglycerin alkyl ether (generic).</SUBJECT> <SECTNO>721.10454</SECTNO> <SUBJECT>Propoxylated ethoxylated alkylamine (generic).</SUBJECT> <SECTNO>721.10455</SECTNO> <SUBJECT>Oxirane, 2,2′,2″-[ethylidynetris(4,1-phenyleneoxymethylene)]tris-.</SUBJECT> <SECTNO>721.10456</SECTNO> <SUBJECT>Tristyryl phenol alkoxylate salt (generic).</SUBJECT> <SECTNO>721.10457</SECTNO> <SUBJECT>1,2-Benzenedicarboxylic acid, mixed esters with benzyl alc., cyclohexanol, 2-ethyl-1-hexanol, fumaric acid and propylene glycol.</SUBJECT> <SECTNO>721.10458</SECTNO> <SUBJECT>Acrylate of hydroxyimide (generic).</SUBJECT> <SECTNO>721.10459</SECTNO> <SUBJECT>Amino-substituted carbopolycycle (generic).</SUBJECT> <SECTNO>721.10460</SECTNO> <SUBJECT>Azo nickel complex (generic).</SUBJECT> <SECTNO>721.10461</SECTNO> <SUBJECT>Oxazolidine, 3,3′-methylenebis[5-methyl-.</SUBJECT> <SECTNO>721.10462</SECTNO> <SUBJECT>1-Penten-3-one, 1-(4-chlorophenyl)-4,4-dimethyl-.</SUBJECT> <SECTNO>721.10463</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10464</SECTNO> <SUBJECT>Fatty acid, reaction products with alkanolamine (generic).</SUBJECT> <SECTNO>721.10465</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 3-hydroxytricyclo[3.3.1.13,7]dec-1-yl ester.</SUBJECT> <SECTNO>721.10466</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 2-ethyltricyclo[3.3.1.13,7]dec-2-yl ester.</SUBJECT> <SECTNO>721.10467</SECTNO> <SUBJECT>2-Propenoic acid, 3-hydroxytricyclo[3.3.1.13,7]dec-1-yl ester.</SUBJECT> <SECTNO>721.10468</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyltricyclo[3.3.1.13,7]dec-2-yl ester.</SUBJECT> <SECTNO>721.10469</SECTNO> <SUBJECT>2-Propenoic acid, 2-ethyltricyclo[3.3.1.13,7]dec-2-yl ester.</SUBJECT> <SECTNO>721.10470</SECTNO> <SUBJECT>Phosphonium, tetrabutyl-, 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonate (1:1).</SUBJECT> <SECTNO>721.10471</SECTNO> <SUBJECT>2-Propenoic acid, 1,1′-(3-methyl-1,5-pentanediyl) ester.</SUBJECT> <SECTNO>721.10472</SECTNO> <SUBJECT>1,3-Benzenedimethanamine, polymers with epichlorohydrin-polyethylene glycol reaction products.</SUBJECT> <SECTNO>721.10473</SECTNO> <SUBJECT>1-Propanaminium, 3-amino-N-(2-carboxyethyl)-N,N-dimethyl-, N-coco acyl derivs., inner salts.</SUBJECT> <SECTNO>721.10474</SECTNO> <SUBJECT>Substituted amino ethane sulfonic acid salt (generic).</SUBJECT> <SECTNO>721.10475</SECTNO> <SUBJECT>Hexanedioic acid, compd. with N1-(6-aminohexyl)-N1-methyl-1,6-hexanediamine (1:1).</SUBJECT> <SECTNO>721.10476</SECTNO> <SUBJECT>Oxetane, 3-(bromomethyl)-3-methyl-.</SUBJECT> <SECTNO>721.10477</SECTNO> <SUBJECT>Acrylate ester (generic).</SUBJECT> <SECTNO>721.10478</SECTNO> <SUBJECT>Polyether polyol (generic).</SUBJECT> <SECTNO>721.10479</SECTNO> <SUBJECT>Quaternary ammonium compounds, tris(hydrogenated tallow alkyl)methyl, chlorides.</SUBJECT> <SECTNO>721.10480</SECTNO> <SUBJECT>Trimethylolpropane polyol, aminated (generic).</SUBJECT> <SECTNO>721.10481</SECTNO> <SUBJECT>Siloxanes and Silicones, Me vinyl, hydroxy-terminated, reaction products with silica.</SUBJECT> <SECTNO>721.10482</SECTNO> <SUBJECT> Siloxanes and Silicones, di-Me, Me vinyl, hydroxy-terminated, reaction products with silica. <PRTPAGE P="266"/> </SUBJECT> <SECTNO>721.10483</SECTNO> <SUBJECT>Siloxanes and Silicones, di-Me, Me vinyl, hydroxy-terminated, reaction products with [(ethenyldimethylsilyl)oxy]-modified silica.</SUBJECT> <SECTNO>721.10484</SECTNO> <SUBJECT>Siloxanes and Silicones, Me vinyl, hydroxy-terminated, reaction products with [(ethenyldimethylsilyl)oxy]-modified silica.</SUBJECT> <SECTNO>721.10485</SECTNO> <SUBJECT>Reaction products of alcohols, alkyl alcohols, amino alcohols and methanol sodium salts (generic).</SUBJECT> <SECTNO>721.10486</SECTNO> <SUBJECT>Alkyl substituted amino-benzamide (generic).</SUBJECT> <SECTNO>721.10487</SECTNO> <SUBJECT>Alkylbenzenes sulfonic acids, metal salts (generic).</SUBJECT> <SECTNO>721.10488</SECTNO> <SUBJECT>Cuprate, [[[[[[[(sulfonaphthalenyl)]azo]-(substitutedphenyl)]azo]-(substitutedsulfonaphthalenyl)]azo]-substituted phenyl-substituted heteromonocycle], sodium salts (generic).</SUBJECT> <SECTNO>721.10489</SECTNO> <SUBJECT>Substituted aryl sulfonium polyfluorophosphate salts (generic).</SUBJECT> <SECTNO>721.10490</SECTNO> <SUBJECT>HDI biuret, hydroxyethyl methacrylate prepolymer (generic).</SUBJECT> <SECTNO>721.10491</SECTNO> <SUBJECT>Benzenepropanal,.alpha.-methyl-.</SUBJECT> <SECTNO>721.10492</SECTNO> <SUBJECT>Trisphenol (generic).</SUBJECT> <SECTNO>721.10493</SECTNO> <SUBJECT>Tris-alkyl-alkoxy melamine polymer (generic).</SUBJECT> <SECTNO>721.10494</SECTNO> <SUBJECT>Reaction product of trimethylolpropane triacrylate and alkylene imine (generic).</SUBJECT> <SECTNO>721.10495</SECTNO> <SUBJECT>Metal silicate (generic).</SUBJECT> <SECTNO>721.10496</SECTNO> <SUBJECT>Amino alkoxy polydimethylsiloxane, hydroxy-terminated (generic).</SUBJECT> <SECTNO>721.10497</SECTNO> <SUBJECT>Substituted alkyl ester, hydrolysis products with silica and substituted silane (generic).</SUBJECT> <SECTNO>721.10498</SECTNO> <SUBJECT>Substituted alkyl ester, hydrolysis products with silica (generic).</SUBJECT> <SECTNO>721.10499</SECTNO> <SUBJECT>Substituted silane, hydrolysis products with silica (generic).</SUBJECT> <SECTNO>721.10500</SECTNO> <SUBJECT>Acrylated mixed metal oxides (generic).</SUBJECT> <SECTNO>721.10501</SECTNO> <SUBJECT>Tridecyl phthalate (generic).</SUBJECT> <SECTNO>721.10502</SECTNO> <SUBJECT>Modified triethylene glycol dithiol (generic).</SUBJECT> <SECTNO>721.10503</SECTNO> <SUBJECT>1,2-Ethanediol, 1-carbamate.</SUBJECT> <SECTNO>721.10504</SECTNO> <SUBJECT>Surface modified magnesium hydroxide (generic).</SUBJECT> <SECTNO>721.10505</SECTNO> <SUBJECT> Phosphoric acid, mixed mono- and diesters with 2-ethyl-1-hexanol and polyethylene glycol mono-C <E T="52">12-16</E> -alkyl ethers. </SUBJECT> <SECTNO>721.10506</SECTNO> <SUBJECT>Alkylated phenols (generic).</SUBJECT> <SECTNO>721.10507</SECTNO> <SUBJECT>Biphenyl substituted benzopyran (generic).</SUBJECT> <SECTNO>721.10508</SECTNO> <SUBJECT>Alkene substituted Bis phenol (generic).</SUBJECT> <SECTNO>721.10509</SECTNO> <SUBJECT>Pentane, 1,1,1,2,3,3-hexafluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)-.</SUBJECT> <SECTNO>721.10510</SECTNO> <SUBJECT>Alkylaminoalcohol (generic).</SUBJECT> <SECTNO>721.10511</SECTNO> <SUBJECT>Quaternary ammonium salts (generic).</SUBJECT> <SECTNO>721.10512</SECTNO> <SUBJECT>Fatty acid maleic acid amides (generic).</SUBJECT> <SECTNO>721.10513</SECTNO> <SUBJECT>Aromatic acrylate monomer (generic).</SUBJECT> <SECTNO>721.10514</SECTNO> <SUBJECT>[1,1'-Biphenyl]-2,2'-disulfonic acid, 4-[2-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)diazenyl]-4'-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-, sodium salt (1:2).</SUBJECT> <SECTNO>721.10515</SECTNO> <SUBJECT>Partially fluorinated alcohol substituted glycols (generic).</SUBJECT> <SECTNO>721.10516</SECTNO> <SUBJECT>Perfluorinated alkylthio betaine (generic).</SUBJECT> <SECTNO>721.10517</SECTNO> <SUBJECT>Alkyl methacrylates, polymer with substituted carbomonocycle, hydroxymethyl acrylamide and fluorinatedalkyl acrylate (generic).</SUBJECT> <SECTNO>721.10518</SECTNO> <SUBJECT>Diethylene glycol, polymer with diisocyanatoalkane, polyethylene glycol monomethyl ether- and fluorinatedalkanol-blocked (generic).</SUBJECT> <SECTNO>721.10519</SECTNO> <SUBJECT>Perfluoroalkyl acrylate copolymer (generic).</SUBJECT> <SECTNO>721.10520</SECTNO> <SUBJECT>Acetylated fatty acid glycerides (generic).</SUBJECT> <SECTNO>721.10521</SECTNO> <SUBJECT>Fluorosurfactant (generic).</SUBJECT> <SECTNO>721.10522</SECTNO> <SUBJECT>Perfluoroalkylethyl methacrylate copolymer with dialkylaminoethylmethacrylate (generic).</SUBJECT> <SECTNO>721.10523</SECTNO> <SUBJECT>Perfluoroalkylethyl methacrylate copolymer with hydroxymethyl acrylamide, vinyl chloride and long chain fatty alkyl acrylate (generic).</SUBJECT> <SECTNO>721.10524</SECTNO> <SUBJECT>Fluorinated alkylsulfonamidol urethane polymer (generic).</SUBJECT> <SECTNO>721.10525</SECTNO> <SUBJECT>Alkoxy dialkyl aminoalkanol carboxylate (generic).</SUBJECT> <SECTNO>721.10526</SECTNO> <SUBJECT> 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, telomers with C <E T="52">18-26</E> -alkyl acrylate, 1-dodecanethiol, N-(hydroxymethyl)-2-methyl-2-propenamide, polyfluorooctyl methacrylate and vinylidene chloride, 2,2'-[1,2-diazenediylbis(1-methylethylidene)bis[4,5-dihydro-1H-imidazole] hydrochloride (1:2)-initiated (generic). </SUBJECT> <SECTNO>721.10527</SECTNO> <SUBJECT>Perfluoroalkylethyl methacrylate copolymer (generic).</SUBJECT> <SECTNO>721.10528</SECTNO> <SUBJECT>Modified fluorinated acrylates (generic).</SUBJECT> <SECTNO>721.10529</SECTNO> <SUBJECT>Cobalt iron manganese oxide, carboxylic acid-modified (generic).</SUBJECT> <SECTNO>721.10530</SECTNO> <SUBJECT>Acrylate manufacture byproduct distillation residue (generic).</SUBJECT> <SECTNO>721.10531</SECTNO> <SUBJECT>Distillation bottoms from manufacture of brominated cycloalkanes (generic).</SUBJECT> <SECTNO>721.10532</SECTNO> <SUBJECT>Tar, brown coal.</SUBJECT> <SECTNO>721.10533</SECTNO> <SUBJECT>Amine-modified urea-formaldehyde polymer (generic).</SUBJECT> <SECTNO>721.10534</SECTNO> <SUBJECT>Brominated aliphatic alcohol (generic).</SUBJECT> <SECTNO>721.10535</SECTNO> <SUBJECT> Phosphonium, tributyltetradecyl-, chloride (1:1). <PRTPAGE P="267"/> </SUBJECT> <SECTNO>721.10536</SECTNO> <SUBJECT>Long-chain perfluoroalkyl carboxylate chemical substances.</SUBJECT> <SECTNO>721.10537</SECTNO> <SUBJECT>Acrylate ester (generic).</SUBJECT> <SECTNO>721.10538</SECTNO> <SUBJECT>Phosphonium, tetrakis(hydroxymethyl)-, chloride (1:1), reaction products with 1-tetradecanamine and urea.</SUBJECT> <SECTNO>721.10539</SECTNO> <SUBJECT>Bis[phenyl-2H-1,3-benzoxazine]derivative (generic).</SUBJECT> <SECTNO>721.10540</SECTNO> <SUBJECT>1,3-Benzenedimethanamine, N-(2-phenylethyl) derivs.</SUBJECT> <SECTNO>721.10541</SECTNO> <SUBJECT>5,2,6-(Iminomethenimino)-1H-imidazo[4,5-b]pyrazine, octahydro-1,3,4,7,8,10-hexanitro-.</SUBJECT> <SECTNO>721.10542</SECTNO> <SUBJECT>Dodecanedioic acid, 1,12-dimethyl ester.</SUBJECT> <SECTNO>721.10543</SECTNO> <SUBJECT>Oxetane, 3-methyl-3-[(2,2,3,3,3-pentafluoropropoxy)methyl]-.</SUBJECT> <SECTNO>721.10544</SECTNO> <SUBJECT>Oxetane, 3-methyl-3-[[(3,3,4,4,5,5,6,6,6-nonafluorohexyl)oxy]methyl]-.</SUBJECT> <SECTNO>721.10545</SECTNO> <SUBJECT>Aminotriazine modified cresol novolec resin (generic).</SUBJECT> <SECTNO>721.10546</SECTNO> <SUBJECT>Pentenylated polyethylene glycol sulfate salt (generic).</SUBJECT> <SECTNO>721.10547</SECTNO> <SUBJECT>Dialkyl dimethyl ammonium methylcarbonate (generic).</SUBJECT> <SECTNO>721.10548</SECTNO> <SUBJECT>Mixed alkyl phosphate esters alkoxylated (generic).</SUBJECT> <SECTNO>721.10549</SECTNO> <SUBJECT>Ethane, 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)-.</SUBJECT> <SECTNO>721.10550</SECTNO> <SUBJECT>Rare earth salt of a carboxylic acid (generic).</SUBJECT> <SECTNO>721.10551</SECTNO> <SUBJECT>Bisphenol S mono ether (generic).</SUBJECT> <SECTNO>721.10552</SECTNO> <SUBJECT>Oxirane, 2-(1-chlorocyclopropyl)-2-[(2-chlorophenyl)methyl]-.</SUBJECT> <SECTNO>721.10553</SECTNO> <SUBJECT>Potassium titanium oxide.</SUBJECT> <SECTNO>721.10554</SECTNO> <SUBJECT>Iso-tridecanol (generic).</SUBJECT> <SECTNO>721.10555</SECTNO> <SUBJECT>Benzoic acid nonyl ester, branched and linear.</SUBJECT> <SECTNO>721.10556</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), .alpha.- (2-methyl-2-propen-1-yl) -.omega.-hydroxy-,C <E T="52">12-15</E> -alkyl ethers. </SUBJECT> <SECTNO>721.10557</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), .alpha.- (2-methyl-2-propen-1-yl) -.omega.-hydroxy-,C <E T="52">10-16</E> -alkyl ethers. </SUBJECT> <SECTNO>721.10558</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), .alpha.- (2-methyl-2-propen-1-yl) -.omega.-hydroxy-,C <E T="52">12-16</E> -alkyl ethers. </SUBJECT> <SECTNO>721.10559</SECTNO> <SUBJECT> Morpholine, 4-C <E T="52">6-12</E> acyl derivs. </SUBJECT> <SECTNO>721.10560</SECTNO> <SUBJECT>Alkanoldioic dialkyl esters (generic).</SUBJECT> <SECTNO>721.10561</SECTNO> <SUBJECT>Substituted phenol (generic).</SUBJECT> <SECTNO>721.10562</SECTNO> <SUBJECT>Aluminum trihydrate and silane homopolymer (generic).</SUBJECT> <SECTNO>721.10563</SECTNO> <SUBJECT>2-Oxiranemethanamine, N-[3-(2-oxiranylmethoxy)phenyl]-N-(2-oxiranylmethyl)-.</SUBJECT> <SECTNO>721.10564</SECTNO> <SUBJECT>Mixed amino diaryl sulfone isomers (generic).</SUBJECT> <SECTNO>721.10565</SECTNO> <SUBJECT>Ethanol, 2,2′-[[3-[(2-hydroxyethyl)amino]propyl]imino]bis-, N-(hydrogenated tallow alkyl) derivs.</SUBJECT> <SECTNO>721.10566</SECTNO> <SUBJECT> 1-Propanamine, N-(1-methylethyl) -,3-(C <E T="52">12-15</E> -alkyloxy) derivs. </SUBJECT> <SECTNO>721.10567</SECTNO> <SUBJECT>Amidoamine salt (generic).</SUBJECT> <SECTNO>721.10568</SECTNO> <SUBJECT>Diethanolamine salt of polymeric acid (generic).</SUBJECT> <SECTNO>721.10569</SECTNO> <SUBJECT>Tricyclic quaternary amine salt (generic).</SUBJECT> <SECTNO>721.10570</SECTNO> <SUBJECT>Cyclic amine reaction product with acetophenone and formaldehyde acid salt (generic).</SUBJECT> <SECTNO>721.10571</SECTNO> <SUBJECT>1,3-Benzenediol, polymer with 1,1'-methylenebis[isocyanatobenzene].</SUBJECT> <SECTNO>721.10572</SECTNO> <SUBJECT>Benzamide, N-[[4- [(cyclopropylamino) carbonyl]phenyl] sulfonyl]-2-methoxy-.</SUBJECT> <SECTNO>721.10573</SECTNO> <SUBJECT>Magnesium hydroxide surface treated with substituted alkoxysilanes (generic).</SUBJECT> <SECTNO>721.10574</SECTNO> <SUBJECT>Alkylcarboxy polyester acrylate reaction products with mixed metal oxides (generic).</SUBJECT> <SECTNO>721.10575</SECTNO> <SUBJECT>1-Propanone, 1,1'-(oxydi-4,1-phenylene)bis[2-hydroxy-2-methyl-.</SUBJECT> <SECTNO>721.10576</SECTNO> <SUBJECT>Polyalkenyl, N,N'-bistriazole (generic).</SUBJECT> <SECTNO>721.10577</SECTNO> <SUBJECT>Benzenamine, 5-(1,1-dimethylethyl)-2-[(2-ethylhexyl)thio]-,4-methylbenzenesulfonate (1:1).</SUBJECT> <SECTNO>721.10578</SECTNO> <SUBJECT>Unsaturated polyester imide (generic).</SUBJECT> <SECTNO>721.10579</SECTNO> <SUBJECT>Carbon black derived from the pyrolysis of rubber tire shreds (generic).</SUBJECT> <SECTNO>721.10580</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2- ethanediyl)], alpha, alpha′-[1,4- cyclohexanediylbis(methylene)]bis [omega-(2-aminomethylethoxy)-.</SUBJECT> <SECTNO>721.10581</SECTNO> <SUBJECT>Brominated polyurethane prepolymers of methylene diphenyl diisocyanate (MDI) (generic).</SUBJECT> <SECTNO>721.10582</SECTNO> <SUBJECT>Quaternary ammonium compound (generic).</SUBJECT> <SECTNO>721.10583</SECTNO> <SUBJECT>Benzenamine, 4,4′-[1,3-phenylenebis(1-methylethylidene)]bis-.</SUBJECT> <SECTNO>721.10584</SECTNO> <SUBJECT>Cyclopentene, 1,3,3,4,4,5,5-heptafluoro-.</SUBJECT> <SECTNO>721.10585</SECTNO> <SUBJECT>Disiloxane, 1-butyl-1,1,3,3-tetramethyl-.</SUBJECT> <SECTNO>721.10586</SECTNO> <SUBJECT>Disiloxane, 1,3-dibutyl-1,1,3,3-tetramethyl-.</SUBJECT> <SECTNO>721.10587</SECTNO> <SUBJECT>1H-Pyrazole, 3,4-dimethyl-.</SUBJECT> <SECTNO>721.10588</SECTNO> <SUBJECT>Phenol, 2-[1-[[3-(1H-imidazol-1-yl)propyl]imino]ethyl]-.</SUBJECT> <SECTNO>721.10589</SECTNO> <SUBJECT>Unsaturated fatty acids, amides with polyethylenepolyamine (generic).</SUBJECT> <SECTNO>721.10590</SECTNO> <SUBJECT>Fatty acids, amides with triethylentetramine (generic).</SUBJECT> <SECTNO>721.10591</SECTNO> <SUBJECT>Tertiary ammonium compound (generic).</SUBJECT> <SECTNO>721.10592</SECTNO> <SUBJECT>1-Butanol, 4-amino-.</SUBJECT> <SECTNO>721.10593</SECTNO> <SUBJECT>5-Isobenzofurancarboxylic acid, 1,3-dihydro-1,3-dioxo-, 2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl ester.</SUBJECT> <SECTNO>721.10594</SECTNO> <SUBJECT> Hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol, 1,6-hexanediol, hydrazine, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and 1,1′-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[2-propanol], iso-Bu <PRTPAGE P="268"/> alc.-blocked, compds. with triethylamine. </SUBJECT> <SECTNO>721.10595</SECTNO> <SUBJECT>Octadecen-1-aminium, N-ethyl-N,N-dimethy-, ethyl sulfate (1:1).</SUBJECT> <SECTNO>721.10596</SECTNO> <SUBJECT>Oligomeric phenolic ether (generic).</SUBJECT> <SECTNO>721.10597</SECTNO> <SUBJECT>Benzeneacetonitrile, alkoxy-[[(alkylsulfonyl)oxy]imino]- (generic).</SUBJECT> <SECTNO>721.10598</SECTNO> <SUBJECT>Lead strontium titanium zirconium oxide.</SUBJECT> <SECTNO>721.10599</SECTNO> <SUBJECT>Calcium cobalt lead titanium tungsten oxide.</SUBJECT> <SECTNO>721.10600</SECTNO> <SUBJECT>Calcium cobalt lead strontium titanium tungsten oxide.</SUBJECT> <SECTNO>721.10601</SECTNO> <SUBJECT>Lanthanum lead titanium zirconium oxide.</SUBJECT> <SECTNO>721.10602</SECTNO> <SUBJECT>Lead niobium titanium zirconium oxide.</SUBJECT> <SECTNO>721.10603</SECTNO> <SUBJECT>Epoxy modified alkyd resin, partially neutralized (generic).</SUBJECT> <SECTNO>721.10604</SECTNO> <SUBJECT>Polyetherdiamine (generic).</SUBJECT> <SECTNO>721.10605</SECTNO> <SUBJECT>Polyoxyalkylene ether, polymer with aliphatic diisocyanate, homopolymer, alkanol-blocked (generic).</SUBJECT> <SECTNO>721.10606</SECTNO> <SUBJECT>Alkyl substituted alkanediol polymer with aliphatic and alicyclic diisocyanates (generic).</SUBJECT> <SECTNO>721.10607</SECTNO> <SUBJECT>Aliphatic diisocyanate, homopolymer, alkanol-blocked (generic).</SUBJECT> <SECTNO>721.10608</SECTNO> <SUBJECT>Aliphatic diisocyanate polymer with alkanediol and alkylglycol (generic).</SUBJECT> <SECTNO>721.10609</SECTNO> <SUBJECT>Imidodicarbonic diamide, N,N′-dibutyl-N′,2-bis[4-[(4-isocyanatophenyl)methyl]phenyl]-.</SUBJECT> <SECTNO>721.10610</SECTNO> <SUBJECT>Toluene diisocyanate, polymers with polyalkylene glycol (generic).</SUBJECT> <SECTNO>721.10611</SECTNO> <SUBJECT>Benzoic acid, 4-[(1-oxodecyl)oxy]-.</SUBJECT> <SECTNO>721.10618</SECTNO> <SUBJECT>Polyaromatic organophosphorus compound (generic).</SUBJECT> <SECTNO>721.10619</SECTNO> <SUBJECT>Perfluoroalkylethyl methacrylate copolymer (generic).</SUBJECT> <SECTNO>721.10620</SECTNO> <SUBJECT>Oxirane, 2,2′-(phenylene)bis-.</SUBJECT> <SECTNO>721.10621</SECTNO> <SUBJECT>Distillation bottoms, alkylated benzene by-product (generic).</SUBJECT> <SECTNO>721.10622</SECTNO> <SUBJECT>Copper(2 + ), tetraammine-, chloride (1:2).</SUBJECT> <SECTNO>721.10624</SECTNO> <SUBJECT>Dicyclohexylmethane-4,4'-diisocyanate, polymer with ethoxylated, propoxylated polyethers (generic).</SUBJECT> <SECTNO>721.10625</SECTNO> <SUBJECT>Distillation bottoms, alkylated benzene by-product, brominated and bromo diphenyl alkane (generic).</SUBJECT> <SECTNO>721.10626</SECTNO> <SUBJECT>1,4-Butanediol, polymer with substituted alkane and substituted methylene biscarbomonocycle, 2-hydroxyalkyl acrylate-blocked (generic).</SUBJECT> <SECTNO>721.10627</SECTNO> <SUBJECT>Yttrium borate phosphate vanadate with europium and additional dopants (generic).</SUBJECT> <SECTNO>721.10628</SECTNO> <SUBJECT>Mixed metal oxalate (generic).</SUBJECT> <SECTNO>721.10629</SECTNO> <SUBJECT>Fatty acids, tall-oil, reaction products with modified fatty acids and polyalkanolamines (generic).</SUBJECT> <SECTNO>721.10630</SECTNO> <SUBJECT>Amino acid, carboxyalkyl, alkylsulfonate, alkali salt (generic).</SUBJECT> <SECTNO>721.10631</SECTNO> <SUBJECT>Mixed metal borate (generic).</SUBJECT> <SECTNO>721.10632</SECTNO> <SUBJECT>Benzamide, N-[(cyclohexylamino)thioxomethyl]-.</SUBJECT> <SECTNO>721.10633</SECTNO> <SUBJECT>Aromatic sulfonic acid amino azo dye salts (generic).</SUBJECT> <SECTNO>721.10634</SECTNO> <SUBJECT>Iodonium, diphenyl-, 4,4′-di-C10-13-alkyl derivs., (OC-6-11)-hexafluoroantimonates(1-).</SUBJECT> <SECTNO>721.10635</SECTNO> <SUBJECT>Alkyl maleimide substituted bicyclic olefin (generic).</SUBJECT> <SECTNO>721.10636</SECTNO> <SUBJECT>Slimes and sludges, automotive coating, wastewater treatment, solid waste.</SUBJECT> <SECTNO>721.10637</SECTNO> <SUBJECT>Substituted picolinate (generic).</SUBJECT> <SECTNO>721.10638</SECTNO> <SUBJECT>Lithium metal phosphate (generic).</SUBJECT> <SECTNO>721.10639</SECTNO> <SUBJECT>Siloxanes and Silicones, di-Me, polymers with Ph silsesquioxanes, hydrolyzed, reaction products with 2-[[3-(trimethoxysilyl)propoxy]methyl] oxirane.</SUBJECT> <SECTNO>721.10640</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, 1-(2-ethylhexyl) 2-(2-methylpropyl) ester.</SUBJECT> <SECTNO>721.10641</SECTNO> <SUBJECT>Phenol and vinyltoluene based hydrocarbon resin (generic).</SUBJECT> <SECTNO>721.10642</SECTNO> <SUBJECT>Modified polyisocyanates (generic).</SUBJECT> <SECTNO>721.10643</SECTNO> <SUBJECT>Diisocyanate terminated polycarbodiimide (generic).</SUBJECT> <SECTNO>721.10644</SECTNO> <SUBJECT>Reaction product of aluminum hydroxide and modified alkoxysilane (generic).</SUBJECT> <SECTNO>721.10645</SECTNO> <SUBJECT>Multi-walled carbon nanotube (generic) (P-08-0392).</SUBJECT> <SECTNO>721.10646</SECTNO> <SUBJECT>Multi-wall carbon nanotubes (generic) (P-09-257).</SUBJECT> <SECTNO>721.10647</SECTNO> <SUBJECT>Multi-walled carbon nanofibers (generic).</SUBJECT> <SECTNO>721.10648</SECTNO> <SUBJECT>Modified lithium iron phosphates (generic).</SUBJECT> <SECTNO>721.10649</SECTNO> <SUBJECT>MDI modified polyalkylene glycol adipate polyester (generic).</SUBJECT> <SECTNO>721.10651</SECTNO> <SUBJECT>Carbide derived nanocarbon (generic).</SUBJECT> <SECTNO>721.10652</SECTNO> <SUBJECT>Hexanedioic acid, polymer with polyether polyol, 1,1′-methylenebis[4-isocyanatobenzene] and dihydroxydialkyl ether (generic).</SUBJECT> <SECTNO>721.10653</SECTNO> <SUBJECT>Hexanedioic acid, polymer with .alpha.-hydro-.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)],1,1′-methylenebis[4-isocyanatobenzene], dihydroxydialkyl ether and dialkanol ether (generic).</SUBJECT> <SECTNO>721.10654</SECTNO> <SUBJECT>Hexanedioic acid, polymer with .alpha.-hydro-.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)],1,1′-methylenebis[isocyanatobenzene], dihydroxydialkyl ether and dialkanol ether (generic).</SUBJECT> <SECTNO>721.10655</SECTNO> <SUBJECT> Hexanedioic acid, polymer with .alpha.-hydro-.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)],1,1′-methylenebis[4-isocyanatobenzene], dihydroxydialkyl ether, reaction products with dialkylcarbinol (generic). <PRTPAGE P="269"/> </SUBJECT> <SECTNO>721.10656</SECTNO> <SUBJECT>Hexanedioic acid, polymer with .alpha.-hydro-.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)],1,1′-methylenebis[4-isocyanatobenzene], dihydroxydialkyl ether reaction products with dialkylcarbinol (generic).</SUBJECT> <SECTNO>721.10657</SECTNO> <SUBJECT>Castor oil, polymer with hydrogenated vegetable oil, 1,1′-methylenebis[isocyanatobenzene] and isocyanate (generic).</SUBJECT> <SECTNO>721.10658</SECTNO> <SUBJECT>2-Oxepanone, polymer with 1,6-diisocyanatohexane, 2,2-dimethyl-1,3-propanediol and 2,2′-oxybis[ethanol].</SUBJECT> <SECTNO>721.10659</SECTNO> <SUBJECT>Poly(oxy-1,4-butanediyl), -hydro-hydroxy-, polymer with alkyldiisocyanates (generic).</SUBJECT> <SECTNO>721.10660</SECTNO> <SUBJECT>Aliphatic diisocyanate adduct with substituted amino alkyl silane (generic).</SUBJECT> <SECTNO>721.10661</SECTNO> <SUBJECT>Methylenebis[isocyanatobenzene], polymer with alkanedoic acid, alkylene glycols, alkoxylated alkanepolyol and substituted trialkoxysilane (generic).</SUBJECT> <SECTNO>721.10662</SECTNO> <SUBJECT>Acetaldehyde, substituted-, reaction products with 2-butyne-1, 4-diol (generic).</SUBJECT> <SECTNO>721.10663</SECTNO> <SUBJECT>Functionalized multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10664</SECTNO> <SUBJECT>Alkenedioic acid dialkyl ester, reaction products with alkenoic acid alkyl esters and diamine (generic).</SUBJECT> <SECTNO>721.10665</SECTNO> <SUBJECT>2-Propenoic acid, (2-ethyl-2-methyl-1,3-dioxolan-4-yl)methyl ester.</SUBJECT> <SECTNO>721.10666</SECTNO> <SUBJECT>Quaternary ammonium compounds, bis(fattyalkyl) dimethyl, salts with tannins (generic).</SUBJECT> <SECTNO>721.10667</SECTNO> <SUBJECT>Slimes and sludges, aluminum and iron casting, wastewater treatment, solid waste.</SUBJECT> <SECTNO>721.10668</SECTNO> <SUBJECT>Trisodium diethylene triaminepolycarboxylate (generic).</SUBJECT> <SECTNO>721.10669</SECTNO> <SUBJECT>Tertiary amine alkyl ether (generic).</SUBJECT> <SECTNO>721.10670</SECTNO> <SUBJECT>Bromine, manufacture of, by-products from, distillation residues.</SUBJECT> <SECTNO>721.10671</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10672</SECTNO> <SUBJECT>Sodium olefin sulfonate derivative (generic).</SUBJECT> <SECTNO>721.10673</SECTNO> <SUBJECT>Alkanes, C21-34-branched and linear, chloro.</SUBJECT> <SECTNO>721.10674</SECTNO> <SUBJECT>Alkanes, C22-30-branched and linear, chloro.</SUBJECT> <SECTNO>721.10675</SECTNO> <SUBJECT>Alkanes, C24-28, chloro.</SUBJECT> <SECTNO>721.10676</SECTNO> <SUBJECT>Aromatic hydrocarbon mixture (generic).</SUBJECT> <SECTNO>721.10677</SECTNO> <SUBJECT>Alkyl phosphonate (generic).</SUBJECT> <SECTNO>721.10678</SECTNO> <SUBJECT>1,4-Cyclohexanedicarboxylic acid, 1,4-dimethyl ester, hydrogenolysis products.</SUBJECT> <SECTNO>721.10679</SECTNO> <SUBJECT>Carboxylic acid, substituted alkylstannylene ester, reaction products with inorganic acid tetra alkyl ester (generic).</SUBJECT> <SECTNO>721.10680</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10681</SECTNO> <SUBJECT>Alkaneamide, halo-dialkylthienyl-alkoxydialkyl-, manuf. of by-products from (generic).</SUBJECT> <SECTNO>721.10682</SECTNO> <SUBJECT>Fatty acid amide hydrochlorides (generic).</SUBJECT> <SECTNO>721.10683</SECTNO> <SUBJECT>Dialkylamino cocoalkyl alkylamide acid salt (generic).</SUBJECT> <SECTNO>721.10684</SECTNO> <SUBJECT>Substituted benzenamine schiff base (generic).</SUBJECT> <SECTNO>721.10685</SECTNO> <SUBJECT>Phosphoric acid, mixed esters (generic).</SUBJECT> <SECTNO>721.10686</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10687</SECTNO> <SUBJECT>Fatty acid amide hydrochlorides (generic).</SUBJECT> <SECTNO>721.10688</SECTNO> <SUBJECT>Copper, chloro[tris(2-chloroethyl) phosphite-.kappa.P]-.</SUBJECT> <SECTNO>721.10689</SECTNO> <SUBJECT>Organo zinc salts (generic).</SUBJECT> <SECTNO>721.10690</SECTNO> <SUBJECT>Benzenedicarboxylic acid, polymer with substituted alkanediol, dodecanedioic acid, 1,2-ethanediol, alkanedioic acid, alkanediol,.alpha.-hydro-.omega.-hydroxypoly[oxyalkanediyl], 1,3-isobenzofurandione, methylene diphenyl diisocyanate, 2-oxepanone, 2,2'-oxybis[ethanol] and polymethylene polyphenylene isocyanate (generic).</SUBJECT> <SECTNO>721.10691</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>721.10692</SECTNO> <SUBJECT>Fluorinated alkyl dianiline (generic).</SUBJECT> <SECTNO>721.10693</SECTNO> <SUBJECT>Diphenylmethane diisocyanate polymer with alkanoic diacid and alkanediol (generic).</SUBJECT> <SECTNO>721.10695</SECTNO> <SUBJECT>1,2,3-Propanetricarboxamide, N1,N2,N3-tris(2-methylcyclohexyl)-.</SUBJECT> <SECTNO>721.10696</SECTNO> <SUBJECT>Polyfluorinated alkyl thiol (generic).</SUBJECT> <SECTNO>721.10697</SECTNO> <SUBJECT>Polyfluorinated alkyl polyamide (generic).</SUBJECT> <SECTNO>721.10698</SECTNO> <SUBJECT>Polyfluorinated alkyl halide (generic).</SUBJECT> <SECTNO>721.10699</SECTNO> <SUBJECT>Polyfluorinated alkyl thio acrylamide (generic).</SUBJECT> <SECTNO>721.10700</SECTNO> <SUBJECT>Polyfluorinated alkyl thio polyacrylamide (generic).</SUBJECT> <SECTNO>721.10701</SECTNO> <SUBJECT>Polyfluorinated alkyl amine (generic).</SUBJECT> <SECTNO>721.10702</SECTNO> <SUBJECT>Polyfluorinated alkyl thio polyacrylic acid-acrylamide (generic).</SUBJECT> <SECTNO>721.10703</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10704</SECTNO> <SUBJECT>Aryl-substituted alkane.</SUBJECT> <SECTNO>721.10705</SECTNO> <SUBJECT>Aromatic amine with cyclo amino carbonyls (generic).</SUBJECT> <SECTNO>721.10706</SECTNO> <SUBJECT>Infused carbon nanostructures (generic).</SUBJECT> <SECTNO>721.10707</SECTNO> <SUBJECT>Substituted benzyl acrylate (generic).</SUBJECT> <SECTNO>721.10708</SECTNO> <SUBJECT>Zirconium substituted heteropolycyclic (generic).</SUBJECT> <SECTNO>721.10709</SECTNO> <SUBJECT>Alkylphenol (generic).</SUBJECT> <SECTNO>721.10710</SECTNO> <SUBJECT>4, 7-Methano-1H-indene, 3a, 4, 7, 7a-tetrahydro-, polymer with 2-methyl-1, 3-butadiene and 5-(1-methylethenyl)bicyclo[2.2.1]hept-2-ene.</SUBJECT> <SECTNO>721.10711</SECTNO> <SUBJECT> Alkyl substituted catechol (generic). <PRTPAGE P="270"/> </SUBJECT> <SECTNO>721.10712</SECTNO> <SUBJECT>Antimony tris(dialkyldithiocarbamate) (generic).</SUBJECT> <SECTNO>721.10713</SECTNO> <SUBJECT>Antimony tris(dialkyldithiocarbamate) (generic).</SUBJECT> <SECTNO>721.10714</SECTNO> <SUBJECT>Zinc bis(dialkyldithiocarbamate) (generic).</SUBJECT> <SECTNO>721.10715</SECTNO> <SUBJECT>Carbonic acid, dialkyl ester (generic).</SUBJECT> <SECTNO>721.10716</SECTNO> <SUBJECT>Phenol, 2,6-dimethyl-, homopolymer, ether with 2,2′,3,3′,5,5′-hexamethyl[1,1′biphenyl]-4,4′diol (2:1),bis[(ethenylphenyl)methyl] ether.</SUBJECT> <SECTNO>721.10718</SECTNO> <SUBJECT>Substituted picolinic acid (generic).</SUBJECT> <SECTNO>721.10721</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.′-[(1-methylethylidene)di-4,1-phenylene]bis[.omega.-[[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]oxy]-.</SUBJECT> <SECTNO>721.10722</SECTNO> <SUBJECT>Oxirane,2-[(1-propen-1-yloxy)methyl]-.</SUBJECT> <SECTNO>721.10724</SECTNO> <SUBJECT>Oxirane, [[2-(2-ethenyloxy)ethoxy]methyl]-.</SUBJECT> <SECTNO>721.10725</SECTNO> <SUBJECT>Alcohol propoxylate (generic).</SUBJECT> <SECTNO>721.10726</SECTNO> <SUBJECT>Alcohol propoxylate sulfate salt (generic).</SUBJECT> <SECTNO>721.10727</SECTNO> <SUBJECT>Amphoteric fluorinated surfactant (generic).</SUBJECT> <SECTNO>721.10728</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 2-hydroxyethyl esters, telomers with C18-26-alkyl acrylate, 1-dodecanethiol, N-(hydroxymethyl)-2-methyl-2-propenamide, polyfluorooctyl methacrylate, 2,2′-[1,2-diazenediylbis(1-methylethylidene)]bis[4,5-dihydro-1H-imidazole]hydrochloride (1:2)-initiated (generic).</SUBJECT> <SECTNO>721.10729</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, C16-18 esters, telomers with 3-chloro-2-hydroxypropyl methacrylate, 1-dodecanethiol, N-(hydroxymethyl)-2-methyl-2-propenamide, polyfluorooctyl methacrylate, and rel- (1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl methacrylate, 2,2′-[1,2-diazenediylbis(1-methylethylidene)]bis[4,5-dihydro-1H-imidazole]hydrochloride (1:2)-initiated (generic).</SUBJECT> <SECTNO>721.10730</SECTNO> <SUBJECT>Tires, wastes, pyrolyzed, C6-39 oil fraction.</SUBJECT> <SECTNO>721.10731</SECTNO> <SUBJECT>Tires, wastes, pyrolyzed, C7-56 oil fraction.</SUBJECT> <SECTNO>721.10732</SECTNO> <SUBJECT>Neodymium, butadiene iso-Bu neodecanoate complexes.</SUBJECT> <SECTNO>721.10733</SECTNO> <SUBJECT>Tires, wastes, pyrolyzed, C5-15 condensate oil fraction.</SUBJECT> <SECTNO>721.10734</SECTNO> <SUBJECT>Lithium salt of substituted imide (generic).</SUBJECT> <SECTNO>721.10736</SECTNO> <SUBJECT>Alcohols, C9-11-branched, ethoxylated propoxylated.</SUBJECT> <SECTNO>721.10737</SECTNO> <SUBJECT>Carboxylic anhydride, polymer with -hydro—hydroxypoly(oxy-1,2-diethanediyl), compd. with 2,3,4,6,7,8,9,10-octahydropyrimido-[1,2-a]azepine (generic).</SUBJECT> <SECTNO>721.10738</SECTNO> <SUBJECT>Formaldehyde, polymer with 2,3-dimethylphenol, 2,4-dimethylphenol, 2,5-dimethylphenol, 3,5-dimethylphenol, 3-ethylphenol, 4-ethylphenol, 3-methylphenol, 4-methylphenol and phenol.</SUBJECT> <SECTNO>721.10739</SECTNO> <SUBJECT>Caprolactone homopolymer of substituted benzotriazole (generic).</SUBJECT> <SECTNO>721.10740</SECTNO> <SUBJECT>Tin(2 + ) salt of alkylcarboxylic acid (generic).</SUBJECT> <SECTNO>721.10745</SECTNO> <SUBJECT>Alkoxylated quaternary alkyl ammonium fluoroalkylsulfonimide (generic).</SUBJECT> <SECTNO>721.10746</SECTNO> <SUBJECT>Isocyanate terminated urethane polymer (generic).</SUBJECT> <SECTNO>721.10747</SECTNO> <SUBJECT>4-Pyrimidianamine, 2,5 dimethoxy-.</SUBJECT> <SECTNO>721.10748</SECTNO> <SUBJECT>Dicarbomonocycle-substituted carbomonocycledicarboxamide (generic).</SUBJECT> <SECTNO>721.10749</SECTNO> <SUBJECT>Dicarboheterocycle-substituted carbomonocycledicarboxamide (generic).</SUBJECT> <SECTNO>721.10750</SECTNO> <SUBJECT>Tricarbomonocycle-substituted carbomonocycletricarboxamide (generic).</SUBJECT> <SECTNO>721.10751</SECTNO> <SUBJECT>Cycloalkylamino oleyl alkylamide acid salts (generic).</SUBJECT> <SECTNO>721.10752</SECTNO> <SUBJECT>Cycloalkylamino cocoalkyl alkylamide acid salts (generic).</SUBJECT> <SECTNO>721.10753</SECTNO> <SUBJECT>Methanamine, N,N-dimethyl-, reaction products with alkylamine-epichlorohydrin polymer, chlorides (generic).</SUBJECT> <SECTNO>721.10754</SECTNO> <SUBJECT>Mixture of alkylated benzene, brominated (generic) and alkylated benzene, dibrominated (generic).</SUBJECT> <SECTNO>721.10755</SECTNO> <SUBJECT>Single-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10756</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10757</SECTNO> <SUBJECT>Fatty acids, diesters with dihydroxy bicyclic diether (generic).</SUBJECT> <SECTNO>721.10758</SECTNO> <SUBJECT>Thermolized wasted plastic (generic).</SUBJECT> <SECTNO>721.10759</SECTNO> <SUBJECT>Polyphosphoric acids, esters with substituted amines, compounds with alkyl pyridines (generic).</SUBJECT> <SECTNO>721.10760</SECTNO> <SUBJECT>Zinc carboxylate salt (generic).</SUBJECT> <SECTNO>721.10761</SECTNO> <SUBJECT>Fatty acid amide (generic).</SUBJECT> <SECTNO>721.10763</SECTNO> <SUBJECT>Alkanaminium, [substituted carbomonocycle [(alkylamino)carbomonocycle]alkylene]-substituted carbomonocycle, carboxylate salt (generic).</SUBJECT> <SECTNO>721.10764</SECTNO> <SUBJECT>Substituted perfluoroether (generic).</SUBJECT> <SECTNO>721.10766</SECTNO> <SUBJECT>Pyridine, 4-decyl-.</SUBJECT> <SECTNO>721.10767</SECTNO> <SUBJECT>Fluoroether (generic).</SUBJECT> <SECTNO>721.10768</SECTNO> <SUBJECT>N-(2-hydroxyethyl) alkenamide (generic).</SUBJECT> <SECTNO>721.10769</SECTNO> <SUBJECT>1-Octadecanaminium, N,N-dimethyl-N-[3-(triethoxysilyl)propyl]-, chloride (1:1), reaction products with ethylene glycol.</SUBJECT> <SECTNO>721.10770</SECTNO> <SUBJECT>Fluoroalkyl sulfonamide derivatives (generic).</SUBJECT> <SECTNO>721.10771</SECTNO> <SUBJECT> Hexane, 1,6-diisocyanato-, homopolymer, .alpha.-[1-[[[3-[[3-(dimethylamino)propyl] amino]propyl]amino]carbonyl]- 1,2,2,2-tetrafluoroethyl]-.omega.- (1,1,2,2,3,3,3- <PRTPAGE P="271"/> heptafluoropropoxy) poly[oxy[trifluoro(trifluoromethyl)- 1,2-ethanediyl]]-blocked. </SUBJECT> <SECTNO>721.10772</SECTNO> <SUBJECT>Fluorinated oxirane polymer (generic).</SUBJECT> <SECTNO>721.10773</SECTNO> <SUBJECT>Methylene bisacetophenone derivative (generic).</SUBJECT> <SECTNO>721.10774</SECTNO> <SUBJECT>Amine adduct (generic).</SUBJECT> <SECTNO>721.10775</SECTNO> <SUBJECT>Metal hydroxide, treated with alkenyl alkoxy silane (generic).</SUBJECT> <SECTNO>721.10777</SECTNO> <SUBJECT>2,4-Hexadienoic acid, 3-(trimethoxysilyl)propyl ester.</SUBJECT> <SECTNO>721.10778</SECTNO> <SUBJECT>2,4,Hexadienoic acid, 3-(trimethoxysilyl)propyl ester (2E,4E)-.</SUBJECT> <SECTNO>721.10779</SECTNO> <SUBJECT>Substituted alkene, reaction products with isophoronediamine (generic).</SUBJECT> <SECTNO>721.10780</SECTNO> <SUBJECT>Propaneperoxoic acid, 2,2-dimethyl-, 1,1,3,3-tetramethylbutyl ester.</SUBJECT> <SECTNO>721.10781</SECTNO> <SUBJECT>Fatty acid amide hydrochlorides (generic).</SUBJECT> <SECTNO>721.10782</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10783</SECTNO> <SUBJECT>Fatty acid amide acetates (generic).</SUBJECT> <SECTNO>721.10784</SECTNO> <SUBJECT>Mixed butyltin mercaptoester sulfides (generic).</SUBJECT> <SECTNO>721.10785</SECTNO> <SUBJECT>Mixed methyltin mercaptoester sulfides (generic).</SUBJECT> <SECTNO>721.10786</SECTNO> <SUBJECT>Trisubsituted ethoxylated carbomonocycle (generic).</SUBJECT> <SECTNO>721.10787</SECTNO> <SUBJECT>Multi-functional novolac type epoxy resin (generic).</SUBJECT> <SECTNO>721.10788</SECTNO> <SUBJECT>Alkanedioic acids, polymer with substituted propanediol, alkanediols, and polyethylene glycol and MDI (generic).</SUBJECT> <SECTNO>721.10793</SECTNO> <SUBJECT>Phosphoric acid, iron (2 + ) lithium salt (1:1:1).</SUBJECT> <SECTNO>721.10794</SECTNO> <SUBJECT>Alkenyl succinate, amine salts (generic).</SUBJECT> <SECTNO>721.10795</SECTNO> <SUBJECT>Amine salt of vegetable oil, polymer with cycloaliphatic glycol, hydroxy substituted carboxylic acid, aliphatic diisocyanate and tetra hydroxy alkane (generic).</SUBJECT> <SECTNO>721.10796</SECTNO> <SUBJECT>Polymer of terephthalic acid and ethyl benzene with multi-walled carbon nanotube (generic).</SUBJECT> <SECTNO>721.10797</SECTNO> <SUBJECT>Polycarbamoylsulfonic acid sodium salt (generic).</SUBJECT> <SECTNO>721.10798</SECTNO> <SUBJECT>Phosphonic acid chloride, diester (generic).</SUBJECT> <SECTNO>721.10799</SECTNO> <SUBJECT>Substituted dimethyl phenols (generic).</SUBJECT> <SECTNO>721.10800</SECTNO> <SUBJECT>2-Propenoic acid, 4-phenoxybutyl ester.</SUBJECT> <SECTNO>721.10801</SECTNO> <SUBJECT>Organic phosphonate salt (generic).</SUBJECT> <SECTNO>721.10802</SECTNO> <SUBJECT>Quaternized protein/silicone copolymer (generic).</SUBJECT> <SECTNO>721.10803</SECTNO> <SUBJECT>1,5-Pentanediamine.</SUBJECT> <SECTNO>721.10804</SECTNO> <SUBJECT>Cashew-nutshell-liquid, polymer with formaldehyde, reaction products with diethanolamine and diisopropanol amine.</SUBJECT> <SECTNO>721.10805</SECTNO> <SUBJECT>Fatty acid imidazolines (generic).</SUBJECT> <SECTNO>721.10806</SECTNO> <SUBJECT>Trimellitic anhydride, polymer with alkanolamine and tetrahydrophthalic anhydride (generic).</SUBJECT> <SECTNO>721.10807</SECTNO> <SUBJECT>Aliphatic ether ethyl alcohol (generic).</SUBJECT> <SECTNO>721.10808</SECTNO> <SUBJECT>Bisxylenol diglycidyl ether polymer (generic).</SUBJECT> <SECTNO>721.10809</SECTNO> <SUBJECT>Cyclotetrasiloxane, 2,4,6,8-tetrakis[3-[2-(2-methoxyethoxy)ethoxy]propyl]-2,4,6,8-tetramethyl-.</SUBJECT> <SECTNO>721.10810</SECTNO> <SUBJECT>Heterocyclic amine potassium salt (generic).</SUBJECT> <SECTNO>721.10811</SECTNO> <SUBJECT>Heterocyclic amine substituted acrylamide (generic).</SUBJECT> <SECTNO>721.10812</SECTNO> <SUBJECT>Alkylbenzene sulfonic acid (generic).</SUBJECT> <SECTNO>721.10813</SECTNO> <SUBJECT>Benzenesulfonic acid, dimethyl-, alkyl derivatives, sodium salt (generic).</SUBJECT> <SECTNO>721.10814</SECTNO> <SUBJECT>2-Propenoic acid, 3-phenyl-, zinc salt (2:1), (2E)-.</SUBJECT> <SECTNO>721.10815</SECTNO> <SUBJECT>Fatty acids, satd. and unsatd alkyl-, esters with polyol (generic).</SUBJECT> <SECTNO>721.10816</SECTNO> <SUBJECT>Fluoroalkyl acrylate copolymer modified with polysiloxanes (generic).</SUBJECT> <SECTNO>721.10817</SECTNO> <SUBJECT>Fluoroalkyl acrylate copolymer (generic).</SUBJECT> <SECTNO>721.10818</SECTNO> <SUBJECT>Fluoroalkyl methacrylate copolymer (generic).</SUBJECT> <SECTNO>721.10819</SECTNO> <SUBJECT>Zinc carboxylate (generic).</SUBJECT> <SECTNO>721.10820</SECTNO> <SUBJECT>Phenol, styrenated, reaction products with polyethylene glycol and 2-[(2-propen-1-yloxy)methyl]oxirane.</SUBJECT> <SECTNO>721.10821</SECTNO> <SUBJECT>Quaternary ammonium compounds, tri-C8-10-alkylmethyl, hydrogen sulfates (generic).</SUBJECT> <SECTNO>721.10822</SECTNO> <SUBJECT>1,2,3-Propanetriol, homopolymer, dodecanoate.</SUBJECT> <SECTNO>721.10823</SECTNO> <SUBJECT>2-Propenal, 3-[4-(1-methylethyl)phenyl]-.</SUBJECT> <SECTNO>721.10824</SECTNO> <SUBJECT>Brominated filtration residue (generic).</SUBJECT> <SECTNO>721.10825</SECTNO> <SUBJECT>Fatty acids reaction products with polyethylenepolyamine and naphthenic acids (generic).</SUBJECT> <SECTNO>721.10826</SECTNO> <SUBJECT>Substituted aminoalkyl nitrile (generic).</SUBJECT> <SECTNO>721.10827</SECTNO> <SUBJECT>Cyclooctadiene metal derivatives (generic).</SUBJECT> <SECTNO>721.10828</SECTNO> <SUBJECT>1,2,3-Propanetriol, homopolymer, alkanoates (generic) and Glycerides, alkanoate, mono-, di- and tri- (generic).</SUBJECT> <SECTNO>721.10829</SECTNO> <SUBJECT>Xanthylium, x-[2-(alcoxycarbonyl)phenyl]- bis(alkylamino)-dimethyl-, x′-[x″ -[hydroxy-x″′-[[[[hydroxy-x′′′′-(phenyldiazenyl)-sulfo-2- naphthalenyl]amino]carbonyl] amino]sulfo-naphthalenyl] diazenyl]benzoate, sodium salt (generic).</SUBJECT> <SECTNO>721.10830</SECTNO> <SUBJECT>2-Butene, 1,1,1,4,4,4-hexafluoro-, (2Z)-.</SUBJECT> <SECTNO>721.10831</SECTNO> <SUBJECT>Aluminum phosphate (generic).</SUBJECT> <SECTNO>721.10832</SECTNO> <SUBJECT>Alkyl triazine (generic).</SUBJECT> <SECTNO>721.10833</SECTNO> <SUBJECT>Substituted bis 2,6-xylenol (generic).</SUBJECT> <SECTNO>721.10834</SECTNO> <SUBJECT>Heteropolycyclic diacrylate (generic).</SUBJECT> <SECTNO>721.10835</SECTNO> <SUBJECT> 1,6-Hexanediamine, N1-(6-aminohexyl)-, polymer with 2- <PRTPAGE P="272"/> (chloromethyl)oxirane, <E T="03">N</E> -(dithiocarboxy) derivs., sodium salts. </SUBJECT> <SECTNO>721.10836</SECTNO> <SUBJECT>Dimethylaminoalkyl alkene amide (generic).</SUBJECT> <SECTNO>721.10837</SECTNO> <SUBJECT>Substituted naphthalene polymer glycidyl ether (generic).</SUBJECT> <SECTNO>721.10838</SECTNO> <SUBJECT>Alkylpolycarboxylic acid, derivative, tris(fluorinatedalkoxy)alkyl ester salt (generic).</SUBJECT> <SECTNO>721.10839</SECTNO> <SUBJECT> Tricyclo[3.3.1.13,7]decan-1-amine, <E T="03">N,N</E> -dimethyl-. </SUBJECT> <SECTNO>721.10840</SECTNO> <SUBJECT>Sulfosuccinic acid ester, alkylamine derivs., sodium salt (generic).</SUBJECT> <SECTNO>721.10841</SECTNO> <SUBJECT> Bismuth nitrate oxide (Bi <E T="0732">3</E> (NO <E T="0732">3</E> )O <E T="0732">4</E> ). </SUBJECT> <SECTNO>721.10843</SECTNO> <SUBJECT>Substituted amide aromatic carboxylic acid, metal salt (generic).</SUBJECT> <SECTNO>721.10844</SECTNO> <SUBJECT>Graphene nanoplatelets having a predominant thickness of 1-10 layers with lateral dimension predominantly less than 2 microns.</SUBJECT> <SECTNO>721.10845</SECTNO> <SUBJECT> Methanaminium, <E T="03">N</E> -[4-[[4-(dimethylamino)phenyl] phenylmethylene]-2,5-cyclohexadien-1- ylidene]- <E T="03">N</E> -methyl-, ethanedioate, ethanedioate (2:2:1). </SUBJECT> <SECTNO>721.10846</SECTNO> <SUBJECT>Sulfurized hydrocarbon (generic).</SUBJECT> <SECTNO>721.10847</SECTNO> <SUBJECT> Oxiranemethanaminium, <E T="03">N,N,N</E> -trimethyl-, bromide. </SUBJECT> <SECTNO>721.10848</SECTNO> <SUBJECT>Aryloxyalkyl amine (generic).</SUBJECT> <SECTNO>721.10849</SECTNO> <SUBJECT>Phenol-biphenyl-formaldehyde polycondensate (generic).</SUBJECT> <SECTNO>721.10850</SECTNO> <SUBJECT>Polymer of phenol, biphenyl and resorcinol (generic).</SUBJECT> <SECTNO>721.10851</SECTNO> <SUBJECT>Trichloroethylene.</SUBJECT> <SECTNO>721.10852</SECTNO> <SUBJECT>Fatty acids compound with cyclohexanamine (generic).</SUBJECT> <SECTNO>721.10853</SECTNO> <SUBJECT>Fluoro-modified acrylic copolymer (generic).</SUBJECT> <SECTNO>721.10854</SECTNO> <SUBJECT>Siloxanes and Silicones, alkyl, alky propoxy ethyl, methyl octyl, alkyl polyfluorooctyl (generic).</SUBJECT> <SECTNO>721.10855</SECTNO> <SUBJECT> Partially fluorinated alcohol, reaction products with phosphorus oxide (P <E T="9145">2</E> O <E T="9145">5</E> ) amine salts (generic). </SUBJECT> <SECTNO>721.10856</SECTNO> <SUBJECT>Fatty acids amine salt (generic).</SUBJECT> <SECTNO>721.10857</SECTNO> <SUBJECT>Organophosphorus polymer (generic).</SUBJECT> <SECTNO>721.10858</SECTNO> <SUBJECT>Fluorinated acid alkylester (generic).</SUBJECT> <SECTNO>721.10859</SECTNO> <SUBJECT>Quaternary alkyl methyl amine ethoxylate methyl chloride (generic).</SUBJECT> <SECTNO>721.10860</SECTNO> <SUBJECT>Substituted carboxamide (generic).</SUBJECT> <SECTNO>721.10861</SECTNO> <SUBJECT>Phosphoric acid, sodium titanium (4+) salt (3:1:2).</SUBJECT> <SECTNO>721.10862</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, monohexadecyl ether, phosphate; Oxirane, 2-methyl-, polymer with oxirane, monohexadecyl ether, phosphate, sodium salt; Oxirane, 2-methyl-, polymer with oxirane, monohexadecyl ether, phosphate, potassium salt; Oxirane, 2-methyl-, polymer with oxirane, monohexadecyl ether, phosphate, ammonium salt; Ethanol, 2-amino-, compd. with 2-methyloxirane polymer with oxirane monohexadecyl ether phosphate; and Ethanol, 2,2′2″,-nitrilotris-, compd. with 2-methyloxirane polymer with oxirane monohexadecyl ether phosphate.</SUBJECT> <SECTNO>721.10863</SECTNO> <SUBJECT>Nitrile amine (generic).</SUBJECT> <SECTNO>721.10864</SECTNO> <SUBJECT>1,3-propanediamine, N1, N1-alkyl (generic).</SUBJECT> <SECTNO>721.10865</SECTNO> <SUBJECT>2-Pyridinecarboxylic acid, 4,5,6-trichloro-.</SUBJECT> <SECTNO>721.10866</SECTNO> <SUBJECT>Imidazoliurn, polymer with cyclic anhydride and alkenoic acid, alkali salt (generic).</SUBJECT> <SECTNO>721.10867</SECTNO> <SUBJECT>Hydrochlorofluorocarbon (generic).</SUBJECT> <SECTNO>721.10868</SECTNO> <SUBJECT>Alkylalkenoic acid copolymer (generic).</SUBJECT> <SECTNO>721.10869</SECTNO> <SUBJECT>D-Glucitol, alkylamino-N-acyl derivs. (generic).</SUBJECT> <SECTNO>721.10870</SECTNO> <SUBJECT>Cyclohexanedicarboxylic acid, dialkyl ester (generic).</SUBJECT> <SECTNO>721.10872</SECTNO> <SUBJECT>Heteropolycyclic, polymer with alkanedioic acid, di-alkenoate (generic).</SUBJECT> <SECTNO>721.10875</SECTNO> <SUBJECT>Alkali transition metal oxide (generic).</SUBJECT> <SECTNO>721.10876</SECTNO> <SUBJECT>Perfluoroalkyl substituted alkyl sulfonate (generic).</SUBJECT> <SECTNO>721.10877</SECTNO> <SUBJECT>Polyfluorinated alkyl quaternary ammonium chloride (generic).</SUBJECT> <SECTNO>721.10878</SECTNO> <SUBJECT>Polyfluorinatedalkylsulfonyl substituted alkane derivative (generic).</SUBJECT> <SECTNO>721.10879</SECTNO> <SUBJECT> 1-Octadecanaminium, <E T="03">N</E> -(3-chloro-2-hydroxypropyl)- <E T="03">N,N</E> -dimethyl-, chloride (1:1). </SUBJECT> <SECTNO>721.10880</SECTNO> <SUBJECT>Fatty acid rxn products with aminoalkylamines (generic).</SUBJECT> <SECTNO>721.10881</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10882</SECTNO> <SUBJECT>Trialkylammonium borodibenzoate (generic).</SUBJECT> <SECTNO>721.10883</SECTNO> <SUBJECT>Fatty ester derivatives, reaction products with alkanolamine, hydroxylated, borated (generic).</SUBJECT> <SECTNO>721.10884</SECTNO> <SUBJECT>Benzenepropanol, 1-benzoate.</SUBJECT> <SECTNO>721.10885</SECTNO> <SUBJECT> Alcohols, C <E T="52">12-22</E> , distn. residues. </SUBJECT> <SECTNO>721.10886</SECTNO> <SUBJECT>Phosphoric acid, mixed Bu and decyl and octyl and 2-(2-phenoxyethoxy)ethyl and 2-phenoxyethyl esters.</SUBJECT> <SECTNO>721.10887</SECTNO> <SUBJECT>Phosphoric acid, mixed Bu and decyl and octyl and 2-(2-phenoxyethoxy)ethyl and 2-phenoxyethyl esters, potassium salts.</SUBJECT> <SECTNO>721.10888</SECTNO> <SUBJECT>Siloxanes and Silicones, 3-[(2-aminoethyl)amino)propyl Me, di-Me, reaction products with cadmium zinc selenide sulfide, lauric acid and oleylamine.</SUBJECT> <SECTNO>721.10889</SECTNO> <SUBJECT>Dodecanoic acid, reaction products with cadmium zinc selenide sulfide and oleylamine.</SUBJECT> <SECTNO>721.10890</SECTNO> <SUBJECT>Phosphonic acid, P-tetradecyl-, reaction products with cadmium selenide (CdSe).</SUBJECT> <SECTNO>721.10891</SECTNO> <SUBJECT>Alkyl silicate, polymer with 2-(chloromethyl)oxirane and 4,4′-(1-methylethylidene)bis[phenol], alkoxylated (generic).</SUBJECT> <SECTNO>721.10892</SECTNO> <SUBJECT> Reaction product of a mixture of aromatic dianhydrides and aliphatic <PRTPAGE P="273"/> esters with an aromatic diamine (generic). </SUBJECT> <SECTNO>721.10893</SECTNO> <SUBJECT>Fatty acids, tall-oil, reaction products with an ether and triethylenetetramine (generic).</SUBJECT> <SECTNO>721.10894</SECTNO> <SUBJECT>Substituted benzyl acrylate (generic).</SUBJECT> <SECTNO>721.10895</SECTNO> <SUBJECT>Fluoroalkyl acrylate copolymer (generic).</SUBJECT> <SECTNO>721.10896</SECTNO> <SUBJECT>1-Hexanol, 6-mercapto-.</SUBJECT> <SECTNO>721.10897</SECTNO> <SUBJECT>Phenol, 2,2′-[1,2-disubstituted-1,2-ethanediyl] bis(iminomethylene)bis[substituted- (generic).</SUBJECT> <SECTNO>721.10898</SECTNO> <SUBJECT>Carbomonocycles, polymer with substituted heteromonocycle, succinate, methyl acrylate (generic).</SUBJECT> <SECTNO>721.10899</SECTNO> <SUBJECT>Halogenated alkyl trimethylaminium halide (generic).</SUBJECT> <SECTNO>721.10900</SECTNO> <SUBJECT>Titanium salt, reaction products with silica (generic).</SUBJECT> <SECTNO>721.10901</SECTNO> <SUBJECT>Formaldehyde, reaction products with aniline and aromatic mono- and di-phenol mixture (generic).</SUBJECT> <SECTNO>721.10903</SECTNO> <SUBJECT>Acrylated mixed metal oxides (generic).</SUBJECT> <SECTNO>721.10904</SECTNO> <SUBJECT>Phenol, 1,1-dimethylalkyl derivatives (generic).</SUBJECT> <SECTNO>721.10905</SECTNO> <SUBJECT>Butanedioic acid, 2-methylene-, dialkyl ester (generic).</SUBJECT> <SECTNO>721.10906</SECTNO> <SUBJECT>Magnesium alkaryl sulfonate (generic).</SUBJECT> <SECTNO>721.10907</SECTNO> <SUBJECT>Polyfluorohydrocarbon (generic).</SUBJECT> <SECTNO>721.10908</SECTNO> <SUBJECT>Aluminum calcium oxide salt (generic).</SUBJECT> <SECTNO>721.10909</SECTNO> <SUBJECT>Polyalkyltrisiloxane (generic).</SUBJECT> <SECTNO>721.10910</SECTNO> <SUBJECT>Oxirane, 2,2′-[[1-[4-[1-methyl-1-[4-(2-oxiranylmethoxy)phenyl] ethyl]phenyl]ethylidene]bis(4,1- phenyleneoxymethylene)]bis- (P-15-356, Chemical A).</SUBJECT> <SECTNO>721.10911</SECTNO> <SUBJECT>2-Propanol, 1,3-bis[4-[1-[4-[1-methyl-1-[4-(2-oxiranylmethoxy) phenyl]ethyl]phenyl]-1-[4-(2-oxiranylmethoxy) phenyl]ethyl]phenoxy]- (P-15-356, Chemical B).</SUBJECT> <SECTNO>721.10912</SECTNO> <SUBJECT>Aliphatic acrylate (generic).</SUBJECT> <SECTNO>721.10914</SECTNO> <SUBJECT>Polyitaconic acid, sodium zinc salt (generic).</SUBJECT> <SECTNO>721.10915</SECTNO> <SUBJECT>Fatty acid esters with polyols polyalkyl ethers (generic).</SUBJECT> <SECTNO>721.10916</SECTNO> <SUBJECT>2,7-Naphthalenedisulfonic acid, 4-amino-3-[substituted]-5-hydroxy-6-[(1E)-2-phenyldiazenyl]-, lithium salt (1:3) (generic).</SUBJECT> <SECTNO>721.10917</SECTNO> <SUBJECT>Polymethylsiloxane, distillation residues (generic).</SUBJECT> <SECTNO>721.10918</SECTNO> <SUBJECT>Perfluorobutanesulfonamide and polyoxyalkylene containing polyurethane (generic).</SUBJECT> <SECTNO>721.10919</SECTNO> <SUBJECT>Quaternary ammonium compounds, (3-chloro-2-hydroxypropyl)coco alkyldimethyl, chlorides.</SUBJECT> <SECTNO>721.10921</SECTNO> <SUBJECT>2-Furancarboxyaldehyde, 5-(chloromethyl)-.</SUBJECT> <SECTNO>721.10922</SECTNO> <SUBJECT>1,2,4,5,7,8-Hexoxonane, 3,6,9-trimethyl-, 3,6,9-tris(alkyl) derivs. (generic).</SUBJECT> <SECTNO>721.10923</SECTNO> <SUBJECT>9-Octadecen-1-amine, hydrochloride (1:1), (9Z)-.</SUBJECT> <SECTNO>721.10924</SECTNO> <SUBJECT>Vegetable fatty acid alkyl esters (generic).</SUBJECT> <SECTNO>721.10927</SECTNO> <SUBJECT>Bimodal mixture consisting of multi-walled carbon nanotubes and other classes of carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10928</SECTNO> <SUBJECT>Coke (coal), secondary pitch; a carbon-containing residue from the coking of air blown pitch coke oil and/or pitch distillate; composed primarily of isotropic carbon, it contains small amounts of sulfur and ash constituents.</SUBJECT> <SECTNO>721.10929</SECTNO> <SUBJECT>Single-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10930</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10931</SECTNO> <SUBJECT>Kaolin, reaction products with polysiloxane (generic).</SUBJECT> <SECTNO>721.10932</SECTNO> <SUBJECT>Fatty acid amides (generic).</SUBJECT> <SECTNO>721.10933</SECTNO> <SUBJECT>Copolymers of perfluorinated and alkyl methacrylates (generic).</SUBJECT> <SECTNO>721.10934</SECTNO> <SUBJECT>Alkenoic acid, polymer with alkyl alkenoate, alkylalkylalkenoate, alkenoic acid and tridecafluoro alkylalkenoate, compds. with alkylaminoalcanol (generic).</SUBJECT> <SECTNO>721.10935</SECTNO> <SUBJECT>Titanium oxide compound (generic).</SUBJECT> <SECTNO>721.10936</SECTNO> <SUBJECT>Fatty acid amide hydrochlorides (generic).</SUBJECT> <SECTNO>721.10937</SECTNO> <SUBJECT>Plastics, wastes, pyrolyzed, bulk pyrolysate (generic).</SUBJECT> <SECTNO>721.10938</SECTNO> <SUBJECT>Plastics, wastes, pyrolyzed, light distillate (generic).</SUBJECT> <SECTNO>721.10939</SECTNO> <SUBJECT>Plastics, wastes, pyrolyzed, middle distillate (generic).</SUBJECT> <SECTNO>721.10940</SECTNO> <SUBJECT>Plastics, wastes, pyrolyzed, heavy distillate (generic).</SUBJECT> <SECTNO>721.10941</SECTNO> <SUBJECT>Carbon silicon oxide.</SUBJECT> <SECTNO>721.10943</SECTNO> <SUBJECT>Sulfonated alkylbenzene salts (generic).</SUBJECT> <SECTNO>721.10944</SECTNO> <SUBJECT>Substituted quinoline derivative (generic).</SUBJECT> <SECTNO>721.10945</SECTNO> <SUBJECT>Algal oil amide (generic).</SUBJECT> <SECTNO>721.10946</SECTNO> <SUBJECT>Bismuth compound (generic).</SUBJECT> <SECTNO>721.10947</SECTNO> <SUBJECT>Sulfur thulium ytterbium yttrium oxide.</SUBJECT> <SECTNO>721.10948</SECTNO> <SUBJECT>Gadolinium sulfur ytterbium yttrium oxide, erbium- and thulium-doped.</SUBJECT> <SECTNO>721.10949</SECTNO> <SUBJECT>Neodymium sulfur yttrium oxide.</SUBJECT> <SECTNO>721.10950</SECTNO> <SUBJECT>Erbium gadolinium neodymium sulfur ytterbium yttrium oxide (P-15-615).</SUBJECT> <SECTNO>721.10951</SECTNO> <SUBJECT>Erbium gadolinium sulfur ytterbium yttrium oxide.</SUBJECT> <SECTNO>721.10952</SECTNO> <SUBJECT>Erbium gadolinium ytterbium oxide.</SUBJECT> <SECTNO>721.10953</SECTNO> <SUBJECT>Erbium gadolinium sulfur ytterbium oxide.</SUBJECT> <SECTNO>721.10954</SECTNO> <SUBJECT> 2-Ethylhexanoic acid, compound with alkyamino cyclohexane (generic); and 2-Ethylhexanoic acid, compound with cyclohexylamine (generic). <PRTPAGE P="274"/> </SUBJECT> <SECTNO>721.10955</SECTNO> <SUBJECT>Propenoic acid, alkyl ester, polymer with 1,3-cyclohexanedialkylamine, reaction products with oxirane(alkoxyalkyl) (generic).</SUBJECT> <SECTNO>721.10956</SECTNO> <SUBJECT>Acrylic acid, polymer with polyalkylene polyamine (generic).</SUBJECT> <SECTNO>721.10957</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, 1-(2-phenylhydrazide).</SUBJECT> <SECTNO>721.10958</SECTNO> <SUBJECT>Dialkylol amine, polymer with succinic anhydride and aromatic carboxylic acid (generic).</SUBJECT> <SECTNO>721.10959</SECTNO> <SUBJECT>Dialkyl fattyalkylamino propanamide alkylamine acetates (generic).</SUBJECT> <SECTNO>721.10960</SECTNO> <SUBJECT>Dialkylaminopropylaminopropanoate ester (generic).</SUBJECT> <SECTNO>721.10961</SECTNO> <SUBJECT>Ethylene glycol ester of an aromatic substituted propenoic acid (generic).</SUBJECT> <SECTNO>721.10962</SECTNO> <SUBJECT>Phosphoric acid, metal salt (generic).</SUBJECT> <SECTNO>721.10963</SECTNO> <SUBJECT>Alkanoic acid, tetramethylheteromonocycle ester (generic).</SUBJECT> <SECTNO>721.10964</SECTNO> <SUBJECT>Polyether polyester urethane phosphate (generic).</SUBJECT> <SECTNO>721.10965</SECTNO> <SUBJECT>Propanamide, 2-hydroxy-N,N-dimethyl-.</SUBJECT> <SECTNO>721.10966</SECTNO> <SUBJECT>1-Propene, 2-bromo-3,3,3-trifluoro-.</SUBJECT> <SECTNO>721.10967</SECTNO> <SUBJECT>Pyrolysis oil product (generic).</SUBJECT> <SECTNO>721.10968</SECTNO> <SUBJECT>1-Octanamine, 7 (or 8)-(aminomethyl)-.</SUBJECT> <SECTNO>721.10969</SECTNO> <SUBJECT>Substituted alkanolamine ether (generic).</SUBJECT> <SECTNO>721.10970</SECTNO> <SUBJECT>Butanedioic acid, alkyl amine, dimethylbutyl ester (generic).</SUBJECT> <SECTNO>721.10971</SECTNO> <SUBJECT>Carbon nanotube (generic).</SUBJECT> <SECTNO>721.10972</SECTNO> <SUBJECT>Metal salt of mineral acid, reaction products with alumina, aluminum hydroxide, aluminum hydroxide oxide (Al(OH)O), silica, titanium oxide (TiO2) and 3-(triethoxysilyl)-1-propanamine (generic).</SUBJECT> <SECTNO>721.10973</SECTNO> <SUBJECT>Halogenated bisphenol A, polymer with epichlorohydrin, alkenoate (generic).</SUBJECT> <SECTNO>721.10974</SECTNO> <SUBJECT>Halogenated bisphenol A, polymer with bisphenol A diglycidyl ether and epoxidized phenol-formaldehyde resin, alkenoate (generic).</SUBJECT> <SECTNO>721.10975</SECTNO> <SUBJECT>Silicon, tris[dialkyl phenyl]-dialkyl-dioxoalkane-naphthalene disulfonate (generic).</SUBJECT> <SECTNO>721.10976</SECTNO> <SUBJECT>Tar acids fraction (generic).</SUBJECT> <SECTNO>721.10977</SECTNO> <SUBJECT>Dialkyl fattyalkylamino propanamide alkylamine (generic).</SUBJECT> <SECTNO>721.10978</SECTNO> <SUBJECT>Fattyalkylaminopropanoate ester (generic).</SUBJECT> <SECTNO>721.10979</SECTNO> <SUBJECT>Boron sodium oxide (B5NaO8), labeled with boron-10.</SUBJECT> <SECTNO>721.10980</SECTNO> <SUBJECT>Perfluoropolyether modified organosilane (generic).</SUBJECT> <SECTNO>721.10981</SECTNO> <SUBJECT>Modified phenol-formaldehyde resin (generic).</SUBJECT> <SECTNO>721.10982</SECTNO> <SUBJECT>Disubstituted benzene alkanal (generic).</SUBJECT> <SECTNO>721.10983</SECTNO> <SUBJECT>Phthalic anhydride, polymer with alkylene glycol and alkanepolyol, acrylate (generic).</SUBJECT> <SECTNO>721.10984</SECTNO> <SUBJECT>2-Pyridinecarboxylic acid, 4,5-dichloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-.</SUBJECT> <SECTNO>721.10985</SECTNO> <SUBJECT>Dialkylamino alkylamide inner salt (generic).</SUBJECT> <SECTNO>721.10986</SECTNO> <SUBJECT>Nanocarbon (generic).</SUBJECT> <SECTNO>721.10987</SECTNO> <SUBJECT>Barium molybdenum niobium tantalum tellurium vanadium zinc oxide.</SUBJECT> <SECTNO>721.10988</SECTNO> <SUBJECT>Alkanoic acids, esters with alkanetriol (generic).</SUBJECT> <SECTNO>721.10989</SECTNO> <SUBJECT>Manganese, tris[.mu.-(2-ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical A).</SUBJECT> <SECTNO>721.10990</SECTNO> <SUBJECT>Manganese, [.mu.-(acetato-.kappa.O:.kappa.O')]bis[.mu.-(2-ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical B).</SUBJECT> <SECTNO>721.10991</SECTNO> <SUBJECT>Manganese, bis[.mu.-(acetato-.kappa.O:.kappa.O')][.mu.-(2-ethylhexanoato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical C).</SUBJECT> <SECTNO>721.10992</SECTNO> <SUBJECT>Manganese, tris[.mu.-(acetato-.kappa.O:.kappa.O')]bis(octahydro-1,4,7-trimethyl-1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7)di- (P-16-182, chemical D).</SUBJECT> <SECTNO>721.10993</SECTNO> <SUBJECT>Aryl polyolefin (generic).</SUBJECT> <SECTNO>721.10994</SECTNO> <SUBJECT>Melamine nitrate (generic).</SUBJECT> <SECTNO>721.10995</SECTNO> <SUBJECT>Lecithins, soya, hydrogenated.</SUBJECT> <SECTNO>721.10996</SECTNO> <SUBJECT>1,2,4-Benzenetricarboxylic acid, mixed decyl and octyl triesters.</SUBJECT> <SECTNO>721.10997</SECTNO> <SUBJECT>Multiwalled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.10998</SECTNO> <SUBJECT>Propanoic acid, iron (2+) salt (2:1).</SUBJECT> <SECTNO>721.10999</SECTNO> <SUBJECT>1-Butanaminium, N,N,N-tributyl-, carbonic acid (1:1).</SUBJECT> <SECTNO>721.11000</SECTNO> <SUBJECT>1-Butanaminium, N,N,N-tributyl-, methyl carbonate (1:1).</SUBJECT> <SECTNO>721.11001</SECTNO> <SUBJECT>1-Butanaminium, N,N,N-tributyl-, ethyl carbonate (1:1).</SUBJECT> <SECTNO>721.11002</SECTNO> <SUBJECT>1-Butanaminium, N,N,N-tributyl-, propyl carbonate (1:1).</SUBJECT> <SECTNO>721.11003</SECTNO> <SUBJECT>1-Butanaminium, N,N,N-tributyl-, and 1-methylethyl carbonate.</SUBJECT> <SECTNO>721.11004</SECTNO> <SUBJECT>Anilino substituted bis-triazinyl derivative of 4,4′-diaminostilbene-2,2′-disulfonic acid, mixed amine sodium salt (generic).</SUBJECT> <SECTNO>721.11005</SECTNO> <SUBJECT>12-Hydroxystearic acid, reaction products with alkylene diamine and alkanoic acid (generic).</SUBJECT> <SECTNO>721.11006</SECTNO> <SUBJECT> Alkyldiene, polymer, hydroxy terminated alkoxysilylalkylcarbamate. <PRTPAGE P="275"/> </SUBJECT> <SECTNO>721.11007</SECTNO> <SUBJECT>Alkylaldehyde, reaction products with substituted carbomonocycle-substituted heteromonocycle-alkylene glycol bis[[[[substituted(oxoneoalkyl)oxy]alkyl] amino]alkyl] ether polymer and alkyl substituted alkanediamine, acetate salts (generic).</SUBJECT> <SECTNO>721.11008</SECTNO> <SUBJECT>Hydroxy functional triglyceride polymer with glycerol mono-ester and 1,1′-methylenebis[4-isocyanatobenzene] (generic).</SUBJECT> <SECTNO>721.11009</SECTNO> <SUBJECT>Hydroxy functional triglyceride polymer with glycerol mono-ester and 1,1′-methylenebis[isocyanatobenzene] (generic).</SUBJECT> <SECTNO>721.11010</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl),.alpha.-(1-oxodocosyl)-.omega.-[(1-oxodocosyl)oxy]-.</SUBJECT> <SECTNO>721.11011</SECTNO> <SUBJECT>Pulp, cellulose, reaction products with lignin.</SUBJECT> <SECTNO>721.11012</SECTNO> <SUBJECT>Alkyl carbonate, polymer with, substituted alkanes and substituted heteromonocycle, substituted alkyl acrylate-blocked (generic).</SUBJECT> <SECTNO>721.11013</SECTNO> <SUBJECT>Substituted heteromonocycle, polymer with substituted alkane and ethoxylated alkane, substituted heteromonocycle substituted alkyl ester-blocked (generic).</SUBJECT> <SECTNO>721.11014</SECTNO> <SUBJECT>Substituted heteromonocycle, telomer with substituted carbomonocycles, substituted alkyl ester (generic).</SUBJECT> <SECTNO>721.11015</SECTNO> <SUBJECT>Aliphatic polycarboxylic acid, polymer with alicyclic polyhydric alcohol and polyoxyalkylene (generic).</SUBJECT> <SECTNO>721.11016</SECTNO> <SUBJECT>Di-ammonium di-carboxylate (generic).</SUBJECT> <SECTNO>721.11017</SECTNO> <SUBJECT>Sodium tungsten oxide.</SUBJECT> <SECTNO>721.11018</SECTNO> <SUBJECT>Fatty acids, tall-oil, polymers with alkanoic acid, substituted carbomonocycle, alkyl peroxide-initiated (generic).</SUBJECT> <SECTNO>721.11019</SECTNO> <SUBJECT>Alkyl bisphenol (generic).</SUBJECT> <SECTNO>721.11020-721.11023</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>721.11024</SECTNO> <SUBJECT>Polyphosphoric acids, 2-[alkyl-1-oxo-2-propen-1-yl)oxy]ethyl esters, compds. with N-(aminoiminomethyl)urea (generic).</SUBJECT> <SECTNO>721.11025</SECTNO> <SUBJECT>Polyphosphoric acids, 2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl esters, compds. with alkyl amino, polymers with Bu acrylate, N-(hydroxymethyl)propenamide and styrene (generic).</SUBJECT> <SECTNO>721.11026</SECTNO> <SUBJECT>Bismuth bromide iodide oxide.</SUBJECT> <SECTNO>721.11027</SECTNO> <SUBJECT>Aluminum cobalt lithium nickel oxide.</SUBJECT> <SECTNO>721.11028</SECTNO> <SUBJECT>Alkylarylamine (generic).</SUBJECT> <SECTNO>721.11029</SECTNO> <SUBJECT>Aliphatic N-alkyl urea polymer containing cyclohexyl groups and trimethoxy silanes (generic).</SUBJECT> <SECTNO>721.11030</SECTNO> <SUBJECT>Aliphatic N-alkyl urea polymer containing aspartic ester groups and trimethoxy silanes (generic).</SUBJECT> <SECTNO>721.11031</SECTNO> <SUBJECT>Alkyl heteromonocycle, polymer with heteromonocycle, carboxyalkyl alkyl ether (generic).</SUBJECT> <SECTNO>721.11032</SECTNO> <SUBJECT>Benzene dicarboxylic acid, polymer with alkane dioic acid and aliphatic diamine (generic).</SUBJECT> <SECTNO>721.11033</SECTNO> <SUBJECT>Manganese cyclic (tri)amine chloride complex (generic).</SUBJECT> <SECTNO>721.11034</SECTNO> <SUBJECT>Xanthylium, (sulfoaryl)—bis [(substituted aryl) amino]-, sulfo derivs., inner salts, metal salts (generic).</SUBJECT> <SECTNO>721.11035</SECTNO> <SUBJECT>Substituted triazinyl metal salt, diazotized, coupled with substituted pyridobenzimidazolesulfonic acids, substituted pyridobenzimidazolesulfonic acids, diazotized substituted alkanesulfonic acid, diazotized substituted aromatic sulfonate, diazotized substituted aromatic sulfonate, metal salts (generic).</SUBJECT> <SECTNO>721.11036</SECTNO> <SUBJECT>Carbon black, (organic acidic carbocyclic)-modified, inorganic salt (generic).</SUBJECT> <SECTNO>721.11037</SECTNO> <SUBJECT>Carbon black, (organic acidic carbocyclic)-modified, metal salt (generic).</SUBJECT> <SECTNO>721.11038</SECTNO> <SUBJECT>Polyaralkyl aryl ester of methacrylic acid (generic).</SUBJECT> <SECTNO>721.11039</SECTNO> <SUBJECT>Phenol, 2-[[[3-(octyloxy)propyl]imino]methyl]-.</SUBJECT> <SECTNO>721.11040</SECTNO> <SUBJECT>Phenol, 2-[[[3-(decyloxy)propyl]imino]methyl]-.</SUBJECT> <SECTNO>721.11041</SECTNO> <SUBJECT>Alkyl phenol (generic).</SUBJECT> <SECTNO>721.11042</SECTNO> <SUBJECT>Nitrile-butadiene-acrylate terpolymers (generic).</SUBJECT> <SECTNO>721.11043</SECTNO> <SUBJECT>Starch, polymer with 2-propenoic acid, potassium salt, oxidized.</SUBJECT> <SECTNO>721.11044</SECTNO> <SUBJECT>Pentanedioic acid, 2-methyl-.</SUBJECT> <SECTNO>721.11045</SECTNO> <SUBJECT>2-Pentanol, 4-methyl-, reaction products with phosphorus oxide (P2O5), compounds with alkylamine (generic).</SUBJECT> <SECTNO>721.11046</SECTNO> <SUBJECT>Hydroxy alkylbiphenyl (generic).</SUBJECT> <SECTNO>721.11047</SECTNO> <SUBJECT>Alkyl alkenoic acid, polymer with alkenylcarbomonocycle telomer with substituted alkanoic acid hydroxyl alkyl substituted alkenyl substituted alkyl ester, polyalkylene glycol alkyl ether alkyl alkenoate, dialkylene glycol diheteromonocyclic ether and alkylcarbomonocyclic alkenoate, metal salt (generic).</SUBJECT> <SECTNO>721.11048</SECTNO> <SUBJECT>Alkyl alkenoic acid, polymer with alkenylcarbomonocycle telomer with substituted alkanoic acid hydroxyl alkyl substituted alkenyl substituted alkyl ester, alkanediol diheteromonocyclic ether, polyalkylene glycol alkyl ether alkyl alkenoate and alkylcarbomonocyclic alkenoate, metal salt (generic).</SUBJECT> <SECTNO>721.11049</SECTNO> <SUBJECT> Alkyl alkenoic acid, polymer with bis heteromonocyclic substituted alkyl carbomonocycle, alkenylcarbomonocycle telomer with substituted alkanoic acid hydroxyl alkyl substituted alkenyl substituted alkyl ester, polyalkylene glycol alkyl ether alkyl alkenoate and <PRTPAGE P="276"/> alkylcarbomonocyclic alkenoate, metal salt (generic). </SUBJECT> <SECTNO>721.11050</SECTNO> <SUBJECT>Certain functionalized methacrylate-substituted polymers.</SUBJECT> <SECTNO>721.11051</SECTNO> <SUBJECT>Waste plastics, poly(ethylene terephthalate), depolymd. with polypropylene glycol ether with glycerol (3:1), polymers with alkenoic and alkanoic acids (generic).</SUBJECT> <SECTNO>721.11052</SECTNO> <SUBJECT>1,3,5-Naphthalenetrisulfonic acid.</SUBJECT> <SECTNO>721.11053</SECTNO> <SUBJECT>Certain halogenated sodium benzoate salts.</SUBJECT> <SECTNO>721.11054</SECTNO> <SUBJECT>Certain halogenated benzoic acids.</SUBJECT> <SECTNO>721.11055</SECTNO> <SUBJECT>Certain halogenated benzoic acids ethyl esters.</SUBJECT> <SECTNO>721.11056</SECTNO> <SUBJECT>Neodymium aluminium alkyl polymer complexes (generic).</SUBJECT> <SECTNO>721.11057</SECTNO> <SUBJECT>Fatty acid amide alkyl amine salts (generic).</SUBJECT> <SECTNO>721.11058</SECTNO> <SUBJECT>Fatty acid derived imidazoline salts (generic).</SUBJECT> <SECTNO>721.11068</SECTNO> <SUBJECT> Alkanes, C <E T="52">20-28</E> , chloro. </SUBJECT> <SECTNO>721.11069</SECTNO> <SUBJECT>Slack waxes (petroleum), chloro.</SUBJECT> <SECTNO>721.11070</SECTNO> <SUBJECT>Hexacosane, chloro derivs. and octacosane, chloro derivs.</SUBJECT> <SECTNO>721.11071</SECTNO> <SUBJECT> Alkanes, C <E T="52">20-24</E> , chloro. </SUBJECT> <SECTNO>721.11072</SECTNO> <SUBJECT> Alkanes, C <E T="52">14-16</E> , chloro. </SUBJECT> <SECTNO>721.11073</SECTNO> <SUBJECT>Tetradecane, chloro derivs.</SUBJECT> <SECTNO>721.11074</SECTNO> <SUBJECT>Octadecane, chloro derivs.</SUBJECT> <SECTNO>721.11075</SECTNO> <SUBJECT> Alkanes, C <E T="52">18-20</E> , chloro. </SUBJECT> <SECTNO>721.11076</SECTNO> <SUBJECT> Alkanes, C <E T="52">14-17</E> , chloro. </SUBJECT> <SECTNO>721.11077</SECTNO> <SUBJECT> Alkanes, C <E T="52">22-30</E> , chloro. </SUBJECT> <SECTNO>721.11078</SECTNO> <SUBJECT>Chlorofluorocarbon (generic).</SUBJECT> <SECTNO>721.11079</SECTNO> <SUBJECT>Silane, 1,1′-(1,2-ethanediyl)bis[1,1-dichloro-1-methyl]-, hydrolysis products with chloroethenyldimethylsilane.</SUBJECT> <SECTNO>721.11080</SECTNO> <SUBJECT>Silicophosphonate—sodium silicate (generic).</SUBJECT> <SECTNO>721.11081</SECTNO> <SUBJECT>3-Butenenitrile, 2-(acetyloxy).</SUBJECT> <SECTNO>721.11082</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>721.11083</SECTNO> <SUBJECT>Alkenoic acid, reaction products with polyethylene glycol ether with hydroxyalkyl substituted alkane (generic).</SUBJECT> <SECTNO>721.11084</SECTNO> <SUBJECT>Alkyl substituted alkenoic acid, alkyl ester, polymer with alkyl substituted alkenoate and alkenoic acid, hydroxy substituted[(oxoalkyl)oxy]alkyl ester, reaction products with alkanoic acid, dipentaerythritil and isocyanate substituted carbomonocycle, compds. with alkylamine (generic).</SUBJECT> <SECTNO>721.11085</SECTNO> <SUBJECT>Heteromonocycle ester with alkanediol (generic).</SUBJECT> <SECTNO>721.11086</SECTNO> <SUBJECT>Substituted carbomonocycle, polymer with (aminoalkyl)-alkanediamine, (haloalkyl)oxirane, dialkyl-alkanediamine and alkyl-alkanamine, reaction products with dialkanolamine and [[(alkyl)oxy]alkyl]oxirane (generic).</SUBJECT> <SECTNO>721.11087</SECTNO> <SUBJECT>Carboxylic acid amine (1:1) (generic).</SUBJECT> <SECTNO>721.11088</SECTNO> <SUBJECT>Mix fatty acids compd with amine (1:1) (generic).</SUBJECT> <SECTNO>721.11089</SECTNO> <SUBJECT>Mix fatty acids compd with amine (1:1) (generic).</SUBJECT> <SECTNO>721.11090</SECTNO> <SUBJECT>Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, compd. with N,N-diethylethanamine (1:1).</SUBJECT> <SECTNO>721.11091</SECTNO> <SUBJECT>Manganese (2+), bisoctahydro-1,4,7-trimethyl-1H-1,4,7-triazonine-.kappa.N1,.kappa.N4,.kappa.N7) tri-.mu.-oxidi-, hexafluorophosphate(1-) (1:2).</SUBJECT> <SECTNO>721.11092</SECTNO> <SUBJECT>2′-Fluoro-4″-alkyl-4-propyl-1,1′:4′1″-terphenyl (generic).</SUBJECT> <SECTNO>721.11093</SECTNO> <SUBJECT>4-ethyl-2′-fluoro-4″-alkyl-1,1′4′,1″-terphenyl (generic).</SUBJECT> <SECTNO>721.11094</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl),alpha-(2-benzoyl)-omega-[(2-benzoylbenzoyl)oxy]-.</SUBJECT> <SECTNO>721.11095</SECTNO> <SUBJECT>Asbestos.</SUBJECT> <SECTNO>721.11097</SECTNO> <SUBJECT>Benzene, 1,4-bis(alkyl)-, homopolymer (generic).</SUBJECT> <SECTNO>721.11098</SECTNO> <SUBJECT>Polyethylene glycol polymer with aliphatic polycarbodiimide bis(alkoxysilylpropyl) amine blocked (generic).</SUBJECT> <SECTNO>721.11099</SECTNO> <SUBJECT>Fluorinated organopolysilazane (generic).</SUBJECT> <SECTNO>721.11100</SECTNO> <SUBJECT>Carbopolycycle-bis(diazonium), dihalo-, chloride (1:2), reaction products with metal hydroxide, 4-[(dioxoalkyl)amino] substituted benzene, 2-[(dioxoalkyl) amino] substituted benzene, 5-[(dioxoalkyl)amino]-2-hydroxy-substituted benzene and oxo-n-phenylalkanamide (generic).</SUBJECT> <SECTNO>721.11101</SECTNO> <SUBJECT>Blocked polyester polyurethane, neutralized (generic).</SUBJECT> <SECTNO>721.11102</SECTNO> <SUBJECT>Methoxy-terminated polysiloxane (generic).</SUBJECT> <SECTNO>721.11103</SECTNO> <SUBJECT>Hydroxystyrene resin (generic).</SUBJECT> <SECTNO>721.11104</SECTNO> <SUBJECT>Benzenesulfonic acid 1,2-diazenediylbis[6-ethenyl]-3-sulfophenyl diazenyl-2-sulfophenyl ethenyl salt (generic).</SUBJECT> <SECTNO>721.11105</SECTNO> <SUBJECT>Ethanaminium, alkyl-, salt with triazole (generic).</SUBJECT> <SECTNO>721.11106</SECTNO> <SUBJECT>Substituted-(hydroxyalkyl)-alkyl-alkanoic acid, hydroxy-(substitutedalkyl)-alkyl-, polymer with alpha-hydro-omega-hydroxypoly[oxy (alkylethanediyl)] and isocyanato-(isocyanatoalkyl)-multialkylcycloalkane, salt, alkanol-blocked, compds. (generic).</SUBJECT> <SECTNO>721.11107</SECTNO> <SUBJECT>Alkanediol, 2,2-bis (substituted alkyl)- polymer with substituted alkane, heteromonocycles, alkenoate (generic).</SUBJECT> <SECTNO>721.11108</SECTNO> <SUBJECT>Sulfurized alkylphenol, calcium salts (generic).</SUBJECT> <SECTNO>721.11109</SECTNO> <SUBJECT>Monoheteropentacycloalkane-4-carboxylic acid, substituted cyclo-alkyl ester (generic).</SUBJECT> <SECTNO>721.11110</SECTNO> <SUBJECT>Modified carboxypolyamine salt (generic).</SUBJECT> <SECTNO>721.11111</SECTNO> <SUBJECT>1,3,5-Triazine-2,4-diamine,   6-phenyl-, reaction products with polyalkylene glycol mono- alkyl ether and 2,4-toluene diisocyanate (generic).</SUBJECT> <SECTNO>721.11112</SECTNO> <SUBJECT> Fatty acids, polymers with benzoic acid, cyclohexanedicarboxylic acid anhydride, aliphatic diisocyanate, alkyl diol, <PRTPAGE P="277"/> alkyl triol, pentaerythritol, phthalic anhydride, polyalkylene glycol amine, and aromatic dicarboxylate sulfonic acid sodium salt (generic). </SUBJECT> <SECTNO>721.11113</SECTNO> <SUBJECT>Branched alkyl (C=17) carboxylic acid (generic).</SUBJECT> <SECTNO>721.11114</SECTNO> <SUBJECT>Branched alkyl (C=18) alcohol (generic).</SUBJECT> <SECTNO>721.11115</SECTNO> <SUBJECT>Alkoxy silane modified butadiene styrene copolymer (generic).</SUBJECT> <SECTNO>721.11116</SECTNO> <SUBJECT>Substituted carbocycle, N-[[[4-[[(4-substituted carbocyclic)amino] sulfonyl]carbocyclic]amino]carbonyl]- 4-methyl- (generic).</SUBJECT> <SECTNO>721.11117</SECTNO> <SUBJECT>Aliphatic polyester (generic).</SUBJECT> <SECTNO>721.11118</SECTNO> <SUBJECT>Modified acrylic polymer (generic).</SUBJECT> <SECTNO>721.11119</SECTNO> <SUBJECT>Functionalized polyimide and functionalized polyamide (generic).</SUBJECT> <SECTNO>721.11120</SECTNO> <SUBJECT>Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, Me 3,3,4,4,5,5,6,6,6-nonafluorohexyl.</SUBJECT> <SECTNO>721.11121-721.11122</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>721.11123</SECTNO> <SUBJECT>Carboxylic acids, C6-18 and C8-15-di-, polymers with diethylene glycol, glycerol, oleic acid, phthalic, acid and sorbitol.</SUBJECT> <SECTNO>721.11124</SECTNO> <SUBJECT>2-Propenenitrile, polymer with methanamine, hydrogenated, 3-aminopropylterminated, ethoxylated propoxylated.</SUBJECT> <SECTNO>721.11125</SECTNO> <SUBJECT>Dicarboxylic acids, polymers with alkyl prop-2-enoate, alkyl 2-ethylprop-2-enoate, alkyl[(alkenyl)alkyl]alkanediol, alkanediol, alkanedioic acid, alkyl 2-methylprop-2-enoate, alkyl prop-2-enoic acid, alkylene [isocyanatocarbomonocycle] and alkanediol, alkanolamine-blocked, compds. with 2-(alkylamino)alkanol (generic).</SUBJECT> <SECTNO>721.11126</SECTNO> <SUBJECT>Mixed metal oxide (generic).</SUBJECT> <SECTNO>721.11127</SECTNO> <SUBJECT>Modified alkyl polyamine (generic).</SUBJECT> <SECTNO>721.11128</SECTNO> <SUBJECT>Alkyl polyamine (generic).</SUBJECT> <SECTNO>721.11129</SECTNO> <SUBJECT>Silica gel, reaction products with chromium oxide (CrO3) and ethoxydiethyl aluminum.</SUBJECT> <SECTNO>721.11130</SECTNO> <SUBJECT>Carboxylic acids, C6-18 and C5-15-di-, polymers with diethylene glycol, glycerol, sorbitol and terephthalic acid.</SUBJECT> <SECTNO>721.11131</SECTNO> <SUBJECT>1-Tetradecene, homopolymer, hydrogenated.</SUBJECT> <SECTNO>721.11132</SECTNO> <SUBJECT>Fluorocyanophenyl alkylbenzoate (generic).</SUBJECT> <SECTNO>721.11133</SECTNO> <SUBJECT>Fluorinated acrylic copolymer (generic).</SUBJECT> <SECTNO>721.11134</SECTNO> <SUBJECT>Oxyalkylene urethane polyolefin (generic).</SUBJECT> <SECTNO>721.11135</SECTNO> <SUBJECT>Imino alkane amine phosphate (generic).</SUBJECT> <SECTNO>721.11136</SECTNO> <SUBJECT>Fatty acids, tall-oil, reaction products with 2-[(2-aminoalkyl)amino]alkanol, compds. with alkylene oxide-glycidyl o-tolyl ether polymer dihydrogen phosphate alkyl ether (generic).</SUBJECT> <SECTNO>721.11137</SECTNO> <SUBJECT>Oxirane, 2-alkyl-, polymer with oxirane, mono[N-[3-(carboxyamino)-4(or 6)-alkylphenyl]carbamate], alkyl ether, ester with 2,2′,2″-nitrilotris-[alkanol] (generic).</SUBJECT> <SECTNO>721.11138</SECTNO> <SUBJECT>Formaldehyde, polymer with (chloromethyl)oxirane and substituted aromatic compounds (generic).</SUBJECT> <SECTNO>721.11139</SECTNO> <SUBJECT>Acid, reaction products with cadmium selenide (CdSe), trioctylphosphine and trioctylphosphine oxide (generic).</SUBJECT> <SECTNO>721.11140</SECTNO> <SUBJECT>Acid, reaction products with cadmium selenide sulfide, acid, trioctylphosphine and trioctylphosphine oxide (generic).</SUBJECT> <SECTNO>721.11141</SECTNO> <SUBJECT>Acid, reaction products with cadmium zinc selenide sulfide, trioctylphosphine and trioctylphosphine oxide (generic).</SUBJECT> <SECTNO>721.11142</SECTNO> <SUBJECT>Metal oxide reaction products with cadmium metal selenide sulfide, and amine (generic).</SUBJECT> <SECTNO>721.11143</SECTNO> <SUBJECT>Alkanoic acid, alkyl-, substituted alkyl ester, polymer with alkyl alkenoate, substituted carbomonocycle, substituted alkyl alkenoate and alkyl substituted alkenoate, substituted alkanenitrile-initiated, polymers with substituted alkanenitrile-initiated, alkanoic acid-alkane substituted acrylates-substituted carbomonocycle polymer, compds. with alkylamino alkanol (generic).</SUBJECT> <SECTNO>721.11144</SECTNO> <SUBJECT>Manganese bipyridine carboxylate complex (generic).</SUBJECT> <SECTNO>721.11145</SECTNO> <SUBJECT>Sulfuric acid mixed salt (generic).</SUBJECT> <SECTNO>721.11146</SECTNO> <SUBJECT>2-Propenoic acid, alkyl-2-(alkylalkyl)alkyl ester (generic).</SUBJECT> <SECTNO>721.11147</SECTNO> <SUBJECT>Allyloxymethylacrylate (generic).</SUBJECT> <SECTNO>721.11148</SECTNO> <SUBJECT>Polyurethane, methacrylate blocked (generic).</SUBJECT> <SECTNO>721.11149</SECTNO> <SUBJECT>Carbon nanomaterial (generic).</SUBJECT> <SECTNO>721.11150</SECTNO> <SUBJECT>2-Pyrrolidinone, 1-butyl-.</SUBJECT> <SECTNO>721.11151</SECTNO> <SUBJECT>2-Butanone 1,1,1,3,4,4,4-heptafluoro-3-(trifluoromethyl)-.</SUBJECT> <SECTNO>721.11152</SECTNO> <SUBJECT>Propanenitrile, 2,3,3,3 tetrafluoro-2-(trifluoromethyl)-.</SUBJECT> <SECTNO>721.11153</SECTNO> <SUBJECT>Polymeric sulfide (generic).</SUBJECT> <SECTNO>721.11154</SECTNO> <SUBJECT>Quaternary ammonium salts (generic).</SUBJECT> <SECTNO>721.11155</SECTNO> <SUBJECT>Alkyl methacrylates, polymer with olefins (generic).</SUBJECT> <SECTNO>721.11156</SECTNO> <SUBJECT>Hexanedioic acid, 1,6-bis(3,5,5-trimethylhexyl) ester.</SUBJECT> <SECTNO>721.11157</SECTNO> <SUBJECT>Alkylaminium hydroxide (generic).</SUBJECT> <SECTNO>721.11158</SECTNO> <SUBJECT>Polyamine polyacid adducts (generic).</SUBJECT> <SECTNO>721.11159</SECTNO> <SUBJECT>Aromatic isocyanate, polymer with alkyloxirane polymer with oxirane ether with alkyldiol (2:l) and alkyloxirane polymer with oxirane ether with alkyltriol (3:l) (generic).</SUBJECT> <SECTNO>721.11160</SECTNO> <SUBJECT> Aromatic isocyanate polymer with alkyloxirane, alkyloxirane polymer with oxirane ether with alkanetriol and oxirane (generic). <PRTPAGE P="278"/> </SUBJECT> <SECTNO>721.11161</SECTNO> <SUBJECT>Oils, hedychium flavescens.</SUBJECT> <SECTNO>721.11162</SECTNO> <SUBJECT>Siloxanes and silicones, cetyl Me, di-Me, Me 2-(triethoxysilyl)ethyl.</SUBJECT> <SECTNO>721.11163—721.11165</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>721.11166</SECTNO> <SUBJECT>1H-Benz[de] isoquinoline-1,3(2H)-dione-2-(alkyl)-(alkylamino) (generic).</SUBJECT> <SECTNO>721.11167</SECTNO> <SUBJECT>Siloxanes and Silicones, di-Me, hydrogen-terminated, reaction products with acrylic acid and 2-ethyl-2-[(2-propen-1-yloxyl)methyl]-1,3-propanediol, polymers with chlorotrimethylsilane-iso-Pr alc.-sodium silicate reaction products.</SUBJECT> <SECTNO>721.11168</SECTNO> <SUBJECT>2-Pentanone, 2,2′,2″-[O,O′,O″-(ethenylsilylidyne)trioxime].</SUBJECT> <SECTNO>721.11169</SECTNO> <SUBJECT>2-Pentanone, 2,2′,2″- [O,O′,O″-(methylsilylidyne)trioxime].</SUBJECT> <SECTNO>721.11170</SECTNO> <SUBJECT>Naphthalene trisulfonic acid sodium salt (generic).</SUBJECT> <SECTNO>721.11171</SECTNO> <SUBJECT>Polymer of aliphatic dicarboxylic acid and dicycloalkaneamine (generic).</SUBJECT> <SECTNO>721.11172</SECTNO> <SUBJECT>Hexanedioic acid, polymer with trifunctional polyol, 1,1′-methylenebis [isocyanatobenzene], and 2,2′-oxybis[ethanol] (generic).</SUBJECT> <SECTNO>721.11174</SECTNO> <SUBJECT>Silane-treated aluminosilicate (generic).</SUBJECT> <SECTNO>721.11175</SECTNO> <SUBJECT>Heteropolycycliccarboxylic acid, 1,3-dihydro-disubstituted-, polymer with 1,1′-methylenebis[4-isocyanatobenzene], reaction products with silica (generic).</SUBJECT> <SECTNO>721.11176</SECTNO> <SUBJECT>Carbonic acid, alkyl carbomonocyclic ester (generic).</SUBJECT> <SECTNO>721.11177</SECTNO> <SUBJECT>1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 2-(chloromethyl)oxirane, reaction products with polyethylene-polypropylene glycol 2-aminopropyl Me ether.</SUBJECT> <SECTNO>721.11178</SECTNO> <SUBJECT>Copolyamide of an aromatic dicarboxylic acid and a mixture of diamines (generic).</SUBJECT> <SECTNO>721.11179</SECTNO> <SUBJECT>Single-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.11180</SECTNO> <SUBJECT>Arenesulfonic acid, alkyl derivatives, metal salts (generic).</SUBJECT> <SECTNO>721.11181</SECTNO> <SUBJECT>Heteromonocycle, 2-[(bicarbomonocycle-2-substituted)alkyl]- (generic).</SUBJECT> <SECTNO>721.11182</SECTNO> <SUBJECT>Silanized amorphous silica (generic).</SUBJECT> <SECTNO>721.11183</SECTNO> <SUBJECT>Esteramine (generic).</SUBJECT> <SECTNO>721.11184</SECTNO> <SUBJECT>Formic acid, compds. with hydrolyzed bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-N1-(1,3- dimethylbutylidene)-N2-[2- [(1, 3-dimethylbutylidene)amino] ethyl]-1,2-ethanediamine- dialdehyde-2-(methylamino) ethanol reaction products acetates (salts), (generic).</SUBJECT> <SECTNO>721.11185</SECTNO> <SUBJECT>Propanoic acid, 2-hydroxy-, compds. with hydrolyzed bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-N1-(1,3-dimethylbutylidene)-N2-[2- [(1, 3-dimethylbutylidene)amino] ethyl]-1,2-ethanediamine- dialdehyde-2-(methylamino) ethanol reaction products formates (salts), (generic).</SUBJECT> <SECTNO>721.11186</SECTNO> <SUBJECT>Formic acid, compds. with hydrolyzed bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-N1-(1,3-dimethylbutylidene)-N2-[2- [(1, 3-dimethylbutylidene)amino] ethyl]-1,2-ethanediamine- dialdehyde-2-(methylamino) ethanol reaction products sulfamates (salts), (generic).</SUBJECT> <SECTNO>721.11187</SECTNO> <SUBJECT>Formic acid, compds. with hydrolyzed bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-N1-(1,3-dimethylbutylidene)-N2-[2- [(1, 3-dimethylbutylidene)amino] ethyl]-1,2-ethanediamine- dialdehyde-2-(methylamino) ethanol reaction products acetates (salts), (generic).</SUBJECT> <SECTNO>721.11188</SECTNO> <SUBJECT>Propanoic acid, 2-hydroxy-, compds. with hydrolyzed bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-N1-(1,3-dimethylbutylidene)-N2-[2- [(1, 3-dimethylbutylidene)amino] ethyl]-1,2-ethanediamine- dialdehyde-2-(methylamino) ethanol reaction products formates (salts), (generic).</SUBJECT> <SECTNO>721.11189</SECTNO> <SUBJECT>Formic acid, compds. with hydrolyzed bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-N1-(1,3-dimethylbutylidene)-N2-[2- [(1, 3-dimethylbutylidene)amino] ethyl]-1,2-ethanediamine- dialdehyde-2-(methylamino) ethanol reaction products sulfamates (salts), (generic).</SUBJECT> <SECTNO>721.11190</SECTNO> <SUBJECT>Inorganic acids, metal salts, compds. with modified heteroaromatics, (generic).</SUBJECT> <SECTNO>721.11191</SECTNO> <SUBJECT>Inorganic acids, metal salts, compds. with substituted aromatic heterocycle, (generic).</SUBJECT> <SECTNO>721.11192</SECTNO> <SUBJECT>Glucosyltransferase, International Union of Biochemistry and Molecular Biology Number: 2.4.1.5.</SUBJECT> <SECTNO>721.11194</SECTNO> <SUBJECT>Alkene reaction and distillation by-products and residues (generic).</SUBJECT> <SECTNO>721.11195</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, monobutyl ether, monoether with propylene oxide-2-[[3-(triethoxysilyl)propoxy]methyl]oxirane polymer.</SUBJECT> <SECTNO>721.11196</SECTNO> <SUBJECT>Aliphatic acrylate (generic).</SUBJECT> <SECTNO>721.11197</SECTNO> <SUBJECT>Flue dust, glass-manufg. desulfurization. Definition: The dust produced from the flue gas exhaust cleaning of a glass manufacturing process using carbonate containing substances. It consists primarily of Na2S04, Na2CO3, and Na4(SO4)(CO3).</SUBJECT> <SECTNO>721.11198</SECTNO> <SUBJECT>Organo-titanate (generic).</SUBJECT> <SECTNO>721.11199</SECTNO> <SUBJECT>Dialkyl 7,10-dioxa, dithiahexadeca diene (generic).</SUBJECT> <SECTNO>721.11200</SECTNO> <SUBJECT> Haloalkyl substituted carbomonocycle (generic). <PRTPAGE P="279"/> </SUBJECT> <SECTNO>721.11201</SECTNO> <SUBJECT>Amine- and hydroxy-functional acrylic polymer, neutralized (generic).</SUBJECT> <SECTNO>721.11202</SECTNO> <SUBJECT>Amine- and hydroxy-functional acrylic polymer (generic).</SUBJECT> <SECTNO>721.11203</SECTNO> <SUBJECT>Hydroxy acrylic polymer, methanesulfonates (generic).</SUBJECT> <SECTNO>721.11204</SECTNO> <SUBJECT>Alkyl perfluorinated acryloyl ester (generic).</SUBJECT> <SECTNO>721.11205</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.-(2-methyl-2-propen-1-yl)-.omega.-hydroxy-.</SUBJECT> <SECTNO>721.11206</SECTNO> <SUBJECT>Alkylidene dicarbomonocycle, polymer with halo-substituted heteromonocycle and disubstituted alkyl carbomonocycle alkenedioate alkylalkenoate (generic).</SUBJECT> <SECTNO>721.11207</SECTNO> <SUBJECT>Aluminum boron cobalt lithium nickel oxide.</SUBJECT> <SECTNO>721.11208</SECTNO> <SUBJECT>Aluminum boron cobalt lithium magnesium nickel oxide.</SUBJECT> <SECTNO>721.11209</SECTNO> <SUBJECT>Heteropolycyclic-alkanol carbomonocycle-alkanesulfonate (generic).</SUBJECT> <SECTNO>721.11210</SECTNO> <SUBJECT>(Substituted-dialkyl(C=1~7)silyl)alkanenitrile (generic).</SUBJECT> <SECTNO>721.11211</SECTNO> <SUBJECT>Substituted heteromonocycle, polymer with diisocyanato alkane and alkanediol, substituted heteromonocycle homopolymer ester with substituted alkylacrylate; blocked (generic).</SUBJECT> <SECTNO>721.11212</SECTNO> <SUBJECT>Glycolipids, sophorose-contg., candida bombicola-fermented, from C16-18 and C18-unsatd. glycerides and D-glucose, hydrolyzed, sodium salts.</SUBJECT> <SECTNO>721.11213</SECTNO> <SUBJECT>Glycolipids, sophorose-contg., candida bombicola-fermented, from C16-18 and C18-unsatd. glycerides and D-glucose, hydrolyzed, potassium salts.</SUBJECT> <SECTNO>721.11214</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 2-(2-butoxyethoxy)ethyl ester, polymer with 1,3-butadiene and 2-propenenitrile.</SUBJECT> <SECTNO>721.11215</SECTNO> <SUBJECT>Halogenated benzoic acid ethyl ester (generic).</SUBJECT> <SECTNO>721.11216</SECTNO> <SUBJECT>Halogenated benzoic acid (generic).</SUBJECT> <SECTNO>721.11217</SECTNO> <SUBJECT>Certain halogenated sodium benzoate salts.</SUBJECT> <SECTNO>721.11218</SECTNO> <SUBJECT>Benzoic acid, 2, 3, 6-trifluoro, sodium salt (1:1).</SUBJECT> <SECTNO>721.11219</SECTNO> <SUBJECT>Fatty acids, diesters with dihydroxyalkane, fatty acids, esters with dihydroxyalkane (generic).</SUBJECT> <SECTNO>721.11220</SECTNO> <SUBJECT>Substituted carbomonocycle, polymer with halo substituted heteromonocycle and polyoxyalkylene polymer with alkylenebis[isocyanatocarbomonocycle] bis (carbomonocycledicarboxylate), reaction products with alkylamines, hydrolyzed (generic).</SUBJECT> <SECTNO>721.11221</SECTNO> <SUBJECT>Fatty acids, C16 and C18-unsatd., Me esters, chlorinated.</SUBJECT> <SECTNO>721.11222</SECTNO> <SUBJECT>Chlorinated complex esters (generic).</SUBJECT> <SECTNO>721.11223</SECTNO> <SUBJECT>Sodium branched chain alkyl hydroxyl and branched chain alkenyl sulfonates (generic).</SUBJECT> <SECTNO>721.11224</SECTNO> <SUBJECT>Spiro tetrafluoroborate (generic).</SUBJECT> <SECTNO>721.11225</SECTNO> <SUBJECT>2-Pyridinecarboxylic acid, 6-(4-chloro-2-fluoro-3-methoxyphenyl)-4,5-difluoro-, phenylmethyl ester.</SUBJECT> <SECTNO>721.11226</SECTNO> <SUBJECT>2-Pyridinecarboxylic acid, 4-amino-6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoro-, phenylmethyl ester, hydrochloride (1:1).</SUBJECT> <SECTNO>721.11227</SECTNO> <SUBJECT>1,2,4-Benzenetricarboxylic acid, 1,2,4-trinonyl ester.</SUBJECT> <SECTNO>721.11228</SECTNO> <SUBJECT>Aliphatic polyamines, polymers with bisphenol A and epichlorohydrin (generic).</SUBJECT> <SECTNO>721.11229</SECTNO> <SUBJECT>Epoxy-amine adduct, methanesulfonates (generic).</SUBJECT> <SECTNO>721.11230</SECTNO> <SUBJECT>Modified ethylene-vinyl alcohol copolymer (generic).</SUBJECT> <SECTNO>721.11231</SECTNO> <SUBJECT>Cashew, nutshell liq., polymer with acid and halohydrin (generic).</SUBJECT> <SECTNO>721.11232</SECTNO> <SUBJECT>Pentaerythritol ester of mixed linear and branched carboxylic acids (generic).</SUBJECT> <SECTNO>721.11233</SECTNO> <SUBJECT>Cashew nut shell liquid, branched polyester-polyether polyol (generic).</SUBJECT> <SECTNO>721.11234</SECTNO> <SUBJECT>Methylene diphenyl diisocyanate terminated polyurethane resin (generic).</SUBJECT> <SECTNO>721.11235</SECTNO> <SUBJECT>2-Furancarboxylic acid, tetrahydro-.</SUBJECT> <SECTNO>721.11236</SECTNO> <SUBJECT>Heteromonocycle, homopolymer, alkyl substituted carbamate, alkyl ester (generic).</SUBJECT> <SECTNO>721.11237</SECTNO> <SUBJECT>Polysiloxanes, di alkyl, substituted alkyl group terminated, alkoxylated, reaction products with alkanoic acid, isocyanate substituted-alkyl carbomonocycle and polyol (generic).</SUBJECT> <SECTNO>721.11238</SECTNO> <SUBJECT>Substituted carbomonocycle, polymer with substituted heteromonocycle and substituted polyalkylene glycol (generic).</SUBJECT> <SECTNO>721.11239</SECTNO> <SUBJECT>Alkanedioic acid, polymers with alkanoic acid-dipentaerythritol reaction products, substituted alkanedioc acid, substituted alkanoic acid, isocyanato-(isocyanatoalkyl)-alkyl substituted carbomonocycle and alkyl substituted alkanediol (generic).</SUBJECT> <SECTNO>721.11240</SECTNO> <SUBJECT>Substituted carbomonocycle, polymer with diisocyanatoalkane, substituted alkylacrylate blocked (generic).</SUBJECT> <SECTNO>721.11241</SECTNO> <SUBJECT>1,2-Ethanediol, 1,2-dibenzoate.</SUBJECT> <SECTNO>721.11242</SECTNO> <SUBJECT>Alkenoic acid, reaction products with [oxybis(alkylene)]bis[(substituted alkyl)-alkanediol], polymers with isocyanatoalkane and substituted alkanoic acid, substituted monoacrylate alkanoate-blocked (generic).</SUBJECT> <SECTNO>721.11243</SECTNO> <SUBJECT> Aromatic dicarboxylic acid, compound with alkane diamines, polymer with alkane diamine and dicarboxylic acid (generic). <PRTPAGE P="280"/> </SUBJECT> <SECTNO>721.11244</SECTNO> <SUBJECT>Aromatic dicarboxylic acid, compound with alkyl diamines, homopolymer (generic).</SUBJECT> <SECTNO>721.11245</SECTNO> <SUBJECT>Aspartic acid, tallow modified diester (generic).</SUBJECT> <SECTNO>721.11246</SECTNO> <SUBJECT>Substituted alkanediol, polymer with heteromonocycles, alkenoate, metal complexes (generic).</SUBJECT> <SECTNO>721.11247</SECTNO> <SUBJECT>Organic salt (generic).</SUBJECT> <SECTNO>721.11248</SECTNO> <SUBJECT>1,2-Cyclohexane­dicarboxylic acid, 1-(phenylmethyl) ester, ester with 2,2,4-trimethyl-1, 3-pentanediol mono(2-methylpropanoate).</SUBJECT> <SECTNO>721.11249</SECTNO> <SUBJECT>Alkylaminium-trialkyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, halide (1:1), polymer with alpha-(2-methyl-1-oxo-2-propen-1-yl)- omega-alkoxypoly(oxy-1,2-alkanediyl) (generic).</SUBJECT> <SECTNO>721.11250</SECTNO> <SUBJECT>Substituted carboxylic acid, polymer with 2,4-diisocyanato-1-methylbenzene, hexanedioic acid, alpha-hydro-omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)], 1,1'-methylenebis[4-isocyanatobenzene], 2,2'-oxybis[ethanol], 1,1'-oxybis[2-propanol] and 1,2-propanediol (generic).</SUBJECT> <SECTNO>721.11251</SECTNO> <SUBJECT>Unsaturated polyfluoro ester (generic).</SUBJECT> <SECTNO>721.11252</SECTNO> <SUBJECT>Acetic acid, 2-(2-butoxyethoxy)-.</SUBJECT> <SECTNO>721.11253</SECTNO> <SUBJECT>Sulfuric acid, ammonium salt (1:?).</SUBJECT> <SECTNO>721.11254</SECTNO> <SUBJECT>Alkylamide, polymer with alkylamine, formaldehyde, and polycyanamide, alkyl acid salt (generic).</SUBJECT> <SECTNO>721.11255</SECTNO> <SUBJECT>Cashew nutshell liquid, polymer with diisocyanatoalkane, substituted-polyoxyalkyldiol and polyether polyol (generic).</SUBJECT> <SECTNO>721.11256</SECTNO> <SUBJECT>Silane, ethenyltrimethoxy-, polymer with ethene and 1-propene.</SUBJECT> <SECTNO>721.11257</SECTNO> <SUBJECT>Hydrogenated fatty acid dimers, polymers with 1,1'-methylenebis[4-isocyanatobenzene], polypropylene glycol, polypropylene glycol ether with trimethylolpropane (3:1), and 1,3-propanediol, polypropylene glycol monomethacrylate-blocked (generic).</SUBJECT> <SECTNO>721.11258</SECTNO> <SUBJECT>Amino-silane (generic).</SUBJECT> <SECTNO>721.11260</SECTNO> <SUBJECT>Acetic acid, 2-oxo-, sodium salt (1:1).</SUBJECT> <SECTNO>721.11261</SECTNO> <SUBJECT>Branched alkenyl acid, alkyl ester, homopolymer (generic).</SUBJECT> <SECTNO>721.11262</SECTNO> <SUBJECT>Alkenoic acid, reaction products with bis substituted alkane and ether polyol (generic).</SUBJECT> <SECTNO>721.11263</SECTNO> <SUBJECT>Ethanol, 2-butoxy-, 1,1′-ester (generic).</SUBJECT> <SECTNO>721.11264</SECTNO> <SUBJECT>Heteromonocycle, 4,6-dimethyl-2-(1-phenylethyl)- (generic).</SUBJECT> <SECTNO>721.11265</SECTNO> <SUBJECT>Aromatic dianhydride, polymer with aromatic diamine and heteroatom bridged aromatic diamine, reaction products with aromatic anhydride (generic).</SUBJECT> <SECTNO>721.11266</SECTNO> <SUBJECT>Metal, bis(2,4-pentanedionato-kO2,kO4)- (T-4)- (generic).</SUBJECT> <SECTNO>721.11267</SECTNO> <SUBJECT>Silane amine carbonate (generic).</SUBJECT> <SECTNO>721.11268</SECTNO> <SUBJECT>Hydrochlorofluoroolefin (generic).</SUBJECT> <SECTNO>721.11269</SECTNO> <SUBJECT>Fatty acid modified aromatic polyester polyol (generic).</SUBJECT> <SECTNO>721.11270</SECTNO> <SUBJECT>Dodecanedioic acid and 1,6-hexanediol polymer with 3-hydroxy-2,2-dimethylpropyl-2,2-dimethylhydracrylate, neopentylglycol, 1,2-ethanediol, adipic acid, isophthalic acid, terephthalic acid, 2-Oxooxopane, BayFlex 2002H and 1,1′-methylenebis(isocyanatobenzene) (generic).</SUBJECT> <SECTNO>721.11271</SECTNO> <SUBJECT>Ethanone, 1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-.</SUBJECT> <SECTNO>721.11272</SECTNO> <SUBJECT>Vegetable oil, polymer with alkanedioic acid, alkali lignin, diethylene glycol- and polyol-depolymd. poly(ethylene terephthalate) waste plastics and arylcarboxylic acid anhydride (generic).</SUBJECT> <SECTNO>721.11273</SECTNO> <SUBJECT>Vegetable oil, polymer with alkanedioic acid, alkali lignin, diethylene glycol- and polyol-depolymd. poly(ethylene terephthalate) waste plastics (generic).</SUBJECT> <SECTNO>721.11274</SECTNO> <SUBJECT>Waste plastics, poly(ethylene terephthalate), depolymd. with diethylene glycol, polymers with alkanedioic acid, alkali lignin and arylcarboxylic acid anhydride (generic).</SUBJECT> <SECTNO>721.11275</SECTNO> <SUBJECT>Waste plastics, poly(ethylene terephthalate), depolymd. with diethylene glycol and polyol, polymers with alkanedioic acid, alkali lignin and arylcarboxylic acid anhydride (generic).</SUBJECT> <SECTNO>721.11276</SECTNO> <SUBJECT>Vegetable oil, polymer with alkanedioic acid, alkali lignin, diethylene glycol- and polyol-depolymd. poly(ethylene terephthalate) waste plastics and arylcarboxylic acid anhydride (generic).</SUBJECT> <SECTNO>721.11277</SECTNO> <SUBJECT>Vegetable oil, polymer with alkanedioic acid, alkali lignin, diethylene glycol-depolymd. poly(ethylene terephthalate) waste plastics and arylcarboxylic acid anhydride (generic).</SUBJECT> <SECTNO>721.11278</SECTNO> <SUBJECT>Amides, tallow, N,N-bis(2-hydroxypropyl).</SUBJECT> <SECTNO>721.11279</SECTNO> <SUBJECT>Substituted propanoic acid, polymer with alkylisocyanate-substituted carbomonocycle, dialkyl carbonate, hydroxyl alkyl substituted alkanediol, alkanediol, isocyanato substituted carbomonocycle, alkanol substituted amines-blocked, compds. with (alkylamino)alkanol (generic).</SUBJECT> <SECTNO>721.11280</SECTNO> <SUBJECT>Propanediol phosphate (generic).</SUBJECT> <SECTNO>721.11281</SECTNO> <SUBJECT>Substituted cashew, nutshell liquid, polymer with epichlorohydrin, phosphate (generic).</SUBJECT> <SECTNO>721.11282</SECTNO> <SUBJECT>2,5-Furandione, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5(or 6)-yl ester, ester with 2,3-dihydroxypropyl neodecanoate.</SUBJECT> <SECTNO>721.11283</SECTNO> <SUBJECT> Waste plastics, polyester, depolymd. with glycols, polymers with dicarboxylic acids (generic). <PRTPAGE P="281"/> </SUBJECT> <SECTNO>721.11284</SECTNO> <SUBJECT>Di(substituted-1,3-trialkylammonium) dialkylammonium salt (generic).</SUBJECT> <SECTNO>721.11285</SECTNO> <SUBJECT>Substituted alkanoic acid, polymer with alkylcarbonate, alkanediols and isocyanate substituted carbomonocycles, sodium salt, alkenoic acid substituted polyol reaction products-blocked (generic).</SUBJECT> <SECTNO>721.11286</SECTNO> <SUBJECT>Alkenoic acid, ester with [oxybis(alkylene)]bis[alkyl-substituted alkanediol], polymer with alkylcarbonate, alkanediols, substituted alkanoic acid and isocyanate and alkyl substituted carbomonocycle, sodium salt (generic).</SUBJECT> <SECTNO>721.11287</SECTNO> <SUBJECT>Castor oil, reaction products with soybean oil.</SUBJECT> <SECTNO>721.11288</SECTNO> <SUBJECT>Benzene, 1-(chloromethyl)-3-methyl-.</SUBJECT> <SECTNO>721.11289</SECTNO> <SUBJECT>1-Butanaminium,N,N,N-tributyl-,2(or 5)- [[benzoyldihydrodioxo [(sulfophenyl) amino]heteropolycycle]oxy]-5(or 2)-(1,1-dimethylpropyl)benzenesulfonate (2:1) (generic).</SUBJECT> <SECTNO>721.11290</SECTNO> <SUBJECT>Alkylsilsesquioxane, ethoxy-terminated (generic).</SUBJECT> <SECTNO>721.11291</SECTNO> <SUBJECT>Polythioether, short chain diol polymer terminated with aliphatic diisocyanate (generic).</SUBJECT> <SECTNO>721.11292</SECTNO> <SUBJECT>Alkenoic acid, polymer with alkenylcarbomonocycle, [alkanediylbis (substituted alkylene)] bis[heteromonocycle] and (alkylalkenyl) aromatic, salt (generic).</SUBJECT> <SECTNO>721.11293</SECTNO> <SUBJECT>Alkenoic acid, polymer with substituted alkyloxirane, alkenylcarbomonocycle, alkyl substituted alkyl alkanediol and (alkylalkenyl) aromatic, salt (generic).</SUBJECT> <SECTNO>721.11294</SECTNO> <SUBJECT>Alkyl alkenoic acid, alkyl ester, telomer with alkylthiol, substituted carbomonocycle, substituted alkyl alkyl alkenoate and hydroxyalkyl alkenoate, tertbutyl alkyl peroxoate-initiated (generic).</SUBJECT> <SECTNO>721.11295</SECTNO> <SUBJECT>Isocyanate terminated polyurethane resin (generic).</SUBJECT> <SECTNO>721.11296</SECTNO> <SUBJECT>N-Alkyl propanamide (generic).</SUBJECT> <SECTNO>721.11297</SECTNO> <SUBJECT>N-Alkyl acetamide (generic).</SUBJECT> <SECTNO>721.11300</SECTNO> <SUBJECT>Alkanes, C11-16-branched and linear.</SUBJECT> <SECTNO>721.11301</SECTNO> <SUBJECT>Alkyl alkenoic acid, alkoxyalkyl ester, polymer with alkyl alkenoate, alkyl alkyl alkenoate and tris alkyl silyl alkyl alkenoate (generic).</SUBJECT> <SECTNO>721.11302</SECTNO> <SUBJECT>Alkyldiamine, aminoalkyl dimethylaminoalkyl dimethyl-, reaction products with propylene oxide (generic).</SUBJECT> <SECTNO>721.11303</SECTNO> <SUBJECT>2-oxepanone, reaction products with alkylenediamine-alkyleneimine polymer, 2-[[(2-alkyl)oxy]alkyl]oxirane and tetrahydro-2H-pyran-2-one (generic).</SUBJECT> <SECTNO>721.11304</SECTNO> <SUBJECT>Dicarboxylic acids, polymers with alkanoic acid, alkanediol, substituted-alkylalkanoic acid, substituted alkyl carbomonocycle, alkanedioic acid and alkanediol, alkanolamine blocked, compds. with alkanolamine (generic).</SUBJECT> <SECTNO>721.11305</SECTNO> <SUBJECT>Unsaturated polycyclic hydrocarbon (generic).</SUBJECT> <SECTNO>721.11306</SECTNO> <SUBJECT>Glycerides, soya mono- and di-, epoxidized, acetates.</SUBJECT> <SECTNO>721.11307</SECTNO> <SUBJECT>Glycerides, C16-18 and C18-unsatd. mono- and di-, epoxidized, acetates.</SUBJECT> <SECTNO>721.11308</SECTNO> <SUBJECT>Mixed metal oxide (generic).</SUBJECT> <SECTNO>721.11309</SECTNO> <SUBJECT>Urea, reaction products with N-butylphosphorothioic triamide and formaldehyde.</SUBJECT> <SECTNO>721.11310</SECTNO> <SUBJECT>Fatty acids reaction products with ethyleneamines and dialkyl ester (generic).</SUBJECT> <SECTNO>721.11311</SECTNO> <SUBJECT>Pentaerythritol, mixed esters with linear and branched fatty acids (generic).</SUBJECT> <SECTNO>721.11312</SECTNO> <SUBJECT>Alcohol capped polycarbodiimide from diethyldiisocyanatobenzene (generic).</SUBJECT> <SECTNO>721.11313</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with methoxirane homopolymer, 1,1′-methylenebis[4-isocyanatobenzene], and glycerolpropylene oxide polymer (generic).</SUBJECT> <SECTNO>721.11314</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with methoxirane homopolymer, 1,1′-methylenebis[isocyanatobenzene], and glycerol-propylene oxide polymer (generic).</SUBJECT> <SECTNO>721.11315</SECTNO> <SUBJECT>Lithium nickel hydride oxide.</SUBJECT> <SECTNO>721.11316</SECTNO> <SUBJECT>Lithium nickel potassium oxide.</SUBJECT> <SECTNO>721.11317</SECTNO> <SUBJECT>Hydrolyzed functionalized di-amino silanol polymer (generic).</SUBJECT> <SECTNO>721.11318</SECTNO> <SUBJECT>Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with dimethyl carbonate, 1,6-hexanediol, diamine and 1,1′-methylenebis[4-isocyanatocyclohexane], pentaerythritol triacrylate-blocked, compds. with triethylamine (generic).</SUBJECT> <SECTNO>721.11319</SECTNO> <SUBJECT>Waste plastics, poly(ethylene terephthalate), polymers with diethylene glycol, glycerol, polyerythritol, triethylene glycol, trimethylolalkane and polypropylene glycol (generic).</SUBJECT> <SECTNO>721.11320</SECTNO> <SUBJECT>Waste plastics, poly(ethylene terephthalate), polymers with diethylene glycol, glycerol, polyerythritol, phthalic anhydride, triethylene glycol, trimethylolalkane and polypropylene glycol (generic).</SUBJECT> <SECTNO>721.11321</SECTNO> <SUBJECT>Naphtha oils (generic).</SUBJECT> <SECTNO>721.11322</SECTNO> <SUBJECT>Saccharide reaction products with acid anhydride, etherified (generic).</SUBJECT> <SECTNO>721.11323</SECTNO> <SUBJECT>Alkyl alkenoic acid, alkyl ester, telomer with alkyl alkenoate, substituted alkyl alkyl alkenoate, alkylthiol, substituted carbomonocycle, hydroxyalkyl alkyl alkenoate and alkyl alkyl alkenoate (generic).</SUBJECT> <SECTNO>721.11324</SECTNO> <SUBJECT> Formaldehyde, polymer with 2-phenoxyalkanol and .alpha.-phenyl-.omega.-hydroxypoly(oxy-1,2-alkylenediyl), dihydrogen phosphate 2- <PRTPAGE P="282"/> phenoxyalkyl hydrogen phosphate, alkaline salt (generic). </SUBJECT> <SECTNO>721.11325</SECTNO> <SUBJECT>Substituted polyalkylenepolycarbomonocycle ester, polymer with dialkanolamine, [(hydroxyalkoxy)carbonyl] derivs., (alkoxyalkoxy)alkanol-blocked (generic).</SUBJECT> <SECTNO>721.11326</SECTNO> <SUBJECT>Carbomonocycles, polymer with haloalkyl-substituted heteromonocycle and hydro-hydroxypoly[oxy(alkyl-alkanediyl)], dialkyl-alkanediamine-terminated, hydroxyalkylated acetates (salts) (generic).</SUBJECT> <SECTNO>721.11327</SECTNO> <SUBJECT>Alkanoic acid, compds. with substituted carbomonocycle-dialkyl-alkanediamine-halosubstitued heteromonocycle-polyalkylene glycol polymer dialkanolamine reaction products (generic).</SUBJECT> <SECTNO>721.11328</SECTNO> <SUBJECT>Substituted carbomoncycle, polymer with haloalkyl substituted heteromonocycle, dialkyl-alkanediamine and hydro-hydroxypoly[oxy(alkylalkanediyl)], reaction products with metal oxide and dialkanolamine, acetates (salts) (generic).</SUBJECT> <SECTNO>721.11329</SECTNO> <SUBJECT>Non-metal tetrakis (hydroxyalkyl)-, halide, polymer with amide oxidized (generic).</SUBJECT> <SECTNO>721.11330</SECTNO> <SUBJECT>Polymer of polyethylene polyamine and alkanediol diglycidyl ether (generic).</SUBJECT> <SECTNO>721.11331</SECTNO> <SUBJECT>Triarylalkyl phosphonium halide salt (generic).</SUBJECT> <SECTNO>721.11332</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(2-butyloctyl) ether.</SUBJECT> <SECTNO>721.11333</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(2-hexyldecyl) ether.</SUBJECT> <SECTNO>721.11334</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(2-octyldodecyl) ether.</SUBJECT> <SECTNO>721.11335</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether.</SUBJECT> <SECTNO>721.11336</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(2-dodecylhexadecyl) ether.</SUBJECT> <SECTNO>721.11337</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(2-tetradecyloctadecyl) ether.</SUBJECT> <SECTNO>721.11338</SECTNO> <SUBJECT>Alkyl tri dithiocarbamate tri salt (generic).</SUBJECT> <SECTNO>721.11339</SECTNO> <SUBJECT>Methacrylic acid heterocyclic alkyl ester (generic).</SUBJECT> <SECTNO>721.11340</SECTNO> <SUBJECT>Alkylnitrile imidazole (generic).</SUBJECT> <SECTNO>721.11341</SECTNO> <SUBJECT>Crosslinked polymer of alkyl acrylamides, acrylate esters, and alkyl acrylamide sulfonate salt (generic).</SUBJECT> <SECTNO>721.11342</SECTNO> <SUBJECT>Propane, 1,1,1,3,3,3-hexafluoro-2-methoxy-.</SUBJECT> <SECTNO>721.11343</SECTNO> <SUBJECT>Heteromonocycle, alkenyl alkyl (generic).</SUBJECT> <SECTNO>721.11344</SECTNO> <SUBJECT>Phosphonium, tributylethyl-, diethyl phosphate (1:1).</SUBJECT> <SECTNO>721.11345</SECTNO> <SUBJECT>Hydrochlorofluoroolefin (generic).</SUBJECT> <SECTNO>721.11346</SECTNO> <SUBJECT>Perfluoropolyether halide (generic).</SUBJECT> <SECTNO>721.11347</SECTNO> <SUBJECT>Perfluoropolyether aryl (generic).</SUBJECT> <SECTNO>721.11348</SECTNO> <SUBJECT>Substituted aryl perfluoropolyether (generic).</SUBJECT> <SECTNO>721.11349</SECTNO> <SUBJECT>Sulfonated perfluoropolyether aromatic transition metal salt (generic).</SUBJECT> <SECTNO>721.11350</SECTNO> <SUBJECT>Sulfonated perfluoropolyether aryl alkali metal salt (generic).</SUBJECT> <SECTNO>721.11360</SECTNO> <SUBJECT>Benzenepropanal, .alpha.,.alpha.,3-trimethyl-.</SUBJECT> <SECTNO>721.11361</SECTNO> <SUBJECT>Multiwalled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.11372</SECTNO> <SUBJECT>Phenol-formaldehyde epoxy, polymer with an alkyl polyether polysulfide (generic).</SUBJECT> <SECTNO>721.11375</SECTNO> <SUBJECT>2,4-Hexadien-1-ol, 1-acetate, (2E,4E)-.</SUBJECT> <SECTNO>721.11376</SECTNO> <SUBJECT>2-Alkenoic acid, 2-alkyl-, alkyl ester, polymer with 2-(dialkylamino)alkyl 2-alkyl-2-alkenoate, alkyl 2-alkyl-2-alkenoate and a-(2-alkyl-1-oxo-2-alken-1-yl)-o-alkoxypoly(oxy-1,2-alkanediyl), [(1-alkoxy-2-alkyl-1-alken-1-yl)oxy]trialkylsilane-initiated (generic).</SUBJECT> <SECTNO>721.11377</SECTNO> <SUBJECT>Benzenesulfonamide, N-[2-[[(phenylamino)carbonyl]amino]phenyl]-.</SUBJECT> <SECTNO>721.11378</SECTNO> <SUBJECT>1H-Imidazole-1-propanenitrile,2-ethyl-ar-methyl-.</SUBJECT> <SECTNO>721.11379</SECTNO> <SUBJECT>Lithium, isotope of mass 6.</SUBJECT> <SECTNO>721.11380</SECTNO> <SUBJECT> Silsesquioxanes, 3-(dimethyloctadecylammonio)propyl Me Pr, polymers with silicic acid (H <E T="52">4</E> SiO <E T="52">4</E> ) tetra-Et ester, (2-hydroxyethoxy)- and methoxy-terminated, chlorides. </SUBJECT> <SECTNO>721.11383</SECTNO> <SUBJECT>Triarylsulfonium salt (generic).</SUBJECT> <SECTNO>721.11384</SECTNO> <SUBJECT>Organic acid, compds. with bisphenol A-epichlorohydrin-polypropylene glycol diglycidyl ether polymer-disubstituted amine-disubstituted polypropylene glycol reaction products (generic).</SUBJECT> <SECTNO>721.11385</SECTNO> <SUBJECT>Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane and .alpha.-(2-oxiranylmethyl)-.omega.-(2-oxiranylmethoxy)poly[oxy(methyl-1,2-ethanediyl)], reaction products with disubstituted amine and disubstituted polypropylene glycol, organic acid salts (generic).</SUBJECT> <SECTNO>721.11386</SECTNO> <SUBJECT>Organic acid, 2-substituted-, compds. with bisphenol A-epichlorohydrin-polypropylene glycol diglycidyl ether polymer-disubstituted amine-disubstituted polypropylene glycol reaction products (generic).</SUBJECT> <SECTNO>721.11387</SECTNO> <SUBJECT>Phenol, 4,4′-(1-methylethylidene)bis-, polymer with .alpha.-(2-substituted-methylethyl)-.omega.-(2-substituted-methylethoxy)poly[oxy(methyl-1,2-ethanediyl)], 2-(chloromethyl)oxirane and .alpha.-(2-oxiranylmethyl)-.omega.-(2-oxiranylmethoxy)poly[oxy(methyl-1,2-ethanediyl)], alkylphenyl ethers, reaction products with disubstituted amine, organic acid salts (generic).</SUBJECT> <SECTNO>721.11388</SECTNO> <SUBJECT> Organic acid, compds. with bisphenol A-epichlorohydrin- <PRTPAGE P="283"/> disubstituted polypropylene glycol-polypropylene glycol diglycidyl ether polymer alkylphenyl ethers-disubstituted amine reaction products (generic). </SUBJECT> <SECTNO>721.11389</SECTNO> <SUBJECT>Organic acid, compds. with bisphenol A-epichlorohydrin-polypropylene glycol diglycidyl ether polymer-disubstituted polypropylene glycol reaction products (generic).</SUBJECT> <SECTNO>721.11390</SECTNO> <SUBJECT>Branched cyclic and linear hydrocarbons from plastic depolymerization (generic).</SUBJECT> <SECTNO>721.11391</SECTNO> <SUBJECT>Alkane, alkene, styrenic compounds derived from plastic depolymerization (generic).</SUBJECT> <SECTNO>721.11392</SECTNO> <SUBJECT>Carbon compound derived from plastic depolymerization (generic).</SUBJECT> <SECTNO>721.11393</SECTNO> <SUBJECT>Branched cyclic and linear hydrocarbons from plastic depolymerization (generic).</SUBJECT> <SECTNO>721.11394</SECTNO> <SUBJECT>Phosphonic acid, dimethyl ester, polymer with alkyl diols (generic).</SUBJECT> <SECTNO>721.11395</SECTNO> <SUBJECT>1H-Imidazole, 1,2,4,5-tetramethyl-.</SUBJECT> <SECTNO>721.11396</SECTNO> <SUBJECT>1-Propanaminium, N,N′-(oxydi-2,1-ethanediyl)bis[3-chloro-2-hydroxy-N,N-dimethyl-, chloride (1:2).</SUBJECT> <SECTNO>721.11397</SECTNO> <SUBJECT>Fatty acid, polymer with alkanedioic acid dialkyl ester, hydroxyl alkyl substituted alkanediol, substituted carbomonocycle and alkylol substituted alkane (generic).</SUBJECT> <SECTNO>721.11398</SECTNO> <SUBJECT>2,5-Furandione, polymer with ethenylbenzene, 4-hydroxy-substituted butyl amide, polymers with epichlorohydrin and trimethylolpropane, sodium salts (generic).</SUBJECT> <SECTNO>721.11399</SECTNO> <SUBJECT>2,5-Furandione, polymer with ethenylbenzene, 4-hydroxy-substitutedbutyl [3-[2-[1-[[(substitutedphenyl)amino]carbonyl]-2-oxopropyl]diazenyl]phenyl]methyl amide, polymers with epichlorohydrin and trimethylolpropane, sodium salts (generic).</SUBJECT> <SECTNO>721.11400</SECTNO> <SUBJECT>Alkane, bis(alkoxymethyl)-dimethyl- (generic).</SUBJECT> <SECTNO>721.11401</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with diethanolamine, polymers with substituted-alkyl acrylate, formats (salts) (generic).</SUBJECT> <SECTNO>721.11402</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl, methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with diethanolamine, polymers with substituted-alkyl methacrylate, formats (salts) (generic).</SUBJECT> <SECTNO>721.11403</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-oxrianylmethyl 2-methyl-2-propenoate, and 1,2-propaneidol mono(2-methyl-2-propenoate), reaction products with diethanolamine, polymers with alkylene glycol monoacrylate, formats (salts) (generic).</SUBJECT> <SECTNO>721.11404</SECTNO> <SUBJECT>Butanedioic acid, 2-methylene-, polymer with 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-1-propanesulfonic acid, sodium zinc salt.</SUBJECT> <SECTNO>721.11405</SECTNO> <SUBJECT>Heteromonocycle, alkenoic 1:1 salt, polymer with .alpha.-(2-methyl-1-oxo-2-propen-1-yl)-.omega.-methoxypoly(oxy-1,2-ethanediyl) and methyl-alkenoic acid (generic).</SUBJECT> <SECTNO>721.11406</SECTNO> <SUBJECT>Substituted benzylic ether polyethylene glycol alkyl ether derivative (generic).</SUBJECT> <SECTNO>721.11407</SECTNO> <SUBJECT>Alkylmultiheteroatom, 2-functionalisedalkyl-2-hydroxyalkyl-, polymer with alkylheteroatom-multialkylfunctionalised carbomonocycleheteroatom and multiglycidylether difunctionalised polyalkylene glycol (generic).</SUBJECT> <SECTNO>721.11408</SECTNO> <SUBJECT>Benzenedicarboxylic acid, reaction products with isobenzofurandione and diethylene glycol (generic).</SUBJECT> <SECTNO>721.11409</SECTNO> <SUBJECT>Formaldehyde, polymer with N1-(2-aminoethyl)-alkanediamine, 5-amino-1,3,3-trimethylcyclohexanemethanamine, 2-(chloromethyl)oxirane, 4,4′-(1-methylethylidene)bis[phenol] and .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl) (generic).</SUBJECT> <SECTNO>721.11411</SECTNO> <SUBJECT>1-Butanol, reaction products with 2-[(2-propen-1-yloxy)methyl]oxirane.</SUBJECT> <SECTNO>721.11412</SECTNO> <SUBJECT>Alkyldiamine, aminoalkyl dimethylaminoalkyl dimethyl- (generic).</SUBJECT> <SECTNO>721.11413</SECTNO> <SUBJECT>Oxirane, 2-(chloromethyl)-, polymer with 2-methyloxirane polymer with oxirane bis(2-aminopropyl) ether.</SUBJECT> <SECTNO>721.11414</SECTNO> <SUBJECT>Terpolymer of vinylidene fluoride, tetrafluoroethylene and 2,3,3,3-tetrafluoropropene (generic).</SUBJECT> <SECTNO>721.11415</SECTNO> <SUBJECT>Phosphonium, tributylmethyl-, iodide (1:1).</SUBJECT> <SECTNO>721.11416</SECTNO> <SUBJECT>Phosphorous acid, triisotridecyl ester.</SUBJECT> <SECTNO>721.11417</SECTNO> <SUBJECT>1,3-Butanediol, (3R)-.</SUBJECT> <SECTNO>721.11418</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>721.11419</SECTNO> <SUBJECT>Metal oxide-chloro (generic).</SUBJECT> <SECTNO>721.11422</SECTNO> <SUBJECT>Alkanediamine, dialkyl-, polymer with .alpha.-hydro-.omega.-[(1-oxo-2-propen-1-yl)oxy]poly(oxy-1,2-ethanediyl) ether with substituted alkyl-substituted alkanediol, reaction products with alkyl-alkanamine (generic).</SUBJECT> <SECTNO>721.11426</SECTNO> <SUBJECT>Halogenated sodium benzene alkylcarboxylate (generic).</SUBJECT> <SECTNO>721.11427</SECTNO> <SUBJECT>Halogenated sodium benzene alkylcarboxylate (generic) (P-19-87).</SUBJECT> <SECTNO>721.11428</SECTNO> <SUBJECT>Halogenated sodium benzene alkylcarboxylate (generic) (P-19-89).</SUBJECT> <SECTNO>721.11429</SECTNO> <SUBJECT>Halogenated sodium benzoate (generic) (P-19-90).</SUBJECT> <SECTNO>721.11430</SECTNO> <SUBJECT>Halogenated benzene alkylcarboxylic acid (generic) (P-19-91).</SUBJECT> <SECTNO>721.11431</SECTNO> <SUBJECT> Halogenated benzene alkylcarboxylic acid (generic) (P-19-92). <PRTPAGE P="284"/> </SUBJECT> <SECTNO>721.11432</SECTNO> <SUBJECT>Halogenated benzoic acid (generic) (P-19-93).</SUBJECT> <SECTNO>721.11433</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-97).</SUBJECT> <SECTNO>721.11434</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-100).</SUBJECT> <SECTNO>721.11435</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-101).</SUBJECT> <SECTNO>721.11436</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-102).</SUBJECT> <SECTNO>721.11437</SECTNO> <SUBJECT>Halogenated benzoic acid, ethyl ester (generic) (P-19-103).</SUBJECT> <SECTNO>721.11438</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-104).</SUBJECT> <SECTNO>721.11439</SECTNO> <SUBJECT>Halogenated benzoic acid, ethyl ester (generic) (P-19-105).</SUBJECT> <SECTNO>721.11440</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-106).</SUBJECT> <SECTNO>721.11441</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-107).</SUBJECT> <SECTNO>721.11442</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid, ethyl ester (generic) (P-19-108).</SUBJECT> <SECTNO>721.11443</SECTNO> <SUBJECT>Halogenated benzoic acid, ethyl ester (generic) (P-19-110).</SUBJECT> <SECTNO>721.11447</SECTNO> <SUBJECT>1,3-Cyclohexanedimethanamine adduct (generic).</SUBJECT> <SECTNO>721.11448</SECTNO> <SUBJECT>Polychloropropane (generic).</SUBJECT> <SECTNO>721.11449</SECTNO> <SUBJECT>1-Propanaminium, 2-hydroxy-N,N-dimethyl-N-[3-[(1-oxooctyl)amino]propyl]-3-sulfo-, inner salt.</SUBJECT> <SECTNO>721.11450</SECTNO> <SUBJECT>Polyol, reaction products with formaldehyde and methanol (generic).</SUBJECT> <SECTNO>721.11451</SECTNO> <SUBJECT>Metal, alkenoic acid-alkyl alkenoate-alkyl substituted alkenoate polymer carbopolycycle complexes (generic).</SUBJECT> <SECTNO>721.11452</SECTNO> <SUBJECT>Phosphonomethylated ether diamine (generic).</SUBJECT> <SECTNO>721.11453</SECTNO> <SUBJECT>Phosphonium, trihexyltetradecyl-, salt with 1,1,1-trifluoro-N-[(trifluoromethyl) sulfonyl]methanesulfonamide (1:1).</SUBJECT> <SECTNO>721.11454</SECTNO> <SUBJECT>Calcium manganese titanium oxide.</SUBJECT> <SECTNO>721.11455</SECTNO> <SUBJECT>Rare earth oxide (generic).</SUBJECT> <SECTNO>721.11456</SECTNO> <SUBJECT>Acid-modified polyether (generic).</SUBJECT> <SECTNO>721.11457</SECTNO> <SUBJECT>Alkenoic acid polymer with 2-ethyl-2-(hydroxymethyl)-1,3-alkyldiol, 1,1'-methylenebis(4-isocyantocarbomonocycle) and 3-methyl-1,5-alkyldiol (generic).</SUBJECT> <SECTNO>721.11458</SECTNO> <SUBJECT>Bis-alkoxy substituted alkane, polymer with aminoalkanol (generic).</SUBJECT> <SECTNO>721.11460</SECTNO> <SUBJECT>1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(3,5,5-trimethyl-1-oxohexyl)amino]-, inner salt.</SUBJECT> <SECTNO>721.11461</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, (2-oxo-1,3-dioxolan-4-yl)methyl ester.</SUBJECT> <SECTNO>721.11463</SECTNO> <SUBJECT>Butanoic acid, 4-(dimethylamino)-, ethyl ester.</SUBJECT> <SECTNO>721.11464</SECTNO> <SUBJECT>1-Butanaminium, 4-amino-N-(2-hydroxy-3-sulfopropyl)-N,N-dimethyl- 4-oxo-, N-coco alkyl derivs., inner salts.</SUBJECT> <SECTNO>721.11465</SECTNO> <SUBJECT>Indium manganese yttrium oxide.</SUBJECT> <SECTNO>721.11466</SECTNO> <SUBJECT>Aromatic amide oxime (generic).</SUBJECT> <SECTNO>721.11467</SECTNO> <SUBJECT>Carbon nanotubes (generic).</SUBJECT> <SECTNO>721.11468</SECTNO> <SUBJECT>Aromatic hydrocarbon resin (generic).</SUBJECT> <SECTNO>721.11469</SECTNO> <SUBJECT>Pentaerythritol ester of mixed linear and branched carboxylic acids (generic) (P-17-193, chemical A).</SUBJECT> <SECTNO>721.11470</SECTNO> <SUBJECT>Dipentaerythritol ester of mixed linear and branched carboxylic acids (generic) (P-17-193, chemical B).</SUBJECT> <SECTNO>721.11471</SECTNO> <SUBJECT>Alkylheterocyclic amine blocked isocyanate, alkoxysilane polymer (generic).</SUBJECT> <SECTNO>721.11472</SECTNO> <SUBJECT>Isocyanic acid, polymethylenepolyphenylene ester, caprolactam- and phenol-blocked.</SUBJECT> <SECTNO>721.11473</SECTNO> <SUBJECT>Benzamide, 2-(trifluoromethyl)-.</SUBJECT> <SECTNO>721.11474</SECTNO> <SUBJECT>Cashew, nutshell liq. polymer with formaldehyde, phenol and resorcinol.</SUBJECT> <SECTNO>721.11475</SECTNO> <SUBJECT>Polyester polyol (generic).</SUBJECT> <SECTNO>721.11476</SECTNO> <SUBJECT>Fluorinated acrylate, polymer with alkyloxirane homopolymer monoether with alkanediol mono(2-methyl-2-propenoate), tert-Bu 2-ethylhexaneperoxoate-initiated (generic).</SUBJECT> <SECTNO>721.11477</SECTNO> <SUBJECT>2,5-Furandione, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 3a,4,5,6,7,7ahexahydro- 4,7-methano-1H-inden-5(or 6)-yl ester, ester with 2,3-dihydroxypropyl neodecanoate, polymer with 5-isocyanato-l-(isocyanatomethyl)-1,3, 3-trimethylcyclohexane, 2-hydroxyethyl acrylate- and 2-hydroxyethyl methacrylate-blocked.</SUBJECT> <SECTNO>721.11478</SECTNO> <SUBJECT>Perfluoroalkyl ethyl- and vinyl-modified organopolysiloxane (generic).</SUBJECT> <SECTNO>721.11479</SECTNO> <SUBJECT>Perfluoroalkyl ethyl- and vinyl-modified organopolysiloxane (generic).</SUBJECT> <SECTNO>721.11480</SECTNO> <SUBJECT>Oxirane, 2,2′-[cyclohexylidenebis(4,1-phenyleneoxymethylene)]bis-.</SUBJECT> <SECTNO>721.11481</SECTNO> <SUBJECT>Saturated fatty acid, reaction products with cadmium zinc selenide sulfide and polymeric amine (generic).</SUBJECT> <SECTNO>721.11482</SECTNO> <SUBJECT>Saturated fatty acid, reaction products with cadmium zinc selenide sulfide, alkylamine and polymeric amine (generic).</SUBJECT> <SECTNO>721.11483</SECTNO> <SUBJECT>Heteropolycyclic, halo substituted alkyl substituted-diaromatic amino substituted carbomonocycle, halo substituted alkyl substituted heteropolycyclic, tetraaromatic metalloid salt (1:1) (generic).</SUBJECT> <SECTNO>721.11484</SECTNO> <SUBJECT>Alkanediol, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, alkylaminoalkyl methacrylate-, and dialkylheteromonocycle-blocked (generic).</SUBJECT> <SECTNO>721.11485</SECTNO> <SUBJECT>Alkanediol, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, alkylaminoalkyl methacrylate-blocked (generic).</SUBJECT> <SECTNO>721.11486</SECTNO> <SUBJECT>Synthetic oil from tires (generic).</SUBJECT> <SECTNO>721.11487</SECTNO> <SUBJECT> 1,3-Propanediamine, N1,N1-dimethyl-, polymers with alkylene glycol ether with alkyltriol (3:1) mixed <PRTPAGE P="285"/> acrylates and adipates, and alkylene glycol monoacrylate ether with alkyltriol (3:1) (generic). </SUBJECT> <SECTNO>721.11488</SECTNO> <SUBJECT>1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with oxirane, 4-(dimethylamino)benzoate.</SUBJECT> <SECTNO>721.11489</SECTNO> <SUBJECT>Titanium (4+) hydroxyl-alkylcarboxylate salt complex (generic).</SUBJECT> <SECTNO>721.11491</SECTNO> <SUBJECT>Cyclohexane, 1,4-bis(ethoxymethyl)-.</SUBJECT> <SECTNO>721.11492</SECTNO> <SUBJECT>2-Butanone, 3-methyl-, peroxide.</SUBJECT> <SECTNO>721.11493</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with ammonium 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-1-propanesulfonate (1:1), N,N-dimethyl-2-propenamide and .alpha.-(2-methyl-1-oxo-2-propen-1-yl)-.omega.-(dodecyloxy)poly(oxy-1,2-ethanediyl).</SUBJECT> <SECTNO>721.11494</SECTNO> <SUBJECT>Iso-alkylamine, N-isoalkyl-N-methyl (generic).</SUBJECT> <SECTNO>721.11495</SECTNO> <SUBJECT>Octadecanoic acid, 9(or 10)-(dibutoxyphosphinyl)-, 1,1'-(2,2-dimethyl-1,3-propanediyl) ester.</SUBJECT> <SECTNO>721.11496</SECTNO> <SUBJECT>1,3-Benzenedicarboxylic acid, polymer with 3-methyl-1,5-pentanediol.</SUBJECT> <SECTNO>721.11497</SECTNO> <SUBJECT>Oxirane, 2-methyl-, polymer with oxirane, mono(3,5,5-trimethylhexanoate).</SUBJECT> <SECTNO>721.11498</SECTNO> <SUBJECT>Formaldehyde, reaction products with 1,3-benzenedimethanamine and p-tert-butylphenol.</SUBJECT> <SECTNO>721.11499</SECTNO> <SUBJECT>2-Propanol, 1-butoxy-, 2,2′-ester (generic).</SUBJECT> <SECTNO>721.11500</SECTNO> <SUBJECT>Haloalkane (generic).</SUBJECT> <SECTNO>721.11501</SECTNO> <SUBJECT>Ethanamine, N-ethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:?).</SUBJECT> <SECTNO>721.11502</SECTNO> <SUBJECT>Copper, [[2,2′,2″-(nitrilo-.kappa.N)tris[ethanolato-.kappa.O]](2-)]- (P-19-109, chemical A).</SUBJECT> <SECTNO>721.11503</SECTNO> <SUBJECT>Copper, bis[2-(amino-.kappa.N)ethanolato-.kappa.O]-(P-19-109, chemical B).</SUBJECT> <SECTNO>721.11504</SECTNO> <SUBJECT>Carbonic acid, di(lithium-6Li) salt.</SUBJECT> <SECTNO>721.11505</SECTNO> <SUBJECT>Lithium chloride (6LiCl).</SUBJECT> <SECTNO>721.11507</SECTNO> <SUBJECT>Tar acids (shale oil), C6-9 fraction, alkyl phenols, low boiling.</SUBJECT> <SECTNO>721.11508</SECTNO> <SUBJECT>2-Propenoic acid, mixed esters with heterocyclic dimethanol and heterocyclic methanol (generic).</SUBJECT> <SECTNO>721.11509</SECTNO> <SUBJECT>Alkane, diisocyanato-(isocyanatoalkyl)- (generic).</SUBJECT> <SECTNO>721.11510</SECTNO> <SUBJECT>Phenol, polymer with formaldehyde, 5-methyl-1,3-benzenediol-terminated, sodium salts (generic).</SUBJECT> <SECTNO>721.11511</SECTNO> <SUBJECT>N-Alkyl heteromonocyclic diphenolamide, polymer with bisphenol A, haloaryl-substituted sulfone, compd. with cyclic sulfonate ester, polyaryl alcohol terminated (generic).</SUBJECT> <SECTNO>721.11512</SECTNO> <SUBJECT>1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris[3-(2-oxiranyl)propyl]-.</SUBJECT> <SECTNO>721.11513</SECTNO> <SUBJECT>2-Propenoic acid, cycloalkyl ester (generic).</SUBJECT> <SECTNO>721.11514</SECTNO> <SUBJECT>Organic sulfonate compound (generic).</SUBJECT> <SECTNO>721.11515</SECTNO> <SUBJECT>Thiophenium, 1-(2,7-disubstituted-1-naphthalenyl)tetrahydro-, salt with polyfluoro-N-polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (generic).</SUBJECT> <SECTNO>721.11516</SECTNO> <SUBJECT>Sulfonium, triphenyl-, salt with 2,3-bis(substituted) 5-sulfocarbopolycyclic-2,3-carboxylate derivative (1:1) (generic).</SUBJECT> <SECTNO>721.11517</SECTNO> <SUBJECT>Thiophenium, 1-(2,7-disubstituted-1-naphthalenyl)tetrahydro-, salt with polyfluoro-N-polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (generic).</SUBJECT> <SECTNO>721.11518</SECTNO> <SUBJECT>Sulfonium, triphenyl-, 5-(alkyl) fluoropentane derivative (generic).</SUBJECT> <SECTNO>721.11519</SECTNO> <SUBJECT>Sulfonium, triphenyl-, salt with substituted-alkyl 4-substituted-benzoate (generic).</SUBJECT> <SECTNO>721.11520</SECTNO> <SUBJECT>Substituted-triphenylsulfonium, inner salt (generic).</SUBJECT> <SECTNO>721.11521</SECTNO> <SUBJECT>Sulfonium, triphenyl-, salt with disubstituted-heterocyclic compound (1:1) (generic).</SUBJECT> <SECTNO>721.11522</SECTNO> <SUBJECT>Sulfonium, triphenyl-, salt with 2,4,5-trisubstituted-benzenesulfonate (1:1) (generic).</SUBJECT> <SECTNO>721.11523</SECTNO> <SUBJECT>Substituted heterocyclic onium compound, salt with 2,2,2-trifluoro-1-(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-1-oxo-2-propen-1-yl)oxy] tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[(1-ethylcyclopentyl)oxy]benzene and 4-ethenylphenol, di-Me 2,2′-(1,2-diazenediyl)bis[2-methylpropanoate]-initiated (generic).</SUBJECT> <SECTNO>721.11524</SECTNO> <SUBJECT>Substituted heterocyclic onium compound, salt with 2,2,2-trifluoro-1-(sulfomethyl)-1-(trifluoromethyl) ethyl 3-[(2-methyl-1-oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[[1-(1-methylethyl)cyclopentyl]oxy]benzene and 4-ethenylphenol, di-Me 2,2′-(1,2-diazenediyl)bis[2-methylpropanoate]-initiated (generic).</SUBJECT> <SECTNO>721.11525</SECTNO> <SUBJECT>Dibenzothiophenium, aryl substituted trifluoro-hydroxy-(triheterosubstitutedalkyl)alkanoate (1:1) (generic).</SUBJECT> <SECTNO>721.11526</SECTNO> <SUBJECT>Substituted heterocyclic onium compound, salt with 1-(difluorosulfomethyl)-2,2,2-trifluoroethyl 3-[(2-methyl-1-oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 3-ethenylphenol, 1-(1-methylethyl)cyclopentyl 2-methyl-2-propenoate and 1-(7-oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2-methyl-2-propenoate, di-Me 2,2′-(1,2-diazenediyl)bis[2-methylpropenoate]- initiated (generic).</SUBJECT> <SECTNO>721.11527</SECTNO> <SUBJECT>Sulfonium, triphenyl-, trifluoro-hydroxy-(triheterosubstitutedalkyl)alkanoate (1:1) (generic).</SUBJECT> <SECTNO>721.11528</SECTNO> <SUBJECT> Heterotrisubstituted-bile acid, 1-(difluorosulfomethyl)-2,2,2-trifluoroethyl <PRTPAGE P="286"/> ester, ion(1-), (5)-, triphenylsulfonium (1:1) (generic). </SUBJECT> <SECTNO>721.11529</SECTNO> <SUBJECT>Aromatic sulfonium tricyclo fluoroalkyl sulfonic acid salt (generic).</SUBJECT> <SECTNO>721.11530</SECTNO> <SUBJECT>Substituted, (alkylaromatic)diaromatic salt with trihalo-[(trihaloalkyl)substituted]substituted alkaneamide (generic).</SUBJECT> <SECTNO>721.11531</SECTNO> <SUBJECT>Triarylsulfonium substituted oxatricycloalkyloxycarbonyl dihalo alkane sulfonate (generic).</SUBJECT> <SECTNO>721.11532</SECTNO> <SUBJECT>Substituted triarylsulfonium carbopolycyclic heteromonocyclic dihalo sulfoacetate (generic).</SUBJECT> <SECTNO>721.11533</SECTNO> <SUBJECT>Substituted triarylsulfonium substituted carbopolycyclic carboxylate (generic).</SUBJECT> <SECTNO>721.11534</SECTNO> <SUBJECT>Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with substituted heteropolycycle dihalo sulfoalkanoate (1:1) (generic).</SUBJECT> <SECTNO>721.11535</SECTNO> <SUBJECT>Heteropolycycle, alkylaromatic-, salt with dihalo-substituted alkyl carbopolycycle carboxylate (generic).</SUBJECT> <SECTNO>721.11536</SECTNO> <SUBJECT>Sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl polycarbocyclic alkane-1-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11537</SECTNO> <SUBJECT>Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with dihalo substituted alkyl carbopolycyclic carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11538</SECTNO> <SUBJECT>Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, substituted carbomonocyclic ester (generic).</SUBJECT> <SECTNO>721.11539</SECTNO> <SUBJECT>Heteropolycycle, aromatic-, salt with dihalo-substituted alkyl carbopolycycle carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11540</SECTNO> <SUBJECT>Triarylsulfonium alkylestersulfonate (generic).</SUBJECT> <SECTNO>721.11541</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-168).</SUBJECT> <SECTNO>721.11542</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-169).</SUBJECT> <SECTNO>721.11543</SECTNO> <SUBJECT>Halogenated benzoic acid (generic) (P-19-171).</SUBJECT> <SECTNO>721.11544</SECTNO> <SUBJECT>Halogenated benzoic acid (generic) (P-19-172).</SUBJECT> <SECTNO>721.11545</SECTNO> <SUBJECT>Halogenated benzoic acid (generic) (P-19-173).</SUBJECT> <SECTNO>721.11546</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-175).</SUBJECT> <SECTNO>721.11547</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-176).</SUBJECT> <SECTNO>721.11548</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-177).</SUBJECT> <SECTNO>721.11549</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-178).</SUBJECT> <SECTNO>721.11550</SECTNO> <SUBJECT>Halogenated alkylbenzoic acid (generic) (P-19-179).</SUBJECT> <SECTNO>721.11551</SECTNO> <SUBJECT>Halogenated sodium benzoate (generic) (P-19-180).</SUBJECT> <SECTNO>721.11552</SECTNO> <SUBJECT>Halogenated sodium benzoate (generic) (P-19-181).</SUBJECT> <SECTNO>721.11553</SECTNO> <SUBJECT>Halogenated sodium benzoate (generic) (P-19-182).</SUBJECT> <SECTNO>721.11554</SECTNO> <SUBJECT>Halogenated sodium alkylbenzoate (generic) (P-19-184).</SUBJECT> <SECTNO>721.11555</SECTNO> <SUBJECT>Halogenated sodium alkylbenzoate (generic) (P-19-187).</SUBJECT> <SECTNO>721.11556</SECTNO> <SUBJECT>Rosin adduct ester, polymer with polyols, compd. with ethanolamine (generic).</SUBJECT> <SECTNO>721.11557</SECTNO> <SUBJECT>Rosin adduct ester, polymer with polyols, potassium salt (generic).</SUBJECT> <SECTNO>721.11558</SECTNO> <SUBJECT>1,3-Propanediol, 2,2-dimethyl-, 1,3-diacetate.</SUBJECT> <SECTNO>721.11559</SECTNO> <SUBJECT>9-Octadecenoic acid (Z)-, compd. with N-cyclohexylcyclohexanamine (1:1).</SUBJECT> <SECTNO>721.11560</SECTNO> <SUBJECT>Bis[(hydroxyalkoxy)aryl]carbopolycyclic (generic).</SUBJECT> <SECTNO>721.11561</SECTNO> <SUBJECT>2-[2-(methylcarboxymonocyclic)amino)ethoxy]alcohol (generic).</SUBJECT> <SECTNO>721.11562</SECTNO> <SUBJECT>Formaldehyde, polymer with alkyl aryl ketone (generic).</SUBJECT> <SECTNO>721.11563</SECTNO> <SUBJECT>Propanedioic acid, 1,3-dihexyl ester.</SUBJECT> <SECTNO>721.11564</SECTNO> <SUBJECT>Propanedioic acid, 1,3-dicyclohexyl ester.</SUBJECT> <SECTNO>721.11565</SECTNO> <SUBJECT>Propanedioic acid, 2,2-bis(hydroxymethyl)-, 1,3-dicyclohexyl ester.</SUBJECT> <SECTNO>721.11566</SECTNO> <SUBJECT>Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and phenol, Buether.</SUBJECT> <SECTNO>721.11567</SECTNO> <SUBJECT>Fatty acids, coco, iso-Bu esters.</SUBJECT> <SECTNO>721.11568</SECTNO> <SUBJECT>Heptanal, 6-hydroxy-2,6-dimethyl-.</SUBJECT> <SECTNO>721.11569</SECTNO> <SUBJECT>Glycine, reaction products with sodium O-iso-Pr carbonodithioate, sodium salts.</SUBJECT> <SECTNO>721.11570</SECTNO> <SUBJECT>Aliphatic urethane methacrylate (generic).</SUBJECT> <SECTNO>721.11571</SECTNO> <SUBJECT>Hindered amine alkyl ester compounds (generic).</SUBJECT> <SECTNO>721.11572</SECTNO> <SUBJECT>N-alkyl-dialkylpiperidine (generic).</SUBJECT> <SECTNO>721.11573</SECTNO> <SUBJECT>Tetraalkylpiperidinium halide (generic).</SUBJECT> <SECTNO>721.11574</SECTNO> <SUBJECT>Tetraalkylpiperidinium hydroxide (generic).</SUBJECT> <SECTNO>721.11575</SECTNO> <SUBJECT>Amidoamino quaternary ammonium salt (generic).</SUBJECT> <SECTNO>721.11576</SECTNO> <SUBJECT>Tri alkyl, mono alkoxy, fatty acid ester, ammonium salt (generic).</SUBJECT> <SECTNO>721.11577</SECTNO> <SUBJECT>Benzenediamine, ar-chloro-ar, ar-diethyl-ar-methyl-.</SUBJECT> <SECTNO>721.11578</SECTNO> <SUBJECT>1,4-benzenedicarboxylic acid, 1,4-dipentyl ester, branched and linear.</SUBJECT> <SECTNO>721.11579</SECTNO> <SUBJECT>Dialkyltin dialkylcarboxylate (generic).</SUBJECT> <SECTNO>721.11580</SECTNO> <SUBJECT>Alkyltin dodecylthioester (generic).</SUBJECT> <SECTNO>721.11581</SECTNO> <SUBJECT>Alkyltin tetradecylthioester (generic).</SUBJECT> <SECTNO>721.11582</SECTNO> <SUBJECT>Undecanol, branched.</SUBJECT> <SECTNO>721.11583</SECTNO> <SUBJECT> Hydroxy alkanoic acid, compds. with aminoalkoxyalcohol-epoxy polymer-alkanolamine reaction products (generic). <PRTPAGE P="287"/> </SUBJECT> <SECTNO>721.11584</SECTNO> <SUBJECT>1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with ethyleneamine, 2-(chloromethyl)oxirane, 2-[[4-(1,1-dimethylethyl)phenoxy]methyl]oxirane, 2,2′-[1,6-hexanediylbis(oxymethylene)]bis[oxirane], 4,4′-(1-methylethylidene)bis[phenol], alkyl ether amine, and 2-[(2-methylphenoxy methyl]oxirane (generic).</SUBJECT> <SECTNO>721.11585</SECTNO> <SUBJECT>Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-, 2,2-bis(hydroxymethyl)butyl ester.</SUBJECT> <SECTNO>721.11586</SECTNO> <SUBJECT>1-Octadecanaminium, N,N-dimethyl-N-[3-(triethoxysilyl)propyl]-, chloride (1:1).</SUBJECT> <SECTNO>721.11587</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, 3-methyl-3-buten-1-yl ester.</SUBJECT> <SECTNO>721.11588</SECTNO> <SUBJECT>Mixed metal oxide (generic).</SUBJECT> <SECTNO>721.11589</SECTNO> <SUBJECT>Amines, polyethylenepoly-, triethylenetetramine fraction, polymers with guanidine hydrochloride (1:1).</SUBJECT> <SECTNO>721.11590</SECTNO> <SUBJECT>Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 3,6,9,12-tetraoxatetradeca-1, 13-diene, glycidyl ether.</SUBJECT> <SECTNO>721.11591</SECTNO> <SUBJECT>1,4-Benzenedicarboxylic acid, 1,4-bis(2-phenoxyethyl) ester.</SUBJECT> <SECTNO>721.11592</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.-nonyl-.omega.-hydroxy-, branched and linear.</SUBJECT> <SECTNO>721.11593</SECTNO> <SUBJECT>1-Butanamine, N-butyl-N-[(triethoxysilyl)methyl]-.</SUBJECT> <SECTNO>721.11594</SECTNO> <SUBJECT>Alkenylamide (generic).</SUBJECT> <SECTNO>721.11595</SECTNO> <SUBJECT>Isoalkylaminium, N-isoalkyl, -N, N-dimethyl chloride (generic).</SUBJECT> <SECTNO>721.11596</SECTNO> <SUBJECT>Aldehyde, polymer with mixed alkane polyamines, 2,2′-[1,4-alkanediylbis(oxyalkylene)]bis[oxirane], 2-(alkoxyalkyloxirane, 4,4′-(1-alkylidene)bis[phenol], 2,2′-[(1-alkylidene)bis(4,1-alkyleneoxyalkylene)]bis[oxirane] and 2-(aryloxyalkyl)oxirane, acetate (salt) (generic).</SUBJECT> <SECTNO>721.11597</SECTNO> <SUBJECT>Alkanedioic acid, compds. with substituted arylalkylamine-arylalcohol disubstituted alkane-the diglycidyl ether of a arylalcohol disubstituted alkane-epichlorohydrin-aldehyde-2,2′[(1-alkylidene)bis[4,1-aryleneoxy(alkyl-2,1-alkanediyl)oxyalkylene]]bis[oxirane]-alkanepolyamine polymer-1-[[2-[(2-aminoalkyl)amino]alkyl]amino]-3-aryloxy-2-alcohol reaction products (generic).</SUBJECT> <SECTNO>721.11598</SECTNO> <SUBJECT>Polyazaalkane with oxirane and methyloxirane, haloalkane (generic).</SUBJECT> <SECTNO>721.11599</SECTNO> <SUBJECT>Dibromoalkyl ether tetrabromobisphenol A (generic).</SUBJECT> <SECTNO>721.11600</SECTNO> <SUBJECT>Octanal, 7(or 8)-formyl-.</SUBJECT> <SECTNO>721.11601</SECTNO> <SUBJECT>Sulfonium, trisaryl-, 7, 7-dialkyl-2-heteropolycyclic-1-alkanesulfonate (1:1) (generic).</SUBJECT> <SECTNO>721.11602</SECTNO> <SUBJECT>Alkenoic acid, polymer with (alkyl alkenyl) polyether (generic).</SUBJECT> <SECTNO>721.11603</SECTNO> <SUBJECT>Substituted heteromonocycle, polymer with substituted alkanediol and diisocyanate substituted carbomonocyle, alkylene glycol acrylate-blocked (generic).</SUBJECT> <SECTNO>721.11635</SECTNO> <SUBJECT>1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-.</SUBJECT> <SECTNO>721.11636</SECTNO> <SUBJECT>1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-N,N-bis(2-hydroxyethyl)-.</SUBJECT> <SECTNO>721.11637</SECTNO> <SUBJECT>1,3-Propanediamine, N1,N1-dimethyl-N3-(2,2,6,6-tetramethyl-4-piperidinyl)-.</SUBJECT> <SECTNO>721.11638</SECTNO> <SUBJECT>2-Propenoic acid, polymer with aliphatic cyclic epoxide (generic).</SUBJECT> <SECTNO>721.11639</SECTNO> <SUBJECT>1-Butanone, 2-(dimethylamino)-1-[4-(2-ethyl-2-methyl-3-oxazolidinyl)phenyl]-2-(phenylmethyl)-.</SUBJECT> <SECTNO>721.11640</SECTNO> <SUBJECT>Acrylic acid, tricyclo alkyl ester (generic).</SUBJECT> <SECTNO>721.11641</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C12-14-alkyl ethers, phosphates, sodium salts.</SUBJECT> <SECTNO>721.11642</SECTNO> <SUBJECT>N-alkyl heteromonocyclic diphenolamide (generic).</SUBJECT> <SECTNO>721.11643</SECTNO> <SUBJECT>Reaction products of alkyl-terminated alkylalumuminoxanes and [[(pentaalkylphenyl-(pentaalkylphenyl)amino)alkyl]alkanediaminato]bis(aralkyl) transition metal coordination compound (generic).</SUBJECT> <SECTNO>721.11644</SECTNO> <SUBJECT>Multi-walled carbon nanotubes (generic).</SUBJECT> <SECTNO>721.11645</SECTNO> <SUBJECT>Carbomonocyclic sulfonium, salt with trihalo-sulfoalkyl hydroxycarbopolycyclic carboxylate (generic).</SUBJECT> <SECTNO>721.11646</SECTNO> <SUBJECT>Heterocyclic onium compound with 1-substituted-alkyl 2,2,2-trisubstitutedalkyl 2-methyl-2-propenoate (1:1) polymer with acenaphthylene, 4-ethenyl-a,a-dimethylbenzenemethanol and 4-ethenylphenyl acetate, hydrolyzed (generic).</SUBJECT> <SECTNO>721.11647</SECTNO> <SUBJECT>Sulfonium, triphenyl-, 1,2-substituted-alkyltricycloalkyl-1-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11648</SECTNO> <SUBJECT>N-substituted-beta-alanine, heterosubstituted-alkyl ester, ion(1-), triphenyl sulfonium (1:1) (generic).</SUBJECT> <SECTNO>721.11649</SECTNO> <SUBJECT>Sulfonium, [4-(1,1-dimethylethyl)phenyl]diphenyl-, salt with heterosubstituted-alkyl tricycloalkane-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11650</SECTNO> <SUBJECT>Dibenzothiophenium, 5-phenyl-, salt with 2,2-diheterosubstituted-2-sulfoethyl substituted-heterotricycloalkane-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11651</SECTNO> <SUBJECT> Substituted heterocyclic onium compound, salt with heteropolysubstitutedalkyl substitutedtricycloalkanecarboxylate (1:1), polymer with disubstituted aromatic compound and 1-methylcyclopentyl 2-methyl-2- <PRTPAGE P="288"/> propenoate, di-Me 2,2′-(1,2-diazenediyl)bis[2-methylpropenoate]-initiated (generic). </SUBJECT> <SECTNO>721.11652</SECTNO> <SUBJECT>Substituted-2H-thiopyrylium, salt with heterosubstituted-alkyl tricycloalkane-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11653</SECTNO> <SUBJECT>Sulfonium, triphenyl-, salt with 2,2-dihalo-2-sulfoethyl-2-oxo substituted-heterotricycloalkane-heteropolycyclo-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11654</SECTNO> <SUBJECT>Sulfonium, triphenyl-, salt with 5-alkyl-2-alkyl-4-(2,4,6-substituted tri-carbomonocycle, hetero-acid) benzenesulfonate (1:1) (generic).</SUBJECT> <SECTNO>721.11655</SECTNO> <SUBJECT>Phenoxanthiinium, 10-phenyl, 5-alkyl-2-alkyl-4-(2,4,6-substituted tri-carbomonocycle, hetero-acid) benzenesulfonate (1:1) (generic).</SUBJECT> <SECTNO>721.11656</SECTNO> <SUBJECT>Substituted, triaryl-, tricycloalkane alkyl disubstituted (generic) (P-20-156).</SUBJECT> <SECTNO>721.11657</SECTNO> <SUBJECT>Substituted, triaryl-, tricycloalkane alkyl disubstituted (generic) (P-20-162).</SUBJECT> <SECTNO>721.11658</SECTNO> <SUBJECT>Naphthalene derivative (generic).</SUBJECT> <SECTNO>721.11659</SECTNO> <SUBJECT>Mixed amine salt (generic).</SUBJECT> <SECTNO>721.11660</SECTNO> <SUBJECT>Oxyalkylene modified polyalkyl amine alkyl diacid polymer with 2-(chloromethyl)oxirane (generic).</SUBJECT> <SECTNO>721.11661</SECTNO> <SUBJECT>Formaldehyde, homopolymer, reaction products with N-propyl-1-propanamine.</SUBJECT> <SECTNO>721.11662</SECTNO> <SUBJECT>2-Propenoic acid, polymer with 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-1-propanesulfonic acid.</SUBJECT> <SECTNO>721.11663</SECTNO> <SUBJECT>Benzoic acid, alkyl derivs. (generic).</SUBJECT> <SECTNO>721.11664</SECTNO> <SUBJECT>Aminoalkylated imidazole (generic).</SUBJECT> <SECTNO>721.11665</SECTNO> <SUBJECT>Fatty acids and fatty acid unsatd., reaction products with ethyleneamines and maleic anhydride (generic).</SUBJECT> <SECTNO>721.11666</SECTNO> <SUBJECT> Aromatic anhydride polymer with bisalkylbiphenylbisamine compound with alkylamino acrylate ester (generic).</SUBJECT> <SECTNO>721.11667</SECTNO> <SUBJECT>Propanoic acid, hydroxyl- (hydroxyalkyl)-alkyl-, polymer with 1,6-diisocyanatoalkane and poly[oxy(alkyl-alkanediyl)] ether with alkyl (hydroxyalkyl)- alkanediol, 2-propenoate (ester), lithium salt, glycerol monoacrylate 1-neodecanoate- and alkylene glycol monoacrylate-blocked (generic).</SUBJECT> <SECTNO>721.11668</SECTNO> <SUBJECT>Polyol adduct of bisaldehyde (generic).</SUBJECT> <SECTNO>721.11669</SECTNO> <SUBJECT>2,5-Furandione, polymer with ethenylbenzene, 4-hydroxy-substituted butyl amide, sodium salts (generic).</SUBJECT> <SECTNO>721.11670</SECTNO> <SUBJECT>2,5-Furandione, polymer with ethenylbenzene, 4-hydroxy- substituted butyl[3-[2-[1-[[(2-methoxyphenyl)amino]carbonyl]-2-oxopropyl]diazenyl]phenyl]substituted, sodium salts (generic).</SUBJECT> <SECTNO>721.11671</SECTNO> <SUBJECT>Butanamide, 2-[2-[(substituted phenyl)diazenyl]-N-(2-methoxyphenyl)-3-oxo- (generic).</SUBJECT> <SECTNO>721.11672</SECTNO> <SUBJECT>Polycyclic substituted alkane, polymer with cyclicalkylamine, epoxide, and polycyclic epoxide ether, reaction products with dialkylamine substituted alkyl amine (generic).</SUBJECT> <SECTNO>721.11673</SECTNO> <SUBJECT>Polycyclic alkane, polymer with monocyclic amine, polycyclic epoxide ether, reaction products with dialkylamine alkyl amine (generic).</SUBJECT> <SECTNO>721.11674</SECTNO> <SUBJECT>Polycyclic substituted alkane, polymer with epoxide, reaction products with cyclicalkylamine and dialkylamine substituted alkyl amine (generic).</SUBJECT> <SECTNO>721.11675</SECTNO> <SUBJECT>Substituted carbopolycyclic dicarboxylic acid dialkyl ester, polymer with alkanediol and carbopolycyclic bis(substituted carbopolycycle) bisalkanol (generic).</SUBJECT> <SECTNO>721.11676</SECTNO> <SUBJECT>D-Glucopyranose, oligomeric, Bu glycosides, polymers with epichlorohydrin, 2-hydroxy-3-sulfopropyl ethers, sodium salts.</SUBJECT> <SECTNO>721.11677</SECTNO> <SUBJECT>Alkyl polyoxyethylene ethers, carboxymethylated (generic).</SUBJECT> <SECTNO>721.11678</SECTNO> <SUBJECT>Iron, complexes with ethylenediamine-4-hydroxycarbomonocycle hetero-acid-2-oxoacetic acid reaction products, potassium salts (generic).</SUBJECT> <SECTNO>721.11679</SECTNO> <SUBJECT>Iron, complexes with ethylenediamine-4-hydroxycarbomonocycle hetero-acid potassium salt (1:1)-potassium 2-oxoacetate (1:1) reaction products, potassium salts (generic).</SUBJECT> <SECTNO>721.11680</SECTNO> <SUBJECT>Iron, complexes with ethylenediamine-4-hydroxycarbomonocycle hetero-acid-2-oxoacetic acid reaction products, sodium salts (generic).</SUBJECT> <SECTNO>721.11681</SECTNO> <SUBJECT>Iron, complexes with ethylenediamine-4-hydroxycarbomonocycle hetero-acid sodium salt (1:1)-sodium 2-oxoacetate (1:1) reaction products, sodium salts (generic).</SUBJECT> <SECTNO>721.11682</SECTNO> <SUBJECT>Alkaneic acid, dialkyl ester polymer with alkanediol, (isocyanatocarbomonocycle) alkyl)carbomonocycle) carbamate (generic).</SUBJECT> <SECTNO>721.11683</SECTNO> <SUBJECT>Amides, from C8-18 and C18-unsatd. glycerides and diethylenetriamine, ethoxylated.</SUBJECT> <SECTNO>721.11684</SECTNO> <SUBJECT>Amides, from diethylenetriamine and palm kernel-oil, ethoxylated.</SUBJECT> <SECTNO>721.11685</SECTNO> <SUBJECT>Amides, from coconut oil and diethylenetriamine, ethoxylated.</SUBJECT> <SECTNO>721.11686</SECTNO> <SUBJECT>Phenol-formaldehyde polymer with amino-oxirane copolymer and benzoates (generic).</SUBJECT> <SECTNO>721.11687</SECTNO> <SUBJECT>Fatty acids, tall-oil polymers with aminoalkyl, dialkyl alkane diamine, polyalkylene polyamine alkanepolyamine fraction, and tris-[(alkylamino)alkyl] phenol (generic).</SUBJECT> <SECTNO>721.11688</SECTNO> <SUBJECT> Isocyanic acid, polyalkylenepolycycloalkylene ester, 2- <PRTPAGE P="289"/> alkoxy alkanol and 1-alkoxy alkanol and alkylene diol blocked (generic). </SUBJECT> <SECTNO>721.11689</SECTNO> <SUBJECT>1,4-Cyclohexanedicarboxylic acid, 1,4-bis(2-ethylhexyl) ester.</SUBJECT> <SECTNO>721.11690</SECTNO> <SUBJECT>Carbomonocylic-oxazolidine (generic).</SUBJECT> <SECTNO>721.11691</SECTNO> <SUBJECT>Propoxylated, ethoxylated alkoxyalkyl ether (generic).</SUBJECT> <SECTNO>721.11692</SECTNO> <SUBJECT>Phosphoric acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 1,2-ethanediol.</SUBJECT> <SECTNO>721.11693</SECTNO> <SUBJECT>2-Propenoic acid, 2-(hydrogenated animal-based nitrogen-substituted)ethyl ester (generic).</SUBJECT> <SECTNO>721.11694</SECTNO> <SUBJECT>2-Propenoic acid, nitrogen-substituted alkyl, N-C16-18-acyl derivs. (generic).</SUBJECT> <SECTNO>721.11695</SECTNO> <SUBJECT>Modified graphene (generic).</SUBJECT> <SECTNO>721.11696</SECTNO> <SUBJECT>Maltodextrin, polymer with 2-propenoic acid and N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethanaminium chloride (1:1), sodium salt, peroxydisulfuric acid ([(HO)S(O)2]2O2) sodium salt (1:2)-initiated.</SUBJECT> <SECTNO>721.11697</SECTNO> <SUBJECT>Ashes (residues), reactions products with dicarboxylic acid, silicic acid (H4SiO4) tetra-Et ester and 2-[[3-(trialkoxysilyl)alkoxy]methyl]oxirane (generic) (P-20-112).</SUBJECT> <SECTNO>721.11698</SECTNO> <SUBJECT>Ashes (residues), reactions products with substituted tricarboxylic acid, silicic acid (H4SiO4) tetra-Et ester and 2-[[3-(trialkoxysilyl)alkoxy]methyl] oxirane (generic) (P-20-113).</SUBJECT> <SECTNO>721.11699</SECTNO> <SUBJECT>Ashes (residues), reactions products with dicarboxylic acid, silicic acid (H4SiO4) tetra-Et ester and 2-[[3-(trialkoxysilyl)alkoxy]methyl]oxirane (generic) (P-20-114).</SUBJECT> <SECTNO>721.11700</SECTNO> <SUBJECT>Ashes (residues), reactions products with substituted tricarboxylic acid, silicic acid (H4SiO4) tetra-Et ester and 2-[[3-(trialkoxysilyl)alkoxy]methyl] oxirane (generic) (P-20-115).</SUBJECT> <SECTNO>721.11701</SECTNO> <SUBJECT>Ashes (residues), reactions products with dicarboxylic acid, silicic acid (H4SiO4) tetra-Et ester and 2-[[3-(trialkoxysilyl)alkoxy]methyl]oxirane (generic) (P-20-116).</SUBJECT> <SECTNO>721.11702</SECTNO> <SUBJECT>Ashes (residues), reactions products with dicarboxylic acid, silicic acid (H4SiO4) tetra-Et ester and 2-[[3-(trialkoxysilyl)alkoxy]methyl]oxirane (generic) (P-20-117).</SUBJECT> <SECTNO>721.11703</SECTNO> <SUBJECT>Silsesquioxanes, alkyl, alkoxy- and hydroxy- terminated (generic).</SUBJECT> <SECTNO>721.11704</SECTNO> <SUBJECT>1,3-Benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, 1,2-ethanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, hexanedioic acid, 1,6-hexanediol and 1,3-isobenzofurandione, N-[[1,3,3-trimethyl-5-[[[2-[(1-oxo-2- propen-1-yl)oxy]ethoxy]carbonyl]amino]cyclohexyl]methyl]carbamate N-[3,3,5-trimethyl-5-[[[[2-[(1-oxo-2-propen-1-yl)oxy]ethoxy]carbonyl]amino]methyl]cyclohexyl]carbamate.</SUBJECT> <SECTNO>721.11705</SECTNO> <SUBJECT>Methyl phenylethyl cyclopropanemethanol (generic).</SUBJECT> <SECTNO>721.11706</SECTNO> <SUBJECT>[(Substituted-carbomonocyclic)amino] oxoalkenoic acid, inorganic salt (generic).</SUBJECT> <SECTNO>721.11707</SECTNO> <SUBJECT>Sulfonium, triphenyl-, heterocyclic compound-carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11708</SECTNO> <SUBJECT>Sulfonium, carbocyclic-, salt with 1-(alkyl) 2-[4-[polyhydro-2-carbomonocyclic-5-(polyfluoro-2-sulfoalkyl)-4,7-methano-1,3-benzodioxol-2-yl]carbomonocyclic oxy]acetate (1:1) (generic).</SUBJECT> <SECTNO>721.11709</SECTNO> <SUBJECT>Sulfonium, triphenyl-, polyfluoro-polyhydrospiro[9H-carbopolycyclic-9,2′-[4,7]methano[1,3]benzodioxole]-5′-alkenesulfonic acid (1:1) (generic).</SUBJECT> <SECTNO>721.11710</SECTNO> <SUBJECT>Heteropolycyclic, trihaloalkyl carbomonocycle-, hydroxy carbomonocyclic salt (generic).</SUBJECT> <SECTNO>721.11711</SECTNO> <SUBJECT>Sulfonium, tricarbocyclic-, 2-heteroatom-substituted-4-(alkyl)carbomonocyclic carboxylate (1:1) (generic).</SUBJECT> <SECTNO>721.11712</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl-, aminoalkyl ester, polymer with hydroxyalkyl alkenoate and octadecyl alkenoate, acetate (salts) (generic).</SUBJECT> <SECTNO>721.11713</SECTNO> <SUBJECT>Pyrazole-polycarboxylic acid, polyhaloaryl-polyhydro-alkyl-polyalkyl ester (generic).</SUBJECT> <SECTNO>721.11714</SECTNO> <SUBJECT>Alkenoic acid, reaction products with alkylamine-alkanediyl diacrylate polymer and [oxybis(alkylene)]bis[alkyl-alkanediol] (generic).</SUBJECT> <SECTNO>721.11715</SECTNO> <SUBJECT>Nonane, branched.</SUBJECT> <SECTNO>721.11752</SECTNO> <SUBJECT>Quaternary ammonium salt of polyisobutene succinic acid (generic).</SUBJECT> <SECTNO>721.11753</SECTNO> <SUBJECT>2-Propenoic acid, 2-alkyl-, 2-(dialkylamino)alkyl ester, polymer with .alpha.-(2-alkyl-1-oxo-2-alken-1-yl)-.omega.-methoxypoly(oxy-1,2-alkanediyl) (generic).</SUBJECT> <SECTNO>721.11754</SECTNO> <SUBJECT>Alkanedioic acid, polymer with cycloalkyl dimethanol, alkyl and cycloalkyl diisocyanates, dimethyl-alkanediol, dihydroxyalkanoic acid methylenebis[isocyanatocyclohexane], hydroxyethyl acrylate- and polyalkyl glycol monoalkyl ether blocked (generic).</SUBJECT> <SECTNO>721.11755</SECTNO> <SUBJECT>Poly(oxy-1,4-butanediyl), .alpha.-hydro-.omega.-hydroxy-, polymer with 1,1′-methylenebis[4-isocyanatobenzene], caprolactam-blocked.</SUBJECT> <SECTNO>721.11756</SECTNO> <SUBJECT>Tall-oil pitch, fraction, sterol-low (generic).</SUBJECT> <SECTNO>721.11757</SECTNO> <SUBJECT>Carboxylic acid, reaction products with metal hydroxide, inorganic dioxide and metal (generic).</SUBJECT> <SECTNO>721.11758</SECTNO> <SUBJECT> Multi-walled carbon nanotubes; closed; 4.4-12.8 nm diameter; bundle length 10.6-211.1 µm; Grade: Jenotube 6. <PRTPAGE P="290"/> </SUBJECT> <SECTNO>721.11759</SECTNO> <SUBJECT>Multi-walled carbon nanotubes; closed; 5.1-11.6 nm diameter; bundle length 1.9-552.0 µm; Grade: Jenotube 8.</SUBJECT> <SECTNO>721.11760</SECTNO> <SUBJECT>Multi-walled carbon nanotubes; closed; 7.9-14.2 nm diameter; bundle length 9.4-106.4 µm; Grade: Jenotube 10.</SUBJECT> <SECTNO>721.11761</SECTNO> <SUBJECT>Multi-walled carbon nanotubes; closed; 17.0-34.7 nm diameter; globular shape; Grade: Jenotube 20.</SUBJECT> <SECTNO>721.11762</SECTNO> <SUBJECT>Nonanamide, N,N-dimethyl-.</SUBJECT> <SECTNO>721.11763</SECTNO> <SUBJECT>2-Propenoic acid, 2-methyl, 2-(dimethylamino)ethyl ester, polymers with 2-(C16-18-acylamino)ethyl acrylate and hydroxyalkyl acrylate, acetates (generic).</SUBJECT> <SECTNO>721.11765</SECTNO> <SUBJECT>2H-Pyran, tetrahydro-4-methyl.</SUBJECT> <SECTNO>721.11766</SECTNO> <SUBJECT>Organic acid ester, polymer with aliphatic diols and 1,1′-methylenebis[4-isocyanatobenzene] (generic).</SUBJECT> <SECTNO>721.11767</SECTNO> <SUBJECT>4,4-Methylenebis (2,6-dimethyl phenol) polymer with 2-(chloromethyl)oxirane, 1,4-benzenediol, 2-methyl-2-propenoic acid, mixed alkyl substituted 2-methyl 2-propenoate, and ethyl 2-propenoate, reaction products with 2-(dimethylamino) ethanol (generic).</SUBJECT> <SECTNO>721.11768</SECTNO> <SUBJECT>Phenol, methylethylidene, polymer chloromethyl epoxide and methylethylidene bis-oxy, bis-amine (generic).</SUBJECT> <SECTNO>721.11769</SECTNO> <SUBJECT>Amine, methylethylidenebis(oxy) (generic).</SUBJECT> <SECTNO>721.11770</SECTNO> <SUBJECT>Carbamic acid, N-[3-(trialkoxysilyl)propyl]-, C,C′-[2,2,4(or 2,4,4)-trimethyl-1,6-hexanediyl] ester (generic).</SUBJECT> <SECTNO>721.11771</SECTNO> <SUBJECT>Arylfurandione, [bis(trihaloalkyl)alkylidene]bis-, polymer with alkanediamine (generic).</SUBJECT> <SECTNO>721.11772</SECTNO> <SUBJECT>Phosphonic acid, dimethyl ester, reaction products with alkyl-alkyl-alkanediol and alkanediol (generic).</SUBJECT> <SECTNO>721.11773</SECTNO> <SUBJECT>Silane, halogenated (generic).</SUBJECT> <SECTNO>721.11774</SECTNO> <SUBJECT>Heteromonocycle, polymer, substituted aliphatic carbamate, [2-[(1-oxo-2-propen-1-yl)oxy]alkyl]ester (generic).</SUBJECT> <SECTNO>721.11775</SECTNO> <SUBJECT>Alkanes, C4-8-branched and linear.</SUBJECT> <SECTNO>721.11776</SECTNO> <SUBJECT>5H-1,2-Oxathiole, 2,2-dioxide.</SUBJECT> <SECTNO>721.11777</SECTNO> <SUBJECT>Per- and poly-fluoroalkyl chemical substances designated as inactive on the TSCA Inventory.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>15 U.S.C. 2604, 2607, and 2625(c).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>49 FR 35018, Sept. 5, 1984, unless otherwise noted.</P> </SOURCE> <EDNOTE> <HD SOURCE="HED">Editorial Note:</HD> <P>Nomenclature changes to part 721 appear at 87 FR 39764, July 5, 2022.</P> </EDNOTE> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 721.1</SECTNO> <SUBJECT>Scope and applicability.</SUBJECT> <P>(a) This part identifies uses of chemical substances, except for microorganisms regulated under part 725 of this chapter, which EPA has determined are significant new uses under the authority of section 5(a)(2) of the Toxic Substances Control Act. In addition, it specifies procedures for manufacturers and processors to report on those significant new uses. This subpart A contains general provisions applicable to this part. Subpart B of this part identifies generic requirements for certain significant new uses cross referenced in specific provisions of subpart E of this part. Subpart C of this part identifies generic reporting requirements for certain significant new uses cross referenced in specific provisions of subpart E of this part. Subpart E of this part identifies chemical substances and their significant new uses.</P> <P>(b) This subpart A contains provisions governing submission and review of notices for the chemical substances and significant new uses identified in subpart E of this part. The provisions of this subpart A apply to the chemical substances and significant new uses identified in subpart E of this part, except to the extent that they are specifically modified or supplanted by specific requirements in subpart E of this part. In the event of a conflict between the provisions of this subpart A and the provisions of subpart E of this part, the provisions of subpart E of this part shall govern.</P> <P>(c) The provisions of part 720 of this chapter apply to this part 721. For purposes of this part 721, wherever the phrase “new chemical substance” appears in part 720 of this chapter, it shall mean the chemical substance subject to this part 721. In the event of a conflict between the provisions of part 720 of this chapter and the provisions of this part 721, the provisions of this part 721 shall govern.</P> <CITA>[53 FR 28358, July 27, 1988, as amended at 62 FR 17932, Apr. 11, 1997; 87 FR 39764, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>The definitions in section 3 of the Act, 15 U.S.C. 2602, and § 720.3 of this chapter apply to this part. In addition, the following definitions apply to this part:</P> <P> <E T="03">Acutely toxic effects</E> A chemical substance produces acutely toxic effects if <PRTPAGE P="291"/> it kills within a short time period (usually 14 days): </P> <P> (1) At least 50 percent of the exposed mammalian test animals following oral administration of a single dose of the test substance at 25 milligrams or less per kilogram of body weight (LD <E T="52">50</E> ). </P> <P> (2) At least 50 percent of the exposed mammalian test animals following dermal administration of a single dose of the test substance at 50 milligrams or less per kilogram of body weight (LD <E T="52">50</E> ). </P> <P> (3) At least 50 percent of the exposed mammalian test animals following administration of the test substance for 8 hours or less by continuous inhalation at a steady concentration in air at 0.5 milligrams or less per liter of air (LC <E T="52">50</E> ). </P> <P> <E T="03">CAS Number</E> means Chemical Abstracts Service Registry Number assigned to a chemical substance on the Inventory. </P> <P> <E T="03">Chemical name</E> means the scientific designation of a chemical substance in accordance with the nomenclature system developed by the International Union of Pure and Applied Chemistry or the Chemical Abstracts Service's rules of nomenclature, or a name which will clearly identify a chemical substance for the purpose of conducting a hazard evaluation. </P> <P> <E T="03">Chemical protective clothing</E> means items of clothing that provide a protective barrier to prevent dermal contact with chemical substances of concern. Examples can include, but are not limited to: full body protective clothing, boots, coveralls, gloves, jackets, and pants. </P> <P> <E T="03">Commercial use</E> means the use of a chemical substance or any mixture containing the chemical substance in a commercial enterprise providing saleable goods or a service to consumers (e.g., a commercial dry cleaning establishment or painting contractor). </P> <P> <E T="03">Common name</E> means any designation or identification such as code name, code number, trade name, brand name, or generic chemical name used to identify a chemical substance other than by its chemical name. </P> <P> <E T="03">Consumer</E> means a private individual who uses a chemical substance or any product containing the chemical substance in or around a permanent or temporary household or residence, during recreation, or for any personal use or enjoyment. </P> <P> <E T="03">Consumer product</E> means a chemical substance that is directly, or as part of a mixture, sold or made available to consumers for their use in or around a permanent or temporary household or residence, in or around a school, or in recreation. </P> <P> <E T="03">Customer</E> means any person to whom a manufacturer or processor distributes any quantity of a chemical substance, or of a mixture containing the chemical substance, whether or not a sale is involved. </P> <P> <E T="03">Director of the Office of Pollution Prevention and Toxics</E> means the Director of the EPA Office of Pollution Prevention and Toxics or any EPA employee delegated by the Office Director to carry out the Office Director's functions under this part. </P> <P> <E T="03">Employer</E> means any manufacturer, processor, or user of chemical substances or mixtures. </P> <P> <E T="03">Environmentally transformed</E> A chemical substance is “environmentally transformed” when its chemical structure changes as a result of the action of environmental processes on it. </P> <P> <E T="03">Facility</E> means all buildings, equipment, structures, and other stationary items which are located on a single site or on contiguous or adjacent sites and which are owned or operated by the same person (or by any person which controls, is controlled by, or under common control with such person). </P> <P> <E T="03">Identity</E> means any chemical or common name used to identify a chemical substance or a mixture containing that substance. </P> <P> <E T="03">Immediate use</E> A chemical substance is for the “immediate use” of a person if it is under the control of, and used only by, the person who transferred it from a labeled container and will only be used by that person within the work shift in which it is transferred from the labeled container. </P> <P> <E T="03">Impervious</E> Chemical protective clothing is “impervious” to a chemical substance if the substance causes no chemical or mechanical degradation, permeation, or penetration of the chemical protective clothing under the conditions of, and the duration of, exposure. <PRTPAGE P="292"/> </P> <P> <E T="03">Manufacturing stream</E> means all reasonably anticipated transfer, flow, or disposal of a chemical substance, regardless of physical state or concentration, through all intended operations of manufacture, including the cleaning of equipment. </P> <P> <E T="03">Metalworking fluid</E> means a liquid of any viscosity or color containing intentionally added water and used in metal machining operations for the purpose of cooling, lubricating, or rust inhibition. </P> <P> <E T="03">NIOSH</E> means the National Institute for Occupational Safety and Health of the U.S. Department of Health and Human Services. </P> <P> <E T="03">Non-enclosed process</E> means any equipment system (such as an open-top reactor, storage tank, or mixing vessel) in which a chemical substance is manufactured, processed, or otherwise used where significant direct contact of the bulk chemical substance and the workplace air may occur. </P> <P> <E T="03">Non-industrial use</E> means use other than at a facility where chemical substances or mixtures are manufactured or processed. </P> <P> <E T="03">Personal protective equipment</E> means any chemical protective clothing or device placed on the body to prevent contact with, and exposure to, an identified chemical substance or substances in the work area. Examples include, but are not limited to, chemical protective clothing, aprons, hoods, chemical goggles, face splash shields, or equivalent eye protection, and various types of respirators. Barrier creams are not included in this definition. </P> <P> <E T="03">Powder or dry solid form</E> means a state where all or part of the substance would have the potential to become fine, loose, solid particles. </P> <P> <E T="03">Principal importer</E> means the first importer who, knowing that a chemical substance will be imported for a significant new use rather than manufactured in the United States, specifies the chemical substance and the amount to be imported. Only persons who are incorporated, licensed, or doing business in the United States may be principal importers. </P> <P> <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture containing the chemical substance, after manufacture of the substance, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture containing the chemical substance is included in this definition. If a chemical substance or mixture containing impurities is processed for commercial purposes, the impurities also are processed for commercial purposes. </P> <P> <E T="03">Process solely for export</E> means to process for commercial purposes solely for export from the United States under the following restrictions on activity in the United States: Processing must be performed at sites under the control of the processor; distribution in commerce is limited to purposes of export; and the processor may not use the chemical substance except in small quantities solely for research and development. </P> <P> <E T="03">Process stream</E> means all reasonably anticipated transfer, flow, or disposal of a chemical substance, regardless of physical state or concentration, through all intended operations of processing, including the cleaning of equipment. </P> <P> <E T="03">Recipient</E> means any person who purchases or otherwise obtains a chemical substance directly from a person who manufactures or processes the substance. </P> <P> <E T="03">Safety Data Sheet (SDS)</E> means written or printed material concerning a hazardous chemical substance that is prepared as required under § 721.72(c). </P> <P> <E T="03">Serious acute effects</E> means human injury or human disease processes that have a short latency period for development, result from short-term exposure to a chemical substance, or are a combination of these factors and which are likely to result in death or severe or prolonged incapacitation. </P> <P> <E T="03">Serious chronic effects</E> means human injury or human disease processes that have a long latency period for development, result from long-term exposure to a chemical substance, or are a combination of these factors and which are likely to result in death or severe or prolonged incapacitation. </P> <P> <E T="03">Short-term test indicative of carcinogenic potential</E> means either any limited bioassay that measures tumor or <PRTPAGE P="293"/> preneoplastic induction, or any test indicative of interaction of a chemical substance with DNA (i.e., positive response in assays for gene mutation, chromosomal aberrations, DNA damage and repair, or cellular transformation). </P> <P> <E T="03">Short-term test indicative of the potential to cause a developmentally toxic effect</E> means either any <E T="03">in vivo</E> preliminary development toxicity screen conducted in a mammalian species, or any <E T="03">in vitro</E> developmental toxicity screen, including any test system other than the intact pregnant mammal, that has been extensively evaluated and judged reliable for its ability to predict the potential to cause developmentally toxic effects in intact systems across a broad range of chemicals or within a class of chemicals that includes the substance of concern. </P> <P> <E T="03">Significant adverse environmental effects</E> means injury to the environment by a chemical substance which reduces or adversely affects the productivity, utility, value, or function of biological, commercial, or agricultural resources, or which may adversely affect a threatened or endangered species. A substance will be considered to have the potential for significant adverse environmental effects if it has one of the following: </P> <P> (1) An acute aquatic EC <E T="52">50</E> of 1 mg/L or less. </P> <P> (2) An acute aquatic EC <E T="52">50</E> of 20 mg/L or less where the ratio of aquatic vertebrate 24-hour to 48-hour EC <E T="52">50</E> is greater than or equal to 2.0. </P> <P>(3) A Maximum Acceptable Toxicant Concentration (MATC) of less than or equal to 100 parts per billion (100 ppb).</P> <P> (4) An acute aquatic EC <E T="52">50</E> of 20 mg/L or less coupled with either a measured bioconcentration factor (BCF) equal to or greater than 1,000x or in the absence of bioconcentration data a log P value equal to or greater than 4.3. </P> <P> <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way is one site. There may be more than one manufacturing plant on a single site. </P> <P> <E T="03">Site-limited intermediate</E> means an intermediate manufactured, processed, and used only within a site and not distributed in commerce other than as an impurity or for disposal. Imported intermediates cannot be “site-limited.” </P> <P> <E T="03">Spray application</E> means any method of projecting a jet of vapor of finely divided liquid onto a surface to be coated; whether by compressed air, hydraulic pressure, electrostatic forces, or other methods of generating a spray. </P> <P> <E T="03">Use stream</E> means all reasonably anticipated transfer, flow, or disposal of a chemical substance, regardless of physical state or concentration, through all intended operations of industrial, commercial, or consumer use. </P> <P> <E T="03">Waters of the United States</E> has the meaning set forth in 40 CFR 122.2. </P> <P> <E T="03">Work area</E> means a room or defined space in a workplace where a chemical substance is manufactured, processed, or used and where employees are present. </P> <P> <E T="03">Workplace</E> means an establishment at one geographic location containing one or more work areas. </P> <CITA>[53 FR 28358, July 27, 1988, as amended at 54 FR 31306, July 27, 1989; 58 FR 63516, Dec. 1, 1993; 87 FR 39764, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.5</SECTNO> <SUBJECT>Persons who must report.</SUBJECT> <P>(a) The following persons must submit a significant new use notice as specified under the provisions of section 5(a)(1)(B) of the Act, part 720 of this chapter, and § 721.25:</P> <P>(1) A person who intends to manufacture or process for commercial purposes a chemical substance identified in a specific section in subpart E of this part, and intends to engage in a significant new use of the substance identified in that section.</P> <P>(2) A person who intends to manufacture or process for commercial purposes a chemical substance identified in a specific section in subpart E of this part, and intends to distribute the substance in commerce. A person described in this paragraph is not required to submit a significant new use notice if that person can document one or more of the following as to each recipient of the substance from that person:</P> <P> (i) That the person has notified the recipient, in writing, of the specific section in subpart E of this part which identifies the substance and its designated significant new uses. <PRTPAGE P="294"/> </P> <P>(ii) That the recipient has knowledge of the specific section in subpart E of this part which identifies the substance and its designated significant new uses.</P> <P>(iii) That the recipient cannot undertake any significant new use described in the specific section in subpart E of this part.</P> <P>(b) A person described in paragraph (a)(2) of this section must submit a significant new use notice if that person has knowledge at the time of commercial distribution of the substance identified in the specific section in subpart E of this part that a recipient intends to engage in a designated significant new use of that substance without submitting a notice under this part.</P> <P>(c) A person who processes a chemical substance identified in a specific section in subpart E of this part for a significant new use of that substance is not required to submit a significant new use notice if that person can document each of the following:</P> <P>(1) That the person does not know the specific chemical identity of the chemical substance being processed.</P> <P>(2) That the person is processing the chemical substance without knowledge that the substance is identified in subpart E of this part.</P> <P>(d)(1) If at any time after commencing distribution in commerce of a chemical substance identified in a specific section in subpart E of this part a person described in paragraph (a)(2) of this section has knowledge that a recipient of the substance is engaging in a significant new use of that substance designated in that section without submitting a notice under this part, the person is required to cease supplying the chemical substance to that recipient and to submit a significant new use notice for that chemical substance and significant new use, unless the person is able to document each of the following:</P> <P>(i) That the person has notified the recipient and EPA enforcement authorities (at the address in paragraph (d)(1)(iii) of this section), in writing within 15 working days of the time the person develops knowledge that the recipient is engaging in a significant new use, that the recipient is engaging in a significant new use without submitting a significant new use notice.</P> <P>(ii) That, within 15 working days of notifying the recipient as described in paragraph (d)(1)(i) of this section, the person received from the recipient, in writing, a statement of assurance that the recipient is aware of the terms of the applicable section in subpart E of this part and will not engage in the significant new use.</P> <P>(iii) That the person has promptly provided EPA enforcement authorities with a copy of the recipient's statement of assurance described in paragraph (d)(1)(ii) of this section. The copy must be sent to the Office of Enforcement and Compliance Assurance, Office of Compliance (2224A), U.S. Environmental Protection Agency, Ariel Rios, 1200 Pennsylvania Ave., N.W., Washington, DC, 20044.</P> <P>(2) If EPA notifies the manufacturer or processor that the recipient is engaging in a significant new use after providing the statement of assurance described in paragraph (d)(1)(ii) of this section and without submitting a notice under this part, the manufacturer or processor shall immediately cease distribution to that recipient until the manufacturer or processor or the recipient has submitted a significant new use notice under this part and the notice review period has ended.</P> <P>(3) If, after receiving a statement of assurance from a recipient under paragraph (d)(1)(ii) of this section, a manufacturer or processor has knowledge that the recipient is engaging in a significant new use without submitting a notice under this part, the manufacturer or processor must immediately cease distributing the substance to that recipient and notify EPA enforcement authorities at the address identified in paragraph (d)(1)(iii) of this section. The manufacturer or processor may not resume distribution to that recipient until any one of the following has occurred:</P> <P>(i) The manufacturer or processor has submitted a significant new use notice under this part and the notice review period has ended.</P> <P> (ii) The recipient has submitted a significant new use notice under this part and the notice review period has ended. <PRTPAGE P="295"/> </P> <P>(iii) The manufacturer or processor has received notice from EPA enforcement authorities that it may resume distribution to that recipient.</P> <P>(e) Any significant new use notice relating to import of a substance must be submitted by the principal importer.</P> <CITA>[53 FR 28359, July 27, 1988, as amended at 60 FR 34464, July 3, 1995; 87 FR 39764, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.11</SECTNO> <SUBJECT>Applicability determination when the specific chemical identity is confidential.</SUBJECT> <P> (a) A person who intends to manufacture or process a chemical substance which is subject to a significant new use rule in subpart E of this part may ask EPA whether the substance or a proposed use is subject to the requirements of this part if that substance is described by a generic chemical name or if the significant new use is confidential and therefore not described specifically in the rule. EPA will answer such an inquiry only if EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture or process the chemical substance for commercial purposes. </P> <P> (b) To establish a <E T="03">bona fide</E> intent to manufacture (including import) or process a chemical substance, the person who proposes to manufacture (including import) or process the substance must submit the request to EPA via CDX. Prior to submission to EPA via CDX, such <E T="03">bona fide</E> intents to manufacture (including import) or process must be generated and completed using e-PMN software. See 40 CFR 720.40(a)(2)(ii) for information on how to access the e-PMN software. A <E T="03">bona fide</E> intent to manufacture (including import) or process must contain: </P> <P>(1) The specific chemical identity of the chemical substance that the person intends to manufacture (including import) or process.</P> <P>(2) A signed statement that the person intends to manufacture (including import) or process the chemical substance for commercial purposes.</P> <P>(3) A description of the research and development activities conducted to date, and the purpose for which the person will manufacture (including import) or process the chemical substance.</P> <P>(4) An elemental analysis.</P> <P>(5) Either an X-ray diffraction pattern (for inorganic substances), a mass spectrum (for most other substances), or an infrared spectrum of the particular chemical substance, or, if such data do not resolve uncertainties with respect to the identity of the chemical substance, additional or alternative spectra or other data to identify the substance.</P> <P>(c) If an importer or processor cannot provide all the information required in paragraph (b) of this section because it is claimed as confidential business information by the importer's or processor's manufacturer or supplier, the manufacturer or supplier may supply the information directly to EPA.</P> <P>(d) EPA will review the information submitted by the manufacturer (including importer) or processor under paragraph (b) of this section to determine whether that person has shown a bona fide intent to manufacture (including import) or process the chemical substance. If necessary, EPA will compare this information to the information requested for the confidential chemical substance under § 720.85(b)(3)(iii) of this chapter.</P> <P> (e) If the manufacturer or processor has shown a <E T="03">bona fide</E> intent to manufacture or process the substance and has provided sufficient unambiguous chemical identity information to enable EPA to make a conclusive determination as to the identity of the substance, EPA will inform the manufacturer or processor whether the chemical substance is subject to this part and, if so, which section in subpart E of this part applies, and identify any confidential significant new use designations. </P> <P> (f) A disclosure to a person with a <E T="03">bona fide</E> intent to manufacture or process a particular chemical substance that the substance is subject to this part or of confidential significant new use designations will not be considered public disclosure of confidential business information under section 14 of the Act. </P> <P> (g) EPA will answer an inquiry on whether a particular chemical substance is subject to this part or identify and confidential significant new uses within 30 days after receipt of a <PRTPAGE P="296"/> complete submission under paragraph (b) of this section. </P> <CITA>[53 FR 28359, July 27, 1988, as amended at 60 FR 34464, July 3, 1995; 71 FR 33641, June 12, 2006; 80 FR 42746, July 20, 2015; 87 FR 39764, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.20</SECTNO> <SUBJECT>Exports and imports.</SUBJECT> <P>Persons who intend to export a chemical substance identified in subpart E of this part, or in any proposed rule which would amend subpart E of this part, are subject to the export notification provisions of section 12(b) of the Act. The regulations that interpret section 12(b) appear at 40 CFR part 707. Persons who import a substance identified in a specific section in subpart E of this part are subject to the import certification requirements under section 13 of the Act, which are codified at 19 CFR 12.118 through 12.127 and 127.28. The EPA policy in support of the import certification requirements appears at 40 CFR part 707.</P> <CITA>[53 FR 28360, July 27, 1988]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.25</SECTNO> <SUBJECT>Notice requirements and procedures.</SUBJECT> <P>(a) Each person who is required to submit a significant new use notice under this part must submit the notice at least 90 calendar days before commencing manufacture or processing of a chemical substance identified in subpart E of this part for a significant new use. The submitter must comply with any applicable requirement of section 5(b) of the Act, and the notice must include the information and test data specified in section 5(d)(1) of the Act. The notice must be submitted on EPA Form 7710-25, and must comply with the requirements of part 720 of this chapter, except to the extent that they are inconsistent with this part 721.</P> <P>(b) If two or more persons are required to submit a significant new use notice for the same chemical substance and significant new use identified in subpart E of this part, they may submit a joint notice to EPA. Persons submitting a joint notice must individually complete the certification section of part I of the required notification form. Persons who are required to submit individually, but elect to submit jointly, remain individually liable for the failure to submit required information which is known to or reasonably ascertainable by them and test data in their possession or control.</P> <P>(c) EPA will process the notice in accordance with the procedures of part 720 of this chapter, except to the extent they are inconsistent with this part.</P> <P>(d) Any person submitting a significant new use notice in response to the requirements of this part 721 shall not manufacture or process a chemical substance identified in subpart E of this part for a significant new use until the notice review period, including all extensions and suspensions, has expired.</P> <CITA>[53 FR 28360, July 27, 1988, as amended at 60 FR 16311, Mar. 29, 1995; 75 FR 787, Jan. 6, 2010; 87 FR 39765, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.30</SECTNO> <SUBJECT>EPA approval of alternative control measures.</SUBJECT> <P>(a) In certain sections of subpart E of this part, significant new uses for the identified substances are described as the failure to establish and implement programs providing for the use of either: specific measures to control worker exposure to or release of substances which are identified in such sections, or alternative measures to control worker exposure or environmental release which EPA has determined provide substantially the same degree of protection as the specified control measures. Persons who manufacture or process a chemical substance identified in such sections and who intend to employ alternative measures to control worker exposure or environmental release must submit a request to EPA for a determination of equivalency before commencing manufacture or processing involving the alternative control measures.</P> <P>(b) Persons submitting a request for a determination of equivalency to EPA under this part must submit the request to EPA via CDX using e-PMN software in the manner set forth in 40 CFR 720.40(a)(2)(i). See 40 CFR 720.40(a)(2)(ii) for information on how to obtain e-PMN software. Support documents related to these requests must be submitted in the manner set forth in 40 CFR 720.40(c). A request for a determination of equivalency must contain:</P> <P> (1) The name of the submitter. <PRTPAGE P="297"/> </P> <P>(2) The specific chemical identity of the substance.</P> <P>(3) The citation for the specific section in subpart E of this part which pertains to the substance for which the request is being submitted.</P> <P>(4) A detailed description of the activities involved.</P> <P>(5) The specifications of the alternative worker exposure control measures or environmental release control measures.</P> <P>(6) An analysis justifying why such alternative control measures provide substantially the same degree of protection as the specific control measures identified in the specific section in subpart E of this part which pertains to the substance for which the request is being submitted.</P> <P>(7) The data and information described in § 720.50 (a) and (b) of this chapter unless such data and information have already been submitted to the Office of Pollution Prevention and Toxics, EPA.</P> <P>(c) Requests for determinations of equivalency will be reviewed by EPA within 45 days. Determinations under this paragraph will be made by the Director, Office of Pollution Prevention and Toxics, or designee. Notice of the results of such determinations will be mailed to the submitter.</P> <P>(d) If EPA notifies the submitter under paragraph (c) of this section that EPA has determined that the alternative control measures provide substantially the same degree of protection as the specified control measures identified in the specified section of subpart E of this part which pertains to the substance for which the request is being submitted, the submitter may commence manufacture or processing in accordance with the specifications for alternative worker exposure control measures or environmental release control measures identified in the submitter's request, and may alter any corresponding notification to workers to reflect such alternative controls. Deviations from the activities described in the EPA notification constitute a significant new use and are subject to the requirements of this part.</P> <CITA>[53 FR 28360, July 27, 1988, as amended at 60 FR 34464, July 3, 1995; 71 FR 33641, June 12, 2006; 75 FR 787, Jan. 6, 2010; 78 FR 72827, Dec. 4, 2013; 87 FR 39765, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.35</SECTNO> <SUBJECT>Compliance and enforcement.</SUBJECT> <P>(a) Failure to comply with any provision of this part is a violation of section 15(1) of the Act (15 U.S.C. 2614).</P> <P>(b) Using for commercial purposes a chemical substance which a person knew or had reason to know was manufactured or processed in violation of this part is a violation of section 15(2) of the Act (15 U.S.C. 2614).</P> <P>(c) Failure or refusal to permit access to or copying of records, as required by section 11 of the Act, is a violation of section 15(3) of the Act (15 U.S.C. 2614).</P> <P>(d) Failure or refusal to permit entry or inspection, as required by section 11 of the Act, is a violation of section 15(4) of the Act.</P> <P>(e) Violators of the Act or of this part may be subject to the civil and criminal penalties in section 16 of the Act (15 U.S.C. 2615) for each violation. The submission of false or misleading information in connection with the requirement of any provision of this part may subject persons to penalties calculated as if they never filed a notice.</P> <P>(f) Under the authority of sections 7 and 17 of the Act, EPA may:</P> <P>(1) Seek to enjoin the manufacture or processing of a chemical substance in violation of this part.</P> <P>(2) Act to seize any chemical substance which is being manufactured or processed in violation of this part.</P> <P>(3) Take any other appropriate action.</P> <CITA>[53 FR 28361, July 27, 1988, as amended at 87 FR 39765, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.40</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <P>Any person subject to the requirements of this part must retain documentation of information contained in that person's significant new use notice. This documentation must be maintained for a period of 5 years from the date of the submission of the significant new use notice.</P> <CITA>[53 FR 28361, July 27, 1988]</CITA> </SECTION> <SECTION> <PRTPAGE P="298"/> <SECTNO>§ 721.45</SECTNO> <SUBJECT>Exemptions.</SUBJECT> <P>The persons identified in § 721.5 are not subject to the notification requirements of § 721.25 for a chemical substance identified in subpart E of this part, unless otherwise specified in a specific section in subpart E, if:</P> <P>(a) The person has applied for and has been granted an exemption for test marketing the substance for a significant new use identified in subpart E of this part in accordance with section 5(h)(1) of the Act and § 720.38 of this chapter.</P> <P>(b) The person manufactures or processes the substance for a significant new use identified in subpart E of this part in small quantities solely for research and development in accordance with § 721.47.</P> <P>(c) The person has applied for and been granted an exemption under section 5(h)(5) of the Act.</P> <P>(d) The person manufactures or processes the substance only as an impurity.</P> <P>(e) The person manufactures or processes the substance only as a byproduct which is used only by public or private organizations that (1) burn it as a fuel, (2) dispose of it as a waste, including in a landfill or for enriching soil, or (3) extract component chemical substances from it for commercial purposes.</P> <P>(f) The person imports or processes the substance as part of an article.</P> <P>(g) The person manufactures or processes the substance solely for export and, when distributing the substance in commerce, labels the substance in accordance with section 12(a)(1)(B) of the Act.</P> <P>(h) The person submits a significant new use notice for the substance prior to the promulgation date of the section in subpart E of this part which identifies the substance, and the person receives written notification of compliance from EPA prior to the effective date of such section. The notice submitter must comply with any applicable requirement of section 5(b) of the Act. The notice must include the information and test data specified in section 5(d)(1) of the Act and must be submitted on the notice form in appendix A to part 720 of this chapter. For purposes of this exemption, the specific section in subpart E of this part which identifies the substance and §§ 721.1, 721.3, 721.11, 721.35, and 721.40 apply; after the effective date of the section in subpart E of this part which identifies the substance, § 721.5 applies and § 721.20 continues to apply. EPA will provide the notice submitter with written notification of compliance only if one of the following occurs:</P> <P>(1) EPA is unable to make the finding that the activities described in the significant new use notice will or may present an unreasonable risk of injury to health or the environment under reasonably foreseeable circumstances.</P> <P>(2) EPA and the person negotiate a consent order under section 5(e) of the Act, such order to take effect on the effective date of the section in subpart E of this part which identifies the substance.</P> <P>(i) The person is operating under the terms of a consent order issued under section 5(e) of the Act applicable to that person. If a provision of such section 5(e) order is inconsistent with a specific significant new use identified in subpart E of this part, abiding by the provision of the section 5(e) order exempts the person from submitting a significant new use notice for that specific significant new use.</P> <CITA>[53 FR 28361, July 27, 1988, as amended at 87 FR 39765, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.47</SECTNO> <SUBJECT>Conditions for research and development exemption.</SUBJECT> <P>(a) A person who manufactures or processes a chemical substance identifies in subpart E of this part for a significant new use identified in subpart E of this part is not subject to the notification requirements of § 721.25 if the following conditions are met:</P> <P>(1) The person manufactures or processes the substance for the significant new use in small quantities solely for research and development.</P> <P> (2) The manufacturer or processor notifies all persons in its employ or to whom it directly distributes the chemical substance, who are engaged in experimentation, research, or analysis on the chemical substance, including the manufacture, processing, use, transport, storage, and disposal of the substance associated with research and development activities, of any risk to <PRTPAGE P="299"/> health, identified under paragraph (b) of this section, which may be associated with the substance. The notification must be made in accordance with paragraph (c) of this section. </P> <P>(3) The chemical substance is used by, or directly under the supervision of, a technically qualified individual.</P> <P>(b)(1) To determine whether notification under paragraph (a)(2) of this section is required, the manufacturer or processor must review and evaluate the following information to determine whether there is reason to believe there is any risk to health which may be associated with the chemicals substance:</P> <P>(i) Information in its possession or control concerning any significant adverse reaction by persons exposed to the chemical substance which may reasonably be associated with such exposure.</P> <P>(ii) Information provided to the manufacturer or processor by a supplier or any other person concerning a health risk believed to be associated with the substance.</P> <P>(iii) Health and environmental effects data in its possession or control concerning the substance.</P> <P>(iv) Information on health effects which accompanies any EPA rule or order issued under section 4, 5, or 6 of the Act that applies to the substance and of which the manufacturer or processor has knowledge.</P> <P>(2) When the research and development activity is conducted solely in a laboratory and exposure to the chemical substance is controlled through the implementation of prudent laboratory practices for handling chemical substances of unknown toxicity, and any distribution, except for purposes of disposal, is to other such laboratories for further research and development activity, the information specified in paragraph (b)(1) of this section need not be reviewed and evaluated. (For purposes of this paragraph (b)(2), a laboratory is defined as a contained research facility where relatively small quantities of chemical substances are used on a pro-production basis, and where activities involve the use of containers for reactions, transfers, and other handling of substances designed to be easily manipulated by a single individual).</P> <P>(c)(1) The manufacturer or processor must notify the persons identified in paragraph (a)(2) of this section by means of a container labeling system, conspicuous placement of notices in areas where exposure may occur, written notification to each person potentially exposed, or any other method of notification which adequately informs persons of health risks which the manufacturer or processor has reason to believe may be associated with the substance, as determined under paragraph (b)(1) of this section.</P> <P>(2) If the manufacturer or processor distributes a chemical substance manufactured or processed under this section to persons not in its employ, the manufacturer or processor must in written form:</P> <P>(i) Notify those persons that the substance is to be used only for research and development purposes.</P> <P>(ii) Provide the notice of health risks specified in paragraph (c)(1) of this section.</P> <P>(3) The adequacy of any notification under this section is the responsibility of the manufacturer or processor.</P> <P>(d) Quantities of the chemical substance, or of mixtures or articles containing the chemical substance, remaining after completion of research and development activities may be:</P> <P>(1) Disposed of as a waste in accordance with applicable Federal, State, and local regulations, to the extent the disposal activity is not identified as a significant new use for the substance in subpart E of this part, or</P> <P>(2) Used for a commercial purpose, to the extent the use is not identified as a significant new use of the substance in subpart E of this part.</P> <P>(e)(1) Persons who manufacture or process a chemical substance under this section must retain the following records:</P> <P>(i) Copies of or citations to information reviewed and evaluated under paragraph (b)(1) of this section to determine the need to make any notification of risk.</P> <P> (ii) Documentation of the nature and method of notification under paragraph (c)(1) of this section including copies of any labels or written notices used. <PRTPAGE P="300"/> </P> <P>(iii) Documentation of prudent laboratory practices used instead of notification and evaluation under paragraph (b)(2) of this section.</P> <P>(iv) The names and addresses of any persons other than the manufacturer or processor to whom the substance is distributed, the identity of the substance, the amount distributed, and copies of the notifications required under paragraph (c)(2) of this section.</P> <P>(2) [Reserved]</P> <CITA>[53 FR 28361, July 27, 1988, as amended at 58 FR 34204, June 23, 1993; 87 FR 39765, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Certain Significant New Uses</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>54 FR 31308, July 27, 1989, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 721.50</SECTNO> <SUBJECT>Applicability.</SUBJECT> <P>This subpart B identifies certain significant new uses of chemical substances identified in subpart E of this part. The provisions of this subpart B apply only when referenced as applying to a chemical substance identified in subpart E of this part.</P> </SECTION> <SECTION> <SECTNO>§ 721.63</SECTNO> <SUBJECT>Protection in the workplace.</SUBJECT> <P>(a) Whenever a substance is identified in subpart E of this part as being subject to this section, any manner or method of manufacturing (including importing) or processing associated with any use of the substance is considered a significant new use unless a program is established whereby:</P> <P>(1) Each person who is reasonably likely to be dermally exposed in the work area to the chemical substance through direct handling of the substance or through contact with equipment on which the substance may exist, or because the substance becomes airborne in the form listed in paragraph (a)(6) of this section, and cited in subpart E of this part for the chemical substance, is provided with, and is required to wear, personal protective equipment that provides a barrier to prevent dermal exposure to the substance in the specific work area where it is selected for use. Each such item of personal protective equipment must be selected and used in accordance with 29 CFR 1910.132 and 1910.133.</P> <P>(2) In addition to any other personal protective equipment selected in paragraph (a)(1) of this section, the following items are required:</P> <P>(i) Gloves.</P> <P>(ii) Full body chemical protective clothing.</P> <P>(iii) Chemical goggles or equivalent eye protection.</P> <P>(iv) Clothing which covers any other exposed areas of the arms, legs, and torso. Clothing provided under this paragraph need not be tested or evaluated under the requirements of paragraph (a)(3) of this section.</P> <P>(3) The employer is able to demonstrate that each item of chemical protective clothing, including gloves, selected provides an impervious barrier to prevent dermal exposure during normal and expected duration and conditions of exposure within the work area by any one or a combination of the following:</P> <P>(i) Testing the material used to make the chemical protective clothing and the construction of the clothing to establish that the protective clothing will be impervious for the expected duration and conditions of exposure. The testing must subject the chemical protective clothing to the expected conditions of exposure, including the likely combinations of chemical substances to which the clothing may be exposed in the work area.</P> <P>(ii) Evaluating the specifications from the manufacturer or supplier of the chemical protective clothing, or of the material used in construction of the clothing, to establish that the chemical protective clothing will be impervious to the chemical substance alone and in likely combination with other chemical substances in the work area.</P> <P> (4) Each person who is reasonably likely to be exposed to the chemical substance by inhalation in the work area in one or more of the forms listed in paragraph (a)(6) of this section and cited in subpart E of this part for the chemical substance, is provided with, and is required to wear, at a minimum, a NIOSH-approved respirator from one of the categories listed in paragraph (a)(5) of this section, and the respirator <PRTPAGE P="301"/> is used in accordance with 29 CFR 1910.134 and 42 CFR part 84. </P> <P>(5) The following NIOSH-certified respirators meet the requirements for paragraph (a)(4) of this section:</P> <P>(i) Category 19C Type C supplied-air respirator operated in pressure demand or other positive pressure mode and equipped with a full facepiece.</P> <P>(ii) Category 19C Type C supplied-air respirator operated in pressure demand or continuous flow mode and equipped with a tight-fitting facepiece.</P> <P>(iii) Category 19C Type C supplied-air respirator operated in pressure demand or continuous flow mode and equipped with a hood or helmet or tight-fitting facepiece.</P> <P>(iv) Category 21C air-purifying respirator equipped with a full facepiece and high efficiency particulate filters.</P> <P>(v) Category 21C powered air-purifying respirator equipped with a tight-fitting facepiece and high efficiency particulate filters.</P> <P>(vi) Category 21C powered air-purifying respirator equipped with a loose-fitting hood or helmet and high efficiency particulate filters.</P> <P>(vii) Category 21C air-purifying respirator equipped with a high efficiency particulate filter including disposable respirators.</P> <P>(viii) Category 23C air-purifying respirator equipped with a full facepiece and combination cartridges approved for paints, lacquers, and enamels. (Approval label may preclude use for some paints, lacquers, or enamels.)</P> <P>(ix) Category 23C powered air-purifying respirator equipped with a tight-fitting facepiece and combination cartridges approved for paints, lacquers, and enamels. (Approval label may preclude use for some paints, lacquers, or enamels.)</P> <P>(x) Category 23C powered air-purifying respirator equipped with a loose-fitting hood or helmet and combination cartridges approved for paints, lacquers, and enamels. (Approval label may preclude use for some paints, lacquers, or enamels.)</P> <P>(xi) Category 23C air-purifying respirator equipped with combination cartridges approved for paints, lacquers, and enamels, including disposable respirators. (Approval label may preclude use for some paints, lacquers, or enamels.)</P> <P>(xii) Category 23C air-purifying respirator equipped with a full facepiece and organic gas/vapor cartridges.</P> <P>(xiii) Category 23C powered air-purifying respirator equipped with a tight-fitting facepiece and organic gas/vapor cartridges.</P> <P>(xiv) Category 23C powered air-purifying respirator equipped with a loose-fitting hood or helmet and organic gas/vapor cartridges.</P> <P>(xv) Category 23C air-purifying respirator equipped with organic gas/vapor cartridges, including disposable respirators.</P> <P>(xvi) NIOSH-certified N100 (if oil aerosols absent), R100, or P100 filtering facepiece respirator. (APF =10).</P> <P>(xvii) NIOSH-certified air-purifying half-mask respirator equipped with N100 (if oil aerosols absent), R100, or P100 filters. (APF =10).</P> <P>(xviii) NIOSH-certified air-purifying half mask respirator equipped with appropriate gas/vapor cartridges. (APF =10).</P> <P>(xix) NIOSH-certified air-purifying half-mask respirator equipped with appropriate gas/vapor cartridges in combination with N100, R100, or P100 filters or an appropriate canister incorporating N100, R100, or P100 filters. (APF =10).</P> <P>(xx) NIOSH-certified negative pressure (demand) supplied-air respirator equipped with a half-mask. (APF =10).</P> <P>(xxi) NIOSH-certified negative pressure (demand) self-contained breathing apparatus (SCBA) equipped with a half mask. (APF =10).</P> <P>(xxii) NIOSH-certified powered air-purifying respirator equipped with a hood or helmet and HEPA filters. (APF =25).</P> <P>(xxiii) NIOSH-certified powered air-purifying respirator with a hood or helmet equipped with appropriate gas/vapor cartridges. (APF =25).</P> <P>(xxiv) NIOSH-certified powered air-purifying respirator with a hood or helmet and with appropriate gas/vapor cartridges in combination with HEPA filters. (APF =25).</P> <P> (xxv) NIOSH-certified powered air-purifying respirator equipped with a loose fitting facepiece and HEPA filters. (APF =25). <PRTPAGE P="302"/> </P> <P>(xxvi) NIOSH-certified powered air-purifying respirator equipped with a loose fitting facepiece with appropriate gas/vapor cartridges. (APF =25).</P> <P>(xxvii) NIOSH-certified powered air-purifying respirator equipped with a loose fitting facepiece with appropriate gas/vapor cartridges in combination with HEPA filters. (APF =25).</P> <P>(xxviii) NIOSH-certified continuous flow supplied-air respirator equipped with a hood or helmet. (APF =25).</P> <P>(xxix) NIOSH-certified continuous flow supplied-air respirator equipped with a loose fitting facepiece. (APF =25).</P> <P>(xxx) NIOSH-certified air-purifying full facepiece respirator equipped with N100, R-100, or P-100 filter(s). (APF =50).</P> <P>(xxxi) NIOSH-certified air-purifying full facepiece respirator equipped with appropriate gas/vapor cartridges or canisters. (APF =50).</P> <P>(xxxii) NIOSH-certified air-purifying full facepiece respirator equipped with appropriate gas/vapor cartridges in combination with N100, R100, or P100 filters or an appropriate canister incorporating N100, R100, or P100 filters. (APF =50).</P> <P>(xxxiii) NIOSH-certified powered air-purifying respirator equipped with a tight-fitting half mask and HEPA filters. (APF =50).</P> <P>(xxxiv) NIOSH-certified powered air-purifying respirator equipped with a tight-fitting half mask and appropriate gas/vapor cartridges or canisters. (APF =50).</P> <P>(xxxv) NIOSH-certified powered air-purifying respirator with a tight-fitting half mask and appropriate gas/vapor cartridges in combination with HEPA filters. (APF =50).</P> <P>(xxxvi) NIOSH-certified pressure-demand or other positive pressure mode supplied-air respirator equipped with a half-mask. (APF =50).</P> <P>(xxxvii) NIOSH-certified negative pressure (demand) supplied-air respirator equipped with a full facepiece. (APF =50).</P> <P>(xxxviii) NIOSH-certified continuous flow supplied-air respirator equipped with a tight-fitting half mask. (APF =50).</P> <P>(xxxix) NIOSH-certified negative pressure (demand) self-contained breathing apparatus (SCBA) equipped with a hood or helmet or a full facepiece. (APF =50).</P> <P>(xl) NIOSH-certified powered air purifying full facepiece respirator equipped with HEPA filters. (APF =1,000).</P> <P>(xli) NIOSH-certified powered air purifying full facepiece respirator equipped with appropriate gas/vapor cartridges. (APF =1,000).</P> <P>(xlii) NIOSH-certified powered air purifying fill facepiece respirator equipped with appropriate gas/vapor cartridges in combination with HEPA filters. (APF =1,000).</P> <P> (xliii) NIOSH-certified powered air-purifying respirator equipped with a hood or helmet and N100, R100, or P100 filters <E T="03">with evidence demonstrating protection level of 1,000 or greater.</E> See 40 CFR 721.63(a)(5)(li). (APF =1,000). </P> <P> (xliv) NIOSH-certified powered air-purifying respirator equipped with a hood or helmet and appropriate gas/vapor cartridges <E T="03">with evidence demonstrating protection level of 1,000 or greater.</E> See 40 CFR 721.63(a)(5)(li). (APF =1,000). </P> <P> (xlv) NIOSH-certified powered air-purifying respirator with a loose-fitting hood or helmet that is equipped with an appropriate gas/vapor cartridge in combination with HEPA filters <E T="03">with evidence demonstrating protection level of 1,000 or greater.</E> See 40 CFR 721.63(a)(5)(li). (APF =1,000). </P> <P>(xlvi) NIOSH-certified continuous flow supplied-air respirator equipped with a full facepiece. (APF =1,000).</P> <P> (xlvii) NIOSH-certified continuous flow supplied-air respirator equipped with a hood or helmet <E T="03">with evidence demonstrating protection level of 1,000 or greater.</E> See 40 CFR 721.63(a)(5)(li). (APF =1,000). </P> <P>(xlviii) NIOSH-certified pressure-demand supplied-air respirator equipped with a full facepiece. (APF =1,000).</P> <P> (xlix) NIOSH-certified pressure-demand or other positive-pressure mode ( <E T="03">e.g.,</E> open/closed circuit) self-contained breathing apparatus (SCBA) equipped with a hood or helmet or a full facepiece. (APF =10,000). </P> <P> (l) If one of the respirators in paragraph (a)(5)(i) through (a)(5)(xv) is cited for a substance identified in subpart E an employer may substitute a <PRTPAGE P="303"/> respirator from paragraphs (a)(5)(xvi) through (a)(5)(xlix) as long as its assigned protection factor is equal to or greater than the respirator cited in subpart E for that substance. </P> <P>(li) Without testing data that demonstrates a level of protection of 1,000 or greater, all air purifying respirators and supplied air respirators with helmets/hoods are to be treated as loose-fitting facepiece respirators with an APF of 25.</P> <P>(6) When cited in subpart E of this part for a substance, the following airborne form(s) of the substance, in combination or alone, are referenced by paragraphs (a)(1) and (4) of this section:</P> <P>(i) Dust.</P> <P>(ii) Mist.</P> <P>(iii) Fume.</P> <P>(iv) Smoke.</P> <P>(v) Vapor.</P> <P>(vi) Gas.</P> <P> (vii) Particulate or aerosol (solids or liquid droplets suspended in a gas, <E T="03">e.g.,</E> dust, fume, mist, smoke). </P> <P>(viii) Gas/vapor.</P> <P> (ix) Combination particulate and gas/vapor (gas and liquid/solid physical forms are both present, <E T="03">e.g.,</E> particulates and acid gases or particulates and organic vapors). </P> <P> (7) Where people are reasonably likely to have dermal or eye exposure to the chemical substance in the work area, either through direct handling of the substance, or through contact with surfaces on which the substance may exist, or because the substance becomes airborne in the form listed in paragraph (a)(6) of this section, and the form is cited in subpart E of this part for the chemical substance, engineering control measures ( <E T="03">e.g.,</E> enclosure or confinement of the operation, general and local ventilation) or administrative control measures ( <E T="03">e.g.,</E> workplace policies and procedures) shall be implemented to prevent exposure, where feasible. Where engineering, work practice, and administrative controls are not feasible or dermal or eye exposure is still reasonably likely, each person who is reasonably likely to be exposed to the chemical substance by dermal or eye exposure must be provided with, and is required to wear, personal protective equipment (PPE) to prevent dermal or eye exposure to the substance. Refer to 29 CFR 1910.132 and 29 CFR 1910.133 for requirements on selection and use of PPE. </P> <P> (8) Where each person who is reasonably likely to be exposed to the chemical substance by inhalation in the work area in one or more of the forms listed in paragraph (a)(6) of this section and cited in subpart E of this part for the chemical substance, engineering control measures ( <E T="03">e.g.,</E> enclosure or confinement of the operation, general and local ventilation) or administrative control measures ( <E T="03">e.g.,</E> workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. When engineering, work practice, and administrative controls are not feasible or inhalation exposure is still reasonably likely, each person who is reasonably likely to be exposed to the chemical substance by inhalation in the work area in one or more of the forms listed in paragraph (a)(6) of this section and cited in subpart E of this part for the chemical substance, must be provided with, and is required to wear, a NIOSH- certified respirator from one of the categories listed in paragraph (a)(5) of this section. Refer to 29 CFR 1910.134 and 42 CFR part 84 for requirements on the selection, use, and maintenance of respirators, including establishing respiratory protection program, medical determination, and other administrative and programmatic requirements for respiratory protection. </P> <P>(b) If a substance identified in subpart E of this part is present in the work area only as a mixture, an employer is exempt from the provisions of this section if the concentration of the substance in the mixture does not exceed a concentration set in subpart E of this part. The exemption does not apply if the employer has reason to believe that during intended use or processing in the work area, the substance in the mixture may be concentrated above the level set in subpart E of this part.</P> <P> (c)(1) If at any time after commencing distribution in commerce of a chemical substance that is identified in subpart E of this part as subject to this section, the person has knowledge that a recipient of the substance is engaging in an activity that is not consistent <PRTPAGE P="304"/> with the implementation of a program specified in paragraph (a) of this section, the person is considered to have knowledge that the recipient is engaging in a significant new use and is required to follow the procedures in § 721.5(d) unless the person is able to document the following: </P> <P>(i) That the person has notified the recipient in writing within 15 working days of the time the person first has knowledge that the recipient is engaging in an activity that is not consistent with the implementation of a program specified in paragraph (a) of this section, and that the person has knowledge of the failure of implementation.</P> <P>(ii) That within 15 working days of notifying the recipient that the recipient is engaging in an activity that is not consistent with the implementation of a program specified in paragraph (a) of this section the person has received from the recipient, in writing, a statement of assurance that the recipient has established the program required under paragraph (a) of this section, and will take appropriate measures to avoid activities that are inconsistent with implementation of the program required under paragraph (a) of this section.</P> <P>(2) If, after receiving a statement of assurance from a recipient under paragraph (c)(1)(ii) of this section, a manufacturer or processor has knowledge that the recipient is engaging in an activity that is not consistent with the implementation of the program specified in paragraph (a) of this section, that person is considered to have knowledge that the person is engaging in a significant new use and is required to follow the procedures in § 721.5(d).</P> <CITA>[54 FR 31308, July 27, 1989, as amended at 87 FR 39765, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.72</SECTNO> <SUBJECT>Hazard communication program.</SUBJECT> <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of that substance is any manner or method of manufacture (including import) or processing associated with any use of that substance without establishing a hazard communication program as described in this section. Paragraphs (a) through (h) of this section apply to SNURs issued July 5, 2022. Paragraphs (i) and (j) of his section apply to SNURs issued on or after July 5, 2022. Any person subject to the requirements of paragraphs (a) through (h) of this section have the option of following the requirements of paragraph (i) of this section or using the statements specified in paragraphs (g) or (h) of this section.</P> <P> (a) <E T="03">Written hazard communication program.</E> Each employer shall develop and implement a written hazard communication program for the substance in each workplace. The written program will, at a minimum, describe how the requirements of this section for labels, SDSs, and other forms of warning material will be satisfied. The employer must make the written hazard communication program available, upon request, to all employees, contractor employees, and their designated representatives. The employer may rely on an existing hazard communication program, including an existing program established under the Occupational Health and Safety Administration (OSHA) Hazard Communication Standard in 29 CFR 1910.1200 of 2012 to comply with this paragraph provided that the existing hazard communication program satisfies the requirements of this paragraph. The written program shall include the following: </P> <P>(1) A list of each substance identified in subpart E of this part as subject to this section known to be present in the work area. The list must be maintained in the work area and must use the identity provided on the appropriate SDS for each substance required under paragraph (c) of this section. The list may be compiled for the workplace or for individual work areas.</P> <P>(2) The methods the employer will use to inform employees of the hazards of non-routine tasks involving the substance, for example, the cleaning of reactor vessels, and the hazards associated with the substance contained in unlabeled pipes in their work area.</P> <P> (3) The methods the employer will use to inform contractors of the presence of the substance in the employer's workplace and of the provisions of this part applicable to the substance if employees of the contractor work in the <PRTPAGE P="305"/> employer's workplace and are reasonably likely to be exposed to the substance while in the employer's workplace. </P> <P> (b) <E T="03">Labeling.</E> (1) Each employer shall ensure that each container of the substance in the workplace is labeled in accordance with this paragraph (b)(1). </P> <P>(i) The label shall, at a minimum, contain the following information:</P> <P>(A) A statement of health hazard(s) and precautionary measure(s) for the substance, if any, identified in subpart E of this part or by the employer.</P> <P>(B) The identity by which the substance may be commonly recognized.</P> <P>(C) A statement of environmental hazard(s) and precautionary measure(s) for the substance, if any, identified in subpart E of this part or by the employer.</P> <P>(D) A statement of exposure and precautionary measure(s), if any, identified in subpart E of this part or by the employer.</P> <P>(ii) The employer may use signs, placards, process sheets, batch tickets, operating procedures, or other such written materials in lieu of affixing labels to individual stationary process containers, as long as the alternative method identifies the containers to which it is applicable and conveys information specified by paragraph (b)(1)(i) of this section. Any written materials must be readily accessible to the employees in their work areas throughout each work shift.</P> <P>(iii) The employer need not label portable containers into which the substance is transferred from labeled containers, and which are intended only for the immediate use of the employee who performs the transfer.</P> <P>(iv) The employer shall not remove or deface an existing label on incoming containers of the substance unless the container is immediately relabeled with the information specified in paragraph (b)(1)(i) of this section.</P> <P>(2) Each employer shall ensure that each container of the substance leaving its workplace for distribution in commerce is labeled in accordance with this paragraph.</P> <P>(i) The label shall, at a minimum, contain the following information:</P> <P>(A) The information required under paragraph (b)(1)(i) of this section.</P> <P>(B) The name and address of the manufacturer or a responsible party who can provide additional information on the substance for hazard evaluation and any appropriate emergency procedures.</P> <P>(ii) The label shall not conflict with the requirements of the Hazardous Materials Transportation Act (18 U.S.C. 1801 et. seq.) and regulations issued under that Act by the Department of Transportation.</P> <P>(3) The label, or alternative forms of warning, shall be legible and prominently displayed.</P> <P>(4) The label, or alternative forms of warning, shall be in English; however, the information may be repeated in other languages.</P> <P>(5) If the label or alternative form of warning is to be applied to a mixture containing a substance identified in subpart E of this part as subject to this section in combination with another substance identified in subpart E of this part and/or a substance defined as a “hazardous chemical” under the Occupational Safety and Health Administration (OSHA) Hazard Communication Standard (29 CFR 1910.1200), the employer may prescribe on the label, SDS, or alternative form of warning, the measures to control worker exposure or environmental release which the employer determines provide the greatest degree of protection. However, should these control measures differ from the applicable measures required under subpart E of this part, the employer must seek a determination of equivalency for such alternative control measures pursuant to § 721.30 before prescribing them under this paragraph (b)(5).</P> <P> (c) <E T="03">Safety data sheets.</E> (1) Each employer must obtain or develop a SDS for the substance. </P> <P>(2) Each SDS shall contain, at a minimum, the following information:</P> <P>(i) The identity used on the container label of the substance under this section, and, if not claimed confidential, the chemical and common name of the substance. If the chemical and common name are claimed confidential, a generic chemical name must be used.</P> <P> (ii) Physical and chemical characteristics of the substance known to the <PRTPAGE P="306"/> employer (such as vapor pressure, flash point). </P> <P>(iii) The physical hazards of the substance known to the employer, including the potential for fire, explosion, and reactivity.</P> <P>(iv) The potential human and environmental hazards as specified in subpart E of this part for the substance.</P> <P>(v) Signs and symptoms of exposure, and any medical conditions which are expected to be aggravated by exposure to the substance known to the employer.</P> <P>(vi) The primary routes of exposure to the substance.</P> <P>(vii) Precautionary measures to control worker exposure and/or environmental release identified in subpart E of this part for the substance, or alternative control measures which EPA has determined under § 721.30 provide substantially the same degree of protection as the identified control measures.</P> <P>(viii) Any generally applicable precautions for safe handling and use of the substance which are known to the employer, including appropriate hygienic practices, protective measures during repair and maintenance of contaminated equipment, and procedures for response to spills and leaks.</P> <P>(ix) Any generally applicable control measures which are known to the employer, such as appropriate engineering controls, work practices, or personal protective equipment.</P> <P>(x) Emergency first aid procedures known to the employer.</P> <P>(xi) The date of preparation of the SDS or of its last revision.</P> <P>(xii) The name, address, and telephone number of the individual preparing or distributing the SDS, or a responsible party who can provide additional information on the substance for hazard evaluation and any appropriate emergency procedures.</P> <P>(3) If no relevant information is found or known for any given category on the SDS, the employer must mark the SDS to indicate that no applicable information was found.</P> <P>(4) Where multiple mixtures containing the substance have similar compositions (i.e., the chemical ingredients are essentially the same, but the specific composition varies from mixture to mixture) and similar hazards, the employer may prepare one SDS to apply to all of these multiple mixtures.</P> <P>(5) If the employer becomes aware of any significant new information regarding the hazards of the substance or ways to protect against the hazards, this new information must be added to the SDS within 3 months from the time the employer becomes aware of the new information. If the substance is not currently being manufactured, processed, or used in the employer's workplace, the employer must add the new information to the SDS before the substance is reintroduced into the workplace.</P> <P>(6) The employer must ensure that persons receiving the substance from the employer are provided an appropriate SDS with their initial shipment and with the first shipment after an SDS is revised. The employer may either provide the SDS with the shipped containers or send it to the person prior to or at the time of shipment.</P> <P>(7) The employer must maintain a copy of the SDS in its workplace, and must ensure that it is readily accessible during each work shift to employees when they are in their work areas. (Easy and immediate electronic access and other alternatives to maintaining paper copies of the safety data sheets are permitted as long as complete and accurate versions of the SDS are available immediately to employees in each workplace by such options.)</P> <P>(8) The SDS may be kept in any form, including as operating procedures, and may be designed to cover groups of substances in a work area where it may be more appropriate to address the potential hazards of a process rather than individual substances. However, in all cases, the required information must be provided for each substance and must be readily accessible during each work shift to employees when they are in their work areas.</P> <P>(9) The SDS must be in English; however, the information may be repeated in other languages.</P> <P> (d) <E T="03">Employee information and training.</E> Each employer must ensure that employees are provided with information <PRTPAGE P="307"/> and training on the substance identified in subpart E of this part. This information and training must be provided at the time of each employee's initial assignment to a work area containing the substance and whenever the substance subject to this section is introduced into the employee's work area for the first time. </P> <P>(1) Information provided to employees under this paragraph shall include:</P> <P>(i) The requirements of this section.</P> <P>(ii) Any operations in the work area where the substance is present.</P> <P>(iii) The location and availability of the written hazard communication program required under paragraph (a) of this section, including the list of substances identified in subpart E of this part as subject to this section, and SDSs required by paragraph (c) of this section.</P> <P>(2) Training provided to employees shall include:</P> <P>(i) Methods and observations that may be used to detect the presence or release of the substance in or from an employee's work area (such as monitoring conducted by the employer, continuous monitoring devices, visual appearance, or odor of the substance when being released).</P> <P>(ii) The potential human health and environmental hazards of the substance as specified in subpart E of this part.</P> <P>(iii) The measures employees can take to protect themselves and the environment from the substance, including specific procedures the employer has implemented to protect employees and the environment from exposure to the substance, including appropriate work practices, emergency procedures, personal protective equipment, engineering controls, and other measures to control worker exposure and/or environmental release required under subpart E of the part, or alternative control measures which EPA has determined under § 721.30 provide substantially the same degree of protection as the specified control measures.</P> <P>(iv) The requirements of the hazard communication program developed by the employer under this section, including an explanation of the labeling system and the SDS required by this section and guidance on obtaining and using appropriate hazard information.</P> <P> (e) <E T="03">Low concentrations in mixtures.</E> If a substance identified in subpart E of this part is present in the work area only as a mixture, an employer is exempt from the provisions of this section if the concentration of the substance in the mixture does not exceed a concentration set in subpart E of this part. The exemption does not apply if the employer has reason to believe that during intended use or processing in the work area, the substance in the mixture may be concentrated above the level set in subpart E of this part. </P> <P> (f) <E T="03">Existing hazard communication program.</E> The employer need not take additional actions if existing programs and procedures satisfy the requirements of this section. </P> <P> (g) <E T="03">Human health, environmental hazard, exposure, and precautionary statements.</E> Whenever referenced in subpart E of this part for a substance, the following human health and environmental hazard, exposure, and precautionary statements shall appear on each label as specified in paragraph (b) of this section and the SDS as specified in paragraph (c) of this section. Additional statements may be included as long as they are true and do not alter the meaning of the required statements. </P> <P>(1) Human health hazard statements:</P> <P>(i) Causes skin irritation.</P> <P>(ii) Respiratory complications. (You may also use paragraph (g)(1)(x) of this section for this designation.).</P> <P>(iii) Central nervous system effects. (You may also use paragraph (g)(1)(xi) of this section for this designation but you must include this specific effect.)</P> <P>(iv) Internal organ effects. (You may also use paragraph (g)(1)(xi) of this section for this designation.)</P> <P>(v) Birth defects. (You may also use paragraph (g)(1)(xii) of this section for this designation but you must include this specific effect.)</P> <P>(vi) Reproductive effects. (You may also use paragraph (g)(1)(xii) of this section for this designation but you must include this specific effect.)</P> <P>(vii) May cause cancer.</P> <P> (viii) Immune system effects. (You may also use paragraph (g)(1)(xi) of <PRTPAGE P="308"/> this section for this designation but you must include this specific effect.) </P> <P>(ix) Developmental effects. (You may also use paragraph (g)(1)(xii) of this section for this designation but you must include this specific effect.)</P> <P>(x) May cause allergy or asthma symptoms or breathing difficulties ifinhaled.</P> <P>(xi) May cause damage to organs (state all organs identified in subpart E of this part for this substance) through prolonged or repeated exposure.</P> <P>(xii) May damage fertility or the unborn child (state specific effect identified in subpart E of this part for this substance).</P> <P>(xiii) May cause an allergic skin reaction.</P> <P>(xiv) Causes eye irritation.</P> <P>(2) Human health hazard precautionary statements:</P> <P>(i) Avoid skin contact. (You may also use paragraph (g)(2)(vi) of this section for this designation.)</P> <P>(ii) Avoid breathing substance. (You may also use paragraph (g)(2)(viii) of this section for this designation.)</P> <P>(iii) Avoid ingestion.</P> <P>(iv) Use respiratory protection. (You may also use paragraph (g)(2)(vii) of this section for this designation.)</P> <P>(v) Use skin protection. (You may also use paragraph (g)(2)(vi) of this section for this designation.)</P> <P>(vi) Wear protective gloves/protective clothing/eye protection/face protection.(Chemical manufacturer or distributor to specify type of equipment, as required.)</P> <P>(vii) Wear respiratory protection. (Chemical manufacturer or distributor to specify equipment as required.)</P> <P>(viii) Avoid breathing dust/fume/gas/mist/vapors/spray. (Chemical manufacturer or distributor to specify applicable conditions.)</P> <P>(3) Environmental hazard statements: This substance may be:</P> <P>(i) Toxic to fish. (You may also use paragraph (g)(3)(iii) of this section for this designation.)</P> <P>(ii) Toxic to aquatic organisms. (You may also use paragraph (g)(3)(iii) of this section for this designation.)</P> <P>(iii) Toxic to aquatic life.</P> <P>(4) Environmental hazard precautionary statements: Notice to users:</P> <P>(i) Disposal restrictions apply. (You may also use paragraph (g)(4)(iv) of this section for this designation.)</P> <P>(ii) Spill clean-up restrictions apply. (You may also use paragraph (g)(4)(iv) of this section for this designation.)</P> <P>(iii) Do not release to water. (You may also use paragraph (g)(4)(iv) of this section for this designation.)</P> <P>(iv) Dispose of contents/container to . . . (Specify disposal requirements in subpart E of this part and whether they apply to contents, container or both.)</P> <P>(5) Each human health or environmental hazard precautionary statement identified in subpart E of this part for the label on the substance container must be followed by the statement, “See SDS for details.”</P> <P> (h) <E T="03">Human health, environmental hazard exposure and precautionary statements.</E> (1) Whenever referenced in subpart E of this part for a substance, the following human health, environmental hazard, exposure, and precautionary statements shall appear on each label as specified in paragraph (b) of this section. Additional statements may be included as long as they are true and do not alter the meaning of the required statements. </P> <P> (i) <E T="03">Precautionary statements.</E> (A) The health effects of this chemical substance have not been determined. </P> <P>(B) When using this substance, use skin protection.</P> <P>(C) Use respiratory protection when there is a reasonable likelihood of exposure in the work area from dust, mist, or smoke from spray application.</P> <P>(D) Chemicals similar in structure to this substance have been found to cause cancer in laboratory animals.</P> <P> (ii) <E T="03">Human health hazard statements.</E> (A) Causes skin irritation. </P> <P>(B) Respiratory complications. (You may also use paragraph (h)(1)(ii)(J) of this section for this designation.)</P> <P>(C) Central nervous system effects. (You may also use paragraph (h)(1)(ii)(K) of this section for this designation but you must include this specific effect.)</P> <P>(D) Internal organ effects. (You may also use paragraph (h)(1)(ii)(K) of this section for this designation.)</P> <P> (E) Birth defects. (You may also use paragraph (h)(1)(ii)(L) of this section <PRTPAGE P="309"/> for this designation but you must include this specific effect.) </P> <P>(F) Reproductive effects. (You may also use paragraph (h)(1)(ii)(L) of this section for this designation but you must include this specific effect.)</P> <P>(G) Cancer.</P> <P>(H) Immune system effects. (You may also use paragraph (h)(1)(ii)(K) of this section for this designation but you must include this specific effect.)</P> <P>(I) Developmental effects. (You may also use paragraph (h)(1)(ii)(L) of this section for this designation but you must include this specific effect.)</P> <P>(J) May cause allergy or asthma symptoms or breathing difficulties if inhaled.</P> <P>(K) May cause damage to organs (state all organs identified in subpart E of this part for this substance) through prolonged or repeated exposure.</P> <P>(L) May damage fertility or the unborn child (state specific effect identified in subpart E of this part for this substance).</P> <P>(M) May cause an allergic skin reaction.</P> <P>(N) Causes eye irritation.</P> <P> (iii) <E T="03">Human health hazard precautionary statements.</E> When using this substance: </P> <P>(A) Avoid skin contact. (You may also use paragraph (h)(1)(iii)(F) of this section for this designation.)</P> <P>(B) Avoid breathing substance. (You may also use paragraph (h)(1)(iii)(H) of this section for this designation.)</P> <P>(C) Avoid ingestion.</P> <P>(D) Use respiratory protection. (You may also use paragraph (h)(1)(iii)(G) of this section for this designation.)</P> <P>(E) Use skin protection. (You may also use paragraph (h)(1)(iii)(F) of this section for this designation.)</P> <P>(F) Wear protective gloves/protective clothing/eye protection/face protection. (Chemical manufacturer or distributor to specify type of equipment, as required.)</P> <P>(G) Wear respiratory protection. (Chemical manufacturer or distributor to specify equipment as required.)</P> <P>(H) Avoid breathing dust/fume/gas/mist/vapors/spray. (Chemical manufacturer or distributor to specify applicable conditions.)</P> <P> (iv) <E T="03">Environmental hazard statements.</E> (A) Toxic to fish. (You may also use paragraph (h)(1)(iv)(C) of this section for this designation.) </P> <P>(B) Toxic to aquatic organisms. (You may also use paragraph (h)(1)(iv)(C) of this section for this designation.)</P> <P>(C) Toxic to aquatic life.</P> <P> (v) <E T="03">Environmental hazard precautionary statements.</E> Notice to Users: </P> <P>(A) Disposal restrictions apply. (You may also use paragraph (h)(1)(v)(D) of this section for this designation)</P> <P>(B) Spill clean-up restrictions apply. (You may also use paragraph (h)(1)(v)(D) of this section for this designation)</P> <P>(C) Do not release to water. (You may also use paragraph (h)(1)(v)(D) of this section for this designation.)</P> <P>(D) Dispose of contents/container to . . . (Specify disposal requirements in subpart E of this part and whether they apply to contents, container or both.)</P> <P> (vi) <E T="03">Additional statements.</E> Each human health or environmental precautionary statement identified in subpart E of this part for the label on the substance container must be followed by the statement, “See SDS for details.” </P> <P>(2) Whenever referenced in subpart E of this part for a substance, the following human health, environmental hazard, exposure, and precautionary statements shall appear on each SDS as specified in paragraph (c) of this section. Additional statements may be included as long as they are true and do not alter the meaning of the required statements.</P> <P> (i) <E T="03">Precautionary statements.</E> (A) The health effects of this chemical substance have not been determined. </P> <P>(B) When using this substance, use skin protection.</P> <P>(C) Use respiratory protection when there is a reasonable likelihood of exposure in the work area from dust, mist, or smoke from spray application.</P> <P>(D) Chemicals similar in structure to this substance have been found to cause cancer in laboratory animals.</P> <P> (ii) <E T="03">Human health hazard statements.</E> (A) Causes skin irritation. </P> <P>(B) Respiratory complications. (You may also use paragraph (h)(2)(ii)(J) of this section for this designation.)</P> <P> (C) Central nervous system effects. (You may also use paragraph <PRTPAGE P="310"/> (h)(2)(ii)(K) of this section for this designation but you must include this specific effect.) </P> <P>(D) Internal organ effects. (You may also use paragraph (h)(2)(ii)(K) of this section for this designation.)</P> <P>(E) Birth defects. (You may also use paragraph (h)(2)(ii)(L) of this section for this designation but you must include this specific effect.)</P> <P>(F) Reproductive effects. (You may also use paragraph (h)(2)(ii)(L) of this section for this designation but you must include this specific effect.)</P> <P>(G) May cause cancer.</P> <P>(H) Immune system effects. (You may also use paragraph (h)(2)(ii)(K) of this section for this designation but you must include this specific effect.)</P> <P>(I) Developmental effects. (You may also use paragraph (h)(2)(ii)(L) of this section for this designation but you must include this specific effect.)</P> <P>(J) May cause allergy or asthma symptoms or breathing difficulties if inhaled.</P> <P>(K) May cause damage to organs (state all organs identified in subpart E of this part for this substance.) through prolonged or repeated exposure.</P> <P>(L) May damage fertility or the unborn child (state specific effect identified in subpart E of this part for this substance).</P> <P>(M) May cause an allergic skin reaction.</P> <P>(N) Causes eye irritation.</P> <P> (iii) <E T="03">Human health hazard precautionary statements.</E> (A) Avoid skin contact. (You may also use paragraph (h)(2)(iii)(F) of this section for this designation.) </P> <P>(B) Avoid breathing substance. (You may also use paragraph (h)(2)(iii)(H) of this section for this designation.)</P> <P>(C) Avoid ingestion.</P> <P>(D) Use respiratory protection. (You may also use paragraph (h)(2)(iii)(G) of this section for this designation.)</P> <P>(E) Use skin protection. (You may also use paragraph (h)(2)(iii)(F) of this section for this designation.)</P> <P>(F) Wear protective gloves/protective clothing/eye protection/face protection.(Chemical manufacturer or distributor to specify type of equipment, as required.)</P> <P>(G) Wear respiratory protection. (Chemical manufacturer or distributor to specify equipment as required.)</P> <P>(H) Avoid breathing dust/fume/gas/mist/vapors/spray. (Chemical manufacturer or distributor to specify applicable conditions.)</P> <P> (iv) <E T="03">Environmental hazard statements.</E> (A) Toxic to fish. (You may also use paragraph (h)(2)(iv)(C) of this section for this designation.) </P> <P>(B) Toxic to aquatic organisms. (You may also use paragraph (h)(2)(iv)(C) of this section for this designation.)</P> <P>(C) Toxic to aquatic life.</P> <P> (v) <E T="03">Environmental hazard precautionary statements.</E> Notice to Users: </P> <P>(A) Disposal restrictions apply. (You may also use paragraph (h)(2)(v)(D) of this section for this designation.)</P> <P>(B) Spill clean-up restrictions apply. (You may also use paragraph (h)(2)(v)(D) of this section for this designation.)</P> <P>(C) Do not release to water. (You may also use paragraph (h)(2)(v)(D) of this section for this designation.)</P> <P>(D) Dispose of contents/container to . . . (Specify disposal requirements in subpart E of this part and whether they apply to contents, container or both.)</P> <P> (i) <E T="03">Written hazard communication program.</E> Each employer shall develop and implement a written hazard communication program for the substance in each workplace in accordance with 29 CFR 1910.1200. </P> <P> (j) <E T="03">Human health, environmental hazard, exposure, and precautionary statements.</E> In addition to the requirements for the hazard communication program specified in paragraph (i) of this section, whenever referenced in subpart E of this part for a substance, the following human health and environmental hazard, exposure, and precautionary statements shall appear as specified in paragraph (i) of this section. </P> <P>(1) Human health hazard statements:</P> <P>(i) Causes skin irritation.</P> <P>(ii) May cause cancer.</P> <P>(iii) Immune system effects.</P> <P>(iv) Developmental effects.</P> <P>(v) May cause allergy or asthma symptoms or breathing difficulties if inhaled.</P> <P> (vi) May cause damage to organs (state all organs identified in subpart E <PRTPAGE P="311"/> of this part for this substance) through prolonged or repeated exposure. </P> <P>(vii) May damage fertility or the unborn child (state specific effect identified in subpart E of this part for this substance).</P> <P>(viii) May cause an allergic skin reaction.</P> <P>(ix) Causes eye irritation.</P> <P>(2) Human health hazard precautionary statements:</P> <P>(i) Avoid ingestion.</P> <P>(ii) Wear protective gloves/protective clothing/eye protection/face protection. (Chemical manufacturer or distributor to specify type of equipment, as required.)</P> <P>(iii) Wear respiratory protection.(Chemical manufacturer or distributor to specify equipment as required.)</P> <P>(iv) Avoid breathing dust/fume/gas/mist/vapors/spray.(Chemical manufacturer or distributor to specify applicable conditions.)</P> <P>(3) Environmental hazard statements: This substance may be:</P> <P>(i) Toxic to aquatic life.</P> <P>(ii) Very toxic to aquatic life.</P> <P>(iii) Harmful to aquatic life.</P> <P>(iv) Very toxic to aquatic life with long term effects.</P> <P>(v) Toxic to aquatic life with long lasting effects.</P> <P>(vi) Harmful to aquatic life with long lasting effects.</P> <P>(vii) May cause long lasting harmful effects to aquatic life.</P> <P>(4) Environmental hazard precautionary statements: Notice to users:</P> <P>(i) Avoid release to the environment (if this is not the intended use.)</P> <P>(ii) Collect spillage.</P> <P>(iii) Dispose of contents/container to . . . (Specify disposal requirements in subpart E of this part and whether they apply to contents, container or both.)</P> <CITA>[54 FR 31308, July 27, 1989, as amended at 55 FR 45996, Oct. 31, 1990; 58 FR 34204, June 23, 1993; 87 FR 39766, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.80</SECTNO> <SUBJECT>Industrial, commercial, and consumer activities.</SUBJECT> <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is:</P> <P>(a) Use in non-enclosed processes.</P> <P>(b) Any manner or method of manufacture in non-enclosed processes associated with any use.</P> <P>(c) Any manner or method of processing in non-enclosed processes associated with any use.</P> <P>(d) Use beyond the site of manufacture.</P> <P>(e) Processing beyond the site of manufacture.</P> <P>(f) Any manner or method of manufacture (excluding import) of the substance associated with any use.</P> <P>(g) Use other than as an intermediate.</P> <P>(h) Use other than as a site-limited intermediate.</P> <P>(i) Use as an intermediate where the concentration of the intermediate substance in the product intended for distribution in commerce exceeds the concentration specified in subpart E of this part for the substance.</P> <P>(j) Use other than as described in the premanufacture notice referenced in subpart E of this part for the substance.</P> <P>(k) Use other than allowed by the section 5(e) consent order referenced in subpart E of this part for the substance.</P> <P>(l) Non-industrial use.</P> <P>(m) Commercial use.</P> <P>(n) Non-commercial use.</P> <P>(o) Use in a consumer product.</P> <P>(p) Aggregate manufacturing volume for any use greater than that specified in subpart E of this part for the substance.</P> <P>(q) Aggregate manufacturing volume for any use greater than that allowed by the section 5(e) consent order referenced in subpart E of this part for the substance.</P> <P>(r) Aggregate manufacturing volume for any use greater than that specified in subpart E of this part for the substance unless the manufacturer has submitted the results of the health or environmental effects studies identified in subpart E of this part for the substance and those studies comply with the procedures and criteria for developing and evaluating data identified in subpart E of this part for the substance.</P> <P> (s) Annual manufacturing volume for any use greater than that specified in <PRTPAGE P="312"/> subpart E of this part for the substance. </P> <P>(t) Annual manufacturing volume for any use greater than that allowed by the section 5(e) consent order referenced in subpart E of this part for the substance.</P> <P>(u) Annual manufacturing volume for any use greater than that specified in subpart E of this part for the substance unless the manufacturer has submitted the results of the health or environmental effects studies identified in subpart E of this part for the substance and those studies comply with the procedures and criteria for developing and evaluating data identified in subpart E of this part for the substance.</P> <P>(v) Use in the form of:</P> <P>(1) A powder.</P> <P>(2) A solid.</P> <P>(3) A liquid.</P> <P>(4) A gas.</P> <P>(w) Any manner or method of manufacture of the substance in the following form associated with any use:</P> <P>(1) A powder.</P> <P>(2) A solid.</P> <P>(3) A liquid.</P> <P>(4) A gas.</P> <P>(x) Any manner or method of processing of the substance in the following form associated with any use:</P> <P>(1) A powder.</P> <P>(2) A solid.</P> <P>(3) A liquid.</P> <P>(4) A gas.</P> <P>(y) Use involving an application method that generates:</P> <P>(1) A vapor, mist, or aerosol.</P> <P>(2) A dust.</P> <CITA>[54 FR 31308, July 27, 1989, as amended at 87 FR 39769, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.85</SECTNO> <SUBJECT>Disposal.</SUBJECT> <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is any method of:</P> <P>(a) Disposal of the process stream associated with any use of the substance or with any manner or method of manufacturing associated with any use of the substance other than by the following. This provision does not supersede any applicable Federal, State, or local laws and regulations.</P> <P>(1) Incineration.</P> <P>(2) Landfill.</P> <P>(3) Deep well injection.</P> <P>(b) Disposal of the process stream associated with any use or with any manner or method of processing associated with any use other than by the following. This provision does not supersede any applicable Federal, State, or local laws and regulations.</P> <P>(1) Incineration.</P> <P>(2) Landfill.</P> <P>(3) Deep well injection.</P> <P>(c) Disposal of the use stream associated with any use, other than by the following. This provision does not supersede any applicable Federal, State, or local laws and regulations.</P> <P>(1) Incineration.</P> <P>(2) Landfill.</P> <P>(3) Deep well injection.</P> <P>(d) Disposal of the substance associated with any use of the substance, or with any manner or method of manufacture or processing in association with any use. This provision does not supersede any applicable Federal, State, or local laws and regulations.</P> <CITA>[54 FR 31308, July 27, 1989, as amended at 87 FR 39769, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.90</SECTNO> <SUBJECT>Release to water.</SUBJECT> <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is:</P> <P>(a) Any predictable or purposeful release of a manufacturing stream associated with any use of the substance, from any site:</P> <P>(1) Into the waters of the United States.</P> <P>(2) Into the waters of the United States without application of one or more of the following treatment technologies as specified in subpart E of this part either by the discharger or, in the case of a release through publicly-owned treatment works, by a combination of treatment by the discharger and the publicly-owned treatment works:</P> <P>(i) Chemical precipitation and settling.</P> <P>(ii) Biological treatment (activated sludge or equivalent) plus clarification.</P> <P>(iii) Steam stripping.</P> <P>(iv) Resin or activated carbon adsorption.</P> <P> (v) Chemical destruction or conversion. <PRTPAGE P="313"/> </P> <P>(vi) Primary wastewater treatment.</P> <P>(3) Into the waters of the United States without primary wastewater treatment, and secondary wastewater treatment as defined in 40 CFR part 133.</P> <P>(4) Into the waters of the United States if the quotient from the following formula:</P> <MATH SPAN="2" DEEP="19"> <MID>ER25SE06.006</MID> </MATH> <FP>exceeds the level specified in subpart E of this part when calculated using the methods described in § 721.91. In lieu of calculating the above quotient, monitoring or alternative calculations may be used to predict the surface water concentration which will result from the intended release of the substance, if the monitoring procedures or calculations have been approved for such purpose by EPA. EPA will review and act on written requests to approve monitoring procedures or alternative calculations within 90 days after such requests are received. EPA will inform submitters of the disposition of such requests in writing, and will explain the reasons therefor when they are denied.</FP> <P>(b) Any predictable or purposeful release of a process stream containing the substance associated with any use of the substance from any site:</P> <P>(1) Into the waters of the United States.</P> <P>(2) Into the waters of the United States without application of one or more of the following treatment technologies as specified in subpart E of this part either by the discharger or, in the case of a release through publicly-owned treatment works, by a combination of treatment by the discharger and the publicly-owned treatment works:</P> <P>(i) Chemical precipitation and settling.</P> <P>(ii) Biological treatment (activated sludge or equivalent) plus clarification.</P> <P>(iii) Steam stripping.</P> <P>(iv) Resin or activated carbon adsorption.</P> <P>(v) Chemical destruction or conversion.</P> <P>(vi) Primary wastewater treatment.</P> <P>(3) Into the waters of the United States without primary wastewater treatment, and secondary wastewater treatment as defined in 40 CFR part 133.</P> <P>(4) Into the waters of the United States if the quotient from the following formula:</P> <MATH SPAN="2" DEEP="19"> <MID>ER25SE06.006</MID> </MATH> <FP>exceeds the level specified in subpart E of this part when calculated using the methods described in § 721.91. In lieu of calculating the above quotient, monitoring or alternative calculations may be used to predict the surface water concentration which will result from the intended release of the substance, if the monitoring procedures or calculations have been approved for such purpose by EPA. EPA will review and act on written requests to approve monitoring procedures or alternative calculations within 90 days after such requests are received. EPA will inform submitters of the disposition of such requests in writing, and will explain the reasons therefor when they are denied.</FP> <P>(c) Any predictable or purposeful release of a use stream containing the substance associated with any use of the substance from any site:</P> <P>(1) Into the waters of the United States.</P> <P> (2) Into the waters of the United States without application of one or <PRTPAGE P="314"/> more of the following treatment technologies as specified in subpart E of this part either by the discharger or, in the case of a release through publicly-owned treatment works, by a combination of treatment by the discharger and the publicly-owned treatment works: </P> <P>(i) Chemical precipitation and settling.</P> <P>(ii) Biological treatment (activated sludge or equivalent) plus clarification.</P> <P>(iii) Steam stripping.</P> <P>(iv) Resin or activated carbon adsorption.</P> <P>(v) Chemical destruction or conversion.</P> <P>(vi) Primary wastewater treatment.</P> <P>(3) Into the waters of the United States without primary wastewater treatment, and secondary wastewater treatment as defined in 40 CFR part 133.</P> <P>(4) Into the waters of the United States if the quotient from:</P> <MATH SPAN="2" DEEP="19"> <MID>ER25SE06.006</MID> </MATH> <FP>exceeds the level specified in subpart E of this part, when calculated using the methods described in § 721.91. In lieu of calculating the above quotient, however, monitoring or alternative calculations may be used to predict the surface water concentration expected to result from intended release of the substance, if the monitoring procedures or calculations have been approved for such purpose by EPA. EPA will review and act on written requests to approve monitoring procedures or alternative calculations within 90 days after such requests are received. EPA will inform submitters of the disposition of such requests in writing, and will explain the reasons therefor when they are denied.</FP> </SECTION> <SECTION> <SECTNO>§ 721.91</SECTNO> <SUBJECT>Computation of estimated surface water concentrations: Instructions.</SUBJECT> <P>These instructions describe the use of the equation specified in § 721.90(a)(4), (b)(4), and (c)(4) to compute estimated surface water concentrations which will result from release of a substance identified in subpart E of this part. The equation shall be computed for each site using the stream flow rate appropriate for the site according to paragraph (b) of this section, and the highest number of kilograms calculated to be released for that site on a given day according to paragraph (a) of this section. Two variables shall be considered in computing the equation, the number of kilograms released, and receiving stream flow.</P> <P> (a) <E T="03">Number of kilograms released.</E> (1) To calculate the number of kilograms of substance to be released from manufacturing, processing, or use operations, as specified in the numerator of the equation, develop a process description diagram which describes each manufacturing, processing, or use operation involving the substance. The process description must include the major unit operation steps and chemical conversions. A unit operation is a functional step in a manufacturing, processing, or use operation where substances undergo chemical changes and/or changes in location, temperature, pressure, physical state, or similar characteristics. Include steps in which the substance is formulated into mixtures, suspensions, solutions, etc. </P> <P>(2) Indicate on each diagram the entry point of all feedstocks (e.g., reactants, solvents, and catalysts) used in the operation. Identify each feedstock and specify its approximate weight regardless of whether the process is continuous or batch.</P> <P>(3) Identify all release points from which the substance or wastes containing the substance will be released into air, land, or water. Indicate these release points on the diagram. Do not include accidental releases or fugitive emissions.</P> <P> (4) For releases identified in the diagram that are destined for water, estimate the amount of substance that will be released before the substance enters control technology. The kilograms of <PRTPAGE P="315"/> substance released may be estimated based on: </P> <P>(i) The mass balance of the operation, i.e., totaling inputs and outputs, including wastes for each part of the process such that outputs equal inputs. The amount released to water may be the difference between the amount of the substance in the starting material (or formed in a reaction) minus the amount of waste material removed from each part of the process and not released to water and the amount of the substance in the final product.</P> <P>(ii) Physical properties such as water solubility where a known volume of water being discharged is assumed to contain the substance at concentrations equal to its solubility in water. This approach is particularly useful where the waste stream results from separation of organic/water phases or filtration of the substance from an aqueous stream to be discharged.</P> <P>(iii) Measurements of flow rates of the process/use stream and known concentrations of the substance in the stream.</P> <P>(5) After releases of a substance to water are estimated for each operation on a site, total the releases of the substance to water from all operations at that site. The value (number of kilograms) specified in the numerator of the equation should reflect total kilograms of substance released to water per day from all operations at a single site.</P> <P>(6) Use the highest expected daily release of the substance for each site.</P> <P>(7) When a substance is designated in subpart E of this part with a specific control technology and a percentage removal of the substance from wastewater resulting from use of the specified control technology, you may subtract that percentage from the highest expected daily release if that control technology is applied.</P> <P> (b) <E T="03">Receiving stream flow.</E> (1) The receiving stream flow shall be expressed in million liters per day (MLD). The flow rate data to be used must be for the point of release on the water body that first receives release of the substance whether by direct discharge from a site, or by indirect discharge through a Publicly-Owned Treatment Works (POTW) for each site. The flow rate reported shall be the lowest 7-day average stream flow with a recurrence interval of 10 years (7-Q-10). If the 7-Q-10 flow rate is not available for the actual point of release, the stream flow rate should be used from the U.S. Geological Survey (USGS) gauging station that is nearest the point of release that is expected to have a flow rate less than or equal to the receiving stream flow at the point of release. </P> <P>(2) Receiving stream flow data may be available from the National Pollutant Discharge Elimination System (NPDES) permit for the site or the POTW releasing the substance to surface water, from the NPDES permit-writing authority for the site or the POTW, or from USGS publications, such as the water-data report series.</P> <P>(3) If receiving stream flow data are not available for a stream, either the value of 10 MLD or the daily flow of wastewater from the site or the POTW releasing the substance must be used as an assumed minimum stream flow. Similarly, if stream flow data are not available because the location of the point of release of the substance to surface water is a lake, estuary, bay, or ocean, then the flow rate to be used must be the daily flow of wastewater from the site or the POTW releasing the substance to surface water. Wastewater flow data may be available from the NPDES permit or NPDES authority for the site or the POTW releasing the substance to water.</P> <CITA>[54 FR 31308, July 27, 1989, as amended at 87 FR 39769, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Recordkeeping Requirements</HD> <SECTION> <SECTNO>§ 721.100</SECTNO> <SUBJECT>Applicability.</SUBJECT> <P> This subpart C identifies certain additional recordkeeping requirements applicable to manufacturers and processors of substances identified in subpart E of this part for each specific substance. The provisions of this subpart C apply only when referenced in subpart E of this part for a substance and significant new use identified in that subpart E. If the provisions in this <PRTPAGE P="316"/> subpart C conflict with general provisions of subpart A of this part, the provisions of this subpart C shall apply. </P> <CITA>[54 FR 31313, July 27, 1989, as amended at 87 FR 39769, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.125</SECTNO> <SUBJECT>Recordkeeping requirements.</SUBJECT> <P>At the time EPA adds a substance to subpart E of this part, EPA will specify appropriate recordkeeping requirements which correspond to the significant new use designations for the substance selected from subpart B of this part. Each manufacturer and processor of the substance shall maintain the records for 5 years from the date of their creation. In addition to the records specified in § 721.40, the records whose maintenance this section requires may include the following:</P> <P>(a) Records documenting the manufacturing volume of the substance and the corresponding dates of manufacture.</P> <P>(b) Records documenting volumes of the substance purchased in the United States by processors of the substance, names and addresses of suppliers, and corresponding dates of purchase.</P> <P>(c) Records documenting the names and addresses (including shipment destination address, if different) of all persons outside the site of manufacture or processing to whom the manufacturer or processor directly sells or transfers the substance, the date of each sale or transfer, and the quantity of the substance sold or transferred on such date.</P> <P>(d) Records documenting establishment and implementation of a program for the use of any applicable personal protective equipment required under § 721.63.</P> <P>(e) Records documenting the determinations required by § 721.63(a)(3) that chemical protective clothing is impervious to the substance.</P> <P>(f) Records documenting establishment and implementation of the hazard communication program required under § 721.72.</P> <P>(g) Copies of labels required under § 721.72(b).</P> <P>(h) Copies of safety data sheets required under § 721.72(c).</P> <P>(i) Records documenting compliance with any applicable industrial, commercial, and consumer use limitations under § 721.80.</P> <P>(j) Records documenting compliance with any applicable disposal requirements under § 721.85, including the method of disposal, location of disposal sites, dates of disposal, and volume of the substance disposed. Where the estimated disposal volume is not known to or reasonably ascertainable by the manufacturer or processor, that person must maintain other records which demonstrate establishment and implementation of a program that ensures compliance with any applicable disposal requirements.</P> <P>(k) Records documenting establishment and implementation of procedures that ensure compliance with any applicable water discharge limitations under § 721.90.</P> <CITA>[54 FR 31313, July 27, 1989, as amended at 87 FR 39769, July 5, 2022]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Expedited Process for Issuing Significant New Use Rules for Selected Chemical Substances and Limitation or Revocation of Selected Significant New Use Rules</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>54 FR 31314, July 27, 1989, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 721.160</SECTNO> <SUBJECT>Notification requirements for new chemical substances subject to section 5(e) orders.</SUBJECT> <P> (a) <E T="03">Selection of substances.</E> (1) In accordance with the expedited process specified in this section, EPA will issue significant new use notification requirements and other specific requirements for each new chemical substance that is the subject of a final order issued under section 5(e) of the Act, except for an order that prohibits manufacture of the substance, unless EPA determines that significant new use notification requirements are not needed for the substance. </P> <P> (2) If EPA determines that significant new use notification requirements are not needed for a substance that is subject to a final order issued under section 5(e) of the Act, except for an order that prohibits manufacture of the substance, EPA will issue a notice in the <E T="04">Federal Register</E> explaining why the significant new use requirements are not needed. <PRTPAGE P="317"/> </P> <P> (b) <E T="03">Designation of requirements.</E> (1) The significant new use notification and other specific requirements will be based on and be consistent with the provisions included in the final order issued for the substance under section 5(e) of the Act. EPA may also designate additional activities as significant new uses which will be subject to notification. Designation of additional activities as significant new uses will be done in accordance with the criteria and procedures under § 721.170, or through a separate rulemaking proceeding. </P> <P>(2) Significant new use requirements and other specific requirements designated under this section will be listed in subpart E of this part. For each substance, subpart E will identify:</P> <P>(i) The chemical name.</P> <P>(ii) The activities designated as significant new uses.</P> <P>(iii) Other specific requirements applicable to the substance, including recordkeeping requirements or any other requirements included in the final section 5(e) order.</P> <P> (c) <E T="03">Procedures for issuing significant new use rules.</E> (1) EPA will issue significant new use rules under this section by one of the following three processes: direct final rulemaking, interim final rulemaking, or notice and comment rulemaking. EPA will use the direct final rulemaking process to issue significant new use rules unless it determines that, in a particular case, one of the other processes is more appropriate. </P> <P> (2) <E T="04">Federal Register</E> documents issued to propose or establish significant new uses under this section will contain the following: </P> <P>(i) The chemical identity of the substance or, if its specific identity is claimed confidential, an appropriate generic chemical name and an accession number assigned by EPA.</P> <P>(ii) The premanufacture notice number.</P> <P>(iii) The CAS number, where available and not claimed confidential.</P> <P>(iv) A summary of EPA's findings under section 5(e)(1)(A) of the Act for the final order issued under section 5(e).</P> <P>(v) Designation of the significant new uses subject to, or proposed to be subject to, notification and any other applicable requirements.</P> <P>(vi) Any modifications of subpart A of this part applicable to the specific substance and significant new uses.</P> <P> (vii) If the <E T="04">Federal Register</E> document establishes a final rule, or notifies the public that a final rule will not be issued after public comment has been received, the document will describe comments received and EPA's response. </P> <P> (3) <E T="03">Direct final rulemaking.</E> (i) When EPA uses the direct final rulemaking procedure to issue a significant new use rule, it will issue a final rule in the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance. </P> <P> (ii) The <E T="04">Federal Register</E> document will state that, unless written notice is received by EPA within 30 days of publication that someone wishes to submit adverse or critical comments, the rule will be effective 60 days from the date of publication. The written notice of intent to submit adverse or critical comments should state which SNUR(s) will be the subject of the adverse or critical comments, if several SNURs are established through the direct final rule. If notice is received within 30 days that someone wishes to submit adverse or critical comments, the section(s) of the direct final rule containing the SNUR(s) for which a notice of intent to comment was received will be withdrawn by EPA issuing a document in the final rule section of the <E T="04">Federal Register,</E> and a proposal will be published in the proposed rule section of the <E T="04">Federal Register.</E> The proposal will establish a 30-day comment period. </P> <P>(iii) If EPA, having considered any timely comments submitted in response to the proposal, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P> <P> (4) <E T="03">Notice and comment rulemaking.</E> (i) When EPA uses a notice and comment procedure to issue a significant new use rule, EPA will issue a proposal in <PRTPAGE P="318"/> the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance. Persons will be given 30 days to comment on whether EPA should establish notification requirements for the substance under this part. </P> <P>(ii) If EPA, having considered any timely comments, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P> <P> (5) <E T="03">Interim final rulemaking.</E> (i) When EPA uses the interim final rulemaking procedure to issue a significant new use rule, EPA will issue an interim final rule in the final rule section of the <E T="04">Federal Register</E> following its decision to develop a significant new use rule for a specific new chemical substance. The document will state EPA's reasons for using the interim final rulemaking procedure. </P> <P>(A) The significant new use rule will take effect on the date of publication.</P> <P>(B) Persons will be given 30 days from the date of publication to submit comments.</P> <P> (ii) Interim final rules issued under this section shall cease to be in effect 180 days after publication unless, within the 180-day period, EPA issues a final rule in the <E T="04">Federal Register</E> responding to any written comments received during the 30-day comment period specified in paragraph (c)(5)(i)(B) of this section and promulgating final significant new use notification requirements and other requirements for the substance. </P> <P> (d) <E T="03">Schedule for issuing significant new use rules.</E> (1) Unless EPA determines that a significant new use rule should not be issued under this section, EPA will issue a proposed rule, a direct final rule, or an interim final rule within 180 days of receipt of a valid notice of commencement under § 720.102 of this chapter for any substance for which the notice of commencement was received on or after October 10, 1989. </P> <P>(2) Unless EPA determines that a significant new use rule should not be issued under this section, EPA will issue a proposed rule, a direct final rule, or an interim final rule within 1 year of October 10, 1989, for any substance for which the valid notice of commencement under § 720.102 of this chapter was received before October 10, 1989.</P> <P>(3) If EPA receives adverse or critical significant comments following publication of a proposed or interim final rule, EPA will either withdraw the rule or issue a final rule addressing the comments received.</P> <CITA>[54 FR 31314, July 27, 1989, as amended at 87 FR 39769, July 5, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.170</SECTNO> <SUBJECT>Notification requirements for selected new chemical substances that have completed pre­manu­facture review.</SUBJECT> <P> (a) <E T="03">Selection of substances.</E> In accordance with the expedited process specified in this section, EPA may issue significant new use notification and recordkeeping requirements for any new chemical substance for which a premanufacture notice has been submitted under part 720 of this chapter if EPA determines that activities other than those described in the premanufacture notice may result in significant changes in human exposure or environmental release levels and/or that concern exists about the substance's health or environmental effects. </P> <P> (b) <E T="03">Concern criteria.</E> EPA may determine that concern exists about a substance's health or environmental effects if EPA makes any one of the following findings: </P> <P>(1)(i) The substance may cause carcinogenic effects because the substance:</P> <P>(A) Has been shown by valid test data to cause carcinogenic effects in humans or in at least one species of laboratory animal.</P> <P>(B) Has been shown to be a possible carcinogen based on the weight of the evidence in short-term tests indicative of the potential to cause carcinogenic effects.</P> <P> (C) Is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another substance that has been shown by test data to cause carcinogenic effects in humans or in at least one species of laboratory animal, provided that if there is more than one <PRTPAGE P="319"/> such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues. </P> <P>(D) Is known or can reasonably be anticipated, based on valid scientific data or established scientific principles, to be metabolized in humans or transformed in the environment to a substance which may have the potential to cause carcinogenic effects under the criteria in paragraphs (b)(1)(i) (A), (B), or (C) of this section.</P> <P>(ii) No substance may be regulated based on a finding under paragraph (b)(1) of this section unless EPA has also made the finding under § 721.170(c)(2)(ii).</P> <P>(2) The substance has been shown by valid test data to cause acutely toxic effects in at least one species of laboratory animal or is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another substance that has been shown by valid test data to cause acutely toxic effects in at least one species of laboratory animal, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P> <P>(3) The substance may cause serious chronic effects, serious acute effects, or developmentally toxic effects under reasonably anticipated conditions of exposure because the substance:</P> <P>(i) Has been shown by valid test data to cause serious chronic effects, serious acute effects, or developmentally toxic effects in humans or in at least one species of laboratory animal at dose levels that could be of concern under reasonably anticipated conditions of exposure.</P> <P>(ii) Is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another chemical substance that has been shown by valid test data to cause serious chronic effects, serious acute effects, or developmentally toxic effects in humans or in at least one species of laboratory animal at dose levels that could be of concern under reasonably anticipated conditions of exposure, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P> <P>(iii) Is known or can reasonably be anticipated, based on valid scientific data or established scientific principles, to be metabolized in humans or transformed in the environment to a substance which may have the potential to cause serious chronic effects, serious acute effects, or developmentally toxic effects under the criteria in paragraph (b)(3) (i) and (ii) of this section.</P> <P>(iv) Has been shown to potentially cause developmentally toxic effects based on the weight of the evidence in short-term tests indicative of the potential to cause developmentally toxic effects.</P> <P>(4) The substance may cause significant adverse environmental effects under reasonably anticipated conditions of release because the substance:</P> <P>(i) Has been shown by valid test data to cause significant adverse environmental effects at dose levels that could be of concern under reasonably anticipated conditions of release.</P> <P>(ii) Is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another substance that has been shown by valid test data to cause significant adverse environmental effects at dose levels that could be of concern under reasonably anticipated conditions of release, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P> <P>(iii) Has been determined, based on calculations using the substance's physical and chemical properties, to be potentially able to cause significant adverse environmental effects at dose levels that could be of concern under reasonably anticipated conditions of release.</P> <P>(iv) Is known or can reasonably be anticipated, based on valid scientific data or established scientific principles, to be environmentally transformed to a substance which may have the potential to cause significant adverse environmental effects under the criteria in paragraph (b)(4) (i), (ii), and (iii) of this section.</P> <P> (5) Concern exists about the health or environmental effects of one or more <PRTPAGE P="320"/> impurities or byproducts of the substance because the impurity or byproduct meets one or more of the criteria in paragraph (b) (1) through (4) of this section and either: </P> <P>(i) The impurity or byproduct is a new chemical substance and may be present in concentrations that could cause adverse health or environmental effects under reasonably anticipated conditions of exposure or release.</P> <P>(ii) Reasonably anticipated manufacture, processing, or use activities involving the substance for which a premanufacture notice has been submitted may result in significantly increased human exposure to or environmental release of the impurity or byproduct compared to exposure or release levels resulting from existing activities involving the impurity or byproduct.</P> <P> (c) <E T="03">Designation of requirements.</E> (1) When EPA decides to establish significant new use reporting requirements under this section, EPA may designate as a significant new use any one or more of the activities set forth in subpart B of this part. In addition, EPA may designate specific recordkeeping requirements described under subpart C of this part that are applicable to the substance. </P> <P>(2) EPA may designate as a significant new use only those activities that (i) are different from those described in the premanufacture notice for the substance, including any amendments, deletions, and additions of activities to the premanufacture notice, and (ii) may be accompanied by changes in exposure or release levels that are significant in relation to the health or environmental concerns identified under paragraph (b) of this section.</P> <P> (d) <E T="03">Procedures for issuing significant new use rules.</E> (1) Significant new use requirements designated under this section will be listed in subpart E of this part. For each substance, subpart E of this part will identify: </P> <P>(i) The chemical name.</P> <P>(ii) The activities designated as significant new uses, which may include one or more of the activities described in paragraph (c) of this section.</P> <P>(iii) Other specific requirements applicable to the substance.</P> <P>(2) When EPA determines that a substance is a candidate for a significant new use rule under this section, it will notify the person that submitted the premanufacture notice for the substance no later than 7 calendar days before the expiration of the notice review period under § 720.75 of this chapter. In providing this notice, EPA will describe the health or environmental concerns identified under paragraph (b) of this section and the activities under consideration for designation as significant new uses. Such notice may be by telephone, but in this event will be confirmed in writing no later than 30 days after completion of the notice review period.</P> <P> (3) <E T="04">Federal Register</E> documents issued to propose or establish significant new uses under this section will contain the following: </P> <P>(i) The chemical identity of the substance or, if its specific identity is claimed confidential, an appropriate generic chemical name and an accession number assigned by EPA.</P> <P>(ii) The premanufacture notice number.</P> <P>(iii) The CAS number, where available and not claimed confidential.</P> <P>(iv) A summary of the basis for action under this section.</P> <P>(v) Designation of the significant new uses subject to, or proposed to be subject to, notification and any other applicable requirements.</P> <P>(vi) Any modifications of subpart A of this part applicable to the specific substance and significant new uses.</P> <P> (vii) If the <E T="04">Federal Register</E> document establishes a final rule, or notifies the public that a final rule will not be issued after public comment has been received, the document will describe comments received and EPA's response. </P> <P> (4) EPA will issue significant new use rules under this section by one of the following three processes: direct final rulemaking, interim final rulemaking, or notice and comment rulemaking. EPA will use the direct final rulemaking process to issue significant new use rules unless it determines that, in a particular case, one of the other processes is more appropriate. <PRTPAGE P="321"/> </P> <P> (i)(A) When EPA uses the direct final rulemaking procedure to issue a significant new use rule it will issue a direct final rule in the final rule section of the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance. </P> <P> (B) The <E T="04">Federal Register</E> document will state that, unless written notice is received by EPA within 30 days after the date of publication that someone wishes to submit adverse or critical comments, the SNUR will be effective 60 days from date of publication. The written notice of intent to submit adverse or critical comments should state which SNUR(s) will be the subject of the adverse or critical comments, if several SNURs are established through the direct final rule. If notice is received within 30 days after the date of publication that someone wishes to submit adverse or critical comments, the section(s) of the direct final rule containing the SNUR(s) for which a notice of intent to comment was received will be withdrawn by EPA issuing a document in the final rule section of the <E T="04">Federal Register,</E> and EPA will issue a proposed rule in the proposed rule section of the <E T="04">Federal Register.</E> The proposed rule will establish a 30-day comment period. </P> <P>(C) If EPA, having considered any timely comments submitted in response to the proposal, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P> <P> (ii)(A) When EPA uses a notice and comment procedure to issue a significant new use rule, EPA will issue a proposed rule in the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance. Persons will be given 30 days to comment on whether EPA should establish notification requirements for the substance under this part. </P> <P>(B) If EPA, having considered any timely comments, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P> <P> (iii)(A) When EPA uses the interim final rulemaking procedure to issue a significant new use rule, EPA will issue an interim final rule in the final rule section of the <E T="04">Federal Register</E> following its decision to develop a significant new use rule for a specific new chemical substance. The document will state EPA's reasons for using the interim final rulemaking procedure. </P> <P> ( <E T="03">1</E> ) The significant new use rule will take effect on the date of publication. </P> <P> ( <E T="03">2</E> ) Persons will be given 30 days from the date of publication to submit comments. </P> <P> (B) An interim final rule issued under this section shall cease to be in effect 180 days after publication unless, within the 180-day period, EPA issues a final rule in the <E T="04">Federal Register</E> responding to any written comments received during the 30-day comment period specified in paragraph (d)(4)(iii)(A)( <E T="03">2</E> ) of this section and promulgating final significant new use notification requirements and other requirements for the substance. </P> <P> (e) <E T="03">Schedule for issuing significant new use rules.</E> (1) EPA will issue a proposed rule, an interim final rule, or a direct final rule within 270 days of receipt of the notice of commencement under § 720.102 of this chapter for any substance for which the notice of commencement was received on or after October 10, 1989. </P> <P>(2) If EPA receives adverse or critical comments within the designated comment period following publication of a proposed rule or an interim final rule, EPA will either withdraw the rule or issue a final rule addressing the comments received.</P> <CITA>[54 FR 31314, July 27, 1989, as amended at 60 FR 16316, Mar. 29, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.185</SECTNO> <SUBJECT>Limitation or revocation of certain notification requirements.</SUBJECT> <P> (a) <E T="03">Criteria for modification or revocation.</E> EPA may at any time modify or revoke significant new use notification requirements for a chemical substance which has been added to subpart E of this part using the procedures under § 721.160 or § 721.170. Such action may be taken under this section if EPA makes one of the following determinations, <PRTPAGE P="322"/> unless other information shows that the requirements should be retained: </P> <P>(1) Test data or other information obtained by EPA provide a reasonable basis for concluding that activities designated as significant new uses of the substance will not present an unreasonable risk of injury to human health or the environment.</P> <P>(2) EPA has promulgated a rule under section 4 or 6 of the Act, or EPA or another agency has taken action under another law for the substance that eliminates the need for significant new use notification under section 5(a)(2) of the Act.</P> <P>(3) EPA has received significant new use notices for some or all of the activities designated as significant new uses of the substance and, after reviewing such notices, concluded that there is no need to require additional notice from persons who propose to engage in identical or similar activities.</P> <P>(4) EPA has examined new information, or has reexamined the test data or other information or analysis supporting its decision to add the substance to subpart E of this part under § 721.170 and has concluded that the substance does not meet the criteria under § 721.170(b).</P> <P>(5) For a substance added to subpart E of this part under § 721.160, EPA has examined new information, or has reexamined the test data or other in­for­ma­tion or analysis supporting its finding under section 5(e)(1)(A)(ii)(I) of the Act, and has concluded that a rational basis no longer exists for the findings that activities involving the substance may present an unreasonable risk of injury to human health or the environment required under section 5(e)(1)(A) of the Act.</P> <P>(6) For a substance added to subpart E of this part under § 721.160, certain activities involving the substance have been designated as significant new uses pending the completion of testing, and adequate test data developed in accordance with applicable procedures and criteria have been submitted to EPA.</P> <P> (b) <E T="03">Procedures for limitation or revocation.</E> Modification or revocation of significant new use notification requirements for a substance that has been added to subpart E of this part using the procedures described under § 721.160 or § 721.170 may occur either at EPA's initiative or in response to a written request. </P> <P>(1) Any affected person may request modification or revocation of significant new use notification requirements for a chemical substance that has been added to subpart E of this part using the procedures described in § 721.160 or § 721.170 by submitting a request that is accompanied by information sufficient to support the request. Persons submitting a request to EPA under this part must submit the request to EPA using e-PMN software in the manner set forth in 40 CFR 720.40(a)(2)(i). See 40 CFR 720.40(a)(2)(ii) for information on how to obtain the e-PMN software. Support documents related to these requests must also be submitted to EPA in the manner set forth in 40 CFR 720.40(c).</P> <P>(2) The Director of the Office of Pollution Prevention and Toxics will consider the request, make a determination whether to initiate rulemaking to modify the requirements, and notify the requester of that determination by certified letter. If the request is denied, the letter will explain why EPA has concluded that the significant new use notification requirements for that substance should remain in effect.</P> <P> (3) If EPA concludes that significant new use notification requirements for a substance should be limited or revoked, EPA will propose the changes in the <E T="04">Federal Register,</E> briefly describe the grounds for the action, and provide interested parties an opportunity to comment. </P> <CITA>[54 FR 31314, July 27, 1989, as amended at 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995; 71 FR 33641, June 12, 2006; 76 FR 30836, May 27, 2011; 78 FR 72827, Dec. 4, 2013]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Significant New Uses for Specific Chemical Substances</HD> <SECTION> <SECTNO>§ 721.225</SECTNO> <SUBJECT>2-Chloro-N-methyl-N-substituted acetamide (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance 2-chloro- <E T="03">N</E> -methyl- <E T="03">N</E> -substituted acetamide (PMN P-84-393) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. <PRTPAGE P="323"/> </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(1), (a)(3), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(2)(i), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDSs are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and con­sumer activities.</E> Requirements as specified § 721.80(g). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The recordkeeping requirements as specified in § 721.125 (a) through (g) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 32412, Aug. 9, 1990, as amended at 57 FR 20424, May 13, 1992. Redesignated at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.267</SECTNO> <SUBJECT>N-[2-[(substituted dinitrophenyl)azo]diallylamino-4- substituted phenyl] acetamide (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as <E T="03">N</E> -[2-[(substituted dinitrophenyl)azo]diallylamino-4-substituted phenyl] acetamide (PMN P-95-513) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63734, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.275</SECTNO> <SUBJECT>Halogenated-N-(2-propenyl)-N-(substituted phenyl) acetamide.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated- <E T="03">N</E> -(2-propenyl)- <E T="03">N</E> -(substituted phenyl) acetamide (P-83-1085) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3). </P> <P> (ii) <E T="03">Industrial, commercial, and con­sumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (e), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 25988, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.285</SECTNO> <SUBJECT> Acetamide, <E T="7462">N</E> -[4-(pentyloxy)phenyl]-, acetamide, <E T="7462">N</E> -[2-nitro-4-(pentyloxy)phenyl]-, and acetamide, <E T="7462">N</E> -[2-amino-4-(pentyloxy)phenyl]-. </SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified as acetamide, <E T="03">N</E> -[4-(pentyloxy)phenyl]- (PMN P-92-31), acetamide, <E T="03">N</E> -[2-nitro-4- <PRTPAGE P="324"/> (pentyloxy)phenyl]- (PMN P-92-32), and acetamide, <E T="03">N</E> -[2-amino-4-(pentyloxy)phenyl]- (PMN P-92-33) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 90 ppb for PMNs P-92-31 and P-92-32, and N = 30 ppb for P-92-33). When calculating the surface water concentrations according to the instructions in § 721.90(a)(4), the statement that the amount of the substance that will be released will be calculated before the substance enters control technology does not apply. Instead, if the waste stream containing the substance will be treated before release, then the amount of the substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 25 percent removal efficiency may be attributed to such treatment. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51702, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.303</SECTNO> <SUBJECT>Acetic acid, 2-methoxy-, methyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as acetic acid, 2-methoxy-, methyl ester (PMN P-99-0365, CAS No. 6290-49-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81398, Dec. 26, 2000, as amended at 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.304</SECTNO> <SUBJECT>Acetic acid, [(5-chloro-8-quinolinyl)oxy-], 1-methyl hexyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as acetic acid, [(5-chloro-8-quinolinyl)oxy-]-, 1-methylhexyl ester (PMN P-01-170; CAS No. 99607-70-2) is subject to reporting under this section for the significant new use described in paragraph (a)(1) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(1), (a)(3), (a)(4), and (a)(5)(iv). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), (d), (e), and, (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70173, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.305</SECTNO> <SUBJECT>Di-substituted acetophenone (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as di-substituted acetophenone (PMN P-97-93) is subject to reporting under this section for the significant <PRTPAGE P="325"/> new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(2)(i), (g)(2)(v). The following statement shall appear on each label as specified in § 721.72(b) and the SDS as specified in § 721.72(c): This substance is expected to be dermally absorbed and may cause effects to the liver, kidney, adrenal glands, and the heart. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 44574, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.320</SECTNO> <SUBJECT>Acrylamide-substituted epoxy.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as acrylamide-substituted epoxy (PMN P-92-660) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(2)(iv), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vi), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51681, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.321</SECTNO> <SUBJECT>Substituted acrylamides and acrylic acid copolymer (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted acrylamides and acrylic acid copolymer (PMN P-00-0490) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (v)(1), and (x)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15079, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <PRTPAGE P="326"/> <SECTNO>§ 721.323</SECTNO> <SUBJECT>Substituted acrylamide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as substituted acrylamide (PMN P-90-1687) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(iii), (a)(3), (a)(4), (a)(6)(ii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). Section 721.63 (a)(5)(i), (a)(5)(ii), and (a)(5)(iii) apply to manufacturing operations only; § 721.63(a)(5)(ix), (a)(5)(x), and (a)(5)(xi) apply to processing and use operations only. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(ii) (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). The following additional statement shall appear on each label and SDS as required by this paragraph: This substance may cause nervous system effects. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51702, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.324</SECTNO> <SUBJECT>Alkoxylated acrylate polymer (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkoxylated acrylate polymer (PMN P-98-807) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 366, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.329</SECTNO> <SUBJECT>Halogenated benzyl ester acrylate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated benzyl ester acrylate (PMN P-90-1527) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (b), and (c) (concentration set at 1.0 percent). The reporting requirement for § 721.63(a)(5)(i) applies only during manufacture. The reporting requirement for § 721.63 (a)(5)(ii), (a)(5)(iv), and (a)(5)(v) applies only during processing. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g), (g)(1)(iv), (g)(2)(ii), (g)(2)(iv), and (g)(5). The following statement shall appear on each label as specified in § 721.72(b) and the Safety Data Sheet (SDS) as specified in § 721.72 (c): The substance may cause internal organ effects (kidney and blood). The requirements of this section do not apply when the PMN substance is bound or embedded into a plastic, resin matrix, or pellet. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). <PRTPAGE P="327"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 366, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.330</SECTNO> <SUBJECT>Aromatic acrylate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an aromatic acrylate (PMN P-01-420) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified § 721.90(a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70174, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.333</SECTNO> <SUBJECT>Dimethyl alkylamine salt (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as a Dimethyl alkylamine salt (PMNs P-99-0368 and P-99-0369) are subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81398, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.336</SECTNO> <SUBJECT>Perfluoroalkylethyl acrylate copolymer (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a perfluoroalkylethyl acrylate copolymer (PMN P-94-241) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80(y)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63734, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.338</SECTNO> <SUBJECT>Certain salts of an acrylate copolymer.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as 2-propenoic acid, polymer with 2-propenamide, ammonium salt (PMN P- <PRTPAGE P="328"/> 00-0333; CAS No. 55554-55-7) and generically as salt of an acrylate copolymer (PMN P-00-0334) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(2), (w)(2), and (x)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15079, Mar. 28, 2003, as amended at 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.405</SECTNO> <SUBJECT>Polyether acrylate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a polyether acrylate (PMN P-95-666) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3419, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.430</SECTNO> <SUBJECT>Oxo-substituted amino­al­kanoic acid derivative.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as oxo-substituted amino al­kan­oic acid derivative (PMN No. P-92-692) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a) through (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (a)(2), and (a)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 32236, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.435</SECTNO> <SUBJECT>Alkylphenylpolyether­alk­a­nol­a­mines (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkylphenylpolyether­alk­a­nol­a­mines (PMNs P-97-880/881/882) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) [Reserved] <PRTPAGE P="329"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44574, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.445</SECTNO> <SUBJECT>Substituted ethyl alken­a­mide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted ethyl alkenamide (PMN No. P-86-1315) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(ii), (g)(1)(vii), (g)(2)(i), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and con­sumer activities.</E> Use other than polymerizing all residual materials from the manufacture, processing, and equipment rinsing of the PMN substance so that no monomers of the PMN substance are released to the environment. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[58 FR 32236, June 8, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.450</SECTNO> <SUBJECT>Hydrofluorochloroalkene (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydrofluorochloroalkene (PMN P-97-593) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The recordkeeping requirements specified in § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44574, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.463</SECTNO> <SUBJECT>Acrylate of polymer based on isophorone diisocyanate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as acrylate of polymer based on isophorone diisocyanate (PMN P-00-0626) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), (c)(4) (N = 3 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15079, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <PRTPAGE P="330"/> <SECTNO>§ 721.465</SECTNO> <SUBJECT>Alkoxylated alkylpolyol acrylates, adduct with alkylamine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkoxylated alkylpolyol acrylates, adduct with alkylamine (PMNs P-98-0082, P-98-0083, and P-98-0084 are subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15079, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.480</SECTNO> <SUBJECT>Aminoester of polyalkenylated alkyldicarboxylic acid (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as Aminoester of polyalkenylated alkyldicarboxylic acid (PMN P-99-0115) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 81398, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.484</SECTNO> <SUBJECT>Fluorinated acrylic copolymer (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a fluorinated acrylic copolymer (PMN P-95-1208) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), (x)(1), and (y)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63735, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.505</SECTNO> <SUBJECT>Halogenated acrylonitrile.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated acrylonitrile, (PMN P-90-299) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(ii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(iii), (g)(1)(iv), (g)(1)(v), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). <PRTPAGE P="331"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (h). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 15792, Apr. 17, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.520</SECTNO> <SUBJECT>Alanine, N-(2-carboxyethyl)-N-alkyl-, salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alanine, <E T="03">N-</E> (2-carboxyethyl)- <E T="03">N-</E> alkyl-, salt (P-89-336) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k) and (q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), (c)(4) (where N = 100). The requirement of 40 CFR 721.91(a)(4) that the amount of the substance estimated to be released to water is calculated before entering control technology is not retained. Instead, if the waste stream containing the PMN substance will be treated using biological treatment (activated sludge or equivalent) plus clarification, then the amount of PMN substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 90 percent removal efficiency may be attributed to such treatment. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 15789, Apr. 17, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.522</SECTNO> <SUBJECT>Oxirane, methyl-, polymer with oxirane, mono(3,5,5,-trimethylhexyl) ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as oxirane, methyl-, polymer with oxirane, mono (3,5,5,-trimethylhexyl) ether (PMN P-99-669, SNUN S-09-1, and SNUN S-13-29; CAS No. 204336-40-3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80. A significant new use is use other than as a wetting agent, dispersing agent and defoaming/deaerating agent in waterborne coatings, inks, and paints, water based adhesives, and ultraviolet curable coatings; wetting agent in water miscible metalworking fluids, powdered construction additives for use in cementitious mortars, grouts and tile adhesives, and in liquid admixtures for concrete; and a substrate wetting and anticratering additive for ultraviolet curable inkjet ink. </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="332"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 15080, Mar. 28, 2003, as amended at 80 FR 37164, June 30, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.524</SECTNO> <SUBJECT> Alcohols, C <E T="9145">6-12</E> , ethoxylated, reaction product with maleic anhydride. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alcohols, C <E T="52">6-12</E> , ethoxylated, reaction product with maleic anhydride (PMN P-88-1108) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 300). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3419, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.525</SECTNO> <SUBJECT>1-propanol, 3-propoxy-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1-propanol, 3-propoxy- (PMN P-00-0827; CAS No. 4161-22-2) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i) and (a)(3). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(o) and (j). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 15080, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.530</SECTNO> <SUBJECT>Propanoyl chloride, 3-chloro-2,2-dimethyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as propanoyl chloride, 3-chloro-2,2-dimethyl- (PMN P-84-491; CAS No. 4300-97-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f) and (g)(1)(vii), (g)(2)(i) through (g)(2)(v), and (g)(4)(i). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1) and (c)(1). (In lieu of incineration, persons subject to this section may dispose of wastes containing the substance by chemically treating liquid wastes so that the first hydrolysis product is less than 10 ppm prior to discharge or purifying the <PRTPAGE P="333"/> waste stream so that the first hydrolysis product is less than 10 ppm. Those purified waste streams may be reused or sold. All of the substance removed by these processes must be incinerated or treated and released as described in this paragraph (a)(2)(iv).) </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e) through (f), (i) and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 32412, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993; 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.532</SECTNO> <SUBJECT>1-Butanol, 3-methoxy-3-methyl-, acetate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1-butanol, 3-methoxy-3-methyl-, acetate (PMN P-00-618; SNUN S-05-03; and SNUN S-11-4; CAS No. 103429-90-9) is subject to reporting under this section for the significant new uses described in paragraphs (a)(2) and (a)(3) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80. The significant new use is any use other than the use described in P-00-618. </P> <P>(ii) [Reserved]</P> <P>(3) The significant new uses for any use other than the use described in P-00-618:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(1), (a)(3)(i), (b) (concentration set at 0.1 percent), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures ( <E T="03">e.g.,</E> enclosure or confinement of the operation, general and local ventilation) or administrative control measures ( <E T="03">e.g.,</E> workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. Butyl rubber gloves with a minimum thickness of 16.6 mils or Silver shield gloves with a minimum thickness of 2.7 mils have been tested in accordance with the American Society for Testing Materials (ASTM) F739 method and found by EPA to satisfy the consent orders and § 721.63(a)(2)(i) requirements for dermal protection to 100 percent chemical substance. Silver Shield gloves with a minimum thickness of 2.7 mils have been tested in accordance with the American Society for Testing Materials (ASTM) F739 method and found by EPA to satisfy the consent orders and § 721.63(a)(2)(i) requirements for dermal protection for paint formulations where concentrations of the chemical substance is 10% or less. Gloves and other dermal protection may not be used for a time period longer than they are actually tested and must be replaced at the end of each work shift. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72(a), (b) (concentration set at 0.1 percent), (c), (d), (f), (g)(1)(iv), (g)(1)(iv), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f), (o), and any application method that generates a vapor, mist, or aerosol when the percent concentration of the SNUN substance in the final product exceeds 10%. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 15080, Mar. 28, 2003, as amended at 80 FR 37164, June 30, 2015]</CITA> </SECTION> <SECTION> <PRTPAGE P="334"/> <SECTNO>§ 721.533</SECTNO> <SUBJECT>Propane, 1,1,1,3,3-pentachloro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as propane, 1,1,1,3,3-pentachloro- (PMN P-99-1327; CAS No. 23153-23-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15080, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.535</SECTNO> <SUBJECT>Halogenated alkane (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated alkane (PMN P-01-433) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70174, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.536</SECTNO> <SUBJECT>Halogenated phenyl alkane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated phenyl alkane (PMN P-89-867) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply once the substance has been incorporated into a resin. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (6)(i), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. As an alternative to the respiratory requirements in this section manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (g)(1)(vii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P>(iv) [Reserved]</P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. <PRTPAGE P="335"/> </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51681, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.537</SECTNO> <SUBJECT>Organosilane ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an organosilane ester (PMN P-96-1661/P-95-1654) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(r) (370,000 kilogram (kg)) (90-day subchronic inhalation study in rats-(40 CFR 799.9346) (62 FR 43828, August 15, 1997) (FRL-5719-5). A person may not manufacture or import the substance beyond the aggregate production volume limit, unless that person conducts this study on the substance and submits all final reports and underlying data in accordance with the procedures and criteria specified in paragraphs (a)(2)(i)(A), (a)(2)(i)(B), (a)(2)(i)(C), and (a)(2)(i)(D) of this section. </P> <P> (A) Each study required to be performed pursuant to this section must be scientifically valid. <E T="03">Scientific valid</E> means that the study was conducted according to: </P> <P> ( <E T="03">1</E> ) The test guidelines specified in paragraph (a)(2)(i) of this section. </P> <P> ( <E T="03">2</E> ) An EPA-approved protocol. </P> <P> ( <E T="03">3</E> ) TSCA Good Laboratory Practice Standards at 40 CFR part 792. </P> <P> ( <E T="03">4</E> ) Using methodologies generally accepted at the time the study is initiated. </P> <P> ( <E T="03">5</E> ) Any deviation from these requirements must be approved in writing by EPA. </P> <P>(B) Before starting to conduct any of the studies in paragraph (a)(2)(i) of this section, the person must obtain approval of test protocols from EPA by submitting written protocols. EPA will respond to the person within 4 weeks of receiving the written protocols. Published test guidelines specified in paragraph (a)(2)(i) of this section (e.g., 40 CFR part 797 or part 798) provide general guidance for development of test protocols, but are not themselves acceptable protocols.</P> <P>(C) The person shall:</P> <P> ( <E T="03">1</E> ) Conduct each study in good faith with due care. </P> <P> ( <E T="03">2</E> ) Promptly furnish to EPA the results of any interim phase of each study. </P> <P> ( <E T="03">3</E> ) Submit, in triplicate (with an additional sanitized copy, if confidential business information is involved), the final report of each study and all underlying data (“the report and data”) to EPA no later than 14 weeks prior to exceeding the applicable production volume limit. The final report shall contain the contents specified in 40 CFR 792.185. </P> <P> (D)( <E T="03">1</E> ) Except as described in paragraph (a)(2)(i)(D)( <E T="03">2</E> ) of this section, if, within 6 weeks of EPA's receipt of a test report and data, the person receives written notice that EPA finds that the data generated by a study are scientifically invalid, the person is prohibited from further manufacture and import of the PMN substance beyond the applicable production volume limit. </P> <P> ( <E T="03">2</E> ) The person may continue to manufacture and import the PMN substance beyond the applicable production limit only if so notified, in writing, by EPA in response to the person's compliance with either of the following paragraphs (a)(2)(i)(D)( <E T="03">2</E> )( <E T="03">i</E> ) or (a)(2)(i)(D)( <E T="03">2</E> )( <E T="03">ii</E> ) of this section. </P> <P> ( <E T="03">i</E> ) The person may reconduct the study. If there is sufficient time to reconduct the study and submit the report and data to EPA at least 14 weeks before exceeding the production limit as required by paragraph (a)(2)(i)(C)( <E T="03">3</E> ) of this section, the person shall comply with paragraph (a)(2)(i)(C)( <E T="03">3</E> ) of this section. If there is insufficient time for the person to comply with paragraph (a)(2)(ii)(C)( <E T="03">3</E> ) of this section, the person may exceed the production limit and shall submit the report and data in triplicate to EPA within a reasonable period of time, all as specified by EPA in the notice described in paragraph (a)(2)(i)(D)( <E T="03">1</E> ) of this section. EPA will respond to the person in writing, within 6 weeks of receiving the person's report and data. <PRTPAGE P="336"/> </P> <P> ( <E T="03">ii</E> ) The person may, within 4 weeks of receiving from EPA the notice described in paragraph (a)(2)(i)(D)( <E T="03">1</E> ) of this section, submit to EPA a written report refuting EPA's finding. EPA will respond to the person in writing, within 4 weeks of receiving the person's report. </P> <P>(E) The person is not required to conduct a study specified in paragraph (a)(2)(i) of this section if notified in writing by EPA that it is unnecessary to conduct that study.</P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3419, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.538</SECTNO> <SUBJECT>Phenol, 4-(1,1-dimethyl- ethyl)-, homopolymer.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as phenol, 4-(1,1-dimethylethyl)-, homopolymer (PMN P-95-243; CAS No. 30813-81-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(3) of this section. </P> <P> (2) <E T="03">High moleculation weight exemption.</E> A batch of the chemical substance may be exempt from the provisions of this rule if the average number molecular weight of the substance is greater than 1,000 and the low molecular weight species below 1,000 and 500 are less than 25 percent and 10 percent, respectively. To be eligible for this exemption, the batch must be individually measured. </P> <P>(3) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (d), (f), (g)(3)(i), (g)(4)(i), and (g)(5). The label and safety data sheet (SDS) as required by this paragraph shall also include the following statement: This substance is toxic to aquatic invertebrate. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activites.</E> Requirements as specified in § 721.80(q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4) and (b)(4) (N = 9). When calculating the surface water concentrations according to the instructions in § 721.91, the statement that the amount of the substance that will be released will be calculated before the substance enters control technology does not apply. Instead, if the waste stream containing the substance will be treated using primary and secondary wastewater treatment with control of suspended solids, before release, then the amount of the substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 95 percent removal efficiency may be attributed to such treatment. These requirements do not apply to the sites specifically exempted in the TSCA section 5(e) consent order for this substance. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3420, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.539</SECTNO> <SUBJECT>Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[1-[(4-nonylphenoxy)methyl]-2-(2-propenyloxy)ethoxy]-, branched, ammonium salts.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[1-[(4-nonylphenoxy)methyl]-2-(2-propenyloxy)ethoxy]-, branched, ammonium salts (PMN P-96-1240; CAS No. 184719-88-8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. <PRTPAGE P="337"/> </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3420, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.540</SECTNO> <SUBJECT>Alkylphenoxypolyalkoxy­amine (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as akylphenoxypolyalkoxyamine (PMN P-86-1489) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (f), and (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Section 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (f), (g), (h), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 26097, June 26, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.545</SECTNO> <SUBJECT>Polyalkenylalkylphenol (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a Polyalkenylalkylphenol (PMN P-99-0472) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81398, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.550</SECTNO> <SUBJECT>Alkyl alkenoate, azobis-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkyl alkenoate, azobis- (PMN P-88-2470) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), (a)(6)(ii), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), and (g)(5). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q). <PRTPAGE P="338"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), (f), (g), and (h). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 46771, Nov. 6, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.555</SECTNO> <SUBJECT>Alkyl amino nitriles (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkyl amino nitriles (PMNs P-96-1674 and P-96-1675) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(iii), (a)(4), (a)(5)(i), (a)(6)(ii),(a)(6)(v), and (c). A full face shield is required if splashing or spraying occurs. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (c)(1) and (c)(2)(iv). The SDS required by this paragraph shall include the following statement: Ocular exposure may cause death. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (l). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 65709, Nov. 30, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.558</SECTNO> <SUBJECT>2-Propanol, 1,1′-iminobis-, N-tallow alkyl derivs., hydrochlorides.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 2-propanol, 1,1′-iminobis-, N-tallow alkyl derivs., hydrochlorides (PMN P-96-1426; CAS No. 1078715-59-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44575, Aug. 20, 1998, as amended at 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.562</SECTNO> <SUBJECT>Substituted alkylamine salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted alkylamine salt (PMN P-85-941) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where n = 70). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45080, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <PRTPAGE P="339"/> <SECTNO>§ 721.575</SECTNO> <SUBJECT>Substituted alkyl halide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted alkyl halide (PMN P-83-1222) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(ii), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a), and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b), and (c), respectively. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), and (f). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 46772, Nov. 6, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.600</SECTNO> <SUBJECT>3-Alkyl-2-(2-anilino)vinyl thi­azolinium salt (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as 3-alkyl-2-(2-ani­lino)vin­yl­thi­azo­li­nium salt (PMN P-84-1007) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e), (f) [concentration set at 1 percent], (g)(1)(iii), (g)(1) (may be lethal if inhaled or in contact with eyes), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when an SDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS in not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[55 FR 26102, June 26, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.625</SECTNO> <SUBJECT>Alkylated diarylamine, sul­furized (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkylated diarylamine, sul­furized (PMN P-89-506) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="340"/> </P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q) </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 26099, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.630</SECTNO> <SUBJECT>Salt of a modified tallow alkylenediamine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a salt of a modified tallow alkylenediamine (PMN P-96-1425) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44575, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.632</SECTNO> <SUBJECT>Silicoaluminophosphates, compd. with organic amine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as Silicoaluminophosphates, compd. with organic amine (PMN P-98-1274) is subject to reporting under this section for the significant new uses described in paragraph (a)(2)of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (b) and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the New Chemical Exposure Limit (NCEL) provisions listed in the section TSCA 5(e) consent order for these substances. The NCEL is 0.1 mg/m <SU>3</SU> as an 8-hour time weighted average verified by actual monitoring data. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (g)(1)(ii), (g)(1)(iv), (g)(1) (vii), (g)(2)(i), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81398, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.633</SECTNO> <SUBJECT>Aluminosilicates, phospho-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as aluminosilicates, phospho- (PMN P-98-1275 and SNUN S-11-10; CAS No. 201167-69-3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(4), (b), and (c). When determining which <PRTPAGE P="341"/> persons are reasonably likely to be exposed as required for § 721.63(a)(4) engineering control measures ( <E T="03">e.g.,</E> enclosure or confinement of the operation, general and local ventilation) or administrative control measures ( <E T="03">e.g.,</E> workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. The following NIOSH-certified respirators with an APF of at least 50 meet the requirements of § 721.63(a)(4): NIOSH-certified air-purifying, tight-fitting full-face respirator equipped with N100 (if oil aerosols absent), R100, or P100 filters; NIOSH-certified powered air-purifying respirator equipped with a tight-fitting full facepiece and high efficiency particulate air (HEPA) filters; NIOSH-certified supplied-air respirator operated in positive pressure demand or continuous flow mode and equipped with a hood, or helmet or tight-fitting facepiece. As an alternative to the respiratory requirements listed here, a manufacturer or processor may choose to follow the New Chemical Exposure Limit (NCEL) provisions listed in the TSCA section 5(e) consent order for these substances. The NCEL is 0.1 mg/m <SU>3</SU> as an 8-hour time weighted average verified by actual monitoring data. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (g)(1)(ii), (g)(1)(iv), (g)(1) (vii), (g)(2)(i), (g)(2)(iv), and (g)(5). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), (d), (f), (g), and (h) are applicable to manufacturers and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81399, Dec. 26, 2000, as amended at 80 FR 37164, June 30, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.638</SECTNO> <SUBJECT>Silyl amine, potassium salt (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as silyl amine, potassium salt (PMN P-00-1086) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitation or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15080, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.639</SECTNO> <SUBJECT>Amine aldehyde condensate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an amine aldehyde condensate (PMN P-94-1810) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45080, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.640</SECTNO> <SUBJECT>Amine substituted metal salts.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as amine substituted metal salts <PRTPAGE P="342"/> (PMNs P-96-1337/1338/1339) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 4). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3421, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.641</SECTNO> <SUBJECT>Alkylpoly(oxyalkylene)amine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an alkylpoly(oxyalkylene)amine (PMN P-96-1430) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3421, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.642</SECTNO> <SUBJECT> Amines, <E T="7462">N</E> -(C <E T="9145">14-18</E> and C <E T="9145">16-18</E> unsaturated alkyl)] dipropylene-tri-, tripropylenetetra-, and tetrapropylenepenta-. </SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances amines, <E T="03">N</E> -(C <E T="52">14-18</E> and C <E T="52">16-18</E> unsaturated alkyl)] dipropylenetri-, (PMN P-94-1244), tripropylenetetra- (PMN P-94-1245), and tetrapropylenepenta- (PMN P-94-1246) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11041, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.643</SECTNO> <SUBJECT>Ethoxylated alcohol, phosphated, amine salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as an ethoxylated alcohol, phosphated, amine salt (PMN P-96-1478) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 8). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3421, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="343"/> <SECTNO>§ 721.644</SECTNO> <SUBJECT> Amines, C <E T="9145">12-14</E> -tert-alkyl, sulfonates. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as amines, C <E T="52">12-14</E> -tert-alkyl, sulfonates (PMN P-98-400; CAS No. 197527-19-8) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 366, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.646</SECTNO> <SUBJECT>Aminofluoran derivative (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as aminofluoran derivative (PMN P-95-512) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63735, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.647</SECTNO> <SUBJECT>Alkoxylated alkyl amine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an alkoxylated alkyl amine (PMN P-01-578) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 70174, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.648</SECTNO> <SUBJECT>Alkyl dialkylamino phenylsulfonyl alkenoate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkyl dialkylamino phenylsulfonyl alkenoate (PMN P-00-0816) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="344"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15080, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.650</SECTNO> <SUBJECT>11-Aminoundecanoic acid.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 11-ami­no­un­de­ca­noic acid, CAS Number 2432-99-7, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is any use other than as.</P> <P>(i) An intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-aminoundecanoic acid will be fully polymerized during the manufacturing process, or</P> <P>(ii) A component in photoprocessing solutions.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Definitions.</E> In addition to the definitions in § 721.3, the following definitions apply to this section: </P> <P> (i) <E T="03">Enclosed process</E> means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases. </P> <P> (ii) <E T="03">Internal subunit</E> means a subunit that is covalently linked to at least two other subunits. <E T="03">Internal subunits</E> of polymer molecules are chemically derived from monomer molecules that have formed covalent links between two or more other molecules. </P> <P> (iii) <E T="03">Monomer</E> means a chemical substance that has the capacity to form links between two or more other molecules. </P> <P> (iv) <E T="03">Polymer</E> means a chemical substance that consists of at least a simple weight majority of polymer molecules but consists of less than a simple weight majority of molecules with the same molecular weight. Collectively, such polymer molecules must be distributed over a range of molecular weights wherein differences in molecular weight are primarly attributable to differences in the number of internal subunits. </P> <P> (v) <E T="03">Polymer molecule</E> means a molecule which includes at least four covalently linked subunits, at least two of which are internal subunits. </P> <P> (vi) <E T="03">Subunit</E> means an atom or group of associated atoms chemically derived from corresponding reactants. </P> <P>(2) [Reserved]</P> <CITA>[52 FR 19865, May 28, 1987. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.655</SECTNO> <SUBJECT>Ethoxylated alkyl quaternary ammonium compound.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an ethoxylated alkyl quaternary ammonium compound (PMN P-96-573) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3421, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.715</SECTNO> <SUBJECT>Trisubstituted anthracene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as trisubstituted anthracene (PMN P-91-689) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(iii), (a)(2)(iv), (a)(3), <PRTPAGE P="345"/> (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (First limit set at 500 kg; second limit set at 25,000 kg). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 10 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27481, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.720</SECTNO> <SUBJECT>Alkoxylated fatty acid amide, alkylsulfate salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an alkoxylated fatty acid amide, alkylsulfate salt (PMN P-97-136) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3422, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.750</SECTNO> <SUBJECT>Aromatic amine compound.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance aromatic amine compound (PMN P-86-334) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent) and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i) through (g)(2)(iii), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c), respectively. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e) and (f). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 39899, Sept. 28, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="346"/> <SECTNO>§ 721.757</SECTNO> <SUBJECT>Polyoxyalkylene substituted aromatic azo colorant.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as polyoxyalkylene substituted aromatic azo colorant (PMN P-92-1131) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (w)(1) and (w)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51681, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.775</SECTNO> <SUBJECT>Brominated aromatic com­pound (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a brominated aromatic compound (PMN P-84-824) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(1), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(2)(v). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when an SDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS in not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (j) (use as an additive flame retardant for plastics) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (g), (i), and (k). </P> <P> (2) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P> (3) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[55 FR 26098, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.785</SECTNO> <SUBJECT>Halogenated alkane aromatic compound (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a halogenated alkane aromatic compound (PMN P-94-1747) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (g)(1)(vii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activites.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. <PRTPAGE P="347"/> </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[61 FR 63735, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.805</SECTNO> <SUBJECT>Benzenamine, 4,4′-[1,3-phenylenebis(1-methylethyl idene)]bis[2,6-dimethyl-.</SUBJECT> <P>(a) Chemical substances and significant new uses subject to reporting. (1) The chemical substance benzenamine, 4,4′-[1,3-phenylenebis(1-methyl ethylidene)]bis[2,6-dimethyl- (CAS Registry Number 2716-12-3; PMN P-86-501) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(xv), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), and (c)(2). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(vi), (b)(2)(vi), and (c)(2)(vi). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements as specified in § 721.125 (a) through (k) are applicable to manufacturers, importers, and processors of these substances . </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 31330, July 15, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.825</SECTNO> <SUBJECT>Certain aromatic ether diamines.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The following chemical substances are subject to reporting under this section for the significant new uses described in paragraphs (a)(2), (a)(3), and (a)(4) of this section: Benzenamine, 4,4′-[[1,1′-biphenyl]-2,5-diylbis(oxy)]bis- (CAS Number 94148-67-1, Premanufacture notice (PMN) P-85-335); 1,2,4,5-benzenetetracarboxylic acid, diethyl ester, compound with 4,4′-[[1,1′-biphenyl]-2,5-diylbis(oxy)]bis[benzenamine] (1:1) (PMN P-85-336); and 1,2,4,5-benzenetetracarboxylic acid, 1,4-diethyl ester, compound with 4,4′-[[1,1′-biphenyl]-2,5-diylbis(oxy)]bis[benzenamine] (1:1), polymer with 4,4′-[[1,1′-biphenyl]-2,5-diylbis(oxy)]bis[benzenamine]-1,5-diethyl-1,2,4,5-benzenetetra carboxylate (1:1), reaction products with phthalic anhydride (PMN P-86-1153). </P> <P>(2) The significant new use for P-85-335 is: Manufacture, import, or processing in a quantity of 100,000 pounds per year, or greater, for any use.</P> <P>(3) The significant new use for P-85-336 is: Any use.</P> <P>(4) The significant new use for P-86-1153 is: Manufacture, import, or processing in a quantity of 225,000 pounds per year, or greater, for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes a substance identified in paragraph (a)(3) of this section and intends to distribute the substance in commerce must submit a significant new use notice. <PRTPAGE P="348"/> </P> <P>(2) [Reserved]</P> <CITA>[59 FR 43296, Aug. 23, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.840</SECTNO> <SUBJECT>Alkyl substituted diaromatic hydrocarbons.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an alkyl substituted di­aro­matic hydrocarbons (PMN P-91-710) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46464, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.843</SECTNO> <SUBJECT>Substituted phenylazophenylazo phenol (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted phenylazophenylazo, phenol (PMN P-00-0420) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15081, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.875</SECTNO> <SUBJECT>Aromatic nitro compound.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance aromatic nitro compound (PMN P-86-335) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), and (g)(2)(i) through (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c), respectively. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), and (f). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 39899, Sept. 28, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="349"/> <SECTNO>§ 721.910</SECTNO> <SUBJECT>Propanetriol polyalkylenepolyolamine aryl aldimine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as propanetriol polyalkylenepolyolamine aryl aldimine (PMN P-99-0873) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15081, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.925</SECTNO> <SUBJECT>Substituted aromatic (generic).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted aromatic (PMN P-84-954) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), and (g)(2)(v). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when an SDS is not required under § 721.72(c). The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c), respectively. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (level set at 0.25 ppm). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[55 FR 26098, June 26, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.950</SECTNO> <SUBJECT>Sodium salt of an alkylated, sulfonated aromatic (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a sodium salt of an alkylated, sulfonated aromatic (PMN P-84-591) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (j) (use as a dye leveler) and (q). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 26098, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="350"/> <SECTNO>§ 721.977</SECTNO> <SUBJECT>Aryloxyarene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as aryloxyarene (PMN P-92-314) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(iii), and (g)(5). The label and SDS as required by this paragraph shall also include the following statement: This substance may be toxic to sediment organisms. </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3422, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.980</SECTNO> <SUBJECT>Sodium salt of azo acid dye.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a sodium salt of azo acid dye (PMN P-95-633) is subject to eporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), and (x)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3422, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.981</SECTNO> <SUBJECT>Substituted naphtholoazo-substituted naphthalenyl-substituted azonaphthol chromium complex.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted naphtholoazo-substituted naphthalenyl-substituted azonaphthol chromium complex (PMN P-93-1631) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (v)(2), (w)(2), and (x)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3422, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.982</SECTNO> <SUBJECT> Calcium, bis(2,4-pentanedionato- <E T="7462">O,O</E> ′). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance calcium, bis(2,4-pentanedionato-O,O′) (PMN P-93-214, CAS no. 19372-44-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply if the substance is embedded or encapsulated in a plastic matrix. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set a 1.0 percent); and (c). <PRTPAGE P="351"/> As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(1)(ix), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (d), (f) through (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27482, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.983</SECTNO> <SUBJECT>Sulfonyl azide intermediate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as sulfonyl azide intermediate (PMN P-99-1202 and SNUN S-15-6) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1), (b)(1), and (c)(1). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). It is a significant new use to import, process, or use this chemical substance as a powder unless less than 1% of particles by weight are less than 200 microns. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70174, Dec. 17, 2003, as amended at 86 FR 30213, June 7, 2021]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.984</SECTNO> <SUBJECT>Amino-hydroxy sulfonaphthylazo-disubstituted phenyl azo benzene carboxylate salt (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as amino-hydroxy sulfonaphthylazo-disubstituted phenyl azo benzene carboxylate salt (PMN P-00-0351) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(2), (w)(2), (x)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15081, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.987</SECTNO> <SUBJECT>Dialkylaminophenyl imino pyrazole acid ester (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as dialkylaminophenyl imino pyrazole acid ester (PMN P-98-45) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="352"/> this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44575, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.988</SECTNO> <SUBJECT>Pyrazolone azomethine dye (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a pyrazolone azomethine dye (PMN P-98-91) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44575, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.990</SECTNO> <SUBJECT>1,4-Benzedicarboxylic acid, dimethyl ester, polymer with 1,4 - butanediol, cyclized.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,4-benzedicarboxylic acid, dimethyl ester, polymer with 1,4 - butanediol, cyclized (PMN P-00-0789; CAS No. 263244-54-8) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15081, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1000</SECTNO> <SUBJECT>Benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(tri­fluoro­methyl)-.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenamine, 3-chloro-2,6-dinitro- <E T="03">N,N</E> -dipropyl-4-(trifluoromethyl)- (P-86-83) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), and (g)(2)(v). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when an SDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information in an SDS or label does not apply when an SDS and label are not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 720.80(h). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(3), (b)(1), (b)(3), (c)(1), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable <PRTPAGE P="353"/> to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (f), (i), and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 25989, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1025</SECTNO> <SUBJECT>Benzenamine, 4-chloro-2-methyl-; benzenamine, 4-chloro-2-methyl-, hydrochloride; and ben­zenamine, 2-chloro-6-methyl-.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new use subject to reporting.</E> (1) The chemical substances benzenamine, 4-chloro-2-methyl- (CAS Number 95-69-2); benzenamine, 4-chloro-2-methyl-, hydrochloride (CAS Number 3165-93-3); and benzenamine, 2-chloro-6-methyl- (CAS Number 87-63-8) are subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph: </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes a substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[54 FR 12447, Mar. 27, 1989; 54 FR 17707, Apr. 25, 1989. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1050</SECTNO> <SUBJECT>Benzenamine, 2,5-dibutoxy-4-(4-morpholinyl)-, sulfate.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenamine, 2,5-dibutoxy-4-(4-morpholinyl), sulfate (PMN P-90-1809; CAS number 130169-66-3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(i) and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1), unless the substance is released to the Passaic Valley Sewerage Commission publicly-owned treatment works (NPDES Number NJ0021016) which discharges to the New York Bay. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), (f) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44061, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1055</SECTNO> <SUBJECT>Benzeneamine, 3,5-difluoro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzeneamine, 3,5-difluoro- (PMN P-97-648; CAS No. 372-39-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the new chemical exposure limit (NCEL) provisions listed in the TSCA section 5(e) consent order for this substance. This NCEL is set at 0.4 mg/m <SU>3</SU> . </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(iii), <PRTPAGE P="354"/> (g)(1)(iv), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i) and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 367, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1068</SECTNO> <SUBJECT> Benzenamine, 4-isocyanato- <E T="7462">N,N</E> -bis(4-isocyanatophenyl)-2,5-dimethoxy-. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenamine, 4-isocyanato- <E T="03">N,N-</E> bis(4-isocyanatophenyl)-2,5-dimethoxy- (PMN P-92-168) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(ii), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (22,000 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51682, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1070</SECTNO> <SUBJECT>Benzenamine, 4-methoxy-2-methyl-N-(3-methylphenyl).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as benzenamine, 4-methoxy-2-methyl-N-(3-methylphenyl) (PMN P-01-152; CAS No. 93072-06-1) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 5). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70174, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1075</SECTNO> <SUBJECT>Benzenamine, 4-(1-methyl­bu­toxy)-, hydrochloride.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenamine, 4-(1-methylbutoxy)-, hydrochloride (PMN P-90-559) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), <PRTPAGE P="355"/> (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Modifications or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44062, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1085</SECTNO> <SUBJECT>Benzenamine,4,4′-methylenebis[N-ethyl-N-methyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a Benzenamine,4,4′-methylenebis[N-ethyl-N-methyl- (PMN P-99-0557; CAS No. 76176-94-8) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 81399, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1105</SECTNO> <SUBJECT>Benzenamine, 4,4′-methylenebis[2-methyl-6-(1-methylethyl)]-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenamine, 4,4′-methylenebis[2-methyl-6-(1-methylethyl)]- (PMN P-96-93; CAS No. 16298-38-7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3422, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1120</SECTNO> <SUBJECT>Benzenamine, 4,4′-[1,4-phenyl­ene­bis(1-methyl­ethyli­dene)]bis[2,6-dimethyl-.</SUBJECT> <P>(a) Chemical substances and significant new uses subject to reporting. (1) The chemical substance benzenamine, 4,4′-[1,4-phenylenebis(1-methylethylidene)]bis- (CAS Registry Number 2716-10-1; PMN P-86-503) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iii) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), and (c)(2). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(vi), (b)(2)(vi), and (c)(2)(vi). <PRTPAGE P="356"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), (j), and (k) are applicable to manufacturers, importers, and processors of these substances . </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 31330, July 15, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1150</SECTNO> <SUBJECT>Substituted polyglycidyl ben­zena­mine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The following chemical substance, referred to by premanufacture notice number and its generic chemical name, is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section: Substituted polyglycidyl benzeneamine, P-83-394. </P> <P>(2) The significant new uses are:</P> <P>(i) Use in spray applications.</P> <P>(ii) Manufacture or processing without establishing a program whereby:</P> <P>(A) During all stages of manufacture and processing of the substance, and during response to emergencies and spills involving the substance, any person employed by or under the control of the manufacturer or processor who may potentially be dermally exposed to the substance wears:</P> <P> ( <E T="03">1</E> ) Gloves which cover the arm up to the elbow and which have been determined to be impervious to the substance under conditions of exposure (gloves may be determined to be impervious by standard testing methods or by reliance on the manufacturer's specifications for those gloves selected); </P> <P> ( <E T="03">2</E> ) A face shield of at least 8 inches in length; and </P> <P> ( <E T="03">3</E> ) Clothing which covers any other exposed areas of the arms, legs, and torso. </P> <P>(B) All workers described in paragraph (a)(ii)(A) of this section are informed in writing, or by presenting the information as part of a training program in a safety meeting where attendance is recorded, of the following: To avoid all contact with this substance; that structurally similar chemicals have been found to cause cancer, reproductive effects, kidney and liver effects in laboratory animals, and allergic reactions in humans; that this substance is a severe skin and eye irritant; and that the use of impervious gloves, face shields and other clothing to cover exposed areas of the arms, the legs, and the torso is required.</P> <P>(C) A label is affixed to each container of the substance or of a formulation containing the substance which (in a print size no smaller than ten point type) contains, at a minimum, the following information:</P> <EXTRACT> <FP>WARNING: CONTACT WITH SKIN AND EYES IS HARMFUL</FP> <FP>—Severe skin and eye irritant.</FP> <FP>—Similar chemicals cause cancer, reproductive effects, and kidney and liver changes in laboratory animals. They have also caused allergic reactions in humans.</FP> <FP>—Prevent all contact with skin, eyes, and clothing.</FP> <FP>—Wear impervious gloves, face shield, and protective clothing. Promptly remove and wash contaminated non-impervious clothing before re-use.</FP> <FP>—Wash thoroughly after handling and before eating, drinking, or smoking.</FP> <FP>STORAGE INSTRUCTIONS:</FP> <FP>—Keep closure tight and upright to prevent leakage.</FP> <FP>—Keep container closed during shipment and when not in use.</FP> <FP>—In case of spillage absorb with sand or vermiculite and flush with plenty of water.</FP> <FP>FIRST AID:</FP> <FP>—In case of eye contact, immediately flush with plenty of water and get immediate medical attention.</FP> <FP>—In case of skin contact, immediately wash with soap and water and get immediate medical attention.</FP> </EXTRACT> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> In addition to the requirements of § 721.17, manufacturers, importers, and processors of the chemical substance identified in paragraph (a)(1) of this section must maintain the <PRTPAGE P="357"/> following records for five years from their creation: </P> <P>(i) The names of persons informed, the date they are informed, and the means by which they are informed in accordance with paragraph (a)(2)(ii)(B) of this section.</P> <P>(ii) The names of any transferee and the dates of any transfers of containers which are labeled in accordance with paragraph (a)(2)(ii)(C) of this section.</P> <P>(iii) The method used to determine that the protective gloves are impervious to the substance and date and the results of that determination.</P> <P>(2) [Reserved]</P> <CITA>[49 FR 43653, Oct. 31, 1984. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1155</SECTNO> <SUBJECT>1,4-benzenediol, 2-(1,1,3,3-tetramethylbutyl)- and Bis(dimethylamino substituted)carbomonocycle.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as 1,4-benzenediol, 2-(1,1,3,3-tetramethylbutyl)- and Bis (dimethylamino substituted)carbomonocycle (PMN P-96-92) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3422, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1187</SECTNO> <SUBJECT>Bis(imidoethylene) benzene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance bis(imidoethylene)benzene (PMN P-93-1447) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11041, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1193</SECTNO> <SUBJECT>Benzene, 2-bromo-1,4-dimethoxy-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, 2-bromo-1,4-dimethoxy- (PMN P-95-17, CAS No. 25245-34-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45081, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <PRTPAGE P="358"/> <SECTNO>§ 721.1210</SECTNO> <SUBJECT>Benzene, (2-chloroethoxy)-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, (2-chloroethoxy)- (PMN P-87-1471) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i), (a)(2)(iii), (a)(2)(iv), (a)(3) (applies to gloves only), (a)(4), (a)(5)(iii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1) and (c)(1). Disposal other than as described in the premanufacture notice referenced in paragraph (a)(1) of this section. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44062, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1225</SECTNO> <SUBJECT>Benzene, 1,2-dimethyl-, poly­propene derivatives, sulfonated, po­tas­sium salts.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, 1,2-dimethyl-, polypropene derivatives, sulfonated, potassium salts (PMN P-89-711) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent, and (f). The following environmental hazard statement shall appear on each label as specified in § 721.72(b) of this section and the SDS as specified in § 721.72(c) of this section: EPA is requiring aquatic toxicity testing and fate testing for a substance in this product. These requirements are based on EPA's determination that the substance causes toxicity to fish and aquatic organisms based on data on the substance and similar sulfonate compounds. EPA has further determined that discharge of this substance may cause toxicity to fish and aquatic organisms at concentrations as low as 25 ppb. Water releases of the substance are subject to an EPA Significant New Use Rule (SNUR) under 40 CFR part 721 which requires that EPA be notified 90 days prior to use resulting in surface water concentrations in excess of this level. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 25 ppb). The requirement of 40 CFR 721.91(a)(4) that the amount of the substance estimated to be released to water is calculated before entering control technology is not retained. If the waste stream containing the substance will be treated using biological treatment (activated sludge or equivalent) plus clarification, then the amount of substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 50 percent removal efficiency may attributed to such treatment. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements <PRTPAGE P="359"/> are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 15789, Apr. 17, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1230</SECTNO> <SUBJECT>Benzene, ethenyl-, ar-bromo derivatives.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, ethenyl-, ar-bromo derivatives (PMN P-84-660; CAS No. 125904-11-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this SNUR do not apply when the substance is present only in a mixture or in a polymer matrix, if the combined concentration of this substance and the substance identified in § 721.1240 as benzene, (2-bromoethyl)-, ar-bromo derivatives (PMN P-84-704; CAS No. 125904-10-1), present as residual monomers in the mixture or polymer matrix, does not exceed 0.5% by weight or volume. This exemption does not apply if there is reason to believe that during intended use, processing, or other handling, these substances combined may be reconcentrated above the 0.5% level in the mixture or polymer matrix. </P> <P> (2) The significant new uses are: (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) (including when the substance becomes airborne in any form), (a)(3), (a)(4) (when the substance becomes airborne in any form), (a)(5)(iii), (a)(5)(xii), (a)(5)(xiii), (a)(5)(xiv), (a)(5)(xv) and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the NCEL provisions in the TSCA section 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vi) (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (a), (b), (j) (flame retardant), and (l). </P> <P> (iv) <E T="03">Disposal.</E> It is a significant new use to dispose of the substance other than as follows: </P> <P>(A) The following forms of the substance - the substance as a commercial chemical product or manufacturing chemical intermediate; the substance as an off-specification commercial chemical product or manufacturing chemical intermediate; the substance as a residue remaining in a container or in an inner liner removed from a container that has held the substance, unless the container is empty as defined in 40 CFR 261.7(b)(3); any residue or contaminated soil, water, or other debris resulting from the cleanup of a spill into or on any land or water of the substance as a commercial chemical product or manufacturing chemical intermediate, or any residue or contaminated soil, water, or other debris resulting from the cleanup of a spill into or on any land or water, of the substance as an off-specification commercial chemical product or manufacturing chemical intermediate; and any waste stream containing greater than 1.0% of this substance and the substance identified in § 721.1240 combined - shall be disposed of as follows: Requirements as specified in § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), and (c)(2); the landfill shall be operated in accordance with Subtitle C of the Resource Conservation and Recovery Act.</P> <P>(B) Any forms of the substance other than those described in paragraph (a)(2)(iv)(A) of this section, including waste streams containing 1.0% or less of this substance and the substance identified in § 721.1240, shall be disposed of as follows: § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), (c)(2), (a)(3), (b)(3), (c)(3), carbon adsorption followed by either physical destruction, or as specified in § 721.90; the landfill shall be operated in accordance with the Resource Conservation and Recovery Act.</P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(iv), (b)(2)(iv), <PRTPAGE P="360"/> (c)(2)(iv), (a)(2)(v), (b)(2)(v), (c)(2)(v), (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[67 FR 17647, Apr. 11, 2002]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1240</SECTNO> <SUBJECT>Benzene, (2-bromoethyl)-, ar-bromo derivatives.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, (2-bromoethyl)-, ar-bromo derivatives (PMN P-84-704; CAS No. 125904-10-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this SNUR do not apply when the substance is present only in a mixture or in a polymer matrix, if the combined concentration of this substance and the substance identified in § 721.1230 as benzene, ethenyl-, ar-bromo derivatives (PMN P-84-660; CAS No.125904-11-2) present as residual monomers in the mixture or polymer matrix, does not exceed 0.5% by weight or volume. This exemption does not apply if there is reason to believe that during intended use, processing, or other handling, these substances combined may be reconcentrated above the 0.5% level in the mixture or polymer matrix. </P> <P> (2) The significant new uses are: (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) (including when the substance becomes airborne in any form), (a)(3), (a)(4) (when the substance becomes airborne in any form), (a)(5)(iii), (a)(5)(xii), (a)(5)(xiii), (a)(5)(xiv), (a)(5)(xv), and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the NCEL provisions in the TSCA section 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vi) (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (a), (b), (c), (h) (in the manufacture of the substance identified in § 721.1230), and (l). </P> <P> (iv) <E T="03">Disposal.</E> It is a significant new use to dispose of the substance other than as follows: </P> <P>(A) The following forms of the substance - the substance as a commercial chemical product or manufacturing chemical intermediate; the substance as an off-specification commercial chemical product or manufacturing chemical intermediate; the substance as a residue remaining in a container or in an inner liner removed from a container that has held the substance, unless the container is empty as defined in 40 CFR 261.7(b)(3); any residue or contaminated soil, water, or other debris resulting from the cleanup of a spill into or on any land or water of the substance as a commercial chemical product or manufacturing chemical intermediate, or any residue or contaminated soil, water, or other debris resulting from the cleanup of a spill into or on any land or water, of the substance as an off-specification commercial chemical product or manufacturing chemical intermediate; and any waste stream containing greater than 1.0% of this substance and the substance identified in § 721.1230 combined - shall be disposed of as follows: Requirements as specified in § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), and (c)(2); the landfill shall be operated in accordance with Subtitle C of the Resource Conservation and Recovery Act.</P> <P> (B) Any forms of the substance other than those described in paragraph (a)(2)(iv)(A) of this section, including waste streams containing 1.0% or less of this substance and the substance identified in § 721.1240, shall be disposed of as follows: § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), (c)(2), (a)(3), (b)(3), (c)(3), carbon adsorption followed by either physical destruction, or as specified in § 721.90; the landfill shall be operated in accordance with the Resource Conservation and Recovery Act. <PRTPAGE P="361"/> </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(iv), (b)(2)(iv), (c)(2)(iv), (a)(2)(v), (b)(2)(v), (c)(2)(v),(a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[67 FR 17648, Apr. 11, 2002]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1300</SECTNO> <SUBJECT>[(Dinitrophenyl)azo]-[2,4-dia­mino-5-methoxybenzene] derivatives.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as [(dinitrophenyl)azo]-[2,4-di­a­mino-5-methoxybenzene] derivatives (P-83-817 and P-83-818) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), and (x)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a), (b), (c), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 25990, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1325</SECTNO> <SUBJECT>Benzene, 1-(1-methyl­bu-toxy)-4-nitro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, 1-(1-methylbutoxy)-4-nitro- (PMN P-90-560) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(ix), (g)(2)(i), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (p) (production limit set at 43,000 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Modifications or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44062, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1350</SECTNO> <SUBJECT>Benzene, (1-methylethyl)(2-phenylethyl)-.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, (1-methylethyl)(2-phenylethyl)-, (PMN P-88-894) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(iii), (a)(2)(iv), (a)(3), (b) (concentration set at 1.0 percent), and (c). However, the personal protective clothing required in paragraph (a)(2)(iv) must be tested or evaluated under the requirements of paragraph (a)(3). Furthermore, the imperviousness of gloves required under paragraph (a)(2)(i) may not be demonstrated according to paragraph (a)(3)(ii), but rather must be tested according to paragraph (a)(3)(i) with the following additional requirements: There must <PRTPAGE P="362"/> be no permeation of the PMN substance greater than 16 ppb after 8 hours of testing in accordance with the American Society for Testing and Materials (ASTM) F739-85 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases.” Gloves may not be used for a time period longer than they are actually tested and must be replaced at the end of each work shift. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(2)(i), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), (g)(4)(i) and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). In addition, a significant use of the substance is any manner or method of manufacturing, processing, or use other than as an insulating oil for capacitors or transformers. </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), (c)(2), (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 40210, Aug. 13, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1372</SECTNO> <SUBJECT>Substituted nitrobenzene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a substituted nitrobenzene (PMN P-92-1125) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 50 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51682, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1375</SECTNO> <SUBJECT>Disubstituted nitrobenzene (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance disubstituted nitrobenzene (PMN P-84-860) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f) and (g)(1)(vii), (g)(2)(i), (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when a SDS in not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e), (f) and (i). <PRTPAGE P="363"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 32416, Aug. 9, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1425</SECTNO> <SUBJECT>Pentabromoethylbenzene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance pentabromoethylbenzene (CAS Number 85-22-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph: </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[54 FR 18286, Apr. 28, 1989. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1430</SECTNO> <SUBJECT>Pentachlorobenzene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance pentachlorobenzene (CAS No. 608-93-5) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1435</SECTNO> <SUBJECT>1,2,4,5-Tetrachlorobenzene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 1,2,4,5-tetrachlorobenzene (CAS No. 95-94-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1440</SECTNO> <SUBJECT>1,3,5-Trinitrobenzene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 1,3,5-trinitrobenzene (CAS No. 95-35-4) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1450</SECTNO> <SUBJECT>1,3-Benzenediamine, 4-(1,1-di­methylethyl)-ar-methyl.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The following chemical substance, referred to by its PMN number and chemical name, is subject to reporting under <PRTPAGE P="364"/> this section for the significant new uses described in paragraph (a)(2) of this section: P-85-929; 1,3-Benzenediamine, 4-(l,1-dimethylethyl)- <E T="03">ar</E> -methyl. </P> <P>(2) The significant new uses are:</P> <P>(i) Use other than for applications where the substance will be completely reacted (cured or used as a chemical intermediate).</P> <P>(ii) Any method of disposal other than by landfill, incineration, or for wastewater from vent scrubbers, steam vacuum ejectors, pad washings, equipment washouts, and stormwater runoffs, wastewater treatment in permitted industrial wastewater treatment facilities. Each method of disposal must meet all applicable local, State, and Federal laws and regulations.</P> <P>(iii) Any manner or method of manufacturing, importing, or processing without establishing a program whereby:</P> <P>(A) Any person who may be exposed dermally to the substance wears:</P> <P> ( <E T="03">1</E> ) Gloves which have been determined to be impervious to the substance under the conditions of exposure, including the duration of exposure. This determination is made either by testing the gloves under the conditions of exposure or by evaluating the specifications provided by the manufacturer of the gloves. Testing or evaluation of specifications includes consideration of permeability, penetration, and potential chemical and mechanical degradation by the substance and associated chemical substances. </P> <P> ( <E T="03">2</E> ) Clothing which covers any other exposed areas of the arms, legs, and torso. </P> <P> ( <E T="03">3</E> ) Chemical safety goggles or equivalent eye protection. </P> <P> (B) Any person who may be exposed to the substance through inhalation during manufacture, in addition to the dermal protective equipment described in paragraph (a)(2)(iii)(A) of this section, wears at a minimum, a National Institute for Occupational Safety and Health approved, category 23C respirator, organic vapor type. Use of the respirator must be according to 29 CFR 1910.134 and 30 CFR part 11. If a full-face type respirator is selected and worn, the chemical safety goggles requirement in paragraph (a)(2)(iii)(A)( <E T="03">3</E> ) of this section is waived. </P> <P> (C)( <E T="03">1</E> ) All persons who may be exposed to the substance are informed, in writing, and by presenting the information as part of a training program in safety meetings at which attendance is recorded, by means of the following statement: </P> <EXTRACT> <P>WARNING: Avoid all contact. Chemicals similar in structure to [insert appropriate name] have been found to cause chronic organ and systemic effects and cancer in laboratory animals. To protect yourself, you must wear chemical safety goggles or equivalent eye protection, impervious gloves, and protective clothing while handling this material.</P> </EXTRACT> <P> ( <E T="03">2</E> ) During manufacture, the warning statement in paragraph (a)(2)(iii)(C)( <E T="03">1</E> ) of this section shall include the additional following statement: </P> <EXTRACT> <P>Respirators are required during clean-up or loading of bulk material.</P> </EXTRACT> <P> (D) All persons that receive the PMN substance are notified by means of a Safety Data Sheet (“SDS”) which includes, at a minimum, the language specified in paragraph (a)(2)(iii)(C)( <E T="03">1</E> ) of this section, and specifies the requirements for protective equipment in paragraph (a)(2)(iii)(A) and (a)(2)(iii)(B) of this section. </P> <P> (E) Each container of the substance distributed in commerce has affixed to it a label which includes a Warning Statement which consists, at a minimum, of the language specified in paragraph (a)(2)(iii)(C)( <E T="03">1</E> ) of this section. The first word of the Warning Statement is capitalized, and the type size of the first word is no smaller than 6-point type for a label 5 square inches or less in area, 10-point type for a label above 5 but no greater than 10 square inches in area, 12-point type for a label above 10 but no greater than 15 square inches in area, 14-point type for a label above 15 but no greater than 30 square inches in area, or 18-point type for a label over 30 square inches in area. The type size of the remainder of the Warning Statement is no smaller than 6-point type. All required label text is of sufficient prominence, and is placed with such conspicuousness relative to other label text and graphic material, to ensure that the Warning Statement <PRTPAGE P="365"/> is read and understood by the ordinary individual under customary conditions of purchase and use. </P> <P>(iv) Manufacturing and importing the substance for any use at greater than the aggregrate volumes allowed under the consent order issued for Premanufacture Notice P-85-929, without submitting to EPA the corresponding scientifically valid toxicity test data required under that order, developed according to EPA's Good Laboratory Practice standards at 40 CFR part 792 and EPA's testing guidelines at 40 CFR 798.2650 and 798.3300.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Determining whether a use is a significant new use.</E> (i) Any person who intends to manufacture or import the substance identified in paragraph (a)(1) of this section shall, before commencing any manufacture or import, submit to EPA the information required under § 721.11(b). </P> <P> (ii) EPA will review this information to determine whether the person has a <E T="03">bona fide</E> intent to manufacture or import the substance. If EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture or import the substance, EPA will tell the person the specific production volumes which would constitute a significant new use under paragraph (a)(2)(iv) of this section. </P> <P> (iii) A disclosure to a person with a <E T="03">bona fide</E> intent to manufacture or import the substance of the specific production volumes which would constitute a significant new use under paragraph (a)(2)(iv) of this section will not be considered public disclosure of confidential business information under section 14 of the Act. </P> <P> (2) <E T="03">Recordkeeping.</E> In addition to the requirements of § 721.40, manufacturers, importers, and processors must maintain the following records for 5 years after the date they are created: </P> <P>(i) Any determination that gloves are impervious to the substance.</P> <P>(ii) Names of persons who have attended safety meetings in accordance with paragraph (a)(2)(iii)(C) of this section, the dates of such meetings, and copies of any written information provided in accordance with paragraph (a)(2)(iii)(C) of this section.</P> <P>(iii) Copies of any SDSs used.</P> <P>(iv) Names and addresses of all persons to whom the substance is sold or transferred including shipment destination address if different, the date of each transfer, and the quantity of substance sold or transferred on such date.</P> <P>(v) Copies of any labels used.</P> <P>(vi) Any names used for the substance and the corresponding dates of use.</P> <P>(vii) Quantities of the substance manufactured or imported, with the corresponding dates of manufacture or import.</P> <P>(viii) Quantities of the substance purchased in the United States by processors of the substance, names and addresses of suppliers, and corresponding dates of purchase.</P> <P>(ix) Information on disposal of the substance, including dates waste material is disposed of, location of disposal sites, volume of disposed solid material, estimated volume of any disposed liquid wastes containing the substance, and method of disposal.</P> <CITA>[55 FR 20795, May 21, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1500</SECTNO> <SUBJECT>1,2-Benzenediamine, 4-ethoxy, sulfate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The following chemical substance referred to by its chemical name is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section: 1,2-benzenediamine, 4-ethoxy, sulfate, PMN P-83-105. </P> <P>(2) The significant new use is: Manufacture, import, or processing in powder or dry solid form.</P> <P>(b) [Reserved]</P> <SECAUTH>(Sec. 5, Pub. L. 94-469, 90 Stat. 2012 (15 U.S.C. 2604))</SECAUTH> <CITA>[49 FR 43061, Oct. 26, 1984. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="366"/> <SECTNO>§ 721.1550</SECTNO> <SUBJECT>Benzenediazonium, 4-(di­methyl­amino)-, salt with 2-hy­droxy-5-sul­fo­benzoic acid (1:1).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenediazonium, 4-(dimethylamino)-, salt with 2-hydroxy-5-sulfobenzoic acid (1:1) (CAS No. 124737-31-1) (P-90-1366) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(iii), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (a)(6)(ii), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), and (g)(5). In addition, the following human health hazard statement shall appear on each label as specified at § 721.72(b) and the SDS as specified at § 721.72(c). Additional statements may be included as long as they are true and do not alter the meaning of the required statement. Human health hazard statements: This substance may cause severe acute toxicity and death or serious neurotoxic effects. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (volume set at 31,000 kg). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 80 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance as specified in § 721.125 (a) through (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 40211, Aug. 13, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1555</SECTNO> <SUBJECT>Substituted phenyl azo substituted benzenediazonium salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted phenyl azo substituted benzenediazonium salt (PMN P-92-652) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51682, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1568</SECTNO> <SUBJECT>Benzenediazonium, 2-(methoxycarbonyl)-, chloride (1:1).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenediazonium, 2-(methoxycarbonyl)-, chloride (1:1) (PMN P-93-533; CAS No. 35358-78-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="367"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51682, Oct. 4, 1993, as amended at 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1576</SECTNO> <SUBJECT>1,3-Benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,3-benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester (PMN P-98-1162; CAS No. 119581-93-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 367, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1577</SECTNO> <SUBJECT>1,4-Benzenedicarboxylic acid, bis [4-(ethenyloxy) butyl] ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,4-benzenedicarboxylic acid, bis[4-(ethenyloxy) butyl] ester (PMN P-98-1163; CAS No. 117397-31-6) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 367, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1578</SECTNO> <SUBJECT>1,4-Benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,4-benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester (PMN P-98-1164; CAS No. 209072-72-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 367, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1579</SECTNO> <SUBJECT>1,2,4-Benzenetricarboxylic acid, tris [4-(ethenyloxy) butyl] ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,2,4-benzenetricarboxylic acid, tris [4-(ethenyloxy) butyl] ester (PMN P-98-1165; CAS No. 196109-17-8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) [Reserved] <PRTPAGE P="368"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 367, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1580</SECTNO> <SUBJECT>Disubstituted benzene ether, polymer with substituted phenol (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as disubstituted benzene ether, polymer with substituted phenol (PMN P-98-155) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44575, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1612</SECTNO> <SUBJECT>Substituted 2-nitro- and 2-aminobenzesulfonamide.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as substituted 2-nitro- and 2-aminobenzenesulfonamide (PMNs P-88-1937 and P-88-1938) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a) through (d), (f), (g)(3)(i), (g)(3)(ii), (g)(4)(i), and (g)(5). The following additional statements shall appear on each label and SDS required by this paragraph: This substance may be toxic to terrestrial organisms and plants. Notice to user: Release to water restrictions apply. </P> <P> (ii) <E T="03">Disposal.</E> Requirements as specified in § 721.85. A significant new use of these substances is any release of the substances to land. </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 100 ppb for P-88-1937 and N = 10 ppb for P-88-1938). When calculating the surface water concentrations according to the instructions in § 721.91(a)(4), the statement that the amount of the substances that will be released will be calculated before the substances enter control technology does not apply. Instead, if the waste stream containing the PMN substances will be treated before release, the amount of the PMN substances reasonably likely to be removed from the waste stream by treatment may be subtracted in calculating the number of kilograms released. No more than 50 percent removal efficiency may be attributed to such treatment. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (j), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27482, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1620</SECTNO> <SUBJECT>Benzenesulfonamide, alkylphenyl substituted phenyl substituted carbonyl- (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as benzenesulfonamide alkylphenyl substituted phenyl substituted carbonyl- (PMN P-00-368) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="369"/> </P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 1.0%), and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the new chemical exposure limit (NCEL) provisions listed in the TSCA section 5(e) consent order for this chemical substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721,72(a), (b), (c), (d), (e) (concentration set at 1.0%), (f), (g)(1)(iv), (g)(2)(ii), (g)(2)(iv), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 30). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), (d), (f), (g), (h), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70174, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1625</SECTNO> <SUBJECT>Benzenesulfonic acid, dodecyl-, branched, compds. with N,N-dimethyl-1,3-propanediamine (2:1).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenesulfonic acid, dodecyl-, branched, compds. with N,N-dimethyl-1,3-propanediamine (2:1) (PMN P-90-456; CAS No. 319926-68-6) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 19242, Apr. 25, 1991; 56 FR 29903, July 1, 1991. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993; 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1630</SECTNO> <SUBJECT>1,2-Ethanediol bis(4-methylbenzenesulfonate); 2,2-oxybis-ethane bis(4-methylbenzenesulfonate); ethanol, 2,2′-[oxybis(2,1-ethanediyl oxy)]bis-, bis(4-methylbenzenesulfonate); ethanol, 2,2′-[oxybis (2,1-ethane diyloxy)] bis-, bis(4-methylbenzenesulfonate); ethanol, 2,2′-[[1-[(2-propenyloxy) methyl]-1,2-ethanediyl] bis(oxy)]bis-, bis(4-methylbenzene sulfonate); and ethanol, 2-[1-[[2-[2-[[(4-methylphenyl)sulfonyl] oxy]ethoxy] ethoxy]methyl]-2-(2-propenyloxy)ethoxy]-, 4-methylbenzenesulfonate.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances 1,2-ethanediol bis(4-methylbenzenesulfonate) (PMN P-93-1193, CAS no. 6315-52-2), 2,2-oxybis-ethane bis(4-methylbenzenesulfonate) (PMN P-93-1194, CAS no. 7460-82-4), ethanol, 2,2′-[oxybis(2,1-ethanediyloxy)]bis-, bis(4-methylbenzene-sulfonate) (PMN P-93-1195, CAS no. 19249-03-7), ethanol, 2,2′-[oxybis(2,1-ethanediyloxy)] bis-, bis(4-methylbenzene sulfonate) (PMN P-93-1196, CAS no. 37860-51-8), ethanol, 2,2′-[[1-[(2-propenyloxy) methyl]-1,2-ethanediyl]bis(oxy)]bis-, bis(4-methylbenzene sulfonate) (PMN P-93-1203, CAS no. 114719-15-2), and ethanol, 2-[1-[[2-[2- [[(4-methylphenyl) sulfonyl] oxy]ethoxy] ethoxy]methyl]-2-(2-propenyloxy)ethoxy]-, 4-methylbenzenesulfonate (PMN P-93-1204, CAS no. 124029-00-1) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="370"/> this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27482, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1637</SECTNO> <SUBJECT>1,2-Propanediol, 3-(2-propenyloxy)-, bis(4-methylbenzene sulfonate); 2-propanol, 1-[2-[[(4-methylphenyl)sulfonyl] oxy]ethoxy]-3-(2-propenyloxy)-4-methylbenzenesulfonate; and 2-propanol, 1-[2-[2-[[(4-methylphenyl)sulfonyl]oxy] ethoxy]ethoxy]-3-(2-propenyloxy)-, 4-methylbenzenesulfonate.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances 1,2-propanediol, 3-(2-propenyloxy)-, bis(4-methylbenzenesulfonate) (PMN P-93-1198, CAS no. 114719-19-6), 2-propanol, 1-[2-[[(4-methylphenyl)sulfonyl]oxy]ethoxy]-3-(2-propenyloxy)-4-methylbenzenesulfonate (PMN P-93-1199, CAS no. 124213-39-4), and 2-propanol, 1-[2-[2-[[(4-methylphenyl)sulfonyl]oxy] ethoxy]ethoxy]-3-(2-propenyloxy)-, 4-methylbenzenesulfonate (PMN P-93-1200, CAS no. 124028-99-5) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27482, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1640</SECTNO> <SUBJECT>3,6,9,12,-Tetraoxatetradecane-1,14-diol, bis(4-methylbenzenesulfonate; 3,6,9,13-tetraoxahexadec-15-ene-1,11-diol, bis(4-methylbenzenesulfonate); 3,6,9,12,16-pentaoxanonadec-18-ene-1,14-diol, bis(4-methyl benzenesulfonate); and 3,6,9,12-tetraoxatetradecane-1,14-diol, 7-[(2-propenyloxy)methyl]-, bis(4-methylbenzenesulfonate).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances 3,6,9,12-tetraoxatetradecane-1,14-diol, bis(4-methylbenzenesulfonate (PMN P-93-1197, CAS no. 41024-91-3), 3,6,9,13-tetraoxahexadec-15-ene-1,11-diol, bis(4-methylbenzenesulfonate) (PMN P-93-1201), 3,6,9,12,16-pentaoxanonadec-18-ene-1,14-diol, bis(4-methyl benzenesulfonate) (PMN P-93-1202), and 3,6,9,12-tetraoxatetradecane-1,14-diol, 7-[(2-propenyloxy)methyl]-, bis(4-methylbenzenesulfonate) (PMN P-93-1205) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27483, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1643</SECTNO> <SUBJECT>Benzenesulfonic acid, amino substituted phenylazo-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a benzenesulfonic acid, amino substituted phenylazo- (PMN P-95-86) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. <PRTPAGE P="371"/> </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(w)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45081, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1645</SECTNO> <SUBJECT> Benzenesulfonic acid, 4-methyl-, reaction products with oxirane mono[(CC <E T="9145">10-16</E> -alkyloxy)methyl] derivatives and 2,2,4(or 2,4,4)-trimethyl-1,6-hexanediamine. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance benzenesulfonic acid, 4-methyl-, reaction products with oxirane mono[(C <E T="52">10-16</E> -alkyloxy)methyl] derivatives and 2,2,4(or 2,4,4)-trimethyl-1,6-hexanediamine (PMN P-93-1047, CAS no. 147170-38-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27483, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1648</SECTNO> <SUBJECT>Substituted benzenesulfonic acid salt (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted benzenesulfonic acid (PMN P-99-1304) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 70175, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1650</SECTNO> <SUBJECT>Alkylbenzenesulfonic acid and sodium salts.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkyl benzenesulfonic acid and sodium salts (PMNs P-88-1783, P-88-2231, P-88-2237, and P-88-2530) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P> (A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not <PRTPAGE P="372"/> being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. </P> <P>(B) The employer must ensure that persons who will receive this substance from the employer are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44062, Sept. 23, 1993, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1655</SECTNO> <SUBJECT>Alkylbenzenesulfonic acid (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkylbenzenesulfonic acid (PMN P-98-679) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 367, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1660</SECTNO> <SUBJECT>Benzidine-based chemical substances.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The benzidine-based chemical substances listed in Table 1 and Table 2 of this section are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s40,r40,r40,xl140"> <TTITLE>Table 1—Benzidine-Based Chemical Substances</TTITLE> <BOXHD> <CHED H="1">CAS or accession No.</CHED> <CHED H="1">C.I. name</CHED> <CHED H="1">C.I. No.</CHED> <CHED H="1">Chemical name</CHED> </BOXHD> <ROW> <ENT I="01">117-33-9</ENT> <ENT>Not available</ENT> <ENT>Not available</ENT> <ENT>1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-[2-[4'-[2-(4-hydroxyphenyl)diazenyl][1,1'-biphenyl]-4-yl]diazenyl]-</ENT> </ROW> <ROW> <ENT I="01">65150-87-0</ENT> <ENT>Not available</ENT> <ENT>Not available</ENT> <ENT>1,3,6-Naphthalenetrisulfonic acid, 8-hydroxy-7-[2-[4'-[2-(2-hydroxy-1-naphthalenyl)diazenyl][1,1'- biphenyl]-4-yl]diazenyl]-, lithium salt (1:3)</ENT> </ROW> <ROW> <ENT I="01">68214-82-4</ENT> <ENT>Direct Navy BH</ENT> <ENT>22590</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 5-amino-3-[2-[4'-[2-(7-amino-1-hydroxy-3-sulfo-2- naphthalenyl)diazenyl][1,1'-biphenyl]-4- yl]diazenyl]-4-hydroxy-, sodium salt (1:2)</ENT> </ROW> <ROW> <ENT I="01">72379-45-4</ENT> <ENT>Not available</ENT> <ENT>Not available</ENT> <ENT> 2,7-Naphthalenedisulfonic acid, 4-amino-5- <LI>hydroxy-3-[2-[4'-[2-[2-hydroxy-4-[(2- methylphenyl)amino]phenyl]diazenyl][1,1'- biphenyl]-4-yl]diazenyl]-6-(2-phenyldiazenyl)-</LI> </ENT> </ROW> <ROW> <ENT I="01"> Accession No. 21808 <LI O="xl">CAS No. CBI (NA)</LI> </ENT> <ENT>CBI</ENT> <ENT>CBI</ENT> <ENT> 2,7-Naphthalenedisulfonic acid, 4-amino-5- <LI>hydroxy [[[(substituted phenylamino)] substituted phenylazo] diphenyl]azo-, phenylazo-, disodium salt. (generic name)</LI> </ENT> </ROW> <ROW> <ENT I="01"> Accession No. 24921 <LI O="xl">CAS No.</LI> </ENT> <ENT>CBI</ENT> <ENT>CBI</ENT> <ENT>4-(Substituted naphthalenyl )azo diphenylyl azo-substituted carbopolycycle azo benzenesulfonic acid, sodium salt. (generic name)</ENT> </ROW> <ROW> <PRTPAGE P="373"/> <ENT I="01"> Accession No. 26256 <LI O="xl">CAS No. CBI (NA)</LI> </ENT> <ENT>CBI</ENT> <ENT>CBI</ENT> <ENT> 4-(Substituted phenyl)azo biphenylyl azo- <LI>substituted carbopolycycloazo benzenesulfonic acid, sodium salt. (generic name)</LI> </ENT> </ROW> <ROW> <ENT I="01"> Accession No. 26267 <LI O="xl">CAS No. CBI (NA)</LI> </ENT> <ENT>CBI</ENT> <ENT>CBI</ENT> <ENT> 4-(Substituted phenyl)azo biphenylyl azo - <LI>substituted carbopolycycle azo benzenesulfonic acid, sodium salt. (generic name)</LI> </ENT> </ROW> <ROW> <ENT I="01"> Accession No. 26701 <LI O="xl">CAS No. CBI (NA)</LI> </ENT> <ENT>CBI</ENT> <ENT>CBI</ENT> <ENT>Phenylazoaminohydroxynaphthalenylazobiphenylazo substituted benzene sodium sulfonate. (generic name).</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="4" OPTS="L2" CDEF="s40,r40,r40,r140"> <TTITLE>Table 2—Benzidine-Based Chemical Substances</TTITLE> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">C.I. name</CHED> <CHED H="1">C.I. No.</CHED> <CHED H="1">Chemical name</CHED> </BOXHD> <ROW> <ENT I="01">92-87-5</ENT> <ENT>Benzidine</ENT> <ENT>Not available</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine.</ENT> </ROW> <ROW> <ENT I="01">531-85-1</ENT> <ENT>Benzidine · 2HCl</ENT> <ENT>Not available</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine, dihydrochloride.</ENT> </ROW> <ROW> <ENT I="01">573-58-0</ENT> <ENT>C.I. Direct Red 28</ENT> <ENT>22120</ENT> <ENT>1- Naphthalenesulfonic acid, 3,3′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis[4-amino-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">1937-37-7</ENT> <ENT>C.I. Direct Black 38</ENT> <ENT>30235</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′-[(2,4-diaminophenyl) azo][1,1′-biphenyl]-4- yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2302-97-8</ENT> <ENT>C.I. Direct Red 44</ENT> <ENT>22500</ENT> <ENT>1-Naphthalenesulfonic acid, 8,8′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis[7-hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2429-73-4</ENT> <ENT>C.I. Direct Blue 2</ENT> <ENT>22590</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4′-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo][1,1′-biphenyl]-4-yl]azo]-4-hydroxy-, trisodium salt.</ENT> </ROW> <ROW> <ENT I="01">2429-79-0</ENT> <ENT>C.I. Direct Orange 8</ENT> <ENT>22130</ENT> <ENT>Benzoic acid, 5-[[4′-[(1-amino-4-sulfo-2-naphthalenyl) azo][1,1′-biphenyl]-4-yl]azo]-2- hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2429-81-4</ENT> <ENT>C.I. Direct Brown 31</ENT> <ENT>35660</ENT> <ENT>Benzoic acid, 5-[[4′-[[2,6-diamino-3-[[8-hydroxy-3,6-disulfo-7-[(4-sulfo-1-naphthalenyl)azo]-2- naphthalenyl]azo]-5-methylphenyl]azo][1,1′- biphenyl]-4-yl]azo]-2-hydroxy-, tetrasodium salt.</ENT> </ROW> <ROW> <ENT I="01">2429-82-5</ENT> <ENT>C.I. Direct Brown 2</ENT> <ENT>22311</ENT> <ENT>Benzoic acid, 5-[[4′-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl) azo][1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2429-83-6</ENT> <ENT>Direct Black 4</ENT> <ENT>30245</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′-[(2,4-diamino-5-methylphenyl)azo][1,1′-biphenyl]-4-yl]azo] -5-hydroxy-6-(phenylazo)-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2429-84-7</ENT> <ENT>C.I. Direct Red 1</ENT> <ENT>22310</ENT> <ENT>Benzoic acid, 5-[[4′-[(2-amino-8-hydroxy-6-sulfo-1-naphthalenyl)azo][1,1′-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2586-58-5</ENT> <ENT>C.I. Direct Brown 1:2</ENT> <ENT>30110</ENT> <ENT>Benzoic acid, 5-[[4′-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo][1,1′-biphenyl]-4- yl]azo]-2-hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">2602-46-2</ENT> <ENT>C.I. Direct Blue 6</ENT> <ENT>22610</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 3,3′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt.</ENT> </ROW> <ROW> <ENT I="01">2893-80-3</ENT> <ENT>C.I. Direct Brown 6</ENT> <ENT>30140</ENT> <ENT>Benzoic acid, 5-[[4′-[[2,4-dihydroxy-3-[(4-sulfophenyl) azo]phenyl]azo][1,1′-biphenyl]-4- yl]azo]-2-hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">3530-19-6</ENT> <ENT>C.I. Direct Red 37</ENT> <ENT>22240</ENT> <ENT>1,3-Naphthalenedisulfonic acid, 8-[[4′-[(4-ethoxyphenyl)azo][1,1′-biphenyl]-4-yl]azo]-7-hydroxy-, disodium salt</ENT> </ROW> <ROW> <ENT I="01">3567-65-5</ENT> <ENT>C.I. Acid Red 85</ENT> <ENT>22245</ENT> <ENT>1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-[[4′-[[4-[[(4-methylphenyl)sulfonyl]oxy]phenyl]azo][1,1′-biphenyl]-4-yl]azo]-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">3626-28-6</ENT> <ENT>C.I. Direct Green 1</ENT> <ENT>30280</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[[4′-[(4-hydroxyphenyl)azo][1,1′- biphenyl]-4- yl]azo]-6-(phenylazo)-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">3811-71-0</ENT> <ENT>C.I. Direct Brown 1</ENT> <ENT>30045</ENT> <ENT>Benzoic acid, 5-[[4′-[[2,4-diamino-5-[(4-sulfophenyl) azo]phenyl]azo][1,1′ biphenyl]-4- yl]azo]-2-hydroxy-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">4335-09-5</ENT> <ENT>C.I. Direct Green 6</ENT> <ENT>30295</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-[[4′-[(4-hydroxyphenyl)azo][1,1′-biphenyl]-4- yl]azo]-3-[(4-nitrophenyl)azo]-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">6358-80-1</ENT> <ENT>C.I. Acid Black 94</ENT> <ENT>30336</ENT> <ENT>2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[[4′-[[4-hydroxy-2-[(2- methylphenyl)amino]phenyl]azo] [1,1′- biphenyl]-4-yl]azo]-6-[(4-sulfophenyl) azo]-, trisodium salt.</ENT> </ROW> <ROW> <ENT I="01">6360-29-8</ENT> <ENT>C.I. Direct Brown 27</ENT> <ENT>31725</ENT> <ENT>Benzoic acid, 5-[[4′-[[4-[(4-amino-7-sulfo-1-naphthalenyl)azo]-6-sulfo-1-naphthalenyl]azo][1,1′-biphenyl]-4-yl] azo]-2- hydroxy-, trisodium salt.</ENT> </ROW> <ROW> <PRTPAGE P="374"/> <ENT I="01">6360-54-9</ENT> <ENT>C.I. Direct Brown 154</ENT> <ENT>30120</ENT> <ENT>Benzoic acid, 5-[[4′-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl] azo][1,1′-biphenyl]-4-yl]azo]-2- hydroxy-3-methyl-, disodium salt.</ENT> </ROW> <ROW> <ENT I="01">8014-91-3</ENT> <ENT>C.I. Direct Brown 74</ENT> <ENT>36300</ENT> <ENT>Benzoic acid, 3,3′-[(3,7-disulfo-1,5-naphthalenediyl)bis [azo(6-hydroxy-3,1-phenylene)azo[6(or7)-sulfo-4,1-naphthalenediyl]azo[1,1′-biphenyl]-4,4′-diylazo]]bis[6-hydroxy-, hexasodium salt.</ENT> </ROW> <ROW> <ENT I="01">16071-86-6</ENT> <ENT>C.I. Direct Brown 95</ENT> <ENT>30145</ENT> <ENT>Cuprate(2-), [5-[[4′-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulfophenyl)azo]phenyl] azo][1,1′- biphenyl]-4-yl]azo]-2-hydroxybenzoato(4-)]-, disodium salt.</ENT> </ROW> </GPOTABLE> <P>(2) The significant new uses are:</P> <P>(i) For each of the chemical substances listed in Table 2 of this section, any use other than use as a reagent to test for hydrogen peroxide in milk; a reagent to test for hydrogen sulfate, hydrogen cyanide, and nicotine; a stain in microscopy; a reagent for detecting blood; an analytical standard; and, additionally for Colour Index (C.I.) Direct Red 28 (Congo Red) (CAS No. 573-58-0), an indicator dye.</P> <P>(ii) For the chemical substances listed in Table 1 of this section: Any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph (b). </P> <P> (1) <E T="03">Revocation of certain notification exemptions.</E> The provisions of § 721.45(f) do not apply to this section. A person who imports or processes a chemical substance identified in paragraph (a)(1) of this section as part of an article for a significant new use described in paragraph (a)(2) of this section is not exempt from submitting a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[79 FR 77909, Dec. 29, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1675</SECTNO> <SUBJECT>Disulfonic acid rosin amine salt of a benzidine derivative (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as disulfonic acid rosin amine salt of a benzidine derivative (PMN P-87-1337) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and con­sumer activities.</E> Requirements as specified in § 721.80 (f), (v)(1), (w)(1), and (x)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 33304, Aug. 15, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1680</SECTNO> <SUBJECT>Substituted benzoic acid (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted benzoic acid (PMN P-01-423) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), <PRTPAGE P="375"/> (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70175, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1700</SECTNO> <SUBJECT>Halonitrobenzoic acid, substituted (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance halonitrobenzoic acid, substituted (PMN P-86-1098) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(vii), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b), (c), (d), (e) (concentration set at 1.0 percent), (f) and (g)(1)(vi), (g)(2)(i) through (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees to be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e) through (g) and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 32416, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1705</SECTNO> <SUBJECT>Benzoic acid, 3-amino-, diazotized, coupled with 6-amino-4-hydroxy-2-naphthalenesulfonic acid, diazotized, (3-aminophenyl)phosphonic acid and diazotized 2,5-diethoxybenzenamine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as benzoic acid, 3-amino-, diazotized, coupled with 6-amino-4-hydroxy-2-naphthalenesulfonic acid, diazotized, (3-amino-phenyl)phosphonic acid and diazotized 2,5-diethoxybenzenamine (PMN P-96-1216; CAS No. 163879-69-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), and (x)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3423, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1725</SECTNO> <SUBJECT>Benzoic acid, 3,3′-methyl­enebis [6 amino-, di-2-propenyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The following chemical substance, referred to by its CAS Number and chemical name, is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section: 61386-02-5, Benzoic acid, 3,3′-methylenebis [6 amino-, di-2-propenyl ester. <PRTPAGE P="376"/> </P> <P>(2) The significant new uses are: (i) Any use other than the use described in Premanufacture Notice P-82-438.</P> <P>(ii) Any manner or method of manufacturing or processing the substance for the use described in Pre­man­u­fac­ture Notice P-82-438 different than the manner or method described in Premanufacture Notice P-82-438.</P> <P> (b) <E T="03">Special provisions.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Determining whether a specific use is subject to this rule.</E> (i) A person who intends to manufacture, import, or process the chemical substance identified in paragraph (a)(1) of this section may ask EPA whether the use for which the person intends to manufacture, import, or process the substance is a significant new use under paragraph (a)(2)(i) of this section. EPA will answer such an inquiry only if EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance. </P> <P> (ii) To establish a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance, the person must submit to EPA: </P> <P>(A) All materials and statements required under § 721.6.</P> <P>(B) The specific use for which the person intends to manufacture, import, or process the chemical substance.</P> <P> (iii) EPA will review the information submitted by the person under this paragraph to determine whether the person has a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance. </P> <P> (iv) If EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance, EPA will tell the person whether the use for which the person intends to manufacture, import, or process the substance is a significant new use under paragraph (a)(2)(i) of this section. If EPA tells the person that the intended use is not a significant new use under paragraph (a)(2)(i) of this section, EPA will tell the person what activities would constitute a significant new use under paragraph (a)(2)(ii) of this section. </P> <P> (v) A disclosure to a person with a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance of the significant new uses subject to this section will not be considered public disclosure of confidential business information under section 14 of the Act. </P> <P>(vi) EPA will answer an inquiry on whether a particular use is subject to this section within 30 days after receipt of a complete submission under paragraph (b)(1) of this section.</P> <P>(2) [Reserved]</P> <CITA>[51 FR 16687, May 6, 1986. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1728</SECTNO> <SUBJECT>Benzoic acid, 2-(3-phenylbutylidene)amino-, methyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzoic acid, 2-(3-phenylbutylidene)amino-, methyl ester (PMN P-85-1211) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (10,600 kg). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51682, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1729</SECTNO> <SUBJECT> Boric acid (H <E T="9145">3</E> BO <E T="9145">3</E> ), mixed esters with polyethylene glycol mono-Bu ether and polyethylene glycol mono Me ether. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as boric acid (H <E T="52">3</E> BO <E T="52">3</E> ), mixed esters with polyethylene glycol mono-Bu ether and polyethylene glycol mono Me ether (PMN P-97-635; CAS No. 183290-62-2) is subject to reporting under this section for the <PRTPAGE P="377"/> significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i) and (a)(3). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 300). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 368, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1730</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), α-butyl-ω-hydroxy, ester with boric acid (H <E T="9145">3</E> BO <E T="9145">3</E> ). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as poly(oxy-1,2-ethanediyl), α-butyl-ω-hydroxy, ester with boric acid (H <E T="52">3</E> BO <E T="52">3</E> ) (PMN P-97-636; CAS No. 106008-93-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i) and (a)(3). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 300). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 368, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1731</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy, ester with boric acid (H <E T="9145">3</E> BO <E T="9145">3</E> ). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy, ester with boric acid (H <E T="52">3</E> BO <E T="52">3</E> ) (PMN P-97-637; CAS No. 106008-94-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i) and (a)(3). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 300). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 368, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1732</SECTNO> <SUBJECT>Nitrobenzoic acid octyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as nitrobenzoic acid octyl ester (PMN P-93-343) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 1 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="378"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51682, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1734</SECTNO> <SUBJECT>Substituted benzonitrile (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted benzonitrile (PMN P-97-1029) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i), (a)(3), (a)(4), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), and (a)(6)(v). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The recordkeeping requirements specified in § 721.125 (a), (b), (c), (d), (e), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44576, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1735</SECTNO> <SUBJECT>Alkylbisoxyalkyl (sub­sti­tut­ed-1,1-dimethylethylphenyl) ben­zo­tria­zole (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance alkylbisoxyalkyl (substituted-1,1-dimethylethylphenyl) benzotriazole (PMN P-86-1771) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(vii), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (d), (e) (concentration set at 1.0 percent), (f) and (g)(1)(iv), (g)(2)(i) through (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (k) (light stabilizer for polymers) and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e) through (g), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 21413, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1738</SECTNO> <SUBJECT>Substituted benzotriazole (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted benzotriazole (PMN P-94-1744) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(ii), (a)(5)(iv), (a)(6)(i), (b) (concentration set at 1.0%), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0%), (f), (g)(1)(iv), (g)(1)(vi), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). <PRTPAGE P="379"/> </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements specified in § 721.125(a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[61 FR 63736, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1745</SECTNO> <SUBJECT>Ethoxybenzothiazole disulfide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as ethoxybenzothiazole disulfide (PMN P-90-1384) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i) through (vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (d) and (f) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44063, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1747</SECTNO> <SUBJECT>Substituted benzophenone (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted benzophenone (PMN P-02-262) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P> (ii) <E T="03">Release to water.</E> Requirement as specified § 721.90(b)(1) and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70175, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1750</SECTNO> <SUBJECT> 1 <E T="7462">H</E> -Benzotriazole, 5-(pen­tyl­oxy)- and 1 <E T="7462">H</E> -ben­zo­tri­a­zole, 5-(pen­tyl­oxy)-, sodium and potassium salts. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances 1 <E T="03">H</E> -benzotriazole, 5-(pen­tyl­oxy)- (PMN P-92-34, CAS no. 133145-29-6), 1 <E T="03">H</E> -ben­zo­tri­a­zole, 5-(pen­tyl­oxy)-, sodium salt (PMN P-92-35), and 1 <E T="03">H</E> -benzotriazole, 5-(pentyloxy)- , potassium salt (PMN P-92-36) are subject to reporting for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of these substances is any manner or method of manufacture, import, or processing associated with any use of these substances without providing risk notification as follows: </P> <P> (A) If as a result of the test data required under the section 5(e) consent order for these substances, the employer becomes aware that these substances may present a risk of injury to the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into a SDS as described in § 721.72(c) within 90 days <PRTPAGE P="380"/> from the time the employer becomes aware of the new information. If these substances are not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substances are reintroduced into the workplace. </P> <P>(B) The employer must ensure that persons who will receive, or who have received these substances from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial consumer activities.</E> Requirements as specified in § 721.80(p) (limit set at 9,500 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of these substances, as specified in § 721.125 (a), (c), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 32237, June 8, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1755</SECTNO> <SUBJECT>Methylenebisbenzotriazole.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance methylenebisbenzotriazole (P-93-578) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> During both manufacture and use of the substance, requirements as specified in § 721.63 (a)(4), (a)(6)(i), (b) (concentration set at 1.0 percent) and (c). During manufacture of the PMN substance § 721.63(a)(5)(i); during use of the PMN substance § 721.63 (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), and (a)(5)(vii). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(1)(vi), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[60 FR 11041, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1760</SECTNO> <SUBJECT>Substituted benzotriazole derivatives.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as substituted benzotriazole derivatives (PMNs P-93-374 and P-93-375) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(vi), (g)(2)(i), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g), (v)(1), (w)(1), and (x)(1). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="381"/> this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11041, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1765</SECTNO> <SUBJECT>2-Substituted benzotriazole.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as 2-substituted benzotriazole (PMN P-90-335) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iv), (g)(1)(vi), (g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), (c)(4), ­(where N = 80). However, contrary to § 721.91(a)(4), if the waste stream containing the PMN substance will be treated using biological treatment (activated sludge or equivalent) plus clarification, then the amount of PMN substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 75 percent removal efficiency may be attributed to such treatment. </P> <P> (b) <E T="03">Special requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 19235, Apr. 25, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993; 60 FR 30468, June 9, 1995; 63 FR 45955, Aug. 28, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1767</SECTNO> <SUBJECT>Substituted 6,6′-(1-methylethylidene)bis[3,4-dihydro-3-phenyl-1,3-benzoxazine] (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted 6,6′-(1-methylethylidene)bis[3,4-dihydro-3-phenyl-1,3-benzoxazine] (PMN P-00-0993) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15081, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1775</SECTNO> <SUBJECT> 6-Nitro-2(3 <E T="7462">H</E> )-benzo­xazo­lone. </SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance 6-nitro-2(3 <E T="03">H</E> )-benzoxazolone (PMN P-84-963) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), <PRTPAGE P="382"/> (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), and (g)(2)(v). The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c), respectively. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), (x)(1), and (y)(2). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (d), (e), (f), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[55 FR 26100, June 26, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1790</SECTNO> <SUBJECT>Polybrominated biphenyls.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified as 1,1′-(Biphenyl, 4,4′-dibromo- (CAS No. 92-86-4); 1,1′-(Biphenyl, 2-bromo- (CAS No. 2052-07-5); 1,1′-(Biphenyl, 3-bromo- (CAS No. 2113-57-7); 1,1′-(Biphenyl, 2,2′, 3,3′, 4,4′, 5,5′, 6,6′-decabromo- (CAS No. 13654-09-6); Nonabromobiphenyl (CAS No. 27753-52-2); Octabromobiphenyl (CAS No. 27858-07-7); and Hexabromobiphenyl (CAS No. 36355-01-8) are subject to reporting under this section for the significant new uses described in paragraph (a)(1)(i) of this section. </P> <P>(i) The significant new use is: Any use.</P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes a substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(B) [Reserved]</P> <P>(2) The chemical substance identified as 1,1′-(Biphenyl, 4-bromo- (CAS No. 92-66-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2)(i) of this section.</P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Industrial, commercial, and consumer activites.</E> Requirements as specified in § 721.80 (f), (j), and (s) (10,000 kilograms). </P> <P> (B) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (C) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P>(b) [Reserved]</P> <CITA>[63 FR 45955, Aug. 28, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1800</SECTNO> <SUBJECT>3,3′,5,5′-Tetra­methyl­bi­phenyl-4,4′-diol.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as 3,3′,5,5′-tetramethylbiphenyl-4,4′-diol (PMN P-88-972) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(vii), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1 <PRTPAGE P="383"/> percent), (f), (g)(1)(iv), (g)(1)(ix), (g)(2)(ii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (k) (monomer for epoxy resins and engineering plastics or an antioxidizing agent for lubricating oils) and (p) (level set at 42,000 kg and 366,000 kg). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[55 FR 33308, Aug. 15, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1805</SECTNO> <SUBJECT>Substituted bisaniline.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted bisaniline (PMN P-96-1410) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 4). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3423, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1820</SECTNO> <SUBJECT>Bisphenol derivative.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as bisphenol derivative (PMN No. P-92-509) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1) (systemic effects—depression in body weight gain and blood effects), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv) (when in dust or mist form), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (d), and (f) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 32237, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1825</SECTNO> <SUBJECT>Bisphenol A, epichloro­hy­drin, polyalkylenepolyol and poly­iso­cyanato derivative.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as bisphenol A, epichlorohydrin, polyalkylenepolyol and polyisocyanato derivative (PMN P-89-750) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="384"/> </P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(viii), (a)(5)(ix), (a)(6)(ii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f) and (g)(1)(vi), (g)(1)(vii), (g)(2)(i) through (g)(2)(v), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q) (The production limit applies to the aggregate production volume of both P-89-750 and P-89-760. P-89-760 is the preferred substance for use in performing these tests. Results from such testing can be used to evaluate the toxicity of P-89-750 as well). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(ii) (Oil and grease separation may be used as an alternative treatment), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 46772, Nov. 6, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1850</SECTNO> <SUBJECT>Toluene sulfonamide bis­phe­nol A epoxy adduct.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as toluene sulfonamide bisphenol A epoxy adduct (PMN P-90-113) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows. (A) If, as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into a Safety Data Sheet (SDS) as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. </P> <P>(B) The employer must ensure that persons who have received, or will receive, this substance from the employer are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (c), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 15791, Apr. 17, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="385"/> <SECTNO>§ 721.1852</SECTNO> <SUBJECT>Di-alkyl borane (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as di-alkyl borane (PMN P-00-1087) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 200 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15081, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1875</SECTNO> <SUBJECT>Boric acid, alkyl and substituted alkyl esters (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance boric acid, alkyl and substituted alkyl esters (PMN P-86-1252) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3), (b) [concentration set at 0.1 percent], and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (d), (e) [concentration set at 0.1 percent], (f), and (g)(1)(i), (g)(1)(iv), (g)(1)(vii), (g)(1)(viii), and (g)(1)(ix), (g)(2)(i) and (g)(2)(v), (g)(4)(i) and (g)(4)(iii), and (g)(5). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on a SDS does not apply when a SDS was not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1) and (b)(1). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 26108, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1878</SECTNO> <SUBJECT>Alkali metal alkyl borohydride (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkali metal alkyl borohydride (PMN P-00-1089) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15082, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <PRTPAGE P="386"/> <SECTNO>§ 721.1880</SECTNO> <SUBJECT>Borate(1-), tris(acetato-.kappa.O)hydro-, sodium, (T-4)-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as borate(1-), tris(acetato-.kappa.O)hydro-, sodium, (T-4)- (PMN P-00-0922; CAS No. 56553-60-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 300 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15082, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1900</SECTNO> <SUBJECT>Substituted bromothiophene.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted bromothiophene (P-83-769) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), and (a)(6)(i). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(1)(i)(D) and (g)(2)(iv). The provision of § 721.72(g) requiring placement of specific information in an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a), (b), (c), (d), (f), and (g). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 25990, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1907</SECTNO> <SUBJECT> Butanamide, 2,2′-[3′dichloro[1,1′-biphenyl]-4,4′-diyl)bisazobis <E T="7462">N</E> -2,3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo-. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as butanamide, 2,2′-[3′dichloro[1,1′-biphenyl]-4,4′-diyl)bisazobis <E T="03">N</E> -2,3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo- (PMN P-93-1111) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). The following additional statements shall appear on each label and Safety Data Sheet (SDS) as specified by this paragraph: This substance decomposes in polymers or sheet metal coatings at temperatures greater than 280 °C to give 3,3′ DCB a suspect human carcinogen. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f) and processing or use at temperatures above 280 °C. </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (b)(1) and (c)(1). When the substance is processed or used as a colorant for dyeing plastics, this section does not apply. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 5742, Feb. 4, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="387"/> <SECTNO>§ 721.1920</SECTNO> <SUBJECT>1,4-Bis(3-hydroxy-4-benzoylphenoxy)butane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,4-bis(3-hydroxy-4-benzoylphenoxy)butane (PMN P-93-483) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 1 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51683, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1925</SECTNO> <SUBJECT>Substituted carboheterocyclic butane tetracarboxylate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted carboheterocyclic butane tetracarboxylate (PMNs P-90-440 and P-95-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply when particle sizes of the chemical substance is greater than 250 microns. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(vi), (g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, and specified in § 721.125 (a) through (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 19242, Apr. 25, 1991. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993; 67 FR 12885, Mar. 20, 2002]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1930</SECTNO> <SUBJECT>Butanoic acid, antimony (3=) salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as butanoic acid, antimony (3=) salt (PMN P-94-1143; CAS No. 53856-17-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (g)(1)(i), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(v), and (g)(5). The label and SDS as required by this paragraph shall also include the following statement: This substance may cause neurologic effects. This substance may cause cardiovascular effects. This substance may cause ocular irritation. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (675,000 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="388"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3423, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.1950</SECTNO> <SUBJECT> 2-Butenedioic acid ( <E T="7462">Z</E> ), mono(2-((1-oxopropenyloxy)ethyl) ester . </SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as 2-butenedioic acid ( <E T="03">Z</E> ), mono(2-((1-oxopropenyloxy)ethyl) ester (PMN P-85-543) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(xi), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f) (g)(1)(iii), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v) and (g)(5). The provision of § 721.72(d) requiring that employees to be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44063, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2025</SECTNO> <SUBJECT>Substituted phenylimino carbamate derivative.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted phenylimino carbamate derivative (PMN P-91-487) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46464, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2060</SECTNO> <SUBJECT>Disubstituted benzenedicarboxylic acid (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a disubstituted benzenedicarboxylic acid (PMN P-01-77) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified § 721.90(a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. <PRTPAGE P="389"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70175, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2075</SECTNO> <SUBJECT>Carbamodithioic acid, methyl-, compound with methanamine (1:1).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as carbamodithioic acid, methyl-, compound with methanamine (1:1) (P-84-1042), is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(1)(vi), and (g)(2)(i). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when an SDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information in an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 720.80(k). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(2), (b)(2), and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (g), (i), and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 25990, June 5, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2076</SECTNO> <SUBJECT>D-Glucuronic acid, polymer with 6-deoxy-L-mannose and D-glucose, acetate, calcium magnesium potassium sodium salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as D-Glucuronic acid, polymer with 6-deoxy-L-mannose and D-glucose, acetate, calcium magnesium potassium sodium salt (PMN P-00-7; SNUN S-05-1; SNUN S-06-4; SNUN S-07-03; and SNUN S-07-5; CAS No. 125005-87-0) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80. The significant new use is any use other than manufacture of the substance where greater than 5 percent of the chemical substance consists of particle sizes below 10 microns. </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70175, Dec. 17, 2003, as amended at 80 FR 37165, June 30, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2077</SECTNO> <SUBJECT>Substituted carbazate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted carbazate (PMN P-97-267) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (c)(1) and (c)(2)(iv). The SDS required by this paragraph shall include the following <PRTPAGE P="390"/> statements: Overexposure to this material may cause severe acute toxicity including death. This concern is particularly true with respect to direct contact to the eyes. Exposure to the eyes may cause severe acute toxicity including death. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (a), (b), (c), and (j). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 65710, Nov. 30, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2078</SECTNO> <SUBJECT>1-Piperidinecarboxylic acid, 2-[(dichloro-hydroxy-carbomonocycle)hydrazono]-, methyl ester (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as 1-piperidinecarboxylic acid, 2-[(dichloro-hydroxy-carbomonocycle) hydrazono]-, methyl ester (PMN P-96-756) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g), (l), and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 44576, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2079</SECTNO> <SUBJECT>Dichloro, hydroxy, hydrazino-carbomonocycle (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as dichloro, hydroxy, hydrazino-carbomonocycle (PMN P-96-757) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g), (l), and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 44576, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="391"/> <SECTNO>§ 721.2081</SECTNO> <SUBJECT>Dichloro, hydroxy, hydrazino-carbomonocycle-monohydrochloride (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as dichloro, hydroxy, hydrazino-carbomonocycle-monohydrochloride (PMN P-96-758) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g), (l), and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 44576, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2083</SECTNO> <SUBJECT>Polysubstituted carbomonocyclic hydroxylamine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a polysubstituted carbomonocyclic hydroxylamine (PMN P-97-878) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), and (a)(6)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The recordkeeping requirements specified in § 721.125 (a), (b), (c), and (d) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44576, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2084</SECTNO> <SUBJECT>Carbon oxyfluoride (Carbonic difluoride).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance carbon oxyfluoride (CAS No. 353-50-4), also referred to as carbonic difluoride, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2085</SECTNO> <SUBJECT>Hydroxyalkylquinoline dioxoindandialkylcarboxamide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydroxyalkylquinoline dioxoindandialkylcarboxamide (PMN P-94-682) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). <PRTPAGE P="392"/> </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11042, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2086</SECTNO> <SUBJECT>Coco acid triamine condensate, polycarboxylic acid salts.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as coco acid triamine condensate, poly­car­box­ylic acid salts. (PMN P-92-446) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46464, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2087</SECTNO> <SUBJECT>3-furancarboxaldehyde, tetrahydro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a 3-furancarboxaldehyde, tetrahydro- (PMN P-98-1048; CAS No. 79710-86-4) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 368, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2088</SECTNO> <SUBJECT>Carboxylic acids, (C6-C9) branched and linear.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as carboxylic acids, (C6-C9) branched and linear (PMNs P-93-313, 314, 315, and 316) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(i), (g)(3)(ii), (g)(4)(iii) and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 300 ppb for P-93-313, 314, and 315 and N = 50 ppb for P-93-316). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (f), (g), (h), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11042, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2089</SECTNO> <SUBJECT>Tetrasubstituted aminocarboxylic acid.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a tetrasubstituted aminocarboxylic acid (PMN P-85-619) is subject to reporting under this section <PRTPAGE P="393"/> for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(vii), (g)(2)(iii), (g)(3)(ii), (g)(4)(ii), (g)(4)(iii), and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (h) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45081, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2091</SECTNO> <SUBJECT>Propane, 1,1,1,3,3,3-hexachloro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as propane, 1,1,1,3,3,3-hexachloro- (PMN P-96-273; CAS No. 3607-78-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3423, Jan. 22, 1998, as amended at 79 FR 34636, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2092</SECTNO> <SUBJECT>3-Methylcholanthrene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 3-methylcholanthrene (CAS No. 56-49-5) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2093</SECTNO> <SUBJECT>Alkenyl carboxylate, metal salt (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkenyl carboxylate, metal salt (PMN P-99-0848) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j) (an emulsifier for metalworking fluids) and (q). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 15082, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2094</SECTNO> <SUBJECT> <E T="7462">N,N</E> ′-di(alkyl heteromonocycle)amino chlorotriazine. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The <PRTPAGE P="394"/> chemical substance identified generically as <E T="03">N,N</E> ′-di(alkyl heteromonocycle)amino chlorotriazine (PMN P-93-1369) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i) (this respirator meets the minimum requirement for persons exposed via inhalation during manufacture), (a)(5)(ii), (a)(5)(iv), (a)(5)(v) (these three respirators meet the minimum requirements for persons exposed via inhalation during processing and use), (a)(6)(i), (a)(6)(ii), (a)(6)(iii), (a)(6)(iv), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72(a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(1)(viii), (g)(1)(ix), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3424, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2095</SECTNO> <SUBJECT>Chromate(3-), bis 2-[[substituted-3-[(5-sulfo-1-naphthalenyl)azo] phenyl]azo]substituted monocycle, trisodium (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as chromate(3-), bis 2-[[substituted-3-[(5-sulfo-1-naphthalenyl) azo]phenyl]azo]substituted monocycle, trisodium (PMN P-95-1242) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (v)(1), (w)(1), and (y)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63736, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2097</SECTNO> <SUBJECT>Azo chromium complex dyestuff preparation (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an azo chromium complex dyestuff preparation (PMN P-95-240) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), and (x)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63736, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <PRTPAGE P="395"/> <SECTNO>§ 721.2098</SECTNO> <SUBJECT>Aliphatic polycarboxylic acid metal salt (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an aliphatic polycarboxylic acid metal salt (PMN P-01-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(v)(1), (x)(1), and (f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2120</SECTNO> <SUBJECT>Cyclic amide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a cyclic amide (PMN P-92-131) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (concentration set at 70 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46465, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2121</SECTNO> <SUBJECT>Thiosubstituted carbonate ester (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as Thiosubstituted carbonate ester (PMN P-99-0654) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 81399, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2122</SECTNO> <SUBJECT>Substituted phenyl azo substituted sulfo carbopolycycle.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted phenyl azo substituted sulfo carbopolycycle (PMN P-96-702) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(r) (204,000 kg) (activated sludge adsorption isotherm- OPPTS 835.1110 test guideline (public draft; 61 FR 16486, April 15, 1996) (FRL-5363-1), daphnid acute toxicity-§ 797.1300, fish acute toxicity-§ 797.1400, murine immune allergic response study ( <E T="03">Toxicology and Applied Pharmacology</E> 112:190-197 (1992)). A person may not manufacture or import the substance beyond the following aggregate production volume limits, unless that person conducts the following corresponding studies on the substance and submits all final reports and underlying data in <PRTPAGE P="396"/> accordance with the procedures and criteria specified in paragraphs (a)(2)(i)(A), (a)(2)(i)(B), (a)(2)(i)(C), and (a)(2)(i)(D) of this section. </P> <P> (A) Each study required to be performed pursuant to this section must be scientifically valid. <E T="03">Scientifically valid</E> means that the study was conducted according to: </P> <P> ( <E T="03">1</E> ) The test guidelines specified in paragraph (a)(2)(i) of this section. </P> <P> ( <E T="03">2</E> ) An EPA-approved protocol. </P> <P> ( <E T="03">3</E> ) TSCA Good Laboratory Practice Standards at 40 CFR part 792. </P> <P> ( <E T="03">4</E> ) Using methodologies generally accepted at the time the study is initiated. </P> <P> ( <E T="03">5</E> ) Any deviation from these requirements must be approved in writing by EPA. </P> <P>(B) Before starting to conduct any of the studies in paragraph (a)(2)(i) of this section, the person must obtain approval of test protocols from EPA by submitting written protocols. EPA will respond to the person within 4 weeks of receiving the written protocols. Published test guidelines specified in paragraph (a)(2)(i) of this section (e.g., 40 CFR part 797 or part 798) provide general guidance for development of test protocols, but are not themselves acceptable protocols.</P> <P>(C) The person shall:</P> <P> ( <E T="03">1</E> ) Conduct each study in good faith with due care. </P> <P> ( <E T="03">2</E> ) Promptly furnish to EPA the results of any interim phase of each study. </P> <P> ( <E T="03">3</E> ) Submit, in triplicate (with an additional sanitized copy, if confidential business information is involved), the final report of each study and all underlying data (“the report and data”) to EPA no later than 14 weeks prior to exceeding the applicable production volume limit. The final report shall contain the contents specified in 40 CFR 792.185. </P> <P> (D)( <E T="03">1</E> ) Except as described in paragraph (a)(2)(i)(D)( <E T="03">2</E> ) of this section, if, within 6 weeks of EPA's receipt of a test report and data, the person receives written notice that EPA finds that the data generated by a study are scientifically invalid, the person is prohibited from further manufacture and import of the PMN substance beyond the applicable production volume limit. </P> <P> ( <E T="03">2</E> ) The person may continue to manufacture and import the PMN substance beyond the applicable production limit only if so notified, in writing, by EPA in response to the person's compliance with either of the following paragraph (a)(2)(i)(D)( <E T="03">2</E> )( <E T="03">i</E> ) or (a)(2)(i)(D)( <E T="03">2</E> )( <E T="03">ii</E> ) of this section. </P> <P> ( <E T="03">i</E> ) The person may reconduct the study. If there is sufficient time to reconduct the study and submit the report and data to EPA at least 14 weeks before exceeding the production limit as required by paragraph (a)(2)(i)(C)( <E T="03">3</E> ) of this section, the person shall comply with paragraph (a)(2)(i)(C)( <E T="03">3</E> ) of this section. If there is insufficient time for the person to comply with paragraph (a)(2)(i)(C)( <E T="03">3</E> ) of this section, the person may exceed the production limit and shall submit the report and data in triplicate to EPA within a reasonable period of time, all as specified by EPA in the notice described in paragraph (a)(2)(i)(D)( <E T="03">1</E> ) of this section. EPA will respond to the person in writing, within 6 weeks of receiving the person's report and data. </P> <P> ( <E T="03">ii</E> ) The person may, within 4 weeks of receiving from EPA the notice described in paragraph (a)(2)(i)(D)( <E T="03">1</E> ) of this section, submit to EPA a written report refuting EPA's finding. EPA will respond to the person in writing, within 4 weeks of receiving the person's report. </P> <P>(E) The person is not required to conduct a study specified in paragraph (a)(2)(i) of this section if notified in writing by EPA that it is unnecessary to conduct that study.</P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3424, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="397"/> <SECTNO>§ 721.2140</SECTNO> <SUBJECT>Carbo­poly­cycli­col azo­alkyl­aminoalkyl­carbo­mono­cyclic ester, halogen acid salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as carbopolycyclicol azo­al­kyl­a­mino­al­kyl­car­bo­mon­o­cyc­lic ester, halogen acid salt (PMN P-88-1682) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (f), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4) and (c)(4) (where N = 1 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44063, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2145</SECTNO> <SUBJECT>Ceteareth-25 sorbate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as ceteareth-25 sorbate (PMN P-96-941) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provision of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3425, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2155</SECTNO> <SUBJECT>Alkoxyamino-alkyl-coumarin (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkoxyamino-alkyl-coumarin. (PMN P-00-0108) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15082, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2175</SECTNO> <SUBJECT>Salt of cyclodiamine and mineral acid.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a salt of cyclodiamine and mineral acid (PMN P-91-838) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="398"/> this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46465, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2222</SECTNO> <SUBJECT> Cyclohexanamine, <E T="7462">N,N</E> -dimethyl-, compd. with alpha-isotridecyl-omega-hydroxypoly(oxy-1,2-ethanediyl) phosphate. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as cyclohexanamine, <E T="03">N,N</E> -dimethyl-, compd. with alpha-isotridecyl-omega-hydroxypoly(oxy-1,2-ethanediyl) phosphate (PMN P-96-1176; CAS No. 164383-18-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3425, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2250</SECTNO> <SUBJECT> 1,4-Cyclohexanediamine, <E T="7462">cis</E> - and <E T="7462">trans-.</E> </SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified as 1,4-cyclohexanediamine, <E T="03">cis-</E> and <E T="03">trans-</E> (PMNs P-87-1881 and P-87-1882; CAS numbers 15827-56-2 and 2615-25-0) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(iii), (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44064, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2260</SECTNO> <SUBJECT>1,2-Cyclohexanedicarboxylic acid, 2,2-bis[[[[2-[(oxiranylmethoxy) carbonyl]cyclohexy]carbonyl] oxy]methyl]-1,3-propanediyl bis(oxiranylmethyl) ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance 1,2-cyclohexanedicarboxylic acid, 2,2-bis[[[[2-[(oxiranylmethoxy) carbonyl] cyclohexy]carbonyl] oxy]methyl]-1,3-propanediyl bis(oxiranylmethyl) ester (PMN P-92-471) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(ii), (a)(5)(viii), (a)(5)(ix), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(ii), (g)(2)(iv), and (g)(5). </P> <P>(iii) Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(q).</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. <PRTPAGE P="399"/> </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51702, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2265</SECTNO> <SUBJECT>Polyalkylene oxide dialkylamine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as Polyalkylene oxide dialkylamine (PMN P-99-0423) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81399, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2270</SECTNO> <SUBJECT>Aliphatic dicarboxylic acid salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as aliphatic dicarboxylic acid salt (PMN P-92-1352) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 1,000 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51683, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2275</SECTNO> <SUBJECT> <E T="7462">N,N,N′,N′</E> -Tetrakis(oxi­ranyl- methyl)-1,3-cyclohexane di­meth­anamine. </SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as <E T="03">N,N,N′,N′</E> -tetrakis(oxiranylmethyl)-1,3-cyclohexanedimethanamine (P-84-7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (h). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 25991, June 5, 1991. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="400"/> <SECTNO>§ 721.2280</SECTNO> <SUBJECT>Cyclopropanecarboxaldehyde.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as cyclopropanecarboxaldehyde (PMN P-96-33) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(xii), (a)(5)(xiii), (a)(5)(xiv), (a)(6)(v), (b) (concentration set at 1.0 percent), and (c). Each person who is reasonsonably likely to be exposed by inhalation to the PMN substance in vapor form during loading of rail cars is provided with, and is required to wear, at a minimum, a National Institute for Occupational Safety and Health (NIOSH) approved category 19C Type C supplied-air respirator operated in pressure demand or other positive pressure mode and equipped with a full facepiece with an assigned protection factor (APF) of 200. As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the new chemical exposure limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the TSCA section 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iv), (g)(1)(ix), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activites.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3425, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2287</SECTNO> <SUBJECT>DDT (Dichlorodiphenyltrichloroethane).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance DDT (dichlorodiphenyltrichloroethane) (CAS No. 50-29-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2340</SECTNO> <SUBJECT>Dialkenylamide (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a dialkenylamide (P-87-502) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(xii), (a)(5)(xiii), (a)(5)(xiv), (a)(5)(xv), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). <PRTPAGE P="401"/> </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2) and (c)(1), (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 26099, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2345</SECTNO> <SUBJECT>Alkyletherpropyl dialkylamines.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as alkyletherpropyl dialkylamines (PMNs P-96-1510/1511/1512/1513/1514) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3425, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2350</SECTNO> <SUBJECT>Alkyltri, tetra, and pentaamines.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkyltri, tetra, and pentaamines (PMNs P-96-406/407/408) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3425, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2355</SECTNO> <SUBJECT>Diethylstilbestrol.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance diethylstilbestrol (CAS No. 56-53-1) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63516, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2380</SECTNO> <SUBJECT>Disubstituted diamino ani­sole.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The following chemical substance referred to by its premanufacture notice number and generic chemical name is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section: P-83-822, disubstituted diamino anisole. <PRTPAGE P="402"/> </P> <P>(2) The significant new uses are:</P> <P>(i) Use other than as an intermediate.</P> <P>(ii) Manufacture, import, or processing for use as an intermediate without establishing a program whereby:</P> <P>(A) Persons employed by or under the control of the manufacturer, importer, or processor who may be exposed to the substance (including those persons involved in maintenance, packaging, and storage operations) wear protective gloves determined to be impervious to the substance by testing the gloves under the conditions of exposure or by evaluating the specifications provided by the manufacturer of the gloves, and</P> <P>(B) Packages containing the substance (including those storing the substance between manufacturing or importing and processing stages) are labeled to indicate that the substance should be handled only while using gloves determined to be impervious to the substance.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> In addition to the requirements of § 721.17, manufacturers, importers, and processors of the chemical substance identified in paragraph (a)(1) of this section must maintain the following records for 5 years from their creation: </P> <P>(i) The results of any determination that gloves are impervious.</P> <P>(ii) The names of persons required to wear gloves.</P> <P>(iii) Copies of labels described in paragraph (a)(2)(ii)(B) of this section.</P> <P>(2) [Reserved]</P> <CITA>[50 FR 34465, Aug. 26, 1985. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2385</SECTNO> <SUBJECT>Fluoroalkyl diester (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as fluoroalkyl diester (PMNs P-98-1046 and P-98-1047) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 368, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2410</SECTNO> <SUBJECT>Alkoxylated alkyldiethylenetriamine, alkyl sulfate salts.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkoxylated dialkyldiethylenetriamine, alkyl sulfate salts (PMN P-94-325, 326, and 327) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(o). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11042, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2420</SECTNO> <SUBJECT>Alkoxylated dialkyldiethylenetriamine, alkyl sulfate salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an alkoxylated dialkyldiethylenetriamine, alkyl sulfate salt (PMN P-91-288) is subject to <PRTPAGE P="403"/> reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46465, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2465</SECTNO> <SUBJECT>Xanthylium, 9-(2-(ethoxycarbonyl)phenyl)-3,6-bis(ethylamino)-2,7-dimethyl-, ethyl sulfate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as xanthylium, 9-(2-(ethoxycarbonyl)phenyl)-3,6-bis(ethylamino)-2,7-dimethyl-, ethyl sulfate (PMN P-00-1195; CAS No. 26694-69-9) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f) and (j) (a basic dye for complex basic dye pigment manufacture). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15082, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2475</SECTNO> <SUBJECT>Dimetridazole.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as dimetridazole (P-90-1308) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5) (iii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iii), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v) and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f) and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44064, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2480</SECTNO> <SUBJECT>Isoalkyldimethylamine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as isoalkyldimethylamine (PMN P-96-1320) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 3). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="404"/> this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44577, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2485</SECTNO> <SUBJECT>1,3-Dioxolane, 2-ethenyl-.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1,3-Dioxolane, 2-ethenyl- (PMN P-96-1006; CAS No. 3984-22-3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(3)(i), (a)(4), (a)(5)(iii), (a)(5)(xii), (a)(5)(xiii), (a)(5)(xiv), (a)(6)(v), (b) (concentration set at 1.0 percent), and (c). The imperviousness of each item pursuant to (a)(2)(i) and (a)(2)(ii) must be demonstrated by actual testing under (a)(3)(i) and not by manufacturer specifications. Permeation testing shall be conducted according to the ASTM F739 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases.” Results shall be recorded as a cumulative permeation rate as a function of time, and shall be documented in accordance with ASTM F739 using the format specified in ASTM F1194-89 “Guide for Documenting the Results of Chemical Permeation Testing on Protective Clothing Materials.” Gloves may not be used for a time period longer than they are actually tested and must be replaced at the end of each work shift. The manufacturer, importer, or processor must submit all test data to the Agency and must receive written Agency approval for each type of glove tested prior to use of such gloves. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(2)(ii), (g)(2)(iii), and (g)(5). The following statements shall appear on each label as specified in § 721.72(b) and the SDS as specified in § 721.72(c): This substance may cause fatality. When using this substance avoid dermal contact. When using this substance use respiratory protection or engineering and process controls to mitigate respiratory exposure. When using this substance use dermal protection to prevent dermal exposure. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), and (h) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44577, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2520</SECTNO> <SUBJECT>Alkylated diphenyls.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkylated diphenyls (PMN Nos. P-90-237, P-90-248, and P-90-249) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 1 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[58 FR 32237, June 8, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="405"/> <SECTNO>§ 721.2527</SECTNO> <SUBJECT>Acetamide, N-[2-[2-(2-bromo-6-cyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as acetamide, N-[2-[2-(2-bromo-6-cyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]- (PMN P-95-514; CAS No. 2537-62-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63736, Dec. 2, 1996, as amended at 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2532</SECTNO> <SUBJECT>Substituted diphenylmethane (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted diphenylmethane (PMN P-97-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44577, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2535</SECTNO> <SUBJECT>Benzene, 1,1′-methylanebis[4-isocyanato-, homopolymer, Bu alc.-blocked.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, 1,1′-methylanebis[4-isocyanato-, homopolymer, Bu alc.-blocked (PMN P-95-1386; CAS No. 186321-98-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(y)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3425, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2540</SECTNO> <SUBJECT>Diphenylmethane diisocyanate (MDI) modified.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a diphenylmethane diiso­cy­a­nate (MDI) modified (PMN P-92-294) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), (x)(2), (y)(1), and (y)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), <PRTPAGE P="406"/> (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46465, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2560</SECTNO> <SUBJECT>Alkylated diphenyl oxide (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance alkylated diphenyl oxide (PMN P-84-1079) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3), (b) [concentration set at 1.0 percent], and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (d), (e) [concentration set at 1.0 percent], (f), and (g)(1)(vi) and (g)(1)(ix), (g)(2)(i) and (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when a SDS was not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). The term intermediate as used in § 721.80(g) is defined as an intermediate for making sulfonated surfactants. </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 26109, June 26, 1990, as amended at 57 FR 54305, Nov. 18, 1992. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2565</SECTNO> <SUBJECT>Alkylated sulfonated diphenyl oxide, alkali and amine salts.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified as alkylated sulfonated diphenyl oxide, alkali salt (PMN P-93-352) and alkylated sulfonated diphenyl oxide, amine salt (PMN P-93-353) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 20 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51683, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2570</SECTNO> <SUBJECT>Alkylated diphenyls (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as alkylated diphenyls (PMNs P-97-869/870/871) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. <PRTPAGE P="407"/> </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44577, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2575</SECTNO> <SUBJECT>Disubstituted diphenylsulfone.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as disubstituted diphenylsulfone (PMN P-92-1119) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). The following additional statements shall appear on each label and SDS as required by this paragraph: This substance may cause blood effects. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (o), and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (b)(1) and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51683, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2577</SECTNO> <SUBJECT>Certain copper complexes of (substituted sulfonaphthyl azo substituted phenyl) disulfonaphthyl azo, amine salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as cuprate(3-), [3-[2-[5-(hydroxy-.kappa.O)-4-[2-[1-(hydroxy-.kappa.O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-.kappa.N1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, hydrogen, compd. with 2,2′-iminobis[ethanol] (1:3:3) (PMN P-00-0364; CAS No. 1078726-27-8) and cuprate(3-), [3-[2-[5-(hydroxy-.kappa.O)-4-[2-[1-(hydroxy-.kappa.O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-.kappa.N1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, ammonium (1:3) (PMN P-00-0365; CAS No. 1078726-28-9) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), (x)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15082, Mar. 28, 2003, as amended at 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2580</SECTNO> <SUBJECT>C.I. Disperse Red 152 (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as C.I. disperse red 152 (PMN P-97-820) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="408"/> </P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), and (x)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44577, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2582</SECTNO> <SUBJECT>Reaction product of alkylene diamine, MDl, substituted carbomonocyclic amine and alkylamine (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as reaction product of alkylene diamine, MDl, substituted carbomonocyclic amine and alkylamine (PMN P-98-1262) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15083, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2584</SECTNO> <SUBJECT>Dodecanoic acid, 12-amino-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as dodecanoic acid, 12-amino- (PMN P-98-0823; CAS No. 693-57-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (g). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the NCEL provision listed in the 5(e) consent order for this substance. The NCEL is 1.0 mg/m <SU>3</SU> as an 8-hour time-weighted average verified by actual monitoring data. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e), (f), (g)(1)(ii), (g)(1)(vii), (g)(2)(ii), and (g)(2)(iv). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g), (r) (6,000,000 kg.), and a carcinogenicity study (OPPTS 870.4200). A person may not manufacture or import the substance beyond the aggregate production volume limit, unless that person conducts this study on the substance and submits all final reports and underlying data in accordance with the procedures and criteria specified in paragraphs (a)(2)(iii)(A), (a)(2)(iii)(B), (a)(2)(iii)(C), and (a)(2)(iii)(D) of this section. </P> <P> (A) Each study required to be performed pursuant to this section must be scientifically valid. <E T="03">Scientifically valid</E> means that the study was conducted according to: </P> <P> ( <E T="03">1</E> ) The test guidelines specified in paragraph (a)(2)(iii) of this section. </P> <P> ( <E T="03">2</E> ) An EPA-approved protocol. </P> <P> ( <E T="03">3</E> ) TSCA Good Laboratory Practice Standards at 40 CFR part 792. </P> <P> ( <E T="03">4</E> ) Using methodologies generally accepted at the time the study is initiated. </P> <P> ( <E T="03">5</E> ) Any deviation from these requirements must be approved in writing by EPA. </P> <P> (B) Before starting to conduct any of the studies in paragraph (a)(2)(iii) of this section, the person must obtain approval of test protocols from EPA by submitting written protocols. EPA will respond to the person within 4 weeks of receiving the written protocols. Published test guidelines specified in paragraph (a)(2)(iii) of this section (e.g., 40 <PRTPAGE P="409"/> CFR part 797 or part 798) provide general guidance for development of test protocols, but are not themselves acceptable protocols. </P> <P>(C) The person shall:</P> <P> ( <E T="03">1</E> ) Conduct each study in good faith with due care. </P> <P> ( <E T="03">2</E> ) Promptly furnish to EPA the results of any interim phase of each study. </P> <P> ( <E T="03">3</E> ) Submit, in triplicate (with an additional sanitized copy, if confidential business information is involved), the final report of each study and all underlying data (“the report and data”) to EPA no later than 14 weeks prior to exceeding the applicable production volume limit. The final report shall contain the contents specified in 40 CFR 792.185. </P> <P> (D)( <E T="03">1</E> ) Except as described in paragraph (a)(2)(iii)(D)( <E T="03">2</E> ) of this section, if, within 6 weeks of EPA's receipt of a test report and data, the person receives written notice that EPA finds that the data generated by a study are scientifically invalid, the person is prohibited from further manufacture and import of the PMN substance beyond the applicable production volume limit. </P> <P> ( <E T="03">2</E> ) The person may continue to manufacture and import the PMN substance beyond the applicable production limit only if so notified, in writing, by EPA in response to the person's compliance with either of the following paragraphs (a)(2)(iii)(D)( <E T="03">2</E> )( <E T="03">i</E> ) or (a)(2)(iii)(D)( <E T="03">2</E> )( <E T="03">ii</E> ) of this section. </P> <P> ( <E T="03">i</E> ) The person may reconduct the study. If there is sufficient time to reconduct the study and submit the report and data to EPA at least 14 weeks before exceeding the production limit as required by paragraph (a)(2)(iii)(C)( <E T="03">3</E> ) of this section, the person shall comply with paragraph (a)(2)(iii)(C)( <E T="03">3</E> ) of this section. If there is insufficient time for the person to comply with paragraph (a)(2)(iii)(C)( <E T="03">3</E> ) of this section, the person may exceed the production limit and shall submit the report and data in triplicate to EPA within a reasonable period of time, all as specified by EPA in the notice described in paragraph (a)(2)(iii)(D)( <E T="03">1</E> ) of this section. EPA will respond to the person in writing, within 6 weeks of receiving the person's report and data. </P> <P> ( <E T="03">ii</E> ) The person may, within 4 weeks of receiving from EPA the notice described in paragraph (a)(2)(iii)(D)( <E T="03">1</E> ) of this section, submit to EPA a written report refuting EPA's finding. EPA will respond to the person in writing, within 4 weeks of receiving the person's report. </P> <P>(E) The person is not required to conduct a study specified in paragraph (a)(2)(iii) of this section if notified in writing by EPA that it is unnecessary to conduct that study.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15083, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2585</SECTNO> <SUBJECT>Sodium salts of dodecylphenol (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as sodium salts of dodecylphenol (PMNs P-97-1060/1061/1062) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44577, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="410"/> <SECTNO>§ 721.2600</SECTNO> <SUBJECT>Epibromohydrin.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance epibromohydrin, CAS Number 3132-64-7, [Listed in TSCA Inventory as oxirane,(bromoethyl)-] is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is any use.</P> <P> (b) <E T="03">Special requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[52 FR 41300, Oct. 27, 1987. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2625</SECTNO> <SUBJECT>Reaction product of alkane­diol and epichlorohydrin.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as reaction product of alkanediol and epichlorohydrin (PMN P-89-760) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(viii), (a)(5)(ix), (a)(6)(ii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), and (g)(1)(vi), (g)(1)(vii), (g)(2)(i) through (g)(2)(v), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l), and (q). (The production limit applies to the aggregate production volume of both P-89-750 and P-89-760. Results from testing this substance can be used to evaluate the toxicity P-89-750 as well.) </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(ii) (Oil and grease separation may be used as an alternative treatment.), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 46772, Nov. 6, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2673</SECTNO> <SUBJECT>Aromatic epoxide resin (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as aromatic epoxide resin (PMN P-99-1399) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(y)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15083, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <PRTPAGE P="411"/> <SECTNO>§ 721.2675</SECTNO> <SUBJECT>Perfluoroalkyl epoxide (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as perfluoroalkyl epoxide (PMN P-86-562) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(i) and (g)(2)(v). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when an SDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (v) <E T="03">Release to water.</E> § 721.90 (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (g), (i), (j), and (k). </P> <P> (2) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P> (3) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 26099, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2685</SECTNO> <SUBJECT>Polyisobutene epoxide (generic).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as polyisobutene epoxide (PMNs P-99-951 and P-99-952) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2725</SECTNO> <SUBJECT>Trichlorobutylene oxide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance trichlorobutylene oxide (TCBO), CAS Number 3083-25-8, [Listed in TSCA Inventory as oxirane, (2,2,2-trichloroethyl)-] is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is any use.</P> <P> (b) <E T="03">Special requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. <PRTPAGE P="412"/> </P> <P>(2) [Reserved]</P> <CITA>[52 FR 41300, Oct. 27, 1987. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2752</SECTNO> <SUBJECT>Epoxy resin containing phosphorus (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an epoxy resin containing phosphorus (PMN P-00-912) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.575(b)(1) apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2755</SECTNO> <SUBJECT>Cycloaliphatic epoxy resin (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as cycloaliphatic epoxy resin (PMN P-98-105) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(viii), (a)(5)(ix), (a)(5)(x), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the NCEL provisions listed in the TSCA section 5(e) consent order for this substance. The NCEL is 0.3 mg/m <SU>3</SU> . </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(i), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 368, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2800</SECTNO> <SUBJECT>Erionite fiber.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance, erionite fiber (CAS No. 66733-21-9 (when an exact molecular formula is known) and 12510-42-8 (when an exact molecular formula is not known)), is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by the following paragraphs: </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P> (2) <E T="03">Exemptions.</E> Section 721.45 applies to this section except for § 721.45(f). A person who intends to import or process the substance identified in paragraph (a)(1) of this section as part of an <PRTPAGE P="413"/> article is subject to the notification provisions of § 721.25. </P> <CITA>[56 FR 56472, Nov. 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2805</SECTNO> <SUBJECT>2-Propenoic acid, 2-(phenylthio)ethyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 2-propenoic acid, 2-(phenylthio)ethyl ester (PMN P-96-824; CAS No. 95175-38-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3426, Jan. 22, 1998, as amended at 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2825</SECTNO> <SUBJECT>Alkyl ester (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance alkyl ester (PMN P-84-968) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent) and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(ix), (g)(2)(i), (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees to be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). The provision of § 721.72(g) requiring placement of specific information on a label does not apply when a label is not required under § 721.72(b). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (k) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e), (f), (i) and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 32414, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2900</SECTNO> <SUBJECT>Substituted aminobenzoic acid ester (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance substituted aminobenzoic acid ester (PMN P-84-951) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii) and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the <PRTPAGE P="414"/> written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on a SDS does not apply when a SDS in not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e), (f), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 32415, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2920</SECTNO> <SUBJECT> <E T="7462">tert</E> -Amyl peroxy alkylene ester (generic name). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance <E T="03">tert</E> -amyl peroxy alkylene ester (PMN P-85-1180) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (d), (e) (concentration set at 1.0 percent), (f) and (g)(1)(vii), (g)(2)(i), (g)(2)(v), (g)(4)(i), and (g)(5). The provision of § 721.72(d) requiring that employees to be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2) and (a)(3), (b)(1), (b)(2) and (b)(3). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(vi), (b)(2)(vi) and (c)(2)(vi). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 32413, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2925</SECTNO> <SUBJECT>Brominated aromatic ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a brominated aromatic ester (PMN P-95-1128) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(1), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P>(ii) [Reserved]</P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="415"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3426, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.2950</SECTNO> <SUBJECT>Carboxylic acid glycidyl esters.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as carboxylic acid glycidyl ester (PMN P-92-776) is subject to reporting under this section for the significant new uses described in this paragraph. </P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(vi), (g)(1)(vii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (D) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (C) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P>(2) The chemical substance identified as carboxylic acid glycidyl ester (PMN P-92-777) is subject to reporting under this section for the significant new uses described in this paragraph.</P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(iii), (a)(3), (a)(4), (a)(5)(i) (§ 721.63(a)(5)(i) applies only during processing operations), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(vi), (g)(1)(vii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (D) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (C) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P>(b) [Reserved]</P> <CITA>[59 FR 27483, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3000</SECTNO> <SUBJECT>Dicarboxylic acid monoester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The following chemical substance referred to <PRTPAGE P="416"/> by its premanufacture notice number and its generic chemical name is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section: dicarboxylic acid monoester, P-83-255. </P> <P>(2) The significant new uses are:</P> <P>(i) Any manufacture in the United States for commercial purposes.</P> <P>(ii) Failure to require the use of gloves determined to be impervious to the substance, and/or failure to require the use of clothing to prevent dermal contact for any person involved in any processing or use operation where dermal contact may occur. (Gloves may be determined to be impervious to the substance either by testing the gloves under the conditions of use or by relying on the manufacturer's specifications.)</P> <P>(iii) Distribution in commerce by any person, including importers, processors, and distributors, without affixing to each container of any formulation containing the substance a label that includes, in letters no smaller than 10 point type, the following statements:</P> <EXTRACT> <P>WARNING! HARMFUL IF INHALED OR ABSORBED THROUGH THE SKIN. MAY CAUSE REPRODUCTIVE EFFECTS.</P> <FP SOURCE="FP-1">—Do not get in eye, on skin, or clothing.</FP> <FP SOURCE="FP-1">—Do not breathe (vapor, mist, spray, dust).</FP> <FP SOURCE="FP-1">—Use with adequate ventilation.</FP> <FP SOURCE="FP-1">—Wear impervious gloves and protective equipment to prevent contact or exposure.</FP> <FP SOURCE="FP-1">—Promptly remove contaminated non-imprevious clothing, wash before reuse.</FP> <FP SOURCE="FP-1">—Discard contaminated leather shoes.</FP> <FP SOURCE="FP-1">—Wash thoroughly after handling, and before eating, drinking, or smoking.</FP> <FP SOURCE="FP-1">—Keep container closed.</FP> <P>FIRST AID: In case of contact.</P> <P>EYES: Immediately flush with water for at least 15 minutes.</P> <P>SKIN: Promptly wash thoroughly with mild soap and water.</P> <P>INHALATION: Remove to fresh air. If breathing is difficult, give oxygen.</P> <P>INGESTION: If conscious, give water and induce vomiting.</P> </EXTRACT> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> In addition to the requirements of § 721.17, importers and processors of the chemical substance identified in paragraph (a)(1) of this section must maintain the following records for five years from their creation: </P> <P>(i) The names of persons required to wear protective clothing.</P> <P>(ii) The name and address of each person to whom the substance is sold or transferred and the date of such sale or transfer.</P> <P>(2) [Reserved]</P> <CITA>[49 FR 43064, Oct. 26, 1984. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3020</SECTNO> <SUBJECT>Ethaneperoxoic acid, 1,1-dimethylpropyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as ethaneperoxoic acid, 1,1-dimethylpropyl ester (PMN P-85-680; CAS No. 690-83-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 61). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 26111, June 26, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993; 78 FR 46286, July 31, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3025</SECTNO> <SUBJECT> Fatty acids C <E T="9145">12-18</E> , C <E T="9145">18</E> unsaturated, C <E T="9145">12-18</E> alkyl esters (generic). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as fatty acids C <E T="52">12-18</E> , C <E T="52">18</E> unsaturated, C <E T="52">12-18</E> alkyl esters (PMNs P-94-697 <PRTPAGE P="417"/> through P-94-895) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (750,000 kilograms). </P> <P> (ii) <E T="03">Hazard communication program.</E> A significant new use of these substances is any manner or method of manufacture, import, or processing associated with any use of these substances without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the TSCA section 5(e) consent order for these substances, the employer becomes aware that these substances may present a risk of injury to human health or the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substances are reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive or who have received the substances from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A), are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) within 90 days from the time the employer becomes aware of the new information.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 369, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3031</SECTNO> <SUBJECT> Boric acid (H <E T="9145">3</E> BO <E T="9145">3</E> , zinc salt (2 = 3). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as boric acid (H <E T="52">3</E> BO <E T="52">3</E> ), zinc salt (2 = 3) (PMN P-97-552; CAS No. 10192-46-8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 3). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44578, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3032</SECTNO> <SUBJECT> Boric acid (H <E T="9145">3</E> BO <E T="9145">3</E> ), zinc salt. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as boric acid (H <E T="52">3</E> BO <E T="52">2</E> ), zinc salt (PMN P-97-553; CAS No. 14720-55-9) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 3). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44578, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="418"/> <SECTNO>§ 721.3034</SECTNO> <SUBJECT>Methylamine esters.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as methylamine esters (PMN P-94-982) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11042, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3062</SECTNO> <SUBJECT>1H-Indene-2-carboxylic acid, 5-chloro-2,3-dihydro-1-oxo-, methyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1H-indene-2-carboxylic acid, 5-chloro-2,3-dihydro-1-oxo-, methyl ester (PMN P-00-966; CAS No. 65738-56-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 200). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003, as amended at 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3063</SECTNO> <SUBJECT>Certain substituted phenyl azo substituted phenyl esters.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as glycine, N-[3-(acetylamino)-4-[2-(2-cyano-4-nitrophenyl)diazenyl]phenyl]-N-(2-methoxy-2-oxoethyl)-, methyl ester (PMN P-95-0655: CAS No. 149850-30-6); L-alanine, N-[5-(acetylamino)-2-chloro-4-[2-(2-cyano-4-nitrophenyl)diazenyl]phenyl]-, methyl ester (PMN P-95-0782; CAS No. 157707-95-4); and generically as substituted phenyl azo substituted phenyl esters (PMN P-95-0871) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(w)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[61 FR 63736, Dec. 2, 1996, as amended at 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3080</SECTNO> <SUBJECT>Substituted phosphate ester (generic).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted phosphate ester (PMN P-85-730) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), <PRTPAGE P="419"/> (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Release to water.</E> Section 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P>(3) Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.</P> <CITA>[55 FR 26100, June 26, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3085</SECTNO> <SUBJECT>Brominated phthalate ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as brominated phthalate ester (PMN P-90-581) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (ii) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of these substances without providing risk notification as follows. </P> <P>(A) If as a result of the test data required under the TSCA section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health or the environment the employer must incorporate this new information, and any information on methods for protecting against such risk, into a SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substances are reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive, or who have received the substance from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3426, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3100</SECTNO> <SUBJECT>Oligomeric silicic acid ester compound with a hy­droxyl­al­kyla­mine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as oligomeric silicic acid ester compound with a hydroxylalkylamine (PMN P-91-118) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(a). </P> <P> (ii) [Reserved] <PRTPAGE P="420"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46465, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3110</SECTNO> <SUBJECT>Polycarboxylic acid ester (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a polycarboxylic acid ester (PMN P-97-1108) is subject to reporting under this section for the significant new use described in paragraph (a)(1) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or evocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3130</SECTNO> <SUBJECT> Sulfuric acid, mono-C <E T="9145">9-11</E> -alkyl esters, sodium salts. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as sulfuric acid, mono-C <E T="52">9-11</E> -alkyl esters, sodium salts (PMN P-01-149; CAS No. 84501-49-5) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(s) (5,000 kilogram (kg)). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3135</SECTNO> <SUBJECT>Phosphorous modified epoxy resin (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a phosphorous modified epoxy resin (PMNs P-00-992 and P-01-471) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified § 721.90(a)(4), (b)(4), and (c)(4) (N = 6). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70176, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3140</SECTNO> <SUBJECT>Vinyl epoxy ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance vinyl epoxy ester (PMN P-85-527) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent) and (c). <PRTPAGE P="421"/> </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iii), (g)(1)(vii), (g)(2)(i) through (g)(2)(iii), (g)(2)(v), (g)(4)(i), and (g)(5). The provision of § 721.72(d) requiring that employees to be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (k) (as an injection molding coating), and (y). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(2), (b)(2), and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), (f), (g), (h), and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 39900, Sept. 28, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3152</SECTNO> <SUBJECT> Ethanaminium, <E T="7462">N</E> -ethyl-2-hydroxy- <E T="7462">N,N</E> -bis(2-hydroxyethyl)-, diester with C <E T="9145">12-18</E> fatty acids, ethyl sulfates (salts). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance ethanaminium, <E T="03">N</E> -ethyl-2-hydroxy- <E T="03">N,N</E> -bis(2-hydroxyethyl)-, diester with C <E T="52">12-18</E> fatty acids, ethyl sulfates (salts) (P-94-24) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health or the environment the employer must incorporate this new information, and any information on methods for protecting against such risk, into a safety data sheet (SDS) as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive, or who have received, this substance from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (1,900,000 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[60 FR 45081, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3155</SECTNO> <SUBJECT>3,8-Dioxa-4,7-disiladecane, 4,4,7,7-tetraethoxy-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 3,8-dioxa-4,7-disiladecane, 4,4,7,7-tetraethoxy- (PMN P-95-1326; CAS No. 16068-37-4) is subject to reporting under this section for the significant new <PRTPAGE P="422"/> uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(y)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3426, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3160</SECTNO> <SUBJECT>1-Chloro-2-bromoethane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 1-chloro-2-bromoethane (CAS No. 107-04-0) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[53 FR 2845, Feb. 2, 1988. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3220</SECTNO> <SUBJECT>Pentachloroethane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance pentachloroethane, CAS Number 76-01-7, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[51 FR 32079, Sept. 9, 1986. Redesignated at 53 FR 2845, Feb. 2, 1988 and correctly redesignated at 56 FR 29903, July 1, 1991. Further redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3248</SECTNO> <SUBJECT>Ethane, 1,2,2- trichlorodifluoro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as ethane, 1,2,2-trichlorodifluoro- (CAS No. 354-21-2, PMN No. P-92-595) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[58 FR 32237, June 8, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3260</SECTNO> <SUBJECT>Ethanediimidic acids.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as ethanediimidic acids (PMNs P-90-1472 and P-90-1473), are subject to reporting under this section for the significant <PRTPAGE P="423"/> new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e), (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(4)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1) and (b)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44065, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3310</SECTNO> <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)],α-(1-oxo-2-propenyl)-ω-[(tetrahydro-2-furanyl)methoxy]-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as poly[oxy(methyl-1,2-ethanediyl)],α-(1-oxo-2-propenyl)-ω-[(tetrahydro-2-furanyl)methoxy]- (PMN P-98-150; CAS No.149303-87-7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80. Manufacture of the PMN substance with an average number of moles of propoxy group between 5 and 14. </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 369, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3320</SECTNO> <SUBJECT> Ethanol, 2-amino-, com­pound with <E T="7462">N</E> -hydroxy- <E T="7462">N</E> -nitro­soben­zena­mine (1:1). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as ethanol, 2-amino-, compound with <E T="03">N</E> -hydroxy- <E T="03">N</E> -nitrosobenzenamine (1:1) (P-86-542), is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), and (g)(2)(v). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 720.80(k) (monomer stabilizer). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 25990, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <PRTPAGE P="424"/> <SECTNO>§ 721.3340</SECTNO> <SUBJECT>Ethanol, 2,2′-(hexylamino)bis-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as ethanol, 2,2′-(hexylamino)bis- (PMN P-91-1346) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements as specified at § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 31968, July 20, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3350</SECTNO> <SUBJECT>N-Nitrosodiethanolamine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance N-nitrosodiethanolamine (CAS No. 1116-54-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63517, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3360</SECTNO> <SUBJECT>Substituted ethanolamine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted ethanolamine (PMN P-91-490) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), (x)(2), (y)(1), and (y)(2). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 1 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125(a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46466, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3364</SECTNO> <SUBJECT>Aliphatic ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an aliphatic ether (PMN P-93-1381) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27484, May 27, 1994]</CITA> </SECTION> <SECTION> <PRTPAGE P="425"/> <SECTNO>§ 721.3374</SECTNO> <SUBJECT>Alkylenediolalkyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as an alkylenediolalkyl ether (PMN P-93-362) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51684, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3380</SECTNO> <SUBJECT>Benzenamine, 4-methoxy-2-methyl-N-phenyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzenamine, 4-methoxy-2-methyl-N-phenyl- (PMN P-83-910; CAS No. 41317-15-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(1)(i)(D) and (g)(2)(v). The provision of § 721.72(g) requiring placement of specific information in an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a), (b), (c), (d), (f), and (g). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 25989, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993; 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3420</SECTNO> <SUBJECT>Benzene, 1-bromo-4-methoxy-2-methyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as benzene, 1-bromo-4-methoxy-2-methyl- (PMN P-83-906; CAS No. 27060-75-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(1)(i)(D) and (g)(2)(v). The provision of § 721.72(g) requiring placement of specific information in an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a), (b), (c), (d), (f), and (g). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[56 FR 25990, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993; 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3430</SECTNO> <SUBJECT>4-Bromophenyl phenyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 4-bromophenyl phenyl ether (CAS No. 101-55-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P> (2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use. <PRTPAGE P="426"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63517, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3435</SECTNO> <SUBJECT>Butoxy-substituted ether alkane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as butoxy-substituted ether alkane (PMN P-92-755) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3), (b) (concentration set at 1.0 percent), and (c). In addition, the employer must be able to demonstrate that the gloves selected for handling the chemical substance provide an impervious barrier to prevent dermal exposure during normal and expected duration and conditions of exposure within the work area by testing the material used to make the gloves and the construction of the gloves to establish that they will be impervious for the expected duration and conditions of exposure. The testing must subject the gloves to the expected conditions of exposure, including the likely combinations of chemical substances to which the gloves may be exposed in the work area. There must be no permeation of the gloves by the chemical substance (or an EPA-approved analogue) greater than 0.16 µg/cm <SU>2</SU> /min after 8 h of testing in accordance with the most recent versions of the American Society for Testing and Materials (ASTM) F739 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases” and ASTM F1194 “Guide for Documenting the Results of Chemical Permeation Testing of Protective Clothing Materials.” The employer must submit all test data to the Agency and must receive written Agency approval of the test results for each type of glove tested prior to use of such gloves. Nitrile gloves with a minimum thickness of 0.5588 mm have already been tested and found to satisfy the terms of this section. Gloves contaminated with the PMN substance shall be disposed of after every work shift. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(ix), (g)(2)(i), (g)(2)(v), and (g)(5). In addition, the human health hazard statements shall include a statement that this substance may cause systemic toxicity and blood effects. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and records documenting compliance with the glove permeability testing requirements of this section are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51684, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3437</SECTNO> <SUBJECT>Dialkyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as dialkyl ether (PMN P-93-1308) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 180 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. <PRTPAGE P="427"/> </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11042, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3438</SECTNO> <SUBJECT>Chlorohydroxyalkyl butyl ether (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as chlorohydroxyalkyl butyl ether (PMN P-99-1295) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 3). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70177, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3440</SECTNO> <SUBJECT>Haloalkyl substituted cyclic ethers.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances haloalkyl substituted cyclic ethers (PMN P-85-368 and P-85-369) are subject to reporting under this section for the significant new uses described in this paragraph. </P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii) and (a)(6)(v) and (a)(6)(vi), (b) [concentration set at 1.0 percent], and (c). </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (d), (e) [concentration set at 1.0 percent], (f), and (g)(1)(iii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv) and (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when a SDS was not required under § 721.72(c). The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c), respectively. </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (D) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1) and (a)(2), (b)(1) and (b)(2), and (c)(1) and (c)(2). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of the substances, as specified in § 721.125 (a) through (k). </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (C) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P>(2) The chemical substance haloalkyl substituted cyclic ether (PMN P-85-367) is subject to reporting under this section for the significant new uses described in this paragraph.</P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), and (a)(6)(v) and (a)(6)(vi), (b) [concentration set at 0.1 percent], and (c). </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (d), (e) [concentration set at 0.1 percent], (f), and (g)(1)(iii), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv) and (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when a SDS was not required under § 721.72(c). The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not <PRTPAGE P="428"/> apply when a label and SDS are not required under § 721.72 (b) and (c), respectively. </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (D) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1) and (b)(2), and (c)(1) and (c)(2). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (C) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <P>(b) [Reserved]</P> <CITA>[55 FR 26109, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3465</SECTNO> <SUBJECT>Stilbene diglycidyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as stilbene diglycidyl ether (PMN P-96-1427) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(3), (a)(4), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory protection requirements of this section, manufacturers, importers, and processors of this substance may follow the terms of the new chemical exposure limits section in the TSCA section 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(ii), (g)(1)(vi), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). The label and SDS as required by this paragraph shall also include the following statement: When using this substance use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.5 milligram (mg)/meter (m <SU>3</SU> ). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3426, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3480</SECTNO> <SUBJECT>Halogenated biphenyl glycidyl ethers.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as halogenated biphenyl glycidyl ethers (PMNs P-90-1844, P-90-1845, and P-90-1846) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), (b) (concentration set at 0.1 percent) and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(iv), (g)(1)(vi), (g)(i)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii) and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) <PRTPAGE P="429"/> through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44065, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3485</SECTNO> <SUBJECT>Hydrofluorocarbon alkyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydrofluorocarbon alkyl ether (PMN P-95-1578) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. Non-spray uses are exempt from the provisions of this rule. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iii), and (a)(6)(v). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3427, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3486</SECTNO> <SUBJECT>Polyglycerin mono(4-nonylphenyl) ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a polyglycerin mono(4-nonylphenyl) ether (PMN P-94-2230) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45082, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3488</SECTNO> <SUBJECT> Poly(oxy-1,2-ethanediyl), alpha substituted-omega-hydroxy-, C <E T="9145">16-20</E> alkyl ethers. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as poly(oxy-1,2-ethanediyl), alpha substituted-omega-hydroxy-, C <E T="52">16-20</E> alkyl ethers (PMN P-87-323) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 20). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3427, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3500</SECTNO> <SUBJECT>Perhalo alkoxy ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as perhalo alkoxy ether (PMN P-83-1227) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), <PRTPAGE P="430"/> (a)(6)(v), (a)(6)(vi), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communicatiom program.</E> Requirements as specified in § 721.72 (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(ii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a), and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b), and (c), respectively. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), and (f). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 46772, Nov. 6, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3520</SECTNO> <SUBJECT>Aliphatic polyglycidyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance aliphatic polyglycidyl ether (PMN P-89-1036) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5) (vii), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c) through (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 39900, Sept. 28, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3550</SECTNO> <SUBJECT>Dipropylene glycol dimethyl ether.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified as dipropylene glycol dimethyl ether (PMN P-93-507; CAS No. 111109-77-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. This class 2 substance is exempt from the notification requirements of this rule if it contains less than 5 percent by weight of the specific isomer, propane, 2,2′-oxybis[1-methoxy- (CAS No. 189354-80-1), which is one of the possible products of the manufacturing process for PMN P-93-507. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), and (a)(3). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(o). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements specified in § 721.125 (a), (b), (c), (d), and (e) are applicable to manufacturers, <PRTPAGE P="431"/> importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[62 FR 59583, Nov. 4, 1997; 62 FR 63035, Nov. 26, 1997]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3560</SECTNO> <SUBJECT>Derivative of tetra­chloro­ethy­lene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The following chemical substance referred to by its premanufacture notice number and generic chemical name is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section: Derivative of tetrachloroethylene, P-82-684. </P> <P>(2) The significant new uses are: (i) Manufacture or processing without requiring use of the following by persons employed by or under the control of the manufacturer or processor who are involved in, and in the immediate area of, any operation where dermal contact and/or inhalation of the substance may occur:</P> <P>(A) A respirator, approved by the National Institute for Occupational Safety (NIOSH) to provide protection against dusts having an air contamination level not less than 0.05 mg per cubic meter of air and fitted according to procedures established by the Occupational Safety and Health Administration and Mine Safety and Health Administration regulations and set forth at 29 CFR 1910.134, and 30 CFR part 11, respectively, and</P> <P>(B) Gloves which are determined to be impervious to the substance under the conditions of potential exposure (gloves must be determined to be impervious to the substance either by testing the gloves under the conditions of exposure, including the duration of exposure, or by evaluating the data and specifications supplied by the glove manufacturer or others, in the context of the conditions of exposure including the duration of exposure, associated chemical substances, chemical and mechanical stresses, and potential durations of exposures.</P> <P>(ii) Manufacture or processing without requiring that any container of the substance or of a formulation containing the substance be:</P> <P>(A) Packaged to prevent any leakage of the substance to the environment.</P> <P>(B) Labeled on the package that the substance should be handled only while using NIOSH approved respirators and impervious gloves.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> In addition to the requirements of § 721.17, manufacturers and processors of the substance identified in paragraph (a)(1) of this section must maintain the following records for five years from the date of their creation: </P> <P>(i) The names of persons required to wear protective equipment in accordance with paragraph (a)(2) of this section.</P> <P>(ii) The names and addresses of any person to whom the substance is sold or transferred and the dates of such sale or transfer.</P> <P>(iii) Records of respirator fit tests for each person required to wear a respirator in accordance with paragraph (a)(2) of this section.</P> <P>(iv) The method for determining that the gloves described in paragraph (a)(2) of this section are impervious to the substance, the date(s) of such determination, and the results of that determination.</P> <P>(2) [Reserved]</P> <SECAUTH>(Secs. 5, 8, Pub. L. 94-469, 90 Stat. 2012 (15 U.S.C. 2604, 2607))</SECAUTH> <CITA>[49 FR 42932, Oct. 25, 1984. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29947, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3565</SECTNO> <SUBJECT>Ethylenediamine, substituted, sodium salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as ethylenediamine, substituted, sodium salt (PMN P-97-328) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="432"/> this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3427, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3620</SECTNO> <SUBJECT>Fatty acid amine condensate, polycarboxylic acid salts.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a fatty acid amine condensate, polycarboxylic acid salts. (PMN P-92-445) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46466, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3625</SECTNO> <SUBJECT>Fatty acid amine salt (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as fatty acid amine salt (PMN P-88-1889) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (f), and (g)(3)(ii). The provisions of § 721.72(g) would require the following warning language on the label: Minimize releases to the environment. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (k) and (q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 33305, Aug. 15, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3627</SECTNO> <SUBJECT>Branched synthetic fatty acid.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a branched synthetic fatty acid (PMN P-94-422) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (g), and (l). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11043, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <PRTPAGE P="433"/> <SECTNO>§ 721.3629</SECTNO> <SUBJECT>Triethanolamine salts of fatty acids.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as triethanolamine salts of fatty acids (PMN Nos. P-92-156, P-92-157, and P-92-159) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of these substances is any manner or method of manufacture, import, or processing associated with any use of these substances without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the section 5(e) consent order for these substances, the employer becomes aware that these substances may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If these substances are not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substances are reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive, or who have received these substances from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 32238, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3635</SECTNO> <SUBJECT> Octadecanoic acid, ester with 1,2-propanediol, phosphate, anhydride with silicic acid (H <E T="9145">4</E> SiO <E T="9145">4</E> ). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as octadecanoic acid, ester with 1,2-propanediol, phosphate, anhydride with silicic acid (H <E T="52">4</E> SiO <E T="52">4</E> ) (PMN P-96-1520; CAS No. 177771-31-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(i), and (g)(5). The following statement shall appear on each label as specified in § 721.72(b) and the SDS as specified in § 721.72(c): Do not release into the environment in quantities that allow surface water concentrations to exceed 6 ppb. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (15 months). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 6). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44578, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="434"/> <SECTNO>§ 721.3680</SECTNO> <SUBJECT>Ethylene oxide adduct of fatty acid ester with pentaerythritol.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as ethylene oxide adduct of fatty acid ester with pentaerythritol (PMN P-91-442) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46466, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3700</SECTNO> <SUBJECT>Fatty acid, ester with styrenated phenol, ethylene oxide adduct.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as fatty acid, ester with styrenated phenol, ethylene oxide adduct (P-90-364) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 400 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44065, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3710</SECTNO> <SUBJECT>Polyether modified fatty acids (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a Polyether modified fatty acids (PMN P-99-0435) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81399, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3720</SECTNO> <SUBJECT>Fatty amide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a fatty amide (PMN P-91-87) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. <PRTPAGE P="435"/> </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46466, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3740</SECTNO> <SUBJECT>Bisalkylated fatty alkyl amine oxide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as bisalkylated fatty alkyl amine oxide (PMN P-90-643) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (concentration set at 80 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 19238, Apr. 25, 1991. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3760</SECTNO> <SUBJECT>Fluorene-containing diaromatic amines.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as fluorene-containing diaromatic amines (PMN P-88-998 and P-88-999) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where n = 1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45082, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3764</SECTNO> <SUBJECT>Fluorene substituted aromatic amine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a fluorene substituted aromatic amine (PMN P-91-43) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(iii), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). However, these requirements do not apply after the PMN substance is adhered onto film or incorporated into prepreg form (resin impregnated substrate). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5) during manufacture. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to <PRTPAGE P="436"/> manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[62 FR 42692, Aug. 8, 1997]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3780</SECTNO> <SUBJECT>Substituted and disubstituted tetrafluoro alkenes (generic).</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted and disubstituted tetrafluoro alkene (PMN P-84-105) is subject to reporting under this section for the significant new uses described in paragraph (a)(1)(i) of this section. </P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 1%), and (c). </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (d), (e) (concentration set at 1%), (f), (g)(1)(i), (g)(1)(iv), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). In addition, the precautionary statements described under § 721.72(g) shall include: This substance may cause eye irritation. </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (g) and (i). </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P>(2) The chemical substance identified generically as disubstituted tetrafluoro alkene (PMN P-84-106) is subject to reporting under this section for the significant new uses described in paragraph (a)(2)(i) of this section.</P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 1%), and (c). </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (d), (e) (concentration set at 1%), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(v), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). In addition, the precautionary statements described under § 721.72(g) shall include: This substance may cause eye irritation. </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (g) and (i). </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P>(3) The chemical substance identified generically as disubstituted tetrafluoro alkene (PMN P-84-107) is subject to reporting under this section for the significant new uses described in paragraph (a)(3)(i) of this section.</P> <P>(i) The significant new uses are:</P> <P> (A) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 1%), and (c). </P> <P> (B) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (d), (e) (concentration set at 1%), (f), (g)(1)(iv), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). In addition, the precautionary statements described under § 721.72(g) shall include: This substance may cause eye irritation. </P> <P> (C) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (ii) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (A) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (g) and (i). </P> <P> (B) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[67 FR 17649, Apr. 11, 2002]</CITA> </SECTION> <SECTION> <PRTPAGE P="437"/> <SECTNO>§ 721.3790</SECTNO> <SUBJECT>Polyfluorocarboxylates.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as polyfluorocarboxylates (PMNs P-94-322 and P-94-323) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11043, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3800</SECTNO> <SUBJECT>Formaldehyde, condensated polyoxyethylene fatty acid, ester with styrenated phenol, ethylene oxide adduct.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as formaldehyde, condensated polyoxyethylene fatty acid, ester with styrenated phenol, ethylene oxide adduct (PMN P-90-360) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4) and (c)(4) (where N = 400 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44066, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3805</SECTNO> <SUBJECT>Formaldehyde, reaction products with 1,3-benzenedimethanamine and bisphenol A.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as formaldehyde, reaction products with 1,3-benzenedimethanamine and bisphenol A (PMN P-00-0738; CAS No. 259871-68-6) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3807</SECTNO> <SUBJECT>Formaldehyde, polymer with phenol and 1,2,3-propanetriol, methylated.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as formaldehyde, polymer with phenol and 1,2,3-propanetriol, methylated (PMN P-99-0044; CAS No. 209810-57-1) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 3 ppb). </P> <P> (ii) [Reserved] <PRTPAGE P="438"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3810</SECTNO> <SUBJECT>Formaldehyde, polymers with substituted phenols (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as Formaldehyde, polymers with substituted phenols (PMN P-99-0558) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81400, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3812</SECTNO> <SUBJECT>Substituted phenols and formaldehyde polymer, alkylated (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted phenols and formaldehyde polymer, alkylated (PMN P-00-0542) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j) (a resin for can and tube coatings). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3815</SECTNO> <SUBJECT>Furan, 2-(ethoxymethyl)- tetrahydro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance furan, 2-(ethoxymethyl) tetrahydro- (P-93-721) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P>(A) If, as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health or the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into a Safety Data Sheet (SDS) as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace.</P> <P> (B) The employer must ensure that persons who will receive, or who have received this substance from the employer within 5 years from the date the <PRTPAGE P="439"/> employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[60 FR 11043, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3818</SECTNO> <SUBJECT>Furan, octafluorotetrahydro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as furan, octafluorotetrahydro- (PMN P-99-0965; CAS No. 773-14-8) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j) (a heat transfer agent). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3820</SECTNO> <SUBJECT>L-Glutamic acid, N-(1-oxododecyl)-, disodium salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as L-Glutamic acid, N-(1-oxododecyl)-, disodium salt (PMN P-99-0207; CAS No. 50622-20-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81400, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3821</SECTNO> <SUBJECT>L-Glutamic acid, N-(1-oxododecyl)-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as L-Glutamic acid, N-(1-oxododecyl)- (PMN P-99-0208; CAS No. 3397-65-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. <PRTPAGE P="440"/> </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81400, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3830</SECTNO> <SUBJECT>Phenol, 2-[[[3-(dimethylamino) propyl]amino]methyl]-6-methyl-, 4-polybutene derivs.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as phenol, 2-[[[3-(dimethylamino)propyl] amino]methyl]-6- methyl-, 4-polybutene derivs. (PMN P-99-0531; CAS No. 1078715-83-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81400, Dec. 26, 2000, as amended at 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3835</SECTNO> <SUBJECT>Chloroformate (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a chloroformate (PMN P-01-1) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Releases to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70177, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3840</SECTNO> <SUBJECT>Tetraglycidalamines (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as tetraglycidalamines (PMN P-86-500 and P-86-502) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (a)(5) (vi), (a)(6)(i), (a)(5)(xi) and (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). The respirator required under § 721.63 (a)(5)(vi) is applicable only when the PMN substance is in the form of a dust. The respirator required under § 721.63 (a)(5)(xi) is applicable only when the PMN substance is in the form of a mist. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (o). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2) and (c)(1), (c)(2). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(vi), (b)(2)(vi) and (c)(2)(vi). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable <PRTPAGE P="441"/> to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 26101, June 26, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3845</SECTNO> <SUBJECT>Alkyl substituted aromatic glycidyl ether (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkyl substituted aromatic glycidyl ether (PMN P-97-661) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(v), (g) (4) (iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c),(d),(e), (f), (g), (h),(i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 369, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3848</SECTNO> <SUBJECT> Glycine, <E T="7462">N</E> -(carboxymethyl)- <E T="7462">N</E> -dodecyl-, monosodium salt. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as glycine, <E T="03">N</E> -(carboxymethyl)- <E T="03">N</E> -dodecyl-, monosodium salt (PMN P-00-469; CAS No. 141321-68-8) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), (c)(4) (N = 30 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3860</SECTNO> <SUBJECT>Glycol monobenzoate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as generically as glycol monobenzoate (P-90-1357) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P> (A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. <PRTPAGE P="442"/> </P> <P>(B) The employer must ensure that persons who have received, or will receive, this substance from the employer are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 40211, Aug. 13, 1991, as amended at 56 FR 46729, Sept. 16, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3880</SECTNO> <SUBJECT>Polyalkylene glycol substituted acetate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as polyalkylene glycol substituted acetate (PMN P-91-1269) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive this substance from the employer, or who have received this substance from the employer within 5 years from the date the employer becomes aware of this new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44066, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.3900</SECTNO> <SUBJECT>Alkyl polyethylene glycol phosphate, potassium salt.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkyl polyethylene glycol phosphate, potassium salt (P-90-481), is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, <PRTPAGE P="443"/> import, or processing associated with any use of this substance without providing risk notification as follows. </P> <P>(A) If, as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into a Safety Data Sheet (SDS) as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who have received, or will receive, this substance from the employer are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (c), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 15792, Apr. 17, 1991; 56 FR 29903, July 1, 1991. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4000</SECTNO> <SUBJECT>Polyoxy alkylene glycol amine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as polyoxy alkylene glycol amine (PMN P-91-1372) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified at § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements as specified at § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 31968, July 20, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4040</SECTNO> <SUBJECT> Glycols, polyethylene-, 3-sulfo-2-hydroxypropyl- <E T="7462">p</E> -(1,1,3,3-tetra­methylbutyl)phenyl ether, sodium salt. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as glycols, polyethylene-, 3-sulfo-2-hydroxypropyl- <E T="03">p</E> -(1,1,3,3-tetramethyl butyl)phenyl ether, sodium salt (P-90-1565) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P> (A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health or the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described at § 721.72(c) <PRTPAGE P="444"/> within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. </P> <P>(B) The employer must ensure that persons who have received, or will receive, this substance from the employer are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (volume set at 1,115,000 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 40212, Aug. 13, 1991, as amended at 56 FR 46729, Sept. 16, 1991. Redesignated at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4060</SECTNO> <SUBJECT>Alkylene glycol tereph­tha­late and substituted benzoate esters (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkylene glycol terephthalate and substituted benzoate esters (PMN P-89-596) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q) </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c) and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 26101, June 26, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4080</SECTNO> <SUBJECT>MNNG (N-methyl-N′-nitro-N-nitrosoguanidine).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance MNNG (N-methyl-N′-nitro-N-nitrosoguanidine) (CAS No. 70-25-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63517, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4085</SECTNO> <SUBJECT>Guanidine, pentaethyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as guanidine, pentaethyl- (PMN P-94-1018; CAS No. 13439-89-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), and (a)(3). </P> <P> (ii) [Reserved] <PRTPAGE P="445"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), and (e) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3427, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4090</SECTNO> <SUBJECT> Ethanaminium, <E T="7462">N</E> -[bis(diethylamino)-methylene]- <E T="7462">N</E> -ethyl-, bromide. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as ethanaminium, <E T="03">N</E> -[bis(diethylamino)-methylene]- <E T="03">N</E> -ethyl-, bromide (PMN P-94-1019; CAS No. 89610-32-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3427, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4095</SECTNO> <SUBJECT>Quaternary ammonium alkyltherpropyl trialkylamine halides.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as quaternary ammonium alkyltherpropyl trialkylamine halides (PMNs P-96-1280/81/1504/1505/1506/1507/1508) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4096</SECTNO> <SUBJECT>Substituted anilino halobenzamide (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted anilino halobenzamide (PMN P-99-1288) is subject to reporting under this section for the significant new use described in paragraph (a)(1) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70177, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4097</SECTNO> <SUBJECT>7-Oxabicyclo[4.1.0]heptane-3-carboxylic acid, methyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 7-oxabicyclo[4.1.0]heptane-3-carboxylic acid, methyl ester (PMN P-98-101) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="446"/> </P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The recordkeeping requirements specified in § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44578, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4098</SECTNO> <SUBJECT>Substituted heteroaromatic-2[[4-(dimethylamino) phenyl]azo]-3-methyl-, salts (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as substituted heteroaromatic-2[[4-(dimethylamino)phenyl]azo]-3-methyl-, salts (PMNs P-97-582 and P-97-583) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 44578, Aug. 20, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4100</SECTNO> <SUBJECT>Tris(disubstituted alkyl) het­er­o­cy­cle.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as tris(disubstituted alkyl) heterocycle (P-90-142) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iv), (a)(6)(i), (b) (concentration set at 0.1 percent) and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vi), (g)(1)(vii), (g)(2)(iv), (g)(5). The hazard communication requirements do not apply when the chemical substance is present in a plastic, an elastomer, a rubber matrix, or in a solution. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). Any amount of the PMN substance imported in a plastic, an elastomer, a rubber matrix, or in a solution, such that inhalation is precluded, shall not be included in the production limit calculations. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 40212, Aug. 13, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4105</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-butyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as Bicyclo[2.2.1]hept-2-ene, 5-butyl- (PMN P-98-315; CAS No. 22094-81-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). <PRTPAGE P="447"/> </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 369, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4106</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-hexyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as Bicyclo[2.2.1]hept-2-ene, 5-hexyl- (PMN P-98-316; CAS No. 22094-83-3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 370, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4107</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-octyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as Bicyclo[2.2.1]hept-2-ene, 5-octyl- (PMN P-98-317; CAS No. 22094-84-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 370, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4108</SECTNO> <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-decyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified Bicyclo[2.2.1]hept-2-ene, 5-decyl- (PMN P-98-318; CAS No. 22094-85-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 370, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4110</SECTNO> <SUBJECT>Allyloxysubstituted heterocycle.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an allyloxysubstituted heterocycle (PMN P-93-1471) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 70 ppb). <PRTPAGE P="448"/> </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11043, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4128</SECTNO> <SUBJECT>Dimethyl-3-substituted heteromonocycle.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as dimethyl-3-substituted heteromonocycle (PMN No. P-91-1322) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3), (a)(6)(ii), (a)(6)(iii), (a)(6)(v), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(2)(i), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (d) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 32238, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4133</SECTNO> <SUBJECT>Dimethyl-3-substituted heteromonocyclic amine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as dimethyl-3-substituted heteromonocycle (PMN No. P-91-1323) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(2)(iv), (a)(3), (a)(6)(ii), (a)(6)(iii), (a)(6)(v), (b) (concentration set at 1.0 percent). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(2)(i), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (d) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 32238, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4136</SECTNO> <SUBJECT>Alkyl heteropolycyclic-aniline (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkyl heteropolycyclic-aniline <PRTPAGE P="449"/> (PMN P-00-0067) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 1 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4140</SECTNO> <SUBJECT>Hexachloronorbornadiene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance 1,2,3,4,7,7-hexachloronorbornadiene, CAS Number 3389-71-7, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Use other than as an intermediate in the production of isodrin or endrin.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Definitions.</E> In addition to the definitions in § 721.3, the following definitions apply: </P> <P> (i) “Endrin” means the pesticide 2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1a alpha, 2 <E T="03">beta</E> ,2 <E T="03">abeta</E> ,3 <E T="03">alpha</E> ,6 <E T="03">alpha</E> ,6 <E T="03">abeta,</E> 7 <E T="03">beta</E> ,7 <E T="03">aalpha</E> )-, CAS Number 72-20-8. </P> <P> (ii) “Isodrin” means the pesticide 1,4:5,8-Dimethano-naphthalene,1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1 <E T="03">alpha,</E> 4 <E T="03">alpha,</E> 4 <E T="03">abeta,</E> 5 <E T="03">beta,</E> 8 <E T="03">beta,</E> 8 <E T="03">abeta</E> )-, CAS Number 465-73-6. </P> <P>(2) [Reserved]</P> <CITA>[50 FR 47538, Nov. 19, 1985. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4155</SECTNO> <SUBJECT>Hexachloropropene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance hexachloropropene (CAS No. 1888-71-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63517, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4158</SECTNO> <SUBJECT>Hexadecanoic acid, ethenyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hexadecanoic acid, ethenyl ester (PMN P-97-302; CAS No. 693-38-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i) and (a)(3). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f) and (j). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4160</SECTNO> <SUBJECT>Hexafluoropropylene oxide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The <PRTPAGE P="450"/> chemical substance hexafluoropropylene oxide (HFPO), CAS Number 428-59-1 [Listed in TSCA Inventory as oxirane, tri­fluor­o(tri­fluor­o­methyl)-] is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is any use other than as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Definitions.</E> In addition to the definitions in § 721.3, the following definitions apply to this section: </P> <P> (i) <E T="03">Enclosed process</E> means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases. </P> <P>(ii) [Reserved]</P> <P>(2) [Reserved]</P> <CITA>[52 FR 41300, Oct. 27, 1987. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4180</SECTNO> <SUBJECT>Hexamethylphosphoramide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance hex­a­methyl­phos­phomide, CAS Number 680-31-9, is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Any use.</P> <P> (b) <E T="03">Special provisions.</E> The provisions of subpart A of the part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a signficant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[51 FR 9453, Mar. 19, 1986. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4215</SECTNO> <SUBJECT>Hexanedioic acid, diethenyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hexanedioic acid, diethenyl ester (PMN P-90-1564) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply once the substance has been incorporated into a polymer matrix with the level of residual monomer below 0.1 percent. </P> <P> (2) The significant new uses are: (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (There must be no permeation of the PMN substance greater than 0.05 µg/min · cm <SU>2</SU> after 8 hours of testing in accordance with the most current version of the American Society for Testing and Materials (ASTM) F739 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases.” For conditions of exposure which are intermittent, gloves may be tested in accordance with the most current version of ASTM F1383 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases Under Conditions of Intermittent Contact,” provided the contact time in testing is greater than or equal to the expected duration of dermal contact, and the purge time used in testing is less than or equal to the expected duration of noncontact during the intermittent cycle of dermal exposure in the workplace. If ASTM F1383 is used for testing, manufacturers, importers, and processors must submit to the Agency a description of worker activities involving the PMN substance which includes daily frequencies and durations of potential worker exposures. The results of all glove permeation testing must be reported in accordance with the most current version of ASTM F1194 “Guide for Documenting the Results of Chemical Permeation Testing of Protective Clothing <PRTPAGE P="451"/> Materials.” Manufacturers, importers, and processors must submit all test data to the Agency and must receive written Agency approval for each type of glove tested prior to use of such gloves. The following gloves have been tested in accordance with the ASTM F739 method and found by EPA to satisfy the requirements for continuous use: North/B-161-R/Butyl rubber gloves (These gloves are acceptable for the solid form of the substance only.), 0.04 cm thick; and Ansell Edmont/4H/PE/EVOH/PE Laminate gloves, 0.006 cm thick. (Gloves may not be used for a time period longer than they are actually tested and must be replaced at the end of each work shift.), (a)(2)(ii) (With the exception of laboratory activities, full body chemical protective clothing is required for any worker activity in which the substance is reasonably likely to contact the worker in the following state(s): Open liquid pool or solid of greater than 5 kg; liquid spray or splash; mist; aerosol dust; or any worker activity which have potential for contact with the PMN chemical for more than 10 min/h. At a minimum, a chemical protective apron is required for any worker activity with potential for contact with the PMN chemical which is not covered by this paragraph)), (a)(2)(iii), (a)(3), (a)(4), (a)(5)(iii) (if cartridge service life testing is not available), (a)(5)(xii) or (a)(5)(xiii) (if data on cartridge service life testing has been reviewed and approved in writing by EPA), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), and (a)(6)(v). As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (h)(1)(vi) (The following additional statements shall appear on each label required by this paragraph: The health effects of this material have not been fully determined but are currently being tested. EPA is concerned however, that this material may have serious chronic health and environmental effects. When using this material, use eye and skin protection, which includes gloves which have been determined to be impervious to this substance. Use respiratory protection, unless workplace airborne concentrations are maintained at or below an 8-h time weighted average (TWA) of 1 ppm, when there is a likelihood of exposure in the work area from dust, mist, smoke or vapors.), (h)(2)(ii)(F), (h)(2)(ii)(G), (h)(2)(ii)(I), (h)(2)(iii)(A), (h)(2)(iii)(B), (h)(2)(iii)(C), (h)(2)(iii)(E), (h)(2)(iv)(A), (h)(2)(iv)(B). The following additional statements shall appear on each SDS required by this paragraph: This substance may cause moderate skin irritation. This substance may cause neurotoxicity. When using this substance, use respiratory protection, unless workplace airborne concentrations are maintained at or below an 8-h TWA of 1 ppm. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 80 ppb). When calculating the surface water concentrations according to the instructions in § 721.91(a)(4), the statement that the amount of the substance that will be released will be calculated before the substance enters control technology does not apply. Instead, if the waste stream containing the substance will be treated before release, then the amount of the substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 75 percent removal efficiency may be attributed to such treatment. In addition, when the substance is released in combination with the substances hexanoic acid, 2-ethyl-, ethenyl ester, neononanoic acid, ethenyl ester, and propanoic acid, 2,2-dimethyl-, ethenyl ester, the quotient from the formula referenced in this section shall not exceed the average of the quotient applicable to the other substances weighted by the proportion of each substance present in the total daily amount released. <PRTPAGE P="452"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. Manufacturers, importers, and processors of the substance must document that the PMN substance has been incorporated into a polymer matrix with the level of residual monomer below 0.1 percent if this section does not apply as described in paragraph (a)(1) of this section. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51703, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4250</SECTNO> <SUBJECT>Hexanoic acid, 2-ethyl-, ethenyl ester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hexanoic acid, 2-ethyl-, ethenyl ester (PMN P-91-826) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply once the substance has been incorporated into a polymer matrix with the level of residual monomer below 0.1 percent. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i) (There must be no permeation of the substance greater than 0.02 µg/min · cm <SU>2</SU> after 8 hours of testing in accordance with the most current version of the American Society for Testing and Materials (ASTM) F739 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases.” For conditions of exposure which are intermittent, gloves may be tested in accordance with the most current version of ASTM F1383 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases Under Conditions of Intermittent Contact,” provided the contact time in testing is greater than or equal to the expected duration of dermal contact, and the purge time used in testing is less than or equal to the expected duration of noncontact during the intermittent cycle of dermal exposure in the workplace. If ASTM F1383 is used for testing, manufacturers, importers, and processors must submit to the Agency a description of worker activities involving the substance which includes daily frequencies and durations of potential worker exposures. The results of all glove permeation testing must be reported in accordance with the most current version of ASTM F1194 “Guide for Documenting the Results of Chemical Permeation Testing of Protective Clothing Materials.” Manufacturers, importers, and processors must submit all test data to the Agency and must receive written Agency approval for each type of glove tested prior to use of such gloves. The following gloves have been tested in accordance with the ASTM F739 method and found by EPA to satisfy the requirements for continuous use: North/F101/Vitron gloves, 0.03 cm thick; and Ansell/Edmont/4H/PE/EVOH/PE Laminate gloves, 0.006 cm thick.(Gloves may not be used for a time period longer than they are actually tested and must be replaced at the end of each work shift.), (a)(2)(ii) (With the exception of laboratory activities, full body chemical protective clothing is required for any worker activity in which the substance is reasonably likely to contact the worker in the following state(s): Open liquid pool or solid of greater than 5 kg; liquid spray or splash; mist; aerosol dust; or any worker activity which have potential for contact with the PMN chemical for more than 10 min/h. At a minimum, a chemical protective apron is required for any worker activity with potential for contact with the PMN chemical which is not covered by this paragraph), (a)(2)(iii), (a)(3), (a)(4), (a)(5)(iii) (if cartridge service life testing is not available), (a)(5)(xii) or (a)(5)(xiii) (if data on cartridge service life testing has been reviewed and approved in writing by EPA), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), and (a)(6)(v). As an alternative to the respiratory requirements in this section, <PRTPAGE P="453"/> manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (h)(1)(vi) (The following additional statements shall appear on each label required by this paragraph: The health effects of this material have not been fully determined but are currently being tested. EPA is concerned however, that this material may have serious chronic health and environmental effects. When using this material, use eye and skin protection, which includes gloves which have been determined to be impervious to this substance. Use respiratory protection, unless workplace airborne concentrations are maintained at or below an 8-h time weighted average (TWA) of 1 ppm, when there is a likelihood of exposure in the work area from dust, mist, smoke or vapors.), (h)(2)(ii)(F), (h)(2)(ii)(G), (h)(2)(ii)(I), (h)(2)(iii)(A), (h)(2)(iii)(B), (h)(2)(iii)(C), (h)(2)(iii)(E), (h)(2)(iv)(A), (h)(2)(iv)(B). The following additional statements shall appear on each SDS required by this paragraph: This substance may cause moderate skin irritation. This substance may cause neurotoxicity. When using this substance, use respiratory protection, unless workplace airborne concentrations are maintained at or below an 8-h TWA of 1 ppm. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 7 ppb). When calculating the surface water concentrations according to the instructions in § 721.91(a)(4), the statement that the amount of the substance that will be released will be calculated before the substance enters control technology does not apply. Instead, if the waste stream containing the substance will be treated before release, then the amount of the substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 75 percent removal efficiency may be attributed to such treatment. In addition, when the substance is released in combination with the substances hexanedioic acid, diethenyl ester, neononanoic acid, ethenyl ester, and propanoic acid, 2,2-dimethyl-, ethenyl ester, the quotient from the formula referenced in this section shall not exceed the average of the quotient applicable to the other substances weighted by the proportion of each substance present in the total daily amount released. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. Manufacturers, importers, and processors of the substance must document that the substance has been incorporated into a polymer matrix with the level of residual monomer below 0.1 percent if this section does not apply as described in paragraph (a)(1) of this section. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51704, Oct. 4, 1993, as amended at 58 FR 68311, Dec. 27, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4255</SECTNO> <SUBJECT>1,4,7,10,13,16-Hexaoxacyclooctadecane, 2-[(2-propenyl oxy)methyl]-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance 1,4,7,10,13,16-hexaoxacyclooctadecane, 2-[(2-propenyloxy)methyl]- (PMN P-93-1208, CAS no. 84812-04-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (ii) [Reserved] <PRTPAGE P="454"/> </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27484, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4257</SECTNO> <SUBJECT>Hydrazine, (2-fluorophenyl).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hydrazine, (2-fluorophenyl) (PMN P-95-2101; CAS No. 2368-80-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4258</SECTNO> <SUBJECT>Substituted naphthalene hydrazide (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted naphthalene hydrazide (PMN P-01-69) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirement as specified § 721.90(a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 70177, Dec. 17, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4259</SECTNO> <SUBJECT>Aliphatic polyisocyanate homopolymer.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an aliphatic polyisocyanate homopolymer (PMN P-96-1239) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4260</SECTNO> <SUBJECT>Hydrazine, [4-(1-methyl­bu­toxy)phenyl]-, monohydrochloride.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hydrazine, [4-(1-methylbutoxy)phenyl]-, monohydrochloride (PMN P-90-558; CAS number 124993-63-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). <PRTPAGE P="455"/> </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5). In addition, the following human health hazard statement shall appear on each label and SDS required by this section: This substance may cause eye irritation. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (p) (production limit set at 15,500 kg). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Modification or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 44066, Sept. 23, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4265</SECTNO> <SUBJECT> Hydrazinecarboxamide, <E T="7462">N</E> -(3,5-difluorophenyl-). </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hydrazinecarboxamide, <E T="03">N</E> -(3,5-difluorophenyl-) (PMN P-97-649; CAS No. 167412-23-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) (applies only when the substance is in a solution), (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the NCEL provisions listed in the TSCA section 5(e) consent order for this substance. The NCEL is set at 0.4 mg/m <SU>3</SU> . </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(iii), (g)(1)(iv), (g)(1)(v), (g)(1)(vii), (g)(1)(ix), (g)(2)(i) (applies only when the substance is in a solvent), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v) (applies only when the substance is in a solvent), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 370, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4270</SECTNO> <SUBJECT>Nitrophenoxylalkanoic acid substituted thiazino hydrazide (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance nitrophenoxylalkanoic acid substituted thiazino hydrazide (PMN P-88-270) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(vii), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b), (c), (d), (e) (concentration set at 1.0 percent), (f) and (g)(1)(iv) (also acute toxicity), (g)(2)(i) through (g)(2)(v), (g)(4)(i) and (g)(5). The provision of § 721.72(d) requiring that employees to be provided with information on the location and availability of a written hazard communication program does not apply when the written program is not required under § 721.72(a). <PRTPAGE P="456"/> </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g) (industrial intermediates only). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1) and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 32415, Aug. 9, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4280</SECTNO> <SUBJECT>Substituted hydrazine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted hydrazine (PMN P-90-594) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2), (g)(3), (g)(4)(i), (g)(4)(iii), and (g)(5). In addition, the human health hazard statement shall include mutagenicity. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), and (c)(1). </P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 40213, Aug. 13, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4300</SECTNO> <SUBJECT> Hydrazinecarboxamide, <E T="7462">N,N′</E> -1,6-hexanediylbis [2,2-dimethyl-]. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hydrazinecarboxamide, <E T="03">N,N′</E> -1,6-hex­ane­diyl­bis [2,2-dimethyl- (P-87-1192)] is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P>(ii) Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set a 0.1 percent), (f), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(3), and (g)(5).</P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (k) (any application which, if there are releases to water or discharges to land, will not result in releases to facilities with a National Pollutant Discharge Elimination System permit), and (l). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (b)(4), (c)(4), (where N = 30). </P> <P>(A) Selling or transferring the substance to any person for use where the substance is released to surface waters without notifying in writing the parties listed in subparagraph (B) of the identities of all such persons. Such notification shall be sent within 15 days of the date of the first sale or transfer and shall contain the following information:</P> <P> ( <E T="03">1</E> ) The name and address (including shipment destination address, if different) of the person to whom the substance is sold or transferred. <PRTPAGE P="457"/> </P> <P> ( <E T="03">2</E> ) The date on which sale or transfer commenced. </P> <P> ( <E T="03">3</E> ) The chemical identity of the substance. </P> <P> ( <E T="03">4</E> ) The name of the stream or river into which the specific buyer or transferee is expected to discharge the substance. </P> <P> ( <E T="03">5</E> ) Notification that the substance is subject to a Significant New Use Rule issued under section 5 of the Toxic Substances Control Act. </P> <P> ( <E T="03">6</E> ) A summary of the water release restrictions contained in paragraph (a)(iv) of this section. </P> <P> ( <E T="03">7</E> ) A request that the party notify the following office of any information which indicates that the in-stream concentration of the PMN substance specified in paragraph (a)(iv) of this section has been exceeded: Chief, New Chemicals Branch, Chemical Control Division (7405), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room E-447, 1200 Pennsylvania Ave., NW., Washington, DC 20460. </P> <P>(B) The parties to be notified are as follows.</P> <P> ( <E T="03">1</E> ) The Director, Water Management Division (or, in the case of Regions 5 and 10, Water Division) at the headquarters of the EPA region in which the specific buyer or transferee is located. </P> <P> ( <E T="03">2</E> ) The Agency, Department, or Office of the State or U.S. Territory with jurisdiction over point source water discharges in the State or Territory in which the specific buyer or transferee is located (EPA is available for consultation regarding the identity and address of the appropriate Agency, etc.) </P> <P> ( <E T="03">3</E> ) The Publicly Owned Treatment Works (POTW) authority, if any, expected to receive the discharge of the PMN substance from the specific buyer or transferee. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), (i), and records documenting notification to parties identified in § 721.90. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 15792, Apr. 17, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4320</SECTNO> <SUBJECT> Hydrazinecarboxamide, <E T="7462">N,N′</E> -(methylenedi-4,1-phenylene)bis [2,2-dimethyl-. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance hydrazinecarboxamide, <E T="03">N,N′</E> -(methylenedi-4,1-phenylene)bis[2,2-dimethyl- (PMN P-88-522) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(viii) through (a)(5)(xiv), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv) (and blood effects), (g)(1)(vii), (g)(2)(iv), (g)(2)(v), (g)(4)(iii), and (g)(5). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f) and (l). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (b)(1) and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable <PRTPAGE P="458"/> to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), (f), (g), (h), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 46773, Nov. 6, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4340</SECTNO> <SUBJECT>Substituted thiazino hydrazine salt (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance substituted thiazino hydrazine salt (PMN P-88-63) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii) through (a)(5)(vii), and (a)(6)(i), (b) [concentration set at 0.1 percent], and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) [concentration set at 0.1 percent], (f), and (g)(1)(iv) and (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v), (g)(4)(i), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (l). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1) and (a)(2) and (b)(1) and (b)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 26112, June 26, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4360</SECTNO> <SUBJECT>Certain hydrogen containing chlorofluorocarbons.</SUBJECT> <P>(a) Chemical substances and significant new uses subject to reporting.</P> <P>(1) The chemical substances ethane, 2-chloro-1,1,1-trifluoro- (CAS Number 75-88-7) and ethane, 1,2-dichloro-1,1-difluoro- (CAS Number 1649-08-7) are subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section.</P> <P>(2) The significant new use is: Use other than as an intermediate.</P> <P>(b) [Reserved]</P> <CITA>[55 FR 35632, Aug. 31, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4365</SECTNO> <SUBJECT>Substituted ethoxylated hydrocarbon (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as Substituted ethoxylated hydrocarbon (PMN P-99-0313) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified § 721.90 (a)(4), (b)(4), and (c)(4) (N = 1 ppb). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 81400, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4380</SECTNO> <SUBJECT>Modified hydrocarbon resin.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a modified hydrocarbon resin (P-91-1418) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="459"/> </P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive this substance from the employer, or who have received the substance from the employer within 5 years from the date the employer becomes aware of the information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44067, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4385</SECTNO> <SUBJECT>Hydrofluoric acid, reaction products with heptane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a hydrofluoric acid, reaction products with heptane (PMN P-98-1036; CAS No. 207409-71-0) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 370, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4390</SECTNO> <SUBJECT>Trisubstituted hydroquinone diester.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as trisubstituted hydroquinone diester (PMN No. P-92-329) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(i), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4) (where N = 30 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (j), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions <PRTPAGE P="460"/> of § 721.185 apply to this significant new use rule. </P> <CITA>[58 FR 32239, June 8, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4420</SECTNO> <SUBJECT>Substituted hydroxylamine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted hydroxylamine (PMN P-84-492) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communicatiom program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), and (g)(2)(i) through (g)(2)(iii). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a), and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an SDS does not apply when an SDS is not required under § 721.72(c). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4) (chemically treated liquid wastes must contain no more than 10 ppm of the substance prior to discharge), (b)(4) (chemically treated liquid wastes must contain no more than 10 ppm of the substance prior to discharge), and (c)(4) (chemically treated liquid wastes must contain no more than 10 ppm of the substance prior to discharge). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), (f), and (j). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[55 FR 46773, Nov. 6, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4460</SECTNO> <SUBJECT>Amidinothiopropionic acid hydrochloride.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as amidinothiopropionic acid hydrochloride (PMN P-91-102) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46466, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4461</SECTNO> <SUBJECT>Hydrofluoric acid, reaction products with octane (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydrofluoric acid, reaction products with octane (PMN P-99-0052) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. <PRTPAGE P="461"/> </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 81400, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4462</SECTNO> <SUBJECT>Hydrochlorofluorocarbon.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydrochlorofluorocarbon (PMN P-95-1317) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4463</SECTNO> <SUBJECT>Hydrochlorofluorocarbon.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydrochlorofluorocarbon (PMN P-94-1453) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45082, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4464</SECTNO> <SUBJECT>Mixture of hydrofluoro alkanes and hydrofluoro alkene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as a mixture of hydrofluoro alkanes and hydrofluoro alkene (PMNs P-96-945/946/947/948) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements specified as in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4465</SECTNO> <SUBJECT>Hydrofluoroalkane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a hydrofluoroalkane (PMN P-96-1288) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) <PRTPAGE P="462"/> and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3428, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4467</SECTNO> <SUBJECT>Quaternary ammonium hydroxide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a quaternary ammonium hydroxide (PMN P-95-1806) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3429, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4468</SECTNO> <SUBJECT>1H-Imidazole, 2-ethyl-4,5-dihydro-4-methyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 1H-imidazole, 2-ethyl-4,5-dihydro-4-methyl- (PMN P-97-217; CAS No. 931-35-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 40). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3429, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4469</SECTNO> <SUBJECT>Imidazolethione.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an imidazolethione (PMNs P-91-1131 and P-90-564) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. Formulations or mixtures containing the PMN substance in concentrations at or below 10 percent by weight or volume are exempt from the provisions of this rule. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(ix), (g)(2)(i), (g)(2)(v), and (g)(5). The label and SDS as required by this paragraph shall also include the following statements: This substance may cause thyroid cancer. This substance may cause thyroid effects. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), and (h) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3429, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4470</SECTNO> <SUBJECT>2,4-Imidazolidinedione, bromochloro-5,5-dimethyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance 2,4- <PRTPAGE P="463"/> imidazolidinedione, bromochloro-5,5-dimethyl- (PMN P-94-34) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(3), (w)(3), and (x)(3). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 10 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11043, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4472</SECTNO> <SUBJECT>Phenyl, alkyl, hydroxyalkyl substituted imidazole (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as phenyl, alkyl, hydroxyalkyl substituted imidazole (PMNs P-98-843 and P-86-65) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), and (g)(1)(iii). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(r) (56,000 kg) (acute oral study (OPPTS 870.1100 test guideline) followed by a (90-day subchronic inhalation study in rats (40 CFR 799.9346). A person may not manufacture or import the substance beyond the aggregate production volume limit, unless that person conducts this study on the substance and submits all final reports and underlying data in accordance with the procedures and criteria specified in paragraphs (a)(2)(iii)(A), (a)(2)(iii)(B), (a)(2)(iii)(C), and (a)(2)(iii)(D) of this section. </P> <P> (A) Each study required to be performed pursuant to this section must be scientifically valid. <E T="03">Scientifically valid</E> means that the study was conducted according to: </P> <P> ( <E T="03">1</E> ) The test guidelines specified in paragraph (a)(2)(iii) of this section. </P> <P> ( <E T="03">2</E> ) An EPA-approved protocol. </P> <P> ( <E T="03">3</E> ) TSCA Good Laboratory Practice Standards at 40 CFR part 792. </P> <P> ( <E T="03">4</E> ) Using methodologies generally accepted at the time the study is initiated. </P> <P> ( <E T="03">5</E> ) Any deviation from these requirements must be approved in writing by EPA. </P> <P>(B) Before starting to conduct any of the studies in paragraph (a)(2)(iii) of this section, the person must obtain approval of test protocols from EPA by submitting written protocols. EPA will respond to the person within 4 weeks of receiving the written protocols. Published test guidelines specified in paragraph (a)(2)(iii) of this section (e.g., 40 CFR part 797 or part 798) provide general guidance for development of test protocols, but are not themselves acceptable protocols.</P> <P>(C) The person shall:</P> <P> ( <E T="03">1</E> ) Conduct each study in good faith with due care. </P> <P> ( <E T="03">2</E> ) Promptly furnish to EPA the results of any interim phase of each study. </P> <P> ( <E T="03">3</E> ) Submit, in triplicate (with an additional sanitized copy, if confidential business information is involved), the final report of each study and all underlying data (“the report and data”) to EPA no later than 14 weeks prior to exceeding the applicable production volume limit. The final report shall contain the contents specified in 40 CFR 792.185. </P> <P> (D)( <E T="03">1</E> ) Except as described in paragraph (a)(2)(iii)(D)( <E T="03">2</E> ), if, within 6 weeks of EPA's receipt of a test report and data, the person receives written notice that EPA finds that the data generated by a study are scientifically invalid, the person is prohibited from further manufacture and import of the PMN substance beyond the applicable production volume limit. <PRTPAGE P="464"/> </P> <P> ( <E T="03">2</E> ) The person may continue to manufacture and import the PMN substance beyond the applicable production limit only if so notified, in writing, by EPA in response to the person's compliance with either of the following paragraphs (a)(2)(iii)(D)( <E T="03">2</E> )( <E T="03">i</E> ) or (a)(2)(iii)(D)( <E T="03">2</E> )( <E T="03">ii</E> ) of this section. </P> <P> ( <E T="03">i</E> ) The person may reconduct the study. If there is sufficient time to reconduct the study and submit the report and data to EPA at least 14 weeks before exceeding the production limit as required by paragraph (a)(2)(iii)(C)( <E T="03">3</E> ) of this section, the person shall comply with paragraph (a)(2)(iii)(C)( <E T="03">3</E> ) of this section. If there is insufficient time for the person to comply with paragraph (a)(2)(iii)(C)( <E T="03">3</E> ) of this section, the person may exceed the production limit and shall submit the report and data in triplicate to EPA within a reasonable period of time, all as specified by EPA in the notice described in paragraph (a)(2)(iii)(D)( <E T="03">1</E> ) of this section. EPA will respond to the person in writing, within 6 weeks of receiving the person's report and data. </P> <P> ( <E T="03">ii</E> ) The person may, within 4 weeks of receiving from EPA the notice described in paragraph (a)(2)(iii)(D)( <E T="03">1</E> ) of this section, submit to EPA a written report refuting EPA's finding. EPA will respond to the person in writing, within 4 weeks of receiving the person's report. </P> <P>(E) The person is not required to conduct a study specified in paragraph (a)(2)(iii) of this section if notified in writing by EPA that it is unnecessary to conduct that study.</P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 370, Jan. 5, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4473</SECTNO> <SUBJECT>Dialkylamidoimidazoline.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as dialkylamidoimidazoline (PMN P-94-1864) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 45082, Aug. 30, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4476</SECTNO> <SUBJECT>Substituted imines.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as substituted imines (PMNs P-95-1557/1558) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3429, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <PRTPAGE P="465"/> <SECTNO>§ 721.4480</SECTNO> <SUBJECT>2-Imino-1,3-thiazin-4-one-5,6-dihydromonohydrochloride.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 2-imino-1,3-thiazin-4-one-5,6-dihydromonohydrochloride (PMN P-91-101) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (f), (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), and (x)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46466, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4484</SECTNO> <SUBJECT>Halogenated indane (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a halogenated indane (PMN P-94-351) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to P-94-351 after incorporation into a plastic, resin matrix, or pelletized so humans are not reasonally likely to be exposed. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements during manufacture as specified in § 721.63 (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements during manufacture as specified in § 721.72 (a), (b), (c), (d), (e), (f), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[61 FR 63737, Dec. 2, 1996, as amended at 62 FR 27694, May 21, 1997]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4486</SECTNO> <SUBJECT>Propanoic acid, 2-methyl-, (1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester, rel-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as propanoic acid, 2-methyl-, (1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester, rel- (PMNs P-98-0497 and P-98-0509; CAS No. 85586-67-0) are subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (15,000 kg/yr). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15084, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4490</SECTNO> <SUBJECT>Capped aliphatic isocyanate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The <PRTPAGE P="466"/> chemical substance identified generically as a capped aliphatic isocyanate (PMN P-86-1146) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(xi), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (d), (e) (concentration set at 0.1 percent), (f), (h)(1)(ii)(G), (h)(1)(iii)(A), (h)(1)(iii)(B), (h)(1)(iii)(D), and (h)(1)(iii)(E). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). </P> <P> (iv) <E T="03">Disposal.</E> Requirements as specified in § 721.90 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b) through (g), (i), and (j) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51685, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4494</SECTNO> <SUBJECT>Polycyclic isocyanate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as a polycyclic isocyanate (PMN P-94-437) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(ii), (a)(6)(iii), (a)(6)(iv), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 1.0%), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(i), and (g)(5). In addition the following human health and environmental hazard and precautionary statements shall appear on each label as specified in paragraph (b) of this section and the SDS as specified in paragraph (c) of this section: This substance may cause skin sensitization. This substance may cause pulmonary sensitization. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[61 FR 63737, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4497</SECTNO> <SUBJECT>Aliphatic polyisocyanates (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as aliphatic polyisocyanates (P-91-1210 and P-92-714) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. Non-spray uses are exempt from the provisions of this rule. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(iii), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(viii), (a)(5)(ix), (a)(5)(x), (a)(5)(xi), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). Manufacturers, importers, and processors who implement the product stewardship provisions of the <PRTPAGE P="467"/> section 5(e) consent order for these substances are exempt from the requirements of §§ 721.63 and 721.72. </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (h) are applicable to manufacturers, importers, and processors of this substance. Manufacturers, importers, and processors who implement the product stewardship provisions or keep records as required by the section 5(e) consent order for these substances are exempt from the requirements of § 721.125. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Applicability of § 721.5.</E> The provisions of § 721.5 do not apply to manufacturers, importers, and processors, implementing the product stewardship provisions in the section 5(e) consent order for these substances. </P> <CITA>[61 FR 63737, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4500</SECTNO> <SUBJECT>Isopropylamine distillation residues and ethylamine distillation residues.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new use subject to reporting.</E> (1) The following chemical substances referred to by their Chemical Abstracts Service (CAS) register numbers and chemical names are subject to reporting under this section for the significant new use identified in paragraph (a)(2) of this section: CAS No. 79771-08-7, isopropylamine distillation residues, and CAS No. 79771-09-98, ethylamine distillation residues. </P> <P>(2) The significant new use is use in metalworking fluids.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Notice Requirements and Procedures.</E> Section 721.10 applies to this section, except persons submitting a notice must complete only Parts I and III of the notice form. </P> <P>(2) [Reserved]</P> <SECAUTH>(Sec. 5, Pub. L. 94-469, 90 Stat. 2012 (15 U.S.C. 2604))</SECAUTH> <CITA>[49 FR 46378, Nov. 26, 1984. Redesignated at 51 FR 23539, June 30, 1986, and 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4520</SECTNO> <SUBJECT>Isopropylidene, bis(1,1-dimethylpropyl) derivative.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as isopropylidene, bis(1,1-dimethylpropyl) derivative (PMN P-85-648) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3) (applies to gloves only), (b) (concentration set at 0.1 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(ii), (b)(2)(ii), and (c)(2)(ii). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44067, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4550</SECTNO> <SUBJECT>Diperoxy ketal.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The <PRTPAGE P="468"/> chemical substance identified generically as diperoxy ketal (PMN-92-1394) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51705, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4565</SECTNO> <SUBJECT>Modified hydroxystyrene homopolymer (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as Modified hydroxystyrene homopolymer (PMN P-99-0610) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81401, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4568</SECTNO> <SUBJECT>Methylpolychloro aliphatic ketone.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as methylpolychloro aliphatic ketone (PMN No. P-91-1321) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3), (a)(6)(ii), (a)(6)(iii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). The employer is able to demonstrate that the gloves selected for handling P-91-1321 provide an impervious barrier to prevent dermal exposure during normal and expected duration and conditions of exposure within the work area by testing the material used to make the gloves and the construction of the gloves to establish that they will be impervious for the expected duration and conditions of exposure. The testing must subject the gloves to the expected conditions of exposure, including the likely combinations of chemical substances to which the gloves may be exposed in the work area. There must be no permeation of P-91-1321 greater than 0.017 mg/cm <SU>2</SU> /min after 8 h of testing in accordance with the most recent versions of the American Society for Testing and Materials (ASTM) F739 “Standard Test Method for Resistance of Protective Clothing Materials to Permeation by Liquids or Gases” and ASTM F1194 “Guide for Documenting the Results of Chemical Permeation Testing of Protective Clothing Materials.” The employer must submit all test data to the Agency and must receive written Agency approval of the test results for each type of glove tested prior to use of such gloves. Neoprene gloves with a minimum thickness of 1.50 mm have already been tested and found to satisfy the terms of this rule. <PRTPAGE P="469"/> Nitrile gloves with a minimum thickness of 0.61 mm also satisfy the terms of this rule, as long as the duration of exposure to P-91-1321 is less than 2 h per work shift. If the duration of exposure is longer than 2 h, nitrile gloves shall be discarded and replaced every 2 h. Unless otherwise indicated, gloves contaminated with P-91-1321 shall be disposed of after every work shift. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(v), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (g) and (q). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(1), (b)(1), (c)(1). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (d) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 32239, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4575</SECTNO> <SUBJECT> L-aspartic acid, <E T="7462">N,N′</E> - [(1E) - 1,2 - ethenediylbis[(3-sulfo-4, 1-phenylene)imino [6-(phenylamino)-1,3,5-triazine- 4,2- diyl]]]bis-, hexasodium salt. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as l-aspartic acid, <E T="03">N,N′</E> - [(1E) - 1,2 - ethenediylbis[(3-sulfo-4, 1-phenylene) imino[6-(phenylamino)-1,3,5-triazine-4,2-diyl]]]bis-, hexasodium salt (PMN P-99-1167; CAS No. 205764-98-3) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), (x)(1), and (f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15085, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4585</SECTNO> <SUBJECT>Lecithins, phospholipase A2-hydrolyzed.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified generically as lecithins, phospholipase A2-hydrolyzed (PMN P-93-333) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(i), and (g)(3)(ii). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 10 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[59 FR 27484, May 27, 1994]</CITA> </SECTION> <SECTION> <PRTPAGE P="470"/> <SECTNO>§ 721.4587</SECTNO> <SUBJECT>Lithium manganese oxide (LiMn204) (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as lithium manganese oxide (LiMn204) (P-96-175) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of these substances without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the section 5(e) consent order for these substances, the employer becomes aware that these substances may present a risk of injury to human health or the environment the employer must incorporate this new information, and any information on methods for protecting against such risk, into a Safety Data Sheet (SDS) as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If these substances are not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substances are reintroduced into the workplace.</P> <P>(B) The employer must ensure that persons who will receive, or who have received their substances from the employer within 5 years from the date the employer becomes aware of the new information described in paragraph (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of these substances. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[61 FR 63738, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4589</SECTNO> <SUBJECT>Propanedioic acid, [(4-methoxyphenyl)methylene]-, bis(1,2,2,6,6-pentamethyl-4-piperdinyl) ester (9CI).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as propanedioic acid, [(4-methoxyphenyl)methylene]-, bis(1,2,2,6,6-pentamethyl-4-piperdinyl) ester (9CI) (PMN P-95-1411; CAS No. 147783-69-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[63 FR 3429, Jan. 22, 1998, as amended at 67 FR 12882, Mar. 20, 2002]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4590</SECTNO> <SUBJECT>Mannich-based adduct.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as a Mannich-based adduct (PMN P-93-66) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h). <PRTPAGE P="471"/> </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 8 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[58 FR 51705, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4594</SECTNO> <SUBJECT>Substituted azo metal complex dye.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted azo metal complex dye (PMN P-94-499) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11044, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4596</SECTNO> <SUBJECT>Diazo substituted carbomonocyclic metal complex.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a diazo substituted carbomonocyclic metal complex (PMN P-94-1039) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[60 FR 11044, Mar. 1, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4600</SECTNO> <SUBJECT>Recovered metal hydroxide.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a recovered metal hydroxide (PMN P-91-809) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows: </P> <P>(A) If as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to the environment, the employer must incorporate this new information, and any information on methods for protecting against such risk, into an SDS as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace.</P> <P> (B) The employer must ensure that persons who will receive this substance from the employer, or who have received this substance from the employer within 5 years from the date the employer becomes aware of the new information described under paragraph <PRTPAGE P="472"/> (a)(2)(i)(A) of this section, are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[57 FR 44067, Sept. 23, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4610</SECTNO> <SUBJECT>Mixed metal oxides (generic).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as mixed metal oxides (PMN P-98-0002) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements listed here, a manufacturer, importer, or processor may choose to follow the NCEL provisions listed in the TSCA 5(e) consent order for this substance. The NCEL is 0.05 mg/m <SU>3</SU> as an 8-hour time weighted average verified by actual monitoring data. </P> <P>(ii) Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f) (g)(1)(ii), (g)(1)(vii), (g)(2)(ii), (g)(2)(iii), and (g)(2)(iv).</P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[65 FR 81401, Dec. 26, 2000]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4620</SECTNO> <SUBJECT>Zinc, bis(N,N-dipropyl-.beta.-alaninato-.kappa.N,.kappa.O)-, (T-4)-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as zinc, bis(N,N-dipropyl-.beta.-alaninato-.kappa.N,.kappa.O)-, (T-4)- (PMN P-90-274; CAS No. 135364-47-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> A significant new use of this substance is any manner or method of manufacture, import, or processing associated with any use of this substance without providing risk notification as follows. (A) If, as a result of the test data required under the section 5(e) consent order for this substance, the employer becomes aware that this substance may present a risk of injury to human health, the employer must incorporate this new information, and any information on methods for protecting against such risk, into a Safety Data Sheet (SDS) as described in § 721.72(c) within 90 days from the time the employer becomes aware of the new information. If this substance is not being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to an SDS before the substance is reintroduced into the workplace. <PRTPAGE P="473"/> </P> <P>(B) The employer must ensure that persons who have received, or will receive, this substance from the employer are provided an SDS as described in § 721.72(c) containing the information required under paragraph (a)(2)(i)(A) of this section within 90 days from the time the employer becomes aware of the new information.</P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (production limit set at 573,300 kg). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (c), (h), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 15789, Apr. 17, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993; 79 FR 34637, June 18, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4660</SECTNO> <SUBJECT>Alcohol, alkali metal salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as alcohol, alkali metal salt (PMN P-91-151) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 5 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), and (k). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 40213, Aug. 13, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4663</SECTNO> <SUBJECT>Fluorinated carboxylic acid alkali metal salts.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substances identified as fluorinated carboxylic acid alkali metal salts (PMNs P-95-979/980/981) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80 (v)(2), (w)(2), and (x)(2). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4), (N = 100 ppb for P-95-979), (N = 30 ppb for P-95-980), and (N = 3 ppb for P-95-981). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63738, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4668</SECTNO> <SUBJECT>Hydrated alkaline earth metal salts of metalloid oxyanions.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as hydrated alkaline earth metal salts of metalloid oxyanions (PMN P-94-1557) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(5)(viii), (a)(6)(i), (b), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e), (f), (g)(1)(vi), (g)(1)(ix), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5). <PRTPAGE P="474"/> </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[61 FR 63738, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4685</SECTNO> <SUBJECT>Substituted purine metal salt (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted purine metal salt (PMN P-95-175) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 8) </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[61 FR 63739, Dec. 2, 1996]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4700</SECTNO> <SUBJECT>Metalated alkylphenol copolymer (generic name).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance metalated alkylphenol copolymer (PMN P-87-723) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(1)(i)(C), (b)(1)(ii), (b)(1)(iii), (b)(1)(iv), (b)(2), (c)(1), (f), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j) (industrial coating material). </P> <P> (iii) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (a)(3), (b)(1), (b)(3), (c)(1), and (c)(3). </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(3), (b)(3), and (c)(3). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The recordkeeping requirements as specified in § 721.125 (a) through (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[55 FR 32416, Aug. 9, 1990, as amended at 57 FR 20424, May 13, 1992. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4720</SECTNO> <SUBJECT>Disubstituted phenoxazine, chlorometalate salt.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as disubstituted phenoxazine, chlorometalate salt (PMN P-90-0002) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), <PRTPAGE P="475"/> (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46467, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4740</SECTNO> <SUBJECT>Alkali metal nitrites.</SUBJECT> <P> (a) <E T="03">Chemical substances and significant new use subject to reporting.</E> (1) The category of chemical substances which are nitrites of the alkali metals (Group IA in the periodic classification of chemical elements) lithium, sodium, potassium, rubidium, cesium, and francium, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Use as an ingredient in metalworking fluids (as defined in 40 CFR 721.3) containing amines.</P> <P>(b) [Reserved]</P> <CITA>[58 FR 27944, May 12, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4792</SECTNO> <SUBJECT> 2-propenoic acid, 2-methyl-, C <E T="9145">11-14</E> -isoalkyl esters, C <E T="9145">13</E> -rich. </SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 2-propenoic acid, 2-methyl-, C <E T="52">11-14</E> -isoalkyl esters, C <E T="52">13</E> -rich (PMN P-99-1189; CAS No. 85736-97-6) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j) (a monomer for casting automotive parts adhesives or impregnation fluid). </P> <P> (ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90(c)(4) (N = 1 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[68 FR 15085, Mar. 28, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4794</SECTNO> <SUBJECT>Polypiperidinol-acrylate methacrylate.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as polypiperidinol-acrylate methacrylate (PMN P-88-1304) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set 1.0 percent), (f), (g)(1)(vi), (g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v). The following additional statement shall appear on each label and SDS required by this paragraph: This substance may cause acute and chronic toxicity. </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[59 FR 27484, May 27, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4820</SECTNO> <SUBJECT>Methane, bromodifluoro-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as methane, bromodifluoro- is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P> (2) The significant new uses are: <PRTPAGE P="476"/> </P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(v), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(ii), (g)(2)(iii), and (g)(5). In addition, the following statements shall appear on the label and SDS: This substance may cause cardiotoxicity. Evacuate area before the concentration of this substance in the area reaches 1 percent. Residential use is prohibited due to cardiotoxic dangers. General consumer use is prohibited, with the exception of outdoor automotive use and outdoor marine use. Following discharge and evacuation, use protective gear (self-contained breathing apparatus) before reentering an area in which the airborne concentration of the PMN substance exceeds 1 percent. </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k) (Use in portable fire extinguishers intended for consumer use except for outdoor automotive use and outdoor marine use; use in fire extinguisher units with an Underwriters Laboratory (UL) rating of less than 5BC; use in other than rechargeable fire extinguisher units; use in occupied areas from which personnel cannot be evacuated before the concentration of the PMN substance exceeds 1 percent or egress cannot occur within 30 seconds; or use without protective gear (self-contained breathing apparatus) being made available in the event that, following discharge of the PMN substance and evacuation of the area, personnel must reenter an area in which the airborne concentration of the PMN substance exceeds 1 percent.) </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (f) through (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[56 FR 19238, Apr. 25, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993; 59 FR 39296, Aug. 2, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4840</SECTNO> <SUBJECT>Substituted tri­phenyl­meth­ane.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted triphenylmethane (PMN P-87-1553) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), (x)(1) and (y)(2). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), and (i). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 40216, Aug. 13, 1991. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4880</SECTNO> <SUBJECT>Methanol, trichloro-, carbonate (2:1).</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as methanol, trichloro-, carbonate (2:1) (CAS No. 32315-10-9) (PMN P-90-1535) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(ii), (g)(1)(iii), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(5). The following additional human hazard precautionary statement shall appear on the label: <PRTPAGE P="477"/> This substance may react to form phosgene gas. When using this substance, handle with extreme caution. </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (f), (g), and (h). </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule. </P> <CITA>[56 FR 40213, Aug. 13, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4885</SECTNO> <SUBJECT>Methanone, [5-[[3-(2H-benzotriazol-2-yl)-2-hydroxy-5-(1,1,3,3-tetramethylbutyl)phenyl]methyl]-2-hydroxy-4-(octyloxy) phenyl]phenyl-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as methanone, [5-[[3-(2H-benzotriazol-2-yl)-2-hydroxy-5-(1,1,3,3-tetramethylbutyl)phenyl]methyl]-2-hydroxy-4-(octyloxy)phenyl]phenyl- (PMN P-96-942; CAS No.162245-07-0) is subject to the reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(ii), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (b) (concentration set at 1.0 percent), and (c). As an alternative to the respiratory protection requirements of this section, manufacturers, importers, and processors of this substance may follow the terms of the new chemical exposure limits section in the TSCA section 5(e) consent order for this substance. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(vi), (g)(1)(viii), (g)(2)(ii), (g)(2)(iv), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[63 FR 3430, Jan. 22, 1998]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.4925</SECTNO> <SUBJECT>Methyl n-butyl ketone.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance methyl n-butyl ketone, CAS Number 591-78-6, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except for § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes the substance identified in paragraph (a)(1) of this section and intends to distribute the substance in commerce must submit a significant new use notice. </P> <P>(2) [Reserved]</P> <CITA>[52 FR 11825, Apr. 13, 1987. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.5050</SECTNO> <SUBJECT>2,2′-[(1-Methyl­ethylidene)­bis[4,1-phenyl­oxy[1-(butoxy­methyl)-(2,1-ethan­ediyl]oxy­methyl­ene]]biso­xirane, reaction product with a diamine.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The <PRTPAGE P="478"/> chemical substance identified generically as 2,2′-[(1-methyl­ethyl­i­dene)­bis[4,1-phenyl­oxy[1-(bu­toxy­methyl)-(2,1-eth­ane­diyl]oxy­methyl­ene]]­biso­xirane, reaction product with a diamine (PMN P-91-934), is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1). </P> <P>(ii) [Reserved]</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[57 FR 46467, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.5075</SECTNO> <SUBJECT>Mixed methyltin mercaptoester sulfides.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as mixed methyltin mercaptoester sulfides (PMN P-92-177) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(i), (g)(1)(iii), (g)(1)(iv), (g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(3)(i), (g)(3)(ii), (g)(4)(i), and (g)(5). </P> <P> (ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q). </P> <P> (iii) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1) and (a)(2) (only in a facility permitted to landfill Resources Conservation and Recovery Act (RCRA) hazardous wastes with the landfill operated in accordance with subtitle C of RCRA). </P> <P>(iv) [Reserved]</P> <P> (v) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4) (where N = 2 ppb). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f) through (k) are applicable to manufacturers, importers, and processors of this substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <P> (3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section. </P> <CITA>[58 FR 51685, Oct. 4, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.5175</SECTNO> <SUBJECT>Mitomycin C.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance mitomycin C (CAS No. 5007-7) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. </P> <P>(2) The significant new use is: Manufacture, import, or processing of 10,000 pounds or more per year per facility for any use.</P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c). </P> <P>(2) [Reserved]</P> <CITA>[58 FR 63517, Dec. 1, 1993]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.5185</SECTNO> <SUBJECT>2-Propen-1-one, 1-(4-morpholinyl)-.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified as 2-propen-1-one, 1-(4-morpholinyl)- (PMN P-95-169; SNUN S-08-7; SNUN S-14-1; and SNUN S-17-10; CAS No. 5117-12-4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this rule do not apply to quantities of the chemical substance after it has been completely <PRTPAGE P="479"/> reacted (cured) because 2-propen-1-one, 1-(4-morpholinyl)- will no longer exist. </P> <P>(2) The significant new uses are:</P> <P> (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(1), (a)(2)(i) and (iv), (a)(3)(i) and (ii), (a)(6)(v), (b), and (c). </P> <P>(A) Safety 4/4H EVOH/PE laminate, Ansell Edmont Neoprene number 865, and Solvex Nitrile Rubber number 275 gloves have been tested in accordance with the American Society for Testing Materials (ASTM) F739 method and found by EPA to satisfy the consent orders and § 721.63(a)(2)(i) requirements for dermal protection to 100 percent PMN substance. Gloves and other dermal protection may not be used for a time period longer than they are actually tested and must be replaced at the end of each work shift. For additional dermal protection materials, a company must submit all test data to the Agency and must receive written Agency approval for each type of material tested prior to use of that material as worker dermal protection. However, for the purposes of determining the imperviousness of gloves, up to 1 year after the commencement of commercial manufacture or import, the employer may use the method described in § 721.63(a)(3)(ii), thereafter, they must use the method described in § 721.63(a)(3)(i). For purposes of § 721.63(b), the concentration is set at 1.0%.</P> <P> (B) Additional requirements for use as a monomer for stereolithography: Requirements as specified in § 721.63(a)(4) and (5), (a)(6)(v), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(4), engineering control measures ( <E T="03">e.g.,</E> enclosure or confinement of the operation, general and local ventilation) or administrative control measures ( <E T="03">e.g.,</E> workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health assigned protection factor of at least 50. </P> <P> (ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(1)(vi), (g)(2)(v), and (g)(5). </P> <P> (iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(y)(1). It is a significant new use to use the chemical substance for any use other than as a monomer for use in ultraviolet ink jet applications or stereolithography, unless the chemical substance is processed and used in an enclosed process. </P> <P> (iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 100). </P> <P> (b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph. </P> <P> (1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this chemical substance. </P> <P> (2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section. </P> <CITA>[65 FR 371, Jan. 5, 2000, as amended at 76 FR 27914, May 13, 2011; 80 FR 37165, June 30, 2015; 85 FR 68000, Oct. 27, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 721.5192</SECTNO> <SUBJECT>Substituted 1,6-dihydroxy naphthalene.</SUBJECT> <P> (a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as substituted 1,6-dihydroxy naphthalene (PMN P-87-1036) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. </P> <P>(2) The significant new uses are:</P> <P>